Dmel_gene_ID	Dmel_gene_symbol	Human_gene_HGNC_ID	Human_gene_OMIM_ID	Human_gene_symbol	DIOPT_score	OMIM_Phenotype_IDs	OMIM_Phenotype_IDs[name]
FBgn0031081	Nep3	HGNC:8918	OMIM:300550	PHEX	3	307800	307800[HYPOPHOSPHATEMIC RICKETS, X-LINKED DOMINANT; XLHR]
FBgn0031081	Nep3	HGNC:14668	OMIM:618104	MMEL1	6		
FBgn0031081	Nep3	HGNC:7154	OMIM:120520	MME	6	617017,617018	617017[CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2T; CMT2T],617018[SPINOCEREBELLAR ATAXIA 43; SCA43]
FBgn0031081	Nep3	HGNC:13275	OMIM:610145	ECE2	11		
FBgn0031081	Nep3	HGNC:3147	OMIM:605896	ECEL1	4	615065	615065[ARTHROGRYPOSIS, DISTAL, TYPE 5D; DA5D]
FBgn0031081	Nep3	HGNC:3146	OMIM:600423	ECE1	14	145500,613870	145500[HYPERTENSION, ESSENTIAL],613870[HIRSCHSPRUNG DISEASE, CARDIAC DEFECTS, AND AUTONOMIC DYSFUNCTION; HCAD]
FBgn0031081	Nep3	HGNC:6308	OMIM:613883	KEL	4	110900	110900[BLOOD GROUP--KELL SYSTEM; KEL]
FBgn0031081	Nep3	HGNC:53615		EEF1AKMT4-ECE2	5		
FBgn0031086	fd19B	HGNC:3735	OMIM:602939	FOXS1	3		
FBgn0031086	fd19B	HGNC:3803	OMIM:602211	FOXD2	3		
FBgn0031086	fd19B	HGNC:3806	OMIM:602617	FOXE1	3	241850,616534	241850[HYPOTHYROIDISM, THYROIDAL OR ATHYROIDAL, WITH SPIKY HAIR AND CLEFT PALATE],616534[THYROID CANCER, NONMEDULLARY, 4; NMTC4]
FBgn0031086	fd19B	HGNC:18521	OMIM:611084	FOXD4L1	3		
FBgn0031086	fd19B	HGNC:3817	OMIM:603252	FOXL1	3		
FBgn0031086	fd19B	HGNC:3804	OMIM:611539	FOXD3	3	607836	607836[AUTOIMMUNE DISEASE, SUSCEPTIBILITY TO, 1; AIS1]
FBgn0031086	fd19B	HGNC:18523	OMIM:611086	FOXD4L3	3		
FBgn0031086	fd19B	HGNC:3805	OMIM:601092	FOXD4	3		
FBgn0031086	fd19B	HGNC:18522		FOXD4L5	3		
FBgn0031086	fd19B	HGNC:23762	OMIM:611085	FOXD4L4	3		
FBgn0031086	fd19B	HGNC:31986		FOXD4L6	3		
FBgn0031086	fd19B	HGNC:3800	OMIM:601090	FOXC1	3	601631,602482	601631[ANTERIOR SEGMENT DYSGENESIS 3; ASGD3],602482[AXENFELD-RIEGER SYNDROME, TYPE 3; RIEG3]
FBgn0031086	fd19B	HGNC:3815	OMIM:601093	FOXI1	3	600791	600791[DEAFNESS, AUTOSOMAL RECESSIVE 4, WITH ENLARGED VESTIBULAR AQUEDUCT; DFNB4]
FBgn0031086	fd19B	HGNC:3808	OMIM:601094	FOXE3	3	610256,612968,617349	610256[ANTERIOR SEGMENT DYSGENESIS 2; ASGD2],612968[CATARACT 34, MULTIPLE TYPES; CTRCT34],617349[AORTIC ANEURYSM, FAMILIAL THORACIC 11, SUSCEPTIBILITY TO; AAT11]
FBgn0031086	fd19B	HGNC:32448	OMIM:617202	FOXI2	3		
FBgn0031086	fd19B	HGNC:20951	OMIM:612788	FOXQ1	3		
FBgn0031086	fd19B	HGNC:29178	OMIM:616035	FOXJ3	4		
FBgn0031086	fd19B	HGNC:24818	OMIM:619162	FOXJ2	3		
FBgn0031082	CG17003	HGNC:21186	OMIM:615556	ATAT1	10		
FBgn0053217	CG33217	HGNC:30134	OMIM:609455	PELP1	8		
FBgn0052350	Vps11	HGNC:14583	OMIM:608549	VPS11	13	616683,619637	616683[LEUKODYSTROPHY, HYPOMYELINATING, 12; HLD12],619637[DYSTONIA 32; DYT32]
FBgn0024733	RpL10	HGNC:10298	OMIM:312173	RPL10	11	300847,300998	300847[AUTISM, SUSCEPTIBILITY TO, X-LINKED 5; AUTSX5],300998[INTELLECTUAL DEVELOPMENTAL DISORDER, X-LINKED, SYNDROMIC, 35; MRXS35]
FBgn0024733	RpL10	HGNC:17976	OMIM:619655	RPL10L	12	619689	619689[SPERMATOGENIC FAILURE 63; SPGF63]
FBgn0040372	G9a	HGNC:14129	OMIM:604599	EHMT2	11		
FBgn0040372	G9a	HGNC:24650	OMIM:607001	EHMT1	11	610253	610253[KLEEFSTRA SYNDROME 1; KLEFS1]
FBgn0040372	G9a	HGNC:11479	OMIM:300254	SUV39H1	3		
FBgn0040372	G9a	HGNC:17287	OMIM:606503	SUV39H2	4		
FBgn0000316	cin	HGNC:15465	OMIM:603930	GPHN	15	615501	615501[MOLYBDENUM COFACTOR DEFICIENCY, COMPLEMENTATION GROUP C; MOCODC]
FBgn0000022	ac	HGNC:24311	OMIM:609155	ASCL4	4		
FBgn0000022	ac	HGNC:738	OMIM:100790	ASCL1	10		
FBgn0000022	ac	HGNC:739	OMIM:601886	ASCL2	7		
FBgn0000022	ac	HGNC:740	OMIM:609154	ASCL3	4		
FBgn0000022	ac	HGNC:33169		ASCL5	3		
FBgn0004170	sc	HGNC:24311	OMIM:609155	ASCL4	4		
FBgn0004170	sc	HGNC:738	OMIM:100790	ASCL1	8		
FBgn0004170	sc	HGNC:739	OMIM:601886	ASCL2	7		
FBgn0004170	sc	HGNC:740	OMIM:609154	ASCL3	4		
FBgn0004170	sc	HGNC:33169		ASCL5	3		
FBgn0002561	l(1)sc	HGNC:24311	OMIM:609155	ASCL4	6		
FBgn0002561	l(1)sc	HGNC:738	OMIM:100790	ASCL1	9		
FBgn0002561	l(1)sc	HGNC:739	OMIM:601886	ASCL2	7		
FBgn0002561	l(1)sc	HGNC:740	OMIM:609154	ASCL3	7		
FBgn0002561	l(1)sc	HGNC:33169		ASCL5	5		
FBgn0000137	ase	HGNC:24311	OMIM:609155	ASCL4	3		
FBgn0000137	ase	HGNC:738	OMIM:100790	ASCL1	5		
FBgn0000137	ase	HGNC:739	OMIM:601886	ASCL2	5		
FBgn0000137	ase	HGNC:740	OMIM:609154	ASCL3	3		
FBgn0029522	CG13373	HGNC:17712	OMIM:605567	SIVA1	4		
FBgn0052817	CG32817	HGNC:17712	OMIM:605567	SIVA1	3		
FBgn0029524	CG3176	HGNC:17712	OMIM:605567	SIVA1	3		
FBgn0023536	CG3156	HGNC:41	OMIM:605454	ABCB10	15		
FBgn0023536	CG3156	HGNC:49	OMIM:605464	ABCB8	4		
FBgn0023535	arg	HGNC:664	OMIM:107830	ARG2	14		
FBgn0023535	arg	HGNC:663	OMIM:608313	ARG1	13	207800	207800[ARGININEMIA]
FBgn0023537	CG17896	HGNC:7179	OMIM:603178	ALDH6A1	13	614105	614105[METHYLMALONATE SEMIALDEHYDE DEHYDROGENASE DEFICIENCY; MMSDHD]
FBgn0010019	Cyp4g1	HGNC:23198	OMIM:608614	CYP4V2	5	210370	210370[BIETTI CRYSTALLINE CORNEORETINAL DYSTROPHY; BCD]
FBgn0010019	Cyp4g1	HGNC:2594	OMIM:107910	CYP19A1	3	139300,613546	139300[AROMATASE EXCESS SYNDROME; AEXS],613546[AROMATASE DEFICIENCY]
FBgn0011822	Pgcl	HGNC:2530	OMIM:116890	CTSE	6		
FBgn0011822	Pgcl	HGNC:8887	OMIM:169730	PGA5	4		
FBgn0011822	Pgcl	HGNC:8886	OMIM:169720	PGA4	4		
FBgn0011822	Pgcl	HGNC:9958	OMIM:179820	REN	6	267430,613092	267430[RENAL TUBULAR DYSGENESIS; RTD],613092[TUBULOINTERSTITIAL KIDNEY DISEASE, AUTOSOMAL DOMINANT, 4; ADTKD4]
FBgn0011822	Pgcl	HGNC:8890	OMIM:169740	PGC	5		
FBgn0011822	Pgcl	HGNC:13395	OMIM:605631	NAPSA	6		
FBgn0011822	Pgcl	HGNC:2529	OMIM:116840	CTSD	5	610127	610127[CEROID LIPOFUSCINOSIS, NEURONAL, 10; CLN10]
FBgn0040373	CG3038	HGNC:918	OMIM:603094	B3GALNT1	5	111400,615021	111400[BLOOD GROUP, P1PK SYSTEM],615021[BLOOD GROUP, GLOBOSIDE SYSTEM; GLOB]
FBgn0040373	CG3038	HGNC:916	OMIM:603093	B3GALT1	4		
FBgn0040373	CG3038	HGNC:917	OMIM:603018	B3GALT2	4		
FBgn0040373	CG3038	HGNC:920	OMIM:604066	B3GALT5	4		
FBgn0040373	CG3038	HGNC:28714		B3GNT9	3		
FBgn0040373	CG3038	HGNC:24141	OMIM:615315	B3GNT6	3		
FBgn0040373	CG3038	HGNC:13528	OMIM:605863	B3GNT3	3		
FBgn0000108	Appl	HGNC:598	OMIM:104776	APLP2	12		
FBgn0000108	Appl	HGNC:620	OMIM:104760	APP	13	104300,605714	104300[ALZHEIMER DISEASE, FAMILIAL, 1; AD1],605714[CEREBRAL AMYLOID ANGIOPATHY, APP-RELATED]
FBgn0000108	Appl	HGNC:597	OMIM:104775	APLP1	11		
FBgn0025640	CG13369	HGNC:30325	OMIM:611132	RBKS	14		
FBgn0025635	Hinfp	HGNC:17850	OMIM:607099	HINFP	12		
FBgn0001341	Mybbp1A	HGNC:7546	OMIM:604885	MYBBP1A	8		
FBgn0003575	su(sable)	HGNC:17808	OMIM:619498	ZC3H4	5		
FBgn0003575	su(sable)	HGNC:30941		ZC3H8	5		
FBgn0003575	su(sable)	HGNC:24762		ZC3H6	6		
FBgn0025634	CG13367	HGNC:29941	OMIM:614518	GATAD1	10	614672	614672[CARDIOMYOPATHY, DILATED, 2B; CMD2B]
FBgn0025638	Roc1a	HGNC:9928	OMIM:603814	RBX1	15		
FBgn0025638	Roc1a	HGNC:10070	OMIM:603863	RNF7	4		
FBgn0040383	CG5254	HGNC:14411	OMIM:607571	SLC25A21	15	618811	618811[MITOCHONDRIAL DNA DEPLETION SYNDROME 18; MTDPS18]
FBgn0027343	fz3	HGNC:4047	OMIM:601766	FZD9	4		
FBgn0027343	fz3	HGNC:4045	OMIM:603410	FZD7	3		
FBgn0027343	fz3	HGNC:4041	OMIM:606143	FZD3	3		
FBgn0027343	fz3	HGNC:4039	OMIM:606147	FZD10	4		
FBgn0027343	fz3	HGNC:4043	OMIM:601723	FZD5	4		
FBgn0027343	fz3	HGNC:4038	OMIM:603408	FZD1	3		
FBgn0027343	fz3	HGNC:10776	OMIM:604156	SFRP1	3		
FBgn0027343	fz3	HGNC:10777	OMIM:604157	SFRP2	3		
FBgn0027343	fz3	HGNC:10779	OMIM:604158	SFRP5	3		
FBgn0027343	fz3	HGNC:3959	OMIM:605083	FRZB	3	165720	165720[OSTEOARTHRITIS SUSCEPTIBILITY 1; OS1]
FBgn0027343	fz3	HGNC:10778	OMIM:606570	SFRP4	3	265900	265900[PYLE DISEASE; PYL]
FBgn0025621	CG16989	HGNC:24076		HEATR6	12		
FBgn0015799	Rbf	HGNC:9893	OMIM:116957	RBL1	14		
FBgn0015799	Rbf	HGNC:9894	OMIM:180203	RBL2	14	619690	619690[BRUNET-WAGNER NEURODEVELOPMENTAL SYNDROME; BRUWAG]
FBgn0015799	Rbf	HGNC:9884	OMIM:614041	RB1	4	109800,180200,182280,259500	109800[BLADDER CANCER],180200[RETINOBLASTOMA; RB1],182280[SMALL CELL CANCER OF THE LUNG],259500[OSTEOGENIC SARCOMA]
FBgn0015288	RpL22	HGNC:27610		RPL22L1	9		
FBgn0015288	RpL22	HGNC:10315	OMIM:180474	RPL22	12		
FBgn0025639	Hmt4-20	HGNC:24283	OMIM:610881	KMT5B	8	617788	617788[INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL DOMINANT 51; MRD51]
FBgn0025639	Hmt4-20	HGNC:28405	OMIM:613198	KMT5C	7		
FBgn0002579	RpL36	HGNC:13631	OMIM:617893	RPL36	10		
FBgn0026879	CG13364	HGNC:26932	OMIM:615808	TMA7	10		
FBgn0025633	spdi	HGNC:24764		SMTNL2	3		
FBgn0025633	spdi	HGNC:30615	OMIM:608793	SPECC1	9		
FBgn0025633	spdi	HGNC:32394	OMIM:613664	SMTNL1	3		
FBgn0025633	spdi	HGNC:11126	OMIM:602127	SMTN	4		
FBgn0025633	spdi	HGNC:29022	OMIM:614140	SPECC1L	11	145420,600251	145420[TEEBI HYPERTELORISM SYNDROME 1; TBHS1],600251[FACIAL CLEFTING, OBLIQUE, 1; OBLFC1]
FBgn0040339	MED22	HGNC:11477	OMIM:185641	MED22	13		
FBgn0040340	TRAM	HGNC:16855	OMIM:608485	TRAM2	10		
FBgn0040340	TRAM	HGNC:28371	OMIM:617505	TRAM1L1	11		
FBgn0040340	TRAM	HGNC:20568	OMIM:605190	TRAM1	13		
FBgn0040347	mus81	HGNC:29814	OMIM:606591	MUS81	14		
FBgn0040337	CG3021	HGNC:25481	OMIM:610230	TRMU	15	580000,613070	580000[DEAFNESS, AMINOGLYCOSIDE-INDUCED],613070[LIVER FAILURE, INFANTILE, TRANSIENT; LFIT]
FBgn0026143	Cdc45	HGNC:1739	OMIM:603465	CDC45	14	617063	617063[MEIER-GORLIN SYNDROME 7; MGORS7]
FBgn0040338	TfIIA-S-2	HGNC:4647	OMIM:600519	GTF2A2	7		
FBgn0040350	CG3690	HGNC:8494	OMIM:604047	SLC22A13	4		
FBgn0040350	CG3690	HGNC:10970	OMIM:607582	SLC22A6	3		
FBgn0040350	CG3690	HGNC:20302	OMIM:608276	SLC22A16	3		
FBgn0040350	CG3690	HGNC:10968	OMIM:604190	SLC22A4	3	180300	180300[RHEUMATOID ARTHRITIS; RA]
FBgn0040350	CG3690	HGNC:10969	OMIM:603377	SLC22A5	3	212140	212140[CARNITINE DEFICIENCY, SYSTEMIC PRIMARY; CDSP]
FBgn0040350	CG3690	HGNC:8495	OMIM:604048	SLC22A14	4		
FBgn0040350	CG3690	HGNC:10971	OMIM:604995	SLC22A7	4		
FBgn0040350	CG3690	HGNC:10972	OMIM:607581	SLC22A8	4		
FBgn0040350	CG3690	HGNC:10966	OMIM:602608	SLC22A2	3		
FBgn0040350	CG3690	HGNC:32935	OMIM:610792	SLC22A25	3		
FBgn0040350	CG3690	HGNC:10963	OMIM:602607	SLC22A1	3		
FBgn0040350	CG3690	HGNC:10967	OMIM:604842	SLC22A3	3		
FBgn0040350	CG3690	HGNC:16874	OMIM:185861	SV2B	4		
FBgn0040350	CG3690	HGNC:20566	OMIM:185860	SV2A	3		
FBgn0040350	CG3690	HGNC:30670	OMIM:610291	SV2C	3		
FBgn0040350	CG3690	HGNC:17989	OMIM:607096	SLC22A12	3	220150	220150[HYPOURICEMIA, RENAL, 1; RHUC1]
FBgn0040350	CG3690	HGNC:18120	OMIM:607097	SLC22A11	3		
FBgn0040350	CG3690	HGNC:16261	OMIM:607579	SLC22A9	3		
FBgn0040350	CG3690	HGNC:28542	OMIM:611698	SLC22A24	3		
FBgn0040350	CG3690	HGNC:18057	OMIM:607580	SLC22A10	3		
FBgn0040349	CG3699	HGNC:18349	OMIM:615194	DHRS2	3		
FBgn0040349	CG3699	HGNC:16985	OMIM:611596	DHRS4	3		
FBgn0040349	CG3699	HGNC:19731	OMIM:615196	DHRS4L2	3		
FBgn0040349	CG3699	HGNC:23238	OMIM:612832	HSD17B14	5		
FBgn0040348	CG3703	HGNC:25418	OMIM:619250	RUNDC1	14		
FBgn0040346	CG3704	HGNC:17030	OMIM:611479	GPN1	13		
FBgn0040345	CG3708	HGNC:7637	OMIM:164060	NAP1L1	6		
FBgn0040345	CG3708	HGNC:7638	OMIM:300026	NAP1L2	6		
FBgn0040345	CG3708	HGNC:7639	OMIM:300117	NAP1L3	5		
FBgn0040345	CG3708	HGNC:7640	OMIM:601651	NAP1L4	6		
FBgn0025642	CG32812	HGNC:16920	OMIM:602293	CIB1	3	618267	618267[EPIDERMODYSPLASIA VERRUCIFORMIS, SUSCEPTIBILITY TO, 3; EV3]
FBgn0025642	CG32812	HGNC:24927		CHP2	4		
FBgn0025642	CG32812	HGNC:33703	OMIM:610646	CIB4	3		
FBgn0025642	CG32812	HGNC:9318	OMIM:613821	PPP3R2	3		
FBgn0025642	CG32812	HGNC:17433	OMIM:606988	CHP1	4	618438	618438[SPASTIC ATAXIA 9, AUTOSOMAL RECESSIVE; SPAX9]
FBgn0025642	CG32812	HGNC:26065	OMIM:611585	TESC	4		
FBgn0024362	Naa30A	HGNC:19844	OMIM:617989	NAA30	12		
FBgn0024364	CG11417	HGNC:15898	OMIM:618765	ESF1	12		
FBgn0023169	AMPKalpha	HGNC:9377	OMIM:600497	PRKAA2	14		
FBgn0023169	AMPKalpha	HGNC:9376	OMIM:602739	PRKAA1	11		
FBgn0024985	Rilpl	HGNC:26814	OMIM:614092	RILPL1	14	619790	619790[OCULOPHARYNGODISTAL MYOPATHY 4; OPDM4]
FBgn0024985	Rilpl	HGNC:30266	OMIM:607848	RILP	6		
FBgn0024985	Rilpl	HGNC:28787	OMIM:614093	RILPL2	4		
FBgn0027794	Lrpprc2	HGNC:15714	OMIM:607544	LRPPRC	8	220111	220111[MITOCHONDRIAL COMPLEX IV DEFICIENCY, NUCLEAR TYPE 5; MC4DN5]
FBgn0024986	CG3719	HGNC:17772	OMIM:609063	TXN2	5	616811	616811[COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 29; COXPD29]
FBgn0000826	png	HGNC:18593	OMIM:609779	NEK11	4		
FBgn0024365	CG12773	HGNC:15595	OMIM:611316	SLC12A8	14		
FBgn0024360	MTPAP	HGNC:25532	OMIM:613669	MTPAP	12	613672	613672[SPASTIC ATAXIA 4, AUTOSOMAL RECESSIVE; SPAX4]
FBgn0024360	MTPAP	HGNC:26184	OMIM:610641	TUT1	3		
FBgn0025641	DAAM	HGNC:18143	OMIM:606627	DAAM2	11	619263	619263[NEPHROTIC SYNDROME, TYPE 24; NPHS24]
FBgn0025641	DAAM	HGNC:18142	OMIM:606626	DAAM1	15		
FBgn0025641	DAAM	HGNC:23791	OMIM:610982	INF2	3	613237,614455	613237[FOCAL SEGMENTAL GLOMERULOSCLEROSIS 5; FSGS5],614455[CHARCOT-MARIE-TOOTH DISEASE, DOMINANT INTERMEDIATE E; CMTDIE]
FBgn0025641	DAAM	HGNC:2876	OMIM:602121	DIAPH1	3	124900,616632	124900[DEAFNESS, AUTOSOMAL DOMINANT 1, WITH OR WITHOUT THROMBOCYTOPENIA; DFNA1],616632[SEIZURES, CORTICAL BLINDNESS, AND MICROCEPHALY SYNDROME; SCBMS]
FBgn0025641	DAAM	HGNC:2877	OMIM:300108	DIAPH2	3	300511	300511[PREMATURE OVARIAN FAILURE 2A; POF2A]
FBgn0025641	DAAM	HGNC:15480	OMIM:614567	DIAPH3	3	609129	609129[AUDITORY NEUROPATHY, AUTOSOMAL DOMINANT 1; AUNA1]
FBgn0025641	DAAM	HGNC:18464	OMIM:610639	GRID2IP	3		
FBgn0028550	Atf3	HGNC:3796	OMIM:164810	FOS	3		
FBgn0028550	Atf3	HGNC:3798	OMIM:601575	FOSL2	3		
FBgn0028550	Atf3	HGNC:13718	OMIM:136515	FOSL1	3		
FBgn0028550	Atf3	HGNC:785	OMIM:603148	ATF3	5		
FBgn0028550	Atf3	HGNC:3797	OMIM:164772	FOSB	3		
FBgn0028550	Atf3	HGNC:958	OMIM:612476	BATF	3		
FBgn0028550	Atf3	HGNC:28915	OMIM:612470	BATF3	3		
FBgn0028550	Atf3	HGNC:25163	OMIM:614983	BATF2	3		
FBgn0028550	Atf3	HGNC:17546	OMIM:608657	JDP2	4		
FBgn0026876	CG11403	HGNC:2736	OMIM:601150	DDX11	14	613398	613398[WARSAW BREAKAGE SYNDROME; WABS]
FBgn0026876	CG11403	HGNC:2737	OMIM:601151	DDX12P	6		
FBgn0026876	CG11403	HGNC:37101		DDX11L8	7		
FBgn0040368	eIF4E7	HGNC:3293	OMIM:605895	EIF4E2	3		
FBgn0040368	eIF4E7	HGNC:3287	OMIM:133440	EIF4E	13	615091	615091[AUTISM, SUSCEPTIBILITY TO, 19; AUTS19]
FBgn0040368	eIF4E7	HGNC:33179		EIF4E1B	12		
FBgn0040368	eIF4E7	HGNC:31837	OMIM:609896	EIF4E3	3		
FBgn0026872	CG14777	HGNC:26827	OMIM:618100	MPV17L	6		
FBgn0029580	CG14778	HGNC:26827	OMIM:618100	MPV17L	5		
FBgn0025381	rush	HGNC:20757	OMIM:615208	PLEKHF2	15		
FBgn0025381	rush	HGNC:20764	OMIM:615200	PLEKHF1	7		
FBgn0025394	inc	HGNC:21423	OMIM:611285	KCTD5	14		
FBgn0025394	inc	HGNC:25705	OMIM:616386	KCTD17	9	616398	616398[DYSTONIA 26, MYOCLONIC; DYT26]
FBgn0025394	inc	HGNC:21294	OMIM:613422	KCTD2	11		
FBgn0000482	dor	HGNC:15972	OMIM:608551	VPS18	15		
FBgn0024897	b6	HGNC:7953	OMIM:600750	NPTX2	5		
FBgn0025391	Scgdelta	HGNC:10807	OMIM:601411	SGCD	13	601287,606685	601287[MUSCULAR DYSTROPHY, LIMB-GIRDLE, AUTOSOMAL RECESSIVE 6; LGMDR6],606685[CARDIOMYOPATHY, DILATED, 1L; CMD1L]
FBgn0025391	Scgdelta	HGNC:10809	OMIM:608896	SGCG	11	253700	253700[MUSCULAR DYSTROPHY, LIMB-GIRDLE, AUTOSOMAL RECESSIVE 5; LGMDR5]
FBgn0025391	Scgdelta	HGNC:14075	OMIM:608113	SGCZ	11		
FBgn0023530	CG3740	HGNC:25443	OMIM:614297	C19orf12	14	614298,615043	614298[NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 4; NBIA4],615043[SPASTIC PARAPLEGIA 43, AUTOSOMAL RECESSIVE; SPG43]
FBgn0003517	sta	HGNC:6502	OMIM:150370	RPSA	13	271400	271400[ASPLENIA, ISOLATED CONGENITAL; ICAS]
FBgn0025382	Rab27	HGNC:9766	OMIM:603868	RAB27A	14	607624	607624[GRISCELLI SYNDROME, TYPE 2; GS2]
FBgn0025382	Rab27	HGNC:9767	OMIM:603869	RAB27B	10		
FBgn0052808	CG32808	HGNC:6362	OMIM:606135	KLK14	3		
FBgn0052808	CG32808	HGNC:6369	OMIM:605644	KLK8	3		
FBgn0052808	CG32808	HGNC:20453	OMIM:610601	KLK15	3		
FBgn0052808	CG32808	HGNC:6365	OMIM:603767	KLK4	4	204700	204700[AMELOGENESIS IMPERFECTA, HYPOMATURATION TYPE, IIA1; AI2A1]
FBgn0052808	CG32808	HGNC:6366	OMIM:605643	KLK5	3		
FBgn0052808	CG32808	HGNC:6364	OMIM:176820	KLK3	3		
FBgn0052808	CG32808	HGNC:6361	OMIM:605505	KLK13	4		
FBgn0052808	CG32808	HGNC:6360	OMIM:605539	KLK12	3		
FBgn0052808	CG32808	HGNC:6357	OMIM:147910	KLK1	3	615953	615953[KALLIKREIN, DECREASED URINARY ACTIVITY OF]
FBgn0052808	CG32808	HGNC:6363	OMIM:147960	KLK2	3		
FBgn0052808	CG32808	HGNC:6359	OMIM:604434	KLK11	4		
FBgn0052808	CG32808	HGNC:6368	OMIM:604438	KLK7	3		
FBgn0027791	O-fut2	HGNC:14683	OMIM:610249	POFUT2	15		
FBgn0027793	CG14787	HGNC:23920		CDY1B	3		
FBgn0027793	CG14787	HGNC:23921		CDY2B	3		
FBgn0027793	CG14787	HGNC:1811	OMIM:603778	CDYL	4		
FBgn0027793	CG14787	HGNC:14601	OMIM:608024	ECI2	3		
FBgn0027793	CG14787	HGNC:23030	OMIM:618816	CDYL2	3		
FBgn0026873	MED18	HGNC:25944	OMIM:612384	MED18	13		
FBgn0023513	CG14803	HGNC:21475	OMIM:615614	MMS22L	11		
FBgn0014411	Vps26	HGNC:28119	OMIM:610027	VPS26B	13		
FBgn0014411	Vps26	HGNC:12711	OMIM:605506	VPS26A	12		
FBgn0023514	CG14805	HGNC:17956		WDR18	13		
FBgn0029594	Coa8	HGNC:20492	OMIM:616003	COA8	10	619061	619061[MITOCHONDRIAL COMPLEX IV DEFICIENCY, NUCLEAR TYPE 17; MC4DN17]
FBgn0023519	mRpL16	HGNC:14476	OMIM:611829	MRPL16	12		
FBgn0023509	mip130	HGNC:30830	OMIM:609375	LIN9	12		
FBgn0023510	Rbcn-3B	HGNC:26790	OMIM:613214	WDR72	5	613211	613211[AMELOGENESIS IMPERFECTA, HYPOMATURATION TYPE, IIA3; AI2A3]
FBgn0023510	Rbcn-3B	HGNC:13490	OMIM:613473	WDR7	15		
FBgn0023508	Ocrl	HGNC:6077	OMIM:147264	INPP5B	13		
FBgn0023508	Ocrl	HGNC:8108	OMIM:300535	OCRL	12	300555,309000	300555[DENT DISEASE 2; DENT2],309000[LOWE OCULOCEREBRORENAL SYNDROME; OCRL]
FBgn0023522	CG11596	HGNC:23435	OMIM:616552	CARNMT1	14		
FBgn0023521	CG3587	HGNC:25160		KTI12	14		
FBgn0025630	Rtca	HGNC:17981	OMIM:611286	RTCA	12		
FBgn0025629	CG4045	HGNC:7030	OMIM:604466	METTL1	15		
FBgn0025628	CG4199	HGNC:26398	OMIM:617298	AIFM3	14		
FBgn0025625	Sik2	HGNC:21680	OMIM:608973	SIK2	10		
FBgn0025625	Sik2	HGNC:11142	OMIM:605705	SIK1	4	616341	616341[DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 30; DEE30]
FBgn0025625	Sik2	HGNC:0		SIK1B	6		
FBgn0025631	moody	HGNC:7463	OMIM:600665	MTNR1A	4		
FBgn0025631	moody	HGNC:7464	OMIM:600804	MTNR1B	4	125853	125853[TYPE 2 DIABETES MELLITUS; T2D]
FBgn0025631	moody	HGNC:4535	OMIM:606383	GPR84	7		
FBgn0000667	Actn	HGNC:166	OMIM:604638	ACTN4	11	603278	603278[FOCAL SEGMENTAL GLOMERULOSCLEROSIS 1; FSGS1]
FBgn0000667	Actn	HGNC:164	OMIM:102573	ACTN2	13	612158,618654,618655	612158[CARDIOMYOPATHY, DILATED, 1AA, WITH OR WITHOUT LEFT VENTRICULAR NONCOMPACTION; CMD1AA],618654[MYOPATHY, CONGENITAL, WITH STRUCTURED CORES AND Z-LINE ABNORMALITIES; MYOCOZ],618655[MYOPATHY, DISTAL, 6, ADULT-ONSET, AUTOSOMAL DOMINANT; MPD6]
FBgn0000667	Actn	HGNC:163	OMIM:102575	ACTN1	13	615193	615193[BLEEDING DISORDER, PLATELET-TYPE, 15; BDPLT15]
FBgn0000667	Actn	HGNC:165	OMIM:102574	ACTN3	10	617749	617749[ACTN3 DEFICIENCY]
FBgn0003964	usp	HGNC:10479	OMIM:180247	RXRG	12		
FBgn0003964	usp	HGNC:10477	OMIM:180245	RXRA	13		
FBgn0003964	usp	HGNC:10478	OMIM:180246	RXRB	12		
FBgn0023545	PIG-K	HGNC:8965	OMIM:605087	PIGK	15	618879	618879[NEURODEVELOPMENTAL DISORDER WITH HYPOTONIA AND CEREBELLAR ATROPHY, WITH OR WITHOUT SEIZURES; NEDHCAS]
FBgn0023520	CG3857	HGNC:25763	OMIM:613176	SMG9	11	616920,619995	616920[HEART AND BRAIN MALFORMATION SYNDROME; HBMS],619995[NEURODEVELOPMENTAL DISORDER WITH INTENTION TREMOR, PYRAMIDAL SIGNS, DYSPRAXIA, AND OCULAR ANOMALIES; NEDITPO]
FBgn0023512	eIF2Bepsilon	HGNC:3261	OMIM:603945	EIF2B5	14	603896	603896[LEUKOENCEPHALOPATHY WITH VANISHING WHITE MATTER; VWM]
FBgn0023511	Edem1	HGNC:15877	OMIM:610302	EDEM2	6		
FBgn0023511	Edem1	HGNC:18967	OMIM:607673	EDEM1	3		
FBgn0023511	Edem1	HGNC:0		MMP24-AS1-EDEM2	5		
FBgn0023518	trr	HGNC:7133	OMIM:602113	KMT2D	8	147920	147920[KABUKI SYNDROME 1; KABUK1]
FBgn0023518	trr	HGNC:13726	OMIM:606833	KMT2C	10	617768	617768[KLEEFSTRA SYNDROME 2; KLEFS2]
FBgn0023518	trr	HGNC:15840	OMIM:606834	KMT2B	4	617284,619934	617284[DYSTONIA 28, CHILDHOOD-ONSET; DYT28],619934[INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL DOMINANT 68; MRD68]
FBgn0026088	CG14818	HGNC:17823		BBLN	6		
FBgn0026089	CG14817	HGNC:14514	OMIM:611997	MRPL57	9		
FBgn0023517	Pgam5	HGNC:28763	OMIM:614939	PGAM5	14		
FBgn0023516	Pex5	HGNC:30024	OMIM:611058	PEX5L	8		
FBgn0023516	Pex5	HGNC:9719	OMIM:600414	PEX5	14	202370,214110,616716	202370[PEROXISOME BIOGENESIS DISORDER 2B; PBD2B],214110[PEROXISOME BIOGENESIS DISORDER 2A (ZELLWEGER); PBD2A],616716[RHIZOMELIC CHONDRODYSPLASIA PUNCTATA, TYPE 5; RCDP5]
FBgn0023515	Gcna	HGNC:15805	OMIM:300369	GCNA	9	301077	301077[SPERMATOGENIC FAILURE, X-LINKED, 4; SPGFX4]
FBgn0028969	deltaCOP	HGNC:649	OMIM:600820	ARCN1	14	617164	617164[SHORT STATURE-MICROGNATHIA SYNDROME; SSMG]
FBgn0026090	Lamtor5	HGNC:17955	OMIM:608521	LAMTOR5	11		
FBgn0025624	CG4025	HGNC:28769	OMIM:613360	DRAM2	11	616502	616502[CONE-ROD DYSTROPHY 21; CORD21]
FBgn0025624	CG4025	HGNC:25645	OMIM:610776	DRAM1	11		
FBgn0025624	CG4025	HGNC:34415	OMIM:617291	TMEM150B	5		
FBgn0025624	CG4025	HGNC:24677	OMIM:616757	TMEM150A	3		
FBgn0025624	CG4025	HGNC:37263	OMIM:617292	TMEM150C	4		
FBgn0040395	Unc-76	HGNC:3660	OMIM:604826	FEZ2	14		
FBgn0040395	Unc-76	HGNC:3659	OMIM:604825	FEZ1	10		
FBgn0000382	csw	HGNC:9644	OMIM:176876	PTPN11	12	151100,156250,163950,607785	151100[LEOPARD SYNDROME 1; LPRD1],156250[METACHONDROMATOSIS; METCDS],163950[NOONAN SYNDROME 1; NS1],607785[JUVENILE MYELOMONOCYTIC LEUKEMIA; JMML]
FBgn0000382	csw	HGNC:9658	OMIM:176883	PTPN6	10		
FBgn0023507	D2hgdh	HGNC:28358	OMIM:609186	D2HGDH	14	600721	600721[D-2-HYDROXYGLUTARIC ACIDURIA 1; D2HGA1]
FBgn0023507	D2hgdh	HGNC:19708	OMIM:607490	LDHD	3	245450	245450[D-LACTIC ACIDURIA WITH GOUT; DLACD]
FBgn0004654	Pgd	HGNC:8891	OMIM:172200	PGD	14		
FBgn0023540	CG3630	HGNC:30655	OMIM:609747	ABRA	8		
FBgn0025839	ND-B14.5A	HGNC:7691	OMIM:602139	NDUFA7	14		
FBgn0011576	Cyp4d2	HGNC:23198	OMIM:608614	CYP4V2	6	210370	210370[BIETTI CRYSTALLINE CORNEORETINAL DYSTROPHY; BCD]
FBgn0011576	Cyp4d2	HGNC:13265	OMIM:611517	CYP4F11	4		
FBgn0011576	Cyp4d2	HGNC:26820	OMIM:611495	CYP4F22	4	604777	604777[ICHTHYOSIS, CONGENITAL, AUTOSOMAL RECESSIVE 5; ARCI5]
FBgn0011576	Cyp4d2	HGNC:2645	OMIM:604426	CYP4F2	5		
FBgn0011576	Cyp4d2	HGNC:2646	OMIM:601270	CYP4F3	4		
FBgn0011576	Cyp4d2	HGNC:20244	OMIM:614999	CYP4X1	4		
FBgn0011576	Cyp4d2	HGNC:2642	OMIM:601310	CYP4A11	3		
FBgn0011576	Cyp4d2	HGNC:18857	OMIM:611485	CYP4F12	4		
FBgn0011576	Cyp4d2	HGNC:20575	OMIM:615341	CYP4A22	4		
FBgn0011576	Cyp4d2	HGNC:2644	OMIM:124075	CYP4B1	4		
FBgn0011576	Cyp4d2	HGNC:2648	OMIM:611545	CYP4F8	4		
FBgn0011576	Cyp4d2	HGNC:20583	OMIM:618953	CYP4Z1	4		
FBgn0011576	Cyp4d2	HGNC:2594	OMIM:107910	CYP19A1	4	139300,613546	139300[AROMATASE EXCESS SYNDROME; AEXS],613546[AROMATASE DEFICIENCY]
FBgn0015036	Cyp4ae1	HGNC:23198	OMIM:608614	CYP4V2	6	210370	210370[BIETTI CRYSTALLINE CORNEORETINAL DYSTROPHY; BCD]
FBgn0015036	Cyp4ae1	HGNC:13265	OMIM:611517	CYP4F11	3		
FBgn0015036	Cyp4ae1	HGNC:26820	OMIM:611495	CYP4F22	3	604777	604777[ICHTHYOSIS, CONGENITAL, AUTOSOMAL RECESSIVE 5; ARCI5]
FBgn0015036	Cyp4ae1	HGNC:2645	OMIM:604426	CYP4F2	3		
FBgn0015036	Cyp4ae1	HGNC:2646	OMIM:601270	CYP4F3	3		
FBgn0015036	Cyp4ae1	HGNC:20244	OMIM:614999	CYP4X1	4		
FBgn0015036	Cyp4ae1	HGNC:2642	OMIM:601310	CYP4A11	3		
FBgn0015036	Cyp4ae1	HGNC:18857	OMIM:611485	CYP4F12	3		
FBgn0015036	Cyp4ae1	HGNC:20575	OMIM:615341	CYP4A22	4		
FBgn0015036	Cyp4ae1	HGNC:2644	OMIM:124075	CYP4B1	3		
FBgn0015036	Cyp4ae1	HGNC:2648	OMIM:611545	CYP4F8	3		
FBgn0015036	Cyp4ae1	HGNC:20583	OMIM:618953	CYP4Z1	4		
FBgn0015036	Cyp4ae1	HGNC:2594	OMIM:107910	CYP19A1	3	139300,613546	139300[AROMATASE EXCESS SYNDROME; AEXS],613546[AROMATASE DEFICIENCY]
FBgn0003116	pn	HGNC:13420	OMIM:617413	PRUNE1	15	617481	617481[NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, HYPOTONIA, AND VARIABLE BRAIN ANOMALIES; NMIHBA]
FBgn0003116	pn	HGNC:25209	OMIM:610691	PRUNE2	3		
FBgn0023549	Mct1	HGNC:17027	OMIM:607550	SLC16A10	3		
FBgn0023549	Mct1	HGNC:10923	OMIM:300095	SLC16A2	3	300523	300523[ALLAN-HERNDON-DUDLEY SYNDROME; AHDS]
FBgn0023549	Mct1	HGNC:10924	OMIM:603877	SLC16A3	7		
FBgn0023549	Mct1	HGNC:16270	OMIM:610409	SLC16A8	7		
FBgn0023549	Mct1	HGNC:26417		SLC16A14	8		
FBgn0023549	Mct1	HGNC:23093	OMIM:615765	SLC16A11	4		
FBgn0023549	Mct1	HGNC:23520	OMIM:614242	SLC16A9	5		
FBgn0023549	Mct1	HGNC:10922	OMIM:600682	SLC16A1	7	245340,610021,616095	245340[ERYTHROCYTE LACTATE TRANSPORTER DEFECT],610021[HYPERINSULINEMIC HYPOGLYCEMIA, FAMILIAL, 7; HHF7],616095[MONOCARBOXYLATE TRANSPORTER 1 DEFICIENCY; MCT1D]
FBgn0023549	Mct1	HGNC:10927	OMIM:603880	SLC16A6	6		
FBgn0023549	Mct1	HGNC:10925	OMIM:603878	SLC16A4	6		
FBgn0023549	Mct1	HGNC:31037		SLC16A13	6		
FBgn0023549	Mct1	HGNC:10926	OMIM:603879	SLC16A5	7		
FBgn0023549	Mct1	HGNC:10928	OMIM:603654	SLC16A7	7		
FBgn0023549	Mct1	HGNC:23094	OMIM:611910	SLC16A12	11	612018	612018[CATARACT 47; CTRCT47]
FBgn0003048	pcx	HGNC:8736	OMIM:617656	PCNX2	11		
FBgn0003048	pcx	HGNC:18760	OMIM:617657	PCNX3	12		
FBgn0003048	pcx	HGNC:19740	OMIM:617655	PCNX1	12		
FBgn0023527	CG3071	HGNC:25758	OMIM:616194	UTP15	14		
FBgn0040391	CG2854	HGNC:25241		TCAIM	11		
FBgn0003079	Raf	HGNC:1097	OMIM:164757	BRAF	14	114500,115150,155600,211980,613706,613707	114500[COLORECTAL CANCER; CRC],115150[CARDIOFACIOCUTANEOUS SYNDROME 1; CFC1],155600[MELANOMA, CUTANEOUS MALIGNANT, SUSCEPTIBILITY TO, 1; CMM1],211980[LUNG CANCER],613706[NOONAN SYNDROME 7; NS7],613707[LEOPARD SYNDROME 3; LPRD3]
FBgn0003079	Raf	HGNC:9829	OMIM:164760	RAF1	11	611553,611554,615916	611553[NOONAN SYNDROME 5; NS5],611554[LEOPARD SYNDROME 2; LPRD2],615916[CARDIOMYOPATHY, DILATED, 1NN; CMD1NN]
FBgn0003079	Raf	HGNC:646	OMIM:311010	ARAF	12		
FBgn0040389	mRpL14	HGNC:14279	OMIM:611827	MRPL14	14		
FBgn0023529	Grp170	HGNC:16931	OMIM:601746	HYOU1	15	233600	233600[IMMUNODEFICIENCY 59 AND HYPOGLYCEMIA; IMD59]
FBgn0023528	CG2924	HGNC:37269	OMIM:615832	UBE2QL1	3		
FBgn0023528	CG2924	HGNC:19248	OMIM:612501	UBE2Q2	13		
FBgn0023528	CG2924	HGNC:15698	OMIM:617429	UBE2Q1	14		
FBgn0027296	temp	HGNC:30449		PTAR1	11		
FBgn0023524	CG3078	HGNC:12570	OMIM:607995	UNC93A	5		
FBgn0023524	CG3078	HGNC:13481	OMIM:608204	UNC93B1	3	610551	610551[ENCEPHALOPATHY, ACUTE, INFECTION-INDUCED (HERPES-SPECIFIC), SUSCEPTIBILITY TO, 1; IIAE1]
FBgn0023525	CG3191	HGNC:12404	OMIM:600415	TTPA	3	277460	277460[ATAXIA WITH VITAMIN E DEFICIENCY; AVED]
FBgn0023525	CG3191	HGNC:16114		TTPAL	3		
FBgn0023525	CG3191	HGNC:10024	OMIM:180090	RLBP1	3	136880,607475,607476	136880[FUNDUS ALBIPUNCTATUS],607475[BOTHNIA RETINAL DYSTROPHY],607476[NEWFOUNDLAND ROD-CONE DYSTROPHY; NFRCD]
FBgn0023525	CG3191	HGNC:23046	OMIM:616945	CLVS2	3		
FBgn0023525	CG3191	HGNC:23139	OMIM:611292	CLVS1	3		
FBgn0000377	crn	HGNC:15762	OMIM:610952	CRNKL1	14		
FBgn0001330	kz	HGNC:17210	OMIM:617362	DHX37	15	273250,618731	273250[46,XY SEX REVERSAL 11; SRXY11],618731[NEURODEVELOPMENTAL DISORDER WITH BRAIN ANOMALIES AND WITH OR WITHOUT VERTEBRAL OR CARDIAC ANOMALIES; NEDBAVC]
FBgn0004397	Vinc	HGNC:12665	OMIM:193065	VCL	13	611407,613255	611407[CARDIOMYOPATHY, DILATED, 1W; CMD1W],613255[CARDIOMYOPATHY, FAMILIAL HYPERTROPHIC, 15; CMH15]
FBgn0023550	FarO	HGNC:26222	OMIM:616107	FAR1	5	616154,619338	616154[PEROXISOMAL FATTY ACYL-CoA REDUCTASE 1 DISORDER; PFCRD],619338[CATARACTS, SPASTIC PARAPARESIS, AND SPEECH DELAY; CSPSD]
FBgn0023550	FarO	HGNC:25531	OMIM:616156	FAR2	5		
FBgn0023542	Nmd3	HGNC:24250	OMIM:611021	NMD3	13		
FBgn0023541	Cyp4d14	HGNC:23198	OMIM:608614	CYP4V2	6	210370	210370[BIETTI CRYSTALLINE CORNEORETINAL DYSTROPHY; BCD]
FBgn0023541	Cyp4d14	HGNC:13265	OMIM:611517	CYP4F11	4		
FBgn0023541	Cyp4d14	HGNC:26820	OMIM:611495	CYP4F22	4	604777	604777[ICHTHYOSIS, CONGENITAL, AUTOSOMAL RECESSIVE 5; ARCI5]
FBgn0023541	Cyp4d14	HGNC:2645	OMIM:604426	CYP4F2	4		
FBgn0023541	Cyp4d14	HGNC:2646	OMIM:601270	CYP4F3	4		
FBgn0023541	Cyp4d14	HGNC:20244	OMIM:614999	CYP4X1	4		
FBgn0023541	Cyp4d14	HGNC:2642	OMIM:601310	CYP4A11	3		
FBgn0023541	Cyp4d14	HGNC:18857	OMIM:611485	CYP4F12	4		
FBgn0023541	Cyp4d14	HGNC:20575	OMIM:615341	CYP4A22	3		
FBgn0023541	Cyp4d14	HGNC:2644	OMIM:124075	CYP4B1	4		
FBgn0023541	Cyp4d14	HGNC:2648	OMIM:611545	CYP4F8	4		
FBgn0023541	Cyp4d14	HGNC:20583	OMIM:618953	CYP4Z1	3		
FBgn0023541	Cyp4d14	HGNC:2594	OMIM:107910	CYP19A1	4	139300,613546	139300[AROMATASE EXCESS SYNDROME; AEXS],613546[AROMATASE DEFICIENCY]
FBgn0005670	Cyp4d1	HGNC:23198	OMIM:608614	CYP4V2	6	210370	210370[BIETTI CRYSTALLINE CORNEORETINAL DYSTROPHY; BCD]
FBgn0005670	Cyp4d1	HGNC:13265	OMIM:611517	CYP4F11	4		
FBgn0005670	Cyp4d1	HGNC:26820	OMIM:611495	CYP4F22	4	604777	604777[ICHTHYOSIS, CONGENITAL, AUTOSOMAL RECESSIVE 5; ARCI5]
FBgn0005670	Cyp4d1	HGNC:2645	OMIM:604426	CYP4F2	4		
FBgn0005670	Cyp4d1	HGNC:2646	OMIM:601270	CYP4F3	4		
FBgn0005670	Cyp4d1	HGNC:20244	OMIM:614999	CYP4X1	5		
FBgn0005670	Cyp4d1	HGNC:2642	OMIM:601310	CYP4A11	3		
FBgn0005670	Cyp4d1	HGNC:18857	OMIM:611485	CYP4F12	4		
FBgn0005670	Cyp4d1	HGNC:20575	OMIM:615341	CYP4A22	4		
FBgn0005670	Cyp4d1	HGNC:2644	OMIM:124075	CYP4B1	4		
FBgn0005670	Cyp4d1	HGNC:2648	OMIM:611545	CYP4F8	4		
FBgn0005670	Cyp4d1	HGNC:20583	OMIM:618953	CYP4Z1	5		
FBgn0005670	Cyp4d1	HGNC:2594	OMIM:107910	CYP19A1	4	139300,613546	139300[AROMATASE EXCESS SYNDROME; AEXS],613546[AROMATASE DEFICIENCY]
FBgn0004655	wapl	HGNC:23293	OMIM:610754	WAPL	10		
FBgn0013432	bcn92	HGNC:21365	OMIM:613311	LYRM4	12	615595	615595[COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 19; COXPD19]
FBgn0004861	ph-p	HGNC:15682		PHC3	9		
FBgn0004861	ph-p	HGNC:3183	OMIM:602979	PHC2	6		
FBgn0004861	ph-p	HGNC:3182	OMIM:602978	PHC1	5	615414	615414[MICROCEPHALY 11, PRIMARY, AUTOSOMAL RECESSIVE; MCPH11]
FBgn0004860	ph-d	HGNC:15682		PHC3	7		
FBgn0004860	ph-d	HGNC:3183	OMIM:602979	PHC2	6		
FBgn0004860	ph-d	HGNC:3182	OMIM:602978	PHC1	4	615414	615414[MICROCEPHALY 11, PRIMARY, AUTOSOMAL RECESSIVE; MCPH11]
FBgn0040394	CG16903	HGNC:20569	OMIM:613384	CCNL1	10		
FBgn0040394	CG16903	HGNC:20570	OMIM:613482	CCNL2	9		
FBgn0040066	wds	HGNC:12757	OMIM:609012	WDR5	15		
FBgn0040066	wds	HGNC:17826		WDR5B	9		
FBgn0040336	Seipin	HGNC:15832	OMIM:606158	BSCL2	12	269700,270685,615924,619112	269700[LIPODYSTROPHY, CONGENITAL GENERALIZED, TYPE 2; CGL2],270685[SPASTIC PARAPLEGIA 17, AUTOSOMAL DOMINANT; SPG17],615924[ENCEPHALOPATHY, PROGRESSIVE, WITH OR WITHOUT LIPODYSTROPHY; PELD],619112[NEURONOPATHY, DISTAL HEREDITARY MOTOR, TYPE VC; HMN5C]
FBgn0040333	brv3	HGNC:9015	OMIM:604670	PKDREJ	3		
FBgn0040333	brv3	HGNC:9011	OMIM:604532	PKD2L1	3		
FBgn0040333	brv3	HGNC:18053	OMIM:609721	PKD1L1	4	617205	617205[HETEROTAXY, VISCERAL, 8, AUTOSOMAL; HTX8]
FBgn0040333	brv3	HGNC:21716	OMIM:607895	PKD1L3	3		
FBgn0040334	Tsp3A	HGNC:13594		TSPAN17	3		
FBgn0040334	Tsp3A	HGNC:28743	OMIM:610120	TSPAN33	10		
FBgn0040334	Tsp3A	HGNC:23303		TSPAN14	3		
FBgn0040334	Tsp3A	HGNC:17753	OMIM:613136	TSPAN5	3		
FBgn0029629	eIF3g1	HGNC:3274	OMIM:603913	EIF3G	13		
FBgn0011566	Smyd3	HGNC:15513	OMIM:608783	SMYD3	14		
FBgn0011566	Smyd3	HGNC:20982	OMIM:610663	SMYD2	10		
FBgn0011566	Smyd3	HGNC:20986	OMIM:606846	SMYD1	9		
FBgn0011606	Klp3A	HGNC:13339	OMIM:300521	KIF4A	13	300923	300923[INTELLECTUAL DEVELOPMENTAL DISORDER, X-LINKED 100; XLID100]
FBgn0011606	Klp3A	HGNC:6322	OMIM:609184	KIF4B	11		
FBgn0040375	CG13760	HGNC:14237	OMIM:619171	GUCD1	13		
FBgn0040377	Vha36-3	HGNC:13527	OMIM:609398	ATP6V1D	13		
FBgn0040388	boi	HGNC:17104	OMIM:608707	CDON	5	614226	614226[HOLOPROSENCEPHALY 11; HPE11]
FBgn0040388	boi	HGNC:17173	OMIM:608708	BOC	6		
FBgn0003714	tko	HGNC:10380	OMIM:603021	MRPS12	14		
FBgn0001150	gt	HGNC:11722	OMIM:188595	TEF	3		
FBgn0003371	sgg	HGNC:4617	OMIM:605004	GSK3B	12		
FBgn0003371	sgg	HGNC:4616	OMIM:606784	GSK3A	11		
FBgn0003068	per	HGNC:8846	OMIM:603426	PER2	7	604348	604348[ADVANCED SLEEP PHASE SYNDROME, FAMILIAL, 1; FASPS1]
FBgn0003068	per	HGNC:8845	OMIM:602260	PER1	6		
FBgn0003068	per	HGNC:8847	OMIM:603427	PER3	8	616882	616882[ADVANCED SLEEP PHASE SYNDROME, FAMILIAL, 3; FASPS3]
FBgn0024993	CG2662	HGNC:17958		SAMD1	3		
FBgn0024993	CG2662	HGNC:24582		SAMD13	4		
FBgn0024996	eIF2Bbeta	HGNC:3258	OMIM:606454	EIF2B2	15	603896	603896[LEUKOENCEPHALOPATHY WITH VANISHING WHITE MATTER; VWM]
FBgn0024997	CG2681	HGNC:10857	OMIM:602212	SIAH1	4	619314	619314[BURATTI-HAREL SYNDROME; BURHAS]
FBgn0024997	CG2681	HGNC:10858	OMIM:602213	SIAH2	4		
FBgn0024997	CG2681	HGNC:30553	OMIM:615609	SIAH3	3		
FBgn0024991	CG2694	HGNC:15805	OMIM:300369	GCNA	4	301077	301077[SPERMATOGENIC FAILURE, X-LINKED, 4; SPGFX4]
FBgn0040356	CG12498	HGNC:28996	OMIM:611633	RTF1	4		
FBgn0003996	w	HGNC:73	OMIM:603076	ABCG1	6		
FBgn0003996	w	HGNC:13884	OMIM:607784	ABCG4	5		
FBgn0003996	w	HGNC:74	OMIM:603756	ABCG2	8	138900,614490	138900[URIC ACID CONCENTRATION, SERUM, QUANTITATIVE TRAIT LOCUS 1; UAQTL1],614490[BLOOD GROUP, JUNIOR SYSTEM; JR]
FBgn0003996	w	HGNC:13887	OMIM:605460	ABCG8	4	210250,611465	210250[SITOSTEROLEMIA 1; STSL1],611465[GALLBLADDER DISEASE 4; GBD4]
FBgn0040384	CG32795	HGNC:32008	OMIM:616551	TMEM120B	13		
FBgn0040384	CG32795	HGNC:21697	OMIM:616550	TMEM120A	11		
FBgn0024980	Syx4	HGNC:11433	OMIM:186590	STX1A	5		
FBgn0024980	Syx4	HGNC:11438	OMIM:600876	STX3	4	619445,619446	619445[DIARRHEA 12, WITH MICROVILLUS ATROPHY; DIAR12],619446[RETINAL DYSTROPHY AND MICROVILLUS INCLUSION DISEASE; RDMVID]
FBgn0024980	Syx4	HGNC:3403	OMIM:132350	STX2	4		
FBgn0024980	Syx4	HGNC:11439	OMIM:186591	STX4	4		
FBgn0024980	Syx4	HGNC:11429	OMIM:605014	STX11	5	603552	603552[HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS, FAMILIAL, 4; FHL4]
FBgn0024980	Syx4	HGNC:19300		STX19	5		
FBgn0000376	crm	HGNC:14122		CRAMP1	9		
FBgn0024973	CG2701	HGNC:24103	OMIM:614216	ASCC2	14		
FBgn0024998	CG2685	HGNC:16461	OMIM:618083	WBP11	12	619227	619227[VERTEBRAL, CARDIAC, TRACHEOESOPHAGEAL, RENAL, AND LIMB DEFECTS; VCTERL]
FBgn0024995	CG2680	HGNC:30042	OMIM:617231	LHPP	5		
FBgn0024995	CG2680	HGNC:30259	OMIM:609246	PDXP	4		
FBgn0024995	CG2680	HGNC:8909	OMIM:172280	PGP	4		
FBgn0024994	Ugalt	HGNC:11021	OMIM:605634	SLC35A1	4	603585	603585[CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIf; CDG2F]
FBgn0024994	Ugalt	HGNC:11022	OMIM:314375	SLC35A2	13	300896	300896[CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIm; CDG2M]
FBgn0024994	Ugalt	HGNC:11023	OMIM:605632	SLC35A3	7	615553	615553[ARTHROGRYPOSIS, IMPAIRED INTELLECTUAL DEVELOPMENT, AND SEIZURES; AMRS]
FBgn0024992	Spg7	HGNC:315	OMIM:604581	AFG3L2	4	610246,614487,618977	610246[SPINOCEREBELLAR ATAXIA 28; SCA28],614487[SPASTIC ATAXIA 5, AUTOSOMAL RECESSIVE; SPAX5],618977[OPTIC ATROPHY 12; OPA12]
FBgn0024992	Spg7	HGNC:12843	OMIM:607472	YME1L1	3	617302	617302[OPTIC ATROPHY 11; OPA11]
FBgn0024992	Spg7	HGNC:11237	OMIM:602783	SPG7	13	607259	607259[SPASTIC PARAPLEGIA 7, AUTOSOMAL RECESSIVE; SPG7]
FBgn0025838	CG2652	HGNC:24859	OMIM:602116	YEATS4	3		
FBgn0011276	HLH3B	HGNC:11557	OMIM:186855	TAL2	7	613065	613065[LEUKEMIA, ACUTE LYMPHOBLASTIC; ALL]
FBgn0011276	HLH3B	HGNC:11556	OMIM:187040	TAL1	6	613065	613065[LEUKEMIA, ACUTE LYMPHOBLASTIC; ALL]
FBgn0011276	HLH3B	HGNC:6734	OMIM:151440	LYL1	5	151440	151440[LYMPHOBLASTIC LEUKEMIA-DERIVED SEQUENCE 1; LYL1]
FBgn0004647	N	HGNC:7882	OMIM:600275	NOTCH2	10	102500,610205	102500[HAJDU-CHENEY SYNDROME; HJCYS],610205[ALAGILLE SYNDROME 2; ALGS2]
FBgn0004647	N	HGNC:7883	OMIM:600276	NOTCH3	10	125310,130720,615293	125310[CEREBRAL ARTERIOPATHY, AUTOSOMAL DOMINANT, WITH SUBCORTICAL INFARCTS AND LEUKOENCEPHALOPATHY, TYPE 1; CADASIL1],130720[LATERAL MENINGOCELE SYNDROME; LMNS],615293[MYOFIBROMATOSIS, INFANTILE, 2; IMF2]
FBgn0004647	N	HGNC:7881	OMIM:190198	NOTCH1	12	109730,616028	109730[AORTIC VALVE DISEASE 1; AOVD1],616028[ADAMS-OLIVER SYNDROME 5; AOS5]
FBgn0004647	N	HGNC:7884	OMIM:164951	NOTCH4	5		
FBgn0040396	CG3939	HGNC:28218	OMIM:616967	TXNDC17	9		
FBgn0000479	dnc	HGNC:8781	OMIM:600127	PDE4B	12		
FBgn0000479	dnc	HGNC:8795	OMIM:602973	PDE9A	3		
FBgn0000479	dnc	HGNC:8783	OMIM:600129	PDE4D	10	614613	614613[ACRODYSOSTOSIS 2 WITH OR WITHOUT HORMONE RESISTANCE; ACRDYS2]
FBgn0000479	dnc	HGNC:8780	OMIM:600126	PDE4A	8		
FBgn0000479	dnc	HGNC:8782	OMIM:600128	PDE4C	9		
FBgn0029662	CG12206	HGNC:31673	OMIM:613283	GRXCR1	9	613285	613285[DEAFNESS, AUTOSOMAL RECESSIVE 25; DFNB25]
FBgn0029662	CG12206	HGNC:33862	OMIM:615762	GRXCR2	4	615837	615837[DEAFNESS, AUTOSOMAL RECESSIVE 101; DFNB101]
FBgn0029661	CG16781	HGNC:26025	OMIM:610637	MARCHF5	7		
FBgn0028746	CG18508	HGNC:31690	OMIM:619979	C18orf32	5	619985	619985[GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 25; GPIBD25]
FBgn0040355	CG3526	HGNC:20589	OMIM:614719	KCMF1	3		
FBgn0029648	CG3603	HGNC:3554	OMIM:601417	HSD17B8	15		
FBgn0029648	CG3603	HGNC:25891	OMIM:619394	CBR4	5		
FBgn0028369	kirre	HGNC:23204	OMIM:607761	KIRREL3	11		
FBgn0028369	kirre	HGNC:15734	OMIM:607428	KIRREL1	11	619201	619201[NEPHROTIC SYNDROME, TYPE 23; NPHS23]
FBgn0028369	kirre	HGNC:18816	OMIM:607762	KIRREL2	10		
FBgn0003285	rst	HGNC:23204	OMIM:607761	KIRREL3	12		
FBgn0003285	rst	HGNC:15734	OMIM:607428	KIRREL1	13	619201	619201[NEPHROTIC SYNDROME, TYPE 23; NPHS23]
FBgn0003285	rst	HGNC:18816	OMIM:607762	KIRREL2	11		
FBgn0029664	CG10802	HGNC:43946		PTGES3L-AARSD1	7		
FBgn0029664	CG10802	HGNC:28417	OMIM:613212	AARSD1	10		
FBgn0029666	CG10803	HGNC:11313	OMIM:600063	RO60	13		
FBgn0052792	ppk8	HGNC:101	OMIM:611741	ASIC3	7		
FBgn0052792	ppk8	HGNC:100	OMIM:602866	ASIC1	6		
FBgn0052792	ppk8	HGNC:21263	OMIM:606715	ASIC4	7		
FBgn0052792	ppk8	HGNC:99	OMIM:601784	ASIC2	7		
FBgn0052792	ppk8	HGNC:17537	OMIM:616693	ASIC5	7		
FBgn0052792	ppk8	HGNC:10599	OMIM:600228	SCNN1A	4	264350,613021,618126	264350[PSEUDOHYPOALDOSTERONISM, TYPE I, AUTOSOMAL RECESSIVE; PHA1B],613021[BRONCHIECTASIS WITH OR WITHOUT ELEVATED SWEAT CHLORIDE 2; BESC2],618126[LIDDLE SYNDROME 3; LIDLS3]
FBgn0052792	ppk8	HGNC:10600	OMIM:600760	SCNN1B	4	177200,211400,264350	177200[LIDDLE SYNDROME 1; LIDLS1],211400[BRONCHIECTASIS WITH OR WITHOUT ELEVATED SWEAT CHLORIDE 1; BESC1],264350[PSEUDOHYPOALDOSTERONISM, TYPE I, AUTOSOMAL RECESSIVE; PHA1B]
FBgn0052792	ppk8	HGNC:10601	OMIM:601328	SCNN1D	4		
FBgn0052792	ppk8	HGNC:10602	OMIM:600761	SCNN1G	3	264350,613071,618114	264350[PSEUDOHYPOALDOSTERONISM, TYPE I, AUTOSOMAL RECESSIVE; PHA1B],613071[BRONCHIECTASIS WITH OR WITHOUT ELEVATED SWEAT CHLORIDE 3; BESC3],618114[LIDDLE SYNDROME 2; LIDLS2]
FBgn0023215	Mnt	HGNC:7188	OMIM:603039	MNT	6		
FBgn0015286	Rala	HGNC:9839	OMIM:179550	RALA	13	619311	619311[HIATT-NEU-COOPER NEURODEVELOPMENTAL SYNDROME; HINCONS]
FBgn0015286	Rala	HGNC:9840	OMIM:179551	RALB	9		
FBgn0023216	Parg	HGNC:8605	OMIM:603501	PARG	7		
FBgn0023216	Parg	HGNC:1094	OMIM:603156	BPHL	6		
FBgn0029672	CG2875	HGNC:28461	OMIM:612819	NOC4L	13		
FBgn0052791	DIP-alpha	HGNC:17302	OMIM:613173	NEGR1	6		
FBgn0052791	DIP-alpha	HGNC:34550	OMIM:618861	IGLON5	6		
FBgn0052791	DIP-alpha	HGNC:6705	OMIM:603241	LSAMP	7		
FBgn0052791	DIP-alpha	HGNC:8143	OMIM:600632	OPCML	7	167000	167000[OVARIAN CANCER]
FBgn0052791	DIP-alpha	HGNC:17941	OMIM:607938	NTM	7		
FBgn0029667	Gas8	HGNC:4166	OMIM:605178	GAS8	13	616726	616726[CILIARY DYSKINESIA, PRIMARY, 33; CILD33]
FBgn0029665	CG14270	HGNC:25152	OMIM:617380	TIMM29	13		
FBgn0029663	CG10804	HGNC:31399	OMIM:610299	SLC6A17	4	616269	616269[INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 48; MRT48]
FBgn0029663	CG10804	HGNC:13621	OMIM:607971	SLC6A15	5		
FBgn0029663	CG10804	HGNC:27960	OMIM:608893	SLC6A19	6	138500,234500,242600	138500[HYPERGLYCINURIA],234500[HARTNUP DISORDER; HND],242600[IMINOGLYCINURIA]
FBgn0029663	CG10804	HGNC:26441	OMIM:610300	SLC6A18	7		
FBgn0029663	CG10804	HGNC:30927	OMIM:605616	SLC6A20	5	138500,242600	138500[HYPERGLYCINURIA],242600[IMINOGLYCINURIA]
FBgn0028491	CG2930	HGNC:10920	OMIM:600544	SLC15A1	14		
FBgn0028491	CG2930	HGNC:10921	OMIM:602339	SLC15A2	12		
FBgn0028491	CG2930	HGNC:18068	OMIM:610408	SLC15A3	3		
FBgn0028491	CG2930	HGNC:23090	OMIM:615806	SLC15A4	4		
FBgn0028491	CG2930	HGNC:33455		SLC15A5	3		
FBgn0029687	Vap33	HGNC:12649	OMIM:605704	VAPB	13	182980,608627	182980[SPINAL MUSCULAR ATROPHY, LATE-ONSET, FINKEL TYPE; SMAFK],608627[AMYOTROPHIC LATERAL SCLEROSIS 8; ALS8]
FBgn0029687	Vap33	HGNC:12648	OMIM:605703	VAPA	12		
FBgn0029690	CG6414	HGNC:26741		CES4A	5		
FBgn0029690	CG6414	HGNC:108	OMIM:100740	ACHE	4	112100	112100[YT BLOOD GROUP ANTIGEN]
FBgn0029690	CG6414	HGNC:983	OMIM:177400	BCHE	3	617936	617936[BUTYRYLCHOLINESTERASE DEFICIENCY; BCHED]
FBgn0029690	CG6414	HGNC:26459	OMIM:618678	CES5A	5		
FBgn0029690	CG6414	HGNC:1863	OMIM:114835	CES1	7	618057	618057[DRUG METABOLISM, ALTERED, CES1-RELATED]
FBgn0029690	CG6414	HGNC:1864	OMIM:605278	CES2	6		
FBgn0029690	CG6414	HGNC:1865	OMIM:605279	CES3	5		
FBgn0029689	CG6428	HGNC:20123	OMIM:618472	ASPG	13		
FBgn0029685	CG2938	HGNC:16014	OMIM:611686	CASD1	14		
FBgn0000221	brn	HGNC:918	OMIM:603094	B3GALNT1	6	111400,615021	111400[BLOOD GROUP, P1PK SYSTEM],615021[BLOOD GROUP, GLOBOSIDE SYSTEM; GLOB]
FBgn0000221	brn	HGNC:916	OMIM:603093	B3GALT1	8		
FBgn0000221	brn	HGNC:15684	OMIM:615333	B3GNT5	7		
FBgn0000221	brn	HGNC:917	OMIM:603018	B3GALT2	6		
FBgn0000221	brn	HGNC:920	OMIM:604066	B3GALT5	6		
FBgn0000221	brn	HGNC:15629	OMIM:605581	B3GNT2	6		
FBgn0000221	brn	HGNC:15683	OMIM:605864	B3GNT4	6		
FBgn0000221	brn	HGNC:28714		B3GNT9	8		
FBgn0000221	brn	HGNC:18811	OMIM:615313	B3GNT7	7		
FBgn0000221	brn	HGNC:24141	OMIM:615315	B3GNT6	9		
FBgn0000221	brn	HGNC:24139	OMIM:615357	B3GNT8	6		
FBgn0000221	brn	HGNC:13528	OMIM:605863	B3GNT3	9		
FBgn0026084	cib	HGNC:11881	OMIM:300159	TMSB4X	5		
FBgn0026084	cib	HGNC:11879	OMIM:188399	TMSB10	3		
FBgn0066114	GlcAT-I	HGNC:923	OMIM:606374	B3GAT3	14	245600	245600[MULTIPLE JOINT DISLOCATIONS, SHORT STATURE, AND CRANIOFACIAL DYSMORPHISM WITH OR WITHOUT CONGENITAL HEART DEFECTS; JDSCD]
FBgn0066114	GlcAT-I	HGNC:922	OMIM:607497	B3GAT2	5		
FBgn0066114	GlcAT-I	HGNC:921	OMIM:151290	B3GAT1	7		
FBgn0029706	CG3626	HGNC:30264	OMIM:617835	PDPR	12		
FBgn0040907	mRpL33	HGNC:14487	OMIM:610059	MRPL33	9		
FBgn0002707	mei-9	HGNC:3436	OMIM:133520	ERCC4	14	278760,610965,615272	278760[XERODERMA PIGMENTOSUM, COMPLEMENTATION GROUP F; XPF],610965[XFE PROGEROID SYNDROME; XFEPS],615272[FANCONI ANEMIA, COMPLEMENTATION GROUP Q; FANCQ]
FBgn0000635	Fas2	HGNC:7657	OMIM:602040	NCAM2	11		
FBgn0000635	Fas2	HGNC:7656	OMIM:116930	NCAM1	11		
FBgn0026080	Tip60	HGNC:17016	OMIM:609880	KAT7	3		
FBgn0026080	Tip60	HGNC:5275	OMIM:601409	KAT5	13	619103	619103[NEURODEVELOPMENTAL DISORDER WITH DYSMORPHIC FACIES, SLEEP DISTURBANCE, AND BRAIN ABNORMALITIES; NEDFASB]
FBgn0026080	Tip60	HGNC:17933	OMIM:609912	KAT8	5	618974	618974[LI-GHORBANI-WEISZ-HUBSHMAN SYNDROME; LIGOWS]
FBgn0026079	Nsun2	HGNC:25994	OMIM:610916	NSUN2	14	611091	611091[INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 5; MRT5]
FBgn0004832	Xpac	HGNC:12814	OMIM:611153	XPA	15	278700	278700[XERODERMA PIGMENTOSUM, COMPLEMENTATION GROUP A; XPA]
FBgn0029693	Cmtr1	HGNC:21077	OMIM:616189	CMTR1	12		
FBgn0000179	bi	HGNC:11602	OMIM:601621	TBX3	10	181450	181450[ULNAR-MAMMARY SYNDROME; UMS]
FBgn0000179	bi	HGNC:11597	OMIM:600747	TBX2	11	618223	618223[VERTEBRAL ANOMALIES AND VARIABLE ENDOCRINE AND T-CELL DYSFUNCTION; VETD]
FBgn0029708	CG3556	HGNC:4268	OMIM:609342	CBLIF	4	261000	261000[INTRINSIC FACTOR DEFICIENCY; IFD]
FBgn0029708	CG3556	HGNC:11652	OMIM:189905	TCN1	5		
FBgn0029708	CG3556	HGNC:11653	OMIM:613441	TCN2	4	275350	275350[TRANSCOBALAMIN II DEFICIENCY]
FBgn0029709	CHOp24	HGNC:16996	OMIM:619642	TMED2	13		
FBgn0029712	CG15912	HGNC:28171		HDHD3	15		
FBgn0029714	CG3527	HGNC:16912	OMIM:611531	EMG1	13	211180	211180[BOWEN-CONRADI SYNDROME; BWCNS]
FBgn0022768	Pp2C1	HGNC:9277	OMIM:605100	PPM1D	9	114480,617450	114480[BREAST CANCER],617450[JANSEN-DE VRIES SYNDROME; JDVS]
FBgn0029715	CG11444	HGNC:14634	OMIM:607075	PDAP1	13		
FBgn0029713	CG11436	HGNC:25596	OMIM:619388	TTC17	8		
FBgn0029711	Usf	HGNC:12593	OMIM:191523	USF1	9	602491	602491[HYPERLIPIDEMIA, FAMILIAL COMBINED, 1; FCHL1]
FBgn0029711	Usf	HGNC:12594	OMIM:600390	USF2	8		
FBgn0003210	rb	HGNC:566	OMIM:603401	AP3B1	13	608233	608233[HERMANSKY-PUDLAK SYNDROME 2; HPS2]
FBgn0003210	rb	HGNC:567	OMIM:602166	AP3B2	12	617276	617276[DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 48; DEE48]
FBgn0003210	rb	HGNC:563	OMIM:601025	AP2B1	3		
FBgn0003210	rb	HGNC:572	OMIM:607245	AP4B1	3	614066	614066[SPASTIC PARAPLEGIA 47, AUTOSOMAL RECESSIVE; SPG47]
FBgn0011760	ctp	HGNC:24596	OMIM:608942	DYNLL2	13		
FBgn0011760	ctp	HGNC:15476	OMIM:601562	DYNLL1	9		
FBgn0028325	Pdha	HGNC:8807	OMIM:179061	PDHA2	15	619828	619828[SPERMATOGENIC FAILURE 70; SPGF70]
FBgn0028325	Pdha	HGNC:8806	OMIM:300502	PDHA1	14	312170	312170[PYRUVATE DEHYDROGENASE E1-ALPHA DEFICIENCY; PDHAD]
FBgn0029722	CG7024	HGNC:8807	OMIM:179061	PDHA2	10	619828	619828[SPERMATOGENIC FAILURE 70; SPGF70]
FBgn0029722	CG7024	HGNC:8806	OMIM:300502	PDHA1	10	312170	312170[PYRUVATE DEHYDROGENASE E1-ALPHA DEFICIENCY; PDHAD]
FBgn0029727	CG6978	HGNC:20151	OMIM:607557	SLC17A8	4	605583	605583[DEAFNESS, AUTOSOMAL DOMINANT 25; DFNA25]
FBgn0029727	CG6978	HGNC:10933	OMIM:604322	SLC17A5	5	269920,604369	269920[INFANTILE SIALIC ACID STORAGE DISEASE; ISSD],604369[SALLA DISEASE; SD]
FBgn0029727	CG6978	HGNC:16703	OMIM:607563	SLC17A6	4		
FBgn0029727	CG6978	HGNC:16704	OMIM:605208	SLC17A7	4		
FBgn0029727	CG6978	HGNC:10929	OMIM:182308	SLC17A1	4		
FBgn0029727	CG6978	HGNC:10932	OMIM:604216	SLC17A4	4		
FBgn0029727	CG6978	HGNC:10930	OMIM:611049	SLC17A2	6		
FBgn0029727	CG6978	HGNC:10931	OMIM:611034	SLC17A3	5	612671	612671[URIC ACID CONCENTRATION, SERUM, QUANTITATIVE TRAIT LOCUS 4; UAQTL4]
FBgn0029733	CG6927	HGNC:4328	OMIM:600421	GLRA3	3		
FBgn0029733	CG6927	HGNC:4329	OMIM:138492	GLRB	3	614619	614619[HYPEREKPLEXIA 2; HKPX2]
FBgn0029733	CG6927	HGNC:4327	OMIM:305990	GLRA2	3	301076	301076[INTELLECTUAL DEVELOPMENTAL DISORDER, X-LINKED, SYNDROMIC, PILORGE TYPE; MRXSP]
FBgn0029733	CG6927	HGNC:31715		GLRA4	4		
FBgn0029733	CG6927	HGNC:4326	OMIM:138491	GLRA1	3	149400	149400[HYPEREKPLEXIA 1; HKPX1]
FBgn0029737	CG6903	HGNC:26527	OMIM:610453	HGSNAT	14	252930,616544	252930[MUCOPOLYSACCHARIDOSIS, TYPE IIIC; MPS3C],616544[RETINITIS PIGMENTOSA 73; RP73]
FBgn0004368	Ptp4E	HGNC:9665	OMIM:176882	PTPRB	12		
FBgn0004368	Ptp4E	HGNC:9673	OMIM:600925	PTPRJ	6	114500	114500[COLORECTAL CANCER; CRC]
FBgn0004368	Ptp4E	HGNC:9678	OMIM:600579	PTPRO	4	614196	614196[NEPHROTIC SYNDROME, TYPE 6; NPHS6]
FBgn0004368	Ptp4E	HGNC:9672	OMIM:602510	PTPRH	5		
FBgn0025679	Klf15	HGNC:14536	OMIM:606465	KLF15	5		
FBgn0025679	Klf15	HGNC:18830	OMIM:609602	KLF17	3		
FBgn0029745	Rpn13R	HGNC:15759	OMIM:610650	ADRM1	8		
FBgn0003449	snf	HGNC:11155	OMIM:603520	SNRPB2	10		
FBgn0003449	snf	HGNC:11151	OMIM:182285	SNRPA	12		
FBgn0011761	dhd	HGNC:12435	OMIM:187700	TXN	7		
FBgn0011761	dhd	HGNC:17772	OMIM:609063	TXN2	3	616811	616811[COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 29; COXPD29]
FBgn0011761	dhd	HGNC:16470	OMIM:617790	TXNDC2	4		
FBgn0011761	dhd	HGNC:31454	OMIM:617789	TXNDC8	5		
FBgn0029755	Sas10	HGNC:24477	OMIM:611614	UTP3	14		
FBgn0014024	Rnp4F	HGNC:16860	OMIM:611684	SART3	11		
FBgn0029752	TrxT	HGNC:12435	OMIM:187700	TXN	11		
FBgn0029752	TrxT	HGNC:17772	OMIM:609063	TXN2	3	616811	616811[COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 29; COXPD29]
FBgn0029752	TrxT	HGNC:16470	OMIM:617790	TXNDC2	5		
FBgn0029752	TrxT	HGNC:31454	OMIM:617789	TXNDC8	5		
FBgn0029747	CG5062	HGNC:17229	OMIM:605152	CFAP45	4	619608	619608[HETEROTAXY, VISCERAL, 11, AUTOSOMAL, WITH MALE INFERTILITY; HTX11]
FBgn0026751	XRCC1	HGNC:12828	OMIM:194360	XRCC1	11	617633	617633[SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 26; SCAR26]
FBgn0010014	CanB	HGNC:9317	OMIM:601302	PPP3R1	12		
FBgn0010014	CanB	HGNC:9318	OMIM:613821	PPP3R2	7		
FBgn0029761	SK	HGNC:6292	OMIM:602983	KCNN3	10	618658	618658[ZIMMERMANN-LABAND SYNDROME 3; ZLS3]
FBgn0029761	SK	HGNC:6291	OMIM:605879	KCNN2	10	619724,619725	619724[DYSTONIA 34, MYOCLONIC; DYT34],619725[NEURODEVELOPMENTAL DISORDER WITH OR WITHOUT VARIABLE MOVEMENT OR BEHAVIORAL ABNORMALITIES; NEDMAB]
FBgn0029761	SK	HGNC:6290	OMIM:602982	KCNN1	11		
FBgn0029761	SK	HGNC:6293	OMIM:602754	KCNN4	4	616689	616689[DEHYDRATED HEREDITARY STOMATOCYTOSIS 2; DHS2]
FBgn0029763	Usp16-45	HGNC:20080	OMIM:618439	USP45	11	618513	618513[LEBER CONGENITAL AMAUROSIS 19; LCA19]
FBgn0029763	Usp16-45	HGNC:12614	OMIM:604735	USP16	9		
FBgn0029765	CG16756	HGNC:28387	OMIM:612750	LYZL4	7		
FBgn0029765	CG16756	HGNC:31353	OMIM:300593	SPACA5	5		
FBgn0029765	CG16756	HGNC:19142		SPACA5B	7		
FBgn0029765	CG16756	HGNC:29613	OMIM:612748	LYZL2	8		
FBgn0029765	CG16756	HGNC:16260	OMIM:612749	SPACA3	8		
FBgn0029765	CG16756	HGNC:6480	OMIM:149750	LALBA	6		
FBgn0029765	CG16756	HGNC:6740	OMIM:153450	LYZ	7	105200	105200[AMYLOIDOSIS, FAMILIAL VISCERAL]
FBgn0029765	CG16756	HGNC:30502		LYZL1	8		
FBgn0029765	CG16756	HGNC:29614	OMIM:612751	LYZL6	8		
FBgn0029771	CG12730	HGNC:19178	OMIM:607890	CMTM7	3		
FBgn0029771	CG12730	HGNC:19175	OMIM:607887	CMTM4	4		
FBgn0026702	Pop1	HGNC:30129	OMIM:602486	POP1	14	617396	617396[ANAUXETIC DYSPLASIA 2; ANXD2]
FBgn0004687	Mlc-c	HGNC:29823	OMIM:609930	MYL6B	12		
FBgn0004687	Mlc-c	HGNC:7587	OMIM:609931	MYL6	14		
FBgn0004687	Mlc-c	HGNC:7584	OMIM:160790	MYL3	10	608751	608751[CARDIOMYOPATHY, FAMILIAL HYPERTROPHIC, 8; CMH8]
FBgn0004687	Mlc-c	HGNC:7582	OMIM:160780	MYL1	12	618414	618414[MYOPATHY, CONGENITAL, WITH FAST-TWITCH (TYPE II) FIBER ATROPHY; MYOFTA]
FBgn0004687	Mlc-c	HGNC:7585	OMIM:160770	MYL4	10	617280	617280[ATRIAL FIBRILLATION, FAMILIAL, 18; ATFB18]
FBgn0029778	RhoGAP5A	HGNC:1943	OMIM:118423	CHN1	15	604356	604356[DUANE RETRACTION SYNDROME 2; DURS2]
FBgn0029778	RhoGAP5A	HGNC:1944	OMIM:602857	CHN2	13		
FBgn0029778	RhoGAP5A	HGNC:30207	OMIM:610496	ARHGAP29	3		
FBgn0029769	frma	HGNC:6308	OMIM:613883	KEL	4	110900	110900[BLOOD GROUP--KELL SYSTEM; KEL]
FBgn0029762	NAAT1	HGNC:11049	OMIM:126455	SLC6A3	3	188890,613135	188890[TOBACCO ADDICTION, SUSCEPTIBILITY TO],613135[PARKINSONISM-DYSTONIA 1, INFANTILE-ONSET; PKDYS1]
FBgn0029762	NAAT1	HGNC:11044	OMIM:607952	SLC6A11	3		
FBgn0029762	NAAT1	HGNC:31399	OMIM:610299	SLC6A17	4	616269	616269[INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 48; MRT48]
FBgn0029762	NAAT1	HGNC:11045	OMIM:603080	SLC6A12	3		
FBgn0029762	NAAT1	HGNC:11054	OMIM:606205	SLC6A7	4		
FBgn0029762	NAAT1	HGNC:11048	OMIM:163970	SLC6A2	3	604715	604715[ORTHOSTATIC INTOLERANCE]
FBgn0029762	NAAT1	HGNC:13621	OMIM:607971	SLC6A15	4		
FBgn0029762	NAAT1	HGNC:11050	OMIM:182138	SLC6A4	3	164230,607834	164230[OBSESSIVE-COMPULSIVE DISORDER; OCD],607834[ANXIETY]
FBgn0029762	NAAT1	HGNC:11055	OMIM:300036	SLC6A8	3	300352	300352[CEREBRAL CREATINE DEFICIENCY SYNDROME 1; CCDS1]
FBgn0029762	NAAT1	HGNC:11056	OMIM:601019	SLC6A9	4	617301	617301[GLYCINE ENCEPHALOPATHY WITH NORMAL SERUM GLYCINE]
FBgn0029762	NAAT1	HGNC:11051	OMIM:604159	SLC6A5	4	614618	614618[HYPEREKPLEXIA 3; HKPX3]
FBgn0029762	NAAT1	HGNC:11047	OMIM:300444	SLC6A14	3		
FBgn0029762	NAAT1	HGNC:11052	OMIM:186854	SLC6A6	3	145350	145350[HYPOTAURINEMIC RETINAL DEGENERATION AND CARDIOMYOPATHY; HTRDC]
FBgn0029762	NAAT1	HGNC:11046	OMIM:615097	SLC6A13	3		
FBgn0029762	NAAT1	HGNC:11042	OMIM:137165	SLC6A1	3	616421	616421[MYOCLONIC-ATONIC EPILEPSY; MAE]
FBgn0029762	NAAT1	HGNC:13622	OMIM:607972	SLC6A16	4		
FBgn0029756	CG3309	HGNC:32690		DENND6B	13		
FBgn0029756	CG3309	HGNC:26635		DENND6A	13		
FBgn0028474	CG4119	HGNC:23244	OMIM:612427	RBM25	13		
FBgn0029785	RpL35	HGNC:10344	OMIM:618315	RPL35	14	618312	618312[DIAMOND-BLACKFAN ANEMIA 19; DBA19]
FBgn0000394	cv	HGNC:12429	OMIM:605049	TWSG1	14		
FBgn0029791	AdamTS-B	HGNC:13202	OMIM:605421	ADAMTS9	3		
FBgn0029791	AdamTS-B	HGNC:17178	OMIM:611681	ADAMTS20	3		
FBgn0029791	AdamTS-B	HGNC:221	OMIM:605007	ADAMTS5	3		
FBgn0029791	AdamTS-B	HGNC:220	OMIM:603876	ADAMTS4	3		
FBgn0029791	AdamTS-B	HGNC:217	OMIM:605174	ADAMTS1	4		
FBgn0029791	AdamTS-B	HGNC:224	OMIM:605175	ADAMTS8	3		
FBgn0029791	AdamTS-B	HGNC:19706	OMIM:610113	ADAMTSL4	3	225100,225200	225100[ECTOPIA LENTIS 2, ISOLATED, AUTOSOMAL RECESSIVE; ECTOL2],225200[ECTOPIA LENTIS ET PUPILLAE]
FBgn0029791	AdamTS-B	HGNC:25835	OMIM:614476	THSD4	3	619825	619825[AORTIC ANEURYSM, FAMILIAL THORACIC 12; AAT12]
FBgn0029791	AdamTS-B	HGNC:17108	OMIM:607510	ADAMTS16	5		
FBgn0029791	AdamTS-B	HGNC:17110	OMIM:607512	ADAMTS18	5	615458	615458[MICROCORNEA, MYOPIC CHORIORETINAL ATROPHY, AND TELECANTHUS; MMCAT]
FBgn0029791	AdamTS-B	HGNC:1366	OMIM:604134	ADAMTS13	4	274150	274150[THROMBOTIC THROMBOCYTOPENIC PURPURA, HEREDITARY; TTP]
FBgn0029791	AdamTS-B	HGNC:223	OMIM:605009	ADAMTS7	11		
FBgn0029791	AdamTS-B	HGNC:222	OMIM:605008	ADAMTS6	5		
FBgn0029791	AdamTS-B	HGNC:14605	OMIM:606184	ADAMTS12	10		
FBgn0029791	AdamTS-B	HGNC:13201	OMIM:608990	ADAMTS10	5	277600	277600[WEILL-MARCHESANI SYNDROME 1; WMS1]
FBgn0029791	AdamTS-B	HGNC:19262	OMIM:617785	PAPLN	3		
FBgn0029791	AdamTS-B	HGNC:17109	OMIM:607511	ADAMTS17	4	613195	613195[WEILL-MARCHESANI SYNDROME 4; WMS4]
FBgn0029791	AdamTS-B	HGNC:17111	OMIM:607513	ADAMTS19	4		
FBgn0029791	AdamTS-B	HGNC:14631	OMIM:612277	ADAMTSL2	3	231050	231050[GELEOPHYSIC DYSPLASIA 1; GPHYSD1]
FBgn0029791	AdamTS-B	HGNC:219	OMIM:605011	ADAMTS3	3	618154	618154[HENNEKAM LYMPHANGIECTASIA-LYMPHEDEMA SYNDROME 3; HKLLS3]
FBgn0029791	AdamTS-B	HGNC:218	OMIM:604539	ADAMTS2	3	225410	225410[EHLERS-DANLOS SYNDROME, DERMATOSPARAXIS TYPE; EDSDERMS]
FBgn0029791	AdamTS-B	HGNC:14899	OMIM:607506	ADAMTS14	3		
FBgn0029791	AdamTS-B	HGNC:27912		ADAMTSL5	3		
FBgn0029798	Rtel1	HGNC:15888	OMIM:608833	RTEL1	13	615190,616373	615190[DYSKERATOSIS CONGENITA, AUTOSOMAL RECESSIVE 5; DKCB5],616373[PULMONARY FIBROSIS AND/OR BONE MARROW FAILURE, TELOMERE-RELATED, 3; PFBMFT3]
FBgn0029798	Rtel1	HGNC:20473	OMIM:605882	BRIP1	5	114480,609054	114480[BREAST CANCER],609054[FANCONI ANEMIA, COMPLEMENTATION GROUP J; FANCJ]
FBgn0029801	CG15771	HGNC:16140	OMIM:610763	NANP	13		
FBgn0029812	Prosbeta2R1	HGNC:9544	OMIM:604030	PSMB7	7		
FBgn0029812	Prosbeta2R1	HGNC:9538	OMIM:176847	PSMB10	5	619175	619175[PROTEASOME-ASSOCIATED AUTOINFLAMMATORY SYNDROME 5; PRAAS5]
FBgn0029816	CG12729	HGNC:9571	OMIM:617858	PSMF1	5		
FBgn0029820	CG16721	HGNC:25655		TCP11L1	14		
FBgn0029820	CG16721	HGNC:11658	OMIM:186982	TCP11	11		
FBgn0029820	CG16721	HGNC:8072	OMIM:300315	NXF2	5		
FBgn0029820	CG16721	HGNC:48335		TCP11X2	6		
FBgn0029820	CG16721	HGNC:28627	OMIM:619889	TCP11L2	12		
FBgn0029820	CG16721	HGNC:48369		TCP11X1	4		
FBgn0029821	CG4020	HGNC:26222	OMIM:616107	FAR1	6	616154,619338	616154[PEROXISOMAL FATTY ACYL-CoA REDUCTASE 1 DISORDER; PFCRD],619338[CATARACTS, SPASTIC PARAPARESIS, AND SPEECH DELAY; CSPSD]
FBgn0029821	CG4020	HGNC:25531	OMIM:616156	FAR2	5		
FBgn0029823	Shmt	HGNC:10852	OMIM:138450	SHMT2	8	619121	619121[NEURODEVELOPMENTAL DISORDER WITH CARDIOMYOPATHY, SPASTICITY, AND BRAIN ABNORMALITIES; NEDCASB]
FBgn0029823	Shmt	HGNC:10850	OMIM:182144	SHMT1	14		
FBgn0029819	Usp30	HGNC:20065	OMIM:612492	USP30	14		
FBgn0014340	mof	HGNC:17016	OMIM:609880	KAT7	3		
FBgn0014340	mof	HGNC:5275	OMIM:601409	KAT5	4	619103	619103[NEURODEVELOPMENTAL DISORDER WITH DYSMORPHIC FACIES, SLEEP DISTURBANCE, AND BRAIN ABNORMALITIES; NEDFASB]
FBgn0014340	mof	HGNC:17933	OMIM:609912	KAT8	13	618974	618974[LI-GHORBANI-WEISZ-HUBSHMAN SYNDROME; LIGOWS]
FBgn0029818	GAA1	HGNC:4446	OMIM:603048	GPAA1	13	617810	617810[GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 15; GPIBD15]
FBgn0029807	CG3108	HGNC:2300	OMIM:603101	CPB2	7		
FBgn0029807	CG3108	HGNC:21011	OMIM:609563	CPO	6		
FBgn0029807	CG3108	HGNC:2298	OMIM:114851	CPA3	6		
FBgn0029807	CG3108	HGNC:2297	OMIM:600688	CPA2	7		
FBgn0029807	CG3108	HGNC:15740	OMIM:607635	CPA4	9		
FBgn0029807	CG3108	HGNC:2299	OMIM:114852	CPB1	6		
FBgn0029807	CG3108	HGNC:2296	OMIM:114850	CPA1	7		
FBgn0029807	CG3108	HGNC:17245	OMIM:609562	CPA6	6	614417,614418	614417[EPILEPSY, FAMILIAL TEMPORAL LOBE, 5; ETL5],614418[FEBRILE SEIZURES, FAMILIAL, 11; FEB11]
FBgn0029807	CG3108	HGNC:15722	OMIM:609561	CPA5	6		
FBgn0029804	CG3097	HGNC:2300	OMIM:603101	CPB2	8		
FBgn0029804	CG3097	HGNC:21011	OMIM:609563	CPO	6		
FBgn0029804	CG3097	HGNC:2298	OMIM:114851	CPA3	7		
FBgn0029804	CG3097	HGNC:2297	OMIM:600688	CPA2	7		
FBgn0029804	CG3097	HGNC:15740	OMIM:607635	CPA4	10		
FBgn0029804	CG3097	HGNC:2299	OMIM:114852	CPB1	6		
FBgn0029804	CG3097	HGNC:2296	OMIM:114850	CPA1	7		
FBgn0029804	CG3097	HGNC:17245	OMIM:609562	CPA6	9	614417,614418	614417[EPILEPSY, FAMILIAL TEMPORAL LOBE, 5; ETL5],614418[FEBRILE SEIZURES, FAMILIAL, 11; FEB11]
FBgn0029804	CG3097	HGNC:15722	OMIM:609561	CPA5	7		
FBgn0013987	MAPk-Ak2	HGNC:6887	OMIM:602006	MAPKAPK2	12		
FBgn0013987	MAPk-Ak2	HGNC:6889	OMIM:606723	MAPKAPK5	3	619869	619869[NEUROCARDIOFACIODIGITAL SYNDROME; NCFD]
FBgn0013987	MAPk-Ak2	HGNC:6888	OMIM:602130	MAPKAPK3	15	617111	617111[MACULAR DYSTROPHY, PATTERNED, 3; MDPT3]
FBgn0029800	lin-52	HGNC:19856		LIN52	12		
FBgn0261383	IntS6	HGNC:27334		INTS6L	12		
FBgn0261383	IntS6	HGNC:14879	OMIM:604331	INTS6	12		
FBgn0261383	IntS6	HGNC:30369	OMIM:300359	SAGE1	3		
FBgn0052758	Snx27	HGNC:20073	OMIM:611541	SNX27	14		
FBgn0053080	CG33080	HGNC:19918	OMIM:618255	MYORG	4	618317	618317[BASAL GANGLIA CALCIFICATION, IDIOPATHIC, 7, AUTOSOMAL RECESSIVE; IBGC7]
FBgn0027564	CG3149	HGNC:30220	OMIM:611908	RFT1	13	612015	612015[CONGENITAL DISORDER OF GLYCOSYLATION, TYPE In; CDG1N]
FBgn0029789	PGAP1	HGNC:25712	OMIM:611655	PGAP1	14	615802	615802[NEURODEVELOPMENTAL DISORDER WITH DYSMORPHIC FEATURES, SPASTICITY, AND BRAIN ABNORMALITIES; NEDDSBA]
FBgn0046687	Tre1	HGNC:7463	OMIM:600665	MTNR1A	6		
FBgn0046687	Tre1	HGNC:7464	OMIM:600804	MTNR1B	5	125853	125853[TYPE 2 DIABETES MELLITUS; T2D]
FBgn0046687	Tre1	HGNC:4506	OMIM:300207	GPR50	4		
FBgn0046687	Tre1	HGNC:4535	OMIM:606383	GPR84	7		
FBgn0015794	Rab18	HGNC:14244	OMIM:602207	RAB18	13	614222	614222[WARBURG MICRO SYNDROME 3; WARBM3]
FBgn0029783	Sirt4	HGNC:14932	OMIM:604482	SIRT4	12		
FBgn0029826	CG6041	HGNC:6358	OMIM:602673	KLK10	3		
FBgn0029827	CG6048	HGNC:30079	OMIM:610477	TMPRSS9	3		
FBgn0029830	Grip	HGNC:18708	OMIM:604597	GRIP1	9	617667	617667[FRASER SYNDROME 3; FRASRS3]
FBgn0029830	Grip	HGNC:23841		GRIP2	7		
FBgn0029831	CG5966	HGNC:9155	OMIM:246600	PNLIP	11	614338	614338[PANCREATIC LIPASE DEFICIENCY; PNLIPD]
FBgn0029831	CG5966	HGNC:17661	OMIM:607460	PLA1A	3		
FBgn0029831	CG5966	HGNC:9156	OMIM:604422	PNLIPRP1	9		
FBgn0029831	CG5966	HGNC:23492		PNLIPRP3	7		
FBgn0029831	CG5966	HGNC:9157	OMIM:604423	PNLIPRP2	6		
FBgn0029833	MCTS1	HGNC:23357	OMIM:300587	MCTS1	14		
FBgn0029834	CG5937	HGNC:21213	OMIM:617411	ARFGEF3	14		
FBgn0029835	CG5921	HGNC:12597	OMIM:605242	USH1C	7	276904,602092	276904[USHER SYNDROME, TYPE IC; USH1C],602092[DEAFNESS, AUTOSOMAL RECESSIVE 18A; DFNB18A]
FBgn0029835	CG5921	HGNC:16361	OMIM:607928	WHRN	3	607084,611383	607084[DEAFNESS, AUTOSOMAL RECESSIVE 31; DFNB31],611383[USHER SYNDROME, TYPE IID; USH2D]
FBgn0029843	Nep1	HGNC:8918	OMIM:300550	PHEX	4	307800	307800[HYPOPHOSPHATEMIC RICKETS, X-LINKED DOMINANT; XLHR]
FBgn0029843	Nep1	HGNC:14668	OMIM:618104	MMEL1	11		
FBgn0029843	Nep1	HGNC:7154	OMIM:120520	MME	11	617017,617018	617017[CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2T; CMT2T],617018[SPINOCEREBELLAR ATAXIA 43; SCA43]
FBgn0029843	Nep1	HGNC:13275	OMIM:610145	ECE2	6		
FBgn0029843	Nep1	HGNC:3147	OMIM:605896	ECEL1	3	615065	615065[ARTHROGRYPOSIS, DISTAL, TYPE 5D; DA5D]
FBgn0029843	Nep1	HGNC:3146	OMIM:600423	ECE1	5	145500,613870	145500[HYPERTENSION, ESSENTIAL],613870[HIRSCHSPRUNG DISEASE, CARDIAC DEFECTS, AND AUTONOMIC DYSFUNCTION; HCAD]
FBgn0029843	Nep1	HGNC:6308	OMIM:613883	KEL	4	110900	110900[BLOOD GROUP--KELL SYSTEM; KEL]
FBgn0029849	Efr	HGNC:20584	OMIM:610923	SLC35B4	14		
FBgn0003514	sqh	HGNC:15754	OMIM:609905	MYL9	14	619365	619365[MEGACYSTIS-MICROCOLON-INTESTINAL HYPOPERISTALSIS SYNDROME 4; MMIHS4]
FBgn0003514	sqh	HGNC:29827	OMIM:609211	MYL12B	7		
FBgn0003514	sqh	HGNC:29825	OMIM:617177	MYL10	3		
FBgn0003514	sqh	HGNC:16701		MYL12A	12		
FBgn0003514	sqh	HGNC:7586	OMIM:160782	MYL5	3		
FBgn0003514	sqh	HGNC:7583	OMIM:160781	MYL2	3	608758,619424	608758[CARDIOMYOPATHY, FAMILIAL HYPERTROPHIC, 10; CMH10],619424[MYOPATHY, MYOFIBRILLAR, 12, INFANTILE-ONSET, WITH CARDIOMYOPATHY; MFM12]
FBgn0003514	sqh	HGNC:21719	OMIM:613993	MYL7	3		
FBgn0003514	sqh	HGNC:29824	OMIM:617378	MYLPF	3	619110	619110[ARTHROGRYPOSIS, DISTAL, TYPE 1C; DA1C]
FBgn0029848	Btnd	HGNC:12705	OMIM:603570	VNN1	11		
FBgn0029848	Btnd	HGNC:16431	OMIM:606592	VNN3	8		
FBgn0029848	Btnd	HGNC:12706	OMIM:603571	VNN2	12		
FBgn0029848	Btnd	HGNC:1122	OMIM:609019	BTD	12	253260	253260[BIOTINIDASE DEFICIENCY]
FBgn0040069	vanin-like	HGNC:12705	OMIM:603570	VNN1	10		
FBgn0040069	vanin-like	HGNC:16431	OMIM:606592	VNN3	8		
FBgn0040069	vanin-like	HGNC:12706	OMIM:603571	VNN2	11		
FBgn0040069	vanin-like	HGNC:1122	OMIM:609019	BTD	13	253260	253260[BIOTINIDASE DEFICIENCY]
FBgn0052751	CG32751	HGNC:12705	OMIM:603570	VNN1	10		
FBgn0052751	CG32751	HGNC:16431	OMIM:606592	VNN3	8		
FBgn0052751	CG32751	HGNC:12706	OMIM:603571	VNN2	10		
FBgn0052751	CG32751	HGNC:1122	OMIM:609019	BTD	14	253260	253260[BIOTINIDASE DEFICIENCY]
FBgn0052750	CG32750	HGNC:12705	OMIM:603570	VNN1	12		
FBgn0052750	CG32750	HGNC:16431	OMIM:606592	VNN3	8		
FBgn0052750	CG32750	HGNC:12706	OMIM:603571	VNN2	11		
FBgn0052750	CG32750	HGNC:1122	OMIM:609019	BTD	12	253260	253260[BIOTINIDASE DEFICIENCY]
FBgn0026060	Mipp2	HGNC:7102	OMIM:605391	MINPP1	13	188470,619527	188470[THYROID CANCER, NONMEDULLARY, 2; NMTC2],619527[PONTOCEREBELLAR HYPOPLASIA, TYPE 16; PCH16]
FBgn0029840	raptor	HGNC:30287	OMIM:607130	RPTOR	15		
FBgn0029839	CG4660	HGNC:29656		THEM6	9		
FBgn0029838	CG4666	HGNC:29656		THEM6	13		
FBgn0029837	Tsp5D	HGNC:1686	OMIM:151525	CD53	4		
FBgn0029837	Tsp5D	HGNC:11859	OMIM:602644	TSPAN4	6		
FBgn0029837	Tsp5D	HGNC:21640	OMIM:613137	TSPAN9	10		
FBgn0029003	mab-21	HGNC:6758	OMIM:604357	MAB21L2	12	615877	615877[MICROPHTHALMIA/COLOBOMA AND SKELETAL DYSPLASIA SYNDROME; MCSKS]
FBgn0029003	mab-21	HGNC:6757	OMIM:601280	MAB21L1	13	618479	618479[CEREBELLAR, OCULAR, CRANIOFACIAL, AND GENITAL SYNDROME; COFG]
FBgn0027546	CG4766	HGNC:6758	OMIM:604357	MAB21L2	14	615877	615877[MICROPHTHALMIA/COLOBOMA AND SKELETAL DYSPLASIA SYNDROME; MCSKS]
FBgn0027546	CG4766	HGNC:6757	OMIM:601280	MAB21L1	12	618479	618479[CEREBELLAR, OCULAR, CRANIOFACIAL, AND GENITAL SYNDROME; COFG]
FBgn0015818	Spx	HGNC:10771	OMIM:605593	SF3B4	10	154400	154400[ACROFACIAL DYSOSTOSIS 1, NAGER TYPE; AFD1]
FBgn0029853	Josd	HGNC:28853	OMIM:615324	JOSD2	13		
FBgn0029853	Josd	HGNC:28953	OMIM:615323	JOSD1	13		
FBgn0028982	Spt6	HGNC:11470	OMIM:601333	SUPT6H	14		
FBgn0029857	wuho	HGNC:12756	OMIM:605924	WDR4	13	618346,618347	618346[MICROCEPHALY, GROWTH DEFICIENCY, SEIZURES, AND BRAIN MALFORMATIONS; MIGSB],618347[GALLOWAY-MOWAT SYNDROME 6; GAMOS6]
FBgn0029858	mldr	HGNC:19958	OMIM:609947	PRORP	13	619737	619737[COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 54; COXPD54]
FBgn0029861	CG3815	HGNC:20816	OMIM:618645	PHF12	14		
FBgn0029863	CG3823	HGNC:12404	OMIM:600415	TTPA	3	277460	277460[ATAXIA WITH VITAMIN E DEFICIENCY; AVED]
FBgn0029863	CG3823	HGNC:16114		TTPAL	3		
FBgn0029863	CG3823	HGNC:10024	OMIM:180090	RLBP1	3	136880,607475,607476	136880[FUNDUS ALBIPUNCTATUS],607475[BOTHNIA RETINAL DYSTROPHY],607476[NEWFOUNDLAND ROD-CONE DYSTROPHY; NFRCD]
FBgn0029863	CG3823	HGNC:23046	OMIM:616945	CLVS2	3		
FBgn0029863	CG3823	HGNC:23139	OMIM:611292	CLVS1	3		
FBgn0029866	CG3842	HGNC:19979	OMIM:616796	RDH14	5		
FBgn0029866	CG3842	HGNC:17964	OMIM:607849	RDH11	8	616108	616108[RETINAL DYSTROPHY, JUVENILE CATARACTS, AND SHORT STATURE SYNDROME; RDJCSS]
FBgn0029866	CG3842	HGNC:19977	OMIM:608830	RDH12	8	612712	612712[LEBER CONGENITAL AMAUROSIS 13; LCA13]
FBgn0029866	CG3842	HGNC:28326	OMIM:616157	DHRS13	3		
FBgn0029866	CG3842	HGNC:19978		RDH13	7		
FBgn0029873	CG3918	HGNC:26716		SREK1IP1	9		
FBgn0014031	Agxt	HGNC:341	OMIM:604285	AGXT	14	259900	259900[HYPEROXALURIA, PRIMARY, TYPE I; HP1]
FBgn0000524	dx	HGNC:29151	OMIM:616110	DTX4	12		
FBgn0000524	dx	HGNC:3060	OMIM:602582	DTX1	13		
FBgn0000524	dx	HGNC:15973	OMIM:613141	DTX2	11		
FBgn0014026	RpL7A	HGNC:10364	OMIM:185640	RPL7A	11		
FBgn0029874	CG3342	HGNC:23397	OMIM:617398	FKBP15	4		
FBgn0003139	PpV	HGNC:9323	OMIM:612725	PPP6C	15		
FBgn0003139	PpV	HGNC:9299	OMIM:176915	PPP2CA	3	618354	618354[NEURODEVELOPMENTAL DISORDER AND LANGUAGE DELAY WITH OR WITHOUT STRUCTURAL BRAIN ABNORMALITIES; NEDLBA]
FBgn0003139	PpV	HGNC:9300	OMIM:176916	PPP2CB	3		
FBgn0003139	PpV	HGNC:9319	OMIM:602035	PPP4C	3		
FBgn0029868	ND-B16.6	HGNC:17194	OMIM:609435	NDUFA13	11	607464,618249	607464[THYROID CARCINOMA, HURTHLE CELL],618249[MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 28; MC1DN28]
FBgn0028685	Rpt4	HGNC:9553	OMIM:602708	PSMC6	14		
FBgn0026015	Top3beta	HGNC:11993	OMIM:603582	TOP3B	14		
FBgn0029856	CG11700	HGNC:10417	OMIM:191343	RPS27A	3		
FBgn0029856	CG11700	HGNC:12463	OMIM:191339	UBB	6		
FBgn0040918	schlank	HGNC:23749	OMIM:615335	CERS5	13		
FBgn0040918	schlank	HGNC:23826	OMIM:615336	CERS6	13		
FBgn0040918	schlank	HGNC:23752	OMIM:615276	CERS3	6	615023	615023[ICHTHYOSIS, CONGENITAL, AUTOSOMAL RECESSIVE 9; ARCI9]
FBgn0040918	schlank	HGNC:14076	OMIM:606920	CERS2	9		
FBgn0040918	schlank	HGNC:23747	OMIM:615334	CERS4	7		
FBgn0023458	Rbcn-3A	HGNC:2937	OMIM:605671	DMXL1	11		
FBgn0023458	Rbcn-3A	HGNC:2938	OMIM:612186	DMXL2	13	616113,617605,618663	616113[POLYENDOCRINE-POLYNEUROPATHY SYNDROME; PEPNS],617605[DEAFNESS, AUTOSOMAL DOMINANT 71; DFNA71],618663[DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 81; DEE81]
FBgn0029877	CG17717	HGNC:23356	OMIM:613335	MARCHF8	3		
FBgn0029877	CG17717	HGNC:28038	OMIM:613332	MARCHF2	7		
FBgn0029877	CG17717	HGNC:28728	OMIM:613333	MARCHF3	5		
FBgn0029878	Pat1	HGNC:622	OMIM:605324	APPBP2	14		
FBgn0029879	APC7	HGNC:17380	OMIM:606949	ANAPC7	13	619699	619699[FERGUSON-BONNI NEURODEVELOPMENTAL SYNDROME; FERBON]
FBgn0029881	pigs	HGNC:24846	OMIM:611398	GAS2L2	7	618449	618449[CILIARY DYSKINESIA, PRIMARY, 41; CILD41]
FBgn0029881	pigs	HGNC:16955	OMIM:602128	GAS2L1	11		
FBgn0029881	pigs	HGNC:4167	OMIM:602835	GAS2	3		
FBgn0029881	pigs	HGNC:27475	OMIM:617224	GAS2L3	3		
FBgn0028360	Cdc7	HGNC:1745	OMIM:603311	CDC7	12		
FBgn0062413	Ctr1A	HGNC:11016	OMIM:603085	SLC31A1	14		
FBgn0062413	Ctr1A	HGNC:11017	OMIM:603088	SLC31A2	7		
FBgn0025815	Mcm6	HGNC:6949	OMIM:601806	MCM6	14	223100	223100[LACTOSE INTOLERANCE, ADULT TYPE]
FBgn0029502	Coq7	HGNC:2244	OMIM:601683	COQ7	12	616733	616733[COENZYME Q10 DEFICIENCY, PRIMARY, 8; COQ10D8]
FBgn0029903	pod1	HGNC:44424		CORO7-PAM16	11		
FBgn0029903	pod1	HGNC:26161	OMIM:611668	CORO7	9		
FBgn0029906	xit	HGNC:23161	OMIM:608103	ALG8	12	608104,617874	608104[CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Ih; CDG1H],617874[POLYCYSTIC LIVER DISEASE 3 WITH OR WITHOUT KIDNEY CYSTS; PCLD3]
FBgn0029907	Atx-1	HGNC:10548	OMIM:601556	ATXN1	6	164400	164400[SPINOCEREBELLAR ATAXIA 1; SCA1]
FBgn0029907	Atx-1	HGNC:33279	OMIM:614301	ATXN1L	7		
FBgn0029905	Nf-YC	HGNC:13544	OMIM:607268	CHRAC1	3		
FBgn0029905	Nf-YC	HGNC:7806	OMIM:605344	NFYC	10		
FBgn0029905	Nf-YC	HGNC:18755	OMIM:607269	POLE4	3		
FBgn0003390	shf	HGNC:18081	OMIM:605186	WIF1	12		
FBgn0029897	RpL17	HGNC:44661		RPL17-C18orf32	11		
FBgn0029897	RpL17	HGNC:10307	OMIM:603661	RPL17	8		
FBgn0029896	CG3168	HGNC:25417	OMIM:611699	SVOP	3		
FBgn0029896	CG3168	HGNC:8494	OMIM:604047	SLC22A13	4		
FBgn0029896	CG3168	HGNC:10970	OMIM:607582	SLC22A6	3		
FBgn0029896	CG3168	HGNC:20302	OMIM:608276	SLC22A16	3		
FBgn0029896	CG3168	HGNC:10968	OMIM:604190	SLC22A4	3	180300	180300[RHEUMATOID ARTHRITIS; RA]
FBgn0029896	CG3168	HGNC:10969	OMIM:603377	SLC22A5	3	212140	212140[CARNITINE DEFICIENCY, SYSTEMIC PRIMARY; CDSP]
FBgn0029896	CG3168	HGNC:8495	OMIM:604048	SLC22A14	3		
FBgn0029896	CG3168	HGNC:10971	OMIM:604995	SLC22A7	4		
FBgn0029896	CG3168	HGNC:10972	OMIM:607581	SLC22A8	4		
FBgn0029896	CG3168	HGNC:16874	OMIM:185861	SV2B	7		
FBgn0029896	CG3168	HGNC:20566	OMIM:185860	SV2A	8		
FBgn0029896	CG3168	HGNC:30670	OMIM:610291	SV2C	7		
FBgn0029896	CG3168	HGNC:17989	OMIM:607096	SLC22A12	3	220150	220150[HYPOURICEMIA, RENAL, 1; RHUC1]
FBgn0029894	CG14440	HGNC:28043		ZNF821	6		
FBgn0029893	CG14442	HGNC:28043		ZNF821	4		
FBgn0029892	CG3184	HGNC:25199	OMIM:613210	DPH7	14		
FBgn0029887	CG3198	HGNC:24309	OMIM:609434	LUC7L3	11		
FBgn0029887	CG3198	HGNC:6723	OMIM:607782	LUC7L	3		
FBgn0029885	CG3224	HGNC:30943	OMIM:616698	ZNF593	14		
FBgn0029882	CG3226	HGNC:30423	OMIM:606186	CACYBP	14		
FBgn0029912	CG4557	HGNC:11870	OMIM:601126	TMF1	11		
FBgn0029924	CG4586	HGNC:119	OMIM:609751	ACOX1	9	264470,618960	264470[PEROXISOMAL ACYL-CoA OXIDASE DEFICIENCY],618960[MITCHELL SYNDROME; MITCH]
FBgn0029924	CG4586	HGNC:120	OMIM:601641	ACOX2	6	617308	617308[BILE ACID SYNTHESIS DEFECT, CONGENITAL, 6; CBAS6]
FBgn0052736	CG32736	HGNC:37257		SMIM4	12		
FBgn0029929	CG4593	HGNC:25591	OMIM:619100	CCDC25	14		
FBgn0029932	CG4607	HGNC:11011	OMIM:606813	SLC2A6	5		
FBgn0029932	CG4607	HGNC:13812	OMIM:605245	SLC2A8	6		
FBgn0029932	CG4607	HGNC:11006	OMIM:138160	SLC2A2	3	125853,227810	125853[TYPE 2 DIABETES MELLITUS; T2D],227810[FANCONI-BICKEL SYNDROME; FBS]
FBgn0029932	CG4607	HGNC:18067	OMIM:610372	SLC2A12	3		
FBgn0029932	CG4607	HGNC:13444	OMIM:606145	SLC2A10	4	208050	208050[ARTERIAL TORTUOSITY SYNDROME; ATORS]
FBgn0029937	CG8300	HGNC:34395		FAM177B	9		
FBgn0029937	CG8300	HGNC:19829	OMIM:619181	FAM177A1	10		
FBgn0027342	fz4	HGNC:4042	OMIM:604579	FZD4	5	133780	133780[EXUDATIVE VITREORETINOPATHY 1; EVR1]
FBgn0029936	CG4617	HGNC:5003	OMIM:604702	HMGXB4	8		
FBgn0029935	CG4615	HGNC:30133	OMIM:614581	MMD2	12		
FBgn0029935	CG4615	HGNC:7153	OMIM:604467	MMD	14		
FBgn0000330	cm	HGNC:569	OMIM:610366	AP3M1	12		
FBgn0000330	cm	HGNC:570	OMIM:610469	AP3M2	14		
FBgn0029925	CG3040	HGNC:26719		LRRC57	13		
FBgn0052732	Setd3	HGNC:20493	OMIM:615671	SETD3	13		
FBgn0029913	Cht11	HGNC:8524	OMIM:603578	OVGP1	4		
FBgn0029913	Cht11	HGNC:1932	OMIM:601525	CHI3L1	4	181500,611960	181500[SCHIZOPHRENIA; SCZD],611960[ASTHMA-RELATED TRAITS, SUSCEPTIBILITY TO, 7; ASRT7]
FBgn0029913	Cht11	HGNC:1936	OMIM:600031	CHIT1	4	614122	614122[CHITOTRIOSIDASE DEFICIENCY; CHITD]
FBgn0029913	Cht11	HGNC:17432	OMIM:606080	CHIA	3		
FBgn0029913	Cht11	HGNC:1933	OMIM:601526	CHI3L2	3		
FBgn0029911	CG14435	HGNC:18452	OMIM:612060	ZNRF1	11		
FBgn0029911	CG14435	HGNC:22316	OMIM:612061	ZNRF2	13		
FBgn0029939	CG9650	HGNC:13221	OMIM:606557	BCL11A	11	617101	617101[INTELLECTUAL DEVELOPMENTAL DISORDER WITH PERSISTENCE OF FETAL HEMOGLOBIN]
FBgn0029939	CG9650	HGNC:13222	OMIM:606558	BCL11B	12	617237,618092	617237[IMMUNODEFICIENCY 49; IMD49],618092[INTELLECTUAL DEVELOPMENTAL DISORDER WITH SPEECH DELAY, DYSMORPHIC FACIES, AND T-CELL ABNORMALITIES; IDDSFTA]
FBgn0029939	CG9650	HGNC:15981	OMIM:613226	ZNF296	3		
FBgn0029942	CG2059	HGNC:16407		ABHD11	14		
FBgn0029944	Dok	HGNC:24583	OMIM:611435	DOK3	6		
FBgn0029944	Dok	HGNC:2990	OMIM:602919	DOK1	8		
FBgn0029944	Dok	HGNC:2991	OMIM:604997	DOK2	9		
FBgn0029944	Dok	HGNC:19868	OMIM:608333	DOK4	3		
FBgn0029944	Dok	HGNC:16173	OMIM:608334	DOK5	3		
FBgn0029944	Dok	HGNC:28301	OMIM:611402	DOK6	3		
FBgn0029944	Dok	HGNC:16970	OMIM:607744	FRS3	3		
FBgn0029944	Dok	HGNC:16971	OMIM:607743	FRS2	3		
FBgn0029945	Acsf3	HGNC:27288	OMIM:614245	ACSF3	14	614265	614265[COMBINED MALONIC AND METHYLMALONIC ACIDURIA; CMAMMA]
FBgn0029950	rumpel	HGNC:11041	OMIM:604024	SLC5A6	5	618973,619903	618973[SODIUM-DEPENDENT MULTIVITAMIN TRANSPORTER DEFICIENCY; SMVTD],619903[PERIPHERAL MOTOR NEUROPATHY, CHILDHOOD-ONSET, BIOTIN-RESPONSIVE; COMNB]
FBgn0029950	rumpel	HGNC:11040	OMIM:601843	SLC5A5	6	274400	274400[THYROID DYSHORMONOGENESIS 1; TDH1]
FBgn0029950	rumpel	HGNC:28750	OMIM:612455	SLC5A12	7		
FBgn0029950	rumpel	HGNC:19119	OMIM:608044	SLC5A8	7		
FBgn0029950	rumpel	HGNC:22146		SLC5A9	3		
FBgn0029949	CG15035	HGNC:30695	OMIM:609668	PPTC7	12		
FBgn0029943	Atg5	HGNC:589	OMIM:604261	ATG5	14	617584	617584[SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 25; SCAR25]
FBgn0025549	unc-119	HGNC:12565	OMIM:604011	UNC119	14	615518	615518[IMMUNODEFICIENCY 13; IMD13]
FBgn0025549	unc-119	HGNC:16488		UNC119B	12		
FBgn0004198	ct	HGNC:2557	OMIM:116896	CUX1	10	618330	618330[GLOBAL DEVELOPMENTAL DELAY WITH OR WITHOUT IMPAIRED INTELLECTUAL DEVELOPMENT; GDDI]
FBgn0004198	ct	HGNC:19347	OMIM:610648	CUX2	11	618141	618141[DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 67; DEE67]
FBgn0022786	Hira	HGNC:4916	OMIM:600237	HIRA	11		
FBgn0029959	Rab39	HGNC:16521	OMIM:619558	RAB39A	12		
FBgn0029959	Rab39	HGNC:16499	OMIM:300774	RAB39B	12	300271,311510	300271[INTELLECTUAL DEVELOPMENTAL DISORDER, X-LINKED 72; XLID72],311510[WAISMAN SYNDROME; WSMN]
FBgn0016041	Tom40	HGNC:25756		TOMM40L	11		
FBgn0016041	Tom40	HGNC:18001	OMIM:608061	TOMM40	15		
FBgn0029958	Pdp	HGNC:9279	OMIM:605993	PDP1	15	608782	608782[PYRUVATE DEHYDROGENASE PHOSPHATASE DEFICIENCY; PDHPD]
FBgn0029958	Pdp	HGNC:30263	OMIM:615499	PDP2	14		
FBgn0027553	NELF-B	HGNC:24324	OMIM:611180	NELFB	14		
FBgn0029962	CARPA	HGNC:1369	OMIM:604642	CA10	10		
FBgn0029962	CARPA	HGNC:1370	OMIM:604644	CA11	9		
FBgn0029964	CG1409	HGNC:29679	OMIM:614336	PAM16	8	613320	613320[SPONDYLOMETAPHYSEAL DYSPLASIA, MEGARBANE-DAGHER-MELKI TYPE; SMDMDM]
FBgn0029968	Ir7g	HGNC:4581	OMIM:138243	GRIK3	3		
FBgn0029968	Ir7g	HGNC:4587	OMIM:138254	GRIN2C	3		
FBgn0029968	Ir7g	HGNC:4575	OMIM:610659	GRID1	3		
FBgn0040087	p115	HGNC:30904	OMIM:603344	USO1	11		
FBgn0010292	bys	HGNC:1157	OMIM:603871	BYSL	13		
FBgn0029975	spidey	HGNC:18646	OMIM:609574	HSD17B12	14		
FBgn0029975	spidey	HGNC:16475	OMIM:619067	HSDL1	4		
FBgn0029975	spidey	HGNC:5212	OMIM:605573	HSD17B3	5	264300	264300[17-BETA HYDROXYSTEROID DEHYDROGENASE III DEFICIENCY]
FBgn0029976	snz	HGNC:21883		SNX25	13		
FBgn0029976	snz	HGNC:21335	OMIM:606589	SNX13	4		
FBgn0004403	RpS14a	HGNC:10387	OMIM:130620	RPS14	7	153550	153550[CHROMOSOME 5q DELETION SYNDROME]
FBgn0004404	RpS14b	HGNC:10387	OMIM:130620	RPS14	13	153550	153550[CHROMOSOME 5q DELETION SYNDROME]
FBgn0003447	sn	HGNC:11148	OMIM:602689	FSCN1	13		
FBgn0003447	sn	HGNC:3960	OMIM:607643	FSCN2	13	607921	607921[RETINITIS PIGMENTOSA 30; RP30]
FBgn0003447	sn	HGNC:3961	OMIM:615800	FSCN3	4		
FBgn0004657	mys	HGNC:6163	OMIM:604160	ITGB8	3		
FBgn0004657	mys	HGNC:6160	OMIM:147561	ITGB5	5		
FBgn0004657	mys	HGNC:6161	OMIM:147558	ITGB6	6	616221	616221[AMELOGENESIS IMPERFECTA, TYPE IH; AI1H]
FBgn0004657	mys	HGNC:6155	OMIM:600065	ITGB2	10	116920	116920[LEUKOCYTE ADHESION DEFICIENCY, TYPE I; LAD1]
FBgn0004657	mys	HGNC:6153	OMIM:135630	ITGB1	14		
FBgn0004657	mys	HGNC:6158	OMIM:147557	ITGB4	5	226730,619816	226730[EPIDERMOLYSIS BULLOSA, JUNCTIONAL 5B, WITH PYLORIC ATRESIA; JEB5B],619816[EPIDERMOLYSIS BULLOSA, JUNCTIONAL 5A, INTERMEDIATE; JEB5A]
FBgn0004657	mys	HGNC:6162	OMIM:147559	ITGB7	10		
FBgn0004657	mys	HGNC:6156	OMIM:173470	ITGB3	8	608446,619267,619271	608446[MYOCARDIAL INFARCTION, SUSCEPTIBILITY TO],619267[GLANZMANN THROMBASTHENIA 2; GT2],619271[BLEEDING DISORDER, PLATELET-TYPE, 24; BDPLT24]
FBgn0029993	CG1571	HGNC:18744	OMIM:605483	DNAI2	6	612444	612444[CILIARY DYSKINESIA, PRIMARY, 9; CILD9]
FBgn0040319	Gclc	HGNC:4311	OMIM:606857	GCLC	14	230450,608446	230450[GAMMA-GLUTAMYLCYSTEINE SYNTHETASE DEFICIENCY, HEMOLYTIC ANEMIA DUE TO],608446[MYOCARDIAL INFARCTION, SUSCEPTIBILITY TO]
FBgn0029997	CG2258	HGNC:15486	OMIM:606671	NCKIPSD	12		
FBgn0029996	UbcE2H	HGNC:12484	OMIM:601082	UBE2H	15		
FBgn0029995	CG2256	HGNC:25678	OMIM:619564	EFCAB1	11		
FBgn0029994	Ldsdh1	HGNC:18685	OMIM:612127	HSD17B13	4		
FBgn0029994	Ldsdh1	HGNC:17693	OMIM:612830	DHRS3	4		
FBgn0029994	Ldsdh1	HGNC:30311	OMIM:608989	SDR16C5	5		
FBgn0029994	Ldsdh1	HGNC:22960	OMIM:612831	HSD17B11	5		
FBgn0029994	Ldsdh1	HGNC:19975	OMIM:607599	RDH10	4		
FBgn0029992	Upf2	HGNC:17854	OMIM:605529	UPF2	14		
FBgn0004656	fs(1)h	HGNC:1104	OMIM:601541	BRD3	8		
FBgn0004656	fs(1)h	HGNC:1103	OMIM:601540	BRD2	9		
FBgn0004656	fs(1)h	HGNC:1105	OMIM:602144	BRDT	9	617644	617644[SPERMATOGENIC FAILURE 21; SPGF21]
FBgn0004656	fs(1)h	HGNC:13575	OMIM:608749	BRD4	9		
FBgn0003656	sws	HGNC:16268	OMIM:603197	PNPLA6	12	215470,245800,275400,612020	215470[BOUCHER-NEUHAUSER SYNDROME; BNHS],245800[LAURENCE-MOON SYNDROME; LNMS],275400[OLIVER-MCFARLANE SYNDROME; OMCS],612020[SPASTIC PARAPLEGIA 39, AUTOSOMAL RECESSIVE; SPG39]
FBgn0003656	sws	HGNC:24768	OMIM:612122	PNPLA7	13		
FBgn0029980	Dhdds	HGNC:20603	OMIM:608172	DHDDS	15	613861,617836	613861[RETINITIS PIGMENTOSA 59; RP59],617836[DEVELOPMENTAL DELAY AND SEIZURES WITH OR WITHOUT MOVEMENT ABNORMALITIES; DEDSM]
FBgn0029979	mahe	HGNC:2740	OMIM:608469	DDX17	8		
FBgn0029979	mahe	HGNC:2746	OMIM:180630	DDX5	6		
FBgn0029977	hdm	HGNC:28569	OMIM:617670	MEIOB	12	617706	617706[SPERMATOGENIC FAILURE 22; SPGF22]
FBgn0029971	ND-MNLL	HGNC:7695	OMIM:603837	NDUFB1	7		
FBgn0029970	Nek2	HGNC:7745	OMIM:604043	NEK2	9	615565	615565[RETINITIS PIGMENTOSA 67; RP67]
FBgn0029970	Nek2	HGNC:13387	OMIM:609799	NEK8	3	613824,615415	613824[NEPHRONOPHTHISIS 9; NPHP9],615415[RENAL-HEPATIC-PANCREATIC DYSPLASIA 2; RHPD2]
FBgn0029970	Nek2	HGNC:7749	OMIM:604884	NEK6	4		
FBgn0029970	Nek2	HGNC:18593	OMIM:609779	NEK11	3		
FBgn0029970	Nek2	HGNC:13386	OMIM:606848	NEK7	3		
FBgn0029969	Acat1	HGNC:83	OMIM:604770	ACAA2	3		
FBgn0029969	Acat1	HGNC:93	OMIM:607809	ACAT1	15	203750	203750[ALPHA-METHYLACETOACETIC ACIDURIA]
FBgn0029965	Ir7b	HGNC:4587	OMIM:138254	GRIN2C	3		
FBgn0029965	Ir7b	HGNC:4576	OMIM:602368	GRID2	3	616204	616204[SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 18; SCAR18]
FBgn0029965	Ir7b	HGNC:4575	OMIM:610659	GRID1	3		
FBgn0029963	CG10920	HGNC:17587	OMIM:613221	MTCH2	10		
FBgn0029963	CG10920	HGNC:17586	OMIM:610449	MTCH1	9		
FBgn0029999	CG1575	HGNC:25988	OMIM:616717	TEX10	10		
FBgn0030004	CG10958	HGNC:24245	OMIM:615288	DRC1	15	615294	615294[CILIARY DYSKINESIA, PRIMARY, 21; CILD21]
FBgn0030013	GIIIspla2	HGNC:17934	OMIM:611651	PLA2G3	8		
FBgn0020653	Trxr1	HGNC:12437	OMIM:601112	TXNRD1	5		
FBgn0020653	Trxr1	HGNC:18155	OMIM:606448	TXNRD2	10	617825	617825[GLUCOCORTICOID DEFICIENCY 5; GCCD5]
FBgn0020653	Trxr1	HGNC:4623	OMIM:138300	GSR	4	618660	618660[HEMOLYTIC ANEMIA DUE TO GLUTATHIONE REDUCTASE DEFICIENCY]
FBgn0030034	CG10555	HGNC:11340	OMIM:600192	SS18	7		
FBgn0030034	CG10555	HGNC:15592	OMIM:606472	SS18L1	6		
FBgn0030034	CG10555	HGNC:15593	OMIM:606473	SS18L2	7		
FBgn0030035	PIG-T	HGNC:14938	OMIM:610272	PIGT	14	615398,615399	615398[MULTIPLE CONGENITAL ANOMALIES-HYPOTONIA-SEIZURES SYNDROME 3; MCAHS3],615399[PAROXYSMAL NOCTURNAL HEMOGLOBINURIA 2; PNH2]
FBgn0015519	nAChRalpha3	HGNC:1962	OMIM:118507	CHRNB2	3	605375	605375[EPILEPSY, NOCTURNAL FRONTAL LOBE, 3; ENFL3]
FBgn0015519	nAChRalpha3	HGNC:1959	OMIM:118505	CHRNA5	4	612052	612052[SMOKING AS A QUANTITATIVE TRAIT LOCUS 3; SQTL3]
FBgn0015519	nAChRalpha3	HGNC:1955	OMIM:100690	CHRNA1	3	253290,601462,608930	253290[MULTIPLE PTERYGIUM SYNDROME, LETHAL TYPE; LMPS],601462[MYASTHENIC SYNDROME, CONGENITAL, 1A, SLOW-CHANNEL; CMS1A],608930[MYASTHENIC SYNDROME, CONGENITAL, 1B, FAST-CHANNEL; CMS1B]
FBgn0015519	nAChRalpha3	HGNC:1957	OMIM:118503	CHRNA3	8	191800,612052	191800[BLADDER DYSFUNCTION, AUTONOMIC, WITH IMPAIRED PUPILLARY REFLEX AND SECONDARY CAKUT; BAIPRCK],612052[SMOKING AS A QUANTITATIVE TRAIT LOCUS 3; SQTL3]
FBgn0015519	nAChRalpha3	HGNC:1964	OMIM:118509	CHRNB4	3		
FBgn0015519	nAChRalpha3	HGNC:1958	OMIM:118504	CHRNA4	7	188890,600513	188890[TOBACCO ADDICTION, SUSCEPTIBILITY TO],600513[EPILEPSY, NOCTURNAL FRONTAL LOBE, 1; ENFL1]
FBgn0015519	nAChRalpha3	HGNC:15963	OMIM:606888	CHRNA6	9		
FBgn0015519	nAChRalpha3	HGNC:1956	OMIM:118502	CHRNA2	8	610353	610353[EPILEPSY, NOCTURNAL FRONTAL LOBE, 4; ENFL4]
FBgn0015519	nAChRalpha3	HGNC:1963	OMIM:118508	CHRNB3	3		
FBgn0030029	CG15343	HGNC:30260	OMIM:603287	PNPO	5	610090	610090[PYRIDOXAMINE 5-PRIME-PHOSPHATE OXIDASE DEFICIENCY; PNPOD]
FBgn0017566	ND-75	HGNC:7707	OMIM:157655	NDUFS1	15	618226	618226[MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 5; MC1DN5]
FBgn0030015	CG10761	HGNC:26025	OMIM:610637	MARCHF5	8		
FBgn0030011	Gbeta5	HGNC:4400	OMIM:139130	GNB3	3	145500,617024	145500[HYPERTENSION, ESSENTIAL],617024[NIGHT BLINDNESS, CONGENITAL STATIONARY, TYPE 1H; CSNB1H]
FBgn0030011	Gbeta5	HGNC:4396	OMIM:139380	GNB1	3	613065,614286,616973	613065[LEUKEMIA, ACUTE LYMPHOBLASTIC; ALL],614286[MYELODYSPLASTIC SYNDROME; MDS],616973[INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL DOMINANT 42; MRD42]
FBgn0030011	Gbeta5	HGNC:20731	OMIM:610863	GNB4	3	615185	615185[CHARCOT-MARIE-TOOTH DISEASE, DOMINANT INTERMEDIATE F; CMTDIF]
FBgn0030011	Gbeta5	HGNC:4401	OMIM:604447	GNB5	14	617173,617182	617173[INTELLECTUAL DEVELOPMENTAL DISORDER WITH CARDIAC ARRHYTHMIA; IDDCA],617182[LANGUAGE DELAY AND ATTENTION DEFICIT-HYPERACTIVITY DISORDER/COGNITIVE IMPAIRMENT WITH OR WITHOUT CARDIAC ARRHYTHMIA; LADCI]
FBgn0030007	alpha-PheRS	HGNC:3592	OMIM:602918	FARSA	13	619013	619013[RAJAB INTERSTITIAL LUNG DISEASE WITH BRAIN CALCIFICATIONS 2; RILDBC2]
FBgn0025800	Smox	HGNC:6774	OMIM:603295	SMAD9	3	615342	615342[PULMONARY HYPERTENSION, PRIMARY, 2; PPH2]
FBgn0025800	Smox	HGNC:6768	OMIM:601366	SMAD2	8	619656,619657	619656[LOEYS-DIETZ SYNDROME 6; LDS6],619657[CONGENITAL HEART DEFECTS, MULTIPLE TYPES, 8, WITH OR WITHOUT HETEROTAXY; CHTD8]
FBgn0025800	Smox	HGNC:6767	OMIM:601595	SMAD1	3		
FBgn0025800	Smox	HGNC:6771	OMIM:603110	SMAD5	4		
FBgn0025800	Smox	HGNC:6769	OMIM:603109	SMAD3	10	613795	613795[LOEYS-DIETZ SYNDROME 3; LDS3]
FBgn0030000	CG2260	HGNC:13923	OMIM:611440	WDR46	13		
FBgn0030038	CG1440	HGNC:1059	OMIM:602403	BLMH	14		
FBgn0023506	Es2	HGNC:16817	OMIM:601755	ESS2	15		
FBgn0053181	CG33181	HGNC:19429	OMIM:610801	SLC41A1	13	619468	619468[NEPHRONOPHTHISIS-LIKE NEPHROPATHY 2; NPHPL2]
FBgn0053181	CG33181	HGNC:31045	OMIM:610802	SLC41A2	12		
FBgn0053181	CG33181	HGNC:31046	OMIM:610803	SLC41A3	8		
FBgn0030049	Trf4-1	HGNC:16705	OMIM:605198	TENT4A	9		
FBgn0030049	Trf4-1	HGNC:30758	OMIM:605540	TENT4B	8		
FBgn0030053	CG12081	HGNC:20704	OMIM:611248	KLHDC3	13		
FBgn0025864	Crag	HGNC:26079		DENND4C	13		
FBgn0025864	Crag	HGNC:24321	OMIM:600382	DENND4A	12		
FBgn0025864	Crag	HGNC:29044	OMIM:619843	DENND4B	12		
FBgn0025864	Crag	HGNC:29134	OMIM:617503	DENND3	3		
FBgn0030055	Rubicon	HGNC:28991	OMIM:613516	RUBCN	11	615705	615705[SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 15; SCAR15]
FBgn0030055	Rubicon	HGNC:20420		RUBCNL	7		
FBgn0030056	CAH3	HGNC:1380	OMIM:114780	CA6	3		
FBgn0030056	CAH3	HGNC:1381	OMIM:114770	CA7	3		
FBgn0030056	CAH3	HGNC:1371	OMIM:603263	CA12	3	143860	143860[HYPERCHLORHIDROSIS, ISOLATED; HYCHL]
FBgn0030056	CAH3	HGNC:1372	OMIM:604832	CA14	3		
FBgn0030056	CAH3	HGNC:1383	OMIM:603179	CA9	3		
FBgn0030056	CAH3	HGNC:1368	OMIM:114800	CA1	3		
FBgn0030056	CAH3	HGNC:1377	OMIM:114761	CA5A	3	615751	615751[CARBONIC ANHYDRASE VA DEFICIENCY, HYPERAMMONEMIA DUE TO; CA5AD]
FBgn0030056	CAH3	HGNC:14914	OMIM:611436	CA13	3		
FBgn0030056	CAH3	HGNC:1374	OMIM:114750	CA3	3		
FBgn0030056	CAH3	HGNC:1375	OMIM:114760	CA4	3		
FBgn0030056	CAH3	HGNC:1378	OMIM:300230	CA5B	3		
FBgn0027864	Ogg1	HGNC:8125	OMIM:601982	OGG1	14	144700	144700[RENAL CELL CARCINOMA, NONPAPILLARY; RCC]
FBgn0030057	Ppt1	HGNC:9325	OMIM:600722	PPT1	14	256730	256730[CEROID LIPOFUSCINOSIS, NEURONAL, 1; CLN1]
FBgn0030054	Caf1-180	HGNC:1910	OMIM:601246	CHAF1A	8		
FBgn0040929	CG12659	HGNC:26994		INO80C	10		
FBgn0030050	CG12111	HGNC:14556	OMIM:613579	CLEC6A	3		
FBgn0030050	CG12111	HGNC:14555	OMIM:609962	CLEC4E	3		
FBgn0026679	IntS4	HGNC:25048	OMIM:611348	INTS4	14		
FBgn0003023	otu	HGNC:25402	OMIM:300713	OTUD5	3	301056	301056[MULTIPLE CONGENITAL ANOMALIES-NEURODEVELOPMENTAL SYNDROME, X-LINKED; MCAND]
FBgn0003023	otu	HGNC:24949	OMIM:611744	OTUD4	8		
FBgn0003023	otu	HGNC:30881	OMIM:300776	ALG13	7	300884	300884[DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 36; DEE36]
FBgn0003023	otu	HGNC:27346	OMIM:612022	OTUD1	4		
FBgn0030041	CG12116	HGNC:11257	OMIM:182125	SPR	7	612716	612716[DYSTONIA, DOPA-RESPONSIVE, DUE TO SEPIAPTERIN REDUCTASE DEFICIENCY]
FBgn0014032	Sptr	HGNC:11257	OMIM:182125	SPR	15	612716	612716[DYSTONIA, DOPA-RESPONSIVE, DUE TO SEPIAPTERIN REDUCTASE DEFICIENCY]
FBgn0021767	org-1	HGNC:11592	OMIM:602054	TBX1	8	187500,188400,192430,217095	187500[TETRALOGY OF FALLOT; TOF],188400[DIGEORGE SYNDROME; DGS],192430[VELOCARDIOFACIAL SYNDROME; VCFS],217095[CONOTRUNCAL HEART MALFORMATIONS; CTHM]
FBgn0021767	org-1	HGNC:11595	OMIM:604613	TBX18	4	143400	143400[CONGENITAL ANOMALIES OF KIDNEY AND URINARY TRACT 2; CAKUT2]
FBgn0021767	org-1	HGNC:11593	OMIM:604648	TBX10	6		
FBgn0021767	org-1	HGNC:14010	OMIM:616061	MGA	3		
FBgn0030037	Miga	HGNC:24741	OMIM:616773	MIGA1	12		
FBgn0030037	Miga	HGNC:23621	OMIM:616774	MIGA2	14		
FBgn0041629	Hexo2	HGNC:4878	OMIM:606869	HEXA	7	272800	272800[TAY-SACHS DISEASE; TSD]
FBgn0041629	Hexo2	HGNC:4879	OMIM:606873	HEXB	7	268800	268800[SANDHOFF DISEASE]
FBgn0030061	CG1785	HGNC:4333	OMIM:605691	NOP53	13		
FBgn0030063	CG1789	HGNC:24329	OMIM:609440	UTP11	13		
FBgn0030067	Rbm13	HGNC:13703		MAK16	12		
FBgn0030073	CG10962	HGNC:28639	OMIM:616159	DHRS11	11		
FBgn0030071	CG12661	HGNC:25911	OMIM:616275	FAM136A	7		
FBgn0011586	e(r)	HGNC:3447	OMIM:601191	ERH	13		
FBgn0030066	Uros1	HGNC:12592	OMIM:606938	UROS	15	263700	263700[PORPHYRIA, CONGENITAL ERYTHROPOIETIC; CEP]
FBgn0011661	Moe	HGNC:12691	OMIM:123900	EZR	13		
FBgn0011661	Moe	HGNC:7373	OMIM:309845	MSN	14	300988	300988[IMMUNODEFICIENCY 50; IMD50]
FBgn0011661	Moe	HGNC:9944	OMIM:179410	RDX	13	611022	611022[DEAFNESS, AUTOSOMAL RECESSIVE 24; DFNB24]
FBgn0026411	Lim1	HGNC:6593	OMIM:601999	LHX1	12		
FBgn0026411	Lim1	HGNC:14216	OMIM:605992	LHX5	10		
FBgn0027330	l(1)G0020	HGNC:29830	OMIM:609221	NAT10	14		
FBgn0030082	HP1b	HGNC:1555	OMIM:604478	CBX5	9		
FBgn0030082	HP1b	HGNC:1551	OMIM:604511	CBX1	12		
FBgn0030082	HP1b	HGNC:1553	OMIM:604477	CBX3	12		
FBgn0052707	APC4	HGNC:19990	OMIM:606947	ANAPC4	13		
FBgn0052708	CG32708	HGNC:17369	OMIM:618750	ABT1	13		
FBgn0052706	CG32706	HGNC:17369	OMIM:618750	ABT1	10		
FBgn0030085	CG6999	HGNC:17369	OMIM:618750	ABT1	10		
FBgn0030086	CCT2	HGNC:1615	OMIM:605139	CCT2	14		
FBgn0030088	Arfrp1	HGNC:662	OMIM:604699	ARFRP1	14		
FBgn0030089	AP-1gamma	HGNC:555	OMIM:603533	AP1G1	13	619467,619548	619467[USMANI-RIAZUDDIN SYNDROME, AUTOSOMAL DOMINANT; USRISD],619548[USMANI-RIAZUDDIN SYNDROME, AUTOSOMAL RECESSIVE; USRISR]
FBgn0030089	AP-1gamma	HGNC:556	OMIM:603534	AP1G2	12		
FBgn0030093	Bap111	HGNC:11109	OMIM:603111	SMARCE1	10	607174,616938	607174[MENINGIOMA, FAMILIAL, SUSCEPTIBILITY TO],616938[COFFIN-SIRIS SYNDROME 5; CSS5]
FBgn0026206	mei-P26	HGNC:19018	OMIM:609318	TRIM45	3		
FBgn0026206	mei-P26	HGNC:19028	OMIM:616996	TRIM56	4		
FBgn0030099	CG12056	HGNC:28471		CYB5D2	14		
FBgn0030100	CG12106	HGNC:23332	OMIM:616700	COMMD3	12		
FBgn0030104	CG15368	HGNC:13008	OMIM:604761	ZFAND5	7		
FBgn0030104	CG15368	HGNC:30164	OMIM:610183	ZFAND6	6		
FBgn0010269	Dsor1	HGNC:6842	OMIM:601263	MAP2K2	14	615280	615280[CARDIOFACIOCUTANEOUS SYNDROME 4; CFC4]
FBgn0010269	Dsor1	HGNC:6840	OMIM:176872	MAP2K1	15	155950,615279	155950[MELORHEOSTOSIS, ISOLATED; MEL],615279[CARDIOFACIOCUTANEOUS SYNDROME 3; CFC3]
FBgn0030114	CG17754	HGNC:6355	OMIM:300348	KLHL4	11		
FBgn0030114	CG17754	HGNC:6356	OMIM:608064	KLHL5	14		
FBgn0030114	CG17754	HGNC:6352	OMIM:605332	KLHL1	10		
FBgn0028292	ric8a	HGNC:25555	OMIM:609147	RIC8B	13		
FBgn0028292	ric8a	HGNC:29550	OMIM:609146	RIC8A	13		
FBgn0030122	Aladin	HGNC:13666	OMIM:605378	AAAS	13	231550	231550[ACHALASIA-ADDISONIANISM-ALACRIMA SYNDROME; AAAS]
FBgn0002576	lz	HGNC:10473	OMIM:600210	RUNX3	4		
FBgn0002576	lz	HGNC:10471	OMIM:151385	RUNX1	4	601399,601626	601399[PLATELET DISORDER, FAMILIAL, WITH ASSOCIATED MYELOID MALIGNANCY; FPDMM],601626[LEUKEMIA, ACUTE MYELOID; AML]
FBgn0002576	lz	HGNC:10472	OMIM:600211	RUNX2	5	119600,156510	119600[CLEIDOCRANIAL DYSPLASIA; CCD],156510[METAPHYSEAL DYSPLASIA WITH MAXILLARY HYPOPLASIA WITH OR WITHOUT BRACHYDACTYLY; MDMHB]
FBgn0040234	c12.2	HGNC:29071	OMIM:617509	VWA8	13		
FBgn0040235	c12.1	HGNC:26939		CWC15	13		
FBgn0040236	c11.1	HGNC:26857		MROH2B	9		
FBgn0040236	c11.1	HGNC:26958		MROH1	13		
FBgn0040236	c11.1	HGNC:27936		MROH2A	8		
FBgn0040236	c11.1	HGNC:16125		MROH8	3		
FBgn0040236	c11.1	HGNC:24802		MROH7	4		
FBgn0040236	c11.1	HGNC:24121	OMIM:608080	MRO	3		
FBgn0040236	c11.1	HGNC:27814		MROH6	3		
FBgn0040236	c11.1	HGNC:26287		MROH9	3		
FBgn0030121	Cfp1	HGNC:24343	OMIM:609150	CXXC1	14		
FBgn0030120	CG17440	HGNC:24343	OMIM:609150	CXXC1	8		
FBgn0052703	Erk7	HGNC:24667	OMIM:618616	MAPK15	12		
FBgn0000077	amx	HGNC:24128	OMIM:610014	TM2D3	12		
FBgn0030109	CG12121	HGNC:17830	OMIM:618490	GPR107	13		
FBgn0030109	CG12121	HGNC:17829	OMIM:618491	GPR108	11		
FBgn0030102	SmydA-9	HGNC:15513	OMIM:608783	SMYD3	5		
FBgn0030102	SmydA-9	HGNC:20982	OMIM:610663	SMYD2	6		
FBgn0030102	SmydA-9	HGNC:20986	OMIM:606846	SMYD1	5		
FBgn0030101	CG12118	HGNC:25221	OMIM:611935	MMADHC	9	277410	277410[METHYLMALONIC ACIDURIA AND HOMOCYSTINURIA, cblD TYPE; MAHCD]
FBgn0030096	Zpr1	HGNC:13051	OMIM:603901	ZPR1	13	619321	619321[GROWTH RESTRICTION, HYPOPLASTIC KIDNEYS, ALOPECIA, AND DISTINCTIVE FACIES; GKAF]
FBgn0014868	Ost48	HGNC:2728	OMIM:602202	DDOST	14	614507	614507[CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Ir; CDG1R]
FBgn0030092	fh	HGNC:3951	OMIM:606829	FXN	12	229300	229300[FRIEDREICH ATAXIA; FRDA]
FBgn0004856	Bx42	HGNC:16696	OMIM:603055	SNW1	14		
FBgn0030087	CG7766	HGNC:8926	OMIM:300798	PHKA2	13	306000	306000[GLYCOGEN STORAGE DISEASE IXa1; GSD9A1]
FBgn0030087	CG7766	HGNC:8925	OMIM:311870	PHKA1	13	300559	300559[GLYCOGEN STORAGE DISEASE IXd; GSD9D]
FBgn0030087	CG7766	HGNC:8927	OMIM:172490	PHKB	3	261750	261750[GLYCOGEN STORAGE DISEASE IXb; GSD9B]
FBgn0030081	CG7246	HGNC:18279		UTP6	14		
FBgn0030077	CG15365	HGNC:30139	OMIM:610484	LZTS3	6		
FBgn0030077	CG15365	HGNC:13861	OMIM:606551	LZTS1	4	133239	133239[ESOPHAGEAL CANCER]
FBgn0030077	CG15365	HGNC:29381	OMIM:610454	LZTS2	6		
FBgn0026149	BCL7-like	HGNC:1004	OMIM:601406	BCL7A	11		
FBgn0026149	BCL7-like	HGNC:1006	OMIM:605847	BCL7C	10		
FBgn0026149	BCL7-like	HGNC:1005	OMIM:605846	BCL7B	11		
FBgn0030136	RpS28b	HGNC:10418	OMIM:603685	RPS28	13	606164	606164[DIAMOND-BLACKFAN ANEMIA 15 WITH MANDIBULOFACIAL DYSOSTOSIS; DBA15]
FBgn0001186	Hex-A	HGNC:23302	OMIM:617221	HKDC1	9	619614	619614[RETINITIS PIGMENTOSA 92; RP92]
FBgn0001186	Hex-A	HGNC:4922	OMIM:142600	HK1	10	235700,605285,617460,618547	235700[HEMOLYTIC ANEMIA, NONSPHEROCYTIC, DUE TO HEXOKINASE DEFICIENCY],605285[NEUROPATHY, HEREDITARY MOTOR AND SENSORY, RUSSE TYPE; HMSNR],617460[RETINITIS PIGMENTOSA 79; RP79],618547[NEURODEVELOPMENTAL DISORDER WITH VISUAL DEFECTS AND BRAIN ANOMALIES; NEDVIBA]
FBgn0001186	Hex-A	HGNC:4923	OMIM:601125	HK2	9		
FBgn0001186	Hex-A	HGNC:4925	OMIM:142570	HK3	9		
FBgn0001186	Hex-A	HGNC:4195	OMIM:138079	GCK	13	125851,125853,602485,606176	125851[MATURITY-ONSET DIABETES OF THE YOUNG, TYPE 2; MODY2],125853[TYPE 2 DIABETES MELLITUS; T2D],602485[HYPERINSULINEMIC HYPOGLYCEMIA, FAMILIAL, 3; HHF3],606176[DIABETES MELLITUS, PERMANENT NEONATAL, 1; PNDM1]
FBgn0030141	Gga	HGNC:17079	OMIM:606006	GGA3	12		
FBgn0030141	Gga	HGNC:16064	OMIM:606005	GGA2	12		
FBgn0030141	Gga	HGNC:17842	OMIM:606004	GGA1	13		
FBgn0027084	LysRS	HGNC:6215	OMIM:601421	KARS	15	613641,613916,619147,619196	613641[CHARCOT-MARIE-TOOTH DISEASE, RECESSIVE INTERMEDIATE B; CMTRIB],613916[DEAFNESS, AUTOSOMAL RECESSIVE 89; DFNB89],619147[LEUKOENCEPHALOPATHY, PROGRESSIVE, INFANTILE-ONSET, WITH OR WITHOUT DEAFNESS; LEPID],619196[DEAFNESS, CONGENITAL, AND ADULT-ONSET PROGRESSIVE LEUKOENCEPHALOPATHY; DEAPLE]
FBgn0052699	LPCAT	HGNC:25718	OMIM:610472	LPCAT1	14		
FBgn0052699	LPCAT	HGNC:30059	OMIM:612039	LPCAT4	7		
FBgn0052699	LPCAT	HGNC:26032	OMIM:612040	LPCAT2	12		
FBgn0052702	Cubn	HGNC:2548	OMIM:602997	CUBN	12	261100,618884	261100[IMERSLUND-GRASBECK SYNDROME 1; IGS1],618884[PROTEINURIA, CHRONIC BENIGN; PROCHOB]
FBgn0028327	l(1)G0320	HGNC:11323	OMIM:600868	SSR1	14		
FBgn0020378	Sp1	HGNC:30690		SP9	10		
FBgn0020378	Sp1	HGNC:19196	OMIM:608306	SP8	9		
FBgn0020378	Sp1	HGNC:14530	OMIM:608613	SP6	3		
FBgn0020378	Sp1	HGNC:17321	OMIM:606633	SP7	5	613849	613849[OSTEOGENESIS IMPERFECTA, TYPE XII; OI12]
FBgn0052698	CARPB	HGNC:1369	OMIM:604642	CA10	13		
FBgn0052698	CARPB	HGNC:1380	OMIM:114780	CA6	3		
FBgn0052698	CARPB	HGNC:1371	OMIM:603263	CA12	3	143860	143860[HYPERCHLORHIDROSIS, ISOLATED; HYCHL]
FBgn0052698	CARPB	HGNC:1372	OMIM:604832	CA14	3		
FBgn0052698	CARPB	HGNC:1383	OMIM:603179	CA9	3		
FBgn0052698	CARPB	HGNC:1370	OMIM:604644	CA11	11		
FBgn0052698	CARPB	HGNC:1368	OMIM:114800	CA1	3		
FBgn0052698	CARPB	HGNC:1377	OMIM:114761	CA5A	3	615751	615751[CARBONIC ANHYDRASE VA DEFICIENCY, HYPERAMMONEMIA DUE TO; CA5AD]
FBgn0052698	CARPB	HGNC:14914	OMIM:611436	CA13	3		
FBgn0052698	CARPB	HGNC:1374	OMIM:114750	CA3	3		
FBgn0052698	CARPB	HGNC:1375	OMIM:114760	CA4	3		
FBgn0052698	CARPB	HGNC:1378	OMIM:300230	CA5B	3		
FBgn0026415	Idgf4	HGNC:8524	OMIM:603578	OVGP1	4		
FBgn0026415	Idgf4	HGNC:1932	OMIM:601525	CHI3L1	4	181500,611960	181500[SCHIZOPHRENIA; SCZD],611960[ASTHMA-RELATED TRAITS, SUSCEPTIBILITY TO, 7; ASRT7]
FBgn0026415	Idgf4	HGNC:1936	OMIM:600031	CHIT1	4	614122	614122[CHITOTRIOSIDASE DEFICIENCY; CHITD]
FBgn0026415	Idgf4	HGNC:17432	OMIM:606080	CHIA	3		
FBgn0026415	Idgf4	HGNC:1933	OMIM:601526	CHI3L2	3		
FBgn0030164	CG1889	HGNC:3624	OMIM:601624	FCN2	3		
FBgn0030164	CG1889	HGNC:3623	OMIM:601252	FCN1	3		
FBgn0030164	CG1889	HGNC:25922	OMIM:613357	FIBCD1	3		
FBgn0030164	CG1889	HGNC:3625	OMIM:604973	FCN3	3	613860	613860[FICOLIN 3 DEFICIENCY]
FBgn0030164	CG1889	HGNC:7035	OMIM:600596	MFAP4	3		
FBgn0004045	Yp1	HGNC:18821	OMIM:609252	LIPI	3		
FBgn0005391	Yp2	HGNC:18821	OMIM:609252	LIPI	3		
FBgn0030163	CG1791	HGNC:3624	OMIM:601624	FCN2	3		
FBgn0030163	CG1791	HGNC:3623	OMIM:601252	FCN1	3		
FBgn0030163	CG1791	HGNC:25922	OMIM:613357	FIBCD1	3		
FBgn0030163	CG1791	HGNC:3625	OMIM:604973	FCN3	3	613860	613860[FICOLIN 3 DEFICIENCY]
FBgn0030163	CG1791	HGNC:7035	OMIM:600596	MFAP4	3		
FBgn0030177	CG2972	HGNC:29540	OMIM:613586	NOB1	14		
FBgn0030181	CG12645	HGNC:16841	OMIM:603795	LITAF	4	601098	601098[CHARCOT-MARIE-TOOTH DISEASE, DEMYELINATING, TYPE 1C; CMT1C]
FBgn0028342	ATPsyndelta	HGNC:837	OMIM:603150	ATP5F1D	13	618120	618120[MITOCHONDRIAL COMPLEX V (ATP SYNTHASE) DEFICIENCY, NUCLEAR TYPE 5; MC5DN5]
FBgn0028480	CG17841	HGNC:29646	OMIM:611627	TLCD3A	10		
FBgn0028480	CG17841	HGNC:25295	OMIM:615175	TLCD3B	12	619531	619531[CONE-ROD DYSTROPHY 22; CORD22]
FBgn0000711	flw	HGNC:9281	OMIM:176875	PPP1CA	5		
FBgn0000711	flw	HGNC:9283	OMIM:176914	PPP1CC	5		
FBgn0000711	flw	HGNC:9282	OMIM:600590	PPP1CB	13	617506	617506[NOONAN SYNDROME-LIKE DISORDER WITH LOOSE ANAGEN HAIR 2; NSLH2]
FBgn0030200	RabX2	HGNC:9758	OMIM:179508	RAB1A	3		
FBgn0030200	RabX2	HGNC:19982		RAB19	3		
FBgn0030200	RabX2	HGNC:18370	OMIM:612565	RAB1B	3		
FBgn0030208	PPP4R2r	HGNC:18296	OMIM:613822	PPP4R2	8		
FBgn0052687	CG32687	HGNC:26968		LRRC58	13		
FBgn0030207	CG2887	HGNC:14887	OMIM:611328	DNAJB5	7		
FBgn0030207	CG2887	HGNC:5270	OMIM:604572	DNAJB1	6		
FBgn0030207	CG2887	HGNC:30718	OMIM:610263	DNAJB13	3	617091	617091[CILIARY DYSKINESIA, PRIMARY, 34; CILD34]
FBgn0030207	CG2887	HGNC:14886	OMIM:611327	DNAJB4	5		
FBgn0052683	CG32683	HGNC:712	OMIM:107941	ARRB2	5		
FBgn0052683	CG32683	HGNC:710	OMIM:301770	ARR3	4	301010	301010[MYOPIA 26, X-LINKED, FEMALE-LIMITED; MYP26]
FBgn0052683	CG32683	HGNC:10521	OMIM:181031	SAG	5	258100,613758	258100[OGUCHI DISEASE 1],613758[RETINITIS PIGMENTOSA 47; RP47]
FBgn0052683	CG32683	HGNC:711	OMIM:107940	ARRB1	4		
FBgn0030196	Psf3	HGNC:25851	OMIM:610610	GINS3	15		
FBgn0052679	CG32679	HGNC:8946	OMIM:607076	PI15	4		
FBgn0052679	CG32679	HGNC:16249		R3HDML	4		
FBgn0052679	CG32679	HGNC:21245		PI16	3		
FBgn0052679	CG32679	HGNC:18007	OMIM:607141	GLIPR2	3		
FBgn0052679	CG32679	HGNC:28392	OMIM:610395	GLIPR1L1	4		
FBgn0052679	CG32679	HGNC:18206		CRISPLD1	3		
FBgn0052679	CG32679	HGNC:25248	OMIM:612434	CRISPLD2	3		
FBgn0052679	CG32679	HGNC:16904	OMIM:618062	CRISP3	3		
FBgn0052679	CG32679	HGNC:304	OMIM:601193	CRISP1	3		
FBgn0052679	CG32679	HGNC:12024	OMIM:187430	CRISP2	3		
FBgn0052679	CG32679	HGNC:33849	OMIM:616572	CLEC18B	3		
FBgn0052679	CG32679	HGNC:30388	OMIM:616571	CLEC18A	3		
FBgn0028331	l(1)G0289	HGNC:20945	OMIM:606826	PLXDC1	11		
FBgn0028331	l(1)G0289	HGNC:21013	OMIM:606827	PLXDC2	12		
FBgn0030191	CG15306	HGNC:6892	OMIM:605788	MAPRE3	4		
FBgn0030191	CG15306	HGNC:6891	OMIM:605789	MAPRE2	4	616734	616734[SKIN CREASES, CONGENITAL SYMMETRIC CIRCUMFERENTIAL, 2; CSCSC2]
FBgn0030191	CG15306	HGNC:6890	OMIM:603108	MAPRE1	4		
FBgn0011770	Gip	HGNC:26948	OMIM:619128	HYI	14		
FBgn0030183	Ypel	HGNC:18329	OMIM:609726	YPEL5	5		
FBgn0030183	Ypel	HGNC:12845	OMIM:608082	YPEL1	12		
FBgn0030183	Ypel	HGNC:18326	OMIM:609723	YPEL2	14		
FBgn0030183	Ypel	HGNC:18327	OMIM:609724	YPEL3	11		
FBgn0030183	Ypel	HGNC:18328	OMIM:609725	YPEL4	11		
FBgn0030178	Naxe	HGNC:24785	OMIM:618607	YJEFN3	7		
FBgn0030178	Naxe	HGNC:18453	OMIM:608862	NAXE	13	617186	617186[ENCEPHALOPATHY, PROGRESSIVE, EARLY-ONSET, WITH BRAIN EDEMA AND/OR LEUKOENCEPHALOPATHY, 1; PEBEL1]
FBgn0052685	ZAP3	HGNC:17798	OMIM:619766	YLPM1	10		
FBgn0067052	Rab9D	HGNC:9758	OMIM:179508	RAB1A	3		
FBgn0067052	Rab9D	HGNC:19982		RAB19	3		
FBgn0067052	Rab9D	HGNC:18370	OMIM:612565	RAB1B	3		
FBgn0030217	CG2124	HGNC:25790	OMIM:614272	FASTKD5	9		
FBgn0030223	CG2111	HGNC:500	OMIM:151530	ANPEP	3		
FBgn0030223	CG2111	HGNC:30748	OMIM:606950	TRHDE	3		
FBgn0030223	CG2111	HGNC:18173	OMIM:606832	ERAP1	4		
FBgn0030223	CG2111	HGNC:26904	OMIM:610046	LVRN	3		
FBgn0030223	CG2111	HGNC:7900	OMIM:606793	NPEPPS	3		
FBgn0030223	CG2111	HGNC:29499	OMIM:609497	ERAP2	4		
FBgn0030223	CG2111	HGNC:6656	OMIM:151300	LNPEP	4		
FBgn0052677	X11Lbeta	HGNC:579	OMIM:602712	APBA2	9		
FBgn0052677	X11Lbeta	HGNC:580	OMIM:604262	APBA3	8		
FBgn0052677	X11Lbeta	HGNC:578	OMIM:602414	APBA1	9		
FBgn0003204	ras	HGNC:6052	OMIM:146690	IMPDH1	13	180105,613837	180105[RETINITIS PIGMENTOSA 10; RP10],613837[LEBER CONGENITAL AMAUROSIS 11; LCA11]
FBgn0003204	ras	HGNC:6053	OMIM:146691	IMPDH2	10	617995	617995[IMPDH2 ENZYME ACTIVITY, VARIATION IN; IMPDH2V]
FBgn0030228	BTBD9	HGNC:21228	OMIM:611237	BTBD9	14		
FBgn0052672	Atg8a	HGNC:13291	OMIM:607452	GABARAPL2	5		
FBgn0052672	Atg8a	HGNC:13353	OMIM:609605	MAP1LC3C	3		
FBgn0052672	Atg8a	HGNC:4067	OMIM:605125	GABARAP	12		
FBgn0052672	Atg8a	HGNC:4068	OMIM:607420	GABARAPL1	8		
FBgn0052672	Atg8a	HGNC:4069		GABARAPL3	3		
FBgn0052675	Tango5	HGNC:29559	OMIM:611753	VMP1	13		
FBgn0030230	Rph	HGNC:17056	OMIM:612159	RPH3A	10		
FBgn0030230	Rph	HGNC:2986	OMIM:604568	DOC2B	12		
FBgn0030230	Rph	HGNC:10296	OMIM:604881	RPH3AL	5		
FBgn0030230	Rph	HGNC:2985	OMIM:604567	DOC2A	9		
FBgn0052676	stx	HGNC:16298	OMIM:606700	MIDN	11		
FBgn0030222	CG9806	HGNC:500	OMIM:151530	ANPEP	3		
FBgn0030222	CG9806	HGNC:30748	OMIM:606950	TRHDE	3		
FBgn0030222	CG9806	HGNC:18173	OMIM:606832	ERAP1	4		
FBgn0030222	CG9806	HGNC:26904	OMIM:610046	LVRN	3		
FBgn0030222	CG9806	HGNC:7900	OMIM:606793	NPEPPS	3		
FBgn0030222	CG9806	HGNC:29499	OMIM:609497	ERAP2	4		
FBgn0030222	CG9806	HGNC:6656	OMIM:151300	LNPEP	4		
FBgn0030221	Rab9Db	HGNC:9758	OMIM:179508	RAB1A	3		
FBgn0030221	Rab9Db	HGNC:19982		RAB19	3		
FBgn0030221	Rab9Db	HGNC:18370	OMIM:612565	RAB1B	3		
FBgn0030218	CG1628	HGNC:22921	OMIM:608157	SLC25A2	11		
FBgn0030218	CG1628	HGNC:10985	OMIM:603861	SLC25A15	14	238970	238970[HYPERORNITHINEMIA-HYPERAMMONEMIA-HOMOCITRULLINURIA SYNDROME; HHHS]
FBgn0030215	CG15296	HGNC:33702	OMIM:616658	MICOS13	3	618329	618329[COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 37; COXPD37]
FBgn0034554	CAH14	HGNC:1382	OMIM:114815	CA8	3	613227	613227[CEREBELLAR ATAXIA, MENTAL RETARDATION, AND DYSEQUILIBRIUM SYNDROME 3; CAMRQ3]
FBgn0034554	CAH14	HGNC:1369	OMIM:604642	CA10	3		
FBgn0034554	CAH14	HGNC:1380	OMIM:114780	CA6	3		
FBgn0034554	CAH14	HGNC:1371	OMIM:603263	CA12	3	143860	143860[HYPERCHLORHIDROSIS, ISOLATED; HYCHL]
FBgn0034554	CAH14	HGNC:1372	OMIM:604832	CA14	3		
FBgn0034554	CAH14	HGNC:1383	OMIM:603179	CA9	3		
FBgn0034554	CAH14	HGNC:1370	OMIM:604644	CA11	3		
FBgn0034554	CAH14	HGNC:1368	OMIM:114800	CA1	3		
FBgn0034554	CAH14	HGNC:1377	OMIM:114761	CA5A	3	615751	615751[CARBONIC ANHYDRASE VA DEFICIENCY, HYPERAMMONEMIA DUE TO; CA5AD]
FBgn0034554	CAH14	HGNC:14914	OMIM:611436	CA13	3		
FBgn0034554	CAH14	HGNC:1374	OMIM:114750	CA3	3		
FBgn0034554	CAH14	HGNC:1375	OMIM:114760	CA4	3		
FBgn0034554	CAH14	HGNC:1378	OMIM:300230	CA5B	3		
FBgn0050295	Ipk1	HGNC:14645	OMIM:619043	IPPK	11		
FBgn0034558	Cib2	HGNC:24579	OMIM:605564	CIB2	14	609439,614869	609439[DEAFNESS, AUTOSOMAL RECESSIVE 48; DFNB48],614869[USHER SYNDROME, TYPE IJ; USH1J]
FBgn0034558	Cib2	HGNC:24580	OMIM:610645	CIB3	13		
FBgn0034560	CAH15	HGNC:1382	OMIM:114815	CA8	3	613227	613227[CEREBELLAR ATAXIA, MENTAL RETARDATION, AND DYSEQUILIBRIUM SYNDROME 3; CAMRQ3]
FBgn0034560	CAH15	HGNC:1369	OMIM:604642	CA10	3		
FBgn0034560	CAH15	HGNC:1380	OMIM:114780	CA6	3		
FBgn0034560	CAH15	HGNC:1371	OMIM:603263	CA12	3	143860	143860[HYPERCHLORHIDROSIS, ISOLATED; HYCHL]
FBgn0034560	CAH15	HGNC:1372	OMIM:604832	CA14	3		
FBgn0034560	CAH15	HGNC:1383	OMIM:603179	CA9	3		
FBgn0034560	CAH15	HGNC:1370	OMIM:604644	CA11	3		
FBgn0034560	CAH15	HGNC:1368	OMIM:114800	CA1	3		
FBgn0034560	CAH15	HGNC:1377	OMIM:114761	CA5A	3	615751	615751[CARBONIC ANHYDRASE VA DEFICIENCY, HYPERAMMONEMIA DUE TO; CA5AD]
FBgn0034560	CAH15	HGNC:14914	OMIM:611436	CA13	3		
FBgn0034560	CAH15	HGNC:1374	OMIM:114750	CA3	4		
FBgn0034560	CAH15	HGNC:1375	OMIM:114760	CA4	3		
FBgn0034560	CAH15	HGNC:1378	OMIM:300230	CA5B	3		
FBgn0020617	Rx	HGNC:1494	OMIM:601527	ALX1	3	613456	613456[FRONTONASAL DYSPLASIA 3; FND3]
FBgn0020617	Rx	HGNC:18662	OMIM:601881	RAX	6	611038	611038[MICROPHTHALMIA, ISOLATED 3; MCOP3]
FBgn0020617	Rx	HGNC:18286	OMIM:610362	RAX2	3	610381,613757	610381[CONE-ROD DYSTROPHY 11; CORD11],613757[MACULAR DEGENERATION, AGE-RELATED, 6; ARMD6]
FBgn0020617	Rx	HGNC:18060	OMIM:300382	ARX	3	300004,300215,300419,308350,309510	300004[CORPUS CALLOSUM, AGENESIS OF, WITH ABNORMAL GENITALIA],300215[LISSENCEPHALY, X-LINKED, 2; LISX2],300419[INTELLECTUAL DEVELOPMENTAL DISORDER, X-LINKED 29; XLID29],308350[DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 1; DEE1],309510[PARTINGTON SYNDROME; PRTS]
FBgn0020617	Rx	HGNC:449	OMIM:606014	ALX3	3	136760	136760[FRONTONASAL DYSPLASIA 1; FND1]
FBgn0020617	Rx	HGNC:450	OMIM:605420	ALX4	3	609597,613451,615529	609597[PARIETAL FORAMINA 2; PFM2],613451[FRONTONASAL DYSPLASIA 2; FND2],615529[CRANIOSYNOSTOSIS 5, SUSCEPTIBILITY TO; CRS5]
FBgn0034564	CG9344	HGNC:17017	OMIM:607286	LSM6	14		
FBgn0034572	CG9346	HGNC:30855	OMIM:617849	U2SURP	13		
FBgn0034576	ND-B14.7	HGNC:20371	OMIM:612638	NDUFA11	11	618236	618236[MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 14; MC1DN14]
FBgn0034577	cpa	HGNC:1488	OMIM:601580	CAPZA1	14		
FBgn0034577	cpa	HGNC:1490	OMIM:601571	CAPZA2	14		
FBgn0034577	cpa	HGNC:24205	OMIM:608722	CAPZA3	7		
FBgn0034579	mRpL54	HGNC:16685	OMIM:611858	MRPL54	12		
FBgn0034580	Cht8	HGNC:8524	OMIM:603578	OVGP1	5		
FBgn0034580	Cht8	HGNC:1932	OMIM:601525	CHI3L1	6	181500,611960	181500[SCHIZOPHRENIA; SCZD],611960[ASTHMA-RELATED TRAITS, SUSCEPTIBILITY TO, 7; ASRT7]
FBgn0034580	Cht8	HGNC:1936	OMIM:600031	CHIT1	9	614122	614122[CHITOTRIOSIDASE DEFICIENCY; CHITD]
FBgn0034580	Cht8	HGNC:17432	OMIM:606080	CHIA	9		
FBgn0034580	Cht8	HGNC:1933	OMIM:601526	CHI3L2	5		
FBgn0003748	Treh	HGNC:12266	OMIM:275360	TREH	14	612119	612119[TREHALASE DEFICIENCY]
FBgn0034582	Cht9	HGNC:8524	OMIM:603578	OVGP1	4		
FBgn0034582	Cht9	HGNC:1932	OMIM:601525	CHI3L1	5	181500,611960	181500[SCHIZOPHRENIA; SCZD],611960[ASTHMA-RELATED TRAITS, SUSCEPTIBILITY TO, 7; ASRT7]
FBgn0034582	Cht9	HGNC:1936	OMIM:600031	CHIT1	6	614122	614122[CHITOTRIOSIDASE DEFICIENCY; CHITD]
FBgn0034582	Cht9	HGNC:17432	OMIM:606080	CHIA	6		
FBgn0034582	Cht9	HGNC:1933	OMIM:601526	CHI3L2	4		
FBgn0022700	Cht4	HGNC:8524	OMIM:603578	OVGP1	5		
FBgn0022700	Cht4	HGNC:1932	OMIM:601525	CHI3L1	6	181500,611960	181500[SCHIZOPHRENIA; SCZD],611960[ASTHMA-RELATED TRAITS, SUSCEPTIBILITY TO, 7; ASRT7]
FBgn0022700	Cht4	HGNC:1936	OMIM:600031	CHIT1	6	614122	614122[CHITOTRIOSIDASE DEFICIENCY; CHITD]
FBgn0022700	Cht4	HGNC:17432	OMIM:606080	CHIA	8		
FBgn0022700	Cht4	HGNC:1933	OMIM:601526	CHI3L2	5		
FBgn0050293	Cht12	HGNC:8524	OMIM:603578	OVGP1	4		
FBgn0050293	Cht12	HGNC:1932	OMIM:601525	CHI3L1	4	181500,611960	181500[SCHIZOPHRENIA; SCZD],611960[ASTHMA-RELATED TRAITS, SUSCEPTIBILITY TO, 7; ASRT7]
FBgn0050293	Cht12	HGNC:1936	OMIM:600031	CHIT1	4	614122	614122[CHITOTRIOSIDASE DEFICIENCY; CHITD]
FBgn0050293	Cht12	HGNC:17432	OMIM:606080	CHIA	5		
FBgn0050293	Cht12	HGNC:1933	OMIM:601526	CHI3L2	3		
FBgn0034578	CG15653	HGNC:21868	OMIM:614769	COA1	11		
FBgn0034573	Sou	HGNC:26181		RMND5B	13		
FBgn0034573	Sou	HGNC:25850	OMIM:618964	RMND5A	14		
FBgn0050291	CG30291	HGNC:18673	OMIM:608202	CDK5RAP3	14		
FBgn0034568	CG3216	HGNC:7943	OMIM:108960	NPR1	7		
FBgn0034568	CG3216	HGNC:7944	OMIM:108961	NPR2	6	602875,615923,616255	602875[ACROMESOMELIC DYSPLASIA 1; AMD1],615923[EPIPHYSEAL CHONDRODYSPLASIA, MIURA TYPE; ECDM],616255[SHORT STATURE WITH NONSPECIFIC SKELETAL ABNORMALITIES; SNSK]
FBgn0034568	CG3216	HGNC:4691	OMIM:300041	GUCY2F	3		
FBgn0034568	CG3216	HGNC:4688	OMIM:601330	GUCY2C	3	614616,614665	614616[DIARRHEA 6; DIAR6],614665[MECONIUM ILEUS]
FBgn0034567	CG15651	HGNC:17997	OMIM:606596	FKRP	14	606612,607155,613153	606612[MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH OR WITHOUT IMPAIRED INTELLECTUAL DEVELOPMENT), TYPE B, 5; MDDGB5],607155[MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (LIMB-GIRDLE), TYPE C, 5; MDDGC5],613153[MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 5; MDDGA5]
FBgn0008636	hbn	HGNC:18060	OMIM:300382	ARX	3	300004,300215,300419,308350,309510	300004[CORPUS CALLOSUM, AGENESIS OF, WITH ABNORMAL GENITALIA],300215[LISSENCEPHALY, X-LINKED, 2; LISX2],300419[INTELLECTUAL DEVELOPMENTAL DISORDER, X-LINKED 29; XLID29],308350[DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 1; DEE1],309510[PARTINGTON SYNDROME; PRTS]
FBgn0015524	otp	HGNC:8518	OMIM:604529	OTP	9		
FBgn0011674	insc	HGNC:33116	OMIM:610668	INSC	10		
FBgn0016984	sktl	HGNC:8994	OMIM:603275	PIP5K1A	12		
FBgn0016984	sktl	HGNC:8996	OMIM:606102	PIP5K1C	10	611369	611369[LETHAL CONGENITAL CONTRACTURE SYNDROME 3; LCCS3]
FBgn0016984	sktl	HGNC:8995	OMIM:602745	PIP5K1B	10		
FBgn0016984	sktl	HGNC:28711	OMIM:612865	PIP5KL1	3		
FBgn0016984	sktl	HGNC:23733		PIPSL	5		
FBgn0034588	CG9394	HGNC:26957	OMIM:614124	GPCPD1	8		
FBgn0002736	mago	HGNC:6815	OMIM:602603	MAGOH	13		
FBgn0002736	mago	HGNC:25504	OMIM:619552	MAGOHB	14		
FBgn0034592	CG9406	HGNC:28166	OMIM:619617	EFCAB2	8		
FBgn0021872	Xbp1	HGNC:12801	OMIM:194355	XBP1	10	612371	612371[MAJOR AFFECTIVE DISORDER 7; MAFD7]
FBgn0026582	Hmg-2	HGNC:5002	OMIM:605535	HMG20B	11		
FBgn0026582	Hmg-2	HGNC:5001	OMIM:605534	HMG20A	13		
FBgn0003162	Pu	HGNC:4193	OMIM:600225	GCH1	14	128230,233910	128230[DYSTONIA, DOPA-RESPONSIVE; DRD],233910[HYPERPHENYLALANINEMIA, BH4-DEFICIENT, B; HPABH4B]
FBgn0003891	tud	HGNC:21339	OMIM:611200	TDRD6	10		
FBgn0003891	tud	HGNC:45037		TDRD15	9		
FBgn0003891	tud	HGNC:11712	OMIM:605796	TDRD1	4		
FBgn0034611	MFS16	HGNC:20644	OMIM:619136	SLC37A2	15		
FBgn0034611	MFS16	HGNC:11024	OMIM:608094	SLC37A1	12		
FBgn0034611	MFS16	HGNC:20651	OMIM:619137	SLC37A3	5		
FBgn0016726	RpL29	HGNC:10331	OMIM:601832	RPL29	9		
FBgn0020306	dom	HGNC:16974	OMIM:611421	SRCAP	8	136140,619595	136140[FLOATING-HARBOR SYNDROME; FLHS],619595[DEVELOPMENTAL DELAY, HYPOTONIA, MUSCULOSKELETAL DEFECTS, AND BEHAVIORAL ABNORMALITIES; DEHMBA]
FBgn0020306	dom	HGNC:11958	OMIM:606265	EP400	10		
FBgn0034622	BBS9	HGNC:30000	OMIM:607968	BBS9	14	615986	615986[BARDET-BIEDL SYNDROME 9; BBS9]
FBgn0034628	Acox57D-p	HGNC:119	OMIM:609751	ACOX1	9	264470,618960	264470[PEROXISOMAL ACYL-CoA OXIDASE DEFICIENCY],618960[MITCHELL SYNDROME; MITCH]
FBgn0034628	Acox57D-p	HGNC:120	OMIM:601641	ACOX2	8	617308	617308[BILE ACID SYNTHESIS DEFECT, CONGENITAL, 6; CBAS6]
FBgn0034629	Acox57D-d	HGNC:119	OMIM:609751	ACOX1	9	264470,618960	264470[PEROXISOMAL ACYL-CoA OXIDASE DEFICIENCY],618960[MITCHELL SYNDROME; MITCH]
FBgn0034629	Acox57D-d	HGNC:120	OMIM:601641	ACOX2	9	617308	617308[BILE ACID SYNTHESIS DEFECT, CONGENITAL, 6; CBAS6]
FBgn0034627	eEFSec	HGNC:24614	OMIM:607695	EEFSEC	15		
FBgn0034626	bisc	HGNC:24142	OMIM:610080	TM2D1	13		
FBgn0000395	cv-2	HGNC:24154	OMIM:608699	BMPER	12	608022	608022[DIAPHANOSPONDYLODYSOSTOSIS]
FBgn0000395	cv-2	HGNC:13572	OMIM:617553	FCGBP	3		
FBgn0000395	cv-2	HGNC:17585	OMIM:609344	KCP	4		
FBgn0000395	cv-2	HGNC:37203	OMIM:619794	VWC2L	3		
FBgn0000395	cv-2	HGNC:30200	OMIM:611108	VWC2	3		
FBgn0034624	CG17974	HGNC:8946	OMIM:607076	PI15	4		
FBgn0034624	CG17974	HGNC:16249		R3HDML	4		
FBgn0034624	CG17974	HGNC:21245		PI16	3		
FBgn0034624	CG17974	HGNC:28392	OMIM:610395	GLIPR1L1	4		
FBgn0034624	CG17974	HGNC:25248	OMIM:612434	CRISPLD2	3		
FBgn0034624	CG17974	HGNC:16904	OMIM:618062	CRISP3	3		
FBgn0034624	CG17974	HGNC:304	OMIM:601193	CRISP1	3		
FBgn0034624	CG17974	HGNC:12024	OMIM:187430	CRISP2	3		
FBgn0034624	CG17974	HGNC:33849	OMIM:616572	CLEC18B	3		
FBgn0034624	CG17974	HGNC:30388	OMIM:616571	CLEC18A	3		
FBgn0034623	CG9822	HGNC:8946	OMIM:607076	PI15	3		
FBgn0034623	CG9822	HGNC:16249		R3HDML	3		
FBgn0034623	CG9822	HGNC:21245		PI16	3		
FBgn0034623	CG9822	HGNC:28392	OMIM:610395	GLIPR1L1	4		
FBgn0034623	CG9822	HGNC:16904	OMIM:618062	CRISP3	3		
FBgn0034623	CG9822	HGNC:304	OMIM:601193	CRISP1	3		
FBgn0034623	CG9822	HGNC:12024	OMIM:187430	CRISP2	3		
FBgn0034623	CG9822	HGNC:33849	OMIM:616572	CLEC18B	3		
FBgn0034623	CG9822	HGNC:30388	OMIM:616571	CLEC18A	3		
FBgn0050394	CG30394	HGNC:28237	OMIM:616525	SLC38A10	11		
FBgn0050394	CG30394	HGNC:13447	OMIM:608490	SLC38A1	3		
FBgn0050394	CG30394	HGNC:13448	OMIM:605180	SLC38A2	3		
FBgn0050394	CG30394	HGNC:19863	OMIM:616518	SLC38A6	3		
FBgn0034614	CG9752	HGNC:28144	OMIM:611342	C9orf64	14		
FBgn0050390	Sgf29	HGNC:25156	OMIM:613374	SGF29	13		
FBgn0050392	CG30392	HGNC:33756		GLTPD2	8		
FBgn0050392	CG30392	HGNC:28116	OMIM:615467	CPTP	12		
FBgn0034612	CG10505	HGNC:55	OMIM:605250	ABCC4	8		
FBgn0034612	CG10505	HGNC:52	OMIM:612509	ABCC10	5		
FBgn0034612	CG10505	HGNC:53	OMIM:601107	ABCC2	5	237500	237500[DUBIN-JOHNSON SYNDROME; DJS]
FBgn0034612	CG10505	HGNC:51	OMIM:158343	ABCC1	6	618915	618915[DEAFNESS, AUTOSOMAL DOMINANT 77; DFNA77]
FBgn0034612	CG10505	HGNC:59	OMIM:600509	ABCC8	5	125853,240800,256450,610374,618857	125853[TYPE 2 DIABETES MELLITUS; T2D],240800[HYPOGLYCEMIA, LEUCINE-INDUCED; LIH],256450[HYPERINSULINEMIC HYPOGLYCEMIA, FAMILIAL, 1; HHF1],610374[DIABETES MELLITUS, TRANSIENT NEONATAL, 2; TNDM2],618857[DIABETES MELLITUS, PERMANENT NEONATAL, 3; PNDM3]
FBgn0034612	CG10505	HGNC:14640	OMIM:607041	ABCC12	5		
FBgn0034612	CG10505	HGNC:60	OMIM:601439	ABCC9	5	239850,608569,614050,619719	239850[CANTU SYNDROME],608569[CARDIOMYOPATHY, DILATED, 1O; CMD1O],614050[ATRIAL FIBRILLATION, FAMILIAL, 12; ATFB12],619719[INTELLECTUAL DISABILITY AND MYOPATHY SYNDROME; IDMYS]
FBgn0034612	CG10505	HGNC:57	OMIM:603234	ABCC6	5	177850,264800,614473	177850[PSEUDOXANTHOMA ELASTICUM, FORME FRUSTE],264800[PSEUDOXANTHOMA ELASTICUM; PXE],614473[ARTERIAL CALCIFICATION, GENERALIZED, OF INFANCY, 2; GACI2]
FBgn0034612	CG10505	HGNC:56	OMIM:605251	ABCC5	5		
FBgn0034612	CG10505	HGNC:14639	OMIM:607040	ABCC11	5	117800	117800[APOCRINE GLAND SECRETION, VARIATION IN]
FBgn0034612	CG10505	HGNC:54	OMIM:604323	ABCC3	5		
FBgn0034612	CG10505	HGNC:1884	OMIM:602421	CFTR	5	167800,211400,219700,277180	167800[PANCREATITIS, HEREDITARY; PCTT],211400[BRONCHIECTASIS WITH OR WITHOUT ELEVATED SWEAT CHLORIDE 1; BESC1],219700[CYSTIC FIBROSIS; CF],277180[VAS DEFERENS, CONGENITAL BILATERAL APLASIA OF; CBAVD]
FBgn0034606	ASPP	HGNC:12000	OMIM:602143	TP53BP2	13		
FBgn0034606	ASPP	HGNC:18838	OMIM:607463	PPP1R13L	3		
FBgn0034606	ASPP	HGNC:14950	OMIM:606455	PPP1R13B	14		
FBgn0034605	Ugt49C1	HGNC:12531	OMIM:606435	UGT1A10	5		
FBgn0034605	Ugt49C1	HGNC:12545	OMIM:603064	UGT2B11	8		
FBgn0034605	Ugt49C1	HGNC:12530	OMIM:191740	UGT1A1	8	143500,218800,237900,601816,606785	143500[GILBERT SYNDROME],218800[CRIGLER-NAJJAR SYNDROME, TYPE I],237900[HYPERBILIRUBINEMIA, TRANSIENT FAMILIAL NEONATAL; HBLRTFN],601816[BILIRUBIN, SERUM LEVEL OF, QUANTITATIVE TRAIT LOCUS 1; BILIQTL1],606785[CRIGLER-NAJJAR SYNDROME, TYPE II]
FBgn0034605	Ugt49C1	HGNC:12555	OMIM:601291	UGT8	6		
FBgn0034605	Ugt49C1	HGNC:12539	OMIM:606432	UGT1A7	5		
FBgn0034605	Ugt49C1	HGNC:13479	OMIM:606497	UGT2B28	7		
FBgn0034605	Ugt49C1	HGNC:27266	OMIM:616384	UGT3A2	4		
FBgn0034605	Ugt49C1	HGNC:12544	OMIM:600070	UGT2B10	7		
FBgn0034605	Ugt49C1	HGNC:12537	OMIM:606430	UGT1A5	5		
FBgn0034605	Ugt49C1	HGNC:12546	OMIM:600069	UGT2B15	7		
FBgn0034605	Ugt49C1	HGNC:12541	OMIM:606434	UGT1A9	5		
FBgn0034605	Ugt49C1	HGNC:28528	OMIM:616382	UGT2A3	8		
FBgn0034605	Ugt49C1	HGNC:12535	OMIM:606428	UGT1A3	7		
FBgn0034605	Ugt49C1	HGNC:12536	OMIM:606429	UGT1A4	5		
FBgn0034605	Ugt49C1	HGNC:12540	OMIM:606433	UGT1A8	5		
FBgn0034605	Ugt49C1	HGNC:26625	OMIM:616383	UGT3A1	4		
FBgn0034605	Ugt49C1	HGNC:12547	OMIM:601903	UGT2B17	7	612560	612560[BONE MINERAL DENSITY QUANTITATIVE TRAIT LOCUS 12; BMND12]
FBgn0034605	Ugt49C1	HGNC:12553	OMIM:600067	UGT2B4	8		
FBgn0034605	Ugt49C1	HGNC:12538	OMIM:606431	UGT1A6	5		
FBgn0034605	Ugt49C1	HGNC:12554	OMIM:600068	UGT2B7	7		
FBgn0034605	Ugt49C1	HGNC:28183	OMIM:619809	UGT2A2	7		
FBgn0027073	Ugt49B1	HGNC:12531	OMIM:606435	UGT1A10	5		
FBgn0027073	Ugt49B1	HGNC:12545	OMIM:603064	UGT2B11	9		
FBgn0027073	Ugt49B1	HGNC:12530	OMIM:191740	UGT1A1	7	143500,218800,237900,601816,606785	143500[GILBERT SYNDROME],218800[CRIGLER-NAJJAR SYNDROME, TYPE I],237900[HYPERBILIRUBINEMIA, TRANSIENT FAMILIAL NEONATAL; HBLRTFN],601816[BILIRUBIN, SERUM LEVEL OF, QUANTITATIVE TRAIT LOCUS 1; BILIQTL1],606785[CRIGLER-NAJJAR SYNDROME, TYPE II]
FBgn0027073	Ugt49B1	HGNC:12555	OMIM:601291	UGT8	7		
FBgn0027073	Ugt49B1	HGNC:12539	OMIM:606432	UGT1A7	5		
FBgn0027073	Ugt49B1	HGNC:13479	OMIM:606497	UGT2B28	7		
FBgn0027073	Ugt49B1	HGNC:27266	OMIM:616384	UGT3A2	4		
FBgn0027073	Ugt49B1	HGNC:12544	OMIM:600070	UGT2B10	9		
FBgn0027073	Ugt49B1	HGNC:12537	OMIM:606430	UGT1A5	5		
FBgn0027073	Ugt49B1	HGNC:12546	OMIM:600069	UGT2B15	8		
FBgn0027073	Ugt49B1	HGNC:12541	OMIM:606434	UGT1A9	5		
FBgn0027073	Ugt49B1	HGNC:28528	OMIM:616382	UGT2A3	9		
FBgn0027073	Ugt49B1	HGNC:12535	OMIM:606428	UGT1A3	7		
FBgn0027073	Ugt49B1	HGNC:12536	OMIM:606429	UGT1A4	5		
FBgn0027073	Ugt49B1	HGNC:12540	OMIM:606433	UGT1A8	5		
FBgn0027073	Ugt49B1	HGNC:26625	OMIM:616383	UGT3A1	4		
FBgn0027073	Ugt49B1	HGNC:12547	OMIM:601903	UGT2B17	8	612560	612560[BONE MINERAL DENSITY QUANTITATIVE TRAIT LOCUS 12; BMND12]
FBgn0027073	Ugt49B1	HGNC:12553	OMIM:600067	UGT2B4	9		
FBgn0027073	Ugt49B1	HGNC:12538	OMIM:606431	UGT1A6	6		
FBgn0027073	Ugt49B1	HGNC:12554	OMIM:600068	UGT2B7	8		
FBgn0027073	Ugt49B1	HGNC:28183	OMIM:619809	UGT2A2	8		
FBgn0034598	CG4266	HGNC:19304	OMIM:616023	SCAF4	10		
FBgn0034598	CG4266	HGNC:20959	OMIM:616024	SCAF8	10		
FBgn0050389	CG30389	HGNC:25572	OMIM:610301	MACO1	13		
FBgn0034590	Magi	HGNC:18957	OMIM:606382	MAGI2	10	617609	617609[NEPHROTIC SYNDROME, TYPE 15; NPHS15]
FBgn0034590	Magi	HGNC:29647	OMIM:615943	MAGI3	10		
FBgn0034590	Magi	HGNC:946	OMIM:602625	MAGI1	10		
FBgn0034590	Magi	HGNC:30006		MAGIX	3		
FBgn0020312	Tmtc3	HGNC:26899	OMIM:617218	TMTC3	15	617255	617255[LISSENCEPHALY 8; LIS8]
FBgn0011824	CG4038	HGNC:14264	OMIM:606468	GAR1	13		
FBgn0034585	Rbpn-5	HGNC:24817	OMIM:611869	RABEP2	3		
FBgn0034585	Rbpn-5	HGNC:17677	OMIM:603616	RABEP1	9		
FBgn0026369	Sara	HGNC:20756	OMIM:608880	ZFYVE16	11		
FBgn0026369	Sara	HGNC:6775	OMIM:603755	ZFYVE9	11		
FBgn0003731	Egfr	HGNC:3432	OMIM:600543	ERBB4	10	615515	615515[AMYOTROPHIC LATERAL SCLEROSIS 19; ALS19]
FBgn0003731	Egfr	HGNC:3430	OMIM:164870	ERBB2	10	137800,167000,211980,613659,619465	137800[GLIOMA SUSCEPTIBILITY 1; GLM1],167000[OVARIAN CANCER],211980[LUNG CANCER],613659[GASTRIC CANCER],619465[VISCERAL NEUROPATHY, FAMILIAL, 2, AUTOSOMAL RECESSIVE; VSCN2]
FBgn0003731	Egfr	HGNC:3431	OMIM:190151	ERBB3	9	133180,243180,607598	133180[ERYTHROLEUKEMIA, FAMILIAL, SUSCEPTIBILITY TO; FERLK],243180[VISCERAL NEUROPATHY, FAMILIAL, 1, AUTOSOMAL RECESSIVE; VSCN1],607598[LETHAL CONGENITAL CONTRACTURE SYNDROME 2; LCCS2]
FBgn0003731	Egfr	HGNC:3236	OMIM:131550	EGFR	11	211980,616069	211980[LUNG CANCER],616069[INFLAMMATORY SKIN AND BOWEL DISEASE, NEONATAL, 2; NISBD2]
FBgn0034641	mahj	HGNC:30911	OMIM:617259	DCAF1	14		
FBgn0034644	Ip6k	HGNC:20739	OMIM:609851	IPMK	3		
FBgn0034644	Ip6k	HGNC:18360	OMIM:606991	IP6K1	12		
FBgn0034644	Ip6k	HGNC:17313	OMIM:606992	IP6K2	10		
FBgn0034644	Ip6k	HGNC:17269	OMIM:606993	IP6K3	11		
FBgn0034645	ND-B12	HGNC:7698	OMIM:603839	NDUFB3	13	618246	618246[MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 25; MC1DN25]
FBgn0034650	NC2alpha	HGNC:3019	OMIM:602289	DRAP1	9		
FBgn0034651	CG15676	HGNC:12662	OMIM:300133	VBP1	4		
FBgn0050263	stum	HGNC:30491		STUM	7		
FBgn0034654	eIF3k	HGNC:24656	OMIM:609596	EIF3K	14		
FBgn0034655	CG10307	HGNC:20264	OMIM:610846	LRRC10	3		
FBgn0034655	CG10307	HGNC:37215		LRRC10B	4		
FBgn0050290	Ppcdc	HGNC:28107	OMIM:609854	PPCDC	13		
FBgn0010228	HmgZ	HGNC:4983	OMIM:163905	HMGB1	4		
FBgn0010228	HmgZ	HGNC:5000	OMIM:163906	HMGB2	5		
FBgn0010228	HmgZ	HGNC:5004	OMIM:300193	HMGB3	5	300915	300915[MICROPHTHALMIA, SYNDROMIC 13; MCOPS13]
FBgn0027360	Tim10	HGNC:11814	OMIM:602251	TIMM10	14		
FBgn0034649	PIG-M	HGNC:18858	OMIM:610273	PIGM	15	610293	610293[GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 1; GPIBD1]
FBgn0034646	Rae1	HGNC:9828	OMIM:603343	RAE1	13		
FBgn0050284	CG30284	HGNC:25252		GRAMD1C	6		
FBgn0050284	CG30284	HGNC:29305		GRAMD1A	6		
FBgn0050284	CG30284	HGNC:29214		GRAMD1B	6		
FBgn0016641	PTP-ER	HGNC:9659	OMIM:176889	PTPN7	4		
FBgn0016641	PTP-ER	HGNC:9680	OMIM:602853	PTPRR	4		
FBgn0016641	PTP-ER	HGNC:9657	OMIM:176879	PTPN5	4		
FBgn0000326	clt	HGNC:26741		CES4A	5		
FBgn0000326	clt	HGNC:108	OMIM:100740	ACHE	3	112100	112100[YT BLOOD GROUP ANTIGEN]
FBgn0000326	clt	HGNC:983	OMIM:177400	BCHE	4	617936	617936[BUTYRYLCHOLINESTERASE DEFICIENCY; BCHED]
FBgn0000326	clt	HGNC:26459	OMIM:618678	CES5A	5		
FBgn0000326	clt	HGNC:1863	OMIM:114835	CES1	5	618057	618057[DRUG METABOLISM, ALTERED, CES1-RELATED]
FBgn0000326	clt	HGNC:1864	OMIM:605278	CES2	4		
FBgn0000326	clt	HGNC:1865	OMIM:605279	CES3	5		
FBgn0034636	twz	HGNC:18249	OMIM:613420	KCTD1	11	181270	181270[SCALP-EAR-NIPPLE SYNDROME; SENS]
FBgn0034636	twz	HGNC:23297	OMIM:615240	KCTD15	15		
FBgn0034636	twz	HGNC:21302	OMIM:609848	KCTD11	3		
FBgn0010470	Fkbp14	HGNC:3718	OMIM:186946	FKBP2	3		
FBgn0010470	Fkbp14	HGNC:18625	OMIM:614505	FKBP14	9	614557	614557[EHLERS-DANLOS SYNDROME, KYPHOSCOLIOTIC TYPE, 2; EDSKSCL2]
FBgn0010470	Fkbp14	HGNC:3723	OMIM:607062	FKBP7	4		
FBgn0010415	Sdc	HGNC:10659	OMIM:142460	SDC2	6		
FBgn0010415	Sdc	HGNC:10661	OMIM:600017	SDC4	6		
FBgn0010415	Sdc	HGNC:10660	OMIM:186357	SDC3	5	601665	601665[OBESITY]
FBgn0010415	Sdc	HGNC:10658	OMIM:186355	SDC1	6		
FBgn0004362	HmgD	HGNC:4983	OMIM:163905	HMGB1	4		
FBgn0004362	HmgD	HGNC:5000	OMIM:163906	HMGB2	5		
FBgn0004362	HmgD	HGNC:5004	OMIM:300193	HMGB3	4	300915	300915[MICROPHTHALMIA, SYNDROMIC 13; MCOPS13]
FBgn0050398	CG30398	HGNC:25207		MITD1	11		
FBgn0034657	LBR	HGNC:6518	OMIM:600024	LBR	13	169400,215140,613471,618019	169400[PELGER-HUET ANOMALY; PHA],215140[GREENBERG DYSPLASIA; GRBGD],613471[REYNOLDS SYNDROME],618019[RHIZOMELIC SKELETAL DYSPLASIA WITH OR WITHOUT PELGER-HUET ANOMALY; SKPHA]
FBgn0034657	LBR	HGNC:2860	OMIM:602858	DHCR7	5	270400	270400[SMITH-LEMLI-OPITZ SYNDROME; SLOS]
FBgn0034657	LBR	HGNC:11863	OMIM:603414	TM7SF2	10		
FBgn0034658	Grx1t	HGNC:16065	OMIM:606820	GLRX2	12		
FBgn0034658	Grx1t	HGNC:4330	OMIM:600443	GLRX	6		
FBgn0034659	CG4021	HGNC:21100	OMIM:609590	QKI	3		
FBgn0034659	CG4021	HGNC:18117	OMIM:610421	KHDRBS3	8		
FBgn0034659	CG4021	HGNC:18116	OMIM:602489	KHDRBS1	8		
FBgn0034659	CG4021	HGNC:18114	OMIM:610487	KHDRBS2	7		
FBgn0034666	CG9294	HGNC:16517	OMIM:609862	TMPRSS6	3	206200	206200[IRON-REFRACTORY IRON DEFICIENCY ANEMIA; IRIDA]
FBgn0034666	CG9294	HGNC:15475	OMIM:608018	PRSS27	3		
FBgn0034666	CG9294	HGNC:14134	OMIM:609341	TPSG1	3		
FBgn0034674	CG9304	HGNC:26912		TMEM145	6		
FBgn0034674	CG9304	HGNC:28899	OMIM:607787	GPR180	6		
FBgn0025573	PpN58A	HGNC:9281	OMIM:176875	PPP1CA	3		
FBgn0025573	PpN58A	HGNC:9283	OMIM:176914	PPP1CC	4		
FBgn0025573	PpN58A	HGNC:9282	OMIM:600590	PPP1CB	5	617506	617506[NOONAN SYNDROME-LIKE DISORDER WITH LOOSE ANAGEN HAIR 2; NSLH2]
FBgn0034665	CG4372	HGNC:318	OMIM:613228	AGA	7	208400	208400[ASPARTYLGLUCOSAMINURIA; AGU]
FBgn0034661	tpr	HGNC:16517	OMIM:609862	TMPRSS6	3	206200	206200[IRON-REFRACTORY IRON DEFICIENCY ANEMIA; IRIDA]
FBgn0034661	tpr	HGNC:15475	OMIM:608018	PRSS27	3		
FBgn0034661	tpr	HGNC:14134	OMIM:609341	TPSG1	3		
FBgn0042098	CG18735	HGNC:30405	OMIM:613797	PRSS33	4		
FBgn0042098	CG18735	HGNC:15475	OMIM:608018	PRSS27	3		
FBgn0042098	CG18735	HGNC:14134	OMIM:609341	TPSG1	3		
FBgn0034660	Loxl2	HGNC:6664	OMIM:153455	LOX	3	617168	617168[AORTIC ANEURYSM, FAMILIAL THORACIC 10; AAT10]
FBgn0034660	Loxl2	HGNC:13869	OMIM:607163	LOXL3	12	619781	619781[MYOPIA 28, AUTOSOMAL RECESSIVE; MYP28]
FBgn0034660	Loxl2	HGNC:6665	OMIM:153456	LOXL1	3	177650	177650[EXFOLIATION SYNDROME; XFS]
FBgn0034660	Loxl2	HGNC:6666	OMIM:606663	LOXL2	12		
FBgn0034660	Loxl2	HGNC:17171	OMIM:607318	LOXL4	10		
FBgn0050404	Tango11	HGNC:24858	OMIM:614785	MFF	10	617086	617086[ENCEPHALOPATHY DUE TO DEFECTIVE MITOCHONDRIAL AND PEROXISOMAL FISSION 2; EMPF2]
FBgn0034681	CG9308	HGNC:16996	OMIM:619642	TMED2	6		
FBgn0067102	GlcT	HGNC:12524	OMIM:602874	UGCG	15		
FBgn0034691	Synj	HGNC:11504	OMIM:609410	SYNJ2	10		
FBgn0034691	Synj	HGNC:11503	OMIM:604297	SYNJ1	13	615530,617389	615530[PARKINSON DISEASE 20, EARLY-ONSET; PARK20],617389[DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 53; DEE53]
FBgn0034694	Plekhm1	HGNC:34006	OMIM:619186	PLEKHM3	9		
FBgn0034694	Plekhm1	HGNC:25969		DEF8	3		
FBgn0034694	Plekhm1	HGNC:20420		RUBCNL	4		
FBgn0034694	Plekhm1	HGNC:29017	OMIM:611466	PLEKHM1	9	611497,618107	611497[OSTEOPETROSIS, AUTOSOMAL RECESSIVE 6; OPTB6],618107[OSTEOPETROSIS, AUTOSOMAL DOMINANT 3; OPTA3]
FBgn0050281	CG30281	HGNC:3624	OMIM:601624	FCN2	6		
FBgn0050281	CG30281	HGNC:3623	OMIM:601252	FCN1	5		
FBgn0050281	CG30281	HGNC:25922	OMIM:613357	FIBCD1	6		
FBgn0050281	CG30281	HGNC:3695	OMIM:605776	FGL1	3		
FBgn0050281	CG30281	HGNC:3625	OMIM:604973	FCN3	5	613860	613860[FICOLIN 3 DEFICIENCY]
FBgn0050281	CG30281	HGNC:7035	OMIM:600596	MFAP4	4		
FBgn0029147	NtR	HGNC:1958	OMIM:118504	CHRNA4	3	188890,600513	188890[TOBACCO ADDICTION, SUSCEPTIBILITY TO],600513[EPILEPSY, NOCTURNAL FRONTAL LOBE, 1; ENFL1]
FBgn0034700	CG11269	HGNC:33911	OMIM:617098	RNASEK	7		
FBgn0034704	Fbxo42	HGNC:29249	OMIM:609109	FBXO42	12		
FBgn0034707	MED16	HGNC:17556	OMIM:604062	MED16	13		
FBgn0034708	Vps35	HGNC:13487	OMIM:601501	VPS35	14	614203	614203[PARKINSON DISEASE 17; PARK17]
FBgn0034713	CG11291	HGNC:30259	OMIM:609246	PDXP	7		
FBgn0034713	CG11291	HGNC:8909	OMIM:172280	PGP	7		
FBgn0025186	ari-2	HGNC:690	OMIM:605615	ARIH2	15		
FBgn0025186	ari-2	HGNC:689	OMIM:605624	ARIH1	3		
FBgn0020307	dve	HGNC:10541	OMIM:602075	SATB1	7	619228,619229	619228[DEVELOPMENTAL DELAY WITH DYSMORPHIC FACIES AND DENTAL ANOMALIES; DEFDA],619229[KOHLSCHUTTER-TONZ SYNDROME-LIKE; KTZSL]
FBgn0020307	dve	HGNC:21637	OMIM:608148	SATB2	6	612313	612313[GLASS SYNDROME; GLASS]
FBgn0034716	Oatp58Dc	HGNC:23612	OMIM:609013	SLCO4C1	3		
FBgn0034716	Oatp58Dc	HGNC:10953	OMIM:612436	SLCO4A1	3		
FBgn0034716	Oatp58Dc	HGNC:23613	OMIM:613365	SLCO6A1	3		
FBgn0034716	Oatp58Dc	HGNC:10955	OMIM:601460	SLCO2A1	3	167100,614441	167100[HYPERTROPHIC OSTEOARTHROPATHY, PRIMARY, AUTOSOMAL DOMINANT; PHOAD],614441[HYPERTROPHIC OSTEOARTHROPATHY, PRIMARY, AUTOSOMAL RECESSIVE, 2; PHOAR2]
FBgn0034716	Oatp58Dc	HGNC:10962	OMIM:604988	SLCO2B1	3		
FBgn0034716	Oatp58Dc	HGNC:10952	OMIM:612435	SLCO3A1	4		
FBgn0034716	Oatp58Dc	HGNC:10956	OMIM:602883	SLCO1A2	6		
FBgn0034716	Oatp58Dc	HGNC:10959	OMIM:604843	SLCO1B1	4	237450	237450[HYPERBILIRUBINEMIA, ROTOR TYPE; HBLRR]
FBgn0034716	Oatp58Dc	HGNC:10961	OMIM:605495	SLCO1B3	4	237450	237450[HYPERBILIRUBINEMIA, ROTOR TYPE; HBLRR]
FBgn0034716	Oatp58Dc	HGNC:13819	OMIM:613389	SLCO1C1	4		
FBgn0034716	Oatp58Dc	HGNC:32934	OMIM:619875	SLCO1B7	4		
FBgn0034715	Oatp58Db	HGNC:23612	OMIM:609013	SLCO4C1	3		
FBgn0034715	Oatp58Db	HGNC:10953	OMIM:612436	SLCO4A1	3		
FBgn0034715	Oatp58Db	HGNC:23613	OMIM:613365	SLCO6A1	3		
FBgn0034715	Oatp58Db	HGNC:10955	OMIM:601460	SLCO2A1	3	167100,614441	167100[HYPERTROPHIC OSTEOARTHROPATHY, PRIMARY, AUTOSOMAL DOMINANT; PHOAD],614441[HYPERTROPHIC OSTEOARTHROPATHY, PRIMARY, AUTOSOMAL RECESSIVE, 2; PHOAR2]
FBgn0034715	Oatp58Db	HGNC:10962	OMIM:604988	SLCO2B1	4		
FBgn0034715	Oatp58Db	HGNC:10952	OMIM:612435	SLCO3A1	4		
FBgn0034715	Oatp58Db	HGNC:10956	OMIM:602883	SLCO1A2	5		
FBgn0034715	Oatp58Db	HGNC:10959	OMIM:604843	SLCO1B1	4	237450	237450[HYPERBILIRUBINEMIA, ROTOR TYPE; HBLRR]
FBgn0034715	Oatp58Db	HGNC:10961	OMIM:605495	SLCO1B3	4	237450	237450[HYPERBILIRUBINEMIA, ROTOR TYPE; HBLRR]
FBgn0034715	Oatp58Db	HGNC:13819	OMIM:613389	SLCO1C1	4		
FBgn0034715	Oatp58Db	HGNC:32934	OMIM:619875	SLCO1B7	4		
FBgn0050277	Oatp58Da	HGNC:23612	OMIM:609013	SLCO4C1	3		
FBgn0050277	Oatp58Da	HGNC:10953	OMIM:612436	SLCO4A1	4		
FBgn0050277	Oatp58Da	HGNC:23613	OMIM:613365	SLCO6A1	3		
FBgn0050277	Oatp58Da	HGNC:10955	OMIM:601460	SLCO2A1	3	167100,614441	167100[HYPERTROPHIC OSTEOARTHROPATHY, PRIMARY, AUTOSOMAL DOMINANT; PHOAD],614441[HYPERTROPHIC OSTEOARTHROPATHY, PRIMARY, AUTOSOMAL RECESSIVE, 2; PHOAR2]
FBgn0050277	Oatp58Da	HGNC:10962	OMIM:604988	SLCO2B1	3		
FBgn0050277	Oatp58Da	HGNC:10952	OMIM:612435	SLCO3A1	4		
FBgn0050277	Oatp58Da	HGNC:10956	OMIM:602883	SLCO1A2	5		
FBgn0050277	Oatp58Da	HGNC:10959	OMIM:604843	SLCO1B1	4	237450	237450[HYPERBILIRUBINEMIA, ROTOR TYPE; HBLRR]
FBgn0050277	Oatp58Da	HGNC:10961	OMIM:605495	SLCO1B3	4	237450	237450[HYPERBILIRUBINEMIA, ROTOR TYPE; HBLRR]
FBgn0050277	Oatp58Da	HGNC:13819	OMIM:613389	SLCO1C1	4		
FBgn0050277	Oatp58Da	HGNC:32934	OMIM:619875	SLCO1B7	4		
FBgn0034712	Alp8	HGNC:438	OMIM:171760	ALPL	7	146300,241500,241510	146300[HYPOPHOSPHATASIA, ADULT; HPPA],241500[HYPOPHOSPHATASIA, INFANTILE; HPPI],241510[HYPOPHOSPHATASIA, CHILDHOOD; HPPC]
FBgn0034712	Alp8	HGNC:441	OMIM:171810	ALPG	8		
FBgn0034712	Alp8	HGNC:439	OMIM:171800	ALPP	7		
FBgn0034712	Alp8	HGNC:437	OMIM:171740	ALPI	7		
FBgn0034710	Alp7	HGNC:438	OMIM:171760	ALPL	8	146300,241500,241510	146300[HYPOPHOSPHATASIA, ADULT; HPPA],241500[HYPOPHOSPHATASIA, INFANTILE; HPPI],241510[HYPOPHOSPHATASIA, CHILDHOOD; HPPC]
FBgn0034710	Alp7	HGNC:441	OMIM:171810	ALPG	8		
FBgn0034710	Alp7	HGNC:439	OMIM:171800	ALPP	7		
FBgn0034710	Alp7	HGNC:437	OMIM:171740	ALPI	7		
FBgn0034709	Swim	HGNC:19168	OMIM:616064	TINAGL1	14		
FBgn0034709	Swim	HGNC:14599	OMIM:606749	TINAG	12		
FBgn0034705	CG11170	HGNC:25866	OMIM:300959	DIPK2B	4		
FBgn0034705	CG11170	HGNC:28490	OMIM:612200	DIPK2A	10		
FBgn0034703	CG3045	HGNC:25461	OMIM:616283	PUS3	15	617051	617051[NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY AND GRAY SCLERAE; NEDMIGS]
FBgn0034697	GM130	HGNC:32204		GOLGA6D	6		
FBgn0034697	GM130	HGNC:32206		GOLGA6C	6		
FBgn0034697	GM130	HGNC:13567	OMIM:610288	GOLGA6A	6		
FBgn0034697	GM130	HGNC:31973	OMIM:609619	GOLGA8B	5		
FBgn0034697	GM130	HGNC:44404		GOLGA8M	5		
FBgn0034697	GM130	HGNC:31972	OMIM:616180	GOLGA8A	5		
FBgn0034697	GM130	HGNC:32205		GOLGA6B	6		
FBgn0034697	GM130	HGNC:38650		GOLGA8J	5		
FBgn0034697	GM130	HGNC:4425	OMIM:602580	GOLGA2	9		
FBgn0034697	GM130	HGNC:37444		GOLGA6L1	3		
FBgn0034697	GM130	HGNC:44405		GOLGA8N	4		
FBgn0034697	GM130	HGNC:26695		GOLGA6L2	3		
FBgn0034697	GM130	HGNC:44406		GOLGA8O	5		
FBgn0034697	GM130	HGNC:38652		GOLGA8K	4		
FBgn0034697	GM130	HGNC:37443		GOLGA8H	4		
FBgn0034697	GM130	HGNC:25328		GOLGA8G	4		
FBgn0034697	GM130	HGNC:44409		GOLGA8S	3		
FBgn0034697	GM130	HGNC:44410		GOLGA8T	3		
FBgn0034697	GM130	HGNC:44408		GOLGA8Q	4		
FBgn0034697	GM130	HGNC:32378		GOLGA8F	3		
FBgn0034692	CG13502	HGNC:25280	OMIM:617095	TTC25	9	617092	617092[CILIARY DYSKINESIA, PRIMARY, 35; CILD35]
FBgn0034689	CG2921	HGNC:17872	OMIM:616332	ARMT1	12		
FBgn0034688	CG11474	HGNC:17872	OMIM:616332	ARMT1	13		
FBgn0034687	CG11475	HGNC:17872	OMIM:616332	ARMT1	10		
FBgn0005778	PpD5	HGNC:9281	OMIM:176875	PPP1CA	4		
FBgn0005778	PpD5	HGNC:9283	OMIM:176914	PPP1CC	5		
FBgn0005778	PpD5	HGNC:9282	OMIM:600590	PPP1CB	4	617506	617506[NOONAN SYNDROME-LIKE DISORDER WITH LOOSE ANAGEN HAIR 2; NSLH2]
FBgn0034722	Rtf1	HGNC:28996	OMIM:611633	RTF1	12		
FBgn0034726	PolE4	HGNC:13544	OMIM:607268	CHRAC1	4		
FBgn0034726	PolE4	HGNC:18755	OMIM:607269	POLE4	13		
FBgn0022985	qkr58E-2	HGNC:18117	OMIM:610421	KHDRBS3	8		
FBgn0022985	qkr58E-2	HGNC:18116	OMIM:602489	KHDRBS1	8		
FBgn0022985	qkr58E-2	HGNC:18114	OMIM:610487	KHDRBS2	7		
FBgn0034728	rad50	HGNC:9816	OMIM:604040	RAD50	13	613078	613078[NIJMEGEN BREAKAGE SYNDROME-LIKE DISORDER; NBSLD]
FBgn0034730	ppk12	HGNC:101	OMIM:611741	ASIC3	8		
FBgn0034730	ppk12	HGNC:100	OMIM:602866	ASIC1	8		
FBgn0034730	ppk12	HGNC:21263	OMIM:606715	ASIC4	8		
FBgn0034730	ppk12	HGNC:99	OMIM:601784	ASIC2	10		
FBgn0034730	ppk12	HGNC:17537	OMIM:616693	ASIC5	7		
FBgn0034730	ppk12	HGNC:10599	OMIM:600228	SCNN1A	3	264350,613021,618126	264350[PSEUDOHYPOALDOSTERONISM, TYPE I, AUTOSOMAL RECESSIVE; PHA1B],613021[BRONCHIECTASIS WITH OR WITHOUT ELEVATED SWEAT CHLORIDE 2; BESC2],618126[LIDDLE SYNDROME 3; LIDLS3]
FBgn0034730	ppk12	HGNC:10600	OMIM:600760	SCNN1B	4	177200,211400,264350	177200[LIDDLE SYNDROME 1; LIDLS1],211400[BRONCHIECTASIS WITH OR WITHOUT ELEVATED SWEAT CHLORIDE 1; BESC1],264350[PSEUDOHYPOALDOSTERONISM, TYPE I, AUTOSOMAL RECESSIVE; PHA1B]
FBgn0034730	ppk12	HGNC:10601	OMIM:601328	SCNN1D	3		
FBgn0034730	ppk12	HGNC:10602	OMIM:600761	SCNN1G	3	264350,613071,618114	264350[PSEUDOHYPOALDOSTERONISM, TYPE I, AUTOSOMAL RECESSIVE; PHA1B],613071[BRONCHIECTASIS WITH OR WITHOUT ELEVATED SWEAT CHLORIDE 3; BESC3],618114[LIDDLE SYNDROME 2; LIDLS2]
FBgn0034731	CG10384	HGNC:18117	OMIM:610421	KHDRBS3	6		
FBgn0034731	CG10384	HGNC:18116	OMIM:602489	KHDRBS1	6		
FBgn0034731	CG10384	HGNC:18114	OMIM:610487	KHDRBS2	7		
FBgn0034733	CG4752	HGNC:8149	OMIM:614243	OPLAH	14	260005	260005[5-OXOPROLINASE DEFICIENCY; OPLAHD]
FBgn0034734	CG4554	HGNC:17897	OMIM:612822	UTP20	14		
FBgn0034735	CG4610	HGNC:19261	OMIM:614667	MTO1	14	614702	614702[COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 10; COXPD10]
FBgn0034736	gas	HGNC:26741		CES4A	6		
FBgn0034736	gas	HGNC:11764	OMIM:188450	TG	3	274700,608175	274700[THYROID DYSHORMONOGENESIS 3; TDH3],608175[AUTOIMMUNE THYROID DISEASE, SUSCEPTIBILITY TO, 3; AITD3]
FBgn0034736	gas	HGNC:108	OMIM:100740	ACHE	4	112100	112100[YT BLOOD GROUP ANTIGEN]
FBgn0034736	gas	HGNC:983	OMIM:177400	BCHE	3	617936	617936[BUTYRYLCHOLINESTERASE DEFICIENCY; BCHED]
FBgn0034736	gas	HGNC:26459	OMIM:618678	CES5A	5		
FBgn0034736	gas	HGNC:1863	OMIM:114835	CES1	5	618057	618057[DRUG METABOLISM, ALTERED, CES1-RELATED]
FBgn0034736	gas	HGNC:1848	OMIM:114840	CEL	3	609812	609812[MATURITY-ONSET DIABETES OF THE YOUNG, TYPE 8, WITH EXOCRINE DYSFUNCTION; MODY8]
FBgn0034736	gas	HGNC:1864	OMIM:605278	CES2	5		
FBgn0034736	gas	HGNC:1865	OMIM:605279	CES3	5		
FBgn0034736	gas	HGNC:14291	OMIM:600568	NLGN1	3	618830	618830[AUTISM, SUSCEPTIBILITY TO, 20; AUTS20]
FBgn0034736	gas	HGNC:14289	OMIM:300336	NLGN3	3	300425,300494	300425[AUTISM, SUSCEPTIBILITY TO, X-LINKED 1; AUTSX1],300494[ASPERGER SYNDROME, X-LINKED, SUSCEPTIBILITY TO, 1; ASPGX1]
FBgn0034736	gas	HGNC:14287	OMIM:300427	NLGN4X	3	300495,300497	300495[AUTISM, SUSCEPTIBILITY TO, X-LINKED 2; AUTSX2],300497[ASPERGER SYNDROME, X-LINKED, SUSCEPTIBILITY TO, 2; ASPGX2]
FBgn0034736	gas	HGNC:14290	OMIM:606479	NLGN2	3		
FBgn0034729	CG10344	HGNC:27387		ZDHHC24	14		
FBgn0034729	CG10344	HGNC:20106		ZDHHC22	4		
FBgn0034727	mRpS29	HGNC:2673	OMIM:602074	DAP3	14		
FBgn0022986	qkr58E-1	HGNC:21100	OMIM:609590	QKI	3		
FBgn0022986	qkr58E-1	HGNC:18117	OMIM:610421	KHDRBS3	12		
FBgn0022986	qkr58E-1	HGNC:18116	OMIM:602489	KHDRBS1	10		
FBgn0022986	qkr58E-1	HGNC:18114	OMIM:610487	KHDRBS2	10		
FBgn0022984	qkr58E-3	HGNC:18117	OMIM:610421	KHDRBS3	7		
FBgn0022984	qkr58E-3	HGNC:18116	OMIM:602489	KHDRBS1	7		
FBgn0022984	qkr58E-3	HGNC:18114	OMIM:610487	KHDRBS2	6		
FBgn0034720	Liprin-gamma	HGNC:29173	OMIM:618301	KAZN	13		
FBgn0017482	T3dh	HGNC:16354	OMIM:611083	ADHFE1	15		
FBgn0034739	CG3927	HGNC:18117	OMIM:610421	KHDRBS3	7		
FBgn0034739	CG3927	HGNC:18116	OMIM:602489	KHDRBS1	7		
FBgn0034739	CG3927	HGNC:18114	OMIM:610487	KHDRBS2	6		
FBgn0034743	RpS16	HGNC:10396	OMIM:603675	RPS16	14		
FBgn0034744	Vps20	HGNC:25675	OMIM:610901	CHMP6	13		
FBgn0026261	bonsai	HGNC:14504	OMIM:611979	MRPS15	11		
FBgn0034740	nsr	HGNC:18117	OMIM:610421	KHDRBS3	8		
FBgn0034740	nsr	HGNC:18116	OMIM:602489	KHDRBS1	8		
FBgn0034740	nsr	HGNC:18114	OMIM:610487	KHDRBS2	7		
FBgn0034758	CG13510	HGNC:13234	OMIM:610503	CDIP1	3		
FBgn0034758	CG13510	HGNC:16841	OMIM:603795	LITAF	6	601098	601098[CHARCOT-MARIE-TOOTH DISEASE, DEMYELINATING, TYPE 1C; CMT1C]
FBgn0034759	CG13511	HGNC:16841	OMIM:603795	LITAF	3	601098	601098[CHARCOT-MARIE-TOOTH DISEASE, DEMYELINATING, TYPE 1C; CMT1C]
FBgn0034761	CG4250	HGNC:16841	OMIM:603795	LITAF	6	601098	601098[CHARCOT-MARIE-TOOTH DISEASE, DEMYELINATING, TYPE 1C; CMT1C]
FBgn0050273	CG30273	HGNC:16841	OMIM:603795	LITAF	3	601098	601098[CHARCOT-MARIE-TOOTH DISEASE, DEMYELINATING, TYPE 1C; CMT1C]
FBgn0050269	CG30269	HGNC:16841	OMIM:603795	LITAF	3	601098	601098[CHARCOT-MARIE-TOOTH DISEASE, DEMYELINATING, TYPE 1C; CMT1C]
FBgn0034763	RYBP	HGNC:17363	OMIM:607534	YAF2	12		
FBgn0034763	RYBP	HGNC:10480	OMIM:607535	RYBP	9		
FBgn0050275	CG30275	HGNC:15872		CFAP61	13		
FBgn0050268	CG30268	HGNC:15872		CFAP61	13		
FBgn0034774	CG13526	HGNC:18180	OMIM:605183	CALML5	3		
FBgn0034774	CG13526	HGNC:20834	OMIM:618759	CABP7	3		
FBgn0011211	blw	HGNC:823	OMIM:164360	ATP5F1A	15	615228,616045	615228[MITOCHONDRIAL COMPLEX V (ATP SYNTHASE) DEFICIENCY, NUCLEAR TYPE 4; MC5DN4],616045[COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 22; COXPD22]
FBgn0050274	CG30274	HGNC:1996	OMIM:123295	CKMT2	6		
FBgn0050274	CG30274	HGNC:31736	OMIM:613415	CKMT1A	5		
FBgn0050274	CG30274	HGNC:1995	OMIM:123290	CKMT1B	4		
FBgn0050274	CG30274	HGNC:1991	OMIM:123280	CKB	5		
FBgn0050274	CG30274	HGNC:1994	OMIM:123310	CKM	6		
FBgn0050272	MFS1	HGNC:20151	OMIM:607557	SLC17A8	4	605583	605583[DEAFNESS, AUTOSOMAL DOMINANT 25; DFNA25]
FBgn0050272	MFS1	HGNC:10933	OMIM:604322	SLC17A5	4	269920,604369	269920[INFANTILE SIALIC ACID STORAGE DISEASE; ISSD],604369[SALLA DISEASE; SD]
FBgn0050272	MFS1	HGNC:16703	OMIM:607563	SLC17A6	3		
FBgn0050272	MFS1	HGNC:16192	OMIM:612107	SLC17A9	3	616063	616063[POROKERATOSIS 8, DISSEMINATED SUPERFICIAL ACTINIC TYPE; POROK8]
FBgn0050272	MFS1	HGNC:16704	OMIM:605208	SLC17A7	4		
FBgn0050272	MFS1	HGNC:10929	OMIM:182308	SLC17A1	4		
FBgn0050272	MFS1	HGNC:10932	OMIM:604216	SLC17A4	4		
FBgn0050272	MFS1	HGNC:10930	OMIM:611049	SLC17A2	5		
FBgn0050272	MFS1	HGNC:10931	OMIM:611034	SLC17A3	5	612671	612671[URIC ACID CONCENTRATION, SERUM, QUANTITATIVE TRAIT LOCUS 4; UAQTL4]
FBgn0050265	CG30265	HGNC:20151	OMIM:607557	SLC17A8	4	605583	605583[DEAFNESS, AUTOSOMAL DOMINANT 25; DFNA25]
FBgn0050265	CG30265	HGNC:10933	OMIM:604322	SLC17A5	4	269920,604369	269920[INFANTILE SIALIC ACID STORAGE DISEASE; ISSD],604369[SALLA DISEASE; SD]
FBgn0050265	CG30265	HGNC:16703	OMIM:607563	SLC17A6	3		
FBgn0050265	CG30265	HGNC:16704	OMIM:605208	SLC17A7	4		
FBgn0050265	CG30265	HGNC:10929	OMIM:182308	SLC17A1	5		
FBgn0050265	CG30265	HGNC:10932	OMIM:604216	SLC17A4	5		
FBgn0050265	CG30265	HGNC:10930	OMIM:611049	SLC17A2	5		
FBgn0050265	CG30265	HGNC:10931	OMIM:611034	SLC17A3	6	612671	612671[URIC ACID CONCENTRATION, SERUM, QUANTITATIVE TRAIT LOCUS 4; UAQTL4]
FBgn0034782	CG12490	HGNC:20151	OMIM:607557	SLC17A8	3	605583	605583[DEAFNESS, AUTOSOMAL DOMINANT 25; DFNA25]
FBgn0034782	CG12490	HGNC:10933	OMIM:604322	SLC17A5	5	269920,604369	269920[INFANTILE SIALIC ACID STORAGE DISEASE; ISSD],604369[SALLA DISEASE; SD]
FBgn0034782	CG12490	HGNC:16704	OMIM:605208	SLC17A7	3		
FBgn0034782	CG12490	HGNC:10929	OMIM:182308	SLC17A1	5		
FBgn0034782	CG12490	HGNC:10932	OMIM:604216	SLC17A4	5		
FBgn0034782	CG12490	HGNC:10930	OMIM:611049	SLC17A2	4		
FBgn0034782	CG12490	HGNC:10931	OMIM:611034	SLC17A3	5	612671	612671[URIC ACID CONCENTRATION, SERUM, QUANTITATIVE TRAIT LOCUS 4; UAQTL4]
FBgn0034783	CG9825	HGNC:20151	OMIM:607557	SLC17A8	4	605583	605583[DEAFNESS, AUTOSOMAL DOMINANT 25; DFNA25]
FBgn0034783	CG9825	HGNC:10933	OMIM:604322	SLC17A5	4	269920,604369	269920[INFANTILE SIALIC ACID STORAGE DISEASE; ISSD],604369[SALLA DISEASE; SD]
FBgn0034783	CG9825	HGNC:16703	OMIM:607563	SLC17A6	3		
FBgn0034783	CG9825	HGNC:16704	OMIM:605208	SLC17A7	4		
FBgn0034783	CG9825	HGNC:10929	OMIM:182308	SLC17A1	5		
FBgn0034783	CG9825	HGNC:10932	OMIM:604216	SLC17A4	5		
FBgn0034783	CG9825	HGNC:10930	OMIM:611049	SLC17A2	5		
FBgn0034783	CG9825	HGNC:10931	OMIM:611034	SLC17A3	6	612671	612671[URIC ACID CONCENTRATION, SERUM, QUANTITATIVE TRAIT LOCUS 4; UAQTL4]
FBgn0034784	CG9826	HGNC:20151	OMIM:607557	SLC17A8	3	605583	605583[DEAFNESS, AUTOSOMAL DOMINANT 25; DFNA25]
FBgn0034784	CG9826	HGNC:10933	OMIM:604322	SLC17A5	5	269920,604369	269920[INFANTILE SIALIC ACID STORAGE DISEASE; ISSD],604369[SALLA DISEASE; SD]
FBgn0034784	CG9826	HGNC:16704	OMIM:605208	SLC17A7	3		
FBgn0034784	CG9826	HGNC:10929	OMIM:182308	SLC17A1	4		
FBgn0034784	CG9826	HGNC:10932	OMIM:604216	SLC17A4	4		
FBgn0034784	CG9826	HGNC:10930	OMIM:611049	SLC17A2	4		
FBgn0034784	CG9826	HGNC:10931	OMIM:611034	SLC17A3	4	612671	612671[URIC ACID CONCENTRATION, SERUM, QUANTITATIVE TRAIT LOCUS 4; UAQTL4]
FBgn0034785	CG3649	HGNC:20151	OMIM:607557	SLC17A8	4	605583	605583[DEAFNESS, AUTOSOMAL DOMINANT 25; DFNA25]
FBgn0034785	CG3649	HGNC:10933	OMIM:604322	SLC17A5	4	269920,604369	269920[INFANTILE SIALIC ACID STORAGE DISEASE; ISSD],604369[SALLA DISEASE; SD]
FBgn0034785	CG3649	HGNC:16703	OMIM:607563	SLC17A6	3		
FBgn0034785	CG3649	HGNC:16704	OMIM:605208	SLC17A7	4		
FBgn0034785	CG3649	HGNC:10929	OMIM:182308	SLC17A1	5		
FBgn0034785	CG3649	HGNC:10932	OMIM:604216	SLC17A4	5		
FBgn0034785	CG3649	HGNC:10930	OMIM:611049	SLC17A2	5		
FBgn0034785	CG3649	HGNC:10931	OMIM:611034	SLC17A3	6	612671	612671[URIC ACID CONCENTRATION, SERUM, QUANTITATIVE TRAIT LOCUS 4; UAQTL4]
FBgn0010078	RpL23	HGNC:10316	OMIM:603662	RPL23	14		
FBgn0004896	fd59A	HGNC:3803	OMIM:602211	FOXD2	7		
FBgn0004896	fd59A	HGNC:3806	OMIM:602617	FOXE1	3	241850,616534	241850[HYPOTHYROIDISM, THYROIDAL OR ATHYROIDAL, WITH SPIKY HAIR AND CLEFT PALATE],616534[THYROID CANCER, NONMEDULLARY, 4; NMTC4]
FBgn0004896	fd59A	HGNC:18521	OMIM:611084	FOXD4L1	5		
FBgn0004896	fd59A	HGNC:3817	OMIM:603252	FOXL1	4		
FBgn0004896	fd59A	HGNC:3804	OMIM:611539	FOXD3	9	607836	607836[AUTOIMMUNE DISEASE, SUSCEPTIBILITY TO, 1; AIS1]
FBgn0004896	fd59A	HGNC:18523	OMIM:611086	FOXD4L3	6		
FBgn0004896	fd59A	HGNC:3805	OMIM:601092	FOXD4	6		
FBgn0004896	fd59A	HGNC:18522		FOXD4L5	5		
FBgn0004896	fd59A	HGNC:23762	OMIM:611085	FOXD4L4	6		
FBgn0004896	fd59A	HGNC:31986		FOXD4L6	5		
FBgn0004896	fd59A	HGNC:3800	OMIM:601090	FOXC1	3	601631,602482	601631[ANTERIOR SEGMENT DYSGENESIS 3; ASGD3],602482[AXENFELD-RIEGER SYNDROME, TYPE 3; RIEG3]
FBgn0004896	fd59A	HGNC:3802	OMIM:601091	FOXD1	3		
FBgn0004896	fd59A	HGNC:3808	OMIM:601094	FOXE3	3	610256,612968,617349	610256[ANTERIOR SEGMENT DYSGENESIS 2; ASGD2],612968[CATARACT 34, MULTIPLE TYPES; CTRCT34],617349[AORTIC ANEURYSM, FAMILIAL THORACIC 11, SUSCEPTIBILITY TO; AAT11]
FBgn0004896	fd59A	HGNC:3816	OMIM:602291	FOXJ1	3	618699	618699[CILIARY DYSKINESIA, PRIMARY, 43; CILD43]
FBgn0034789	PIP5K59B	HGNC:8994	OMIM:603275	PIP5K1A	14		
FBgn0034789	PIP5K59B	HGNC:8996	OMIM:606102	PIP5K1C	11	611369	611369[LETHAL CONGENITAL CONTRACTURE SYNDROME 3; LCCS3]
FBgn0034789	PIP5K59B	HGNC:8995	OMIM:602745	PIP5K1B	10		
FBgn0034789	PIP5K59B	HGNC:8998	OMIM:603261	PIP4K2B	3		
FBgn0034789	PIP5K59B	HGNC:8997	OMIM:603140	PIP4K2A	3		
FBgn0034789	PIP5K59B	HGNC:28711	OMIM:612865	PIP5KL1	3		
FBgn0034789	PIP5K59B	HGNC:23733		PIPSL	5		
FBgn0034793	asrij	HGNC:16074	OMIM:619596	OCIAD1	14		
FBgn0034793	asrij	HGNC:28685	OMIM:619633	OCIAD2	7		
FBgn0034795	MED23	HGNC:2372	OMIM:605042	MED23	14	614249	614249[INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 18, WITH OR WITHOUT EPILEPSY; MRT18]
FBgn0034792	YME1L	HGNC:315	OMIM:604581	AFG3L2	4	610246,614487,618977	610246[SPINOCEREBELLAR ATAXIA 28; SCA28],614487[SPASTIC ATAXIA 5, AUTOSOMAL RECESSIVE; SPAX5],618977[OPTIC ATROPHY 12; OPA12]
FBgn0034792	YME1L	HGNC:12843	OMIM:607472	YME1L1	13	617302	617302[OPTIC ATROPHY 11; OPA11]
FBgn0034792	YME1L	HGNC:11237	OMIM:602783	SPG7	4	607259	607259[SPASTIC PARAPLEGIA 7, AUTOSOMAL RECESSIVE; SPG7]
FBgn0034791	EMC8-9	HGNC:20273		EMC9	13		
FBgn0034791	EMC8-9	HGNC:7864	OMIM:604886	EMC8	13		
FBgn0001263	inaD	HGNC:28881	OMIM:603199	PATJ	4		
FBgn0001263	inaD	HGNC:7208	OMIM:603785	MPDZ	4	615219	615219[HYDROCEPHALUS, CONGENITAL, 2, WITH OR WITHOUT BRAIN OR EYE ANOMALIES; HYC2]
FBgn0001263	inaD	HGNC:6657	OMIM:609732	LNX1	4		
FBgn0001263	inaD	HGNC:20421	OMIM:609733	LNX2	4		
FBgn0034786	CG13531	HGNC:11226	OMIM:610844	SPG11	12	602099,604360,616668	602099[AMYOTROPHIC LATERAL SCLEROSIS 5, JUVENILE; ALS5],604360[SPASTIC PARAPLEGIA 11, AUTOSOMAL RECESSIVE; SPG11],616668[CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2X; CMT2X]
FBgn0000405	CycB	HGNC:18709	OMIM:300456	CCNB3	3		
FBgn0000405	CycB	HGNC:1580	OMIM:602755	CCNB2	10		
FBgn0000405	CycB	HGNC:1578	OMIM:123835	CCNA2	3		
FBgn0000405	CycB	HGNC:1579	OMIM:123836	CCNB1	11		
FBgn0000405	CycB	HGNC:1577	OMIM:604036	CCNA1	3		
FBgn0000405	CycB	HGNC:18576	OMIM:607752	CCNO	3	615872	615872[CILIARY DYSKINESIA, PRIMARY, 29; CILD29]
FBgn0000405	CycB	HGNC:25805		CNTD2	3		
FBgn0028371	jbug	HGNC:3754	OMIM:300017	FLNA	3	300048,300049,300244,300321,304120,305620,309350,311300,314400	300048[INTESTINAL PSEUDOOBSTRUCTION, NEURONAL, CHRONIC IDIOPATHIC, X-LINKED],300049[PERIVENTRICULAR NODULAR HETEROTOPIA 1; PVNH1],300244[TERMINAL OSSEOUS DYSPLASIA; TOD],300321[FG SYNDROME 2; FGS2],304120[OTOPALATODIGITAL SYNDROME, TYPE II; OPD2],305620[FRONTOMETAPHYSEAL DYSPLASIA 1; FMD1],309350[MELNICK-NEEDLES SYNDROME; MNS],311300[OTOPALATODIGITAL SYNDROME, TYPE I; OPD1],314400[CARDIAC VALVULAR DYSPLASIA, X-LINKED; CVD1]
FBgn0050259	CG30259	HGNC:29937	OMIM:611088	CCDC65	14	615504	615504[CILIARY DYSKINESIA, PRIMARY, 27; CILD27]
FBgn0005631	robo1	HGNC:17985	OMIM:607528	ROBO4	3	618496	618496[AORTIC VALVE DISEASE 3; AOVD3]
FBgn0005631	robo1	HGNC:10249	OMIM:602430	ROBO1	9		
FBgn0005631	robo1	HGNC:10250	OMIM:602431	ROBO2	11	610878	610878[VESICOURETERAL REFLUX 2; VUR2]
FBgn0005631	robo1	HGNC:13433	OMIM:608630	ROBO3	8	607313	607313[GAZE PALSY, FAMILIAL HORIZONTAL, WITH PROGRESSIVE SCOLIOSIS 1; HGPPS1]
FBgn0020257	Ppa	HGNC:28624	OMIM:609081	FBXL14	14		
FBgn0034756	Cyp6d2	HGNC:2638	OMIM:605325	CYP3A5	4	145500	145500[HYPERTENSION, ESSENTIAL]
FBgn0034756	Cyp6d2	HGNC:17450	OMIM:606534	CYP3A43	4		
FBgn0034756	Cyp6d2	HGNC:11609	OMIM:274180	TBXAS1	3	231095	231095[GHOSAL HEMATODIAPHYSEAL DYSPLASIA; GHDD]
FBgn0034756	Cyp6d2	HGNC:2637	OMIM:124010	CYP3A4	4	619073	619073[VITAMIN D-DEPENDENT RICKETS, TYPE 3; VDDR3]
FBgn0034756	Cyp6d2	HGNC:51504		CYP3A7-CYP3A51P	4		
FBgn0034753	CG2852	HGNC:14650	OMIM:606093	PPIG	3		
FBgn0034753	CG2852	HGNC:9256	OMIM:123842	PPIC	7		
FBgn0034753	CG2852	HGNC:33996		PPIAL4G	3		
FBgn0034753	CG2852	HGNC:7833	OMIM:161565	NKTR	3		
FBgn0034753	CG2852	HGNC:14651	OMIM:606095	PPIH	3		
FBgn0034753	CG2852	HGNC:9257	OMIM:601753	PPID	3		
FBgn0034753	CG2852	HGNC:9255	OMIM:123841	PPIB	13	259440	259440[OSTEOGENESIS IMPERFECTA, TYPE IX; OI9]
FBgn0034753	CG2852	HGNC:9259	OMIM:604486	PPIF	3		
FBgn0034753	CG2852	HGNC:33995		PPIAL4C	3		
FBgn0034753	CG2852	HGNC:9253	OMIM:123840	PPIA	3		
FBgn0034753	CG2852	HGNC:33999		PPIAL4F	3		
FBgn0034753	CG2852	HGNC:53889		PPIAL4H	3		
FBgn0040091	Ugt317A1	HGNC:12545	OMIM:603064	UGT2B11	3		
FBgn0040091	Ugt317A1	HGNC:12530	OMIM:191740	UGT1A1	3	143500,218800,237900,601816,606785	143500[GILBERT SYNDROME],218800[CRIGLER-NAJJAR SYNDROME, TYPE I],237900[HYPERBILIRUBINEMIA, TRANSIENT FAMILIAL NEONATAL; HBLRTFN],601816[BILIRUBIN, SERUM LEVEL OF, QUANTITATIVE TRAIT LOCUS 1; BILIQTL1],606785[CRIGLER-NAJJAR SYNDROME, TYPE II]
FBgn0040091	Ugt317A1	HGNC:12555	OMIM:601291	UGT8	3		
FBgn0040091	Ugt317A1	HGNC:13479	OMIM:606497	UGT2B28	3		
FBgn0040091	Ugt317A1	HGNC:27266	OMIM:616384	UGT3A2	3		
FBgn0040091	Ugt317A1	HGNC:12544	OMIM:600070	UGT2B10	3		
FBgn0040091	Ugt317A1	HGNC:12546	OMIM:600069	UGT2B15	3		
FBgn0040091	Ugt317A1	HGNC:28528	OMIM:616382	UGT2A3	3		
FBgn0040091	Ugt317A1	HGNC:12535	OMIM:606428	UGT1A3	3		
FBgn0040091	Ugt317A1	HGNC:26625	OMIM:616383	UGT3A1	3		
FBgn0040091	Ugt317A1	HGNC:12547	OMIM:601903	UGT2B17	3	612560	612560[BONE MINERAL DENSITY QUANTITATIVE TRAIT LOCUS 12; BMND12]
FBgn0040091	Ugt317A1	HGNC:12553	OMIM:600067	UGT2B4	3		
FBgn0040091	Ugt317A1	HGNC:12554	OMIM:600068	UGT2B7	3		
FBgn0034750	CG3732	HGNC:13058	OMIM:604347	ZRANB2	13		
FBgn0019949	Cdk9	HGNC:1780	OMIM:603251	CDK9	13		
FBgn0019949	Cdk9	HGNC:1733	OMIM:603309	CDK13	3	617360	617360[CONGENITAL HEART DEFECTS, DYSMORPHIC FACIAL FEATURES, AND INTELLECTUAL DEVELOPMENTAL DISORDER; CHDFIDD]
FBgn0019949	Cdk9	HGNC:24224	OMIM:615514	CDK12	3		
FBgn0034748	CG17807	HGNC:25189	OMIM:613306	ALKBH8	15	618504	618504[INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 71; MRT71]
FBgn0034748	CG17807	HGNC:26725	OMIM:615666	TRMT9B	4		
FBgn0034745	tous	HGNC:26485	OMIM:614259	CFAP57	14		
FBgn0034803	CG9849	HGNC:16047	OMIM:619674	PRADC1	14		
FBgn0034816	CG3085	HGNC:11725	OMIM:608953	TEKT2	14		
FBgn0034827	Klp59D	HGNC:6393	OMIM:604538	KIF2C	6		
FBgn0034827	Klp59D	HGNC:6318	OMIM:602591	KIF2A	6	615411	615411[CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 3; CDCBM3]
FBgn0034827	Klp59D	HGNC:29443	OMIM:615142	KIF2B	5		
FBgn0034827	Klp59D	HGNC:19916	OMIM:613747	KIF24	4		
FBgn0034829	CG9899	HGNC:16850	OMIM:609366	CTR9	5		
FBgn0034826	CG13544	HGNC:25184	OMIM:611032	SPATA17	7		
FBgn0034825	Gpdh2	HGNC:4455	OMIM:138420	GPD1	7	614480	614480[HYPERTRIGLYCERIDEMIA, TRANSIENT INFANTILE; HTGTI]
FBgn0034825	Gpdh2	HGNC:28956	OMIM:611778	GPD1L	7	611777	611777[BRUGADA SYNDROME 2; BRGDA2]
FBgn0034824	Klp59C	HGNC:6393	OMIM:604538	KIF2C	6		
FBgn0034824	Klp59C	HGNC:6318	OMIM:602591	KIF2A	6	615411	615411[CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 3; CDCBM3]
FBgn0034824	Klp59C	HGNC:29443	OMIM:615142	KIF2B	5		
FBgn0034824	Klp59C	HGNC:19916	OMIM:613747	KIF24	4		
FBgn0034822	RpL37b	HGNC:10347	OMIM:604181	RPL37	8		
FBgn0034821	CG9876	HGNC:9142	OMIM:167420	PRRX1	9	202650	202650[AGNATHIA-OTOCEPHALY COMPLEX; AGOTC]
FBgn0034821	CG9876	HGNC:21338	OMIM:604675	PRRX2	7		
FBgn0034817	Art7	HGNC:25557	OMIM:610087	PRMT7	14	617157	617157[SHORT STATURE, BRACHYDACTYLY, IMPAIRED INTELLECTUAL DEVELOPMENT, AND SEIZURES; SBIDDS]
FBgn0003062	Fib	HGNC:3599	OMIM:134795	FBL	13		
FBgn0003062	Fib	HGNC:35458		FBLL1	5		
FBgn0034814	CG9890	HGNC:13070	OMIM:605465	ZNF277	15		
FBgn0010622	DCTN3-p24	HGNC:2713	OMIM:607387	DCTN3	5		
FBgn0034802	CNBP	HGNC:13164	OMIM:116955	CNBP	14	602668	602668[MYOTONIC DYSTROPHY 2; DM2]
FBgn0034802	CNBP	HGNC:31749		ZCCHC13	12		
FBgn0034800	CG3788	HGNC:23061	OMIM:617340	UPP2	11		
FBgn0034800	CG3788	HGNC:12576	OMIM:191730	UPP1	14		
FBgn0010660	Nup214	HGNC:8064	OMIM:114350	NUP214	10	601626,613065,618426	601626[LEUKEMIA, ACUTE MYELOID; AML],613065[LEUKEMIA, ACUTE LYMPHOBLASTIC; ALL],618426[ENCEPHALOPATHY, ACUTE, INFECTION-INDUCED, SUSCEPTIBILITY TO, 9; IIAE9]
FBgn0034835	CG3092	HGNC:26198	OMIM:617267	MAIP1	3		
FBgn0050410	Rpi	HGNC:10297	OMIM:180430	RPIA	14	608611	608611[RIBOSE 5-PHOSPHATE ISOMERASE DEFICIENCY; RPIAD]
FBgn0034858	eIF2Bdelta	HGNC:3260	OMIM:606687	EIF2B4	12	603896	603896[LEUKOENCEPHALOPATHY WITH VANISHING WHITE MATTER; VWM]
FBgn0034863	SkpF	HGNC:10899	OMIM:601434	SKP1	8		
FBgn0034859	CG3520	HGNC:23377	OMIM:614606	FOCAD	12	619991	619991[LIVER DISEASE, SEVERE CONGENITAL; SCOLIV]
FBgn0028497	Mtmr6	HGNC:14596	OMIM:606260	MTMR9	3		
FBgn0028497	Mtmr6	HGNC:7449	OMIM:300171	MTMR1	4		
FBgn0028497	Mtmr6	HGNC:7453	OMIM:603561	MTMR6	13		
FBgn0028497	Mtmr6	HGNC:7448	OMIM:300415	MTM1	3	310400	310400[MYOPATHY, CENTRONUCLEAR, X-LINKED; CNMX]
FBgn0028497	Mtmr6	HGNC:7451	OMIM:603558	MTMR3	3		
FBgn0028497	Mtmr6	HGNC:7452	OMIM:603559	MTMR4	3		
FBgn0028497	Mtmr6	HGNC:7450	OMIM:603557	MTMR2	4	601382	601382[CHARCOT-MARIE-TOOTH DISEASE, TYPE 4B1; CMT4B1]
FBgn0028497	Mtmr6	HGNC:7454	OMIM:603562	MTMR7	14		
FBgn0028497	Mtmr6	HGNC:16825	OMIM:301061	MTMR8	14		
FBgn0040660	CG13551	HGNC:871	OMIM:614981	ATP5IF1	9		
FBgn0034854	Golgin245	HGNC:4427	OMIM:602509	GOLGA4	11		
FBgn0003977	vir	HGNC:24500	OMIM:616447	VIRMA	12		
FBgn0034849	CG3500	HGNC:30712	OMIM:618562	TEX261	13		
FBgn0046253	CG3502	HGNC:500	OMIM:151530	ANPEP	4		
FBgn0046253	CG3502	HGNC:30748	OMIM:606950	TRHDE	3		
FBgn0046253	CG3502	HGNC:18173	OMIM:606832	ERAP1	5		
FBgn0046253	CG3502	HGNC:26904	OMIM:610046	LVRN	5		
FBgn0046253	CG3502	HGNC:7900	OMIM:606793	NPEPPS	4		
FBgn0046253	CG3502	HGNC:29499	OMIM:609497	ERAP2	5		
FBgn0046253	CG3502	HGNC:6656	OMIM:151300	LNPEP	5		
FBgn0050417	tbrd-3	HGNC:1104	OMIM:601541	BRD3	3		
FBgn0050417	tbrd-3	HGNC:1103	OMIM:601540	BRD2	4		
FBgn0050417	tbrd-3	HGNC:1105	OMIM:602144	BRDT	5	617644	617644[SPERMATOGENIC FAILURE 21; SPGF21]
FBgn0050417	tbrd-3	HGNC:13575	OMIM:608749	BRD4	5		
FBgn0050412	CG30412	HGNC:26198	OMIM:617267	MAIP1	3		
FBgn0034842	Prosbeta5R1	HGNC:31963	OMIM:611137	PSMB11	7		
FBgn0034842	Prosbeta5R1	HGNC:9545	OMIM:177046	PSMB8	11	256040	256040[PROTEASOME-ASSOCIATED AUTOINFLAMMATORY SYNDROME 1; PRAAS1]
FBgn0034842	Prosbeta5R1	HGNC:9542	OMIM:600306	PSMB5	12		
FBgn0034838	CG12782	HGNC:9828	OMIM:603343	RAE1	7		
FBgn0034837	RpL22-like	HGNC:27610		RPL22L1	8		
FBgn0034837	RpL22-like	HGNC:10315	OMIM:180474	RPL22	10		
FBgn0034834	LS2	HGNC:23156	OMIM:191318	U2AF2	8		
FBgn0050185	AIMP3	HGNC:3212	OMIM:609206	EEF1E1	10		
FBgn0034877	levy	HGNC:2277	OMIM:602072	COX6A1	14	616039	616039[CHARCOT-MARIE-TOOTH DISEASE, RECESSIVE INTERMEDIATE D; CMTRID]
FBgn0034877	levy	HGNC:2279	OMIM:602009	COX6A2	12	619062	619062[MITOCHONDRIAL COMPLEX IV DEFICIENCY, NUCLEAR TYPE 18; MC4DN18]
FBgn0034877	levy	HGNC:35239		COX6A1P2	3		
FBgn0010501	Dcp-1	HGNC:1504	OMIM:600636	CASP3	10		
FBgn0010501	Dcp-1	HGNC:1508	OMIM:601761	CASP7	12		
FBgn0010501	Dcp-1	HGNC:1507	OMIM:601532	CASP6	5		
FBgn0034880	ItgaPS5	HGNC:6140	OMIM:192975	ITGA4	5		
FBgn0034880	ItgaPS5	HGNC:6145	OMIM:603963	ITGA9	6		
FBgn0034880	ItgaPS5	HGNC:6152	OMIM:151510	ITGAX	3		
FBgn0034880	ItgaPS5	HGNC:6148	OMIM:153370	ITGAL	3		
FBgn0034880	ItgaPS5	HGNC:6134	OMIM:192968	ITGA1	3		
FBgn0034880	ItgaPS5	HGNC:6137	OMIM:192974	ITGA2	3		
FBgn0034880	ItgaPS5	HGNC:6135	OMIM:604042	ITGA10	3		
FBgn0034880	ItgaPS5	HGNC:6136	OMIM:604789	ITGA11	3		
FBgn0034880	ItgaPS5	HGNC:6149	OMIM:120980	ITGAM	3		
FBgn0034880	ItgaPS5	HGNC:6143	OMIM:600536	ITGA7	3	613204	613204[MUSCULAR DYSTROPHY, CONGENITAL, DUE TO INTEGRIN ALPHA-7 DEFICIENCY]
FBgn0034880	ItgaPS5	HGNC:6142	OMIM:147556	ITGA6	3	619817	619817[EPIDERMOLYSIS BULLOSA, JUNCTIONAL 6, WITH PYLORIC ATRESIA; JEB6]
FBgn0034880	ItgaPS5	HGNC:6139	OMIM:605025	ITGA3	3	614748	614748[EPIDERMOLYSIS BULLOSA, JUNCTIONAL 7, WITH INTERSTITIAL LUNG DISEASE AND NEPHROTIC SYNDROME; JEB7]
FBgn0034880	ItgaPS5	HGNC:6146	OMIM:602453	ITGAD	3		
FBgn0034880	ItgaPS5	HGNC:6147	OMIM:604682	ITGAE	3		
FBgn0015277	Pi3K59F	HGNC:8974	OMIM:602609	PIK3C3	15		
FBgn0034882	Eglp1	HGNC:633	OMIM:107776	AQP1	5	110450	110450[BLOOD GROUP, COLTON SYSTEM; CO]
FBgn0034882	Eglp1	HGNC:7103	OMIM:154050	MIP	5	615274	615274[CATARACT 15, MULTIPLE TYPES; CTRCT15]
FBgn0034882	Eglp1	HGNC:634	OMIM:107777	AQP2	4	125800	125800[DIABETES INSIPIDUS, NEPHROGENIC, 2, AUTOSOMAL; NDI2]
FBgn0034882	Eglp1	HGNC:638	OMIM:600442	AQP5	4	600231	600231[PALMOPLANTAR KERATODERMA, BOTHNIAN TYPE; PPKB]
FBgn0034882	Eglp1	HGNC:637	OMIM:600308	AQP4	5		
FBgn0034882	Eglp1	HGNC:642	OMIM:603750	AQP8	3		
FBgn0034882	Eglp1	HGNC:639	OMIM:601383	AQP6	4		
FBgn0034882	Eglp1	HGNC:636	OMIM:600170	AQP3	3	607457	607457[GIL BLOOD GROUP]
FBgn0034882	Eglp1	HGNC:640	OMIM:602974	AQP7	3	614411	614411[GLYCEROL QUANTITATIVE TRAIT LOCUS; GLYCQTL]
FBgn0034882	Eglp1	HGNC:16029	OMIM:606578	AQP10	4		
FBgn0034882	Eglp1	HGNC:643	OMIM:602914	AQP9	3		
FBgn0034882	Eglp1	HGNC:0		LOC100509620	3		
FBgn0004795	retn	HGNC:3031	OMIM:603265	ARID3A	11		
FBgn0004795	retn	HGNC:14350	OMIM:612457	ARID3B	8		
FBgn0004795	retn	HGNC:21209		ARID3C	9		
FBgn0034887	St1	HGNC:11456	OMIM:602385	SULT1C2	6		
FBgn0034887	St1	HGNC:14903	OMIM:608359	SULT4A1	6		
FBgn0034887	St1	HGNC:30004	OMIM:615819	SULT1A4	7		
FBgn0034887	St1	HGNC:33543	OMIM:617151	SULT1C3	7		
FBgn0034887	St1	HGNC:11459	OMIM:604125	SULT2B1	7	617571	617571[ICHTHYOSIS, CONGENITAL, AUTOSOMAL RECESSIVE 14; ARCI14]
FBgn0034887	St1	HGNC:11457	OMIM:608357	SULT1C4	6		
FBgn0034887	St1	HGNC:17845	OMIM:608436	SULT1B1	9		
FBgn0034887	St1	HGNC:11458	OMIM:125263	SULT2A1	6		
FBgn0034887	St1	HGNC:11377	OMIM:600043	SULT1E1	8		
FBgn0034887	St1	HGNC:11455	OMIM:600641	SULT1A3	4		
FBgn0034887	St1	HGNC:11453	OMIM:171150	SULT1A1	8		
FBgn0034887	St1	HGNC:33433	OMIM:617152	SULT6B1	5		
FBgn0034887	St1	HGNC:11454	OMIM:601292	SULT1A2	8		
FBgn0016762	angel	HGNC:19961	OMIM:619537	ANGEL1	13		
FBgn0016762	angel	HGNC:30534	OMIM:619001	ANGEL2	10		
FBgn0034893	mRpL43	HGNC:14517	OMIM:611848	MRPL43	14		
FBgn0013548	l(2)dtl	HGNC:30288	OMIM:610617	DTL	11		
FBgn0034897	Sesn	HGNC:20746	OMIM:607767	SESN2	11		
FBgn0034897	Sesn	HGNC:23060	OMIM:607768	SESN3	13		
FBgn0034897	Sesn	HGNC:21595	OMIM:606103	SESN1	12		
FBgn0034902	CG5532	HGNC:20952	OMIM:615318	TMEM14C	13		
FBgn0034902	CG5532	HGNC:21384	OMIM:619865	TMEM14B	9		
FBgn0034902	CG5532	HGNC:21076	OMIM:616870	TMEM14A	7		
FBgn0034902	CG5532	HGNC:15660		TMEM14DP	5		
FBgn0034902	CG5532	HGNC:34386		TMEM14EP	3		
FBgn0000562	egl	HGNC:28507		EXD1	8		
FBgn0034898	CG18128	HGNC:7892	OMIM:164050	PNP	8	613179	613179[PURINE NUCLEOSIDE PHOSPHORYLASE DEFICIENCY]
FBgn0011297	Alg3	HGNC:23056	OMIM:608750	ALG3	14	601110	601110[CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Id; CDG1D]
FBgn0034894	sigmar	HGNC:20620	OMIM:616438	TNFAIP8L3	10		
FBgn0034894	sigmar	HGNC:26277	OMIM:612112	TNFAIP8L2	11		
FBgn0034894	sigmar	HGNC:17260	OMIM:612111	TNFAIP8	14		
FBgn0034894	sigmar	HGNC:28279	OMIM:615869	TNFAIP8L1	9		
FBgn0050183	CG30183	HGNC:14082	OMIM:616027	ANLN	3	616032	616032[FOCAL SEGMENTAL GLOMERULOSCLEROSIS 8; FSGS8]
FBgn0011296	l(2)efl	HGNC:2388	OMIM:123580	CRYAA	7	604219	604219[CATARACT 9, MULTIPLE TYPES; CTRCT9]
FBgn0011296	l(2)efl	HGNC:26511	OMIM:610695	HSPB6	7		
FBgn0011296	l(2)efl	HGNC:5247	OMIM:602179	HSPB2	4		
FBgn0011296	l(2)efl	HGNC:2389	OMIM:123590	CRYAB	12	608810,613763,613869,615184	608810[MYOPATHY, MYOFIBRILLAR, 2; MFM2],613763[CATARACT 16, MULTIPLE TYPES; CTRCT16],613869[MYOPATHY, MYOFIBRILLAR, FATAL INFANTILE HYPERTONIC, ALPHA-B CRYSTALLIN-RELATED],615184[CARDIOMYOPATHY, DILATED, 1II; CMD1II]
FBgn0011296	l(2)efl	HGNC:30171	OMIM:608014	HSPB8	3	158590,608673	158590[NEURONOPATHY, DISTAL HEREDITARY MOTOR, TYPE IIA; HMN2A],608673[CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2L; CMT2L]
FBgn0011296	l(2)efl	HGNC:5246	OMIM:602195	HSPB1	5	606595,608634	606595[CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2F; CMT2F],608634[NEURONOPATHY, DISTAL HEREDITARY MOTOR, TYPE IIB; HMN2B]
FBgn0011296	l(2)efl	HGNC:5248	OMIM:604624	HSPB3	3	613376	613376[NEURONOPATHY, DISTAL HEREDITARY MOTOR, TYPE IIC; HMN2C]
FBgn0011296	l(2)efl	HGNC:0		CRYAA2	8		
FBgn0034885	Eglp4	HGNC:633	OMIM:107776	AQP1	5	110450	110450[BLOOD GROUP, COLTON SYSTEM; CO]
FBgn0034885	Eglp4	HGNC:7103	OMIM:154050	MIP	5	615274	615274[CATARACT 15, MULTIPLE TYPES; CTRCT15]
FBgn0034885	Eglp4	HGNC:634	OMIM:107777	AQP2	4	125800	125800[DIABETES INSIPIDUS, NEPHROGENIC, 2, AUTOSOMAL; NDI2]
FBgn0034885	Eglp4	HGNC:638	OMIM:600442	AQP5	5	600231	600231[PALMOPLANTAR KERATODERMA, BOTHNIAN TYPE; PPKB]
FBgn0034885	Eglp4	HGNC:637	OMIM:600308	AQP4	6		
FBgn0034885	Eglp4	HGNC:642	OMIM:603750	AQP8	3		
FBgn0034885	Eglp4	HGNC:639	OMIM:601383	AQP6	5		
FBgn0034885	Eglp4	HGNC:636	OMIM:600170	AQP3	4	607457	607457[GIL BLOOD GROUP]
FBgn0034885	Eglp4	HGNC:640	OMIM:602974	AQP7	3	614411	614411[GLYCEROL QUANTITATIVE TRAIT LOCUS; GLYCQTL]
FBgn0034885	Eglp4	HGNC:16029	OMIM:606578	AQP10	3		
FBgn0034885	Eglp4	HGNC:643	OMIM:602914	AQP9	4		
FBgn0034884	Eglp3	HGNC:633	OMIM:107776	AQP1	6	110450	110450[BLOOD GROUP, COLTON SYSTEM; CO]
FBgn0034884	Eglp3	HGNC:7103	OMIM:154050	MIP	5	615274	615274[CATARACT 15, MULTIPLE TYPES; CTRCT15]
FBgn0034884	Eglp3	HGNC:634	OMIM:107777	AQP2	5	125800	125800[DIABETES INSIPIDUS, NEPHROGENIC, 2, AUTOSOMAL; NDI2]
FBgn0034884	Eglp3	HGNC:638	OMIM:600442	AQP5	5	600231	600231[PALMOPLANTAR KERATODERMA, BOTHNIAN TYPE; PPKB]
FBgn0034884	Eglp3	HGNC:637	OMIM:600308	AQP4	6		
FBgn0034884	Eglp3	HGNC:642	OMIM:603750	AQP8	4		
FBgn0034884	Eglp3	HGNC:639	OMIM:601383	AQP6	4		
FBgn0034884	Eglp3	HGNC:636	OMIM:600170	AQP3	6	607457	607457[GIL BLOOD GROUP]
FBgn0034884	Eglp3	HGNC:640	OMIM:602974	AQP7	4	614411	614411[GLYCEROL QUANTITATIVE TRAIT LOCUS; GLYCQTL]
FBgn0034884	Eglp3	HGNC:16029	OMIM:606578	AQP10	3		
FBgn0034884	Eglp3	HGNC:643	OMIM:602914	AQP9	5		
FBgn0034883	Eglp2	HGNC:633	OMIM:107776	AQP1	5	110450	110450[BLOOD GROUP, COLTON SYSTEM; CO]
FBgn0034883	Eglp2	HGNC:7103	OMIM:154050	MIP	5	615274	615274[CATARACT 15, MULTIPLE TYPES; CTRCT15]
FBgn0034883	Eglp2	HGNC:634	OMIM:107777	AQP2	4	125800	125800[DIABETES INSIPIDUS, NEPHROGENIC, 2, AUTOSOMAL; NDI2]
FBgn0034883	Eglp2	HGNC:638	OMIM:600442	AQP5	5	600231	600231[PALMOPLANTAR KERATODERMA, BOTHNIAN TYPE; PPKB]
FBgn0034883	Eglp2	HGNC:637	OMIM:600308	AQP4	6		
FBgn0034883	Eglp2	HGNC:642	OMIM:603750	AQP8	4		
FBgn0034883	Eglp2	HGNC:639	OMIM:601383	AQP6	4		
FBgn0034883	Eglp2	HGNC:636	OMIM:600170	AQP3	4	607457	607457[GIL BLOOD GROUP]
FBgn0034883	Eglp2	HGNC:640	OMIM:602974	AQP7	3	614411	614411[GLYCEROL QUANTITATIVE TRAIT LOCUS; GLYCQTL]
FBgn0034883	Eglp2	HGNC:16029	OMIM:606578	AQP10	3		
FBgn0034883	Eglp2	HGNC:643	OMIM:602914	AQP9	5		
FBgn0034879	Rrp4	HGNC:17097	OMIM:602238	EXOSC2	15	617763	617763[SHORT STATURE, HEARING LOSS, RETINITIS PIGMENTOSA, AND DISTINCTIVE FACIES; SHRF]
FBgn0034876	wmd	HGNC:30796	OMIM:605986	STRAP	13		
FBgn0050181	ppk3	HGNC:101	OMIM:611741	ASIC3	3		
FBgn0050181	ppk3	HGNC:100	OMIM:602866	ASIC1	3		
FBgn0050181	ppk3	HGNC:21263	OMIM:606715	ASIC4	3		
FBgn0050181	ppk3	HGNC:17537	OMIM:616693	ASIC5	3		
FBgn0034907	CG5539	HGNC:26176	OMIM:609349	REEP4	6		
FBgn0034907	CG5539	HGNC:23711	OMIM:609348	REEP3	6		
FBgn0034907	CG5539	HGNC:17975	OMIM:609347	REEP2	6	615625	615625[SPASTIC PARAPLEGIA 72, AUTOSOMAL RECESSIVE; SPG72]
FBgn0034907	CG5539	HGNC:25786	OMIM:609139	REEP1	7	610250,614751,620011	610250[SPASTIC PARAPLEGIA 31, AUTOSOMAL DOMINANT; SPG31],614751[NEURONOPATHY, DISTAL HEREDITARY MOTOR, TYPE VB; HMN5B],620011[SPINAL MUSCULAR ATROPHY, DISTAL, AUTOSOMAL RECESSIVE, 6; DSMA6]
FBgn0034908	CG5543	HGNC:25495	OMIM:617233	WDR70	14		
FBgn0034911	GlyT	HGNC:11054	OMIM:606205	SLC6A7	3		
FBgn0034911	GlyT	HGNC:11056	OMIM:601019	SLC6A9	7	617301	617301[GLYCINE ENCEPHALOPATHY WITH NORMAL SERUM GLYCINE]
FBgn0034911	GlyT	HGNC:11051	OMIM:604159	SLC6A5	7	614618	614618[HYPEREKPLEXIA 3; HKPX3]
FBgn0034911	GlyT	HGNC:11047	OMIM:300444	SLC6A14	4		
FBgn0034914	CG5554	HGNC:25237	OMIM:616766	TMX4	10		
FBgn0034914	CG5554	HGNC:15487	OMIM:610527	TMX1	14		
FBgn0024234	gbb	HGNC:1072	OMIM:112265	BMP5	10		
FBgn0024234	gbb	HGNC:1073	OMIM:112266	BMP6	11		
FBgn0024234	gbb	HGNC:1074	OMIM:112267	BMP7	13		
FBgn0024234	gbb	HGNC:21650		BMP8A	10		
FBgn0024234	gbb	HGNC:1075	OMIM:602284	BMP8B	9		
FBgn0034919	CG5569	HGNC:29918	OMIM:612911	NDUFAF3	14	618240	618240[MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 18; MC1DN18]
FBgn0034931	CG2812	HGNC:29141	OMIM:615734	WDR47	10		
FBgn0023477	Taldo	HGNC:11559	OMIM:602063	TALDO1	14	606003	606003[TRANSALDOLASE DEFICIENCY; TALDOD]
FBgn0001123	Galphas	HGNC:4388	OMIM:139312	GNAL	12	615073	615073[DYSTONIA 25; DYT25]
FBgn0001123	Galphas	HGNC:4392	OMIM:139320	GNAS	10	103580,166350,174800,219080,603233,612462,612463,617686	103580[PSEUDOHYPOPARATHYROIDISM, TYPE IA; PHP1A],166350[OSSEOUS HETEROPLASIA, PROGRESSIVE; POH],174800[MCCUNE-ALBRIGHT SYNDROME; MAS],219080[ACTH-INDEPENDENT MACRONODULAR ADRENAL HYPERPLASIA; AIMAH1],603233[PSEUDOHYPOPARATHYROIDISM, TYPE IB; PHP1B],612462[PSEUDOHYPOPARATHYROIDISM, TYPE IC; PHP1C],612463[PSEUDOPSEUDOHYPOPARATHYROIDISM; PPHP],617686[PITUITARY ADENOMA 3, MULTIPLE TYPES; PITA3]
FBgn0034936	Stoml2	HGNC:14559	OMIM:608292	STOML2	13		
FBgn0034937	fzr2	HGNC:24824	OMIM:603619	FZR1	7		
FBgn0034937	fzr2	HGNC:1723	OMIM:603618	CDC20	4		
FBgn0034937	fzr2	HGNC:24222		CDC20B	3		
FBgn0034939	thoc5	HGNC:19074	OMIM:612733	THOC5	14		
FBgn0034943	Fmo-1	HGNC:3772	OMIM:136131	FMO4	6		
FBgn0034943	Fmo-1	HGNC:3769	OMIM:136130	FMO1	7		
FBgn0034943	Fmo-1	HGNC:3773	OMIM:603957	FMO5	9		
FBgn0034943	Fmo-1	HGNC:3771	OMIM:136132	FMO3	7	602079	602079[TRIMETHYLAMINURIA; TMAU]
FBgn0034943	Fmo-1	HGNC:3770	OMIM:603955	FMO2	8		
FBgn0020764	Alas	HGNC:4188	OMIM:607422	GCAT	4		
FBgn0020764	Alas	HGNC:396	OMIM:125290	ALAS1	12		
FBgn0020764	Alas	HGNC:397	OMIM:301300	ALAS2	14	300751,300752	300751[ANEMIA, SIDEROBLASTIC, 1; SIDBA1],300752[PROTOPORPHYRIA, ERYTHROPOIETIC, X-LINKED; XLEPP]
FBgn0003008	or	HGNC:2013	OMIM:601507	AP3S1	13		
FBgn0003008	or	HGNC:571	OMIM:602416	AP3S2	13		
FBgn0003008	or	HGNC:28782	OMIM:615543	ARPIN	3		
FBgn0003008	or	HGNC:38824		ARPIN-AP3S2	3		
FBgn0002791	mr	HGNC:19989	OMIM:606946	ANAPC2	14		
FBgn0005612	Sox14	HGNC:11193	OMIM:604747	SOX14	5		
FBgn0005612	Sox14	HGNC:18196	OMIM:612202	SOX7	4		
FBgn0005612	Sox14	HGNC:11200	OMIM:184430	SOX4	7	618506	618506[COFFIN-SIRIS SYNDROME 10; CSS10]
FBgn0005612	Sox14	HGNC:11199	OMIM:313430	SOX3	4	300123,312000	300123[INTELLECTUAL DEVELOPMENTAL DISORDER, X-LINKED, WITH PANHYPOPITUITARISM],312000[PANHYPOPITUITARISM, X-LINKED; PHPX]
FBgn0005612	Sox14	HGNC:11195	OMIM:184429	SOX2	4	206900	206900[MICROPHTHALMIA, SYNDROMIC 3; MCOPS3]
FBgn0005612	Sox14	HGNC:11197	OMIM:604974	SOX21	4		
FBgn0005612	Sox14	HGNC:11198	OMIM:601947	SOX12	8		
FBgn0005612	Sox14	HGNC:11191	OMIM:600898	SOX11	3	615866	615866[COFFIN-SIRIS SYNDROME 9; CSS9]
FBgn0005612	Sox14	HGNC:11189	OMIM:602148	SOX1	3		
FBgn0005612	Sox14	HGNC:11196	OMIM:601297	SOX15	4		
FBgn0005612	Sox14	HGNC:11194	OMIM:601618	SOX18	5	137940,607823	137940[HYPOTRICHOSIS-LYMPHEDEMA-TELANGIECTASIA-RENAL DEFECT SYNDROME; HLTRS],607823[HYPOTRICHOSIS-LYMPHEDEMA-TELANGIECTASIA SYNDROME; HLTS]
FBgn0005612	Sox14	HGNC:18122	OMIM:610928	SOX17	5	613674	613674[VESICOURETERAL REFLUX 3; VUR3]
FBgn0005612	Sox14	HGNC:11311	OMIM:480000	SRY	3	400044,400045	400044[46,XY SEX REVERSAL 1; SRXY1],400045[46,XX SEX REVERSAL 1; SRXX1]
FBgn0050178	CG30178	HGNC:9718	OMIM:602505	PXN	6		
FBgn0050178	CG30178	HGNC:11767	OMIM:602353	TGFB1I1	6		
FBgn0050178	CG30178	HGNC:17371	OMIM:605126	FHL5	3		
FBgn0050178	CG30178	HGNC:14061	OMIM:605390	LPXN	5		
FBgn0034950	Pask	HGNC:17270	OMIM:607505	PASK	11		
FBgn0034957	Rsph4a	HGNC:21558	OMIM:612647	RSPH4A	12	612649	612649[CILIARY DYSKINESIA, PRIMARY, 11; CILD11]
FBgn0034957	Rsph4a	HGNC:14241	OMIM:607548	RSPH6A	11		
FBgn0034959	Xxylt	HGNC:26639	OMIM:614552	XXYLT1	13		
FBgn0034962	MAN1	HGNC:28887	OMIM:607844	LEMD3	12	166700	166700[BUSCHKE-OLLENDORFF SYNDROME; BOS]
FBgn0034962	MAN1	HGNC:21244	OMIM:616312	LEMD2	9	212500,619322	212500[CATARACT 46, JUVENILE-ONSET, WITH OR WITHOUT ARRHYTHMIC CARDIOMYOPATHY; CTRCT46],619322[MARBACH-RUSTAD PROGEROID SYNDROME; MARUPS]
FBgn0034964	IntS1	HGNC:24555	OMIM:611345	INTS1	14	618571	618571[NEURODEVELOPMENTAL DISORDER WITH CATARACTS, POOR GROWTH, AND DYSMORPHIC FACIES; NDCAGF]
FBgn0003353	sei	HGNC:18862	OMIM:608168	KCNH6	9		
FBgn0003353	sei	HGNC:18863	OMIM:608169	KCNH7	10		
FBgn0003353	sei	HGNC:6251	OMIM:152427	KCNH2	11	609620,613688	609620[SHORT QT SYNDROME 1; SQT1],613688[LONG QT SYNDROME 2; LQT2]
FBgn0034968	RpL12	HGNC:10302	OMIM:180475	RPL12	14		
FBgn0034971	Gpat4	HGNC:28157	OMIM:610958	GPAT3	11		
FBgn0034971	Gpat4	HGNC:20880	OMIM:608143	GPAT4	13		
FBgn0034970	yki	HGNC:16262	OMIM:606608	YAP1	11	120433	120433[COLOBOMA, OCULAR, WITH OR WITHOUT HEARING IMPAIRMENT, CLEFT LIP/PALATE, AND/OR MENTAL RETARDATION; COB1]
FBgn0034970	yki	HGNC:24042	OMIM:607392	WWTR1	9		
FBgn0023170	RpL39	HGNC:17094	OMIM:607547	RPL39L	11		
FBgn0023170	RpL39	HGNC:10350	OMIM:300899	RPL39	11		
FBgn0023170	RpL39	HGNC:26015		RPL39P5	5		
FBgn0034965	ppk29	HGNC:101	OMIM:611741	ASIC3	5		
FBgn0034965	ppk29	HGNC:100	OMIM:602866	ASIC1	5		
FBgn0034965	ppk29	HGNC:21263	OMIM:606715	ASIC4	5		
FBgn0034965	ppk29	HGNC:99	OMIM:601784	ASIC2	4		
FBgn0034965	ppk29	HGNC:17537	OMIM:616693	ASIC5	4		
FBgn0034965	ppk29	HGNC:10599	OMIM:600228	SCNN1A	3	264350,613021,618126	264350[PSEUDOHYPOALDOSTERONISM, TYPE I, AUTOSOMAL RECESSIVE; PHA1B],613021[BRONCHIECTASIS WITH OR WITHOUT ELEVATED SWEAT CHLORIDE 2; BESC2],618126[LIDDLE SYNDROME 3; LIDLS3]
FBgn0034965	ppk29	HGNC:10600	OMIM:600760	SCNN1B	3	177200,211400,264350	177200[LIDDLE SYNDROME 1; LIDLS1],211400[BRONCHIECTASIS WITH OR WITHOUT ELEVATED SWEAT CHLORIDE 1; BESC1],264350[PSEUDOHYPOALDOSTERONISM, TYPE I, AUTOSOMAL RECESSIVE; PHA1B]
FBgn0034965	ppk29	HGNC:10601	OMIM:601328	SCNN1D	3		
FBgn0034965	ppk29	HGNC:10602	OMIM:600761	SCNN1G	3	264350,613071,618114	264350[PSEUDOHYPOALDOSTERONISM, TYPE I, AUTOSOMAL RECESSIVE; PHA1B],613071[BRONCHIECTASIS WITH OR WITHOUT ELEVATED SWEAT CHLORIDE 3; BESC3],618114[LIDDLE SYNDROME 2; LIDLS2]
FBgn0028552	gammaSnap1	HGNC:7642	OMIM:603216	NAPG	14		
FBgn0011726	tsr	HGNC:1874	OMIM:601442	CFL1	9		
FBgn0011726	tsr	HGNC:1875	OMIM:601443	CFL2	11	610687	610687[NEMALINE MYOPATHY 7; NEM7]
FBgn0011726	tsr	HGNC:15750	OMIM:609114	DSTN	10		
FBgn0034963	Not11	HGNC:25217		CNOT11	12		
FBgn0013764	Chi	HGNC:6533	OMIM:603450	LDB2	12		
FBgn0013764	Chi	HGNC:6532	OMIM:603451	LDB1	11		
FBgn0061198	HSPC300	HGNC:23057	OMIM:611183	BRK1	13		
FBgn0034958	CG3907	HGNC:29051	OMIM:619559	EFCAB14	3		
FBgn0034956	CG4324	HGNC:25417	OMIM:611699	SVOP	15		
FBgn0034956	CG4324	HGNC:27034	OMIM:611700	SVOPL	3		
FBgn0034951	CG3860	HGNC:8503	OMIM:167040	OSBP	4		
FBgn0034951	CG3860	HGNC:8504	OMIM:606729	OSBP2	4		
FBgn0034951	CG3860	HGNC:16398	OMIM:606730	OSBPL1A	10		
FBgn0034951	CG3860	HGNC:15761	OMIM:606731	OSBPL2	11	616340	616340[DEAFNESS, AUTOSOMAL DOMINANT 67; DFNA67]
FBgn0034951	CG3860	HGNC:16370	OMIM:606732	OSBPL3	3		
FBgn0034951	CG3860	HGNC:16387	OMIM:606735	OSBPL7	3		
FBgn0034948	PPP1R15	HGNC:14375	OMIM:611048	PPP1R15A	6		
FBgn0034948	PPP1R15	HGNC:14951	OMIM:613257	PPP1R15B	3	616817	616817[MICROCEPHALY, SHORT STATURE, AND IMPAIRED GLUCOSE METABOLISM 2; MSSGM2]
FBgn0034940	CG16787	HGNC:21301		C6orf136	10		
FBgn0034938	CG3803	HGNC:2263	OMIM:603646	COX15	14	615119	615119[MITOCHONDRIAL COMPLEX IV DEFICIENCY, NUCLEAR TYPE 6; MC4DN6]
FBgn0034933	CG3735	HGNC:28440	OMIM:619663	UTP25	14		
FBgn0015268	Nap1	HGNC:7637	OMIM:164060	NAP1L1	13		
FBgn0015268	Nap1	HGNC:7638	OMIM:300026	NAP1L2	6		
FBgn0015268	Nap1	HGNC:7639	OMIM:300117	NAP1L3	5		
FBgn0015268	Nap1	HGNC:7640	OMIM:601651	NAP1L4	12		
FBgn0034925	CG5339	HGNC:24586	OMIM:609388	METTL9	13		
FBgn0034923	Upf3	HGNC:20332	OMIM:605530	UPF3A	10		
FBgn0034923	Upf3	HGNC:20439	OMIM:300298	UPF3B	11	300676	300676[INTELLECTUAL DEVELOPMENTAL DISORDER, X-LINKED, SYNDROMIC 14; MRXS14]
FBgn0034921	DCP1	HGNC:24451	OMIM:609843	DCP1B	10		
FBgn0034921	DCP1	HGNC:18714	OMIM:607010	DCP1A	10		
FBgn0025334	PHDP	HGNC:691	OMIM:602753	PHOX2A	6	602078	602078[FIBROSIS OF EXTRAOCULAR MUSCLES, CONGENITAL, 2; CFEOM2]
FBgn0025334	PHDP	HGNC:9143	OMIM:603851	PHOX2B	7	209880,613013	209880[CENTRAL HYPOVENTILATION SYNDROME, CONGENITAL, 1; CCHS1],613013[NEUROBLASTOMA, SUSCEPTIBILITY TO, 2; NBLST2]
FBgn0025336	CG4882	HGNC:14512	OMIM:611989	MRPS27	9		
FBgn0025352	Mtpbeta	HGNC:4803	OMIM:143450	HADHB	14	609015	609015[MITOCHONDRIAL TRIFUNCTIONAL PROTEIN DEFICIENCY; MTPD]
FBgn0004581	bgcn	HGNC:24721	OMIM:616530	YTHDC2	7		
FBgn0034918	Pym	HGNC:30258	OMIM:619753	PYM1	13		
FBgn0021895	ytr	HGNC:30240	OMIM:619629	SNRNP27	12		
FBgn0034915	eIF6	HGNC:6159	OMIM:602912	EIF6	14		
FBgn0034913	Snap29	HGNC:11133	OMIM:604202	SNAP29	14	609528	609528[CEREBRAL DYSGENESIS, NEUROPATHY, ICHTHYOSIS, AND PALMOPLANTAR KERATODERMA SYNDROME; CEDNIK]
FBgn0003401	shu	HGNC:3722	OMIM:604839	FKBP6	13		
FBgn0034909	pippin	HGNC:11011	OMIM:606813	SLC2A6	4		
FBgn0034909	pippin	HGNC:13812	OMIM:605245	SLC2A8	5		
FBgn0028411	Nxt1	HGNC:18151	OMIM:300320	NXT2	13		
FBgn0028411	Nxt1	HGNC:15913	OMIM:605811	NXT1	14		
FBgn0010278	Ssrp	HGNC:11327	OMIM:604328	SSRP1	13		
FBgn0034904	CG15800	HGNC:10899	OMIM:601434	SKP1	3		
FBgn0034973	CG13564	HGNC:32068	OMIM:616574	MICOS10	6		
FBgn0034975	enok	HGNC:17016	OMIM:609880	KAT7	3		
FBgn0034975	enok	HGNC:13013	OMIM:601408	KAT6A	9	616268	616268[ARBOLEDA-THAM SYNDROME; ARTHS]
FBgn0034975	enok	HGNC:17582	OMIM:605880	KAT6B	9	603736,606170	603736[OHDO SYNDROME, SBBYS VARIANT; SBBYSS],606170[GENITOPATELLAR SYNDROME; GTPTS]
FBgn0034975	enok	HGNC:5275	OMIM:601409	KAT5	3	619103	619103[NEURODEVELOPMENTAL DISORDER WITH DYSMORPHIC FACIES, SLEEP DISTURBANCE, AND BRAIN ABNORMALITIES; NEDFASB]
FBgn0041706	CG3253	HGNC:15685	OMIM:605517	B4GAT1	10	615287	615287[MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 13; MDDGA13]
FBgn0041706	CG3253	HGNC:16522	OMIM:609709	LARGE2	3		
FBgn0041706	CG3253	HGNC:6511	OMIM:603590	LARGE1	3	608840,613154	608840[MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH IMPAIRED INTELLECTUAL DEVELOPMENT), TYPE B, 6; MDDGB6],613154[MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 6; MDDGA6]
FBgn0021875	Zfrp8	HGNC:8762	OMIM:600866	PDCD2	15		
FBgn0021875	Zfrp8	HGNC:28194	OMIM:615661	PDCD2L	4		
FBgn0015544	spag	HGNC:26151	OMIM:611477	RPAP3	15		
FBgn0034985	CG3328	HGNC:26316		MYRFL	6		
FBgn0034985	CG3328	HGNC:1181	OMIM:608329	MYRF	10	618113,618280	618113[ENCEPHALITIS/ENCEPHALOPATHY, MILD, WITH REVERSIBLE MYELIN VACUOLIZATION; MMERV],618280[CARDIAC-UROGENITAL SYNDROME; CUGS]
FBgn0034988	cN-IIIB	HGNC:28300		NT5C3B	11		
FBgn0034988	cN-IIIB	HGNC:17820	OMIM:606224	NT5C3A	11	266120	266120[URIDINE 5-PRIME MONOPHOSPHATE HYDROLASE DEFICIENCY, HEMOLYTIC ANEMIA DUE TO]
FBgn0034989	CG3356	HGNC:16803	OMIM:614454	UBE3C	15		
FBgn0034989	CG3356	HGNC:13478	OMIM:608047	UBE3B	4	244450	244450[KAUFMAN OCULOCEREBROFACIAL SYNDROME; KOS]
FBgn0050418	nord	HGNC:26256	OMIM:616506	NDNF	9	618841	618841[HYPOGONADOTROPIC HYPOGONADISM 25 WITH ANOSMIA; HH25]
FBgn0005636	nvy	HGNC:1535	OMIM:133435	RUNX1T1	11		
FBgn0005636	nvy	HGNC:1537	OMIM:603870	CBFA2T3	13		
FBgn0005636	nvy	HGNC:1536	OMIM:603672	CBFA2T2	11		
FBgn0034999	Fatp3	HGNC:10999	OMIM:603314	SLC27A5	4		
FBgn0034999	Fatp3	HGNC:10997	OMIM:604193	SLC27A3	5		
FBgn0034999	Fatp3	HGNC:10995	OMIM:600691	SLC27A1	10		
FBgn0034999	Fatp3	HGNC:11000	OMIM:604196	SLC27A6	6		
FBgn0034999	Fatp3	HGNC:10996	OMIM:603247	SLC27A2	5		
FBgn0034999	Fatp3	HGNC:10998	OMIM:604194	SLC27A4	10	608649	608649[ICHTHYOSIS PREMATURITY SYNDROME; IPS]
FBgn0004101	bs	HGNC:11291	OMIM:600589	SRF	10		
FBgn0005638	slbo	HGNC:1833	OMIM:116897	CEBPA	8	601626	601626[LEUKEMIA, ACUTE MYELOID; AML]
FBgn0005638	slbo	HGNC:1834	OMIM:189965	CEBPB	6		
FBgn0005638	slbo	HGNC:1835	OMIM:116898	CEBPD	7		
FBgn0005638	slbo	HGNC:1836	OMIM:600749	CEBPE	8	245480	245480[SPECIFIC GRANULE DEFICIENCY 1; SGD1]
FBgn0005638	slbo	HGNC:1837	OMIM:138972	CEBPG	6		
FBgn0034986	mRpS17	HGNC:14047	OMIM:611980	MRPS17	12		
FBgn0041582	tamo	HGNC:14681	OMIM:607662	SPATA2	7		
FBgn0041582	tamo	HGNC:28393		SPATA2L	5		
FBgn0023081	gek	HGNC:29829	OMIM:613991	CDC42BPG	8		
FBgn0023081	gek	HGNC:10252	OMIM:604002	ROCK2	3		
FBgn0023081	gek	HGNC:10251	OMIM:601702	ROCK1	3		
FBgn0023081	gek	HGNC:1737	OMIM:603412	CDC42BPA	14		
FBgn0023081	gek	HGNC:1738	OMIM:614062	CDC42BPB	12	619841	619841[CHILTON-OKUR-CHUNG NEURODEVELOPMENTAL SYNDROME; CHOCNS]
FBgn0023081	gek	HGNC:2933	OMIM:605377	DMPK	4	160900	160900[MYOTONIC DYSTROPHY 1; DM1]
FBgn0034972	CG10339	HGNC:26741		CES4A	3		
FBgn0034972	CG10339	HGNC:108	OMIM:100740	ACHE	3	112100	112100[YT BLOOD GROUP ANTIGEN]
FBgn0034972	CG10339	HGNC:983	OMIM:177400	BCHE	3	617936	617936[BUTYRYLCHOLINESTERASE DEFICIENCY; BCHED]
FBgn0034972	CG10339	HGNC:26459	OMIM:618678	CES5A	3		
FBgn0034972	CG10339	HGNC:1863	OMIM:114835	CES1	3	618057	618057[DRUG METABOLISM, ALTERED, CES1-RELATED]
FBgn0034972	CG10339	HGNC:1848	OMIM:114840	CEL	3	609812	609812[MATURITY-ONSET DIABETES OF THE YOUNG, TYPE 8, WITH EXOCRINE DYSFUNCTION; MODY8]
FBgn0034972	CG10339	HGNC:1864	OMIM:605278	CES2	3		
FBgn0034972	CG10339	HGNC:1865	OMIM:605279	CES3	3		
FBgn0034972	CG10339	HGNC:14291	OMIM:600568	NLGN1	3	618830	618830[AUTISM, SUSCEPTIBILITY TO, 20; AUTS20]
FBgn0034972	CG10339	HGNC:14289	OMIM:300336	NLGN3	3	300425,300494	300425[AUTISM, SUSCEPTIBILITY TO, X-LINKED 1; AUTSX1],300494[ASPERGER SYNDROME, X-LINKED, SUSCEPTIBILITY TO, 1; ASPGX1]
FBgn0034972	CG10339	HGNC:14287	OMIM:300427	NLGN4X	3	300495,300497	300495[AUTISM, SUSCEPTIBILITY TO, X-LINKED 2; AUTSX2],300497[ASPERGER SYNDROME, X-LINKED, SUSCEPTIBILITY TO, 2; ASPGX2]
FBgn0034972	CG10339	HGNC:14290	OMIM:606479	NLGN2	3		
FBgn0002787	Rpn8	HGNC:9565	OMIM:157970	PSMD7	14		
FBgn0035005	CG3483	HGNC:5384	OMIM:601149	IDH3A	5	619007	619007[RETINITIS PIGMENTOSA 90; RP90]
FBgn0035008	CG3494	HGNC:26004		LRRC40	3		
FBgn0035009	CG16837	HGNC:15467	OMIM:607168	DYNLRB2	5		
FBgn0035009	CG16837	HGNC:15468	OMIM:607167	DYNLRB1	4		
FBgn0050169	Brca2	HGNC:1101	OMIM:600185	BRCA2	3	114480,155255,176807,194070,605724,612555,613029,613347	114480[BREAST CANCER],155255[MEDULLOBLASTOMA; MDB],176807[PROSTATE CANCER],194070[WILMS TUMOR 1; WT1],605724[FANCONI ANEMIA, COMPLEMENTATION GROUP D1; FANCD1],612555[BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2; BROVCA2],613029[GLIOMA SUSCEPTIBILITY 3; GLM3],613347[PANCREATIC CANCER, SUSCEPTIBILITY TO, 2]
FBgn0035020	CG13585	HGNC:27321		SMIM14	13		
FBgn0035024	CG11414	HGNC:28079	OMIM:617508	ZNF598	14		
FBgn0035025	uri	HGNC:13236	OMIM:603494	URI1	8		
FBgn0035027	CG3511	HGNC:28954	OMIM:618274	PPWD1	13		
FBgn0035034	CG3565	HGNC:25678	OMIM:619564	EFCAB1	4		
FBgn0035035	Samtor	HGNC:26475	OMIM:617855	BMT2	14		
FBgn0035039	Adck1	HGNC:21738		ADCK5	4		
FBgn0035039	Adck1	HGNC:19038		ADCK1	14		
FBgn0015040	Cyp9c1	HGNC:2638	OMIM:605325	CYP3A5	8	145500	145500[HYPERTENSION, ESSENTIAL]
FBgn0015040	Cyp9c1	HGNC:17450	OMIM:606534	CYP3A43	7		
FBgn0015040	Cyp9c1	HGNC:11609	OMIM:274180	TBXAS1	7	231095	231095[GHOSAL HEMATODIAPHYSEAL DYSPLASIA; GHDD]
FBgn0015040	Cyp9c1	HGNC:2637	OMIM:124010	CYP3A4	8	619073	619073[VITAMIN D-DEPENDENT RICKETS, TYPE 3; VDDR3]
FBgn0015040	Cyp9c1	HGNC:51504		CYP3A7-CYP3A51P	6		
FBgn0035042	CG3640	HGNC:8946	OMIM:607076	PI15	4		
FBgn0035042	CG3640	HGNC:16249		R3HDML	4		
FBgn0035042	CG3640	HGNC:21245		PI16	3		
FBgn0035042	CG3640	HGNC:28392	OMIM:610395	GLIPR1L1	5		
FBgn0035042	CG3640	HGNC:18206		CRISPLD1	3		
FBgn0035042	CG3640	HGNC:25248	OMIM:612434	CRISPLD2	3		
FBgn0035042	CG3640	HGNC:16904	OMIM:618062	CRISP3	3		
FBgn0035042	CG3640	HGNC:304	OMIM:601193	CRISP1	3		
FBgn0035042	CG3640	HGNC:12024	OMIM:187430	CRISP2	3		
FBgn0035042	CG3640	HGNC:33849	OMIM:616572	CLEC18B	3		
FBgn0035042	CG3640	HGNC:30388	OMIM:616571	CLEC18A	3		
FBgn0035044	CG3663	HGNC:26278	OMIM:612928	ISOC2	9		
FBgn0035044	CG3663	HGNC:24254		ISOC1	11		
FBgn0035046	ND-19	HGNC:7692	OMIM:603359	NDUFA8	14	619272	619272[MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 37; MC1DN37]
FBgn0035049	Mmp1	HGNC:7157	OMIM:185261	MMP11	3		
FBgn0035049	Mmp1	HGNC:7162	OMIM:602262	MMP16	8		
FBgn0035049	Mmp1	HGNC:14246	OMIM:608482	MMP25	4		
FBgn0035049	Mmp1	HGNC:7163	OMIM:602285	MMP17	3		
FBgn0035049	Mmp1	HGNC:7167	OMIM:604629	MMP20	4	612529	612529[AMELOGENESIS IMPERFECTA, HYPOMATURATION TYPE, IIA2; AI2A2]
FBgn0035049	Mmp1	HGNC:7165	OMIM:601807	MMP19	4	611543	611543[CAVITARY OPTIC DISC ANOMALIES; CODA]
FBgn0035049	Mmp1	HGNC:7161	OMIM:602261	MMP15	7		
FBgn0035049	Mmp1	HGNC:7172	OMIM:604871	MMP24	9		
FBgn0035049	Mmp1	HGNC:7160	OMIM:600754	MMP14	9	277950	277950[WINCHESTER SYNDROME; WNCHRS]
FBgn0035049	Mmp1	HGNC:7173	OMIM:185250	MMP3	4	614466	614466[CORONARY HEART DISEASE, SUSCEPTIBILITY TO, 6; CHDS6]
FBgn0035049	Mmp1	HGNC:7159	OMIM:600108	MMP13	3	250400,602111	250400[METAPHYSEAL DYSPLASIA, SPAHR TYPE; MDST],602111[SPONDYLOEPIMETAPHYSEAL DYSPLASIA, MISSOURI TYPE; SEMDM]
FBgn0035049	Mmp1	HGNC:7155	OMIM:120353	MMP1	4	226600,606963	226600[EPIDERMOLYSIS BULLOSA DYSTROPHICA, AUTOSOMAL RECESSIVE; RDEB],606963[PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; COPD]
FBgn0035049	Mmp1	HGNC:14250	OMIM:618101	MMP27	4		
FBgn0035049	Mmp1	HGNC:7175	OMIM:120355	MMP8	5		
FBgn0035049	Mmp1	HGNC:14366	OMIM:608417	MMP28	3		
FBgn0035049	Mmp1	HGNC:7156	OMIM:185260	MMP10	4		
FBgn0035049	Mmp1	HGNC:7158	OMIM:601046	MMP12	4		
FBgn0035049	Mmp1	HGNC:7174	OMIM:178990	MMP7	3		
FBgn0035049	Mmp1	HGNC:14249	OMIM:605470	MMP26	5		
FBgn0035049	Mmp1	HGNC:5171	OMIM:142290	HPX	3		
FBgn0035049	Mmp1	HGNC:7176	OMIM:120361	MMP9	3	613073	613073[METAPHYSEAL ANADYSPLASIA 2; MANDP2]
FBgn0035049	Mmp1	HGNC:14357	OMIM:608416	MMP21	3	616749	616749[HETEROTAXY, VISCERAL, 7, AUTOSOMAL; HTX7]
FBgn0260456	CG4806	HGNC:21863	OMIM:612074	RBM28	12	612079	612079[ALOPECIA, NEUROLOGIC DEFECTS, AND ENDOCRINOPATHY SYNDROME; ANES]
FBgn0035032	ATPsynF	HGNC:848	OMIM:619792	ATP5MF	12		
FBgn0069913	CG4681	HGNC:29585		TEX9	10		
FBgn0035026	Fcp1	HGNC:2498	OMIM:604927	CTDP1	13	604168	604168[CONGENITAL CATARACTS, FACIAL DYSMORPHISM, AND NEUROPATHY; CCFDN]
FBgn0016687	Nurf-38	HGNC:9226	OMIM:179030	PPA1	14		
FBgn0016687	Nurf-38	HGNC:28883	OMIM:609988	PPA2	12	617222,617223	617222[SUDDEN CARDIAC FAILURE, INFANTILE; SCFI],617223[SUDDEN CARDIAC FAILURE, ALCOHOL-INDUCED; SCFAI]
FBgn0035016	CG4612	HGNC:15797		PABPC1L	3		
FBgn0035016	CG4612	HGNC:8554	OMIM:604679	PABPC1	3		
FBgn0035016	CG4612	HGNC:8557	OMIM:603407	PABPC4	3		
FBgn0035016	CG4612	HGNC:8556	OMIM:604680	PABPC3	3		
FBgn0035016	CG4612	HGNC:13629	OMIM:300407	PABPC5	3		
FBgn0035016	CG4612	HGNC:31955		PABPC4L	3		
FBgn0017556	Prosalpha4T2	HGNC:22985	OMIM:617841	PSMA8	6		
FBgn0017556	Prosalpha4T2	HGNC:9536	OMIM:606607	PSMA7	7		
FBgn0015300	Ssl	HGNC:2460	OMIM:115441	CSNK2B	5	618732	618732[POIRIER-BIENVENU NEURODEVELOPMENTAL SYNDROME; POBINDS]
FBgn0035004	Pgam5-2	HGNC:28763	OMIM:614939	PGAM5	9		
FBgn0010414	SerT	HGNC:11049	OMIM:126455	SLC6A3	5	188890,613135	188890[TOBACCO ADDICTION, SUSCEPTIBILITY TO],613135[PARKINSONISM-DYSTONIA 1, INFANTILE-ONSET; PKDYS1]
FBgn0010414	SerT	HGNC:11044	OMIM:607952	SLC6A11	3		
FBgn0010414	SerT	HGNC:31399	OMIM:610299	SLC6A17	3	616269	616269[INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 48; MRT48]
FBgn0010414	SerT	HGNC:11054	OMIM:606205	SLC6A7	3		
FBgn0010414	SerT	HGNC:11048	OMIM:163970	SLC6A2	5	604715	604715[ORTHOSTATIC INTOLERANCE]
FBgn0010414	SerT	HGNC:13621	OMIM:607971	SLC6A15	3		
FBgn0010414	SerT	HGNC:11050	OMIM:182138	SLC6A4	11	164230,607834	164230[OBSESSIVE-COMPULSIVE DISORDER; OCD],607834[ANXIETY]
FBgn0010414	SerT	HGNC:11046	OMIM:615097	SLC6A13	3		
FBgn0010414	SerT	HGNC:11042	OMIM:137165	SLC6A1	3	616421	616421[MYOCLONIC-ATONIC EPILEPSY; MAE]
FBgn0010414	SerT	HGNC:13622	OMIM:607972	SLC6A16	3		
FBgn0000037	mAChR-A	HGNC:1950	OMIM:118510	CHRM1	11		
FBgn0000037	mAChR-A	HGNC:1953	OMIM:118495	CHRM4	7		
FBgn0000037	mAChR-A	HGNC:1951	OMIM:118493	CHRM2	6		
FBgn0000037	mAChR-A	HGNC:1952	OMIM:118494	CHRM3	11	100100	100100[PRUNE BELLY SYNDROME; PBS]
FBgn0000037	mAChR-A	HGNC:1954	OMIM:118496	CHRM5	11		
FBgn0050421	Usp15-31	HGNC:12609	OMIM:300050	USP11	3		
FBgn0050421	Usp15-31	HGNC:20060	OMIM:619536	USP31	11		
FBgn0050421	Usp15-31	HGNC:20072		USP43	10		
FBgn0035057	CG3880	HGNC:28055	OMIM:612057	SAPCD2	13		
FBgn0035057	CG3880	HGNC:13938		SAPCD1	3		
FBgn0035059	CG3894	HGNC:16156	OMIM:608597	NEURL2	14		
FBgn0035065	CG3589	HGNC:28531	OMIM:611017	TYSND1	13		
FBgn0000157	Dll	HGNC:2914	OMIM:600029	DLX1	7		
FBgn0000157	Dll	HGNC:2915	OMIM:126255	DLX2	3		
FBgn0000157	Dll	HGNC:2916	OMIM:600525	DLX3	4	104510,190320	104510[AMELOGENESIS IMPERFECTA, TYPE IV; AI4],190320[TRICHODENTOOSSEOUS SYNDROME; TDO]
FBgn0000157	Dll	HGNC:2918	OMIM:600028	DLX5	3	183600,220600	183600[SPLIT-HAND/FOOT MALFORMATION 1; SHFM1],220600[SPLIT-HAND/FOOT MALFORMATION 1 WITH SENSORINEURAL HEARING LOSS, AUTOSOMAL RECESSIVE; SHFM1D]
FBgn0000157	Dll	HGNC:2919	OMIM:600030	DLX6	7		
FBgn0000157	Dll	HGNC:2917	OMIM:601911	DLX4	6	616788	616788[OROFACIAL CLEFT 15; OFC15]
FBgn0022343	CG3760	HGNC:26928	OMIM:618789	CDV3	6		
FBgn0035085	CG3770	HGNC:6588	OMIM:609718	LHFPL2	12		
FBgn0035088	CG3776	HGNC:26198	OMIM:617267	MAIP1	13		
FBgn0035091	CG3829	HGNC:1663	OMIM:173510	CD36	5	608404,610938,611162	608404[PLATELET GLYCOPROTEIN IV DEFICIENCY],610938[CORONARY HEART DISEASE, SUSCEPTIBILITY TO, 7; CHDS7],611162[MALARIA, SUSCEPTIBILITY TO]
FBgn0035091	CG3829	HGNC:1664	OMIM:601040	SCARB1	5	610762	610762[HIGH DENSITY LIPOPROTEIN CHOLESTEROL LEVEL QUANTITATIVE TRAIT LOCUS 6; HDLCQ6]
FBgn0035091	CG3829	HGNC:1665	OMIM:602257	SCARB2	4	254900	254900[EPILEPSY, PROGRESSIVE MYOCLONIC, 4, WITH OR WITHOUT RENAL FAILURE; EPM4]
FBgn0010435	emp	HGNC:1663	OMIM:173510	CD36	5	608404,610938,611162	608404[PLATELET GLYCOPROTEIN IV DEFICIENCY],610938[CORONARY HEART DISEASE, SUSCEPTIBILITY TO, 7; CHDS7],611162[MALARIA, SUSCEPTIBILITY TO]
FBgn0010435	emp	HGNC:1664	OMIM:601040	SCARB1	8	610762	610762[HIGH DENSITY LIPOPROTEIN CHOLESTEROL LEVEL QUANTITATIVE TRAIT LOCUS 6; HDLCQ6]
FBgn0010435	emp	HGNC:1665	OMIM:602257	SCARB2	10	254900	254900[EPILEPSY, PROGRESSIVE MYOCLONIC, 4, WITH OR WITHOUT RENAL FAILURE; EPM4]
FBgn0035090	CG2736	HGNC:1663	OMIM:173510	CD36	3	608404,610938,611162	608404[PLATELET GLYCOPROTEIN IV DEFICIENCY],610938[CORONARY HEART DISEASE, SUSCEPTIBILITY TO, 7; CHDS7],611162[MALARIA, SUSCEPTIBILITY TO]
FBgn0035090	CG2736	HGNC:1664	OMIM:601040	SCARB1	5	610762	610762[HIGH DENSITY LIPOPROTEIN CHOLESTEROL LEVEL QUANTITATIVE TRAIT LOCUS 6; HDLCQ6]
FBgn0035090	CG2736	HGNC:1665	OMIM:602257	SCARB2	3	254900	254900[EPILEPSY, PROGRESSIVE MYOCLONIC, 4, WITH OR WITHOUT RENAL FAILURE; EPM4]
FBgn0050424	cGlr2	HGNC:21367	OMIM:613973	CGAS	3		
FBgn0035087	CG2765	HGNC:11800	OMIM:601926	THRSP	5		
FBgn0035087	CG2765	HGNC:20715	OMIM:300961	MID1IP1	9		
FBgn0027599	CG2790	HGNC:27030	OMIM:617048	DNAJC21	14	617052	617052[BONE MARROW FAILURE SYNDROME 3; BMFS3]
FBgn0035082	CG2811	HGNC:25100	OMIM:613378	GGACT	14		
FBgn0043792	CG30427	HGNC:26222	OMIM:616107	FAR1	6	616154,619338	616154[PEROXISOMAL FATTY ACYL-CoA REDUCTASE 1 DISORDER; PFCRD],619338[CATARACTS, SPASTIC PARAPARESIS, AND SPEECH DELAY; CSPSD]
FBgn0043792	CG30427	HGNC:25531	OMIM:616156	FAR2	6		
FBgn0035078	Tpc2	HGNC:14409	OMIM:606521	SLC25A19	11	607196,613710	607196[MICROCEPHALY, AMISH TYPE; MCPHA],613710[THIAMINE METABOLISM DYSFUNCTION SYNDROME 4 (BILATERAL STRIATAL DEGENERATION AND PROGRESSIVE POLYNEUROPATHY TYPE); THMD4]
FBgn0035076	Ance-5	HGNC:13557	OMIM:300335	ACE2	3		
FBgn0035076	Ance-5	HGNC:2707	OMIM:106180	ACE	5	267430,612624,614519	267430[RENAL TUBULAR DYSGENESIS; RTD],612624[MICROVASCULAR COMPLICATIONS OF DIABETES, SUSCEPTIBILITY TO, 3; MVCD3],614519[HEMORRHAGE, INTRACEREBRAL, SUSCEPTIBILITY TO; ICH]
FBgn0035073	CG16896	HGNC:30888		TBC1D31	12		
FBgn0023181	Orc4	HGNC:8490	OMIM:603056	ORC4	14	613800	613800[MEIER-GORLIN SYNDROME 2; MGORS2]
FBgn0041205	key	HGNC:17142	OMIM:602432	OPTN	4	137760,606657,613435	137760[GLAUCOMA, PRIMARY OPEN ANGLE; POAG],606657[GLAUCOMA, NORMAL TENSION, SUSCEPTIBILITY TO],613435[AMYOTROPHIC LATERAL SCLEROSIS 12 WITH OR WITHOUT FRONTOTEMPORAL DEMENTIA; ALS12]
FBgn0041205	key	HGNC:5961	OMIM:300248	IKBKG	4	300291,300636,301081,308300	300291[ECTODERMAL DYSPLASIA AND IMMUNODEFICIENCY 1; EDAID1],300636[IMMUNODEFICIENCY 33; IMD33],301081[AUTOINFLAMMATORY DISEASE, SYSTEMIC, X-LINKED; SAIDX],308300[INCONTINENTIA PIGMENTI; IP]
FBgn0035064	TyrRS-m	HGNC:24249	OMIM:610957	YARS2	15	613561	613561[MYOPATHY, LACTIC ACIDOSIS, AND SIDEROBLASTIC ANEMIA 2; MLASA2]
FBgn0035060	Eps-15	HGNC:3419	OMIM:600051	EPS15	11		
FBgn0035060	Eps-15	HGNC:24634	OMIM:616826	EPS15L1	13		
FBgn0027590	GstE12	HGNC:4642	OMIM:600437	GSTT2	3		
FBgn0027590	GstE12	HGNC:33437		GSTT2B	3		
FBgn0027590	GstE12	HGNC:26930		GSTT4	3		
FBgn0040666	CG12848	HGNC:23518	OMIM:608842	CHCHD1	13		
FBgn0035050	SiaT	HGNC:10860	OMIM:109675	ST6GAL1	11		
FBgn0035050	SiaT	HGNC:23364	OMIM:610135	ST6GALNAC6	3		
FBgn0035050	SiaT	HGNC:19342	OMIM:610134	ST6GALNAC5	3		
FBgn0035050	SiaT	HGNC:10861	OMIM:608472	ST6GAL2	11		
FBgn0001325	Kr	HGNC:1001	OMIM:109565	BCL6	3		
FBgn0050429	CG30429	HGNC:29807		MORN3	12		
FBgn0004919	gol	HGNC:21154		RNF133	4		
FBgn0004919	gol	HGNC:22411		RNF148	4		
FBgn0004919	gol	HGNC:18280	OMIM:619163	RNF130	9		
FBgn0004919	gol	HGNC:23138		RNF150	12		
FBgn0004919	gol	HGNC:21153	OMIM:300439	RNF128	6		
FBgn0004919	gol	HGNC:23137		RNF149	7		
FBgn0001147	gsb-n	HGNC:8621	OMIM:167410	PAX7	8	268220,618578	268220[RHABDOMYOSARCOMA 2; RMS2],618578[MYOPATHY, CONGENITAL, PROGRESSIVE, WITH SCOLIOSIS; MYOSCO]
FBgn0001147	gsb-n	HGNC:8617	OMIM:606597	PAX3	9	122880,148820,193500,268220	122880[CRANIOFACIAL-DEAFNESS-HAND SYNDROME; CDHS],148820[WAARDENBURG SYNDROME, TYPE 3; WS3],193500[WAARDENBURG SYNDROME, TYPE 1; WS1],268220[RHABDOMYOSARCOMA 2; RMS2]
FBgn0020386	Pdk1	HGNC:8816	OMIM:605213	PDPK1	13		
FBgn0020386	Pdk1	HGNC:49897		PDPK2P	5		
FBgn0035099	CG6845	HGNC:26562	OMIM:619861	DCST2	12		
FBgn0035101	p130CAS	HGNC:7733	OMIM:602265	NEDD9	13		
FBgn0035101	p130CAS	HGNC:971	OMIM:602941	BCAR1	13		
FBgn0035101	p130CAS	HGNC:16898	OMIM:609906	EFS	6		
FBgn0035101	p130CAS	HGNC:15878	OMIM:618888	CASS4	5		
FBgn0035104	CG13875	HGNC:33984	OMIM:614713	RASSF10	10		
FBgn0035104	CG13875	HGNC:15739	OMIM:610383	RASSF9	9		
FBgn0027786	Mtch	HGNC:17587	OMIM:613221	MTCH2	15		
FBgn0027786	Mtch	HGNC:17586	OMIM:610449	MTCH1	12		
FBgn0035107	mri	HGNC:21445	OMIM:615933	BTBD10	13		
FBgn0035107	mri	HGNC:21052	OMIM:615932	KCTD20	11		
FBgn0024945	NitFhit	HGNC:7828	OMIM:604618	NIT1	12		
FBgn0024945	NitFhit	HGNC:29878	OMIM:616769	NIT2	3		
FBgn0024945	NitFhit	HGNC:3701	OMIM:601153	FHIT	3		
FBgn0035109	CG13876	HGNC:28384		C3orf38	14		
FBgn0035111	Dis3l2	HGNC:28648	OMIM:614184	DIS3L2	11	267000	267000[PERLMAN SYNDROME; PRLMNS]
FBgn0035122	mRpL17	HGNC:14053	OMIM:611830	MRPL17	13		
FBgn0035124	ttm2	HGNC:23656	OMIM:607381	TIMM50	12	617698	617698[3-METHYLGLUTACONIC ACIDURIA, TYPE IX; MGCA9]
FBgn0004373	fwd	HGNC:8984	OMIM:602758	PI4KB	12		
FBgn0052845	CG32845	HGNC:8988	OMIM:601052	PIN1	7		
FBgn0035121	Tudor-SN	HGNC:30646	OMIM:602181	SND1	13		
FBgn0024806	DIP2	HGNC:17217	OMIM:607711	DIP2A	13		
FBgn0024806	DIP2	HGNC:29284	OMIM:611379	DIP2B	13	136630	136630[INTELLECTUAL DEVELOPMENTAL DISORDER, FRA12A TYPE]
FBgn0024806	DIP2	HGNC:29150	OMIM:611380	DIP2C	14		
FBgn0000541	E(bx)	HGNC:3581	OMIM:601819	BPTF	13	617755	617755[NEURODEVELOPMENTAL DISORDER WITH DYSMORPHIC FACIES AND DISTAL LIMB ANOMALIES; NEDDFL]
FBgn0035110	thoc7	HGNC:29874	OMIM:611965	THOC7	13		
FBgn0027587	Prp4k	HGNC:17346	OMIM:602338	PRPF4B	12		
FBgn0025592	Gk1	HGNC:28635		GK5	3		
FBgn0025592	Gk1	HGNC:4291	OMIM:600148	GK2	13		
FBgn0025592	Gk1	HGNC:4289	OMIM:300474	GK	13	307030	307030[GLYCEROL KINASE DEFICIENCY; GKD]
FBgn0025592	Gk1	HGNC:4292	OMIM:600149	GK3P	3		
FBgn0035106	rno	HGNC:1102	OMIM:604589	BRD1	3		
FBgn0035106	rno	HGNC:14255	OMIM:602410	BRPF1	3	617333	617333[INTELLECTUAL DEVELOPMENTAL DISORDER WITH DYSMORPHIC FACIES AND PTOSIS; IDDDFP]
FBgn0035106	rno	HGNC:14256	OMIM:616856	BRPF3	3		
FBgn0035106	rno	HGNC:22982	OMIM:300618	JADE3	10		
FBgn0035106	rno	HGNC:22984	OMIM:610515	JADE2	7		
FBgn0035106	rno	HGNC:30027	OMIM:610514	JADE1	7		
FBgn0035103	Vdup1	HGNC:16952	OMIM:606599	TXNIP	6		
FBgn0035103	Vdup1	HGNC:25225		ARRDC2	5		
FBgn0035103	Vdup1	HGNC:29263	OMIM:612464	ARRDC3	5		
FBgn0035103	Vdup1	HGNC:28087	OMIM:619788	ARRDC4	4		
FBgn0035103	Vdup1	HGNC:28633	OMIM:619768	ARRDC1	6		
FBgn0035102	CG7049	HGNC:20376	OMIM:607939	SUMF1	13	272200	272200[MULTIPLE SULFATASE DEFICIENCY; MSD]
FBgn0035102	CG7049	HGNC:20415	OMIM:607940	SUMF2	5		
FBgn0035134	CG1231	HGNC:16403	OMIM:605308	ZNF346	6		
FBgn0035134	CG1231	HGNC:29983	OMIM:606452	ZMAT3	8		
FBgn0035134	CG1231	HGNC:25844		ZMAT4	8		
FBgn0035134	CG1231	HGNC:17521	OMIM:609124	ZNF385A	3		
FBgn0035134	CG1231	HGNC:26191		ZNF385D	3		
FBgn0035134	CG1231	HGNC:29377	OMIM:301007	ZMAT1	4		
FBgn0035134	CG1231	HGNC:26332	OMIM:612344	ZNF385B	3		
FBgn0035134	CG1231	HGNC:33722		ZNF385C	3		
FBgn0040291	Roc1b	HGNC:9928	OMIM:603814	RBX1	7		
FBgn0040291	Roc1b	HGNC:10070	OMIM:603863	RNF7	3		
FBgn0035140	BORCS6	HGNC:25939	OMIM:616599	BORCS6	9		
FBgn0035142	Hipk	HGNC:4915	OMIM:604424	HIPK3	12		
FBgn0035142	Hipk	HGNC:14402	OMIM:606868	HIPK2	12		
FBgn0035142	Hipk	HGNC:19006	OMIM:608003	HIPK1	11		
FBgn0035142	Hipk	HGNC:19007	OMIM:611712	HIPK4	3		
FBgn0035143	Ppm1	HGNC:19388	OMIM:619309	PPM1F	3		
FBgn0035143	Ppm1	HGNC:9278	OMIM:605119	PPM1G	3		
FBgn0035143	Ppm1	HGNC:9275	OMIM:606108	PPM1A	5		
FBgn0035143	Ppm1	HGNC:9276	OMIM:603770	PPM1B	4		
FBgn0035143	Ppm1	HGNC:26845		PPM1N	5		
FBgn0035145	MED14	HGNC:2370	OMIM:300182	MED14	13		
FBgn0035147	Gale	HGNC:4116	OMIM:606953	GALE	13	230350	230350[GALACTOSEMIA III; GALAC3]
FBgn0035150	Rev1	HGNC:14060	OMIM:606134	REV1	13		
FBgn0035149	MED30	HGNC:23032	OMIM:610237	MED30	12		
FBgn0035148	CG3402	HGNC:30684	OMIM:616484	TAX1BP3	12		
FBgn0016715	Reg-2	HGNC:28171		HDHD3	12		
FBgn0035146	CG13893	HGNC:40047		SEC14L6	10		
FBgn0035146	CG13893	HGNC:10699	OMIM:607558	SEC14L2	12		
FBgn0035146	CG13893	HGNC:20627	OMIM:612825	SEC14L4	12		
FBgn0035146	CG13893	HGNC:29032	OMIM:619412	SEC14L5	4		
FBgn0035146	CG13893	HGNC:10698	OMIM:601504	SEC14L1	5		
FBgn0035146	CG13893	HGNC:18655	OMIM:612824	SEC14L3	13		
FBgn0035144	Kah	HGNC:15952		SCRT2	5		
FBgn0035144	Kah	HGNC:15950	OMIM:605858	SCRT1	5		
FBgn0035141	Cypl	HGNC:9260	OMIM:601301	PPIL1	13	619301	619301[PONTOCEREBELLAR HYPOPLASIA, TYPE 14; PCH14]
FBgn0052343	Atac3	HGNC:4074	OMIM:600610	GABPB1	8		
FBgn0052343	Atac3	HGNC:28441		GABPB2	9		
FBgn0052344	CG32344	HGNC:20084	OMIM:611665	DDX54	14		
FBgn0035165	CG13887	HGNC:24131	OMIM:619612	BCAP29	11		
FBgn0035165	CG13887	HGNC:16695	OMIM:300398	BCAP31	14	300475	300475[DEAFNESS, DYSTONIA, AND CEREBRAL HYPOMYELINATION; DDCH]
FBgn0035168	Cep290	HGNC:29021	OMIM:610142	CEP290	7	610188,610189,611134,611755,615991	610188[JOUBERT SYNDROME 5; JBTS5],610189[SENIOR-LOKEN SYNDROME 6; SLSN6],611134[MECKEL SYNDROME, TYPE 4; MKS4],611755[LEBER CONGENITAL AMAUROSIS 10; LCA10],615991[BARDET-BIEDL SYNDROME 14; BBS14]
FBgn0035169	Dci	HGNC:23920		CDY1B	5		
FBgn0035169	Dci	HGNC:1809	OMIM:400016	CDY1	3		
FBgn0035169	Dci	HGNC:23921		CDY2B	5		
FBgn0035169	Dci	HGNC:1810	OMIM:400018	CDY2A	3		
FBgn0035169	Dci	HGNC:1811	OMIM:603778	CDYL	6		
FBgn0035169	Dci	HGNC:14601	OMIM:608024	ECI2	8		
FBgn0035169	Dci	HGNC:23030	OMIM:618816	CDYL2	6		
FBgn0035171	CG12502	HGNC:21075		TMEM200A	4		
FBgn0035171	CG12502	HGNC:33785		TMEM200B	3		
FBgn0035171	CG12502	HGNC:37208		TMEM200C	4		
FBgn0052479	Usp10	HGNC:12608	OMIM:609818	USP10	7		
FBgn0028999	nerfin-1	HGNC:6090	OMIM:600010	INSM1	11		
FBgn0028999	nerfin-1	HGNC:17539	OMIM:614027	INSM2	10		
FBgn0035173	CG13907	HGNC:17027	OMIM:607550	SLC16A10	3		
FBgn0035173	CG13907	HGNC:10923	OMIM:300095	SLC16A2	3	300523	300523[ALLAN-HERNDON-DUDLEY SYNDROME; AHDS]
FBgn0035173	CG13907	HGNC:10924	OMIM:603877	SLC16A3	5		
FBgn0035173	CG13907	HGNC:16270	OMIM:610409	SLC16A8	6		
FBgn0035173	CG13907	HGNC:26417		SLC16A14	9		
FBgn0035173	CG13907	HGNC:23093	OMIM:615765	SLC16A11	5		
FBgn0035173	CG13907	HGNC:23520	OMIM:614242	SLC16A9	4		
FBgn0035173	CG13907	HGNC:10922	OMIM:600682	SLC16A1	6	245340,610021,616095	245340[ERYTHROCYTE LACTATE TRANSPORTER DEFECT],610021[HYPERINSULINEMIC HYPOGLYCEMIA, FAMILIAL, 7; HHF7],616095[MONOCARBOXYLATE TRANSPORTER 1 DEFICIENCY; MCT1D]
FBgn0035173	CG13907	HGNC:10927	OMIM:603880	SLC16A6	5		
FBgn0035173	CG13907	HGNC:10925	OMIM:603878	SLC16A4	6		
FBgn0035173	CG13907	HGNC:31037		SLC16A13	6		
FBgn0035173	CG13907	HGNC:10926	OMIM:603879	SLC16A5	6		
FBgn0035173	CG13907	HGNC:10928	OMIM:603654	SLC16A7	6		
FBgn0035173	CG13907	HGNC:23094	OMIM:611910	SLC16A12	6	612018	612018[CATARACT 47; CTRCT47]
FBgn0035166	JMJD5	HGNC:25840	OMIM:611917	KDM8	12		
FBgn0035164	CG13901	HGNC:24542	OMIM:616467	DPCD	14		
FBgn0035162	Sf3b3	HGNC:10770	OMIM:605592	SF3B3	15		
FBgn0035161	CG13898	HGNC:13714	OMIM:607315	CABP5	3		
FBgn0052483	CG32483	HGNC:29507	OMIM:619723	SCPEP1	15		
FBgn0035154	hiro	HGNC:29507	OMIM:619723	SCPEP1	15		
FBgn0035179	CG12038	HGNC:31729	OMIM:614544	DIPK1C	10		
FBgn0035179	CG12038	HGNC:28290	OMIM:614543	DIPK1B	4		
FBgn0035179	CG12038	HGNC:32213	OMIM:614542	DIPK1A	4		
FBgn0040281	Aplip1	HGNC:6882	OMIM:604641	MAPK8IP1	10	125853	125853[TYPE 2 DIABETES MELLITUS; T2D]
FBgn0040281	Aplip1	HGNC:6883	OMIM:607755	MAPK8IP2	7		
FBgn0004425	LysB	HGNC:28387	OMIM:612750	LYZL4	6		
FBgn0004425	LysB	HGNC:31353	OMIM:300593	SPACA5	4		
FBgn0004425	LysB	HGNC:19142		SPACA5B	6		
FBgn0004425	LysB	HGNC:29613	OMIM:612748	LYZL2	6		
FBgn0004425	LysB	HGNC:16260	OMIM:612749	SPACA3	7		
FBgn0004425	LysB	HGNC:6480	OMIM:149750	LALBA	6		
FBgn0004425	LysB	HGNC:6740	OMIM:153450	LYZ	11	105200	105200[AMYLOIDOSIS, FAMILIAL VISCERAL]
FBgn0004425	LysB	HGNC:30502		LYZL1	6		
FBgn0004425	LysB	HGNC:29614	OMIM:612751	LYZL6	6		
FBgn0004428	LysE	HGNC:28387	OMIM:612750	LYZL4	6		
FBgn0004428	LysE	HGNC:31353	OMIM:300593	SPACA5	4		
FBgn0004428	LysE	HGNC:19142		SPACA5B	7		
FBgn0004428	LysE	HGNC:29613	OMIM:612748	LYZL2	7		
FBgn0004428	LysE	HGNC:16260	OMIM:612749	SPACA3	8		
FBgn0004428	LysE	HGNC:6480	OMIM:149750	LALBA	5		
FBgn0004428	LysE	HGNC:6740	OMIM:153450	LYZ	12	105200	105200[AMYLOIDOSIS, FAMILIAL VISCERAL]
FBgn0004428	LysE	HGNC:30502		LYZL1	8		
FBgn0004428	LysE	HGNC:29614	OMIM:612751	LYZL6	6		
FBgn0004430	LysS	HGNC:28387	OMIM:612750	LYZL4	6		
FBgn0004430	LysS	HGNC:31353	OMIM:300593	SPACA5	4		
FBgn0004430	LysS	HGNC:19142		SPACA5B	6		
FBgn0004430	LysS	HGNC:29613	OMIM:612748	LYZL2	7		
FBgn0004430	LysS	HGNC:16260	OMIM:612749	SPACA3	7		
FBgn0004430	LysS	HGNC:6480	OMIM:149750	LALBA	5		
FBgn0004430	LysS	HGNC:6740	OMIM:153450	LYZ	11	105200	105200[AMYLOIDOSIS, FAMILIAL VISCERAL]
FBgn0004430	LysS	HGNC:30502		LYZL1	7		
FBgn0004430	LysS	HGNC:29614	OMIM:612751	LYZL6	6		
FBgn0004429	LysP	HGNC:28387	OMIM:612750	LYZL4	6		
FBgn0004429	LysP	HGNC:31353	OMIM:300593	SPACA5	4		
FBgn0004429	LysP	HGNC:19142		SPACA5B	7		
FBgn0004429	LysP	HGNC:29613	OMIM:612748	LYZL2	6		
FBgn0004429	LysP	HGNC:16260	OMIM:612749	SPACA3	8		
FBgn0004429	LysP	HGNC:6480	OMIM:149750	LALBA	5		
FBgn0004429	LysP	HGNC:6740	OMIM:153450	LYZ	13	105200	105200[AMYLOIDOSIS, FAMILIAL VISCERAL]
FBgn0004429	LysP	HGNC:30502		LYZL1	7		
FBgn0004429	LysP	HGNC:29614	OMIM:612751	LYZL6	6		
FBgn0004427	LysD	HGNC:28387	OMIM:612750	LYZL4	6		
FBgn0004427	LysD	HGNC:31353	OMIM:300593	SPACA5	4		
FBgn0004427	LysD	HGNC:19142		SPACA5B	6		
FBgn0004427	LysD	HGNC:29613	OMIM:612748	LYZL2	6		
FBgn0004427	LysD	HGNC:16260	OMIM:612749	SPACA3	7		
FBgn0004427	LysD	HGNC:6480	OMIM:149750	LALBA	5		
FBgn0004427	LysD	HGNC:6740	OMIM:153450	LYZ	11	105200	105200[AMYLOIDOSIS, FAMILIAL VISCERAL]
FBgn0004427	LysD	HGNC:30502		LYZL1	6		
FBgn0004427	LysD	HGNC:29614	OMIM:612751	LYZL6	6		
FBgn0035189	CG9119	HGNC:30204	OMIM:615810	C11orf54	14		
FBgn0063667	meep	HGNC:30204	OMIM:615810	C11orf54	14		
FBgn0004431	LysX	HGNC:28387	OMIM:612750	LYZL4	6		
FBgn0004431	LysX	HGNC:31353	OMIM:300593	SPACA5	4		
FBgn0004431	LysX	HGNC:19142		SPACA5B	6		
FBgn0004431	LysX	HGNC:29613	OMIM:612748	LYZL2	6		
FBgn0004431	LysX	HGNC:16260	OMIM:612749	SPACA3	7		
FBgn0004431	LysX	HGNC:6480	OMIM:149750	LALBA	5		
FBgn0004431	LysX	HGNC:6740	OMIM:153450	LYZ	10	105200	105200[AMYLOIDOSIS, FAMILIAL VISCERAL]
FBgn0004431	LysX	HGNC:30502		LYZL1	6		
FBgn0004431	LysX	HGNC:29614	OMIM:612751	LYZL6	7		
FBgn0035187	Trhn	HGNC:12008	OMIM:191060	TPH1	14		
FBgn0035187	Trhn	HGNC:20692	OMIM:607478	TPH2	11	608516,613003	608516[MAJOR DEPRESSIVE DISORDER; MDD],613003[ATTENTION DEFICIT-HYPERACTIVITY DISORDER, SUSCEPTIBILITY TO, 7; ADHD7]
FBgn0035187	Trhn	HGNC:8582	OMIM:612349	PAH	3	261600	261600[PHENYLKETONURIA; PKU]
FBgn0024277	trio	HGNC:12303	OMIM:601893	TRIO	12	617061,618825	617061[INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL DOMINANT 44, WITH MICROCEPHALY; MRD44],618825[INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL DOMINANT 63, WITH MACROCEPHALY; MRD63]
FBgn0024277	trio	HGNC:4814	OMIM:604605	KALRN	11		
FBgn0024277	trio	HGNC:30275	OMIM:610215	ARHGEF25	4		
FBgn0035192	galene	HGNC:19439	OMIM:613655	KCNK18	5	613656	613656[MIGRAINE WITH OR WITHOUT AURA, SUSCEPTIBILITY TO, 13; MGR13]
FBgn0035199	tfc	HGNC:14556	OMIM:613579	CLEC6A	3		
FBgn0035199	tfc	HGNC:17935	OMIM:604862	CD207	3	613393	613393[BIRBECK GRANULE DEFICIENCY]
FBgn0035199	tfc	HGNC:23059	OMIM:600347	BCAN	4		
FBgn0035199	tfc	HGNC:13257	OMIM:605306	CLEC4A	3		
FBgn0035199	tfc	HGNC:17213	OMIM:612502	COLEC11	3	265050	265050[3MC SYNDROME 2; 3MC2]
FBgn0035199	tfc	HGNC:13523	OMIM:605872	CLEC4M	5		
FBgn0035199	tfc	HGNC:1641	OMIM:604672	CD209	4	607948,609423,614371	607948[MYCOBACTERIUM TUBERCULOSIS, SUSCEPTIBILITY TO],609423[HUMAN IMMUNODEFICIENCY VIRUS TYPE 1, SUSCEPTIBILITY TO],614371[DENGUE VIRUS, SUSCEPTIBILITY TO]
FBgn0035199	tfc	HGNC:16916	OMIM:605999	CLEC10A	3		
FBgn0035203	Acat2	HGNC:83	OMIM:604770	ACAA2	3		
FBgn0035203	Acat2	HGNC:94	OMIM:100678	ACAT2	14	614055	614055[ACETYL-CoA ACETYLTRANSFERASE-2 DEFICIENCY; ACAT2D]
FBgn0035203	Acat2	HGNC:93	OMIM:607809	ACAT1	3	203750	203750[ALPHA-METHYLACETOACETIC ACIDURIA]
FBgn0035205	Ctr9	HGNC:16850	OMIM:609366	CTR9	12		
FBgn0035207	Herc4	HGNC:24521	OMIM:609248	HERC4	13		
FBgn0035207	Herc4	HGNC:4876	OMIM:605200	HERC3	12		
FBgn0035207	Herc4	HGNC:26072	OMIM:609249	HERC6	6		
FBgn0035207	Herc4	HGNC:24368	OMIM:608242	HERC5	7		
FBgn0035207	Herc4	HGNC:26736		HECTD2	4		
FBgn0010246	Myo61F	HGNC:13880	OMIM:600642	MYO1G	3		
FBgn0010246	Myo61F	HGNC:7595	OMIM:601478	MYO1A	3		
FBgn0010246	Myo61F	HGNC:13879	OMIM:614636	MYO1H	9	619482	619482[CENTRAL HYPOVENTILATION SYNDROME, CONGENITAL, 2, AND AUTONOMIC DYSFUNCTION; CCHS2]
FBgn0010246	Myo61F	HGNC:7597	OMIM:606538	MYO1C	12		
FBgn0010246	Myo61F	HGNC:7598	OMIM:606539	MYO1D	3		
FBgn0010246	Myo61F	HGNC:7596	OMIM:606537	MYO1B	3		
FBgn0010246	Myo61F	HGNC:7599	OMIM:601479	MYO1E	3	614131	614131[FOCAL SEGMENTAL GLOMERULOSCLEROSIS 6; FSGS6]
FBgn0011361	ND-ACP	HGNC:7694	OMIM:603836	NDUFAB1	11		
FBgn0010786	Pbgd	HGNC:4982	OMIM:609806	HMBS	11	176000	176000[PORPHYRIA, ACUTE INTERMITTENT; AIP]
FBgn0029514	CG9166	HGNC:21721	OMIM:614624	MALSU1	11		
FBgn0003295	ru	HGNC:16083	OMIM:608962	RHBDL2	4		
FBgn0003295	ru	HGNC:10007	OMIM:603264	RHBDL1	6		
FBgn0003295	ru	HGNC:16502	OMIM:619017	RHBDL3	9		
FBgn0052320	CG32320	HGNC:26562	OMIM:619861	DCST2	9		
FBgn0035217	FucTD	HGNC:19234	OMIM:616931	FUT10	4		
FBgn0035217	FucTD	HGNC:19233	OMIM:616932	FUT11	3		
FBgn0035217	FucTD	HGNC:4016	OMIM:136835	FUT5	4		
FBgn0035217	FucTD	HGNC:4017	OMIM:136836	FUT6	5	613852	613852[FUCOSYLTRANSFERASE 6 DEFICIENCY]
FBgn0035217	FucTD	HGNC:4014	OMIM:111100	FUT3	4	618983	618983[BLOOD GROUP, LEWIS SYSTEM; LE]
FBgn0035217	FucTD	HGNC:4015	OMIM:104230	FUT4	4		
FBgn0035217	FucTD	HGNC:4018	OMIM:602030	FUT7	4		
FBgn0035217	FucTD	HGNC:4020	OMIM:606865	FUT9	4		
FBgn0004635	rho	HGNC:16083	OMIM:608962	RHBDL2	4		
FBgn0004635	rho	HGNC:10007	OMIM:603264	RHBDL1	6		
FBgn0004635	rho	HGNC:16502	OMIM:619017	RHBDL3	9		
FBgn0028567	robl62A	HGNC:15467	OMIM:607168	DYNLRB2	6		
FBgn0028567	robl62A	HGNC:15468	OMIM:607167	DYNLRB1	5		
FBgn0035227	Iml1	HGNC:18423	OMIM:614191	DEPDC5	13	604364	604364[EPILEPSY, FAMILIAL FOCAL, WITH VARIABLE FOCI 1; FFEVF1]
FBgn0011204	cue	HGNC:25323		LRP5L	3		
FBgn0028577	hfp	HGNC:17042	OMIM:604819	PUF60	14	615583	615583[VERHEIJ SYNDROME; VRJS]
FBgn0043458	CG12084	HGNC:30960	OMIM:617764	ZER1	15		
FBgn0020248	stet	HGNC:16083	OMIM:608962	RHBDL2	5		
FBgn0020248	stet	HGNC:10007	OMIM:603264	RHBDL1	9		
FBgn0020248	stet	HGNC:16502	OMIM:619017	RHBDL3	14		
FBgn0052319	Naa30B	HGNC:19844	OMIM:617989	NAA30	9		
FBgn0043865	SA2	HGNC:11354	OMIM:604358	STAG1	7	617635	617635[INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL DOMINANT 47; MRD47]
FBgn0043865	SA2	HGNC:11356	OMIM:608489	STAG3	7	615723,619672	615723[PREMATURE OVARIAN FAILURE 8; POF8],619672[SPERMATOGENIC FAILURE 61; SPGF61]
FBgn0043865	SA2	HGNC:11355	OMIM:300826	STAG2	7	301022,301043	301022[MULLEGAMA-KLEIN-MARTINEZ SYNDROME; MKMS],301043[HOLOPROSENCEPHALY 13, X-LINKED; HPE13]
FBgn0035206	sturkopf	HGNC:26145	OMIM:613570	LDAH	14		
FBgn0035204	Nt5a	HGNC:21556		NT5DC1	13		
FBgn0010333	Rac1	HGNC:9802	OMIM:602049	RAC2	12	608203,618986,618987	608203[IMMUNODEFICIENCY 73A WITH DEFECTIVE NEUTROPHIL CHEMOTAXIS AND LEUKOCYTOSIS; IMD73A],618986[IMMUNODEFICIENCY 73B WITH DEFECTIVE NEUTROPHIL CHEMOTAXIS AND LYMPHOPENIA; IMD73B],618987[IMMUNODEFICIENCY 73C WITH DEFECTIVE NEUTROPHIL CHEMOTAXIS AND HYPOGAMMAGLOBULINEMIA; IMD73C]
FBgn0010333	Rac1	HGNC:9801	OMIM:602048	RAC1	12	617751	617751[INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL DOMINANT 48; MRD48]
FBgn0010333	Rac1	HGNC:9803	OMIM:602050	RAC3	9	618577	618577[NEURODEVELOPMENTAL DISORDER WITH STRUCTURAL BRAIN ANOMALIES AND DYSMORPHIC FACIES; NEDBAF]
FBgn0010333	Rac1	HGNC:672	OMIM:179505	RHOG	4		
FBgn0010333	Rac1	HGNC:17736	OMIM:605857	RHOQ	3		
FBgn0010333	Rac1	HGNC:17794	OMIM:606366	RHOU	3		
FBgn0010333	Rac1	HGNC:1736	OMIM:116952	CDC42	3	616737	616737[TAKENOUCHI-KOSAKI SYNDROME; TKS]
FBgn0035194	Psf1	HGNC:28980	OMIM:610608	GINS1	15	617827	617827[IMMUNODEFICIENCY 55; IMD55]
FBgn0052318	CG32318	HGNC:28980	OMIM:610608	GINS1	5	617827	617827[IMMUNODEFICIENCY 55; IMD55]
FBgn0052318	CG32318	HGNC:6388	OMIM:148760	KIF11	3	152950	152950[MICROCEPHALY WITH OR WITHOUT CHORIORETINOPATHY, LYMPHEDEMA, OR MENTAL RETARDATION; MCLMR]
FBgn0004378	Klp61F	HGNC:6388	OMIM:148760	KIF11	14	152950	152950[MICROCEPHALY WITH OR WITHOUT CHORIORETINOPATHY, LYMPHEDEMA, OR MENTAL RETARDATION; MCLMR]
FBgn0035229	pns	HGNC:19344	OMIM:617278	DENND5A	13	617281	617281[DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 49; DEE49]
FBgn0035229	pns	HGNC:28338	OMIM:617279	DENND5B	13		
FBgn0041342	Pcyt1	HGNC:8755	OMIM:300948	PCYT1B	12		
FBgn0041342	Pcyt1	HGNC:8754	OMIM:123695	PCYT1A	14	608940	608940[SPONDYLOMETAPHYSEAL DYSPLASIA WITH CONE-ROD DYSTROPHY; SMDCRD]
FBgn0035231	Pcyt2	HGNC:8755	OMIM:300948	PCYT1B	13		
FBgn0035231	Pcyt2	HGNC:8754	OMIM:123695	PCYT1A	14	608940	608940[SPONDYLOMETAPHYSEAL DYSPLASIA WITH CONE-ROD DYSTROPHY; SMDCRD]
FBgn0035233	Pex10	HGNC:8851	OMIM:602859	PEX10	14	614870,614871	614870[PEROXISOME BIOGENESIS DISORDER 6A (ZELLWEGER); PBD6A],614871[PEROXISOME BIOGENESIS DISORDER 6B; PBD6B]
FBgn0035236	Tmep	HGNC:28797		TMEM184A	9		
FBgn0035236	Tmep	HGNC:25587	OMIM:613937	TMEM184C	5		
FBgn0035236	Tmep	HGNC:1310		TMEM184B	13		
FBgn0035237	CG13917	HGNC:21019	OMIM:617945	BTBD8	4		
FBgn0035237	CG13917	HGNC:0		KIAA1107	3		
FBgn0035244	ABCB7	HGNC:48	OMIM:300135	ABCB7	14	301310	301310[ANEMIA, SIDEROBLASTIC, AND SPINOCEREBELLAR ATAXIA; ASAT]
FBgn0035244	ABCB7	HGNC:47	OMIM:605452	ABCB6	3	111600,609153,614497,615402	111600[BLOOD GROUP, LANGEREIS SYSTEM; LAN],609153[PSEUDOHYPERKALEMIA, FAMILIAL, 2, DUE TO RED CELL LEAK; PSHK2],614497[MICROPHTHALMIA, ISOLATED, WITH COLOBOMA 7; MCOPCB7],615402[DYSCHROMATOSIS UNIVERSALIS HEREDITARIA 3; DUH3]
FBgn0053230	CG33230	HGNC:1258		SETD4	14		
FBgn0013753	Bgb	HGNC:1539	OMIM:121360	CBFB	13	601626	601626[LEUKEMIA, ACUTE MYELOID; AML]
FBgn0035248	CG13919	HGNC:21754		TMEM60	12		
FBgn0013755	Bro	HGNC:1539	OMIM:121360	CBFB	12	601626	601626[LEUKEMIA, ACUTE MYELOID; AML]
FBgn0025712	CG13920	HGNC:25864		TMEM35A	14		
FBgn0035252	CG7970	HGNC:7224	OMIM:137960	MPV17	4	256810,618400	256810[MITOCHONDRIAL DNA DEPLETION SYNDROME 6 (HEPATOCEREBRAL TYPE); MTDPS6],618400[CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2EE; CMT2EE]
FBgn0035252	CG7970	HGNC:28177	OMIM:616133	MPV17L2	4		
FBgn0035252	CG7970	HGNC:9716	OMIM:617399	PXMP2	7		
FBgn0035254	CG7974	HGNC:24932	OMIM:619569	C9orf78	14		
FBgn0035266	Gk2	HGNC:28635		GK5	3		
FBgn0035266	Gk2	HGNC:4291	OMIM:600148	GK2	9		
FBgn0035266	Gk2	HGNC:4289	OMIM:300474	GK	11	307030	307030[GLYCEROL KINASE DEFICIENCY; GKD]
FBgn0035268	CG8001	HGNC:29175	OMIM:619763	WDTC1	3		
FBgn0035268	CG8001	HGNC:24891	OMIM:615820	DCAF8	12	610100	610100[GIANT AXONAL NEUROPATHY 2, AUTOSOMAL DOMINANT; GAN2]
FBgn0035268	CG8001	HGNC:31810		DCAF8L1	11		
FBgn0035268	CG8001	HGNC:31811		DCAF8L2	8		
FBgn0027903	PolD2	HGNC:9176	OMIM:600815	POLD2	15		
FBgn0035272	mRpL46	HGNC:1192	OMIM:611851	MRPL46	14		
FBgn0011573	Cdc37	HGNC:1735	OMIM:605065	CDC37	13		
FBgn0011573	Cdc37	HGNC:17179	OMIM:610346	CDC37L1	7		
FBgn0035273	CG12020	HGNC:14887	OMIM:611328	DNAJB5	3		
FBgn0035273	CG12020	HGNC:5270	OMIM:604572	DNAJB1	3		
FBgn0035273	CG12020	HGNC:30718	OMIM:610263	DNAJB13	6	617091	617091[CILIARY DYSKINESIA, PRIMARY, 34; CILD34]
FBgn0035273	CG12020	HGNC:14886	OMIM:611327	DNAJB4	3		
FBgn0067864	Patj	HGNC:28881	OMIM:603199	PATJ	9		
FBgn0067864	Patj	HGNC:7208	OMIM:603785	MPDZ	8	615219	615219[HYDROCEPHALUS, CONGENITAL, 2, WITH OR WITHOUT BRAIN OR EYE ANOMALIES; HYC2]
FBgn0025820	JTBR	HGNC:6201	OMIM:604671	JTB	13		
FBgn0024510	dlt	HGNC:1713	OMIM:607465	CDAN1	12	224120	224120[ANEMIA, CONGENITAL DYSERYTHROPOIETIC, TYPE Ia; CDAN1A]
FBgn0035271	CG2021	HGNC:20471	OMIM:607288	LSM8	14		
FBgn0013811	Dhc62B	HGNC:2949	OMIM:603334	DNAH3	3		
FBgn0013811	Dhc62B	HGNC:18661	OMIM:610061	DNAH7	3		
FBgn0013811	Dhc62B	HGNC:2943	OMIM:603340	DNAH12	6		
FBgn0022702	Cht2	HGNC:8524	OMIM:603578	OVGP1	3		
FBgn0022702	Cht2	HGNC:2496	OMIM:600873	CTBS	3		
FBgn0022702	Cht2	HGNC:17432	OMIM:606080	CHIA	4		
FBgn0035265	PIG-Wb	HGNC:23213	OMIM:610275	PIGW	13	616025	616025[GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 11; GPIBD11]
FBgn0035264	Oseg4	HGNC:29250	OMIM:613602	WDR35	14	613610,614091	613610[CRANIOECTODERMAL DYSPLASIA 2; CED2],614091[SHORT-RIB THORACIC DYSPLASIA 7 WITH OR WITHOUT POLYDACTYLY; SRTD7]
FBgn0027594	drpr	HGNC:3232	OMIM:604266	MEGF6	3		
FBgn0027594	drpr	HGNC:33631	OMIM:610278	PEAR1	8		
FBgn0027594	drpr	HGNC:29634	OMIM:612453	MEGF10	12	614399	614399[MYOPATHY, AREFLEXIA, RESPIRATORY DISTRESS, AND DYSPHAGIA, EARLY-ONSET; EMARDD]
FBgn0027594	drpr	HGNC:29635	OMIM:612454	MEGF11	11		
FBgn0035262	CG18171	HGNC:11693	OMIM:186975	TCTE1	3		
FBgn0035256	CG13930	HGNC:26252	OMIM:619156	WDR78	9		
FBgn0035255	RabX5	HGNC:9775	OMIM:605662	RAB36	12		
FBgn0035255	RabX5	HGNC:16519	OMIM:610917	RAB34	12		
FBgn0026372	RpL23A	HGNC:10317	OMIM:602326	RPL23A	10		
FBgn0035251	Vta1	HGNC:20954	OMIM:610902	VTA1	14		
FBgn0035249	CG17249	HGNC:9343	OMIM:179755	PRCC	10	605074	605074[RENAL CELL CARCINOMA, PAPILLARY, 1; RCCP1]
FBgn0025725	alphaCOP	HGNC:2230	OMIM:601924	COPA	14	616414	616414[AUTOIMMUNE INTERSTITIAL LUNG, JOINT, AND KIDNEY DISEASE; AILJK]
FBgn0035247	Mettl2	HGNC:25856	OMIM:609525	METTL8	9		
FBgn0035247	Mettl2	HGNC:28343	OMIM:618903	METTL6	3		
FBgn0035247	Mettl2	HGNC:25755	OMIM:618902	METTL2A	13		
FBgn0035247	Mettl2	HGNC:18272	OMIM:607846	METTL2B	13		
FBgn0013342	nSyb	HGNC:12647	OMIM:603177	VAMP8	4		
FBgn0013342	nSyb	HGNC:12642	OMIM:185880	VAMP1	8	108600,618323	108600[SPASTIC ATAXIA 1, AUTOSOMAL DOMINANT; SPAX1],618323[MYASTHENIC SYNDROME, CONGENITAL, 25, PRESYNAPTIC; CMS25]
FBgn0013342	nSyb	HGNC:12644	OMIM:603657	VAMP3	6		
FBgn0013342	nSyb	HGNC:12643	OMIM:185881	VAMP2	11	618760	618760[NEURODEVELOPMENTAL DISORDER WITH HYPOTONIA AND AUTISTIC FEATURES WITH OR WITHOUT HYPERKINETIC MOVEMENTS; NEDHAHM]
FBgn0013342	nSyb	HGNC:12645	OMIM:606909	VAMP4	3		
FBgn0035245	GC	HGNC:4247	OMIM:137167	GGCX	14	277450,610842	277450[VITAMIN K-DEPENDENT CLOTTING FACTORS, COMBINED DEFICIENCY OF, 1; VKCFD1],610842[PSEUDOXANTHOMA ELASTICUM-LIKE DISORDER WITH MULTIPLE COAGULATION FACTOR DEFICIENCY]
FBgn0035243	CG13926	HGNC:26938	OMIM:614908	HIKESHI	14	616881	616881[LEUKODYSTROPHY, HYPOMYELINATING, 13; HLD13]
FBgn0035238	CG12104	HGNC:20161	OMIM:614032	TOX4	4		
FBgn0035238	CG12104	HGNC:18988	OMIM:606863	TOX	5		
FBgn0035238	CG12104	HGNC:11972	OMIM:611416	TOX3	4		
FBgn0035238	CG12104	HGNC:16095	OMIM:611163	TOX2	4		
FBgn0035235	CG7879	HGNC:9898	OMIM:607179	RBM12	7	617629	617629[SCHIZOPHRENIA 19; SCZD19]
FBgn0035235	CG7879	HGNC:32310		RBM12B	7		
FBgn0035232	CG12099	HGNC:10055	OMIM:615998	RNF10	15		
FBgn0052313	CG32313	HGNC:8946	OMIM:607076	PI15	3		
FBgn0052313	CG32313	HGNC:16249		R3HDML	3		
FBgn0052313	CG32313	HGNC:18007	OMIM:607141	GLIPR2	3		
FBgn0052313	CG32313	HGNC:28592	OMIM:610394	GLIPR1L2	3		
FBgn0052313	CG32313	HGNC:17001	OMIM:602692	GLIPR1	3		
FBgn0052313	CG32313	HGNC:28392	OMIM:610395	GLIPR1L1	3		
FBgn0052313	CG32313	HGNC:18206		CRISPLD1	3		
FBgn0052313	CG32313	HGNC:25248	OMIM:612434	CRISPLD2	3		
FBgn0052313	CG32313	HGNC:304	OMIM:601193	CRISP1	3		
FBgn0052313	CG32313	HGNC:12024	OMIM:187430	CRISP2	3		
FBgn0052313	CG32313	HGNC:33849	OMIM:616572	CLEC18B	3		
FBgn0052313	CG32313	HGNC:30388	OMIM:616571	CLEC18A	3		
FBgn0035228	CG12091	HGNC:30695	OMIM:609668	PPTC7	14		
FBgn0035283	CG12024	HGNC:31350		CUEDC1	13		
FBgn0035285	CG12025	HGNC:26142		TMEM134	10		
FBgn0035285	CG12025	HGNC:15876	OMIM:617019	TMEM230	3		
FBgn0035294	Mfap1	HGNC:7032	OMIM:600215	MFAP1	14		
FBgn0035295	Cnb	HGNC:29616	OMIM:611425	CNTROB	5		
FBgn0035298	SCOT	HGNC:18606	OMIM:610289	OXCT2	13		
FBgn0035298	SCOT	HGNC:8527	OMIM:601424	OXCT1	15	245050	245050[SUCCINYL-CoA:3-OXOACID-CoA TRANSFERASE DEFICIENCY; SCOTD]
FBgn0035300	CG1139	HGNC:19659	OMIM:608332	SLC36A3	7		
FBgn0035300	CG1139	HGNC:18762	OMIM:608331	SLC36A2	7	138500,242600	138500[HYPERGLYCINURIA],242600[IMINOGLYCINURIA]
FBgn0035300	CG1139	HGNC:19660	OMIM:613760	SLC36A4	7		
FBgn0035300	CG1139	HGNC:18761	OMIM:606561	SLC36A1	7		
FBgn0035300	CG1139	HGNC:32434	OMIM:615585	SLC38A8	3	609218	609218[FOVEAL HYPOPLASIA 2; FVH2]
FBgn0002872	mu2	HGNC:21163	OMIM:607593	MDC1	4		
FBgn0035293	CG5687	HGNC:11041	OMIM:604024	SLC5A6	5	618973,619903	618973[SODIUM-DEPENDENT MULTIVITAMIN TRANSPORTER DEFICIENCY; SMVTD],619903[PERIPHERAL MOTOR NEUROPATHY, CHILDHOOD-ONSET, BIOTIN-RESPONSIVE; COMNB]
FBgn0035293	CG5687	HGNC:11040	OMIM:601843	SLC5A5	5	274400	274400[THYROID DYSHORMONOGENESIS 1; TDH1]
FBgn0035293	CG5687	HGNC:28750	OMIM:612455	SLC5A12	5		
FBgn0035293	CG5687	HGNC:19119	OMIM:608044	SLC5A8	5		
FBgn0035290	dsb	HGNC:1663	OMIM:173510	CD36	5	608404,610938,611162	608404[PLATELET GLYCOPROTEIN IV DEFICIENCY],610938[CORONARY HEART DISEASE, SUSCEPTIBILITY TO, 7; CHDS7],611162[MALARIA, SUSCEPTIBILITY TO]
FBgn0035290	dsb	HGNC:1664	OMIM:601040	SCARB1	6	610762	610762[HIGH DENSITY LIPOPROTEIN CHOLESTEROL LEVEL QUANTITATIVE TRAIT LOCUS 6; HDLCQ6]
FBgn0035290	dsb	HGNC:1665	OMIM:602257	SCARB2	7	254900	254900[EPILEPSY, PROGRESSIVE MYOCLONIC, 4, WITH OR WITHOUT RENAL FAILURE; EPM4]
FBgn0035287	CG13937	HGNC:21755	OMIM:610124	CHST13	3		
FBgn0035287	CG13937	HGNC:19650	OMIM:606376	CHST10	4		
FBgn0035287	CG13937	HGNC:17423	OMIM:610129	CHST12	3		
FBgn0035287	CG13937	HGNC:19898	OMIM:610191	CHST9	4		
FBgn0035287	CG13937	HGNC:15993	OMIM:610190	CHST8	6	616265	616265[PEELING SKIN SYNDROME 3; PSS3]
FBgn0035287	CG13937	HGNC:17422	OMIM:610128	CHST11	3	618167	618167[OSTEOCHONDRODYSPLASIA, BRACHYDACTYLY, AND OVERLAPPING MALFORMED DIGITS; OCBMD]
FBgn0042712	HBS1	HGNC:4834	OMIM:612450	HBS1L	14		
FBgn0004636	Rap1	HGNC:9855	OMIM:179520	RAP1A	14		
FBgn0004636	Rap1	HGNC:9857	OMIM:179530	RAP1B	12		
FBgn0004636	Rap1	HGNC:0		RAP1BL	4		
FBgn0035317	Oseg2	HGNC:30391	OMIM:607386	IFT172	14	615630,616394,619471	615630[SHORT-RIB THORACIC DYSPLASIA 10 WITH OR WITHOUT POLYDACTYLY; SRTD10],616394[RETINITIS PIGMENTOSA 71; RP71],619471[BARDET-BIEDL SYNDROME 20; BBS20]
FBgn0040507	ACXD	HGNC:235	OMIM:600292	ADCY4	6		
FBgn0040507	ACXD	HGNC:238	OMIM:600385	ADCY7	6		
FBgn0040507	ACXD	HGNC:233	OMIM:103071	ADCY2	6		
FBgn0052301	CG32301	HGNC:235	OMIM:600292	ADCY4	6		
FBgn0052301	CG32301	HGNC:238	OMIM:600385	ADCY7	7		
FBgn0052301	CG32301	HGNC:233	OMIM:103071	ADCY2	6		
FBgn0052305	CG32305	HGNC:235	OMIM:600292	ADCY4	6		
FBgn0052305	CG32305	HGNC:238	OMIM:600385	ADCY7	6		
FBgn0052305	CG32305	HGNC:233	OMIM:103071	ADCY2	7		
FBgn0015359	CG2034	HGNC:30617	OMIM:615019	ELP5	3		
FBgn0035323	CG13807	HGNC:31022	OMIM:614547	RAMAC	3		
FBgn0035332	CG13801	HGNC:8101	OMIM:611409	OCA2	7	203200,227220	203200[ALBINISM, OCULOCUTANEOUS, TYPE II; OCA2],227220[SKIN/HAIR/EYE PIGMENTATION, VARIATION IN, 1; SHEP1]
FBgn0035334	CG8993	HGNC:12435	OMIM:187700	TXN	3		
FBgn0035334	CG8993	HGNC:17772	OMIM:609063	TXN2	13	616811	616811[COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 29; COXPD29]
FBgn0035336	CG9004	HGNC:13244	OMIM:611269	NOM1	14		
FBgn0035337	CG15877	HGNC:22421		C7orf50	9		
FBgn0035335	mRpL23	HGNC:10322	OMIM:600789	MRPL23	14		
FBgn0035335	mRpL23	HGNC:0		LOC107987373	5		
FBgn0035333	CG1317	HGNC:30550	OMIM:613297	MARCHF6	15	613608	613608[EPILEPSY, FAMILIAL ADULT MYOCLONIC, 3; FAME3]
FBgn0000543	ecd	HGNC:17029	OMIM:616464	ECD	14		
FBgn0015360	oxt	HGNC:15517	OMIM:608125	XYLT2	14	264800,605822	264800[PSEUDOXANTHOMA ELASTICUM; PXE],605822[SPONDYLOOCULAR SYNDROME; SOS]
FBgn0015360	oxt	HGNC:15516	OMIM:608124	XYLT1	14	264800,615777	264800[PSEUDOXANTHOMA ELASTICUM; PXE],615777[DESBUQUOIS DYSPLASIA 2; DBQD2]
FBgn0035321	CG1275	HGNC:20797	OMIM:605745	CYBRD1	12		
FBgn0035321	CG1275	HGNC:2571	OMIM:600019	CYB561	11	618182	618182[ORTHOSTATIC HYPOTENSION 2; ORTHYP2]
FBgn0035321	CG1275	HGNC:23014	OMIM:618757	CYB561A3	7		
FBgn0035318	CG9018	HGNC:29039	OMIM:614695	RPRD2	3		
FBgn0035318	CG9018	HGNC:16209	OMIM:614694	RPRD1B	14		
FBgn0035318	CG9018	HGNC:25560	OMIM:610347	RPRD1A	12		
FBgn0026593	CG5707	HGNC:29446	OMIM:619045	SERHL2	9		
FBgn0026593	CG5707	HGNC:14408	OMIM:607979	SERHL	4		
FBgn0035312	CG15820	HGNC:29446	OMIM:619045	SERHL2	10		
FBgn0035312	CG15820	HGNC:14408	OMIM:607979	SERHL	5		
FBgn0026570	CG5704	HGNC:29446	OMIM:619045	SERHL2	10		
FBgn0026570	CG5704	HGNC:14408	OMIM:607979	SERHL	5		
FBgn0035309	CG15879	HGNC:29446	OMIM:619045	SERHL2	11		
FBgn0035309	CG15879	HGNC:14408	OMIM:607979	SERHL	6		
FBgn0035308	CG15822	HGNC:18379		SESTD1	11		
FBgn0016794	dos	HGNC:4066	OMIM:604439	GAB1	8	605428	605428[DEAFNESS, AUTOSOMAL RECESSIVE 26; DFNB26]
FBgn0016794	dos	HGNC:14458	OMIM:606203	GAB2	8		
FBgn0016794	dos	HGNC:18325		GAB4	8		
FBgn0016794	dos	HGNC:17515	OMIM:300482	GAB3	6		
FBgn0062517	CG16984	HGNC:28388	OMIM:611025	ENKUR	13		
FBgn0035355	CG16985	HGNC:20999	OMIM:615652	ACOT13	14		
FBgn0035356	CG16986	HGNC:20999	OMIM:615652	ACOT13	15		
FBgn0053233	CG33233	HGNC:8494	OMIM:604047	SLC22A13	4		
FBgn0053233	CG33233	HGNC:10970	OMIM:607582	SLC22A6	3		
FBgn0053233	CG33233	HGNC:20302	OMIM:608276	SLC22A16	3		
FBgn0053233	CG33233	HGNC:10968	OMIM:604190	SLC22A4	3	180300	180300[RHEUMATOID ARTHRITIS; RA]
FBgn0053233	CG33233	HGNC:10969	OMIM:603377	SLC22A5	3	212140	212140[CARNITINE DEFICIENCY, SYSTEMIC PRIMARY; CDSP]
FBgn0053233	CG33233	HGNC:8495	OMIM:604048	SLC22A14	4		
FBgn0053233	CG33233	HGNC:10971	OMIM:604995	SLC22A7	4		
FBgn0053233	CG33233	HGNC:10972	OMIM:607581	SLC22A8	4		
FBgn0053233	CG33233	HGNC:10966	OMIM:602608	SLC22A2	3		
FBgn0053233	CG33233	HGNC:32935	OMIM:610792	SLC22A25	3		
FBgn0053233	CG33233	HGNC:10963	OMIM:602607	SLC22A1	3		
FBgn0053233	CG33233	HGNC:10967	OMIM:604842	SLC22A3	3		
FBgn0053233	CG33233	HGNC:16874	OMIM:185861	SV2B	3		
FBgn0053233	CG33233	HGNC:20566	OMIM:185860	SV2A	3		
FBgn0053233	CG33233	HGNC:30670	OMIM:610291	SV2C	3		
FBgn0053233	CG33233	HGNC:17989	OMIM:607096	SLC22A12	3	220150	220150[HYPOURICEMIA, RENAL, 1; RHUC1]
FBgn0053233	CG33233	HGNC:18120	OMIM:607097	SLC22A11	3		
FBgn0053233	CG33233	HGNC:16261	OMIM:607579	SLC22A9	3		
FBgn0053233	CG33233	HGNC:28542	OMIM:611698	SLC22A24	3		
FBgn0053233	CG33233	HGNC:18057	OMIM:607580	SLC22A10	3		
FBgn0053234	CG33234	HGNC:8494	OMIM:604047	SLC22A13	4		
FBgn0053234	CG33234	HGNC:10970	OMIM:607582	SLC22A6	3		
FBgn0053234	CG33234	HGNC:20302	OMIM:608276	SLC22A16	3		
FBgn0053234	CG33234	HGNC:10968	OMIM:604190	SLC22A4	3	180300	180300[RHEUMATOID ARTHRITIS; RA]
FBgn0053234	CG33234	HGNC:10969	OMIM:603377	SLC22A5	3	212140	212140[CARNITINE DEFICIENCY, SYSTEMIC PRIMARY; CDSP]
FBgn0053234	CG33234	HGNC:8495	OMIM:604048	SLC22A14	4		
FBgn0053234	CG33234	HGNC:10971	OMIM:604995	SLC22A7	4		
FBgn0053234	CG33234	HGNC:10972	OMIM:607581	SLC22A8	4		
FBgn0053234	CG33234	HGNC:10966	OMIM:602608	SLC22A2	3		
FBgn0053234	CG33234	HGNC:32935	OMIM:610792	SLC22A25	3		
FBgn0053234	CG33234	HGNC:10963	OMIM:602607	SLC22A1	3		
FBgn0053234	CG33234	HGNC:10967	OMIM:604842	SLC22A3	3		
FBgn0053234	CG33234	HGNC:16874	OMIM:185861	SV2B	3		
FBgn0053234	CG33234	HGNC:20566	OMIM:185860	SV2A	3		
FBgn0053234	CG33234	HGNC:30670	OMIM:610291	SV2C	3		
FBgn0053234	CG33234	HGNC:17989	OMIM:607096	SLC22A12	3	220150	220150[HYPOURICEMIA, RENAL, 1; RHUC1]
FBgn0053234	CG33234	HGNC:18120	OMIM:607097	SLC22A11	3		
FBgn0053234	CG33234	HGNC:16261	OMIM:607579	SLC22A9	3		
FBgn0053234	CG33234	HGNC:28542	OMIM:611698	SLC22A24	3		
FBgn0053234	CG33234	HGNC:18057	OMIM:607580	SLC22A10	3		
FBgn0052296	Mrtf	HGNC:29819	OMIM:609463	MRTFB	9		
FBgn0052296	Mrtf	HGNC:14334	OMIM:606078	MRTFA	10	618847	618847[IMMUNODEFICIENCY 66; IMD66]
FBgn0052296	Mrtf	HGNC:16067	OMIM:606127	MYOCD	7	618719	618719[MEGABLADDER, CONGENITAL; MGBL]
FBgn0027082	ProRS-m	HGNC:30563	OMIM:612036	PARS2	14	618437	618437[DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 75; DEE75]
FBgn0011828	Pxn	HGNC:14966	OMIM:605158	PXDN	13	269400	269400[ANTERIOR SEGMENT DYSGENESIS 7; ASGD7]
FBgn0011828	Pxn	HGNC:12015	OMIM:606765	TPO	5	274500	274500[THYROID DYSHORMONOGENESIS 2A; TDH2A]
FBgn0011828	Pxn	HGNC:26359	OMIM:615904	PXDNL	11		
FBgn0011828	Pxn	HGNC:6678	OMIM:150205	LPO	4		
FBgn0011828	Pxn	HGNC:7218	OMIM:606989	MPO	5	104300,254600	104300[ALZHEIMER DISEASE, FAMILIAL, 1; AD1],254600[MYELOPEROXIDASE DEFICIENCY; MPOD]
FBgn0011828	Pxn	HGNC:3423	OMIM:131399	EPX	5	261500	261500[EOSINOPHIL PEROXIDASE DEFICIENCY; EPXD]
FBgn0010909	msn	HGNC:30765	OMIM:610005	TNIK	13	617028	617028[INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 54; MRT54]
FBgn0010909	msn	HGNC:17565	OMIM:609426	MINK1	12		
FBgn0010909	msn	HGNC:6866	OMIM:604666	MAP4K4	11		
FBgn0010909	msn	HGNC:25391	OMIM:300791	NRK	4		
FBgn0010905	Spn	HGNC:14946	OMIM:602468	PPP1R9A	11		
FBgn0010905	Spn	HGNC:9298	OMIM:603325	PPP1R9B	9		
FBgn0010905	Spn	HGNC:27312	OMIM:619233	SAMD14	3		
FBgn0035348	CG16758	HGNC:7892	OMIM:164050	PNP	14	613179	613179[PURINE NUCLEOSIDE PHOSPHORYLASE DEFICIENCY]
FBgn0035344	Cyp4d20	HGNC:23198	OMIM:608614	CYP4V2	6	210370	210370[BIETTI CRYSTALLINE CORNEORETINAL DYSTROPHY; BCD]
FBgn0035344	Cyp4d20	HGNC:13265	OMIM:611517	CYP4F11	4		
FBgn0035344	Cyp4d20	HGNC:26820	OMIM:611495	CYP4F22	4	604777	604777[ICHTHYOSIS, CONGENITAL, AUTOSOMAL RECESSIVE 5; ARCI5]
FBgn0035344	Cyp4d20	HGNC:2645	OMIM:604426	CYP4F2	5		
FBgn0035344	Cyp4d20	HGNC:2646	OMIM:601270	CYP4F3	4		
FBgn0035344	Cyp4d20	HGNC:20244	OMIM:614999	CYP4X1	4		
FBgn0035344	Cyp4d20	HGNC:2642	OMIM:601310	CYP4A11	3		
FBgn0035344	Cyp4d20	HGNC:18857	OMIM:611485	CYP4F12	4		
FBgn0035344	Cyp4d20	HGNC:20575	OMIM:615341	CYP4A22	4		
FBgn0035344	Cyp4d20	HGNC:2644	OMIM:124075	CYP4B1	4		
FBgn0035344	Cyp4d20	HGNC:2648	OMIM:611545	CYP4F8	5		
FBgn0035344	Cyp4d20	HGNC:20583	OMIM:618953	CYP4Z1	4		
FBgn0035344	Cyp4d20	HGNC:2594	OMIM:107910	CYP19A1	4	139300,613546	139300[AROMATASE EXCESS SYNDROME; AEXS],613546[AROMATASE DEFICIENCY]
FBgn0035370	Non2	HGNC:11106	OMIM:601735	SMARCD1	3	618779	618779[COFFIN-SIRIS SYNDROME 11; CSS11]
FBgn0035370	Non2	HGNC:11107	OMIM:601736	SMARCD2	4	617475	617475[SPECIFIC GRANULE DEFICIENCY 2; SGD2]
FBgn0035370	Non2	HGNC:11108	OMIM:601737	SMARCD3	4		
FBgn0044452	Atg2	HGNC:29028	OMIM:616225	ATG2A	13		
FBgn0044452	Atg2	HGNC:20187	OMIM:616226	ATG2B	14		
FBgn0035374	mRpS35	HGNC:16635	OMIM:611995	MRPS35	13		
FBgn0035375	Pgant6	HGNC:33844	OMIM:615138	GALNTL6	14		
FBgn0035375	Pgant6	HGNC:19873	OMIM:608043	GALNT10	14		
FBgn0035383	CPT2	HGNC:2330	OMIM:600650	CPT2	14	255110,600649,608836,614212	255110[CARNITINE PALMITOYLTRANSFERASE II DEFICIENCY, MYOPATHIC, STRESS-INDUCED],600649[CARNITINE PALMITOYLTRANSFERASE II DEFICIENCY, INFANTILE],608836[CARNITINE PALMITOYLTRANSFERASE II DEFICIENCY, LETHAL NEONATAL],614212[ENCEPHALOPATHY, ACUTE, INFECTION-INDUCED, SUSCEPTIBILITY TO, 4; IIAE4]
FBgn0035384	CG2113	HGNC:30655	OMIM:609747	ABRA	6		
FBgn0035384	CG2113	HGNC:21230		ABRACL	3		
FBgn0035388	CG2162	HGNC:23512		R3HCC1L	10		
FBgn0035388	CG2162	HGNC:27329		R3HCC1	6		
FBgn0040308	Prx4	HGNC:17169	OMIM:300927	PRDX4	14		
FBgn0040308	Prx4	HGNC:9352	OMIM:176763	PRDX1	4	277400	277400[METHYLMALONIC ACIDURIA AND HOMOCYSTINURIA, cblC TYPE; MAHCC]
FBgn0040308	Prx4	HGNC:9354	OMIM:604769	PRDX3	4	619862,619871	619862[SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 32; SCAR32],619871[CORNEAL DYSTROPHY, PUNCTIFORM AND POLYCHROMATIC PRE-DESCEMET; PPPCD]
FBgn0040308	Prx4	HGNC:9353	OMIM:600538	PRDX2	4		
FBgn0052485	CG32485	HGNC:28381	OMIM:301086	MOSPD2	3		
FBgn0052485	CG32485	HGNC:10024	OMIM:180090	RLBP1	3	136880,607475,607476	136880[FUNDUS ALBIPUNCTATUS],607475[BOTHNIA RETINAL DYSTROPHY],607476[NEWFOUNDLAND ROD-CONE DYSTROPHY; NFRCD]
FBgn0035392	CG1271	HGNC:28635		GK5	15		
FBgn0035392	CG1271	HGNC:4291	OMIM:600148	GK2	3		
FBgn0035392	CG1271	HGNC:4289	OMIM:300474	GK	3	307030	307030[GLYCEROL KINASE DEFICIENCY; GKD]
FBgn0035393	CG16753	HGNC:15811		SLX9	5		
FBgn0035397	PAN3	HGNC:29991	OMIM:617448	PAN3	12		
FBgn0035390	scramb2	HGNC:16495	OMIM:607611	PLSCR3	8		
FBgn0035390	scramb2	HGNC:19952		PLSCR5	9		
FBgn0035390	scramb2	HGNC:9092	OMIM:604170	PLSCR1	10		
FBgn0035390	scramb2	HGNC:16497	OMIM:607612	PLSCR4	7		
FBgn0035390	scramb2	HGNC:16494	OMIM:607610	PLSCR2	8		
FBgn0004372	aly	HGNC:30830	OMIM:609375	LIN9	7		
FBgn0052487	CG32487	HGNC:30259	OMIM:609246	PDXP	10		
FBgn0052487	CG32487	HGNC:8909	OMIM:172280	PGP	10		
FBgn0052488	CG32488	HGNC:30259	OMIM:609246	PDXP	10		
FBgn0052488	CG32488	HGNC:8909	OMIM:172280	PGP	11		
FBgn0035372	CG12093	HGNC:25102		TP53I13	7		
FBgn0035371	AhcyL1	HGNC:22204	OMIM:616520	AHCYL2	14		
FBgn0035371	AhcyL1	HGNC:344	OMIM:607826	AHCYL1	14		
FBgn0035401	Alg2	HGNC:23159	OMIM:607905	ALG2	14	607906,616228	607906[CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Ii; CDG1I],616228[MYASTHENIC SYNDROME, CONGENITAL, 14; CMS14]
FBgn0024194	rasp	HGNC:18270	OMIM:605743	HHAT	15	600092	600092[NIVELON-NIVELON-MABILLE SYNDROME; NNMS]
FBgn0024194	rasp	HGNC:13242	OMIM:608116	HHATL	7		
FBgn0052280	CG32280	HGNC:13234	OMIM:610503	CDIP1	10		
FBgn0052280	CG32280	HGNC:16841	OMIM:603795	LITAF	4	601098	601098[CHARCOT-MARIE-TOOTH DISEASE, DEMYELINATING, TYPE 1C; CMT1C]
FBgn0052280	CG32280	HGNC:53927		LITAFD	3		
FBgn0052281	CG32281	HGNC:23141	OMIM:611023	TRMT5	15	616539	616539[PERIPHERAL NEUROPATHY WITH VARIABLE SPASTICITY, EXERCISE INTOLERANCE, AND DEVELOPMENTAL DELAY; PNSED]
FBgn0001233	Hsp83	HGNC:5258	OMIM:140572	HSP90AB1	14		
FBgn0001233	Hsp83	HGNC:5253	OMIM:140571	HSP90AA1	14		
FBgn0001233	Hsp83	HGNC:12028	OMIM:191175	HSP90B1	4		
FBgn0001233	Hsp83	HGNC:5259		HSP90AB3P	3		
FBgn0035421	nSMase	HGNC:11121	OMIM:603498	SMPD2	15		
FBgn0035423	eIF1	HGNC:30792		EIF1B	12		
FBgn0035423	eIF1	HGNC:3249	OMIM:619901	EIF1	13		
FBgn0035424	Larp4B	HGNC:28987	OMIM:616513	LARP4B	7		
FBgn0035424	Larp4B	HGNC:24320	OMIM:618657	LARP4	8		
FBgn0035432	ZnT63C	HGNC:20303	OMIM:611145	SLC30A8	3	125853	125853[TYPE 2 DIABETES MELLITUS; T2D]
FBgn0035432	ZnT63C	HGNC:11015	OMIM:602095	SLC30A4	3		
FBgn0035432	ZnT63C	HGNC:11012	OMIM:609521	SLC30A1	11		
FBgn0035432	ZnT63C	HGNC:25355	OMIM:611146	SLC30A10	10	613280	613280[HYPERMANGANESEMIA WITH DYSTONIA 1; HMNDYT1]
FBgn0035436	CG12016	HGNC:17871	OMIM:608705	NMRK2	11		
FBgn0035436	CG12016	HGNC:26057	OMIM:608704	NMRK1	12		
FBgn0035438	Gtpx	HGNC:4556	OMIM:138322	GPX4	9	250220	250220[SPONDYLOMETAPHYSEAL DYSPLASIA, SEDAGHATIAN TYPE; SMDS]
FBgn0035438	Gtpx	HGNC:4559	OMIM:615784	GPX7	5		
FBgn0035438	Gtpx	HGNC:33100	OMIM:617172	GPX8	6		
FBgn0004167	kst	HGNC:11274	OMIM:182870	SPTB	3	616649,617948	616649[SPHEROCYTOSIS, TYPE 2; SPH2],617948[ELLIPTOCYTOSIS 3; EL3]
FBgn0004167	kst	HGNC:15680	OMIM:605916	SPTBN5	13		
FBgn0004167	kst	HGNC:14896	OMIM:606214	SPTBN4	3	617519	617519[NEURODEVELOPMENTAL DISORDER WITH HYPOTONIA, NEUROPATHY, AND DEAFNESS; NEDHND]
FBgn0004167	kst	HGNC:11276	OMIM:604985	SPTBN2	3	600224,615386	600224[SPINOCEREBELLAR ATAXIA 5; SCA5],615386[SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 14; SCAR14]
FBgn0004167	kst	HGNC:11275	OMIM:182790	SPTBN1	3	619475	619475[DEVELOPMENTAL DELAY, IMPAIRED SPEECH, AND BEHAVIORAL ABNORMALITIES; DDISBA]
FBgn0035443	CG12010	HGNC:18119	OMIM:613940	SPATA5	3	616577	616577[NEURODEVELOPMENTAL DISORDER WITH HEARING LOSS, SEIZURES, AND BRAIN ABNORMALITIES; NEDHSB]
FBgn0035443	CG12010	HGNC:28762	OMIM:619578	SPATA5L1	8	619615,619616	619615[DEAFNESS, AUTOSOMAL RECESSIVE 119; DFNB119],619616[NEURODEVELOPMENTAL DISORDER WITH HEARING LOSS AND SPASTICITY; NEDHLS]
FBgn0035444	CG12012	HGNC:1109	OMIM:615628	BRI3	12		
FBgn0035445	Ids	HGNC:5389	OMIM:300823	IDS	15	309900	309900[MUCOPOLYSACCHARIDOSIS, TYPE II; MPS2]
FBgn0027616	Ythdc1	HGNC:30626	OMIM:617283	YTHDC1	9		
FBgn0035440	CG14969	HGNC:21652	OMIM:607649	OSTM1	12	259720	259720[OSTEOPETROSIS, AUTOSOMAL RECESSIVE 5; OPTB5]
FBgn0035437	Strip	HGNC:22209	OMIM:617919	STRIP2	13		
FBgn0035437	Strip	HGNC:25916	OMIM:617918	STRIP1	14		
FBgn0035435	PIG-C	HGNC:8960	OMIM:601730	PIGC	14	617816	617816[GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 16; GPIBD16]
FBgn0035425	CG17746	HGNC:19388	OMIM:619309	PPM1F	3		
FBgn0035425	CG17746	HGNC:9278	OMIM:605119	PPM1G	3		
FBgn0035425	CG17746	HGNC:9275	OMIM:606108	PPM1A	5		
FBgn0035425	CG17746	HGNC:9276	OMIM:603770	PPM1B	4		
FBgn0035425	CG17746	HGNC:26845		PPM1N	4		
FBgn0035422	RpL28	HGNC:10330	OMIM:603638	RPL28	13		
FBgn0035420	hob	HGNC:28960	OMIM:610664	BLTP2	13		
FBgn0047135	CG32276	HGNC:20607		SERP2	13		
FBgn0047135	CG32276	HGNC:10759	OMIM:617674	SERP1	13		
FBgn0035415	CG14966	HGNC:28443		C15orf40	12		
FBgn0035407	Asciz	HGNC:29034	OMIM:614693	ATMIN	7		
FBgn0035402	Usp5	HGNC:12611	OMIM:603591	USP13	12		
FBgn0035402	Usp5	HGNC:12628	OMIM:601447	USP5	13		
FBgn0035400	CG11537	HGNC:23376		MFSD14B	13		
FBgn0035400	CG11537	HGNC:23363		MFSD14A	14		
FBgn0035400	CG11537	HGNC:23672		MFSD14C	4		
FBgn0026189	promL	HGNC:20685	OMIM:617160	PROM2	10		
FBgn0026189	promL	HGNC:9454	OMIM:604365	PROM1	13	603786,608051,612095,612657	603786[STARGARDT DISEASE 4; STGD4],608051[MACULAR DYSTROPHY, RETINAL, 2; MCDR2],612095[RETINITIS PIGMENTOSA 41; RP41],612657[CONE-ROD DYSTROPHY 12; CORD12]
FBgn0035398	Cht7	HGNC:8524	OMIM:603578	OVGP1	7		
FBgn0035398	Cht7	HGNC:1932	OMIM:601525	CHI3L1	8	181500,611960	181500[SCHIZOPHRENIA; SCZD],611960[ASTHMA-RELATED TRAITS, SUSCEPTIBILITY TO, 7; ASRT7]
FBgn0035398	Cht7	HGNC:1936	OMIM:600031	CHIT1	11	614122	614122[CHITOTRIOSIDASE DEFICIENCY; CHITD]
FBgn0035398	Cht7	HGNC:17432	OMIM:606080	CHIA	10		
FBgn0035398	Cht7	HGNC:1933	OMIM:601526	CHI3L2	6		
FBgn0005640	Eip63E	HGNC:8749	OMIM:311550	CDK16	4		
FBgn0005640	Eip63E	HGNC:1722	OMIM:116940	CDK1	3		
FBgn0005640	Eip63E	HGNC:8883	OMIM:610679	CDK14	14		
FBgn0005640	Eip63E	HGNC:8751	OMIM:169190	CDK18	4		
FBgn0005640	Eip63E	HGNC:1771	OMIM:116953	CDK2	4		
FBgn0005640	Eip63E	HGNC:8750	OMIM:603440	CDK17	5		
FBgn0005640	Eip63E	HGNC:14434	OMIM:616147	CDK15	11		
FBgn0035452	CG10359	HGNC:3624	OMIM:601624	FCN2	3		
FBgn0035452	CG10359	HGNC:3623	OMIM:601252	FCN1	3		
FBgn0035452	CG10359	HGNC:25922	OMIM:613357	FIBCD1	4		
FBgn0035452	CG10359	HGNC:3695	OMIM:605776	FGL1	3		
FBgn0035452	CG10359	HGNC:3625	OMIM:604973	FCN3	3	613860	613860[FICOLIN 3 DEFICIENCY]
FBgn0035452	CG10359	HGNC:7035	OMIM:600596	MFAP4	3		
FBgn0035453	CG10357	HGNC:18821	OMIM:609252	LIPI	3		
FBgn0035455	CG10862	HGNC:12474	OMIM:602961	UBE2D1	4		
FBgn0035455	CG10862	HGNC:12477	OMIM:602916	UBE2E1	3		
FBgn0035455	CG10862	HGNC:12475	OMIM:602962	UBE2D2	3		
FBgn0035455	CG10862	HGNC:12478	OMIM:602163	UBE2E2	3		
FBgn0035455	CG10862	HGNC:12479	OMIM:604151	UBE2E3	3		
FBgn0035455	CG10862	HGNC:21647		UBE2D4	3		
FBgn0035449	CG14971	HGNC:17117	OMIM:619530	SLC35C2	15		
FBgn0026259	eIF5B	HGNC:30793	OMIM:606086	EIF5B	13		
FBgn0014388	sty	HGNC:11271	OMIM:300531	SPRY3	9		
FBgn0014388	sty	HGNC:15533	OMIM:607984	SPRY4	9	615266	615266[HYPOGONADOTROPIC HYPOGONADISM 17 WITH OR WITHOUT ANOSMIA; HH17]
FBgn0014388	sty	HGNC:11270	OMIM:602466	SPRY2	11	616818	616818[IgA NEPHROPATHY, SUSCEPTIBILITY TO, 3; IGAN3]
FBgn0014388	sty	HGNC:11269	OMIM:602465	SPRY1	9		
FBgn0035462	IntS10	HGNC:25548	OMIM:611353	INTS10	13		
FBgn0035464	PIG-B	HGNC:8959	OMIM:604122	PIGB	14	618580	618580[DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 80; DEE80]
FBgn0004888	Scsalpha1	HGNC:11449	OMIM:611224	SUCLG1	15	245400	245400[MITOCHONDRIAL DNA DEPLETION SYNDROME 9 (ENCEPHALOMYOPATHIC TYPE WITH METHYLMALONIC ACIDURIA); MTDPS9]
FBgn0004875	enc	HGNC:16968	OMIM:605488	ARPP21	9		
FBgn0004875	enc	HGNC:29167	OMIM:619886	R3HDM2	8		
FBgn0004875	enc	HGNC:9757	OMIM:619474	R3HDM1	8		
FBgn0013751	Awh	HGNC:21735	OMIM:608215	LHX6	10		
FBgn0013751	Awh	HGNC:28838	OMIM:604425	LHX8	12		
FBgn0035469	Lamtor4	HGNC:33772	OMIM:618834	LAMTOR4	12		
FBgn0035471	Sc2	HGNC:4551	OMIM:610057	TECR	13	614020	614020[INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 14; MRT14]
FBgn0035471	Sc2	HGNC:27365	OMIM:617242	TECRL	8	614021	614021[VENTRICULAR TACHYCARDIA, CATECHOLAMINERGIC POLYMORPHIC, 3; CPVT3]
FBgn0041147	ida	HGNC:15713	OMIM:606948	ANAPC5	14		
FBgn0035473	mge	HGNC:18002	OMIM:607046	TOMM22	15		
FBgn0035470	Ccz1	HGNC:21691		CCZ1	14		
FBgn0035470	Ccz1	HGNC:21717		CCZ1B	12		
FBgn0052263	CG32263	HGNC:7224	OMIM:137960	MPV17	3	256810,618400	256810[MITOCHONDRIAL DNA DEPLETION SYNDROME 6 (HEPATOCEREBRAL TYPE); MTDPS6],618400[CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2EE; CMT2EE]
FBgn0052263	CG32263	HGNC:28177	OMIM:616133	MPV17L2	9		
FBgn0052262	CG32262	HGNC:7224	OMIM:137960	MPV17	4	256810,618400	256810[MITOCHONDRIAL DNA DEPLETION SYNDROME 6 (HEPATOCEREBRAL TYPE); MTDPS6],618400[CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2EE; CMT2EE]
FBgn0052262	CG32262	HGNC:28177	OMIM:616133	MPV17L2	10		
FBgn0052262	CG32262	HGNC:9716	OMIM:617399	PXMP2	3		
FBgn0052264	CG32264	HGNC:20956	OMIM:608724	PHACTR2	8		
FBgn0052264	CG32264	HGNC:25793	OMIM:608726	PHACTR4	7		
FBgn0052264	CG32264	HGNC:20990	OMIM:608723	PHACTR1	8	618298	618298[DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 70; DEE70]
FBgn0052264	CG32264	HGNC:15833	OMIM:608725	PHACTR3	7		
FBgn0035458	ppk27	HGNC:101	OMIM:611741	ASIC3	3		
FBgn0035458	ppk27	HGNC:100	OMIM:602866	ASIC1	4		
FBgn0035458	ppk27	HGNC:21263	OMIM:606715	ASIC4	3		
FBgn0035458	ppk27	HGNC:17537	OMIM:616693	ASIC5	4		
FBgn0042179	Ugt305A1	HGNC:12545	OMIM:603064	UGT2B11	4		
FBgn0042179	Ugt305A1	HGNC:12530	OMIM:191740	UGT1A1	4	143500,218800,237900,601816,606785	143500[GILBERT SYNDROME],218800[CRIGLER-NAJJAR SYNDROME, TYPE I],237900[HYPERBILIRUBINEMIA, TRANSIENT FAMILIAL NEONATAL; HBLRTFN],601816[BILIRUBIN, SERUM LEVEL OF, QUANTITATIVE TRAIT LOCUS 1; BILIQTL1],606785[CRIGLER-NAJJAR SYNDROME, TYPE II]
FBgn0042179	Ugt305A1	HGNC:12555	OMIM:601291	UGT8	4		
FBgn0042179	Ugt305A1	HGNC:13479	OMIM:606497	UGT2B28	4		
FBgn0042179	Ugt305A1	HGNC:27266	OMIM:616384	UGT3A2	4		
FBgn0042179	Ugt305A1	HGNC:12544	OMIM:600070	UGT2B10	4		
FBgn0042179	Ugt305A1	HGNC:12546	OMIM:600069	UGT2B15	4		
FBgn0042179	Ugt305A1	HGNC:28528	OMIM:616382	UGT2A3	4		
FBgn0042179	Ugt305A1	HGNC:12535	OMIM:606428	UGT1A3	4		
FBgn0042179	Ugt305A1	HGNC:26625	OMIM:616383	UGT3A1	4		
FBgn0042179	Ugt305A1	HGNC:12547	OMIM:601903	UGT2B17	4	612560	612560[BONE MINERAL DENSITY QUANTITATIVE TRAIT LOCUS 12; BMND12]
FBgn0042179	Ugt305A1	HGNC:12553	OMIM:600067	UGT2B4	4		
FBgn0042179	Ugt305A1	HGNC:12554	OMIM:600068	UGT2B7	4		
FBgn0042179	Ugt305A1	HGNC:28183	OMIM:619809	UGT2A2	3		
FBgn0000449	dib	HGNC:2602	OMIM:126065	CYP24A1	3	143880	143880[HYPERCALCEMIA, INFANTILE, 1; HCINF1]
FBgn0035498	Fit1	HGNC:15889	OMIM:607900	FERMT1	13	173650	173650[KINDLER SYNDROME; KNDLRS]
FBgn0035498	Fit1	HGNC:15767	OMIM:607746	FERMT2	14		
FBgn0035498	Fit1	HGNC:23151	OMIM:607901	FERMT3	10	612840	612840[LEUKOCYTE ADHESION DEFICIENCY, TYPE III; LAD3]
FBgn0028484	Ack	HGNC:19297	OMIM:606994	TNK2	12		
FBgn0028484	Ack	HGNC:11940	OMIM:608076	TNK1	8		
FBgn0003206	Ras64B	HGNC:10447	OMIM:165090	RRAS	9		
FBgn0003206	Ras64B	HGNC:6407	OMIM:190070	KRAS	4	108010,109800,114480,163200,211980,260350,600268,601626,609942,613659,614470,615278	108010[ARTERIOVENOUS MALFORMATIONS OF THE BRAIN],109800[BLADDER CANCER],114480[BREAST CANCER],163200[SCHIMMELPENNING-FEUERSTEIN-MIMS SYNDROME; SFM],211980[LUNG CANCER],260350[PANCREATIC CANCER],600268[OCULOECTODERMAL SYNDROME; OES],601626[LEUKEMIA, ACUTE MYELOID; AML],609942[NOONAN SYNDROME 3; NS3],613659[GASTRIC CANCER],614470[RAS-ASSOCIATED AUTOIMMUNE LEUKOPROLIFERATIVE DISORDER; RALD],615278[CARDIOFACIOCUTANEOUS SYNDROME 2; CFC2]
FBgn0003206	Ras64B	HGNC:7989	OMIM:164790	NRAS	3	114500,137550,162900,163200,188470,249400,613224,614470	114500[COLORECTAL CANCER; CRC],137550[MELANOCYTIC NEVUS SYNDROME, CONGENITAL; CMNS],162900[NEVUS, EPIDERMAL],163200[SCHIMMELPENNING-FEUERSTEIN-MIMS SYNDROME; SFM],188470[THYROID CANCER, NONMEDULLARY, 2; NMTC2],249400[MELANOSIS, NEUROCUTANEOUS; NCMS],613224[NOONAN SYNDROME 6; NS6],614470[RAS-ASSOCIATED AUTOIMMUNE LEUKOPROLIFERATIVE DISORDER; RALD]
FBgn0003206	Ras64B	HGNC:17271	OMIM:600098	RRAS2	13	618624	618624[NOONAN SYNDROME 12; NS12]
FBgn0003206	Ras64B	HGNC:5173	OMIM:190020	HRAS	4	109800,137550,162900,163200,188470,218040	109800[BLADDER CANCER],137550[MELANOCYTIC NEVUS SYNDROME, CONGENITAL; CMNS],162900[NEVUS, EPIDERMAL],163200[SCHIMMELPENNING-FEUERSTEIN-MIMS SYNDROME; SFM],188470[THYROID CANCER, NONMEDULLARY, 2; NMTC2],218040[COSTELLO SYNDROME; CSTLO]
FBgn0040696	CG18675	HGNC:1301	OMIM:615494	CFAP298	13	615500	615500[CILIARY DYSKINESIA, PRIMARY, 26; CILD26]
FBgn0040696	CG18675	HGNC:11657	OMIM:608365	TCP10L	3		
FBgn0035515	CG14997	HGNC:20390	OMIM:617658	SQOR	14	619221	619221[SULFIDE:QUINONE OXIDOREDUCTASE DEFICIENCY; SQORD]
FBgn0011692	pav	HGNC:6392	OMIM:605064	KIF23	14	105600	105600[ANEMIA, CONGENITAL DYSERYTHROPOIETIC, TYPE IIIa; CDAN3A]
FBgn0011692	pav	HGNC:7212	OMIM:605498	KIF20B	3		
FBgn0011692	pav	HGNC:9787	OMIM:605664	KIF20A	3	619433	619433[CARDIOMYOPATHY, FAMILIAL RESTRICTIVE, 6; RCM6]
FBgn0035517	CG1265	HGNC:28503		SLC66A3	14		
FBgn0035519	CG1309	HGNC:13921	OMIM:142620	ABHD16A	14	619735	619735[SPASTIC PARAPLEGIA 86, AUTOSOMAL RECESSIVE; SPG86]
FBgn0035519	CG1309	HGNC:16128		ABHD16B	10		
FBgn0035521	VhaM9.7-a	HGNC:863	OMIM:603931	ATP6V0E1	13		
FBgn0035521	VhaM9.7-a	HGNC:21723	OMIM:611019	ATP6V0E2	12		
FBgn0035523	Ctl1	HGNC:18798	OMIM:606105	SLC44A1	14	618868	618868[NEURODEGENERATION, CHILDHOOD-ONSET, WITH ATAXIA, TREMOR, OPTIC ATROPHY, AND COGNITIVE DECLINE; CONATOC]
FBgn0035523	Ctl1	HGNC:28689		SLC44A3	12		
FBgn0035526	CG1316	HGNC:24468	OMIM:608888	RBM45	13		
FBgn0015829	TfIIEbeta	HGNC:4651	OMIM:189964	GTF2E2	14	616943	616943[TRICHOTHIODYSTROPHY 6, NONPHOTOSENSITIVE; TTD6]
FBgn0041630	Hexo1	HGNC:4878	OMIM:606869	HEXA	8	272800	272800[TAY-SACHS DISEASE; TSD]
FBgn0041630	Hexo1	HGNC:4879	OMIM:606873	HEXB	9	268800	268800[SANDHOFF DISEASE]
FBgn0035529	Fdx2	HGNC:3638	OMIM:103260	FDX1	13		
FBgn0035529	Fdx2	HGNC:30546	OMIM:614585	FDX2	4	251900	251900[MITOCHONDRIAL MYOPATHY, EPISODIC, WITH OR WITHOUT OPTIC ATROPHY AND REVERSIBLE LEUKOENCEPHALOPATHY; MEOAL]
FBgn0035528	CG15012	HGNC:1280	OMIM:617894	TMEM50B	13		
FBgn0035528	CG15012	HGNC:30590	OMIM:605348	TMEM50A	14		
FBgn0035524	CG11583	HGNC:24170	OMIM:618466	BRIX1	14		
FBgn0035520	CG11586	HGNC:26433	OMIM:619930	ZMAT2	15		
FBgn0035518	CG15011	HGNC:18726		NFXL1	14		
FBgn0041171	ago	HGNC:16712	OMIM:606278	FBXW7	8	620012	620012[DEVELOPMENTAL DELAY, HYPOTONIA, AND IMPAIRED LANGUAGE; DEDHIL]
FBgn0028664	VhaM9.7-c	HGNC:863	OMIM:603931	ATP6V0E1	14		
FBgn0028664	VhaM9.7-c	HGNC:21723	OMIM:611019	ATP6V0E2	12		
FBgn0004574	Rop	HGNC:11446	OMIM:608339	STXBP3	6		
FBgn0004574	Rop	HGNC:11445	OMIM:601717	STXBP2	10	613101	613101[HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS, FAMILIAL, 5, WITH OR WITHOUT MICROVILLUS INCLUSION DISEASE; FHL5]
FBgn0004574	Rop	HGNC:11444	OMIM:602926	STXBP1	15	612164	612164[DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 4; DEE4]
FBgn0035499	Chd64	HGNC:2155	OMIM:600806	CNN1	6		
FBgn0035499	Chd64	HGNC:2156	OMIM:602373	CNN2	5		
FBgn0035499	Chd64	HGNC:2157	OMIM:602374	CNN3	5		
FBgn0035499	Chd64	HGNC:11553	OMIM:600818	TAGLN	6		
FBgn0035499	Chd64	HGNC:11554	OMIM:604634	TAGLN2	8		
FBgn0035499	Chd64	HGNC:29868	OMIM:607953	TAGLN3	9		
FBgn0004516	Gad1	HGNC:4092	OMIM:605363	GAD1	14	619124	619124[DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 89; DEE89]
FBgn0004516	Gad1	HGNC:4093	OMIM:138275	GAD2	13		
FBgn0004516	Gad1	HGNC:18966	OMIM:616569	CSAD	4		
FBgn0004516	Gad1	HGNC:27949	OMIM:615601	GADL1	4		
FBgn0016013	Faa	HGNC:3579	OMIM:613871	FAH	14	276700	276700[TYROSINEMIA, TYPE I; TYRSN1]
FBgn0024179	wit	HGNC:173	OMIM:102581	ACVR2A	3		
FBgn0024179	wit	HGNC:1078	OMIM:600799	BMPR2	9	178600,265450	178600[PULMONARY HYPERTENSION, PRIMARY, 1; PPH1],265450[PULMONARY VENOOCCLUSIVE DISEASE 1, AUTOSOMAL DOMINANT; PVOD1]
FBgn0035491	Dpy-30L2	HGNC:24590	OMIM:612032	DPY30	8		
FBgn0035488	CG11593	HGNC:1083	OMIM:603292	BNIP2	8		
FBgn0035488	CG11593	HGNC:779	OMIM:608179	ATCAY	9	601238	601238[CEREBELLAR ATAXIA, CAYMAN TYPE; ATCAY]
FBgn0035488	CG11593	HGNC:25209	OMIM:610691	PRUNE2	6		
FBgn0035488	CG11593	HGNC:16976	OMIM:611275	BNIPL	6		
FBgn0052251	Claspin	HGNC:19715	OMIM:605434	CLSPN	12		
FBgn0052250	PMP34	HGNC:10987	OMIM:606795	SLC25A17	13		
FBgn0035534	mRpS6	HGNC:14051	OMIM:611973	MRPS6	11		
FBgn0035539	slow	HGNC:13944	OMIM:609897	EGFL8	6		
FBgn0035539	slow	HGNC:20594	OMIM:608582	EGFL7	8		
FBgn0035540	Syx17	HGNC:11432	OMIM:604204	STX17	13		
FBgn0035542	TP53INP	HGNC:18022	OMIM:606185	TP53INP1	4		
FBgn0035542	TP53INP	HGNC:16104	OMIM:617549	TP53INP2	3		
FBgn0000038	nAChRbeta1	HGNC:1962	OMIM:118507	CHRNB2	5	605375	605375[EPILEPSY, NOCTURNAL FRONTAL LOBE, 3; ENFL3]
FBgn0000038	nAChRbeta1	HGNC:1959	OMIM:118505	CHRNA5	4	612052	612052[SMOKING AS A QUANTITATIVE TRAIT LOCUS 3; SQTL3]
FBgn0000038	nAChRbeta1	HGNC:1955	OMIM:100690	CHRNA1	5	253290,601462,608930	253290[MULTIPLE PTERYGIUM SYNDROME, LETHAL TYPE; LMPS],601462[MYASTHENIC SYNDROME, CONGENITAL, 1A, SLOW-CHANNEL; CMS1A],608930[MYASTHENIC SYNDROME, CONGENITAL, 1B, FAST-CHANNEL; CMS1B]
FBgn0000038	nAChRbeta1	HGNC:1957	OMIM:118503	CHRNA3	4	191800,612052	191800[BLADDER DYSFUNCTION, AUTONOMIC, WITH IMPAIRED PUPILLARY REFLEX AND SECONDARY CAKUT; BAIPRCK],612052[SMOKING AS A QUANTITATIVE TRAIT LOCUS 3; SQTL3]
FBgn0000038	nAChRbeta1	HGNC:1964	OMIM:118509	CHRNB4	5		
FBgn0000038	nAChRbeta1	HGNC:1958	OMIM:118504	CHRNA4	5	188890,600513	188890[TOBACCO ADDICTION, SUSCEPTIBILITY TO],600513[EPILEPSY, NOCTURNAL FRONTAL LOBE, 1; ENFL1]
FBgn0000038	nAChRbeta1	HGNC:15963	OMIM:606888	CHRNA6	4		
FBgn0000038	nAChRbeta1	HGNC:1956	OMIM:118502	CHRNA2	4	610353	610353[EPILEPSY, NOCTURNAL FRONTAL LOBE, 4; ENFL4]
FBgn0000038	nAChRbeta1	HGNC:1961	OMIM:100710	CHRNB1	5	616313,616314	616313[MYASTHENIC SYNDROME, CONGENITAL, 2A, SLOW-CHANNEL; CMS2A],616314[MYASTHENIC SYNDROME, CONGENITAL, 2C, ASSOCIATED WITH ACETYLCHOLINE RECEPTOR DEFICIENCY; CMS2C]
FBgn0000038	nAChRbeta1	HGNC:1963	OMIM:118508	CHRNB3	4		
FBgn0000038	nAChRbeta1	HGNC:1965	OMIM:100720	CHRND	3	253290,616321,616322,616323	253290[MULTIPLE PTERYGIUM SYNDROME, LETHAL TYPE; LMPS],616321[MYASTHENIC SYNDROME, CONGENITAL, 3A, SLOW-CHANNEL; CMS3A],616322[MYASTHENIC SYNDROME, CONGENITAL, 3B, FAST-CHANNEL; CMS3B],616323[MYASTHENIC SYNDROME, CONGENITAL, 3C, ASSOCIATED WITH ACETYLCHOLINE RECEPTOR DEFICIENCY; CMS3C]
FBgn0000038	nAChRbeta1	HGNC:1966	OMIM:100725	CHRNE	3	605809,608931,616324	605809[MYASTHENIC SYNDROME, CONGENITAL, 4A, SLOW-CHANNEL; CMS4A],608931[MYASTHENIC SYNDROME, CONGENITAL, 4C, ASSOCIATED WITH ACETYLCHOLINE RECEPTOR DEFICIENCY; CMS4C],616324[MYASTHENIC SYNDROME, CONGENITAL, 4B, FAST-CHANNEL; CMS4B]
FBgn0000038	nAChRbeta1	HGNC:1967	OMIM:100730	CHRNG	3	253290,265000	253290[MULTIPLE PTERYGIUM SYNDROME, LETHAL TYPE; LMPS],265000[MULTIPLE PTERYGIUM SYNDROME, ESCOBAR VARIANT; EVMPS]
FBgn0035558	CG11357	HGNC:918	OMIM:603094	B3GALNT1	4	111400,615021	111400[BLOOD GROUP, P1PK SYSTEM],615021[BLOOD GROUP, GLOBOSIDE SYSTEM; GLOB]
FBgn0035558	CG11357	HGNC:916	OMIM:603093	B3GALT1	5		
FBgn0035558	CG11357	HGNC:15684	OMIM:615333	B3GNT5	3		
FBgn0035558	CG11357	HGNC:917	OMIM:603018	B3GALT2	4		
FBgn0035558	CG11357	HGNC:920	OMIM:604066	B3GALT5	4		
FBgn0035558	CG11357	HGNC:15629	OMIM:605581	B3GNT2	3		
FBgn0035558	CG11357	HGNC:15683	OMIM:605864	B3GNT4	3		
FBgn0035558	CG11357	HGNC:28714		B3GNT9	4		
FBgn0035558	CG11357	HGNC:18811	OMIM:615313	B3GNT7	3		
FBgn0035558	CG11357	HGNC:24141	OMIM:615315	B3GNT6	5		
FBgn0035558	CG11357	HGNC:24139	OMIM:615357	B3GNT8	4		
FBgn0035558	CG11357	HGNC:13528	OMIM:605863	B3GNT3	4		
FBgn0052246	CG32246	HGNC:25525	OMIM:610115	NDC1	5		
FBgn0015805	HDAC1	HGNC:4854	OMIM:605166	HDAC3	4		
FBgn0015805	HDAC1	HGNC:4853	OMIM:605164	HDAC2	13		
FBgn0015805	HDAC1	HGNC:4852	OMIM:601241	HDAC1	14		
FBgn0035541	CG15019	HGNC:28229	OMIM:616998	LLPH	7		
FBgn0035538	DopEcR	HGNC:4508	OMIM:604106	GPR52	4		
FBgn0035538	DopEcR	HGNC:4476	OMIM:601909	GPR21	4		
FBgn0035537	CG11342	HGNC:27050	OMIM:619601	BCDIN3D	13		
FBgn0035533	Cip4	HGNC:25463	OMIM:617555	FCHSD1	3		
FBgn0035533	Cip4	HGNC:12304	OMIM:604504	TRIP10	14		
FBgn0035533	Cip4	HGNC:17069	OMIM:606191	FNBP1	13		
FBgn0035533	Cip4	HGNC:20851	OMIM:608848	FNBP1L	13		
FBgn0035532	CG15014	HGNC:23807	OMIM:616662	THUMPD1	15	619989	619989[NEURODEVELOPMENTAL DISORDER WITH SPEECH DELAY AND VARIABLE OCULAR ANOMALIES; NEDSOA]
FBgn0052238	TTLL1B	HGNC:16118	OMIM:619838	TTLL9	4		
FBgn0052238	TTLL1B	HGNC:1312	OMIM:608955	TTLL1	15		
FBgn0035574	RhoGEF64C	HGNC:14592	OMIM:606450	NET1	3		
FBgn0035574	RhoGEF64C	HGNC:683	OMIM:612115	ARHGEF3	3		
FBgn0027085	LeuRS-m	HGNC:17095	OMIM:604544	LARS2	15	615300,617021	615300[PERRAULT SYNDROME 4; PRLTS4],617021[HYDROPS, LACTIC ACIDOSIS, AND SIDEROBLASTIC ANEMIA; HLASA]
FBgn0035581	Dnah3	HGNC:2951	OMIM:603336	DNAH6	3		
FBgn0035581	Dnah3	HGNC:2949	OMIM:603334	DNAH3	13		
FBgn0035581	Dnah3	HGNC:2952	OMIM:603337	DNAH8	3	619095	619095[SPERMATOGENIC FAILURE 46; SPGF46]
FBgn0035581	Dnah3	HGNC:2940	OMIM:603332	DNAH1	3	617576,617577	617576[SPERMATOGENIC FAILURE 18; SPGF18],617577[CILIARY DYSKINESIA, PRIMARY, 37; CILD37]
FBgn0035581	Dnah3	HGNC:18661	OMIM:610061	DNAH7	5		
FBgn0035581	Dnah3	HGNC:2953	OMIM:603330	DNAH9	3	618300	618300[CILIARY DYSKINESIA, PRIMARY, 40; CILD40]
FBgn0035581	Dnah3	HGNC:2942	OMIM:603339	DNAH11	3	611884	611884[CILIARY DYSKINESIA, PRIMARY, 7; CILD7]
FBgn0035581	Dnah3	HGNC:2950	OMIM:603335	DNAH5	3	608644	608644[CILIARY DYSKINESIA, PRIMARY, 3; CILD3]
FBgn0035581	Dnah3	HGNC:2948	OMIM:603333	DNAH2	3	619094	619094[SPERMATOGENIC FAILURE 45; SPGF45]
FBgn0035581	Dnah3	HGNC:2941	OMIM:605884	DNAH10	3	619515	619515[SPERMATOGENIC FAILURE 56; SPGF56]
FBgn0035581	Dnah3	HGNC:2946	OMIM:610063	DNAH17	3	618643	618643[SPERMATOGENIC FAILURE 39; SPGF39]
FBgn0035581	Dnah3	HGNC:2943	OMIM:603340	DNAH12	4		
FBgn0028699	Rh50	HGNC:10006	OMIM:180297	RHAG	12	185000,268150	185000[OVERHYDRATED HEREDITARY STOMATOCYTOSIS; OHST],268150[RH-NULL, REGULATOR TYPE; RHNR]
FBgn0028699	Rh50	HGNC:18140	OMIM:605381	RHCG	11		
FBgn0028699	Rh50	HGNC:10009	OMIM:111680	RHD	6	111690,619462	111690[BLOOD GROUP, RH SYSTEM],619462[HEMOLYTIC DISEASE OF FETUS AND NEWBORN, RH-INDUCED; HDFNRH]
FBgn0028699	Rh50	HGNC:10008	OMIM:111700	RHCE	6	617970	617970[RH-NULL, AMORPH TYPE; RHNA]
FBgn0028699	Rh50	HGNC:14572	OMIM:607079	RHBG	14		
FBgn0035577	CG13708	HGNC:25965		LRRC49	11		
FBgn0035575	CG7509	HGNC:2313	OMIM:603104	CPN2	9		
FBgn0035575	CG7509	HGNC:4443	OMIM:173511	GP5	5		
FBgn0035575	CG7509	HGNC:20818	OMIM:619327	LRRC15	7		
FBgn0035568	CG18418	HGNC:10981	OMIM:604165	SLC25A11	10	618464	618464[PARAGANGLIOMAS 6; PGL6]
FBgn0035567	CG7514	HGNC:10981	OMIM:604165	SLC25A11	10	618464	618464[PARAGANGLIOMAS 6; PGL6]
FBgn0035585	ATPsynCF6L	HGNC:847	OMIM:603152	ATP5PF	10		
FBgn0052232	t-Grip128	HGNC:18600	OMIM:608147	TUBGCP5	3		
FBgn0035584	CG17030	HGNC:12490	OMIM:603890	UBE2L6	4		
FBgn0035584	CG17030	HGNC:12488	OMIM:603721	UBE2L3	4		
FBgn0030234	CG15211	HGNC:19178	OMIM:607890	CMTM7	4		
FBgn0030234	CG15211	HGNC:19177	OMIM:607889	CMTM6	6		
FBgn0030234	CG15211	HGNC:19175	OMIM:607887	CMTM4	9		
FBgn0030234	CG15211	HGNC:9087	OMIM:300112	PLP2	4		
FBgn0030234	CG15211	HGNC:19174	OMIM:607886	CMTM3	4		
FBgn0030234	CG15211	HGNC:18553	OMIM:600340	PLLP	5		
FBgn0030234	CG15211	HGNC:19179	OMIM:607891	CMTM8	4		
FBgn0030234	CG15211	HGNC:13253	OMIM:616074	CKLF	3		
FBgn0030234	CG15211	HGNC:19176	OMIM:607888	CMTM5	3		
FBgn0030239	Pgls	HGNC:8903	OMIM:604951	PGLS	15		
FBgn0030243	CG2186	HGNC:27223		RBM33	7		
FBgn0030247	CG15208	HGNC:1260	OMIM:603191	CFAP410	7	602271,617547	602271[SPONDYLOMETAPHYSEAL DYSPLASIA, AXIAL; SMDAX],617547[RETINAL DYSTROPHY WITH OR WITHOUT MACULAR STAPHYLOMA; RDMS]
FBgn0003965	v	HGNC:11708	OMIM:191070	TDO2	15	600627	600627[HYPERTRYPTOPHANEMIA; HYPTRP]
FBgn0030251	CG2145	HGNC:14369	OMIM:606720	ENDOU	12		
FBgn0030257	SmydA-4	HGNC:15513	OMIM:608783	SMYD3	3		
FBgn0030257	SmydA-4	HGNC:20982	OMIM:610663	SMYD2	3		
FBgn0030257	SmydA-4	HGNC:20986	OMIM:606846	SMYD1	3		
FBgn0052670	Rab9Fb	HGNC:9758	OMIM:179508	RAB1A	3		
FBgn0052670	Rab9Fb	HGNC:19982		RAB19	3		
FBgn0052670	Rab9Fb	HGNC:18370	OMIM:612565	RAB1B	3		
FBgn0030246	CG1582	HGNC:2750	OMIM:603115	DHX9	4		
FBgn0030246	CG1582	HGNC:20086		DHX57	14		
FBgn0030246	CG1582	HGNC:14410	OMIM:612767	DHX36	5		
FBgn0030246	CG1582	HGNC:15815	OMIM:612720	DHX29	4		
FBgn0030246	CG1582	HGNC:16716	OMIM:616423	DHX30	4	617804	617804[NEURODEVELOPMENTAL DISORDER WITH SEVERE MOTOR IMPAIRMENT AND ABSENT LANGUAGE; NEDMIAL]
FBgn0017561	Ork1	HGNC:6272	OMIM:601745	KCNK1	3		
FBgn0017561	Ork1	HGNC:6277	OMIM:603219	KCNK2	5		
FBgn0017561	Ork1	HGNC:19439	OMIM:613655	KCNK18	4	613656	613656[MIGRAINE WITH OR WITHOUT AURA, SUSCEPTIBILITY TO, 13; MGR13]
FBgn0017561	Ork1	HGNC:6273	OMIM:605873	KCNK10	5		
FBgn0017561	Ork1	HGNC:6280	OMIM:603493	KCNK5	5		
FBgn0017561	Ork1	HGNC:14464	OMIM:607369	KCNK16	6		
FBgn0017561	Ork1	HGNC:14465	OMIM:607370	KCNK17	6		
FBgn0017561	Ork1	HGNC:6279	OMIM:605720	KCNK4	5	618381	618381[FACIAL DYSMORPHISM, HYPERTRICHOSIS, EPILEPSY, INTELLECTUAL/DEVELOPMENTAL DELAY, AND GINGIVAL OVERGROWTH SYNDROME; FHEIG]
FBgn0017561	Ork1	HGNC:6281	OMIM:603939	KCNK6	4		
FBgn0030245	CG1637	HGNC:33781	OMIM:610490	ACP7	14		
FBgn0030242	sofe	HGNC:9341	OMIM:603484	PRC1	12		
FBgn0030241	feo	HGNC:9341	OMIM:603484	PRC1	12		
FBgn0003321	sbr	HGNC:8073	OMIM:300316	NXF3	10		
FBgn0003321	sbr	HGNC:23984		NXF2B	10		
FBgn0003321	sbr	HGNC:8071	OMIM:602647	NXF1	12		
FBgn0003321	sbr	HGNC:8072	OMIM:300315	NXF2	5		
FBgn0003321	sbr	HGNC:8075	OMIM:300319	NXF5	9		
FBgn0052669	CG32669	HGNC:11041	OMIM:604024	SLC5A6	12	618973,619903	618973[SODIUM-DEPENDENT MULTIVITAMIN TRANSPORTER DEFICIENCY; SMVTD],619903[PERIPHERAL MOTOR NEUROPATHY, CHILDHOOD-ONSET, BIOTIN-RESPONSIVE; COMNB]
FBgn0052669	CG32669	HGNC:11040	OMIM:601843	SLC5A5	8	274400	274400[THYROID DYSHORMONOGENESIS 1; TDH1]
FBgn0052669	CG32669	HGNC:28750	OMIM:612455	SLC5A12	11		
FBgn0052669	CG32669	HGNC:19119	OMIM:608044	SLC5A8	12		
FBgn0003360	sesB	HGNC:10992	OMIM:300151	SLC25A6	9		
FBgn0003360	sesB	HGNC:10991	OMIM:300150	SLC25A5	10		
FBgn0003360	sesB	HGNC:25319	OMIM:610796	SLC25A31	8		
FBgn0003360	sesB	HGNC:10990	OMIM:103220	SLC25A4	12	609283,615418,617184	609283[PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL DOMINANT 2; PEOA2],615418[MITOCHONDRIAL DNA DEPLETION SYNDROME 12B (CARDIOMYOPATHIC TYPE), AUTOSOMAL RECESSIVE; MTDPS12B],617184[MITOCHONDRIAL DNA DEPLETION SYNDROME 12A (CARDIOMYOPATHIC TYPE), AUTOSOMAL DOMINANT; MTDPS12A]
FBgn0025111	Ant2	HGNC:10992	OMIM:300151	SLC25A6	9		
FBgn0025111	Ant2	HGNC:10991	OMIM:300150	SLC25A5	9		
FBgn0025111	Ant2	HGNC:25319	OMIM:610796	SLC25A31	8		
FBgn0025111	Ant2	HGNC:10990	OMIM:103220	SLC25A4	10	609283,615418,617184	609283[PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL DOMINANT 2; PEOA2],615418[MITOCHONDRIAL DNA DEPLETION SYNDROME 12B (CARDIOMYOPATHIC TYPE), AUTOSOMAL RECESSIVE; MTDPS12B],617184[MITOCHONDRIAL DNA DEPLETION SYNDROME 12A (CARDIOMYOPATHIC TYPE), AUTOSOMAL DOMINANT; MTDPS12A]
FBgn0030263	CG2076	HGNC:17281	OMIM:619205	GHITM	14		
FBgn0027498	CG2061	HGNC:24767		LANCL3	15		
FBgn0027498	CG2061	HGNC:6508	OMIM:604155	LANCL1	4		
FBgn0027498	CG2061	HGNC:6509	OMIM:612919	LANCL2	5		
FBgn0015245	Hsp60A	HGNC:5261	OMIM:118190	HSPD1	15	605280,612233	605280[SPASTIC PARAPLEGIA 13, AUTOSOMAL DOMINANT; SPG13],612233[LEUKODYSTROPHY, HYPOMYELINATING, 4; HLD4]
FBgn0028686	Rpt3	HGNC:9551	OMIM:602707	PSMC4	15		
FBgn0030269	CDK2AP1	HGNC:14002	OMIM:602198	CDK2AP1	9		
FBgn0030269	CDK2AP1	HGNC:30833		CDK2AP2	8		
FBgn0030276	Dlic	HGNC:2966	OMIM:611406	DYNC1LI2	13		
FBgn0030276	Dlic	HGNC:18745	OMIM:615890	DYNC1LI1	13		
FBgn0030286	Gapvd1	HGNC:23375	OMIM:611714	GAPVD1	14		
FBgn0030291	CG1738	HGNC:25332		C1orf131	5		
FBgn0000499	dsh	HGNC:3087	OMIM:601368	DVL3	13	616894	616894[ROBINOW SYNDROME, AUTOSOMAL DOMINANT 3; DRS3]
FBgn0000499	dsh	HGNC:3086	OMIM:602151	DVL2	12		
FBgn0000499	dsh	HGNC:3084	OMIM:601365	DVL1	10	616331	616331[ROBINOW SYNDROME, AUTOSOMAL DOMINANT 2; DRS2]
FBgn0004864	hop	HGNC:6190	OMIM:147795	JAK1	11	618999	618999[AUTOINFLAMMATION, IMMUNE DYSREGULATION, AND EOSINOPHILIA; AIIDE]
FBgn0004864	hop	HGNC:12440	OMIM:176941	TYK2	10	611521	611521[IMMUNODEFICIENCY 35; IMD35]
FBgn0004864	hop	HGNC:6192	OMIM:147796	JAK2	11	133100,254450,263300,600880,601626,614521	133100[ERYTHROCYTOSIS, FAMILIAL, 1; ECYT1],254450[MYELOFIBROSIS],263300[POLYCYTHEMIA VERA; PV],600880[BUDD-CHIARI SYNDROME; BDCHS],601626[LEUKEMIA, ACUTE MYELOID; AML],614521[THROMBOCYTHEMIA 3; THCYT3]
FBgn0004864	hop	HGNC:6193	OMIM:600173	JAK3	10	600802	600802[SEVERE COMBINED IMMUNODEFICIENCY, AUTOSOMAL RECESSIVE, T CELL-NEGATIVE, B CELL-POSITIVE, NK CELL-NEGATIVE]
FBgn0030289	GCS1	HGNC:24862	OMIM:601336	MOGS	15	606056	606056[CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIb; CDG2B]
FBgn0028421	Kap3	HGNC:17060	OMIM:601836	KIFAP3	15		
FBgn0001491	l(1)10Bb	HGNC:29629	OMIM:603477	BUD31	14		
FBgn0026268	Antdh	HGNC:28639	OMIM:616159	DHRS11	11		
FBgn0052668	CG32668	HGNC:23045	OMIM:618424	ARMC2	12	618433	618433[SPERMATOGENIC FAILURE 38; SPGF38]
FBgn0020255	Ran	HGNC:9846	OMIM:601179	RAN	13		
FBgn0030268	Klp10A	HGNC:6393	OMIM:604538	KIF2C	11		
FBgn0030268	Klp10A	HGNC:6318	OMIM:602591	KIF2A	14	615411	615411[CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 3; CDCBM3]
FBgn0030268	Klp10A	HGNC:29443	OMIM:615142	KIF2B	9		
FBgn0030268	Klp10A	HGNC:19916	OMIM:613747	KIF24	4		
FBgn0010391	SrpRalpha	HGNC:11307	OMIM:182180	SRPRA	14		
FBgn0027359	Tim8	HGNC:11818	OMIM:606659	TIMM8B	14		
FBgn0027359	Tim8	HGNC:11817	OMIM:300356	TIMM8A	8	304700	304700[MOHR-TRANEBJAERG SYNDROME; MTS]
FBgn0001145	Gs2	HGNC:4341	OMIM:138290	GLUL	14	610015	610015[GLUTAMINE DEFICIENCY, CONGENITAL]
FBgn0030300	Sk1	HGNC:19256	OMIM:610307	CERK	4		
FBgn0030300	Sk1	HGNC:11240	OMIM:603730	SPHK1	12		
FBgn0030300	Sk1	HGNC:18859	OMIM:607092	SPHK2	12		
FBgn0030300	Sk1	HGNC:21699	OMIM:608381	CERKL	3	608380	608380[RETINITIS PIGMENTOSA 26; RP26]
FBgn0030304	Cyp4g15	HGNC:23198	OMIM:608614	CYP4V2	5	210370	210370[BIETTI CRYSTALLINE CORNEORETINAL DYSTROPHY; BCD]
FBgn0030304	Cyp4g15	HGNC:2594	OMIM:107910	CYP19A1	3	139300,613546	139300[AROMATASE EXCESS SYNDROME; AEXS],613546[AROMATASE DEFICIENCY]
FBgn0030305	Uba5	HGNC:23230	OMIM:610552	UBA5	15	617132,617133	617132[DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 44; DEE44],617133[SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 24; SCAR24]
FBgn0030306	Spase25	HGNC:28962	OMIM:619411	SPCS2	14		
FBgn0052666	Drak	HGNC:11395	OMIM:604726	STK17A	8		
FBgn0052666	Drak	HGNC:11396	OMIM:604727	STK17B	9		
FBgn0030310	PGRP-SA	HGNC:30013	OMIM:608199	PGLYRP2	4		
FBgn0030310	PGRP-SA	HGNC:8904	OMIM:604963	PGLYRP1	7		
FBgn0030310	PGRP-SA	HGNC:30014	OMIM:608197	PGLYRP3	9		
FBgn0030310	PGRP-SA	HGNC:30015	OMIM:608198	PGLYRP4	6		
FBgn0030311	CG11699	HGNC:17206		TMEM242	13		
FBgn0030313	Reepl1	HGNC:26176	OMIM:609349	REEP4	5		
FBgn0030313	Reepl1	HGNC:30078	OMIM:609346	REEP6	4	617304	617304[RETINITIS PIGMENTOSA 77; RP77]
FBgn0030313	Reepl1	HGNC:23711	OMIM:609348	REEP3	5		
FBgn0030313	Reepl1	HGNC:17975	OMIM:609347	REEP2	5	615625	615625[SPASTIC PARAPLEGIA 72, AUTOSOMAL RECESSIVE; SPG72]
FBgn0030313	Reepl1	HGNC:25786	OMIM:609139	REEP1	5	610250,614751,620011	610250[SPASTIC PARAPLEGIA 31, AUTOSOMAL DOMINANT; SPG31],614751[NEURONOPATHY, DISTAL HEREDITARY MOTOR, TYPE VB; HMN5B],620011[SPINAL MUSCULAR ATROPHY, DISTAL, AUTOSOMAL RECESSIVE, 6; DSMA6]
FBgn0030313	Reepl1	HGNC:30077	OMIM:125265	REEP5	3		
FBgn0030318	rho-4	HGNC:16083	OMIM:608962	RHBDL2	6		
FBgn0030318	rho-4	HGNC:10007	OMIM:603264	RHBDL1	6		
FBgn0030318	rho-4	HGNC:16502	OMIM:619017	RHBDL3	7		
FBgn0030321	CG1703	HGNC:70	OMIM:603429	ABCF1	13		
FBgn0002723	Met	HGNC:701	OMIM:602550	ARNTL	4		
FBgn0002723	Met	HGNC:18984	OMIM:614517	ARNTL2	4		
FBgn0004370	Ptp10D	HGNC:9665	OMIM:176882	PTPRB	11		
FBgn0004370	Ptp10D	HGNC:9673	OMIM:600925	PTPRJ	6	114500	114500[COLORECTAL CANCER; CRC]
FBgn0004370	Ptp10D	HGNC:9678	OMIM:600579	PTPRO	4	614196	614196[NEPHROTIC SYNDROME, TYPE 6; NPHS6]
FBgn0004370	Ptp10D	HGNC:9672	OMIM:602510	PTPRH	5		
FBgn0030323	Vlet	HGNC:30201	OMIM:616704	COMMD10	11		
FBgn0000618	e(y)2	HGNC:24449	OMIM:619015	ENY2	13		
FBgn0003277	Polr2A	HGNC:9187	OMIM:180660	POLR2A	14	618603	618603[NEURODEVELOPMENTAL DISORDER WITH HYPOTONIA AND VARIABLE INTELLECTUAL AND BEHAVIORAL ABNORMALITIES; NEDHIB]
FBgn0003277	Polr2A	HGNC:30074	OMIM:614258	POLR3A	3	264090,607694	264090[WIEDEMANN-RAUTENSTRAUCH SYNDROME; WDRTS],607694[LEUKODYSTROPHY, HYPOMYELINATING, 7, WITH OR WITHOUT OLIGODONTIA AND/OR HYPOGONADOTROPIC HYPOGONADISM; HLD7]
FBgn0030329	prtp	HGNC:21073	OMIM:616412	TXNDC5	13		
FBgn0030330	Tango10	HGNC:33758		BTBD17	11		
FBgn0030330	Tango10	HGNC:6564	OMIM:600626	LGALS3BP	3		
FBgn0030331	CG15221	HGNC:8494	OMIM:604047	SLC22A13	4		
FBgn0030331	CG15221	HGNC:10970	OMIM:607582	SLC22A6	3		
FBgn0030331	CG15221	HGNC:20302	OMIM:608276	SLC22A16	3		
FBgn0030331	CG15221	HGNC:10968	OMIM:604190	SLC22A4	3	180300	180300[RHEUMATOID ARTHRITIS; RA]
FBgn0030331	CG15221	HGNC:10969	OMIM:603377	SLC22A5	3	212140	212140[CARNITINE DEFICIENCY, SYSTEMIC PRIMARY; CDSP]
FBgn0030331	CG15221	HGNC:8495	OMIM:604048	SLC22A14	4		
FBgn0030331	CG15221	HGNC:10971	OMIM:604995	SLC22A7	4		
FBgn0030331	CG15221	HGNC:10972	OMIM:607581	SLC22A8	4		
FBgn0030331	CG15221	HGNC:10966	OMIM:602608	SLC22A2	3		
FBgn0030331	CG15221	HGNC:32935	OMIM:610792	SLC22A25	3		
FBgn0030331	CG15221	HGNC:10963	OMIM:602607	SLC22A1	3		
FBgn0030331	CG15221	HGNC:10967	OMIM:604842	SLC22A3	3		
FBgn0030331	CG15221	HGNC:20566	OMIM:185860	SV2A	3		
FBgn0030331	CG15221	HGNC:30670	OMIM:610291	SV2C	4		
FBgn0030331	CG15221	HGNC:17989	OMIM:607096	SLC22A12	3	220150	220150[HYPOURICEMIA, RENAL, 1; RHUC1]
FBgn0030331	CG15221	HGNC:18120	OMIM:607097	SLC22A11	3		
FBgn0030331	CG15221	HGNC:16261	OMIM:607579	SLC22A9	3		
FBgn0030331	CG15221	HGNC:28542	OMIM:611698	SLC22A24	3		
FBgn0030331	CG15221	HGNC:18057	OMIM:607580	SLC22A10	3		
FBgn0030334	Karl	HGNC:612	OMIM:107740	APOD	3		
FBgn0030339	Cyp28c1	HGNC:2638	OMIM:605325	CYP3A5	3	145500	145500[HYPERTENSION, ESSENTIAL]
FBgn0030339	Cyp28c1	HGNC:17450	OMIM:606534	CYP3A43	3		
FBgn0030339	Cyp28c1	HGNC:11609	OMIM:274180	TBXAS1	4	231095	231095[GHOSAL HEMATODIAPHYSEAL DYSPLASIA; GHDD]
FBgn0030339	Cyp28c1	HGNC:2637	OMIM:124010	CYP3A4	3	619073	619073[VITAMIN D-DEPENDENT RICKETS, TYPE 3; VDDR3]
FBgn0030339	Cyp28c1	HGNC:51504		CYP3A7-CYP3A51P	3		
FBgn0030343	ATP7	HGNC:870	OMIM:606882	ATP7B	13	277900	277900[WILSON DISEASE; WND]
FBgn0030343	ATP7	HGNC:869	OMIM:300011	ATP7A	13	300489,304150,309400	300489[SPINAL MUSCULAR ATROPHY, DISTAL, X-LINKED 3; SMAX3],304150[OCCIPITAL HORN SYNDROME; OHS],309400[MENKES DISEASE; MNK]
FBgn0030345	CG1847	HGNC:358	OMIM:605555	AIP	14	102200	102200[PITUITARY ADENOMA 1, MULTIPLE TYPES; PITA1]
FBgn0030345	CG1847	HGNC:359	OMIM:604392	AIPL1	12	604393	604393[LEBER CONGENITAL AMAUROSIS 4; LCA4]
FBgn0030347	CG15739	HGNC:30042	OMIM:617231	LHPP	4		
FBgn0030347	CG15739	HGNC:30259	OMIM:609246	PDXP	5		
FBgn0030347	CG15739	HGNC:8909	OMIM:172280	PGP	5		
FBgn0030352	sicily	HGNC:28625	OMIM:612392	NDUFAF6	13	618239,618913	618239[MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 17; MC1DN17],618913[FANCONI RENOTUBULAR SYNDROME 5; FRTS5]
FBgn0030360	CG1806	HGNC:11322	OMIM:601599	SSPN	3		
FBgn0030362	regucalcin	HGNC:9989	OMIM:300212	RGN	15		
FBgn0030361	CG1492	HGNC:4250	OMIM:612346	GGT1	8	231950	231950[GLUTATHIONURIA]
FBgn0030361	CG1492	HGNC:4251	OMIM:137181	GGT2	8	137181	137181[GAMMA-GLUTAMYLTRANSFERASE 2; GGT2]
FBgn0030361	CG1492	HGNC:4260	OMIM:137168	GGT5	7		
FBgn0030361	CG1492	HGNC:16437	OMIM:612338	GGTLC1	5		
FBgn0030361	CG1492	HGNC:18596	OMIM:612339	GGTLC2	5		
FBgn0030361	CG1492	HGNC:4259	OMIM:612342	GGT7	4		
FBgn0030361	CG1492	HGNC:33426	OMIM:612340	GGTLC3	4		
FBgn0001083	fw	HGNC:15985	OMIM:611691	SVEP1	4		
FBgn0001083	fw	HGNC:19291	OMIM:608399	CSMD3	4		
FBgn0001083	fw	HGNC:19290	OMIM:608398	CSMD2	3		
FBgn0030359	CG18130	HGNC:16473	OMIM:607421	NME8	3	610852	610852[CILIARY DYSKINESIA, PRIMARY, 6; CILD6]
FBgn0030359	CG18130	HGNC:21343	OMIM:618584	NME9	6		
FBgn0003865	tsg	HGNC:12429	OMIM:605049	TWSG1	15		
FBgn0030358	Pdzd8	HGNC:26974	OMIM:614235	PDZD8	13	620021	620021[INTELLECTUAL DEVELOPMENTAL DISORDER WITH AUTISM AND DYSMORPHIC FACIES; IDDADF]
FBgn0030357	Sclp	HGNC:23421		LRRC20	11		
FBgn0030354	Upf1	HGNC:9962	OMIM:601430	UPF1	14		
FBgn0030349	CG10353	HGNC:21625	OMIM:610108	ANO1	8		
FBgn0030349	CG10353	HGNC:1183	OMIM:610109	ANO2	7		
FBgn0030349	CG10353	HGNC:31677	OMIM:605096	ANO7	6		
FBgn0030349	CG10353	HGNC:29329	OMIM:610216	ANO8	3		
FBgn0030349	CG10353	HGNC:25240	OMIM:608663	ANO6	7	262890	262890[SCOTT SYNDROME; SCTS]
FBgn0030349	CG10353	HGNC:27337	OMIM:608662	ANO5	9	166260,611307,613319	166260[GNATHODIAPHYSEAL DYSPLASIA; GDD],611307[MUSCULAR DYSTROPHY, LIMB-GIRDLE, AUTOSOMAL RECESSIVE 12; LGMDR12],613319[MIYOSHI MUSCULAR DYSTROPHY 3; MMD3]
FBgn0030349	CG10353	HGNC:23837	OMIM:610111	ANO4	7		
FBgn0030349	CG10353	HGNC:14004	OMIM:610110	ANO3	5	615034	615034[DYSTONIA 24; DYT24]
FBgn0030349	CG10353	HGNC:20679	OMIM:619963	ANO9	4		
FBgn0030348	CG10352	HGNC:30042	OMIM:617231	LHPP	4		
FBgn0030348	CG10352	HGNC:30259	OMIM:609246	PDXP	4		
FBgn0030348	CG10352	HGNC:8909	OMIM:172280	PGP	5		
FBgn0030346	BORCS5	HGNC:17950	OMIM:616598	BORCS5	13		
FBgn0030344	Nrd1	HGNC:5381	OMIM:146680	IDE	4		
FBgn0030344	Nrd1	HGNC:7995	OMIM:602651	NRDC	12		
FBgn0030342	CG10347	HGNC:24306	OMIM:606109	NUDCD1	14		
FBgn0030341	p24-1	HGNC:33945		TMED7-TICAM2	9		
FBgn0030341	p24-1	HGNC:28889		TMED3	13		
FBgn0030341	p24-1	HGNC:17291	OMIM:605395	TMED1	5		
FBgn0030341	p24-1	HGNC:21354	OMIM:608321	TICAM2	3		
FBgn0030341	p24-1	HGNC:24253	OMIM:619990	TMED7	7		
FBgn0030341	p24-1	HGNC:24251	OMIM:616876	TMED5	5		
FBgn0001218	Hsc70-3	HGNC:5232	OMIM:140550	HSPA1A	3		
FBgn0001218	Hsc70-3	HGNC:5233	OMIM:603012	HSPA1B	4		
FBgn0001218	Hsc70-3	HGNC:5234	OMIM:140559	HSPA1L	4		
FBgn0001218	Hsc70-3	HGNC:5238	OMIM:138120	HSPA5	15		
FBgn0001218	Hsc70-3	HGNC:5244	OMIM:600548	HSPA9	3	182170,616854	182170[ANEMIA, SIDEROBLASTIC, 4; SIDBA4],616854[EVEN-PLUS SYNDROME; EVPLS]
FBgn0001218	Hsc70-3	HGNC:5239	OMIM:140555	HSPA6	4		
FBgn0001218	Hsc70-3	HGNC:5235	OMIM:140560	HSPA2	4		
FBgn0001218	Hsc70-3	HGNC:5241	OMIM:600816	HSPA8	4		
FBgn0030332	CG9360	HGNC:28639	OMIM:616159	DHRS11	14		
FBgn0030327	FucT6	HGNC:4019	OMIM:602589	FUT8	15	618005	618005[CONGENITAL DISORDER OF GLYCOSYLATION WITH DEFECTIVE FUCOSYLATION 1; CDGF1]
FBgn0030364	Lsm12a	HGNC:26407	OMIM:611793	LSM12	14		
FBgn0030365	Tango4	HGNC:9089	OMIM:605961	PLRG1	14		
FBgn0030369	Cyp318a1	HGNC:20244	OMIM:614999	CYP4X1	3		
FBgn0030369	Cyp318a1	HGNC:2644	OMIM:124075	CYP4B1	3		
FBgn0030377	CG1924	HGNC:2060	OMIM:601858	CLGN	12		
FBgn0030377	CG1924	HGNC:1473	OMIM:114217	CANX	13		
FBgn0030370	Uch-L5R	HGNC:19678	OMIM:610667	UCHL5	11		
FBgn0030367	Cyp311a1	HGNC:23198	OMIM:608614	CYP4V2	3	210370	210370[BIETTI CRYSTALLINE CORNEORETINAL DYSTROPHY; BCD]
FBgn0030367	Cyp311a1	HGNC:20244	OMIM:614999	CYP4X1	3		
FBgn0030367	Cyp311a1	HGNC:2644	OMIM:124075	CYP4B1	3		
FBgn0030367	Cyp311a1	HGNC:20583	OMIM:618953	CYP4Z1	3		
FBgn0030366	Usp7	HGNC:12630	OMIM:602519	USP7	13	616863	616863[HAO-FOUNTAIN SYNDROME; HAFOUS]
FBgn0043001	Chrac-16	HGNC:13544	OMIM:607268	CHRAC1	13		
FBgn0043001	Chrac-16	HGNC:18755	OMIM:607269	POLE4	4		
FBgn0030384	CG2577	HGNC:2456	OMIM:604253	CSNK1G3	3		
FBgn0030384	CG2577	HGNC:2451	OMIM:600505	CSNK1A1	6		
FBgn0030384	CG2577	HGNC:2454	OMIM:606274	CSNK1G1	3		
FBgn0030384	CG2577	HGNC:20289		CSNK1A1L	4		
FBgn0030384	CG2577	HGNC:2453	OMIM:600863	CSNK1E	3		
FBgn0030384	CG2577	HGNC:2455	OMIM:602214	CSNK1G2	3		
FBgn0030384	CG2577	HGNC:2452	OMIM:600864	CSNK1D	3	615224	615224[ADVANCED SLEEP PHASE SYNDROME, FAMILIAL, 2; FASPS2]
FBgn0030386	CG2574	HGNC:12477	OMIM:602916	UBE2E1	3		
FBgn0030386	CG2574	HGNC:12478	OMIM:602163	UBE2E2	3		
FBgn0030386	CG2574	HGNC:12479	OMIM:604151	UBE2E3	4		
FBgn0052654	Sec16	HGNC:29006	OMIM:612854	SEC16A	10		
FBgn0052654	Sec16	HGNC:30301	OMIM:612855	SEC16B	5		
FBgn0052654	Sec16	HGNC:53757		CRYZL2P-SEC16B	3		
FBgn0030407	Fpgs	HGNC:3824	OMIM:136510	FPGS	14		
FBgn0030406	CG1463	HGNC:26089		ZNHIT6	11		
FBgn0030403	CG1824	HGNC:41	OMIM:605454	ABCB10	4		
FBgn0030403	CG1824	HGNC:49	OMIM:605464	ABCB8	13		
FBgn0030400	Pits	HGNC:14282	OMIM:611720	IRF2BPL	11	618088	618088[NEURODEVELOPMENTAL DISORDER WITH REGRESSION, ABNORMAL MOVEMENTS, LOSS OF SPEECH, AND SEIZURES; NEDAMSS]
FBgn0030400	Pits	HGNC:21728	OMIM:615331	IRF2BP1	11		
FBgn0030400	Pits	HGNC:21729	OMIM:615332	IRF2BP2	11	617765	617765[IMMUNODEFICIENCY, COMMON VARIABLE, 14; CVID14]
FBgn0030395	Mks1	HGNC:7121	OMIM:609883	MKS1	12	249000,615990,617121	249000[MECKEL SYNDROME, TYPE 1; MKS1],615990[BARDET-BIEDL SYNDROME 13; BBS13],617121[JOUBERT SYNDROME 28; JBTS28]
FBgn0030391	Rab40	HGNC:18283	OMIM:301065	RAB40A	10		
FBgn0030391	Rab40	HGNC:18285	OMIM:619551	RAB40C	14		
FBgn0030391	Rab40	HGNC:25410	OMIM:300405	RAB40AL	10		
FBgn0030391	Rab40	HGNC:18284	OMIM:619550	RAB40B	11		
FBgn0030411	CG2540	HGNC:32363	OMIM:617446	CHAC2	12		
FBgn0030411	CG2540	HGNC:28680	OMIM:614587	CHAC1	5		
FBgn0030412	Tomosyn	HGNC:30757	OMIM:609381	STXBP5L	14		
FBgn0030412	Tomosyn	HGNC:19665	OMIM:604586	STXBP5	14		
FBgn0015024	CkIalpha	HGNC:2451	OMIM:600505	CSNK1A1	15		
FBgn0015024	CkIalpha	HGNC:20289		CSNK1A1L	11		
FBgn0015024	CkIalpha	HGNC:2453	OMIM:600863	CSNK1E	3		
FBgn0015024	CkIalpha	HGNC:2452	OMIM:600864	CSNK1D	5	615224	615224[ADVANCED SLEEP PHASE SYNDROME, FAMILIAL, 2; FASPS2]
FBgn0015024	CkIalpha	HGNC:53829		TPTEP2-CSNK1E	3		
FBgn0030421	Agpat1	HGNC:324	OMIM:603099	AGPAT1	13		
FBgn0030421	Agpat1	HGNC:325	OMIM:603100	AGPAT2	12	608594	608594[LIPODYSTROPHY, CONGENITAL GENERALIZED, TYPE 1; CGL1]
FBgn0030425	Nep6	HGNC:8918	OMIM:300550	PHEX	3	307800	307800[HYPOPHOSPHATEMIC RICKETS, X-LINKED DOMINANT; XLHR]
FBgn0030425	Nep6	HGNC:14668	OMIM:618104	MMEL1	3		
FBgn0030425	Nep6	HGNC:7154	OMIM:120520	MME	3	617017,617018	617017[CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2T; CMT2T],617018[SPINOCEREBELLAR ATAXIA 43; SCA43]
FBgn0030425	Nep6	HGNC:13275	OMIM:610145	ECE2	3		
FBgn0030425	Nep6	HGNC:3147	OMIM:605896	ECEL1	3	615065	615065[ARTHROGRYPOSIS, DISTAL, TYPE 5D; DA5D]
FBgn0030425	Nep6	HGNC:3146	OMIM:600423	ECE1	3	145500,613870	145500[HYPERTENSION, ESSENTIAL],613870[HIRSCHSPRUNG DISEASE, CARDIAC DEFECTS, AND AUTONOMIC DYSFUNCTION; HCAD]
FBgn0030425	Nep6	HGNC:6308	OMIM:613883	KEL	5	110900	110900[BLOOD GROUP--KELL SYSTEM; KEL]
FBgn0030433	mRpL49	HGNC:1176	OMIM:606866	MRPL49	13		
FBgn0030435	CG4645	HGNC:28476	OMIM:617522	YIPF2	13		
FBgn0030435	CG4645	HGNC:25231	OMIM:617521	YIPF1	15		
FBgn0030434	Brms1	HGNC:20512	OMIM:618514	BRMS1L	14		
FBgn0030434	Brms1	HGNC:17262	OMIM:606259	BRMS1	12		
FBgn0030431	CG4407	HGNC:24671	OMIM:610595	FLAD1	12	255100	255100[LIPID STORAGE MYOPATHY DUE TO FLAVIN ADENINE DINUCLEOTIDE SYNTHETASE DEFICIENCY; LSMFLAD]
FBgn0052649	Coq8	HGNC:16812	OMIM:606980	COQ8A	12	612016	612016[COENZYME Q10 DEFICIENCY, PRIMARY, 4; COQ10D4]
FBgn0052649	Coq8	HGNC:19041	OMIM:615567	COQ8B	15	615573	615573[NEPHROTIC SYNDROME, TYPE 9; NPHS9]
FBgn0052647	CG32647	HGNC:2845	OMIM:600594	DGCR2	6		
FBgn0030420	pira	HGNC:30402	OMIM:612846	SENP7	9		
FBgn0030420	pira	HGNC:20944	OMIM:605003	SENP6	8		
FBgn0020513	Paics	HGNC:8587	OMIM:172439	PAICS	14	619859	619859[PHOSPHORIBOSYLAMINOIMIDAZOLE CARBOXYLASE DEFICIENCY; PAICSD]
FBgn0030452	MFS10	HGNC:20151	OMIM:607557	SLC17A8	3	605583	605583[DEAFNESS, AUTOSOMAL DOMINANT 25; DFNA25]
FBgn0030452	MFS10	HGNC:10933	OMIM:604322	SLC17A5	6	269920,604369	269920[INFANTILE SIALIC ACID STORAGE DISEASE; ISSD],604369[SALLA DISEASE; SD]
FBgn0030452	MFS10	HGNC:16703	OMIM:607563	SLC17A6	3		
FBgn0030452	MFS10	HGNC:16704	OMIM:605208	SLC17A7	3		
FBgn0030452	MFS10	HGNC:10929	OMIM:182308	SLC17A1	4		
FBgn0030452	MFS10	HGNC:10932	OMIM:604216	SLC17A4	3		
FBgn0030452	MFS10	HGNC:10930	OMIM:611049	SLC17A2	3		
FBgn0030452	MFS10	HGNC:10931	OMIM:611034	SLC17A3	3	612671	612671[URIC ACID CONCENTRATION, SERUM, QUANTITATIVE TRAIT LOCUS 4; UAQTL4]
FBgn0030456	CG4332	HGNC:2087	OMIM:604783	CLPTM1	3		
FBgn0030456	CG4332	HGNC:24308	OMIM:612585	CLPTM1L	13		
FBgn0030457	CG12096	HGNC:9563	OMIM:604452	PSMD5	14		
FBgn0029133	REG	HGNC:9568	OMIM:600654	PSME1	5		
FBgn0029133	REG	HGNC:9569	OMIM:602161	PSME2	4		
FBgn0029133	REG	HGNC:9570	OMIM:605129	PSME3	15		
FBgn0004456	mew	HGNC:6143	OMIM:600536	ITGA7	12	613204	613204[MUSCULAR DYSTROPHY, CONGENITAL, DUE TO INTEGRIN ALPHA-7 DEFICIENCY]
FBgn0004456	mew	HGNC:6142	OMIM:147556	ITGA6	12	619817	619817[EPIDERMOLYSIS BULLOSA, JUNCTIONAL 6, WITH PYLORIC ATRESIA; JEB6]
FBgn0004456	mew	HGNC:6139	OMIM:605025	ITGA3	11	614748	614748[EPIDERMOLYSIS BULLOSA, JUNCTIONAL 7, WITH INTERSTITIAL LUNG DISEASE AND NEPHROTIC SYNDROME; JEB7]
FBgn0030460	Coq5	HGNC:28722	OMIM:616359	COQ5	13	619028	619028[COENZYME Q10 DEFICIENCY, PRIMARY, 9; COQ10D9]
FBgn0025463	Bap60	HGNC:11106	OMIM:601735	SMARCD1	15	618779	618779[COFFIN-SIRIS SYNDROME 11; CSS11]
FBgn0025463	Bap60	HGNC:11107	OMIM:601736	SMARCD2	11	617475	617475[SPECIFIC GRANULE DEFICIENCY 2; SGD2]
FBgn0025463	Bap60	HGNC:11108	OMIM:601737	SMARCD3	11		
FBgn0052638	CG32638	HGNC:13539	OMIM:608729	AGTRAP	12		
FBgn0030449	Fer3HCH	HGNC:3987	OMIM:300308	FTHL17	10		
FBgn0030449	Fer3HCH	HGNC:17345	OMIM:608847	FTMT	12		
FBgn0030449	Fer3HCH	HGNC:3999	OMIM:134790	FTL	8	600886,606159,615604	600886[HYPERFERRITINEMIA WITH OR WITHOUT CATARACT; HRFTC],606159[NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 3; NBIA3],615604[L-FERRITIN DEFICIENCY; LFTD]
FBgn0030449	Fer3HCH	HGNC:3976	OMIM:134770	FTH1	11	615517	615517[HEMOCHROMATOSIS, TYPE 5; HFE5]
FBgn0030449	Fer3HCH	HGNC:33525		FTH1P19	4		
FBgn0010303	hep	HGNC:6847	OMIM:603014	MAP2K7	12		
FBgn0030437	hec	HGNC:1440	OMIM:114131	CALCR	9	166710	166710[OSTEOPOROSIS]
FBgn0030437	hec	HGNC:16709	OMIM:114190	CALCRL	9	618773	618773[LYMPHATIC MALFORMATION 8; LMPHM8]
FBgn0000346	comt	HGNC:8016	OMIM:601633	NSF	14	619340	619340[DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 96; DEE96]
FBgn0030465	CG15743	HGNC:26019	OMIM:614010	IMPAD1	14	614078	614078[CHONDRODYSPLASIA WITH JOINT DISLOCATIONS, GPAPP TYPE]
FBgn0030466	CG15744	HGNC:17849	OMIM:606823	ADGRA2	11		
FBgn0030466	CG15744	HGNC:13838	OMIM:612302	ADGRA1	4		
FBgn0030466	CG15744	HGNC:13839	OMIM:612303	ADGRA3	10		
FBgn0030468	CG1622	HGNC:25512		PRPF38B	10		
FBgn0040309	Prx2	HGNC:17169	OMIM:300927	PRDX4	5		
FBgn0040309	Prx2	HGNC:9352	OMIM:176763	PRDX1	9	277400	277400[METHYLMALONIC ACIDURIA AND HOMOCYSTINURIA, cblC TYPE; MAHCC]
FBgn0040309	Prx2	HGNC:9354	OMIM:604769	PRDX3	4	619862,619871	619862[SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 32; SCAR32],619871[CORNEAL DYSTROPHY, PUNCTIFORM AND POLYCHROMATIC PRE-DESCEMET; PPPCD]
FBgn0040309	Prx2	HGNC:9353	OMIM:600538	PRDX2	10		
FBgn0030474	CG15747	HGNC:25305	OMIM:616173	NSRP1	11	620001	620001[NEURODEVELOPMENTAL DISORDER WITH SPASTICITY, SEIZURES, AND BRAIN ABNORMALITIES; NEDSSBA]
FBgn0030477	dmrt11E	HGNC:2935	OMIM:604935	DMRT2	7		
FBgn0030477	dmrt11E	HGNC:13911	OMIM:614806	DMRTC2	3		
FBgn0030478	CG1640	HGNC:18062	OMIM:138210	GPT2	13	616281	616281[NEURODEVELOPMENTAL DISORDER WITH SPASTIC PARAPLEGIA AND MICROCEPHALY; NEDSPM]
FBgn0030478	CG1640	HGNC:4552	OMIM:138200	GPT	13		
FBgn0030480	Tim9a	HGNC:11819	OMIM:607384	TIMM9	15		
FBgn0030480	Tim9a	HGNC:4022	OMIM:607388	TIMM10B	3		
FBgn0030481	CG1662	HGNC:7224	OMIM:137960	MPV17	4	256810,618400	256810[MITOCHONDRIAL DNA DEPLETION SYNDROME 6 (HEPATOCEREBRAL TYPE); MTDPS6],618400[CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2EE; CMT2EE]
FBgn0030481	CG1662	HGNC:28177	OMIM:616133	MPV17L2	10		
FBgn0030481	CG1662	HGNC:9716	OMIM:617399	PXMP2	3		
FBgn0030482	Bcat	HGNC:976	OMIM:113520	BCAT1	14		
FBgn0030482	Bcat	HGNC:977	OMIM:113530	BCAT2	14	618850	618850[HYPERVALINEMIA AND HYPERLEUCINE-ISOLEUCINEMIA; HVLI]
FBgn0030484	GstT4	HGNC:4641	OMIM:600436	GSTT1	6		
FBgn0030484	GstT4	HGNC:4642	OMIM:600437	GSTT2	7		
FBgn0030484	GstT4	HGNC:33437		GSTT2B	4		
FBgn0030484	GstT4	HGNC:26930		GSTT4	3		
FBgn0030486	Set2	HGNC:18420	OMIM:612778	SETD2	11	616831	616831[LUSCAN-LUMISH SYNDROME; LLS]
FBgn0030485	CG1998	HGNC:1334	OMIM:619853	FAXDC2	15		
FBgn0030479	Rbp1-like	HGNC:10789	OMIM:600572	SRSF7	7		
FBgn0030479	Rbp1-like	HGNC:10785	OMIM:603364	SRSF3	7		
FBgn0010198	RpS15Aa	HGNC:10389	OMIM:603674	RPS15A	14	618313	618313[DIAMOND-BLACKFAN ANEMIA 20; DBA20]
FBgn0030467	CG1764	HGNC:2715	OMIM:604743	DDAH1	15		
FBgn0030467	CG1764	HGNC:2716	OMIM:604744	DDAH2	11		
FBgn0030499	CG11178	HGNC:28994	OMIM:612927	AVL9	14		
FBgn0030501	BthD	HGNC:18251	OMIM:607914	SELENOH	7		
FBgn0030503	Tango2	HGNC:25439	OMIM:616830	TANGO2	13	616878	616878[METABOLIC CRISES, RECURRENT, WITH RHABDOMYOLYSIS, CARDIAC ARRHYTHMIAS, AND NEURODEGENERATION; MECRCN]
FBgn0030505	NFAT	HGNC:7774	OMIM:604708	NFAT5	7		
FBgn0030505	NFAT	HGNC:7778	OMIM:602699	NFATC4	4		
FBgn0030505	NFAT	HGNC:7776	OMIM:600490	NFATC2	5		
FBgn0030505	NFAT	HGNC:7777	OMIM:602698	NFATC3	6		
FBgn0030505	NFAT	HGNC:7775	OMIM:600489	NFATC1	3		
FBgn0030507	CG11164	HGNC:25671	OMIM:610326	RNASEH2B	14	610181	610181[AICARDI-GOUTIERES SYNDROME 2; AGS2]
FBgn0030509	CG11162	HGNC:1334	OMIM:619853	FAXDC2	9		
FBgn0030509	CG11162	HGNC:10545	OMIM:607545	MSMO1	3	616834	616834[MICROCEPHALY, CONGENITAL CATARACT, AND PSORIASIFORM DERMATITIS; MCCPD]
FBgn0002878	mus101	HGNC:17008	OMIM:607760	TOPBP1	11		
FBgn0030518	CG11134	HGNC:17581	OMIM:612491	APIP	15		
FBgn0030519	CG11151	HGNC:16211		SCP2D1	8		
FBgn0020909	Rtc1	HGNC:17687	OMIM:611405	RCL1	13		
FBgn0030528	CG11095	HGNC:8055		NUDT8	12		
FBgn0030528	CG11095	HGNC:8054	OMIM:609231	NUDT7	6		
FBgn0027537	Nup93-1	HGNC:28958	OMIM:614351	NUP93	13	616892	616892[NEPHROTIC SYNDROME, TYPE 12; NPHS12]
FBgn0052626	AMPdeam	HGNC:469	OMIM:102771	AMPD2	13	615686,615809	615686[SPASTIC PARAPLEGIA 63, AUTOSOMAL RECESSIVE; SPG63],615809[PONTOCEREBELLAR HYPOPLASIA, TYPE 9; PCH9]
FBgn0052626	AMPdeam	HGNC:470	OMIM:102772	AMPD3	5	612874	612874[ERYTHROCYTE AMP DEAMINASE DEFICIENCY]
FBgn0052626	AMPdeam	HGNC:468	OMIM:102770	AMPD1	5	615511	615511[MYOPATHY DUE TO MYOADENYLATE DEAMINASE DEFICIENCY; MMDD]
FBgn0030530	jub	HGNC:6612	OMIM:604543	LIMD1	9		
FBgn0030530	jub	HGNC:20250	OMIM:609066	AJUBA	4		
FBgn0030530	jub	HGNC:20964	OMIM:614790	WTIP	9		
FBgn0030529	Clic	HGNC:2062	OMIM:602872	CLIC1	10		
FBgn0030529	Clic	HGNC:13518	OMIM:606536	CLIC4	12		
FBgn0030529	Clic	HGNC:2063	OMIM:300138	CLIC2	13	300886	300886[INTELLECTUAL DEVELOPMENTAL DISORDER, X-LINKED, SYNDROMIC 32; MRXS32]
FBgn0030529	Clic	HGNC:2065	OMIM:615321	CLIC6	7		
FBgn0030529	Clic	HGNC:13517	OMIM:607293	CLIC5	12	616042	616042[DEAFNESS, AUTOSOMAL RECESSIVE 103; DFNB103]
FBgn0030529	Clic	HGNC:2064	OMIM:606533	CLIC3	11		
FBgn0030525	CG10996	HGNC:24063	OMIM:137030	GALM	11	618881	618881[GALACTOSEMIA IV; GALAC4]
FBgn0030524	CG10993	HGNC:17369	OMIM:618750	ABT1	12		
FBgn0030521	CtsB	HGNC:2527	OMIM:116810	CTSB	14	148370	148370[KERATOLYTIC WINTER ERYTHEMA; KWE]
FBgn0030520	Pdcd4	HGNC:8763	OMIM:608610	PDCD4	13		
FBgn0001612	Grip91	HGNC:18598	OMIM:617818	TUBGCP3	15		
FBgn0001087	g	HGNC:568	OMIM:607246	AP3D1	13	617050	617050[HERMANSKY-PUDLAK SYNDROME 10; HPS10]
FBgn0030514	Mrgn1	HGNC:20254	OMIM:607559	MGRN1	11		
FBgn0030514	Mrgn1	HGNC:29402		RNF157	10		
FBgn0030512	Nadsyn	HGNC:29832	OMIM:608285	NADSYN1	14	618845	618845[VERTEBRAL, CARDIAC, RENAL, AND LIMB DEFECTS SYNDROME 3; VCRL3]
FBgn0030506	DNAlig4	HGNC:6601	OMIM:601837	LIG4	13	254500,606593	254500[MYELOMA, MULTIPLE],606593[LIG4 SYNDROME]
FBgn0030504	CG2691	HGNC:29100	OMIM:617723	RRP12	13		
FBgn0030502	tth	HGNC:20225	OMIM:601670	DPF1	5		
FBgn0030502	tth	HGNC:17427	OMIM:601672	DPF3	5		
FBgn0030502	tth	HGNC:9964	OMIM:601671	DPF2	6	618027	618027[COFFIN-SIRIS SYNDROME 7; CSS7]
FBgn0030500	Ndc80	HGNC:16909	OMIM:607272	NDC80	7		
FBgn0000173	ben	HGNC:31710		UBE2NL	10		
FBgn0000173	ben	HGNC:12492	OMIM:603679	UBE2N	14		
FBgn0044817	Ste12DOR	HGNC:2460	OMIM:115441	CSNK2B	4	618732	618732[POIRIER-BIENVENU NEURODEVELOPMENTAL SYNDROME; POBINDS]
FBgn0040871	CG12479	HGNC:32068	OMIM:616574	MICOS10	10		
FBgn0004649	yl	HGNC:6694	OMIM:600073	LRP2	3	222448	222448[DONNAI-BARROW SYNDROME]
FBgn0030566	betaNACtes4	HGNC:30547		BTF3L4	3		
FBgn0030566	betaNACtes4	HGNC:1125	OMIM:602542	BTF3	3		
FBgn0052598	betaNACtes6	HGNC:30547		BTF3L4	3		
FBgn0052598	betaNACtes6	HGNC:1125	OMIM:602542	BTF3	3		
FBgn0030571	CG14414	HGNC:28413		RBM18	12		
FBgn0030573	nmdyn-D6	HGNC:20567	OMIM:608294	NME6	13		
FBgn0030575	CG5321	HGNC:18308	OMIM:300777	TMLHE	4	300872	300872[AUTISM, SUSCEPTIBILITY TO, X-LINKED 6; AUTSX6]
FBgn0030575	CG5321	HGNC:964	OMIM:603312	BBOX1	14		
FBgn0030577	CG5334	HGNC:7113	OMIM:608426	MKRN2	8		
FBgn0030577	CG5334	HGNC:7112	OMIM:607754	MKRN1	10		
FBgn0030577	CG5334	HGNC:7114	OMIM:603856	MKRN3	7	615346	615346[PRECOCIOUS PUBERTY, CENTRAL, 2; CPPB2]
FBgn0030577	CG5334	HGNC:7115		MKRN4P	3		
FBgn0030578	CG5347	HGNC:7113	OMIM:608426	MKRN2	11		
FBgn0030578	CG5347	HGNC:7112	OMIM:607754	MKRN1	13		
FBgn0030578	CG5347	HGNC:7114	OMIM:603856	MKRN3	10	615346	615346[PRECOCIOUS PUBERTY, CENTRAL, 2; CPPB2]
FBgn0030578	CG5347	HGNC:7115		MKRN4P	6		
FBgn0015010	Ag5r	HGNC:8946	OMIM:607076	PI15	3		
FBgn0015010	Ag5r	HGNC:16249		R3HDML	3		
FBgn0015010	Ag5r	HGNC:21245		PI16	3		
FBgn0015010	Ag5r	HGNC:28392	OMIM:610395	GLIPR1L1	4		
FBgn0015010	Ag5r	HGNC:16904	OMIM:618062	CRISP3	3		
FBgn0015010	Ag5r	HGNC:304	OMIM:601193	CRISP1	3		
FBgn0015010	Ag5r	HGNC:12024	OMIM:187430	CRISP2	3		
FBgn0015010	Ag5r	HGNC:33849	OMIM:616572	CLEC18B	3		
FBgn0015010	Ag5r	HGNC:30388	OMIM:616571	CLEC18A	3		
FBgn0020508	Ag5r2	HGNC:8946	OMIM:607076	PI15	3		
FBgn0020508	Ag5r2	HGNC:16249		R3HDML	3		
FBgn0020508	Ag5r2	HGNC:21245		PI16	3		
FBgn0020508	Ag5r2	HGNC:28392	OMIM:610395	GLIPR1L1	4		
FBgn0020508	Ag5r2	HGNC:16904	OMIM:618062	CRISP3	3		
FBgn0020508	Ag5r2	HGNC:304	OMIM:601193	CRISP1	3		
FBgn0020508	Ag5r2	HGNC:12024	OMIM:187430	CRISP2	3		
FBgn0020508	Ag5r2	HGNC:33849	OMIM:616572	CLEC18B	3		
FBgn0020508	Ag5r2	HGNC:30388	OMIM:616571	CLEC18A	3		
FBgn0030576	CG15890	HGNC:16055	OMIM:608956	SLC46A2	6		
FBgn0030576	CG15890	HGNC:30521	OMIM:611672	SLC46A1	8	229050	229050[FOLATE MALABSORPTION, HEREDITARY]
FBgn0030576	CG15890	HGNC:27501	OMIM:616764	SLC46A3	10		
FBgn0015774	NetB	HGNC:8030	OMIM:602349	NTN3	9		
FBgn0015774	NetB	HGNC:8029	OMIM:601614	NTN1	11	618264	618264[MIRROR MOVEMENTS 4; MRMV4]
FBgn0015774	NetB	HGNC:25208		NTN5	4		
FBgn0030574	sbm	HGNC:11059	OMIM:607933	SLC7A11	3		
FBgn0030574	sbm	HGNC:11058	OMIM:607959	SLC7A10	4		
FBgn0030574	sbm	HGNC:11065	OMIM:603593	SLC7A7	4	222700	222700[LYSINURIC PROTEIN INTOLERANCE; LPI]
FBgn0030574	sbm	HGNC:11064	OMIM:605641	SLC7A6	5		
FBgn0030574	sbm	HGNC:11067	OMIM:604144	SLC7A9	14	220100	220100[CYSTINURIA]
FBgn0030574	sbm	HGNC:11063	OMIM:600182	SLC7A5	5		
FBgn0030574	sbm	HGNC:11066	OMIM:604235	SLC7A8	5		
FBgn0030574	sbm	HGNC:23092	OMIM:617256	SLC7A13	5		
FBgn0030572	mRpS25	HGNC:14511	OMIM:611987	MRPS25	13	619025	619025[COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 50; COXPD50]
FBgn0030582	CG14411	HGNC:24307		MTMR11	6		
FBgn0030582	CG14411	HGNC:25999		MTMR10	15		
FBgn0030582	CG14411	HGNC:18191	OMIM:606501	MTMR12	10		
FBgn0000535	eag	HGNC:6250	OMIM:603305	KCNH1	13	135500,611816	135500[ZIMMERMANN-LABAND SYNDROME 1; ZLS1],611816[TEMPLE-BARAITSER SYNDROME; TMBTS]
FBgn0000535	eag	HGNC:6254	OMIM:605716	KCNH5	12		
FBgn0030605	ND-B18	HGNC:7702	OMIM:603842	NDUFB7	15		
FBgn0030607	dob	HGNC:30802	OMIM:609059	PNPLA2	10	610717	610717[NEUTRAL LIPID STORAGE DISEASE WITH MYOPATHY; NLSDM]
FBgn0030607	dob	HGNC:24888	OMIM:611589	PNPLA5	7		
FBgn0030607	dob	HGNC:18590	OMIM:609567	PNPLA3	9		
FBgn0030607	dob	HGNC:21246	OMIM:612121	PNPLA1	5	615024	615024[ICHTHYOSIS, CONGENITAL, AUTOSOMAL RECESSIVE 10; ARCI10]
FBgn0053177	CG33177	HGNC:7061	OMIM:138330	MGST1	9		
FBgn0053177	CG33177	HGNC:9599	OMIM:605172	PTGES	7		
FBgn0053178	CG33178	HGNC:7061	OMIM:138330	MGST1	9		
FBgn0053178	CG33178	HGNC:9599	OMIM:605172	PTGES	7		
FBgn0030612	Dbct	HGNC:2698	OMIM:248610	DBT	14	248600	248600[MAPLE SYRUP URINE DISEASE; MSUD]
FBgn0030611	CG15027	HGNC:25638		TMA16	12		
FBgn0030610	Cox17	HGNC:2264	OMIM:604813	COX17	9		
FBgn0030608	Lsd-2	HGNC:248	OMIM:103195	PLIN2	10		
FBgn0030608	Lsd-2	HGNC:9076	OMIM:170290	PLIN1	7	613877	613877[LIPODYSTROPHY, FAMILIAL PARTIAL, TYPE 4; FPLD4]
FBgn0030608	Lsd-2	HGNC:16893	OMIM:602702	PLIN3	7		
FBgn0030608	Lsd-2	HGNC:33196	OMIM:613248	PLIN5	6		
FBgn0030600	hiw	HGNC:23386	OMIM:610392	MYCBP2	14		
FBgn0027601	pdgy	HGNC:26101	OMIM:610465	ACSF2	4		
FBgn0052591	CG32591	HGNC:25246		ENKD1	3		
FBgn0030598	CG9503	HGNC:24288		CHDH	6		
FBgn0030597	Eo	HGNC:24288		CHDH	4		
FBgn0030596	CG12398	HGNC:24288		CHDH	7		
FBgn0030594	fiz	HGNC:24288		CHDH	6		
FBgn0030593	CG9512	HGNC:24288		CHDH	6		
FBgn0030592	CG9514	HGNC:24288		CHDH	8		
FBgn0030590	CG9518	HGNC:24288		CHDH	7		
FBgn0030589	CG9519	HGNC:24288		CHDH	6		
FBgn0030588	CG9521	HGNC:24288		CHDH	6		
FBgn0030587	CG9522	HGNC:24288		CHDH	6		
FBgn0030586	CG12539	HGNC:24288		CHDH	6		
FBgn0052590	CG32590	HGNC:37247	OMIM:616601	BORCS8	13		
FBgn0030584	Grx5	HGNC:20134	OMIM:609588	GLRX5	15	616859,616860	616859[SPASTICITY, CHILDHOOD-ONSET, WITH HYPERGLYCINEMIA; SPAHGC],616860[ANEMIA, SIDEROBLASTIC, 3, PYRIDOXINE-REFRACTORY; SIDBA3]
FBgn0003301	rut	HGNC:232	OMIM:103072	ADCY1	12	610154	610154[DEAFNESS, AUTOSOMAL RECESSIVE 44; DFNB44]
FBgn0003301	rut	HGNC:236	OMIM:600293	ADCY5	3	606703,619647,619651	606703[DYSKINESIA WITH OROFACIAL INVOLVEMENT, AUTOSOMAL DOMINANT; DSKOD],619647[DYSKINESIA WITH OROFACIAL INVOLVEMENT, AUTOSOMAL RECESSIVE; DSKOR],619651[NEURODEVELOPMENTAL DISORDER WITH HYPERKINETIC MOVEMENTS AND DYSKINESIA; NEDHYD]
FBgn0003301	rut	HGNC:237	OMIM:600294	ADCY6	3	616287	616287[LETHAL CONGENITAL CONTRACTURE SYNDROME 8; LCCS8]
FBgn0030613	Rab3-GEF	HGNC:6766	OMIM:603584	MADD	15	619004,619005	619004[DEEAH SYNDROME; DEEAH],619005[NEURODEVELOPMENTAL DISORDER WITH DYSMORPHIC FACIES, IMPAIRED SPEECH, AND HYPOTONIA; NEDDISH]
FBgn0030620	CG5662	HGNC:7506	OMIM:608555	MTX2	12	619127	619127[MANDIBULOACRAL DYSPLASIA PROGEROID SYNDROME; MDPS]
FBgn0030625	CG5877	HGNC:20186	OMIM:618631	NRDE2	11		
FBgn0015926	dah	HGNC:23279	OMIM:618510	DYTN	5		
FBgn0026428	HDAC6	HGNC:14067	OMIM:606542	HDAC7	3		
FBgn0026428	HDAC6	HGNC:14063	OMIM:605314	HDAC4	4	619797	619797[NEURODEVELOPMENTAL DISORDER WITH CENTRAL HYPOTONIA AND DYSMORPHIC FACIES; NEDCHF]
FBgn0026428	HDAC6	HGNC:14064	OMIM:300272	HDAC6	14	300863	300863[CHONDRODYSPLASIA WITH PLATYSPONDYLY, DISTINCTIVE BRACHYDACTYLY, HYDROCEPHALY, AND MICROPHTHALMIA]
FBgn0026428	HDAC6	HGNC:18128	OMIM:608544	HDAC10	7		
FBgn0026428	HDAC6	HGNC:14068	OMIM:605315	HDAC5	4		
FBgn0026428	HDAC6	HGNC:14065	OMIM:606543	HDAC9	3		
FBgn0030631	Prp5	HGNC:18681	OMIM:617848	DDX46	14		
FBgn0030634	CG9164	HGNC:29060	OMIM:619584	WSCD1	8		
FBgn0030634	CG9164	HGNC:29117	OMIM:619253	WSCD2	10		
FBgn0003132	Pp1-13C	HGNC:9281	OMIM:176875	PPP1CA	9		
FBgn0003132	Pp1-13C	HGNC:9283	OMIM:176914	PPP1CC	11		
FBgn0003132	Pp1-13C	HGNC:9282	OMIM:600590	PPP1CB	4	617506	617506[NOONAN SYNDROME-LIKE DISORDER WITH LOOSE ANAGEN HAIR 2; NSLH2]
FBgn0030630	CG12608	HGNC:20882	OMIM:607811	PAK1IP1	13		
FBgn0030629	CG9123	HGNC:20882	OMIM:607811	PAK1IP1	11		
FBgn0030623	PPYR1	HGNC:17062	OMIM:617369	HABP4	3		
FBgn0030623	PPYR1	HGNC:17860	OMIM:607378	SERBP1	3		
FBgn0030616	RpL37a	HGNC:10347	OMIM:604181	RPL37	13		
FBgn0030615	Cyp4s3	HGNC:23198	OMIM:608614	CYP4V2	6	210370	210370[BIETTI CRYSTALLINE CORNEORETINAL DYSTROPHY; BCD]
FBgn0030615	Cyp4s3	HGNC:13265	OMIM:611517	CYP4F11	4		
FBgn0030615	Cyp4s3	HGNC:26820	OMIM:611495	CYP4F22	4	604777	604777[ICHTHYOSIS, CONGENITAL, AUTOSOMAL RECESSIVE 5; ARCI5]
FBgn0030615	Cyp4s3	HGNC:2645	OMIM:604426	CYP4F2	4		
FBgn0030615	Cyp4s3	HGNC:2646	OMIM:601270	CYP4F3	4		
FBgn0030615	Cyp4s3	HGNC:20244	OMIM:614999	CYP4X1	4		
FBgn0030615	Cyp4s3	HGNC:2642	OMIM:601310	CYP4A11	4		
FBgn0030615	Cyp4s3	HGNC:18857	OMIM:611485	CYP4F12	4		
FBgn0030615	Cyp4s3	HGNC:20575	OMIM:615341	CYP4A22	4		
FBgn0030615	Cyp4s3	HGNC:2644	OMIM:124075	CYP4B1	4		
FBgn0030615	Cyp4s3	HGNC:2648	OMIM:611545	CYP4F8	4		
FBgn0030615	Cyp4s3	HGNC:20583	OMIM:618953	CYP4Z1	3		
FBgn0030615	Cyp4s3	HGNC:2594	OMIM:107910	CYP19A1	4	139300,613546	139300[AROMATASE EXCESS SYNDROME; AEXS],613546[AROMATASE DEFICIENCY]
FBgn0030614	CG9072	HGNC:11579	OMIM:610058	TBCA	4		
FBgn0014455	Ahcy	HGNC:343	OMIM:180960	AHCY	15	613752	613752[HYPERMETHIONINEMIA WITH S-ADENOSYLHOMOCYSTEINE HYDROLASE DEFICIENCY]
FBgn0030638	CG11655	HGNC:10905	OMIM:182396	SLC10A1	7	619256	619256[HYPERCHOLANEMIA, FAMILIAL, 2; FHCA2]
FBgn0030638	CG11655	HGNC:10906	OMIM:601295	SLC10A2	9	613291	613291[BILE ACID MALABSORPTION, PRIMARY, 1; PBAM1]
FBgn0030638	CG11655	HGNC:22980	OMIM:618563	SLC10A4	6		
FBgn0030638	CG11655	HGNC:30603	OMIM:613366	SLC10A6	8		
FBgn0030638	CG11655	HGNC:22979	OMIM:312090	SLC10A3	11		
FBgn0030638	CG11655	HGNC:22981	OMIM:618582	SLC10A5	10		
FBgn0030645	Alg14	HGNC:28287	OMIM:612866	ALG14	14	616227,619031,619036	616227[MYASTHENIC SYNDROME, CONGENITAL, 15; CMS15],619031[INTELLECTUAL DEVELOPMENTAL DISORDER WITH EPILEPSY, BEHAVIORAL ABNORMALITIES, AND COARSE FACIES; IDDEBF],619036[MYOPATHY, EPILEPSY, AND PROGRESSIVE CEREBRAL ATROPHY; MEPCA]
FBgn0030647	CG6324	HGNC:26809	OMIM:613259	RPTN	3		
FBgn0030648	CG6340	HGNC:30559	OMIM:619996	RSRC2	10		
FBgn0027287	Gmap	HGNC:12305	OMIM:604505	TRIP11	9	184260,200600	184260[ODONTOCHONDRODYSPLASIA 1; ODCD1],200600[ACHONDROGENESIS, TYPE IA; ACG1A]
FBgn0030653	CG7860	HGNC:16448	OMIM:609212	ASRGL1	13		
FBgn0030658	CG7872	HGNC:34187		DNAJC25	7		
FBgn0030658	CG7872	HGNC:37501		DNAJC25-GNG10	9		
FBgn0030660	CG8097	HGNC:25536	OMIM:618904	DALRD3	11	618910	618910[DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 86; DEE86]
FBgn0030661	Alp11	HGNC:438	OMIM:171760	ALPL	7	146300,241500,241510	146300[HYPOPHOSPHATASIA, ADULT; HPPA],241500[HYPOPHOSPHATASIA, INFANTILE; HPPI],241510[HYPOPHOSPHATASIA, CHILDHOOD; HPPC]
FBgn0030661	Alp11	HGNC:441	OMIM:171810	ALPG	7		
FBgn0030661	Alp11	HGNC:439	OMIM:171800	ALPP	7		
FBgn0030661	Alp11	HGNC:437	OMIM:171740	ALPI	7		
FBgn0030663	CG8117	HGNC:11615	OMIM:604128	TCEA3	9		
FBgn0030663	CG8117	HGNC:11614	OMIM:604784	TCEA2	8		
FBgn0030663	CG8117	HGNC:11612	OMIM:601425	TCEA1	9		
FBgn0030663	CG8117	HGNC:28277	OMIM:301084	TCEANC	5		
FBgn0030668	CG8128	HGNC:8053	OMIM:606261	NUDT6	13		
FBgn0030671	Hap40	HGNC:3547	OMIM:305423	F8A1	5		
FBgn0030671	Hap40	HGNC:31849		F8A2	6		
FBgn0030671	Hap40	HGNC:31850		F8A3	8		
FBgn0030672	CG9281	HGNC:71	OMIM:612510	ABCF2	11		
FBgn0030672	CG9281	HGNC:0		LOC114483834	8		
FBgn0030670	Pis	HGNC:1769	OMIM:605893	CDIPT	15		
FBgn0030669	CG9240	HGNC:14598	OMIM:605977	IMMP2L	3		
FBgn0030669	CG9240	HGNC:26317	OMIM:612323	IMMP1L	15		
FBgn0003463	sog	HGNC:1949	OMIM:603475	CHRD	13		
FBgn0030655	CG9213	HGNC:26508		CWF19L2	14		
FBgn0030654	CG15643	HGNC:26128		C12orf49	12		
FBgn0004391	shtd	HGNC:19988	OMIM:608473	ANAPC1	15	618625	618625[ROTHMUND-THOMSON SYNDROME, TYPE 1; RTS1]
FBgn0040285	Scamp	HGNC:10565	OMIM:606913	SCAMP3	13		
FBgn0040285	Scamp	HGNC:30385	OMIM:613764	SCAMP4	4		
FBgn0040285	Scamp	HGNC:10564	OMIM:606912	SCAMP2	10		
FBgn0040285	Scamp	HGNC:10563	OMIM:606911	SCAMP1	12		
FBgn0040285	Scamp	HGNC:30386	OMIM:613766	SCAMP5	5		
FBgn0030674	HUWE1	HGNC:30892	OMIM:300697	HUWE1	14	309590	309590[INTELLECTUAL DEVELOPMENTAL DISORDER, X-LINKED, SYNDROMIC, TURNER TYPE; MRXST]
FBgn0026666	MagR	HGNC:28660	OMIM:611006	ISCA1	13	617613	617613[MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 5; MMDS5]
FBgn0030679	CG8206	HGNC:33879		DNLZ	7		
FBgn0027329	CCT6	HGNC:1621	OMIM:610730	CCT6B	12		
FBgn0027329	CCT6	HGNC:1620	OMIM:104613	CCT6A	13		
FBgn0030683	Mvd	HGNC:7529	OMIM:603236	MVD	14	614714	614714[POROKERATOSIS 7, MULTIPLE TYPES; POROK7]
FBgn0030686	mRpL3	HGNC:10379	OMIM:607118	MRPL3	13	614582	614582[COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 9; COXPD9]
FBgn0030687	Polr3A	HGNC:30074	OMIM:614258	POLR3A	14	264090,607694	264090[WIEDEMANN-RAUTENSTRAUCH SYNDROME; WDRTS],607694[LEUKODYSTROPHY, HYPOMYELINATING, 7, WITH OR WITHOUT OLIGODONTIA AND/OR HYPOGONADOTROPIC HYPOGONADISM; HLD7]
FBgn0053172	CG33172	HGNC:12758	OMIM:606031	WDR6	13		
FBgn0030692	mRpS30	HGNC:8769	OMIM:611991	MRPS30	13		
FBgn0026374	Rhp	HGNC:19973	OMIM:601031	RHPN1	13		
FBgn0026374	Rhp	HGNC:19974	OMIM:617932	RHPN2	14		
FBgn0026374	Rhp	HGNC:37708		RHPN2P1	3		
FBgn0030694	CG15602	HGNC:20758	OMIM:619635	ZFYVE19	13	619849	619849[CHOLESTASIS, PROGRESSIVE FAMILIAL INTRAHEPATIC, 9; PFIC9]
FBgn0030696	CG8509	HGNC:9308	OMIM:600756	PTPA	8		
FBgn0003345	sd	HGNC:11716	OMIM:603170	TEAD3	12		
FBgn0003345	sd	HGNC:11714	OMIM:189967	TEAD1	13	108985	108985[SVEINSSON CHORIORETINAL ATROPHY; SCRA]
FBgn0003345	sd	HGNC:11715	OMIM:601729	TEAD2	11		
FBgn0003345	sd	HGNC:11717	OMIM:601714	TEAD4	11		
FBgn0030697	CG8565	HGNC:11305	OMIM:601939	SRPK1	5		
FBgn0030697	CG8565	HGNC:11306	OMIM:602980	SRPK2	5		
FBgn0030697	CG8565	HGNC:11402	OMIM:301002	SRPK3	6		
FBgn0030699	CG8578	HGNC:6702	OMIM:603256	LRRFIP1	6		
FBgn0030699	CG8578	HGNC:6703	OMIM:614043	LRRFIP2	11		
FBgn0030700	CG15914	HGNC:20887	OMIM:610165	GTDC1	14		
FBgn0001105	Gbeta13F	HGNC:4400	OMIM:139130	GNB3	9	145500,617024	145500[HYPERTENSION, ESSENTIAL],617024[NIGHT BLINDNESS, CONGENITAL STATIONARY, TYPE 1H; CSNB1H]
FBgn0001105	Gbeta13F	HGNC:4396	OMIM:139380	GNB1	15	613065,614286,616973	613065[LEUKEMIA, ACUTE LYMPHOBLASTIC; ALL],614286[MYELODYSPLASTIC SYNDROME; MDS],616973[INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL DOMINANT 42; MRD42]
FBgn0001105	Gbeta13F	HGNC:4398	OMIM:139390	GNB2	12	619464,619503	619464[SICK SINUS SYNDROME 4; SSS4],619503[NEURODEVELOPMENTAL DISORDER WITH HYPOTONIA AND DYSMORPHIC FACIES; NEDHYDF]
FBgn0001105	Gbeta13F	HGNC:20731	OMIM:610863	GNB4	13	615185	615185[CHARCOT-MARIE-TOOTH DISEASE, DOMINANT INTERMEDIATE F; CMTDIF]
FBgn0001105	Gbeta13F	HGNC:4401	OMIM:604447	GNB5	3	617173,617182	617173[INTELLECTUAL DEVELOPMENTAL DISORDER WITH CARDIAC ARRHYTHMIA; IDDCA],617182[LANGUAGE DELAY AND ATTENTION DEFICIT-HYPERACTIVITY DISORDER/COGNITIVE IMPAIRMENT WITH OR WITHOUT CARDIAC ARRHYTHMIA; LADCI]
FBgn0001092	Gapdh2	HGNC:24864	OMIM:609169	GAPDHS	5		
FBgn0001092	Gapdh2	HGNC:4141	OMIM:138400	GAPDH	11		
FBgn0030701	CG16952	HGNC:18269	OMIM:610386	BTBD7	12		
FBgn0030704	CG15916	HGNC:26120		RBFA	10		
FBgn0003392	shi	HGNC:2974	OMIM:602378	DNM2	12	160150,606482,615368	160150[MYOPATHY, CENTRONUCLEAR, 1; CNM1],606482[CHARCOT-MARIE-TOOTH DISEASE, DOMINANT INTERMEDIATE B; CMTDIB],615368[LETHAL CONGENITAL CONTRACTURE SYNDROME 5; LCCS5]
FBgn0003392	shi	HGNC:29125	OMIM:611445	DNM3	12		
FBgn0003392	shi	HGNC:2972	OMIM:602377	DNM1	13	616346	616346[DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 31; DEE31]
FBgn0003392	shi	HGNC:2973	OMIM:603850	DNM1L	3	610708,614388	610708[OPTIC ATROPHY 5; OPA5],614388[ENCEPHALOPATHY DUE TO DEFECTIVE MITOCHONDRIAL AND PEROXISOMAL FISSION 1; EMPF1]
FBgn0003392	shi	HGNC:7533	OMIM:147890	MX2	3		
FBgn0030706	Lrp4	HGNC:6698	OMIM:603507	LRP6	5	610947,616724	610947[CORONARY ARTERY DISEASE, AUTOSOMAL DOMINANT 2; ADCAD2],616724[TOOTH AGENESIS, SELECTIVE, 7; STHAG7]
FBgn0030706	Lrp4	HGNC:6697	OMIM:603506	LRP5	4	144750,166710,259770,601813,601884,607634,607636,617875	144750[ENDOSTEAL HYPEROSTOSIS, AUTOSOMAL DOMINANT],166710[OSTEOPOROSIS],259770[OSTEOPOROSIS-PSEUDOGLIOMA SYNDROME; OPPG],601813[EXUDATIVE VITREORETINOPATHY 4; EVR4],601884[BONE MINERAL DENSITY QUANTITATIVE TRAIT LOCUS 1; BMND1],607634[OSTEOPETROSIS, AUTOSOMAL DOMINANT 1; OPTA1],607636[MOVED TO 144750],617875[POLYCYSTIC LIVER DISEASE 4 WITH OR WITHOUT KIDNEY CYSTS; PCLD4]
FBgn0030706	Lrp4	HGNC:6696	OMIM:604270	LRP4	13	212780,614305,616304	212780[CENANI-LENZ SYNDACTYLY SYNDROME; CLSS],614305[SCLEROSTEOSIS 2; SOST2],616304[MYASTHENIC SYNDROME, CONGENITAL, 17; CMS17]
FBgn0030706	Lrp4	HGNC:6692	OMIM:107770	LRP1	3	604093	604093[KERATOSIS PILARIS ATROPHICANS; KPA]
FBgn0030707	CG8916	HGNC:4075	OMIM:137160	GABRA1	9	611136,615744	611136[EPILEPSY, IDIOPATHIC GENERALIZED, SUSCEPTIBILITY TO, 13; EIG13],615744[DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 19; DEE19]
FBgn0030707	CG8916	HGNC:4088	OMIM:600233	GABRG3	5		
FBgn0030707	CG8916	HGNC:4087	OMIM:137164	GABRG2	7	607681,618396	607681[FEBRILE SEIZURES, FAMILIAL, 8; FEB8],618396[DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 74; DEE74]
FBgn0030707	CG8916	HGNC:4079	OMIM:137142	GABRA5	8	618559	618559[DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 79; DEE79]
FBgn0030707	CG8916	HGNC:4086	OMIM:137166	GABRG1	5		
FBgn0030707	CG8916	HGNC:4078	OMIM:137141	GABRA4	8		
FBgn0030707	CG8916	HGNC:4076	OMIM:137140	GABRA2	10	103780,618557	103780[ALCOHOL DEPENDENCE],618557[DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 78; DEE78]
FBgn0030707	CG8916	HGNC:4077	OMIM:305660	GABRA3	6		
FBgn0030707	CG8916	HGNC:4085	OMIM:300093	GABRE	5		
FBgn0030707	CG8916	HGNC:4080	OMIM:137143	GABRA6	10		
FBgn0030711	Rrp47	HGNC:29911	OMIM:606997	C1D	10		
FBgn0045073	Stim	HGNC:19205	OMIM:610841	STIM2	10		
FBgn0045073	Stim	HGNC:11386	OMIM:605921	STIM1	13	160565,185070,612783	160565[MYOPATHY, TUBULAR AGGREGATE, 1; TAM1],185070[STORMORKEN SYNDROME; STRMK],612783[IMMUNODEFICIENCY 10; IMD10]
FBgn0053180	Ranbp16	HGNC:14428	OMIM:606141	RANBP17	12		
FBgn0053180	Ranbp16	HGNC:14108	OMIM:606140	XPO7	15		
FBgn0010315	CycD	HGNC:1582	OMIM:168461	CCND1	11	114500,193300,254500	114500[COLORECTAL CANCER; CRC],193300[VON HIPPEL-LINDAU SYNDROME; VHLS],254500[MYELOMA, MULTIPLE]
FBgn0010315	CycD	HGNC:1583	OMIM:123833	CCND2	12	615938	615938[MEGALENCEPHALY-POLYMICROGYRIA-POLYDACTYLY-HYDROCEPHALUS SYNDROME 3; MPPH3]
FBgn0010315	CycD	HGNC:1585	OMIM:123834	CCND3	10		
FBgn0030703	MSBP	HGNC:16090	OMIM:300435	PGRMC1	15		
FBgn0030703	MSBP	HGNC:16089	OMIM:607735	PGRMC2	12		
FBgn0065035	AlkB	HGNC:17911	OMIM:605345	ALKBH1	15		
FBgn0002914	Myb	HGNC:11137	OMIM:602777	SNAPC4	3		
FBgn0002914	Myb	HGNC:7545	OMIM:189990	MYB	10		
FBgn0002914	Myb	HGNC:7547	OMIM:159405	MYBL1	11		
FBgn0002914	Myb	HGNC:7548	OMIM:601415	MYBL2	7		
FBgn0026076	UBL3	HGNC:12504	OMIM:604711	UBL3	9		
FBgn0014391	sun	HGNC:838	OMIM:606153	ATP5F1E	11	614053	614053[MITOCHONDRIAL COMPLEX V (ATP SYNTHASE) DEFICIENCY, NUCLEAR TYPE 3; MC5DN3]
FBgn0014391	sun	HGNC:34026		ATP5F1EP2	6		
FBgn0027093	ArgRS	HGNC:21406	OMIM:611524	RARS2	4	611523	611523[PONTOCEREBELLAR HYPOPLASIA, TYPE 6; PCH6]
FBgn0027093	ArgRS	HGNC:9870	OMIM:107820	RARS	14	616140	616140[LEUKODYSTROPHY, HYPOMYELINATING, 9; HLD9]
FBgn0000319	Chc	HGNC:2092	OMIM:118955	CLTC	14	617854	617854[INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL DOMINANT 56; MRD56]
FBgn0000319	Chc	HGNC:2093	OMIM:601273	CLTCL1	12		
FBgn0030695	PGRP-LE	HGNC:30013	OMIM:608199	PGLYRP2	3		
FBgn0030695	PGRP-LE	HGNC:8904	OMIM:604963	PGLYRP1	6		
FBgn0030695	PGRP-LE	HGNC:30014	OMIM:608197	PGLYRP3	6		
FBgn0030695	PGRP-LE	HGNC:30015	OMIM:608198	PGLYRP4	6		
FBgn0052581	sordd2	HGNC:26783		RNF185	13		
FBgn0052581	sordd2	HGNC:10068	OMIM:602677	RNF5	9		
FBgn0030693	sordd1	HGNC:26783		RNF185	12		
FBgn0030693	sordd1	HGNC:10068	OMIM:602677	RNF5	9		
FBgn0030693	sordd1	HGNC:8851	OMIM:602859	PEX10	3	614870,614871	614870[PEROXISOME BIOGENESIS DISORDER 6A (ZELLWEGER); PBD6A],614871[PEROXISOME BIOGENESIS DISORDER 6B; PBD6B]
FBgn0025809	Paf-AHalpha	HGNC:8576	OMIM:603074	PAFAH1B3	12		
FBgn0025809	Paf-AHalpha	HGNC:8575	OMIM:602508	PAFAH1B2	15		
FBgn0030691	Efhc1.1	HGNC:26233	OMIM:300817	EFHC2	14		
FBgn0030691	Efhc1.1	HGNC:16406	OMIM:608815	EFHC1	4	254770,607631	254770[EPILEPSY, MYOCLONIC JUVENILE; EJM],607631[EPILEPSY, JUVENILE ABSENCE, SUSCEPTIBILITY TO, 1; EJA1]
FBgn0030685	Graf	HGNC:26545	OMIM:615936	ARHGAP42	12		
FBgn0030685	Graf	HGNC:8148	OMIM:300127	OPHN1	9	300486	300486[INTELLECTUAL DEVELOPMENTAL DISORDER, X-LINKED, SYNDROMIC, BILLUART TYPE; MRXSBL]
FBgn0030685	Graf	HGNC:26099	OMIM:609746	ARHGAP10	11		
FBgn0030685	Graf	HGNC:17073	OMIM:605370	ARHGAP26	14	607785	607785[JUVENILE MYELOMONOCYTIC LEUKEMIA; JMML]
FBgn0030678	CG11679	HGNC:21176	OMIM:614917	RMND1	13	614922	614922[COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 11; COXPD11]
FBgn0011741	Arp6	HGNC:24025	OMIM:619729	ACTR6	15		
FBgn0030676	CG12379	HGNC:33879		DNLZ	11		
FBgn0030731	Mfe2	HGNC:5213	OMIM:601860	HSD17B4	15	233400,261515	233400[PERRAULT SYNDROME 1; PRLTS1],261515[D-BIFUNCTIONAL PROTEIN DEFICIENCY]
FBgn0004066	Prosalpha4	HGNC:22985	OMIM:617841	PSMA8	13		
FBgn0004066	Prosalpha4	HGNC:9536	OMIM:606607	PSMA7	13		
FBgn0000536	eas	HGNC:24649	OMIM:609858	ETNK1	14		
FBgn0000536	eas	HGNC:25575	OMIM:609859	ETNK2	11		
FBgn0000536	eas	HGNC:1937	OMIM:118491	CHKA	3	620023	620023[NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, MOVEMENT ABNORMALITIES, AND SEIZURES; NEDMIMS]
FBgn0030733	UQCR-14	HGNC:12582	OMIM:191330	UQCRB	14	615158	615158[MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 3; MC3DN3]
FBgn0030735	CG3632	HGNC:7449	OMIM:300171	MTMR1	4		
FBgn0030735	CG3632	HGNC:7453	OMIM:603561	MTMR6	3		
FBgn0030735	CG3632	HGNC:7448	OMIM:300415	MTM1	4	310400	310400[MYOPATHY, CENTRONUCLEAR, X-LINKED; CNMX]
FBgn0030735	CG3632	HGNC:7451	OMIM:603558	MTMR3	12		
FBgn0030735	CG3632	HGNC:7452	OMIM:603559	MTMR4	13		
FBgn0030735	CG3632	HGNC:7450	OMIM:603557	MTMR2	4	601382	601382[CHARCOT-MARIE-TOOTH DISEASE, TYPE 4B1; CMT4B1]
FBgn0030735	CG3632	HGNC:7454	OMIM:603562	MTMR7	3		
FBgn0030735	CG3632	HGNC:16825	OMIM:301061	MTMR8	3		
FBgn0030739	SWIP	HGNC:29174	OMIM:615748	WASHC4	14	615817	615817[INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 43; MRT43]
FBgn0052579	CG32579	HGNC:25508	OMIM:619940	XKR8	6		
FBgn0052579	CG32579	HGNC:29394		XKR4	7		
FBgn0052579	CG32579	HGNC:27806		XKR6	10		
FBgn0052579	CG32579	HGNC:23062		XKR7	7		
FBgn0052579	CG32579	HGNC:20937		XKR9	6		
FBgn0260450	CalpC	HGNC:1479	OMIM:114230	CAPN2	5		
FBgn0260450	CalpC	HGNC:1476	OMIM:114220	CAPN1	4	616907	616907[SPASTIC PARAPLEGIA 76, AUTOSOMAL RECESSIVE; SPG76]
FBgn0260450	CalpC	HGNC:1478	OMIM:604822	CAPN11	4		
FBgn0260450	CalpC	HGNC:1480	OMIM:114240	CAPN3	5	253600,618129	253600[MUSCULAR DYSTROPHY, LIMB-GIRDLE, AUTOSOMAL RECESSIVE 1; LGMDR1],618129[MUSCULAR DYSTROPHY, LIMB-GIRDLE, AUTOSOMAL DOMINANT 4; LGMDD4]
FBgn0260450	CalpC	HGNC:16664	OMIM:610229	CAPN14	4		
FBgn0260450	CalpC	HGNC:1485	OMIM:618777	CAPN8	3		
FBgn0260450	CalpC	HGNC:13249	OMIM:608839	CAPN12	3		
FBgn0260450	CalpC	HGNC:1486	OMIM:606401	CAPN9	5		
FBgn0260450	CalpC	HGNC:16663	OMIM:610228	CAPN13	4		
FBgn0260450	CalpC	HGNC:1477	OMIM:605286	CAPN10	4	601283	601283[TYPE 2 DIABETES MELLITUS 1; T2D1]
FBgn0003416	sl	HGNC:9066	OMIM:600220	PLCG2	10	614468,614878	614468[FAMILIAL COLD AUTOINFLAMMATORY SYNDROME 3; FCAS3],614878[AUTOINFLAMMATION, ANTIBODY DEFICIENCY, AND IMMUNE DYSREGULATION; APLAID]
FBgn0003416	sl	HGNC:9065	OMIM:172420	PLCG1	13		
FBgn0005411	U2af50	HGNC:23156	OMIM:191318	U2AF2	15		
FBgn0030743	CG9921	HGNC:24318		HIGD1B	5		
FBgn0030743	CG9921	HGNC:28311		HIGD2A	12		
FBgn0030743	CG9921	HGNC:29527	OMIM:618623	HIGD1A	3		
FBgn0030743	CG9921	HGNC:28044		HIGD1C	4		
FBgn0030743	CG9921	HGNC:26984		HIGD2B	7		
FBgn0004432	Cyp1	HGNC:14650	OMIM:606093	PPIG	3		
FBgn0004432	Cyp1	HGNC:9256	OMIM:123842	PPIC	3		
FBgn0004432	Cyp1	HGNC:33996		PPIAL4G	4		
FBgn0004432	Cyp1	HGNC:7833	OMIM:161565	NKTR	3		
FBgn0004432	Cyp1	HGNC:14651	OMIM:606095	PPIH	3		
FBgn0004432	Cyp1	HGNC:24369		PPIAL4A	3		
FBgn0004432	Cyp1	HGNC:9257	OMIM:601753	PPID	3		
FBgn0004432	Cyp1	HGNC:9255	OMIM:123841	PPIB	3	259440	259440[OSTEOGENESIS IMPERFECTA, TYPE IX; OI9]
FBgn0004432	Cyp1	HGNC:33998		PPIAL4D	3		
FBgn0004432	Cyp1	HGNC:9259	OMIM:604486	PPIF	11		
FBgn0004432	Cyp1	HGNC:33995		PPIAL4C	4		
FBgn0004432	Cyp1	HGNC:9253	OMIM:123840	PPIA	6		
FBgn0004432	Cyp1	HGNC:33999		PPIAL4F	4		
FBgn0004432	Cyp1	HGNC:33997	OMIM:608608	PPIAL4E	3		
FBgn0004432	Cyp1	HGNC:53889		PPIAL4H	4		
FBgn0030738	CG9915	HGNC:25467		IWS1	11		
FBgn0030734	ERp44	HGNC:18311	OMIM:609170	ERP44	15		
FBgn0040207	kat80	HGNC:6217	OMIM:602703	KATNB1	12	616212	616212[LISSENCEPHALY 6 WITH MICROCEPHALY; LIS6]
FBgn0004598	Fur2	HGNC:8569	OMIM:167405	PCSK6	7		
FBgn0004598	Fur2	HGNC:8747	OMIM:600488	PCSK5	10		
FBgn0004598	Fur2	HGNC:8746	OMIM:600487	PCSK4	5		
FBgn0004598	Fur2	HGNC:8568	OMIM:136950	FURIN	4		
FBgn0004598	Fur2	HGNC:8748	OMIM:604872	PCSK7	3		
FBgn0030745	CG4239	HGNC:25535	OMIM:611236	TMEM38B	12	615066	615066[OSTEOGENESIS IMPERFECTA, TYPE XIV; OI14]
FBgn0030745	CG4239	HGNC:28462	OMIM:611235	TMEM38A	13		
FBgn0004367	mei-41	HGNC:882	OMIM:601215	ATR	11	210600,614564	210600[SECKEL SYNDROME 1; SCKL1],614564[CUTANEOUS TELANGIECTASIA AND CANCER SYNDROME, FAMILIAL; FCTCS]
FBgn0030747	CG4301	HGNC:13534	OMIM:605867	ATP8B2	3		
FBgn0030747	CG4301	HGNC:3706	OMIM:602397	ATP8B1	3	147480,211600,243300	147480[CHOLESTASIS, INTRAHEPATIC, OF PREGNANCY, 1; ICP1],211600[CHOLESTASIS, PROGRESSIVE FAMILIAL INTRAHEPATIC, 1; PFIC1],243300[CHOLESTASIS, BENIGN RECURRENT INTRAHEPATIC, 1; BRIC1]
FBgn0030747	CG4301	HGNC:13554	OMIM:300516	ATP11C	9	301015	301015[HEMOLYTIC ANEMIA, CONGENITAL, X-LINKED; HACXL]
FBgn0030747	CG4301	HGNC:13552	OMIM:605868	ATP11A	9	619810,619851	619810[DEAFNESS, AUTOSOMAL DOMINANT 84; DFNA84],619851[LEUKODYSTROPHY, HYPOMYELINATING, 24; HLD24]
FBgn0030747	CG4301	HGNC:13542	OMIM:605855	ATP10A	4		
FBgn0030747	CG4301	HGNC:13553	OMIM:605869	ATP11B	9		
FBgn0030747	CG4301	HGNC:13549	OMIM:619815	ATP10D	5		
FBgn0030747	CG4301	HGNC:13543	OMIM:619791	ATP10B	6		
FBgn0030747	CG4301	HGNC:13535	OMIM:605866	ATP8B3	3		
FBgn0030748	Traf-like	HGNC:12032	OMIM:601895	TRAF2	3		
FBgn0030753	rngo	HGNC:18961		DDI1	13		
FBgn0030753	rngo	HGNC:24578		DDI2	14		
FBgn0030753	rngo	HGNC:1167	OMIM:613125	NRIP3	3		
FBgn0030753	rngo	HGNC:23078		NRIP2	3		
FBgn0026181	Rok	HGNC:10252	OMIM:604002	ROCK2	14		
FBgn0026181	Rok	HGNC:10251	OMIM:601702	ROCK1	13		
FBgn0030752	Cdc50	HGNC:16667	OMIM:611028	TMEM30A	13		
FBgn0030752	Cdc50	HGNC:27254	OMIM:611029	TMEM30B	7		
FBgn0030749	AnxB11	HGNC:541	OMIM:106490	ANXA3	3		
FBgn0030749	AnxB11	HGNC:536	OMIM:602573	ANXA13	4		
FBgn0030749	AnxB11	HGNC:545	OMIM:186360	ANXA7	10		
FBgn0030749	AnxB11	HGNC:542	OMIM:106491	ANXA4	5		
FBgn0030749	AnxB11	HGNC:535	OMIM:602572	ANXA11	10	617839,619733	617839[AMYOTROPHIC LATERAL SCLEROSIS 23; ALS23],619733[INCLUSION BODY MYOPATHY AND BRAIN WHITE MATTER ABNORMALITIES; IBMWMA]
FBgn0030749	AnxB11	HGNC:533	OMIM:151690	ANXA1	3		
FBgn0030749	AnxB11	HGNC:534	OMIM:608008	ANXA10	4		
FBgn0030746	CG9981	HGNC:13534	OMIM:605867	ATP8B2	5		
FBgn0030746	CG9981	HGNC:3706	OMIM:602397	ATP8B1	5	147480,211600,243300	147480[CHOLESTASIS, INTRAHEPATIC, OF PREGNANCY, 1; ICP1],211600[CHOLESTASIS, PROGRESSIVE FAMILIAL INTRAHEPATIC, 1; PFIC1],243300[CHOLESTASIS, BENIGN RECURRENT INTRAHEPATIC, 1; BRIC1]
FBgn0030746	CG9981	HGNC:13536	OMIM:609123	ATP8B4	4		
FBgn0030746	CG9981	HGNC:13554	OMIM:300516	ATP11C	10	301015	301015[HEMOLYTIC ANEMIA, CONGENITAL, X-LINKED; HACXL]
FBgn0030746	CG9981	HGNC:13552	OMIM:605868	ATP11A	10	619810,619851	619810[DEAFNESS, AUTOSOMAL DOMINANT 84; DFNA84],619851[LEUKODYSTROPHY, HYPOMYELINATING, 24; HLD24]
FBgn0030746	CG9981	HGNC:13533	OMIM:605870	ATP8A2	4	615268	615268[CEREBELLAR ATAXIA, MENTAL RETARDATION, AND DYSEQUILIBRIUM SYNDROME 4; CAMRQ4]
FBgn0030746	CG9981	HGNC:13553	OMIM:605869	ATP11B	11		
FBgn0030746	CG9981	HGNC:13549	OMIM:619815	ATP10D	3		
FBgn0030746	CG9981	HGNC:13531	OMIM:609542	ATP8A1	4		
FBgn0030746	CG9981	HGNC:13543	OMIM:619791	ATP10B	3		
FBgn0030746	CG9981	HGNC:13535	OMIM:605866	ATP8B3	5		
FBgn0010416	TH1	HGNC:15934	OMIM:605297	NELFCD	14		
FBgn0010412	RpS19a	HGNC:10402	OMIM:603474	RPS19	12	105650	105650[DIAMOND-BLACKFAN ANEMIA 1; DBA1]
FBgn0030786	mRpL22	HGNC:14480	OMIM:611835	MRPL22	14		
FBgn0030788	Sap30	HGNC:25663	OMIM:610398	SAP30L	14		
FBgn0030788	Sap30	HGNC:10532	OMIM:603378	SAP30	11		
FBgn0030790	CG4768	HGNC:30103		C16orf72	10		
FBgn0030792	CG4789	HGNC:18072	OMIM:618542	RABL3	13	618680	618680[PANCREATIC CANCER, SUSCEPTIBILITY TO, 5; PNCA5]
FBgn0030795	ppk28	HGNC:101	OMIM:611741	ASIC3	6		
FBgn0030795	ppk28	HGNC:100	OMIM:602866	ASIC1	7		
FBgn0030795	ppk28	HGNC:21263	OMIM:606715	ASIC4	7		
FBgn0030795	ppk28	HGNC:99	OMIM:601784	ASIC2	6		
FBgn0030795	ppk28	HGNC:17537	OMIM:616693	ASIC5	7		
FBgn0030795	ppk28	HGNC:10599	OMIM:600228	SCNN1A	3	264350,613021,618126	264350[PSEUDOHYPOALDOSTERONISM, TYPE I, AUTOSOMAL RECESSIVE; PHA1B],613021[BRONCHIECTASIS WITH OR WITHOUT ELEVATED SWEAT CHLORIDE 2; BESC2],618126[LIDDLE SYNDROME 3; LIDLS3]
FBgn0030795	ppk28	HGNC:10600	OMIM:600760	SCNN1B	4	177200,211400,264350	177200[LIDDLE SYNDROME 1; LIDLS1],211400[BRONCHIECTASIS WITH OR WITHOUT ELEVATED SWEAT CHLORIDE 1; BESC1],264350[PSEUDOHYPOALDOSTERONISM, TYPE I, AUTOSOMAL RECESSIVE; PHA1B]
FBgn0030795	ppk28	HGNC:10601	OMIM:601328	SCNN1D	3		
FBgn0030795	ppk28	HGNC:10602	OMIM:600761	SCNN1G	3	264350,613071,618114	264350[PSEUDOHYPOALDOSTERONISM, TYPE I, AUTOSOMAL RECESSIVE; PHA1B],613071[BRONCHIECTASIS WITH OR WITHOUT ELEVATED SWEAT CHLORIDE 3; BESC3],618114[LIDDLE SYNDROME 2; LIDLS2]
FBgn0030796	CG4829	HGNC:4250	OMIM:612346	GGT1	10	231950	231950[GLUTATHIONURIA]
FBgn0030796	CG4829	HGNC:4251	OMIM:137181	GGT2	8	137181	137181[GAMMA-GLUTAMYLTRANSFERASE 2; GGT2]
FBgn0030796	CG4829	HGNC:4260	OMIM:137168	GGT5	7		
FBgn0030796	CG4829	HGNC:16437	OMIM:612338	GGTLC1	3		
FBgn0030796	CG4829	HGNC:18596	OMIM:612339	GGTLC2	3		
FBgn0030796	CG4829	HGNC:4259	OMIM:612342	GGT7	4		
FBgn0030799	CG4872	HGNC:2418	OMIM:123740	CRYM	13	616357	616357[DEAFNESS, AUTOSOMAL DOMINANT 40; DFNA40]
FBgn0030801	Polr3I	HGNC:17888	OMIM:606121	CRCP	12		
FBgn0027556	CG4928	HGNC:12570	OMIM:607995	UNC93A	15		
FBgn0030802	DENR	HGNC:2769	OMIM:604550	DENR	14		
FBgn0030800	Nprl2	HGNC:24969	OMIM:607072	NPRL2	14	617116	617116[EPILEPSY, FAMILIAL FOCAL, WITH VARIABLE FOCI 2; FFEVF2]
FBgn0030793	Rai1	HGNC:2992	OMIM:605996	DXO	14		
FBgn0030791	CG9132	HGNC:25528	OMIM:611624	NECAP2	13		
FBgn0030791	CG9132	HGNC:24539	OMIM:611623	NECAP1	13	615833	615833[DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 21; DEE21]
FBgn0030789	Rrp45	HGNC:9137	OMIM:606180	EXOSC9	13	618065	618065[PONTOCEREBELLAR HYPOPLASIA, TYPE 1D; PCH1D]
FBgn0030787	CG9609	HGNC:4662	OMIM:600860	GTF3A	9		
FBgn0001250	if	HGNC:6140	OMIM:192975	ITGA4	3		
FBgn0001250	if	HGNC:6145	OMIM:603963	ITGA9	3		
FBgn0001250	if	HGNC:6152	OMIM:151510	ITGAX	3		
FBgn0001250	if	HGNC:6148	OMIM:153370	ITGAL	3		
FBgn0001250	if	HGNC:6134	OMIM:192968	ITGA1	3		
FBgn0001250	if	HGNC:6137	OMIM:192974	ITGA2	3		
FBgn0001250	if	HGNC:6135	OMIM:604042	ITGA10	3		
FBgn0001250	if	HGNC:6136	OMIM:604789	ITGA11	3		
FBgn0001250	if	HGNC:6149	OMIM:120980	ITGAM	3		
FBgn0001250	if	HGNC:6138	OMIM:607759	ITGA2B	10	187800,273800	187800[BLEEDING DISORDER, PLATELET-TYPE, 16; BDPLT16],273800[GLANZMANN THROMBASTHENIA 1; GT1]
FBgn0001250	if	HGNC:6141	OMIM:135620	ITGA5	11		
FBgn0001250	if	HGNC:6150	OMIM:193210	ITGAV	10		
FBgn0001250	if	HGNC:6144	OMIM:604063	ITGA8	12	191830	191830[RENAL HYPODYSPLASIA/APLASIA 1; RHDA1]
FBgn0001250	if	HGNC:6146	OMIM:602453	ITGAD	3		
FBgn0001250	if	HGNC:6147	OMIM:604682	ITGAE	3		
FBgn0027528	goe	HGNC:8918	OMIM:300550	PHEX	3	307800	307800[HYPOPHOSPHATEMIC RICKETS, X-LINKED DOMINANT; XLHR]
FBgn0027528	goe	HGNC:6308	OMIM:613883	KEL	4	110900	110900[BLOOD GROUP--KELL SYSTEM; KEL]
FBgn0030775	CG9673	HGNC:6360	OMIM:605539	KLK12	3		
FBgn0015336	CG15865	HGNC:30438		MB21D2	4		
FBgn0015336	CG15865	HGNC:26722	OMIM:613936	TMEM102	3		
FBgn0030768	Nemp	HGNC:29001	OMIM:616496	NEMP1	12		
FBgn0030768	Nemp	HGNC:33700	OMIM:616497	NEMP2	11		
FBgn0030808	RhoGAP15B	HGNC:16924	OMIM:606645	ARAP2	7		
FBgn0030808	RhoGAP15B	HGNC:24097	OMIM:606647	ARAP3	10		
FBgn0030808	RhoGAP15B	HGNC:16925	OMIM:606646	ARAP1	9		
FBgn0030816	CG16700	HGNC:19659	OMIM:608332	SLC36A3	8		
FBgn0030816	CG16700	HGNC:18762	OMIM:608331	SLC36A2	8	138500,242600	138500[HYPERGLYCINURIA],242600[IMINOGLYCINURIA]
FBgn0030816	CG16700	HGNC:19660	OMIM:613760	SLC36A4	9		
FBgn0030816	CG16700	HGNC:13447	OMIM:608490	SLC38A1	3		
FBgn0030816	CG16700	HGNC:18761	OMIM:606561	SLC36A1	10		
FBgn0030816	CG16700	HGNC:14679	OMIM:608065	SLC38A4	3		
FBgn0030816	CG16700	HGNC:25582	OMIM:614236	SLC38A7	3		
FBgn0030816	CG16700	HGNC:19863	OMIM:616518	SLC38A6	3		
FBgn0030816	CG16700	HGNC:32434	OMIM:615585	SLC38A8	3	609218	609218[FOVEAL HYPOPLASIA 2; FVH2]
FBgn0030816	CG16700	HGNC:18044	OMIM:604437	SLC38A3	3	619881	619881[DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 102; DEE102]
FBgn0030817	CG4991	HGNC:19659	OMIM:608332	SLC36A3	7		
FBgn0030817	CG4991	HGNC:18762	OMIM:608331	SLC36A2	8	138500,242600	138500[HYPERGLYCINURIA],242600[IMINOGLYCINURIA]
FBgn0030817	CG4991	HGNC:19660	OMIM:613760	SLC36A4	8		
FBgn0030817	CG4991	HGNC:13447	OMIM:608490	SLC38A1	3		
FBgn0030817	CG4991	HGNC:18761	OMIM:606561	SLC36A1	8		
FBgn0030817	CG4991	HGNC:14679	OMIM:608065	SLC38A4	3		
FBgn0030817	CG4991	HGNC:25582	OMIM:614236	SLC38A7	4		
FBgn0030817	CG4991	HGNC:19863	OMIM:616518	SLC38A6	3		
FBgn0030817	CG4991	HGNC:32434	OMIM:615585	SLC38A8	3	609218	609218[FOVEAL HYPOPLASIA 2; FVH2]
FBgn0030817	CG4991	HGNC:18044	OMIM:604437	SLC38A3	3	619881	619881[DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 102; DEE102]
FBgn0000163	baz	HGNC:14446	OMIM:619353	PARD3B	11		
FBgn0000163	baz	HGNC:16051	OMIM:606745	PARD3	13		
FBgn0030828	CG5162	HGNC:6619	OMIM:151670	LIPC	3	125853,612797,614025	125853[TYPE 2 DIABETES MELLITUS; T2D],612797[HIGH DENSITY LIPOPROTEIN CHOLESTEROL LEVEL QUANTITATIVE TRAIT LOCUS 12; HDLCQ12],614025[HEPATIC LIPASE DEFICIENCY]
FBgn0030823	TTLL1A	HGNC:16118	OMIM:619838	TTLL9	4		
FBgn0030823	TTLL1A	HGNC:1312	OMIM:608955	TTLL1	9		
FBgn0030823	TTLL1A	HGNC:21586	OMIM:608291	TTL	3		
FBgn0002590	RpS5a	HGNC:10426	OMIM:603630	RPS5	13		
FBgn0065032	Arpc3B	HGNC:706	OMIM:604225	ARPC3	12		
FBgn0030812	wcy	HGNC:17327	OMIM:615049	WAC	11	616708	616708[DESANTO-SHINAWI SYNDROME; DESSH]
FBgn0030809	Ubr1	HGNC:16808	OMIM:605981	UBR1	12	243800	243800[JOHANSON-BLIZZARD SYNDROME; JBS]
FBgn0030809	Ubr1	HGNC:21289	OMIM:609134	UBR2	14		
FBgn0030806	CG13001	HGNC:24931	OMIM:300897	ZC4H2	13	301041,314580	301041[WIEACKER-WOLFF SYNDROME, FEMALE-RESTRICTED; WRWFFR],314580[WIEACKER-WOLFF SYNDROME; WRWF]
FBgn0030805	wus	HGNC:25802		DNAJC22	14		
FBgn0030838	CG5445	HGNC:21215	OMIM:612217	ILRUN	11		
FBgn0004854	B-H2	HGNC:953	OMIM:605211	BARHL1	9		
FBgn0004854	B-H2	HGNC:954	OMIM:605212	BARHL2	8		
FBgn0004854	B-H2	HGNC:956	OMIM:604823	BARX2	3		
FBgn0004854	B-H2	HGNC:955	OMIM:603260	BARX1	3		
FBgn0011758	B-H1	HGNC:953	OMIM:605211	BARHL1	10		
FBgn0011758	B-H1	HGNC:954	OMIM:605212	BARHL2	9		
FBgn0011758	B-H1	HGNC:956	OMIM:604823	BARX2	3		
FBgn0011758	B-H1	HGNC:955	OMIM:603260	BARX1	3		
FBgn0030839	ENGase	HGNC:24622	OMIM:611898	ENGASE	11		
FBgn0027602	CG8611	HGNC:16715	OMIM:616533	DDX31	14		
FBgn0024238	Fim	HGNC:6528	OMIM:153430	LCP1	14		
FBgn0024238	Fim	HGNC:9090	OMIM:602734	PLS1	12	618787	618787[DEAFNESS, AUTOSOMAL DOMINANT 76; DFNA76]
FBgn0024238	Fim	HGNC:9091	OMIM:300131	PLS3	14	300910	300910[BONE MINERAL DENSITY QUANTITATIVE TRAIT LOCUS 18; BMND18]
FBgn0030834	CG8675	HGNC:28784		C9orf85	12		
FBgn0030833	CG8915	HGNC:24721	OMIM:616530	YTHDC2	9		
FBgn0026313	X11L	HGNC:579	OMIM:602712	APBA2	7		
FBgn0026313	X11L	HGNC:580	OMIM:604262	APBA3	6		
FBgn0026313	X11L	HGNC:578	OMIM:602414	APBA1	7		
FBgn0030853	ND-24	HGNC:7717	OMIM:600532	NDUFV2	14	618229	618229[MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 7; MC1DN7]
FBgn0030855	CG5800	HGNC:2735	OMIM:601235	DDX10	14		
FBgn0026192	par-6	HGNC:15943	OMIM:607484	PARD6A	12		
FBgn0026192	par-6	HGNC:16076	OMIM:608976	PARD6G	14		
FBgn0026192	par-6	HGNC:16245	OMIM:608975	PARD6B	13		
FBgn0024184	unc-4	HGNC:33194		UNCX	6		
FBgn0026058	OdsH	HGNC:33194		UNCX	6		
FBgn0000617	Taf9	HGNC:17306	OMIM:300754	TAF9B	12		
FBgn0000617	Taf9	HGNC:11542	OMIM:600822	TAF9	12		
FBgn0030872	Ucp4A	HGNC:21065	OMIM:613725	SLC25A27	14		
FBgn0052557	Mco4	HGNC:2295	OMIM:117700	CP	3	604290	604290[ACERULOPLASMINEMIA]
FBgn0052557	Mco4	HGNC:30477	OMIM:618455	HEPHL1	3	261990	261990[ABNORMAL HAIR, JOINT LAXITY, AND DEVELOPMENTAL DELAY; HJDD]
FBgn0052557	Mco4	HGNC:4866	OMIM:300167	HEPH	3		
FBgn0030873	CG15814	HGNC:27735		RNF175	13		
FBgn0030873	CG15814	HGNC:21070		RNF121	15		
FBgn0030871	CG8142	HGNC:9972	OMIM:102577	RFC4	13		
FBgn0030869	Socs16D	HGNC:16833	OMIM:605118	SOCS6	4		
FBgn0030869	Socs16D	HGNC:29846	OMIM:608788	SOCS7	7		
FBgn0030864	CG8173	HGNC:18282	OMIM:611210	PBK	15		
FBgn0030858	IntS2	HGNC:29241	OMIM:611346	INTS2	14		
FBgn0026375	RhoGAPp190	HGNC:675	OMIM:602680	ARHGAP5	13		
FBgn0026375	RhoGAPp190	HGNC:4591	OMIM:605277	ARHGAP35	12		
FBgn0030854	CG8289	HGNC:1555	OMIM:604478	CBX5	4		
FBgn0030854	CG8289	HGNC:1551	OMIM:604511	CBX1	4		
FBgn0030854	CG8289	HGNC:1553	OMIM:604477	CBX3	4		
FBgn0030851	CG8326	HGNC:33451	OMIM:614271	CCDC137	8		
FBgn0030850	stas	HGNC:28948		TMEM41B	13		
FBgn0028343	Ankle2	HGNC:29101	OMIM:616062	ANKLE2	9	616681	616681[MICROCEPHALY 16, PRIMARY, AUTOSOMAL RECESSIVE; MCPH16]
FBgn0030876	Srx	HGNC:16132	OMIM:617583	SRXN1	14		
FBgn0030878	CG6769	HGNC:30958	OMIM:608694	ZNF622	15		
FBgn0030880	CG6788	HGNC:3624	OMIM:601624	FCN2	3		
FBgn0030880	CG6788	HGNC:3623	OMIM:601252	FCN1	3		
FBgn0030880	CG6788	HGNC:25922	OMIM:613357	FIBCD1	4		
FBgn0030880	CG6788	HGNC:3695	OMIM:605776	FGL1	4		
FBgn0030880	CG6788	HGNC:3625	OMIM:604973	FCN3	3	613860	613860[FICOLIN 3 DEFICIENCY]
FBgn0030882	Gss1	HGNC:4624	OMIM:601002	GSS	14	231900,266130	231900[GLUTATHIONE SYNTHETASE DEFICIENCY OF ERYTHROCYTES, HEMOLYTIC ANEMIA DUE TO; GSSDE],266130[GLUTATHIONE SYNTHETASE DEFICIENCY; GSSD]
FBgn0030884	CG6847	HGNC:9155	OMIM:246600	PNLIP	7	614338	614338[PANCREATIC LIPASE DEFICIENCY; PNLIPD]
FBgn0030884	CG6847	HGNC:17661	OMIM:607460	PLA1A	4		
FBgn0030884	CG6847	HGNC:9156	OMIM:604422	PNLIPRP1	6		
FBgn0030884	CG6847	HGNC:23492		PNLIPRP3	6		
FBgn0030884	CG6847	HGNC:6619	OMIM:151670	LIPC	3	125853,612797,614025	125853[TYPE 2 DIABETES MELLITUS; T2D],612797[HIGH DENSITY LIPOPROTEIN CHOLESTEROL LEVEL QUANTITATIVE TRAIT LOCUS 12; HDLCQ12],614025[HEPATIC LIPASE DEFICIENCY]
FBgn0030884	CG6847	HGNC:18821	OMIM:609252	LIPI	4		
FBgn0030884	CG6847	HGNC:18483	OMIM:607365	LIPH	3	604379	604379[HYPOTRICHOSIS 7; HYPT7]
FBgn0030884	CG6847	HGNC:9157	OMIM:604423	PNLIPRP2	4		
FBgn0030889	CG15373	HGNC:29599	OMIM:616906	CASC1	10		
FBgn0030891	Ada3	HGNC:19422	OMIM:602945	TADA3	15		
FBgn0021765	scu	HGNC:4800	OMIM:300256	HSD17B10	15	300438	300438[HSD10 MITOCHONDRIAL DISEASE; HSD10MD]
FBgn0030893	RhoGAP16F	HGNC:21030	OMIM:610578	ARHGAP15	4		
FBgn0030893	RhoGAP16F	HGNC:14130	OMIM:610576	ARHGAP9	3		
FBgn0030893	RhoGAP16F	HGNC:16348	OMIM:610577	ARHGAP12	4		
FBgn0030893	RhoGAP16F	HGNC:31813	OMIM:610591	ARHGAP27	4		
FBgn0022724	Taf8	HGNC:17300	OMIM:609514	TAF8	14	619972	619972[NEURODEVELOPMENTAL DISORDER WITH SEVERE MOTOR IMPAIRMENT, ABSENT LANGUAGE, CEREBRAL HYPOMYELINATION, AND BRAIN ATROPHY; NEDMLHB]
FBgn0030894	Mvb12	HGNC:25153		MVB12A	8		
FBgn0030894	Mvb12	HGNC:23368		MVB12B	8		
FBgn0030890	CG7536	HGNC:12827	OMIM:605237	XPR1	13	616413	616413[BASAL GANGLIA CALCIFICATION, IDIOPATHIC, 6; IBGC6]
FBgn0030883	CG7772	HGNC:26945	OMIM:610235	MTFP1	13		
FBgn0030877	Arp8	HGNC:14672	OMIM:619716	ACTR8	14		
FBgn0083228	Frq2	HGNC:3953	OMIM:603315	NCS1	14		
FBgn0083228	Frq2	HGNC:18212	OMIM:619211	HPCAL4	3		
FBgn0083228	Frq2	HGNC:12722	OMIM:600817	VSNL1	3		
FBgn0083228	Frq2	HGNC:5144	OMIM:142622	HPCA	3	224500	224500[DYSTONIA 2, TORSION, AUTOSOMAL RECESSIVE; DYT2]
FBgn0083228	Frq2	HGNC:5145	OMIM:600207	HPCAL1	4		
FBgn0030915	CG6179	HGNC:17946	OMIM:616759	NOSIP	14		
FBgn0022355	Tsf1	HGNC:11740	OMIM:190000	TF	4	209300	209300[ATRANSFERRINEMIA]
FBgn0022355	Tsf1	HGNC:6720	OMIM:150210	LTF	4		
FBgn0022355	Tsf1	HGNC:7037	OMIM:155750	MELTF	5		
FBgn0030918	CG15056	HGNC:21658	OMIM:609080	FBXL13	4		
FBgn0052549	Nt5b	HGNC:27678		NT5DC4	9		
FBgn0052549	Nt5b	HGNC:8022	OMIM:600417	NT5C2	14	613162	613162[SPASTIC PARAPLEGIA 45, AUTOSOMAL RECESSIVE; SPG45]
FBgn0008635	betaCOP	HGNC:2231	OMIM:600959	COPB1	14	619255	619255[BARALLE-MACKEN SYNDROME; BARMACS]
FBgn0004957	por	HGNC:17652	OMIM:300651	PORCN	13	305600	305600[FOCAL DERMAL HYPOPLASIA; FDH]
FBgn0030899	Hesr	HGNC:18254	OMIM:610331	HES6	3		
FBgn0030899	Hesr	HGNC:19764	OMIM:607348	HES5	3		
FBgn0030931	Xrcc2	HGNC:12829	OMIM:600375	XRCC2	7	617247,619145,619146	617247[FANCONI ANEMIA, COMPLEMENTATION GROUP U; FANCU],619145[SPERMATOGENIC FAILURE 50; SPGF50],619146[PREMATURE OVARIAN FAILURE 17; POF17]
FBgn0027087	HisRS	HGNC:4817	OMIM:600783	HARS2	12	614926	614926[PERRAULT SYNDROME 2; PRLTS2]
FBgn0027087	HisRS	HGNC:4816	OMIM:142810	HARS	15	614504,616625	614504[USHER SYNDROME, TYPE IIIB; USH3B],616625[CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2W; CMT2W]
FBgn0030943	Nup35	HGNC:29797	OMIM:608140	NUP35	13		
FBgn0001079	fu	HGNC:17209	OMIM:607652	STK36	8	619436	619436[CILIARY DYSKINESIA, PRIMARY, 46; CILD46]
FBgn0030949	Cyp308a1	HGNC:2638	OMIM:605325	CYP3A5	4	145500	145500[HYPERTENSION, ESSENTIAL]
FBgn0030949	Cyp308a1	HGNC:17450	OMIM:606534	CYP3A43	4		
FBgn0030949	Cyp308a1	HGNC:11609	OMIM:274180	TBXAS1	4	231095	231095[GHOSAL HEMATODIAPHYSEAL DYSPLASIA; GHDD]
FBgn0030949	Cyp308a1	HGNC:2637	OMIM:124010	CYP3A4	4	619073	619073[VITAMIN D-DEPENDENT RICKETS, TYPE 3; VDDR3]
FBgn0030949	Cyp308a1	HGNC:51504		CYP3A7-CYP3A51P	4		
FBgn0030951	CG6873	HGNC:1874	OMIM:601442	CFL1	9		
FBgn0030951	CG6873	HGNC:1875	OMIM:601443	CFL2	11	610687	610687[NEMALINE MYOPATHY 7; NEM7]
FBgn0030951	CG6873	HGNC:15750	OMIM:609114	DSTN	9		
FBgn0010383	Cyp18a1	HGNC:15654	OMIM:611529	CYP2S1	4		
FBgn0010383	Cyp18a1	HGNC:2610	OMIM:122720	CYP2A6	6	122700,188890,211980	122700[COUMARIN RESISTANCE],188890[TOBACCO ADDICTION, SUSCEPTIBILITY TO],211980[LUNG CANCER]
FBgn0010383	Cyp18a1	HGNC:2611	OMIM:608054	CYP2A7	5		
FBgn0010383	Cyp18a1	HGNC:2608	OMIM:608055	CYP2A13	6		
FBgn0010383	Cyp18a1	HGNC:2615	OMIM:123930	CYP2B6	7	614546	614546[EFAVIRENZ, POOR METABOLISM OF]
FBgn0010383	Cyp18a1	HGNC:2621	OMIM:124020	CYP2C19	7	609535	609535[DRUG METABOLISM, POOR, CYP2C19-RELATED]
FBgn0010383	Cyp18a1	HGNC:2622	OMIM:601129	CYP2C8	7	618018	618018[DRUG METABOLISM, ALTERED, CYP2C8-RELATED]
FBgn0010383	Cyp18a1	HGNC:2623	OMIM:601130	CYP2C9	7	122700	122700[COUMARIN RESISTANCE]
FBgn0010383	Cyp18a1	HGNC:2620	OMIM:601131	CYP2C18	6		
FBgn0010383	Cyp18a1	HGNC:2631	OMIM:124040	CYP2E1	4		
FBgn0010383	Cyp18a1	HGNC:2632	OMIM:124070	CYP2F1	4		
FBgn0010383	Cyp18a1	HGNC:2634	OMIM:601258	CYP2J2	9		
FBgn0010383	Cyp18a1	HGNC:20580	OMIM:608713	CYP2R1	6	600081	600081[VITAMIN D HYDROXYLATION-DEFICIENT RICKETS, TYPE 1B; VDDR1B]
FBgn0010383	Cyp18a1	HGNC:2625	OMIM:124030	CYP2D6	7	608902	608902[DRUG METABOLISM, POOR, CYP2D6-RELATED]
FBgn0010383	Cyp18a1	HGNC:20582	OMIM:610670	CYP2U1	9	615030	615030[SPASTIC PARAPLEGIA 56, AUTOSOMAL RECESSIVE, WITH OR WITHOUT PSEUDOXANTHOMA ELASTICUM; SPG56]
FBgn0010383	Cyp18a1	HGNC:2624		CYP2D7	3		
FBgn0030947	CG6696	HGNC:7015	OMIM:600388	MEP1A	4		
FBgn0030947	CG6696	HGNC:7020	OMIM:600389	MEP1B	6		
FBgn0030947	CG6696	HGNC:31704	OMIM:608860	ASTL	6	619643	619643[OOCYTE MATURATION DEFECT 11; OOMD11]
FBgn0030946	CG6659	HGNC:22205	OMIM:613892	DPY19L1	10		
FBgn0030946	CG6659	HGNC:19414	OMIM:613893	DPY19L2	9	613958	613958[SPERMATOGENIC FAILURE 9; SPGF9]
FBgn0030946	CG6659	HGNC:27829	OMIM:613895	DPY19L4	4		
FBgn0030946	CG6659	HGNC:27120	OMIM:613894	DPY19L3	4		
FBgn0030945	Ing3	HGNC:6063	OMIM:604215	ING2	4		
FBgn0030945	Ing3	HGNC:19421	OMIM:608525	ING5	4		
FBgn0030945	Ing3	HGNC:6062	OMIM:601566	ING1	4	275355	275355[SQUAMOUS CELL CARCINOMA, HEAD AND NECK; HNSCC]
FBgn0030945	Ing3	HGNC:19423	OMIM:608524	ING4	4		
FBgn0030945	Ing3	HGNC:14587	OMIM:607493	ING3	9		
FBgn0030944	Hou	HGNC:15857	OMIM:611625	GID8	14		
FBgn0027335	Rip11	HGNC:29152	OMIM:608599	RAB11FIP2	11		
FBgn0027335	Rip11	HGNC:24845	OMIM:605536	RAB11FIP5	9		
FBgn0027335	Rip11	HGNC:30265	OMIM:608737	RAB11FIP1	7		
FBgn0030932	Ggt-1	HGNC:4250	OMIM:612346	GGT1	14	231950	231950[GLUTATHIONURIA]
FBgn0030932	Ggt-1	HGNC:4251	OMIM:137181	GGT2	13	137181	137181[GAMMA-GLUTAMYLTRANSFERASE 2; GGT2]
FBgn0030932	Ggt-1	HGNC:4260	OMIM:137168	GGT5	7		
FBgn0030932	Ggt-1	HGNC:16437	OMIM:612338	GGTLC1	7		
FBgn0030932	Ggt-1	HGNC:18596	OMIM:612339	GGTLC2	7		
FBgn0030932	Ggt-1	HGNC:4259	OMIM:612342	GGT7	4		
FBgn0030932	Ggt-1	HGNC:4252		GGT3P	4		
FBgn0030932	Ggt-1	HGNC:33426	OMIM:612340	GGTLC3	6		
FBgn0010194	Wnt5	HGNC:12786	OMIM:601570	WNT7A	3	228930,276820	228930[FIBULAR APLASIA OR HYPOPLASIA, FEMORAL BOWING AND POLY-, SYN-, AND OLIGODACTYLY],276820[ULNA AND FIBULA, ABSENCE OF, WITH SEVERE LIMB DEFICIENCY]
FBgn0010194	Wnt5	HGNC:12784	OMIM:164975	WNT5A	4	180700	180700[ROBINOW SYNDROME, AUTOSOMAL DOMINANT 1; DRS1]
FBgn0010194	Wnt5	HGNC:12781	OMIM:601968	WNT2B	3	618168	618168[DIARRHEA 9; DIAR9]
FBgn0010194	Wnt5	HGNC:12780	OMIM:147870	WNT2	3		
FBgn0010194	Wnt5	HGNC:12787	OMIM:601967	WNT7B	3		
FBgn0010194	Wnt5	HGNC:12783	OMIM:603490	WNT4	4	158330,611812	158330[MULLERIAN APLASIA AND HYPERANDROGENISM],611812[46,XX SEX REVERSAL WITH DYSGENESIS OF KIDNEYS, ADRENALS, AND LUNGS; SERKAL]
FBgn0010194	Wnt5	HGNC:16265	OMIM:606361	WNT5B	5		
FBgn0030930	Pgant7	HGNC:23233	OMIM:615132	GALNT16	3		
FBgn0030930	Pgant7	HGNC:4129	OMIM:605005	GALNT7	13		
FBgn0030930	Pgant7	HGNC:19875	OMIM:615130	GALNT11	3		
FBgn0030930	Pgant7	HGNC:23242	OMIM:608369	GALNT13	3		
FBgn0030930	Pgant7	HGNC:4128	OMIM:605148	GALNT6	3		
FBgn0030930	Pgant7	HGNC:21725	OMIM:615133	GALNTL5	3		
FBgn0030930	Pgant7	HGNC:21531	OMIM:615131	GALNT15	3		
FBgn0030955	CG6891	HGNC:18304	OMIM:606748	COTL1	12		
FBgn0030960	Atg101	HGNC:25679	OMIM:615089	ATG101	14		
FBgn0030964	Pvf1	HGNC:8799	OMIM:173430	PDGFA	8		
FBgn0030964	Pvf1	HGNC:8800	OMIM:190040	PDGFB	7	607174,607907,615483	607174[MENINGIOMA, FAMILIAL, SUSCEPTIBILITY TO],607907[DERMATOFIBROSARCOMA PROTUBERANS; DFSP],615483[BASAL GANGLIA CALCIFICATION, IDIOPATHIC, 5; IBGC5]
FBgn0030964	Pvf1	HGNC:8893	OMIM:601121	PGF	3		
FBgn0030964	Pvf1	HGNC:12680	OMIM:192240	VEGFA	4	603933	603933[MICROVASCULAR COMPLICATIONS OF DIABETES, SUSCEPTIBILITY TO, 1; MVCD1]
FBgn0030964	Pvf1	HGNC:12681	OMIM:601398	VEGFB	3		
FBgn0030964	Pvf1	HGNC:3708	OMIM:300091	VEGFD	3		
FBgn0030964	Pvf1	HGNC:12682	OMIM:601528	VEGFC	3	615907	615907[LYMPHATIC MALFORMATION 4; LMPHM4]
FBgn0030969	Usp39	HGNC:20071	OMIM:611594	USP39	13		
FBgn0030973	CG7332	HGNC:23578	OMIM:611649	MINDY3	15		
FBgn0030975	SdhBL	HGNC:10681	OMIM:185470	SDHB	8	115310,171300,606764,606864,619224	115310[PARAGANGLIOMAS 4; PGL4],171300[PHEOCHROMOCYTOMA],606764[GASTROINTESTINAL STROMAL TUMOR; GIST],606864[PARAGANGLIOMA AND GASTRIC STROMAL SARCOMA],619224[MITOCHONDRIAL COMPLEX II DEFICIENCY, NUCLEAR TYPE 4; MC2DN4]
FBgn0030976	CG7378	HGNC:3069	OMIM:600183	DUSP3	5		
FBgn0030976	CG7378	HGNC:28161	OMIM:618368	DUSP26	7		
FBgn0030976	CG7378	HGNC:19681	OMIM:613191	DUSP13	8		
FBgn0030976	CG7378	HGNC:23481	OMIM:618574	DUSP29	8		
FBgn0030976	CG7378	HGNC:25034		DUSP27	4		
FBgn0030974	Flacc	HGNC:20368	OMIM:616453	ZC3H13	5		
FBgn0030970	CG7326	HGNC:21381	OMIM:612495	UBE3D	5		
FBgn0030968	CG7322	HGNC:18985	OMIM:608347	DCXR	15	260800	260800[PENTOSURIA; PNTSU]
FBgn0030966	shop	HGNC:11460	OMIM:606887	SUOX	15	272300	272300[SULFITE OXIDASE DEFICIENCY, ISOLATED; ISOD]
FBgn0030959	CG6961	HGNC:23782	OMIM:611520	POLDIP3	8		
FBgn0030956	CG18259	HGNC:23782	OMIM:611520	POLDIP3	8		
FBgn0030954	CCKLR-17D3	HGNC:1571	OMIM:118445	CCKBR	10		
FBgn0030954	CCKLR-17D3	HGNC:1570	OMIM:118444	CCKAR	11		
FBgn0030992	CG33253	HGNC:13394	OMIM:604766	NPHS2	3	600995	600995[NEPHROTIC SYNDROME, TYPE 2; NPHS2]
FBgn0030992	CG33253	HGNC:3383	OMIM:133090	STOM	8		
FBgn0030992	CG33253	HGNC:19420	OMIM:608327	STOML3	7		
FBgn0030993	Mec2	HGNC:13394	OMIM:604766	NPHS2	3	600995	600995[NEPHROTIC SYNDROME, TYPE 2; NPHS2]
FBgn0030993	Mec2	HGNC:3383	OMIM:133090	STOM	7		
FBgn0030993	Mec2	HGNC:19420	OMIM:608327	STOML3	7		
FBgn0030996	CG14194	HGNC:18896		TMEM185B	11		
FBgn0030996	CG14194	HGNC:17125	OMIM:300031	TMEM185A	12		
FBgn0031000	Muc18B	HGNC:27780	OMIM:613918	HCG22	3		
FBgn0031003	CG7889	HGNC:32221	OMIM:615263	EEF2KMT	14		
FBgn0031003	CG7889	HGNC:32222	OMIM:616123	FAM86B2	11		
FBgn0031003	CG7889	HGNC:25561	OMIM:616124	FAM86C1	5		
FBgn0031003	CG7889	HGNC:28268	OMIM:616122	FAM86B1	11		
FBgn0031005	Hs3st-B	HGNC:5194	OMIM:603244	HS3ST1	3		
FBgn0031005	Hs3st-B	HGNC:5198	OMIM:604058	HS3ST3B1	13		
FBgn0031005	Hs3st-B	HGNC:19419	OMIM:609407	HS3ST5	3		
FBgn0031005	Hs3st-B	HGNC:5196	OMIM:604057	HS3ST3A1	12		
FBgn0031005	Hs3st-B	HGNC:5200	OMIM:604059	HS3ST4	10		
FBgn0031005	Hs3st-B	HGNC:14178	OMIM:619210	HS3ST6	14	619367	619367[ANGIOEDEMA, HEREDITARY, 8; HAE8]
FBgn0031005	Hs3st-B	HGNC:5195	OMIM:604056	HS3ST2	10		
FBgn0040068	Vav	HGNC:12657	OMIM:164875	VAV1	14		
FBgn0040068	Vav	HGNC:12658	OMIM:600428	VAV2	12		
FBgn0040068	Vav	HGNC:12659	OMIM:605541	VAV3	12		
FBgn0031012	CG8051	HGNC:17027	OMIM:607550	SLC16A10	3		
FBgn0031012	CG8051	HGNC:10923	OMIM:300095	SLC16A2	3	300523	300523[ALLAN-HERNDON-DUDLEY SYNDROME; AHDS]
FBgn0031012	CG8051	HGNC:10924	OMIM:603877	SLC16A3	4		
FBgn0031012	CG8051	HGNC:16270	OMIM:610409	SLC16A8	4		
FBgn0031012	CG8051	HGNC:26417		SLC16A14	4		
FBgn0031012	CG8051	HGNC:23093	OMIM:615765	SLC16A11	4		
FBgn0031012	CG8051	HGNC:23520	OMIM:614242	SLC16A9	4		
FBgn0031012	CG8051	HGNC:10922	OMIM:600682	SLC16A1	5	245340,610021,616095	245340[ERYTHROCYTE LACTATE TRANSPORTER DEFECT],610021[HYPERINSULINEMIC HYPOGLYCEMIA, FAMILIAL, 7; HHF7],616095[MONOCARBOXYLATE TRANSPORTER 1 DEFICIENCY; MCT1D]
FBgn0031012	CG8051	HGNC:10927	OMIM:603880	SLC16A6	4		
FBgn0031012	CG8051	HGNC:10925	OMIM:603878	SLC16A4	4		
FBgn0031012	CG8051	HGNC:31037		SLC16A13	5		
FBgn0031012	CG8051	HGNC:10926	OMIM:603879	SLC16A5	4		
FBgn0031012	CG8051	HGNC:10928	OMIM:603654	SLC16A7	5		
FBgn0031012	CG8051	HGNC:23094	OMIM:611910	SLC16A12	5	612018	612018[CATARACT 47; CTRCT47]
FBgn0031011	CG8034	HGNC:10924	OMIM:603877	SLC16A3	5		
FBgn0031011	CG8034	HGNC:16270	OMIM:610409	SLC16A8	4		
FBgn0031011	CG8034	HGNC:26417		SLC16A14	4		
FBgn0031011	CG8034	HGNC:23093	OMIM:615765	SLC16A11	3		
FBgn0031011	CG8034	HGNC:23520	OMIM:614242	SLC16A9	3		
FBgn0031011	CG8034	HGNC:10922	OMIM:600682	SLC16A1	5	245340,610021,616095	245340[ERYTHROCYTE LACTATE TRANSPORTER DEFECT],610021[HYPERINSULINEMIC HYPOGLYCEMIA, FAMILIAL, 7; HHF7],616095[MONOCARBOXYLATE TRANSPORTER 1 DEFICIENCY; MCT1D]
FBgn0031011	CG8034	HGNC:10927	OMIM:603880	SLC16A6	4		
FBgn0031011	CG8034	HGNC:10925	OMIM:603878	SLC16A4	4		
FBgn0031011	CG8034	HGNC:31037		SLC16A13	5		
FBgn0031011	CG8034	HGNC:10926	OMIM:603879	SLC16A5	4		
FBgn0031011	CG8034	HGNC:10928	OMIM:603654	SLC16A7	5		
FBgn0031011	CG8034	HGNC:23094	OMIM:611910	SLC16A12	5	612018	612018[CATARACT 47; CTRCT47]
FBgn0031010	CG8028	HGNC:10924	OMIM:603877	SLC16A3	5		
FBgn0031010	CG8028	HGNC:16270	OMIM:610409	SLC16A8	4		
FBgn0031010	CG8028	HGNC:26417		SLC16A14	4		
FBgn0031010	CG8028	HGNC:23093	OMIM:615765	SLC16A11	4		
FBgn0031010	CG8028	HGNC:23520	OMIM:614242	SLC16A9	3		
FBgn0031010	CG8028	HGNC:10922	OMIM:600682	SLC16A1	5	245340,610021,616095	245340[ERYTHROCYTE LACTATE TRANSPORTER DEFECT],610021[HYPERINSULINEMIC HYPOGLYCEMIA, FAMILIAL, 7; HHF7],616095[MONOCARBOXYLATE TRANSPORTER 1 DEFICIENCY; MCT1D]
FBgn0031010	CG8028	HGNC:10927	OMIM:603880	SLC16A6	4		
FBgn0031010	CG8028	HGNC:10925	OMIM:603878	SLC16A4	3		
FBgn0031010	CG8028	HGNC:31037		SLC16A13	6		
FBgn0031010	CG8028	HGNC:10926	OMIM:603879	SLC16A5	4		
FBgn0031010	CG8028	HGNC:10928	OMIM:603654	SLC16A7	5		
FBgn0031010	CG8028	HGNC:23094	OMIM:611910	SLC16A12	5	612018	612018[CATARACT 47; CTRCT47]
FBgn0052536	CG32536	HGNC:3123	OMIM:605772	EBAG9	8		
FBgn0031006	rictor	HGNC:28611	OMIM:609022	RICTOR	11		
FBgn0031002	CG14196	HGNC:17027	OMIM:607550	SLC16A10	3		
FBgn0031002	CG14196	HGNC:10923	OMIM:300095	SLC16A2	3	300523	300523[ALLAN-HERNDON-DUDLEY SYNDROME; AHDS]
FBgn0031002	CG14196	HGNC:10924	OMIM:603877	SLC16A3	4		
FBgn0031002	CG14196	HGNC:16270	OMIM:610409	SLC16A8	4		
FBgn0031002	CG14196	HGNC:26417		SLC16A14	4		
FBgn0031002	CG14196	HGNC:23093	OMIM:615765	SLC16A11	6		
FBgn0031002	CG14196	HGNC:23520	OMIM:614242	SLC16A9	4		
FBgn0031002	CG14196	HGNC:10922	OMIM:600682	SLC16A1	5	245340,610021,616095	245340[ERYTHROCYTE LACTATE TRANSPORTER DEFECT],610021[HYPERINSULINEMIC HYPOGLYCEMIA, FAMILIAL, 7; HHF7],616095[MONOCARBOXYLATE TRANSPORTER 1 DEFICIENCY; MCT1D]
FBgn0031002	CG14196	HGNC:10927	OMIM:603880	SLC16A6	4		
FBgn0031002	CG14196	HGNC:10925	OMIM:603878	SLC16A4	5		
FBgn0031002	CG14196	HGNC:31037		SLC16A13	5		
FBgn0031002	CG14196	HGNC:10926	OMIM:603879	SLC16A5	4		
FBgn0031002	CG14196	HGNC:10928	OMIM:603654	SLC16A7	5		
FBgn0031002	CG14196	HGNC:23094	OMIM:611910	SLC16A12	5	612018	612018[CATARACT 47; CTRCT47]
FBgn0027603	Ulp1	HGNC:28407	OMIM:612845	SENP5	3		
FBgn0027603	Ulp1	HGNC:17927	OMIM:612157	SENP1	7		
FBgn0027603	Ulp1	HGNC:23116	OMIM:608261	SENP2	8		
FBgn0027603	Ulp1	HGNC:17862	OMIM:612844	SENP3	4		
FBgn0030997	CG7990	HGNC:17893	OMIM:615187	PGAP2	5	614207	614207[HYPERPHOSPHATASIA WITH MENTAL RETARDATION SYNDROME 3; HPMRS3]
FBgn0030995	CG7914	HGNC:13397	OMIM:608341	CYB5R1	3		
FBgn0030995	CG7914	HGNC:32220		CYB5RL	13		
FBgn0030990	CG7556	HGNC:20090	OMIM:611207	DNAJC1	13		
FBgn0030982	CG7423	HGNC:15667	OMIM:606484	MTPN	11		
FBgn0031018	narya	HGNC:20438		RNF212B	8		
FBgn0031018	narya	HGNC:27729	OMIM:612041	RNF212	6	612042,619673	612042[RECOMBINATION RATE QUANTITATIVE TRAIT LOCUS 1; RRQTL1],619673[SPERMATOGENIC FAILURE 62; SPGF62]
FBgn0031020	Naa15-16	HGNC:30782	OMIM:608000	NAA15	13	617787	617787[INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL DOMINANT 50, WITH BEHAVIORAL ABNORMALITIES; MRD50]
FBgn0031020	Naa15-16	HGNC:26164	OMIM:619497	NAA16	14		
FBgn0031021	ND-18	HGNC:7711	OMIM:602694	NDUFS4	14	252010	252010[MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 1; MC1DN1]
FBgn0027621	Pfrx	HGNC:8873	OMIM:171835	PFKFB2	11		
FBgn0027621	Pfrx	HGNC:8875	OMIM:605320	PFKFB4	12		
FBgn0027621	Pfrx	HGNC:8872	OMIM:311790	PFKFB1	13		
FBgn0027621	Pfrx	HGNC:8874	OMIM:605319	PFKFB3	12		
FBgn0000257	car	HGNC:18179	OMIM:610034	VPS33A	15	617303	617303[MUCOPOLYSACCHARIDOSIS-PLUS SYNDROME; MPSPS]
FBgn0000257	car	HGNC:12712	OMIM:608552	VPS33B	3	208085,620009,620010	208085[ARTHROGRYPOSIS, RENAL DYSFUNCTION, AND CHOLESTASIS 1; ARCS1],620009[KERATODERMA-ICHTHYOSIS-DEAFNESS SYNDROME, AUTOSOMAL RECESSIVE; KDIDAR],620010[CHOLESTASIS, PROGRESSIVE FAMILIAL INTRAHEPATIC, 12; PFIC12]
FBgn0031037	CG14207	HGNC:2388	OMIM:123580	CRYAA	5	604219	604219[CATARACT 9, MULTIPLE TYPES; CTRCT9]
FBgn0031037	CG14207	HGNC:5247	OMIM:602179	HSPB2	3		
FBgn0031037	CG14207	HGNC:2389	OMIM:123590	CRYAB	4	608810,613763,613869,615184	608810[MYOPATHY, MYOFIBRILLAR, 2; MFM2],613763[CATARACT 16, MULTIPLE TYPES; CTRCT16],613869[MYOPATHY, MYOFIBRILLAR, FATAL INFANTILE HYPERTONIC, ALPHA-B CRYSTALLIN-RELATED],615184[CARDIOMYOPATHY, DILATED, 1II; CMD1II]
FBgn0031037	CG14207	HGNC:30171	OMIM:608014	HSPB8	3	158590,608673	158590[NEURONOPATHY, DISTAL HEREDITARY MOTOR, TYPE IIA; HMN2A],608673[CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2L; CMT2L]
FBgn0031037	CG14207	HGNC:5246	OMIM:602195	HSPB1	5	606595,608634	606595[CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2F; CMT2F],608634[NEURONOPATHY, DISTAL HEREDITARY MOTOR, TYPE IIB; HMN2B]
FBgn0031037	CG14207	HGNC:5248	OMIM:604624	HSPB3	3	613376	613376[NEURONOPATHY, DISTAL HEREDITARY MOTOR, TYPE IIC; HMN2C]
FBgn0031037	CG14207	HGNC:0		CRYAA2	3		
FBgn0031040	CG14210	HGNC:28359	OMIM:611293	CCDC86	8		
FBgn0031044	MKP-4	HGNC:3067	OMIM:604835	DUSP12	14		
FBgn0031045	CG14212	HGNC:16815		PHOSPHO1	7		
FBgn0031045	CG14212	HGNC:28316		PHOSPHO2	6		
FBgn0031047	Rcd-1	HGNC:10445	OMIM:612054	CNOT9	14		
FBgn0031049	Sec61gamma	HGNC:18277	OMIM:609215	SEC61G	14		
FBgn0031052	Elys	HGNC:24618	OMIM:610853	AHCTF1	9		
FBgn0031054	Ssu72	HGNC:25016	OMIM:617680	SSU72	14		
FBgn0004057	Zw	HGNC:4057	OMIM:305900	G6PD	15	300908,611162	300908[ANEMIA, NONSPHEROCYTIC HEMOLYTIC, DUE TO G6PD DEFICIENCY],611162[MALARIA, SUSCEPTIBILITY TO]
FBgn0004057	Zw	HGNC:4795	OMIM:138090	H6PD	3	604931	604931[CORTISONE REDUCTASE DEFICIENCY 1; CORTRD1]
FBgn0031057	Ubqn	HGNC:12508	OMIM:605046	UBQLN1	14		
FBgn0031057	Ubqn	HGNC:1237	OMIM:605440	UBQLN4	12		
FBgn0031057	Ubqn	HGNC:12509	OMIM:300264	UBQLN2	11	300857	300857[AMYOTROPHIC LATERAL SCLEROSIS 15 WITH OR WITHOUT FRONTOTEMPORAL DEMENTIA; ALS15]
FBgn0031057	Ubqn	HGNC:12510	OMIM:605473	UBQLN3	6		
FBgn0031057	Ubqn	HGNC:28294		UBQLNL	6		
FBgn0010341	Cdc42	HGNC:9802	OMIM:602049	RAC2	3	608203,618986,618987	608203[IMMUNODEFICIENCY 73A WITH DEFECTIVE NEUTROPHIL CHEMOTAXIS AND LEUKOCYTOSIS; IMD73A],618986[IMMUNODEFICIENCY 73B WITH DEFECTIVE NEUTROPHIL CHEMOTAXIS AND LYMPHOPENIA; IMD73B],618987[IMMUNODEFICIENCY 73C WITH DEFECTIVE NEUTROPHIL CHEMOTAXIS AND HYPOGAMMAGLOBULINEMIA; IMD73C]
FBgn0010341	Cdc42	HGNC:9801	OMIM:602048	RAC1	3	617751	617751[INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL DOMINANT 48; MRD48]
FBgn0010341	Cdc42	HGNC:9803	OMIM:602050	RAC3	3	618577	618577[NEURODEVELOPMENTAL DISORDER WITH STRUCTURAL BRAIN ANOMALIES AND DYSMORPHIC FACIES; NEDBAF]
FBgn0010341	Cdc42	HGNC:672	OMIM:179505	RHOG	3		
FBgn0010341	Cdc42	HGNC:17736	OMIM:605857	RHOQ	4		
FBgn0010341	Cdc42	HGNC:688	OMIM:607653	RHOJ	3		
FBgn0010341	Cdc42	HGNC:17794	OMIM:606366	RHOU	3		
FBgn0010341	Cdc42	HGNC:1736	OMIM:116952	CDC42	14	616737	616737[TAKENOUCHI-KOSAKI SYNDROME; TKS]
FBgn0031051	Ranbp21	HGNC:17675	OMIM:607845	XPO5	15		
FBgn0031050	Arp10	HGNC:17372	OMIM:619731	ACTR10	14		
FBgn0031048	CG12237	HGNC:16815		PHOSPHO1	12		
FBgn0031048	CG12237	HGNC:28316		PHOSPHO2	14		
FBgn0031043	Naa20A	HGNC:15908	OMIM:610833	NAA20	14	619717	619717[INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 73; MRT73]
FBgn0031042	CG14221	HGNC:12435	OMIM:187700	TXN	3		
FBgn0031042	CG14221	HGNC:16470	OMIM:617790	TXNDC2	3		
FBgn0031042	CG14221	HGNC:31454	OMIM:617789	TXNDC8	3		
FBgn0031042	CG14221	HGNC:21343	OMIM:618584	NME9	5		
FBgn0031036	CG14220	HGNC:29545	OMIM:608250	SUDS3	14		
FBgn0031030	Tao	HGNC:16835	OMIM:613199	TAOK2	9		
FBgn0031030	Tao	HGNC:18133	OMIM:616711	TAOK3	11		
FBgn0031030	Tao	HGNC:29259	OMIM:610266	TAOK1	12	619575	619575[DEVELOPMENTAL DELAY WITH OR WITHOUT INTELLECTUAL IMPAIRMENT OR BEHAVIORAL ABNORMALITIES; DDIB]
FBgn0026430	Grip84	HGNC:18599	OMIM:617817	TUBGCP2	15	618737	618737[PACHYGYRIA, MICROCEPHALY, DEVELOPMENTAL DELAY, AND DYSMORPHIC FACIES, WITH OR WITHOUT SEIZURES; PAMDDFS]
FBgn0031026	CG12231	HGNC:24264	OMIM:614638	DESI2	6		
FBgn0027291	Idh3a	HGNC:5384	OMIM:601149	IDH3A	14	619007	619007[RETINITIS PIGMENTOSA 90; RP90]
FBgn0040890	ksh	HGNC:28330	OMIM:620000	TMEM167A	13		
FBgn0020261	pcm	HGNC:30654	OMIM:607994	XRN1	12		
FBgn0020261	pcm	HGNC:12836	OMIM:608851	XRN2	3		
FBgn0044030	mRpS14	HGNC:14049	OMIM:611978	MRPS14	13	618378	618378[COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 38; COXPD38]
FBgn0052533	CG32533	HGNC:16719	OMIM:615475	DHX34	15		
FBgn0031062	CG14230	HGNC:23387	OMIM:611534	NOL8	9		
FBgn0031064	CG12531	HGNC:11060	OMIM:601872	SLC7A2	3		
FBgn0031064	CG12531	HGNC:11057	OMIM:104615	SLC7A1	3		
FBgn0031064	CG12531	HGNC:11061	OMIM:300443	SLC7A3	3		
FBgn0031064	CG12531	HGNC:29326	OMIM:615720	SLC7A14	14	615725	615725[RETINITIS PIGMENTOSA 68; RP68]
FBgn0010380	AP-1-2beta	HGNC:554	OMIM:600157	AP1B1	13	242150	242150[KERATITIS-ICHTHYOSIS-DEAFNESS SYNDROME, AUTOSOMAL RECESSIVE; KIDAR]
FBgn0010380	AP-1-2beta	HGNC:563	OMIM:601025	AP2B1	12		
FBgn0031065	CG14234	HGNC:33704		TMEM198	13		
FBgn0052528	parvin	HGNC:14653	OMIM:608121	PARVB	14		
FBgn0052528	parvin	HGNC:14652	OMIM:608120	PARVA	13		
FBgn0052528	parvin	HGNC:14654	OMIM:608122	PARVG	5		
FBgn0031068	Alr	HGNC:4236	OMIM:600924	GFER	12	613076	613076[MYOPATHY, MITOCHONDRIAL PROGRESSIVE, WITH CONGENITAL CATARACT AND DEVELOPMENTAL DELAY; MPMCD]
FBgn0031069	Abcd3	HGNC:66	OMIM:601081	ABCD2	4		
FBgn0031069	Abcd3	HGNC:61	OMIM:300371	ABCD1	4	300100	300100[ADRENOLEUKODYSTROPHY; ALD]
FBgn0031069	Abcd3	HGNC:67	OMIM:170995	ABCD3	15	616278	616278[BILE ACID SYNTHESIS DEFECT, CONGENITAL, 5; CBAS5]
FBgn0031069	Abcd3	HGNC:68	OMIM:603214	ABCD4	3	614857	614857[METHYLMALONIC ACIDURIA AND HOMOCYSTINURIA, cblJ TYPE; MAHCJ]
FBgn0026174	SkpD	HGNC:10899	OMIM:601434	SKP1	6		
FBgn0026175	SkpC	HGNC:10899	OMIM:601434	SKP1	7		
FBgn0031078	Nup205	HGNC:18658	OMIM:614352	NUP205	13	616893	616893[NEPHROTIC SYNDROME, TYPE 13; NPHS13]
FBgn0031077	THADA	HGNC:19217	OMIM:611800	THADA	9		
FBgn0031074	SkpE	HGNC:10899	OMIM:601434	SKP1	7		
FBgn0031070	CG12702	HGNC:29302	OMIM:610643	CIP2A	4		
FBgn0042132	CG18809	HGNC:28424		TRIR	8		
FBgn0031061	CG14232	HGNC:15453	OMIM:606809	ACBD3	12		
FBgn0031061	CG14232	HGNC:18633		TMED8	7		
FBgn0031060	Tcs4	HGNC:23075	OMIM:619634	OSGEPL1	14		
FBgn0031066	COX6B	HGNC:2280	OMIM:124089	COX6B1	13	619051	619051[MITOCHONDRIAL COMPLEX IV DEFICIENCY, NUCLEAR TYPE 7; MC4DN7]
FBgn0031066	COX6B	HGNC:24380	OMIM:618127	COX6B2	8		
FBgn0036936	CG14185	HGNC:25430	OMIM:618227	LRRC56	10	618254	618254[CILIARY DYSKINESIA, PRIMARY, 39; CILD39]
FBgn0005198	gig	HGNC:12363	OMIM:191092	TSC2	13	606690,607341,613254	606690[LYMPHANGIOLEIOMYOMATOSIS; LAM],607341[FOCAL CORTICAL DYSPLASIA, TYPE II; FCORD2],613254[TUBEROUS SCLEROSIS 2; TSC2]
FBgn0036959	CG6951	HGNC:2710	OMIM:607638	DCTD	14		
FBgn0036959	CG6951	HGNC:20299	OMIM:618997	CDADC1	4		
FBgn0024814	Clc	HGNC:2091	OMIM:118970	CLTB	13		
FBgn0024814	Clc	HGNC:2090	OMIM:118960	CLTA	13		
FBgn0036967	SCCRO4	HGNC:18184	OMIM:605905	DCUN1D1	4		
FBgn0036967	SCCRO4	HGNC:28409	OMIM:616522	DCUN1D5	13		
FBgn0036967	SCCRO4	HGNC:28734	OMIM:616167	DCUN1D3	3		
FBgn0036967	SCCRO4	HGNC:20328		DCUN1D2	4		
FBgn0036967	SCCRO4	HGNC:28998	OMIM:612977	DCUN1D4	12		
FBgn0052225	CG32225	HGNC:16097	OMIM:614641	LAMP5	8		
FBgn0036964	FRG1	HGNC:3954	OMIM:601278	FRG1	14		
FBgn0036962	CG17122	HGNC:27843		CFAP157	11		
FBgn0036958	CG17233	HGNC:29217	OMIM:616633	PRR12	3	619539	619539[NEUROOCULAR SYNDROME; NOC]
FBgn0036958	CG17233	HGNC:26154	OMIM:619440	QSER1	3		
FBgn0036958	CG17233	HGNC:26282	OMIM:619870	CCDC82	5		
FBgn0036942	CG7328	HGNC:6315	OMIM:614058	KHK	13	229800	229800[FRUCTOSURIA, ESSENTIAL]
FBgn0036941	CG7335	HGNC:6315	OMIM:614058	KHK	6	229800	229800[FRUCTOSURIA, ESSENTIAL]
FBgn0036939	CG7365	HGNC:30041	OMIM:610179	PLB1	10		
FBgn0036937	Ir76b	HGNC:4572	OMIM:138247	GRIA2	3	618917	618917[NEURODEVELOPMENTAL DISORDER WITH LANGUAGE IMPAIRMENT AND BEHAVIORAL ABNORMALITIES; NEDLIB]
FBgn0036937	Ir76b	HGNC:4573	OMIM:305915	GRIA3	3	300699	300699[INTELLECTUAL DEVELOPMENTAL DISORDER, X-LINKED, SYNDROMIC, WU TYPE; MRXSW]
FBgn0036937	Ir76b	HGNC:4580	OMIM:138244	GRIK2	3	611092,619580	611092[INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 6; MRT6],619580[NEURODEVELOPMENTAL DISORDER WITH IMPAIRED LANGUAGE AND ATAXIA AND WITH OR WITHOUT SEIZURES; NEDLAS]
FBgn0036937	Ir76b	HGNC:4581	OMIM:138243	GRIK3	3		
FBgn0036937	Ir76b	HGNC:4571	OMIM:138248	GRIA1	3	619927,619931	619927[INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL DOMINANT 67; MRD67],619931[INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 76; MRT76]
FBgn0036937	Ir76b	HGNC:4583	OMIM:600283	GRIK5	3		
FBgn0036937	Ir76b	HGNC:4579	OMIM:138245	GRIK1	3		
FBgn0036937	Ir76b	HGNC:4574	OMIM:138246	GRIA4	3	617864	617864[NEURODEVELOPMENTAL DISORDER WITH OR WITHOUT SEIZURES AND GAIT ABNORMALITIES; NEDSGA]
FBgn0036937	Ir76b	HGNC:4582	OMIM:600282	GRIK4	3		
FBgn0036937	Ir76b	HGNC:4576	OMIM:602368	GRID2	3	616204	616204[SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 18; SCAR18]
FBgn0036937	Ir76b	HGNC:4575	OMIM:610659	GRID1	3		
FBgn0036934	sNPF-R	HGNC:4464	OMIM:600895	PRLHR	8		
FBgn0036934	sNPF-R	HGNC:7957	OMIM:162642	NPY2R	6		
FBgn0036932	Lamtor1	HGNC:26068	OMIM:613510	LAMTOR1	12		
FBgn0036909	Ccdc58	HGNC:31136		MIX23	14		
FBgn0024889	Kap-alpha1	HGNC:6395	OMIM:600685	KPNA2	3		
FBgn0024889	Kap-alpha1	HGNC:6396	OMIM:601892	KPNA3	5		
FBgn0024889	Kap-alpha1	HGNC:6397	OMIM:602970	KPNA4	5		
FBgn0024889	Kap-alpha1	HGNC:6399	OMIM:610563	KPNA6	14		
FBgn0024889	Kap-alpha1	HGNC:21839	OMIM:614107	KPNA7	3		
FBgn0024889	Kap-alpha1	HGNC:6394	OMIM:600686	KPNA1	13		
FBgn0024889	Kap-alpha1	HGNC:6398	OMIM:604545	KPNA5	13		
FBgn0001324	kto	HGNC:16050	OMIM:611318	MED12L	12	618872	618872[NIZON-ISIDOR SYNDROME; NIZIDS]
FBgn0001324	kto	HGNC:11957	OMIM:300188	MED12	10	300895,301068,305450,309520	300895[OHDO SYNDROME, X-LINKED; OHDOX],301068[HARDIKAR SYNDROME; HDKR],305450[OPITZ-KAVEGGIA SYNDROME; OKS],309520[INTELLECTUAL DEVELOPMENTAL DISORDER, X-LINKED, SYNDROMIC, LUJAN-FRYNS TYPE; MRXSLF]
FBgn0020389	Papss	HGNC:8604	OMIM:603005	PAPSS2	12	612847	612847[BRACHYOLMIA TYPE 4 WITH MILD EPIPHYSEAL AND METAPHYSEAL CHANGES; BCYM4]
FBgn0020389	Papss	HGNC:8603	OMIM:603262	PAPSS1	14		
FBgn0036913	Usp32	HGNC:19143	OMIM:607740	USP32	11		
FBgn0036913	Usp32	HGNC:12629	OMIM:604334	USP6	8		
FBgn0036915	Prp3	HGNC:17348	OMIM:607301	PRPF3	14	601414	601414[RETINITIS PIGMENTOSA 18; RP18]
FBgn0028695	Rpn1	HGNC:9559	OMIM:606223	PSMD2	14		
FBgn0036918	Pfdn6	HGNC:4926	OMIM:605660	PFDN6	13		
FBgn0036919	Grasp65	HGNC:17500	OMIM:608693	GORASP2	11		
FBgn0036919	Grasp65	HGNC:16769	OMIM:606867	GORASP1	8		
FBgn0036921	RhoGDI	HGNC:679	OMIM:602843	ARHGDIB	13		
FBgn0036921	RhoGDI	HGNC:678	OMIM:601925	ARHGDIA	15	615244	615244[NEPHROTIC SYNDROME, TYPE 8; NPHS8]
FBgn0036921	RhoGDI	HGNC:680	OMIM:602844	ARHGDIG	11		
FBgn0004852	Ac76E	HGNC:235	OMIM:600292	ADCY4	10		
FBgn0004852	Ac76E	HGNC:238	OMIM:600385	ADCY7	9		
FBgn0004852	Ac76E	HGNC:233	OMIM:103071	ADCY2	11		
FBgn0004852	Ac76E	HGNC:237	OMIM:600294	ADCY6	3	616287	616287[LETHAL CONGENITAL CONTRACTURE SYNDROME 8; LCCS8]
FBgn0036926	CG7646	HGNC:3953	OMIM:603315	NCS1	4		
FBgn0036926	CG7646	HGNC:18212	OMIM:619211	HPCAL4	5		
FBgn0036926	CG7646	HGNC:12722	OMIM:600817	VSNL1	5		
FBgn0036926	CG7646	HGNC:5144	OMIM:142622	HPCA	4	224500	224500[DYSTONIA 2, TORSION, AUTOSOMAL RECESSIVE; DYT2]
FBgn0036926	CG7646	HGNC:9937	OMIM:179618	RCVRN	6		
FBgn0036926	CG7646	HGNC:5145	OMIM:600207	HPCAL1	5		
FBgn0036926	CG7646	HGNC:4678	OMIM:600364	GUCA1A	3	602093	602093[CONE DYSTROPHY 3; COD3]
FBgn0036926	CG7646	HGNC:4680	OMIM:605128	GUCA1C	3		
FBgn0036926	CG7646	HGNC:4679	OMIM:602275	GUCA1B	5	613827	613827[RETINITIS PIGMENTOSA 48; RP48]
FBgn0013303	Nca	HGNC:3953	OMIM:603315	NCS1	4		
FBgn0013303	Nca	HGNC:7655	OMIM:606722	NCALD	10		
FBgn0013303	Nca	HGNC:18212	OMIM:619211	HPCAL4	5		
FBgn0013303	Nca	HGNC:12722	OMIM:600817	VSNL1	5		
FBgn0013303	Nca	HGNC:5144	OMIM:142622	HPCA	10	224500	224500[DYSTONIA 2, TORSION, AUTOSOMAL RECESSIVE; DYT2]
FBgn0013303	Nca	HGNC:9937	OMIM:179618	RCVRN	3		
FBgn0013303	Nca	HGNC:5145	OMIM:600207	HPCAL1	13		
FBgn0013303	Nca	HGNC:4679	OMIM:602275	GUCA1B	3	613827	613827[RETINITIS PIGMENTOSA 48; RP48]
FBgn0036928	Tom20	HGNC:20947	OMIM:601848	TOMM20	15		
FBgn0036928	Tom20	HGNC:33752		TOMM20L	8		
FBgn0036929	CG7668	HGNC:3624	OMIM:601624	FCN2	3		
FBgn0036929	CG7668	HGNC:3623	OMIM:601252	FCN1	3		
FBgn0036929	CG7668	HGNC:25922	OMIM:613357	FIBCD1	3		
FBgn0036931	CG14183	HGNC:26195		IQCA1	7		
FBgn0036931	CG14183	HGNC:22831		IQCA1L	4		
FBgn0036927	Gabat	HGNC:23	OMIM:137150	ABAT	15	613163	613163[GABA-TRANSAMINASE DEFICIENCY]
FBgn0052220	Csas	HGNC:18290	OMIM:603316	CMAS	10		
FBgn0036922	CG14182	HGNC:27087		MOSMO	12		
FBgn0036920	CG8004	HGNC:7504	OMIM:600605	MTX1	3		
FBgn0036920	CG8004	HGNC:24812	OMIM:619336	MTX3	3		
FBgn0036920	CG8004	HGNC:7506	OMIM:608555	MTX2	14	619127	619127[MANDIBULOACRAL DYSPLASIA PROGEROID SYNDROME; MDPS]
FBgn0020887	Su(z)12	HGNC:17101	OMIM:606245	SUZ12	14	618786	618786[IMAGAWA-MATSUMOTO SYNDROME; IMMAS]
FBgn0014037	Su(Tpl)	HGNC:23114	OMIM:600284	ELL	9		
FBgn0014037	Su(Tpl)	HGNC:17064	OMIM:601874	ELL2	10		
FBgn0014037	Su(Tpl)	HGNC:26221		OCEL1	3		
FBgn0014037	Su(Tpl)	HGNC:23113	OMIM:609885	ELL3	5		
FBgn0014037	Su(Tpl)	HGNC:26401	OMIM:610572	MARVELD2	4	610153	610153[DEAFNESS, AUTOSOMAL RECESSIVE 49; DFNB49]
FBgn0003744	trc	HGNC:17847	OMIM:606964	STK38	14		
FBgn0003744	trc	HGNC:17848	OMIM:615836	STK38L	13		
FBgn0023094	cyc	HGNC:701	OMIM:602550	ARNTL	12		
FBgn0023094	cyc	HGNC:18984	OMIM:614517	ARNTL2	10		
FBgn0036910	Cyp305a1	HGNC:2615	OMIM:123930	CYP2B6	3	614546	614546[EFAVIRENZ, POOR METABOLISM OF]
FBgn0036910	Cyp305a1	HGNC:2621	OMIM:124020	CYP2C19	3	609535	609535[DRUG METABOLISM, POOR, CYP2C19-RELATED]
FBgn0036910	Cyp305a1	HGNC:2622	OMIM:601129	CYP2C8	3	618018	618018[DRUG METABOLISM, ALTERED, CYP2C8-RELATED]
FBgn0036910	Cyp305a1	HGNC:2623	OMIM:601130	CYP2C9	3	122700	122700[COUMARIN RESISTANCE]
FBgn0036910	Cyp305a1	HGNC:2620	OMIM:601131	CYP2C18	3		
FBgn0036910	Cyp305a1	HGNC:2634	OMIM:601258	CYP2J2	6		
FBgn0040786	CG14104	HGNC:31412	OMIM:616528	SWI5	3		
FBgn0036886	CG9300	HGNC:24557	OMIM:615366	NOL11	11		
FBgn0036888	CG9330	HGNC:72	OMIM:618967	ABCF3	15		
FBgn0010417	Taf6	HGNC:11540	OMIM:602955	TAF6	13	617126	617126[ALAZAMI-YUAN SYNDROME; ALYUS]
FBgn0036893	PIG-F	HGNC:8962	OMIM:600153	PIGF	9	619356	619356[ONYCHODYSTROPHY, OSTEODYSTROPHY, IMPAIRED INTELLECTUAL DEVELOPMENT, AND SEIZURES SYNDROME; OORS]
FBgn0029094	asf1	HGNC:20995	OMIM:609189	ASF1A	13		
FBgn0029094	asf1	HGNC:20996	OMIM:609190	ASF1B	12		
FBgn0004623	Gbeta76C	HGNC:4400	OMIM:139130	GNB3	4	145500,617024	145500[HYPERTENSION, ESSENTIAL],617024[NIGHT BLINDNESS, CONGENITAL STATIONARY, TYPE 1H; CSNB1H]
FBgn0004623	Gbeta76C	HGNC:4396	OMIM:139380	GNB1	5	613065,614286,616973	613065[LEUKEMIA, ACUTE LYMPHOBLASTIC; ALL],614286[MYELODYSPLASTIC SYNDROME; MDS],616973[INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL DOMINANT 42; MRD42]
FBgn0004623	Gbeta76C	HGNC:4398	OMIM:139390	GNB2	3	619464,619503	619464[SICK SINUS SYNDROME 4; SSS4],619503[NEURODEVELOPMENTAL DISORDER WITH HYPOTONIA AND DYSMORPHIC FACIES; NEDHYDF]
FBgn0004623	Gbeta76C	HGNC:20731	OMIM:610863	GNB4	4	615185	615185[CHARCOT-MARIE-TOOTH DISEASE, DOMINANT INTERMEDIATE F; CMTDIF]
FBgn0004623	Gbeta76C	HGNC:4401	OMIM:604447	GNB5	3	617173,617182	617173[INTELLECTUAL DEVELOPMENTAL DISORDER WITH CARDIAC ARRHYTHMIA; IDDCA],617182[LANGUAGE DELAY AND ATTENTION DEFICIT-HYPERACTIVITY DISORDER/COGNITIVE IMPAIRMENT WITH OR WITHOUT CARDIAC ARRHYTHMIA; LADCI]
FBgn0022774	Oat	HGNC:8091	OMIM:613349	OAT	14	258870	258870[GYRATE ATROPHY OF CHOROID AND RETINA; GACR]
FBgn0036897	Rnf146	HGNC:21336	OMIM:612137	RNF146	10		
FBgn0036896	wnd	HGNC:6852	OMIM:604915	MAP3K13	10		
FBgn0036896	wnd	HGNC:6851	OMIM:600447	MAP3K12	9		
FBgn0036892	Lon	HGNC:9479	OMIM:605490	LONP1	14	600373	600373[CODAS SYNDROME]
FBgn0005386	ash1	HGNC:19088	OMIM:607999	ASH1L	10	617796	617796[INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL DOMINANT 52; MRD52]
FBgn0005386	ash1	HGNC:15573	OMIM:611060	SETBP1	4	269150,616078	269150[SCHINZEL-GIEDION MIDFACE RETRACTION SYNDROME],616078[INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL DOMINANT 29; MRD29]
FBgn0005386	ash1	HGNC:12766	OMIM:602952	NSD2	3	619695	619695[RAUCH-STEINDL SYNDROME; RAUST]
FBgn0005386	ash1	HGNC:14234	OMIM:606681	NSD1	3	117550	117550[SOTOS SYNDROME; SOTOS]
FBgn0036889	CG14100	HGNC:18485	OMIM:612600	MRM3	13		
FBgn0036887	CG9231	HGNC:17865	OMIM:608017	FAM162A	11		
FBgn0036887	CG9231	HGNC:21549		FAM162B	9		
FBgn0005564	Shal	HGNC:6237	OMIM:300281	KCND1	9		
FBgn0005564	Shal	HGNC:6238	OMIM:605410	KCND2	13		
FBgn0005564	Shal	HGNC:6239	OMIM:605411	KCND3	12	607346,616399	607346[SPINOCEREBELLAR ATAXIA 19; SCA19],616399[BRUGADA SYNDROME 9; BRGDA9]
FBgn0036882	CG9279	HGNC:2711	OMIM:601143	DCTN1	7	105400,168605,607641	105400[AMYOTROPHIC LATERAL SCLEROSIS 1; ALS1],168605[PERRY SYNDROME],607641[NEURONOPATHY, DISTAL HEREDITARY MOTOR, TYPE VIIB; HMN7B]
FBgn0040075	rept	HGNC:10475	OMIM:604788	RUVBL2	15		
FBgn0036856	Mettl5	HGNC:25006	OMIM:618628	METTL5	14	618665	618665[INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 72; MRT72]
FBgn0036859	CG14085	HGNC:28532	OMIM:617266	KIAA0825	6	618498	618498[POLYDACTYLY, POSTAXIAL, TYPE A10; PAPA10]
FBgn0036860	CG14086	HGNC:31658		TMEM72	4		
FBgn0028380	fal	HGNC:15925	OMIM:606754	SAMHD1	11	612952,614415	612952[AICARDI-GOUTIERES SYNDROME 5; AGS5],614415[CHILBLAIN LUPUS 2; CHBL2]
FBgn0003089	pip	HGNC:17223	OMIM:610752	UST	5		
FBgn0036862	Gbs-76A	HGNC:9293	OMIM:602999	PPP1R3C	5		
FBgn0036862	Gbs-76A	HGNC:9294	OMIM:603326	PPP1R3D	6		
FBgn0036862	Gbs-76A	HGNC:14942	OMIM:610541	PPP1R3B	5		
FBgn0036862	Gbs-76A	HGNC:14943	OMIM:619540	PPP1R3E	5		
FBgn0036862	Gbs-76A	HGNC:9291	OMIM:600917	PPP1R3A	6	125853	125853[TYPE 2 DIABETES MELLITUS; T2D]
FBgn0036862	Gbs-76A	HGNC:14944		PPP1R3F	3		
FBgn0036862	Gbs-76A	HGNC:14945	OMIM:619541	PPP1R3G	4		
FBgn0036857	Aldh7A1	HGNC:877	OMIM:107323	ALDH7A1	14	266100	266100[EPILEPSY, PYRIDOXINE-DEPENDENT; EPD]
FBgn0017578	Max	HGNC:6913	OMIM:154950	MAX	13	171300	171300[PHEOCHROMOCYTOMA]
FBgn0026630	nes	HGNC:30244	OMIM:611950	LPCAT3	14		
FBgn0036853	mRpL21	HGNC:14479	OMIM:611834	MRPL21	12		
FBgn0036834	CG6836	HGNC:29955	OMIM:612084	SLC51A	6	619484	619484[CHOLESTASIS, PROGRESSIVE FAMILIAL INTRAHEPATIC, 6; PFIC6]
FBgn0036843	Sfxn2	HGNC:16087	OMIM:615571	SFXN3	3		
FBgn0036843	Sfxn2	HGNC:16086	OMIM:615570	SFXN2	14		
FBgn0036843	Sfxn2	HGNC:16085	OMIM:615569	SFXN1	3		
FBgn0036843	Sfxn2	HGNC:16073	OMIM:615572	SFXN5	4		
FBgn0036846	MESR6	HGNC:25639		C5orf22	13		
FBgn0036849	CG14079	HGNC:18309	OMIM:613947	SPATA6	7		
FBgn0036849	CG14079	HGNC:25472		SPATA6L	9		
FBgn0016797	fz2	HGNC:4043	OMIM:601723	FZD5	14		
FBgn0016797	fz2	HGNC:4046	OMIM:606146	FZD8	12		
FBgn0016797	fz2	HGNC:3959	OMIM:605083	FRZB	3	165720	165720[OSTEOARTHRITIS SUSCEPTIBILITY 1; OS1]
FBgn0016797	fz2	HGNC:10778	OMIM:606570	SFRP4	3	265900	265900[PYLE DISEASE; PYL]
FBgn0036850	Gem2	HGNC:10884	OMIM:602595	GEMIN2	13		
FBgn0036848	Naxd	HGNC:25576	OMIM:615910	NAXD	12	618321	618321[ENCEPHALOPATHY, PROGRESSIVE, EARLY-ONSET, WITH BRAIN EDEMA AND/OR LEUKOENCEPHALOPATHY, 2; PEBEL2]
FBgn0036847	CNPYb	HGNC:28631	OMIM:610047	CNPY4	14		
FBgn0036847	CNPYb	HGNC:11968	OMIM:610774	CNPY3	10	617929	617929[DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 60; DEE60]
FBgn0036844	Mkp3	HGNC:3073	OMIM:602749	DUSP7	12		
FBgn0036844	Mkp3	HGNC:3076	OMIM:300134	DUSP9	10		
FBgn0036844	Mkp3	HGNC:3065	OMIM:608867	DUSP10	3		
FBgn0036844	Mkp3	HGNC:3072	OMIM:602748	DUSP6	10	615269	615269[HYPOGONADOTROPIC HYPOGONADISM 19 WITH OR WITHOUT ANOSMIA; HH19]
FBgn0036842	Ugt316A1	HGNC:12531	OMIM:606435	UGT1A10	3		
FBgn0036842	Ugt316A1	HGNC:12545	OMIM:603064	UGT2B11	5		
FBgn0036842	Ugt316A1	HGNC:12530	OMIM:191740	UGT1A1	5	143500,218800,237900,601816,606785	143500[GILBERT SYNDROME],218800[CRIGLER-NAJJAR SYNDROME, TYPE I],237900[HYPERBILIRUBINEMIA, TRANSIENT FAMILIAL NEONATAL; HBLRTFN],601816[BILIRUBIN, SERUM LEVEL OF, QUANTITATIVE TRAIT LOCUS 1; BILIQTL1],606785[CRIGLER-NAJJAR SYNDROME, TYPE II]
FBgn0036842	Ugt316A1	HGNC:12555	OMIM:601291	UGT8	5		
FBgn0036842	Ugt316A1	HGNC:12539	OMIM:606432	UGT1A7	3		
FBgn0036842	Ugt316A1	HGNC:13479	OMIM:606497	UGT2B28	5		
FBgn0036842	Ugt316A1	HGNC:27266	OMIM:616384	UGT3A2	4		
FBgn0036842	Ugt316A1	HGNC:12544	OMIM:600070	UGT2B10	5		
FBgn0036842	Ugt316A1	HGNC:12537	OMIM:606430	UGT1A5	3		
FBgn0036842	Ugt316A1	HGNC:12546	OMIM:600069	UGT2B15	5		
FBgn0036842	Ugt316A1	HGNC:12541	OMIM:606434	UGT1A9	3		
FBgn0036842	Ugt316A1	HGNC:28528	OMIM:616382	UGT2A3	5		
FBgn0036842	Ugt316A1	HGNC:12535	OMIM:606428	UGT1A3	5		
FBgn0036842	Ugt316A1	HGNC:12536	OMIM:606429	UGT1A4	3		
FBgn0036842	Ugt316A1	HGNC:12540	OMIM:606433	UGT1A8	3		
FBgn0036842	Ugt316A1	HGNC:26625	OMIM:616383	UGT3A1	4		
FBgn0036842	Ugt316A1	HGNC:12547	OMIM:601903	UGT2B17	5	612560	612560[BONE MINERAL DENSITY QUANTITATIVE TRAIT LOCUS 12; BMND12]
FBgn0036842	Ugt316A1	HGNC:12553	OMIM:600067	UGT2B4	5		
FBgn0036842	Ugt316A1	HGNC:12538	OMIM:606431	UGT1A6	3		
FBgn0036842	Ugt316A1	HGNC:12554	OMIM:600068	UGT2B7	5		
FBgn0036842	Ugt316A1	HGNC:28183	OMIM:619809	UGT2A2	4		
FBgn0002945	nkd	HGNC:17045	OMIM:607851	NKD1	7		
FBgn0002945	nkd	HGNC:17046	OMIM:607852	NKD2	6		
FBgn0036839	SmydA-2	HGNC:15513	OMIM:608783	SMYD3	4		
FBgn0036839	SmydA-2	HGNC:20982	OMIM:610663	SMYD2	3		
FBgn0036839	SmydA-2	HGNC:20986	OMIM:606846	SMYD1	3		
FBgn0036838	CG3808	HGNC:24974	OMIM:611151	TRMT2A	14		
FBgn0036838	CG3808	HGNC:25748		TRMT2B	6		
FBgn0036837	CG18135	HGNC:26957	OMIM:614124	GPCPD1	8		
FBgn0036836	CG11619	HGNC:26957	OMIM:614124	GPCPD1	8		
FBgn0036801	MYPT-75D	HGNC:15850	OMIM:613275	PPP1R16B	12		
FBgn0036801	MYPT-75D	HGNC:14941	OMIM:609172	PPP1R16A	12		
FBgn0036807	CG6893	HGNC:10980	OMIM:606794	SLC25A10	6	618972	618972[MITOCHONDRIAL DNA DEPLETION SYNDROME 19; MTDPS19]
FBgn0036811	MED11	HGNC:32687	OMIM:612383	MED11	12		
FBgn0036813	Atg3	HGNC:20962	OMIM:609606	ATG3	14		
FBgn0036819	Dysb	HGNC:17328	OMIM:607145	DTNBP1	11	614076	614076[HERMANSKY-PUDLAK SYNDROME 7; HPS7]
FBgn0036819	Dysb	HGNC:15881	OMIM:611453	DBNDD2	4		
FBgn0036820	Grx1	HGNC:16065	OMIM:606820	GLRX2	11		
FBgn0036820	Grx1	HGNC:4330	OMIM:600443	GLRX	7		
FBgn0014075	Uggt	HGNC:15663	OMIM:605897	UGGT1	15		
FBgn0014075	Uggt	HGNC:15664	OMIM:605898	UGGT2	13		
FBgn0036822	NijB	HGNC:7824	OMIM:602062	NINJ1	5		
FBgn0036822	NijB	HGNC:7825	OMIM:607297	NINJ2	5		
FBgn0036825	RpL26	HGNC:17050		RPL26L1	13		
FBgn0036825	RpL26	HGNC:10327	OMIM:603704	RPL26	14	614900	614900[DIAMOND-BLACKFAN ANEMIA 11; DBA11]
FBgn0036827	CG6843	HGNC:24217	OMIM:605228	CIR1	13		
FBgn0036828	Prp6	HGNC:15860	OMIM:613979	PRPF6	15	613983	613983[RETINITIS PIGMENTOSA 60; RP60]
FBgn0036830	COX6AL2	HGNC:2277	OMIM:602072	COX6A1	8	616039	616039[CHARCOT-MARIE-TOOTH DISEASE, RECESSIVE INTERMEDIATE D; CMTRID]
FBgn0036830	COX6AL2	HGNC:2279	OMIM:602009	COX6A2	6	619062	619062[MITOCHONDRIAL COMPLEX IV DEFICIENCY, NUCLEAR TYPE 18; MC4DN18]
FBgn0036829	Ir75d	HGNC:4572	OMIM:138247	GRIA2	3	618917	618917[NEURODEVELOPMENTAL DISORDER WITH LANGUAGE IMPAIRMENT AND BEHAVIORAL ABNORMALITIES; NEDLIB]
FBgn0036829	Ir75d	HGNC:4573	OMIM:305915	GRIA3	3	300699	300699[INTELLECTUAL DEVELOPMENTAL DISORDER, X-LINKED, SYNDROMIC, WU TYPE; MRXSW]
FBgn0036829	Ir75d	HGNC:4571	OMIM:138248	GRIA1	3	619927,619931	619927[INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL DOMINANT 67; MRD67],619931[INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 76; MRT76]
FBgn0036829	Ir75d	HGNC:4574	OMIM:138246	GRIA4	3	617864	617864[NEURODEVELOPMENTAL DISORDER WITH OR WITHOUT SEIZURES AND GAIT ABNORMALITIES; NEDSGA]
FBgn0027057	CSN1b	HGNC:4549	OMIM:601934	GPS1	14		
FBgn0036826	arx	HGNC:16198		GTSF1L	8		
FBgn0036826	arx	HGNC:26565	OMIM:617484	GTSF1	10		
FBgn0036824	CG3902	HGNC:90	OMIM:606885	ACADS	3	201470	201470[ACYL-CoA DEHYDROGENASE, SHORT-CHAIN, DEFICIENCY OF; ACADSD]
FBgn0036824	CG3902	HGNC:91	OMIM:600301	ACADSB	14	610006	610006[2-METHYLBUTYRYL-CoA DEHYDROGENASE DEFICIENCY]
FBgn0036821	CG3961	HGNC:16526	OMIM:605677	ACSL5	14		
FBgn0036821	CG3961	HGNC:16496	OMIM:604443	ACSL6	12		
FBgn0036821	CG3961	HGNC:3569	OMIM:152425	ACSL1	12		
FBgn0025807	Rad9	HGNC:9827	OMIM:603761	RAD9A	13		
FBgn0025807	Rad9	HGNC:21700	OMIM:608368	RAD9B	12		
FBgn0036816	Indy	HGNC:14430	OMIM:606411	SLC13A3	11	618384	618384[LEUKOENCEPHALOPATHY, ACUTE REVERSIBLE, WITH INCREASED URINARY ALPHA-KETOGLUTARATE; ARLIAK]
FBgn0036816	Indy	HGNC:23089	OMIM:608305	SLC13A5	12	615905	615905[DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 25 WITH AMELOGENESIS IMPERFECTA; DEE25]
FBgn0036816	Indy	HGNC:10916	OMIM:606193	SLC13A1	11		
FBgn0036816	Indy	HGNC:15827	OMIM:604309	SLC13A4	11		
FBgn0036816	Indy	HGNC:10917	OMIM:604148	SLC13A2	13		
FBgn0036814	CG14073	HGNC:25657	OMIM:300688	BCORL1	6	301029	301029[SHUKLA-VERNON SYNDROME; SHUVER]
FBgn0036814	CG14073	HGNC:20893	OMIM:300485	BCOR	6	300166	300166[MICROPHTHALMIA, SYNDROMIC 2; MCOPS2]
FBgn0001078	ftz-f1	HGNC:7984	OMIM:604453	NR5A2	11		
FBgn0001078	ftz-f1	HGNC:7983	OMIM:184757	NR5A1	11	612964,612965,613957,617480	612964[PREMATURE OVARIAN FAILURE 7; POF7],612965[46,XY SEX REVERSAL 3; SRXY3],613957[SPERMATOGENIC FAILURE 8; SPGF8],617480[46,XX SEX REVERSAL 4; SRXX4]
FBgn0036812	Nufip	HGNC:8057	OMIM:604354	NUFIP1	13		
FBgn0036809	CG12477	HGNC:7113	OMIM:608426	MKRN2	6		
FBgn0036809	CG12477	HGNC:7112	OMIM:607754	MKRN1	7		
FBgn0036809	CG12477	HGNC:7114	OMIM:603856	MKRN3	7	615346	615346[PRECOCIOUS PUBERTY, CENTRAL, 2; CPPB2]
FBgn0036808	Dic4	HGNC:10980	OMIM:606794	SLC25A10	6	618972	618972[MITOCHONDRIAL DNA DEPLETION SYNDROME 19; MTDPS19]
FBgn0036806	Cyp12c1	HGNC:2606	OMIM:609506	CYP27B1	5	264700	264700[VITAMIN D HYDROXYLATION-DEFICIENT RICKETS, TYPE 1A; VDDR1A]
FBgn0036806	Cyp12c1	HGNC:33480		CYP27C1	6		
FBgn0036806	Cyp12c1	HGNC:2605	OMIM:606530	CYP27A1	4	213700	213700[CEREBROTENDINOUS XANTHOMATOSIS; CTX]
FBgn0036806	Cyp12c1	HGNC:2602	OMIM:126065	CYP24A1	8	143880	143880[HYPERCALCEMIA, INFANTILE, 1; HCINF1]
FBgn0036806	Cyp12c1	HGNC:2590	OMIM:118485	CYP11A1	3	613743	613743[ADRENAL INSUFFICIENCY, CONGENITAL, WITH 46,XY SEX REVERSAL, PARTIAL OR COMPLETE]
FBgn0036805	Chmp1	HGNC:24287	OMIM:606486	CHMP1B	12		
FBgn0036804	Sgf11	HGNC:25416	OMIM:619010	ATXN7L3	8		
FBgn0042134	Capr	HGNC:21259	OMIM:610375	CAPRIN2	5		
FBgn0042134	Capr	HGNC:6743	OMIM:601178	CAPRIN1	9		
FBgn0036795	CG18233	HGNC:8546	OMIM:176710	P4HA1	5		
FBgn0036795	CG18233	HGNC:30135	OMIM:608987	P4HA3	5		
FBgn0036795	CG18233	HGNC:8547	OMIM:600608	P4HA2	4	617238	617238[MYOPIA 25, AUTOSOMAL DOMINANT; MYP25]
FBgn0036796	CG18231	HGNC:8546	OMIM:176710	P4HA1	4		
FBgn0036796	CG18231	HGNC:30135	OMIM:608987	P4HA3	5		
FBgn0036796	CG18231	HGNC:8547	OMIM:600608	P4HA2	4	617238	617238[MYOPIA 25, AUTOSOMAL DOMINANT; MYP25]
FBgn0052201	CG32201	HGNC:8546	OMIM:176710	P4HA1	4		
FBgn0052201	CG32201	HGNC:30135	OMIM:608987	P4HA3	5		
FBgn0052201	CG32201	HGNC:8547	OMIM:600608	P4HA2	4	617238	617238[MYOPIA 25, AUTOSOMAL DOMINANT; MYP25]
FBgn0052199	CG32199	HGNC:8546	OMIM:176710	P4HA1	5		
FBgn0052199	CG32199	HGNC:30135	OMIM:608987	P4HA3	5		
FBgn0052199	CG32199	HGNC:8547	OMIM:600608	P4HA2	4	617238	617238[MYOPIA 25, AUTOSOMAL DOMINANT; MYP25]
FBgn0052199	CG32199	HGNC:28858	OMIM:614584	P4HTM	3	618493	618493[HYPOTONIA, HYPOVENTILATION, IMPAIRED INTELLECTUAL DEVELOPMENT, DYSAUTONOMIA, EPILEPSY, AND EYE ABNORMALITIES; HIDEA]
FBgn0013717	not	HGNC:23086		USP51	9		
FBgn0013717	not	HGNC:12621	OMIM:612116	USP22	15		
FBgn0013717	not	HGNC:12626	OMIM:604728	USP3	3		
FBgn0013717	not	HGNC:13486	OMIM:300975	USP27X	10	300984	300984[INTELLECTUAL DEVELOPMENTAL DISORDER, X-LINKED 105; XLID105]
FBgn0036787	CG4306	HGNC:21705	OMIM:137170	GGCT	15		
FBgn0052196	CG32196	HGNC:21705	OMIM:137170	GGCT	14		
FBgn0036774	mRpS26	HGNC:14045	OMIM:611988	MRPS26	11		
FBgn0002901	mus304	HGNC:33499	OMIM:606605	ATRIP	4		
FBgn0036784	CG5103	HGNC:25313		TKTL2	13		
FBgn0036784	CG5103	HGNC:11834	OMIM:606781	TKT	14	617044	617044[SHORT STATURE, DEVELOPMENTAL DELAY, AND CONGENITAL HEART DEFECTS; SDDHD]
FBgn0036784	CG5103	HGNC:11835	OMIM:300044	TKTL1	10		
FBgn0036778	Cyp312a1	HGNC:23198	OMIM:608614	CYP4V2	3	210370	210370[BIETTI CRYSTALLINE CORNEORETINAL DYSTROPHY; BCD]
FBgn0036778	Cyp312a1	HGNC:13265	OMIM:611517	CYP4F11	3		
FBgn0036778	Cyp312a1	HGNC:26820	OMIM:611495	CYP4F22	3	604777	604777[ICHTHYOSIS, CONGENITAL, AUTOSOMAL RECESSIVE 5; ARCI5]
FBgn0036778	Cyp312a1	HGNC:2645	OMIM:604426	CYP4F2	3		
FBgn0036778	Cyp312a1	HGNC:2646	OMIM:601270	CYP4F3	3		
FBgn0036778	Cyp312a1	HGNC:18857	OMIM:611485	CYP4F12	3		
FBgn0036778	Cyp312a1	HGNC:20575	OMIM:615341	CYP4A22	3		
FBgn0036778	Cyp312a1	HGNC:2644	OMIM:124075	CYP4B1	3		
FBgn0036778	Cyp312a1	HGNC:2648	OMIM:611545	CYP4F8	3		
FBgn0036778	Cyp312a1	HGNC:20583	OMIM:618953	CYP4Z1	3		
FBgn0036778	Cyp312a1	HGNC:2594	OMIM:107910	CYP19A1	3	139300,613546	139300[AROMATASE EXCESS SYNDROME; AEXS],613546[AROMATASE DEFICIENCY]
FBgn0036775	Polr3D	HGNC:1080	OMIM:187280	POLR3D	11		
FBgn0001134	Grd	HGNC:4075	OMIM:137160	GABRA1	6	611136,615744	611136[EPILEPSY, IDIOPATHIC GENERALIZED, SUSCEPTIBILITY TO, 13; EIG13],615744[DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 19; DEE19]
FBgn0001134	Grd	HGNC:4088	OMIM:600233	GABRG3	4		
FBgn0001134	Grd	HGNC:4087	OMIM:137164	GABRG2	5	607681,618396	607681[FEBRILE SEIZURES, FAMILIAL, 8; FEB8],618396[DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 74; DEE74]
FBgn0001134	Grd	HGNC:4079	OMIM:137142	GABRA5	6	618559	618559[DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 79; DEE79]
FBgn0001134	Grd	HGNC:4086	OMIM:137166	GABRG1	4		
FBgn0001134	Grd	HGNC:4078	OMIM:137141	GABRA4	7		
FBgn0001134	Grd	HGNC:4076	OMIM:137140	GABRA2	6	103780,618557	103780[ALCOHOL DEPENDENCE],618557[DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 78; DEE78]
FBgn0001134	Grd	HGNC:4077	OMIM:305660	GABRA3	6		
FBgn0001134	Grd	HGNC:4085	OMIM:300093	GABRE	5		
FBgn0001134	Grd	HGNC:4080	OMIM:137143	GABRA6	8		
FBgn0036762	CG7430	HGNC:2898	OMIM:238331	DLD	15	246900	246900[DIHYDROLIPOAMIDE DEHYDROGENASE DEFICIENCY; DLDD]
FBgn0036763	TrpRS-m	HGNC:12730	OMIM:604733	WARS2	11	617710,619738	617710[NEURODEVELOPMENTAL DISORDER, MITOCHONDRIAL, WITH ABNORMAL MOVEMENTS AND LACTIC ACIDOSIS, WITH OR WITHOUT SEIZURES; NEMMLAS],619738[PARKINSONISM-DYSTONIA 3, CHILDHOOD-ONSET; PKDYS3]
FBgn0036765	CG7408	HGNC:26286	OMIM:610010	ARSJ	9		
FBgn0036765	CG7408	HGNC:714	OMIM:611542	ARSB	9	253200	253200[MUCOPOLYSACCHARIDOSIS, TYPE VI; MPS6]
FBgn0036765	CG7408	HGNC:32521	OMIM:610009	ARSI	10		
FBgn0036765	CG7408	HGNC:20391	OMIM:610012	SULF1	3		
FBgn0036768	CG7402	HGNC:26286	OMIM:610010	ARSJ	9		
FBgn0036768	CG7402	HGNC:714	OMIM:611542	ARSB	11	253200	253200[MUCOPOLYSACCHARIDOSIS, TYPE VI; MPS6]
FBgn0036768	CG7402	HGNC:32521	OMIM:610009	ARSI	9		
FBgn0036771	Wdr92	HGNC:25176	OMIM:610729	WDR92	14		
FBgn0000568	Eip75B	HGNC:7962	OMIM:602408	NR1D1	3		
FBgn0000568	Eip75B	HGNC:7963	OMIM:602304	NR1D2	4		
FBgn0000568	Eip75B	HGNC:9232	OMIM:170998	PPARA	4		
FBgn0000568	Eip75B	HGNC:9235	OMIM:600409	PPARD	4		
FBgn0000568	Eip75B	HGNC:9236	OMIM:601487	PPARG	4	125853,601665,604367,609338	125853[TYPE 2 DIABETES MELLITUS; T2D],601665[OBESITY],604367[LIPODYSTROPHY, FAMILIAL PARTIAL, TYPE 3; FPLD3],609338[CAROTID INTIMAL MEDIAL THICKNESS 1]
FBgn0036772	CG5290	HGNC:25986		TTC27	14		
FBgn0036770	Prestin	HGNC:14470		SLC26A10	6		
FBgn0036770	Prestin	HGNC:14471	OMIM:610117	SLC26A11	3		
FBgn0036770	Prestin	HGNC:14472	OMIM:610068	SLC26A6	11		
FBgn0036770	Prestin	HGNC:9359	OMIM:604943	SLC26A5	13	613865	613865[DEAFNESS, AUTOSOMAL RECESSIVE 61; DFNB61]
FBgn0036770	Prestin	HGNC:10993	OMIM:610130	SLC26A1	7	167030	167030[NEPHROLITHIASIS, CALCIUM OXALATE; CAON]
FBgn0036770	Prestin	HGNC:3018	OMIM:126650	SLC26A3	6	214700	214700[DIARRHEA 1, SECRETORY CHLORIDE, CONGENITAL; DIAR1]
FBgn0036770	Prestin	HGNC:8818	OMIM:605646	SLC26A4	9	274600,600791	274600[PENDRED SYNDROME; PDS],600791[DEAFNESS, AUTOSOMAL RECESSIVE 4, WITH ENLARGED VESTIBULAR AQUEDUCT; DFNB4]
FBgn0036770	Prestin	HGNC:14469	OMIM:608481	SLC26A9	6		
FBgn0036770	Prestin	HGNC:10994	OMIM:606718	SLC26A2	7	222600,226900,256050,600972	222600[DIASTROPHIC DYSPLASIA; DTD],226900[EPIPHYSEAL DYSPLASIA, MULTIPLE, 4; EDM4],256050[ATELOSTEOGENESIS, TYPE II; AO2],600972[ACHONDROGENESIS, TYPE IB; ACG1B]
FBgn0036770	Prestin	HGNC:14467	OMIM:608479	SLC26A7	6		
FBgn0036770	Prestin	HGNC:14468	OMIM:608480	SLC26A8	5	606766	606766[SPERMATOGENIC FAILURE 3; SPGF3]
FBgn0036769	Tsp74F	HGNC:1630	OMIM:602243	CD151	7	179620,609057	179620[RAPH BLOOD GROUP SYSTEM],609057[EPIDERMOLYSIS BULLOSA SIMPLEX 7, WITH NEPHROPATHY AND DEAFNESS; EBS7]
FBgn0036769	Tsp74F	HGNC:30795		TSPAN11	6		
FBgn0036764	CG5535	HGNC:11060	OMIM:601872	SLC7A2	10		
FBgn0036764	CG5535	HGNC:11057	OMIM:104615	SLC7A1	11		
FBgn0036764	CG5535	HGNC:11061	OMIM:300443	SLC7A3	11		
FBgn0036764	CG5535	HGNC:29326	OMIM:615720	SLC7A14	4	615725	615725[RETINITIS PIGMENTOSA 68; RP68]
FBgn0036764	CG5535	HGNC:11062	OMIM:603752	SLC7A4	6		
FBgn0036761	MED19	HGNC:29600	OMIM:612385	MED19	12		
FBgn0036760	CG5567	HGNC:30259	OMIM:609246	PDXP	12		
FBgn0036760	CG5567	HGNC:8909	OMIM:172280	PGP	15		
FBgn0036759	CG5577	HGNC:30259	OMIM:609246	PDXP	7		
FBgn0036759	CG5577	HGNC:8909	OMIM:172280	PGP	7		
FBgn0036757	Ir75a	HGNC:4572	OMIM:138247	GRIA2	3	618917	618917[NEURODEVELOPMENTAL DISORDER WITH LANGUAGE IMPAIRMENT AND BEHAVIORAL ABNORMALITIES; NEDLIB]
FBgn0036757	Ir75a	HGNC:4573	OMIM:305915	GRIA3	3	300699	300699[INTELLECTUAL DEVELOPMENTAL DISORDER, X-LINKED, SYNDROMIC, WU TYPE; MRXSW]
FBgn0036757	Ir75a	HGNC:4571	OMIM:138248	GRIA1	3	619927,619931	619927[INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL DOMINANT 67; MRD67],619931[INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 76; MRT76]
FBgn0036757	Ir75a	HGNC:4574	OMIM:138246	GRIA4	3	617864	617864[NEURODEVELOPMENTAL DISORDER WITH OR WITHOUT SEIZURES AND GAIT ABNORMALITIES; NEDSGA]
FBgn0036757	Ir75a	HGNC:4576	OMIM:602368	GRID2	3	616204	616204[SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 18; SCAR18]
FBgn0036757	Ir75a	HGNC:4575	OMIM:610659	GRID1	3		
FBgn0036756	Cln3	HGNC:2074	OMIM:607042	CLN3	13	204200	204200[CEROID LIPOFUSCINOSIS, NEURONAL, 3; CLN3]
FBgn0052191	CG32191	HGNC:26286	OMIM:610010	ARSJ	9		
FBgn0052191	CG32191	HGNC:714	OMIM:611542	ARSB	9	253200	253200[MUCOPOLYSACCHARIDOSIS, TYPE VI; MPS6]
FBgn0052191	CG32191	HGNC:32521	OMIM:610009	ARSI	10		
FBgn0052191	CG32191	HGNC:713	OMIM:607574	ARSA	3	250100	250100[METACHROMATIC LEUKODYSTROPHY; MLD]
FBgn0052191	CG32191	HGNC:719	OMIM:300180	ARSE	3	302950	302950[CHONDRODYSPLASIA PUNCTATA 1, X-LINKED RECESSIVE; CDPX1]
FBgn0036754	ais	HGNC:20038	OMIM:612500	DDX52	15		
FBgn0052190	NUCB1	HGNC:8043	OMIM:601323	NUCB1	10		
FBgn0052190	NUCB1	HGNC:8044	OMIM:608020	NUCB2	12		
FBgn0036732	Oatp74D	HGNC:10953	OMIM:612436	SLCO4A1	3		
FBgn0036732	Oatp74D	HGNC:10955	OMIM:601460	SLCO2A1	4	167100,614441	167100[HYPERTROPHIC OSTEOARTHROPATHY, PRIMARY, AUTOSOMAL DOMINANT; PHOAD],614441[HYPERTROPHIC OSTEOARTHROPATHY, PRIMARY, AUTOSOMAL RECESSIVE, 2; PHOAR2]
FBgn0036732	Oatp74D	HGNC:10962	OMIM:604988	SLCO2B1	4		
FBgn0036732	Oatp74D	HGNC:10952	OMIM:612435	SLCO3A1	5		
FBgn0036732	Oatp74D	HGNC:10956	OMIM:602883	SLCO1A2	6		
FBgn0036732	Oatp74D	HGNC:10959	OMIM:604843	SLCO1B1	4	237450	237450[HYPERBILIRUBINEMIA, ROTOR TYPE; HBLRR]
FBgn0036732	Oatp74D	HGNC:10961	OMIM:605495	SLCO1B3	4	237450	237450[HYPERBILIRUBINEMIA, ROTOR TYPE; HBLRR]
FBgn0036732	Oatp74D	HGNC:13819	OMIM:613389	SLCO1C1	5		
FBgn0036732	Oatp74D	HGNC:32934	OMIM:619875	SLCO1B7	4		
FBgn0036734	CG7564	HGNC:21608	OMIM:613056	LUC7L2	10		
FBgn0036734	CG7564	HGNC:24309	OMIM:609434	LUC7L3	4		
FBgn0036734	CG7564	HGNC:6723	OMIM:607782	LUC7L	13		
FBgn0036734	CG7564	HGNC:44671		FMC1-LUC7L2	5		
FBgn0036741	anchor	HGNC:22951		GPR155	14		
FBgn0036742	CG7497	HGNC:9593	OMIM:176802	PTGER1	8		
FBgn0036742	CG7497	HGNC:9591	OMIM:604687	PTGDR	8	607277	607277[ASTHMA-RELATED TRAITS, SUSCEPTIBILITY TO, 1]
FBgn0036742	CG7497	HGNC:9594	OMIM:176804	PTGER2	9	208550	208550[ASTHMA, NASAL POLYPS, AND ASPIRIN INTOLERANCE]
FBgn0036742	CG7497	HGNC:9595	OMIM:176806	PTGER3	10		
FBgn0036742	CG7497	HGNC:9602	OMIM:600022	PTGIR	8		
FBgn0036742	CG7497	HGNC:9596	OMIM:601586	PTGER4	10		
FBgn0036742	CG7497	HGNC:9600	OMIM:600563	PTGFR	6		
FBgn0036742	CG7497	HGNC:11608	OMIM:188070	TBXA2R	7	614009	614009[BLEEDING DISORDER, PLATELET-TYPE, 13, SUSCEPTIBILITY TO; BDPLT13]
FBgn0036745	CG7484	HGNC:17705	OMIM:606254	SELENOF	12		
FBgn0052183	Ccn	HGNC:12771	OMIM:603400	CCN6	7	208230	208230[PROGRESSIVE PSEUDORHEUMATOID DYSPLASIA; PPRD]
FBgn0052183	Ccn	HGNC:2500	OMIM:121009	CCN2	10		
FBgn0052183	Ccn	HGNC:2654	OMIM:602369	CCN1	7		
FBgn0052183	Ccn	HGNC:7885	OMIM:164958	CCN3	8		
FBgn0052183	Ccn	HGNC:12770	OMIM:603399	CCN5	7		
FBgn0052183	Ccn	HGNC:12769	OMIM:603398	CCN4	7		
FBgn0036749	CG7460	HGNC:15862	OMIM:615854	SMOX	6		
FBgn0036749	CG7460	HGNC:20837	OMIM:615853	PAOX	6		
FBgn0036752	Adgf-A	HGNC:1839	OMIM:607575	ADA2	13	182410,615688	182410[SNEDDON SYNDROME; SNDNS],615688[VASCULITIS, AUTOINFLAMMATION, IMMUNODEFICIENCY, AND HEMATOLOGIC DEFECTS SYNDROME; VAIHS]
FBgn0043025	Adgf-A2	HGNC:1839	OMIM:607575	ADA2	7	182410,615688	182410[SNEDDON SYNDROME; SNDNS],615688[VASCULITIS, AUTOINFLAMMATION, IMMUNODEFICIENCY, AND HEMATOLOGIC DEFECTS SYNDROME; VAIHS]
FBgn0036751	Adgf-B	HGNC:1839	OMIM:607575	ADA2	12	182410,615688	182410[SNEDDON SYNDROME; SNDNS],615688[VASCULITIS, AUTOINFLAMMATION, IMMUNODEFICIENCY, AND HEMATOLOGIC DEFECTS SYNDROME; VAIHS]
FBgn0036750	CG6034	HGNC:15862	OMIM:615854	SMOX	7		
FBgn0036750	CG6034	HGNC:20837	OMIM:615853	PAOX	7		
FBgn0036747	CG6052	HGNC:37	OMIM:605414	ABCA7	3	608907	608907[ALZHEIMER DISEASE 9, SUSCEPTIBILITY TO; AD9]
FBgn0036747	CG6052	HGNC:29	OMIM:600046	ABCA1	4	205400,604091	205400[TANGIER DISEASE; TGD],604091[HYPOALPHALIPOPROTEINEMIA, PRIMARY, 1]
FBgn0036747	CG6052	HGNC:32	OMIM:600047	ABCA2	3	618808	618808[INTELLECTUAL DEVELOPMENTAL DISORDER WITH POOR GROWTH AND WITH OR WITHOUT SEIZURES OR ATAXIA; IDPOGSA]
FBgn0036747	CG6052	HGNC:34	OMIM:601691	ABCA4	3	153800,248200,601718,604116	153800[MACULAR DEGENERATION, AGE-RELATED, 2; ARMD2],248200[STARGARDT DISEASE 1; STGD1],601718[RETINITIS PIGMENTOSA 19; RP19],604116[CONE-ROD DYSTROPHY 3; CORD3]
FBgn0036747	CG6052	HGNC:33	OMIM:601615	ABCA3	11	610921	610921[SURFACTANT METABOLISM DYSFUNCTION, PULMONARY, 3; SMDP3]
FBgn0036747	CG6052	HGNC:14637	OMIM:607800	ABCA12	4	242500,601277	242500[ICHTHYOSIS, CONGENITAL, AUTOSOMAL RECESSIVE 4B; ARCI4B],601277[ICHTHYOSIS, CONGENITAL, AUTOSOMAL RECESSIVE 4A; ARCI4A]
FBgn0036747	CG6052	HGNC:30	OMIM:612508	ABCA10	3		
FBgn0036747	CG6052	HGNC:39	OMIM:612507	ABCA9	4		
FBgn0036747	CG6052	HGNC:38	OMIM:612505	ABCA8	4		
FBgn0036747	CG6052	HGNC:36	OMIM:612504	ABCA6	4		
FBgn0036747	CG6052	HGNC:35	OMIM:612503	ABCA5	3	135400	135400[HYPERTRICHOSIS, CONGENITAL GENERALIZED, WITH OR WITHOUT GINGIVAL HYPERPLASIA; HTC3]
FBgn0036747	CG6052	HGNC:14638	OMIM:607807	ABCA13	3		
FBgn0036746	Crtc	HGNC:27301	OMIM:608972	CRTC2	7		
FBgn0036746	Crtc	HGNC:16062	OMIM:607536	CRTC1	9		
FBgn0036746	Crtc	HGNC:26148	OMIM:608986	CRTC3	7		
FBgn0052179	Krn	HGNC:7997	OMIM:142445	NRG1	3	603013	603013[SCHIZOPHRENIA 6; SCZD6]
FBgn0004401	Pep	HGNC:16744	OMIM:611420	CIZ1	5		
FBgn0036740	Vps60	HGNC:26942	OMIM:610900	CHMP5	14		
FBgn0036735	Edc3	HGNC:26114	OMIM:609842	EDC3	13	616460	616460[INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 50; MRT50]
FBgn0036733	U4-U6-60K	HGNC:17349	OMIM:607795	PRPF4	15	615922	615922[RETINITIS PIGMENTOSA 70; RP70]
FBgn0052177	Ndfip	HGNC:17592	OMIM:612050	NDFIP1	12		
FBgn0052177	Ndfip	HGNC:18537	OMIM:610041	NDFIP2	13		
FBgn0015550	tap	HGNC:13805	OMIM:606624	NEUROG2	7		
FBgn0015550	tap	HGNC:13806	OMIM:604882	NEUROG3	9	610370	610370[DIARRHEA 4, MALABSORPTIVE, CONGENITAL; DIAR4]
FBgn0015550	tap	HGNC:7764	OMIM:601726	NEUROG1	8		
FBgn0015550	tap	HGNC:7763	OMIM:601725	NEUROD2	3	618374	618374[DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 72; DEE72]
FBgn0036726	QIL1	HGNC:33702	OMIM:616658	MICOS13	5	618329	618329[COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 37; COXPD37]
FBgn0036727	SecCl	HGNC:4328	OMIM:600421	GLRA3	3		
FBgn0036727	SecCl	HGNC:4329	OMIM:138492	GLRB	3	614619	614619[HYPEREKPLEXIA 2; HKPX2]
FBgn0036727	SecCl	HGNC:4327	OMIM:305990	GLRA2	3	301076	301076[INTELLECTUAL DEVELOPMENTAL DISORDER, X-LINKED, SYNDROMIC, PILORGE TYPE; MRXSP]
FBgn0036727	SecCl	HGNC:31715		GLRA4	3		
FBgn0036727	SecCl	HGNC:4326	OMIM:138491	GLRA1	3	149400	149400[HYPEREKPLEXIA 1; HKPX1]
FBgn0036728	UQCR-Q	HGNC:29594	OMIM:612080	UQCRQ	15	615159	615159[MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 4; MC3DN4]
FBgn0036730	qjt	HGNC:26513	OMIM:617246	NSMCE2	10	617253	617253[SECKEL SYNDROME 10; SCKL10]
FBgn0036723	CG12229	HGNC:9021	OMIM:179050	PKM	4		
FBgn0036723	CG12229	HGNC:9020	OMIM:609712	PKLR	4	102900,266200	102900[ADENOSINE TRIPHOSPHATE, ELEVATED, OF ERYTHROCYTES],266200[PYRUVATE KINASE DEFICIENCY OF RED CELLS]
FBgn0052174	Coq4	HGNC:19693	OMIM:612898	COQ4	13	616276	616276[COENZYME Q10 DEFICIENCY, PRIMARY, 7; COQ10D7]
FBgn0042641	frc	HGNC:20799	OMIM:609182	SLC35D2	9		
FBgn0042641	frc	HGNC:20800	OMIM:610804	SLC35D1	13	269250	269250[SCHNECKENBECKEN DYSPLASIA; SHNKND]
FBgn0042641	frc	HGNC:31723	OMIM:615430	TMEM241	3		
FBgn0053052	Gorab	HGNC:25676	OMIM:607983	GORAB	10	231070	231070[GERODERMA OSTEODYSPLASTICUM; GO]
FBgn0053051	Polr3G	HGNC:28466	OMIM:617457	POLR3GL	10	619234	619234[SHORT STATURE, OLIGODONTIA, DYSMORPHIC FACIES, AND MOTOR DELAY; SOFM]
FBgn0053051	Polr3G	HGNC:30075	OMIM:617456	POLR3G	9		
FBgn0036712	brv2	HGNC:9015	OMIM:604670	PKDREJ	4		
FBgn0036712	brv2	HGNC:21715	OMIM:607894	PKD1L2	4		
FBgn0036712	brv2	HGNC:18053	OMIM:609721	PKD1L1	4	617205	617205[HETEROTAXY, VISCERAL, 8, AUTOSOMAL; HTX8]
FBgn0036712	brv2	HGNC:21716	OMIM:607895	PKD1L3	3		
FBgn0036710	CG6479	HGNC:21898		TMEM209	13		
FBgn0036706	ND-24L	HGNC:7717	OMIM:600532	NDUFV2	9	618229	618229[MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 7; MC1DN7]
FBgn0036702	Afg3l2	HGNC:315	OMIM:604581	AFG3L2	14	610246,614487,618977	610246[SPINOCEREBELLAR ATAXIA 28; SCA28],614487[SPASTIC ATAXIA 5, AUTOSOMAL RECESSIVE; SPAX5],618977[OPTIC ATROPHY 12; OPA12]
FBgn0036702	Afg3l2	HGNC:12843	OMIM:607472	YME1L1	3	617302	617302[OPTIC ATROPHY 11; OPA11]
FBgn0036702	Afg3l2	HGNC:11237	OMIM:602783	SPG7	4	607259	607259[SPASTIC PARAPLEGIA 7, AUTOSOMAL RECESSIVE; SPG7]
FBgn0010352	Ogdh	HGNC:8124	OMIM:613022	OGDH	15	203740	203740[OXOGLUTARATE DEHYDROGENASE DEFICIENCY; OGDHD]
FBgn0010352	Ogdh	HGNC:23537	OMIM:614984	DHTKD1	4	204750,615025	204750[ALPHA-AMINOADIPIC AND ALPHA-KETOADIPIC ACIDURIA; AAKAD],615025[CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2Q; CMT2Q]
FBgn0010352	Ogdh	HGNC:25590	OMIM:617513	OGDHL	13	619701	619701[YOON-BELLEN NEURODEVELOPMENTAL SYNDROME; YOBELN]
FBgn0036686	CG7728	HGNC:23505	OMIM:611448	BMS1	14	107600	107600[APLASIA CUTIS CONGENITA, NONSYNDROMIC; ACC]
FBgn0036688	Fit2	HGNC:15889	OMIM:607900	FERMT1	12	173650	173650[KINDLER SYNDROME; KNDLRS]
FBgn0036688	Fit2	HGNC:15767	OMIM:607746	FERMT2	13		
FBgn0036688	Fit2	HGNC:23151	OMIM:607901	FERMT3	10	612840	612840[LEUKOCYTE ADHESION DEFICIENCY, TYPE III; LAD3]
FBgn0036691	beg	HGNC:29622	OMIM:614479	MCAT	15		
FBgn0036695	Papst2	HGNC:21601	OMIM:610845	SLC35B3	14		
FBgn0036695	Papst2	HGNC:20798	OMIM:610790	SLC35B1	3		
FBgn0036697	rogdi	HGNC:29478	OMIM:614574	ROGDI	13	226750	226750[KOHLSCHUTTER-TONZ SYNDROME; KTZS]
FBgn0036698	CG7724	HGNC:5217	OMIM:109715	HSD3B1	10		
FBgn0036698	CG7724	HGNC:5218	OMIM:613890	HSD3B2	10	201810	201810[ADRENAL HYPERPLASIA, CONGENITAL, DUE TO 3-BETA-HYDROXYSTEROID DEHYDROGENASE 2 DEFICIENCY]
FBgn0036698	CG7724	HGNC:13398	OMIM:300275	NSDHL	3	300831,308050	300831[CK SYNDROME; CKS],308050[CONGENITAL HEMIDYSPLASIA WITH ICHTHYOSIFORM ERYTHRODERMA AND LIMB DEFECTS]
FBgn0036698	CG7724	HGNC:29834	OMIM:616164	SDR42E1	4		
FBgn0036698	CG7724	HGNC:35414		SDR42E2	3		
FBgn0036698	CG7724	HGNC:18324	OMIM:607764	HSD3B7	8	607765	607765[BILE ACID SYNTHESIS DEFECT, CONGENITAL, 1; CBAS1]
FBgn0036696	Pop5	HGNC:17689	OMIM:609992	POP5	13		
FBgn0036687	CG6652	HGNC:1255		LCA5L	6		
FBgn0036687	CG6652	HGNC:31923	OMIM:611408	LCA5	7	604537	604537[LEBER CONGENITAL AMAUROSIS 5; LCA5]
FBgn0036684	CG3764	HGNC:29418	OMIM:610594	FNIP1	11	619705	619705[IMMUNODEFICIENCY 93 AND HYPERTROPHIC CARDIOMYOPATHY; IMD93]
FBgn0036684	CG3764	HGNC:29280	OMIM:612768	FNIP2	12		
FBgn0028693	Rpn12	HGNC:9566	OMIM:617844	PSMD8	15		
FBgn0052163	CG32163	HGNC:30770		NATD1	7		
FBgn0042178	Apl	HGNC:19426		IPO4	13		
FBgn0042177	Arts	HGNC:19426		IPO4	14		
FBgn0025558	CG4101	HGNC:15799		MANBAL	8		
FBgn0036652	CG13032	HGNC:26358		CCDC13	11		
FBgn0000414	Dab	HGNC:2661	OMIM:603448	DAB1	8	615945	615945[SPINOCEREBELLAR ATAXIA 37; SCA37]
FBgn0000414	Dab	HGNC:2662	OMIM:601236	DAB2	6		
FBgn0043577	PGRP-SB2	HGNC:30013	OMIM:608199	PGLYRP2	4		
FBgn0043577	PGRP-SB2	HGNC:8904	OMIM:604963	PGLYRP1	5		
FBgn0043577	PGRP-SB2	HGNC:30014	OMIM:608197	PGLYRP3	4		
FBgn0043577	PGRP-SB2	HGNC:30015	OMIM:608198	PGLYRP4	6		
FBgn0036659	CG9701	HGNC:6530	OMIM:603202	LCT	8	223000	223000[LACTASE DEFICIENCY, CONGENITAL]
FBgn0036659	CG9701	HGNC:15527	OMIM:611135	KLB	6		
FBgn0036659	CG9701	HGNC:6344	OMIM:604824	KL	7	617994	617994[TUMORAL CALCINOSIS, HYPERPHOSPHATEMIC, FAMILIAL, 3; HFTC3]
FBgn0036659	CG9701	HGNC:15583	OMIM:617060	LCTL	11		
FBgn0036659	CG9701	HGNC:19069	OMIM:606619	GBA3	7		
FBgn0004108	Nrt	HGNC:26741		CES4A	3		
FBgn0004108	Nrt	HGNC:108	OMIM:100740	ACHE	4	112100	112100[YT BLOOD GROUP ANTIGEN]
FBgn0004108	Nrt	HGNC:983	OMIM:177400	BCHE	3	617936	617936[BUTYRYLCHOLINESTERASE DEFICIENCY; BCHED]
FBgn0004108	Nrt	HGNC:26459	OMIM:618678	CES5A	3		
FBgn0004108	Nrt	HGNC:1863	OMIM:114835	CES1	3	618057	618057[DRUG METABOLISM, ALTERED, CES1-RELATED]
FBgn0004108	Nrt	HGNC:1864	OMIM:605278	CES2	4		
FBgn0004108	Nrt	HGNC:1865	OMIM:605279	CES3	3		
FBgn0036661	CG9705	HGNC:30359	OMIM:617689	CSDC2	12		
FBgn0036661	CG9705	HGNC:17150	OMIM:616885	CARHSP1	14		
FBgn0036662	CG9706	HGNC:95	OMIM:603690	SLC33A1	14	612539,614482	612539[SPASTIC PARAPLEGIA 42, AUTOSOMAL DOMINANT; SPG42],614482[CONGENITAL CATARACTS, HEARING LOSS, AND NEURODEGENERATION; CCHLND]
FBgn0021768	nudC	HGNC:8045	OMIM:610325	NUDC	14		
FBgn0036666	TSG101	HGNC:15971	OMIM:601387	TSG101	14		
FBgn0036666	TSG101	HGNC:30866	OMIM:610985	UEVLD	6		
FBgn0036668	Zcchc7	HGNC:26209		ZCCHC7	6		
FBgn0003410	sina	HGNC:10857	OMIM:602212	SIAH1	14	619314	619314[BURATTI-HAREL SYNDROME; BURHAS]
FBgn0003410	sina	HGNC:10858	OMIM:602213	SIAH2	11		
FBgn0003410	sina	HGNC:30553	OMIM:615609	SIAH3	5		
FBgn0036670	CG13029	HGNC:27387		ZDHHC24	8		
FBgn0036671	CG9951	HGNC:28909	OMIM:300859	CCDC22	13	300963	300963[RITSCHER-SCHINZEL SYNDROME 2; RTSC2]
FBgn0003250	Rh4	HGNC:14449	OMIM:606665	OPN4	7		
FBgn0036667	kud	HGNC:1164	OMIM:617615	TMEM258	12		
FBgn0025582	eIF3e	HGNC:3277	OMIM:602210	EIF3E	14		
FBgn0004556	Dbp73D	HGNC:20082		DDX51	15		
FBgn0043578	PGRP-SB1	HGNC:30013	OMIM:608199	PGLYRP2	5		
FBgn0043578	PGRP-SB1	HGNC:8904	OMIM:604963	PGLYRP1	5		
FBgn0043578	PGRP-SB1	HGNC:30014	OMIM:608197	PGLYRP3	4		
FBgn0043578	PGRP-SB1	HGNC:30015	OMIM:608198	PGLYRP4	7		
FBgn0063485	Lasp	HGNC:6513	OMIM:602920	LASP1	9		
FBgn0063485	Lasp	HGNC:16932	OMIM:605491	NEBL	3		
FBgn0040512	zetaCOP	HGNC:2243	OMIM:615472	COPZ1	11		
FBgn0040512	zetaCOP	HGNC:19356	OMIM:615526	COPZ2	7		
FBgn0010223	Galphaf	HGNC:4379	OMIM:139313	GNA11	3	145981,615361	145981[HYPOCALCIURIC HYPERCALCEMIA, FAMILIAL, TYPE II; HHC2],615361[HYPOCALCEMIA, AUTOSOMAL DOMINANT 2; HYPOC2]
FBgn0010223	Galphaf	HGNC:4381	OMIM:604406	GNA13	3		
FBgn0010223	Galphaf	HGNC:4390	OMIM:600998	GNAQ	3	163000,185300	163000[CAPILLARY MALFORMATIONS, CONGENITAL; CMC],185300[STURGE-WEBER SYNDROME; SWS]
FBgn0010223	Galphaf	HGNC:4385	OMIM:139360	GNAI2	3	192605	192605[VENTRICULAR TACHYCARDIA, FAMILIAL]
FBgn0010223	Galphaf	HGNC:4394	OMIM:139340	GNAT2	3	613856	613856[ACHROMATOPSIA 4; ACHM4]
FBgn0010223	Galphaf	HGNC:4388	OMIM:139312	GNAL	6	615073	615073[DYSTONIA 25; DYT25]
FBgn0010223	Galphaf	HGNC:4380	OMIM:604394	GNA12	3		
FBgn0010223	Galphaf	HGNC:4395	OMIM:139160	GNAZ	3		
FBgn0010223	Galphaf	HGNC:4382	OMIM:604397	GNA14	3		
FBgn0010223	Galphaf	HGNC:22800	OMIM:139395	GNAT3	3		
FBgn0010223	Galphaf	HGNC:4393	OMIM:139330	GNAT1	3	610444,616389	610444[NIGHT BLINDNESS, CONGENITAL STATIONARY, AUTOSOMAL DOMINANT 3; CSNBAD3],616389[NIGHT BLINDNESS, CONGENITAL STATIONARY, TYPE 1G; CSNB1G]
FBgn0010223	Galphaf	HGNC:4383	OMIM:139314	GNA15	3		
FBgn0010223	Galphaf	HGNC:4392	OMIM:139320	GNAS	5	103580,166350,174800,219080,603233,612462,612463,617686	103580[PSEUDOHYPOPARATHYROIDISM, TYPE IA; PHP1A],166350[OSSEOUS HETEROPLASIA, PROGRESSIVE; POH],174800[MCCUNE-ALBRIGHT SYNDROME; MAS],219080[ACTH-INDEPENDENT MACRONODULAR ADRENAL HYPERPLASIA; AIMAH1],603233[PSEUDOHYPOPARATHYROIDISM, TYPE IB; PHP1B],612462[PSEUDOHYPOPARATHYROIDISM, TYPE IC; PHP1C],612463[PSEUDOPSEUDOHYPOPARATHYROIDISM; PPHP],617686[PITUITARY ADENOMA 3, MULTIPLE TYPES; PITA3]
FBgn0000017	Abl	HGNC:76	OMIM:189980	ABL1	9	608232,617602	608232[LEUKEMIA, CHRONIC MYELOID; CML],617602[CONGENITAL HEART DEFECTS AND SKELETAL MALFORMATIONS SYNDROME; CHDSKM]
FBgn0000017	Abl	HGNC:77	OMIM:164690	ABL2	10		
FBgn0017572	Mo25	HGNC:20292	OMIM:612174	CAB39	15		
FBgn0017572	Mo25	HGNC:20290	OMIM:612175	CAB39L	13		
FBgn0004465	Su(P)	HGNC:17822	OMIM:608152	PTGES2	14		
FBgn0002284	Prosbeta6	HGNC:9537	OMIM:602017	PSMB1	14		
FBgn0036648	CG4098	HGNC:8056	OMIM:606022	NUDT9	13		
FBgn0027500	spd-2	HGNC:25515	OMIM:616426	CEP192	3		
FBgn0036643	Syx8	HGNC:11443	OMIM:604203	STX8	13		
FBgn0053061	CG33061	HGNC:25535	OMIM:611236	TMEM38B	5	615066	615066[OSTEOGENESIS IMPERFECTA, TYPE XIV; OI14]
FBgn0053061	CG33061	HGNC:28462	OMIM:611235	TMEM38A	6		
FBgn0053060	CG33060	HGNC:24590	OMIM:612032	DPY30	3		
FBgn0036620	CG4842	HGNC:5154	OMIM:601688	HPGD	13	119900,259100	119900[DIGITAL CLUBBING, ISOLATED CONGENITAL; DIGC],259100[HYPERTROPHIC OSTEOARTHROPATHY, PRIMARY, AUTOSOMAL RECESSIVE, 1; PHOAR1]
FBgn0042137	CG18814	HGNC:5154	OMIM:601688	HPGD	12	119900,259100	119900[DIGITAL CLUBBING, ISOLATED CONGENITAL; DIGC],259100[HYPERTROPHIC OSTEOARTHROPATHY, PRIMARY, AUTOSOMAL RECESSIVE, 1; PHOAR1]
FBgn0028399	Serinc	HGNC:11699	OMIM:607165	SERINC3	13		
FBgn0028399	Serinc	HGNC:13464	OMIM:614548	SERINC1	14		
FBgn0028399	Serinc	HGNC:23231	OMIM:614549	SERINC2	12		
FBgn0028399	Serinc	HGNC:32237	OMIM:614550	SERINC4	3		
FBgn0028399	Serinc	HGNC:18825	OMIM:614551	SERINC5	4		
FBgn0053158	CG33158	HGNC:25789	OMIM:617538	EFL1	15	617941	617941[SHWACHMAN-DIAMOND SYNDROME 2; SDS2]
FBgn0003515	st	HGNC:73	OMIM:603076	ABCG1	4		
FBgn0003515	st	HGNC:13884	OMIM:607784	ABCG4	3		
FBgn0003515	st	HGNC:74	OMIM:603756	ABCG2	4	138900,614490	138900[URIC ACID CONCENTRATION, SERUM, QUANTITATIVE TRAIT LOCUS 1; UAQTL1],614490[BLOOD GROUP, JUNIOR SYSTEM; JR]
FBgn0003515	st	HGNC:13887	OMIM:605460	ABCG8	3	210250,611465	210250[SITOSTEROLEMIA 1; STSL1],611465[GALLBLADDER DISEASE 4; GBD4]
FBgn0003515	st	HGNC:13886	OMIM:605459	ABCG5	3	618666	618666[SITOSTEROLEMIA 2; STSL2]
FBgn0036641	Smn	HGNC:11117	OMIM:600354	SMN1	7	253300,253400,253550,271150	253300[SPINAL MUSCULAR ATROPHY, TYPE I; SMA1],253400[SPINAL MUSCULAR ATROPHY, TYPE III; SMA3],253550[SPINAL MUSCULAR ATROPHY, TYPE II; SMA2],271150[SPINAL MUSCULAR ATROPHY, TYPE IV; SMA4]
FBgn0036641	Smn	HGNC:11118	OMIM:601627	SMN2	12	253400	253400[SPINAL MUSCULAR ATROPHY, TYPE III; SMA3]
FBgn0026061	Mipp1	HGNC:7102	OMIM:605391	MINPP1	12	188470,619527	188470[THYROID CANCER, NONMEDULLARY, 2; NMTC2],619527[PONTOCEREBELLAR HYPOPLASIA, TYPE 16; PCH16]
FBgn0027080	TyrRS	HGNC:12840	OMIM:603623	YARS1	15	608323,619418	608323[CHARCOT-MARIE-TOOTH DISEASE, DOMINANT INTERMEDIATE C; CMTDIC],619418[NEUROLOGIC, ENDOCRINE, AND PANCREATIC DISEASE, MULTISYSTEM, INFANTILE-ONSET 2; IMNEPD2]
FBgn0036629	GluRS-m	HGNC:29419	OMIM:612799	EARS2	14	614924	614924[COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 12; COXPD12]
FBgn0036623	Agpat3	HGNC:326	OMIM:614794	AGPAT3	15		
FBgn0036623	Agpat3	HGNC:20885	OMIM:614795	AGPAT4	13		
FBgn0036623	Agpat3	HGNC:26756	OMIM:614241	LCLAT1	3		
FBgn0036623	Agpat3	HGNC:20886	OMIM:614796	AGPAT5	3		
FBgn0036622	Agpat4	HGNC:326	OMIM:614794	AGPAT3	14		
FBgn0036622	Agpat4	HGNC:20885	OMIM:614795	AGPAT4	13		
FBgn0036622	Agpat4	HGNC:26756	OMIM:614241	LCLAT1	4		
FBgn0036622	Agpat4	HGNC:20886	OMIM:614796	AGPAT5	3		
FBgn0036621	roq	HGNC:29434	OMIM:609424	RC3H1	12	618998	618998[IMMUNE DYSREGULATION AND SYSTEMIC HYPERINFLAMMATION SYNDROME; IMDYSHI]
FBgn0036621	roq	HGNC:21461	OMIM:615231	RC3H2	11		
FBgn0011693	Pdh	HGNC:5154	OMIM:601688	HPGD	14	119900,259100	119900[DIGITAL CLUBBING, ISOLATED CONGENITAL; DIGC],259100[HYPERTROPHIC OSTEOARTHROPATHY, PRIMARY, AUTOSOMAL RECESSIVE, 1; PHOAR1]
FBgn0036614	Golgin104	HGNC:24349	OMIM:619249	CCDC186	13		
FBgn0044028	Notum	HGNC:27106	OMIM:609847	NOTUM	11		
FBgn0036560	CG5895	HGNC:23148	OMIM:300974	PLCXD1	5		
FBgn0036560	CG5895	HGNC:26462	OMIM:617015	PLCXD2	4		
FBgn0036560	CG5895	HGNC:31822	OMIM:617016	PLCXD3	4		
FBgn0005536	Mbs	HGNC:7618	OMIM:602021	PPP1R12A	10	618820	618820[GENITOURINARY AND/OR BRAIN MALFORMATION SYNDROME; GUBS]
FBgn0005536	Mbs	HGNC:7619	OMIM:603768	PPP1R12B	13		
FBgn0005536	Mbs	HGNC:14947	OMIM:613245	PPP1R12C	5		
FBgn0036566	ClC-c	HGNC:2021	OMIM:600580	CLCN3	12	619512,619517	619512[NEURODEVELOPMENTAL DISORDER WITH HYPOTONIA AND BRAIN ABNORMALITIES; NEDHYBA],619517[NEURODEVELOPMENTAL DISORDER WITH SEIZURES AND BRAIN ABNORMALITIES; NEDSBA]
FBgn0036566	ClC-c	HGNC:2026	OMIM:602024	CLCNKA	3	613090	613090[BARTTER SYNDROME, TYPE 4B, NEONATAL, WITH SENSORINEURAL DEAFNESS; BARTS4B]
FBgn0036566	ClC-c	HGNC:2023	OMIM:300008	CLCN5	11	300009,300554,308990,310468	300009[DENT DISEASE 1; DENT1],300554[HYPOPHOSPHATEMIC RICKETS, X-LINKED RECESSIVE],308990[PROTEINURIA, LOW MOLECULAR WEIGHT, WITH HYPERCALCIURIA AND NEPHROCALCINOSIS],310468[NEPHROLITHIASIS, X-LINKED RECESSIVE, WITH RENAL FAILURE; XRN]
FBgn0036566	ClC-c	HGNC:2022	OMIM:302910	CLCN4	11	300114	300114[RAYNAUD-CLAES SYNDROME; MRXSRC]
FBgn0036566	ClC-c	HGNC:2027	OMIM:602023	CLCNKB	3	607364,613090	607364[BARTTER SYNDROME, TYPE 3; BARTS3],613090[BARTTER SYNDROME, TYPE 4B, NEONATAL, WITH SENSORINEURAL DEAFNESS; BARTS4B]
FBgn0036568	ATPsynbetaL	HGNC:830	OMIM:102910	ATP5F1B	8		
FBgn0036569	IleRS-m	HGNC:29685	OMIM:612801	IARS2	13	616007	616007[CATARACTS, GROWTH HORMONE DEFICIENCY, SENSORY NEUROPATHY, SENSORINEURAL HEARING LOSS, AND SKELETAL DYSPLASIA; CAGSSS]
FBgn0010280	Taf4	HGNC:11537	OMIM:601796	TAF4	10		
FBgn0010280	Taf4	HGNC:11538	OMIM:601689	TAF4B	10	615841	615841[SPERMATOGENIC FAILURE 13; SPGF13]
FBgn0036571	Strump	HGNC:28984	OMIM:610657	WASHC5	14	220210,603563	220210[RITSCHER-SCHINZEL SYNDROME 1; RTSC1],603563[SPASTIC PARAPLEGIA 8, AUTOSOMAL DOMINANT; SPG8]
FBgn0011016	SsRbeta	HGNC:11324	OMIM:600867	SSR2	14		
FBgn0036579	Tmx3	HGNC:24718	OMIM:616102	TMX3	14		
FBgn0036581	MED10	HGNC:28760	OMIM:612382	MED10	12		
FBgn0036580	PDCD-5	HGNC:8764	OMIM:604583	PDCD5	14		
FBgn0052152	CG32152	HGNC:5188	OMIM:610086	PRMT8	4		
FBgn0052152	CG32152	HGNC:5187	OMIM:602950	PRMT1	3		
FBgn0036575	CG5157	HGNC:2570	OMIM:613218	CYB5A	5	250790	250790[METHEMOGLOBINEMIA AND AMBIGUOUS GENITALIA; METAG]
FBgn0036575	CG5157	HGNC:24374	OMIM:611964	CYB5B	5		
FBgn0003076	Pgm1	HGNC:8905	OMIM:171900	PGM1	14	614921	614921[CONGENITAL DISORDER OF GLYCOSYLATION, TYPE It; CDG1T]
FBgn0003076	Pgm1	HGNC:8908	OMIM:600981	PGM5	12		
FBgn0036570	IntS9	HGNC:25592	OMIM:611352	INTS9	14		
FBgn0036565	CG5235	HGNC:2689	OMIM:609312	DBH	4	223360	223360[ORTHOSTATIC HYPOTENSION 1; ORTHYP1]
FBgn0036565	CG5235	HGNC:21063	OMIM:609000	MOXD1	13		
FBgn0036531	CG6244	HGNC:28691	OMIM:619818	ELOF1	9		
FBgn0040230	dbo	HGNC:25056	OMIM:617679	KLHL20	15		
FBgn0036536	CG12713	HGNC:26929	OMIM:615626	C15orf41	13	615631	615631[ANEMIA, CONGENITAL DYSERYTHROPOIETIC, TYPE Ib; CDAN1B]
FBgn0036545	GXIVsPLA2	HGNC:18555	OMIM:611653	PLA2G12B	10		
FBgn0036545	GXIVsPLA2	HGNC:18554	OMIM:611652	PLA2G12A	13		
FBgn0036549	CG10516	HGNC:30629	OMIM:611659	SPSB3	12		
FBgn0036550	CG17026	HGNC:6050	OMIM:602064	IMPA1	7	617323	617323[INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 59; MRT59]
FBgn0036550	CG17026	HGNC:6051	OMIM:605922	IMPA2	8		
FBgn0036551	CG17029	HGNC:6050	OMIM:602064	IMPA1	8	617323	617323[INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 59; MRT59]
FBgn0036551	CG17029	HGNC:6051	OMIM:605922	IMPA2	7		
FBgn0036552	CG17028	HGNC:6050	OMIM:602064	IMPA1	7	617323	617323[INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 59; MRT59]
FBgn0036552	CG17028	HGNC:6051	OMIM:605922	IMPA2	7		
FBgn0036553	CG17027	HGNC:6050	OMIM:602064	IMPA1	8	617323	617323[INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 59; MRT59]
FBgn0036553	CG17027	HGNC:6051	OMIM:605922	IMPA2	7		
FBgn0000115	Arl1	HGNC:692	OMIM:603425	ARL1	14		
FBgn0036557	mRpS31	HGNC:16632	OMIM:611992	MRPS31	12		
FBgn0036556	hzg	HGNC:16890	OMIM:608592	CTDSPL	12		
FBgn0036556	hzg	HGNC:17077	OMIM:608711	CTDSP2	12		
FBgn0036556	hzg	HGNC:21614	OMIM:605323	CTDSP1	15		
FBgn0000212	brm	HGNC:11100	OMIM:603254	SMARCA4	12	613325,614609	613325[RHABDOID TUMOR PREDISPOSITION SYNDROME 2; RTPS2],614609[COFFIN-SIRIS SYNDROME 4; CSS4]
FBgn0000212	brm	HGNC:11098	OMIM:600014	SMARCA2	13	601358,619293	601358[NICOLAIDES-BARAITSER SYNDROME; NCBRS],619293[BLEPHAROPHIMOSIS-IMPAIRED INTELLECTUAL DEVELOPMENT SYNDROME; BIS]
FBgn0000489	Pka-C3	HGNC:9441	OMIM:300083	PRKX	14		
FBgn0000489	Pka-C3	HGNC:9382	OMIM:176893	PRKACG	3	616176	616176[BLEEDING DISORDER, PLATELET-TYPE, 19; BDPLT19]
FBgn0000489	Pka-C3	HGNC:9380	OMIM:601639	PRKACA	3	615830,619142	615830[PIGMENTED NODULAR ADRENOCORTICAL DISEASE, PRIMARY, 4; PPNAD4],619142[CARDIOACROFACIAL DYSPLASIA 1; CAFD1]
FBgn0000489	Pka-C3	HGNC:9381	OMIM:176892	PRKACB	3	619143	619143[CARDIOACROFACIAL DYSPLASIA 2; CAFD2]
FBgn0000489	Pka-C3	HGNC:9444	OMIM:400008	PRKY	6		
FBgn0052150	meru	HGNC:33984	OMIM:614713	RASSF10	3		
FBgn0052150	meru	HGNC:15739	OMIM:610383	RASSF9	4		
FBgn0036538	CG15715	HGNC:24992	OMIM:619526	ZNF706	11		
FBgn0036537	CG18081	HGNC:24992	OMIM:619526	ZNF706	12		
FBgn0036499	CG7276	HGNC:28482	OMIM:617353	DYNLT2B	9	617405	617405[SHORT-RIB THORACIC DYSPLASIA 17 WITH OR WITHOUT POLYDACTYLY; SRTD17]
FBgn0036499	CG7276	HGNC:11695	OMIM:186977	TCTE3	3		
FBgn0036500	CG7275	HGNC:24535	OMIM:616196	DCAF13	14		
FBgn0036501	CG7272	HGNC:30657	OMIM:613683	SLC50A1	5		
FBgn0000565	MsrA	HGNC:7377	OMIM:601250	MSRA	11		
FBgn0004396	CrebA	HGNC:18855	OMIM:611998	CREB3L3	5	619324	619324[HYPERTRIGLYCERIDEMIA 2; HYTG2]
FBgn0004396	CrebA	HGNC:23720	OMIM:608834	CREB3L2	10		
FBgn0004396	CrebA	HGNC:18856	OMIM:616215	CREB3L1	9	616229	616229[OSTEOGENESIS IMPERFECTA, TYPE XVI; OI16]
FBgn0004396	CrebA	HGNC:18854	OMIM:607138	CREB3L4	4		
FBgn0004396	CrebA	HGNC:2347	OMIM:606443	CREB3	3		
FBgn0036510	SCCRO	HGNC:18184	OMIM:605905	DCUN1D1	15		
FBgn0036510	SCCRO	HGNC:28409	OMIM:616522	DCUN1D5	4		
FBgn0036510	SCCRO	HGNC:28734	OMIM:616167	DCUN1D3	3		
FBgn0036510	SCCRO	HGNC:20328		DCUN1D2	13		
FBgn0036510	SCCRO	HGNC:28998	OMIM:612977	DCUN1D4	3		
FBgn0036512	Ufsp2	HGNC:25640	OMIM:611482	UFSP2	12	142669,617974,620028	142669[BEUKES HIP DYSPLASIA; BHD],617974[SPONDYLOEPIMETAPHYSEAL DYSPLASIA, DI ROCCO TYPE; SEMDDR],620028[DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 106; DEE106]
FBgn0036512	Ufsp2	HGNC:33821	OMIM:611481	UFSP1	3		
FBgn0036514	CG12301	HGNC:10665	OMIM:300508	UTP14A	14		
FBgn0036514	CG12301	HGNC:20321	OMIM:608969	UTP14C	13		
FBgn0036515	AIMP2	HGNC:20609	OMIM:600859	AIMP2	13	618006	618006[LEUKODYSTROPHY, HYPOMYELINATING, 17; HLD17]
FBgn0036518	RhoGAP71E	HGNC:18357	OMIM:609568	ARHGAP20	5		
FBgn0036518	RhoGAP71E	HGNC:15669	OMIM:609667	TAGAP	3		
FBgn0036527	CG7304	HGNC:33844	OMIM:615138	GALNTL6	5		
FBgn0036527	CG7304	HGNC:19873	OMIM:608043	GALNT10	4		
FBgn0036527	CG7304	HGNC:19875	OMIM:615130	GALNT11	3		
FBgn0036527	CG7304	HGNC:21725	OMIM:615133	GALNTL5	3		
FBgn0036529	Pgant8	HGNC:33844	OMIM:615138	GALNTL6	7		
FBgn0036529	Pgant8	HGNC:19873	OMIM:608043	GALNT10	6		
FBgn0036528	CG7579	HGNC:33844	OMIM:615138	GALNTL6	5		
FBgn0036528	CG7579	HGNC:19873	OMIM:608043	GALNT10	4		
FBgn0036528	CG7579	HGNC:21725	OMIM:615133	GALNTL5	3		
FBgn0036519	CG7650	HGNC:8759	OMIM:171490	PDC	8		
FBgn0036519	CG7650	HGNC:8770	OMIM:604421	PDCL	14		
FBgn0036516	CG7656	HGNC:1734	OMIM:116948	CDC34	11		
FBgn0036516	CG7656	HGNC:19907	OMIM:612506	UBE2R2	13		
FBgn0036509	CG7739	HGNC:30697	OMIM:611803	ITFG1	12		
FBgn0036505	CG7945	HGNC:938	OMIM:603882	BAG2	14		
FBgn0036502	CG7841	HGNC:14142		MCRIP2	7		
FBgn0036502	CG7841	HGNC:28007	OMIM:616514	MCRIP1	5		
FBgn0026738	CG7857	HGNC:32312	OMIM:300714	OTUD6A	12		
FBgn0026738	CG7857	HGNC:24281	OMIM:612021	OTUD6B	14	617452	617452[INTELLECTUAL DEVELOPMENTAL DISORDER WITH DYSMORPHIC FACIES, SEIZURES, AND DISTAL LIMB ANOMALIES; IDDFSDA]
FBgn0040805	CG12355	HGNC:26827	OMIM:618100	MPV17L	12		
FBgn0029114	Tollo	HGNC:15631	OMIM:300365	TLR7	3	301051,301080	301051[IMMUNODEFICIENCY 74, COVID19-RELATED, X-LINKED; IMD74],301080[SYSTEMIC LUPUS ERYTHEMATOSUS 17; SLEB17]
FBgn0029114	Tollo	HGNC:11849	OMIM:603029	TLR3	4	609423,613002	609423[HUMAN IMMUNODEFICIENCY VIRUS TYPE 1, SUSCEPTIBILITY TO],613002[IMMUNODEFICIENCY 83, SUSCEPTIBILITY TO VIRAL INFECTIONS; IMD83]
FBgn0029114	Tollo	HGNC:15633	OMIM:605474	TLR9	3		
FBgn0029114	Tollo	HGNC:11850	OMIM:603030	TLR4	3		
FBgn0036491	Best4	HGNC:17105	OMIM:607337	BEST3	11		
FBgn0036491	Best4	HGNC:12703	OMIM:607854	BEST1	10	153700,193220,611809,613194	153700[MACULAR DYSTROPHY, VITELLIFORM, 2; VMD2],193220[VITREORETINOCHOROIDOPATHY; VRCP],611809[BESTROPHINOPATHY, AUTOSOMAL RECESSIVE; ARB],613194[RETINITIS PIGMENTOSA 50; RP50]
FBgn0036491	Best4	HGNC:17106	OMIM:607336	BEST4	14		
FBgn0036491	Best4	HGNC:17107	OMIM:607335	BEST2	11		
FBgn0036497	Ran-like	HGNC:9846	OMIM:601179	RAN	6		
FBgn0036496	cocoon	HGNC:11571	OMIM:605078	TARDBP	12	612069	612069[AMYOTROPHIC LATERAL SCLEROSIS 10 WITH OR WITHOUT FRONTOTEMPORAL DEMENTIA; ALS10]
FBgn0036492	Best3	HGNC:17105	OMIM:607337	BEST3	11		
FBgn0036492	Best3	HGNC:12703	OMIM:607854	BEST1	10	153700,193220,611809,613194	153700[MACULAR DYSTROPHY, VITELLIFORM, 2; VMD2],193220[VITREORETINOCHOROIDOPATHY; VRCP],611809[BESTROPHINOPATHY, AUTOSOMAL RECESSIVE; ARB],613194[RETINITIS PIGMENTOSA 50; RP50]
FBgn0036492	Best3	HGNC:17106	OMIM:607336	BEST4	11		
FBgn0036492	Best3	HGNC:17107	OMIM:607335	BEST2	9		
FBgn0036460	CG5114	HGNC:18	OMIM:603488	AAMP	15		
FBgn0002778	mnd	HGNC:11059	OMIM:607933	SLC7A11	6		
FBgn0002778	mnd	HGNC:11058	OMIM:607959	SLC7A10	6		
FBgn0002778	mnd	HGNC:11065	OMIM:603593	SLC7A7	9	222700	222700[LYSINURIC PROTEIN INTOLERANCE; LPI]
FBgn0002778	mnd	HGNC:11064	OMIM:605641	SLC7A6	8		
FBgn0002778	mnd	HGNC:11067	OMIM:604144	SLC7A9	6	220100	220100[CYSTINURIA]
FBgn0002778	mnd	HGNC:11063	OMIM:600182	SLC7A5	8		
FBgn0002778	mnd	HGNC:11066	OMIM:604235	SLC7A8	8		
FBgn0002778	mnd	HGNC:23092	OMIM:617256	SLC7A13	4		
FBgn0036461	Zip71B	HGNC:18607	OMIM:608731	SLC39A6	5		
FBgn0036461	Zip71B	HGNC:20861	OMIM:608733	SLC39A10	6		
FBgn0036461	Zip71B	HGNC:20858	OMIM:608736	SLC39A14	5	144755,617013	144755[HYPEROSTOSIS CRANIALIS INTERNA; HCIN],617013[HYPERMANGANESEMIA WITH DYSTONIA 2; HMNDYT2]
FBgn0036461	Zip71B	HGNC:17129	OMIM:607059	SLC39A4	4	201100	201100[ACRODERMATITIS ENTEROPATHICA, ZINC-DEFICIENCY TYPE; AEZ]
FBgn0036461	Zip71B	HGNC:20862	OMIM:608732	SLC39A8	6	616721	616721[CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIn; CDG2N]
FBgn0036461	Zip71B	HGNC:20502	OMIM:608730	SLC39A5	8	615946	615946[MYOPIA 24, AUTOSOMAL DOMINANT; MYP24]
FBgn0036461	Zip71B	HGNC:20860	OMIM:608734	SLC39A12	4		
FBgn0023174	Prosbeta2	HGNC:9544	OMIM:604030	PSMB7	14		
FBgn0023174	Prosbeta2	HGNC:9538	OMIM:176847	PSMB10	6	619175	619175[PROTEASOME-ASSOCIATED AUTOINFLAMMATORY SYNDROME 5; PRAAS5]
FBgn0027088	GlyRS	HGNC:4162	OMIM:600287	GARS1	15	600794,601472,619042	600794[NEURONOPATHY, DISTAL HEREDITARY MOTOR, TYPE VA; HMN5A],601472[CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2D; CMT2D],619042[SPINAL MUSCULAR ATROPHY, INFANTILE, JAMES TYPE; SMAJI]
FBgn0036479	CG13458	HGNC:21000	OMIM:614773	MSS51	4		
FBgn0036480	Cep135	HGNC:29086	OMIM:611423	CEP135	12	614673	614673[MICROCEPHALY 8, PRIMARY, AUTOSOMAL RECESSIVE; MCPH8]
FBgn0036480	Cep135	HGNC:14927	OMIM:607166	TSGA10	7	617961	617961[SPERMATOGENIC FAILURE 26; SPGF26]
FBgn0052847	CG32847	HGNC:26783		RNF185	7		
FBgn0052847	CG32847	HGNC:10068	OMIM:602677	RNF5	7		
FBgn0036484	Pex3	HGNC:8858	OMIM:603164	PEX3	13	614882,617370	614882[PEROXISOME BIOGENESIS DISORDER 10A (ZELLWEGER); PBD10A],617370[PEROXISOME BIOGENESIS DISORDER 10B; PBD10B]
FBgn0036485	FucTA	HGNC:4016	OMIM:136835	FUT5	11		
FBgn0036485	FucTA	HGNC:4017	OMIM:136836	FUT6	9	613852	613852[FUCOSYLTRANSFERASE 6 DEFICIENCY]
FBgn0036485	FucTA	HGNC:4014	OMIM:111100	FUT3	12	618983	618983[BLOOD GROUP, LEWIS SYSTEM; LE]
FBgn0036485	FucTA	HGNC:4015	OMIM:104230	FUT4	11		
FBgn0036485	FucTA	HGNC:4018	OMIM:602030	FUT7	10		
FBgn0036485	FucTA	HGNC:4020	OMIM:606865	FUT9	12		
FBgn0036487	Prp31	HGNC:15446	OMIM:606419	PRPF31	14	600138	600138[RETINITIS PIGMENTOSA 11; RP11]
FBgn0036488	CG6878	HGNC:16185	OMIM:618894	ROMO1	13		
FBgn0036490	Prx1	HGNC:17169	OMIM:300927	PRDX4	4		
FBgn0036490	Prx1	HGNC:9352	OMIM:176763	PRDX1	6	277400	277400[METHYLMALONIC ACIDURIA AND HOMOCYSTINURIA, cblC TYPE; MAHCC]
FBgn0036490	Prx1	HGNC:9354	OMIM:604769	PRDX3	4	619862,619871	619862[SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 32; SCAR32],619871[CORNEAL DYSTROPHY, PUNCTIFORM AND POLYCHROMATIC PRE-DESCEMET; PPPCD]
FBgn0036490	Prx1	HGNC:9353	OMIM:600538	PRDX2	6		
FBgn0036489	CG7011	HGNC:15927	OMIM:616971	ERGIC3	14		
FBgn0036486	Msh6	HGNC:7329	OMIM:600678	MSH6	13	608089,614350,619097	608089[ENDOMETRIAL CANCER],614350[COLORECTAL CANCER, HEREDITARY NONPOLYPOSIS, TYPE 5; HNPCC5],619097[MISMATCH REPAIR CANCER SYNDROME 3; MMRCS3]
FBgn0047178	CG32147	HGNC:27080		PGPEP1L	12		
FBgn0047178	CG32147	HGNC:13568	OMIM:610694	PGPEP1	15		
FBgn0025776	ind	HGNC:24959	OMIM:616253	GSX2	7	618646	618646[DIENCEPHALIC-MESENCEPHALIC JUNCTION DYSPLASIA SYNDROME 2; DMJDS2]
FBgn0025776	ind	HGNC:20374	OMIM:616542	GSX1	9		
FBgn0036465	Rpn12R	HGNC:9566	OMIM:617844	PSMD8	12		
FBgn0036463	Reck	HGNC:11345	OMIM:605227	RECK	13		
FBgn0036462	mRpL39	HGNC:14027	OMIM:611845	MRPL39	13		
FBgn0003388	shd	HGNC:2606	OMIM:609506	CYP27B1	3	264700	264700[VITAMIN D HYDROXYLATION-DEFICIENT RICKETS, TYPE 1A; VDDR1A]
FBgn0003388	shd	HGNC:33480		CYP27C1	3		
FBgn0003388	shd	HGNC:2602	OMIM:126065	CYP24A1	3	143880	143880[HYPERCALCEMIA, INFANTILE, 1; HCINF1]
FBgn0041604	dlp	HGNC:4452	OMIM:300168	GPC4	13	301026	301026[KEIPERT SYNDROME; KPTS]
FBgn0041604	dlp	HGNC:4449	OMIM:600395	GPC1	9		
FBgn0041604	dlp	HGNC:4454	OMIM:604404	GPC6	12	258315	258315[OMODYSPLASIA 1; OMOD1]
FBgn0041604	dlp	HGNC:4450	OMIM:618446	GPC2	7		
FBgn0036437	Dnaaf6	HGNC:28570	OMIM:300933	PIH1D3	14	300991	300991[CILIARY DYSKINESIA, PRIMARY, 36, X-LINKED; CILD36]
FBgn0036442	CG13473	HGNC:12435	OMIM:187700	TXN	6		
FBgn0036442	CG13473	HGNC:17772	OMIM:609063	TXN2	3	616811	616811[COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 29; COXPD29]
FBgn0036442	CG13473	HGNC:16470	OMIM:617790	TXNDC2	3		
FBgn0036442	CG13473	HGNC:31454	OMIM:617789	TXNDC8	4		
FBgn0036446	Mgat4a	HGNC:7047	OMIM:604623	MGAT4A	13		
FBgn0036446	Mgat4a	HGNC:7048	OMIM:604561	MGAT4B	14		
FBgn0036446	Mgat4a	HGNC:43619	OMIM:610310	MGAT4D	5		
FBgn0036446	Mgat4a	HGNC:30871	OMIM:607385	MGAT4C	3		
FBgn0036450	Tdrd3	HGNC:20612	OMIM:614392	TDRD3	12		
FBgn0036451	Helz	HGNC:16878	OMIM:606699	HELZ	12		
FBgn0029148	NHP2	HGNC:14377	OMIM:606470	NHP2	14	613987	613987[DYSKERATOSIS CONGENITA, AUTOSOMAL RECESSIVE 2; DKCB2]
FBgn0036449	bmm	HGNC:30802	OMIM:609059	PNPLA2	12	610717	610717[NEUTRAL LIPID STORAGE DISEASE WITH MYOPATHY; NLSDM]
FBgn0036449	bmm	HGNC:24888	OMIM:611589	PNPLA5	8		
FBgn0036449	bmm	HGNC:18590	OMIM:609567	PNPLA3	11		
FBgn0036449	bmm	HGNC:21246	OMIM:612121	PNPLA1	6	615024	615024[ICHTHYOSIS, CONGENITAL, AUTOSOMAL RECESSIVE 10; ARCI10]
FBgn0036448	mop	HGNC:8766	OMIM:608074	PDCD6IP	5		
FBgn0036448	mop	HGNC:14406	OMIM:606584	PTPN23	9	618890	618890[NEURODEVELOPMENTAL DISORDER AND STRUCTURAL BRAIN ANOMALIES WITH OR WITHOUT SEIZURES AND SPASTICITY; NEDBASS]
FBgn0036447	Mgat4b	HGNC:7047	OMIM:604623	MGAT4A	5		
FBgn0036447	Mgat4b	HGNC:7048	OMIM:604561	MGAT4B	6		
FBgn0036447	Mgat4b	HGNC:43619	OMIM:610310	MGAT4D	4		
FBgn0053260	Tsen34	HGNC:15506	OMIM:608754	TSEN34	10	612390	612390[PONTOCEREBELLAR HYPOPLASIA, TYPE 2C; PCH2C]
FBgn0036436	CG4914	HGNC:15475	OMIM:608018	PRSS27	3		
FBgn0036426	CG9592	HGNC:28178	OMIM:613734	CCDC115	4	616828	616828[CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIo; CDG2O]
FBgn0026409	Mpcp2	HGNC:10989	OMIM:600370	SLC25A3	14	610773	610773[MITOCHONDRIAL PHOSPHATE CARRIER DEFICIENCY; MPCD]
FBgn0040318	HGTX	HGNC:19321	OMIM:605955	NKX6-2	9	617560	617560[SPASTIC ATAXIA 8, AUTOSOMAL RECESSIVE, WITH HYPOMYELINATING LEUKODYSTROPHY; SPAX8]
FBgn0040318	HGTX	HGNC:7839	OMIM:602563	NKX6-1	9		
FBgn0040318	HGTX	HGNC:26328	OMIM:610772	NKX6-3	8		
FBgn0036428	Gbs-70E	HGNC:9293	OMIM:602999	PPP1R3C	11		
FBgn0036428	Gbs-70E	HGNC:9294	OMIM:603326	PPP1R3D	5		
FBgn0036428	Gbs-70E	HGNC:14942	OMIM:610541	PPP1R3B	9		
FBgn0036428	Gbs-70E	HGNC:14943	OMIM:619540	PPP1R3E	4		
FBgn0036428	Gbs-70E	HGNC:9291	OMIM:600917	PPP1R3A	4	125853	125853[TYPE 2 DIABETES MELLITUS; T2D]
FBgn0036428	Gbs-70E	HGNC:14944		PPP1R3F	4		
FBgn0036428	Gbs-70E	HGNC:14945	OMIM:619541	PPP1R3G	4		
FBgn0036421	CG13481	HGNC:25539	OMIM:614151	RFWD3	4	617784	617784[FANCONI ANEMIA, COMPLEMENTATION GROUP W; FANCW]
FBgn0036415	CG7768	HGNC:14650	OMIM:606093	PPIG	3		
FBgn0036415	CG7768	HGNC:9256	OMIM:123842	PPIC	3		
FBgn0036415	CG7768	HGNC:33996		PPIAL4G	4		
FBgn0036415	CG7768	HGNC:7833	OMIM:161565	NKTR	3		
FBgn0036415	CG7768	HGNC:14651	OMIM:606095	PPIH	3		
FBgn0036415	CG7768	HGNC:24369		PPIAL4A	3		
FBgn0036415	CG7768	HGNC:9257	OMIM:601753	PPID	3		
FBgn0036415	CG7768	HGNC:9255	OMIM:123841	PPIB	3	259440	259440[OSTEOGENESIS IMPERFECTA, TYPE IX; OI9]
FBgn0036415	CG7768	HGNC:33998		PPIAL4D	3		
FBgn0036415	CG7768	HGNC:9259	OMIM:604486	PPIF	12		
FBgn0036415	CG7768	HGNC:33995		PPIAL4C	4		
FBgn0036415	CG7768	HGNC:9253	OMIM:123840	PPIA	6		
FBgn0036415	CG7768	HGNC:33999		PPIAL4F	4		
FBgn0036415	CG7768	HGNC:33997	OMIM:608608	PPIAL4E	3		
FBgn0036415	CG7768	HGNC:53889		PPIAL4H	4		
FBgn0001085	fz	HGNC:4045	OMIM:603410	FZD7	13		
FBgn0001085	fz	HGNC:4041	OMIM:606143	FZD3	5		
FBgn0001085	fz	HGNC:4040	OMIM:600667	FZD2	10	164745	164745[OMODYSPLASIA 2; OMOD2]
FBgn0001085	fz	HGNC:4044	OMIM:603409	FZD6	5	161050	161050[NAIL DISORDER, NONSYNDROMIC CONGENITAL, 1; NDNC1]
FBgn0001085	fz	HGNC:4038	OMIM:603408	FZD1	13		
FBgn0000411	D	HGNC:11193	OMIM:604747	SOX14	5		
FBgn0000411	D	HGNC:18196	OMIM:612202	SOX7	4		
FBgn0000411	D	HGNC:11200	OMIM:184430	SOX4	4	618506	618506[COFFIN-SIRIS SYNDROME 10; CSS10]
FBgn0000411	D	HGNC:11199	OMIM:313430	SOX3	4	300123,312000	300123[INTELLECTUAL DEVELOPMENTAL DISORDER, X-LINKED, WITH PANHYPOPITUITARISM],312000[PANHYPOPITUITARISM, X-LINKED; PHPX]
FBgn0000411	D	HGNC:11195	OMIM:184429	SOX2	3	206900	206900[MICROPHTHALMIA, SYNDROMIC 3; MCOPS3]
FBgn0000411	D	HGNC:11197	OMIM:604974	SOX21	5		
FBgn0000411	D	HGNC:11198	OMIM:601947	SOX12	5		
FBgn0000411	D	HGNC:11189	OMIM:602148	SOX1	4		
FBgn0000411	D	HGNC:11196	OMIM:601297	SOX15	3		
FBgn0000411	D	HGNC:11194	OMIM:601618	SOX18	4	137940,607823	137940[HYPOTRICHOSIS-LYMPHEDEMA-TELANGIECTASIA-RENAL DEFECT SYNDROME; HLTRS],607823[HYPOTRICHOSIS-LYMPHEDEMA-TELANGIECTASIA SYNDROME; HLTS]
FBgn0000411	D	HGNC:18122	OMIM:610928	SOX17	4	613674	613674[VESICOURETERAL REFLUX 3; VUR3]
FBgn0042630	Sox21b	HGNC:11193	OMIM:604747	SOX14	8		
FBgn0042630	Sox21b	HGNC:18196	OMIM:612202	SOX7	4		
FBgn0042630	Sox21b	HGNC:11200	OMIM:184430	SOX4	4	618506	618506[COFFIN-SIRIS SYNDROME 10; CSS10]
FBgn0042630	Sox21b	HGNC:11199	OMIM:313430	SOX3	4	300123,312000	300123[INTELLECTUAL DEVELOPMENTAL DISORDER, X-LINKED, WITH PANHYPOPITUITARISM],312000[PANHYPOPITUITARISM, X-LINKED; PHPX]
FBgn0042630	Sox21b	HGNC:11195	OMIM:184429	SOX2	4	206900	206900[MICROPHTHALMIA, SYNDROMIC 3; MCOPS3]
FBgn0042630	Sox21b	HGNC:11197	OMIM:604974	SOX21	8		
FBgn0042630	Sox21b	HGNC:11198	OMIM:601947	SOX12	5		
FBgn0042630	Sox21b	HGNC:11189	OMIM:602148	SOX1	4		
FBgn0042630	Sox21b	HGNC:11196	OMIM:601297	SOX15	3		
FBgn0042630	Sox21b	HGNC:11194	OMIM:601618	SOX18	4	137940,607823	137940[HYPOTRICHOSIS-LYMPHEDEMA-TELANGIECTASIA-RENAL DEFECT SYNDROME; HLTRS],607823[HYPOTRICHOSIS-LYMPHEDEMA-TELANGIECTASIA SYNDROME; HLTS]
FBgn0042630	Sox21b	HGNC:18122	OMIM:610928	SOX17	4	613674	613674[VESICOURETERAL REFLUX 3; VUR3]
FBgn0036411	Sox21a	HGNC:11193	OMIM:604747	SOX14	7		
FBgn0036411	Sox21a	HGNC:18196	OMIM:612202	SOX7	4		
FBgn0036411	Sox21a	HGNC:11200	OMIM:184430	SOX4	5	618506	618506[COFFIN-SIRIS SYNDROME 10; CSS10]
FBgn0036411	Sox21a	HGNC:11199	OMIM:313430	SOX3	4	300123,312000	300123[INTELLECTUAL DEVELOPMENTAL DISORDER, X-LINKED, WITH PANHYPOPITUITARISM],312000[PANHYPOPITUITARISM, X-LINKED; PHPX]
FBgn0036411	Sox21a	HGNC:11195	OMIM:184429	SOX2	5	206900	206900[MICROPHTHALMIA, SYNDROMIC 3; MCOPS3]
FBgn0036411	Sox21a	HGNC:11197	OMIM:604974	SOX21	6		
FBgn0036411	Sox21a	HGNC:11198	OMIM:601947	SOX12	6		
FBgn0036411	Sox21a	HGNC:11191	OMIM:600898	SOX11	3	615866	615866[COFFIN-SIRIS SYNDROME 9; CSS9]
FBgn0036411	Sox21a	HGNC:11189	OMIM:602148	SOX1	3		
FBgn0036411	Sox21a	HGNC:11196	OMIM:601297	SOX15	4		
FBgn0036411	Sox21a	HGNC:11194	OMIM:601618	SOX18	5	137940,607823	137940[HYPOTRICHOSIS-LYMPHEDEMA-TELANGIECTASIA-RENAL DEFECT SYNDROME; HLTRS],607823[HYPOTRICHOSIS-LYMPHEDEMA-TELANGIECTASIA SYNDROME; HLTS]
FBgn0036411	Sox21a	HGNC:18122	OMIM:610928	SOX17	5	613674	613674[VESICOURETERAL REFLUX 3; VUR3]
FBgn0036411	Sox21a	HGNC:11311	OMIM:480000	SRY	3	400044,400045	400044[46,XY SEX REVERSAL 1; SRXY1],400045[46,XX SEX REVERSAL 1; SRXX1]
FBgn0029167	Hml	HGNC:24154	OMIM:608699	BMPER	3	608022	608022[DIAPHANOSPONDYLODYSOSTOSIS]
FBgn0029167	Hml	HGNC:8516	OMIM:604487	OTOG	7	614945	614945[DEAFNESS, AUTOSOMAL RECESSIVE 18B; DFNB18B]
FBgn0029167	Hml	HGNC:12726	OMIM:613160	VWF	6	193400,277480,613554	193400[VON WILLEBRAND DISEASE, TYPE 1; VWD1],277480[VON WILLEBRAND DISEASE, TYPE 3; VWD3],613554[VON WILLEBRAND DISEASE, TYPE 2; VWD2]
FBgn0029167	Hml	HGNC:7515	OMIM:158373	MUC5AC	7		
FBgn0029167	Hml	HGNC:7517	OMIM:158374	MUC6	6		
FBgn0029167	Hml	HGNC:7512	OMIM:158370	MUC2	6		
FBgn0029167	Hml	HGNC:26901	OMIM:614925	OTOGL	4	614944	614944[DEAFNESS, AUTOSOMAL RECESSIVE 84B; DFNB84B]
FBgn0029167	Hml	HGNC:7516	OMIM:600770	MUC5B	7	178500	178500[INTERSTITIAL LUNG DISEASE 2; ILD2]
FBgn0029167	Hml	HGNC:11720	OMIM:602574	TECTA	3	601543,603629	601543[DEAFNESS, AUTOSOMAL DOMINANT 12; DFNA12],603629[DEAFNESS, AUTOSOMAL RECESSIVE 21; DFNB21]
FBgn0029167	Hml	HGNC:13572	OMIM:617553	FCGBP	4		
FBgn0029167	Hml	HGNC:21998	OMIM:617356	SSPO	7		
FBgn0029167	Hml	HGNC:12857	OMIM:602372	ZAN	3		
FBgn0001108	DCTN1-p150	HGNC:2711	OMIM:601143	DCTN1	13	105400,168605,607641	105400[AMYOTROPHIC LATERAL SCLEROSIS 1; ALS1],168605[PERRY SYNDROME],607641[NEURONOPATHY, DISTAL HEREDITARY MOTOR, TYPE VIIB; HMN7B]
FBgn0052137	CG32137	HGNC:28095	OMIM:617002	BICDL1	15		
FBgn0052137	CG32137	HGNC:33584	OMIM:617003	BICDL2	7		
FBgn0001216	Hsc70-1	HGNC:5232	OMIM:140550	HSPA1A	5		
FBgn0001216	Hsc70-1	HGNC:5233	OMIM:603012	HSPA1B	7		
FBgn0001216	Hsc70-1	HGNC:5234	OMIM:140559	HSPA1L	6		
FBgn0001216	Hsc70-1	HGNC:5238	OMIM:138120	HSPA5	4		
FBgn0001216	Hsc70-1	HGNC:5244	OMIM:600548	HSPA9	3	182170,616854	182170[ANEMIA, SIDEROBLASTIC, 4; SIDBA4],616854[EVEN-PLUS SYNDROME; EVPLS]
FBgn0001216	Hsc70-1	HGNC:5239	OMIM:140555	HSPA6	7		
FBgn0001216	Hsc70-1	HGNC:5235	OMIM:140560	HSPA2	8		
FBgn0001216	Hsc70-1	HGNC:5241	OMIM:600816	HSPA8	9		
FBgn0036398	upSET	HGNC:25566	OMIM:615743	SETD5	8	615761	615761[INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL DOMINANT 23; MRD23]
FBgn0036398	upSET	HGNC:18541	OMIM:608444	KMT2E	8	618512	618512[O&apos;DONNELL-LURIA-RODAN SYNDROME; ODLURO]
FBgn0036398	upSET	HGNC:24280		PHF20L1	3		
FBgn0036398	upSET	HGNC:16098	OMIM:610335	PHF20	3		
FBgn0036402	CG6650	HGNC:25250	OMIM:611861	ADPGK	8		
FBgn0036403	CG6661	HGNC:406	OMIM:606811	ALDH4A1	6	239510	239510[HYPERPROLINEMIA, TYPE II; HYRPRO2]
FBgn0026418	Hsp110	HGNC:5237	OMIM:601113	HSPA4	15		
FBgn0026418	Hsp110	HGNC:17041	OMIM:619077	HSPA4L	13		
FBgn0026418	Hsp110	HGNC:16969	OMIM:610703	HSPH1	13		
FBgn0036405	CG6833	HGNC:12820	OMIM:602930	REXO4	13		
FBgn0036405	CG6833	HGNC:25745	OMIM:611930	ISG20L2	3		
FBgn0013563	Pex1	HGNC:8850	OMIM:602136	PEX1	12	214100,234580,601539	214100[PEROXISOME BIOGENESIS DISORDER 1A (ZELLWEGER); PBD1A],234580[HEIMLER SYNDROME 1; HMLR1],601539[PEROXISOME BIOGENESIS DISORDER 1B; PBD1B]
FBgn0036397	Nprl3	HGNC:14124	OMIM:600928	NPRL3	13	617118	617118[EPILEPSY, FAMILIAL FOCAL, WITH VARIABLE FOCI 3; FFEVF3]
FBgn0036386	CG8833	HGNC:24658		GPATCH1	12		
FBgn0026376	Rgl	HGNC:9842	OMIM:601619	RALGDS	12		
FBgn0026376	Rgl	HGNC:30281	OMIM:605667	RGL1	15		
FBgn0026376	Rgl	HGNC:30282	OMIM:616743	RGL3	7		
FBgn0026376	Rgl	HGNC:9769	OMIM:602306	RGL2	8		
FBgn0026376	Rgl	HGNC:31911	OMIM:612214	RGL4	5		
FBgn0036381	CG8745	HGNC:14404	OMIM:614682	ETNPPL	14		
FBgn0036381	CG8745	HGNC:28249	OMIM:614683	PHYKPL	11	615011	615011[PHOSPHOHYDROXYLYSINURIA; PHLU]
FBgn0036381	CG8745	HGNC:14412	OMIM:612471	AGXT2	3	210100	210100[BETA-AMINOISOBUTYRIC ACIDURIA; BAIBA]
FBgn0036380	CG8757	HGNC:28639	OMIM:616159	DHRS11	11		
FBgn0036368	CG10738	HGNC:7943	OMIM:108960	NPR1	3		
FBgn0036368	CG10738	HGNC:7944	OMIM:108961	NPR2	3	602875,615923,616255	602875[ACROMESOMELIC DYSPLASIA 1; AMD1],615923[EPIPHYSEAL CHONDRODYSPLASIA, MIURA TYPE; ECDM],616255[SHORT STATURE WITH NONSPECIFIC SKELETAL ABNORMALITIES; SNSK]
FBgn0036368	CG10738	HGNC:4691	OMIM:300041	GUCY2F	3		
FBgn0036368	CG10738	HGNC:4688	OMIM:601330	GUCY2C	3	614616,614665	614616[DIARRHEA 6; DIAR6],614665[MECONIUM ILEUS]
FBgn0036376	Liprin-beta	HGNC:9250	OMIM:603142	PPFIBP2	13		
FBgn0036376	Liprin-beta	HGNC:9249	OMIM:603141	PPFIBP1	13	620024	620024[NEURODEVELOPMENTAL DISORDER WITH SEIZURES, MICROCEPHALY, AND BRAIN ABNORMALITIES; NEDSMBA]
FBgn0036372	Abp1	HGNC:2695	OMIM:126660	DBN1	4		
FBgn0036372	Abp1	HGNC:2696	OMIM:610106	DBNL	12		
FBgn0036369	CG10089	HGNC:18894	OMIM:611437	DUSP19	3		
FBgn0036369	CG10089	HGNC:16077	OMIM:616778	DUSP22	9		
FBgn0036369	CG10089	HGNC:16236	OMIM:616776	DUSP15	9		
FBgn0036369	CG10089	HGNC:11447	OMIM:615814	STYX	3		
FBgn0036367	CG10116	HGNC:9155	OMIM:246600	PNLIP	3	614338	614338[PANCREATIC LIPASE DEFICIENCY; PNLIPD]
FBgn0036367	CG10116	HGNC:9156	OMIM:604422	PNLIPRP1	3		
FBgn0036367	CG10116	HGNC:23492		PNLIPRP3	3		
FBgn0036367	CG10116	HGNC:18821	OMIM:609252	LIPI	3		
FBgn0036366	JMJD7	HGNC:34397		JMJD7	11		
FBgn0036366	JMJD7	HGNC:9036	OMIM:606088	PLA2G4B	3		
FBgn0023095	caps	HGNC:16914	OMIM:605492	LRRN2	5		
FBgn0023095	caps	HGNC:20980	OMIM:619623	LRRN1	3		
FBgn0036348	CG17687	HGNC:26684	OMIM:617558	CFAP43	12	236690,617592	236690[HYDROCEPHALUS, NORMAL-PRESSURE, 1; HYDNP1],617592[SPERMATOGENIC FAILURE 19; SPGF19]
FBgn0036359	CG14105	HGNC:33708		TTC36	13		
FBgn0036356	CG10222	HGNC:25513		GPN2	15		
FBgn0036354	Poc1	HGNC:24488	OMIM:614783	POC1A	14	614813	614813[SHORT STATURE, ONYCHODYSPLASIA, FACIAL DYSMORPHISM, AND HYPOTRICHOSIS; SOFT]
FBgn0036354	Poc1	HGNC:30836	OMIM:614784	POC1B	12	615973	615973[CONE-ROD DYSTROPHY 20; CORD20]
FBgn0036353	CG10171	HGNC:25605		TMEM19	13		
FBgn0036328	CG10749	HGNC:6971	OMIM:154100	MDH2	6	617339	617339[DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 51; DEE51]
FBgn0036329	CG11262	HGNC:8101	OMIM:611409	OCA2	8	203200,227220	203200[ALBINISM, OCULOCUTANEOUS, TYPE II; OCA2],227220[SKIN/HAIR/EYE PIGMENTATION, VARIATION IN, 1; SHEP1]
FBgn0036330	CG11263	HGNC:28507		EXD1	6		
FBgn0036334	CG11267	HGNC:5269	OMIM:600141	HSPE1	13		
FBgn0036336	Icmt	HGNC:5350	OMIM:605851	ICMT	15		
FBgn0036340	Srrm1	HGNC:16638	OMIM:605975	SRRM1	8		
FBgn0011284	RpS4	HGNC:10424	OMIM:312760	RPS4X	14		
FBgn0011284	RpS4	HGNC:18501	OMIM:400030	RPS4Y2	10		
FBgn0011284	RpS4	HGNC:10425	OMIM:470000	RPS4Y1	11		
FBgn0036341	Syx13	HGNC:11430	OMIM:606892	STX12	4		
FBgn0036341	Syx13	HGNC:11442	OMIM:603217	STX7	4		
FBgn0036341	Syx13	HGNC:26437		TSNARE1	6		
FBgn0010452	trn	HGNC:16914	OMIM:605492	LRRN2	5		
FBgn0010452	trn	HGNC:17200	OMIM:619748	LRRN3	3		
FBgn0010452	trn	HGNC:20980	OMIM:619623	LRRN1	4		
FBgn0036346	CG11251	HGNC:25318		FAHD2B	7		
FBgn0036346	CG11251	HGNC:24252		FAHD2A	7		
FBgn0036345	CG17300	HGNC:840	OMIM:603270	ATP5PB	4		
FBgn0036337	Adk2	HGNC:257	OMIM:102750	ADK	14	614300	614300[HYPERMETHIONINEMIA DUE TO ADENOSINE KINASE DEFICIENCY]
FBgn0036335	mRpL20	HGNC:14478	OMIM:611833	MRPL20	14		
FBgn0036333	MICAL-like	HGNC:29672		MICALL2	8		
FBgn0036333	MICAL-like	HGNC:29804	OMIM:619563	MICALL1	12		
FBgn0036332	Cul6	HGNC:2555	OMIM:300304	CUL4B	3	300354	300354[INTELLECTUAL DEVELOPMENTAL DISORDER, X-LINKED, SYNDROMIC, CABEZAS TYPE; MRXSC]
FBgn0036332	Cul6	HGNC:2551	OMIM:603134	CUL1	5		
FBgn0036332	Cul6	HGNC:2554	OMIM:603137	CUL4A	3		
FBgn0036327	CG10748	HGNC:6971	OMIM:154100	MDH2	6	617339	617339[DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 51; DEE51]
FBgn0015904	ara	HGNC:14360	OMIM:612985	IRX3	5		
FBgn0015904	ara	HGNC:14361	OMIM:606195	IRX5	4	611174	611174[HAMAMY SYNDROME; HMMS]
FBgn0015904	ara	HGNC:6129	OMIM:606199	IRX4	9		
FBgn0015904	ara	HGNC:14675	OMIM:606196	IRX6	11		
FBgn0015904	ara	HGNC:14358	OMIM:606197	IRX1	5		
FBgn0015904	ara	HGNC:14359	OMIM:606198	IRX2	3		
FBgn0015919	caup	HGNC:14360	OMIM:612985	IRX3	4		
FBgn0015919	caup	HGNC:14361	OMIM:606195	IRX5	4	611174	611174[HAMAMY SYNDROME; HMMS]
FBgn0015919	caup	HGNC:6129	OMIM:606199	IRX4	8		
FBgn0015919	caup	HGNC:14675	OMIM:606196	IRX6	10		
FBgn0015919	caup	HGNC:14358	OMIM:606197	IRX1	5		
FBgn0015919	caup	HGNC:14359	OMIM:606198	IRX2	4		
FBgn0014343	mirr	HGNC:14360	OMIM:612985	IRX3	5		
FBgn0014343	mirr	HGNC:14361	OMIM:606195	IRX5	5	611174	611174[HAMAMY SYNDROME; HMMS]
FBgn0014343	mirr	HGNC:6129	OMIM:606199	IRX4	8		
FBgn0014343	mirr	HGNC:14675	OMIM:606196	IRX6	9		
FBgn0014343	mirr	HGNC:14358	OMIM:606197	IRX1	5		
FBgn0014343	mirr	HGNC:14359	OMIM:606198	IRX2	3		
FBgn0014007	Ptp69D	HGNC:9666	OMIM:151460	PTPRC	6	619924	619924[IMMUNODEFICIENCY 105; IMD105]
FBgn0052112	CG32112	HGNC:26111		ABHD18	13		
FBgn0052109	CG32109	HGNC:25662	OMIM:614888	AAGAB	8	148600	148600[PALMOPLANTAR KERATODERMA, PUNCTATE TYPE IA; PPKP1A]
FBgn0036305	CG10984	HGNC:21316	OMIM:611192	ANKRD11	8	148050	148050[KBG SYNDROME; KBGS]
FBgn0036305	CG10984	HGNC:29135	OMIM:610616	ANKRD12	8		
FBgn0052113	Vps13D	HGNC:23595	OMIM:608877	VPS13D	14	607317	607317[SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 4; SCAR4]
FBgn0052110	CG32110	HGNC:28407	OMIM:612845	SENP5	3		
FBgn0052110	CG32110	HGNC:17927	OMIM:612157	SENP1	9		
FBgn0052110	CG32110	HGNC:23116	OMIM:608261	SENP2	9		
FBgn0052110	CG32110	HGNC:17862	OMIM:612844	SENP3	5		
FBgn0036318	Wbp2	HGNC:28389	OMIM:610981	WBP2NL	8		
FBgn0036318	Wbp2	HGNC:12738	OMIM:606962	WBP2	11	617639	617639[DEAFNESS, AUTOSOMAL RECESSIVE 107; DFNB107]
FBgn0036319	Ent3	HGNC:23097	OMIM:609149	SLC29A4	14		
FBgn0036317	CG10948	HGNC:25474	OMIM:610914	ENOX1	13		
FBgn0036317	CG10948	HGNC:2259	OMIM:300282	ENOX2	11		
FBgn0036316	nebu	HGNC:11011	OMIM:606813	SLC2A6	6		
FBgn0036316	nebu	HGNC:13812	OMIM:605245	SLC2A8	11		
FBgn0036316	nebu	HGNC:11010	OMIM:138230	SLC2A5	3		
FBgn0036316	nebu	HGNC:11006	OMIM:138160	SLC2A2	3	125853,227810	125853[TYPE 2 DIABETES MELLITUS; T2D],227810[FANCONI-BICKEL SYNDROME; FBS]
FBgn0036316	nebu	HGNC:18067	OMIM:610372	SLC2A12	3		
FBgn0036316	nebu	HGNC:13444	OMIM:606145	SLC2A10	3	208050	208050[ARTERIAL TORTUOSITY SYNDROME; ATORS]
FBgn0036314	Sf3a2	HGNC:10766	OMIM:600796	SF3A2	13		
FBgn0036309	Hip1	HGNC:18415	OMIM:605613	HIP1R	12		
FBgn0036309	Hip1	HGNC:4913	OMIM:601767	HIP1	12		
FBgn0010235	Klc	HGNC:6387	OMIM:600025	KLC1	13		
FBgn0010235	Klc	HGNC:20716	OMIM:611729	KLC2	10	609541	609541[SPASTIC PARAPLEGIA, OPTIC ATROPHY, AND NEUROPATHY; SPOAN]
FBgn0010235	Klc	HGNC:20492	OMIM:616003	COA8	3	619061	619061[MITOCHONDRIAL COMPLEX IV DEFICIENCY, NUCLEAR TYPE 17; MC4DN17]
FBgn0010235	Klc	HGNC:21624		KLC4	10		
FBgn0010235	Klc	HGNC:20717	OMIM:601334	KLC3	6		
FBgn0052105	Lmx1a	HGNC:6653	OMIM:600298	LMX1A	11	601412	601412[DEAFNESS, AUTOSOMAL DOMINANT 7; DFNA7]
FBgn0052105	Lmx1a	HGNC:6654	OMIM:602575	LMX1B	12	161200,256020	161200[NAIL-PATELLA SYNDROME; NPS],256020[FOCAL SEGMENTAL GLOMERULOSCLEROSIS 10; FSGS10]
FBgn0036277	CG10418	HGNC:13940	OMIM:607282	LSM2	13		
FBgn0036286	CG10616	HGNC:24299	OMIM:609335	ODR4	11		
FBgn0036291	CG10681	HGNC:28420	OMIM:615178	KXD1	12		
FBgn0036300	Pmm2	HGNC:9115	OMIM:601785	PMM2	15	212065	212065[CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Ia; CDG1A]
FBgn0036300	Pmm2	HGNC:9114	OMIM:601786	PMM1	11		
FBgn0036301	CG4069	HGNC:25272		KLHDC4	14		
FBgn0036299	Tsf2	HGNC:11740	OMIM:190000	TF	8	209300	209300[ATRANSFERRINEMIA]
FBgn0036299	Tsf2	HGNC:6720	OMIM:150210	LTF	7		
FBgn0036299	Tsf2	HGNC:7037	OMIM:155750	MELTF	14		
FBgn0036298	nst	HGNC:8907	OMIM:172100	PGM3	15	615816	615816[IMMUNODEFICIENCY 23; IMD23]
FBgn0004926	eIF2beta	HGNC:3266	OMIM:603908	EIF2S2	15		
FBgn0020388	Gcn5	HGNC:8638	OMIM:602303	KAT2B	12		
FBgn0020388	Gcn5	HGNC:4201	OMIM:602301	KAT2A	13		
FBgn0002466	sti	HGNC:1985	OMIM:605629	CIT	12	617090	617090[MICROCEPHALY 17, PRIMARY, AUTOSOMAL RECESSIVE; MCPH17]
FBgn0036292	CG10646	HGNC:12383	OMIM:608998	EIPR1	14		
FBgn0036289	CG10657	HGNC:10024	OMIM:180090	RLBP1	4	136880,607475,607476	136880[FUNDUS ALBIPUNCTATUS],607475[BOTHNIA RETINAL DYSTROPHY],607476[NEWFOUNDLAND ROD-CONE DYSTROPHY; NFRCD]
FBgn0036289	CG10657	HGNC:23046	OMIM:616945	CLVS2	5		
FBgn0036289	CG10657	HGNC:23139	OMIM:611292	CLVS1	6		
FBgn0020655	ArfGAP1	HGNC:15852	OMIM:608377	ARFGAP1	14		
FBgn0052103	SCaMC	HGNC:20663	OMIM:608745	SLC25A25	13		
FBgn0052103	SCaMC	HGNC:20662	OMIM:608744	SLC25A24	12	612289	612289[FONTAINE PROGEROID SYNDROME; FPS]
FBgn0052103	SCaMC	HGNC:28533	OMIM:610822	SLC25A41	6		
FBgn0052103	SCaMC	HGNC:19375	OMIM:608746	SLC25A23	11		
FBgn0036282	Smyd4-2	HGNC:21067	OMIM:619134	SMYD4	9		
FBgn0052104	CG32104	HGNC:24567	OMIM:611475	RPAP1	12		
FBgn0036279	Ncc69	HGNC:10910	OMIM:600839	SLC12A1	13	601678	601678[BARTTER SYNDROME, TYPE 1, ANTENATAL; BARTS1]
FBgn0036279	Ncc69	HGNC:10911	OMIM:600840	SLC12A2	15	619080,619081,619083	619080[KILQUIST SYNDROME; KILQS],619081[DEAFNESS, AUTOSOMAL DOMINANT 78; DFNA78],619083[DELPIRE-MCNEILL SYNDROME; DELMNES]
FBgn0036279	Ncc69	HGNC:10912	OMIM:600968	SLC12A3	12	263800	263800[GITELMAN SYNDROME; GTLMNS]
FBgn0036278	CrzR	HGNC:4421	OMIM:138850	GNRHR	4	146110	146110[HYPOGONADOTROPIC HYPOGONADISM 7 WITH OR WITHOUT ANOSMIA; HH7]
FBgn0036248	ssp	HGNC:33741		MSANTD1	3		
FBgn0046296	DEF8	HGNC:25969		DEF8	15		
FBgn0036257	RhoGAP68F	HGNC:673	OMIM:602732	ARHGAP1	15		
FBgn0036257	RhoGAP68F	HGNC:34512		PRR5-ARHGAP8	6		
FBgn0036257	RhoGAP68F	HGNC:677	OMIM:609405	ARHGAP8	9		
FBgn0013997	Nrx-IV	HGNC:8011	OMIM:602346	CNTNAP1	10	616286,618186	616286[LETHAL CONGENITAL CONTRACTURE SYNDROME 7; LCCS7],618186[NEUROPATHY, CONGENITAL HYPOMYELINATING, 3; CHN3]
FBgn0013997	Nrx-IV	HGNC:13830	OMIM:604569	CNTNAP2	13	610042,612100	610042[PITT-HOPKINS-LIKE SYNDROME 1; PTHSL1],612100[AUTISM, SUSCEPTIBILITY TO, 15; AUTS15]
FBgn0013997	Nrx-IV	HGNC:18747	OMIM:610518	CNTNAP4	10		
FBgn0013997	Nrx-IV	HGNC:13834	OMIM:610517	CNTNAP3	10		
FBgn0013997	Nrx-IV	HGNC:18748	OMIM:610519	CNTNAP5	10		
FBgn0013997	Nrx-IV	HGNC:32035		CNTNAP3B	10		
FBgn0052099	CG32099	HGNC:14235	OMIM:607756	AASDHPPT	15		
FBgn0027843	CAH2	HGNC:1373	OMIM:611492	CA2	4	259730	259730[OSTEOPETROSIS, AUTOSOMAL RECESSIVE 3; OPTB3]
FBgn0027843	CAH2	HGNC:1380	OMIM:114780	CA6	3		
FBgn0027843	CAH2	HGNC:1381	OMIM:114770	CA7	4		
FBgn0027843	CAH2	HGNC:1371	OMIM:603263	CA12	3	143860	143860[HYPERCHLORHIDROSIS, ISOLATED; HYCHL]
FBgn0027843	CAH2	HGNC:1372	OMIM:604832	CA14	4		
FBgn0027843	CAH2	HGNC:1383	OMIM:603179	CA9	3		
FBgn0027843	CAH2	HGNC:1368	OMIM:114800	CA1	4		
FBgn0027843	CAH2	HGNC:1377	OMIM:114761	CA5A	3	615751	615751[CARBONIC ANHYDRASE VA DEFICIENCY, HYPERAMMONEMIA DUE TO; CA5AD]
FBgn0027843	CAH2	HGNC:14914	OMIM:611436	CA13	4		
FBgn0027843	CAH2	HGNC:1374	OMIM:114750	CA3	4		
FBgn0027843	CAH2	HGNC:1375	OMIM:114760	CA4	3		
FBgn0027843	CAH2	HGNC:1378	OMIM:300230	CA5B	4		
FBgn0036262	CG6910	HGNC:14522	OMIM:606774	MIOX	15		
FBgn0000592	Est-6	HGNC:26741		CES4A	6		
FBgn0000592	Est-6	HGNC:11764	OMIM:188450	TG	3	274700,608175	274700[THYROID DYSHORMONOGENESIS 3; TDH3],608175[AUTOIMMUNE THYROID DISEASE, SUSCEPTIBILITY TO, 3; AITD3]
FBgn0000592	Est-6	HGNC:108	OMIM:100740	ACHE	4	112100	112100[YT BLOOD GROUP ANTIGEN]
FBgn0000592	Est-6	HGNC:983	OMIM:177400	BCHE	3	617936	617936[BUTYRYLCHOLINESTERASE DEFICIENCY; BCHED]
FBgn0000592	Est-6	HGNC:26459	OMIM:618678	CES5A	6		
FBgn0000592	Est-6	HGNC:1863	OMIM:114835	CES1	6	618057	618057[DRUG METABOLISM, ALTERED, CES1-RELATED]
FBgn0000592	Est-6	HGNC:1848	OMIM:114840	CEL	3	609812	609812[MATURITY-ONSET DIABETES OF THE YOUNG, TYPE 8, WITH EXOCRINE DYSFUNCTION; MODY8]
FBgn0000592	Est-6	HGNC:1864	OMIM:605278	CES2	5		
FBgn0000592	Est-6	HGNC:1865	OMIM:605279	CES3	6		
FBgn0000592	Est-6	HGNC:14291	OMIM:600568	NLGN1	3	618830	618830[AUTISM, SUSCEPTIBILITY TO, 20; AUTS20]
FBgn0000592	Est-6	HGNC:14289	OMIM:300336	NLGN3	3	300425,300494	300425[AUTISM, SUSCEPTIBILITY TO, X-LINKED 1; AUTSX1],300494[ASPERGER SYNDROME, X-LINKED, SUSCEPTIBILITY TO, 1; ASPGX1]
FBgn0000592	Est-6	HGNC:14287	OMIM:300427	NLGN4X	3	300495,300497	300495[AUTISM, SUSCEPTIBILITY TO, X-LINKED 2; AUTSX2],300497[ASPERGER SYNDROME, X-LINKED, SUSCEPTIBILITY TO, 2; ASPGX2]
FBgn0000592	Est-6	HGNC:14290	OMIM:606479	NLGN2	3		
FBgn0000594	Est-P	HGNC:26741		CES4A	6		
FBgn0000594	Est-P	HGNC:11764	OMIM:188450	TG	3	274700,608175	274700[THYROID DYSHORMONOGENESIS 3; TDH3],608175[AUTOIMMUNE THYROID DISEASE, SUSCEPTIBILITY TO, 3; AITD3]
FBgn0000594	Est-P	HGNC:108	OMIM:100740	ACHE	4	112100	112100[YT BLOOD GROUP ANTIGEN]
FBgn0000594	Est-P	HGNC:983	OMIM:177400	BCHE	3	617936	617936[BUTYRYLCHOLINESTERASE DEFICIENCY; BCHED]
FBgn0000594	Est-P	HGNC:26459	OMIM:618678	CES5A	6		
FBgn0000594	Est-P	HGNC:1863	OMIM:114835	CES1	6	618057	618057[DRUG METABOLISM, ALTERED, CES1-RELATED]
FBgn0000594	Est-P	HGNC:1848	OMIM:114840	CEL	3	609812	609812[MATURITY-ONSET DIABETES OF THE YOUNG, TYPE 8, WITH EXOCRINE DYSFUNCTION; MODY8]
FBgn0000594	Est-P	HGNC:1864	OMIM:605278	CES2	5		
FBgn0000594	Est-P	HGNC:1865	OMIM:605279	CES3	6		
FBgn0000594	Est-P	HGNC:14291	OMIM:600568	NLGN1	3	618830	618830[AUTISM, SUSCEPTIBILITY TO, 20; AUTS20]
FBgn0000594	Est-P	HGNC:14289	OMIM:300336	NLGN3	3	300425,300494	300425[AUTISM, SUSCEPTIBILITY TO, X-LINKED 1; AUTSX1],300494[ASPERGER SYNDROME, X-LINKED, SUSCEPTIBILITY TO, 1; ASPGX1]
FBgn0000594	Est-P	HGNC:14287	OMIM:300427	NLGN4X	3	300495,300497	300495[AUTISM, SUSCEPTIBILITY TO, X-LINKED 2; AUTSX2],300497[ASPERGER SYNDROME, X-LINKED, SUSCEPTIBILITY TO, 2; ASPGX2]
FBgn0000594	Est-P	HGNC:14290	OMIM:606479	NLGN2	3		
FBgn0036273	INPP5E	HGNC:21474	OMIM:613037	INPP5E	10	213300,610156	213300[JOUBERT SYNDROME 1; JBTS1],610156[MENTAL RETARDATION, TRUNCAL OBESITY, RETINAL DYSTROPHY, AND MICROPENIS SYNDROME; MORMS]
FBgn0036274	CG4328	HGNC:6653	OMIM:600298	LMX1A	9	601412	601412[DEAFNESS, AUTOSOMAL DOMINANT 7; DFNA7]
FBgn0036274	CG4328	HGNC:6654	OMIM:602575	LMX1B	10	161200,256020	161200[NAIL-PATELLA SYNDROME; NPS],256020[FOCAL SEGMENTAL GLOMERULOSCLEROSIS 10; FSGS10]
FBgn0036272	Sms	HGNC:11123	OMIM:300105	SMS	14	309583	309583[INTELLECTUAL DEVELOPMENTAL DISORDER, X-LINKED, SYNDROMIC, SNYDER-ROBINSON TYPE; MRXSSR]
FBgn0036271	Pbgs	HGNC:395	OMIM:125270	ALAD	14	612740	612740[PORPHYRIA, ACUTE HEPATIC]
FBgn0036266	Tsen54	HGNC:27561	OMIM:608755	TSEN54	9	225753,277470,610204	225753[PONTOCEREBELLAR HYPOPLASIA, TYPE 4; PCH4],277470[PONTOCEREBELLAR HYPOPLASIA, TYPE 2A; PCH2A],610204[PONTOCEREBELLAR HYPOPLASIA, TYPE 5; PCH5]
FBgn0022709	Ak1	HGNC:361	OMIM:103000	AK1	13	612631	612631[ADENYLATE KINASE DEFICIENCY, HEMOLYTIC ANEMIA DUE TO]
FBgn0022709	Ak1	HGNC:365	OMIM:608009	AK5	4		
FBgn0022709	Ak1	HGNC:18170	OMIM:191710	CMPK1	5		
FBgn0036263	thoc6	HGNC:28369	OMIM:615403	THOC6	13	613680	613680[BEAULIEU-BOYCOTT-INNES SYNDROME; BBIS]
FBgn0036260	Rh7	HGNC:14449	OMIM:606665	OPN4	3		
FBgn0036258	eIF3l	HGNC:18138	OMIM:619197	EIF3L	14		
FBgn0011455	ND-SGDH	HGNC:7700	OMIM:603841	NDUFB5	15		
FBgn0036254	CG5645	HGNC:25769		KRI1	14		
FBgn0022959	yps	HGNC:2428	OMIM:603437	YBX3	7		
FBgn0022959	yps	HGNC:17948	OMIM:611447	YBX2	6		
FBgn0022959	yps	HGNC:8014	OMIM:154030	YBX1	8		
FBgn0036207	CG10907	HGNC:10664	OMIM:617170	CWC27	13	250410	250410[RETINITIS PIGMENTOSA WITH OR WITHOUT SKELETAL ANOMALIES; RPSKA]
FBgn0004381	Klp68D	HGNC:6320	OMIM:603754	KIF3B	15	618955	618955[RETINITIS PIGMENTOSA 89; RP89]
FBgn0004381	Klp68D	HGNC:6319	OMIM:604683	KIF3A	3		
FBgn0004381	Klp68D	HGNC:6321	OMIM:602845	KIF3C	13		
FBgn0036213	RpL10Ab	HGNC:10299	OMIM:615660	RPL10A	13		
FBgn0036214	CG7264	HGNC:26537		RIBC1	11		
FBgn0036214	CG7264	HGNC:13241		RIBC2	14		
FBgn0036219	CCDC151	HGNC:28303	OMIM:615956	CCDC151	10	616037	616037[CILIARY DYSKINESIA, PRIMARY, 30; CILD30]
FBgn0036221	CG11588	HGNC:25237	OMIM:616766	TMX4	3		
FBgn0036221	CG11588	HGNC:15487	OMIM:610527	TMX1	5		
FBgn0011723	byn	HGNC:11515	OMIM:601397	TBXT	11	182940,615709	182940[NEURAL TUBE DEFECTS, SUSCEPTIBILITY TO; NTD],615709[SACRAL AGENESIS WITH VERTEBRAL ANOMALIES; SAVA]
FBgn0011723	byn	HGNC:11596	OMIM:604614	TBX19	10	201400	201400[ACTH DEFICIENCY, ISOLATED; IAD]
FBgn0036224	Rpt4R	HGNC:9553	OMIM:602708	PSMC6	10		
FBgn0036235	CG6938	HGNC:21625	OMIM:610108	ANO1	8		
FBgn0036235	CG6938	HGNC:1183	OMIM:610109	ANO2	6		
FBgn0036235	CG6938	HGNC:31677	OMIM:605096	ANO7	6		
FBgn0036235	CG6938	HGNC:29329	OMIM:610216	ANO8	3		
FBgn0036235	CG6938	HGNC:25240	OMIM:608663	ANO6	8	262890	262890[SCOTT SYNDROME; SCTS]
FBgn0036235	CG6938	HGNC:27337	OMIM:608662	ANO5	10	166260,611307,613319	166260[GNATHODIAPHYSEAL DYSPLASIA; GDD],611307[MUSCULAR DYSTROPHY, LIMB-GIRDLE, AUTOSOMAL RECESSIVE 12; LGMDR12],613319[MIYOSHI MUSCULAR DYSTROPHY 3; MMD3]
FBgn0036235	CG6938	HGNC:23837	OMIM:610111	ANO4	10		
FBgn0036235	CG6938	HGNC:14004	OMIM:610110	ANO3	7	615034	615034[DYSTONIA 24; DYT24]
FBgn0036235	CG6938	HGNC:20679	OMIM:619963	ANO9	5		
FBgn0036236	CG6931	HGNC:24561		TPGS2	14		
FBgn0036240	CG6928	HGNC:14471	OMIM:610117	SLC26A11	10		
FBgn0041096	rols	HGNC:30212	OMIM:615047	TANC2	11	618906	618906[INTELLECTUAL DEVELOPMENTAL DISORDER WITH AUTISTIC FEATURES AND LANGUAGE DELAY, WITH OR WITHOUT SEIZURES; IDDALDS]
FBgn0041096	rols	HGNC:29364	OMIM:611397	TANC1	9		
FBgn0036239	Pop2	HGNC:14101	OMIM:604913	CNOT7	15		
FBgn0036239	Pop2	HGNC:9207	OMIM:603731	CNOT8	13		
FBgn0026432	Grip163	HGNC:18127	OMIM:610053	TUBGCP6	12	251270	251270[MICROCEPHALY AND CHORIORETINOPATHY, AUTOSOMAL RECESSIVE, 1; MCCRP1]
FBgn0036237	viaf	HGNC:29524	OMIM:611676	PDCL2	10		
FBgn0036237	viaf	HGNC:28860	OMIM:611678	PDCL3	13		
FBgn0036222	SdhAL	HGNC:10680	OMIM:600857	SDHA	7	252011,613642,614165,619259	252011[MITOCHONDRIAL COMPLEX II DEFICIENCY, NUCLEAR TYPE 1; MC2DN1],613642[CARDIOMYOPATHY, DILATED, 1GG; CMD1GG],614165[PARAGANGLIOMAS 5; PGL5],619259[NEURODEGENERATION WITH ATAXIA AND LATE-ONSET OPTIC ATROPHY; NDAXOA]
FBgn0036217	CG5906	HGNC:7224	OMIM:137960	MPV17	3	256810,618400	256810[MITOCHONDRIAL DNA DEPLETION SYNDROME 6 (HEPATOCEREBRAL TYPE); MTDPS6],618400[CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2EE; CMT2EE]
FBgn0036217	CG5906	HGNC:28177	OMIM:616133	MPV17L2	9		
FBgn0000404	CycA	HGNC:18709	OMIM:300456	CCNB3	3		
FBgn0000404	CycA	HGNC:1580	OMIM:602755	CCNB2	4		
FBgn0000404	CycA	HGNC:1578	OMIM:123835	CCNA2	11		
FBgn0000404	CycA	HGNC:1590	OMIM:603775	CCNE2	3		
FBgn0000404	CycA	HGNC:1579	OMIM:123836	CCNB1	4		
FBgn0000404	CycA	HGNC:1577	OMIM:604036	CCNA1	10		
FBgn0036211	CG5946	HGNC:13397	OMIM:608341	CYB5R1	10		
FBgn0036211	CG5946	HGNC:2873	OMIM:613213	CYB5R3	11	250800	250800[METHEMOGLOBINEMIA DUE TO DEFICIENCY OF METHEMOGLOBIN REDUCTASE]
FBgn0036211	CG5946	HGNC:24376	OMIM:608342	CYB5R2	13		
FBgn0036212	CG11597	HGNC:9323	OMIM:612725	PPP6C	3		
FBgn0036212	CG11597	HGNC:9299	OMIM:176915	PPP2CA	5	618354	618354[NEURODEVELOPMENTAL DISORDER AND LANGUAGE DELAY WITH OR WITHOUT STRUCTURAL BRAIN ABNORMALITIES; NEDLBA]
FBgn0036212	CG11597	HGNC:9300	OMIM:176916	PPP2CB	4		
FBgn0036212	CG11597	HGNC:9319	OMIM:602035	PPP4C	5		
FBgn0036208	Gcat	HGNC:4188	OMIM:607422	GCAT	15		
FBgn0036208	Gcat	HGNC:396	OMIM:125290	ALAS1	4		
FBgn0036208	Gcat	HGNC:397	OMIM:301300	ALAS2	4	300751,300752	300751[ANEMIA, SIDEROBLASTIC, 1; SIDBA1],300752[PROTOPORPHYRIA, ERYTHROPOIETIC, X-LINKED; XLEPP]
FBgn0036206	twy	HGNC:24674	OMIM:616807	FBF1	8		
FBgn0015278	Pi3K68D	HGNC:8976	OMIM:602925	PIK3CB	3		
FBgn0015278	Pi3K68D	HGNC:8978	OMIM:601232	PIK3CG	3	619802	619802[IMMUNODEFICIENCY 97 WITH AUTOINFLAMMATION; IMD97]
FBgn0015278	Pi3K68D	HGNC:8975	OMIM:171834	PIK3CA	3	114480,114500,114550,155500,162900,167000,182000,211980,602501,612918,613089,613659,615108,619538	114480[BREAST CANCER],114500[COLORECTAL CANCER; CRC],114550[HEPATOCELLULAR CARCINOMA],155500[MACRODACTYLY],162900[NEVUS, EPIDERMAL],167000[OVARIAN CANCER],182000[KERATOSIS, SEBORRHEIC],211980[LUNG CANCER],602501[MEGALENCEPHALY-CAPILLARY MALFORMATION-POLYMICROGYRIA SYNDROME; MCAP],612918[CONGENITAL LIPOMATOUS OVERGROWTH, VASCULAR MALFORMATIONS, AND EPIDERMAL NEVI],613089[CAPILLARY MALFORMATION OF THE LOWER LIP, LYMPHATIC MALFORMATION OF FACE AND NECK, ASYMMETRY OF FACE AND LIMBS, AND PARTIAL/GENERALIZED OVERGROWTH],613659[GASTRIC CANCER],615108[COWDEN SYNDROME 5; CWS5],619538[CEREBRAL CAVERNOUS MALFORMATIONS 4; CCM4]
FBgn0015278	Pi3K68D	HGNC:8977	OMIM:602839	PIK3CD	3	613328,615513,619281	613328[ROIFMAN-CHITAYAT SYNDROME; ROCHIS],615513[IMMUNODEFICIENCY 14A, AUTOSOMAL DOMINANT; IMD14A],619281[IMMUNODEFICIENCY 14B, AUTOSOMAL RECESSIVE; IMD14B]
FBgn0015278	Pi3K68D	HGNC:8971	OMIM:603601	PIK3C2A	14	618440	618440[OCULOSKELETODENTAL SYNDROME; OCSKD]
FBgn0015278	Pi3K68D	HGNC:8972	OMIM:602838	PIK3C2B	13		
FBgn0015278	Pi3K68D	HGNC:8973	OMIM:609001	PIK3C2G	8		
FBgn0036204	Tim13	HGNC:11816	OMIM:607383	TIMM13	15		
FBgn0028667	Vha16-3	HGNC:855	OMIM:108745	ATP6V0C	14		
FBgn0028668	Vha16-2	HGNC:855	OMIM:108745	ATP6V0C	9		
FBgn0036168	CG7512	HGNC:26002	OMIM:609895	CASZ1	6		
FBgn0036173	CG7394	HGNC:20325	OMIM:615339	DNAJC15	7		
FBgn0036173	CG7394	HGNC:30528	OMIM:608977	DNAJC19	13	610198	610198[3-METHYLGLUTACONIC ACIDURIA, TYPE V; MGCA5]
FBgn0036184	PCID2	HGNC:25653	OMIM:613713	PCID2	14		
FBgn0042138	Apt1	HGNC:6737	OMIM:605599	LYPLA1	13		
FBgn0042138	Apt1	HGNC:20440	OMIM:616548	LYPLAL1	3		
FBgn0042138	Apt1	HGNC:6738	OMIM:616143	LYPLA2	12		
FBgn0052091	CG32091	HGNC:73	OMIM:603076	ABCG1	6		
FBgn0052091	CG32091	HGNC:13884	OMIM:607784	ABCG4	6		
FBgn0052091	CG32091	HGNC:74	OMIM:603756	ABCG2	4	138900,614490	138900[URIC ACID CONCENTRATION, SERUM, QUANTITATIVE TRAIT LOCUS 1; UAQTL1],614490[BLOOD GROUP, JUNIOR SYSTEM; JR]
FBgn0052091	CG32091	HGNC:13887	OMIM:605460	ABCG8	3	210250,611465	210250[SITOSTEROLEMIA 1; STSL1],611465[GALLBLADDER DISEASE 4; GBD4]
FBgn0052091	CG32091	HGNC:13886	OMIM:605459	ABCG5	3	618666	618666[SITOSTEROLEMIA 2; STSL2]
FBgn0036188	Polr3H	HGNC:30349	OMIM:619801	POLR3H	15		
FBgn0015828	TfIIEalpha	HGNC:4650	OMIM:189962	GTF2E1	15		
FBgn0036191	Sugb	HGNC:26656		MFSD6L	4		
FBgn0036199	Bmcp	HGNC:27371	OMIM:610793	SLC25A30	14		
FBgn0036199	Bmcp	HGNC:10984	OMIM:300242	SLC25A14	12		
FBgn0052087	CG32087	HGNC:29559	OMIM:611753	VMP1	6		
FBgn0036196	CG11658	HGNC:16731	OMIM:606604	FBXO32	13		
FBgn0036196	CG11658	HGNC:13596	OMIM:609098	FBXO25	14		
FBgn0036195	Dnai2	HGNC:18744	OMIM:605483	DNAI2	13	612444	612444[CILIARY DYSKINESIA, PRIMARY, 9; CILD9]
FBgn0036194	Dph1	HGNC:3003	OMIM:603527	DPH1	14	616901	616901[DEVELOPMENTAL DELAY WITH SHORT STATURE, DYSMORPHIC FACIAL FEATURES, AND SPARSE HAIR; DEDSSH]
FBgn0036192	Pldn	HGNC:8549	OMIM:604310	BLOC1S6	9	614171	614171[HERMANSKY-PUDLAK SYNDROME 9; HPS9]
FBgn0052085	CG32085	HGNC:14150	OMIM:609082	FBXL16	12		
FBgn0036187	RIOK1	HGNC:18656	OMIM:617753	RIOK1	14		
FBgn0036186	CG6071	HGNC:500	OMIM:151530	ANPEP	3		
FBgn0036186	CG6071	HGNC:30748	OMIM:606950	TRHDE	3		
FBgn0036186	CG6071	HGNC:18173	OMIM:606832	ERAP1	4		
FBgn0036186	CG6071	HGNC:26904	OMIM:610046	LVRN	3		
FBgn0036186	CG6071	HGNC:7900	OMIM:606793	NPEPPS	3		
FBgn0036186	CG6071	HGNC:29499	OMIM:609497	ERAP2	4		
FBgn0036186	CG6071	HGNC:6656	OMIM:151300	LNPEP	4		
FBgn0036183	CG6083	HGNC:386	OMIM:603966	AKR1C3	4		
FBgn0036183	CG6083	HGNC:384	OMIM:600449	AKR1C1	4		
FBgn0036183	CG6083	HGNC:387	OMIM:600451	AKR1C4	4	614279	614279[46,XY SEX REVERSAL 8; SRXY8]
FBgn0036183	CG6083	HGNC:380	OMIM:103830	AKR1A1	5		
FBgn0036183	CG6083	HGNC:381	OMIM:103880	AKR1B1	7		
FBgn0036183	CG6083	HGNC:382	OMIM:604707	AKR1B10	6		
FBgn0036183	CG6083	HGNC:388	OMIM:604741	AKR1D1	5	235555	235555[BILE ACID SYNTHESIS DEFECT, CONGENITAL, 2; CBAS2]
FBgn0036183	CG6083	HGNC:385	OMIM:600450	AKR1C2	4	614279	614279[46,XY SEX REVERSAL 8; SRXY8]
FBgn0036183	CG6083	HGNC:23437	OMIM:617451	AKR1E2	5		
FBgn0036183	CG6083	HGNC:37281	OMIM:616336	AKR1B15	5		
FBgn0003292	rt	HGNC:9202	OMIM:607423	POMT1	15	236670,609308,613155	236670[MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 1; MDDGA1],609308[MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (LIMB-GIRDLE), TYPE C, 1; MDDGC1],613155[MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH IMPAIRED INTELLECTUAL IMPAIRMENT), TYPE B, 1; MDDGB1]
FBgn0003292	rt	HGNC:19743	OMIM:607439	POMT2	4	613150,613156,613158	613150[MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 2; MDDGA2],613156[MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH IMPAIRED INTELLECTUAL DEVELOPMENT), TYPE B, 2; MDDGB2],613158[MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (LIMB-GIRDLE), TYPE C, 2; MDDGC2]
FBgn0052086	CG32086	HGNC:26330		EFHB	9		
FBgn0036142	Adck5	HGNC:21738		ADCK5	15		
FBgn0036142	Adck5	HGNC:19038		ADCK1	4		
FBgn0036143	CG14142	HGNC:35475		MINDY4B	8		
FBgn0036143	CG14142	HGNC:21916		MINDY4	5		
FBgn0064766	CG7600	HGNC:26306		FAM91A1	14		
FBgn0041094	scyl	HGNC:24944	OMIM:607729	DDIT4	11		
FBgn0041094	scyl	HGNC:30555	OMIM:607730	DDIT4L	11		
FBgn0036153	CG7573	HGNC:12877	OMIM:606480	ZMPSTE24	7	275210,608612	275210[RESTRICTIVE DERMOPATHY 1; RSDM1],608612[MANDIBULOACRAL DYSPLASIA WITH TYPE B LIPODYSTROPHY; MADB]
FBgn0036156	CG11726	HGNC:12741	OMIM:603431	EIF4H	3		
FBgn0036157	CG7560	HGNC:7436	OMIM:607093	MTHFR	10	181500,188050,236250,601634	181500[SCHIZOPHRENIA; SCZD],188050[THROMBOPHILIA DUE TO THROMBIN DEFECT; THPH1],236250[HOMOCYSTINURIA DUE TO DEFICIENCY OF N(5,10)-METHYLENETETRAHYDROFOLATE REDUCTASE ACTIVITY],601634[NEURAL TUBE DEFECTS, FOLATE-SENSITIVE; NTDFS]
FBgn0036161	CG7551	HGNC:6315	OMIM:614058	KHK	12	229800	229800[FRUCTOSURIA, ESSENTIAL]
FBgn0036162	Fum3	HGNC:3700	OMIM:136850	FH	10	150800,606812	150800[HEREDITARY LEIOMYOMATOSIS AND RENAL CELL CANCER; HLRCC],606812[FUMARASE DEFICIENCY; FMRD]
FBgn0036160	CG12289	HGNC:6315	OMIM:614058	KHK	11	229800	229800[FRUCTOSURIA, ESSENTIAL]
FBgn0036158	CG6149	HGNC:21607	OMIM:608514	AIG1	11		
FBgn0036158	CG6149	HGNC:21214	OMIM:614348	ADTRP	9		
FBgn0036154	CG6168	HGNC:9753	OMIM:607065	QPCT	8		
FBgn0036154	CG6168	HGNC:25952		QPCTL	7		
FBgn0061469	Ube3a	HGNC:12496	OMIM:601623	UBE3A	14	105830	105830[ANGELMAN SYNDROME; AS]
FBgn0061469	Ube3a	HGNC:26736		HECTD2	3		
FBgn0036147	Plod	HGNC:9083	OMIM:603066	PLOD3	15	612394	612394[BONE FRAGILITY WITH CONTRACTURES, ARTERIAL RUPTURE, AND DEAFNESS; BCARD]
FBgn0036147	Plod	HGNC:9082	OMIM:601865	PLOD2	12	609220	609220[BRUCK SYNDROME 2; BRKS2]
FBgn0036147	Plod	HGNC:9081	OMIM:153454	PLOD1	13	225400	225400[EHLERS-DANLOS SYNDROME, KYPHOSCOLIOTIC TYPE, 1; EDSKSCL1]
FBgn0029172	Fad2	HGNC:21088	OMIM:608370	SCD5	11	619086	619086[DEAFNESS, AUTOSOMAL DOMINANT 79; DFNA79]
FBgn0029172	Fad2	HGNC:10571	OMIM:604031	SCD	9		
FBgn0052079	CG32079	HGNC:19659	OMIM:608332	SLC36A3	6		
FBgn0052079	CG32079	HGNC:18762	OMIM:608331	SLC36A2	6	138500,242600	138500[HYPERGLYCINURIA],242600[IMINOGLYCINURIA]
FBgn0052079	CG32079	HGNC:19660	OMIM:613760	SLC36A4	6		
FBgn0052079	CG32079	HGNC:18761	OMIM:606561	SLC36A1	6		
FBgn0052081	CG32081	HGNC:19659	OMIM:608332	SLC36A3	6		
FBgn0052081	CG32081	HGNC:18762	OMIM:608331	SLC36A2	6	138500,242600	138500[HYPERGLYCINURIA],242600[IMINOGLYCINURIA]
FBgn0052081	CG32081	HGNC:19660	OMIM:613760	SLC36A4	6		
FBgn0052081	CG32081	HGNC:18761	OMIM:606561	SLC36A1	6		
FBgn0052081	CG32081	HGNC:26907	OMIM:616203	SLC38A9	3		
FBgn0036116	CG7888	HGNC:19659	OMIM:608332	SLC36A3	8		
FBgn0036116	CG7888	HGNC:18762	OMIM:608331	SLC36A2	8	138500,242600	138500[HYPERGLYCINURIA],242600[IMINOGLYCINURIA]
FBgn0036116	CG7888	HGNC:19660	OMIM:613760	SLC36A4	8		
FBgn0036116	CG7888	HGNC:18761	OMIM:606561	SLC36A1	8		
FBgn0036116	CG7888	HGNC:25582	OMIM:614236	SLC38A7	3		
FBgn0036118	Blos2	HGNC:20984	OMIM:609768	BLOC1S2	14		
FBgn0036124	CG7839	HGNC:24218	OMIM:612828	CEBPZ	13		
FBgn0036133	emei	HGNC:28483		TMEM161B	14		
FBgn0036133	emei	HGNC:26020	OMIM:618966	TMEM161A	11		
FBgn0036135	mRpL2	HGNC:14056	OMIM:611822	MRPL2	14		
FBgn0036135	mRpL2	HGNC:10368	OMIM:604177	RPL8	3		
FBgn0052082	IRSp53	HGNC:21649	OMIM:611877	BAIAP2L1	8		
FBgn0052082	IRSp53	HGNC:26203	OMIM:617536	BAIAP2L2	6		
FBgn0052082	IRSp53	HGNC:947	OMIM:605475	BAIAP2	10		
FBgn0052076	Alg10	HGNC:23162	OMIM:618355	ALG10	13		
FBgn0052076	Alg10	HGNC:31088	OMIM:603313	ALG10B	12	613688	613688[LONG QT SYNDROME 2; LQT2]
FBgn0036141	wls	HGNC:30238	OMIM:611514	WLS	13	619648	619648[ZAKI SYNDROME; ZKS]
FBgn0036136	Ufd1	HGNC:12520	OMIM:601754	UFD1	15		
FBgn0036134	FoxK	HGNC:6036	OMIM:147685	FOXK2	10		
FBgn0036134	FoxK	HGNC:23480	OMIM:616302	FOXK1	10		
FBgn0003462	Sod1	HGNC:11179	OMIM:147450	SOD1	13	105400,618598	105400[AMYOTROPHIC LATERAL SCLEROSIS 1; ALS1],618598[SPASTIC TETRAPLEGIA AND AXIAL HYPOTONIA, PROGRESSIVE; STAHP]
FBgn0003462	Sod1	HGNC:11181	OMIM:185490	SOD3	3		
FBgn0036128	Elo68beta	HGNC:26292	OMIM:614451	ELOVL7	5		
FBgn0036128	Elo68beta	HGNC:14416	OMIM:611814	ELOVL2	7		
FBgn0036128	Elo68beta	HGNC:15829	OMIM:611546	ELOVL6	3		
FBgn0036128	Elo68beta	HGNC:14415	OMIM:605512	ELOVL4	11	133190,600110,614457	133190[SPINOCEREBELLAR ATAXIA 34; SCA34],600110[STARGARDT DISEASE 3; STGD3],614457[ICHTHYOSIS, SPASTIC QUADRIPLEGIA, AND MENTAL RETARDATION; ISQMR]
FBgn0036128	Elo68beta	HGNC:14418	OMIM:611813	ELOVL1	4	618527	618527[ICHTHYOTIC KERATODERMA, SPASTICITY, HYPOMYELINATION, AND DYSMORPHIC FACIAL FEATURES; IKSHD]
FBgn0036128	Elo68beta	HGNC:21308	OMIM:611805	ELOVL5	6	615957	615957[SPINOCEREBELLAR ATAXIA 38; SCA38]
FBgn0036126	Irbp18	HGNC:1833	OMIM:116897	CEBPA	5	601626	601626[LEUKEMIA, ACUTE MYELOID; AML]
FBgn0036126	Irbp18	HGNC:1834	OMIM:189965	CEBPB	3		
FBgn0036126	Irbp18	HGNC:1835	OMIM:116898	CEBPD	4		
FBgn0036126	Irbp18	HGNC:1836	OMIM:600749	CEBPE	4	245480	245480[SPECIFIC GRANULE DEFICIENCY 1; SGD1]
FBgn0036126	Irbp18	HGNC:1837	OMIM:138972	CEBPG	11		
FBgn0020412	JIL-1	HGNC:10433	OMIM:603606	RPS6KA4	8		
FBgn0020412	JIL-1	HGNC:10434	OMIM:603607	RPS6KA5	11		
FBgn0010741	Pfdn2	HGNC:8867	OMIM:613466	PFDN2	14		
FBgn0052075	CG32075	HGNC:25726	OMIM:300964	LAS1L	7	309585	309585[INTELLECTUAL DEVELOPMENTAL DISORDER, X-LINKED, SYNDROMIC, WILSON-TURNER TYPE; WTS]
FBgn0052069	CG32069	HGNC:18550	OMIM:609382	IER3IP1	12	614231	614231[MICROCEPHALY, EPILEPSY, AND DIABETES SYNDROME 1; MEDS1]
FBgn0036117	CG6321	HGNC:17929	OMIM:611754	AADAT	9		
FBgn0036111	Aps	HGNC:8051	OMIM:609229	NUDT4	13		
FBgn0036111	Aps	HGNC:8050	OMIM:609228	NUDT3	12		
FBgn0036111	Aps	HGNC:18011	OMIM:300528	NUDT11	13		
FBgn0036111	Aps	HGNC:17621	OMIM:300527	NUDT10	12		
FBgn0036111	Aps	HGNC:18012		NUDT4B	4		
FBgn0001179	hay	HGNC:3435	OMIM:133510	ERCC3	15	610651,616390	610651[XERODERMA PIGMENTOSUM, COMPLEMENTATION GROUP B; XPB],616390[TRICHOTHIODYSTROPHY 2, PHOTOSENSITIVE; TTD2]
FBgn0036090	Cnep1r2	HGNC:26759	OMIM:616869	CNEP1R1	14		
FBgn0036096	CG8003	HGNC:25370		ANKMY2	14		
FBgn0052068	Adi1	HGNC:30576	OMIM:613400	ADI1	14		
FBgn0010762	simj	HGNC:30778	OMIM:614998	GATAD2B	10	615074	615074[GAND SYNDROME; GAND]
FBgn0010762	simj	HGNC:29989	OMIM:614997	GATAD2A	9		
FBgn0036099	CG11811	HGNC:4693	OMIM:139270	GUK1	14		
FBgn0026160	tna	HGNC:22229	OMIM:611196	ZMIZ2	13		
FBgn0026160	tna	HGNC:16493	OMIM:607159	ZMIZ1	12	618659	618659[NEURODEVELOPMENTAL DISORDER WITH DYSMORPHIC FACIES AND DISTAL SKELETAL ANOMALIES; NEDDFSA]
FBgn0036105	Blos4	HGNC:14367	OMIM:607471	BCAS4	8		
FBgn0036105	Blos4	HGNC:24206	OMIM:605695	BLOC1S4	13		
FBgn0036107	galla-2	HGNC:26235	OMIM:618382	CIAO2A	3		
FBgn0036107	galla-2	HGNC:24261	OMIM:614778	CIAO2B	14		
FBgn0027615	OXA1L	HGNC:8526	OMIM:601066	OXA1L	13		
FBgn0027615	OXA1L	HGNC:26801	OMIM:610428	COX18	3		
FBgn0036104	CG6418	HGNC:18676	OMIM:613369	DDX42	15		
FBgn0047038	ND-13B	HGNC:7688	OMIM:601677	NDUFA5	13		
FBgn0052066	CG32066	HGNC:25216	OMIM:617978	FAM49B	12		
FBgn0052066	CG32066	HGNC:25373		FAM49A	12		
FBgn0000629	E(z)	HGNC:3527	OMIM:601573	EZH2	14	277590	277590[WEAVER SYNDROME; WVS]
FBgn0000629	E(z)	HGNC:3526	OMIM:601674	EZH1	11		
FBgn0036082	CG12362	HGNC:690	OMIM:605615	ARIH2	3		
FBgn0036082	CG12362	HGNC:689	OMIM:605624	ARIH1	8		
FBgn0036082	CG12362	HGNC:22215		ANKIB1	3		
FBgn0045770	S-Lap3	HGNC:18449	OMIM:170250	LAP3	9		
FBgn0045770	S-Lap3	HGNC:16244		NPEPL1	3		
FBgn0052064	S-Lap4	HGNC:18449	OMIM:170250	LAP3	9		
FBgn0052062	Rbfox1	HGNC:18222	OMIM:605104	RBFOX1	9		
FBgn0052062	Rbfox1	HGNC:27097	OMIM:616999	RBFOX3	8		
FBgn0052062	Rbfox1	HGNC:9906	OMIM:612149	RBFOX2	8		
FBgn0011802	Gem3	HGNC:2743	OMIM:606168	DDX20	6		
FBgn0036070	CG8072	HGNC:8946	OMIM:607076	PI15	3		
FBgn0036070	CG8072	HGNC:16249		R3HDML	3		
FBgn0036070	CG8072	HGNC:21245		PI16	3		
FBgn0036070	CG8072	HGNC:17001	OMIM:602692	GLIPR1	3		
FBgn0036070	CG8072	HGNC:28392	OMIM:610395	GLIPR1L1	4		
FBgn0036070	CG8072	HGNC:25248	OMIM:612434	CRISPLD2	3		
FBgn0036070	CG8072	HGNC:16904	OMIM:618062	CRISP3	3		
FBgn0036070	CG8072	HGNC:304	OMIM:601193	CRISP1	3		
FBgn0036070	CG8072	HGNC:12024	OMIM:187430	CRISP2	3		
FBgn0011569	can	HGNC:17304		TAF5L	4		
FBgn0011569	can	HGNC:11539	OMIM:601787	TAF5	7		
FBgn0052055	CG32055	HGNC:5468	OMIM:601489	IGFALS	4	615961	615961[ACID-LABILE SUBUNIT DEFICIENCY; ACLSD]
FBgn0036072	CG6628	HGNC:8946	OMIM:607076	PI15	4		
FBgn0036072	CG6628	HGNC:16249		R3HDML	4		
FBgn0036072	CG6628	HGNC:21245		PI16	3		
FBgn0036072	CG6628	HGNC:28392	OMIM:610395	GLIPR1L1	5		
FBgn0036072	CG6628	HGNC:25248	OMIM:612434	CRISPLD2	3		
FBgn0036072	CG6628	HGNC:16904	OMIM:618062	CRISP3	3		
FBgn0036072	CG6628	HGNC:304	OMIM:601193	CRISP1	3		
FBgn0036072	CG6628	HGNC:12024	OMIM:187430	CRISP2	3		
FBgn0036072	CG6628	HGNC:33849	OMIM:616572	CLEC18B	4		
FBgn0036072	CG6628	HGNC:30388	OMIM:616571	CLEC18A	3		
FBgn0036043	Ae2	HGNC:11035	OMIM:610207	SLC4A9	5		
FBgn0036043	Ae2	HGNC:11028	OMIM:109280	SLC4A2	15		
FBgn0036043	Ae2	HGNC:18168	OMIM:606757	SLC4A5	5		
FBgn0036043	Ae2	HGNC:11027	OMIM:109270	SLC4A1	13	110500,112010,112050,166900,179800,185020,601550,601551,611162,611590,612653	110500[BLOOD GROUP, DIEGO SYSTEM; DI],112010[BLOOD GROUP--WALDNER TYPE; WD],112050[BLOOD GROUP--WRIGHT ANTIGEN; WR],166900[OVALOCYTOSIS, SOUTHEAST ASIAN; SAO],179800[RENAL TUBULAR ACIDOSIS, DISTAL, 1; DRTA1],185020[CRYOHYDROCYTOSIS; CHC],601550[BLOOD GROUP--SWANN SYSTEM; SW],601551[BLOOD GROUP--FROESE],611162[MALARIA, SUSCEPTIBILITY TO],611590[RENAL TUBULAR ACIDOSIS, DISTAL, 4, WITH HEMOLYTIC ANEMIA; DRTA4],612653[SPHEROCYTOSIS, TYPE 4; SPH4]
FBgn0036043	Ae2	HGNC:11034	OMIM:605024	SLC4A8	6		
FBgn0036043	Ae2	HGNC:13811	OMIM:605556	SLC4A10	6		
FBgn0036043	Ae2	HGNC:11030	OMIM:603345	SLC4A4	5	604278	604278[RENAL TUBULAR ACIDOSIS, PROXIMAL, WITH OCULAR ABNORMALITIES AND MENTAL RETARDATION]
FBgn0036043	Ae2	HGNC:11029	OMIM:106195	SLC4A3	13		
FBgn0036043	Ae2	HGNC:11033	OMIM:603353	SLC4A7	6		
FBgn0036043	Ae2	HGNC:16438	OMIM:610206	SLC4A11	4	217400,217700,613268	217400[CORNEAL DYSTROPHY AND PERCEPTIVE DEAFNESS; CDPD],217700[CORNEAL ENDOTHELIAL DYSTROPHY; CHED],613268[CORNEAL DYSTROPHY, FUCHS ENDOTHELIAL, 4; FECD4]
FBgn0044328	CG32052	HGNC:11120	OMIM:607608	SMPD1	4	257200,607616	257200[NIEMANN-PICK DISEASE, TYPE A],607616[NIEMANN-PICK DISEASE, TYPE B]
FBgn0044328	CG32052	HGNC:17389	OMIM:610728	SMPDL3A	12		
FBgn0044328	CG32052	HGNC:21416	OMIM:617737	SMPDL3B	15		
FBgn0027567	Ciz1	HGNC:16744	OMIM:611420	CIZ1	8		
FBgn0025866	CalpB	HGNC:1479	OMIM:114230	CAPN2	10		
FBgn0025866	CalpB	HGNC:1476	OMIM:114220	CAPN1	9	616907	616907[SPASTIC PARAPLEGIA 76, AUTOSOMAL RECESSIVE; SPG76]
FBgn0025866	CalpB	HGNC:1478	OMIM:604822	CAPN11	9		
FBgn0025866	CalpB	HGNC:1480	OMIM:114240	CAPN3	9	253600,618129	253600[MUSCULAR DYSTROPHY, LIMB-GIRDLE, AUTOSOMAL RECESSIVE 1; LGMDR1],618129[MUSCULAR DYSTROPHY, LIMB-GIRDLE, AUTOSOMAL DOMINANT 4; LGMDD4]
FBgn0025866	CalpB	HGNC:16664	OMIM:610229	CAPN14	4		
FBgn0025866	CalpB	HGNC:1485	OMIM:618777	CAPN8	9		
FBgn0025866	CalpB	HGNC:13249	OMIM:608839	CAPN12	5		
FBgn0025866	CalpB	HGNC:1486	OMIM:606401	CAPN9	10		
FBgn0025866	CalpB	HGNC:16663	OMIM:610228	CAPN13	5		
FBgn0025866	CalpB	HGNC:1477	OMIM:605286	CAPN10	3	601283	601283[TYPE 2 DIABETES MELLITUS 1; T2D1]
FBgn0025866	CalpB	HGNC:1482	OMIM:602537	CAPN5	3	193235	193235[VITREORETINOPATHY, NEOVASCULAR INFLAMMATORY; VRNI]
FBgn0036059	nudE	HGNC:17619	OMIM:609449	NDE1	9	605013,614019	605013[MICROHYDRANENCEPHALY; MHAC],614019[LISSENCEPHALY 4; LIS4]
FBgn0036059	nudE	HGNC:17620	OMIM:607538	NDEL1	13		
FBgn0026404	Dronc	HGNC:1503	OMIM:600639	CASP2	6		
FBgn0026404	Dronc	HGNC:1511	OMIM:602234	CASP9	3		
FBgn0026404	Dronc	HGNC:1505	OMIM:602664	CASP4	3		
FBgn0026404	Dronc	HGNC:1506	OMIM:602665	CASP5	3		
FBgn0026404	Dronc	HGNC:1502	OMIM:605848	CASP14	4	617320	617320[ICHTHYOSIS, CONGENITAL, AUTOSOMAL RECESSIVE 12; ARCI12]
FBgn0036063	CG6674	HGNC:12386	OMIM:603852	TSSC4	8		
FBgn0036058	CG6707	HGNC:19299	OMIM:609865	PIP4P1	13		
FBgn0036058	CG6707	HGNC:25452	OMIM:609864	PIP4P2	12		
FBgn0036057	Hez	HGNC:26407	OMIM:611793	LSM12	10		
FBgn0011836	Taf2	HGNC:11536	OMIM:604912	TAF2	14	615599	615599[NEURODEVELOPMENTAL DISORDER WITH FEEDING DIFFICULTIES, THIN CORPUS CALLOSUM, AND FOOT DEFORMITY; NEDFCF]
FBgn0036053	iPLA2-VIA	HGNC:9039	OMIM:603604	PLA2G6	14	256600,610217,612953	256600[NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 2A; NBIA2A],610217[NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 2B; NBIA2B],612953[PARKINSON DISEASE 14, AUTOSOMAL RECESSIVE; PARK14]
FBgn0036052	CG10809	HGNC:25185	OMIM:613383	ANKRD54	10		
FBgn0004390	RasGAP1	HGNC:9872	OMIM:601589	RASA2	13		
FBgn0004390	RasGAP1	HGNC:20331	OMIM:605182	RASA3	14		
FBgn0004390	RasGAP1	HGNC:9873	OMIM:604118	RASAL1	4		
FBgn0004390	RasGAP1	HGNC:23181	OMIM:607943	RASA4	4		
FBgn0004390	RasGAP1	HGNC:35202		RASA4B	3		
FBgn0015618	Cdk8	HGNC:19338	OMIM:614720	CDK19	12	618916	618916[DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 87; DEE87]
FBgn0015618	Cdk8	HGNC:1779	OMIM:603184	CDK8	13	618748	618748[INTELLECTUAL DEVELOPMENTAL DISORDER WITH HYPOTONIA AND BEHAVIORAL ABNORMALITIES; IDDHBA]
FBgn0028429	I-2	HGNC:9288	OMIM:601792	PPP1R2	11		
FBgn0028429	I-2	HGNC:16324	OMIM:301017	PPP1R2C	8		
FBgn0028429	I-2	HGNC:16318		PPP1R2B	5		
FBgn0028429	I-2	HGNC:9289		PPP1R2P1	5		
FBgn0036044	Zasp67	HGNC:13992	OMIM:609722	PDLIM2	3		
FBgn0036014	CG3222	HGNC:17841	OMIM:619837	MORN5	10		
FBgn0036016	CG3306	HGNC:17841	OMIM:619837	MORN5	10		
FBgn0036018	CG3335	HGNC:29098	OMIM:616444	RBM19	15		
FBgn0036020	Cyp40	HGNC:14650	OMIM:606093	PPIG	4		
FBgn0036020	Cyp40	HGNC:9256	OMIM:123842	PPIC	4		
FBgn0036020	Cyp40	HGNC:33996		PPIAL4G	4		
FBgn0036020	Cyp40	HGNC:7833	OMIM:161565	NKTR	4		
FBgn0036020	Cyp40	HGNC:14651	OMIM:606095	PPIH	3		
FBgn0036020	Cyp40	HGNC:24369		PPIAL4A	3		
FBgn0036020	Cyp40	HGNC:9257	OMIM:601753	PPID	12		
FBgn0036020	Cyp40	HGNC:9255	OMIM:123841	PPIB	4	259440	259440[OSTEOGENESIS IMPERFECTA, TYPE IX; OI9]
FBgn0036020	Cyp40	HGNC:33998		PPIAL4D	3		
FBgn0036020	Cyp40	HGNC:9259	OMIM:604486	PPIF	3		
FBgn0036020	Cyp40	HGNC:33995		PPIAL4C	4		
FBgn0036020	Cyp40	HGNC:9253	OMIM:123840	PPIA	4		
FBgn0036020	Cyp40	HGNC:33999		PPIAL4F	4		
FBgn0036020	Cyp40	HGNC:33997	OMIM:608608	PPIAL4E	3		
FBgn0036020	Cyp40	HGNC:53889		PPIAL4H	4		
FBgn0036028	CG16717	HGNC:1180	OMIM:600911	MPPED2	11		
FBgn0036028	CG16717	HGNC:1306	OMIM:602112	MPPED1	12		
FBgn0036029	CG16719	HGNC:15874	OMIM:610674	SPEF1	10		
FBgn0015321	Ubc4	HGNC:4914	OMIM:602846	UBE2K	15		
FBgn0045823	vsg	HGNC:1632	OMIM:603356	CD164	8	616969	616969[DEAFNESS, AUTOSOMAL DOMINANT 66; DFNA66]
FBgn0045823	vsg	HGNC:30138	OMIM:606356	TMEM123	3		
FBgn0045823	vsg	HGNC:32043		CD164L2	5		
FBgn0036038	defl	HGNC:24484	OMIM:611350	INTS7	14		
FBgn0019644	ATPsynB	HGNC:840	OMIM:603270	ATP5PB	13		
FBgn0036040	CG6749	HGNC:5468	OMIM:601489	IGFALS	4	615961	615961[ACID-LABILE SUBUNIT DEFICIENCY; ACLSD]
FBgn0040475	SH3PX1	HGNC:19245		SNX18	10		
FBgn0040475	SH3PX1	HGNC:28468	OMIM:619107	SNX33	12		
FBgn0040475	SH3PX1	HGNC:14973	OMIM:605952	SNX9	7		
FBgn0036031	CG6761	HGNC:29387		KIAA1841	12		
FBgn0036030	Prps	HGNC:9462	OMIM:311850	PRPS1	14	300661,301835,304500,311070	300661[PHOSPHORIBOSYLPYROPHOSPHATE SYNTHETASE SUPERACTIVITY],301835[ARTS SYNDROME; ARTS],304500[DEAFNESS, X-LINKED 1; DFNX1],311070[CHARCOT-MARIE-TOOTH DISEASE, X-LINKED RECESSIVE, 5; CMTX5]
FBgn0036030	Prps	HGNC:9463	OMIM:611566	PRPS1L1	11		
FBgn0036030	Prps	HGNC:9465	OMIM:311860	PRPS2	14		
FBgn0016081	fry	HGNC:20367	OMIM:614818	FRY	12		
FBgn0016081	fry	HGNC:29127		FRYL	14		
FBgn0010408	RpS9	HGNC:10442	OMIM:603631	RPS9	14		
FBgn0036008	CG3408	HGNC:28817	OMIM:614854	LRRC59	9		
FBgn0036007	path	HGNC:19659	OMIM:608332	SLC36A3	6		
FBgn0036007	path	HGNC:18762	OMIM:608331	SLC36A2	6	138500,242600	138500[HYPERGLYCINURIA],242600[IMINOGLYCINURIA]
FBgn0036007	path	HGNC:19660	OMIM:613760	SLC36A4	6		
FBgn0036007	path	HGNC:18761	OMIM:606561	SLC36A1	6		
FBgn0035969	CG4476	HGNC:11049	OMIM:126455	SLC6A3	3	188890,613135	188890[TOBACCO ADDICTION, SUSCEPTIBILITY TO],613135[PARKINSONISM-DYSTONIA 1, INFANTILE-ONSET; PKDYS1]
FBgn0035969	CG4476	HGNC:11044	OMIM:607952	SLC6A11	3		
FBgn0035969	CG4476	HGNC:31399	OMIM:610299	SLC6A17	4	616269	616269[INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 48; MRT48]
FBgn0035969	CG4476	HGNC:11045	OMIM:603080	SLC6A12	3		
FBgn0035969	CG4476	HGNC:11054	OMIM:606205	SLC6A7	4		
FBgn0035969	CG4476	HGNC:11048	OMIM:163970	SLC6A2	3	604715	604715[ORTHOSTATIC INTOLERANCE]
FBgn0035969	CG4476	HGNC:13621	OMIM:607971	SLC6A15	5		
FBgn0035969	CG4476	HGNC:11050	OMIM:182138	SLC6A4	3	164230,607834	164230[OBSESSIVE-COMPULSIVE DISORDER; OCD],607834[ANXIETY]
FBgn0035969	CG4476	HGNC:11055	OMIM:300036	SLC6A8	3	300352	300352[CEREBRAL CREATINE DEFICIENCY SYNDROME 1; CCDS1]
FBgn0035969	CG4476	HGNC:11056	OMIM:601019	SLC6A9	4	617301	617301[GLYCINE ENCEPHALOPATHY WITH NORMAL SERUM GLYCINE]
FBgn0035969	CG4476	HGNC:11051	OMIM:604159	SLC6A5	3	614618	614618[HYPEREKPLEXIA 3; HKPX3]
FBgn0035969	CG4476	HGNC:11047	OMIM:300444	SLC6A14	3		
FBgn0035969	CG4476	HGNC:11052	OMIM:186854	SLC6A6	3	145350	145350[HYPOTAURINEMIC RETINAL DEGENERATION AND CARDIOMYOPATHY; HTRDC]
FBgn0035969	CG4476	HGNC:11046	OMIM:615097	SLC6A13	3		
FBgn0035969	CG4476	HGNC:11042	OMIM:137165	SLC6A1	3	616421	616421[MYOCLONIC-ATONIC EPILEPSY; MAE]
FBgn0035969	CG4476	HGNC:13622	OMIM:607972	SLC6A16	4		
FBgn0035975	PGRP-LA	HGNC:8904	OMIM:604963	PGLYRP1	4		
FBgn0035975	PGRP-LA	HGNC:30014	OMIM:608197	PGLYRP3	4		
FBgn0035975	PGRP-LA	HGNC:30015	OMIM:608198	PGLYRP4	4		
FBgn0035977	PGRP-LF	HGNC:8904	OMIM:604963	PGLYRP1	7		
FBgn0035977	PGRP-LF	HGNC:30014	OMIM:608197	PGLYRP3	10		
FBgn0035977	PGRP-LF	HGNC:30015	OMIM:608198	PGLYRP4	8		
FBgn0052039	Svip	HGNC:25238		SVIP	6		
FBgn0035980	mRRF1	HGNC:7234	OMIM:604602	MRRF	14		
FBgn0035982	CG4461	HGNC:2388	OMIM:123580	CRYAA	4	604219	604219[CATARACT 9, MULTIPLE TYPES; CTRCT9]
FBgn0035982	CG4461	HGNC:26511	OMIM:610695	HSPB6	3		
FBgn0035982	CG4461	HGNC:5247	OMIM:602179	HSPB2	3		
FBgn0035982	CG4461	HGNC:2389	OMIM:123590	CRYAB	3	608810,613763,613869,615184	608810[MYOPATHY, MYOFIBRILLAR, 2; MFM2],613763[CATARACT 16, MULTIPLE TYPES; CTRCT16],613869[MYOPATHY, MYOFIBRILLAR, FATAL INFANTILE HYPERTONIC, ALPHA-B CRYSTALLIN-RELATED],615184[CARDIOMYOPATHY, DILATED, 1II; CMD1II]
FBgn0035982	CG4461	HGNC:5246	OMIM:602195	HSPB1	4	606595,608634	606595[CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2F; CMT2F],608634[NEURONOPATHY, DISTAL HEREDITARY MOTOR, TYPE IIB; HMN2B]
FBgn0001224	Hsp23	HGNC:2388	OMIM:123580	CRYAA	5	604219	604219[CATARACT 9, MULTIPLE TYPES; CTRCT9]
FBgn0001224	Hsp23	HGNC:26511	OMIM:610695	HSPB6	5		
FBgn0001224	Hsp23	HGNC:5247	OMIM:602179	HSPB2	5		
FBgn0001224	Hsp23	HGNC:2389	OMIM:123590	CRYAB	7	608810,613763,613869,615184	608810[MYOPATHY, MYOFIBRILLAR, 2; MFM2],613763[CATARACT 16, MULTIPLE TYPES; CTRCT16],613869[MYOPATHY, MYOFIBRILLAR, FATAL INFANTILE HYPERTONIC, ALPHA-B CRYSTALLIN-RELATED],615184[CARDIOMYOPATHY, DILATED, 1II; CMD1II]
FBgn0001224	Hsp23	HGNC:30171	OMIM:608014	HSPB8	3	158590,608673	158590[NEURONOPATHY, DISTAL HEREDITARY MOTOR, TYPE IIA; HMN2A],608673[CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2L; CMT2L]
FBgn0001224	Hsp23	HGNC:5246	OMIM:602195	HSPB1	4	606595,608634	606595[CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2F; CMT2F],608634[NEURONOPATHY, DISTAL HEREDITARY MOTOR, TYPE IIB; HMN2B]
FBgn0001224	Hsp23	HGNC:5248	OMIM:604624	HSPB3	3	613376	613376[NEURONOPATHY, DISTAL HEREDITARY MOTOR, TYPE IIC; HMN2C]
FBgn0001224	Hsp23	HGNC:0		CRYAA2	5		
FBgn0001226	Hsp27	HGNC:2388	OMIM:123580	CRYAA	4	604219	604219[CATARACT 9, MULTIPLE TYPES; CTRCT9]
FBgn0001226	Hsp27	HGNC:26511	OMIM:610695	HSPB6	4		
FBgn0001226	Hsp27	HGNC:5247	OMIM:602179	HSPB2	4		
FBgn0001226	Hsp27	HGNC:2389	OMIM:123590	CRYAB	4	608810,613763,613869,615184	608810[MYOPATHY, MYOFIBRILLAR, 2; MFM2],613763[CATARACT 16, MULTIPLE TYPES; CTRCT16],613869[MYOPATHY, MYOFIBRILLAR, FATAL INFANTILE HYPERTONIC, ALPHA-B CRYSTALLIN-RELATED],615184[CARDIOMYOPATHY, DILATED, 1II; CMD1II]
FBgn0001226	Hsp27	HGNC:5246	OMIM:602195	HSPB1	4	606595,608634	606595[CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2F; CMT2F],608634[NEURONOPATHY, DISTAL HEREDITARY MOTOR, TYPE IIB; HMN2B]
FBgn0023129	aay	HGNC:9577	OMIM:172480	PSPH	15	614023	614023[PHOSPHOSERINE PHOSPHATASE DEFICIENCY; PSPHD]
FBgn0015296	Shc	HGNC:10840	OMIM:600560	SHC1	12		
FBgn0015296	Shc	HGNC:29869	OMIM:605217	SHC2	11		
FBgn0015296	Shc	HGNC:16743	OMIM:617372	SHC4	10		
FBgn0015296	Shc	HGNC:18181	OMIM:605263	SHC3	11		
FBgn0040305	MTF-1	HGNC:7428	OMIM:600172	MTF1	7		
FBgn0035995	CG3529	HGNC:11984	OMIM:615519	TOM1L2	13		
FBgn0035995	CG3529	HGNC:11982	OMIM:604700	TOM1	12	619510	619510[IMMUNODEFICIENCY 85 AND AUTOIMMUNITY; IMD85]
FBgn0035995	CG3529	HGNC:11983	OMIM:604701	TOM1L1	5		
FBgn0035999	CG3552	HGNC:34360	OMIM:619240	GDPGP1	14		
FBgn0036004	Jarid2	HGNC:6196	OMIM:601594	JARID2	12		
FBgn0036005	pall	HGNC:29046	OMIM:609100	FBXO28	12	619777	619777[DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 100; DEE100]
FBgn0011327	Uch-L5	HGNC:19678	OMIM:610667	UCHL5	15		
FBgn0036000	CG3434	HGNC:25771		QTRT2	15		
FBgn0035998	CG3437	HGNC:6946	OMIM:603294	MCM3AP	3	618124	618124[PERIPHERAL NEUROPATHY, AUTOSOMAL RECESSIVE, WITH OR WITHOUT IMPAIRED INTELLECTUAL DEVELOPMENT; PNRIID]
FBgn0035998	CG3437	HGNC:30179	OMIM:618796	SAC3D1	11		
FBgn0035997	phol	HGNC:30949	OMIM:614572	ZFP42	4		
FBgn0035997	phol	HGNC:31684	OMIM:300570	YY2	7		
FBgn0035997	phol	HGNC:12856	OMIM:600013	YY1	7	617557	617557[GABRIELE-DE VRIES SYNDROME; GADEVS]
FBgn0005533	RpS17	HGNC:10397	OMIM:180472	RPS17	13	612527	612527[DIAMOND-BLACKFAN ANEMIA 4; DBA4]
FBgn0035989	Atat	HGNC:21186	OMIM:615556	ATAT1	9		
FBgn0035986	CG4022	HGNC:25210		PIH1D2	5		
FBgn0015218	eIF4E1	HGNC:3293	OMIM:605895	EIF4E2	3		
FBgn0015218	eIF4E1	HGNC:3287	OMIM:133440	EIF4E	15	615091	615091[AUTISM, SUSCEPTIBILITY TO, 19; AUTS19]
FBgn0015218	eIF4E1	HGNC:33179		EIF4E1B	13		
FBgn0015218	eIF4E1	HGNC:31837	OMIM:609896	EIF4E3	3		
FBgn0035983	CG4080	HGNC:26077	OMIM:613331	MARCHF1	9		
FBgn0035983	CG4080	HGNC:23356	OMIM:613335	MARCHF8	9		
FBgn0035983	CG4080	HGNC:30550	OMIM:613297	MARCHF6	3	613608	613608[EPILEPSY, FAMILIAL ADULT MYOCLONIC, 3; FAME3]
FBgn0001227	Hsp67Ba	HGNC:2388	OMIM:123580	CRYAA	6	604219	604219[CATARACT 9, MULTIPLE TYPES; CTRCT9]
FBgn0001227	Hsp67Ba	HGNC:26511	OMIM:610695	HSPB6	3		
FBgn0001227	Hsp67Ba	HGNC:5247	OMIM:602179	HSPB2	5		
FBgn0001227	Hsp67Ba	HGNC:2389	OMIM:123590	CRYAB	6	608810,613763,613869,615184	608810[MYOPATHY, MYOFIBRILLAR, 2; MFM2],613763[CATARACT 16, MULTIPLE TYPES; CTRCT16],613869[MYOPATHY, MYOFIBRILLAR, FATAL INFANTILE HYPERTONIC, ALPHA-B CRYSTALLIN-RELATED],615184[CARDIOMYOPATHY, DILATED, 1II; CMD1II]
FBgn0001227	Hsp67Ba	HGNC:30171	OMIM:608014	HSPB8	3	158590,608673	158590[NEURONOPATHY, DISTAL HEREDITARY MOTOR, TYPE IIA; HMN2A],608673[CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2L; CMT2L]
FBgn0001227	Hsp67Ba	HGNC:5246	OMIM:602195	HSPB1	5	606595,608634	606595[CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2F; CMT2F],608634[NEURONOPATHY, DISTAL HEREDITARY MOTOR, TYPE IIB; HMN2B]
FBgn0001227	Hsp67Ba	HGNC:5248	OMIM:604624	HSPB3	3	613376	613376[NEURONOPATHY, DISTAL HEREDITARY MOTOR, TYPE IIC; HMN2C]
FBgn0001227	Hsp67Ba	HGNC:0		CRYAA2	4		
FBgn0001225	Hsp26	HGNC:2388	OMIM:123580	CRYAA	6	604219	604219[CATARACT 9, MULTIPLE TYPES; CTRCT9]
FBgn0001225	Hsp26	HGNC:26511	OMIM:610695	HSPB6	3		
FBgn0001225	Hsp26	HGNC:5247	OMIM:602179	HSPB2	5		
FBgn0001225	Hsp26	HGNC:2389	OMIM:123590	CRYAB	6	608810,613763,613869,615184	608810[MYOPATHY, MYOFIBRILLAR, 2; MFM2],613763[CATARACT 16, MULTIPLE TYPES; CTRCT16],613869[MYOPATHY, MYOFIBRILLAR, FATAL INFANTILE HYPERTONIC, ALPHA-B CRYSTALLIN-RELATED],615184[CARDIOMYOPATHY, DILATED, 1II; CMD1II]
FBgn0001225	Hsp26	HGNC:30171	OMIM:608014	HSPB8	3	158590,608673	158590[NEURONOPATHY, DISTAL HEREDITARY MOTOR, TYPE IIA; HMN2A],608673[CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2L; CMT2L]
FBgn0001225	Hsp26	HGNC:5246	OMIM:602195	HSPB1	5	606595,608634	606595[CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2F; CMT2F],608634[NEURONOPATHY, DISTAL HEREDITARY MOTOR, TYPE IIB; HMN2B]
FBgn0001225	Hsp26	HGNC:5248	OMIM:604624	HSPB3	3	613376	613376[NEURONOPATHY, DISTAL HEREDITARY MOTOR, TYPE IIC; HMN2C]
FBgn0001225	Hsp26	HGNC:0		CRYAA2	4		
FBgn0001229	Hsp67Bc	HGNC:2388	OMIM:123580	CRYAA	5	604219	604219[CATARACT 9, MULTIPLE TYPES; CTRCT9]
FBgn0001229	Hsp67Bc	HGNC:26511	OMIM:610695	HSPB6	3		
FBgn0001229	Hsp67Bc	HGNC:5247	OMIM:602179	HSPB2	4		
FBgn0001229	Hsp67Bc	HGNC:2389	OMIM:123590	CRYAB	4	608810,613763,613869,615184	608810[MYOPATHY, MYOFIBRILLAR, 2; MFM2],613763[CATARACT 16, MULTIPLE TYPES; CTRCT16],613869[MYOPATHY, MYOFIBRILLAR, FATAL INFANTILE HYPERTONIC, ALPHA-B CRYSTALLIN-RELATED],615184[CARDIOMYOPATHY, DILATED, 1II; CMD1II]
FBgn0001229	Hsp67Bc	HGNC:30171	OMIM:608014	HSPB8	3	158590,608673	158590[NEURONOPATHY, DISTAL HEREDITARY MOTOR, TYPE IIA; HMN2A],608673[CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2L; CMT2L]
FBgn0001229	Hsp67Bc	HGNC:5246	OMIM:602195	HSPB1	4	606595,608634	606595[CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2F; CMT2F],608634[NEURONOPATHY, DISTAL HEREDITARY MOTOR, TYPE IIB; HMN2B]
FBgn0001229	Hsp67Bc	HGNC:5248	OMIM:604624	HSPB3	3	613376	613376[NEURONOPATHY, DISTAL HEREDITARY MOTOR, TYPE IIC; HMN2C]
FBgn0001229	Hsp67Bc	HGNC:0		CRYAA2	3		
FBgn0011769	Fdx1	HGNC:3638	OMIM:103260	FDX1	5		
FBgn0011769	Fdx1	HGNC:30546	OMIM:614585	FDX2	15	251900	251900[MITOCHONDRIAL MYOPATHY, EPISODIC, WITH OR WITHOUT OPTIC ATROPHY AND REVERSIBLE LEUKOENCEPHALOPATHY; MEOAL]
FBgn0004379	Klp67A	HGNC:27102	OMIM:614570	KIF18B	8		
FBgn0004379	Klp67A	HGNC:26735	OMIM:619610	KIF19	3		
FBgn0004379	Klp67A	HGNC:29441	OMIM:611271	KIF18A	12		
FBgn0035970	CG4483	HGNC:19160	OMIM:618715	ZDHHC6	13		
FBgn0035968	Slc45-1	HGNC:17939	OMIM:605763	SLC45A1	7	617532	617532[INTELLECTUAL DEVELOPMENTAL DISORDER WITH NEUROPSYCHIATRIC FEATURES; IDDNPF]
FBgn0035968	Slc45-1	HGNC:29196	OMIM:619581	SLC45A4	9		
FBgn0035968	Slc45-1	HGNC:16472	OMIM:606202	SLC45A2	11	227240,606574	227240[SKIN/HAIR/EYE PIGMENTATION, VARIATION IN, 5; SHEP5],606574[ALBINISM, OCULOCUTANEOUS, TYPE IV; OCA4]
FBgn0035968	Slc45-1	HGNC:8642	OMIM:605097	SLC45A3	4		
FBgn0035993	Nf-YA	HGNC:7804	OMIM:189903	NFYA	9		
FBgn0035936	Tsp66E	HGNC:6210	OMIM:600623	CD82	7		
FBgn0011787	mRpL12	HGNC:10378	OMIM:602375	MRPL12	13	618951	618951[COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 45; COXPD45]
FBgn0035944	CG5021	HGNC:20399		TVP23B	13		
FBgn0035944	CG5021	HGNC:20398		TVP23A	14		
FBgn0035944	CG5021	HGNC:30453		TVP23C	5		
FBgn0035944	CG5021	HGNC:42961		TVP23C-CDRT4	8		
FBgn0035947	Srp68	HGNC:11302	OMIM:604858	SRP68	14		
FBgn0035951	CG5068	HGNC:30178	OMIM:611117	PPME1	14		
FBgn0035953	CG5087	HGNC:16803	OMIM:614454	UBE3C	4		
FBgn0035953	CG5087	HGNC:13478	OMIM:608047	UBE3B	15	244450	244450[KAUFMAN OCULOCEREBROFACIAL SYNDROME; KOS]
FBgn0035954	Doc3	HGNC:11605	OMIM:602427	TBX6	10	122600	122600[SPONDYLOCOSTAL DYSOSTOSIS 5; SCDO5]
FBgn0035954	Doc3	HGNC:11598	OMIM:606061	TBX20	3	611363	611363[ATRIAL SEPTAL DEFECT 4; ASD4]
FBgn0035954	Doc3	HGNC:11594	OMIM:604127	TBX15	3	260660	260660[COUSIN SYNDROME]
FBgn0035954	Doc3	HGNC:11600	OMIM:300307	TBX22	3	302905,303400	302905[ABRUZZO-ERICKSON SYNDROME; ABERS],303400[CLEFT PALATE WITH OR WITHOUT ANKYLOGLOSSIA, X-LINKED; CPX]
FBgn0028789	Doc1	HGNC:11592	OMIM:602054	TBX1	3	187500,188400,192430,217095	187500[TETRALOGY OF FALLOT; TOF],188400[DIGEORGE SYNDROME; DGS],192430[VELOCARDIOFACIAL SYNDROME; VCFS],217095[CONOTRUNCAL HEART MALFORMATIONS; CTHM]
FBgn0028789	Doc1	HGNC:11605	OMIM:602427	TBX6	9	122600	122600[SPONDYLOCOSTAL DYSOSTOSIS 5; SCDO5]
FBgn0028789	Doc1	HGNC:11598	OMIM:606061	TBX20	3	611363	611363[ATRIAL SEPTAL DEFECT 4; ASD4]
FBgn0028789	Doc1	HGNC:11594	OMIM:604127	TBX15	4	260660	260660[COUSIN SYNDROME]
FBgn0028789	Doc1	HGNC:11602	OMIM:601621	TBX3	3	181450	181450[ULNAR-MAMMARY SYNDROME; UMS]
FBgn0028789	Doc1	HGNC:11597	OMIM:600747	TBX2	3	618223	618223[VERTEBRAL ANOMALIES AND VARIABLE ENDOCRINE AND T-CELL DYSFUNCTION; VETD]
FBgn0028789	Doc1	HGNC:11595	OMIM:604613	TBX18	3	143400	143400[CONGENITAL ANOMALIES OF KIDNEY AND URINARY TRACT 2; CAKUT2]
FBgn0028789	Doc1	HGNC:11600	OMIM:300307	TBX22	3	302905,303400	302905[ABRUZZO-ERICKSON SYNDROME; ABERS],303400[CLEFT PALATE WITH OR WITHOUT ANKYLOGLOSSIA, X-LINKED; CPX]
FBgn0035957	Argk2	HGNC:1996	OMIM:123295	CKMT2	10		
FBgn0035957	Argk2	HGNC:31736	OMIM:613415	CKMT1A	9		
FBgn0035957	Argk2	HGNC:1995	OMIM:123290	CKMT1B	6		
FBgn0035957	Argk2	HGNC:1991	OMIM:123280	CKB	8		
FBgn0035957	Argk2	HGNC:1994	OMIM:123310	CKM	9		
FBgn0035960	CG4942	HGNC:26801	OMIM:610428	COX18	13		
FBgn0023479	teq	HGNC:9477	OMIM:606709	PRSS12	6	249500	249500[INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 1; MRT1]
FBgn0004244	Rdl	HGNC:4083	OMIM:137192	GABRB3	3	612269,617113	612269[EPILEPSY, CHILDHOOD ABSENCE, SUSCEPTIBILITY TO, 5; ECA5],617113[DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 43; DEE43]
FBgn0004244	Rdl	HGNC:4082	OMIM:600232	GABRB2	3	617829	617829[DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 92; DEE92]
FBgn0004244	Rdl	HGNC:14454	OMIM:300349	GABRQ	3		
FBgn0004244	Rdl	HGNC:4084	OMIM:137163	GABRD	3	613060	613060[EPILEPSY, IDIOPATHIC GENERALIZED, SUSCEPTIBILITY TO, 10; EIG10]
FBgn0004244	Rdl	HGNC:4328	OMIM:600421	GLRA3	3		
FBgn0004244	Rdl	HGNC:4327	OMIM:305990	GLRA2	3	301076	301076[INTELLECTUAL DEVELOPMENTAL DISORDER, X-LINKED, SYNDROMIC, PILORGE TYPE; MRXSP]
FBgn0004244	Rdl	HGNC:4091	OMIM:137162	GABRR2	3		
FBgn0004244	Rdl	HGNC:4090	OMIM:137161	GABRR1	3		
FBgn0004244	Rdl	HGNC:31715		GLRA4	4		
FBgn0004244	Rdl	HGNC:4326	OMIM:138491	GLRA1	3	149400	149400[HYPEREKPLEXIA 1; HKPX1]
FBgn0004244	Rdl	HGNC:4089	OMIM:602729	GABRP	4		
FBgn0004244	Rdl	HGNC:4081	OMIM:137190	GABRB1	3	617153	617153[DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 45; DEE45]
FBgn0004244	Rdl	HGNC:17969	OMIM:618668	GABRR3	3		
FBgn0035965	Use1	HGNC:30882	OMIM:610675	USE1	13		
FBgn0011206	bol	HGNC:15964	OMIM:400026	DAZ2	4		
FBgn0011206	bol	HGNC:15965	OMIM:400027	DAZ3	4		
FBgn0011206	bol	HGNC:15966	OMIM:400048	DAZ4	4		
FBgn0011206	bol	HGNC:2685	OMIM:601486	DAZL	6		
FBgn0011206	bol	HGNC:14273	OMIM:606165	BOLL	12		
FBgn0011206	bol	HGNC:2682	OMIM:400003	DAZ1	5		
FBgn0035959	CG4911	HGNC:19833	OMIM:609103	FBXO33	13		
FBgn0000116	Argk1	HGNC:1996	OMIM:123295	CKMT2	10		
FBgn0000116	Argk1	HGNC:31736	OMIM:613415	CKMT1A	9		
FBgn0000116	Argk1	HGNC:1995	OMIM:123290	CKMT1B	5		
FBgn0000116	Argk1	HGNC:1991	OMIM:123280	CKB	10		
FBgn0000116	Argk1	HGNC:1994	OMIM:123310	CKM	11		
FBgn0016070	smg	HGNC:23023	OMIM:610747	SAMD4A	10		
FBgn0016070	smg	HGNC:25492	OMIM:619231	SAMD4B	10		
FBgn0035952	CG5280	HGNC:18589	OMIM:619678	C22orf23	12		
FBgn0035943	CG5653	HGNC:15862	OMIM:615854	SMOX	6		
FBgn0035943	CG5653	HGNC:20837	OMIM:615853	PAOX	6		
FBgn0035942	ValRS-m	HGNC:12651	OMIM:192150	VARS	7	617802	617802[NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, SEIZURES, AND CORTICAL ATROPHY; NDMSCA]
FBgn0035942	ValRS-m	HGNC:21642	OMIM:612802	VARS2	5	615917	615917[COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 20; COXPD20]
FBgn0035922	Pex7	HGNC:8860	OMIM:601757	PEX7	14	215100,614879	215100[RHIZOMELIC CHONDRODYSPLASIA PUNCTATA, TYPE 1; RCDP1],614879[PEROXISOME BIOGENESIS DISORDER 9B; PBD9B]
FBgn0035923	CG6511	HGNC:24640		EDRF1	14		
FBgn0052026	CG32026	HGNC:5384	OMIM:601149	IDH3A	8	619007	619007[RETINITIS PIGMENTOSA 90; RP90]
FBgn0020633	Mcm7	HGNC:6950	OMIM:600592	MCM7	14		
FBgn0035934	TrpA1	HGNC:497	OMIM:604775	TRPA1	14	615040	615040[EPISODIC PAIN SYNDROME, FAMILIAL, 1; FEPS1]
FBgn0035926	Acbp5	HGNC:17715		ACBD7	4		
FBgn0035926	Acbp5	HGNC:2690	OMIM:125950	DBI	3		
FBgn0003149	Prm	HGNC:15906	OMIM:609928	MYH7B	3		
FBgn0003149	Prm	HGNC:7573	OMIM:160720	MYH3	3	178110,193700,618436,618469	178110[CONTRACTURES, PTERYGIA, AND SPONDYLOCARPOTARSAL FUSION SYNDROME 1A; CPSFS1A],193700[ARTHROGRYPOSIS, DISTAL, TYPE 2A; DA2A],618436[ARTHROGRYPOSIS, DISTAL, TYPE 2B3; DA2B3],618469[CONTRACTURES, PTERYGIA, AND SPONDYLOCARPOTARSAL FUSION SYNDROME 1B; CPSFS1B]
FBgn0003149	Prm	HGNC:7576	OMIM:160710	MYH6	3	613251,613252,614089,614090	613251[CARDIOMYOPATHY, FAMILIAL HYPERTROPHIC, 14; CMH14],613252[CARDIOMYOPATHY, DILATED, 1EE; CMD1EE],614089[ATRIAL SEPTAL DEFECT 3; ASD3],614090[SICK SINUS SYNDROME 3, SUSCEPTIBILITY TO; SSS3]
FBgn0003149	Prm	HGNC:7577	OMIM:160760	MYH7	3	160500,181430,192600,255160,608358,613426	160500[MYOPATHY, DISTAL, 1; MPD1],181430[SCAPULOPERONEAL MYOPATHY, MYH7-RELATED; SPMM],192600[CARDIOMYOPATHY, FAMILIAL HYPERTROPHIC, 1; CMH1],255160[MYOPATHY, MYOSIN STORAGE, AUTOSOMAL RECESSIVE; MSMB],608358[MYOPATHY, MYOSIN STORAGE, AUTOSOMAL DOMINANT; MSMA],613426[CARDIOMYOPATHY, DILATED, 1S; CMD1S]
FBgn0003149	Prm	HGNC:7578	OMIM:160741	MYH8	3	158300,608837	158300[ARTHROGRYPOSIS, DISTAL, TYPE 7; DA7],608837[CARNEY COMPLEX VARIANT]
FBgn0003149	Prm	HGNC:31073	OMIM:609929	MYH15	3		
FBgn0003149	Prm	HGNC:7567	OMIM:160730	MYH1	3		
FBgn0003149	Prm	HGNC:7572	OMIM:160740	MYH2	3	605637	605637[MYOPATHY, PROXIMAL, WITH OPHTHALMOPLEGIA; MYPOP]
FBgn0003149	Prm	HGNC:7574	OMIM:160742	MYH4	3		
FBgn0052022	CG32022	HGNC:12790	OMIM:602915	GET1	9		
FBgn0011509	SrpRbeta	HGNC:24085	OMIM:616883	SRPRB	13		
FBgn0000121	Arr2	HGNC:712	OMIM:107941	ARRB2	5		
FBgn0000121	Arr2	HGNC:710	OMIM:301770	ARR3	4	301010	301010[MYOPIA 26, X-LINKED, FEMALE-LIMITED; MYP26]
FBgn0000121	Arr2	HGNC:10521	OMIM:181031	SAG	5	258100,613758	258100[OGUCHI DISEASE 1],613758[RETINITIS PIGMENTOSA 47; RP47]
FBgn0000121	Arr2	HGNC:711	OMIM:107940	ARRB1	4		
FBgn0035876	Pex2	HGNC:9717	OMIM:170993	PEX2	12	614866,614867	614866[PEROXISOME BIOGENESIS DISORDER 5A (ZELLWEGER); PBD5A],614867[PEROXISOME BIOGENESIS DISORDER 5B; PBD5B]
FBgn0011762	Prim1	HGNC:9369	OMIM:176635	PRIM1	14	620005	620005[PRIMORDIAL DWARFISM-IMMUNODEFICIENCY-LIPODYSTROPHY SYNDROME; PDIL]
FBgn0035877	CG7083	HGNC:29564		PHAF1	13		
FBgn0035890	CG13667	HGNC:29838	OMIM:606073	NDOR1	15		
FBgn0020224	Cbl	HGNC:1541	OMIM:165360	CBL	9	607785,613563	607785[JUVENILE MYELOMONOCYTIC LEUKEMIA; JMML],613563[NOONAN SYNDROME-LIKE DISORDER WITH OR WITHOUT JUVENILE MYELOMONOCYTIC LEUKEMIA; NSLL]
FBgn0020224	Cbl	HGNC:1542	OMIM:604491	CBLB	10		
FBgn0020224	Cbl	HGNC:15961	OMIM:608453	CBLC	6		
FBgn0010825	Gug	HGNC:9965	OMIM:605226	RERE	10	616975	616975[NEURODEVELOPMENTAL DISORDER WITH OR WITHOUT ANOMALIES OF THE BRAIN, EYE, OR HEART; NEDBEH]
FBgn0010825	Gug	HGNC:3033	OMIM:607462	ATN1	7	125370,618494	125370[DENTATORUBRAL-PALLIDOLUYSIAN ATROPHY; DRPLA],618494[CONGENITAL HYPOTONIA, EPILEPSY, DEVELOPMENTAL DELAY, AND DIGITAL ANOMALIES; CHEDDA]
FBgn0035901	Pus7	HGNC:26033	OMIM:616261	PUS7	13	618342	618342[INTELLECTUAL DEVELOPMENTAL DISORDER WITH ABNORMAL BEHAVIOR, MICROCEPHALY, AND SHORT STATURE; IDDABS]
FBgn0035901	Pus7	HGNC:25276		PUS7L	5		
FBgn0035904	GstO3	HGNC:13312	OMIM:605482	GSTO1	14		
FBgn0035904	GstO3	HGNC:23064	OMIM:612314	GSTO2	12		
FBgn0024236	foi	HGNC:18607	OMIM:608731	SLC39A6	11		
FBgn0024236	foi	HGNC:20861	OMIM:608733	SLC39A10	12		
FBgn0024236	foi	HGNC:20858	OMIM:608736	SLC39A14	4	144755,617013	144755[HYPEROSTOSIS CRANIALIS INTERNA; HCIN],617013[HYPERMANGANESEMIA WITH DYSTONIA 2; HMNDYT2]
FBgn0024236	foi	HGNC:17129	OMIM:607059	SLC39A4	5	201100	201100[ACRODERMATITIS ENTEROPATHICA, ZINC-DEFICIENCY TYPE; AEZ]
FBgn0024236	foi	HGNC:20862	OMIM:608732	SLC39A8	4	616721	616721[CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIn; CDG2N]
FBgn0024236	foi	HGNC:20502	OMIM:608730	SLC39A5	4	615946	615946[MYOPIA 24, AUTOSOMAL DOMINANT; MYP24]
FBgn0024236	foi	HGNC:20860	OMIM:608734	SLC39A12	3		
FBgn0035909	ergic53	HGNC:6631	OMIM:601567	LMAN1	14	227300	227300[FACTOR V AND FACTOR VIII, COMBINED DEFICIENCY OF, 1; F5F8D1]
FBgn0035909	ergic53	HGNC:6632	OMIM:609548	LMAN1L	6		
FBgn0260442	rhea	HGNC:15447	OMIM:607349	TLN2	14		
FBgn0260442	rhea	HGNC:11845	OMIM:186745	TLN1	12		
FBgn0260442	rhea	HGNC:13519	OMIM:615466	TLNRD1	3		
FBgn0035915	S-Lap1	HGNC:18449	OMIM:170250	LAP3	11		
FBgn0035915	S-Lap1	HGNC:16244		NPEPL1	3		
FBgn0052351	S-Lap2	HGNC:18449	OMIM:170250	LAP3	11		
FBgn0052351	S-Lap2	HGNC:16244		NPEPL1	3		
FBgn0035918	Cdc6	HGNC:1744	OMIM:602627	CDC6	13	613805	613805[MEIER-GORLIN SYNDROME 5; MGORS5]
FBgn0035918	Cdc6	HGNC:8487	OMIM:601902	ORC1	4	224690	224690[MEIER-GORLIN SYNDROME 1; MGORS1]
FBgn0035916	GAPsec	HGNC:25571	OMIM:616218	TBC1D13	14		
FBgn0017429	CG5989	HGNC:24241	OMIM:619070	LETMD1	14		
FBgn0017430	Nelf-E	HGNC:13974	OMIM:154040	NELFE	10		
FBgn0035911	CG6638	HGNC:6186	OMIM:607036	IVD	15	243500	243500[ISOVALERIC ACIDEMIA; IVA]
FBgn0035907	GstO1	HGNC:13312	OMIM:605482	GSTO1	13		
FBgn0035907	GstO1	HGNC:23064	OMIM:612314	GSTO2	11		
FBgn0035906	GstO2	HGNC:13312	OMIM:605482	GSTO1	11		
FBgn0035906	GstO2	HGNC:23064	OMIM:612314	GSTO2	12		
FBgn0035900	ZC3H3	HGNC:28972	OMIM:618640	ZC3H3	9		
FBgn0035896	CG6983	HGNC:15873		C20orf27	13		
FBgn0052354	CG32354	HGNC:15464	OMIM:605010	SPINK5	4	256500	256500[NETHERTON SYNDROME; NETH]
FBgn0052354	CG32354	HGNC:329	OMIM:103320	AGRN	3	615120	615120[MYASTHENIC SYNDROME, CONGENITAL, 8; CMS8]
FBgn0035889	mkg-p	HGNC:26184	OMIM:610641	TUT1	3		
FBgn0035889	mkg-p	HGNC:28981	OMIM:613692	TUT4	4		
FBgn0001248	Idh	HGNC:5382	OMIM:147700	IDH1	14	137800	137800[GLIOMA SUSCEPTIBILITY 1; GLM1]
FBgn0001248	Idh	HGNC:5383	OMIM:147650	IDH2	5	613657	613657[D-2-HYDROXYGLUTARIC ACIDURIA 2; D2HGA2]
FBgn0035878	CG7182	HGNC:29526	OMIM:610369	HSPA14	6		
FBgn0053057	Tpt	HGNC:20316	OMIM:610470	TRPT1	12		
FBgn0028379	fan	HGNC:12649	OMIM:605704	VAPB	8	182980,608627	182980[SPINAL MUSCULAR ATROPHY, LATE-ONSET, FINKEL TYPE; SMAFK],608627[AMYOTROPHIC LATERAL SCLEROSIS 8; ALS8]
FBgn0028379	fan	HGNC:12648	OMIM:605703	VAPA	6		
FBgn0027549	Nulp1	HGNC:29181	OMIM:612326	TCF25	14		
FBgn0026252	msk	HGNC:9852	OMIM:605586	IPO7	14		
FBgn0026252	msk	HGNC:9853	OMIM:605600	IPO8	13	619472	619472[VISS SYNDROME; VISS]
FBgn0035838	ldbr	HGNC:15594	OMIM:607024	DBR1	14	619441	619441[ENCEPHALITIS, ACUTE, INFECTION (VIRAL)-INDUCED, SUSCEPTIBILITY TO, 11; IIAE11]
FBgn0010350	Cds	HGNC:1800	OMIM:603548	CDS1	13		
FBgn0010350	Cds	HGNC:1801	OMIM:603549	CDS2	12		
FBgn0002899	mus301	HGNC:18536	OMIM:606769	HELQ	15		
FBgn0002899	mus301	HGNC:9186	OMIM:604419	POLQ	3		
FBgn0035848	Uxs	HGNC:17729	OMIM:609749	UXS1	14		
FBgn0035850	Atg18a	HGNC:25471	OMIM:609224	WIPI1	11		
FBgn0035850	Atg18a	HGNC:32225	OMIM:609225	WIPI2	12	618453	618453[INTELLECTUAL DEVELOPMENTAL DISORDER WITH SHORT STATURE AND VARIABLE SKELETAL ANOMALIES; IDDSSA]
FBgn0035851	MED24	HGNC:22963	OMIM:607000	MED24	13		
FBgn0035854	Dhps	HGNC:2869	OMIM:600944	DHPS	14	618480	618480[NEURODEVELOPMENTAL DISORDER WITH SEIZURES AND SPEECH AND WALKING IMPAIRMENT; NEDSSWI]
FBgn0015793	Rab19	HGNC:19983		RAB43	11		
FBgn0015793	Rab19	HGNC:19982		RAB19	8		
FBgn0035867	CG13671	HGNC:28030	OMIM:617792	TXNDC11	10		
FBgn0035872	Cpsf6	HGNC:13871	OMIM:604979	CPSF6	13		
FBgn0035872	Cpsf6	HGNC:30098		CPSF7	9		
FBgn0035871	BI-1	HGNC:11723	OMIM:600748	TMBIM6	14		
FBgn0035868	CG7194	HGNC:21367	OMIM:613973	CGAS	3		
FBgn0035866	Arl5	HGNC:23052	OMIM:608909	ARL5B	14		
FBgn0035866	Arl5	HGNC:696	OMIM:608960	ARL5A	13		
FBgn0035866	Arl5	HGNC:31111		ARL5C	6		
FBgn0027569	cert	HGNC:2205	OMIM:604677	CERT1	14	616351	616351[INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL DOMINANT 34; MRD34]
FBgn0035853	UbcE2M	HGNC:12491	OMIM:603173	UBE2M	14		
FBgn0035852	CG7387	HGNC:11808	OMIM:608382	DNAJA3	6		
FBgn0035849	ERR	HGNC:3474	OMIM:602969	ESRRG	14		
FBgn0035849	ERR	HGNC:3473	OMIM:602167	ESRRB	13	608565	608565[DEAFNESS, AUTOSOMAL RECESSIVE 35; DFNB35]
FBgn0035849	ERR	HGNC:3471	OMIM:601998	ESRRA	12		
FBgn0020392	Nmt	HGNC:7857	OMIM:160993	NMT1	12		
FBgn0020392	Nmt	HGNC:7858	OMIM:603801	NMT2	13		
FBgn0040290	RecQ4	HGNC:9949	OMIM:603780	RECQL4	12	218600,266280,268400	218600[BALLER-GEROLD SYNDROME; BGS],266280[RAPADILINO SYNDROME],268400[ROTHMUND-THOMSON SYNDROME, TYPE 2; RTS2]
FBgn0035842	Setx	HGNC:445	OMIM:608465	SETX	7	602433,606002	602433[AMYOTROPHIC LATERAL SCLEROSIS 4, JUVENILE; ALS4],606002[SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE, WITH AXONAL NEUROPATHY 2; SCAN2]
FBgn0029113	Uba2	HGNC:30661	OMIM:613295	UBA2	14	619959	619959[ACCES SYNDROME; ACCES]
FBgn0042112	mRpL36	HGNC:14490	OMIM:611842	MRPL36	12		
FBgn0035839	CG7550	HGNC:23506	OMIM:611392	ADO	15		
FBgn0035833	CG7565	HGNC:21580	OMIM:609269	KIAA0319	14		
FBgn0035833	CG7565	HGNC:30071	OMIM:613535	KIAA0319L	14		
FBgn0035823	eIF4E5	HGNC:3293	OMIM:605895	EIF4E2	3		
FBgn0035823	eIF4E5	HGNC:3287	OMIM:133440	EIF4E	13	615091	615091[AUTISM, SUSCEPTIBILITY TO, 19; AUTS19]
FBgn0035823	eIF4E5	HGNC:33179		EIF4E1B	12		
FBgn0035823	eIF4E5	HGNC:31837	OMIM:609896	EIF4E3	3		
FBgn0035827	Srp9	HGNC:11304	OMIM:600707	SRP9	13		
FBgn0041156	exex	HGNC:4979	OMIM:142994	MNX1	9	176450	176450[CURRARINO SYNDROME]
FBgn0035830	CG8209	HGNC:18402	OMIM:616378	UBXN1	15		
FBgn0011817	nmo	HGNC:29858	OMIM:609476	NLK	14		
FBgn0035831	Pop4	HGNC:30081	OMIM:606114	POP4	13		
FBgn0027554	CG8042	HGNC:14860	OMIM:611216	UBXN4	11		
FBgn0027554	CG8042	HGNC:18402	OMIM:616378	UBXN1	3		
FBgn0024187	syd	HGNC:6884	OMIM:605431	MAPK8IP3	14	618443	618443[NEURODEVELOPMENTAL DISORDER WITH OR WITHOUT VARIABLE BRAIN ABNORMALITIES; NEDBA]
FBgn0024187	syd	HGNC:14524	OMIM:605430	SPAG9	14		
FBgn0035825	Tmem43	HGNC:28472	OMIM:612048	TMEM43	14	604400,614302,619832	604400[ARRHYTHMOGENIC RIGHT VENTRICULAR DYSPLASIA, FAMILIAL, 5; ARVD5],614302[EMERY-DREIFUSS MUSCULAR DYSTROPHY 7, AUTOSOMAL DOMINANT; EDMD7],619832[AUDITORY NEUROPATHY, AUTOSOMAL DOMINANT 3; AUNA3]
FBgn0003041	pbl	HGNC:3155	OMIM:600586	ECT2	15		
FBgn0016694	Pdp1	HGNC:2697	OMIM:124097	DBP	8		
FBgn0016694	Pdp1	HGNC:4977	OMIM:142385	HLF	11		
FBgn0016694	Pdp1	HGNC:11722	OMIM:188595	TEF	8		
FBgn0052369	CG32369	HGNC:21152		LONRF3	12		
FBgn0052369	CG32369	HGNC:26302		LONRF1	11		
FBgn0052369	CG32369	HGNC:24788		LONRF2	12		
FBgn0052371	CG32371	HGNC:6892	OMIM:605788	MAPRE3	7		
FBgn0052371	CG32371	HGNC:6891	OMIM:605789	MAPRE2	7	616734	616734[SKIN CREASES, CONGENITAL SYMMETRIC CIRCUMFERENTIAL, 2; CSCSC2]
FBgn0052371	CG32371	HGNC:6890	OMIM:603108	MAPRE1	8		
FBgn0035790	Cyp316a1	HGNC:23198	OMIM:608614	CYP4V2	3	210370	210370[BIETTI CRYSTALLINE CORNEORETINAL DYSTROPHY; BCD]
FBgn0035790	Cyp316a1	HGNC:2644	OMIM:124075	CYP4B1	3		
FBgn0035790	Cyp316a1	HGNC:2594	OMIM:107910	CYP19A1	3	139300,613546	139300[AROMATASE EXCESS SYNDROME; AEXS],613546[AROMATASE DEFICIENCY]
FBgn0035793	CG7546	HGNC:13919	OMIM:142590	BAG6	13		
FBgn0028582	lqf	HGNC:21604	OMIM:607262	EPN1	14		
FBgn0028582	lqf	HGNC:18639	OMIM:607263	EPN2	12		
FBgn0028582	lqf	HGNC:18235	OMIM:607264	EPN3	11		
FBgn0028582	lqf	HGNC:26352		ENTHD1	4		
FBgn0035798	frac	HGNC:18794	OMIM:608529	FBN3	4		
FBgn0035798	frac	HGNC:3603	OMIM:134797	FBN1	3	102370,129600,154700,184900,604308,608328,614185,616914	102370[ACROMICRIC DYSPLASIA; ACMICD],129600[ECTOPIA LENTIS 1, ISOLATED, AUTOSOMAL DOMINANT; ECTOL1],154700[MARFAN SYNDROME; MFS],184900[STIFF SKIN SYNDROME; SSKS],604308[MASS SYNDROME],608328[WEILL-MARCHESANI SYNDROME 2; WMS2],614185[GELEOPHYSIC DYSPLASIA 2; GPHYSD2],616914[MARFANOID-PROGEROID-LIPODYSTROPHY SYNDROME; MFLS]
FBgn0035798	frac	HGNC:3604	OMIM:612570	FBN2	3	121050,616118	121050[CONTRACTURAL ARACHNODACTYLY, CONGENITAL; CCA],616118[MACULAR DEGENERATION, EARLY-ONSET; EOMD]
FBgn0035798	frac	HGNC:6910	OMIM:603897	MATN4	3		
FBgn0035798	frac	HGNC:3602	OMIM:604580	FBLN5	3	219100,608895,614434,619764	219100[CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IA; ARCL1A],608895[MACULAR DEGENERATION, AGE-RELATED, 3; ARMD3],614434[CUTIS LAXA, AUTOSOMAL DOMINANT 2; ADCL2],619764[CHARCOT-MARIE-TOOTH DISEASE, DEMYELINATING, TYPE 1H; CMT1H]
FBgn0035798	frac	HGNC:6908	OMIM:602108	MATN2	4		
FBgn0035799	mmm	HGNC:30711	OMIM:617968	WDR63	11		
FBgn0035799	mmm	HGNC:18744	OMIM:605483	DNAI2	3	612444	612444[CILIARY DYSKINESIA, PRIMARY, 9; CILD9]
FBgn0035806	PGRP-SD	HGNC:30013	OMIM:608199	PGLYRP2	4		
FBgn0035806	PGRP-SD	HGNC:8904	OMIM:604963	PGLYRP1	7		
FBgn0035806	PGRP-SD	HGNC:30014	OMIM:608197	PGLYRP3	6		
FBgn0035806	PGRP-SD	HGNC:30015	OMIM:608198	PGLYRP4	6		
FBgn0035811	Mcad	HGNC:89	OMIM:607008	ACADM	14	201450	201450[ACYL-CoA DEHYDROGENASE, MEDIUM-CHAIN, DEFICIENCY OF; ACADMD]
FBgn0035817	CG7409	HGNC:2388	OMIM:123580	CRYAA	4	604219	604219[CATARACT 9, MULTIPLE TYPES; CTRCT9]
FBgn0035817	CG7409	HGNC:26511	OMIM:610695	HSPB6	3		
FBgn0035817	CG7409	HGNC:5247	OMIM:602179	HSPB2	4		
FBgn0035817	CG7409	HGNC:2389	OMIM:123590	CRYAB	4	608810,613763,613869,615184	608810[MYOPATHY, MYOFIBRILLAR, 2; MFM2],613763[CATARACT 16, MULTIPLE TYPES; CTRCT16],613869[MYOPATHY, MYOFIBRILLAR, FATAL INFANTILE HYPERTONIC, ALPHA-B CRYSTALLIN-RELATED],615184[CARDIOMYOPATHY, DILATED, 1II; CMD1II]
FBgn0035817	CG7409	HGNC:5246	OMIM:602195	HSPB1	4	606595,608634	606595[CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2F; CMT2F],608634[NEURONOPATHY, DISTAL HEREDITARY MOTOR, TYPE IIB; HMN2B]
FBgn0035815	Snmp2	HGNC:1663	OMIM:173510	CD36	7	608404,610938,611162	608404[PLATELET GLYCOPROTEIN IV DEFICIENCY],610938[CORONARY HEART DISEASE, SUSCEPTIBILITY TO, 7; CHDS7],611162[MALARIA, SUSCEPTIBILITY TO]
FBgn0035815	Snmp2	HGNC:1664	OMIM:601040	SCARB1	5	610762	610762[HIGH DENSITY LIPOPROTEIN CHOLESTEROL LEVEL QUANTITATIVE TRAIT LOCUS 6; HDLCQ6]
FBgn0035815	Snmp2	HGNC:1665	OMIM:602257	SCARB2	6	254900	254900[EPILEPSY, PROGRESSIVE MYOCLONIC, 4, WITH OR WITHOUT RENAL FAILURE; EPM4]
FBgn0035813	CG8492	HGNC:28387	OMIM:612750	LYZL4	6		
FBgn0035813	CG8492	HGNC:31353	OMIM:300593	SPACA5	3		
FBgn0035813	CG8492	HGNC:19142		SPACA5B	5		
FBgn0035813	CG8492	HGNC:29613	OMIM:612748	LYZL2	4		
FBgn0035813	CG8492	HGNC:16260	OMIM:612749	SPACA3	5		
FBgn0035813	CG8492	HGNC:6480	OMIM:149750	LALBA	6		
FBgn0035813	CG8492	HGNC:6740	OMIM:153450	LYZ	5	105200	105200[AMYLOIDOSIS, FAMILIAL VISCERAL]
FBgn0035813	CG8492	HGNC:30502		LYZL1	3		
FBgn0035813	CG8492	HGNC:29614	OMIM:612751	LYZL6	5		
FBgn0035812	CG7457	HGNC:7801	OMIM:604546	TONSL	13	271510	271510[SPONDYLOEPIMETAPHYSEAL DYSPLASIA, SPONASTRIME TYPE; SEMDSP]
FBgn0035805	CG7506	HGNC:26050	OMIM:612418	TMEM70	14	614052	614052[MITOCHONDRIAL COMPLEX V (ATP SYNTHASE) DEFICIENCY, NUCLEAR TYPE 2; MC5DN2]
FBgn0053276	Urm1	HGNC:28378	OMIM:612693	URM1	13		
FBgn0035800	t-Grip84	HGNC:18599	OMIM:617817	TUBGCP2	8	618737	618737[PACHYGYRIA, MICROCEPHALY, DEVELOPMENTAL DELAY, AND DYSMORPHIC FACIES, WITH OR WITHOUT SEIZURES; PAMDDFS]
FBgn0035795	CG16998	HGNC:31397		PRSS57	3		
FBgn0035791	CG8539	HGNC:2300	OMIM:603101	CPB2	4		
FBgn0035791	CG8539	HGNC:21011	OMIM:609563	CPO	4		
FBgn0035791	CG8539	HGNC:2298	OMIM:114851	CPA3	3		
FBgn0035791	CG8539	HGNC:2297	OMIM:600688	CPA2	4		
FBgn0035791	CG8539	HGNC:15740	OMIM:607635	CPA4	4		
FBgn0035791	CG8539	HGNC:2299	OMIM:114852	CPB1	4		
FBgn0035791	CG8539	HGNC:2296	OMIM:114850	CPA1	4		
FBgn0035791	CG8539	HGNC:17245	OMIM:609562	CPA6	4	614417,614418	614417[EPILEPSY, FAMILIAL TEMPORAL LOBE, 5; ETL5],614418[FEBRILE SEIZURES, FAMILIAL, 11; FEB11]
FBgn0035791	CG8539	HGNC:15722	OMIM:609561	CPA5	4		
FBgn0015033	Cyp4d8	HGNC:23198	OMIM:608614	CYP4V2	5	210370	210370[BIETTI CRYSTALLINE CORNEORETINAL DYSTROPHY; BCD]
FBgn0015033	Cyp4d8	HGNC:13265	OMIM:611517	CYP4F11	3		
FBgn0015033	Cyp4d8	HGNC:26820	OMIM:611495	CYP4F22	3	604777	604777[ICHTHYOSIS, CONGENITAL, AUTOSOMAL RECESSIVE 5; ARCI5]
FBgn0015033	Cyp4d8	HGNC:2645	OMIM:604426	CYP4F2	4		
FBgn0015033	Cyp4d8	HGNC:2646	OMIM:601270	CYP4F3	3		
FBgn0015033	Cyp4d8	HGNC:20244	OMIM:614999	CYP4X1	3		
FBgn0015033	Cyp4d8	HGNC:18857	OMIM:611485	CYP4F12	3		
FBgn0015033	Cyp4d8	HGNC:2603	OMIM:602239	CYP26A1	3		
FBgn0015033	Cyp4d8	HGNC:2644	OMIM:124075	CYP4B1	3		
FBgn0015033	Cyp4d8	HGNC:2648	OMIM:611545	CYP4F8	4		
FBgn0015033	Cyp4d8	HGNC:2594	OMIM:107910	CYP19A1	4	139300,613546	139300[AROMATASE EXCESS SYNDROME; AEXS],613546[AROMATASE DEFICIENCY]
FBgn0024542	Neos	HGNC:15909	OMIM:616825	NCOA5	10		
FBgn0035762	Rint1	HGNC:21876	OMIM:610089	RINT1	14	618641	618641[INFANTILE LIVER FAILURE SYNDROME 3; ILFS3]
FBgn0002909	mus312	HGNC:23845	OMIM:613278	SLX4	3	613951	613951[FANCONI ANEMIA, COMPLEMENTATION GROUP P; FANCP]
FBgn0019662	qm	HGNC:4249	OMIM:606982	GGPS1	14	619518	619518[MUSCULAR DYSTROPHY, CONGENITAL HEARING LOSS, AND OVARIAN INSUFFICIENCY SYNDROME; MDHLO]
FBgn0035771	Sec63	HGNC:21082	OMIM:608648	SEC63	14	617004	617004[POLYCYSTIC LIVER DISEASE 2 WITH OR WITHOUT KIDNEY CYSTS; PCLD2]
FBgn0082598	akirin	HGNC:25744	OMIM:615164	AKIRIN1	12		
FBgn0082598	akirin	HGNC:21407	OMIM:615165	AKIRIN2	14		
FBgn0016983	smid	HGNC:8070	OMIM:602426	NVL	13		
FBgn0016983	smid	HGNC:12666	OMIM:601023	VCP	3	167320,613954,616687	167320[INCLUSION BODY MYOPATHY WITH EARLY-ONSET PAGET DISEASE WITH OR WITHOUT FRONTOTEMPORAL DEMENTIA 1; IBMPFD1],613954[FRONTOTEMPORAL DEMENTIA AND/OR AMYOTROPHIC LATERAL SCLEROSIS 6; FTDALS6],616687[CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2Y; CMT2Y]
FBgn0016983	smid	HGNC:18119	OMIM:613940	SPATA5	3	616577	616577[NEURODEVELOPMENTAL DISORDER WITH HEARING LOSS, SEIZURES, AND BRAIN ABNORMALITIES; NEDHSB]
FBgn0016983	smid	HGNC:28762	OMIM:619578	SPATA5L1	3	619615,619616	619615[DEAFNESS, AUTOSOMAL RECESSIVE 119; DFNB119],619616[NEURODEVELOPMENTAL DISORDER WITH HEARING LOSS AND SPASTICITY; NEDHLS]
FBgn0035777	CG8563	HGNC:2300	OMIM:603101	CPB2	5		
FBgn0035777	CG8563	HGNC:21011	OMIM:609563	CPO	5		
FBgn0035777	CG8563	HGNC:2298	OMIM:114851	CPA3	4		
FBgn0035777	CG8563	HGNC:2297	OMIM:600688	CPA2	4		
FBgn0035777	CG8563	HGNC:15740	OMIM:607635	CPA4	5		
FBgn0035777	CG8563	HGNC:2299	OMIM:114852	CPB1	4		
FBgn0035777	CG8563	HGNC:2296	OMIM:114850	CPA1	5		
FBgn0035777	CG8563	HGNC:17245	OMIM:609562	CPA6	5	614417,614418	614417[EPILEPSY, FAMILIAL TEMPORAL LOBE, 5; ETL5],614418[FEBRILE SEIZURES, FAMILIAL, 11; FEB11]
FBgn0035777	CG8563	HGNC:15722	OMIM:609561	CPA5	5		
FBgn0052379	CG32379	HGNC:2300	OMIM:603101	CPB2	5		
FBgn0052379	CG32379	HGNC:21011	OMIM:609563	CPO	5		
FBgn0052379	CG32379	HGNC:2298	OMIM:114851	CPA3	4		
FBgn0052379	CG32379	HGNC:2297	OMIM:600688	CPA2	5		
FBgn0052379	CG32379	HGNC:15740	OMIM:607635	CPA4	5		
FBgn0052379	CG32379	HGNC:2299	OMIM:114852	CPB1	5		
FBgn0052379	CG32379	HGNC:2296	OMIM:114850	CPA1	5		
FBgn0052379	CG32379	HGNC:17245	OMIM:609562	CPA6	5	614417,614418	614417[EPILEPSY, FAMILIAL TEMPORAL LOBE, 5; ETL5],614418[FEBRILE SEIZURES, FAMILIAL, 11; FEB11]
FBgn0052379	CG32379	HGNC:15722	OMIM:609561	CPA5	5		
FBgn0035779	CG8562	HGNC:2300	OMIM:603101	CPB2	5		
FBgn0035779	CG8562	HGNC:21011	OMIM:609563	CPO	5		
FBgn0035779	CG8562	HGNC:2298	OMIM:114851	CPA3	4		
FBgn0035779	CG8562	HGNC:2297	OMIM:600688	CPA2	5		
FBgn0035779	CG8562	HGNC:15740	OMIM:607635	CPA4	5		
FBgn0035779	CG8562	HGNC:2299	OMIM:114852	CPB1	6		
FBgn0035779	CG8562	HGNC:2296	OMIM:114850	CPA1	5		
FBgn0035779	CG8562	HGNC:17245	OMIM:609562	CPA6	5	614417,614418	614417[EPILEPSY, FAMILIAL TEMPORAL LOBE, 5; ETL5],614418[FEBRILE SEIZURES, FAMILIAL, 11; FEB11]
FBgn0035779	CG8562	HGNC:15722	OMIM:609561	CPA5	5		
FBgn0035780	CG18417	HGNC:2300	OMIM:603101	CPB2	5		
FBgn0035780	CG18417	HGNC:21011	OMIM:609563	CPO	5		
FBgn0035780	CG18417	HGNC:2298	OMIM:114851	CPA3	4		
FBgn0035780	CG18417	HGNC:2297	OMIM:600688	CPA2	5		
FBgn0035780	CG18417	HGNC:15740	OMIM:607635	CPA4	5		
FBgn0035780	CG18417	HGNC:2299	OMIM:114852	CPB1	6		
FBgn0035780	CG18417	HGNC:2296	OMIM:114850	CPA1	5		
FBgn0035780	CG18417	HGNC:17245	OMIM:609562	CPA6	5	614417,614418	614417[EPILEPSY, FAMILIAL TEMPORAL LOBE, 5; ETL5],614418[FEBRILE SEIZURES, FAMILIAL, 11; FEB11]
FBgn0035780	CG18417	HGNC:15722	OMIM:609561	CPA5	5		
FBgn0035785	ppk26	HGNC:101	OMIM:611741	ASIC3	6		
FBgn0035785	ppk26	HGNC:100	OMIM:602866	ASIC1	6		
FBgn0035785	ppk26	HGNC:21263	OMIM:606715	ASIC4	6		
FBgn0035785	ppk26	HGNC:99	OMIM:601784	ASIC2	5		
FBgn0035785	ppk26	HGNC:17537	OMIM:616693	ASIC5	6		
FBgn0035785	ppk26	HGNC:10600	OMIM:600760	SCNN1B	3	177200,211400,264350	177200[LIDDLE SYNDROME 1; LIDLS1],211400[BRONCHIECTASIS WITH OR WITHOUT ELEVATED SWEAT CHLORIDE 1; BESC1],264350[PSEUDOHYPOALDOSTERONISM, TYPE I, AUTOSOMAL RECESSIVE; PHA1B]
FBgn0014011	Rac2	HGNC:9802	OMIM:602049	RAC2	11	608203,618986,618987	608203[IMMUNODEFICIENCY 73A WITH DEFECTIVE NEUTROPHIL CHEMOTAXIS AND LEUKOCYTOSIS; IMD73A],618986[IMMUNODEFICIENCY 73B WITH DEFECTIVE NEUTROPHIL CHEMOTAXIS AND LYMPHOPENIA; IMD73B],618987[IMMUNODEFICIENCY 73C WITH DEFECTIVE NEUTROPHIL CHEMOTAXIS AND HYPOGAMMAGLOBULINEMIA; IMD73C]
FBgn0014011	Rac2	HGNC:9801	OMIM:602048	RAC1	12	617751	617751[INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL DOMINANT 48; MRD48]
FBgn0014011	Rac2	HGNC:9803	OMIM:602050	RAC3	8	618577	618577[NEURODEVELOPMENTAL DISORDER WITH STRUCTURAL BRAIN ANOMALIES AND DYSMORPHIC FACIES; NEDBAF]
FBgn0014011	Rac2	HGNC:672	OMIM:179505	RHOG	4		
FBgn0014011	Rac2	HGNC:17736	OMIM:605857	RHOQ	3		
FBgn0014011	Rac2	HGNC:17794	OMIM:606366	RHOU	3		
FBgn0014011	Rac2	HGNC:1736	OMIM:116952	CDC42	3	616737	616737[TAKENOUCHI-KOSAKI SYNDROME; TKS]
FBgn0035781	CG8560	HGNC:2300	OMIM:603101	CPB2	5		
FBgn0035781	CG8560	HGNC:21011	OMIM:609563	CPO	5		
FBgn0035781	CG8560	HGNC:2298	OMIM:114851	CPA3	4		
FBgn0035781	CG8560	HGNC:2297	OMIM:600688	CPA2	5		
FBgn0035781	CG8560	HGNC:15740	OMIM:607635	CPA4	5		
FBgn0035781	CG8560	HGNC:2299	OMIM:114852	CPB1	6		
FBgn0035781	CG8560	HGNC:2296	OMIM:114850	CPA1	5		
FBgn0035781	CG8560	HGNC:17245	OMIM:609562	CPA6	5	614417,614418	614417[EPILEPSY, FAMILIAL TEMPORAL LOBE, 5; ETL5],614418[FEBRILE SEIZURES, FAMILIAL, 11; FEB11]
FBgn0035781	CG8560	HGNC:15722	OMIM:609561	CPA5	5		
FBgn0052380	SMSr	HGNC:26320	OMIM:611575	SAMD8	13		
FBgn0052380	SMSr	HGNC:28395	OMIM:611574	SGMS2	3	126550	126550[CALVARIAL DOUGHNUT LESIONS WITH BONE FRAGILITY; CDL]
FBgn0052380	SMSr	HGNC:29799	OMIM:611573	SGMS1	3		
FBgn0035772	Sh3beta	HGNC:10822	OMIM:602230	SH3BGR	9		
FBgn0035772	Sh3beta	HGNC:10823	OMIM:300190	SH3BGRL	8		
FBgn0035772	Sh3beta	HGNC:15568	OMIM:615679	SH3BGRL3	7		
FBgn0035772	Sh3beta	HGNC:15567	OMIM:615678	SH3BGRL2	8		
FBgn0035769	CTCF	HGNC:16234	OMIM:607022	CTCFL	9		
FBgn0035769	CTCF	HGNC:13723	OMIM:604167	CTCF	9	615502	615502[INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL DOMINANT 21; MRD21]
FBgn0015298	Srp19	HGNC:11300	OMIM:182175	SRP19	14		
FBgn0035767	Cln7	HGNC:28486	OMIM:611124	MFSD8	14	610951,616170	610951[CEROID LIPOFUSCINOSIS, NEURONAL, 7; CLN7],616170[MACULAR DYSTROPHY WITH CENTRAL CONE INVOLVEMENT; CCMD]
FBgn0035763	mrva	HGNC:25874	OMIM:619976	MFSD1	14		
FBgn0035761	RhoGEF4	HGNC:3663	OMIM:300546	FGD1	3	305400	305400[AARSKOG-SCOTT SYNDROME; AAS]
FBgn0035761	RhoGEF4	HGNC:16027	OMIM:617554	FGD3	5		
FBgn0035761	RhoGEF4	HGNC:19125	OMIM:611104	FGD4	5	609311	609311[CHARCOT-MARIE-TOOTH DISEASE, TYPE 4H; CMT4H]
FBgn0035761	RhoGEF4	HGNC:3664	OMIM:605091	FGD2	4		
FBgn0035761	RhoGEF4	HGNC:25909		ARHGEF39	4		
FBgn0035756	unc-13-4A	HGNC:948	OMIM:604009	BAIAP3	13		
FBgn0035756	unc-13-4A	HGNC:23147	OMIM:608897	UNC13D	7	608898	608898[HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS, FAMILIAL, 3; FHL3]
FBgn0035754	MED4	HGNC:17903	OMIM:605718	MED4	14		
FBgn0012058	Cdc27	HGNC:1728	OMIM:116946	CDC27	14		
FBgn0028648	mRpL50	HGNC:16654	OMIM:611854	MRPL50	12		
FBgn0035753	RpL18	HGNC:10310	OMIM:604179	RPL18	14	618310	618310[DIAMOND-BLACKFAN ANEMIA 18; DBA18]
FBgn0035718	CG14820	HGNC:2300	OMIM:603101	CPB2	7		
FBgn0035718	CG14820	HGNC:21011	OMIM:609563	CPO	8		
FBgn0035718	CG14820	HGNC:2298	OMIM:114851	CPA3	7		
FBgn0035718	CG14820	HGNC:2297	OMIM:600688	CPA2	7		
FBgn0035718	CG14820	HGNC:15740	OMIM:607635	CPA4	7		
FBgn0035718	CG14820	HGNC:2299	OMIM:114852	CPB1	8		
FBgn0035718	CG14820	HGNC:2296	OMIM:114850	CPA1	7		
FBgn0035718	CG14820	HGNC:17245	OMIM:609562	CPA6	7	614417,614418	614417[EPILEPSY, FAMILIAL TEMPORAL LOBE, 5; ETL5],614418[FEBRILE SEIZURES, FAMILIAL, 11; FEB11]
FBgn0035718	CG14820	HGNC:15722	OMIM:609561	CPA5	7		
FBgn0029117	Surf1	HGNC:11474	OMIM:185620	SURF1	13	220110,616684	220110[MITOCHONDRIAL COMPLEX IV DEFICIENCY, NUCLEAR TYPE 1; MC4DN1],616684[CHARCOT-MARIE-TOOTH DISEASE, TYPE 4K; CMT4K]
FBgn0035726	CG9953	HGNC:9480	OMIM:607169	PRSS16	9		
FBgn0035741	BBS1	HGNC:966	OMIM:209901	BBS1	11	209900	209900[BARDET-BIEDL SYNDROME 1; BBS1]
FBgn0035743	Acbp6	HGNC:17715		ACBD7	4		
FBgn0035743	Acbp6	HGNC:2690	OMIM:125950	DBI	3		
FBgn0010387	Acbp2	HGNC:17715		ACBD7	6		
FBgn0010387	Acbp2	HGNC:2690	OMIM:125950	DBI	8		
FBgn0023001	melt	HGNC:25735	OMIM:609594	VEPH1	13		
FBgn0035742	Acbp4	HGNC:17715		ACBD7	5		
FBgn0035742	Acbp4	HGNC:2690	OMIM:125950	DBI	5		
FBgn0002775	msl-3	HGNC:7370	OMIM:300609	MSL3	14	301032	301032[BASILICATA-AKHTAR SYNDROME; MRXSBA]
FBgn0002775	msl-3	HGNC:17837		MSL3P1	5		
FBgn0035733	CG8641	HGNC:18229	OMIM:612842	RASD2	10		
FBgn0035733	CG8641	HGNC:15828	OMIM:605550	RASD1	13		
FBgn0001104	Galphai	HGNC:4387	OMIM:139370	GNAI3	12	602483	602483[AURICULOCONDYLAR SYNDROME 1; ARCND1]
FBgn0001104	Galphai	HGNC:4379	OMIM:139313	GNA11	3	145981,615361	145981[HYPOCALCIURIC HYPERCALCEMIA, FAMILIAL, TYPE II; HHC2],615361[HYPOCALCEMIA, AUTOSOMAL DOMINANT 2; HYPOC2]
FBgn0001104	Galphai	HGNC:4381	OMIM:604406	GNA13	4		
FBgn0001104	Galphai	HGNC:4390	OMIM:600998	GNAQ	4	163000,185300	163000[CAPILLARY MALFORMATIONS, CONGENITAL; CMC],185300[STURGE-WEBER SYNDROME; SWS]
FBgn0001104	Galphai	HGNC:4385	OMIM:139360	GNAI2	11	192605	192605[VENTRICULAR TACHYCARDIA, FAMILIAL]
FBgn0001104	Galphai	HGNC:4394	OMIM:139340	GNAT2	8	613856	613856[ACHROMATOPSIA 4; ACHM4]
FBgn0001104	Galphai	HGNC:4380	OMIM:604394	GNA12	4		
FBgn0001104	Galphai	HGNC:4395	OMIM:139160	GNAZ	5		
FBgn0001104	Galphai	HGNC:4382	OMIM:604397	GNA14	4		
FBgn0001104	Galphai	HGNC:22800	OMIM:139395	GNAT3	8		
FBgn0001104	Galphai	HGNC:4393	OMIM:139330	GNAT1	6	610444,616389	610444[NIGHT BLINDNESS, CONGENITAL STATIONARY, AUTOSOMAL DOMINANT 3; CSNBAD3],616389[NIGHT BLINDNESS, CONGENITAL STATIONARY, TYPE 1G; CSNB1G]
FBgn0001104	Galphai	HGNC:4383	OMIM:139314	GNA15	4		
FBgn0001104	Galphai	HGNC:4392	OMIM:139320	GNAS	3	103580,166350,174800,219080,603233,612462,612463,617686	103580[PSEUDOHYPOPARATHYROIDISM, TYPE IA; PHP1A],166350[OSSEOUS HETEROPLASIA, PROGRESSIVE; POH],174800[MCCUNE-ALBRIGHT SYNDROME; MAS],219080[ACTH-INDEPENDENT MACRONODULAR ADRENAL HYPERPLASIA; AIMAH1],603233[PSEUDOHYPOPARATHYROIDISM, TYPE IB; PHP1B],612462[PSEUDOHYPOPARATHYROIDISM, TYPE IC; PHP1C],612463[PSEUDOPSEUDOHYPOPARATHYROIDISM; PPHP],617686[PITUITARY ADENOMA 3, MULTIPLE TYPES; PITA3]
FBgn0001104	Galphai	HGNC:4384	OMIM:139310	GNAI1	12	619854	619854[NEURODEVELOPMENTAL DISORDER WITH HYPOTONIA, IMPAIRED SPEECH, AND BEHAVIORAL ABNORMALITIES; NEDHISB]
FBgn0001104	Galphai	HGNC:4389	OMIM:139311	GNAO1	5	615473,617493	615473[DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 17; DEE17],617493[NEURODEVELOPMENTAL DISORDER WITH INVOLUNTARY MOVEMENTS; NEDIM]
FBgn0035724	CG10064	HGNC:16053	OMIM:609804	CFAP52	14	619607	619607[HETEROTAXY, VISCERAL, 10, AUTOSOMAL, WITH MALE INFERTILITY; HTX10]
FBgn0035722	CG10075	HGNC:15891	OMIM:611797	UQCC1	14		
FBgn0035720	CG10077	HGNC:2740	OMIM:608469	DDX17	12		
FBgn0035720	CG10077	HGNC:2746	OMIM:180630	DDX5	10		
FBgn0035711	CG8519	HGNC:15980	OMIM:612664	RERG	3		
FBgn0035711	CG8519	HGNC:23804	OMIM:612404	RASL11B	5		
FBgn0035711	CG8519	HGNC:26213		RERGL	3		
FBgn0035711	CG8519	HGNC:23802	OMIM:612403	RASL11A	6		
FBgn0035714	Sbds	HGNC:19440	OMIM:607444	SBDS	14	260400,609135	260400[SHWACHMAN-DIAMOND SYNDROME 1; SDS1],609135[APLASTIC ANEMIA]
FBgn0041194	Prat2	HGNC:9238	OMIM:172450	PPAT	15		
FBgn0052392	Rsph3	HGNC:21054	OMIM:615876	RSPH3	11	616481	616481[CILIARY DYSKINESIA, PRIMARY, 32; CILD32]
FBgn0035715	Ist1	HGNC:28977	OMIM:616434	IST1	14		
FBgn0035713	velo	HGNC:30402	OMIM:612846	SENP7	9		
FBgn0035713	velo	HGNC:20944	OMIM:605003	SENP6	7		
FBgn0005626	ple	HGNC:11782	OMIM:191290	TH	15	605407	605407[SEGAWA SYNDROME, AUTOSOMAL RECESSIVE]
FBgn0035710	SP1173	HGNC:26656		MFSD6L	3		
FBgn0035709	eIF4E4	HGNC:3293	OMIM:605895	EIF4E2	3		
FBgn0035709	eIF4E4	HGNC:3287	OMIM:133440	EIF4E	15	615091	615091[AUTISM, SUSCEPTIBILITY TO, 19; AUTS19]
FBgn0035709	eIF4E4	HGNC:33179		EIF4E1B	13		
FBgn0035709	eIF4E4	HGNC:31837	OMIM:609896	EIF4E3	3		
FBgn0035703	Bulli	HGNC:24326		RMC1	13		
FBgn0020251	sfl	HGNC:7682	OMIM:603950	NDST3	12		
FBgn0020251	sfl	HGNC:7680	OMIM:600853	NDST1	13	616116	616116[INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 46; MRT46]
FBgn0020251	sfl	HGNC:7681	OMIM:603268	NDST2	14		
FBgn0020251	sfl	HGNC:20779	OMIM:615039	NDST4	12		
FBgn0052396	betaTub65B	HGNC:20774	OMIM:602662	TUBB4A	4	128101,612438	128101[DYSTONIA 4, TORSION, AUTOSOMAL DOMINANT; DYT4],612438[LEUKODYSTROPHY, HYPOMYELINATING, 6; HLD6]
FBgn0052396	betaTub65B	HGNC:12412	OMIM:615101	TUBB2A	4	615763	615763[CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 5; CDCBM5]
FBgn0052396	betaTub65B	HGNC:20778	OMIM:191130	TUBB	4	156610,615771	156610[SKIN CREASES, CONGENITAL SYMMETRIC CIRCUMFERENTIAL, 1; CSCSC1],615771[CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 6; CDCBM6]
FBgn0052396	betaTub65B	HGNC:30829	OMIM:612850	TUBB2B	4	610031	610031[CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 7; CDCBM7]
FBgn0052396	betaTub65B	HGNC:20771	OMIM:602660	TUBB4B	5	617879	617879[LEBER CONGENITAL AMAUROSIS WITH EARLY-ONSET DEAFNESS; LCAEOD]
FBgn0052396	betaTub65B	HGNC:20772	OMIM:602661	TUBB3	4	600638,614039	600638[FIBROSIS OF EXTRAOCULAR MUSCLES, CONGENITAL, 3A, WITH OR WITHOUT EXTRAOCULAR INVOLVEMENT; CFEOM3A],614039[CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 1; CDCBM1]
FBgn0052396	betaTub65B	HGNC:16257	OMIM:612901	TUBB1	4	613112	613112[MACROTHROMBOCYTOPENIA, ISOLATED, 1, AUTOSOMAL DOMINANT; MACTHC1]
FBgn0052396	betaTub65B	HGNC:20776	OMIM:615103	TUBB6	4	617732	617732[FACIAL PALSY, CONGENITAL, WITH PTOSIS AND VELOPHARYNGEAL DYSFUNCTION; FPVEPD]
FBgn0052396	betaTub65B	HGNC:20773	OMIM:616768	TUBB8	3	616780	616780[OOCYTE MATURATION DEFECT 2; OOMD2]
FBgn0042185	MCU	HGNC:23526	OMIM:614197	MCU	13		
FBgn0042185	MCU	HGNC:26076		MCUB	5		
FBgn0004619	GluRIA	HGNC:4572	OMIM:138247	GRIA2	12	618917	618917[NEURODEVELOPMENTAL DISORDER WITH LANGUAGE IMPAIRMENT AND BEHAVIORAL ABNORMALITIES; NEDLIB]
FBgn0004619	GluRIA	HGNC:4573	OMIM:305915	GRIA3	14	300699	300699[INTELLECTUAL DEVELOPMENTAL DISORDER, X-LINKED, SYNDROMIC, WU TYPE; MRXSW]
FBgn0004619	GluRIA	HGNC:4581	OMIM:138243	GRIK3	3		
FBgn0004619	GluRIA	HGNC:4571	OMIM:138248	GRIA1	12	619927,619931	619927[INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL DOMINANT 67; MRD67],619931[INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 76; MRT76]
FBgn0004619	GluRIA	HGNC:4583	OMIM:600283	GRIK5	3		
FBgn0004619	GluRIA	HGNC:4579	OMIM:138245	GRIK1	3		
FBgn0004619	GluRIA	HGNC:4574	OMIM:138246	GRIA4	11	617864	617864[NEURODEVELOPMENTAL DISORDER WITH OR WITHOUT SEIZURES AND GAIT ABNORMALITIES; NEDSGA]
FBgn0035704	Vps8	HGNC:29122	OMIM:618366	VPS8	13		
FBgn0035687	Prdm13	HGNC:13998	OMIM:616741	PRDM13	9	619761,619909	619761[CEREBELLAR DYSFUNCTION, IMPAIRED INTELLECTUAL DEVELOPMENT, AND HYPOGONADOTROPIC HYPOGONADISM; CDIDHH],619909[PONTOCEREBELLAR HYPOPLASIA, TYPE 17; PCH17]
FBgn0035689	CG7376	HGNC:19336	OMIM:608048	SHPRH	12		
FBgn0024921	Tnpo	HGNC:6401	OMIM:602901	TNPO1	13		
FBgn0024921	Tnpo	HGNC:19998	OMIM:603002	TNPO2	13	619556	619556[INTELLECTUAL DEVELOPMENTAL DISORDER WITH HYPOTONIA, IMPAIRED SPEECH, AND DYSMORPHIC FACIES; IDDHISD]
FBgn0035693	CG8219	HGNC:6401	OMIM:602901	TNPO1	8		
FBgn0035693	CG8219	HGNC:19998	OMIM:603002	TNPO2	7	619556	619556[INTELLECTUAL DEVELOPMENTAL DISORDER WITH HYPOTONIA, IMPAIRED SPEECH, AND DYSMORPHIC FACIES; IDDHISD]
FBgn0001258	Ldh	HGNC:28335	OMIM:618928	LDHAL6A	11		
FBgn0001258	Ldh	HGNC:6544	OMIM:150150	LDHC	10		
FBgn0001258	Ldh	HGNC:21481		LDHAL6B	9		
FBgn0001258	Ldh	HGNC:6541	OMIM:150100	LDHB	13	614128	614128[LACTATE DEHYDROGENASE B DEFICIENCY; LDHBD]
FBgn0001258	Ldh	HGNC:6535	OMIM:150000	LDHA	13	612933	612933[GLYCOGEN STORAGE DISEASE XI; GSD11]
FBgn0001258	Ldh	HGNC:30866	OMIM:610985	UEVLD	3		
FBgn0035697	CG10163	HGNC:9155	OMIM:246600	PNLIP	3	614338	614338[PANCREATIC LIPASE DEFICIENCY; PNLIPD]
FBgn0035697	CG10163	HGNC:9156	OMIM:604422	PNLIPRP1	3		
FBgn0035697	CG10163	HGNC:23492		PNLIPRP3	3		
FBgn0035697	CG10163	HGNC:18821	OMIM:609252	LIPI	3		
FBgn0035696	Best2	HGNC:17105	OMIM:607337	BEST3	7		
FBgn0035696	Best2	HGNC:12703	OMIM:607854	BEST1	7	153700,193220,611809,613194	153700[MACULAR DYSTROPHY, VITELLIFORM, 2; VMD2],193220[VITREORETINOCHOROIDOPATHY; VRCP],611809[BESTROPHINOPATHY, AUTOSOMAL RECESSIVE; ARB],613194[RETINITIS PIGMENTOSA 50; RP50]
FBgn0035696	Best2	HGNC:17106	OMIM:607336	BEST4	7		
FBgn0035696	Best2	HGNC:17107	OMIM:607335	BEST2	5		
FBgn0004513	Mdr65	HGNC:40	OMIM:171050	ABCB1	8	120080,612244	120080[COLCHICINE RESISTANCE],612244[INFLAMMATORY BOWEL DISEASE 13; IBD13]
FBgn0004513	Mdr65	HGNC:45	OMIM:171060	ABCB4	11	600803,602347,614972	600803[GALLBLADDER DISEASE 1; GBD1],602347[CHOLESTASIS, PROGRESSIVE FAMILIAL INTRAHEPATIC, 3; PFIC3],614972[CHOLESTASIS, INTRAHEPATIC, OF PREGNANCY 3; ICP3]
FBgn0004513	Mdr65	HGNC:42	OMIM:603201	ABCB11	8	601847,605479	601847[CHOLESTASIS, PROGRESSIVE FAMILIAL INTRAHEPATIC, 2; PFIC2],605479[CHOLESTASIS, BENIGN RECURRENT INTRAHEPATIC, 2; BRIC2]
FBgn0004513	Mdr65	HGNC:46	OMIM:611785	ABCB5	8		
FBgn0035695	CG10226	HGNC:40	OMIM:171050	ABCB1	5	120080,612244	120080[COLCHICINE RESISTANCE],612244[INFLAMMATORY BOWEL DISEASE 13; IBD13]
FBgn0035695	CG10226	HGNC:45	OMIM:171060	ABCB4	7	600803,602347,614972	600803[GALLBLADDER DISEASE 1; GBD1],602347[CHOLESTASIS, PROGRESSIVE FAMILIAL INTRAHEPATIC, 3; PFIC3],614972[CHOLESTASIS, INTRAHEPATIC, OF PREGNANCY 3; ICP3]
FBgn0035695	CG10226	HGNC:42	OMIM:603201	ABCB11	7	601847,605479	601847[CHOLESTASIS, PROGRESSIVE FAMILIAL INTRAHEPATIC, 2; PFIC2],605479[CHOLESTASIS, BENIGN RECURRENT INTRAHEPATIC, 2; BRIC2]
FBgn0035695	CG10226	HGNC:46	OMIM:611785	ABCB5	7		
FBgn0002526	LanA	HGNC:6483	OMIM:600805	LAMA3	8	245660,619783,619784	245660[EPIDERMOLYSIS BULLOSA, JUNCTIONAL 2C, LARYNGOONYCHOCUTANEOUS; JEB2C],619783[EPIDERMOLYSIS BULLOSA, JUNCTIONAL 2A, INTERMEDIATE; JEB2A],619784[EPIDERMOLYSIS BULLOSA, JUNCTIONAL 2B, SEVERE; JEB2B]
FBgn0002526	LanA	HGNC:6481	OMIM:150320	LAMA1	4	615960	615960[PORETTI-BOLTSHAUSER SYNDROME; PTBHS]
FBgn0002526	LanA	HGNC:6482	OMIM:156225	LAMA2	4	607855,618138	607855[MUSCULAR DYSTROPHY, CONGENITAL MEROSIN-DEFICIENT, 1A; MDC1A],618138[MUSCULAR DYSTROPHY, LIMB-GIRDLE, AUTOSOMAL RECESSIVE 23; LGMDR23]
FBgn0002526	LanA	HGNC:6484	OMIM:600133	LAMA4	4	615235	615235[CARDIOMYOPATHY, DILATED, 1JJ; CMD1JJ]
FBgn0002526	LanA	HGNC:6485	OMIM:601033	LAMA5	12		
FBgn0035692	Sf3b6	HGNC:30096	OMIM:607835	SF3B6	13		
FBgn0035688	fmt	HGNC:1173	OMIM:610879	PPP6R3	10		
FBgn0035688	fmt	HGNC:19253	OMIM:610877	PPP6R2	10		
FBgn0035688	fmt	HGNC:29195	OMIM:610875	PPP6R1	10		
FBgn0035643	CG13287	HGNC:13993	OMIM:616639	PRDM8	8	616640	616640[EPILEPSY, PROGRESSIVE MYOCLONIC, 10; EPM10]
FBgn0035643	CG13287	HGNC:23535		ZNF488	7		
FBgn0035645	CG5592	HGNC:8494	OMIM:604047	SLC22A13	5		
FBgn0035645	CG5592	HGNC:10970	OMIM:607582	SLC22A6	4		
FBgn0035645	CG5592	HGNC:20302	OMIM:608276	SLC22A16	4		
FBgn0035645	CG5592	HGNC:10968	OMIM:604190	SLC22A4	4	180300	180300[RHEUMATOID ARTHRITIS; RA]
FBgn0035645	CG5592	HGNC:10969	OMIM:603377	SLC22A5	4	212140	212140[CARNITINE DEFICIENCY, SYSTEMIC PRIMARY; CDSP]
FBgn0035645	CG5592	HGNC:8495	OMIM:604048	SLC22A14	5		
FBgn0035645	CG5592	HGNC:10971	OMIM:604995	SLC22A7	5		
FBgn0035645	CG5592	HGNC:10972	OMIM:607581	SLC22A8	4		
FBgn0035645	CG5592	HGNC:10966	OMIM:602608	SLC22A2	4		
FBgn0035645	CG5592	HGNC:21106	OMIM:611697	SLC22A23	3		
FBgn0035645	CG5592	HGNC:32935	OMIM:610792	SLC22A25	4		
FBgn0035645	CG5592	HGNC:10963	OMIM:602607	SLC22A1	4		
FBgn0035645	CG5592	HGNC:10967	OMIM:604842	SLC22A3	4		
FBgn0035645	CG5592	HGNC:23095	OMIM:611461	SLC22A17	3		
FBgn0035645	CG5592	HGNC:20301	OMIM:608275	SLC22A15	3		
FBgn0035645	CG5592	HGNC:17989	OMIM:607096	SLC22A12	4	220150	220150[HYPOURICEMIA, RENAL, 1; RHUC1]
FBgn0035645	CG5592	HGNC:27091		SLC22A31	3		
FBgn0035645	CG5592	HGNC:18120	OMIM:607097	SLC22A11	4		
FBgn0035645	CG5592	HGNC:16261	OMIM:607579	SLC22A9	4		
FBgn0035645	CG5592	HGNC:28542	OMIM:611698	SLC22A24	4		
FBgn0035645	CG5592	HGNC:18057	OMIM:607580	SLC22A10	4		
FBgn0052409	CG32409	HGNC:17083	OMIM:618311	RRS1	13		
FBgn0052407	CG32407	HGNC:28381	OMIM:301086	MOSPD2	9		
FBgn0035675	CG6610	HGNC:17162	OMIM:607285	LSM5	14		
FBgn0035676	ssp6	HGNC:18707	OMIM:612027	GRASP	8		
FBgn0035676	ssp6	HGNC:9506	OMIM:604448	CYTIP	6		
FBgn0035677	CG13293	HGNC:26709	OMIM:619222	SCAI	14		
FBgn0061492	loj	HGNC:28331		TMED6	12		
FBgn0005658	Ets65A	HGNC:3446	OMIM:165080	ERG	8		
FBgn0005658	Ets65A	HGNC:3749	OMIM:193067	FLI1	8	617443	617443[BLEEDING DISORDER, PLATELET-TYPE, 21; BDPLT21]
FBgn0005658	Ets65A	HGNC:18562	OMIM:607150	FEV	6		
FBgn0035679	CG10467	HGNC:24063	OMIM:137030	GALM	14	618881	618881[GALACTOSEMIA IV; GALAC4]
FBgn0035674	CG13295	HGNC:25241		TCAIM	14		
FBgn0035657	alphaKap4	HGNC:6396	OMIM:601892	KPNA3	4		
FBgn0035657	alphaKap4	HGNC:6397	OMIM:602970	KPNA4	4		
FBgn0002638	Rcc1	HGNC:1913	OMIM:179710	RCC1	14		
FBgn0002638	Rcc1	HGNC:17499	OMIM:606051	SERGEF	3		
FBgn0002638	Rcc1	HGNC:4867	OMIM:605109	HERC1	3	617011	617011[MACROCEPHALY, DYSMORPHIC FACIES, AND PSYCHOMOTOR RETARDATION; MDFPMR]
FBgn0002638	Rcc1	HGNC:18243	OMIM:607867	RCBTB1	3	617175	617175[RETINAL DYSTROPHY WITH OR WITHOUT EXTRAOCULAR ANOMALIES; RDEOA]
FBgn0002638	Rcc1	HGNC:10295	OMIM:312610	RPGR	3	300029,300455,300834,304020	300029[RETINITIS PIGMENTOSA 3; RP3],300455[RETINITIS PIGMENTOSA, X-LINKED, AND SINORESPIRATORY INFECTIONS, WITH OR WITHOUT DEAFNESS],300834[MACULAR DEGENERATION, X-LINKED ATROPHIC],304020[CONE-ROD DYSTROPHY, X-LINKED, 1; CORDX1]
FBgn0002638	Rcc1	HGNC:30457	OMIM:617997	RCCD1	3		
FBgn0002638	Rcc1	HGNC:1914	OMIM:603524	RCBTB2	3		
FBgn0035649	CG10483	HGNC:12827	OMIM:605237	XPR1	14	616413	616413[BASAL GANGLIA CALCIFICATION, IDIOPATHIC, 6; IBGC6]
FBgn0035647	CG10486	HGNC:8494	OMIM:604047	SLC22A13	4		
FBgn0035647	CG10486	HGNC:10970	OMIM:607582	SLC22A6	4		
FBgn0035647	CG10486	HGNC:20302	OMIM:608276	SLC22A16	4		
FBgn0035647	CG10486	HGNC:10968	OMIM:604190	SLC22A4	4	180300	180300[RHEUMATOID ARTHRITIS; RA]
FBgn0035647	CG10486	HGNC:10969	OMIM:603377	SLC22A5	4	212140	212140[CARNITINE DEFICIENCY, SYSTEMIC PRIMARY; CDSP]
FBgn0035647	CG10486	HGNC:8495	OMIM:604048	SLC22A14	4		
FBgn0035647	CG10486	HGNC:10971	OMIM:604995	SLC22A7	5		
FBgn0035647	CG10486	HGNC:10972	OMIM:607581	SLC22A8	4		
FBgn0035647	CG10486	HGNC:10966	OMIM:602608	SLC22A2	4		
FBgn0035647	CG10486	HGNC:21106	OMIM:611697	SLC22A23	3		
FBgn0035647	CG10486	HGNC:32935	OMIM:610792	SLC22A25	4		
FBgn0035647	CG10486	HGNC:10963	OMIM:602607	SLC22A1	4		
FBgn0035647	CG10486	HGNC:10967	OMIM:604842	SLC22A3	4		
FBgn0035647	CG10486	HGNC:23095	OMIM:611461	SLC22A17	3		
FBgn0035647	CG10486	HGNC:20301	OMIM:608275	SLC22A15	3		
FBgn0035647	CG10486	HGNC:17989	OMIM:607096	SLC22A12	4	220150	220150[HYPOURICEMIA, RENAL, 1; RHUC1]
FBgn0035647	CG10486	HGNC:27091		SLC22A31	3		
FBgn0035647	CG10486	HGNC:18120	OMIM:607097	SLC22A11	4		
FBgn0035647	CG10486	HGNC:16261	OMIM:607579	SLC22A9	4		
FBgn0035647	CG10486	HGNC:28542	OMIM:611698	SLC22A24	4		
FBgn0035647	CG10486	HGNC:18057	OMIM:607580	SLC22A10	4		
FBgn0052413	CG32413	HGNC:9753	OMIM:607065	QPCT	8		
FBgn0052413	CG32413	HGNC:25952		QPCTL	8		
FBgn0052412	QC	HGNC:9753	OMIM:607065	QPCT	10		
FBgn0052412	QC	HGNC:25952		QPCTL	9		
FBgn0035644	PolE2	HGNC:9178	OMIM:602670	POLE2	14		
FBgn0029121	Sras	HGNC:13721	OMIM:605385	RCE1	14		
FBgn0040239	bc10	HGNC:1055	OMIM:613110	BLCAP	13		
FBgn0035620	Alp9	HGNC:438	OMIM:171760	ALPL	11	146300,241500,241510	146300[HYPOPHOSPHATASIA, ADULT; HPPA],241500[HYPOPHOSPHATASIA, INFANTILE; HPPI],241510[HYPOPHOSPHATASIA, CHILDHOOD; HPPC]
FBgn0035620	Alp9	HGNC:441	OMIM:171810	ALPG	12		
FBgn0035620	Alp9	HGNC:439	OMIM:171800	ALPP	11		
FBgn0035620	Alp9	HGNC:437	OMIM:171740	ALPI	14		
FBgn0035625	Blimp-1	HGNC:9346	OMIM:603423	PRDM1	12		
FBgn0035625	Blimp-1	HGNC:28495	OMIM:616775	ZNF683	5		
FBgn0035626	lin-28	HGNC:32207	OMIM:611044	LIN28B	13		
FBgn0035626	lin-28	HGNC:15986	OMIM:611043	LIN28A	12		
FBgn0016756	Usp47	HGNC:20076	OMIM:614460	USP47	13		
FBgn0035631	Txl	HGNC:12436	OMIM:603049	TXNL1	14		
FBgn0035639	kri	HGNC:12562	OMIM:609329	UCK2	3		
FBgn0035639	kri	HGNC:28334	OMIM:300656	UPRT	15		
FBgn0035639	kri	HGNC:14859	OMIM:609328	UCK1	3		
FBgn0035639	kri	HGNC:15938	OMIM:610866	UCKL1	3		
FBgn0035640	mad2	HGNC:6763	OMIM:601467	MAD2L1	14		
FBgn0035638	Tektin-C	HGNC:26554	OMIM:618686	TEKT5	4		
FBgn0035638	Tektin-C	HGNC:14293	OMIM:612683	TEKT3	4		
FBgn0035638	Tektin-C	HGNC:31012		TEKT4	4		
FBgn0035638	Tektin-C	HGNC:15534	OMIM:609002	TEKT1	12		
FBgn0035636	Cralbp	HGNC:10024	OMIM:180090	RLBP1	4	136880,607475,607476	136880[FUNDUS ALBIPUNCTATUS],607475[BOTHNIA RETINAL DYSTROPHY],607476[NEWFOUNDLAND ROD-CONE DYSTROPHY; NFRCD]
FBgn0035636	Cralbp	HGNC:23046	OMIM:616945	CLVS2	5		
FBgn0035636	Cralbp	HGNC:23139	OMIM:611292	CLVS1	5		
FBgn0040298	Myt1	HGNC:12761	OMIM:193525	WEE1	3		
FBgn0040298	Myt1	HGNC:29650	OMIM:602474	PKMYT1	11		
FBgn0052418	vito	HGNC:28585		NOL12	8		
FBgn0035632	Ppat-Dpck	HGNC:29932	OMIM:609855	COASY	14	615643,618266	615643[NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 6; NBIA6],618266[PONTOCEREBELLAR HYPOPLASIA, TYPE 12; PCH12]
FBgn0035630	CG10576	HGNC:8550	OMIM:602145	PA2G4	13		
FBgn0035627	Sse	HGNC:16856	OMIM:604143	ESPL1	7		
FBgn0035624	Eaf6	HGNC:25674	OMIM:611001	MEAF6	10		
FBgn0035622	TM9SF3	HGNC:21529	OMIM:616872	TM9SF3	14		
FBgn0035619	Alp10	HGNC:438	OMIM:171760	ALPL	10	146300,241500,241510	146300[HYPOPHOSPHATASIA, ADULT; HPPA],241500[HYPOPHOSPHATASIA, INFANTILE; HPPI],241510[HYPOPHOSPHATASIA, CHILDHOOD; HPPC]
FBgn0035619	Alp10	HGNC:441	OMIM:171810	ALPG	10		
FBgn0035619	Alp10	HGNC:439	OMIM:171800	ALPP	10		
FBgn0035619	Alp10	HGNC:437	OMIM:171740	ALPI	10		
FBgn0029118	ScsbetaG	HGNC:11450	OMIM:603922	SUCLG2	15		
FBgn0029118	ScsbetaG	HGNC:11448	OMIM:603921	SUCLA2	4	612073	612073[MITOCHONDRIAL DNA DEPLETION SYNDROME 5 (ENCEPHALOMYOPATHIC WITH OR WITHOUT METHYLMALONIC ACIDURIA); MTDPS5]
FBgn0035600	Cyt-c1	HGNC:2579	OMIM:123980	CYC1	14	615453	615453[MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 6; MC3DN6]
FBgn0035604	Ir64a	HGNC:4572	OMIM:138247	GRIA2	3	618917	618917[NEURODEVELOPMENTAL DISORDER WITH LANGUAGE IMPAIRMENT AND BEHAVIORAL ABNORMALITIES; NEDLIB]
FBgn0035604	Ir64a	HGNC:4573	OMIM:305915	GRIA3	3	300699	300699[INTELLECTUAL DEVELOPMENTAL DISORDER, X-LINKED, SYNDROMIC, WU TYPE; MRXSW]
FBgn0035604	Ir64a	HGNC:4571	OMIM:138248	GRIA1	3	619927,619931	619927[INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL DOMINANT 67; MRD67],619931[INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 76; MRT76]
FBgn0035604	Ir64a	HGNC:4574	OMIM:138246	GRIA4	3	617864	617864[NEURODEVELOPMENTAL DISORDER WITH OR WITHOUT SEIZURES AND GAIT ABNORMALITIES; NEDSGA]
FBgn0035604	Ir64a	HGNC:4575	OMIM:610659	GRID1	3		
FBgn0035603	Pfdn4	HGNC:8868	OMIM:604898	PFDN4	14		
FBgn0035601	Uev1A	HGNC:12495	OMIM:603001	UBE2V2	13		
FBgn0035601	Uev1A	HGNC:12494	OMIM:602995	UBE2V1	8		
FBgn0035601	Uev1A	HGNC:33521		TMEM189-UBE2V1	10		
FBgn0004380	Klp64D	HGNC:6320	OMIM:603754	KIF3B	3	618955	618955[RETINITIS PIGMENTOSA 89; RP89]
FBgn0004380	Klp64D	HGNC:6319	OMIM:604683	KIF3A	14		
FBgn0004380	Klp64D	HGNC:6321	OMIM:602845	KIF3C	4		
FBgn0016031	lama	HGNC:27283		PLBD2	12		
FBgn0016031	lama	HGNC:26215	OMIM:618486	PLBD1	8		
FBgn0035593	Yod1	HGNC:25035	OMIM:612023	YOD1	15		
FBgn0035591	CG4611	HGNC:38844		ATP5MF-PTCD1	5		
FBgn0035591	CG4611	HGNC:22198	OMIM:614774	PTCD1	10		
FBgn0035589	CHMP2B	HGNC:24537	OMIM:609512	CHMP2B	14	600795	600795[FRONTOTEMPORAL DEMENTIA AND/OR AMYOTROPHIC LATERAL SCLEROSIS 7; FTDALS7]
FBgn0035587	Gdap1	HGNC:15968	OMIM:606598	GDAP1	13	214400,607706,607831,608340	214400[CHARCOT-MARIE-TOOTH DISEASE, TYPE 4A; CMT4A],607706[CHARCOT-MARIE-TOOTH DISEASE, AXONAL, WITH VOCAL CORD PARESIS, AUTOSOMAL RECESSIVE],607831[CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2K; CMT2K],608340[CHARCOT-MARIE-TOOTH DISEASE, RECESSIVE INTERMEDIATE A; CMTRIA]
FBgn0035587	Gdap1	HGNC:4213		GDAP1L1	11		
FBgn0028962	AlaRS-m	HGNC:20	OMIM:601065	AARS	6	613287,616339,619661,619691	613287[CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2N; CMT2N],616339[DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 29; DEE29],619661[LEUKOENCEPHALOPATHY, HEREDITARY DIFFUSE, WITH SPHEROIDS 2; HDLS2],619691[TRICHOTHIODYSTROPHY 8, NONPHOTOSENSITIVE; TTD8]
FBgn0028962	AlaRS-m	HGNC:21022	OMIM:612035	AARS2	8	614096,615889	614096[COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 8; COXPD8],615889[LEUKOENCEPHALOPATHY, PROGRESSIVE, WITH OVARIAN FAILURE; LKENP]
FBgn0010747	Srp54k	HGNC:11301	OMIM:604857	SRP54	11	618752	618752[NEUTROPENIA, SEVERE CONGENITAL, 8, AUTOSOMAL DOMINANT; SCN8]
FBgn0035586	Fitm	HGNC:33714	OMIM:612028	FITM1	5		
FBgn0035586	Fitm	HGNC:16135	OMIM:612029	FITM2	11	618635	618635[SIDDIQI SYNDROME; SIDDIS]
FBgn0035588	Dhrs4	HGNC:18349	OMIM:615194	DHRS2	11		
FBgn0035588	Dhrs4	HGNC:16985	OMIM:611596	DHRS4	15		
FBgn0035588	Dhrs4	HGNC:19731	OMIM:615196	DHRS4L2	12		
FBgn0035588	Dhrs4	HGNC:19732	OMIM:615195	DHRS4L1	7		
FBgn0035590	Tcs5	HGNC:16197	OMIM:608679	TP53RK	14	617730	617730[GALLOWAY-MOWAT SYNDROME 4; GAMOS4]
FBgn0035592	CG10674	HGNC:30203	OMIM:618474	WDR83OS	13		
FBgn0031169	CG1494	HGNC:33	OMIM:601615	ABCA3	4	610921	610921[SURFACTANT METABOLISM DYSFUNCTION, PULMONARY, 3; SMDP3]
FBgn0031169	CG1494	HGNC:14637	OMIM:607800	ABCA12	3	242500,601277	242500[ICHTHYOSIS, CONGENITAL, AUTOSOMAL RECESSIVE 4B; ARCI4B],601277[ICHTHYOSIS, CONGENITAL, AUTOSOMAL RECESSIVE 4A; ARCI4A]
FBgn0031169	CG1494	HGNC:39	OMIM:612507	ABCA9	3		
FBgn0031169	CG1494	HGNC:38	OMIM:612505	ABCA8	3		
FBgn0031169	CG1494	HGNC:36	OMIM:612504	ABCA6	3		
FBgn0020369	Rpt6	HGNC:9552	OMIM:601681	PSMC5	15		
FBgn0031174	CG1486	HGNC:28995	OMIM:614244	PDXDC1	9		
FBgn0031174	CG1486	HGNC:0		PDXDC2P-NPIPB14P	4		
FBgn0031174	CG1486	HGNC:0		LOC102724985	7		
FBgn0000709	fliI	HGNC:3750	OMIM:600362	FLII	14		
FBgn0015379	dod	HGNC:8988	OMIM:601052	PIN1	15		
FBgn0011710	Septin1	HGNC:33280	OMIM:612140	SEPTIN14	4		
FBgn0011710	Septin1	HGNC:1717	OMIM:603151	SEPTIN7	4		
FBgn0011710	Septin1	HGNC:9165	OMIM:603696	SEPTIN4	4		
FBgn0011710	Septin1	HGNC:15848	OMIM:300683	SEPTIN6	4		
FBgn0011710	Septin1	HGNC:2879	OMIM:612897	SEPTIN1	4		
FBgn0011710	Septin1	HGNC:25589	OMIM:612887	SEPTIN11	5		
FBgn0011710	Septin1	HGNC:7729	OMIM:601506	SEPTIN2	14		
FBgn0011710	Septin1	HGNC:9164	OMIM:602724	SEPTIN5	4		
FBgn0011710	Septin1	HGNC:16511	OMIM:608418	SEPTIN8	4		
FBgn0011710	Septin1	HGNC:14349	OMIM:611737	SEPTIN10	4		
FBgn0011710	Septin1	HGNC:7323	OMIM:604061	SEPTIN9	4	162100	162100[AMYOTROPHY, HEREDITARY NEURALGIC; HNA]
FBgn0011710	Septin1	HGNC:10750	OMIM:608314	SEPTIN3	4		
FBgn0011710	Septin1	HGNC:26348	OMIM:611562	SEPTIN12	5	614822	614822[SPERMATOGENIC FAILURE 10; SPGF10]
FBgn0003423	slgA	HGNC:9453	OMIM:606810	PRODH	15	239500,600850	239500[HYPERPROLINEMIA, TYPE I; HYRPRO1],600850[SCHIZOPHRENIA 4; SCZD4]
FBgn0003423	slgA	HGNC:17325	OMIM:616377	PRODH2	6		
FBgn0003423	slgA	HGNC:0		LOC102724788	6		
FBgn0020272	mst	HGNC:29678	OMIM:617619	MSTO1	15	617675	617675[MYOPATHY, MITOCHONDRIAL, AND ATAXIA; MMYAT]
FBgn0031182	Cyp6t1	HGNC:2638	OMIM:605325	CYP3A5	4	145500	145500[HYPERTENSION, ESSENTIAL]
FBgn0031182	Cyp6t1	HGNC:17450	OMIM:606534	CYP3A43	4		
FBgn0031182	Cyp6t1	HGNC:11609	OMIM:274180	TBXAS1	3	231095	231095[GHOSAL HEMATODIAPHYSEAL DYSPLASIA; GHDD]
FBgn0031182	Cyp6t1	HGNC:2637	OMIM:124010	CYP3A4	4	619073	619073[VITAMIN D-DEPENDENT RICKETS, TYPE 3; VDDR3]
FBgn0031182	Cyp6t1	HGNC:51504		CYP3A7-CYP3A51P	4		
FBgn0001565	Ddx56	HGNC:18193	OMIM:608023	DDX56	15		
FBgn0015527	peng	HGNC:29676	OMIM:609960	PUM3	13		
FBgn0015558	tty	HGNC:13476	OMIM:605784	TTYH1	12		
FBgn0015558	tty	HGNC:22222	OMIM:608919	TTYH3	13		
FBgn0015558	tty	HGNC:13877	OMIM:608855	TTYH2	12		
FBgn0029067	Dd	HGNC:19085	OMIM:610684	CTDNEP1	13		
FBgn0031171	CG1801	HGNC:37	OMIM:605414	ABCA7	3	608907	608907[ALZHEIMER DISEASE 9, SUSCEPTIBILITY TO; AD9]
FBgn0031171	CG1801	HGNC:32	OMIM:600047	ABCA2	4	618808	618808[INTELLECTUAL DEVELOPMENTAL DISORDER WITH POOR GROWTH AND WITH OR WITHOUT SEIZURES OR ATAXIA; IDPOGSA]
FBgn0031171	CG1801	HGNC:33	OMIM:601615	ABCA3	4	610921	610921[SURFACTANT METABOLISM DYSFUNCTION, PULMONARY, 3; SMDP3]
FBgn0031171	CG1801	HGNC:14637	OMIM:607800	ABCA12	4	242500,601277	242500[ICHTHYOSIS, CONGENITAL, AUTOSOMAL RECESSIVE 4B; ARCI4B],601277[ICHTHYOSIS, CONGENITAL, AUTOSOMAL RECESSIVE 4A; ARCI4A]
FBgn0031171	CG1801	HGNC:30	OMIM:612508	ABCA10	3		
FBgn0031171	CG1801	HGNC:39	OMIM:612507	ABCA9	3		
FBgn0031171	CG1801	HGNC:38	OMIM:612505	ABCA8	3		
FBgn0031171	CG1801	HGNC:36	OMIM:612504	ABCA6	3		
FBgn0031171	CG1801	HGNC:35	OMIM:612503	ABCA5	4	135400	135400[HYPERTRICHOSIS, CONGENITAL GENERALIZED, WITH OR WITHOUT GINGIVAL HYPERPLASIA; HTC3]
FBgn0031171	CG1801	HGNC:14638	OMIM:607807	ABCA13	3		
FBgn0031170	Abca3	HGNC:37	OMIM:605414	ABCA7	3	608907	608907[ALZHEIMER DISEASE 9, SUSCEPTIBILITY TO; AD9]
FBgn0031170	Abca3	HGNC:29	OMIM:600046	ABCA1	4	205400,604091	205400[TANGIER DISEASE; TGD],604091[HYPOALPHALIPOPROTEINEMIA, PRIMARY, 1]
FBgn0031170	Abca3	HGNC:32	OMIM:600047	ABCA2	3	618808	618808[INTELLECTUAL DEVELOPMENTAL DISORDER WITH POOR GROWTH AND WITH OR WITHOUT SEIZURES OR ATAXIA; IDPOGSA]
FBgn0031170	Abca3	HGNC:34	OMIM:601691	ABCA4	3	153800,248200,601718,604116	153800[MACULAR DEGENERATION, AGE-RELATED, 2; ARMD2],248200[STARGARDT DISEASE 1; STGD1],601718[RETINITIS PIGMENTOSA 19; RP19],604116[CONE-ROD DYSTROPHY 3; CORD3]
FBgn0031170	Abca3	HGNC:33	OMIM:601615	ABCA3	13	610921	610921[SURFACTANT METABOLISM DYSFUNCTION, PULMONARY, 3; SMDP3]
FBgn0031170	Abca3	HGNC:14637	OMIM:607800	ABCA12	4	242500,601277	242500[ICHTHYOSIS, CONGENITAL, AUTOSOMAL RECESSIVE 4B; ARCI4B],601277[ICHTHYOSIS, CONGENITAL, AUTOSOMAL RECESSIVE 4A; ARCI4A]
FBgn0031170	Abca3	HGNC:30	OMIM:612508	ABCA10	3		
FBgn0031170	Abca3	HGNC:39	OMIM:612507	ABCA9	4		
FBgn0031170	Abca3	HGNC:38	OMIM:612505	ABCA8	4		
FBgn0031170	Abca3	HGNC:36	OMIM:612504	ABCA6	4		
FBgn0031170	Abca3	HGNC:35	OMIM:612503	ABCA5	3	135400	135400[HYPERTRICHOSIS, CONGENITAL GENERALIZED, WITH OR WITHOUT GINGIVAL HYPERPLASIA; HTC3]
FBgn0031170	Abca3	HGNC:14638	OMIM:607807	ABCA13	3		
FBgn0031145	Ntf-2	HGNC:13722	OMIM:605813	NUTF2	15		
FBgn0025814	Mgstl	HGNC:7061	OMIM:138330	MGST1	12		
FBgn0025814	Mgstl	HGNC:9599	OMIM:605172	PTGES	7		
FBgn0031148	Cbs	HGNC:1550	OMIM:613381	CBS	11	236200	236200[HOMOCYSTINURIA DUE TO CYSTATHIONINE BETA-SYNTHASE DEFICIENCY]
FBgn0031148	Cbs	HGNC:0		CBSL	10		
FBgn0031150	bves	HGNC:1152	OMIM:604577	BVES	10	616812	616812[MUSCULAR DYSTROPHY, LIMB-GIRDLE, AUTOSOMAL RECESSIVE 25; LGMDR25]
FBgn0031150	bves	HGNC:17648	OMIM:605823	POPDC2	6		
FBgn0031150	bves	HGNC:17649	OMIM:605824	POPDC3	6	618848	618848[MUSCULAR DYSTROPHY, LIMB-GIRDLE, AUTOSOMAL RECESSIVE 26; LGMDR26]
FBgn0031161	CG15445	HGNC:17623	OMIM:607981	NUB1	13		
FBgn0031164	CG1724	HGNC:17315	OMIM:605057	TIMM17A	10		
FBgn0031164	CG1724	HGNC:17310	OMIM:300249	TIMM17B	11		
FBgn0031157	CG1503	HGNC:22992	OMIM:608659	SENP8	7		
FBgn0052512	CG32512	HGNC:29631	OMIM:613771	TMEM205	8		
FBgn0031149	Stt3A	HGNC:6172	OMIM:601134	STT3A	15	615596,619714	615596[CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Iw, AUTOSOMAL RECESSIVE; CDG1WAR],619714[CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Iw, AUTOSOMAL DOMINANT; CDG1WAD]
FBgn0031149	Stt3A	HGNC:30611	OMIM:608605	STT3B	5	615597	615597[CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Ix; CDG1X]
FBgn0031143	CG1532	HGNC:14111		GLOD4	12		
FBgn0031132	CG15450	HGNC:28157	OMIM:610958	GPAT3	8		
FBgn0031132	CG15450	HGNC:20880	OMIM:608143	GPAT4	8		
FBgn0027334	l(1)G0004	HGNC:32790	OMIM:618710	PNO1	14		
FBgn0031107	HERC2	HGNC:4868	OMIM:605837	HERC2	13	227220,615516	227220[SKIN/HAIR/EYE PIGMENTATION, VARIATION IN, 1; SHEP1],615516[INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 38; MRT38]
FBgn0031114	cactin	HGNC:29938	OMIM:618536	CACTIN	14		
FBgn0002641	mal	HGNC:18234	OMIM:613274	MOCOS	15	603592	603592[XANTHINURIA, TYPE II; XAN2]
FBgn0031116	CG1695	HGNC:29410	OMIM:611417	SGSM1	13		
FBgn0031116	CG1695	HGNC:29026	OMIM:611418	SGSM2	12		
FBgn0052506	tbc	HGNC:29410	OMIM:611417	SGSM1	14		
FBgn0052506	tbc	HGNC:29026	OMIM:611418	SGSM2	11		
FBgn0031117	GstT3	HGNC:4641	OMIM:600436	GSTT1	9		
FBgn0031117	GstT3	HGNC:4642	OMIM:600437	GSTT2	11		
FBgn0031117	GstT3	HGNC:33437		GSTT2B	7		
FBgn0031117	GstT3	HGNC:26930		GSTT4	4		
FBgn0031119	CG1812	HGNC:29347	OMIM:300980	KLHL15	3	300982	300982[INTELLECTUAL DEVELOPMENTAL DISORDER, X-LINKED 103; XLID103]
FBgn0031119	CG1812	HGNC:25623		KLHL26	5		
FBgn0031119	CG1812	HGNC:18732	OMIM:611201	KLHL9	4		
FBgn0031119	CG1812	HGNC:29266	OMIM:613772	KLHL14	3		
FBgn0031119	CG1812	HGNC:17844		KLHL36	4		
FBgn0031119	CG1812	HGNC:22931	OMIM:300655	KLHL13	4		
FBgn0031119	CG1812	HGNC:21221		KLHL32	4		
FBgn0031119	CG1812	HGNC:21353	OMIM:610749	KLHL31	4		
FBgn0031119	CG1812	HGNC:26634		KLHL34	3		
FBgn0031119	CG1812	HGNC:25888	OMIM:618020	KLHL22	6		
FBgn0026323	Tak1	HGNC:6859	OMIM:602614	MAP3K7	9	157800,617137	157800[CARDIOSPONDYLOCARPOFACIAL SYNDROME; CSCF],617137[FRONTOMETAPHYSEAL DYSPLASIA 2; FMD2]
FBgn0031118	RhoGAP19D	HGNC:23725	OMIM:609870	ARHGAP21	7		
FBgn0031118	RhoGAP19D	HGNC:29293	OMIM:610590	ARHGAP23	8		
FBgn0040650	CG15456	HGNC:28230	OMIM:611802	MIEN1	13		
FBgn0023177	Pp4-19C	HGNC:9323	OMIM:612725	PPP6C	3		
FBgn0023177	Pp4-19C	HGNC:9299	OMIM:176915	PPP2CA	3	618354	618354[NEURODEVELOPMENTAL DISORDER AND LANGUAGE DELAY WITH OR WITHOUT STRUCTURAL BRAIN ABNORMALITIES; NEDLBA]
FBgn0023177	Pp4-19C	HGNC:9300	OMIM:176916	PPP2CB	3		
FBgn0023177	Pp4-19C	HGNC:9319	OMIM:602035	PPP4C	15		
FBgn0031108	CG15459	HGNC:30889	OMIM:615204	ATP5MD	4	618683	618683[MITOCHONDRIAL COMPLEX V (ATP SYNTHASE) DEFICIENCY, NUCLEAR TYPE 6; MC5DN6]
FBgn0031106	Syx16	HGNC:11431	OMIM:603666	STX16	13	603233	603233[PSEUDOHYPOPARATHYROIDISM, TYPE IB; PHP1B]
FBgn0031106	Syx16	HGNC:41993		STX16-NPEPL1	3		
FBgn0031183	CG14621	HGNC:20803		SLC35E1	14		
FBgn0014395	tilB	HGNC:16725	OMIM:614930	LRRC6	14	614935	614935[CILIARY DYSKINESIA, PRIMARY, 19; CILD19]
FBgn0031187	Usp2	HGNC:12631	OMIM:603158	USP8	4	219090	219090[PITUITARY ADENOMA 4, ACTH-SECRETING; PITA4]
FBgn0031187	Usp2	HGNC:12620	OMIM:604729	USP21	6		
FBgn0031187	Usp2	HGNC:12618	OMIM:604725	USP2	9		
FBgn0031189	CG14618	HGNC:28403	OMIM:616013	TRMT10A	13	616033	616033[MICROCEPHALY, SHORT STATURE, AND IMPAIRED GLUCOSE METABOLISM 1; MSSGM1]
FBgn0031189	CG14618	HGNC:26454		TRMT10B	4		
FBgn0027279	l(1)G0196	HGNC:29035	OMIM:611648	PPIP5K2	13	618422	618422[DEAFNESS, AUTOSOMAL RECESSIVE 100; DFNB100]
FBgn0027279	l(1)G0196	HGNC:29023	OMIM:610979	PPIP5K1	11		
FBgn0031188	CG14613	HGNC:28346	OMIM:617975	FAM210A	10		
FBgn0031184	CG14615	HGNC:21349	OMIM:614763	GLYATL3	4		
FBgn0031184	CG14615	HGNC:30519	OMIM:614761	GLYATL1	3		
FBgn0031184	CG14615	HGNC:24178	OMIM:614762	GLYATL2	3		
FBgn0031184	CG14615	HGNC:13734	OMIM:607424	GLYAT	3		
FBgn0031184	CG14615	HGNC:37865		GLYATL1B	3		
FBgn0031628	CG3294	HGNC:12453	OMIM:191317	U2AF1	3		
FBgn0031628	CG3294	HGNC:23019	OMIM:300028	ZRSR2	12		
FBgn0031628	CG3294	HGNC:23020	OMIM:601080	U2AF1L4	3		
FBgn0031628	CG3294	HGNC:12456	OMIM:601079	ZRSR2P1	6		
FBgn0031630	CG15629	HGNC:18685	OMIM:612127	HSD17B13	6		
FBgn0031630	CG15629	HGNC:17693	OMIM:612830	DHRS3	6		
FBgn0031630	CG15629	HGNC:30311	OMIM:608989	SDR16C5	9		
FBgn0031630	CG15629	HGNC:22960	OMIM:612831	HSD17B11	7		
FBgn0031630	CG15629	HGNC:19975	OMIM:607599	RDH10	9		
FBgn0031632	CG15628	HGNC:21349	OMIM:614763	GLYATL3	3		
FBgn0031636	CG12194	HGNC:25874	OMIM:619976	MFSD1	14		
FBgn0031640	Mon1	HGNC:25020	OMIM:608954	MON1B	10		
FBgn0031640	Mon1	HGNC:28207	OMIM:611464	MON1A	13		
FBgn0051660	smog	HGNC:31371	OMIM:614515	GPR179	4	614565	614565[NIGHT BLINDNESS, CONGENITAL STATIONARY, TYPE 1E; CSNB1E]
FBgn0051660	smog	HGNC:23689	OMIM:614573	GPR158	7		
FBgn0031643	CG3008	HGNC:11451	OMIM:603579	RIOK3	15		
FBgn0031639	mRpS2	HGNC:14495	OMIM:611971	MRPS2	14	617950	617950[COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 36; COXPD36]
FBgn0031635	tank	HGNC:13276	OMIM:605170	EI24	12		
FBgn0031634	Ir25a	HGNC:4580	OMIM:138244	GRIK2	3	611092,619580	611092[INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 6; MRT6],619580[NEURODEVELOPMENTAL DISORDER WITH IMPAIRED LANGUAGE AND ATAXIA AND WITH OR WITHOUT SEIZURES; NEDLAS]
FBgn0031634	Ir25a	HGNC:4581	OMIM:138243	GRIK3	3		
FBgn0031634	Ir25a	HGNC:4583	OMIM:600283	GRIK5	3		
FBgn0031634	Ir25a	HGNC:4579	OMIM:138245	GRIK1	3		
FBgn0031634	Ir25a	HGNC:4582	OMIM:600282	GRIK4	3		
FBgn0031634	Ir25a	HGNC:4576	OMIM:602368	GRID2	4	616204	616204[SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 18; SCAR18]
FBgn0031634	Ir25a	HGNC:4575	OMIM:610659	GRID1	3		
FBgn0031633	Fnta	HGNC:3782	OMIM:134635	FNTA	12		
FBgn0031631	CG3225	HGNC:17211	OMIM:605584	DHX38	3	618220	618220[RETINITIS PIGMENTOSA 84; RP84]
FBgn0031631	CG3225	HGNC:2738	OMIM:603403	DHX15	3		
FBgn0031631	CG3225	HGNC:2739	OMIM:603405	DHX16	3	618733	618733[NEUROMUSCULAR OCULOAUDITORY SYNDROME; NMOAS]
FBgn0031631	CG3225	HGNC:15861		DHX35	15		
FBgn0031631	CG3225	HGNC:16718	OMIM:614405	DHX33	3		
FBgn0031631	CG3225	HGNC:2749	OMIM:600396	DHX8	3		
FBgn0031631	CG3225	HGNC:18018	OMIM:607570	DHX40	3		
FBgn0031631	CG3225	HGNC:16717	OMIM:607960	DHX32	3		
FBgn0031631	CG3225	HGNC:20410		DQX1	3		
FBgn0031627	fipi	HGNC:7657	OMIM:602040	NCAM2	4		
FBgn0031627	fipi	HGNC:7656	OMIM:116930	NCAM1	4		
FBgn0031622	CG3251	HGNC:25402	OMIM:300713	OTUD5	3	301056	301056[MULTIPLE CONGENITAL ANOMALIES-NEURODEVELOPMENTAL SYNDROME, X-LINKED; MCAND]
FBgn0031622	CG3251	HGNC:24949	OMIM:611744	OTUD4	7		
FBgn0031622	CG3251	HGNC:30881	OMIM:300776	ALG13	5	300884	300884[DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 36; DEE36]
FBgn0031622	CG3251	HGNC:27346	OMIM:612022	OTUD1	4		
FBgn0028482	bdl	HGNC:32326	OMIM:613773	IGSF9B	5		
FBgn0028482	bdl	HGNC:18132	OMIM:609738	IGSF9	6		
FBgn0020762	Atet	HGNC:73	OMIM:603076	ABCG1	10		
FBgn0020762	Atet	HGNC:13884	OMIM:607784	ABCG4	12		
FBgn0031596	CG15429	HGNC:26516		CYB5D1	13		
FBgn0026319	Traf4	HGNC:12034	OMIM:602464	TRAF4	14		
FBgn0026319	Traf4	HGNC:12032	OMIM:601895	TRAF2	3		
FBgn0026319	Traf4	HGNC:12033	OMIM:601896	TRAF3	3	614849	614849[ENCEPHALOPATHY, ACUTE, INFECTION-INDUCED (HERPES-SPECIFIC), SUSCEPTIBILITY TO, 5; IIAE5]
FBgn0026319	Traf4	HGNC:12031	OMIM:601711	TRAF1	3		
FBgn0022153	l(2)k05819	HGNC:28983	OMIM:618163	TMEM94	14	618316	618316[INTELLECTUAL DEVELOPMENTAL DISORDER WITH CARDIAC DEFECTS AND DYSMORPHIC FACIES; IDDCDF]
FBgn0031601	Dim1	HGNC:30551	OMIM:611595	TXNL4A	14	608572	608572[BURN-MCKEOWN SYNDROME; BMKS]
FBgn0031603	CG15432	HGNC:24563	OMIM:614554	FAM32A	12		
FBgn0031604	Elp3	HGNC:20696	OMIM:612722	ELP3	14		
FBgn0040705	ND-B8	HGNC:7685	OMIM:602137	NDUFA2	15	618235	618235[MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 13; MC1DN13]
FBgn0031611	FIG4	HGNC:16873	OMIM:609390	FIG4	14	216340,611228,612577,612691	216340[YUNIS-VARON SYNDROME; YVS],611228[CHARCOT-MARIE-TOOTH DISEASE, TYPE 4J; CMT4J],612577[AMYOTROPHIC LATERAL SCLEROSIS 11; ALS11],612691[POLYMICROGYRIA, BILATERAL TEMPOROOCCIPITAL; BTOP]
FBgn0031613	HP6	HGNC:1555	OMIM:604478	CBX5	5		
FBgn0031613	HP6	HGNC:1551	OMIM:604511	CBX1	5		
FBgn0031613	HP6	HGNC:1553	OMIM:604477	CBX3	5		
FBgn0011603	ine	HGNC:11049	OMIM:126455	SLC6A3	3	188890,613135	188890[TOBACCO ADDICTION, SUSCEPTIBILITY TO],613135[PARKINSONISM-DYSTONIA 1, INFANTILE-ONSET; PKDYS1]
FBgn0011603	ine	HGNC:11044	OMIM:607952	SLC6A11	3		
FBgn0011603	ine	HGNC:31399	OMIM:610299	SLC6A17	3	616269	616269[INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 48; MRT48]
FBgn0011603	ine	HGNC:11045	OMIM:603080	SLC6A12	3		
FBgn0011603	ine	HGNC:11054	OMIM:606205	SLC6A7	3		
FBgn0011603	ine	HGNC:11048	OMIM:163970	SLC6A2	3	604715	604715[ORTHOSTATIC INTOLERANCE]
FBgn0011603	ine	HGNC:13621	OMIM:607971	SLC6A15	3		
FBgn0011603	ine	HGNC:11050	OMIM:182138	SLC6A4	3	164230,607834	164230[OBSESSIVE-COMPULSIVE DISORDER; OCD],607834[ANXIETY]
FBgn0011603	ine	HGNC:11055	OMIM:300036	SLC6A8	4	300352	300352[CEREBRAL CREATINE DEFICIENCY SYNDROME 1; CCDS1]
FBgn0011603	ine	HGNC:11056	OMIM:601019	SLC6A9	3	617301	617301[GLYCINE ENCEPHALOPATHY WITH NORMAL SERUM GLYCINE]
FBgn0011603	ine	HGNC:11051	OMIM:604159	SLC6A5	3	614618	614618[HYPEREKPLEXIA 3; HKPX3]
FBgn0011603	ine	HGNC:11047	OMIM:300444	SLC6A14	3		
FBgn0011603	ine	HGNC:11052	OMIM:186854	SLC6A6	4	145350	145350[HYPOTAURINEMIC RETINAL DEGENERATION AND CARDIOMYOPATHY; HTRDC]
FBgn0011603	ine	HGNC:11046	OMIM:615097	SLC6A13	4		
FBgn0011603	ine	HGNC:11042	OMIM:137165	SLC6A1	3	616421	616421[MYOCLONIC-ATONIC EPILEPSY; MAE]
FBgn0011603	ine	HGNC:13622	OMIM:607972	SLC6A16	3		
FBgn0031609	CG15443	HGNC:28814		TMCO6	4		
FBgn0053002	mRpL27	HGNC:14483	OMIM:611837	MRPL27	12		
FBgn0019982	Gs1l	HGNC:16818	OMIM:306480	PUDP	14		
FBgn0031607	Secp43	HGNC:30813	OMIM:619597	TRNAU1AP	13		
FBgn0031606	CG15439	HGNC:22203	OMIM:619907	PHF14	13		
FBgn0025684	MFS18	HGNC:16192	OMIM:612107	SLC17A9	15	616063	616063[POROKERATOSIS 8, DISSEMINATED SUPERFICIAL ACTINIC TYPE; POROK8]
FBgn0027609	morgue	HGNC:21647		UBE2D4	3		
FBgn0031600	CG3652	HGNC:28304	OMIM:300996	YIPF6	15		
FBgn0031598	Vps53	HGNC:25608	OMIM:615850	VPS53	14	615851	615851[PONTOCEREBELLAR HYPOPLASIA, TYPE 2E; PCH2E]
FBgn0031585	CG2955	HGNC:6892	OMIM:605788	MAPRE3	5		
FBgn0031585	CG2955	HGNC:6891	OMIM:605789	MAPRE2	4	616734	616734[SKIN CREASES, CONGENITAL SYMMETRIC CIRCUMFERENTIAL, 2; CSCSC2]
FBgn0031585	CG2955	HGNC:6890	OMIM:603108	MAPRE1	4		
FBgn0040102	lectin-24Db	HGNC:24591	OMIM:616256	CLEC4G	4		
FBgn0040102	lectin-24Db	HGNC:742	OMIM:108360	ASGR1	3		
FBgn0040102	lectin-24Db	HGNC:743	OMIM:108361	ASGR2	3		
FBgn0040102	lectin-24Db	HGNC:16916	OMIM:605999	CLEC10A	3		
FBgn0003941	RpL40	HGNC:12458	OMIM:191321	UBA52	14		
FBgn0031592	Art2	HGNC:5188	OMIM:610086	PRMT8	4		
FBgn0031592	Art2	HGNC:5187	OMIM:602950	PRMT1	5		
FBgn0031590	CG3702	HGNC:2087	OMIM:604783	CLPTM1	13		
FBgn0031590	CG3702	HGNC:24308	OMIM:612585	CLPTM1L	3		
FBgn0001075	ft	HGNC:23109	OMIM:612411	FAT4	13	615546,616006	615546[VAN MALDERGEM SYNDROME 2; VMLDS2],616006[HENNEKAM LYMPHANGIECTASIA-LYMPHEDEMA SYNDROME 2; HKLLS2]
FBgn0001075	ft	HGNC:23111	OMIM:612486	DCHS2	3		
FBgn0031589	Naprt	HGNC:30450	OMIM:611552	NAPRT	13		
FBgn0031568	CG10019	HGNC:17027	OMIM:607550	SLC16A10	3		
FBgn0031568	CG10019	HGNC:10923	OMIM:300095	SLC16A2	3	300523	300523[ALLAN-HERNDON-DUDLEY SYNDROME; AHDS]
FBgn0031568	CG10019	HGNC:10924	OMIM:603877	SLC16A3	3		
FBgn0031568	CG10019	HGNC:16270	OMIM:610409	SLC16A8	3		
FBgn0031568	CG10019	HGNC:26417		SLC16A14	4		
FBgn0031568	CG10019	HGNC:23520	OMIM:614242	SLC16A9	3		
FBgn0031568	CG10019	HGNC:10922	OMIM:600682	SLC16A1	3	245340,610021,616095	245340[ERYTHROCYTE LACTATE TRANSPORTER DEFECT],610021[HYPERINSULINEMIC HYPOGLYCEMIA, FAMILIAL, 7; HHF7],616095[MONOCARBOXYLATE TRANSPORTER 1 DEFICIENCY; MCT1D]
FBgn0031568	CG10019	HGNC:31037		SLC16A13	3		
FBgn0031568	CG10019	HGNC:10926	OMIM:603879	SLC16A5	3		
FBgn0031568	CG10019	HGNC:10928	OMIM:603654	SLC16A7	3		
FBgn0031568	CG10019	HGNC:23094	OMIM:611910	SLC16A12	3	612018	612018[CATARACT 47; CTRCT47]
FBgn0004893	bowl	HGNC:8111	OMIM:608891	OSR1	4		
FBgn0004893	bowl	HGNC:15830	OMIM:611297	OSR2	6		
FBgn0051960	CG31960	HGNC:1445	OMIM:114182	CALM2	3	616249	616249[LONG QT SYNDROME 15; LQT15]
FBgn0051960	CG31960	HGNC:1442	OMIM:114180	CALM1	4	614916,616247	614916[VENTRICULAR TACHYCARDIA, CATECHOLAMINERGIC POLYMORPHIC, 4; CPVT4],616247[LONG QT SYNDROME 14; LQT14]
FBgn0051960	CG31960	HGNC:1449	OMIM:114183	CALM3	3	618782	618782[LONG QT SYNDROME 16; LQT16]
FBgn0051960	CG31960	HGNC:18180	OMIM:605183	CALML5	4		
FBgn0003430	slp1	HGNC:3735	OMIM:602939	FOXS1	3		
FBgn0003430	slp1	HGNC:3811	OMIM:164874	FOXG1	6	613454	613454[RETT SYNDROME, CONGENITAL VARIANT]
FBgn0003430	slp1	HGNC:6036	OMIM:147685	FOXK2	4		
FBgn0003430	slp1	HGNC:3817	OMIM:603252	FOXL1	4		
FBgn0003430	slp1	HGNC:3804	OMIM:611539	FOXD3	3	607836	607836[AUTOIMMUNE DISEASE, SUSCEPTIBILITY TO, 1; AIS1]
FBgn0003430	slp1	HGNC:3805	OMIM:601092	FOXD4	3		
FBgn0003430	slp1	HGNC:23480	OMIM:616302	FOXK1	3		
FBgn0003430	slp1	HGNC:3800	OMIM:601090	FOXC1	3	601631,602482	601631[ANTERIOR SEGMENT DYSGENESIS 3; ASGD3],602482[AXENFELD-RIEGER SYNDROME, TYPE 3; RIEG3]
FBgn0003430	slp1	HGNC:3815	OMIM:601093	FOXI1	3	600791	600791[DEAFNESS, AUTOSOMAL RECESSIVE 4, WITH ENLARGED VESTIBULAR AQUEDUCT; DFNB4]
FBgn0003430	slp1	HGNC:32448	OMIM:617202	FOXI2	3		
FBgn0003430	slp1	HGNC:3816	OMIM:602291	FOXJ1	3	618699	618699[CILIARY DYSKINESIA, PRIMARY, 43; CILD43]
FBgn0003430	slp1	HGNC:20951	OMIM:612788	FOXQ1	3		
FBgn0003430	slp1	HGNC:35123	OMIM:612351	FOXI3	3		
FBgn0004567	slp2	HGNC:3811	OMIM:164874	FOXG1	9	613454	613454[RETT SYNDROME, CONGENITAL VARIANT]
FBgn0004567	slp2	HGNC:3817	OMIM:603252	FOXL1	3		
FBgn0004567	slp2	HGNC:3804	OMIM:611539	FOXD3	3	607836	607836[AUTOIMMUNE DISEASE, SUSCEPTIBILITY TO, 1; AIS1]
FBgn0004567	slp2	HGNC:3805	OMIM:601092	FOXD4	3		
FBgn0004567	slp2	HGNC:23480	OMIM:616302	FOXK1	3		
FBgn0004567	slp2	HGNC:3816	OMIM:602291	FOXJ1	3	618699	618699[CILIARY DYSKINESIA, PRIMARY, 43; CILD43]
FBgn0031574	TTLL4B	HGNC:19963	OMIM:612268	TTLL5	3	615860	615860[CONE-ROD DYSTROPHY 19; CORD19]
FBgn0031574	TTLL4B	HGNC:28976	OMIM:618738	TTLL4	11		
FBgn0051773	CG31773	HGNC:3824	OMIM:136510	FPGS	8		
FBgn0000256	capu	HGNC:14074	OMIM:606373	FMN2	8	616193	616193[INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 47; MRT47]
FBgn0000256	capu	HGNC:3768	OMIM:136535	FMN1	4		
FBgn0051957	CG31957	HGNC:28147	OMIM:618473	EIF1AD	13		
FBgn0031533	CG2772	HGNC:6617	OMIM:613497	LIPA	8	278000	278000[LYSOSOMAL ACID LIPASE DEFICIENCY]
FBgn0031533	CG2772	HGNC:23444	OMIM:613922	LIPK	8		
FBgn0031533	CG2772	HGNC:23455	OMIM:613923	LIPM	8		
FBgn0031533	CG2772	HGNC:6622	OMIM:601980	LIPF	8		
FBgn0031533	CG2772	HGNC:21773	OMIM:613921	LIPJ	7		
FBgn0031533	CG2772	HGNC:23452	OMIM:613924	LIPN	8	613943	613943[ICHTHYOSIS, CONGENITAL, AUTOSOMAL RECESSIVE 8; ARCI8]
FBgn0031534	Snx1	HGNC:11172	OMIM:601272	SNX1	11		
FBgn0031534	Snx1	HGNC:11173	OMIM:605929	SNX2	13		
FBgn0031534	Snx1	HGNC:23685		SNX30	3		
FBgn0031535	CG12795	HGNC:28073	OMIM:610699	ZFAND2A	10		
FBgn0031535	CG12795	HGNC:25206	OMIM:613474	ZFAND2B	13		
FBgn0031535	CG12795	HGNC:25858		ZFAND1	3		
FBgn0021967	ND-PDSW	HGNC:7696	OMIM:603843	NDUFB10	15	619003	619003[MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 35; MC1DN35]
FBgn0051776	CG31776	HGNC:33844	OMIM:615138	GALNTL6	6		
FBgn0051776	CG31776	HGNC:19873	OMIM:608043	GALNT10	5		
FBgn0051956	Pgant4	HGNC:33844	OMIM:615138	GALNTL6	11		
FBgn0051956	Pgant4	HGNC:19873	OMIM:608043	GALNT10	10		
FBgn0051956	Pgant4	HGNC:23242	OMIM:608369	GALNT13	3		
FBgn0031544	CG17593	HGNC:24856	OMIM:618260	CCDC47	14	618268	618268[TRICHOHEPATONEURODEVELOPMENTAL SYNDROME; THNS]
FBgn0031546	CG8851	HGNC:8114	OMIM:602015	ODF2	3		
FBgn0031550	IFT57	HGNC:17367	OMIM:606621	IFT57	14	617927	617927[OROFACIODIGITAL SYNDROME XVIII; OFD18]
FBgn0015663	Ugt36A1	HGNC:12531	OMIM:606435	UGT1A10	3		
FBgn0015663	Ugt36A1	HGNC:12545	OMIM:603064	UGT2B11	5		
FBgn0015663	Ugt36A1	HGNC:12530	OMIM:191740	UGT1A1	5	143500,218800,237900,601816,606785	143500[GILBERT SYNDROME],218800[CRIGLER-NAJJAR SYNDROME, TYPE I],237900[HYPERBILIRUBINEMIA, TRANSIENT FAMILIAL NEONATAL; HBLRTFN],601816[BILIRUBIN, SERUM LEVEL OF, QUANTITATIVE TRAIT LOCUS 1; BILIQTL1],606785[CRIGLER-NAJJAR SYNDROME, TYPE II]
FBgn0015663	Ugt36A1	HGNC:12555	OMIM:601291	UGT8	5		
FBgn0015663	Ugt36A1	HGNC:12539	OMIM:606432	UGT1A7	3		
FBgn0015663	Ugt36A1	HGNC:13479	OMIM:606497	UGT2B28	5		
FBgn0015663	Ugt36A1	HGNC:27266	OMIM:616384	UGT3A2	4		
FBgn0015663	Ugt36A1	HGNC:12544	OMIM:600070	UGT2B10	5		
FBgn0015663	Ugt36A1	HGNC:12537	OMIM:606430	UGT1A5	3		
FBgn0015663	Ugt36A1	HGNC:12546	OMIM:600069	UGT2B15	5		
FBgn0015663	Ugt36A1	HGNC:12541	OMIM:606434	UGT1A9	3		
FBgn0015663	Ugt36A1	HGNC:28528	OMIM:616382	UGT2A3	5		
FBgn0015663	Ugt36A1	HGNC:12535	OMIM:606428	UGT1A3	5		
FBgn0015663	Ugt36A1	HGNC:12536	OMIM:606429	UGT1A4	3		
FBgn0015663	Ugt36A1	HGNC:12540	OMIM:606433	UGT1A8	3		
FBgn0015663	Ugt36A1	HGNC:26625	OMIM:616383	UGT3A1	4		
FBgn0015663	Ugt36A1	HGNC:12547	OMIM:601903	UGT2B17	5	612560	612560[BONE MINERAL DENSITY QUANTITATIVE TRAIT LOCUS 12; BMND12]
FBgn0015663	Ugt36A1	HGNC:12553	OMIM:600067	UGT2B4	5		
FBgn0015663	Ugt36A1	HGNC:12538	OMIM:606431	UGT1A6	3		
FBgn0015663	Ugt36A1	HGNC:12554	OMIM:600068	UGT2B7	5		
FBgn0015663	Ugt36A1	HGNC:28183	OMIM:619809	UGT2A2	4		
FBgn0031564	CG2816	HGNC:11248	OMIM:613941	SPINT3	4		
FBgn0031564	CG2816	HGNC:38825		EPPIN-WFDC6	3		
FBgn0031566	CG2818	HGNC:26957	OMIM:614124	GPCPD1	15		
FBgn0040104	lectin-24A	HGNC:10799	OMIM:178642	SFTPA2	3	178500	178500[INTERSTITIAL LUNG DISEASE 2; ILD2]
FBgn0040104	lectin-24A	HGNC:17213	OMIM:612502	COLEC11	3	265050	265050[3MC SYNDROME 2; 3MC2]
FBgn0040104	lectin-24A	HGNC:10798	OMIM:178630	SFTPA1	3	619611	619611[INTERSTITIAL LUNG DISEASE 1; ILD1]
FBgn0040104	lectin-24A	HGNC:10803	OMIM:178635	SFTPD	3		
FBgn0015376	cutlet	HGNC:18435	OMIM:613201	CHTF18	13		
FBgn0031563	CG10031	HGNC:11248	OMIM:613941	SPINT3	3		
FBgn0031563	CG10031	HGNC:11761	OMIM:600033	TFPI2	4		
FBgn0031562	CG3604	HGNC:11248	OMIM:613941	SPINT3	3		
FBgn0031561	IM33	HGNC:38825		EPPIN-WFDC6	5		
FBgn0031561	IM33	HGNC:16164		WFDC6	3		
FBgn0031560	CG16713	HGNC:11248	OMIM:613941	SPINT3	3		
FBgn0031560	CG16713	HGNC:38825		EPPIN-WFDC6	5		
FBgn0031560	CG16713	HGNC:16164		WFDC6	3		
FBgn0051779	Acp24A4	HGNC:15932	OMIM:609031	EPPIN	3		
FBgn0051779	Acp24A4	HGNC:11248	OMIM:613941	SPINT3	3		
FBgn0051779	Acp24A4	HGNC:38825		EPPIN-WFDC6	7		
FBgn0051779	Acp24A4	HGNC:16164		WFDC6	3		
FBgn0031559	CG3513	HGNC:11248	OMIM:613941	SPINT3	4		
FBgn0031559	CG3513	HGNC:38825		EPPIN-WFDC6	3		
FBgn0031558	CG16704	HGNC:11248	OMIM:613941	SPINT3	3		
FBgn0031558	CG16704	HGNC:38825		EPPIN-WFDC6	3		
FBgn0031554	CG15418	HGNC:11248	OMIM:613941	SPINT3	5		
FBgn0031554	CG15418	HGNC:11760	OMIM:152310	TFPI	3		
FBgn0002985	odd	HGNC:8111	OMIM:608891	OSR1	5		
FBgn0002985	odd	HGNC:15830	OMIM:611297	OSR2	5		
FBgn0004892	sob	HGNC:8111	OMIM:608891	OSR1	5		
FBgn0004892	sob	HGNC:15830	OMIM:611297	OSR2	7		
FBgn0051954	CG31954	HGNC:9486	OMIM:613578	PRSS3	5		
FBgn0051954	CG31954	HGNC:9475	OMIM:276000	PRSS1	4	167800	167800[PANCREATITIS, HEREDITARY; PCTT]
FBgn0051954	CG31954	HGNC:9483	OMIM:601564	PRSS2	3	167800	167800[PANCREATITIS, HEREDITARY; PCTT]
FBgn0031540	Pif1	HGNC:26220	OMIM:610953	PIF1	14		
FBgn0005616	msl-2	HGNC:25544	OMIM:614802	MSL2	11		
FBgn0014906	Hydr2	HGNC:18717	OMIM:612196	ABHD2	14		
FBgn0031513	CG3347	HGNC:24343	OMIM:609150	CXXC1	6		
FBgn0031517	CG15406	HGNC:11011	OMIM:606813	SLC2A6	6		
FBgn0031517	CG15406	HGNC:13812	OMIM:605245	SLC2A8	6		
FBgn0031517	CG15406	HGNC:11006	OMIM:138160	SLC2A2	3	125853,227810	125853[TYPE 2 DIABETES MELLITUS; T2D],227810[FANCONI-BICKEL SYNDROME; FBS]
FBgn0031517	CG15406	HGNC:18067	OMIM:610372	SLC2A12	3		
FBgn0031520	CG8837	HGNC:11011	OMIM:606813	SLC2A6	4		
FBgn0031520	CG8837	HGNC:13812	OMIM:605245	SLC2A8	4		
FBgn0053281	CG33281	HGNC:11011	OMIM:606813	SLC2A6	5		
FBgn0053281	CG33281	HGNC:13812	OMIM:605245	SLC2A8	6		
FBgn0053281	CG33281	HGNC:11006	OMIM:138160	SLC2A2	3	125853,227810	125853[TYPE 2 DIABETES MELLITUS; T2D],227810[FANCONI-BICKEL SYNDROME; FBS]
FBgn0053281	CG33281	HGNC:18067	OMIM:610372	SLC2A12	4		
FBgn0053282	CG33282	HGNC:11011	OMIM:606813	SLC2A6	5		
FBgn0053282	CG33282	HGNC:13812	OMIM:605245	SLC2A8	6		
FBgn0053282	CG33282	HGNC:11006	OMIM:138160	SLC2A2	3	125853,227810	125853[TYPE 2 DIABETES MELLITUS; T2D],227810[FANCONI-BICKEL SYNDROME; FBS]
FBgn0053282	CG33282	HGNC:18067	OMIM:610372	SLC2A12	3		
FBgn0031522	CG3285	HGNC:11011	OMIM:606813	SLC2A6	5		
FBgn0031522	CG3285	HGNC:13812	OMIM:605245	SLC2A8	6		
FBgn0031522	CG3285	HGNC:11006	OMIM:138160	SLC2A2	3	125853,227810	125853[TYPE 2 DIABETES MELLITUS; T2D],227810[FANCONI-BICKEL SYNDROME; FBS]
FBgn0031522	CG3285	HGNC:18067	OMIM:610372	SLC2A12	3		
FBgn0031523	CG15408	HGNC:11011	OMIM:606813	SLC2A6	5		
FBgn0031523	CG15408	HGNC:13812	OMIM:605245	SLC2A8	6		
FBgn0031523	CG15408	HGNC:11010	OMIM:138230	SLC2A5	3		
FBgn0031523	CG15408	HGNC:11006	OMIM:138160	SLC2A2	3	125853,227810	125853[TYPE 2 DIABETES MELLITUS; T2D],227810[FANCONI-BICKEL SYNDROME; FBS]
FBgn0031523	CG15408	HGNC:18067	OMIM:610372	SLC2A12	3		
FBgn0016698	Ptpa	HGNC:9308	OMIM:600756	PTPA	15		
FBgn0031529	CG9662	HGNC:24448	OMIM:619023	OSTC	15		
FBgn0031519	Fign	HGNC:13286	OMIM:615383	FIGNL1	14		
FBgn0031519	Fign	HGNC:11233	OMIM:604277	SPAST	4	182601	182601[SPASTIC PARAPLEGIA 4, AUTOSOMAL DOMINANT; SPG4]
FBgn0031519	Fign	HGNC:13285	OMIM:605295	FIGN	6		
FBgn0031516	CG9663	HGNC:73	OMIM:603076	ABCG1	7		
FBgn0031516	CG9663	HGNC:13884	OMIM:607784	ABCG4	6		
FBgn0031516	CG9663	HGNC:74	OMIM:603756	ABCG2	3	138900,614490	138900[URIC ACID CONCENTRATION, SERUM, QUANTITATIVE TRAIT LOCUS 1; UAQTL1],614490[BLOOD GROUP, JUNIOR SYSTEM; JR]
FBgn0031516	CG9663	HGNC:13887	OMIM:605460	ABCG8	3	210250,611465	210250[SITOSTEROLEMIA 1; STSL1],611465[GALLBLADDER DISEASE 4; GBD4]
FBgn0031514	OtopLb	HGNC:19657	OMIM:607827	OTOP2	8		
FBgn0031514	OtopLb	HGNC:19656	OMIM:607806	OTOP1	9		
FBgn0031514	OtopLb	HGNC:19658	OMIM:607828	OTOP3	8		
FBgn0011648	Mad	HGNC:6774	OMIM:603295	SMAD9	11	615342	615342[PULMONARY HYPERTENSION, PRIMARY, 2; PPH2]
FBgn0011648	Mad	HGNC:6768	OMIM:601366	SMAD2	3	619656,619657	619656[LOEYS-DIETZ SYNDROME 6; LDS6],619657[CONGENITAL HEART DEFECTS, MULTIPLE TYPES, 8, WITH OR WITHOUT HETEROTAXY; CHTD8]
FBgn0011648	Mad	HGNC:6767	OMIM:601595	SMAD1	13		
FBgn0011648	Mad	HGNC:6771	OMIM:603110	SMAD5	11		
FBgn0011648	Mad	HGNC:6769	OMIM:603109	SMAD3	3	613795	613795[LOEYS-DIETZ SYNDROME 3; LDS3]
FBgn0031505	ND-B14.5B	HGNC:42956		NDUFC2-KCTD14	7		
FBgn0031505	ND-B14.5B	HGNC:7706	OMIM:603845	NDUFC2	13	619170	619170[MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 36; MC1DN36]
FBgn0031468	CG2975	HGNC:24337	OMIM:610555	C1GALT1	5		
FBgn0031468	CG2975	HGNC:24338	OMIM:300611	C1GALT1C1	3	300622	300622[TN POLYAGGLUTINATION SYNDROME; TNPS]
FBgn0031472	CG2983	HGNC:24337	OMIM:610555	C1GALT1	6		
FBgn0031472	CG2983	HGNC:24338	OMIM:300611	C1GALT1C1	4	300622	300622[TN POLYAGGLUTINATION SYNDROME; TNPS]
FBgn0015521	RpS21	HGNC:10409	OMIM:180477	RPS21	14		
FBgn0031478	CG8814	HGNC:23338	OMIM:616618	ACBD5	11	618863	618863[RETINAL DYSTROPHY WITH LEUKODYSTROPHY; RDLKD]
FBgn0031478	CG8814	HGNC:23337	OMIM:619968	ACBD4	7		
FBgn0051950	Sbat	HGNC:28212	OMIM:617990	NAA38	12		
FBgn0028970	RabGGTb	HGNC:9796	OMIM:179080	RABGGTB	14		
FBgn0041111	lilli	HGNC:3776	OMIM:300806	AFF2	9	309548	309548[INTELLECTUAL DEVELOPMENTAL DISORDER, X-LINKED 109; XLID109]
FBgn0041111	lilli	HGNC:6473	OMIM:601464	AFF3	8	619297	619297[KINSSHIP SYNDROME; KINS]
FBgn0041111	lilli	HGNC:7135	OMIM:159557	AFF1	7		
FBgn0041111	lilli	HGNC:17869	OMIM:604417	AFF4	9	616368	616368[CHOPS SYNDROME; CHOPS]
FBgn0031484	CG3165	HGNC:12270	OMIM:300370	TREX2	10		
FBgn0031484	CG3165	HGNC:12269	OMIM:606609	TREX1	11	152700,192315,225750,610448	152700[SYSTEMIC LUPUS ERYTHEMATOSUS; SLE],192315[VASCULOPATHY, RETINAL, WITH CEREBRAL LEUKOENCEPHALOPATHY AND SYSTEMIC MANIFESTATIONS; RVCLS],225750[AICARDI-GOUTIERES SYNDROME 1; AGS1],610448[CHILBLAIN LUPUS 1; CHBL1]
FBgn0025109	Bem46	HGNC:20293		ABHD13	14		
FBgn0025681	CG3558	HGNC:29320	OMIM:617312	FAM160B1	4		
FBgn0025681	CG3558	HGNC:25378		FAM160A2	10		
FBgn0025681	CG3558	HGNC:16492		FAM160B2	4		
FBgn0025681	CG3558	HGNC:34237		FAM160A1	10		
FBgn0031488	Ccdc85	HGNC:29400		CCDC85A	5		
FBgn0031488	Ccdc85	HGNC:24926	OMIM:605360	CCDC85B	5		
FBgn0031488	Ccdc85	HGNC:35459		CCDC85C	11		
FBgn0031492	Prp40	HGNC:25031		PRPF40B	13		
FBgn0031492	Prp40	HGNC:16463	OMIM:612941	PRPF40A	12		
FBgn0031494	CG17219	HGNC:28793	OMIM:615255	METTL18	13		
FBgn0031495	GABPI	HGNC:28654	OMIM:617334	ZDHHC23	15		
FBgn0031500	CG17221	HGNC:18647	OMIM:610502	RTN4IP1	14	616732	616732[OPTIC ATROPHY 10 WITH OR WITHOUT ATAXIA, MENTAL RETARDATION, AND SEIZURES; OPA10]
FBgn0031500	CG17221	HGNC:19373	OMIM:605171	TP53I3	3		
FBgn0042627	FASN2	HGNC:3594	OMIM:600212	FASN	14		
FBgn0005779	PpD6	HGNC:9281	OMIM:176875	PPP1CA	3		
FBgn0005779	PpD6	HGNC:9283	OMIM:176914	PPP1CC	4		
FBgn0005779	PpD6	HGNC:9282	OMIM:600590	PPP1CB	5	617506	617506[NOONAN SYNDROME-LIKE DISORDER WITH LOOSE ANAGEN HAIR 2; NSLH2]
FBgn0015600	toc	HGNC:20595	OMIM:619358	MTUS2	5		
FBgn0031497	SerRS	HGNC:10537	OMIM:607529	SARS	15	617709	617709[NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, ATAXIA, AND SEIZURES; NEDMAS]
FBgn0031497	SerRS	HGNC:17697	OMIM:612804	SARS2	4	613845	613845[HYPERURICEMIA, PULMONARY HYPERTENSION, RENAL FAILURE, AND ALKALOSIS SYNDROME; HUPRAS]
FBgn0031496	CG17258	HGNC:29272		CCDC191	7		
FBgn0031493	Sf3b2	HGNC:10769	OMIM:605591	SF3B2	12	164210	164210[CRANIOFACIAL MICROSOMIA; CFM]
FBgn0031491	alpha4GT1	HGNC:18149	OMIM:607922	A4GALT	14	111400	111400[BLOOD GROUP, P1PK SYSTEM]
FBgn0031491	alpha4GT1	HGNC:17968	OMIM:616709	A4GNT	10		
FBgn0031489	CG17224	HGNC:23061	OMIM:617340	UPP2	6		
FBgn0031489	CG17224	HGNC:12576	OMIM:191730	UPP1	8		
FBgn0002989	okr	HGNC:17228	OMIM:604289	RAD54B	4	114500,605027	114500[COLORECTAL CANCER; CRC],605027[LYMPHOMA, NON-HODGKIN, FAMILIAL]
FBgn0002989	okr	HGNC:9826	OMIM:603615	RAD54L	15	114480,605027	114480[BREAST CANCER],605027[LYMPHOMA, NON-HODGKIN, FAMILIAL]
FBgn0031485	CG9643	HGNC:33787	OMIM:617794	EEF1AKMT2	12		
FBgn0004584	Rrp1	HGNC:587	OMIM:107748	APEX1	9		
FBgn0004584	Rrp1	HGNC:17889	OMIM:300773	APEX2	3		
FBgn0024920	Ts	HGNC:12441	OMIM:188350	TYMS	15		
FBgn0024947	NTPase	HGNC:3368	OMIM:603160	ENTPD6	13		
FBgn0024947	NTPase	HGNC:3367	OMIM:603162	ENTPD5	14		
FBgn0024947	NTPase	HGNC:14573	OMIM:607577	ENTPD4	4		
FBgn0024947	NTPase	HGNC:19745	OMIM:616753	ENTPD7	3		
FBgn0031479	Prx6a	HGNC:16753	OMIM:602316	PRDX6	14		
FBgn0051694	Ifrd1	HGNC:5457	OMIM:602725	IFRD2	13		
FBgn0051694	Ifrd1	HGNC:5456	OMIM:603502	IFRD1	14		
FBgn0031473	CG3104	HGNC:27110		ANKRD29	10		
FBgn0031469	CG18558	HGNC:24337	OMIM:610555	C1GALT1	4		
FBgn0031469	CG18558	HGNC:24338	OMIM:300611	C1GALT1C1	4	300622	300622[TN POLYAGGLUTINATION SYNDROME; TNPS]
FBgn0031466	CG3119	HGNC:24337	OMIM:610555	C1GALT1	4		
FBgn0031466	CG3119	HGNC:24338	OMIM:300611	C1GALT1C1	3	300622	300622[TN POLYAGGLUTINATION SYNDROME; TNPS]
FBgn0031437	Arpc5	HGNC:23366		ARPC5L	13		
FBgn0031437	Arpc5	HGNC:708	OMIM:604227	ARPC5	14		
FBgn0031442	Prosbeta4R1	HGNC:9539	OMIM:602175	PSMB2	9		
FBgn0031443	Prosbeta4R2	HGNC:9539	OMIM:602175	PSMB2	12		
FBgn0031444	Trf4	HGNC:11589	OMIM:605521	TBPL1	3		
FBgn0031444	Trf4	HGNC:11588	OMIM:600075	TBP	3	168600,607136	168600[PARKINSON DISEASE, LATE-ONSET; PD],607136[SPINOCEREBELLAR ATAXIA 17; SCA17]
FBgn0051690	CG31690	HGNC:25440	OMIM:615856	TMTC2	12		
FBgn0031449	CG31689	HGNC:73	OMIM:603076	ABCG1	7		
FBgn0031449	CG31689	HGNC:13884	OMIM:607784	ABCG4	6		
FBgn0031449	CG31689	HGNC:74	OMIM:603756	ABCG2	3	138900,614490	138900[URIC ACID CONCENTRATION, SERUM, QUANTITATIVE TRAIT LOCUS 1; UAQTL1],614490[BLOOD GROUP, JUNIOR SYSTEM; JR]
FBgn0031452	Cwc25	HGNC:25989		CWC25	13		
FBgn0031456	Tnpo-SR	HGNC:17103	OMIM:610032	TNPO3	14	608423	608423[MUSCULAR DYSTROPHY, LIMB-GIRDLE, AUTOSOMAL DOMINANT 2; LGMDD2]
FBgn0031458	aph-1	HGNC:29509	OMIM:607629	APH1A	14		
FBgn0031458	aph-1	HGNC:24080	OMIM:607630	APH1B	13		
FBgn0028398	Taf10	HGNC:11543	OMIM:600475	TAF10	11		
FBgn0031459	HINT1	HGNC:4912	OMIM:601314	HINT1	14	137200	137200[NEUROMYOTONIA AND AXONAL NEUROPATHY, AUTOSOMAL RECESSIVE; NMAN]
FBgn0031459	HINT1	HGNC:18344	OMIM:609997	HINT2	6		
FBgn0031461	daw	HGNC:6067	OMIM:147390	INHBB	3		
FBgn0031461	daw	HGNC:6068	OMIM:601233	INHBC	4		
FBgn0031461	daw	HGNC:11766	OMIM:190180	TGFB1	4	131300,219700,618213	131300[CAMURATI-ENGELMANN DISEASE; CAEND],219700[CYSTIC FIBROSIS; CF],618213[INFLAMMATORY BOWEL DISEASE, IMMUNODEFICIENCY, AND ENCEPHALOPATHY; IBDIMDE]
FBgn0031461	daw	HGNC:11768	OMIM:190220	TGFB2	3	614816	614816[LOEYS-DIETZ SYNDROME 4; LDS4]
FBgn0031461	daw	HGNC:7865	OMIM:601265	NODAL	3	270100	270100[HETEROTAXY, VISCERAL, 5, AUTOSOMAL; HTX5]
FBgn0031461	daw	HGNC:24029	OMIM:612031	INHBE	4		
FBgn0031461	daw	HGNC:6066	OMIM:147290	INHBA	3		
FBgn0031462	CG2964	HGNC:9021	OMIM:179050	PKM	5		
FBgn0031462	CG2964	HGNC:9020	OMIM:609712	PKLR	6	102900,266200	102900[ADENOSINE TRIPHOSPHATE, ELEVATED, OF ERYTHROCYTES],266200[PYRUVATE KINASE DEFICIENCY OF RED CELLS]
FBgn0031463	G6P	HGNC:4056	OMIM:613742	G6PC1	14	232200	232200[GLYCOGEN STORAGE DISEASE Ia; GSD1A]
FBgn0031463	G6P	HGNC:28906	OMIM:608058	G6PC2	12		
FBgn0031463	G6P	HGNC:24861	OMIM:611045	G6PC3	10	612541	612541[NEUTROPENIA, SEVERE CONGENITAL, 4, AUTOSOMAL RECESSIVE; SCN4]
FBgn0004242	Syt1	HGNC:11510	OMIM:600104	SYT2	12	616040,619461	616040[MYASTHENIC SYNDROME, CONGENITAL, 7A, PRESYNAPTIC, AND DISTAL MOTOR NEUROPATHY, AUTOSOMAL DOMINANT; CMS7A],619461[MYASTHENIC SYNDROME, CONGENITAL, 7B, PRESYNAPTIC, AUTOSOMAL RECESSIVE; CMS7B]
FBgn0004242	Syt1	HGNC:19265	OMIM:613528	SYT9	3		
FBgn0004242	Syt1	HGNC:11512	OMIM:600103	SYT4	3		
FBgn0004242	Syt1	HGNC:19239	OMIM:608741	SYT11	3		
FBgn0004242	Syt1	HGNC:11509	OMIM:185605	SYT1	12	618218	618218[BAKER-GORDON SYNDROME; BAGOS]
FBgn0004242	Syt1	HGNC:11514	OMIM:604146	SYT7	3		
FBgn0004242	Syt1	HGNC:11511	OMIM:600327	SYT3	3		
FBgn0004242	Syt1	HGNC:19266		SYT10	3		
FBgn0004242	Syt1	HGNC:11513	OMIM:600782	SYT5	7		
FBgn0004242	Syt1	HGNC:19264	OMIM:607719	SYT8	6		
FBgn0004242	Syt1	HGNC:0		LOC102724488	3		
FBgn0031460	CG15399	HGNC:18072	OMIM:618542	RABL3	5	618680	618680[PANCREATIC CANCER, SUSCEPTIBILITY TO, 5; PNCA5]
FBgn0019830	colt	HGNC:1421	OMIM:613698	SLC25A20	14	212138	212138[CARNITINE-ACYLCARNITINE TRANSLOCASE DEFICIENCY; CACTD]
FBgn0019830	colt	HGNC:20116	OMIM:615064	SLC25A29	3		
FBgn0019830	colt	HGNC:27442	OMIM:610825	SLC25A45	3		
FBgn0026324	Taf10b	HGNC:11543	OMIM:600475	TAF10	12		
FBgn0031457	Snx21	HGNC:16154	OMIM:619200	SNX21	12		
FBgn0031457	Snx21	HGNC:30390	OMIM:613281	SNX20	10		
FBgn0031451	CG9961	HGNC:8898	OMIM:172270	PGK2	7		
FBgn0031451	CG9961	HGNC:8896	OMIM:311800	PGK1	7	300653	300653[PHOSPHOGLYCERATE KINASE 1 DEFICIENCY]
FBgn0031446	Trf5	HGNC:11589	OMIM:605521	TBPL1	3		
FBgn0031441	CG9962	HGNC:2451	OMIM:600505	CSNK1A1	4		
FBgn0031441	CG9962	HGNC:20289		CSNK1A1L	3		
FBgn0026479	Drp1	HGNC:2974	OMIM:602378	DNM2	3	160150,606482,615368	160150[MYOPATHY, CENTRONUCLEAR, 1; CNM1],606482[CHARCOT-MARIE-TOOTH DISEASE, DOMINANT INTERMEDIATE B; CMTDIB],615368[LETHAL CONGENITAL CONTRACTURE SYNDROME 5; LCCS5]
FBgn0026479	Drp1	HGNC:29125	OMIM:611445	DNM3	3		
FBgn0026479	Drp1	HGNC:2972	OMIM:602377	DNM1	3	616346	616346[DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 31; DEE31]
FBgn0026479	Drp1	HGNC:2973	OMIM:603850	DNM1L	14	610708,614388	610708[OPTIC ATROPHY 5; OPA5],614388[ENCEPHALOPATHY DUE TO DEFECTIVE MITOCHONDRIAL AND PEROXISOMAL FISSION 1; EMPF1]
FBgn0031436	ND-B17.2	HGNC:23987	OMIM:614530	NDUFA12	15	618244	618244[MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 23; MC1DN23]
FBgn0026778	Rad1	HGNC:9806	OMIM:603153	RAD1	13		
FBgn0041337	Cyp309a2	HGNC:2638	OMIM:605325	CYP3A5	3	145500	145500[HYPERTENSION, ESSENTIAL]
FBgn0041337	Cyp309a2	HGNC:17450	OMIM:606534	CYP3A43	3		
FBgn0041337	Cyp309a2	HGNC:11609	OMIM:274180	TBXAS1	3	231095	231095[GHOSAL HEMATODIAPHYSEAL DYSPLASIA; GHDD]
FBgn0041337	Cyp309a2	HGNC:2637	OMIM:124010	CYP3A4	3	619073	619073[VITAMIN D-DEPENDENT RICKETS, TYPE 3; VDDR3]
FBgn0041337	Cyp309a2	HGNC:51504		CYP3A7-CYP3A51P	3		
FBgn0031432	Cyp309a1	HGNC:2638	OMIM:605325	CYP3A5	3	145500	145500[HYPERTENSION, ESSENTIAL]
FBgn0031432	Cyp309a1	HGNC:17450	OMIM:606534	CYP3A43	3		
FBgn0031432	Cyp309a1	HGNC:11609	OMIM:274180	TBXAS1	3	231095	231095[GHOSAL HEMATODIAPHYSEAL DYSPLASIA; GHDD]
FBgn0031432	Cyp309a1	HGNC:2637	OMIM:124010	CYP3A4	3	619073	619073[VITAMIN D-DEPENDENT RICKETS, TYPE 3; VDDR3]
FBgn0031432	Cyp309a1	HGNC:51504		CYP3A7-CYP3A51P	3		
FBgn0031431	CG3515	HGNC:28826	OMIM:611059	WDR82	6		
FBgn0031407	CG4270	HGNC:21245		PI16	3		
FBgn0031407	CG4270	HGNC:18007	OMIM:607141	GLIPR2	7		
FBgn0031407	CG4270	HGNC:28592	OMIM:610394	GLIPR1L2	3		
FBgn0031407	CG4270	HGNC:28392	OMIM:610395	GLIPR1L1	3		
FBgn0031407	CG4270	HGNC:18206		CRISPLD1	3		
FBgn0031407	CG4270	HGNC:25248	OMIM:612434	CRISPLD2	3		
FBgn0031412	CG16995	HGNC:21245		PI16	3		
FBgn0031412	CG16995	HGNC:18007	OMIM:607141	GLIPR2	7		
FBgn0031412	CG16995	HGNC:28592	OMIM:610394	GLIPR1L2	3		
FBgn0031412	CG16995	HGNC:28392	OMIM:610395	GLIPR1L1	3		
FBgn0031412	CG16995	HGNC:18206		CRISPLD1	3		
FBgn0031412	CG16995	HGNC:25248	OMIM:612434	CRISPLD2	3		
FBgn0031419	CG15390	HGNC:28785	OMIM:615393	MTERF4	11		
FBgn0031422	PIG-Wa	HGNC:23213	OMIM:610275	PIGW	14	616025	616025[GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 11; GPIBD11]
FBgn0031424	VGlut	HGNC:20151	OMIM:607557	SLC17A8	12	605583	605583[DEAFNESS, AUTOSOMAL DOMINANT 25; DFNA25]
FBgn0031424	VGlut	HGNC:10933	OMIM:604322	SLC17A5	4	269920,604369	269920[INFANTILE SIALIC ACID STORAGE DISEASE; ISSD],604369[SALLA DISEASE; SD]
FBgn0031424	VGlut	HGNC:16703	OMIM:607563	SLC17A6	14		
FBgn0031424	VGlut	HGNC:16704	OMIM:605208	SLC17A7	13		
FBgn0031424	VGlut	HGNC:10929	OMIM:182308	SLC17A1	3		
FBgn0031424	VGlut	HGNC:10932	OMIM:604216	SLC17A4	3		
FBgn0031424	VGlut	HGNC:10930	OMIM:611049	SLC17A2	4		
FBgn0031424	VGlut	HGNC:10931	OMIM:611034	SLC17A3	4	612671	612671[URIC ACID CONCENTRATION, SERUM, QUANTITATIVE TRAIT LOCUS 4; UAQTL4]
FBgn0031428	CG9886	HGNC:24247	OMIM:610516	GLYCTK	15	220120	220120[D-GLYCERIC ACIDURIA]
FBgn0000490	dpp	HGNC:1072	OMIM:112265	BMP5	3		
FBgn0000490	dpp	HGNC:1073	OMIM:112266	BMP6	3		
FBgn0000490	dpp	HGNC:1074	OMIM:112267	BMP7	3		
FBgn0000490	dpp	HGNC:1069	OMIM:112261	BMP2	9	112600,235200,617877	112600[BRACHYDACTYLY, TYPE A2; BDA2],235200[HEMOCHROMATOSIS, TYPE 1; HFE1],617877[SHORT STATURE, FACIAL DYSMORPHISM, AND SKELETAL ANOMALIES WITH OR WITHOUT CARDIAC ANOMALIES 1; SSFSC1]
FBgn0000490	dpp	HGNC:21650		BMP8A	3		
FBgn0000490	dpp	HGNC:1071	OMIM:112262	BMP4	8	600625,607932	600625[OROFACIAL CLEFT 11; OFC11],607932[MICROPHTHALMIA, SYNDROMIC 6; MCOPS6]
FBgn0000490	dpp	HGNC:4214	OMIM:602880	GDF1	3	208530,613854	208530[RIGHT ATRIAL ISOMERISM; RAI],613854[CONGENITAL HEART DEFECTS, MULTIPLE TYPES, 6; CHTD6]
FBgn0000490	dpp	HGNC:4218	OMIM:606522	GDF3	3	613702,613703,613704	613702[KLIPPEL-FEIL SYNDROME 3, AUTOSOMAL DOMINANT; KFS3],613703[MICROPHTHALMIA, ISOLATED, WITH COLOBOMA 6; MCOPCB6],613704[MICROPHTHALMIA, ISOLATED 7; MCOP7]
FBgn0011818	oaf	HGNC:28752		OAF	13		
FBgn0031430	CG3528	HGNC:28554		CFAP299	13		
FBgn0031426	CG18641	HGNC:18821	OMIM:609252	LIPI	4		
FBgn0031418	CG3609	HGNC:17887	OMIM:606377	DHDH	13		
FBgn0031417	CG3597	HGNC:17887	OMIM:606377	DHDH	8		
FBgn0014010	Rab5	HGNC:9783	OMIM:179512	RAB5A	11		
FBgn0014010	Rab5	HGNC:9784	OMIM:179514	RAB5B	13		
FBgn0014010	Rab5	HGNC:9771	OMIM:605694	RAB31	3		
FBgn0014010	Rab5	HGNC:9764	OMIM:612966	RAB22A	4		
FBgn0014010	Rab5	HGNC:9785	OMIM:604037	RAB5C	13		
FBgn0014010	Rab5	HGNC:16523	OMIM:602206	RAB17	3		
FBgn0031413	CG9967	HGNC:40375		MKRN2OS	11		
FBgn0028570	robl22E	HGNC:15467	OMIM:607168	DYNLRB2	7		
FBgn0028570	robl22E	HGNC:15468	OMIM:607167	DYNLRB1	6		
FBgn0031410	CG17237	HGNC:29823	OMIM:609930	MYL6B	3		
FBgn0031410	CG17237	HGNC:7587	OMIM:609931	MYL6	3		
FBgn0031410	CG17237	HGNC:7584	OMIM:160790	MYL3	3	608751	608751[CARDIOMYOPATHY, FAMILIAL HYPERTROPHIC, 8; CMH8]
FBgn0031410	CG17237	HGNC:7582	OMIM:160780	MYL1	4	618414	618414[MYOPATHY, CONGENITAL, WITH FAST-TWITCH (TYPE II) FIBER ATROPHY; MYOFTA]
FBgn0031410	CG17237	HGNC:7585	OMIM:160770	MYL4	3	617280	617280[ATRIAL FIBRILLATION, FAMILIAL, 18; ATFB18]
FBgn0042186	CG17239	HGNC:6362	OMIM:606135	KLK14	3		
FBgn0042186	CG17239	HGNC:9486	OMIM:613578	PRSS3	3		
FBgn0042186	CG17239	HGNC:9475	OMIM:276000	PRSS1	3	167800	167800[PANCREATITIS, HEREDITARY; PCTT]
FBgn0042186	CG17239	HGNC:6359	OMIM:604434	KLK11	3		
FBgn0011832	Ser12	HGNC:9486	OMIM:613578	PRSS3	3		
FBgn0011832	Ser12	HGNC:9475	OMIM:276000	PRSS1	3	167800	167800[PANCREATITIS, HEREDITARY; PCTT]
FBgn0011832	Ser12	HGNC:6359	OMIM:604434	KLK11	3		
FBgn0051682	Tengl1	HGNC:3346	OMIM:600440	ENDOG	6		
FBgn0052463	Tengl2	HGNC:3346	OMIM:600440	ENDOG	11		
FBgn0052463	Tengl2	HGNC:3347	OMIM:604051	EXOG	4		
FBgn0051679	Tengl3	HGNC:3346	OMIM:600440	ENDOG	6		
FBgn0031374	Wdr62	HGNC:24502	OMIM:613583	WDR62	10	604317	604317[MICROCEPHALY 2, PRIMARY, AUTOSOMAL RECESSIVE, WITH OR WITHOUT CORTICAL MALFORMATIONS; MCPH2]
FBgn0031374	Wdr62	HGNC:29536	OMIM:616786	MAPKBP1	10	617271	617271[NEPHRONOPHTHISIS 20; NPHP20]
FBgn0031378	CG15362	HGNC:18468	OMIM:609998	HINT3	11		
FBgn0031379	CG7289	HGNC:28513		KIAA2013	13		
FBgn0031381	Npc2a	HGNC:14537	OMIM:601015	NPC2	13	607625	607625[NIEMANN-PICK DISEASE, TYPE C2; NPC2]
FBgn0031384	CG4238	HGNC:20363	OMIM:615380	AREL1	13		
FBgn0003557	Su(dx)	HGNC:7727	OMIM:602278	NEDD4	4		
FBgn0003557	Su(dx)	HGNC:16809	OMIM:605532	SMURF2	4		
FBgn0003557	Su(dx)	HGNC:7728	OMIM:606384	NEDD4L	4	617201	617201[PERIVENTRICULAR NODULAR HETEROTOPIA 7; PVNH7]
FBgn0003557	Su(dx)	HGNC:13890	OMIM:606409	ITCH	12	613385	613385[AUTOIMMUNE DISEASE, MULTISYSTEM, WITH FACIAL DYSMORPHISM; ADMFD]
FBgn0003557	Su(dx)	HGNC:16807	OMIM:605568	SMURF1	4		
FBgn0003557	Su(dx)	HGNC:17004	OMIM:602307	WWP1	12		
FBgn0003557	Su(dx)	HGNC:16804	OMIM:602308	WWP2	11		
FBgn0031388	CG12674	HGNC:25459	OMIM:610506	PAF1	4		
FBgn0027509	TBCD	HGNC:11581	OMIM:604649	TBCD	14	617193	617193[ENCEPHALOPATHY, PROGRESSIVE, EARLY-ONSET, WITH BRAIN ATROPHY AND THIN CORPUS CALLOSUM; PEBAT]
FBgn0031392	AIF	HGNC:8768	OMIM:300169	AIFM1	11	300232,300614,300816,310490	300232[SPONDYLOEPIMETAPHYSEAL DYSPLASIA, X-LINKED, WITH HYPOMYELINATING LEUKODYSTROPHY; SEMDHL],300614[DEAFNESS, X-LINKED 5, WITH PERIPHERAL NEUROPATHY; DFNX5],300816[COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 6; COXPD6],310490[CHARCOT-MARIE-TOOTH DISEASE, X-LINKED RECESSIVE, 4, WITH OR WITHOUT CEREBELLAR ATAXIA; CMTX4]
FBgn0031392	AIF	HGNC:24626	OMIM:609448	TXNDC12	5		
FBgn0031399	mio	HGNC:21905	OMIM:615359	MIOS	14		
FBgn0031401	papi	HGNC:11713	OMIM:609501	TDRKH	11		
FBgn0010288	Uch	HGNC:12515	OMIM:603090	UCHL3	13		
FBgn0010288	Uch	HGNC:12513	OMIM:191342	UCHL1	12	613643,615491	613643[PARKINSON DISEASE 5, AUTOSOMAL DOMINANT, SUSCEPTIBILITY TO; PARK5],615491[SPASTIC PARAPLEGIA 79, AUTOSOMAL RECESSIVE; SPG79]
FBgn0031397	CG15385	HGNC:26303	OMIM:619732	PXYLP1	15		
FBgn0053124	CG33124	HGNC:11041	OMIM:604024	SLC5A6	4	618973,619903	618973[SODIUM-DEPENDENT MULTIVITAMIN TRANSPORTER DEFICIENCY; SMVTD],619903[PERIPHERAL MOTOR NEUROPATHY, CHILDHOOD-ONSET, BIOTIN-RESPONSIVE; COMNB]
FBgn0053124	CG33124	HGNC:11040	OMIM:601843	SLC5A5	6	274400	274400[THYROID DYSHORMONOGENESIS 1; TDH1]
FBgn0053124	CG33124	HGNC:28750	OMIM:612455	SLC5A12	6		
FBgn0053124	CG33124	HGNC:19119	OMIM:608044	SLC5A8	7		
FBgn0053124	CG33124	HGNC:11036	OMIM:182380	SLC5A1	3	606824	606824[GLUCOSE/GALACTOSE MALABSORPTION; GGM]
FBgn0053124	CG33124	HGNC:11037	OMIM:182381	SLC5A2	3	233100	233100[RENAL GLUCOSURIA; GLYS]
FBgn0053124	CG33124	HGNC:11038	OMIM:600444	SLC5A3	3		
FBgn0053124	CG33124	HGNC:11039	OMIM:618633	SLC5A4	3		
FBgn0053124	CG33124	HGNC:23091	OMIM:610238	SLC5A11	3		
FBgn0053124	CG33124	HGNC:23155	OMIM:618636	SLC5A10	3		
FBgn0053124	CG33124	HGNC:22146		SLC5A9	3		
FBgn0051668	CG31668	HGNC:11041	OMIM:604024	SLC5A6	5	618973,619903	618973[SODIUM-DEPENDENT MULTIVITAMIN TRANSPORTER DEFICIENCY; SMVTD],619903[PERIPHERAL MOTOR NEUROPATHY, CHILDHOOD-ONSET, BIOTIN-RESPONSIVE; COMNB]
FBgn0051668	CG31668	HGNC:11040	OMIM:601843	SLC5A5	6	274400	274400[THYROID DYSHORMONOGENESIS 1; TDH1]
FBgn0051668	CG31668	HGNC:28750	OMIM:612455	SLC5A12	6		
FBgn0051668	CG31668	HGNC:19119	OMIM:608044	SLC5A8	6		
FBgn0051668	CG31668	HGNC:11036	OMIM:182380	SLC5A1	3	606824	606824[GLUCOSE/GALACTOSE MALABSORPTION; GGM]
FBgn0051668	CG31668	HGNC:11037	OMIM:182381	SLC5A2	3	233100	233100[RENAL GLUCOSURIA; GLYS]
FBgn0051668	CG31668	HGNC:11038	OMIM:600444	SLC5A3	3		
FBgn0051668	CG31668	HGNC:11039	OMIM:618633	SLC5A4	3		
FBgn0051668	CG31668	HGNC:23091	OMIM:610238	SLC5A11	3		
FBgn0051668	CG31668	HGNC:23155	OMIM:618636	SLC5A10	3		
FBgn0051668	CG31668	HGNC:22146		SLC5A9	3		
FBgn0031395	CG10874	HGNC:21098	OMIM:615353	CCDC28A	11		
FBgn0031395	CG10874	HGNC:28163	OMIM:610162	CCDC28B	10	209900	209900[BARDET-BIEDL SYNDROME 1; BBS1]
FBgn0000097	aop	HGNC:3495	OMIM:600618	ETV6	10	601626,616216	601626[LEUKEMIA, ACUTE MYELOID; AML],616216[THROMBOCYTOPENIA 5; THC5]
FBgn0000097	aop	HGNC:18160	OMIM:605255	ETV7	8		
FBgn0031390	tho2	HGNC:19073	OMIM:300395	THOC2	14	300957	300957[INTELLECTUAL DEVELOPMENTAL DISORDER, X-LINKED 12; XLID12]
FBgn0031377	CG15356	HGNC:18071	OMIM:608574	EMSY	9		
FBgn0031375	erm	HGNC:13506	OMIM:607414	FEZF2	9		
FBgn0031375	erm	HGNC:22788	OMIM:613301	FEZF1	9	616030	616030[HYPOGONADOTROPIC HYPOGONADISM 22 WITH OR WITHOUT ANOSMIA; HH22]
FBgn0011570	cpb	HGNC:1491	OMIM:601572	CAPZB	15		
FBgn0031357	mRpL48	HGNC:16653	OMIM:611853	MRPL48	12		
FBgn0031360	CG31937	HGNC:21524	OMIM:612833	DHRS7	15		
FBgn0031373	CG15358	HGNC:2220	OMIM:607620	COLEC10	3	248340	248340[3MC SYNDROME 3; 3MC3]
FBgn0031373	CG15358	HGNC:10799	OMIM:178642	SFTPA2	3	178500	178500[INTERSTITIAL LUNG DISEASE 2; ILD2]
FBgn0031373	CG15358	HGNC:6922	OMIM:154545	MBL2	3	614372	614372[MANNOSE-BINDING LECTIN DEFICIENCY; MBLD]
FBgn0031373	CG15358	HGNC:10803	OMIM:178635	SFTPD	3		
FBgn0031373	CG15358	HGNC:13523	OMIM:605872	CLEC4M	3		
FBgn0031373	CG15358	HGNC:1641	OMIM:604672	CD209	3	607948,609423,614371	607948[MYCOBACTERIUM TUBERCULOSIS, SUSCEPTIBILITY TO],609423[HUMAN IMMUNODEFICIENCY VIRUS TYPE 1, SUSCEPTIBILITY TO],614371[DENGUE VIRUS, SUSCEPTIBILITY TO]
FBgn0051663	CG31663	HGNC:24711	OMIM:613476	MFSD6	3		
FBgn0031367	c-cup	HGNC:30384	OMIM:611874	NENF	4		
FBgn0027597	CG17712	HGNC:28159	OMIM:619933	GFOD2	12		
FBgn0027597	CG17712	HGNC:21096	OMIM:619932	GFOD1	14		
FBgn0031361	CG17652	HGNC:28224		UTP23	14		
FBgn0000579	Eno	HGNC:3350	OMIM:172430	ENO1	13		
FBgn0000579	Eno	HGNC:3353	OMIM:131360	ENO2	12		
FBgn0000579	Eno	HGNC:3354	OMIM:131370	ENO3	12	612932	612932[GLYCOGEN STORAGE DISEASE XIII; GSD13]
FBgn0000579	Eno	HGNC:31670	OMIM:131375	ENO4	3		
FBgn0031359	Rim2	HGNC:25554	OMIM:616149	SLC25A36	14		
FBgn0031359	Rim2	HGNC:29681	OMIM:610816	SLC25A33	10		
FBgn0031356	CG17660	HGNC:25913	OMIM:617203	TMEM87B	12		
FBgn0031356	CG17660	HGNC:24522		TMEM87A	12		
FBgn0021906	RFeSP	HGNC:12587	OMIM:191327	UQCRFS1	13	618775	618775[MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 10; MC3DN10]
FBgn0021906	RFeSP	HGNC:12588		UQCRFS1P1	5		
FBgn0051935	Rab3GAP1	HGNC:17063	OMIM:602536	RAB3GAP1	15	600118,619420	600118[WARBURG MICRO SYNDROME 1; WARBM1],619420[MARTSOLF SYNDROME 2; MARTS2]
FBgn0031347	nis	HGNC:25326	OMIM:618304	QRICH2	3	618341	618341[SPERMATOGENIC FAILURE 35; SPGF35]
FBgn0031345	CG18132	HGNC:21073	OMIM:616412	TXNDC5	3		
FBgn0031327	CG5397	HGNC:26741		CES4A	4		
FBgn0031327	CG5397	HGNC:108	OMIM:100740	ACHE	3	112100	112100[YT BLOOD GROUP ANTIGEN]
FBgn0031327	CG5397	HGNC:983	OMIM:177400	BCHE	3	617936	617936[BUTYRYLCHOLINESTERASE DEFICIENCY; BCHED]
FBgn0031327	CG5397	HGNC:26459	OMIM:618678	CES5A	4		
FBgn0031327	CG5397	HGNC:1863	OMIM:114835	CES1	4	618057	618057[DRUG METABOLISM, ALTERED, CES1-RELATED]
FBgn0031327	CG5397	HGNC:1864	OMIM:605278	CES2	3		
FBgn0031327	CG5397	HGNC:1865	OMIM:605279	CES3	4		
FBgn0041097	robo3	HGNC:17985	OMIM:607528	ROBO4	4	618496	618496[AORTIC VALVE DISEASE 3; AOVD3]
FBgn0041097	robo3	HGNC:10249	OMIM:602430	ROBO1	7		
FBgn0041097	robo3	HGNC:10250	OMIM:602431	ROBO2	7	610878	610878[VESICOURETERAL REFLUX 2; VUR2]
FBgn0041097	robo3	HGNC:13433	OMIM:608630	ROBO3	7	607313	607313[GAZE PALSY, FAMILIAL HORIZONTAL, WITH PROGRESSIVE SCOLIOSIS 1; HGPPS1]
FBgn0011294	a5	HGNC:8630	OMIM:604591	PEBP1	6		
FBgn0011294	a5	HGNC:28319	OMIM:612473	PEBP4	5		
FBgn0031331	CG5440	HGNC:12477	OMIM:602916	UBE2E1	4		
FBgn0031331	CG5440	HGNC:12478	OMIM:602163	UBE2E2	4		
FBgn0031331	CG5440	HGNC:12479	OMIM:604151	UBE2E3	5		
FBgn0026141	Cdlc2	HGNC:24596	OMIM:608942	DYNLL2	13		
FBgn0026141	Cdlc2	HGNC:15476	OMIM:601562	DYNLL1	9		
FBgn0051928	CG31928	HGNC:2530	OMIM:116890	CTSE	3		
FBgn0051928	CG31928	HGNC:8887	OMIM:169730	PGA5	3		
FBgn0051928	CG31928	HGNC:8886	OMIM:169720	PGA4	3		
FBgn0051928	CG31928	HGNC:9958	OMIM:179820	REN	5	267430,613092	267430[RENAL TUBULAR DYSGENESIS; RTD],613092[TUBULOINTERSTITIAL KIDNEY DISEASE, AUTOSOMAL DOMINANT, 4; ADTKD4]
FBgn0051928	CG31928	HGNC:8890	OMIM:169740	PGC	3		
FBgn0051928	CG31928	HGNC:13395	OMIM:605631	NAPSA	5		
FBgn0051928	CG31928	HGNC:2529	OMIM:116840	CTSD	4	610127	610127[CEROID LIPOFUSCINOSIS, NEURONAL, 10; CLN10]
FBgn0053128	CG33128	HGNC:2530	OMIM:116890	CTSE	6		
FBgn0053128	CG33128	HGNC:8887	OMIM:169730	PGA5	6		
FBgn0053128	CG33128	HGNC:8886	OMIM:169720	PGA4	5		
FBgn0053128	CG33128	HGNC:8885	OMIM:169710	PGA3	4		
FBgn0053128	CG33128	HGNC:9958	OMIM:179820	REN	6	267430,613092	267430[RENAL TUBULAR DYSGENESIS; RTD],613092[TUBULOINTERSTITIAL KIDNEY DISEASE, AUTOSOMAL DOMINANT, 4; ADTKD4]
FBgn0053128	CG33128	HGNC:8890	OMIM:169740	PGC	5		
FBgn0053128	CG33128	HGNC:13395	OMIM:605631	NAPSA	6		
FBgn0053128	CG33128	HGNC:934	OMIM:605668	BACE2	3		
FBgn0053128	CG33128	HGNC:2529	OMIM:116840	CTSD	4	610127	610127[CEROID LIPOFUSCINOSIS, NEURONAL, 10; CLN10]
FBgn0051926	CG31926	HGNC:8887	OMIM:169730	PGA5	3		
FBgn0051926	CG31926	HGNC:8886	OMIM:169720	PGA4	3		
FBgn0051926	CG31926	HGNC:9958	OMIM:179820	REN	4	267430,613092	267430[RENAL TUBULAR DYSGENESIS; RTD],613092[TUBULOINTERSTITIAL KIDNEY DISEASE, AUTOSOMAL DOMINANT, 4; ADTKD4]
FBgn0051926	CG31926	HGNC:13395	OMIM:605631	NAPSA	4		
FBgn0051926	CG31926	HGNC:933	OMIM:604252	BACE1	3		
FBgn0051926	CG31926	HGNC:2529	OMIM:116840	CTSD	4	610127	610127[CEROID LIPOFUSCINOSIS, NEURONAL, 10; CLN10]
FBgn0051661	CG31661	HGNC:2530	OMIM:116890	CTSE	3		
FBgn0051661	CG31661	HGNC:8887	OMIM:169730	PGA5	3		
FBgn0051661	CG31661	HGNC:8886	OMIM:169720	PGA4	3		
FBgn0051661	CG31661	HGNC:9958	OMIM:179820	REN	5	267430,613092	267430[RENAL TUBULAR DYSGENESIS; RTD],613092[TUBULOINTERSTITIAL KIDNEY DISEASE, AUTOSOMAL DOMINANT, 4; ADTKD4]
FBgn0051661	CG31661	HGNC:8890	OMIM:169740	PGC	3		
FBgn0051661	CG31661	HGNC:13395	OMIM:605631	NAPSA	5		
FBgn0051661	CG31661	HGNC:2529	OMIM:116840	CTSD	4	610127	610127[CEROID LIPOFUSCINOSIS, NEURONAL, 10; CLN10]
FBgn0031344	CG7420	HGNC:1913	OMIM:179710	RCC1	3		
FBgn0031344	CG7420	HGNC:30297	OMIM:609587	RCC2	3		
FBgn0031344	CG7420	HGNC:17499	OMIM:606051	SERGEF	14		
FBgn0031344	CG7420	HGNC:4867	OMIM:605109	HERC1	3	617011	617011[MACROCEPHALY, DYSMORPHIC FACIES, AND PSYCHOMOTOR RETARDATION; MDFPMR]
FBgn0031344	CG7420	HGNC:18243	OMIM:607867	RCBTB1	3	617175	617175[RETINAL DYSTROPHY WITH OR WITHOUT EXTRAOCULAR ANOMALIES; RDEOA]
FBgn0031344	CG7420	HGNC:10295	OMIM:312610	RPGR	3	300029,300455,300834,304020	300029[RETINITIS PIGMENTOSA 3; RP3],300455[RETINITIS PIGMENTOSA, X-LINKED, AND SINORESPIRATORY INFECTIONS, WITH OR WITHOUT DEAFNESS],300834[MACULAR DEGENERATION, X-LINKED ATROPHIC],304020[CONE-ROD DYSTROPHY, X-LINKED, 1; CORDX1]
FBgn0031344	CG7420	HGNC:30457	OMIM:617997	RCCD1	3		
FBgn0031344	CG7420	HGNC:1914	OMIM:603524	RCBTB2	3		
FBgn0002543	robo2	HGNC:17985	OMIM:607528	ROBO4	5	618496	618496[AORTIC VALVE DISEASE 3; AOVD3]
FBgn0002543	robo2	HGNC:10249	OMIM:602430	ROBO1	6		
FBgn0002543	robo2	HGNC:10250	OMIM:602431	ROBO2	5	610878	610878[VESICOURETERAL REFLUX 2; VUR2]
FBgn0002543	robo2	HGNC:13433	OMIM:608630	ROBO3	6	607313	607313[GAZE PALSY, FAMILIAL HORIZONTAL, WITH PROGRESSIVE SCOLIOSIS 1; HGPPS1]
FBgn0053126	NLaz	HGNC:612	OMIM:107740	APOD	10		
FBgn0051659	CG31659	HGNC:612	OMIM:107740	APOD	5		
FBgn0031335	CG5565	HGNC:16818	OMIM:306480	PUDP	9		
FBgn0051924	CG31924	HGNC:16818	OMIM:306480	PUDP	11		
FBgn0031333	CG5561	HGNC:16818	OMIM:306480	PUDP	6		
FBgn0031332	CG5556	HGNC:16818	OMIM:306480	PUDP	6		
FBgn0028481	CG4341	HGNC:25440	OMIM:615856	TMTC2	14		
FBgn0031296	gNacalpha	HGNC:23290	OMIM:609274	NACA2	6		
FBgn0031296	gNacalpha	HGNC:22196	OMIM:619419	NACAD	5		
FBgn0031296	gNacalpha	HGNC:7629	OMIM:601234	NACA	7		
FBgn0015905	ast	HGNC:25021		ASTE1	12		
FBgn0031298	Atg4a	HGNC:16489	OMIM:300663	ATG4A	14		
FBgn0031298	Atg4a	HGNC:16040	OMIM:611339	ATG4C	5		
FBgn0031298	Atg4a	HGNC:20790	OMIM:611338	ATG4B	13		
FBgn0031298	Atg4a	HGNC:20789	OMIM:611340	ATG4D	5		
FBgn0031301	CG14339	HGNC:30726	OMIM:618661	CFAP70	3	618670	618670[SPERMATOGENIC FAILURE 41; SPGF41]
FBgn0031302	CG14340	HGNC:23271	OMIM:610890	RGS7BP	4		
FBgn0031304	TBC1D23	HGNC:25622	OMIM:617687	TBC1D23	15	617695	617695[PONTOCEREBELLAR HYPOPLASIA, TYPE 11; PCH11]
FBgn0031307	MFS3	HGNC:20151	OMIM:607557	SLC17A8	3	605583	605583[DEAFNESS, AUTOSOMAL DOMINANT 25; DFNA25]
FBgn0031307	MFS3	HGNC:10933	OMIM:604322	SLC17A5	5	269920,604369	269920[INFANTILE SIALIC ACID STORAGE DISEASE; ISSD],604369[SALLA DISEASE; SD]
FBgn0031307	MFS3	HGNC:16703	OMIM:607563	SLC17A6	3		
FBgn0031307	MFS3	HGNC:16704	OMIM:605208	SLC17A7	3		
FBgn0031307	MFS3	HGNC:10929	OMIM:182308	SLC17A1	3		
FBgn0031307	MFS3	HGNC:10932	OMIM:604216	SLC17A4	3		
FBgn0031307	MFS3	HGNC:10930	OMIM:611049	SLC17A2	4		
FBgn0031307	MFS3	HGNC:10931	OMIM:611034	SLC17A3	4	612671	612671[URIC ACID CONCENTRATION, SERUM, QUANTITATIVE TRAIT LOCUS 4; UAQTL4]
FBgn0031310	Vps29	HGNC:14340	OMIM:606932	VPS29	14		
FBgn0031312	Tango14	HGNC:21042	OMIM:610463	NUS1	12	617082,617831	617082[CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Iaa; CDG1AA],617831[INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL DOMINANT 55, WITH SEIZURES; MRD55]
FBgn0031314	IntS14	HGNC:25372		INTS14	14		
FBgn0031315	CG14341	HGNC:6986	OMIM:143170	MEA1	6		
FBgn0051922	CG31922	HGNC:28046	OMIM:619741	ZMAT5	13		
FBgn0031318	CG4887	HGNC:9896	OMIM:300080	RBM10	13	311900	311900[TARP SYNDROME; TARPS]
FBgn0031318	CG4887	HGNC:9902	OMIM:606884	RBM5	11		
FBgn0031318	CG4887	HGNC:9903	OMIM:606886	RBM6	5		
FBgn0031319	CG4896	HGNC:9896	OMIM:300080	RBM10	14	311900	311900[TARP SYNDROME; TARPS]
FBgn0031319	CG4896	HGNC:9902	OMIM:606884	RBM5	14		
FBgn0031319	CG4896	HGNC:9903	OMIM:606886	RBM6	6		
FBgn0031321	Tgt	HGNC:23797	OMIM:609615	QTRT1	14		
FBgn0024314	Plap	HGNC:9043	OMIM:603873	PLAA	15	617527	617527[NEURODEVELOPMENTAL DISORDER WITH PROGRESSIVE MICROCEPHALY, SPASTICITY, AND BRAIN ANOMALIES; NDMSBA]
FBgn0031309	Tfb4	HGNC:4657	OMIM:601750	GTF2H3	15		
FBgn0031299	CG4629	HGNC:28646		NIM1K	11		
FBgn0011244	Hsp60B	HGNC:5261	OMIM:118190	HSPD1	8	605280,612233	605280[SPASTIC PARAPLEGIA 13, AUTOSOMAL DOMINANT; SPG13],612233[LEUKODYSTROPHY, HYPOMYELINATING, 4; HLD4]
FBgn0031275	GABA-B-R3	HGNC:4507	OMIM:607340	GABBR2	3	188890,617903,617904	188890[TOBACCO ADDICTION, SUSCEPTIBILITY TO],617903[NEURODEVELOPMENTAL DISORDER WITH POOR LANGUAGE AND LOSS OF HAND SKILLS; NDPLHS],617904[DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 59; DEE59]
FBgn0031279	CG3544	HGNC:12839	OMIM:604049	XYLB	11		
FBgn0031282	Pex12	HGNC:8854	OMIM:601758	PEX12	14	266510,614859	266510[PEROXISOME BIOGENESIS DISORDER 3B; PBD3B],614859[PEROXISOME BIOGENESIS DISORDER 3A (ZELLWEGER); PBD3A]
FBgn0015621	Clp	HGNC:2327	OMIM:603052	CPSF4	15		
FBgn0015621	Clp	HGNC:33632		CPSF4L	6		
FBgn0010583	dock	HGNC:7664	OMIM:600508	NCK1	14		
FBgn0010583	dock	HGNC:7665	OMIM:604930	NCK2	13		
FBgn0020545	kraken	HGNC:29446	OMIM:619045	SERHL2	12		
FBgn0020545	kraken	HGNC:21398	OMIM:616966	ABHD6	3		
FBgn0020545	kraken	HGNC:14408	OMIM:607979	SERHL	6		
FBgn0031289	CG13950	HGNC:34447	OMIM:617139	LGALS7B	3		
FBgn0031289	CG13950	HGNC:2014	OMIM:153310	CLC	3		
FBgn0031289	CG13950	HGNC:15449	OMIM:608717	LGALS13	3		
FBgn0031289	CG13950	HGNC:6561	OMIM:150570	LGALS1	3		
FBgn0031289	CG13950	HGNC:30054	OMIM:607260	LGALS14	3		
FBgn0002936	ninaA	HGNC:14650	OMIM:606093	PPIG	3		
FBgn0002936	ninaA	HGNC:9256	OMIM:123842	PPIC	5		
FBgn0002936	ninaA	HGNC:33996		PPIAL4G	3		
FBgn0002936	ninaA	HGNC:7833	OMIM:161565	NKTR	3		
FBgn0002936	ninaA	HGNC:14651	OMIM:606095	PPIH	3		
FBgn0002936	ninaA	HGNC:9257	OMIM:601753	PPID	3		
FBgn0002936	ninaA	HGNC:9255	OMIM:123841	PPIB	5	259440	259440[OSTEOGENESIS IMPERFECTA, TYPE IX; OI9]
FBgn0002936	ninaA	HGNC:9259	OMIM:604486	PPIF	3		
FBgn0002936	ninaA	HGNC:33995		PPIAL4C	3		
FBgn0002936	ninaA	HGNC:9253	OMIM:123840	PPIA	3		
FBgn0002936	ninaA	HGNC:33999		PPIAL4F	3		
FBgn0002936	ninaA	HGNC:53889		PPIAL4H	3		
FBgn0046113	GluRIIC	HGNC:4580	OMIM:138244	GRIK2	4	611092,619580	611092[INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 6; MRT6],619580[NEURODEVELOPMENTAL DISORDER WITH IMPAIRED LANGUAGE AND ATAXIA AND WITH OR WITHOUT SEIZURES; NEDLAS]
FBgn0046113	GluRIIC	HGNC:4581	OMIM:138243	GRIK3	4		
FBgn0046113	GluRIIC	HGNC:4583	OMIM:600283	GRIK5	3		
FBgn0046113	GluRIIC	HGNC:4579	OMIM:138245	GRIK1	4		
FBgn0046113	GluRIIC	HGNC:4582	OMIM:600282	GRIK4	4		
FBgn0046113	GluRIIC	HGNC:4576	OMIM:602368	GRID2	4	616204	616204[SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 18; SCAR18]
FBgn0046113	GluRIIC	HGNC:4575	OMIM:610659	GRID1	3		
FBgn0020305	dbe	HGNC:5176	OMIM:612817	KRR1	14		
FBgn0029095	aru	HGNC:21295	OMIM:614987	EPS8L1	10		
FBgn0029095	aru	HGNC:21297	OMIM:614989	EPS8L3	8	612841	612841[HYPOTRICHOSIS 5; HYPT5]
FBgn0029095	aru	HGNC:21296	OMIM:614988	EPS8L2	13	617637	617637[DEAFNESS, AUTOSOMAL RECESSIVE 106; DFNB106]
FBgn0029095	aru	HGNC:3420	OMIM:600206	EPS8	11	615974	615974[DEAFNESS, AUTOSOMAL RECESSIVE 102; DFNB102]
FBgn0031287	CG4291	HGNC:12739	OMIM:604981	WBP4	15		
FBgn0020304	drongo	HGNC:5175	OMIM:600862	AGFG1	10		
FBgn0020304	drongo	HGNC:5177	OMIM:604019	AGFG2	5		
FBgn0031286	CG3862	HGNC:14948		RCC1L	14		
FBgn0031284	PGAP2	HGNC:17893	OMIM:615187	PGAP2	14	614207	614207[HYPERPHOSPHATASIA WITH MENTAL RETARDATION SYNDROME 3; HPMRS3]
FBgn0031283	CG15880	HGNC:17893	OMIM:615187	PGAP2	5	614207	614207[HYPERPHOSPHATASIA WITH MENTAL RETARDATION SYNDROME 3; HPMRS3]
FBgn0000442	Pkg21D	HGNC:9416	OMIM:601591	PRKG2	7	619636,619638	619636[ACROMESOMELIC DYSPLASIA 4; AMD4],619638[SPONDYLOMETAPHYSEAL DYSPLASIA, PAGNAMENTA TYPE; SMDP]
FBgn0000442	Pkg21D	HGNC:9414	OMIM:176894	PRKG1	7	615436	615436[AORTIC ANEURYSM, FAMILIAL THORACIC 8; AAT8]
FBgn0026438	Eaat2	HGNC:10939	OMIM:133550	SLC1A1	5	222730,615232	222730[DICARBOXYLIC AMINOACIDURIA; DCBXA],615232[SCHIZOPHRENIA 18; SCZD18]
FBgn0026438	Eaat2	HGNC:10943	OMIM:109190	SLC1A5	4		
FBgn0026438	Eaat2	HGNC:10945	OMIM:604471	SLC1A7	4		
FBgn0026438	Eaat2	HGNC:10942	OMIM:600229	SLC1A4	4	616657	616657[SPASTIC TETRAPLEGIA, THIN CORPUS CALLOSUM, AND PROGRESSIVE MICROCEPHALY; SPATCCM]
FBgn0026438	Eaat2	HGNC:10941	OMIM:600111	SLC1A3	5	612656	612656[EPISODIC ATAXIA, TYPE 6; EA6]
FBgn0026438	Eaat2	HGNC:10944	OMIM:600637	SLC1A6	5		
FBgn0026438	Eaat2	HGNC:10940	OMIM:600300	SLC1A2	12	617105	617105[DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 41; DEE41]
FBgn0040106	lectin-21Cb	HGNC:11891	OMIM:187520	CLEC3B	4	619977	619977[MACULAR DYSTROPHY, RETINAL, 4; MCDR4]
FBgn0004611	Plc21C	HGNC:9055	OMIM:604114	PLCB2	10		
FBgn0004611	Plc21C	HGNC:15917	OMIM:607120	PLCB1	13	613722	613722[DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 12; DEE12]
FBgn0004611	Plc21C	HGNC:9059	OMIM:600810	PLCB4	3	614669	614669[AURICULOCONDYLAR SYNDROME 2; ARCND2]
FBgn0004611	Plc21C	HGNC:9056	OMIM:600230	PLCB3	12	618961	618961[SPONDYLOMETAPHYSEAL DYSPLASIA WITH CORNEAL DYSTROPHY; SMDCD]
FBgn0004611	Plc21C	HGNC:9060	OMIM:602142	PLCD1	3	151600	151600[NAIL DISORDER, NONSYNDROMIC CONGENITAL, 3; NDNC3]
FBgn0000061	al	HGNC:1494	OMIM:601527	ALX1	5	613456	613456[FRONTONASAL DYSPLASIA 3; FND3]
FBgn0000061	al	HGNC:18060	OMIM:300382	ARX	7	300004,300215,300419,308350,309510	300004[CORPUS CALLOSUM, AGENESIS OF, WITH ABNORMAL GENITALIA],300215[LISSENCEPHALY, X-LINKED, 2; LISX2],300419[INTELLECTUAL DEVELOPMENTAL DISORDER, X-LINKED 29; XLID29],308350[DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 1; DEE1],309510[PARTINGTON SYNDROME; PRTS]
FBgn0000061	al	HGNC:449	OMIM:606014	ALX3	4	136760	136760[FRONTONASAL DYSPLASIA 1; FND1]
FBgn0000061	al	HGNC:450	OMIM:605420	ALX4	3	609597,613451,615529	609597[PARIETAL FORAMINA 2; PFM2],613451[FRONTONASAL DYSPLASIA 2; FND2],615529[CRANIOSYNOSTOSIS 5, SUSCEPTIBILITY TO; CRS5]
FBgn0003278	Polr1B	HGNC:20454	OMIM:602000	POLR1B	14	618939	618939[TREACHER COLLINS SYNDROME 4; TCS4]
FBgn0002593	RpLP1	HGNC:10372	OMIM:180520	RPLP1	13		
FBgn0031254	CG13692	HGNC:27902	OMIM:619117	ARL16	7		
FBgn0031255	BBS8	HGNC:20087	OMIM:608132	TTC8	14	613464,615985	613464[RETINITIS PIGMENTOSA 51; RP51],615985[BARDET-BIEDL SYNDROME 8; BBS8]
FBgn0004583	ex	HGNC:21240		FRMD1	8		
FBgn0004583	ex	HGNC:19839	OMIM:614555	FRMD6	5		
FBgn0031256	shv	HGNC:14889	OMIM:611341	DNAJB11	14	618061	618061[POLYCYSTIC KIDNEY DISEASE 6 WITH OR WITHOUT POLYCYSTIC LIVER DISEASE; PKD6]
FBgn0027592	MED15	HGNC:14248	OMIM:607372	MED15	13		
FBgn0003963	ush	HGNC:16700	OMIM:603693	ZFPM2	5	187500,610187,616067	187500[TETRALOGY OF FALLOT; TOF],610187[DIAPHRAGMATIC HERNIA 3; DIH3],616067[46,XY SEX REVERSAL 9; SRXY9]
FBgn0003963	ush	HGNC:19762	OMIM:601950	ZFPM1	6		
FBgn0031263	Tspo	HGNC:21256	OMIM:619409	TSPO2	8		
FBgn0031263	Tspo	HGNC:1158	OMIM:109610	TSPO	14		
FBgn0031266	Sf3b1	HGNC:10768	OMIM:605590	SF3B1	14	614286	614286[MYELODYSPLASTIC SYNDROME; MDS]
FBgn0023489	Pph13	HGNC:1494	OMIM:601527	ALX1	4	613456	613456[FRONTONASAL DYSPLASIA 3; FND3]
FBgn0023489	Pph13	HGNC:18060	OMIM:300382	ARX	5	300004,300215,300419,308350,309510	300004[CORPUS CALLOSUM, AGENESIS OF, WITH ABNORMAL GENITALIA],300215[LISSENCEPHALY, X-LINKED, 2; LISX2],300419[INTELLECTUAL DEVELOPMENTAL DISORDER, X-LINKED 29; XLID29],308350[DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 1; DEE1],309510[PARTINGTON SYNDROME; PRTS]
FBgn0023489	Pph13	HGNC:449	OMIM:606014	ALX3	3	136760	136760[FRONTONASAL DYSPLASIA 1; FND1]
FBgn0010323	Gsc	HGNC:4612	OMIM:138890	GSC	5	602471	602471[SHORT STATURE, AUDITORY CANAL ATRESIA, MANDIBULAR HYPOPLASIA, AND SKELETAL ABNORMALITIES; SAMS]
FBgn0010323	Gsc	HGNC:4613	OMIM:601845	GSC2	3		
FBgn0031267	Ipk2	HGNC:20739	OMIM:609851	IPMK	13		
FBgn0031267	Ipk2	HGNC:18360	OMIM:606991	IP6K1	3		
FBgn0031267	Ipk2	HGNC:17313	OMIM:606992	IP6K2	3		
FBgn0031267	Ipk2	HGNC:17269	OMIM:606993	IP6K3	3		
FBgn0021874	Nle	HGNC:19889		NLE1	14		
FBgn0031264	uncNacbeta	HGNC:30547		BTF3L4	9		
FBgn0031264	uncNacbeta	HGNC:1125	OMIM:602542	BTF3	9		
FBgn0005660	Ets21C	HGNC:3446	OMIM:165080	ERG	7		
FBgn0005660	Ets21C	HGNC:3749	OMIM:193067	FLI1	7	617443	617443[BLEEDING DISORDER, PLATELET-TYPE, 21; BDPLT21]
FBgn0005660	Ets21C	HGNC:18562	OMIM:607150	FEV	6		
FBgn0031260	Spp	HGNC:16435	OMIM:607106	HM13	15		
FBgn0010602	lwr	HGNC:12485	OMIM:601661	UBE2I	14		
FBgn0043364	cbt	HGNC:11811	OMIM:603301	KLF11	6	610508	610508[MATURITY-ONSET DIABETES OF THE YOUNG, TYPE 7; MODY7]
FBgn0015924	crq	HGNC:1663	OMIM:173510	CD36	4	608404,610938,611162	608404[PLATELET GLYCOPROTEIN IV DEFICIENCY],610938[CORONARY HEART DISEASE, SUSCEPTIBILITY TO, 7; CHDS7],611162[MALARIA, SUSCEPTIBILITY TO]
FBgn0015924	crq	HGNC:1664	OMIM:601040	SCARB1	8	610762	610762[HIGH DENSITY LIPOPROTEIN CHOLESTEROL LEVEL QUANTITATIVE TRAIT LOCUS 6; HDLCQ6]
FBgn0015924	crq	HGNC:1665	OMIM:602257	SCARB2	6	254900	254900[EPILEPSY, PROGRESSIVE MYOCLONIC, 4, WITH OR WITHOUT RENAL FAILURE; EPM4]
FBgn0031253	CG11885	HGNC:22420	OMIM:617528	PSMG3	4		
FBgn0031252	CG13690	HGNC:18518	OMIM:606034	RNASEH2A	15	610333	610333[AICARDI-GOUTIERES SYNDROME 4; AGS4]
FBgn0031250	Ent1	HGNC:11003	OMIM:602193	SLC29A1	10		
FBgn0031250	Ent1	HGNC:11004	OMIM:602110	SLC29A2	8		
FBgn0031250	Ent1	HGNC:23096	OMIM:612373	SLC29A3	9	602782	602782[HISTIOCYTOSIS-LYMPHADENOPATHY PLUS SYNDROME]
FBgn0031213	galectin	HGNC:6568	OMIM:600615	LGALS7	3		
FBgn0031213	galectin	HGNC:6565	OMIM:602518	LGALS4	10		
FBgn0031213	galectin	HGNC:2014	OMIM:153310	CLC	3		
FBgn0031213	galectin	HGNC:15449	OMIM:608717	LGALS13	3		
FBgn0031213	galectin	HGNC:6569	OMIM:606099	LGALS8	10		
FBgn0031213	galectin	HGNC:6570	OMIM:601879	LGALS9	10		
FBgn0031213	galectin	HGNC:25012	OMIM:617902	LGALSL	5		
FBgn0031213	galectin	HGNC:15788	OMIM:606096	LGALS12	4		
FBgn0031213	galectin	HGNC:24842		LGALS9B	10		
FBgn0031213	galectin	HGNC:33874		LGALS9C	10		
FBgn0031213	galectin	HGNC:6563	OMIM:153619	LGALS3	5		
FBgn0031213	galectin	HGNC:6561	OMIM:150570	LGALS1	3		
FBgn0031213	galectin	HGNC:30054	OMIM:607260	LGALS14	3		
FBgn0031213	galectin	HGNC:4577	OMIM:619187	GRIFIN	3		
FBgn0031214	CG11374	HGNC:6565	OMIM:602518	LGALS4	7		
FBgn0031214	CG11374	HGNC:2014	OMIM:153310	CLC	3		
FBgn0031214	CG11374	HGNC:15449	OMIM:608717	LGALS13	3		
FBgn0031214	CG11374	HGNC:6569	OMIM:606099	LGALS8	8		
FBgn0031214	CG11374	HGNC:6570	OMIM:601879	LGALS9	9		
FBgn0031214	CG11374	HGNC:25012	OMIM:617902	LGALSL	3		
FBgn0031214	CG11374	HGNC:15788	OMIM:606096	LGALS12	5		
FBgn0031214	CG11374	HGNC:24842		LGALS9B	9		
FBgn0031214	CG11374	HGNC:33874		LGALS9C	9		
FBgn0031214	CG11374	HGNC:6563	OMIM:153619	LGALS3	3		
FBgn0031214	CG11374	HGNC:6561	OMIM:150570	LGALS1	3		
FBgn0031214	CG11374	HGNC:30054	OMIM:607260	LGALS14	3		
FBgn0031216	Zir	HGNC:19189	OMIM:614194	DOCK6	12	614219	614219[ADAMS-OLIVER SYNDROME 2; AOS2]
FBgn0031216	Zir	HGNC:19190	OMIM:615730	DOCK7	15	615859	615859[DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 23; DEE23]
FBgn0031216	Zir	HGNC:14132	OMIM:607325	DOCK9	4		
FBgn0031216	Zir	HGNC:23479	OMIM:611518	DOCK10	4		
FBgn0031216	Zir	HGNC:23483	OMIM:300681	DOCK11	4		
FBgn0031216	Zir	HGNC:19191	OMIM:611432	DOCK8	13	243700	243700[HYPER-IgE RECURRENT INFECTION SYNDROME 2, AUTOSOMAL RECESSIVE; HIES2]
FBgn0031217	Creld	HGNC:28150	OMIM:607171	CRELD2	10		
FBgn0031217	Creld	HGNC:14630	OMIM:607170	CRELD1	11	606217	606217[ATRIOVENTRICULAR SEPTAL DEFECT, SUSCEPTIBILITY TO, 2; AVSD2]
FBgn0001142	Gs1	HGNC:4341	OMIM:138290	GLUL	9	610015	610015[GLUTAMINE DEFICIENCY, CONGENITAL]
FBgn0031224	CG11454	HGNC:9897	OMIM:617937	RBM11	8		
FBgn0031224	CG11454	HGNC:9904	OMIM:612413	RBM7	12		
FBgn0031228	ND-15	HGNC:7712	OMIM:603847	NDUFS5	9		
FBgn0031229	CG3436	HGNC:30857	OMIM:607797	SNRNP40	14		
FBgn0031231	mRpL10	HGNC:14055	OMIM:611825	MRPL10	13		
FBgn0031233	Tbc1d15-17	HGNC:25694	OMIM:612662	TBC1D15	11		
FBgn0031233	Tbc1d15-17	HGNC:25699	OMIM:616659	TBC1D17	11		
FBgn0031233	Tbc1d15-17	HGNC:28536		TBC1D21	3		
FBgn0031235	CG13693	HGNC:25002	OMIM:616070	CCDC113	11		
FBgn0031240	CG3345	HGNC:21675	OMIM:615796	FSIP2	3	618153	618153[SPERMATOGENIC FAILURE 34; SPGF34]
FBgn0003444	smo	HGNC:11119	OMIM:601500	SMO	13	241800,601707,605462	241800[PALLISTER-HALL-LIKE SYNDROME; PHLS],601707[CURRY-JONES SYNDROME; CRJS],605462[BASAL CELL CARCINOMA, SUSCEPTIBILITY TO, 1; BCC1]
FBgn0031247	CG11562	HGNC:40045	OMIM:614771	PET117	9	619063	619063[MITOCHONDRIAL COMPLEX IV DEFICIENCY, NUCLEAR TYPE 19; MC4DN19]
FBgn0024352	Stip1	HGNC:11387	OMIM:605063	STIP1	13		
FBgn0020622	Pi3K21B	HGNC:8979	OMIM:171833	PIK3R1	11	269880,615214,616005	269880[SHORT SYNDROME],615214[AGAMMAGLOBULINEMIA 7, AUTOSOMAL RECESSIVE; AGM7],616005[IMMUNODEFICIENCY 36; IMD36]
FBgn0020622	Pi3K21B	HGNC:8981	OMIM:606076	PIK3R3	13		
FBgn0020622	Pi3K21B	HGNC:8980	OMIM:603157	PIK3R2	12	603387	603387[MEGALENCEPHALY-POLYMICROGYRIA-POLYDACTYLY-HYDROCEPHALUS SYNDROME 1; MPPH1]
FBgn0017457	U2af38	HGNC:12453	OMIM:191317	U2AF1	11		
FBgn0017457	U2af38	HGNC:23020	OMIM:601080	U2AF1L4	10		
FBgn0017457	U2af38	HGNC:0		U2AF1L5	10		
FBgn0025686	Amnionless	HGNC:14604	OMIM:605799	AMN	11	618882	618882[IMERSLUND-GRASBECK SYNDROME 2; IGS2]
FBgn0031245	CG3625	HGNC:21607	OMIM:608514	AIG1	13		
FBgn0031245	CG3625	HGNC:21214	OMIM:614348	ADTRP	8		
FBgn0031244	CG11601	HGNC:21607	OMIM:608514	AIG1	12		
FBgn0031244	CG11601	HGNC:21214	OMIM:614348	ADTRP	8		
FBgn0031238	CG3645	HGNC:30086		DUS1L	14		
FBgn0031239	CG17075	HGNC:19158		ZDHHC11	8		
FBgn0031239	CG17075	HGNC:17916		ZDHHC1	9		
FBgn0031239	CG17075	HGNC:32962		ZDHHC11B	5		
FBgn0031232	CG11617	HGNC:23729	OMIM:601332	MKX	11		
FBgn0031227	CG3709	HGNC:26505	OMIM:612787	PUS10	14		
FBgn0026787	Nhe1	HGNC:20728	OMIM:612730	SLC9A8	14		
FBgn0002931	net	HGNC:24126	OMIM:619820	ATOH8	7		
FBgn0002121	l(2)gl	HGNC:6629	OMIM:618483	LLGL2	11		
FBgn0002121	l(2)gl	HGNC:6628	OMIM:600966	LLGL1	15		
FBgn0036974	eRF1	HGNC:3477	OMIM:600285	ETF1	15		
FBgn0036975	CG5618	HGNC:4092	OMIM:605363	GAD1	4	619124	619124[DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 89; DEE89]
FBgn0036975	CG5618	HGNC:4093	OMIM:138275	GAD2	4		
FBgn0036975	CG5618	HGNC:18966	OMIM:616569	CSAD	5		
FBgn0036975	CG5618	HGNC:27949	OMIM:615601	GADL1	6		
FBgn0024887	kin17	HGNC:6327	OMIM:601720	KIN	15		
FBgn0036977	CG5665	HGNC:6619	OMIM:151670	LIPC	3	125853,612797,614025	125853[TYPE 2 DIABETES MELLITUS; T2D],612797[HIGH DENSITY LIPOPROTEIN CHOLESTEROL LEVEL QUANTITATIVE TRAIT LOCUS 12; HDLCQ12],614025[HEPATIC LIPASE DEFICIENCY]
FBgn0036977	CG5665	HGNC:18821	OMIM:609252	LIPI	3		
FBgn0001259	in	HGNC:29239	OMIM:610621	INTU	14	617925,617926	617925[SHORT-RIB THORACIC DYSPLASIA 20 WITH POLYDACTYLY; SRTD20],617926[OROFACIODIGITAL SYNDROME XVII; OFD17]
FBgn0036980	RhoBTB	HGNC:18756	OMIM:607352	RHOBTB2	12	618004	618004[DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 64; DEE64]
FBgn0036980	RhoBTB	HGNC:18738	OMIM:607351	RHOBTB1	12		
FBgn0036996	mag	HGNC:6617	OMIM:613497	LIPA	9	278000	278000[LYSOSOMAL ACID LIPASE DEFICIENCY]
FBgn0036996	mag	HGNC:23444	OMIM:613922	LIPK	9		
FBgn0036996	mag	HGNC:23455	OMIM:613923	LIPM	9		
FBgn0036996	mag	HGNC:6622	OMIM:601980	LIPF	9		
FBgn0036996	mag	HGNC:21773	OMIM:613921	LIPJ	8		
FBgn0036996	mag	HGNC:23452	OMIM:613924	LIPN	9	613943	613943[ICHTHYOSIS, CONGENITAL, AUTOSOMAL RECESSIVE 8; ARCI8]
FBgn0036997	CG5955	HGNC:15547	OMIM:615174	TDH	6		
FBgn0036998	CG5969	HGNC:22082	OMIM:300913	VMA21	6	310440	310440[MYOPATHY, X-LINKED, WITH EXCESSIVE AUTOPHAGY; MEAX]
FBgn0036999	isoQC	HGNC:9753	OMIM:607065	QPCT	14		
FBgn0036999	isoQC	HGNC:25952		QPCTL	12		
FBgn0037001	ND-39	HGNC:7693	OMIM:603834	NDUFA9	14	618247	618247[MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 26; MC1DN26]
FBgn0052425	CG32425	HGNC:24564	OMIM:615944	C2CD3	6	615948	615948[OROFACIODIGITAL SYNDROME XIV; OFD14]
FBgn0037003	CG18281	HGNC:23376		MFSD14B	6		
FBgn0037003	CG18281	HGNC:23363		MFSD14A	7		
FBgn0037003	CG18281	HGNC:23672		MFSD14C	4		
FBgn0037004	CG17637	HGNC:23376		MFSD14B	5		
FBgn0037004	CG17637	HGNC:23363		MFSD14A	6		
FBgn0037004	CG17637	HGNC:23672		MFSD14C	3		
FBgn0037005	CG5078	HGNC:23376		MFSD14B	7		
FBgn0037005	CG5078	HGNC:23363		MFSD14A	8		
FBgn0037005	CG5078	HGNC:23672		MFSD14C	3		
FBgn0037009	CG5104	HGNC:21102		SFT2D1	13		
FBgn0037009	CG5104	HGNC:25140		SFT2D2	13		
FBgn0037011	Nubp2	HGNC:8042	OMIM:610779	NUBP2	15		
FBgn0037011	Nubp2	HGNC:8041	OMIM:600280	NUBP1	4		
FBgn0037011	Nubp2	HGNC:20278	OMIM:613621	NUBPL	3	618242	618242[MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 21; MC1DN21]
FBgn0037012	Rcd2	HGNC:2359	OMIM:606189	CRIM1	3		
FBgn0037008	mTerf3	HGNC:24258	OMIM:616930	MTERF3	14		
FBgn0037007	BNIP3	HGNC:1084	OMIM:603293	BNIP3	6		
FBgn0037007	BNIP3	HGNC:1085	OMIM:605368	BNIP3L	5		
FBgn0037000	ZnT77C	HGNC:11012	OMIM:609521	SLC30A1	5		
FBgn0037000	ZnT77C	HGNC:25355	OMIM:611146	SLC30A10	3	613280	613280[HYPERMANGANESEMIA WITH DYSTONIA 1; HMNDYT1]
FBgn0036992	Hpd	HGNC:5147	OMIM:609695	HPD	15	140350,276710	140350[HAWKINSINURIA; HWKS],276710[TYROSINEMIA, TYPE III; TYRSN3]
FBgn0036990	mRpL15	HGNC:14054	OMIM:611828	MRPL15	13		
FBgn0029158	Las	HGNC:16429	OMIM:607031	LIAS	14	614462	614462[HYPERGLYCINEMIA, LACTIC ACIDOSIS, AND SEIZURES; HGCLAS]
FBgn0036988	CG5262	HGNC:25984		TMEM104	14		
FBgn0036987	CG5274	HGNC:21702		C7orf26	14		
FBgn0036986	CG5282	HGNC:23028	OMIM:609925	DPEP2	4		
FBgn0036986	CG5282	HGNC:3002	OMIM:179780	DPEP1	6		
FBgn0036986	CG5282	HGNC:23029	OMIM:609926	DPEP3	5		
FBgn0036984	CG13248	HGNC:11060	OMIM:601872	SLC7A2	5		
FBgn0036984	CG13248	HGNC:11057	OMIM:104615	SLC7A1	4		
FBgn0036984	CG13248	HGNC:11061	OMIM:300443	SLC7A3	4		
FBgn0036984	CG13248	HGNC:11062	OMIM:603752	SLC7A4	13		
FBgn0028978	trbl	HGNC:16228	OMIM:607898	TRIB3	9		
FBgn0028978	trbl	HGNC:30809	OMIM:609462	TRIB2	14		
FBgn0028978	trbl	HGNC:16891	OMIM:609461	TRIB1	10		
FBgn0027565	CG5498	HGNC:28439	OMIM:611130	CHMP7	11		
FBgn0001247	Ide	HGNC:5381	OMIM:146680	IDE	14		
FBgn0001247	Ide	HGNC:7995	OMIM:602651	NRDC	4		
FBgn0036978	Toll-9	HGNC:15634	OMIM:606270	TLR10	8		
FBgn0036978	Toll-9	HGNC:11848	OMIM:603028	TLR2	7	114500,246300,607948	114500[COLORECTAL CANCER; CRC],246300[LEPROSY, SUSCEPTIBILITY TO, 3; LPRS3],607948[MYCOBACTERIUM TUBERCULOSIS, SUSCEPTIBILITY TO]
FBgn0036978	Toll-9	HGNC:11847	OMIM:601194	TLR1	7	613223	613223[LEPROSY, SUSCEPTIBILITY TO, 5; LPRS5]
FBgn0036978	Toll-9	HGNC:16711	OMIM:605403	TLR6	7		
FBgn0036973	Rbbp5	HGNC:9888	OMIM:600697	RBBP5	14		
FBgn0037014	CG13251	HGNC:27709	OMIM:619287	CCDC66	3		
FBgn0037016	CG13252	HGNC:2359	OMIM:606189	CRIM1	3		
FBgn0040634	CG4186	HGNC:28314	OMIM:611238	CHCHD7	11		
FBgn0016696	Pitslre	HGNC:1730	OMIM:116951	CDK11A	10		
FBgn0016696	Pitslre	HGNC:1770	OMIM:603464	CDK10	3	617694	617694[AL KAISSI SYNDROME; ALKAS]
FBgn0016696	Pitslre	HGNC:1729	OMIM:176873	CDK11B	11		
FBgn0037020	Pex14	HGNC:8856	OMIM:601791	PEX14	14	614887	614887[PEROXISOME BIOGENESIS DISORDER 13A (ZELLWEGER); PBD13A]
FBgn0037024	tzn	HGNC:9153	OMIM:609023	PNKD	3	118800	118800[PAROXYSMAL NONKINESIGENIC DYSKINESIA 1; PNKD1]
FBgn0037024	tzn	HGNC:4805	OMIM:138760	HAGH	15	614033	614033[HYDROXYACYL GLUTATHIONE HYDROLASE DEFICIENCY]
FBgn0037024	tzn	HGNC:14177		HAGHL	7		
FBgn0037027	HIPP1	HGNC:1809	OMIM:400016	CDY1	3		
FBgn0037027	HIPP1	HGNC:1811	OMIM:603778	CDYL	3		
FBgn0037027	HIPP1	HGNC:890	OMIM:600529	AUH	3	250950	250950[3-METHYLGLUTACONIC ACIDURIA, TYPE I; MGCA1]
FBgn0037027	HIPP1	HGNC:23030	OMIM:618816	CDYL2	3		
FBgn0037027	HIPP1	HGNC:23408		ECHDC2	3		
FBgn0011591	fng	HGNC:9974	OMIM:602578	RFNG	15		
FBgn0011591	fng	HGNC:7038	OMIM:602577	MFNG	11		
FBgn0011591	fng	HGNC:6560	OMIM:602576	LFNG	12	609813	609813[SPONDYLOCOSTAL DYSOSTOSIS 3, AUTOSOMAL RECESSIVE; SCDO3]
FBgn0027055	CSN3	HGNC:2239	OMIM:604665	COPS3	14		
FBgn0037026	CG3634	HGNC:11351	OMIM:600833	ST7	13		
FBgn0037026	CG3634	HGNC:18441	OMIM:617640	ST7L	11		
FBgn0027364	Six4	HGNC:10890	OMIM:606342	SIX4	7		
FBgn0027364	Six4	HGNC:10891	OMIM:600963	SIX5	5	610896	610896[BRANCHIOOTORENAL SYNDROME 2; BOR2]
FBgn0037022	CG11396	HGNC:24284	OMIM:614139	TRAPPC12	11	617669	617669[ENCEPHALOPATHY, PROGRESSIVE, EARLY-ONSET, WITH BRAIN ATROPHY AND SPASTICITY; PEBAS]
FBgn0037021	Pcif1	HGNC:16200	OMIM:618626	PCIF1	13		
FBgn0037019	Pex16	HGNC:8857	OMIM:603360	PEX16	14	614876,614877	614876[PEROXISOME BIOGENESIS DISORDER 8A (ZELLWEGER); PBD8A],614877[PEROXISOME BIOGENESIS DISORDER 8B; PBD8B]
FBgn0037018	CG4042	HGNC:25496	OMIM:617262	DMAC2	12		
FBgn0037017	CG4074	HGNC:3044	OMIM:605298	VPS26C	14		
FBgn0037037	CG10588	HGNC:5381	OMIM:146680	IDE	4		
FBgn0037037	CG10588	HGNC:7995	OMIM:602651	NRDC	11		
FBgn0037044	Pdss2	HGNC:23041	OMIM:610564	PDSS2	14	614652	614652[COENZYME Q10 DEFICIENCY, PRIMARY, 3; COQ10D3]
FBgn0028402	Polr3E	HGNC:30347	OMIM:617815	POLR3E	13		
FBgn0026179	siz	HGNC:29193	OMIM:612118	IQSEC3	9		
FBgn0026179	siz	HGNC:29059	OMIM:300522	IQSEC2	12	309530	309530[INTELLECTUAL DEVELOPMENTAL DISORDER, X-LINKED 1; XLID1]
FBgn0026179	siz	HGNC:29112	OMIM:610166	IQSEC1	13	618687	618687[INTELLECTUAL DEVELOPMENTAL DISORDER WITH SHORT STATURE AND BEHAVIORAL ABNORMALITIES; IDDSSBA]
FBgn0037050	ICA69	HGNC:14442		ICA1L	13		
FBgn0037050	ICA69	HGNC:5343	OMIM:147625	ICA1	12		
FBgn0028427	Ilk	HGNC:6040	OMIM:602366	ILK	14		
FBgn0004865	Eip78C	HGNC:7962	OMIM:602408	NR1D1	3		
FBgn0004865	Eip78C	HGNC:7963	OMIM:602304	NR1D2	6		
FBgn0037061	Trmt112	HGNC:26940	OMIM:618630	TRMT112	14		
FBgn0053056	CG33056	HGNC:21257	OMIM:614393	OARD1	7		
FBgn0053054	CG33054	HGNC:21257	OMIM:614393	OARD1	14		
FBgn0041100	park	HGNC:8607	OMIM:602544	PRKN	15	167000,211980,600116	167000[OVARIAN CANCER],211980[LUNG CANCER],600116[PARKINSON DISEASE 2, AUTOSOMAL RECESSIVE JUVENILE; PARK2]
FBgn0024150	Ac78C	HGNC:239	OMIM:103070	ADCY8	8		
FBgn0037051	CG10565	HGNC:13192	OMIM:605502	DNAJC2	13		
FBgn0020294	ko	HGNC:25450	OMIM:617359	STOX2	5		
FBgn0020294	ko	HGNC:23508	OMIM:609397	STOX1	5	609404	609404[PREECLAMPSIA/ECLAMPSIA 4; PEE4]
FBgn0037045	CG10584	HGNC:28368	OMIM:615261	METTL22	13		
FBgn0003415	skd	HGNC:22474	OMIM:603808	MED13	15	618009	618009[INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL DOMINANT 61; MRD61]
FBgn0003415	skd	HGNC:22962	OMIM:608771	MED13L	12	616789	616789[IMPAIRED INTELLECTUAL DEVELOPMENT AND DISTINCTIVE FACIAL FEATURES WITH OR WITHOUT CARDIAC DEFECTS; MRFACD]
FBgn0053286	CG33286	HGNC:29599	OMIM:616906	CASC1	8		
FBgn0053287	CG33287	HGNC:29599	OMIM:616906	CASC1	5		
FBgn0037040	CG12983	HGNC:29599	OMIM:616906	CASC1	5		
FBgn0037071	CG7632	HGNC:29446	OMIM:619045	SERHL2	10		
FBgn0037071	CG7632	HGNC:14408	OMIM:607979	SERHL	5		
FBgn0037073	Tsr1	HGNC:25542	OMIM:611214	TSR1	13		
FBgn0053288	CG33288	HGNC:1913	OMIM:179710	RCC1	3		
FBgn0037087	CG7519	HGNC:28790		PBDC1	13		
FBgn0037090	Est-Q	HGNC:26741		CES4A	4		
FBgn0037090	Est-Q	HGNC:108	OMIM:100740	ACHE	3	112100	112100[YT BLOOD GROUP ANTIGEN]
FBgn0037090	Est-Q	HGNC:983	OMIM:177400	BCHE	3	617936	617936[BUTYRYLCHOLINESTERASE DEFICIENCY; BCHED]
FBgn0037090	Est-Q	HGNC:26459	OMIM:618678	CES5A	4		
FBgn0037090	Est-Q	HGNC:1863	OMIM:114835	CES1	3	618057	618057[DRUG METABOLISM, ALTERED, CES1-RELATED]
FBgn0037090	Est-Q	HGNC:1864	OMIM:605278	CES2	3		
FBgn0037090	Est-Q	HGNC:1865	OMIM:605279	CES3	4		
FBgn0037092	M6	HGNC:4460	OMIM:601275	GPM6A	13		
FBgn0037092	M6	HGNC:4461	OMIM:300051	GPM6B	11		
FBgn0037092	M6	HGNC:9086	OMIM:300401	PLP1	11	312080,312920	312080[PELIZAEUS-MERZBACHER DISEASE; PMD],312920[SPASTIC PARAPLEGIA 2, X-LINKED; SPG2]
FBgn0037093	Cdk12	HGNC:1780	OMIM:603251	CDK9	3		
FBgn0037093	Cdk12	HGNC:1733	OMIM:603309	CDK13	12	617360	617360[CONGENITAL HEART DEFECTS, DYSMORPHIC FACIAL FEATURES, AND INTELLECTUAL DEVELOPMENTAL DISORDER; CHDFIDD]
FBgn0037093	Cdk12	HGNC:24224	OMIM:615514	CDK12	11		
FBgn0037094	CG7611	HGNC:21208	OMIM:617424	WDR26	13	617616	617616[SKRABAN-DEARDORFF SYNDROME; SKDEAS]
FBgn0053289	ppk5	HGNC:101	OMIM:611741	ASIC3	6		
FBgn0053289	ppk5	HGNC:100	OMIM:602866	ASIC1	6		
FBgn0053289	ppk5	HGNC:21263	OMIM:606715	ASIC4	6		
FBgn0053289	ppk5	HGNC:99	OMIM:601784	ASIC2	5		
FBgn0053289	ppk5	HGNC:17537	OMIM:616693	ASIC5	4		
FBgn0053289	ppk5	HGNC:10599	OMIM:600228	SCNN1A	3	264350,613021,618126	264350[PSEUDOHYPOALDOSTERONISM, TYPE I, AUTOSOMAL RECESSIVE; PHA1B],613021[BRONCHIECTASIS WITH OR WITHOUT ELEVATED SWEAT CHLORIDE 2; BESC2],618126[LIDDLE SYNDROME 3; LIDLS3]
FBgn0053289	ppk5	HGNC:10600	OMIM:600760	SCNN1B	4	177200,211400,264350	177200[LIDDLE SYNDROME 1; LIDLS1],211400[BRONCHIECTASIS WITH OR WITHOUT ELEVATED SWEAT CHLORIDE 1; BESC1],264350[PSEUDOHYPOALDOSTERONISM, TYPE I, AUTOSOMAL RECESSIVE; PHA1B]
FBgn0053289	ppk5	HGNC:10601	OMIM:601328	SCNN1D	3		
FBgn0053289	ppk5	HGNC:10602	OMIM:600761	SCNN1G	3	264350,613071,618114	264350[PSEUDOHYPOALDOSTERONISM, TYPE I, AUTOSOMAL RECESSIVE; PHA1B],613071[BRONCHIECTASIS WITH OR WITHOUT ELEVATED SWEAT CHLORIDE 3; BESC3],618114[LIDDLE SYNDROME 2; LIDLS2]
FBgn0015283	Rpn10	HGNC:9561	OMIM:601648	PSMD4	15		
FBgn0028663	VhaM9.7-b	HGNC:863	OMIM:603931	ATP6V0E1	14		
FBgn0028663	VhaM9.7-b	HGNC:21723	OMIM:611019	ATP6V0E2	12		
FBgn0052438	SMC5	HGNC:20465	OMIM:609386	SMC5	12		
FBgn0052441	EMC10	HGNC:27609	OMIM:614545	EMC10	11	619264	619264[NEURODEVELOPMENTAL DISORDER WITH DYSMORPHIC FACIES AND VARIABLE SEIZURES; NEDDFAS]
FBgn0037102	CRIF	HGNC:29996	OMIM:605162	GADD45GIP1	12		
FBgn0037098	Wnk	HGNC:14544	OMIM:601844	WNK4	7	614491	614491[PSEUDOHYPOALDOSTERONISM, TYPE IIB; PHA2B]
FBgn0037098	Wnk	HGNC:14543	OMIM:300358	WNK3	9		
FBgn0037098	Wnk	HGNC:14542	OMIM:606249	WNK2	7		
FBgn0037098	Wnk	HGNC:14540	OMIM:605232	WNK1	8	201300,614492	201300[NEUROPATHY, HEREDITARY SENSORY AND AUTONOMIC, TYPE IIA; HSAN2A],614492[PSEUDOHYPOALDOSTERONISM, TYPE IIC; PHA2C]
FBgn0029152	Mkrn1	HGNC:7113	OMIM:608426	MKRN2	9		
FBgn0029152	Mkrn1	HGNC:7112	OMIM:607754	MKRN1	11		
FBgn0029152	Mkrn1	HGNC:7114	OMIM:603856	MKRN3	8	615346	615346[PRECOCIOUS PUBERTY, CENTRAL, 2; CPPB2]
FBgn0029152	Mkrn1	HGNC:7115		MKRN4P	4		
FBgn0026371	SAK	HGNC:11397	OMIM:605031	PLK4	15	616171	616171[MICROCEPHALY AND CHORIORETINOPATHY, AUTOSOMAL RECESSIVE, 2; MCCRP2]
FBgn0015239	Hr78	HGNC:7971	OMIM:601529	NR2C1	10		
FBgn0015239	Hr78	HGNC:7972	OMIM:601426	NR2C2	11		
FBgn0014143	croc	HGNC:3735	OMIM:602939	FOXS1	3		
FBgn0014143	croc	HGNC:3801	OMIM:602402	FOXC2	10	153400	153400[LYMPHEDEMA-DISTICHIASIS SYNDROME; LPHDST]
FBgn0014143	croc	HGNC:3817	OMIM:603252	FOXL1	3		
FBgn0014143	croc	HGNC:3800	OMIM:601090	FOXC1	10	601631,602482	601631[ANTERIOR SEGMENT DYSGENESIS 3; ASGD3],602482[AXENFELD-RIEGER SYNDROME, TYPE 3; RIEG3]
FBgn0014143	croc	HGNC:3815	OMIM:601093	FOXI1	3	600791	600791[DEAFNESS, AUTOSOMAL RECESSIVE 4, WITH ENLARGED VESTIBULAR AQUEDUCT; DFNB4]
FBgn0014143	croc	HGNC:32448	OMIM:617202	FOXI2	3		
FBgn0014143	croc	HGNC:20951	OMIM:612788	FOXQ1	3		
FBgn0014143	croc	HGNC:35123	OMIM:612351	FOXI3	3		
FBgn0037081	barc	HGNC:5276	OMIM:300346	HTATSF1	11		
FBgn0002842	sa	HGNC:17300	OMIM:609514	TAF8	6	619972	619972[NEURODEVELOPMENTAL DISORDER WITH SEVERE MOTOR IMPAIRMENT, ABSENT LANGUAGE, CEREBRAL HYPOMYELINATION, AND BRAIN ATROPHY; NEDMLHB]
FBgn0037074	Tbc1d8-9	HGNC:21710	OMIM:618035	TBC1D9	13		
FBgn0037074	Tbc1d8-9	HGNC:24715	OMIM:301027	TBC1D8B	13	301028	301028[NEPHROTIC SYNDROME, TYPE 20; NPHS20]
FBgn0037074	Tbc1d8-9	HGNC:17791		TBC1D8	12		
FBgn0037074	Tbc1d8-9	HGNC:29097	OMIM:618039	TBC1D9B	12		
FBgn0003042	Pc	HGNC:1552	OMIM:602770	CBX2	5	613080	613080[46,XY SEX REVERSAL 5; SRXY5]
FBgn0003042	Pc	HGNC:1556	OMIM:617438	CBX6	8		
FBgn0003042	Pc	HGNC:1557	OMIM:608457	CBX7	6		
FBgn0003042	Pc	HGNC:1554	OMIM:603079	CBX4	6		
FBgn0003042	Pc	HGNC:15962	OMIM:617354	CBX8	9		
FBgn0037070	CG11309	HGNC:29446	OMIM:619045	SERHL2	11		
FBgn0037070	CG11309	HGNC:14408	OMIM:607979	SERHL	6		
FBgn0027945	ppl	HGNC:4208	OMIM:238330	GCSH	15	605899	605899[GLYCINE ENCEPHALOPATHY; GCE]
FBgn0037064	CG9389	HGNC:6050	OMIM:602064	IMPA1	9	617323	617323[INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 59; MRT59]
FBgn0037064	CG9389	HGNC:6051	OMIM:605922	IMPA2	10		
FBgn0037063	CG9391	HGNC:6050	OMIM:602064	IMPA1	14	617323	617323[INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 59; MRT59]
FBgn0037063	CG9391	HGNC:6051	OMIM:605922	IMPA2	12		
FBgn0037108	Alg11	HGNC:32456	OMIM:613666	ALG11	13	613661	613661[CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Ip; CDG1P]
FBgn0037110	ORMDL	HGNC:16038	OMIM:610075	ORMDL3	14		
FBgn0037110	ORMDL	HGNC:16037	OMIM:610074	ORMDL2	13		
FBgn0037110	ORMDL	HGNC:16036	OMIM:610073	ORMDL1	13		
FBgn0043783	CG32444	HGNC:24063	OMIM:137030	GALM	11	618881	618881[GALACTOSEMIA IV; GALAC4]
FBgn0052445	CG32445	HGNC:24063	OMIM:137030	GALM	12	618881	618881[GALACTOSEMIA IV; GALAC4]
FBgn0052446	Atox1	HGNC:798	OMIM:602270	ATOX1	10		
FBgn0037115	CG11249	HGNC:9021	OMIM:179050	PKM	3		
FBgn0037115	CG11249	HGNC:9020	OMIM:609712	PKLR	3	102900,266200	102900[ADENOSINE TRIPHOSPHATE, ELEVATED, OF ERYTHROCYTES],266200[PYRUVATE KINASE DEFICIENCY OF RED CELLS]
FBgn0037121	Polr2H	HGNC:9195	OMIM:606023	POLR2H	15		
FBgn0022936	CycH	HGNC:1594	OMIM:601953	CCNH	14		
FBgn0037134	CG7407	HGNC:7541		MXRA7	3		
FBgn0037135	eIF2A	HGNC:3254	OMIM:609234	EIF2A	12		
FBgn0037138	P5CDh1	HGNC:406	OMIM:606811	ALDH4A1	13	239510	239510[HYPERPROLINEMIA, TYPE II; HYRPRO2]
FBgn0052448	CG32448	HGNC:21401		SMIM8	11		
FBgn0037130	Syn1	HGNC:11168	OMIM:600026	SNTB1	13		
FBgn0037130	Syn1	HGNC:11167	OMIM:601017	SNTA1	7	612955	612955[LONG QT SYNDROME 12; LQT12]
FBgn0037130	Syn1	HGNC:11169	OMIM:600027	SNTB2	13		
FBgn0037116	Als2	HGNC:20605	OMIM:612402	ALS2CL	9		
FBgn0037116	Als2	HGNC:443	OMIM:606352	ALS2	12	205100,606353,607225	205100[AMYOTROPHIC LATERAL SCLEROSIS 2, JUVENILE; ALS2],606353[PRIMARY LATERAL SCLEROSIS, JUVENILE; PLSJ],607225[SPASTIC PARALYSIS, INFANTILE-ONSET ASCENDING; IAHSP]
FBgn0037109	MED1	HGNC:9234	OMIM:604311	MED1	12		
FBgn0037105	S1P	HGNC:15456	OMIM:603355	MBTPS1	14	618392	618392[SPONDYLOEPIPHYSEAL DYSPLASIA, KONDO-FU TYPE; SEDKF]
FBgn0037140	SLC22A	HGNC:25417	OMIM:611699	SVOP	3		
FBgn0037140	SLC22A	HGNC:8494	OMIM:604047	SLC22A13	5		
FBgn0037140	SLC22A	HGNC:10970	OMIM:607582	SLC22A6	5		
FBgn0037140	SLC22A	HGNC:20302	OMIM:608276	SLC22A16	4		
FBgn0037140	SLC22A	HGNC:10968	OMIM:604190	SLC22A4	5	180300	180300[RHEUMATOID ARTHRITIS; RA]
FBgn0037140	SLC22A	HGNC:10969	OMIM:603377	SLC22A5	5	212140	212140[CARNITINE DEFICIENCY, SYSTEMIC PRIMARY; CDSP]
FBgn0037140	SLC22A	HGNC:8495	OMIM:604048	SLC22A14	5		
FBgn0037140	SLC22A	HGNC:10971	OMIM:604995	SLC22A7	3		
FBgn0037140	SLC22A	HGNC:10972	OMIM:607581	SLC22A8	4		
FBgn0037140	SLC22A	HGNC:10966	OMIM:602608	SLC22A2	4		
FBgn0037140	SLC22A	HGNC:32935	OMIM:610792	SLC22A25	4		
FBgn0037140	SLC22A	HGNC:10963	OMIM:602607	SLC22A1	5		
FBgn0037140	SLC22A	HGNC:10967	OMIM:604842	SLC22A3	5		
FBgn0037140	SLC22A	HGNC:17989	OMIM:607096	SLC22A12	5	220150	220150[HYPOURICEMIA, RENAL, 1; RHUC1]
FBgn0037140	SLC22A	HGNC:18120	OMIM:607097	SLC22A11	5		
FBgn0037140	SLC22A	HGNC:16261	OMIM:607579	SLC22A9	4		
FBgn0037140	SLC22A	HGNC:28542	OMIM:611698	SLC22A24	4		
FBgn0037140	SLC22A	HGNC:18057	OMIM:607580	SLC22A10	4		
FBgn0037142	CG14562	HGNC:15597	OMIM:606118	HPS3	11	614072	614072[HERMANSKY-PUDLAK SYNDROME 3; HPS3]
FBgn0037144	CG7458	HGNC:8494	OMIM:604047	SLC22A13	5		
FBgn0037144	CG7458	HGNC:10970	OMIM:607582	SLC22A6	5		
FBgn0037144	CG7458	HGNC:20302	OMIM:608276	SLC22A16	4		
FBgn0037144	CG7458	HGNC:10968	OMIM:604190	SLC22A4	5	180300	180300[RHEUMATOID ARTHRITIS; RA]
FBgn0037144	CG7458	HGNC:10969	OMIM:603377	SLC22A5	5	212140	212140[CARNITINE DEFICIENCY, SYSTEMIC PRIMARY; CDSP]
FBgn0037144	CG7458	HGNC:8495	OMIM:604048	SLC22A14	5		
FBgn0037144	CG7458	HGNC:10971	OMIM:604995	SLC22A7	3		
FBgn0037144	CG7458	HGNC:10972	OMIM:607581	SLC22A8	4		
FBgn0037144	CG7458	HGNC:10966	OMIM:602608	SLC22A2	4		
FBgn0037144	CG7458	HGNC:32935	OMIM:610792	SLC22A25	4		
FBgn0037144	CG7458	HGNC:10963	OMIM:602607	SLC22A1	5		
FBgn0037144	CG7458	HGNC:10967	OMIM:604842	SLC22A3	5		
FBgn0037144	CG7458	HGNC:23095	OMIM:611461	SLC22A17	3		
FBgn0037144	CG7458	HGNC:17989	OMIM:607096	SLC22A12	5	220150	220150[HYPOURICEMIA, RENAL, 1; RHUC1]
FBgn0037144	CG7458	HGNC:18120	OMIM:607097	SLC22A11	5		
FBgn0037144	CG7458	HGNC:16261	OMIM:607579	SLC22A9	4		
FBgn0037144	CG7458	HGNC:28542	OMIM:611698	SLC22A24	4		
FBgn0037144	CG7458	HGNC:18057	OMIM:607580	SLC22A10	4		
FBgn0029091	Chs2	HGNC:4818	OMIM:601463	HAS1	4		
FBgn0029091	Chs2	HGNC:4819	OMIM:601636	HAS2	4		
FBgn0029091	Chs2	HGNC:4820	OMIM:602428	HAS3	4		
FBgn0037146	P5CS	HGNC:9722	OMIM:138250	ALDH18A1	15	219150,601162,616586,616603	219150[CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IIIA; ARCL3A],601162[SPASTIC PARAPLEGIA 9A, AUTOSOMAL DOMINANT; SPG9A],616586[SPASTIC PARAPLEGIA 9B, AUTOSOMAL RECESSIVE; SPG9B],616603[CUTIS LAXA, AUTOSOMAL DOMINANT 3; ADCL3]
FBgn0000045	Act79B	HGNC:160	OMIM:612458	ACTL6B	3	618468,618470	618468[DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 76; DEE76],618470[INTELLECTUAL DEVELOPMENTAL DISORDER WITH SEVERE SPEECH AND AMBULATION DEFECTS; IDDSSAD]
FBgn0000045	Act79B	HGNC:17780	OMIM:614835	ACTBL2	6		
FBgn0000045	Act79B	HGNC:168	OMIM:605144	ACTR1B	4		
FBgn0000045	Act79B	HGNC:129	OMIM:102610	ACTA1	3	161800,255310,616852	161800[NEMALINE MYOPATHY 3; NEM3],255310[MYOPATHY, CONGENITAL, WITH FIBER-TYPE DISPROPORTION; CFTD],616852[MYOPATHY, SCAPULOHUMEROPERONEAL; SHPM]
FBgn0000045	Act79B	HGNC:132	OMIM:102630	ACTB	6	243310,607371	243310[BARAITSER-WINTER SYNDROME 1; BRWS1],607371[DYSTONIA, JUVENILE-ONSET; DJO]
FBgn0000045	Act79B	HGNC:130	OMIM:102620	ACTA2	5	611788,613834,614042	611788[AORTIC ANEURYSM, FAMILIAL THORACIC 6; AAT6],613834[MULTISYSTEMIC SMOOTH MUSCLE DYSFUNCTION SYNDROME; MSMDS],614042[MOYAMOYA DISEASE 5; MYMY5]
FBgn0000045	Act79B	HGNC:143	OMIM:102540	ACTC1	4	612098,612794,613424	612098[CARDIOMYOPATHY, FAMILIAL HYPERTROPHIC, 11; CMH11],612794[ATRIAL SEPTAL DEFECT 5; ASD5],613424[CARDIOMYOPATHY, DILATED, 1R; CMD1R]
FBgn0000045	Act79B	HGNC:167	OMIM:605143	ACTR1A	3		
FBgn0000045	Act79B	HGNC:144	OMIM:102560	ACTG1	4	604717,614583	604717[DEAFNESS, AUTOSOMAL DOMINANT 20; DFNA20],614583[BARAITSER-WINTER SYNDROME 2; BRWS2]
FBgn0000045	Act79B	HGNC:145	OMIM:102545	ACTG2	5	155310,619431	155310[VISCERAL MYOPATHY 1; VSCM1],619431[MEGACYSTIS-MICROCOLON-INTESTINAL HYPOPERISTALSIS SYNDROME 5; MMIHS5]
FBgn0000045	Act79B	HGNC:37093		POTEI	5		
FBgn0000045	Act79B	HGNC:37094		POTEJ	5		
FBgn0000045	Act79B	HGNC:33905		POTEF	5		
FBgn0000045	Act79B	HGNC:33895	OMIM:608914	POTEE	4		
FBgn0000045	Act79B	HGNC:24022	OMIM:608534	ACTRT3	5		
FBgn0000045	Act79B	HGNC:24027	OMIM:300487	ACTRT1	3		
FBgn0000045	Act79B	HGNC:24026	OMIM:608535	ACTRT2	3		
FBgn0000045	Act79B	HGNC:24018		ACTL8	3		
FBgn0000045	Act79B	HGNC:28494	OMIM:619251	ACTL9	4	619258	619258[SPERMATOGENIC FAILURE 53; SPGF53]
FBgn0000045	Act79B	HGNC:16127		ACTL10	4		
FBgn0000045	Act79B	HGNC:162	OMIM:604304	ACTL7B	3		
FBgn0000045	Act79B	HGNC:161	OMIM:604303	ACTL7A	3		
FBgn0000100	RpLP0	HGNC:10371	OMIM:180510	RPLP0	15		
FBgn0000100	RpLP0	HGNC:36404		RPLP0P6	4		
FBgn0037151	CG7130	HGNC:14886	OMIM:611327	DNAJB4	3		
FBgn0027532	CG7139	HGNC:26916	OMIM:615788	N4BP2L2	5		
FBgn0027532	CG7139	HGNC:29851	OMIM:619139	N4BP2	12		
FBgn0027532	CG7139	HGNC:25037		N4BP2L1	5		
FBgn0037147	CG7140	HGNC:4057	OMIM:305900	G6PD	6	300908,611162	300908[ANEMIA, NONSPHEROCYTIC HEMOLYTIC, DUE TO G6PD DEFICIENCY],611162[MALARIA, SUSCEPTIBILITY TO]
FBgn0037147	CG7140	HGNC:4795	OMIM:138090	H6PD	4	604931	604931[CORTISONE REDUCTASE DEFICIENCY 1; CORTRD1]
FBgn0037141	PolH	HGNC:9181	OMIM:603968	POLH	12	278750	278750[XERODERMA PIGMENTOSUM, VARIANT TYPE; XPV]
FBgn0037141	PolH	HGNC:9182	OMIM:605252	POLI	3		
FBgn0015075	Ddx1	HGNC:2734	OMIM:601257	DDX1	14		
FBgn0004179	Csp	HGNC:24138	OMIM:613945	DNAJC5B	10		
FBgn0004179	Csp	HGNC:16235	OMIM:611203	DNAJC5	12	162350	162350[CEROID LIPOFUSCINOSIS, NEURONAL, 4 (KUFS TYPE); CLN4]
FBgn0004179	Csp	HGNC:24844	OMIM:613946	DNAJC5G	5		
FBgn0025702	Srpk79D	HGNC:11305	OMIM:601939	SRPK1	8		
FBgn0025702	Srpk79D	HGNC:11306	OMIM:602980	SRPK2	8		
FBgn0025702	Srpk79D	HGNC:11402	OMIM:301002	SRPK3	9		
FBgn0027086	IleRS	HGNC:5330	OMIM:600709	IARS	14	617093	617093[GROWTH RETARDATION, IMPAIRED INTELLECTUAL DEVELOPMENT, HYPOTONIA, AND HEPATOPATHY; GRIDHH]
FBgn0027086	IleRS	HGNC:29685	OMIM:612801	IARS2	3	616007	616007[CATARACTS, GROWTH HORMONE DEFICIENCY, SENSORY NEUROPATHY, SENSORINEURAL HEARING LOSS, AND SKELETAL DYSPLASIA; CAGSSS]
FBgn0037162	CG11449	HGNC:17229	OMIM:605152	CFAP45	12	619608	619608[HETEROTAXY, VISCERAL, 11, AUTOSOMAL, WITH MALE INFERTILITY; HTX11]
FBgn0037164	CG11438	HGNC:9230	OMIM:607126	PLPP2	9		
FBgn0037164	CG11438	HGNC:9229	OMIM:607125	PLPP3	9		
FBgn0037164	CG11438	HGNC:9228	OMIM:607124	PLPP1	9		
FBgn0037164	CG11438	HGNC:23496	OMIM:607813	PLPPR4	3		
FBgn0037164	CG11438	HGNC:25993	OMIM:619590	PLPPR1	3		
FBgn0037164	CG11438	HGNC:29566	OMIM:619591	PLPPR2	3		
FBgn0037164	CG11438	HGNC:23497	OMIM:610391	PLPPR3	3		
FBgn0037164	CG11438	HGNC:31703	OMIM:617287	PLPPR5	3		
FBgn0037165	CG11437	HGNC:9230	OMIM:607126	PLPP2	6		
FBgn0037165	CG11437	HGNC:9229	OMIM:607125	PLPP3	6		
FBgn0037165	CG11437	HGNC:9228	OMIM:607124	PLPP1	6		
FBgn0037165	CG11437	HGNC:23496	OMIM:607813	PLPPR4	4		
FBgn0037165	CG11437	HGNC:25993	OMIM:619590	PLPPR1	4		
FBgn0037165	CG11437	HGNC:29566	OMIM:619591	PLPPR2	4		
FBgn0037165	CG11437	HGNC:23497	OMIM:610391	PLPPR3	4		
FBgn0037165	CG11437	HGNC:31703	OMIM:617287	PLPPR5	4		
FBgn0037166	CG11426	HGNC:9230	OMIM:607126	PLPP2	11		
FBgn0037166	CG11426	HGNC:9229	OMIM:607125	PLPP3	10		
FBgn0037166	CG11426	HGNC:9228	OMIM:607124	PLPP1	10		
FBgn0037166	CG11426	HGNC:23496	OMIM:607813	PLPPR4	3		
FBgn0037166	CG11426	HGNC:25993	OMIM:619590	PLPPR1	3		
FBgn0037166	CG11426	HGNC:29566	OMIM:619591	PLPPR2	3		
FBgn0037166	CG11426	HGNC:23497	OMIM:610391	PLPPR3	3		
FBgn0037166	CG11426	HGNC:31703	OMIM:617287	PLPPR5	3		
FBgn0037167	CG11425	HGNC:9230	OMIM:607126	PLPP2	6		
FBgn0037167	CG11425	HGNC:9229	OMIM:607125	PLPP3	6		
FBgn0037167	CG11425	HGNC:9228	OMIM:607124	PLPP1	7		
FBgn0037167	CG11425	HGNC:23496	OMIM:607813	PLPPR4	3		
FBgn0037167	CG11425	HGNC:25993	OMIM:619590	PLPPR1	3		
FBgn0037167	CG11425	HGNC:29566	OMIM:619591	PLPPR2	3		
FBgn0037167	CG11425	HGNC:23497	OMIM:610391	PLPPR3	3		
FBgn0037167	CG11425	HGNC:31703	OMIM:617287	PLPPR5	3		
FBgn0037163	laza	HGNC:9230	OMIM:607126	PLPP2	7		
FBgn0037163	laza	HGNC:9229	OMIM:607125	PLPP3	8		
FBgn0037163	laza	HGNC:9228	OMIM:607124	PLPP1	8		
FBgn0037163	laza	HGNC:23531		PLPP4	4		
FBgn0037163	laza	HGNC:25026	OMIM:610626	PLPP5	5		
FBgn0037163	laza	HGNC:23496	OMIM:607813	PLPPR4	4		
FBgn0037163	laza	HGNC:25993	OMIM:619590	PLPPR1	4		
FBgn0037163	laza	HGNC:29566	OMIM:619591	PLPPR2	4		
FBgn0037163	laza	HGNC:23497	OMIM:610391	PLPPR3	4		
FBgn0037163	laza	HGNC:31703	OMIM:617287	PLPPR5	4		
FBgn0004449	Ten-m	HGNC:29943	OMIM:610119	TENM2	13		
FBgn0004449	Ten-m	HGNC:8117	OMIM:300588	TENM1	13		
FBgn0004449	Ten-m	HGNC:29945	OMIM:610084	TENM4	12	616736	616736[TREMOR, HEREDITARY ESSENTIAL, 5; ETM5]
FBgn0004449	Ten-m	HGNC:29944	OMIM:610083	TENM3	12	615145	615145[MICROPHTHALMIA, ISOLATED, WITH COLOBOMA 9; MCOPCB9]
FBgn0011771	Hem	HGNC:4862	OMIM:141180	NCKAP1L	9	618982	618982[IMMUNODEFICIENCY 72 WITH AUTOINFLAMMATION; IMD72]
FBgn0011771	Hem	HGNC:7666	OMIM:604891	NCKAP1	14		
FBgn0037156	CG11523	HGNC:20343	OMIM:616605	GSKIP	13		
FBgn0028500	Rich	HGNC:17686	OMIM:610354	RIC1	13	618761	618761[CATIFA SYNDROME; CATIFA]
FBgn0037170	Trxr2	HGNC:12437	OMIM:601112	TXNRD1	5		
FBgn0037170	Trxr2	HGNC:18155	OMIM:606448	TXNRD2	12	617825	617825[GLUCOCORTICOID DEFICIENCY 5; GCCD5]
FBgn0037170	Trxr2	HGNC:4623	OMIM:138300	GSR	6	618660	618660[HEMOLYTIC ANEMIA DUE TO GLUTATHIONE REDUCTASE DEFICIENCY]
FBgn0037170	Trxr2	HGNC:20667	OMIM:606235	TXNRD3	3		
FBgn0037172	ND-B14.5AL	HGNC:7691	OMIM:602139	NDUFA7	12		
FBgn0037185	CG11367	HGNC:25441		TMEM64	12		
FBgn0260481	CG32454	HGNC:28052	OMIM:613553	XPNPEP3	3	613159	613159[NEPHRONOPHTHISIS-LIKE NEPHROPATHY 1; NPHPL1]
FBgn0037188	CG7369	HGNC:24246	OMIM:614531	RASGEF1A	8		
FBgn0037188	CG7369	HGNC:24881	OMIM:614532	RASGEF1B	14		
FBgn0037188	CG7369	HGNC:27400		RASGEF1C	10		
FBgn0052451	SPoCk	HGNC:813	OMIM:601929	ATP2A3	3		
FBgn0052451	SPoCk	HGNC:29103	OMIM:613082	ATP2C2	11		
FBgn0052451	SPoCk	HGNC:812	OMIM:108740	ATP2A2	4	101900,124200	101900[ACROKERATOSIS VERRUCIFORMIS; AKV],124200[DARIER-WHITE DISEASE; DAR]
FBgn0052451	SPoCk	HGNC:13211	OMIM:604384	ATP2C1	15	169600	169600[BENIGN CHRONIC PEMPHIGUS; BCPM]
FBgn0052451	SPoCk	HGNC:811	OMIM:108730	ATP2A1	4	601003	601003[BRODY DISEASE; BROD]
FBgn0037186	CG11241	HGNC:14404	OMIM:614682	ETNPPL	3		
FBgn0037186	CG11241	HGNC:28249	OMIM:614683	PHYKPL	3	615011	615011[PHOSPHOHYDROXYLYSINURIA; PHLU]
FBgn0037186	CG11241	HGNC:14412	OMIM:612471	AGXT2	15	210100	210100[BETA-AMINOISOBUTYRIC ACIDURIA; BAIBA]
FBgn0037184	CG14450	HGNC:26223	OMIM:616422	TEFM	9		
FBgn0037182	ArfGAP3	HGNC:661	OMIM:612439	ARFGAP3	12		
FBgn0037182	ArfGAP3	HGNC:13504	OMIM:606908	ARFGAP2	14		
FBgn0053169	CG33169	HGNC:24810	OMIM:609477	SMCO4	6		
FBgn0037200	CG11109	HGNC:7867	OMIM:164031	NOP2	3		
FBgn0037200	CG11109	HGNC:23529	OMIM:617199	NSUN6	14		
FBgn0037202	Ssl1	HGNC:4656	OMIM:601748	GTF2H2	8		
FBgn0037202	Ssl1	HGNC:35418		GTF2H2C_2	11		
FBgn0037202	Ssl1	HGNC:31394		GTF2H2C	8		
FBgn0037203	slif	HGNC:11060	OMIM:601872	SLC7A2	11		
FBgn0037203	slif	HGNC:11057	OMIM:104615	SLC7A1	13		
FBgn0037203	slif	HGNC:11061	OMIM:300443	SLC7A3	12		
FBgn0037203	slif	HGNC:29326	OMIM:615720	SLC7A14	4	615725	615725[RETINITIS PIGMENTOSA 68; RP68]
FBgn0037203	slif	HGNC:11062	OMIM:603752	SLC7A4	6		
FBgn0037205	BoYb	HGNC:25044		TDRD12	3		
FBgn0010348	Arf1	HGNC:652	OMIM:103180	ARF1	12	618185	618185[PERIVENTRICULAR NODULAR HETEROTOPIA 8; PVNH8]
FBgn0010348	Arf1	HGNC:655	OMIM:601177	ARF4	4		
FBgn0010348	Arf1	HGNC:658	OMIM:103188	ARF5	4		
FBgn0010348	Arf1	HGNC:654	OMIM:103190	ARF3	9		
FBgn0010348	Arf1	HGNC:32387		ARL17B	4		
FBgn0037199	EMC4	HGNC:28032	OMIM:616245	EMC4	14		
FBgn0037402	Vha14-2	HGNC:16832	OMIM:607160	ATP6V1F	8		
FBgn0037408	NPFR	HGNC:7956	OMIM:162641	NPY1R	3		
FBgn0037408	NPFR	HGNC:9329	OMIM:601790	NPY4R	4		
FBgn0051559	CG31559	HGNC:31673	OMIM:613283	GRXCR1	9	613285	613285[DEAFNESS, AUTOSOMAL RECESSIVE 25; DFNB25]
FBgn0051559	CG31559	HGNC:33862	OMIM:615762	GRXCR2	4	615837	615837[DEAFNESS, AUTOSOMAL RECESSIVE 101; DFNB101]
FBgn0037396	CG11459	HGNC:2538	OMIM:603308	CTSV	4		
FBgn0037396	CG11459	HGNC:2537	OMIM:116880	CTSL	4		
FBgn0037396	CG11459	HGNC:2536	OMIM:601105	CTSK	3	265800	265800[PYCNODYSOSTOSIS]
FBgn0037396	CG11459	HGNC:2545	OMIM:116845	CTSS	3		
FBgn0037374	jagn	HGNC:26926	OMIM:616012	JAGN1	13	616022	616022[NEUTROPENIA, SEVERE CONGENITAL, 6, AUTOSOMAL RECESSIVE; SCN6]
FBgn0037375	kat-60L1	HGNC:6216	OMIM:606696	KATNA1	8		
FBgn0037375	kat-60L1	HGNC:28361	OMIM:614764	KATNAL1	9		
FBgn0028690	Rpn5	HGNC:9557	OMIM:604450	PSMD12	15	617516	617516[STANKIEWICZ-ISIDOR SYNDROME; STISS]
FBgn0037377	CG1218	HGNC:26051	OMIM:616614	HPF1	14		
FBgn0037379	CG10979	HGNC:27267		ZNF800	9		
FBgn0037384	dgrn	HGNC:10067	OMIM:602850	RNF4	9		
FBgn0037386	CG1208	HGNC:11011	OMIM:606813	SLC2A6	6		
FBgn0037386	CG1208	HGNC:13812	OMIM:605245	SLC2A8	8		
FBgn0037386	CG1208	HGNC:18301	OMIM:611039	SLC2A14	3		
FBgn0037386	CG1208	HGNC:11005	OMIM:138140	SLC2A1	3	601042,606777,608885,612126,614847	601042[DYSTONIA 9; DYT9],606777[GLUT1 DEFICIENCY SYNDROME 1; GLUT1DS1],608885[STOMATIN-DEFICIENT CRYOHYDROCYTOSIS WITH NEUROLOGIC DEFECTS; SDCHCN],612126[GLUT1 DEFICIENCY SYNDROME 2; GLUT1DS2],614847[EPILEPSY, IDIOPATHIC GENERALIZED, SUSCEPTIBILITY TO, 12; EIG12]
FBgn0037386	CG1208	HGNC:11009	OMIM:138190	SLC2A4	3		
FBgn0037386	CG1208	HGNC:11006	OMIM:138160	SLC2A2	3	125853,227810	125853[TYPE 2 DIABETES MELLITUS; T2D],227810[FANCONI-BICKEL SYNDROME; FBS]
FBgn0037386	CG1208	HGNC:11007	OMIM:138170	SLC2A3	3		
FBgn0037386	CG1208	HGNC:18067	OMIM:610372	SLC2A12	3		
FBgn0037386	CG1208	HGNC:13444	OMIM:606145	SLC2A10	3	208050	208050[ARTERIAL TORTUOSITY SYNDROME; ATORS]
FBgn0037387	CG1213	HGNC:11011	OMIM:606813	SLC2A6	4		
FBgn0037387	CG1213	HGNC:13812	OMIM:605245	SLC2A8	5		
FBgn0037387	CG1213	HGNC:18067	OMIM:610372	SLC2A12	3		
FBgn0028436	ECSIT	HGNC:29548	OMIM:608388	ECSIT	14		
FBgn0037395	CG10280	HGNC:31704	OMIM:608860	ASTL	9	619643	619643[OOCYTE MATURATION DEFECT 11; OOMD11]
FBgn0003261	Rm62	HGNC:2740	OMIM:608469	DDX17	9		
FBgn0003261	Rm62	HGNC:2746	OMIM:180630	DDX5	8		
FBgn0037391	CG2017	HGNC:4669	OMIM:602245	GTPBP1	3		
FBgn0037391	CG2017	HGNC:4670	OMIM:607434	GTPBP2	15	617988	617988[JABERI-ELAHI SYNDROME; JABELS]
FBgn0029088	disp	HGNC:19712	OMIM:607503	DISP2	12		
FBgn0029088	disp	HGNC:19711	OMIM:607502	DISP1	15		
FBgn0029088	disp	HGNC:29251	OMIM:611251	DISP3	3		
FBgn0037383	Sec20	HGNC:1082	OMIM:603291	BNIP1	14		
FBgn0037382	Hpr1	HGNC:19070	OMIM:606930	THOC1	14		
FBgn0037376	Hat1	HGNC:4821	OMIM:603053	HAT1	14		
FBgn0037372	CG2091	HGNC:29812	OMIM:610534	DCPS	15	616459	616459[AL-RAQAD SYNDROME; ARS]
FBgn0037329	POLDIP2	HGNC:23781	OMIM:611519	POLDIP2	12		
FBgn0011715	Snr1	HGNC:11103	OMIM:601607	SMARCB1	15	162091,609322,614608	162091[SCHWANNOMATOSIS 1; SWNTS1],609322[RHABDOID TUMOR PREDISPOSITION SYNDROME 1; RTPS1],614608[COFFIN-SIRIS SYNDROME 3; CSS3]
FBgn0037332	Hcs	HGNC:4976	OMIM:609018	HLCS	12	253270	253270[HOLOCARBOXYLASE SYNTHETASE DEFICIENCY]
FBgn0051550	CG31550	HGNC:18643	OMIM:607992	SUGP1	11		
FBgn0051550	CG31550	HGNC:18641	OMIM:607993	SUGP2	3		
FBgn0010051	Itpr	HGNC:6182	OMIM:147267	ITPR3	11	222100	222100[TYPE 1 DIABETES MELLITUS; T1D]
FBgn0010051	Itpr	HGNC:6181	OMIM:600144	ITPR2	12	106190	106190[ANHIDROSIS, ISOLATED, WITH NORMAL SWEAT GLANDS; ANHD]
FBgn0010051	Itpr	HGNC:6180	OMIM:147265	ITPR1	14	117360,206700,606658	117360[SPINOCEREBELLAR ATAXIA 29; SCA29],206700[GILLESPIE SYNDROME; GLSP],606658[SPINOCEREBELLAR ATAXIA 15; SCA15]
FBgn0037338	Snm1	HGNC:17660	OMIM:609682	DCLRE1A	10		
FBgn0037341	CG12746	HGNC:9230	OMIM:607126	PLPP2	3		
FBgn0037341	CG12746	HGNC:9229	OMIM:607125	PLPP3	4		
FBgn0037341	CG12746	HGNC:9228	OMIM:607124	PLPP1	3		
FBgn0037341	CG12746	HGNC:23531		PLPP4	13		
FBgn0037341	CG12746	HGNC:25026	OMIM:610626	PLPP5	15		
FBgn0037341	CG12746	HGNC:23496	OMIM:607813	PLPPR4	3		
FBgn0037341	CG12746	HGNC:25993	OMIM:619590	PLPPR1	3		
FBgn0037341	CG12746	HGNC:29566	OMIM:619591	PLPPR2	3		
FBgn0037341	CG12746	HGNC:23497	OMIM:610391	PLPPR3	3		
FBgn0037341	CG12746	HGNC:31703	OMIM:617287	PLPPR5	3		
FBgn0041191	Rheb	HGNC:21166	OMIM:618956	RHEBL1	7		
FBgn0041191	Rheb	HGNC:10011	OMIM:601293	RHEB	12		
FBgn0037345	PolZ2	HGNC:6764	OMIM:604094	MAD2L2	12	617243	617243[FANCONI ANEMIA, COMPLEMENTATION GROUP V; FANCV]
FBgn0037347	SecS	HGNC:30605	OMIM:613009	SEPSECS	13	613811	613811[PONTOCEREBELLAR HYPOPLASIA, TYPE 2D; PCH2D]
FBgn0019637	Atu	HGNC:30401	OMIM:610507	LEO1	10		
FBgn0037351	RpL13A	HGNC:10304	OMIM:619225	RPL13A	14		
FBgn0051549	CG31549	HGNC:18349	OMIM:615194	DHRS2	3		
FBgn0051549	CG31549	HGNC:16985	OMIM:611596	DHRS4	3		
FBgn0051549	CG31549	HGNC:19731	OMIM:615196	DHRS4L2	3		
FBgn0051549	CG31549	HGNC:23238	OMIM:612832	HSD17B14	4		
FBgn0037354	CG12171	HGNC:18349	OMIM:615194	DHRS2	3		
FBgn0037354	CG12171	HGNC:16985	OMIM:611596	DHRS4	3		
FBgn0037354	CG12171	HGNC:3554	OMIM:601417	HSD17B8	3		
FBgn0037354	CG12171	HGNC:19731	OMIM:615196	DHRS4L2	3		
FBgn0037354	CG12171	HGNC:23238	OMIM:612832	HSD17B14	5		
FBgn0037354	CG12171	HGNC:25891	OMIM:619394	CBR4	3		
FBgn0037356	CG12170	HGNC:26063	OMIM:610324	OXSM	13		
FBgn0037359	MED27	HGNC:2377	OMIM:605044	MED27	14	619286	619286[NEURODEVELOPMENTAL DISORDER WITH SPASTICITY, CATARACTS, AND CEREBELLAR HYPOPLASIA; NEDSCAC]
FBgn0046222	Wdr33	HGNC:25651	OMIM:618082	WDR33	11		
FBgn0037363	Atg17	HGNC:15574	OMIM:606837	RB1CC1	12	114480	114480[BREAST CANCER]
FBgn0037368	CG1239	HGNC:20247	OMIM:611478	MEPCE	11		
FBgn0037370	CG1236	HGNC:4570	OMIM:604296	GRHPR	14	260000	260000[HYPEROXALURIA, PRIMARY, TYPE II; HP2]
FBgn0027497	Madm	HGNC:19339	OMIM:615563	NRBP2	11		
FBgn0027497	Madm	HGNC:7993	OMIM:606010	NRBP1	15		
FBgn0037371	Sym	HGNC:22935	OMIM:602388	SYMPK	14		
FBgn0037369	CG2100	HGNC:17341	OMIM:612907	TRNT1	15	616084,616959	616084[SIDEROBLASTIC ANEMIA WITH B-CELL IMMUNODEFICIENCY, PERIODIC FEVERS, AND DEVELOPMENTAL DELAY; SIFD],616959[RETINITIS PIGMENTOSA AND ERYTHROCYTIC MICROCYTOSIS; RPEM]
FBgn0004878	cas	HGNC:26002	OMIM:609895	CASZ1	7		
FBgn0037365	CG2104	HGNC:9308	OMIM:600756	PTPA	8		
FBgn0037364	Rab23	HGNC:14263	OMIM:606144	RAB23	14	201000	201000[CARPENTER SYNDROME 1; CRPT1]
FBgn0010772	Xe7	HGNC:18783	OMIM:312095	AKAP17A	11		
FBgn0037360	CG2182	HGNC:19357	OMIM:612275	GGNBP2	12		
FBgn0037358	elm	HGNC:16920	OMIM:602293	CIB1	3	618267	618267[EPIDERMODYSPLASIA VERRUCIFORMIS, SUSCEPTIBILITY TO, 3; EV3]
FBgn0037358	elm	HGNC:24927		CHP2	8		
FBgn0037358	elm	HGNC:33703	OMIM:610646	CIB4	3		
FBgn0037358	elm	HGNC:9318	OMIM:613821	PPP3R2	3		
FBgn0037358	elm	HGNC:17433	OMIM:606988	CHP1	13	618438	618438[SPASTIC ATAXIA 9, AUTOSOMAL RECESSIVE; SPAX9]
FBgn0037358	elm	HGNC:26065	OMIM:611585	TESC	3		
FBgn0027951	MTA1-like	HGNC:23784	OMIM:609050	MTA3	13		
FBgn0027951	MTA1-like	HGNC:7410	OMIM:603526	MTA1	12		
FBgn0027951	MTA1-like	HGNC:7411	OMIM:603947	MTA2	12		
FBgn0051548	CG31548	HGNC:18349	OMIM:615194	DHRS2	3		
FBgn0051548	CG31548	HGNC:16985	OMIM:611596	DHRS4	3		
FBgn0051548	CG31548	HGNC:19731	OMIM:615196	DHRS4L2	3		
FBgn0051548	CG31548	HGNC:23238	OMIM:612832	HSD17B14	5		
FBgn0051546	CG31546	HGNC:18349	OMIM:615194	DHRS2	3		
FBgn0051546	CG31546	HGNC:16985	OMIM:611596	DHRS4	3		
FBgn0051546	CG31546	HGNC:19731	OMIM:615196	DHRS4L2	3		
FBgn0051546	CG31546	HGNC:23238	OMIM:612832	HSD17B14	5		
FBgn0044823	Spec2	HGNC:17719	OMIM:619456	CDC42SE1	7		
FBgn0044823	Spec2	HGNC:18547	OMIM:619457	CDC42SE2	12		
FBgn0037350	Dph4	HGNC:26979	OMIM:611072	DNAJC24	10		
FBgn0017550	Rga	HGNC:7878	OMIM:604909	CNOT2	11	618608	618608[INTELLECTUAL DEVELOPMENTAL DISORDER WITH NASAL SPEECH, DYSMORPHIC FACIES, AND VARIABLE SKELETAL ANOMALIES; IDNADFS]
FBgn0014366	noi	HGNC:10767	OMIM:605596	SF3A3	15		
FBgn0037344	CG2926	HGNC:24351	OMIM:611780	PHRF1	10		
FBgn0037344	CG2926	HGNC:10784	OMIM:603668	SCAF11	3		
FBgn0037344	CG2926	HGNC:30403	OMIM:617264	SCAF1	4		
FBgn0037342	CG2931	HGNC:28117	OMIM:613232	RBM42	11		
FBgn0037340	CG14671	HGNC:28178	OMIM:613734	CCDC115	8	616828	616828[CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIo; CDG2O]
FBgn0037339	Pi4KIIalpha	HGNC:30031	OMIM:609763	PI4K2A	12		
FBgn0037339	Pi4KIIalpha	HGNC:18215	OMIM:612101	PI4K2B	11		
FBgn0010399	Nmdar1	HGNC:4584	OMIM:138249	GRIN1	14	614254,617820,619814	614254[NEURODEVELOPMENTAL DISORDER WITH OR WITHOUT HYPERKINETIC MOVEMENTS AND SEIZURES, AUTOSOMAL DOMINANT; NDHMSD],617820[NEURODEVELOPMENTAL DISORDER WITH OR WITHOUT HYPERKINETIC MOVEMENTS AND SEIZURES, AUTOSOMAL RECESSIVE; NDHMSR],619814[DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 101; DEE101]
FBgn0051547	NKCC	HGNC:10910	OMIM:600839	SLC12A1	9	601678	601678[BARTTER SYNDROME, TYPE 1, ANTENATAL; BARTS1]
FBgn0051547	NKCC	HGNC:10911	OMIM:600840	SLC12A2	9	619080,619081,619083	619080[KILQUIST SYNDROME; KILQS],619081[DEAFNESS, AUTOSOMAL DOMINANT 78; DFNA78],619083[DELPIRE-MCNEILL SYNDROME; DELMNES]
FBgn0051547	NKCC	HGNC:10912	OMIM:600968	SLC12A3	10	263800	263800[GITELMAN SYNDROME; GTLMNS]
FBgn0015402	ksr	HGNC:18610	OMIM:610737	KSR2	14		
FBgn0015402	ksr	HGNC:6465	OMIM:601132	KSR1	12		
FBgn0025825	HDAC3	HGNC:4854	OMIM:605166	HDAC3	11		
FBgn0025825	HDAC3	HGNC:4853	OMIM:605164	HDAC2	3		
FBgn0025825	HDAC3	HGNC:4852	OMIM:601241	HDAC1	3		
FBgn0037330	mRpL44	HGNC:16650	OMIM:611849	MRPL44	13	615395	615395[COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 16; COXPD16]
FBgn0037328	RpL35A	HGNC:10345	OMIM:180468	RPL35A	14	612528	612528[DIAMOND-BLACKFAN ANEMIA 5; DBA5]
FBgn0037327	PEK	HGNC:3255	OMIM:604032	EIF2AK3	13	226980	226980[EPIPHYSEAL DYSPLASIA, MULTIPLE, WITH EARLY-ONSET DIABETES MELLITUS]
FBgn0037327	PEK	HGNC:9437	OMIM:176871	EIF2AK2	3	618877,619687	618877[LEUKOENCEPHALOPATHY, DEVELOPMENTAL DELAY, AND EPISODIC NEUROLOGIC REGRESSION SYNDROME; LEUDEN],619687[DYSTONIA 33; DYT33]
FBgn0037297	CG1116	HGNC:21965	OMIM:615742	RGP1	14		
FBgn0037299	Vps37B	HGNC:25754	OMIM:610037	VPS37B	13		
FBgn0037299	Vps37B	HGNC:26097	OMIM:610038	VPS37C	11		
FBgn0037299	Vps37B	HGNC:18287	OMIM:610039	VPS37D	6		
FBgn0037301	Mms19	HGNC:13824	OMIM:614777	MMS19	13		
FBgn0037310	Tim17b1	HGNC:17315	OMIM:605057	TIMM17A	9		
FBgn0037310	Tim17b1	HGNC:17310	OMIM:300249	TIMM17B	9		
FBgn0003275	Polr2F	HGNC:9193	OMIM:604414	POLR2F	14		
FBgn0037325	CG12147	HGNC:2451	OMIM:600505	CSNK1A1	7		
FBgn0037325	CG12147	HGNC:20289		CSNK1A1L	5		
FBgn0037325	CG12147	HGNC:2452	OMIM:600864	CSNK1D	4	615224	615224[ADVANCED SLEEP PHASE SYNDROME, FAMILIAL, 2; FASPS2]
FBgn0037323	CG2663	HGNC:12404	OMIM:600415	TTPA	3	277460	277460[ATAXIA WITH VITAMIN E DEFICIENCY; AVED]
FBgn0037323	CG2663	HGNC:16114		TTPAL	3		
FBgn0001311	kkv	HGNC:4818	OMIM:601463	HAS1	4		
FBgn0001311	kkv	HGNC:4819	OMIM:601636	HAS2	4		
FBgn0001311	kkv	HGNC:4820	OMIM:602428	HAS3	4		
FBgn0037315	Cerk	HGNC:19256	OMIM:610307	CERK	14		
FBgn0037315	Cerk	HGNC:11240	OMIM:603730	SPHK1	4		
FBgn0037315	Cerk	HGNC:18859	OMIM:607092	SPHK2	4		
FBgn0037315	Cerk	HGNC:21699	OMIM:608381	CERKL	4	608380	608380[RETINITIS PIGMENTOSA 26; RP26]
FBgn0037312	CG11999	HGNC:10675	OMIM:602934	SDF2	14		
FBgn0037312	CG11999	HGNC:10676	OMIM:607551	SDF2L1	13		
FBgn0037307	Tim17a2	HGNC:17315	OMIM:605057	TIMM17A	7		
FBgn0037307	Tim17a2	HGNC:17310	OMIM:300249	TIMM17B	8		
FBgn0037305	Enoph	HGNC:24599		ENOPH1	15		
FBgn0260462	CtsF	HGNC:2538	OMIM:603308	CTSV	3		
FBgn0260462	CtsF	HGNC:2537	OMIM:116880	CTSL	3		
FBgn0260462	CtsF	HGNC:2531	OMIM:603539	CTSF	11	615362	615362[CEROID LIPOFUSCINOSIS, NEURONAL, 13 (KUFS TYPE); CLN13]
FBgn0040208	Kat60	HGNC:6216	OMIM:606696	KATNA1	12		
FBgn0040208	Kat60	HGNC:28361	OMIM:614764	KATNAL1	14		
FBgn0037298	Sccpdh1	HGNC:24275		SCCPDH	15		
FBgn0037296	Prosbeta2R2	HGNC:9544	OMIM:604030	PSMB7	6		
FBgn0037296	Prosbeta2R2	HGNC:9538	OMIM:176847	PSMB10	5	619175	619175[PROTEASOME-ASSOCIATED AUTOINFLAMMATORY SYNDROME 5; PRAAS5]
FBgn0004913	Gnf1	HGNC:9969	OMIM:102579	RFC1	13	614575	614575[CEREBELLAR ATAXIA, NEUROPATHY, AND VESTIBULAR AREFLEXIA SYNDROME; CANVAS]
FBgn0037293	RabGGTa	HGNC:9795	OMIM:601905	RABGGTA	15		
FBgn0037292	plh	HGNC:26827	OMIM:618100	MPV17L	5		
FBgn0004436	Ubc6	HGNC:12472	OMIM:312180	UBE2A	12	300860	300860[INTELLECTUAL DEVELOPMENTAL DISORDER, X-LINKED, SYNDROMIC, NASCIMENTO TYPE; MRXSN]
FBgn0004436	Ubc6	HGNC:12473	OMIM:179095	UBE2B	13		
FBgn0037262	MED31	HGNC:24260		MED31	11		
FBgn0037263	slx1	HGNC:28748	OMIM:615823	SLX1B	6		
FBgn0037263	slx1	HGNC:20922	OMIM:615822	SLX1A	12		
FBgn0022981	rpk	HGNC:101	OMIM:611741	ASIC3	6		
FBgn0022981	rpk	HGNC:100	OMIM:602866	ASIC1	6		
FBgn0022981	rpk	HGNC:21263	OMIM:606715	ASIC4	6		
FBgn0022981	rpk	HGNC:99	OMIM:601784	ASIC2	6		
FBgn0022981	rpk	HGNC:17537	OMIM:616693	ASIC5	6		
FBgn0022981	rpk	HGNC:10600	OMIM:600760	SCNN1B	3	177200,211400,264350	177200[LIDDLE SYNDROME 1; LIDLS1],211400[BRONCHIECTASIS WITH OR WITHOUT ELEVATED SWEAT CHLORIDE 1; BESC1],264350[PSEUDOHYPOALDOSTERONISM, TYPE I, AUTOSOMAL RECESSIVE; PHA1B]
FBgn0037265	spartin	HGNC:18514	OMIM:607111	SPART	13	275900	275900[SPASTIC PARAPLEGIA 20, AUTOSOMAL RECESSIVE; SPG20]
FBgn0010750	atms	HGNC:25459	OMIM:610506	PAF1	13		
FBgn0037279	Gmppb	HGNC:22932	OMIM:615320	GMPPB	14	615350,615351,615352	615350[MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 14; MDDGA14],615351[MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH IMPAIRED INTELLECTUAL DEVELOPMENT), TYPE B, 14; MDDGB14],615352[MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (LIMB-GIRDLE), TYPE C, 14; MDDGC14]
FBgn0037280	BBS5	HGNC:970	OMIM:603650	BBS5	15	615983	615983[BARDET-BIEDL SYNDROME 5; BBS5]
FBgn0026417	Hus1-like	HGNC:16485	OMIM:609713	HUS1B	11		
FBgn0026417	Hus1-like	HGNC:5309	OMIM:603760	HUS1	14		
FBgn0037276	CG17387	HGNC:25244	OMIM:613798	CCDC39	13	613807	613807[CILIARY DYSKINESIA, PRIMARY, 14; CILD14]
FBgn0027570	Nep2	HGNC:14668	OMIM:618104	MMEL1	3		
FBgn0027570	Nep2	HGNC:7154	OMIM:120520	MME	3	617017,617018	617017[CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2T; CMT2T],617018[SPINOCEREBELLAR ATAXIA 43; SCA43]
FBgn0027570	Nep2	HGNC:13275	OMIM:610145	ECE2	3		
FBgn0027570	Nep2	HGNC:3146	OMIM:600423	ECE1	4	145500,613870	145500[HYPERTENSION, ESSENTIAL],613870[HIRSCHSPRUNG DISEASE, CARDIAC DEFECTS, AND AUTONOMIC DYSFUNCTION; HCAD]
FBgn0037270	eIF3f1	HGNC:3275	OMIM:603914	EIF3F	12	618295	618295[INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 67; MRT67]
FBgn0037261	CG9775	HGNC:24511	OMIM:614206	CHTOP	3		
FBgn0037232	Suv3	HGNC:11471	OMIM:605122	SUPV3L1	15		
FBgn0037235	CG1103	HGNC:12605	OMIM:606397	CLRN1	3	276902,614180	276902[USHER SYNDROME, TYPE IIIA; USH3A],614180[RETINITIS PIGMENTOSA 61; RP61]
FBgn0037235	CG1103	HGNC:33939	OMIM:618988	CLRN2	3	619174	619174[DEAFNESS, AUTOSOMAL RECESSIVE 117; DFNB117]
FBgn0037238	CG1090	HGNC:10977	OMIM:609839	SLC24A3	4		
FBgn0037238	CG1090	HGNC:20611	OMIM:609802	SLC24A5	6	113750	113750[ALBINISM, OCULOCUTANEOUS, TYPE VI; OCA6]
FBgn0037238	CG1090	HGNC:10978	OMIM:609840	SLC24A4	6	210750,615887	210750[SKIN/HAIR/EYE PIGMENTATION, VARIATION IN, 6; SHEP6],615887[AMELOGENESIS IMPERFECTA, HYPOMATURATION TYPE, IIA5; AI2A5]
FBgn0037239	Sfxn1-3	HGNC:16087	OMIM:615571	SFXN3	13		
FBgn0037239	Sfxn1-3	HGNC:16086	OMIM:615570	SFXN2	3		
FBgn0037239	Sfxn1-3	HGNC:16085	OMIM:615569	SFXN1	15		
FBgn0037239	Sfxn1-3	HGNC:16073	OMIM:615572	SFXN5	5		
FBgn0037240	Cont	HGNC:2171	OMIM:600016	CNTN1	10	612540	612540[MYOPATHY, CONGENITAL, COMPTON-NORTH; MYPCN]
FBgn0037240	Cont	HGNC:2176	OMIM:607220	CNTN6	12		
FBgn0037240	Cont	HGNC:2174	OMIM:607280	CNTN4	12		
FBgn0037240	Cont	HGNC:2173	OMIM:601325	CNTN3	11		
FBgn0037240	Cont	HGNC:2172	OMIM:190197	CNTN2	10	615400	615400[EPILEPSY, FAMILIAL ADULT MYOCLONIC, 5; FAME5]
FBgn0037240	Cont	HGNC:2175	OMIM:607219	CNTN5	10		
FBgn0037241	CG14646	HGNC:25137	OMIM:615975	TMEM129	14		
FBgn0037244	CG14647	HGNC:22401	OMIM:617265	KCTD9	13		
FBgn0051528	CG31528	HGNC:12508	OMIM:605046	UBQLN1	4		
FBgn0051528	CG31528	HGNC:1237	OMIM:605440	UBQLN4	5		
FBgn0051528	CG31528	HGNC:12509	OMIM:300264	UBQLN2	5	300857	300857[AMYOTROPHIC LATERAL SCLEROSIS 15 WITH OR WITHOUT FRONTOTEMPORAL DEMENTIA; ALS15]
FBgn0051528	CG31528	HGNC:12510	OMIM:605473	UBQLN3	5		
FBgn0051528	CG31528	HGNC:28294		UBQLNL	5		
FBgn0037250	CG1074	HGNC:21080		TRMT11	14		
FBgn0037252	CG14650	HGNC:24581	OMIM:606092	DNAJC14	4		
FBgn0037255	Fip1	HGNC:19124	OMIM:607686	FIP1L1	9		
FBgn0051523	CG31523	HGNC:26292	OMIM:614451	ELOVL7	10		
FBgn0051523	CG31523	HGNC:14416	OMIM:611814	ELOVL2	3		
FBgn0051523	CG31523	HGNC:14415	OMIM:605512	ELOVL4	3	133190,600110,614457	133190[SPINOCEREBELLAR ATAXIA 34; SCA34],600110[STARGARDT DISEASE 3; STGD3],614457[ICHTHYOSIS, SPASTIC QUADRIPLEGIA, AND MENTAL RETARDATION; ISQMR]
FBgn0051523	CG31523	HGNC:14418	OMIM:611813	ELOVL1	8	618527	618527[ICHTHYOTIC KERATODERMA, SPASTICITY, HYPOMYELINATION, AND DYSMORPHIC FACIAL FEATURES; IKSHD]
FBgn0051523	CG31523	HGNC:21308	OMIM:611805	ELOVL5	3	615957	615957[SPINOCEREBELLAR ATAXIA 38; SCA38]
FBgn0051522	CG31522	HGNC:26292	OMIM:614451	ELOVL7	14		
FBgn0051522	CG31522	HGNC:14416	OMIM:611814	ELOVL2	5		
FBgn0051522	CG31522	HGNC:14415	OMIM:605512	ELOVL4	5	133190,600110,614457	133190[SPINOCEREBELLAR ATAXIA 34; SCA34],600110[STARGARDT DISEASE 3; STGD3],614457[ICHTHYOSIS, SPASTIC QUADRIPLEGIA, AND MENTAL RETARDATION; ISQMR]
FBgn0051522	CG31522	HGNC:14418	OMIM:611813	ELOVL1	12	618527	618527[ICHTHYOTIC KERATODERMA, SPASTICITY, HYPOMYELINATION, AND DYSMORPHIC FACIAL FEATURES; IKSHD]
FBgn0051522	CG31522	HGNC:21308	OMIM:611805	ELOVL5	4	615957	615957[SPINOCEREBELLAR ATAXIA 38; SCA38]
FBgn0037251	CG9804	HGNC:37216	OMIM:617659	LIPT2	15	617668	617668[ENCEPHALOPATHY, NEONATAL SEVERE, WITH LACTIC ACIDOSIS AND BRAIN ABNORMALITIES; NELABA]
FBgn0037249	eIF3a	HGNC:3271	OMIM:602039	EIF3A	13		
FBgn0037248	srl	HGNC:30022	OMIM:608886	PPARGC1B	4		
FBgn0037248	srl	HGNC:30025	OMIM:617462	PPRC1	6		
FBgn0037248	srl	HGNC:9237	OMIM:604517	PPARGC1A	8		
FBgn0052944	CG32944	HGNC:21332		STK32C	11		
FBgn0052944	CG32944	HGNC:14217		STK32B	13		
FBgn0052944	CG32944	HGNC:28317		STK32A	12		
FBgn0037242	CG9855	HGNC:26025	OMIM:610637	MARCHF5	15		
FBgn0037236	Skp2	HGNC:10901	OMIM:601436	SKP2	12		
FBgn0037231	Vps24	HGNC:29865	OMIM:610052	CHMP3	6		
FBgn0037231	Vps24	HGNC:38847		RNF103-CHMP3	10		
FBgn0037230	Nepl11	HGNC:6308	OMIM:613883	KEL	4	110900	110900[BLOOD GROUP--KELL SYSTEM; KEL]
FBgn0037215	beta-Man	HGNC:6831	OMIM:609489	MANBA	15	248510	248510[MANNOSIDOSIS, BETA A, LYSOSOMAL; MANSB]
FBgn0037218	aux	HGNC:4113	OMIM:602052	GAK	15		
FBgn0037218	aux	HGNC:15469	OMIM:608375	DNAJC6	11	615528	615528[PARKINSON DISEASE 19A, JUVENILE-ONSET; PARK19A]
FBgn0015331	abs	HGNC:18674	OMIM:608170	DDX41	15	616871	616871[MYELOPROLIFERATIVE/LYMPHOPROLIFERATIVE NEOPLASMS, FAMILIAL (MULTIPLE TYPES), SUSCEPTIBILITY TO; MPLPF]
FBgn0010225	Gel	HGNC:30906	OMIM:619666	VILL	8		
FBgn0010225	Gel	HGNC:12690	OMIM:193040	VIL1	10		
FBgn0010225	Gel	HGNC:14188	OMIM:613397	AVIL	11	618594	618594[NEPHROTIC SYNDROME, TYPE 21; NPHS21]
FBgn0010225	Gel	HGNC:4620	OMIM:137350	GSN	13	105120	105120[AMYLOIDOSIS, FINNISH TYPE]
FBgn0010225	Gel	HGNC:21695	OMIM:613416	SCIN	12		
FBgn0010225	Gel	HGNC:1474	OMIM:153615	CAPG	5		
FBgn0037229	flip	HGNC:495	OMIM:610734	ANKRD2	3		
FBgn0037229	flip	HGNC:15819	OMIM:609599	ANKRD1	3		
FBgn0037229	flip	HGNC:23527	OMIM:611640	FANK1	3		
FBgn0037220	CG14641	HGNC:25503	OMIM:612430	RBM22	15		
FBgn0031670	SelT	HGNC:18136	OMIM:607912	SELENOT	14		
FBgn0000299	Col4a1	HGNC:2208	OMIM:303631	COL4A6	8	300914	300914[DEAFNESS, X-LINKED 6; DFNX6]
FBgn0000299	Col4a1	HGNC:2204	OMIM:120070	COL4A3	6	104200,141200,203780	104200[ALPORT SYNDROME 3, AUTOSOMAL DOMINANT; ATS3],141200[HEMATURIA, BENIGN FAMILIAL; BFH],203780[ALPORT SYNDROME 2, AUTOSOMAL RECESSIVE; ATS2]
FBgn0000299	Col4a1	HGNC:2206	OMIM:120131	COL4A4	6	141200,203780	141200[HEMATURIA, BENIGN FAMILIAL; BFH],203780[ALPORT SYNDROME 2, AUTOSOMAL RECESSIVE; ATS2]
FBgn0000299	Col4a1	HGNC:2202	OMIM:120130	COL4A1	9	175780,180000,611773,614519,618564	175780[BRAIN SMALL VESSEL DISEASE 1 WITH OR WITHOUT OCULAR ANOMALIES; BSVD1],180000[RETINAL ARTERIES, TORTUOSITY OF; RATOR],611773[ANGIOPATHY, HEREDITARY, WITH NEPHROPATHY, ANEURYSMS, AND MUSCLE CRAMPS; HANAC],614519[HEMORRHAGE, INTRACEREBRAL, SUSCEPTIBILITY TO; ICH],618564[MICROANGIOPATHY AND LEUKOENCEPHALOPATHY, PONTINE, AUTOSOMAL DOMINANT; PADMAL]
FBgn0000299	Col4a1	HGNC:2203	OMIM:120090	COL4A2	8	614483,614519	614483[BRAIN SMALL VESSEL DISEASE 2; BSVD2],614519[HEMORRHAGE, INTRACEREBRAL, SUSCEPTIBILITY TO; ICH]
FBgn0000299	Col4a1	HGNC:2207	OMIM:303630	COL4A5	7	301050	301050[ALPORT SYNDROME 1, X-LINKED; ATS1]
FBgn0000299	Col4a1	HGNC:2209	OMIM:120215	COL5A1	3	130000,619329	130000[EHLERS-DANLOS SYNDROME, CLASSIC TYPE, 1; EDSCL1],619329[FIBROMUSCULAR DYSPLASIA, MULTIFOCAL; FMDMF]
FBgn0000299	Col4a1	HGNC:2214	OMIM:120120	COL7A1	3	131705,131750,131850,132000,226600,604129,607523	131705[TRANSIENT BULLOUS DERMOLYSIS OF THE NEWBORN; TBDN],131750[EPIDERMOLYSIS BULLOSA DYSTROPHICA, AUTOSOMAL DOMINANT; DDEB],131850[EPIDERMOLYSIS BULLOSA DYSTROPHICA, PRETIBIAL],132000[EPIDERMOLYSIS BULLOSA WITH CONGENITAL LOCALIZED ABSENCE OF SKIN AND DEFORMITY OF NAILS],226600[EPIDERMOLYSIS BULLOSA DYSTROPHICA, AUTOSOMAL RECESSIVE; RDEB],604129[EPIDERMOLYSIS BULLOSA PRURIGINOSA],607523[NAIL DISORDER, NONSYNDROMIC CONGENITAL, 8; NDNC8]
FBgn0000299	Col4a1	HGNC:2186	OMIM:120280	COL11A1	3	154780,228520,603932,604841,618533	154780[MARSHALL SYNDROME; MRSHS],228520[FIBROCHONDROGENESIS 1; FBCG1],603932[INTERVERTEBRAL DISC DISEASE; IDD],604841[STICKLER SYNDROME, TYPE II; STL2],618533[DEAFNESS, AUTOSOMAL DOMINANT 37; DFNA37]
FBgn0000299	Col4a1	HGNC:2187	OMIM:120290	COL11A2	3	184840,215150,601868,609706,614524	184840[OTOSPONDYLOMEGAEPIPHYSEAL DYSPLASIA, AUTOSOMAL DOMINANT; OSMEDA],215150[OTOSPONDYLOMEGAEPIPHYSEAL DYSPLASIA, AUTOSOMAL RECESSIVE; OSMEDB],601868[DEAFNESS, AUTOSOMAL DOMINANT 13; DFNA13],609706[DEAFNESS, AUTOSOMAL RECESSIVE 53; DFNB53],614524[FIBROCHONDROGENESIS 2; FBCG2]
FBgn0260470	SP555	HGNC:30629	OMIM:611659	SPSB3	3		
FBgn0031676	senju	HGNC:20792		SLC35A5	5		
FBgn0031676	senju	HGNC:20753		SLC35A4	3		
FBgn0031682	CG5828	HGNC:19366	OMIM:606162	PANK4	9	619593	619593[CATARACT 49; CTRCT49]
FBgn0031682	CG5828	HGNC:19365	OMIM:606161	PANK3	4		
FBgn0031682	CG5828	HGNC:8598	OMIM:606160	PANK1	4		
FBgn0031682	CG5828	HGNC:15894	OMIM:606157	PANK2	4	234200,607236	234200[NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 1; NBIA1],607236[HYPOPREBETALIPOPROTEINEMIA, ACANTHOCYTOSIS, RETINITIS PIGMENTOSA, AND PALLIDAL DEGENERATION]
FBgn0031683	CG4230	HGNC:16915	OMIM:605998	HAX1	3	610738	610738[NEUTROPENIA, SEVERE CONGENITAL, 3, AUTOSOMAL RECESSIVE; SCN3]
FBgn0031684	ND-13A	HGNC:7713	OMIM:603848	NDUFS6	15	618232	618232[MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 9; MC1DN9]
FBgn0031681	Pgant5	HGNC:4123	OMIM:602273	GALNT1	11		
FBgn0031681	Pgant5	HGNC:4127	OMIM:615129	GALNT5	3		
FBgn0031681	Pgant5	HGNC:23242	OMIM:608369	GALNT13	12		
FBgn0028694	Rpn11	HGNC:16889	OMIM:607173	PSMD14	15		
FBgn0031678	Nepl3	HGNC:14668	OMIM:618104	MMEL1	3		
FBgn0031678	Nepl3	HGNC:7154	OMIM:120520	MME	3	617017,617018	617017[CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2T; CMT2T],617018[SPINOCEREBELLAR ATAXIA 43; SCA43]
FBgn0031678	Nepl3	HGNC:3147	OMIM:605896	ECEL1	3	615065	615065[ARTHROGRYPOSIS, DISTAL, TYPE 5D; DA5D]
FBgn0031678	Nepl3	HGNC:3146	OMIM:600423	ECE1	3	145500,613870	145500[HYPERTENSION, ESSENTIAL],613870[HIRSCHSPRUNG DISEASE, CARDIAC DEFECTS, AND AUTONOMIC DYSFUNCTION; HCAD]
FBgn0031678	Nepl3	HGNC:6308	OMIM:613883	KEL	4	110900	110900[BLOOD GROUP--KELL SYSTEM; KEL]
FBgn0031677	CG14036	HGNC:16198		GTSF1L	7		
FBgn0031677	CG14036	HGNC:26565	OMIM:617484	GTSF1	8		
FBgn0022023	eIF3h	HGNC:3273	OMIM:603912	EIF3H	13		
FBgn0031673	CG31650	HGNC:9935	OMIM:602584	RCN2	13		
FBgn0016075	vkg	HGNC:2208	OMIM:303631	COL4A6	5	300914	300914[DEAFNESS, X-LINKED 6; DFNX6]
FBgn0016075	vkg	HGNC:2204	OMIM:120070	COL4A3	4	104200,141200,203780	104200[ALPORT SYNDROME 3, AUTOSOMAL DOMINANT; ATS3],141200[HEMATURIA, BENIGN FAMILIAL; BFH],203780[ALPORT SYNDROME 2, AUTOSOMAL RECESSIVE; ATS2]
FBgn0016075	vkg	HGNC:2206	OMIM:120131	COL4A4	5	141200,203780	141200[HEMATURIA, BENIGN FAMILIAL; BFH],203780[ALPORT SYNDROME 2, AUTOSOMAL RECESSIVE; ATS2]
FBgn0016075	vkg	HGNC:2202	OMIM:120130	COL4A1	8	175780,180000,611773,614519,618564	175780[BRAIN SMALL VESSEL DISEASE 1 WITH OR WITHOUT OCULAR ANOMALIES; BSVD1],180000[RETINAL ARTERIES, TORTUOSITY OF; RATOR],611773[ANGIOPATHY, HEREDITARY, WITH NEPHROPATHY, ANEURYSMS, AND MUSCLE CRAMPS; HANAC],614519[HEMORRHAGE, INTRACEREBRAL, SUSCEPTIBILITY TO; ICH],618564[MICROANGIOPATHY AND LEUKOENCEPHALOPATHY, PONTINE, AUTOSOMAL DOMINANT; PADMAL]
FBgn0016075	vkg	HGNC:2203	OMIM:120090	COL4A2	4	614483,614519	614483[BRAIN SMALL VESSEL DISEASE 2; BSVD2],614519[HEMORRHAGE, INTRACEREBRAL, SUSCEPTIBILITY TO; ICH]
FBgn0016075	vkg	HGNC:2207	OMIM:303630	COL4A5	5	301050	301050[ALPORT SYNDROME 1, X-LINKED; ATS1]
FBgn0016075	vkg	HGNC:2201	OMIM:120180	COL3A1	3	130050,618343	130050[EHLERS-DANLOS SYNDROME, VASCULAR TYPE; EDSVASC],618343[POLYMICROGYRIA WITH OR WITHOUT VASCULAR-TYPE EHLERS-DANLOS SYNDROME; PMGEDSV]
FBgn0016075	vkg	HGNC:2209	OMIM:120215	COL5A1	3	130000,619329	130000[EHLERS-DANLOS SYNDROME, CLASSIC TYPE, 1; EDSCL1],619329[FIBROMUSCULAR DYSPLASIA, MULTIFOCAL; FMDMF]
FBgn0016075	vkg	HGNC:2214	OMIM:120120	COL7A1	3	131705,131750,131850,132000,226600,604129,607523	131705[TRANSIENT BULLOUS DERMOLYSIS OF THE NEWBORN; TBDN],131750[EPIDERMOLYSIS BULLOSA DYSTROPHICA, AUTOSOMAL DOMINANT; DDEB],131850[EPIDERMOLYSIS BULLOSA DYSTROPHICA, PRETIBIAL],132000[EPIDERMOLYSIS BULLOSA WITH CONGENITAL LOCALIZED ABSENCE OF SKIN AND DEFORMITY OF NAILS],226600[EPIDERMOLYSIS BULLOSA DYSTROPHICA, AUTOSOMAL RECESSIVE; RDEB],604129[EPIDERMOLYSIS BULLOSA PRURIGINOSA],607523[NAIL DISORDER, NONSYNDROMIC CONGENITAL, 8; NDNC8]
FBgn0016075	vkg	HGNC:2186	OMIM:120280	COL11A1	3	154780,228520,603932,604841,618533	154780[MARSHALL SYNDROME; MRSHS],228520[FIBROCHONDROGENESIS 1; FBCG1],603932[INTERVERTEBRAL DISC DISEASE; IDD],604841[STICKLER SYNDROME, TYPE II; STL2],618533[DEAFNESS, AUTOSOMAL DOMINANT 37; DFNA37]
FBgn0031668	CG31917	HGNC:21688	OMIM:618617	ZNHIT1	13		
FBgn0053113	Rtnl1	HGNC:10468	OMIM:603183	RTN2	7	604805	604805[SPASTIC PARAPLEGIA 12, AUTOSOMAL DOMINANT; SPG12]
FBgn0053113	Rtnl1	HGNC:10469	OMIM:604249	RTN3	9		
FBgn0053113	Rtnl1	HGNC:14085	OMIM:604475	RTN4	9		
FBgn0053113	Rtnl1	HGNC:10467	OMIM:600865	RTN1	9		
FBgn0031693	Cyp4ac1	HGNC:23198	OMIM:608614	CYP4V2	6	210370	210370[BIETTI CRYSTALLINE CORNEORETINAL DYSTROPHY; BCD]
FBgn0031693	Cyp4ac1	HGNC:13265	OMIM:611517	CYP4F11	4		
FBgn0031693	Cyp4ac1	HGNC:26820	OMIM:611495	CYP4F22	4	604777	604777[ICHTHYOSIS, CONGENITAL, AUTOSOMAL RECESSIVE 5; ARCI5]
FBgn0031693	Cyp4ac1	HGNC:2645	OMIM:604426	CYP4F2	4		
FBgn0031693	Cyp4ac1	HGNC:2646	OMIM:601270	CYP4F3	4		
FBgn0031693	Cyp4ac1	HGNC:20244	OMIM:614999	CYP4X1	4		
FBgn0031693	Cyp4ac1	HGNC:2642	OMIM:601310	CYP4A11	3		
FBgn0031693	Cyp4ac1	HGNC:18857	OMIM:611485	CYP4F12	4		
FBgn0031693	Cyp4ac1	HGNC:20575	OMIM:615341	CYP4A22	3		
FBgn0031693	Cyp4ac1	HGNC:2644	OMIM:124075	CYP4B1	4		
FBgn0031693	Cyp4ac1	HGNC:2648	OMIM:611545	CYP4F8	4		
FBgn0031693	Cyp4ac1	HGNC:20583	OMIM:618953	CYP4Z1	3		
FBgn0031693	Cyp4ac1	HGNC:2594	OMIM:107910	CYP19A1	5	139300,613546	139300[AROMATASE EXCESS SYNDROME; AEXS],613546[AROMATASE DEFICIENCY]
FBgn0031694	Cyp4ac2	HGNC:23198	OMIM:608614	CYP4V2	6	210370	210370[BIETTI CRYSTALLINE CORNEORETINAL DYSTROPHY; BCD]
FBgn0031694	Cyp4ac2	HGNC:13265	OMIM:611517	CYP4F11	4		
FBgn0031694	Cyp4ac2	HGNC:26820	OMIM:611495	CYP4F22	4	604777	604777[ICHTHYOSIS, CONGENITAL, AUTOSOMAL RECESSIVE 5; ARCI5]
FBgn0031694	Cyp4ac2	HGNC:2645	OMIM:604426	CYP4F2	4		
FBgn0031694	Cyp4ac2	HGNC:2646	OMIM:601270	CYP4F3	4		
FBgn0031694	Cyp4ac2	HGNC:20244	OMIM:614999	CYP4X1	4		
FBgn0031694	Cyp4ac2	HGNC:2642	OMIM:601310	CYP4A11	3		
FBgn0031694	Cyp4ac2	HGNC:18857	OMIM:611485	CYP4F12	4		
FBgn0031694	Cyp4ac2	HGNC:20575	OMIM:615341	CYP4A22	3		
FBgn0031694	Cyp4ac2	HGNC:2644	OMIM:124075	CYP4B1	4		
FBgn0031694	Cyp4ac2	HGNC:2648	OMIM:611545	CYP4F8	4		
FBgn0031694	Cyp4ac2	HGNC:20583	OMIM:618953	CYP4Z1	3		
FBgn0031694	Cyp4ac2	HGNC:2594	OMIM:107910	CYP19A1	4	139300,613546	139300[AROMATASE EXCESS SYNDROME; AEXS],613546[AROMATASE DEFICIENCY]
FBgn0031695	Cyp4ac3	HGNC:23198	OMIM:608614	CYP4V2	6	210370	210370[BIETTI CRYSTALLINE CORNEORETINAL DYSTROPHY; BCD]
FBgn0031695	Cyp4ac3	HGNC:13265	OMIM:611517	CYP4F11	4		
FBgn0031695	Cyp4ac3	HGNC:26820	OMIM:611495	CYP4F22	4	604777	604777[ICHTHYOSIS, CONGENITAL, AUTOSOMAL RECESSIVE 5; ARCI5]
FBgn0031695	Cyp4ac3	HGNC:2645	OMIM:604426	CYP4F2	4		
FBgn0031695	Cyp4ac3	HGNC:2646	OMIM:601270	CYP4F3	4		
FBgn0031695	Cyp4ac3	HGNC:20244	OMIM:614999	CYP4X1	4		
FBgn0031695	Cyp4ac3	HGNC:2642	OMIM:601310	CYP4A11	3		
FBgn0031695	Cyp4ac3	HGNC:18857	OMIM:611485	CYP4F12	4		
FBgn0031695	Cyp4ac3	HGNC:20575	OMIM:615341	CYP4A22	3		
FBgn0031695	Cyp4ac3	HGNC:2644	OMIM:124075	CYP4B1	4		
FBgn0031695	Cyp4ac3	HGNC:2648	OMIM:611545	CYP4F8	4		
FBgn0031695	Cyp4ac3	HGNC:20583	OMIM:618953	CYP4Z1	3		
FBgn0031695	Cyp4ac3	HGNC:2594	OMIM:107910	CYP19A1	4	139300,613546	139300[AROMATASE EXCESS SYNDROME; AEXS],613546[AROMATASE DEFICIENCY]
FBgn0031696	Bub1	HGNC:1148	OMIM:602452	BUB1	10	114500	114500[COLORECTAL CANCER; CRC]
FBgn0031696	Bub1	HGNC:1149	OMIM:602860	BUB1B	3	114500,176430,257300	114500[COLORECTAL CANCER; CRC],176430[PREMATURE CHROMATID SEPARATION TRAIT; PCS],257300[MOSAIC VARIEGATED ANEUPLOIDY SYNDROME 1; MVA1]
FBgn0016076	vri	HGNC:7787	OMIM:605327	NFIL3	7		
FBgn0015031	cype	HGNC:2285	OMIM:124090	COX6C	10		
FBgn0016920	nompC	HGNC:25259		ANKRD44	3		
FBgn0016660	H15	HGNC:11515	OMIM:601397	TBXT	3	182940,615709	182940[NEURAL TUBE DEFECTS, SUSCEPTIBILITY TO; NTD],615709[SACRAL AGENESIS WITH VERTEBRAL ANOMALIES; SAVA]
FBgn0016660	H15	HGNC:11605	OMIM:602427	TBX6	3	122600	122600[SPONDYLOCOSTAL DYSOSTOSIS 5; SCDO5]
FBgn0016660	H15	HGNC:11598	OMIM:606061	TBX20	8	611363	611363[ATRIAL SEPTAL DEFECT 4; ASD4]
FBgn0016660	H15	HGNC:11594	OMIM:604127	TBX15	3	260660	260660[COUSIN SYNDROME]
FBgn0016660	H15	HGNC:11595	OMIM:604613	TBX18	3	143400	143400[CONGENITAL ANOMALIES OF KIDNEY AND URINARY TRACT 2; CAKUT2]
FBgn0016660	H15	HGNC:11600	OMIM:300307	TBX22	3	302905,303400	302905[ABRUZZO-ERICKSON SYNDROME; ABERS],303400[CLEFT PALATE WITH OR WITHOUT ANKYLOGLOSSIA, X-LINKED; CPX]
FBgn0016660	H15	HGNC:11596	OMIM:604614	TBX19	3	201400	201400[ACTH DEFICIENCY, ISOLATED; IAD]
FBgn0016660	H15	HGNC:14010	OMIM:616061	MGA	3		
FBgn0031703	Acsf2	HGNC:26101	OMIM:610465	ACSF2	15		
FBgn0031700	CG14022	HGNC:179	OMIM:600875	ACYP1	7		
FBgn0031700	CG14022	HGNC:180	OMIM:102595	ACYP2	10		
FBgn0031698	Ncoa6	HGNC:15936	OMIM:605299	NCOA6	6		
FBgn0031697	CG14024	HGNC:21755	OMIM:610124	CHST13	3		
FBgn0031697	CG14024	HGNC:19650	OMIM:606376	CHST10	4		
FBgn0031697	CG14024	HGNC:17423	OMIM:610129	CHST12	3		
FBgn0031697	CG14024	HGNC:19898	OMIM:610191	CHST9	4		
FBgn0031697	CG14024	HGNC:15993	OMIM:610190	CHST8	4	616265	616265[PEELING SKIN SYNDROME 3; PSS3]
FBgn0031697	CG14024	HGNC:17422	OMIM:610128	CHST11	4	618167	618167[OSTEOCHONDRODYSPLASIA, BRACHYDACTYLY, AND OVERLAPPING MALFORMED DIGITS; OCBMD]
FBgn0000228	Nin	HGNC:14906	OMIM:608684	NIN	7	614851	614851[SECKEL SYNDROME 7; SCKL7]
FBgn0000228	Nin	HGNC:29163	OMIM:609580	NINL	8		
FBgn0003716	tkv	HGNC:171	OMIM:102576	ACVR1	4	135100	135100[FIBRODYSPLASIA OSSIFICANS PROGRESSIVA; FOP]
FBgn0003716	tkv	HGNC:172	OMIM:601300	ACVR1B	4		
FBgn0003716	tkv	HGNC:1077	OMIM:603248	BMPR1B	13	112600,609441,616849	112600[BRACHYDACTYLY, TYPE A2; BDA2],609441[ACROMESOMELIC DYSPLASIA 3; AMD3],616849[BRACHYDACTYLY, TYPE A1, D; BDA1D]
FBgn0003716	tkv	HGNC:18123	OMIM:608981	ACVR1C	5		
FBgn0003716	tkv	HGNC:1076	OMIM:601299	BMPR1A	9	174900,610069	174900[JUVENILE POLYPOSIS SYNDROME; JPS],610069[POLYPOSIS SYNDROME, HEREDITARY MIXED, 2; HMPS2]
FBgn0003716	tkv	HGNC:175	OMIM:601284	ACVRL1	4	600376	600376[TELANGIECTASIA, HEREDITARY HEMORRHAGIC, TYPE 2; HHT2]
FBgn0003716	tkv	HGNC:11772	OMIM:190181	TGFBR1	4	132800,609192	132800[MULTIPLE SELF-HEALING SQUAMOUS EPITHELIOMA, SUSCEPTIBILITY TO; MSSE],609192[LOEYS-DIETZ SYNDROME 1; LDS1]
FBgn0031707	CG14020	HGNC:37234	OMIM:614949	TMEM231	10	614970,615397	614970[JOUBERT SYNDROME 20; JBTS20],615397[MECKEL SYNDROME, TYPE 11; MKS11]
FBgn0000318	cl	HGNC:28218	OMIM:616967	TXNDC17	15		
FBgn0031711	CG6907	HGNC:1171	OMIM:606985	ELP4	12	617141	617141[ANIRIDIA 2; AN2]
FBgn0051989	Cap-D3	HGNC:28952	OMIM:609276	NCAPD3	9	617984	617984[MICROCEPHALY 22, PRIMARY, AUTOSOMAL RECESSIVE; MCPH22]
FBgn0051648	Cox11	HGNC:2261	OMIM:603648	COX11	14		
FBgn0051915	CG31915	HGNC:16790	OMIM:617533	COLGALT2	13		
FBgn0051915	CG31915	HGNC:23723	OMIM:616626	CERCAM	11		
FBgn0051915	CG31915	HGNC:26182	OMIM:617531	COLGALT1	12	618360	618360[BRAIN SMALL VESSEL DISEASE 3; BSVD3]
FBgn0002525	Lam	HGNC:6637	OMIM:150340	LMNB1	11	169500,619179	169500[LEUKODYSTROPHY, DEMYELINATING, ADULT-ONSET, AUTOSOMAL DOMINANT; ADLD],619179[MICROCEPHALY 26, PRIMARY, AUTOSOMAL DOMINANT; MCPH26]
FBgn0002525	Lam	HGNC:6636	OMIM:150330	LMNA	12	115200,151660,176670,181350,212112,248370,605588,610140,613205,616516,619793	115200[CARDIOMYOPATHY, DILATED, 1A; CMD1A],151660[LIPODYSTROPHY, FAMILIAL PARTIAL, TYPE 2; FPLD2],176670[HUTCHINSON-GILFORD PROGERIA SYNDROME; HGPS],181350[EMERY-DREIFUSS MUSCULAR DYSTROPHY 2, AUTOSOMAL DOMINANT; EDMD2],212112[CARDIOMYOPATHY, DILATED, WITH HYPERGONADOTROPIC HYPOGONADISM],248370[MANDIBULOACRAL DYSPLASIA WITH TYPE A LIPODYSTROPHY; MADA],605588[CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2B1; CMT2B1],610140[HEART-HAND SYNDROME, SLOVENIAN TYPE],613205[MUSCULAR DYSTROPHY, CONGENITAL, LMNA-RELATED],616516[EMERY-DREIFUSS MUSCULAR DYSTROPHY 3, AUTOSOMAL RECESSIVE; EDMD3],619793[RESTRICTIVE DERMOPATHY 2; RSDM2]
FBgn0002525	Lam	HGNC:6638	OMIM:150341	LMNB2	12	608709,616540,619180	608709[LIPODYSTROPHY, PARTIAL, ACQUIRED, SUSCEPTIBILITY TO; APLD],616540[EPILEPSY, PROGRESSIVE MYOCLONIC, 9; EPM9],619180[MICROCEPHALY 27, PRIMARY, AUTOSOMAL DOMINANT; MCPH27]
FBgn0031717	Oscillin	HGNC:4417	OMIM:601798	GNPDA1	13		
FBgn0031717	Oscillin	HGNC:21526	OMIM:613222	GNPDA2	14		
FBgn0031721	CG14017	HGNC:28554		CFAP299	9		
FBgn0004620	GluRIIA	HGNC:4580	OMIM:138244	GRIK2	4	611092,619580	611092[INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 6; MRT6],619580[NEURODEVELOPMENTAL DISORDER WITH IMPAIRED LANGUAGE AND ATAXIA AND WITH OR WITHOUT SEIZURES; NEDLAS]
FBgn0004620	GluRIIA	HGNC:4581	OMIM:138243	GRIK3	4		
FBgn0004620	GluRIIA	HGNC:4583	OMIM:600283	GRIK5	3		
FBgn0004620	GluRIIA	HGNC:4579	OMIM:138245	GRIK1	4		
FBgn0004620	GluRIIA	HGNC:4582	OMIM:600282	GRIK4	4		
FBgn0004620	GluRIIA	HGNC:4585	OMIM:138253	GRIN2A	3	245570	245570[EPILEPSY, FOCAL, WITH SPEECH DISORDER AND WITH OR WITHOUT IMPAIRED INTELLECTUAL DEVELOPMENT; FESD]
FBgn0004620	GluRIIA	HGNC:4576	OMIM:602368	GRID2	3	616204	616204[SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 18; SCAR18]
FBgn0004620	GluRIIA	HGNC:4575	OMIM:610659	GRID1	3		
FBgn0031724	CG18266	HGNC:25079	OMIM:612324	CCDC34	3		
FBgn0031728	Hsp60C	HGNC:5261	OMIM:118190	HSPD1	13	605280,612233	605280[SPASTIC PARAPLEGIA 13, AUTOSOMAL DOMINANT; SPG13],612233[LEUKODYSTROPHY, HYPOMYELINATING, 4; HLD4]
FBgn0031729	CG12511	HGNC:24925	OMIM:301042	FUNDC2	6		
FBgn0031729	CG12511	HGNC:28746	OMIM:300871	FUNDC1	6		
FBgn0051646	DIP-theta	HGNC:17302	OMIM:613173	NEGR1	5		
FBgn0051646	DIP-theta	HGNC:34550	OMIM:618861	IGLON5	6		
FBgn0051646	DIP-theta	HGNC:6705	OMIM:603241	LSAMP	6		
FBgn0051646	DIP-theta	HGNC:8143	OMIM:600632	OPCML	8	167000	167000[OVARIAN CANCER]
FBgn0051646	DIP-theta	HGNC:17941	OMIM:607938	NTM	8		
FBgn0031725	DIP-eta	HGNC:17302	OMIM:613173	NEGR1	7		
FBgn0031725	DIP-eta	HGNC:34550	OMIM:618861	IGLON5	8		
FBgn0031725	DIP-eta	HGNC:6705	OMIM:603241	LSAMP	7		
FBgn0031725	DIP-eta	HGNC:8143	OMIM:600632	OPCML	8	167000	167000[OVARIAN CANCER]
FBgn0031725	DIP-eta	HGNC:17941	OMIM:607938	NTM	7		
FBgn0031723	CG7251	HGNC:25079	OMIM:612324	CCDC34	3		
FBgn0031722	CG14011	HGNC:25079	OMIM:612324	CCDC34	3		
FBgn0031720	CG14013	HGNC:28554		CFAP299	12		
FBgn0014189	Hel25E	HGNC:17821	OMIM:619906	DDX39A	12		
FBgn0014189	Hel25E	HGNC:13917	OMIM:142560	DDX39B	13		
FBgn0031716	CG14015	HGNC:21072	OMIM:612327	MANEA	13		
FBgn0031716	CG14015	HGNC:26452		MANEAL	11		
FBgn0031715	tomb	HGNC:7446	OMIM:604374	TESMIN	3		
FBgn0031713	Coq6	HGNC:20233	OMIM:614647	COQ6	14	614650	614650[COENZYME Q10 DEFICIENCY, PRIMARY, 6; COQ10D6]
FBgn0031710	Vps52	HGNC:10518	OMIM:603443	VPS52	14		
FBgn0031708	CG7382	HGNC:25010	OMIM:615180	TIMM21	13		
FBgn0031730	CG7236	HGNC:1782	OMIM:603442	CDKL2	5		
FBgn0031730	CG7236	HGNC:1781	OMIM:603441	CDKL1	12		
FBgn0031730	CG7236	HGNC:15483	OMIM:608459	CDKL3	3		
FBgn0031730	CG7236	HGNC:11411	OMIM:300203	CDKL5	3	300672	300672[DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 2; DEE2]
FBgn0031730	CG7236	HGNC:19287		CDKL4	11		
FBgn0024191	sip1	HGNC:17165	OMIM:612747	TFIP11	15		
FBgn0031736	CG11030	HGNC:20271	OMIM:610777	NGDN	14		
FBgn0031735	CG11029	HGNC:30041	OMIM:610179	PLB1	10		
FBgn0051913	CG31913	HGNC:21868	OMIM:614769	COA1	12		
FBgn0031741	CG11034	HGNC:3009	OMIM:102720	DPP4	10		
FBgn0031741	CG11034	HGNC:3010	OMIM:126141	DPP6	9	612956,616311	612956[VENTRICULAR FIBRILLATION, PAROXYSMAL FAMILIAL, 2; VF2],616311[INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL DOMINANT 33; MRD33]
FBgn0031741	CG11034	HGNC:3590	OMIM:600403	FAP	9		
FBgn0031741	CG11034	HGNC:20823	OMIM:608209	DPP10	9		
FBgn0043362	bchs	HGNC:20751	OMIM:617485	WDFY3	15	617520	617520[MICROCEPHALY 18, PRIMARY, AUTOSOMAL DOMINANT; MCPH18]
FBgn0043362	bchs	HGNC:29323	OMIM:613316	WDFY4	7		
FBgn0015381	dsf	HGNC:7973	OMIM:603849	NR2E1	5		
FBgn0015381	dsf	HGNC:7974	OMIM:604485	NR2E3	3	268100,611131	268100[ENHANCED S-CONE SYNDROME; ESCS],611131[RETINITIS PIGMENTOSA 37; RP37]
FBgn0001128	Gpdh1	HGNC:4455	OMIM:138420	GPD1	14	614480	614480[HYPERTRIGLYCERIDEMIA, TRANSIENT INFANTILE; HTGTI]
FBgn0001128	Gpdh1	HGNC:28956	OMIM:611778	GPD1L	12	611777	611777[BRUGADA SYNDROME 2; BRGDA2]
FBgn0031752	CG9044	HGNC:19184	OMIM:607172	STK11IP	12		
FBgn0031752	CG9044	HGNC:18006	OMIM:615507	NISCH	3		
FBgn0031753	CG13999	HGNC:26944	OMIM:614459	TMEM138	14	614465	614465[JOUBERT SYNDROME 16; JBTS16]
FBgn0031738	CG9171	HGNC:15685	OMIM:605517	B4GAT1	7	615287	615287[MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 13; MDDGA13]
FBgn0031738	CG9171	HGNC:16522	OMIM:609709	LARGE2	4		
FBgn0031738	CG9171	HGNC:6511	OMIM:603590	LARGE1	3	608840,613154	608840[MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH IMPAIRED INTELLECTUAL DEVELOPMENT), TYPE B, 6; MDDGB6],613154[MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 6; MDDGA6]
FBgn0031732	CG11149	HGNC:15685	OMIM:605517	B4GAT1	6	615287	615287[MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 13; MDDGA13]
FBgn0031732	CG11149	HGNC:16522	OMIM:609709	LARGE2	3		
FBgn0031732	CG11149	HGNC:6511	OMIM:603590	LARGE1	3	608840,613154	608840[MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH IMPAIRED INTELLECTUAL DEVELOPMENT), TYPE B, 6; MDDGB6],613154[MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 6; MDDGA6]
FBgn0031757	Ucp4C	HGNC:12518	OMIM:601693	UCP2	3	607447	607447[BODY MASS INDEX QUANTITATIVE TRAIT LOCUS 4; BMIQ4]
FBgn0031757	Ucp4C	HGNC:21065	OMIM:613725	SLC25A27	6		
FBgn0031758	Ucp4B	HGNC:21065	OMIM:613725	SLC25A27	6		
FBgn0001942	eIF4A	HGNC:3284	OMIM:601102	EIF4A2	12		
FBgn0001942	eIF4A	HGNC:3282	OMIM:602641	EIF4A1	12		
FBgn0001941	ifc	HGNC:20113	OMIM:610862	DEGS2	15		
FBgn0001941	ifc	HGNC:13709	OMIM:615843	DEGS1	13	618404	618404[LEUKODYSTROPHY, HYPOMYELINATING, 18; HLD18]
FBgn0031760	Tsp26A	HGNC:13594		TSPAN17	11		
FBgn0031760	Tsp26A	HGNC:23303		TSPAN14	8		
FBgn0031760	Tsp26A	HGNC:17753	OMIM:613136	TSPAN5	12		
FBgn0031763	CG13996	HGNC:18631		SAMD15	4		
FBgn0051643	CG31643	HGNC:26150	OMIM:617529	FASTKD1	10		
FBgn0051643	CG31643	HGNC:28758	OMIM:617530	FASTKD3	3		
FBgn0051643	CG31643	HGNC:24676	OMIM:606965	FASTK	4		
FBgn0031768	IPIP	HGNC:26509	OMIM:614239	PHETA1	7		
FBgn0031768	IPIP	HGNC:27161	OMIM:614240	PHETA2	8		
FBgn0031769	CG9135	HGNC:30297	OMIM:609587	RCC2	14		
FBgn0031769	CG9135	HGNC:17499	OMIM:606051	SERGEF	3		
FBgn0031772	CG13994	HGNC:9285	OMIM:606670	PPP1R11	11		
FBgn0031774	CG9147	HGNC:40051		C5orf63	3		
FBgn0031776	Pfdn1	HGNC:8866	OMIM:604897	PFDN1	13		
FBgn0051642	CG31642	HGNC:20589	OMIM:614719	KCMF1	4		
FBgn0031784	CG9222	HGNC:14968	OMIM:610709	TSSK1B	5		
FBgn0031784	CG9222	HGNC:11401	OMIM:610710	TSSK2	4		
FBgn0031784	CG9222	HGNC:19825	OMIM:610711	TSSK4	9		
FBgn0031782	WDR79	HGNC:25522	OMIM:612661	WRAP53	15	613988	613988[DYSKERATOSIS CONGENITA, AUTOSOMAL RECESSIVE 3; DKCB3]
FBgn0031779	CG9175	HGNC:9356	OMIM:606395	PREB	14		
FBgn0031777	CG9154	HGNC:27351	OMIM:617793	EEF1AKMT1	15		
FBgn0031775	CG9150	HGNC:28639	OMIM:616159	DHRS11	12		
FBgn0031773	Fbw5	HGNC:13613	OMIM:609072	FBXW5	13		
FBgn0031771	ND-51	HGNC:7716	OMIM:161015	NDUFV1	14	618225	618225[MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 4; MC1DN4]
FBgn0029161	slmo	HGNC:15892		PRELID3B	13		
FBgn0029161	slmo	HGNC:24639	OMIM:616545	PRELID3A	12		
FBgn0000052	Pfas	HGNC:8863	OMIM:602133	PFAS	15		
FBgn0031766	CG9117	HGNC:22180		MBLAC1	13		
FBgn0025742	mtm	HGNC:7449	OMIM:300171	MTMR1	12		
FBgn0025742	mtm	HGNC:7453	OMIM:603561	MTMR6	4		
FBgn0025742	mtm	HGNC:7448	OMIM:300415	MTM1	12	310400	310400[MYOPATHY, CENTRONUCLEAR, X-LINKED; CNMX]
FBgn0025742	mtm	HGNC:7451	OMIM:603558	MTMR3	4		
FBgn0025742	mtm	HGNC:7452	OMIM:603559	MTMR4	4		
FBgn0025742	mtm	HGNC:7450	OMIM:603557	MTMR2	15	601382	601382[CHARCOT-MARIE-TOOTH DISEASE, TYPE 4B1; CMT4B1]
FBgn0025742	mtm	HGNC:7454	OMIM:603562	MTMR7	4		
FBgn0025742	mtm	HGNC:16825	OMIM:301061	MTMR8	3		
FBgn0031764	CG9107	HGNC:24286	OMIM:619449	RRP7A	14	619453	619453[MICROCEPHALY 28, PRIMARY, AUTOSOMAL RECESSIVE; MCPH28]
FBgn0031764	CG9107	HGNC:30454		RRP7BP	3		
FBgn0001170	H2.0	HGNC:4978	OMIM:142995	HLX	10		
FBgn0001089	Gal	HGNC:4298	OMIM:611458	GLB1	11	230500,230600,230650,253010	230500[GM1-GANGLIOSIDOSIS, TYPE I; GM1G1],230600[GM1-GANGLIOSIDOSIS, TYPE II; GM1G2],230650[GM1-GANGLIOSIDOSIS, TYPE III; GM1G3],253010[MUCOPOLYSACCHARIDOSIS, TYPE IVB; MPS4B]
FBgn0001089	Gal	HGNC:28129		GLB1L	12		
FBgn0001089	Gal	HGNC:25147		GLB1L3	3		
FBgn0001089	Gal	HGNC:25129		GLB1L2	4		
FBgn0031759	Kdm5	HGNC:11114	OMIM:314690	KDM5C	13	300534	300534[INTELLECTUAL DEVELOPMENTAL DISORDER, X-LINKED, SYNDROMIC, CLAES-JENSEN TYPE; MRXSCJ]
FBgn0031759	Kdm5	HGNC:18039	OMIM:605393	KDM5B	13	618109	618109[INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 65; MRT65]
FBgn0031759	Kdm5	HGNC:9886	OMIM:180202	KDM5A	15		
FBgn0031759	Kdm5	HGNC:11115	OMIM:426000	KDM5D	11		
FBgn0000308	chic	HGNC:31103		PFN4	9		
FBgn0026755	Ugt37B1	HGNC:12531	OMIM:606435	UGT1A10	3		
FBgn0026755	Ugt37B1	HGNC:12545	OMIM:603064	UGT2B11	5		
FBgn0026755	Ugt37B1	HGNC:12530	OMIM:191740	UGT1A1	5	143500,218800,237900,601816,606785	143500[GILBERT SYNDROME],218800[CRIGLER-NAJJAR SYNDROME, TYPE I],237900[HYPERBILIRUBINEMIA, TRANSIENT FAMILIAL NEONATAL; HBLRTFN],601816[BILIRUBIN, SERUM LEVEL OF, QUANTITATIVE TRAIT LOCUS 1; BILIQTL1],606785[CRIGLER-NAJJAR SYNDROME, TYPE II]
FBgn0026755	Ugt37B1	HGNC:12555	OMIM:601291	UGT8	5		
FBgn0026755	Ugt37B1	HGNC:12539	OMIM:606432	UGT1A7	3		
FBgn0026755	Ugt37B1	HGNC:13479	OMIM:606497	UGT2B28	5		
FBgn0026755	Ugt37B1	HGNC:27266	OMIM:616384	UGT3A2	4		
FBgn0026755	Ugt37B1	HGNC:12544	OMIM:600070	UGT2B10	5		
FBgn0026755	Ugt37B1	HGNC:12537	OMIM:606430	UGT1A5	3		
FBgn0026755	Ugt37B1	HGNC:12546	OMIM:600069	UGT2B15	5		
FBgn0026755	Ugt37B1	HGNC:12541	OMIM:606434	UGT1A9	3		
FBgn0026755	Ugt37B1	HGNC:28528	OMIM:616382	UGT2A3	5		
FBgn0026755	Ugt37B1	HGNC:12535	OMIM:606428	UGT1A3	6		
FBgn0026755	Ugt37B1	HGNC:12536	OMIM:606429	UGT1A4	3		
FBgn0026755	Ugt37B1	HGNC:12540	OMIM:606433	UGT1A8	3		
FBgn0026755	Ugt37B1	HGNC:26625	OMIM:616383	UGT3A1	4		
FBgn0026755	Ugt37B1	HGNC:12547	OMIM:601903	UGT2B17	5	612560	612560[BONE MINERAL DENSITY QUANTITATIVE TRAIT LOCUS 12; BMND12]
FBgn0026755	Ugt37B1	HGNC:12553	OMIM:600067	UGT2B4	5		
FBgn0026755	Ugt37B1	HGNC:12538	OMIM:606431	UGT1A6	3		
FBgn0026755	Ugt37B1	HGNC:12554	OMIM:600068	UGT2B7	5		
FBgn0026755	Ugt37B1	HGNC:28183	OMIM:619809	UGT2A2	4		
FBgn0015623	Cpr	HGNC:9208	OMIM:124015	POR	14	201750,613571	201750[ANTLEY-BIXLER SYNDROME WITH GENITAL ANOMALIES AND DISORDERED STEROIDOGENESIS; ABS1],613571[DISORDERED STEROIDOGENESIS DUE TO CYTOCHROME P450 OXIDOREDUCTASE DEFICIENCY]
FBgn0031803	ppk14	HGNC:101	OMIM:611741	ASIC3	4		
FBgn0031803	ppk14	HGNC:100	OMIM:602866	ASIC1	6		
FBgn0031803	ppk14	HGNC:21263	OMIM:606715	ASIC4	4		
FBgn0031803	ppk14	HGNC:99	OMIM:601784	ASIC2	3		
FBgn0031803	ppk14	HGNC:17537	OMIM:616693	ASIC5	4		
FBgn0031805	Nepl4	HGNC:8918	OMIM:300550	PHEX	3	307800	307800[HYPOPHOSPHATEMIC RICKETS, X-LINKED DOMINANT; XLHR]
FBgn0031805	Nepl4	HGNC:14668	OMIM:618104	MMEL1	3		
FBgn0031805	Nepl4	HGNC:7154	OMIM:120520	MME	3	617017,617018	617017[CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2T; CMT2T],617018[SPINOCEREBELLAR ATAXIA 43; SCA43]
FBgn0031805	Nepl4	HGNC:13275	OMIM:610145	ECE2	3		
FBgn0031805	Nepl4	HGNC:3147	OMIM:605896	ECEL1	3	615065	615065[ARTHROGRYPOSIS, DISTAL, TYPE 5D; DA5D]
FBgn0031805	Nepl4	HGNC:3146	OMIM:600423	ECE1	3	145500,613870	145500[HYPERTENSION, ESSENTIAL],613870[HIRSCHSPRUNG DISEASE, CARDIAC DEFECTS, AND AUTONOMIC DYSFUNCTION; HCAD]
FBgn0031805	Nepl4	HGNC:6308	OMIM:613883	KEL	4	110900	110900[BLOOD GROUP--KELL SYSTEM; KEL]
FBgn0031808	Nepl5	HGNC:8918	OMIM:300550	PHEX	3	307800	307800[HYPOPHOSPHATEMIC RICKETS, X-LINKED DOMINANT; XLHR]
FBgn0031808	Nepl5	HGNC:14668	OMIM:618104	MMEL1	3		
FBgn0031808	Nepl5	HGNC:7154	OMIM:120520	MME	3	617017,617018	617017[CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2T; CMT2T],617018[SPINOCEREBELLAR ATAXIA 43; SCA43]
FBgn0031808	Nepl5	HGNC:13275	OMIM:610145	ECE2	3		
FBgn0031808	Nepl5	HGNC:3147	OMIM:605896	ECEL1	3	615065	615065[ARTHROGRYPOSIS, DISTAL, TYPE 5D; DA5D]
FBgn0031808	Nepl5	HGNC:3146	OMIM:600423	ECE1	3	145500,613870	145500[HYPERTENSION, ESSENTIAL],613870[HIRSCHSPRUNG DISEASE, CARDIAC DEFECTS, AND AUTONOMIC DYSFUNCTION; HCAD]
FBgn0031808	Nepl5	HGNC:6308	OMIM:613883	KEL	5	110900	110900[BLOOD GROUP--KELL SYSTEM; KEL]
FBgn0031815	frj	HGNC:15505	OMIM:606048	MBOAT7	14	617188	617188[INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 57; MRT57]
FBgn0031820	Daxx	HGNC:2681	OMIM:603186	DAXX	8		
FBgn0027496	epsilonCOP	HGNC:2234	OMIM:606942	COPE	14		
FBgn0051638	CG31638	HGNC:28097		CCDC102A	13		
FBgn0051638	CG31638	HGNC:26295		CCDC102B	8		
FBgn0031824	CG9547	HGNC:4189	OMIM:608801	GCDH	15	231670	231670[GLUTARIC ACIDEMIA I; GA1]
FBgn0031822	Phf5a	HGNC:18000	OMIM:617846	PHF5A	14		
FBgn0031818	CG9536	HGNC:30055	OMIM:607069	TMEM115	12		
FBgn0031817	HemK1	HGNC:24923	OMIM:618609	HEMK1	14		
FBgn0031816	Rchy1	HGNC:17479	OMIM:607680	RCHY1	11		
FBgn0031814	retm	HGNC:40047		SEC14L6	3		
FBgn0031814	retm	HGNC:10699	OMIM:607558	SEC14L2	4		
FBgn0031814	retm	HGNC:20627	OMIM:612825	SEC14L4	3		
FBgn0031814	retm	HGNC:29032	OMIM:619412	SEC14L5	14		
FBgn0031814	retm	HGNC:10698	OMIM:601504	SEC14L1	12		
FBgn0031814	retm	HGNC:18655	OMIM:612824	SEC14L3	5		
FBgn0031804	CG9500	HGNC:3624	OMIM:601624	FCN2	5		
FBgn0031804	CG9500	HGNC:3623	OMIM:601252	FCN1	4		
FBgn0031804	CG9500	HGNC:25922	OMIM:613357	FIBCD1	6		
FBgn0031804	CG9500	HGNC:3695	OMIM:605776	FGL1	3		
FBgn0031804	CG9500	HGNC:3625	OMIM:604973	FCN3	4	613860	613860[FICOLIN 3 DEFICIENCY]
FBgn0031804	CG9500	HGNC:7035	OMIM:600596	MFAP4	4		
FBgn0031799	Pez	HGNC:9647	OMIM:603155	PTPN14	11	613611	613611[CHOANAL ATRESIA AND LYMPHEDEMA; CATLPH]
FBgn0031799	Pez	HGNC:9651	OMIM:603271	PTPN21	13		
FBgn0031826	CG9550	HGNC:6938	OMIM:605294	CHST6	9	217800	217800[MACULAR DYSTROPHY, CORNEAL; MCD]
FBgn0031826	CG9550	HGNC:1969	OMIM:603797	CHST1	9		
FBgn0031826	CG9550	HGNC:1970	OMIM:603798	CHST2	8		
FBgn0031826	CG9550	HGNC:1971	OMIM:603799	CHST3	8	143095	143095[SPONDYLOEPIPHYSEAL DYSPLASIA WITH CONGENITAL JOINT DISLOCATIONS; SEDCJD]
FBgn0031826	CG9550	HGNC:1972		CHST4	10		
FBgn0031826	CG9550	HGNC:1973	OMIM:604817	CHST5	9		
FBgn0031826	CG9550	HGNC:13817	OMIM:300375	CHST7	8		
FBgn0051637	CG31637	HGNC:6938	OMIM:605294	CHST6	11	217800	217800[MACULAR DYSTROPHY, CORNEAL; MCD]
FBgn0051637	CG31637	HGNC:1969	OMIM:603797	CHST1	11		
FBgn0051637	CG31637	HGNC:1970	OMIM:603798	CHST2	8		
FBgn0051637	CG31637	HGNC:1971	OMIM:603799	CHST3	9	143095	143095[SPONDYLOEPIPHYSEAL DYSPLASIA WITH CONGENITAL JOINT DISLOCATIONS; SEDCJD]
FBgn0051637	CG31637	HGNC:1972		CHST4	10		
FBgn0051637	CG31637	HGNC:1973	OMIM:604817	CHST5	9		
FBgn0051637	CG31637	HGNC:13817	OMIM:300375	CHST7	9		
FBgn0031830	COX5B	HGNC:2269	OMIM:123866	COX5B	11		
FBgn0031831	COX5BL	HGNC:2269	OMIM:123866	COX5B	6		
FBgn0031836	CG11050	HGNC:21078		HDDC2	11		
FBgn0028467	Ube4A	HGNC:12499	OMIM:603753	UBE4A	14	619639	619639[NEURODEVELOPMENTAL DISORDER WITH HYPOTONIA AND GROSS MOTOR AND SPEECH DELAY; NEDHMS]
FBgn0028467	Ube4A	HGNC:12500	OMIM:613565	UBE4B	3		
FBgn0000392	cup	HGNC:16687	OMIM:607445	EIF4ENIF1	3		
FBgn0031851	Aatf	HGNC:19235	OMIM:608463	AATF	12		
FBgn0046704	Liprin-alpha	HGNC:9245	OMIM:611054	PPFIA1	11		
FBgn0046704	Liprin-alpha	HGNC:9247	OMIM:603144	PPFIA3	11		
FBgn0046704	Liprin-alpha	HGNC:9246	OMIM:603143	PPFIA2	13		
FBgn0046704	Liprin-alpha	HGNC:9248	OMIM:603145	PPFIA4	9		
FBgn0031853	TTLL3B	HGNC:38830		ARPC4-TTLL3	4		
FBgn0031853	TTLL3B	HGNC:34000	OMIM:619193	TTLL8	6		
FBgn0031853	TTLL3B	HGNC:16118	OMIM:619838	TTLL9	3		
FBgn0031853	TTLL3B	HGNC:24483	OMIM:619195	TTLL3	5		
FBgn0031853	TTLL3B	HGNC:21586	OMIM:608291	TTL	3		
FBgn0031855	meng	HGNC:17699		SBK1	11		
FBgn0031855	meng	HGNC:34416		SBK2	7		
FBgn0031855	meng	HGNC:44121		SBK3	5		
FBgn0031854	TTLL3A	HGNC:38830		ARPC4-TTLL3	6		
FBgn0031854	TTLL3A	HGNC:34000	OMIM:619193	TTLL8	10		
FBgn0031854	TTLL3A	HGNC:24483	OMIM:619195	TTLL3	9		
FBgn0025777	homer	HGNC:17514	OMIM:604800	HOMER3	8		
FBgn0025777	homer	HGNC:17512	OMIM:604798	HOMER1	10		
FBgn0025777	homer	HGNC:17513	OMIM:604799	HOMER2	15	616707	616707[DEAFNESS, AUTOSOMAL DOMINANT 68; DFNA68]
FBgn0025595	AkhR	HGNC:4421	OMIM:138850	GNRHR	12	146110	146110[HYPOGONADOTROPIC HYPOGONADISM 7 WITH OR WITHOUT ANOSMIA; HH7]
FBgn0025595	AkhR	HGNC:16341	OMIM:612875	GNRHR2	5		
FBgn0031850	Tsp	HGNC:11788	OMIM:600715	THBS4	12		
FBgn0031850	Tsp	HGNC:11785	OMIM:188060	THBS1	6		
FBgn0031850	Tsp	HGNC:11786	OMIM:188061	THBS2	6	603932	603932[INTERVERTEBRAL DISC DISEASE; IDD]
FBgn0031850	Tsp	HGNC:11787	OMIM:188062	THBS3	13		
FBgn0031850	Tsp	HGNC:2227	OMIM:600310	COMP	15	132400,177170,619161	132400[EPIPHYSEAL DYSPLASIA, MULTIPLE, 1; EDM1],177170[PSEUDOACHONDROPLASIA; PSACH],619161[CARPAL TUNNEL SYNDROME 2; CTS2]
FBgn0028703	Nhe3	HGNC:11079	OMIM:300231	SLC9A6	13	300243	300243[INTELLECTUAL DEVELOPMENTAL DISORDER, X-LINKED, SYNDROMIC, CHRISTIANSON TYPE; MRXSCH]
FBgn0028703	Nhe3	HGNC:17123	OMIM:300368	SLC9A7	12	301024	301024[INTELLECTUAL DEVELOPMENTAL DISORDER, X-LINKED 108; MRX108]
FBgn0028703	Nhe3	HGNC:20653	OMIM:608396	SLC9A9	13	613410	613410[AUTISM, SUSCEPTIBILITY TO, 16; AUTS16]
FBgn0028703	Nhe3	HGNC:20728	OMIM:612730	SLC9A8	3		
FBgn0031848	Nse1	HGNC:29897	OMIM:617263	NSMCE1	14		
FBgn0028990	Spn27A	HGNC:8943	OMIM:602445	SERPINI1	3	604218	604218[ENCEPHALOPATHY, FAMILIAL, WITH NEUROSERPIN INCLUSION BODIES; FENIB]
FBgn0028990	Spn27A	HGNC:3311	OMIM:130135	SERPINB1	3		
FBgn0031844	CG13771	HGNC:17152	OMIM:300862	ACOT9	11		
FBgn0051636	CG31636	HGNC:12404	OMIM:600415	TTPA	3	277460	277460[ATAXIA WITH VITAMIN E DEFICIENCY; AVED]
FBgn0051636	CG31636	HGNC:16114		TTPAL	3		
FBgn0051636	CG31636	HGNC:10024	OMIM:180090	RLBP1	3	136880,607475,607476	136880[FUNDUS ALBIPUNCTATUS],607475[BOTHNIA RETINAL DYSTROPHY],607476[NEWFOUNDLAND ROD-CONE DYSTROPHY; NFRCD]
FBgn0051636	CG31636	HGNC:23046	OMIM:616945	CLVS2	3		
FBgn0051636	CG31636	HGNC:23139	OMIM:611292	CLVS1	4		
FBgn0051635	CG31635	HGNC:27607		PPP1R37	8		
FBgn0051634	Oatp26F	HGNC:23612	OMIM:609013	SLCO4C1	6		
FBgn0051634	Oatp26F	HGNC:10953	OMIM:612436	SLCO4A1	15		
FBgn0051634	Oatp26F	HGNC:19046	OMIM:613543	SLCO5A1	3		
FBgn0051634	Oatp26F	HGNC:23613	OMIM:613365	SLCO6A1	5		
FBgn0031837	DIP-iota	HGNC:17302	OMIM:613173	NEGR1	6		
FBgn0031837	DIP-iota	HGNC:34550	OMIM:618861	IGLON5	10		
FBgn0031837	DIP-iota	HGNC:6705	OMIM:603241	LSAMP	7		
FBgn0031837	DIP-iota	HGNC:8143	OMIM:600632	OPCML	9	167000	167000[OVARIAN CANCER]
FBgn0031837	DIP-iota	HGNC:17941	OMIM:607938	NTM	7		
FBgn0031832	Trmt6	HGNC:20900		TRMT6	15		
FBgn0031829	IFT52	HGNC:15901	OMIM:617094	IFT52	14	617102	617102[SHORT-RIB THORACIC DYSPLASIA 16 WITH OR WITHOUT POLYDACTYLY; SRTD16]
FBgn0031858	CG17378	HGNC:29058	OMIM:611675	KIAA0513	10		
FBgn0031860	Daao2	HGNC:2671	OMIM:124050	DAO	9		
FBgn0031860	Daao2	HGNC:2727	OMIM:124450	DDO	9		
FBgn0051632	sens-2	HGNC:4237	OMIM:600871	GFI1	7	607847,613107	607847[NEUTROPENIA, NONIMMUNE CHRONIC IDIOPATHIC, OF ADULTS],613107[NEUTROPENIA, SEVERE CONGENITAL, 2, AUTOSOMAL DOMINANT; SCN2]
FBgn0051632	sens-2	HGNC:4238	OMIM:604383	GFI1B	8	187900	187900[BLEEDING DISORDER, PLATELET-TYPE, 17; BDPLT17]
FBgn0017551	Rca1	HGNC:28521	OMIM:609110	FBXO43	4	619696,619697	619696[SPERMATOGENIC FAILURE 64; SPGF64],619697[OOCYTE MATURATION DEFECT 12; OOMD12]
FBgn0017551	Rca1	HGNC:13584	OMIM:606013	FBXO5	3		
FBgn0031866	Nlg2	HGNC:1848	OMIM:114840	CEL	3	609812	609812[MATURITY-ONSET DIABETES OF THE YOUNG, TYPE 8, WITH EXOCRINE DYSFUNCTION; MODY8]
FBgn0031866	Nlg2	HGNC:15529	OMIM:400028	NLGN4Y	9		
FBgn0031866	Nlg2	HGNC:14291	OMIM:600568	NLGN1	10	618830	618830[AUTISM, SUSCEPTIBILITY TO, 20; AUTS20]
FBgn0031866	Nlg2	HGNC:14289	OMIM:300336	NLGN3	10	300425,300494	300425[AUTISM, SUSCEPTIBILITY TO, X-LINKED 1; AUTSX1],300494[ASPERGER SYNDROME, X-LINKED, SUSCEPTIBILITY TO, 1; ASPGX1]
FBgn0031866	Nlg2	HGNC:14287	OMIM:300427	NLGN4X	10	300495,300497	300495[AUTISM, SUSCEPTIBILITY TO, X-LINKED 2; AUTSX2],300497[ASPERGER SYNDROME, X-LINKED, SUSCEPTIBILITY TO, 2; ASPGX2]
FBgn0031866	Nlg2	HGNC:14290	OMIM:606479	NLGN2	8		
FBgn0031868	Rat1	HGNC:30654	OMIM:607994	XRN1	3		
FBgn0031868	Rat1	HGNC:12836	OMIM:608851	XRN2	14		
FBgn0004838	Hrb27C	HGNC:7330	OMIM:603328	MSI1	4		
FBgn0004838	Hrb27C	HGNC:2683	OMIM:607430	DAZAP1	12		
FBgn0004838	Hrb27C	HGNC:18585	OMIM:607897	MSI2	4		
FBgn0020616	SA1	HGNC:11354	OMIM:604358	STAG1	14	617635	617635[INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL DOMINANT 47; MRD47]
FBgn0020616	SA1	HGNC:11356	OMIM:608489	STAG3	13	615723,619672	615723[PREMATURE OVARIAN FAILURE 8; POF8],619672[SPERMATOGENIC FAILURE 61; SPGF61]
FBgn0020616	SA1	HGNC:11355	OMIM:300826	STAG2	12	301022,301043	301022[MULLEGAMA-KLEIN-MARTINEZ SYNDROME; MKMS],301043[HOLOPROSENCEPHALY 13, X-LINKED; HPE13]
FBgn0031875	CG3430	HGNC:25782	OMIM:610909	MCMBP	14		
FBgn0031877	Hmgcl	HGNC:5005	OMIM:613898	HMGCL	14	246450	246450[3-HYDROXY-3-METHYLGLUTARYL-CoA LYASE DEFICIENCY; HMGCLD]
FBgn0031877	Hmgcl	HGNC:21359	OMIM:619050	HMGCLL1	13		
FBgn0021944	Coprox	HGNC:2321	OMIM:612732	CPOX	15	121300,618892	121300[COPROPORPHYRIA, HEREDITARY; HCP],618892[HARDEROPORPHYRIA; HARPO]
FBgn0016978	snRNP-U1-70K	HGNC:11150	OMIM:180740	SNRNP70	13		
FBgn0031876	Atac1	HGNC:24523	OMIM:619892	ZZZ3	9		
FBgn0031874	CG13775	HGNC:20721	OMIM:612552	ZBED4	10		
FBgn0031874	CG13775	HGNC:447	OMIM:300178	ZBED1	3		
FBgn0031874	CG13775	HGNC:33273	OMIM:613512	ZBED6	8		
FBgn0031874	CG13775	HGNC:18399	OMIM:301034	DHRSX	3		
FBgn0031873	Gas41	HGNC:24859	OMIM:602116	YEATS4	12		
FBgn0031872	ihog	HGNC:17104	OMIM:608707	CDON	5	614226	614226[HOLOPROSENCEPHALY 11; HPE11]
FBgn0031872	ihog	HGNC:17173	OMIM:608708	BOC	5		
FBgn0031871	Fgop2	HGNC:23098	OMIM:608858	FGFR1OP2	13		
FBgn0031871	Fgop2	HGNC:26119	OMIM:611656	SIKE1	11		
FBgn0031869	CG18304	HGNC:29121	OMIM:615766	MTCL1	4		
FBgn0031869	CG18304	HGNC:16111		SOGA1	4		
FBgn0031869	CG18304	HGNC:21494		SOGA3	6		
FBgn0028554	x16	HGNC:10789	OMIM:600572	SRSF7	10		
FBgn0028554	x16	HGNC:10785	OMIM:603364	SRSF3	7		
FBgn0026196	nop5	HGNC:29926	OMIM:616742	NOP58	14		
FBgn0011737	Wee1	HGNC:12761	OMIM:193525	WEE1	14		
FBgn0011737	Wee1	HGNC:29650	OMIM:602474	PKMYT1	3		
FBgn0011737	Wee1	HGNC:19684	OMIM:614084	WEE2	8	617996	617996[OOCYTE MATURATION DEFECT 5; OOMD5]
FBgn0042092	Polr1F	HGNC:18027	OMIM:608312	TWISTNB	12		
FBgn0031865	Nha1	HGNC:24244	OMIM:611527	SLC9B1	12		
FBgn0031865	Nha1	HGNC:25143	OMIM:611789	SLC9B2	13		
FBgn0031865	Nha1	HGNC:37492		SLC9B1P1	3		
FBgn0015776	nrv1	HGNC:804	OMIM:182330	ATP1B1	14	145500	145500[HYPERTENSION, ESSENTIAL]
FBgn0015776	nrv1	HGNC:806	OMIM:601867	ATP1B3	10		
FBgn0015776	nrv1	HGNC:805	OMIM:182331	ATP1B2	12		
FBgn0015776	nrv1	HGNC:820	OMIM:137217	ATP4B	7		
FBgn0015776	nrv1	HGNC:808	OMIM:301073	ATP1B4	9		
FBgn0031857	LUBEL	HGNC:16031	OMIM:612487	RNF31	10		
FBgn0031856	CG11322	HGNC:15805	OMIM:300369	GCNA	4	301077	301077[SPERMATOGENIC FAILURE, X-LINKED, 4; SPGFX4]
FBgn0031881	MME1	HGNC:1421	OMIM:613698	SLC25A20	10	212138	212138[CARNITINE-ACYLCARNITINE TRANSLOCASE DEFICIENCY; CACTD]
FBgn0031881	MME1	HGNC:20116	OMIM:615064	SLC25A29	3		
FBgn0031881	MME1	HGNC:27442	OMIM:610825	SLC25A45	4		
FBgn0031885	Mnn1	HGNC:7010	OMIM:613733	MEN1	14	131100	131100[MULTIPLE ENDOCRINE NEOPLASIA, TYPE I; MEN1]
FBgn0031887	Ugt307A1	HGNC:12545	OMIM:603064	UGT2B11	4		
FBgn0031887	Ugt307A1	HGNC:12530	OMIM:191740	UGT1A1	4	143500,218800,237900,601816,606785	143500[GILBERT SYNDROME],218800[CRIGLER-NAJJAR SYNDROME, TYPE I],237900[HYPERBILIRUBINEMIA, TRANSIENT FAMILIAL NEONATAL; HBLRTFN],601816[BILIRUBIN, SERUM LEVEL OF, QUANTITATIVE TRAIT LOCUS 1; BILIQTL1],606785[CRIGLER-NAJJAR SYNDROME, TYPE II]
FBgn0031887	Ugt307A1	HGNC:12555	OMIM:601291	UGT8	4		
FBgn0031887	Ugt307A1	HGNC:13479	OMIM:606497	UGT2B28	4		
FBgn0031887	Ugt307A1	HGNC:27266	OMIM:616384	UGT3A2	4		
FBgn0031887	Ugt307A1	HGNC:12544	OMIM:600070	UGT2B10	4		
FBgn0031887	Ugt307A1	HGNC:12546	OMIM:600069	UGT2B15	4		
FBgn0031887	Ugt307A1	HGNC:28528	OMIM:616382	UGT2A3	4		
FBgn0031887	Ugt307A1	HGNC:12535	OMIM:606428	UGT1A3	4		
FBgn0031887	Ugt307A1	HGNC:26625	OMIM:616383	UGT3A1	4		
FBgn0031887	Ugt307A1	HGNC:12547	OMIM:601903	UGT2B17	4	612560	612560[BONE MINERAL DENSITY QUANTITATIVE TRAIT LOCUS 12; BMND12]
FBgn0031887	Ugt307A1	HGNC:12553	OMIM:600067	UGT2B4	4		
FBgn0031887	Ugt307A1	HGNC:12554	OMIM:600068	UGT2B7	4		
FBgn0031887	Ugt307A1	HGNC:28183	OMIM:619809	UGT2A2	3		
FBgn0031893	MICU1	HGNC:1530	OMIM:605084	MICU1	13	615673	615673[MYOPATHY WITH EXTRAPYRAMIDAL SIGNS; MPXPS]
FBgn0031897	CG13784	HGNC:26188		SLC66A2	11		
FBgn0031896	CG4502	HGNC:37269	OMIM:615832	UBE2QL1	13		
FBgn0031896	CG4502	HGNC:19248	OMIM:612501	UBE2Q2	3		
FBgn0031896	CG4502	HGNC:15698	OMIM:617429	UBE2Q1	3		
FBgn0031895	CG4497	HGNC:30490		PABIR2	8		
FBgn0031895	CG4497	HGNC:23490	OMIM:617249	PABIR1	8		
FBgn0031895	CG4497	HGNC:25202		FAM122C	6		
FBgn0051907	Mst27D	HGNC:6892	OMIM:605788	MAPRE3	5		
FBgn0051907	Mst27D	HGNC:6891	OMIM:605789	MAPRE2	5	616734	616734[SKIN CREASES, CONGENITAL SYMMETRIC CIRCUMFERENTIAL, 2; CSCSC2]
FBgn0051907	Mst27D	HGNC:6890	OMIM:603108	MAPRE1	6		
FBgn0031882	Rab30	HGNC:9770	OMIM:605693	RAB30	14		
FBgn0051908	CG31908	HGNC:30232		SZRD1	7		
FBgn0031902	Wnt6	HGNC:12785	OMIM:604663	WNT6	10		
FBgn0031903	Wnt10	HGNC:12786	OMIM:601570	WNT7A	3	228930,276820	228930[FIBULAR APLASIA OR HYPOPLASIA, FEMORAL BOWING AND POLY-, SYN-, AND OLIGODACTYLY],276820[ULNA AND FIBULA, ABSENCE OF, WITH SEVERE LIMB DEFICIENCY]
FBgn0031903	Wnt10	HGNC:12775	OMIM:601906	WNT10B	13	225300,617073	225300[SPLIT-HAND/FOOT MALFORMATION 6; SHFM6],617073[TOOTH AGENESIS, SELECTIVE, 8; STHAG8]
FBgn0031903	Wnt10	HGNC:13829	OMIM:606268	WNT10A	12	150400,224750,257980	150400[TOOTH AGENESIS, SELECTIVE, 4; STHAG4],224750[SCHOPF-SCHULZ-PASSARGE SYNDROME; SSPS],257980[ODONTOONYCHODERMAL DYSPLASIA; OODD]
FBgn0002938	ninaC	HGNC:7601	OMIM:606808	MYO3A	12	607101	607101[DEAFNESS, AUTOSOMAL RECESSIVE 30; DFNB30]
FBgn0002938	ninaC	HGNC:15576	OMIM:610040	MYO3B	10		
FBgn0031905	gudu	HGNC:25583	OMIM:615408	ARMC4	12	615451	615451[CILIARY DYSKINESIA, PRIMARY, 23; CILD23]
FBgn0031910	CG15818	HGNC:13257	OMIM:605306	CLEC4A	3		
FBgn0028387	chm	HGNC:17016	OMIM:609880	KAT7	12		
FBgn0028387	chm	HGNC:5275	OMIM:601409	KAT5	3	619103	619103[NEURODEVELOPMENTAL DISORDER WITH DYSMORPHIC FACIES, SLEEP DISTURBANCE, AND BRAIN ABNORMALITIES; NEDFASB]
FBgn0028387	chm	HGNC:17933	OMIM:609912	KAT8	3	618974	618974[LI-GHORBANI-WEISZ-HUBSHMAN SYNDROME; LIGOWS]
FBgn0031914	CG5973	HGNC:12404	OMIM:600415	TTPA	3	277460	277460[ATAXIA WITH VITAMIN E DEFICIENCY; AVED]
FBgn0031914	CG5973	HGNC:16114		TTPAL	7		
FBgn0031914	CG5973	HGNC:10024	OMIM:180090	RLBP1	3	136880,607475,607476	136880[FUNDUS ALBIPUNCTATUS],607475[BOTHNIA RETINAL DYSTROPHY],607476[NEWFOUNDLAND ROD-CONE DYSTROPHY; NFRCD]
FBgn0031914	CG5973	HGNC:23046	OMIM:616945	CLVS2	3		
FBgn0031914	CG5973	HGNC:23139	OMIM:611292	CLVS1	3		
FBgn0025697	santa-maria	HGNC:1663	OMIM:173510	CD36	5	608404,610938,611162	608404[PLATELET GLYCOPROTEIN IV DEFICIENCY],610938[CORONARY HEART DISEASE, SUSCEPTIBILITY TO, 7; CHDS7],611162[MALARIA, SUSCEPTIBILITY TO]
FBgn0025697	santa-maria	HGNC:1664	OMIM:601040	SCARB1	5	610762	610762[HIGH DENSITY LIPOPROTEIN CHOLESTEROL LEVEL QUANTITATIVE TRAIT LOCUS 6; HDLCQ6]
FBgn0025697	santa-maria	HGNC:1665	OMIM:602257	SCARB2	4	254900	254900[EPILEPSY, PROGRESSIVE MYOCLONIC, 4, WITH OR WITHOUT RENAL FAILURE; EPM4]
FBgn0031913	CG5958	HGNC:12404	OMIM:600415	TTPA	3	277460	277460[ATAXIA WITH VITAMIN E DEFICIENCY; AVED]
FBgn0031913	CG5958	HGNC:16114		TTPAL	6		
FBgn0031913	CG5958	HGNC:10024	OMIM:180090	RLBP1	5	136880,607475,607476	136880[FUNDUS ALBIPUNCTATUS],607475[BOTHNIA RETINAL DYSTROPHY],607476[NEWFOUNDLAND ROD-CONE DYSTROPHY; NFRCD]
FBgn0031913	CG5958	HGNC:23046	OMIM:616945	CLVS2	4		
FBgn0031913	CG5958	HGNC:23139	OMIM:611292	CLVS1	4		
FBgn0031909	CG5181	HGNC:28412	OMIM:612104	NABP2	11		
FBgn0031909	CG5181	HGNC:26232	OMIM:612103	NABP1	12		
FBgn0031904	CG5149	HGNC:29325	OMIM:619331	MEAK7	11		
FBgn0083141	Spn28B	HGNC:8955	OMIM:601799	SERPINB9	3		
FBgn0083141	Spn28B	HGNC:8945	OMIM:605587	SERPINI2	4		
FBgn0083141	Spn28B	HGNC:8943	OMIM:602445	SERPINI1	5	604218	604218[ENCEPHALOPATHY, FAMILIAL, WITH NEUROSERPIN INCLUSION BODIES; FENIB]
FBgn0083141	Spn28B	HGNC:10569	OMIM:600517	SERPINB3	5		
FBgn0083141	Spn28B	HGNC:3311	OMIM:130135	SERPINB1	5		
FBgn0083141	Spn28B	HGNC:775	OMIM:107300	SERPINC1	4	613118	613118[ANTITHROMBIN III DEFICIENCY; AT3D]
FBgn0083141	Spn28B	HGNC:8583	OMIM:173360	SERPINE1	3	613329	613329[PLASMINOGEN ACTIVATOR INHIBITOR-1 DEFICIENCY]
FBgn0083141	Spn28B	HGNC:8948	OMIM:147935	SERPINA4	3		
FBgn0083141	Spn28B	HGNC:10570	OMIM:600518	SERPINB4	6		
FBgn0083141	Spn28B	HGNC:8952	OMIM:601697	SERPINB8	3	617115	617115[PEELING SKIN SYNDROME 5; PSS5]
FBgn0083141	Spn28B	HGNC:8951	OMIM:177010	SERPINE2	3		
FBgn0083141	Spn28B	HGNC:14220	OMIM:615662	SERPINB12	3		
FBgn0083141	Spn28B	HGNC:8942	OMIM:602058	SERPINB10	3		
FBgn0083141	Spn28B	HGNC:8950	OMIM:173321	SERPINB6	4	613453	613453[DEAFNESS, AUTOSOMAL RECESSIVE 91; DFNB91]
FBgn0083141	Spn28B	HGNC:8944	OMIM:604445	SERPINB13	4		
FBgn0031925	Cyp4d21	HGNC:23198	OMIM:608614	CYP4V2	5	210370	210370[BIETTI CRYSTALLINE CORNEORETINAL DYSTROPHY; BCD]
FBgn0031925	Cyp4d21	HGNC:13265	OMIM:611517	CYP4F11	4		
FBgn0031925	Cyp4d21	HGNC:26820	OMIM:611495	CYP4F22	4	604777	604777[ICHTHYOSIS, CONGENITAL, AUTOSOMAL RECESSIVE 5; ARCI5]
FBgn0031925	Cyp4d21	HGNC:2645	OMIM:604426	CYP4F2	4		
FBgn0031925	Cyp4d21	HGNC:2646	OMIM:601270	CYP4F3	5		
FBgn0031925	Cyp4d21	HGNC:20244	OMIM:614999	CYP4X1	3		
FBgn0031925	Cyp4d21	HGNC:2642	OMIM:601310	CYP4A11	3		
FBgn0031925	Cyp4d21	HGNC:18857	OMIM:611485	CYP4F12	4		
FBgn0031925	Cyp4d21	HGNC:20575	OMIM:615341	CYP4A22	4		
FBgn0031925	Cyp4d21	HGNC:2644	OMIM:124075	CYP4B1	4		
FBgn0031925	Cyp4d21	HGNC:2648	OMIM:611545	CYP4F8	4		
FBgn0031925	Cyp4d21	HGNC:20583	OMIM:618953	CYP4Z1	4		
FBgn0031925	Cyp4d21	HGNC:2594	OMIM:107910	CYP19A1	3	139300,613546	139300[AROMATASE EXCESS SYNDROME; AEXS],613546[AROMATASE DEFICIENCY]
FBgn0031926	CG6739	HGNC:16692	OMIM:606475	CD320	3	613646	613646[METHYLMALONIC ACIDURIA, TRANSIENT, DUE TO TRANSCOBALAMIN RECEPTOR DEFECT]
FBgn0040299	Myo28B1	HGNC:7607	OMIM:606541	MYO7B	8		
FBgn0040299	Myo28B1	HGNC:7606	OMIM:276903	MYO7A	7	276900,600060,601317	276900[USHER SYNDROME, TYPE I; USH1],600060[DEAFNESS, AUTOSOMAL RECESSIVE 2; DFNB2],601317[DEAFNESS, AUTOSOMAL DOMINANT 11; DFNA11]
FBgn0041181	Tep3	HGNC:21685	OMIM:608859	CD109	11		
FBgn0041181	Tep3	HGNC:1318	OMIM:120700	C3	4	611378,612925,613779	611378[MACULAR DEGENERATION, AGE-RELATED, 9; ARMD9],612925[HEMOLYTIC UREMIC SYNDROME, ATYPICAL, SUSCEPTIBILITY TO, 5; AHUS5],613779[COMPLEMENT COMPONENT 3 DEFICIENCY, AUTOSOMAL RECESSIVE; C3D]
FBgn0041181	Tep3	HGNC:1323	OMIM:120810	C4A	4	614374,614380	614374[BLOOD GROUP, CHIDO/RODGERS SYSTEM],614380[COMPLEMENT COMPONENT 4A DEFICIENCY; C4AD]
FBgn0041181	Tep3	HGNC:1324	OMIM:120820	C4B	4	614379	614379[COMPLEMENT COMPONENT 4B DEFICIENCY; C4BD]
FBgn0041181	Tep3	HGNC:1331	OMIM:120900	C5	5	609536,615749	609536[COMPLEMENT COMPONENT 5 DEFICIENCY; C5D],615749[ECULIZUMAB, POOR RESPONSE TO]
FBgn0041181	Tep3	HGNC:9750	OMIM:176420	PZP	6		
FBgn0041181	Tep3	HGNC:7	OMIM:103950	A2M	6		
FBgn0041181	Tep3	HGNC:23336	OMIM:610627	A2ML1	5	166760	166760[OTITIS MEDIA, SUSCEPTIBILITY TO; OMS]
FBgn0041181	Tep3	HGNC:23228	OMIM:608841	CPAMD8	3	617319	617319[ANTERIOR SEGMENT DYSGENESIS 8; ASGD8]
FBgn0031941	ATPsynGL	HGNC:14247	OMIM:617473	ATP5MG	11		
FBgn0031941	ATPsynGL	HGNC:13213		ATP5MGL	9		
FBgn0031947	Brd7-9	HGNC:14310	OMIM:618489	BRD7	12		
FBgn0031947	Brd7-9	HGNC:25818	OMIM:618465	BRD9	11		
FBgn0031951	r2d2	HGNC:9438	OMIM:603424	PRKRA	3	612067	612067[DYSTONIA 16; DYT16]
FBgn0031951	r2d2	HGNC:11569	OMIM:605053	TARBP2	4		
FBgn0031952	Cdc14	HGNC:1719	OMIM:603505	CDC14B	10		
FBgn0031952	Cdc14	HGNC:1718	OMIM:603504	CDC14A	9	608653	608653[DEAFNESS, AUTOSOMAL RECESSIVE 32, WITH OR WITHOUT IMMOTILE SPERM; DFNB32]
FBgn0031952	Cdc14	HGNC:22427		CDC14C	5		
FBgn0031950	Herp	HGNC:21915		HERPUD2	14		
FBgn0031950	Herp	HGNC:13744	OMIM:608070	HERPUD1	12		
FBgn0031948	CG7149	HGNC:29361	OMIM:607915	SELENOI	12	618768	618768[SPASTIC PARAPLEGIA 81, AUTOSOMAL RECESSIVE; SPG81]
FBgn0031939	CG13796	HGNC:11049	OMIM:126455	SLC6A3	3	188890,613135	188890[TOBACCO ADDICTION, SUSCEPTIBILITY TO],613135[PARKINSONISM-DYSTONIA 1, INFANTILE-ONSET; PKDYS1]
FBgn0031939	CG13796	HGNC:11044	OMIM:607952	SLC6A11	3		
FBgn0031939	CG13796	HGNC:31399	OMIM:610299	SLC6A17	3	616269	616269[INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 48; MRT48]
FBgn0031939	CG13796	HGNC:11045	OMIM:603080	SLC6A12	3		
FBgn0031939	CG13796	HGNC:11054	OMIM:606205	SLC6A7	3		
FBgn0031939	CG13796	HGNC:11048	OMIM:163970	SLC6A2	3	604715	604715[ORTHOSTATIC INTOLERANCE]
FBgn0031939	CG13796	HGNC:13621	OMIM:607971	SLC6A15	3		
FBgn0031939	CG13796	HGNC:11050	OMIM:182138	SLC6A4	4	164230,607834	164230[OBSESSIVE-COMPULSIVE DISORDER; OCD],607834[ANXIETY]
FBgn0031939	CG13796	HGNC:11055	OMIM:300036	SLC6A8	3	300352	300352[CEREBRAL CREATINE DEFICIENCY SYNDROME 1; CCDS1]
FBgn0031939	CG13796	HGNC:11056	OMIM:601019	SLC6A9	3	617301	617301[GLYCINE ENCEPHALOPATHY WITH NORMAL SERUM GLYCINE]
FBgn0031939	CG13796	HGNC:11051	OMIM:604159	SLC6A5	4	614618	614618[HYPEREKPLEXIA 3; HKPX3]
FBgn0031939	CG13796	HGNC:11047	OMIM:300444	SLC6A14	4		
FBgn0031939	CG13796	HGNC:11052	OMIM:186854	SLC6A6	3	145350	145350[HYPOTAURINEMIC RETINAL DEGENERATION AND CARDIOMYOPATHY; HTRDC]
FBgn0031939	CG13796	HGNC:11046	OMIM:615097	SLC6A13	3		
FBgn0031939	CG13796	HGNC:11042	OMIM:137165	SLC6A1	3	616421	616421[MYOCLONIC-ATONIC EPILEPSY; MAE]
FBgn0031939	CG13796	HGNC:13622	OMIM:607972	SLC6A16	3		
FBgn0031937	CG13795	HGNC:11050	OMIM:182138	SLC6A4	3	164230,607834	164230[OBSESSIVE-COMPULSIVE DISORDER; OCD],607834[ANXIETY]
FBgn0031937	CG13795	HGNC:11051	OMIM:604159	SLC6A5	3	614618	614618[HYPEREKPLEXIA 3; HKPX3]
FBgn0031937	CG13795	HGNC:11047	OMIM:300444	SLC6A14	3		
FBgn0031936	CG13794	HGNC:11050	OMIM:182138	SLC6A4	3	164230,607834	164230[OBSESSIVE-COMPULSIVE DISORDER; OCD],607834[ANXIETY]
FBgn0031936	CG13794	HGNC:11051	OMIM:604159	SLC6A5	3	614618	614618[HYPEREKPLEXIA 3; HKPX3]
FBgn0031936	CG13794	HGNC:11047	OMIM:300444	SLC6A14	4		
FBgn0031935	CG13793	HGNC:11050	OMIM:182138	SLC6A4	3	164230,607834	164230[OBSESSIVE-COMPULSIVE DISORDER; OCD],607834[ANXIETY]
FBgn0031935	CG13793	HGNC:11051	OMIM:604159	SLC6A5	3	614618	614618[HYPEREKPLEXIA 3; HKPX3]
FBgn0031935	CG13793	HGNC:11047	OMIM:300444	SLC6A14	3		
FBgn0053296	CG33296	HGNC:11050	OMIM:182138	SLC6A4	3	164230,607834	164230[OBSESSIVE-COMPULSIVE DISORDER; OCD],607834[ANXIETY]
FBgn0053296	CG33296	HGNC:11051	OMIM:604159	SLC6A5	3	614618	614618[HYPEREKPLEXIA 3; HKPX3]
FBgn0053296	CG33296	HGNC:11047	OMIM:300444	SLC6A14	3		
FBgn0041182	Tep2	HGNC:21685	OMIM:608859	CD109	13		
FBgn0041182	Tep2	HGNC:1318	OMIM:120700	C3	4	611378,612925,613779	611378[MACULAR DEGENERATION, AGE-RELATED, 9; ARMD9],612925[HEMOLYTIC UREMIC SYNDROME, ATYPICAL, SUSCEPTIBILITY TO, 5; AHUS5],613779[COMPLEMENT COMPONENT 3 DEFICIENCY, AUTOSOMAL RECESSIVE; C3D]
FBgn0041182	Tep2	HGNC:1323	OMIM:120810	C4A	4	614374,614380	614374[BLOOD GROUP, CHIDO/RODGERS SYSTEM],614380[COMPLEMENT COMPONENT 4A DEFICIENCY; C4AD]
FBgn0041182	Tep2	HGNC:1324	OMIM:120820	C4B	4	614379	614379[COMPLEMENT COMPONENT 4B DEFICIENCY; C4BD]
FBgn0041182	Tep2	HGNC:1331	OMIM:120900	C5	5	609536,615749	609536[COMPLEMENT COMPONENT 5 DEFICIENCY; C5D],615749[ECULIZUMAB, POOR RESPONSE TO]
FBgn0041182	Tep2	HGNC:9750	OMIM:176420	PZP	5		
FBgn0041182	Tep2	HGNC:7	OMIM:103950	A2M	5		
FBgn0041182	Tep2	HGNC:23336	OMIM:610627	A2ML1	5	166760	166760[OTITIS MEDIA, SUSCEPTIBILITY TO; OMS]
FBgn0041182	Tep2	HGNC:23228	OMIM:608841	CPAMD8	3	617319	617319[ANTERIOR SEGMENT DYSGENESIS 8; ASGD8]
FBgn0031929	CG18585	HGNC:2300	OMIM:603101	CPB2	8		
FBgn0031929	CG18585	HGNC:21011	OMIM:609563	CPO	9		
FBgn0031929	CG18585	HGNC:2298	OMIM:114851	CPA3	7		
FBgn0031929	CG18585	HGNC:2297	OMIM:600688	CPA2	9		
FBgn0031929	CG18585	HGNC:15740	OMIM:607635	CPA4	8		
FBgn0031929	CG18585	HGNC:2299	OMIM:114852	CPB1	10		
FBgn0031929	CG18585	HGNC:2296	OMIM:114850	CPA1	9		
FBgn0031929	CG18585	HGNC:17245	OMIM:609562	CPA6	7	614417,614418	614417[EPILEPSY, FAMILIAL TEMPORAL LOBE, 5; ETL5],614418[FEBRILE SEIZURES, FAMILIAL, 11; FEB11]
FBgn0031929	CG18585	HGNC:15722	OMIM:609561	CPA5	7		
FBgn0027515	CG7115	HGNC:16381	OMIM:611931	PPM1L	14		
FBgn0004177	mts	HGNC:9323	OMIM:612725	PPP6C	3		
FBgn0004177	mts	HGNC:9299	OMIM:176915	PPP2CA	14	618354	618354[NEURODEVELOPMENTAL DISORDER AND LANGUAGE DELAY WITH OR WITHOUT STRUCTURAL BRAIN ABNORMALITIES; NEDLBA]
FBgn0004177	mts	HGNC:9300	OMIM:176916	PPP2CB	11		
FBgn0004177	mts	HGNC:9319	OMIM:602035	PPP4C	3		
FBgn0031968	CG7231	HGNC:25032		FAM151A	8		
FBgn0031968	CG7231	HGNC:33716		FAM151B	14		
FBgn0031975	Tg	HGNC:3381	OMIM:177070	EPB42	4	612690	612690[SPHEROCYTOSIS, TYPE 5; SPH5]
FBgn0031975	Tg	HGNC:3531	OMIM:134570	F13A1	8	188050,608446,613225	188050[THROMBOPHILIA DUE TO THROMBIN DEFECT; THPH1],608446[MYOCARDIAL INFARCTION, SUSCEPTIBILITY TO],613225[FACTOR XIII, A SUBUNIT, DEFICIENCY OF]
FBgn0031975	Tg	HGNC:11780	OMIM:600585	TGM4	11		
FBgn0031975	Tg	HGNC:11777	OMIM:190195	TGM1	12	242300	242300[ICHTHYOSIS, CONGENITAL, AUTOSOMAL RECESSIVE 1; ARCI1]
FBgn0031975	Tg	HGNC:11778	OMIM:190196	TGM2	5		
FBgn0031975	Tg	HGNC:11779	OMIM:600238	TGM3	4	617251	617251[UNCOMBABLE HAIR SYNDROME 2; UHS2]
FBgn0031975	Tg	HGNC:11781	OMIM:603805	TGM5	5	609796	609796[PEELING SKIN SYNDROME 2; PSS2]
FBgn0031975	Tg	HGNC:30790	OMIM:606776	TGM7	3		
FBgn0031975	Tg	HGNC:16255	OMIM:613900	TGM6	4	613908	613908[SPINOCEREBELLAR ATAXIA 35; SCA35]
FBgn0031977	baf	HGNC:16172		BANF2	5		
FBgn0031977	baf	HGNC:17397	OMIM:603811	BANF1	14	614008	614008[NESTOR-GUILLERMO PROGERIA SYNDROME; NGPS]
FBgn0044323	Cka	HGNC:11424	OMIM:614765	STRN	13		
FBgn0044323	Cka	HGNC:15720	OMIM:614766	STRN3	15		
FBgn0044323	Cka	HGNC:15721	OMIM:614767	STRN4	11		
FBgn0031979	CCDC53	HGNC:24256	OMIM:619925	WASHC3	14		
FBgn0031981	Megf8	HGNC:3233	OMIM:604267	MEGF8	14	614976	614976[CARPENTER SYNDROME 2; CRPT2]
FBgn0010287	Trf	HGNC:19841	OMIM:608964	TBPL2	5		
FBgn0010287	Trf	HGNC:11588	OMIM:600075	TBP	5	168600,607136	168600[PARKINSON DISEASE, LATE-ONSET; PD],607136[SPINOCEREBELLAR ATAXIA 17; SCA17]
FBgn0013531	MED20	HGNC:16840	OMIM:612915	MED20	13		
FBgn0011230	poe	HGNC:30313	OMIM:609890	UBR4	15		
FBgn0031980	RpL36A	HGNC:10346	OMIM:180469	RPL36AL	12		
FBgn0031980	RpL36A	HGNC:48349		RPL36A-HNRNPH2	3		
FBgn0031980	RpL36A	HGNC:10359	OMIM:300902	RPL36A	13		
FBgn0031976	CG7367	HGNC:17661	OMIM:607460	PLA1A	3		
FBgn0031976	CG7367	HGNC:18821	OMIM:609252	LIPI	4		
FBgn0031976	CG7367	HGNC:18483	OMIM:607365	LIPH	3	604379	604379[HYPOTRICHOSIS 7; HYPT7]
FBgn0031974	CG12560	HGNC:21349	OMIM:614763	GLYATL3	8		
FBgn0031974	CG12560	HGNC:30519	OMIM:614761	GLYATL1	5		
FBgn0031974	CG12560	HGNC:24178	OMIM:614762	GLYATL2	5		
FBgn0031974	CG12560	HGNC:13734	OMIM:607424	GLYAT	5		
FBgn0031974	CG12560	HGNC:37865		GLYATL1B	3		
FBgn0031973	Spn28Dc	HGNC:18359	OMIM:617471	SERPINA12	3		
FBgn0031972	Wwox	HGNC:12799	OMIM:605131	WWOX	14	133239,614322,616211	133239[ESOPHAGEAL CANCER],614322[SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 12; SCAR12],616211[DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 28; DEE28]
FBgn0031970	CG7227	HGNC:1663	OMIM:173510	CD36	5	608404,610938,611162	608404[PLATELET GLYCOPROTEIN IV DEFICIENCY],610938[CORONARY HEART DISEASE, SUSCEPTIBILITY TO, 7; CHDS7],611162[MALARIA, SUSCEPTIBILITY TO]
FBgn0031970	CG7227	HGNC:1664	OMIM:601040	SCARB1	5	610762	610762[HIGH DENSITY LIPOPROTEIN CHOLESTEROL LEVEL QUANTITATIVE TRAIT LOCUS 6; HDLCQ6]
FBgn0031970	CG7227	HGNC:1665	OMIM:602257	SCARB2	4	254900	254900[EPILEPSY, PROGRESSIVE MYOCLONIC, 4, WITH OR WITHOUT RENAL FAILURE; EPM4]
FBgn0031969	pes	HGNC:1663	OMIM:173510	CD36	4	608404,610938,611162	608404[PLATELET GLYCOPROTEIN IV DEFICIENCY],610938[CORONARY HEART DISEASE, SUSCEPTIBILITY TO, 7; CHDS7],611162[MALARIA, SUSCEPTIBILITY TO]
FBgn0031969	pes	HGNC:1664	OMIM:601040	SCARB1	6	610762	610762[HIGH DENSITY LIPOPROTEIN CHOLESTEROL LEVEL QUANTITATIVE TRAIT LOCUS 6; HDLCQ6]
FBgn0031969	pes	HGNC:1665	OMIM:602257	SCARB2	5	254900	254900[EPILEPSY, PROGRESSIVE MYOCLONIC, 4, WITH OR WITHOUT RENAL FAILURE; EPM4]
FBgn0053121	Spn28Db	HGNC:8945	OMIM:605587	SERPINI2	4		
FBgn0053121	Spn28Db	HGNC:8943	OMIM:602445	SERPINI1	4	604218	604218[ENCEPHALOPATHY, FAMILIAL, WITH NEUROSERPIN INCLUSION BODIES; FENIB]
FBgn0053121	Spn28Db	HGNC:3311	OMIM:130135	SERPINB1	3		
FBgn0053121	Spn28Db	HGNC:8583	OMIM:173360	SERPINE1	3	613329	613329[PLASMINOGEN ACTIVATOR INHIBITOR-1 DEFICIENCY]
FBgn0053121	Spn28Db	HGNC:10570	OMIM:600518	SERPINB4	3		
FBgn0053121	Spn28Db	HGNC:8951	OMIM:177010	SERPINE2	3		
FBgn0053121	Spn28Db	HGNC:24774		SERPINE3	3		
FBgn0051902	Spn28Da	HGNC:8955	OMIM:601799	SERPINB9	3		
FBgn0051902	Spn28Da	HGNC:8945	OMIM:605587	SERPINI2	4		
FBgn0051902	Spn28Da	HGNC:8943	OMIM:602445	SERPINI1	5	604218	604218[ENCEPHALOPATHY, FAMILIAL, WITH NEUROSERPIN INCLUSION BODIES; FENIB]
FBgn0051902	Spn28Da	HGNC:10569	OMIM:600517	SERPINB3	5		
FBgn0051902	Spn28Da	HGNC:3311	OMIM:130135	SERPINB1	5		
FBgn0051902	Spn28Da	HGNC:775	OMIM:107300	SERPINC1	4	613118	613118[ANTITHROMBIN III DEFICIENCY; AT3D]
FBgn0051902	Spn28Da	HGNC:8583	OMIM:173360	SERPINE1	3	613329	613329[PLASMINOGEN ACTIVATOR INHIBITOR-1 DEFICIENCY]
FBgn0051902	Spn28Da	HGNC:10570	OMIM:600518	SERPINB4	6		
FBgn0051902	Spn28Da	HGNC:8952	OMIM:601697	SERPINB8	3	617115	617115[PEELING SKIN SYNDROME 5; PSS5]
FBgn0051902	Spn28Da	HGNC:8951	OMIM:177010	SERPINE2	3		
FBgn0051902	Spn28Da	HGNC:14220	OMIM:615662	SERPINB12	3		
FBgn0051902	Spn28Da	HGNC:8942	OMIM:602058	SERPINB10	3		
FBgn0051902	Spn28Da	HGNC:8950	OMIM:173321	SERPINB6	4	613453	613453[DEAFNESS, AUTOSOMAL RECESSIVE 91; DFNB91]
FBgn0051902	Spn28Da	HGNC:8944	OMIM:604445	SERPINB13	4		
FBgn0031961	CG7102	HGNC:27145		BTBD19	6		
FBgn0031955	CG14535	HGNC:25484	OMIM:614026	KIF26B	7		
FBgn0031955	CG14535	HGNC:20226	OMIM:613231	KIF26A	7		
FBgn0020618	Rack1	HGNC:4399	OMIM:176981	RACK1	14		
FBgn0031986	CG8673	HGNC:918	OMIM:603094	B3GALNT1	6	111400,615021	111400[BLOOD GROUP, P1PK SYSTEM],615021[BLOOD GROUP, GLOBOSIDE SYSTEM; GLOB]
FBgn0031986	CG8673	HGNC:916	OMIM:603093	B3GALT1	7		
FBgn0031986	CG8673	HGNC:15684	OMIM:615333	B3GNT5	5		
FBgn0031986	CG8673	HGNC:917	OMIM:603018	B3GALT2	7		
FBgn0031986	CG8673	HGNC:920	OMIM:604066	B3GALT5	7		
FBgn0031986	CG8673	HGNC:919	OMIM:603095	B3GALT4	4		
FBgn0031986	CG8673	HGNC:15629	OMIM:605581	B3GNT2	3		
FBgn0031986	CG8673	HGNC:15683	OMIM:605864	B3GNT4	3		
FBgn0031986	CG8673	HGNC:28714		B3GNT9	4		
FBgn0031986	CG8673	HGNC:18811	OMIM:615313	B3GNT7	4		
FBgn0031986	CG8673	HGNC:24141	OMIM:615315	B3GNT6	5		
FBgn0031986	CG8673	HGNC:24139	OMIM:615357	B3GNT8	3		
FBgn0031986	CG8673	HGNC:13528	OMIM:605863	B3GNT3	5		
FBgn0031988	CG8668	HGNC:918	OMIM:603094	B3GALNT1	5	111400,615021	111400[BLOOD GROUP, P1PK SYSTEM],615021[BLOOD GROUP, GLOBOSIDE SYSTEM; GLOB]
FBgn0031988	CG8668	HGNC:916	OMIM:603093	B3GALT1	7		
FBgn0031988	CG8668	HGNC:15684	OMIM:615333	B3GNT5	5		
FBgn0031988	CG8668	HGNC:917	OMIM:603018	B3GALT2	5		
FBgn0031988	CG8668	HGNC:920	OMIM:604066	B3GALT5	5		
FBgn0031988	CG8668	HGNC:919	OMIM:603095	B3GALT4	4		
FBgn0031988	CG8668	HGNC:15629	OMIM:605581	B3GNT2	3		
FBgn0031988	CG8668	HGNC:15683	OMIM:605864	B3GNT4	3		
FBgn0031988	CG8668	HGNC:28714		B3GNT9	4		
FBgn0031988	CG8668	HGNC:18811	OMIM:615313	B3GNT7	4		
FBgn0031988	CG8668	HGNC:24141	OMIM:615315	B3GNT6	5		
FBgn0031988	CG8668	HGNC:24139	OMIM:615357	B3GNT8	3		
FBgn0031988	CG8668	HGNC:13528	OMIM:605863	B3GNT3	5		
FBgn0031996	CG8460	HGNC:28474	OMIM:615692	CHID1	14		
FBgn0031997	PGAP5	HGNC:15988	OMIM:611900	MPPE1	14		
FBgn0031999	CG8419	HGNC:19018	OMIM:609318	TRIM45	13		
FBgn0015299	Ssb-c31a	HGNC:19985	OMIM:600503	SUB1	12		
FBgn0032002	CG8353	HGNC:1712	OMIM:123920	CDA	13		
FBgn0032003	CG8349	HGNC:1712	OMIM:123920	CDA	8		
FBgn0032013	Scgalpha	HGNC:10808	OMIM:604149	SGCE	14	159900	159900[DYSTONIA 11, MYOCLONIC; DYT11]
FBgn0032013	Scgalpha	HGNC:10805	OMIM:600119	SGCA	11	608099	608099[MUSCULAR DYSTROPHY, LIMB-GIRDLE, AUTOSOMAL RECESSIVE 3; LGMDR3]
FBgn0032014	CG7840	HGNC:25812	OMIM:611715	SRD5A3	14	612379,612713	612379[CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Iq; CDG1Q],612713[KAHRIZI SYNDROME; KHRZ]
FBgn0032016	Mettl14	HGNC:29330	OMIM:616504	METTL14	15		
FBgn0032018	CG7806	HGNC:55	OMIM:605250	ABCC4	4		
FBgn0032018	CG7806	HGNC:52	OMIM:612509	ABCC10	14		
FBgn0032018	CG7806	HGNC:53	OMIM:601107	ABCC2	4	237500	237500[DUBIN-JOHNSON SYNDROME; DJS]
FBgn0032018	CG7806	HGNC:51	OMIM:158343	ABCC1	4	618915	618915[DEAFNESS, AUTOSOMAL DOMINANT 77; DFNA77]
FBgn0032018	CG7806	HGNC:59	OMIM:600509	ABCC8	4	125853,240800,256450,610374,618857	125853[TYPE 2 DIABETES MELLITUS; T2D],240800[HYPOGLYCEMIA, LEUCINE-INDUCED; LIH],256450[HYPERINSULINEMIC HYPOGLYCEMIA, FAMILIAL, 1; HHF1],610374[DIABETES MELLITUS, TRANSIENT NEONATAL, 2; TNDM2],618857[DIABETES MELLITUS, PERMANENT NEONATAL, 3; PNDM3]
FBgn0032018	CG7806	HGNC:14640	OMIM:607041	ABCC12	4		
FBgn0032018	CG7806	HGNC:60	OMIM:601439	ABCC9	4	239850,608569,614050,619719	239850[CANTU SYNDROME],608569[CARDIOMYOPATHY, DILATED, 1O; CMD1O],614050[ATRIAL FIBRILLATION, FAMILIAL, 12; ATFB12],619719[INTELLECTUAL DISABILITY AND MYOPATHY SYNDROME; IDMYS]
FBgn0032018	CG7806	HGNC:57	OMIM:603234	ABCC6	4	177850,264800,614473	177850[PSEUDOXANTHOMA ELASTICUM, FORME FRUSTE],264800[PSEUDOXANTHOMA ELASTICUM; PXE],614473[ARTERIAL CALCIFICATION, GENERALIZED, OF INFANCY, 2; GACI2]
FBgn0032018	CG7806	HGNC:56	OMIM:605251	ABCC5	4		
FBgn0032018	CG7806	HGNC:14639	OMIM:607040	ABCC11	4	117800	117800[APOCRINE GLAND SECRETION, VARIATION IN]
FBgn0032018	CG7806	HGNC:54	OMIM:604323	ABCC3	4		
FBgn0032020	strat	HGNC:9797	OMIM:603417	RABIF	15		
FBgn0032026	CG7627	HGNC:55	OMIM:605250	ABCC4	13		
FBgn0032026	CG7627	HGNC:52	OMIM:612509	ABCC10	5		
FBgn0032026	CG7627	HGNC:53	OMIM:601107	ABCC2	5	237500	237500[DUBIN-JOHNSON SYNDROME; DJS]
FBgn0032026	CG7627	HGNC:51	OMIM:158343	ABCC1	5	618915	618915[DEAFNESS, AUTOSOMAL DOMINANT 77; DFNA77]
FBgn0032026	CG7627	HGNC:59	OMIM:600509	ABCC8	5	125853,240800,256450,610374,618857	125853[TYPE 2 DIABETES MELLITUS; T2D],240800[HYPOGLYCEMIA, LEUCINE-INDUCED; LIH],256450[HYPERINSULINEMIC HYPOGLYCEMIA, FAMILIAL, 1; HHF1],610374[DIABETES MELLITUS, TRANSIENT NEONATAL, 2; TNDM2],618857[DIABETES MELLITUS, PERMANENT NEONATAL, 3; PNDM3]
FBgn0032026	CG7627	HGNC:14640	OMIM:607041	ABCC12	6		
FBgn0032026	CG7627	HGNC:60	OMIM:601439	ABCC9	5	239850,608569,614050,619719	239850[CANTU SYNDROME],608569[CARDIOMYOPATHY, DILATED, 1O; CMD1O],614050[ATRIAL FIBRILLATION, FAMILIAL, 12; ATFB12],619719[INTELLECTUAL DISABILITY AND MYOPATHY SYNDROME; IDMYS]
FBgn0032026	CG7627	HGNC:57	OMIM:603234	ABCC6	5	177850,264800,614473	177850[PSEUDOXANTHOMA ELASTICUM, FORME FRUSTE],264800[PSEUDOXANTHOMA ELASTICUM; PXE],614473[ARTERIAL CALCIFICATION, GENERALIZED, OF INFANCY, 2; GACI2]
FBgn0032026	CG7627	HGNC:56	OMIM:605251	ABCC5	5		
FBgn0032026	CG7627	HGNC:14639	OMIM:607040	ABCC11	6	117800	117800[APOCRINE GLAND SECRETION, VARIATION IN]
FBgn0032026	CG7627	HGNC:54	OMIM:604323	ABCC3	5		
FBgn0032026	CG7627	HGNC:1884	OMIM:602421	CFTR	5	167800,211400,219700,277180	167800[PANCREATITIS, HEREDITARY; PCTT],211400[BRONCHIECTASIS WITH OR WITHOUT ELEVATED SWEAT CHLORIDE 1; BESC1],219700[CYSTIC FIBROSIS; CF],277180[VAS DEFERENS, CONGENITAL BILATERAL APLASIA OF; CBAVD]
FBgn0032017	CG7810	HGNC:28289		CCDC97	12		
FBgn0032015	Ostgamma	HGNC:30242	OMIM:601385	TUSC3	14	611093	611093[INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 7; MRT7]
FBgn0032015	Ostgamma	HGNC:28880	OMIM:300715	MAGT1	14	300853,301031	300853[IMMUNODEFICIENCY, X-LINKED, WITH MAGNESIUM DEFECT, EPSTEIN-BARR VIRUS INFECTION, AND NEOPLASIA; XMEN],301031[CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Icc; CDG1CC]
FBgn0003502	Btk	HGNC:11719	OMIM:600583	TEC	12		
FBgn0003502	Btk	HGNC:6171	OMIM:186973	ITK	9	613011	613011[LYMPHOPROLIFERATIVE SYNDROME 1; LPFS1]
FBgn0003502	Btk	HGNC:12434	OMIM:600058	TXK	10		
FBgn0003502	Btk	HGNC:1133	OMIM:300300	BTK	8	300755,307200	300755[AGAMMAGLOBULINEMIA, X-LINKED; XLA],307200[ISOLATED GROWTH HORMONE DEFICIENCY, TYPE III, WITH AGAMMAGLOBULINEMIA; IGHD3]
FBgn0003502	Btk	HGNC:1079	OMIM:300101	BMX	7		
FBgn0003502	Btk	HGNC:11298	OMIM:617797	SRMS	3		
FBgn0003502	Btk	HGNC:9617	OMIM:602004	PTK6	3		
FBgn0032010	CG8086	HGNC:26841		ODF3L2	5		
FBgn0032010	CG8086	HGNC:34388		ODF3B	4		
FBgn0032010	CG8086	HGNC:19905	OMIM:608356	ODF3	5		
FBgn0032010	CG8086	HGNC:28735		ODF3L1	3		
FBgn0028987	Spn28F	HGNC:8955	OMIM:601799	SERPINB9	3		
FBgn0028987	Spn28F	HGNC:8945	OMIM:605587	SERPINI2	5		
FBgn0028987	Spn28F	HGNC:8943	OMIM:602445	SERPINI1	6	604218	604218[ENCEPHALOPATHY, FAMILIAL, WITH NEUROSERPIN INCLUSION BODIES; FENIB]
FBgn0028987	Spn28F	HGNC:10569	OMIM:600517	SERPINB3	5		
FBgn0028987	Spn28F	HGNC:3311	OMIM:130135	SERPINB1	5		
FBgn0028987	Spn28F	HGNC:775	OMIM:107300	SERPINC1	4	613118	613118[ANTITHROMBIN III DEFICIENCY; AT3D]
FBgn0028987	Spn28F	HGNC:8583	OMIM:173360	SERPINE1	3	613329	613329[PLASMINOGEN ACTIVATOR INHIBITOR-1 DEFICIENCY]
FBgn0028987	Spn28F	HGNC:10570	OMIM:600518	SERPINB4	7		
FBgn0028987	Spn28F	HGNC:8952	OMIM:601697	SERPINB8	3	617115	617115[PEELING SKIN SYNDROME 5; PSS5]
FBgn0028987	Spn28F	HGNC:8951	OMIM:177010	SERPINE2	3		
FBgn0028987	Spn28F	HGNC:14220	OMIM:615662	SERPINB12	3		
FBgn0028987	Spn28F	HGNC:8942	OMIM:602058	SERPINB10	4		
FBgn0028987	Spn28F	HGNC:24774		SERPINE3	3		
FBgn0028987	Spn28F	HGNC:8950	OMIM:173321	SERPINB6	4	613453	613453[DEAFNESS, AUTOSOMAL RECESSIVE 91; DFNB91]
FBgn0028987	Spn28F	HGNC:8944	OMIM:604445	SERPINB13	5		
FBgn0028987	Spn28F	HGNC:14221	OMIM:615682	SERPINB11	3		
FBgn0032006	Pvr	HGNC:2433	OMIM:164770	CSF1R	5	221820,618476	221820[LEUKOENCEPHALOPATHY, HEREDITARY DIFFUSE, WITH SPHEROIDS 1; HDLS1],618476[BRAIN ABNORMALITIES, NEURODEGENERATION, AND DYSOSTEOSCLEROSIS; BANDDOS]
FBgn0032006	Pvr	HGNC:3763	OMIM:165070	FLT1	10		
FBgn0032006	Pvr	HGNC:3765	OMIM:136351	FLT3	3	601626,613065	601626[LEUKEMIA, ACUTE MYELOID; AML],613065[LEUKEMIA, ACUTE LYMPHOBLASTIC; ALL]
FBgn0032006	Pvr	HGNC:3767	OMIM:136352	FLT4	10	153100,602089,618780	153100[LYMPHATIC MALFORMATION 1; LMPHM1],602089[HEMANGIOMA, CAPILLARY INFANTILE],618780[CONGENITAL HEART DEFECTS, MULTIPLE TYPES, 7; CHTD7]
FBgn0032006	Pvr	HGNC:6307	OMIM:191306	KDR	10	602089	602089[HEMANGIOMA, CAPILLARY INFANTILE]
FBgn0032006	Pvr	HGNC:6342	OMIM:164920	KIT	5	154800,172800,273300,601626,606764	154800[MASTOCYTOSIS, CUTANEOUS; MASTC],172800[PIEBALD TRAIT; PBT],273300[TESTICULAR GERM CELL TUMOR; TGCT],601626[LEUKEMIA, ACUTE MYELOID; AML],606764[GASTROINTESTINAL STROMAL TUMOR; GIST]
FBgn0032006	Pvr	HGNC:8803	OMIM:173490	PDGFRA	6	175510,607685	175510[GIST-PLUS SYNDROME; GISTPS],607685[HYPEREOSINOPHILIC SYNDROME, IDIOPATHIC; HES]
FBgn0032006	Pvr	HGNC:8804	OMIM:173410	PDGFRB	6	131440,228550,601812,615007,616592	131440[MYELOPROLIFERATIVE DISORDER, CHRONIC, WITH EOSINOPHILIA],228550[MYOFIBROMATOSIS, INFANTILE, 1; IMF1],601812[PREMATURE AGING SYNDROME, PENTTINEN TYPE; PENTT],615007[BASAL GANGLIA CALCIFICATION, IDIOPATHIC, 4; IBGC4],616592[KOSAKI OVERGROWTH SYNDROME; KOGS]
FBgn0032005	Snx6	HGNC:14970	OMIM:606098	SNX6	13		
FBgn0032005	Snx6	HGNC:14969	OMIM:605937	SNX5	11		
FBgn0032005	Snx6	HGNC:26423		SNX32	13		
FBgn0032000	CG8372	HGNC:25363	OMIM:619469	TMEM222	14	619470	619470[NEURODEVELOPMENTAL DISORDER WITH MOTOR AND SPEECH DELAY AND BEHAVIORAL ABNORMALITIES; NEDMOSBA]
FBgn0003607	Su(var)205	HGNC:1555	OMIM:604478	CBX5	6		
FBgn0003607	Su(var)205	HGNC:1551	OMIM:604511	CBX1	9		
FBgn0003607	Su(var)205	HGNC:1553	OMIM:604477	CBX3	6		
FBgn0031998	SLC5A11	HGNC:11041	OMIM:604024	SLC5A6	4	618973,619903	618973[SODIUM-DEPENDENT MULTIVITAMIN TRANSPORTER DEFICIENCY; SMVTD],619903[PERIPHERAL MOTOR NEUROPATHY, CHILDHOOD-ONSET, BIOTIN-RESPONSIVE; COMNB]
FBgn0031998	SLC5A11	HGNC:11040	OMIM:601843	SLC5A5	6	274400	274400[THYROID DYSHORMONOGENESIS 1; TDH1]
FBgn0031998	SLC5A11	HGNC:28750	OMIM:612455	SLC5A12	6		
FBgn0031998	SLC5A11	HGNC:19119	OMIM:608044	SLC5A8	6		
FBgn0031998	SLC5A11	HGNC:11036	OMIM:182380	SLC5A1	3	606824	606824[GLUCOSE/GALACTOSE MALABSORPTION; GGM]
FBgn0031998	SLC5A11	HGNC:11037	OMIM:182381	SLC5A2	3	233100	233100[RENAL GLUCOSURIA; GLYS]
FBgn0031998	SLC5A11	HGNC:11038	OMIM:600444	SLC5A3	3		
FBgn0031998	SLC5A11	HGNC:11039	OMIM:618633	SLC5A4	3		
FBgn0031998	SLC5A11	HGNC:23091	OMIM:610238	SLC5A11	3		
FBgn0031998	SLC5A11	HGNC:23155	OMIM:618636	SLC5A10	3		
FBgn0031998	SLC5A11	HGNC:22146		SLC5A9	3		
FBgn0031992	Acbp1	HGNC:17715		ACBD7	11		
FBgn0031992	Acbp1	HGNC:2690	OMIM:125950	DBI	10		
FBgn0031990	PAPLA1	HGNC:29106	OMIM:615003	DDHD2	10	615033	615033[SPASTIC PARAPLEGIA 54, AUTOSOMAL RECESSIVE; SPG54]
FBgn0031990	PAPLA1	HGNC:17018	OMIM:617852	SEC23IP	9		
FBgn0031990	PAPLA1	HGNC:19714	OMIM:614603	DDHD1	3	609340	609340[SPASTIC PARAPLEGIA 28, AUTOSOMAL RECESSIVE; SPG28]
FBgn0031987	CG12375	HGNC:18512	OMIM:618921	LACTB2	13		
FBgn0031985	mon2	HGNC:29177	OMIM:616822	MON2	13		
FBgn0032030	Wdr82	HGNC:28826	OMIM:611059	WDR82	14		
FBgn0032032	CG17294	HGNC:25364		HDHD2	14		
FBgn0032036	CG13384	HGNC:19659	OMIM:608332	SLC36A3	11		
FBgn0032036	CG13384	HGNC:18762	OMIM:608331	SLC36A2	12	138500,242600	138500[HYPERGLYCINURIA],242600[IMINOGLYCINURIA]
FBgn0032036	CG13384	HGNC:19660	OMIM:613760	SLC36A4	14		
FBgn0032036	CG13384	HGNC:18761	OMIM:606561	SLC36A1	14		
FBgn0020497	emb	HGNC:12825	OMIM:602559	XPO1	13		
FBgn0032052	PIG-U	HGNC:15791	OMIM:608528	PIGU	15	618590	618590[NEURODEVELOPMENTAL DISORDER WITH BRAIN ANOMALIES, SEIZURES, AND SCOLIOSIS; NEDBSS]
FBgn0032054	Uba4	HGNC:15765	OMIM:609277	MOCS3	15		
FBgn0032055	Sgp	HGNC:26222	OMIM:616107	FAR1	6	616154,619338	616154[PEROXISOMAL FATTY ACYL-CoA REDUCTASE 1 DISORDER; PFCRD],619338[CATARACTS, SPASTIC PARAPARESIS, AND SPEECH DELAY; CSPSD]
FBgn0032055	Sgp	HGNC:25531	OMIM:616156	FAR2	6		
FBgn0016122	Acer	HGNC:13557	OMIM:300335	ACE2	6		
FBgn0016122	Acer	HGNC:2707	OMIM:106180	ACE	10	267430,612624,614519	267430[RENAL TUBULAR DYSGENESIS; RTD],612624[MICROVASCULAR COMPLICATIONS OF DIABETES, SUSCEPTIBILITY TO, 3; MVCD3],614519[HEMORRHAGE, INTRACEREBRAL, SUSCEPTIBILITY TO; ICH]
FBgn0011259	Sema1a	HGNC:10728	OMIM:601124	SEMA3F	4		
FBgn0011259	Sema1a	HGNC:10741	OMIM:607961	SEMA7A	3	614745,619874	614745[BLOOD GROUP, JOHN MILTON HAGEN SYSTEM; JMH],619874[CHOLESTASIS, PROGRESSIVE FAMILIAL INTRAHEPATIC, 11; PFIC11]
FBgn0011259	Sema1a	HGNC:10727	OMIM:608166	SEMA3E	4	214800	214800[CHARGE SYNDROME]
FBgn0011259	Sema1a	HGNC:10723	OMIM:603961	SEMA3A	5	614897	614897[HYPOGONADOTROPIC HYPOGONADISM 16 WITH OR WITHOUT ANOSMIA; HH16]
FBgn0011259	Sema1a	HGNC:10734	OMIM:603706	SEMA4F	3		
FBgn0011259	Sema1a	HGNC:10732	OMIM:601866	SEMA4D	4		
FBgn0011259	Sema1a	HGNC:10730	OMIM:617029	SEMA4B	4		
FBgn0011259	Sema1a	HGNC:10725	OMIM:602645	SEMA3C	4		
FBgn0011259	Sema1a	HGNC:10731	OMIM:604462	SEMA4C	3		
FBgn0011259	Sema1a	HGNC:30400		SEMA3G	4		
FBgn0011259	Sema1a	HGNC:10735	OMIM:618991	SEMA4G	3		
FBgn0011259	Sema1a	HGNC:10729	OMIM:607292	SEMA4A	3	610282,610283	610282[RETINITIS PIGMENTOSA 35; RP35],610283[CONE-ROD DYSTROPHY 10; CORD10]
FBgn0011259	Sema1a	HGNC:10726	OMIM:609907	SEMA3D	5		
FBgn0011259	Sema1a	HGNC:10740	OMIM:609294	SEMA6C	6		
FBgn0011259	Sema1a	HGNC:10739	OMIM:608873	SEMA6B	6	618876	618876[EPILEPSY, PROGRESSIVE MYOCLONIC, 11; EPM11]
FBgn0011259	Sema1a	HGNC:10738	OMIM:605885	SEMA6A	8		
FBgn0011259	Sema1a	HGNC:16770	OMIM:609295	SEMA6D	8		
FBgn0011259	Sema1a	HGNC:10724	OMIM:601281	SEMA3B	4		
FBgn0032053	mRpL51	HGNC:14044	OMIM:611855	MRPL51	12		
FBgn0032051	CG13097	HGNC:7213	OMIM:605503	MPHOSPH10	12		
FBgn0032050	CG13096	HGNC:24534	OMIM:615874	RSL1D1	9		
FBgn0032049	Bace	HGNC:2530	OMIM:116890	CTSE	9		
FBgn0032049	Bace	HGNC:8887	OMIM:169730	PGA5	7		
FBgn0032049	Bace	HGNC:8886	OMIM:169720	PGA4	5		
FBgn0032049	Bace	HGNC:8885	OMIM:169710	PGA3	3		
FBgn0032049	Bace	HGNC:9958	OMIM:179820	REN	7	267430,613092	267430[RENAL TUBULAR DYSGENESIS; RTD],613092[TUBULOINTERSTITIAL KIDNEY DISEASE, AUTOSOMAL DOMINANT, 4; ADTKD4]
FBgn0032049	Bace	HGNC:8890	OMIM:169740	PGC	8		
FBgn0032049	Bace	HGNC:13395	OMIM:605631	NAPSA	7		
FBgn0032049	Bace	HGNC:2529	OMIM:116840	CTSD	5	610127	610127[CEROID LIPOFUSCINOSIS, NEURONAL, 10; CLN10]
FBgn0026718	Agpat2	HGNC:324	OMIM:603099	AGPAT1	7		
FBgn0026718	Agpat2	HGNC:325	OMIM:603100	AGPAT2	8	608594	608594[LIPODYSTROPHY, CONGENITAL GENERALIZED, TYPE 1; CGL1]
FBgn0027490	D12	HGNC:25489	OMIM:613373	YEATS2	11	615127	615127[EPILEPSY, FAMILIAL ADULT MYOCLONIC, 4; FAME4]
FBgn0032042	CG13398	HGNC:24583	OMIM:611435	DOK3	3		
FBgn0032042	CG13398	HGNC:2990	OMIM:602919	DOK1	4		
FBgn0032042	CG13398	HGNC:2991	OMIM:604997	DOK2	4		
FBgn0032042	CG13398	HGNC:16970	OMIM:607744	FRS3	6		
FBgn0032042	CG13398	HGNC:16971	OMIM:607743	FRS2	7		
FBgn0014417	CG13397	HGNC:7632	OMIM:609701	NAGLU	15	252920,616491	252920[MUCOPOLYSACCHARIDOSIS, TYPE IIIB; MPS3B],616491[CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2V; CMT2V]
FBgn0001084	fy	HGNC:26219	OMIM:610622	FUZ	14	182940	182940[NEURAL TUBE DEFECTS, SUSCEPTIBILITY TO; NTD]
FBgn0040098	lectin-29Ca	HGNC:2220	OMIM:607620	COLEC10	3	248340	248340[3MC SYNDROME 3; 3MC3]
FBgn0040098	lectin-29Ca	HGNC:17213	OMIM:612502	COLEC11	3	265050	265050[3MC SYNDROME 2; 3MC2]
FBgn0040098	lectin-29Ca	HGNC:10803	OMIM:178635	SFTPD	3		
FBgn0032033	CG13392	HGNC:30883	OMIM:615533	TMEM126B	4	618250	618250[MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 29; MC1DN29]
FBgn0032033	CG13392	HGNC:25382	OMIM:612988	TMEM126A	7	612989	612989[OPTIC ATROPHY 7 WITH OR WITHOUT AUDITORY NEUROPATHY; OPA7]
FBgn0032031	CG13390	HGNC:25106	OMIM:610920	GTPBP10	4		
FBgn0032031	CG13390	HGNC:16239	OMIM:610919	MTG2	13		
FBgn0001114	Glt	HGNC:26741		CES4A	4		
FBgn0001114	Glt	HGNC:11764	OMIM:188450	TG	3	274700,608175	274700[THYROID DYSHORMONOGENESIS 3; TDH3],608175[AUTOIMMUNE THYROID DISEASE, SUSCEPTIBILITY TO, 3; AITD3]
FBgn0001114	Glt	HGNC:108	OMIM:100740	ACHE	4	112100	112100[YT BLOOD GROUP ANTIGEN]
FBgn0001114	Glt	HGNC:983	OMIM:177400	BCHE	3	617936	617936[BUTYRYLCHOLINESTERASE DEFICIENCY; BCHED]
FBgn0001114	Glt	HGNC:26459	OMIM:618678	CES5A	4		
FBgn0001114	Glt	HGNC:1863	OMIM:114835	CES1	4	618057	618057[DRUG METABOLISM, ALTERED, CES1-RELATED]
FBgn0001114	Glt	HGNC:1848	OMIM:114840	CEL	3	609812	609812[MATURITY-ONSET DIABETES OF THE YOUNG, TYPE 8, WITH EXOCRINE DYSFUNCTION; MODY8]
FBgn0001114	Glt	HGNC:1864	OMIM:605278	CES2	4		
FBgn0001114	Glt	HGNC:1865	OMIM:605279	CES3	4		
FBgn0001114	Glt	HGNC:14291	OMIM:600568	NLGN1	3	618830	618830[AUTISM, SUSCEPTIBILITY TO, 20; AUTS20]
FBgn0001114	Glt	HGNC:14289	OMIM:300336	NLGN3	3	300425,300494	300425[AUTISM, SUSCEPTIBILITY TO, X-LINKED 1; AUTSX1],300494[ASPERGER SYNDROME, X-LINKED, SUSCEPTIBILITY TO, 1; ASPGX1]
FBgn0001114	Glt	HGNC:14287	OMIM:300427	NLGN4X	3	300495,300497	300495[AUTISM, SUSCEPTIBILITY TO, X-LINKED 2; AUTSX2],300497[ASPERGER SYNDROME, X-LINKED, SUSCEPTIBILITY TO, 2; ASPGX2]
FBgn0001114	Glt	HGNC:14290	OMIM:606479	NLGN2	3		
FBgn0032061	CatB	HGNC:1516	OMIM:115500	CAT	13	614097	614097[ACATALASEMIA]
FBgn0029123	SoxN	HGNC:11193	OMIM:604747	SOX14	3		
FBgn0029123	SoxN	HGNC:18196	OMIM:612202	SOX7	3		
FBgn0029123	SoxN	HGNC:11200	OMIM:184430	SOX4	4	618506	618506[COFFIN-SIRIS SYNDROME 10; CSS10]
FBgn0029123	SoxN	HGNC:11199	OMIM:313430	SOX3	5	300123,312000	300123[INTELLECTUAL DEVELOPMENTAL DISORDER, X-LINKED, WITH PANHYPOPITUITARISM],312000[PANHYPOPITUITARISM, X-LINKED; PHPX]
FBgn0029123	SoxN	HGNC:11195	OMIM:184429	SOX2	7	206900	206900[MICROPHTHALMIA, SYNDROMIC 3; MCOPS3]
FBgn0029123	SoxN	HGNC:11197	OMIM:604974	SOX21	3		
FBgn0029123	SoxN	HGNC:11198	OMIM:601947	SOX12	4		
FBgn0029123	SoxN	HGNC:11189	OMIM:602148	SOX1	7		
FBgn0029123	SoxN	HGNC:11196	OMIM:601297	SOX15	3		
FBgn0029123	SoxN	HGNC:11194	OMIM:601618	SOX18	3	137940,607823	137940[HYPOTRICHOSIS-LYMPHEDEMA-TELANGIECTASIA-RENAL DEFECT SYNDROME; HLTRS],607823[HYPOTRICHOSIS-LYMPHEDEMA-TELANGIECTASIA SYNDROME; HLTS]
FBgn0029123	SoxN	HGNC:18122	OMIM:610928	SOX17	3	613674	613674[VESICOURETERAL REFLUX 3; VUR3]
FBgn0032069	LManVI	HGNC:29623	OMIM:618899	MAN2B2	4		
FBgn0032069	LManVI	HGNC:6826	OMIM:609458	MAN2B1	10	248500	248500[MANNOSIDOSIS, ALPHA B, LYSOSOMAL; MANSA]
FBgn0032068	LManV	HGNC:29623	OMIM:618899	MAN2B2	3		
FBgn0032068	LManV	HGNC:6826	OMIM:609458	MAN2B1	12	248500	248500[MANNOSIDOSIS, ALPHA B, LYSOSOMAL; MANSA]
FBgn0032067	LManIV	HGNC:29623	OMIM:618899	MAN2B2	3		
FBgn0032067	LManIV	HGNC:6826	OMIM:609458	MAN2B1	10	248500	248500[MANNOSIDOSIS, ALPHA B, LYSOSOMAL; MANSA]
FBgn0032066	LManIII	HGNC:29623	OMIM:618899	MAN2B2	3		
FBgn0032066	LManIII	HGNC:6826	OMIM:609458	MAN2B1	10	248500	248500[MANNOSIDOSIS, ALPHA B, LYSOSOMAL; MANSA]
FBgn0004914	Hnf4	HGNC:5024	OMIM:600281	HNF4A	10	125850,125853,616026	125850[MATURITY-ONSET DIABETES OF THE YOUNG, TYPE 1; MODY1],125853[TYPE 2 DIABETES MELLITUS; T2D],616026[FANCONI RENOTUBULAR SYNDROME 4 WITH MATURITY-ONSET DIABETES OF THE YOUNG; FRTS4]
FBgn0004914	Hnf4	HGNC:5026	OMIM:605966	HNF4G	11		
FBgn0032059	PrBP	HGNC:8788	OMIM:602676	PDE6D	13	615665	615665[JOUBERT SYNDROME 22; JBTS22]
FBgn0032058	CG9289	HGNC:26741		CES4A	4		
FBgn0032058	CG9289	HGNC:11764	OMIM:188450	TG	3	274700,608175	274700[THYROID DYSHORMONOGENESIS 3; TDH3],608175[AUTOIMMUNE THYROID DISEASE, SUSCEPTIBILITY TO, 3; AITD3]
FBgn0032058	CG9289	HGNC:108	OMIM:100740	ACHE	4	112100	112100[YT BLOOD GROUP ANTIGEN]
FBgn0032058	CG9289	HGNC:983	OMIM:177400	BCHE	3	617936	617936[BUTYRYLCHOLINESTERASE DEFICIENCY; BCHED]
FBgn0032058	CG9289	HGNC:26459	OMIM:618678	CES5A	4		
FBgn0032058	CG9289	HGNC:1863	OMIM:114835	CES1	4	618057	618057[DRUG METABOLISM, ALTERED, CES1-RELATED]
FBgn0032058	CG9289	HGNC:1848	OMIM:114840	CEL	3	609812	609812[MATURITY-ONSET DIABETES OF THE YOUNG, TYPE 8, WITH EXOCRINE DYSFUNCTION; MODY8]
FBgn0032058	CG9289	HGNC:1864	OMIM:605278	CES2	4		
FBgn0032058	CG9289	HGNC:1865	OMIM:605279	CES3	4		
FBgn0032058	CG9289	HGNC:14291	OMIM:600568	NLGN1	3	618830	618830[AUTISM, SUSCEPTIBILITY TO, 20; AUTS20]
FBgn0032058	CG9289	HGNC:14289	OMIM:300336	NLGN3	3	300425,300494	300425[AUTISM, SUSCEPTIBILITY TO, X-LINKED 1; AUTSX1],300494[ASPERGER SYNDROME, X-LINKED, SUSCEPTIBILITY TO, 1; ASPGX1]
FBgn0032058	CG9289	HGNC:14287	OMIM:300427	NLGN4X	3	300495,300497	300495[AUTISM, SUSCEPTIBILITY TO, X-LINKED 2; AUTSX2],300497[ASPERGER SYNDROME, X-LINKED, SUSCEPTIBILITY TO, 2; ASPGX2]
FBgn0032058	CG9289	HGNC:14290	OMIM:606479	NLGN2	3		
FBgn0032057	CG9287	HGNC:26741		CES4A	4		
FBgn0032057	CG9287	HGNC:11764	OMIM:188450	TG	4	274700,608175	274700[THYROID DYSHORMONOGENESIS 3; TDH3],608175[AUTOIMMUNE THYROID DISEASE, SUSCEPTIBILITY TO, 3; AITD3]
FBgn0032057	CG9287	HGNC:108	OMIM:100740	ACHE	4	112100	112100[YT BLOOD GROUP ANTIGEN]
FBgn0032057	CG9287	HGNC:983	OMIM:177400	BCHE	3	617936	617936[BUTYRYLCHOLINESTERASE DEFICIENCY; BCHED]
FBgn0032057	CG9287	HGNC:26459	OMIM:618678	CES5A	4		
FBgn0032057	CG9287	HGNC:1863	OMIM:114835	CES1	4	618057	618057[DRUG METABOLISM, ALTERED, CES1-RELATED]
FBgn0032057	CG9287	HGNC:1848	OMIM:114840	CEL	3	609812	609812[MATURITY-ONSET DIABETES OF THE YOUNG, TYPE 8, WITH EXOCRINE DYSFUNCTION; MODY8]
FBgn0032057	CG9287	HGNC:1864	OMIM:605278	CES2	4		
FBgn0032057	CG9287	HGNC:1865	OMIM:605279	CES3	4		
FBgn0032057	CG9287	HGNC:14291	OMIM:600568	NLGN1	3	618830	618830[AUTISM, SUSCEPTIBILITY TO, 20; AUTS20]
FBgn0032057	CG9287	HGNC:14289	OMIM:300336	NLGN3	3	300425,300494	300425[AUTISM, SUSCEPTIBILITY TO, X-LINKED 1; AUTSX1],300494[ASPERGER SYNDROME, X-LINKED, SUSCEPTIBILITY TO, 1; ASPGX1]
FBgn0032057	CG9287	HGNC:14287	OMIM:300427	NLGN4X	3	300495,300497	300495[AUTISM, SUSCEPTIBILITY TO, X-LINKED 2; AUTSX2],300497[ASPERGER SYNDROME, X-LINKED, SUSCEPTIBILITY TO, 2; ASPGX2]
FBgn0032057	CG9287	HGNC:14290	OMIM:606479	NLGN2	3		
FBgn0032074	Tsp29Fa	HGNC:1692	OMIM:155740	CD63	8		
FBgn0032074	Tsp29Fa	HGNC:11854	OMIM:300096	TSPAN7	3	300210	300210[INTELLECTUAL DEVELOPMENTAL DISORDER, X-LINKED 58; XLID58]
FBgn0032074	Tsp29Fa	HGNC:11858	OMIM:300191	TSPAN6	3		
FBgn0032075	Tsp29Fb	HGNC:1692	OMIM:155740	CD63	3		
FBgn0032075	Tsp29Fb	HGNC:11854	OMIM:300096	TSPAN7	4	300210	300210[INTELLECTUAL DEVELOPMENTAL DISORDER, X-LINKED 58; XLID58]
FBgn0032075	Tsp29Fb	HGNC:11858	OMIM:300191	TSPAN6	4		
FBgn0040963	CG18662	HGNC:30033	OMIM:610167	PHPT1	5		
FBgn0040964	CG18661	HGNC:14141		METTL26	12		
FBgn0015316	Try29F	HGNC:9486	OMIM:613578	PRSS3	5		
FBgn0015316	Try29F	HGNC:9475	OMIM:276000	PRSS1	5	167800	167800[PANCREATITIS, HEREDITARY; PCTT]
FBgn0015316	Try29F	HGNC:9483	OMIM:601564	PRSS2	3	167800	167800[PANCREATITIS, HEREDITARY; PCTT]
FBgn0032095	Toll-4	HGNC:15632	OMIM:300366	TLR8	3	301078	301078[IMMUNODEFICIENCY 98 WITH AUTOINFLAMMATION, X-LINKED; IMD98]
FBgn0032095	Toll-4	HGNC:15631	OMIM:300365	TLR7	3	301051,301080	301051[IMMUNODEFICIENCY 74, COVID19-RELATED, X-LINKED; IMD74],301080[SYSTEMIC LUPUS ERYTHEMATOSUS 17; SLEB17]
FBgn0032095	Toll-4	HGNC:11849	OMIM:603029	TLR3	3	609423,613002	609423[HUMAN IMMUNODEFICIENCY VIRUS TYPE 1, SUSCEPTIBILITY TO],613002[IMMUNODEFICIENCY 83, SUSCEPTIBILITY TO VIRAL INFECTIONS; IMD83]
FBgn0032095	Toll-4	HGNC:15633	OMIM:605474	TLR9	3		
FBgn0032095	Toll-4	HGNC:6726	OMIM:602226	CD180	3		
FBgn0032095	Toll-4	HGNC:11851	OMIM:603031	TLR5	4	601744,608556,615557	601744[SYSTEMIC LUPUS ERYTHEMATOSUS, SUSCEPTIBILITY TO, 1; SLEB1],608556[LEGIONNAIRE DISEASE, SUSCEPTIBILITY TO],615557[MELIOIDOSIS, SUSCEPTIBILITY TO]
FBgn0032095	Toll-4	HGNC:11850	OMIM:603030	TLR4	4		
FBgn0032095	Toll-4	HGNC:15634	OMIM:606270	TLR10	5		
FBgn0032095	Toll-4	HGNC:11848	OMIM:603028	TLR2	4	114500,246300,607948	114500[COLORECTAL CANCER; CRC],246300[LEPROSY, SUSCEPTIBILITY TO, 3; LPRS3],607948[MYCOBACTERIUM TUBERCULOSIS, SUSCEPTIBILITY TO]
FBgn0032095	Toll-4	HGNC:11847	OMIM:601194	TLR1	4	613223	613223[LEPROSY, SUSCEPTIBILITY TO, 5; LPRS5]
FBgn0032095	Toll-4	HGNC:16711	OMIM:605403	TLR6	4		
FBgn0032101	CG9586	HGNC:26472		CCDC43	14		
FBgn0051708	DIP-zeta	HGNC:17302	OMIM:613173	NEGR1	8		
FBgn0051708	DIP-zeta	HGNC:34550	OMIM:618861	IGLON5	8		
FBgn0051708	DIP-zeta	HGNC:6705	OMIM:603241	LSAMP	6		
FBgn0051708	DIP-zeta	HGNC:8143	OMIM:600632	OPCML	7	167000	167000[OVARIAN CANCER]
FBgn0051708	DIP-zeta	HGNC:17941	OMIM:607938	NTM	8		
FBgn0032090	CG9582	HGNC:14411	OMIM:607571	SLC25A21	8	618811	618811[MITOCHONDRIAL DNA DEPLETION SYNDROME 18; MTDPS18]
FBgn0032089	Rcd-1r	HGNC:10445	OMIM:612054	CNOT9	7		
FBgn0013746	alien	HGNC:30747	OMIM:604508	COPS2	13		
FBgn0032083	CG9541	HGNC:361	OMIM:103000	AK1	4	612631	612631[ADENYLATE KINASE DEFICIENCY, HEMOLYTIC ANEMIA DUE TO]
FBgn0032083	CG9541	HGNC:365	OMIM:608009	AK5	8		
FBgn0032083	CG9541	HGNC:18170	OMIM:191710	CMPK1	4		
FBgn0032078	C1GalTA	HGNC:24337	OMIM:610555	C1GALT1	13		
FBgn0032078	C1GalTA	HGNC:24338	OMIM:300611	C1GALT1C1	3	300622	300622[TN POLYAGGLUTINATION SYNDROME; TNPS]
FBgn0041092	tai	HGNC:7670	OMIM:601937	NCOA3	5		
FBgn0041092	tai	HGNC:7668	OMIM:602691	NCOA1	5		
FBgn0041092	tai	HGNC:7669	OMIM:601993	NCOA2	5		
FBgn0010314	Cks30A	HGNC:2000	OMIM:116901	CKS2	13		
FBgn0010314	Cks30A	HGNC:19083	OMIM:116900	CKS1B	13		
FBgn0026439	Eaat1	HGNC:10939	OMIM:133550	SLC1A1	8	222730,615232	222730[DICARBOXYLIC AMINOACIDURIA; DCBXA],615232[SCHIZOPHRENIA 18; SCZD18]
FBgn0026439	Eaat1	HGNC:10943	OMIM:109190	SLC1A5	7		
FBgn0026439	Eaat1	HGNC:10945	OMIM:604471	SLC1A7	7		
FBgn0026439	Eaat1	HGNC:10942	OMIM:600229	SLC1A4	7	616657	616657[SPASTIC TETRAPLEGIA, THIN CORPUS CALLOSUM, AND PROGRESSIVE MICROCEPHALY; SPATCCM]
FBgn0026439	Eaat1	HGNC:10941	OMIM:600111	SLC1A3	10	612656	612656[EPISODIC ATAXIA, TYPE 6; EA6]
FBgn0026439	Eaat1	HGNC:10944	OMIM:600637	SLC1A6	9		
FBgn0026439	Eaat1	HGNC:10940	OMIM:600300	SLC1A2	5	617105	617105[DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 41; DEE41]
FBgn0012036	Aldh	HGNC:404	OMIM:100650	ALDH2	15	610251	610251[ALCOHOL SENSITIVITY, ACUTE]
FBgn0012036	Aldh	HGNC:15472	OMIM:603687	ALDH1A2	5	620025	620025[DIAPHRAGMATIC HERNIA 4, WITH CARDIOVASCULAR DEFECTS; DIH4]
FBgn0012036	Aldh	HGNC:407	OMIM:100670	ALDH1B1	9		
FBgn0012036	Aldh	HGNC:402	OMIM:100640	ALDH1A1	6		
FBgn0012036	Aldh	HGNC:409	OMIM:600463	ALDH1A3	5	615113	615113[MICROPHTHALMIA, ISOLATED 8; MCOP8]
FBgn0032116	Mco1	HGNC:2295	OMIM:117700	CP	4	604290	604290[ACERULOPLASMINEMIA]
FBgn0032116	Mco1	HGNC:30477	OMIM:618455	HEPHL1	4	261990	261990[ABNORMAL HAIR, JOINT LAXITY, AND DEVELOPMENTAL DELAY; HJDD]
FBgn0032116	Mco1	HGNC:4866	OMIM:300167	HEPH	4		
FBgn0011232	scat	HGNC:18652	OMIM:614633	VPS54	14		
FBgn0032119	CG3769	HGNC:24595	OMIM:617083	DYNC2LI1	14	617088	617088[SHORT-RIB THORACIC DYSPLASIA 15 WITH POLYDACTYLY; SRTD15]
FBgn0032115	CG4438	HGNC:14634	OMIM:607075	PDAP1	13		
FBgn0002973	numb	HGNC:8060	OMIM:603728	NUMB	11		
FBgn0002973	numb	HGNC:8061	OMIM:604018	NUMBL	12		
FBgn0032123	Oatp30B	HGNC:23612	OMIM:609013	SLCO4C1	4		
FBgn0032123	Oatp30B	HGNC:10953	OMIM:612436	SLCO4A1	3		
FBgn0032123	Oatp30B	HGNC:19046	OMIM:613543	SLCO5A1	11		
FBgn0032123	Oatp30B	HGNC:23613	OMIM:613365	SLCO6A1	3		
FBgn0032123	Oatp30B	HGNC:10952	OMIM:612435	SLCO3A1	5		
FBgn0032131	CG3841	HGNC:26741		CES4A	5		
FBgn0032131	CG3841	HGNC:11764	OMIM:188450	TG	3	274700,608175	274700[THYROID DYSHORMONOGENESIS 3; TDH3],608175[AUTOIMMUNE THYROID DISEASE, SUSCEPTIBILITY TO, 3; AITD3]
FBgn0032131	CG3841	HGNC:108	OMIM:100740	ACHE	4	112100	112100[YT BLOOD GROUP ANTIGEN]
FBgn0032131	CG3841	HGNC:983	OMIM:177400	BCHE	4	617936	617936[BUTYRYLCHOLINESTERASE DEFICIENCY; BCHED]
FBgn0032131	CG3841	HGNC:26459	OMIM:618678	CES5A	5		
FBgn0032131	CG3841	HGNC:1863	OMIM:114835	CES1	6	618057	618057[DRUG METABOLISM, ALTERED, CES1-RELATED]
FBgn0032131	CG3841	HGNC:1848	OMIM:114840	CEL	3	609812	609812[MATURITY-ONSET DIABETES OF THE YOUNG, TYPE 8, WITH EXOCRINE DYSFUNCTION; MODY8]
FBgn0032131	CG3841	HGNC:1864	OMIM:605278	CES2	6		
FBgn0032131	CG3841	HGNC:1865	OMIM:605279	CES3	5		
FBgn0032131	CG3841	HGNC:14291	OMIM:600568	NLGN1	3	618830	618830[AUTISM, SUSCEPTIBILITY TO, 20; AUTS20]
FBgn0032131	CG3841	HGNC:14289	OMIM:300336	NLGN3	3	300425,300494	300425[AUTISM, SUSCEPTIBILITY TO, X-LINKED 1; AUTSX1],300494[ASPERGER SYNDROME, X-LINKED, SUSCEPTIBILITY TO, 1; ASPGX1]
FBgn0032131	CG3841	HGNC:14287	OMIM:300427	NLGN4X	3	300495,300497	300495[AUTISM, SUSCEPTIBILITY TO, X-LINKED 2; AUTSX2],300497[ASPERGER SYNDROME, X-LINKED, SUSCEPTIBILITY TO, 2; ASPGX2]
FBgn0032131	CG3841	HGNC:14290	OMIM:606479	NLGN2	3		
FBgn0019809	gcm2	HGNC:4197	OMIM:603715	GCM1	8		
FBgn0019809	gcm2	HGNC:4198	OMIM:603716	GCM2	7	617343,618883	617343[HYPERPARATHYROIDISM 4; HRPT4],618883[HYPOPARATHYROIDISM, FAMILIAL ISOLATED, 2; FIH2]
FBgn0040070	Trx-2	HGNC:12435	OMIM:187700	TXN	13		
FBgn0040070	Trx-2	HGNC:17772	OMIM:609063	TXN2	3	616811	616811[COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 29; COXPD29]
FBgn0040070	Trx-2	HGNC:16470	OMIM:617790	TXNDC2	5		
FBgn0040070	Trx-2	HGNC:31454	OMIM:617789	TXNDC8	5		
FBgn0032135	GlcAT-S	HGNC:923	OMIM:606374	B3GAT3	3	245600	245600[MULTIPLE JOINT DISLOCATIONS, SHORT STATURE, AND CRANIOFACIAL DYSMORPHISM WITH OR WITHOUT CONGENITAL HEART DEFECTS; JDSCD]
FBgn0032136	Apoltp	HGNC:603	OMIM:107730	APOB	4	144010,615558	144010[HYPERCHOLESTEROLEMIA, FAMILIAL, 2; FHCL2],615558[HYPOBETALIPOPROTEINEMIA, FAMILIAL, 1; FHBL1]
FBgn0032136	Apoltp	HGNC:0		LOC400499	3		
FBgn0011207	pelo	HGNC:8829	OMIM:605757	PELO	13		
FBgn0032138	CG4364	HGNC:8848	OMIM:605819	PES1	14		
FBgn0000273	Pka-C1	HGNC:9441	OMIM:300083	PRKX	4		
FBgn0000273	Pka-C1	HGNC:9382	OMIM:176893	PRKACG	9	616176	616176[BLEEDING DISORDER, PLATELET-TYPE, 19; BDPLT19]
FBgn0000273	Pka-C1	HGNC:9380	OMIM:601639	PRKACA	13	615830,619142	615830[PIGMENTED NODULAR ADRENOCORTICAL DISEASE, PRIMARY, 4; PPNAD4],619142[CARDIOACROFACIAL DYSPLASIA 1; CAFD1]
FBgn0000273	Pka-C1	HGNC:9381	OMIM:176892	PRKACB	13	619143	619143[CARDIOACROFACIAL DYSPLASIA 2; CAFD2]
FBgn0032132	CG4382	HGNC:26741		CES4A	5		
FBgn0032132	CG4382	HGNC:11764	OMIM:188450	TG	3	274700,608175	274700[THYROID DYSHORMONOGENESIS 3; TDH3],608175[AUTOIMMUNE THYROID DISEASE, SUSCEPTIBILITY TO, 3; AITD3]
FBgn0032132	CG4382	HGNC:108	OMIM:100740	ACHE	6	112100	112100[YT BLOOD GROUP ANTIGEN]
FBgn0032132	CG4382	HGNC:983	OMIM:177400	BCHE	3	617936	617936[BUTYRYLCHOLINESTERASE DEFICIENCY; BCHED]
FBgn0032132	CG4382	HGNC:26459	OMIM:618678	CES5A	5		
FBgn0032132	CG4382	HGNC:1863	OMIM:114835	CES1	5	618057	618057[DRUG METABOLISM, ALTERED, CES1-RELATED]
FBgn0032132	CG4382	HGNC:1848	OMIM:114840	CEL	3	609812	609812[MATURITY-ONSET DIABETES OF THE YOUNG, TYPE 8, WITH EXOCRINE DYSFUNCTION; MODY8]
FBgn0032132	CG4382	HGNC:1864	OMIM:605278	CES2	6		
FBgn0032132	CG4382	HGNC:1865	OMIM:605279	CES3	5		
FBgn0032132	CG4382	HGNC:14291	OMIM:600568	NLGN1	3	618830	618830[AUTISM, SUSCEPTIBILITY TO, 20; AUTS20]
FBgn0032132	CG4382	HGNC:14289	OMIM:300336	NLGN3	3	300425,300494	300425[AUTISM, SUSCEPTIBILITY TO, X-LINKED 1; AUTSX1],300494[ASPERGER SYNDROME, X-LINKED, SUSCEPTIBILITY TO, 1; ASPGX1]
FBgn0032132	CG4382	HGNC:14287	OMIM:300427	NLGN4X	3	300495,300497	300495[AUTISM, SUSCEPTIBILITY TO, X-LINKED 2; AUTSX2],300497[ASPERGER SYNDROME, X-LINKED, SUSCEPTIBILITY TO, 2; ASPGX2]
FBgn0032132	CG4382	HGNC:14290	OMIM:606479	NLGN2	3		
FBgn0014179	gcm	HGNC:4197	OMIM:603715	GCM1	6		
FBgn0014179	gcm	HGNC:4198	OMIM:603716	GCM2	9	617343,618883	617343[HYPERPARATHYROIDISM 4; HRPT4],618883[HYPOPARATHYROIDISM, FAMILIAL ISOLATED, 2; FIH2]
FBgn0028479	Mtpalpha	HGNC:4801	OMIM:600890	HADHA	15	609015,609016	609015[MITOCHONDRIAL TRIFUNCTIONAL PROTEIN DEFICIENCY; MTPD],609016[LONG-CHAIN 3-HYDROXYACYL-CoA DEHYDROGENASE DEFICIENCY]
FBgn0028479	Mtpalpha	HGNC:3247	OMIM:607037	EHHADH	3	615605	615605[FANCONI RENOTUBULAR SYNDROME 3; FRTS3]
FBgn0032129	jp	HGNC:14202	OMIM:605267	JPH2	12	613873,619492	613873[CARDIOMYOPATHY, FAMILIAL HYPERTROPHIC, 17; CMH17],619492[CARDIOMYOPATHY, DILATED, 2E; CMD2E]
FBgn0032129	jp	HGNC:14201	OMIM:605266	JPH1	12	607831	607831[CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2K; CMT2K]
FBgn0032129	jp	HGNC:14203	OMIM:605268	JPH3	12	606438	606438[HUNTINGTON DISEASE-LIKE 2; HDL2]
FBgn0032129	jp	HGNC:20156	OMIM:619863	JPH4	7		
FBgn0004868	Gdi	HGNC:4227	OMIM:600767	GDI2	11		
FBgn0004868	Gdi	HGNC:4226	OMIM:300104	GDI1	13	300849	300849[INTELLECTUAL DEVELOPMENTAL DISORDER, X-LINKED 41; XLID41]
FBgn0032143	CG4017	HGNC:2300	OMIM:603101	CPB2	8		
FBgn0032143	CG4017	HGNC:21011	OMIM:609563	CPO	8		
FBgn0032143	CG4017	HGNC:2298	OMIM:114851	CPA3	7		
FBgn0032143	CG4017	HGNC:2297	OMIM:600688	CPA2	7		
FBgn0032143	CG4017	HGNC:15740	OMIM:607635	CPA4	9		
FBgn0032143	CG4017	HGNC:2299	OMIM:114852	CPB1	10		
FBgn0032143	CG4017	HGNC:2296	OMIM:114850	CPA1	7		
FBgn0032143	CG4017	HGNC:17245	OMIM:609562	CPA6	7	614417,614418	614417[EPILEPSY, FAMILIAL TEMPORAL LOBE, 5; ETL5],614418[FEBRILE SEIZURES, FAMILIAL, 11; FEB11]
FBgn0032143	CG4017	HGNC:15722	OMIM:609561	CPA5	6		
FBgn0032144	CG17633	HGNC:2300	OMIM:603101	CPB2	8		
FBgn0032144	CG17633	HGNC:21011	OMIM:609563	CPO	8		
FBgn0032144	CG17633	HGNC:2298	OMIM:114851	CPA3	7		
FBgn0032144	CG17633	HGNC:2297	OMIM:600688	CPA2	8		
FBgn0032144	CG17633	HGNC:15740	OMIM:607635	CPA4	8		
FBgn0032144	CG17633	HGNC:2299	OMIM:114852	CPB1	10		
FBgn0032144	CG17633	HGNC:2296	OMIM:114850	CPA1	10		
FBgn0032144	CG17633	HGNC:17245	OMIM:609562	CPA6	7	614417,614418	614417[EPILEPSY, FAMILIAL TEMPORAL LOBE, 5; ETL5],614418[FEBRILE SEIZURES, FAMILIAL, 11; FEB11]
FBgn0032144	CG17633	HGNC:15722	OMIM:609561	CPA5	7		
FBgn0032147	IP3K1	HGNC:6179	OMIM:147522	ITPKB	6		
FBgn0032147	IP3K1	HGNC:14897	OMIM:606476	ITPKC	5		
FBgn0032147	IP3K1	HGNC:6178	OMIM:147521	ITPKA	6		
FBgn0032149	CG4036	HGNC:21900	OMIM:613302	ALKBH4	14		
FBgn0032169	CG4709	HGNC:15948	OMIM:619577	ZGPAT	15		
FBgn0032172	CG5850	HGNC:25587	OMIM:613937	TMEM184C	13		
FBgn0032172	CG5850	HGNC:1310		TMEM184B	4		
FBgn0032171	CG5846	HGNC:9987	OMIM:603200	RFXANK	13	209920	209920[BARE LYMPHOCYTE SYNDROME, TYPE II]
FBgn0032171	CG5846	HGNC:13208	OMIM:605787	ANKRA2	10		
FBgn0032168	CG13126	HGNC:19280	OMIM:616091	METTL17	14		
FBgn0011291	Taf11	HGNC:11544	OMIM:600772	TAF11	12		
FBgn0011291	Taf11	HGNC:53845		TAF11L2	5		
FBgn0015035	Cyp4e3	HGNC:23198	OMIM:608614	CYP4V2	6	210370	210370[BIETTI CRYSTALLINE CORNEORETINAL DYSTROPHY; BCD]
FBgn0015035	Cyp4e3	HGNC:13265	OMIM:611517	CYP4F11	4		
FBgn0015035	Cyp4e3	HGNC:26820	OMIM:611495	CYP4F22	4	604777	604777[ICHTHYOSIS, CONGENITAL, AUTOSOMAL RECESSIVE 5; ARCI5]
FBgn0015035	Cyp4e3	HGNC:2645	OMIM:604426	CYP4F2	4		
FBgn0015035	Cyp4e3	HGNC:2646	OMIM:601270	CYP4F3	4		
FBgn0015035	Cyp4e3	HGNC:20244	OMIM:614999	CYP4X1	4		
FBgn0015035	Cyp4e3	HGNC:2642	OMIM:601310	CYP4A11	3		
FBgn0015035	Cyp4e3	HGNC:18857	OMIM:611485	CYP4F12	4		
FBgn0015035	Cyp4e3	HGNC:20575	OMIM:615341	CYP4A22	4		
FBgn0015035	Cyp4e3	HGNC:2644	OMIM:124075	CYP4B1	4		
FBgn0015035	Cyp4e3	HGNC:2648	OMIM:611545	CYP4F8	4		
FBgn0015035	Cyp4e3	HGNC:20583	OMIM:618953	CYP4Z1	4		
FBgn0015035	Cyp4e3	HGNC:2594	OMIM:107910	CYP19A1	4	139300,613546	139300[AROMATASE EXCESS SYNDROME; AEXS],613546[AROMATASE DEFICIENCY]
FBgn0028704	Nckx30C	HGNC:10976	OMIM:609838	SLC24A2	14		
FBgn0028704	Nckx30C	HGNC:10975	OMIM:603617	SLC24A1	7	613830	613830[NIGHT BLINDNESS, CONGENITAL STATIONARY, TYPE 1D; CSNB1D]
FBgn0000180	bib	HGNC:633	OMIM:107776	AQP1	5	110450	110450[BLOOD GROUP, COLTON SYSTEM; CO]
FBgn0000180	bib	HGNC:7103	OMIM:154050	MIP	4	615274	615274[CATARACT 15, MULTIPLE TYPES; CTRCT15]
FBgn0000180	bib	HGNC:634	OMIM:107777	AQP2	4	125800	125800[DIABETES INSIPIDUS, NEPHROGENIC, 2, AUTOSOMAL; NDI2]
FBgn0000180	bib	HGNC:638	OMIM:600442	AQP5	3	600231	600231[PALMOPLANTAR KERATODERMA, BOTHNIAN TYPE; PPKB]
FBgn0000180	bib	HGNC:637	OMIM:600308	AQP4	4		
FBgn0000180	bib	HGNC:642	OMIM:603750	AQP8	3		
FBgn0000180	bib	HGNC:639	OMIM:601383	AQP6	3		
FBgn0000180	bib	HGNC:636	OMIM:600170	AQP3	3	607457	607457[GIL BLOOD GROUP]
FBgn0000180	bib	HGNC:643	OMIM:602914	AQP9	3		
FBgn0043456	Ndf	HGNC:24434	OMIM:610660	GLYR1	15		
FBgn0011584	Trp1	HGNC:11846	OMIM:602173	SEC62	13		
FBgn0032187	CG4839	HGNC:9416	OMIM:601591	PRKG2	4	619636,619638	619636[ACROMESOMELIC DYSPLASIA 4; AMD4],619638[SPONDYLOMETAPHYSEAL DYSPLASIA, PAGNAMENTA TYPE; SMDP]
FBgn0032187	CG4839	HGNC:9414	OMIM:176894	PRKG1	5	615436	615436[AORTIC ANEURYSM, FAMILIAL THORACIC 8; AAT8]
FBgn0032188	CG13137	HGNC:13666	OMIM:605378	AAAS	6	231550	231550[ACHALASIA-ADDISONIANISM-ALACRIMA SYNDROME; AAAS]
FBgn0005593	RpL7	HGNC:21370	OMIM:617417	RPL7L1	6		
FBgn0005593	RpL7	HGNC:10363	OMIM:604166	RPL7	14		
FBgn0032194	ath	HGNC:17211	OMIM:605584	DHX38	3	618220	618220[RETINITIS PIGMENTOSA 84; RP84]
FBgn0032194	ath	HGNC:2738	OMIM:603403	DHX15	3		
FBgn0032194	ath	HGNC:2739	OMIM:603405	DHX16	3	618733	618733[NEUROMUSCULAR OCULOAUDITORY SYNDROME; NMOAS]
FBgn0032194	ath	HGNC:15861		DHX35	3		
FBgn0032194	ath	HGNC:16718	OMIM:614405	DHX33	14		
FBgn0032194	ath	HGNC:2749	OMIM:600396	DHX8	3		
FBgn0032194	ath	HGNC:18018	OMIM:607570	DHX40	3		
FBgn0032194	ath	HGNC:16717	OMIM:607960	DHX32	3		
FBgn0032194	ath	HGNC:20410		DQX1	3		
FBgn0032195	Bcs1	HGNC:1020	OMIM:603647	BCS1L	15	124000,262000,603358	124000[MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 1; MC3DN1],262000[BJORNSTAD SYNDROME; BJS],603358[GRACILE SYNDROME]
FBgn0032198	eEF1delta	HGNC:3211	OMIM:130592	EEF1D	10		
FBgn0032197	ova	HGNC:7996	OMIM:600879	NRF1	3		
FBgn0032196	CG5708	HGNC:6643	OMIM:180386	LMO3	3		
FBgn0032196	CG5708	HGNC:6644	OMIM:603129	LMO4	8		
FBgn0024320	Npc1a	HGNC:7898	OMIM:608010	NPC1L1	7	617966	617966[LOW DENSITY LIPOPROTEIN CHOLESTEROL LEVEL QUANTITATIVE TRAIT LOCUS 7; LDLCQ7]
FBgn0024320	Npc1a	HGNC:7897	OMIM:607623	NPC1	14	257220	257220[NIEMANN-PICK DISEASE, TYPE C1; NPC1]
FBgn0032192	CG5731	HGNC:4296	OMIM:300644	GLA	9	301500	301500[FABRY DISEASE]
FBgn0032192	CG5731	HGNC:7631	OMIM:104170	NAGA	13	609241,609242	609241[SCHINDLER DISEASE, TYPE I],609242[KANZAKI DISEASE]
FBgn0032191	Snx17	HGNC:14979	OMIM:605963	SNX17	15		
FBgn0032191	Snx17	HGNC:28605	OMIM:619839	SNX31	7		
FBgn0032189	Ripalpha	HGNC:28641	OMIM:617299	RPAIN	7		
FBgn0028675	Sur	HGNC:55	OMIM:605250	ABCC4	3		
FBgn0028675	Sur	HGNC:52	OMIM:612509	ABCC10	3		
FBgn0028675	Sur	HGNC:53	OMIM:601107	ABCC2	3	237500	237500[DUBIN-JOHNSON SYNDROME; DJS]
FBgn0028675	Sur	HGNC:51	OMIM:158343	ABCC1	3	618915	618915[DEAFNESS, AUTOSOMAL DOMINANT 77; DFNA77]
FBgn0028675	Sur	HGNC:59	OMIM:600509	ABCC8	6	125853,240800,256450,610374,618857	125853[TYPE 2 DIABETES MELLITUS; T2D],240800[HYPOGLYCEMIA, LEUCINE-INDUCED; LIH],256450[HYPERINSULINEMIC HYPOGLYCEMIA, FAMILIAL, 1; HHF1],610374[DIABETES MELLITUS, TRANSIENT NEONATAL, 2; TNDM2],618857[DIABETES MELLITUS, PERMANENT NEONATAL, 3; PNDM3]
FBgn0028675	Sur	HGNC:14640	OMIM:607041	ABCC12	3		
FBgn0028675	Sur	HGNC:60	OMIM:601439	ABCC9	8	239850,608569,614050,619719	239850[CANTU SYNDROME],608569[CARDIOMYOPATHY, DILATED, 1O; CMD1O],614050[ATRIAL FIBRILLATION, FAMILIAL, 12; ATFB12],619719[INTELLECTUAL DISABILITY AND MYOPATHY SYNDROME; IDMYS]
FBgn0028675	Sur	HGNC:57	OMIM:603234	ABCC6	3	177850,264800,614473	177850[PSEUDOXANTHOMA ELASTICUM, FORME FRUSTE],264800[PSEUDOXANTHOMA ELASTICUM; PXE],614473[ARTERIAL CALCIFICATION, GENERALIZED, OF INFANCY, 2; GACI2]
FBgn0028675	Sur	HGNC:56	OMIM:605251	ABCC5	3		
FBgn0028675	Sur	HGNC:14639	OMIM:607040	ABCC11	3	117800	117800[APOCRINE GLAND SECRETION, VARIATION IN]
FBgn0028675	Sur	HGNC:54	OMIM:604323	ABCC3	3		
FBgn0051874	Fum4	HGNC:3700	OMIM:136850	FH	8	150800,606812	150800[HEREDITARY LEIOMYOMATOSIS AND RENAL CELL CANCER; HLRCC],606812[FUMARASE DEFICIENCY; FMRD]
FBgn0032181	CG13133	HGNC:2388	OMIM:123580	CRYAA	3	604219	604219[CATARACT 9, MULTIPLE TYPES; CTRCT9]
FBgn0032181	CG13133	HGNC:5247	OMIM:602179	HSPB2	4		
FBgn0032181	CG13133	HGNC:5246	OMIM:602195	HSPB1	3	606595,608634	606595[CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2F; CMT2F],608634[NEURONOPATHY, DISTAL HEREDITARY MOTOR, TYPE IIB; HMN2B]
FBgn0051875	CG31875	HGNC:17441	OMIM:607675	RCOR1	4		
FBgn0004419	me31B	HGNC:2747	OMIM:600326	DDX6	13	618653	618653[INTELLECTUAL DEVELOPMENTAL DISORDER WITH IMPAIRED LANGUAGE AND DYSMORPHIC FACIES; IDDILF]
FBgn0051717	CG31717	HGNC:28174	OMIM:618743	PLPP7	12		
FBgn0051717	CG31717	HGNC:23682	OMIM:611666	PLPP6	14		
FBgn0010407	Ror	HGNC:10256	OMIM:602336	ROR1	13	617654	617654[DEAFNESS, AUTOSOMAL RECESSIVE 108; DFNB108]
FBgn0010407	Ror	HGNC:10257	OMIM:602337	ROR2	13	113000,268310	113000[BRACHYDACTYLY, TYPE B1; BDB1],268310[ROBINOW SYNDROME, AUTOSOMAL RECESSIVE 1; RRS1]
FBgn0032204	CG4953	HGNC:25828		TRAPPC13	14		
FBgn0032205	CG4957	HGNC:24316	OMIM:612958	TACO1	11	619052	619052[MITOCHONDRIAL COMPLEX IV DEFICIENCY, NUCLEAR TYPE 8; MC4DN8]
FBgn0032214	CG4968	HGNC:20351	OMIM:608338	OTUB2	10		
FBgn0032214	CG4968	HGNC:23077	OMIM:608337	OTUB1	14		
FBgn0032217	CG4972	HGNC:26923	OMIM:609156	NCLN	13		
FBgn0032219	CG4995	HGNC:1421	OMIM:613698	SLC25A20	3	212138	212138[CARNITINE-ACYLCARNITINE TRANSLOCASE DEFICIENCY; CACTD]
FBgn0032219	CG4995	HGNC:20116	OMIM:615064	SLC25A29	14		
FBgn0032222	Cox10	HGNC:2260	OMIM:602125	COX10	14	619046	619046[MITOCHONDRIAL COMPLEX IV DEFICIENCY, NUCLEAR TYPE 3; MC4DN3]
FBgn0032223	GATAd	HGNC:4173	OMIM:600576	GATA4	4	187500,607941,614429,614430,615542	187500[TETRALOGY OF FALLOT; TOF],607941[ATRIAL SEPTAL DEFECT 2; ASD2],614429[VENTRICULAR SEPTAL DEFECT 1; VSD1],614430[ATRIOVENTRICULAR SEPTAL DEFECT 4; AVSD4],615542[TESTICULAR ANOMALIES WITH OR WITHOUT CONGENITAL HEART DISEASE; TACHD]
FBgn0032223	GATAd	HGNC:4170	OMIM:305371	GATA1	4	190685,300367,300835,301083,314050	190685[DOWN SYNDROME],300367[THROMBOCYTOPENIA, X-LINKED, WITH OR WITHOUT DYSERYTHROPOIETIC ANEMIA; XLTDA],300835[ANEMIA, X-LINKED, WITH OR WITHOUT NEUTROPENIA AND/OR PLATELET ABNORMALITIES; XLANP],301083[ADENOSINE DEAMINASE, ELEVATED, HEMOLYTIC ANEMIA DUE TO; HAEADA],314050[THROMBOCYTOPENIA WITH BETA-THALASSEMIA, X-LINKED; XLTT]
FBgn0032223	GATAd	HGNC:15802	OMIM:611496	GATA5	3	617912	617912[CONGENITAL HEART DEFECTS, MULTIPLE TYPES, 5; CHTD5]
FBgn0032223	GATAd	HGNC:4172	OMIM:131320	GATA3	4	146255	146255[HYPOPARATHYROIDISM, SENSORINEURAL DEAFNESS, AND RENAL DYSPLASIA SYNDROME; HDRS]
FBgn0032223	GATAd	HGNC:4174	OMIM:601656	GATA6	4	187500,217095,600001,614474,614475	187500[TETRALOGY OF FALLOT; TOF],217095[CONOTRUNCAL HEART MALFORMATIONS; CTHM],600001[HEART DEFECTS, CONGENITAL, AND OTHER CONGENITAL ANOMALIES; HDCA],614474[ATRIOVENTRICULAR SEPTAL DEFECT 5; AVSD5],614475[ATRIAL SEPTAL DEFECT 9; ASD9]
FBgn0032223	GATAd	HGNC:4171	OMIM:137295	GATA2	4	601626,614038,614172,614286	601626[LEUKEMIA, ACUTE MYELOID; AML],614038[LYMPHEDEMA, PRIMARY, WITH MYELODYSPLASIA],614172[IMMUNODEFICIENCY 21; IMD21],614286[MYELODYSPLASTIC SYNDROME; MDS]
FBgn0019932	SamDC	HGNC:457	OMIM:180980	AMD1	14		
FBgn0051715	CG31715	HGNC:15667	OMIM:606484	MTPN	13		
FBgn0032224	Sps2	HGNC:19685	OMIM:600902	SEPHS1	6		
FBgn0032224	Sps2	HGNC:19686	OMIM:606218	SEPHS2	5		
FBgn0032225	CG5022	HGNC:13278	OMIM:612141	EPB41L4A	3		
FBgn0032225	CG5022	HGNC:28214	OMIM:616309	FRMD5	12		
FBgn0032225	CG5022	HGNC:24125	OMIM:607619	FRMD3	11		
FBgn0032229	ClpP	HGNC:2084	OMIM:601119	CLPP	15	614129	614129[PERRAULT SYNDROME 3; PRLTS3]
FBgn0032230	lft	HGNC:18581	OMIM:610466	LIX1	7		
FBgn0032230	lft	HGNC:28715		LIX1L	13		
FBgn0032231	CG5056	HGNC:16105		OSER1	9		
FBgn0032234	gny	HGNC:23157	OMIM:604566	ALG6	14	603147	603147[CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Ic; CDG1C]
FBgn0032236	mRpS7	HGNC:14499	OMIM:611974	MRPS7	13	617872	617872[COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 34; COXPD34]
FBgn0051716	Cnot4	HGNC:7880	OMIM:604911	CNOT4	9		
FBgn0051718	Ir31a	HGNC:4582	OMIM:600282	GRIK4	3		
FBgn0051718	Ir31a	HGNC:4575	OMIM:610659	GRID1	3		
FBgn0003942	RpS27A	HGNC:10417	OMIM:191343	RPS27A	12		
FBgn0003942	RpS27A	HGNC:7732	OMIM:603171	NEDD8	3		
FBgn0025366	Ip259	HGNC:30728	OMIM:612497	NSA2	14		
FBgn0032243	Klp31E	HGNC:19349	OMIM:608283	KIF21A	13	135700	135700[FIBROSIS OF EXTRAOCULAR MUSCLES, CONGENITAL, 1; CFEOM1]
FBgn0032243	Klp31E	HGNC:29442	OMIM:608322	KIF21B	10		
FBgn0032244	RfC3	HGNC:9973	OMIM:600407	RFC5	14		
FBgn0032246	Wdfy2	HGNC:20482	OMIM:610418	WDFY2	15		
FBgn0032246	Wdfy2	HGNC:20451	OMIM:618080	WDFY1	11		
FBgn0032247	CG5188	HGNC:32583	OMIM:610267	METAP1D	14		
FBgn0032247	CG5188	HGNC:15789	OMIM:610151	METAP1	3		
FBgn0004915	TfIIB	HGNC:4648	OMIM:189963	GTF2B	15		
FBgn0032250	holn1	HGNC:1656	OMIM:604470	CD2BP2	14		
FBgn0027052	STUB1	HGNC:11427	OMIM:607207	STUB1	15	615768,618093	615768[SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 16; SCAR16],618093[SPINOCEREBELLAR ATAXIA 48; SCA48]
FBgn0032251	Nse4	HGNC:32961	OMIM:612986	EID3	8		
FBgn0032251	Nse4	HGNC:25935	OMIM:612987	NSMCE4A	10		
FBgn0032252	loh	HGNC:19706	OMIM:610113	ADAMTSL4	10	225100,225200	225100[ECTOPIA LENTIS 2, ISOLATED, AUTOSOMAL RECESSIVE; ECTOL2],225200[ECTOPIA LENTIS ET PUPILLAE]
FBgn0032252	loh	HGNC:25835	OMIM:614476	THSD4	11	619825	619825[AORTIC ANEURYSM, FAMILIAL THORACIC 12; AAT12]
FBgn0032252	loh	HGNC:17108	OMIM:607510	ADAMTS16	3		
FBgn0032252	loh	HGNC:17110	OMIM:607512	ADAMTS18	3	615458	615458[MICROCORNEA, MYOPIC CHORIORETINAL ATROPHY, AND TELECANTHUS; MMCAT]
FBgn0032252	loh	HGNC:1366	OMIM:604134	ADAMTS13	3	274150	274150[THROMBOTIC THROMBOCYTOPENIC PURPURA, HEREDITARY; TTP]
FBgn0032252	loh	HGNC:223	OMIM:605009	ADAMTS7	3		
FBgn0032252	loh	HGNC:14605	OMIM:606184	ADAMTS12	3		
FBgn0032252	loh	HGNC:13201	OMIM:608990	ADAMTS10	3	277600	277600[WEILL-MARCHESANI SYNDROME 1; WMS1]
FBgn0032252	loh	HGNC:19262	OMIM:617785	PAPLN	3		
FBgn0032252	loh	HGNC:17109	OMIM:607511	ADAMTS17	3	613195	613195[WEILL-MARCHESANI SYNDROME 4; WMS4]
FBgn0032252	loh	HGNC:17111	OMIM:607513	ADAMTS19	3		
FBgn0032252	loh	HGNC:14631	OMIM:612277	ADAMTSL2	3	231050	231050[GELEOPHYSIC DYSPLASIA 1; GPHYSD1]
FBgn0032252	loh	HGNC:219	OMIM:605011	ADAMTS3	3	618154	618154[HENNEKAM LYMPHANGIECTASIA-LYMPHEDEMA SYNDROME 3; HKLLS3]
FBgn0032252	loh	HGNC:218	OMIM:604539	ADAMTS2	3	225410	225410[EHLERS-DANLOS SYNDROME, DERMATOSPARAXIS TYPE; EDSDERMS]
FBgn0032252	loh	HGNC:14899	OMIM:607506	ADAMTS14	3		
FBgn0032252	loh	HGNC:27912		ADAMTSL5	3		
FBgn0027611	LManII	HGNC:29623	OMIM:618899	MAN2B2	3		
FBgn0027611	LManII	HGNC:6826	OMIM:609458	MAN2B1	15	248500	248500[MANNOSIDOSIS, ALPHA B, LYSOSOMAL; MANSA]
FBgn0032256	RluA-2	HGNC:24180		RPUSD2	15		
FBgn0026431	Grip75	HGNC:16691	OMIM:609610	TUBGCP4	14	616335	616335[MICROCEPHALY AND CHORIORETINOPATHY, AUTOSOMAL RECESSIVE, 3; MCCRP3]
FBgn0032258	Cog4	HGNC:18620	OMIM:606976	COG4	14	613489,618150	613489[CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIj; CDG2J],618150[SAUL-WILSON SYNDROME; SWILS]
FBgn0051719	RluA-1	HGNC:24180		RPUSD2	12		
FBgn0032253	LManI	HGNC:29623	OMIM:618899	MAN2B2	3		
FBgn0032253	LManI	HGNC:6826	OMIM:609458	MAN2B1	13	248500	248500[MANNOSIDOSIS, ALPHA B, LYSOSOMAL; MANSA]
FBgn0032249	TBC1D16	HGNC:28356	OMIM:616637	TBC1D16	14		
FBgn0032248	Bug22	HGNC:29523	OMIM:617906	CFAP20	14		
FBgn0005683	pie	HGNC:20338	OMIM:611299	G2E3	8		
FBgn0005683	pie	HGNC:18145	OMIM:300414	PHF6	4	301900	301900[BORJESON-FORSSMAN-LEHMANN SYNDROME; BFLS]
FBgn0005683	pie	HGNC:17024	OMIM:607796	PHF11	5		
FBgn0005683	pie	HGNC:18458		PHF7	7		
FBgn0032242	CG5355	HGNC:9358	OMIM:600400	PREP	15		
FBgn0004106	Cdk1	HGNC:1774	OMIM:123831	CDK5	4	616342	616342[LISSENCEPHALY 7 WITH CEREBELLAR HYPOPLASIA; LIS7]
FBgn0004106	Cdk1	HGNC:8749	OMIM:311550	CDK16	3		
FBgn0004106	Cdk1	HGNC:1722	OMIM:116940	CDK1	13		
FBgn0004106	Cdk1	HGNC:8883	OMIM:610679	CDK14	3		
FBgn0004106	Cdk1	HGNC:8751	OMIM:169190	CDK18	3		
FBgn0004106	Cdk1	HGNC:1771	OMIM:116953	CDK2	5		
FBgn0004106	Cdk1	HGNC:8750	OMIM:603440	CDK17	3		
FBgn0004106	Cdk1	HGNC:14434	OMIM:616147	CDK15	3		
FBgn0053303	CG33303	HGNC:10381	OMIM:180470	RPN1	13		
FBgn0027568	Cand1	HGNC:30689	OMIM:610403	CAND2	12		
FBgn0027568	Cand1	HGNC:30688	OMIM:607727	CAND1	14		
FBgn0032228	CG5367	HGNC:2538	OMIM:603308	CTSV	4		
FBgn0032228	CG5367	HGNC:2537	OMIM:116880	CTSL	3		
FBgn0032221	Schip1	HGNC:15678	OMIM:619206	SCHIP1	7		
FBgn0032221	Schip1	HGNC:38842		IQCJ-SCHIP1	9		
FBgn0011703	RnrL	HGNC:10451	OMIM:180410	RRM1	15		
FBgn0032216	Usp14	HGNC:12612	OMIM:607274	USP14	14		
FBgn0027491	Cdk5alpha	HGNC:1776	OMIM:603764	CDK5R2	10		
FBgn0027491	Cdk5alpha	HGNC:1775	OMIM:603460	CDK5R1	12		
FBgn0005322	nmd	HGNC:25903	OMIM:614452	ATAD1	14	618011	618011[HYPEREKPLEXIA 4; HKPX4]
FBgn0032210	CYLD	HGNC:2584	OMIM:605018	CYLD	13	132700,601606,605041,619132	132700[CYLINDROMATOSIS, FAMILIAL],601606[TRICHOEPITHELIOMA, MULTIPLE FAMILIAL, 1],605041[BROOKE-SPIEGLER SYNDROME; BRSS],619132[FRONTOTEMPORAL DEMENTIA AND/OR AMYOTROPHIC LATERAL SCLEROSIS 8; FTDALS8]
FBgn0032209	Hand	HGNC:4808	OMIM:602407	HAND2	13		
FBgn0032209	Hand	HGNC:4807	OMIM:602406	HAND1	11		
FBgn0032208	Ufd4	HGNC:20157	OMIM:618649	HECTD1	15		
FBgn0032208	Ufd4	HGNC:12306	OMIM:604506	TRIP12	3	617752	617752[CLARK-BARAITSER SYNDROME; CLABARS]
FBgn0011305	Rsf1	HGNC:10785	OMIM:603364	SRSF3	3		
FBgn0032200	CG5676	HGNC:24925	OMIM:301042	FUNDC2	10		
FBgn0032200	CG5676	HGNC:28746	OMIM:300871	FUNDC1	11		
FBgn0000229	bsk	HGNC:6886	OMIM:602896	MAPK9	11		
FBgn0000229	bsk	HGNC:6872	OMIM:602897	MAPK10	13		
FBgn0000229	bsk	HGNC:6881	OMIM:601158	MAPK8	13		
FBgn0024248	chico	HGNC:6125	OMIM:147545	IRS1	10	125853	125853[TYPE 2 DIABETES MELLITUS; T2D]
FBgn0024248	chico	HGNC:6126	OMIM:600797	IRS2	9	125853	125853[TYPE 2 DIABETES MELLITUS; T2D]
FBgn0024248	chico	HGNC:6128	OMIM:300904	IRS4	5	301035	301035[HYPOTHYROIDISM, CONGENITAL, NONGOITROUS, 9; CHNG9]
FBgn0032261	CG6094	HGNC:5359	OMIM:603000	MRPL58	14		
FBgn0010398	Lrr47	HGNC:19742	OMIM:609193	LRR1	13		
FBgn0032264	Lip4	HGNC:6617	OMIM:613497	LIPA	12	278000	278000[LYSOSOMAL ACID LIPASE DEFICIENCY]
FBgn0032264	Lip4	HGNC:23444	OMIM:613922	LIPK	12		
FBgn0032264	Lip4	HGNC:23455	OMIM:613923	LIPM	13		
FBgn0032264	Lip4	HGNC:6622	OMIM:601980	LIPF	12		
FBgn0032264	Lip4	HGNC:21773	OMIM:613921	LIPJ	9		
FBgn0032264	Lip4	HGNC:23452	OMIM:613924	LIPN	10	613943	613943[ICHTHYOSIS, CONGENITAL, AUTOSOMAL RECESSIVE 8; ARCI8]
FBgn0032265	CG18301	HGNC:6617	OMIM:613497	LIPA	11	278000	278000[LYSOSOMAL ACID LIPASE DEFICIENCY]
FBgn0032265	CG18301	HGNC:23444	OMIM:613922	LIPK	11		
FBgn0032265	CG18301	HGNC:23455	OMIM:613923	LIPM	12		
FBgn0032265	CG18301	HGNC:6622	OMIM:601980	LIPF	12		
FBgn0032265	CG18301	HGNC:21773	OMIM:613921	LIPJ	9		
FBgn0032265	CG18301	HGNC:23452	OMIM:613924	LIPN	10	613943	613943[ICHTHYOSIS, CONGENITAL, AUTOSOMAL RECESSIVE 8; ARCI8]
FBgn0032266	CG18302	HGNC:6617	OMIM:613497	LIPA	10	278000	278000[LYSOSOMAL ACID LIPASE DEFICIENCY]
FBgn0032266	CG18302	HGNC:23444	OMIM:613922	LIPK	9		
FBgn0032266	CG18302	HGNC:23455	OMIM:613923	LIPM	9		
FBgn0032266	CG18302	HGNC:6622	OMIM:601980	LIPF	9		
FBgn0032266	CG18302	HGNC:21773	OMIM:613921	LIPJ	7		
FBgn0032266	CG18302	HGNC:23452	OMIM:613924	LIPN	8	613943	613943[ICHTHYOSIS, CONGENITAL, AUTOSOMAL RECESSIVE 8; ARCI8]
FBgn0051872	CG31872	HGNC:6617	OMIM:613497	LIPA	6	278000	278000[LYSOSOMAL ACID LIPASE DEFICIENCY]
FBgn0051872	CG31872	HGNC:23444	OMIM:613922	LIPK	6		
FBgn0051872	CG31872	HGNC:23455	OMIM:613923	LIPM	6		
FBgn0051872	CG31872	HGNC:6622	OMIM:601980	LIPF	6		
FBgn0051872	CG31872	HGNC:21773	OMIM:613921	LIPJ	5		
FBgn0051872	CG31872	HGNC:23452	OMIM:613924	LIPN	6	613943	613943[ICHTHYOSIS, CONGENITAL, AUTOSOMAL RECESSIVE 8; ARCI8]
FBgn0043825	CG18284	HGNC:6617	OMIM:613497	LIPA	8	278000	278000[LYSOSOMAL ACID LIPASE DEFICIENCY]
FBgn0043825	CG18284	HGNC:23444	OMIM:613922	LIPK	8		
FBgn0043825	CG18284	HGNC:23455	OMIM:613923	LIPM	8		
FBgn0043825	CG18284	HGNC:6622	OMIM:601980	LIPF	8		
FBgn0043825	CG18284	HGNC:21773	OMIM:613921	LIPJ	7		
FBgn0043825	CG18284	HGNC:23452	OMIM:613924	LIPN	8	613943	613943[ICHTHYOSIS, CONGENITAL, AUTOSOMAL RECESSIVE 8; ARCI8]
FBgn0051871	CG31871	HGNC:6617	OMIM:613497	LIPA	12	278000	278000[LYSOSOMAL ACID LIPASE DEFICIENCY]
FBgn0051871	CG31871	HGNC:23444	OMIM:613922	LIPK	12		
FBgn0051871	CG31871	HGNC:23455	OMIM:613923	LIPM	13		
FBgn0051871	CG31871	HGNC:6622	OMIM:601980	LIPF	13		
FBgn0051871	CG31871	HGNC:21773	OMIM:613921	LIPJ	9		
FBgn0051871	CG31871	HGNC:23452	OMIM:613924	LIPN	10	613943	613943[ICHTHYOSIS, CONGENITAL, AUTOSOMAL RECESSIVE 8; ARCI8]
FBgn0032287	CG6415	HGNC:473	OMIM:238310	AMT	14	605899	605899[GLYCINE ENCEPHALOPATHY; GCE]
FBgn0032290	CG6443	HGNC:15890		RTF2	14		
FBgn0032291	CG17118	HGNC:29523	OMIM:617906	CFAP20	4		
FBgn0032293	Dpy-30L1	HGNC:24590	OMIM:612032	DPY30	8		
FBgn0027550	CG6495	HGNC:16936		LRP11	7		
FBgn0015320	Ubc2	HGNC:12477	OMIM:602916	UBE2E1	12		
FBgn0015320	Ubc2	HGNC:12478	OMIM:602163	UBE2E2	13		
FBgn0015320	Ubc2	HGNC:12479	OMIM:604151	UBE2E3	13		
FBgn0032297	CG17124	HGNC:14953	OMIM:613256	PPP1R14D	6		
FBgn0032297	CG17124	HGNC:9057	OMIM:601140	PPP1R14B	12		
FBgn0032297	CG17124	HGNC:14952	OMIM:613242	PPP1R14C	8		
FBgn0032297	CG17124	HGNC:14871	OMIM:608153	PPP1R14A	8		
FBgn0032296	CG6729	HGNC:25551	OMIM:613175	SMG8	12	619268	619268[ALZAHRANI-KUWAHARA SYNDROME; ALKUS]
FBgn0032294	Vha16-5	HGNC:855	OMIM:108745	ATP6V0C	8		
FBgn0027868	Nup107	HGNC:29914	OMIM:607617	NUP107	13	616730,618078,618348	616730[NEPHROTIC SYNDROME, TYPE 11; NPHS11],618078[OVARIAN DYSGENESIS 6; ODG6],618348[GALLOWAY-MOWAT SYNDROME 7; GAMOS7]
FBgn0032292	EMC3	HGNC:23999		EMC3	12		
FBgn0024740	Lip2	HGNC:6617	OMIM:613497	LIPA	6	278000	278000[LYSOSOMAL ACID LIPASE DEFICIENCY]
FBgn0024740	Lip2	HGNC:23444	OMIM:613922	LIPK	6		
FBgn0024740	Lip2	HGNC:23455	OMIM:613923	LIPM	6		
FBgn0024740	Lip2	HGNC:6622	OMIM:601980	LIPF	6		
FBgn0024740	Lip2	HGNC:21773	OMIM:613921	LIPJ	5		
FBgn0024740	Lip2	HGNC:23452	OMIM:613924	LIPN	6	613943	613943[ICHTHYOSIS, CONGENITAL, AUTOSOMAL RECESSIVE 8; ARCI8]
FBgn0023496	Lip1	HGNC:6617	OMIM:613497	LIPA	9	278000	278000[LYSOSOMAL ACID LIPASE DEFICIENCY]
FBgn0023496	Lip1	HGNC:23444	OMIM:613922	LIPK	9		
FBgn0023496	Lip1	HGNC:23455	OMIM:613923	LIPM	9		
FBgn0023496	Lip1	HGNC:6622	OMIM:601980	LIPF	10		
FBgn0023496	Lip1	HGNC:21773	OMIM:613921	LIPJ	7		
FBgn0023496	Lip1	HGNC:23452	OMIM:613924	LIPN	8	613943	613943[ICHTHYOSIS, CONGENITAL, AUTOSOMAL RECESSIVE 8; ARCI8]
FBgn0032271	CG7329	HGNC:6617	OMIM:613497	LIPA	10	278000	278000[LYSOSOMAL ACID LIPASE DEFICIENCY]
FBgn0032271	CG7329	HGNC:23444	OMIM:613922	LIPK	10		
FBgn0032271	CG7329	HGNC:23455	OMIM:613923	LIPM	11		
FBgn0032271	CG7329	HGNC:6622	OMIM:601980	LIPF	10		
FBgn0032271	CG7329	HGNC:21773	OMIM:613921	LIPJ	8		
FBgn0032271	CG7329	HGNC:23452	OMIM:613924	LIPN	9	613943	613943[ICHTHYOSIS, CONGENITAL, AUTOSOMAL RECESSIVE 8; ARCI8]
FBgn0032303	CG6508	HGNC:2530	OMIM:116890	CTSE	6		
FBgn0032303	CG6508	HGNC:8887	OMIM:169730	PGA5	5		
FBgn0032303	CG6508	HGNC:8886	OMIM:169720	PGA4	4		
FBgn0032303	CG6508	HGNC:8885	OMIM:169710	PGA3	3		
FBgn0032303	CG6508	HGNC:9958	OMIM:179820	REN	7	267430,613092	267430[RENAL TUBULAR DYSGENESIS; RTD],613092[TUBULOINTERSTITIAL KIDNEY DISEASE, AUTOSOMAL DOMINANT, 4; ADTKD4]
FBgn0032303	CG6508	HGNC:8890	OMIM:169740	PGC	5		
FBgn0032303	CG6508	HGNC:13395	OMIM:605631	NAPSA	7		
FBgn0032303	CG6508	HGNC:933	OMIM:604252	BACE1	3		
FBgn0032303	CG6508	HGNC:2529	OMIM:116840	CTSD	5	610127	610127[CEROID LIPOFUSCINOSIS, NEURONAL, 10; CLN10]
FBgn0032304	CG17134	HGNC:2530	OMIM:116890	CTSE	8		
FBgn0032304	CG17134	HGNC:8887	OMIM:169730	PGA5	6		
FBgn0032304	CG17134	HGNC:8886	OMIM:169720	PGA4	5		
FBgn0032304	CG17134	HGNC:8885	OMIM:169710	PGA3	3		
FBgn0032304	CG17134	HGNC:9958	OMIM:179820	REN	7	267430,613092	267430[RENAL TUBULAR DYSGENESIS; RTD],613092[TUBULOINTERSTITIAL KIDNEY DISEASE, AUTOSOMAL DOMINANT, 4; ADTKD4]
FBgn0032304	CG17134	HGNC:8890	OMIM:169740	PGC	6		
FBgn0032304	CG17134	HGNC:13395	OMIM:605631	NAPSA	7		
FBgn0032304	CG17134	HGNC:934	OMIM:605668	BACE2	3		
FBgn0032304	CG17134	HGNC:2529	OMIM:116840	CTSD	5	610127	610127[CEROID LIPOFUSCINOSIS, NEURONAL, 10; CLN10]
FBgn0027363	Stam	HGNC:11357	OMIM:601899	STAM	12		
FBgn0027363	Stam	HGNC:11358	OMIM:606244	STAM2	12		
FBgn0032321	YL-1	HGNC:11644	OMIM:600607	VPS72	14		
FBgn0041781	SCAR	HGNC:12733	OMIM:605875	WASF2	10		
FBgn0041781	SCAR	HGNC:12732	OMIM:605035	WASF1	12	618707	618707[NEURODEVELOPMENTAL DISORDER WITH ABSENT LANGUAGE AND VARIABLE SEIZURES; NEDALVS]
FBgn0041781	SCAR	HGNC:12734	OMIM:605068	WASF3	13		
FBgn0026148	CG12253	HGNC:26522	OMIM:615086	HARBI1	8		
FBgn0026147	TTLL4A	HGNC:19963	OMIM:612268	TTLL5	3	615860	615860[CONE-ROD DYSTROPHY 19; CORD19]
FBgn0026147	TTLL4A	HGNC:28976	OMIM:618738	TTLL4	12		
FBgn0032330	Samuel	HGNC:28706	OMIM:616765	SAMD11	5		
FBgn0032329	Art8	HGNC:18241	OMIM:608274	PRMT6	6		
FBgn0032329	Art8	HGNC:5186	OMIM:601961	PRMT2	3		
FBgn0015756	RpL9	HGNC:10369	OMIM:603686	RPL9	14		
FBgn0000146	aub	HGNC:17644	OMIM:610312	PIWIL2	6		
FBgn0000146	aub	HGNC:9007	OMIM:605571	PIWIL1	9		
FBgn0000146	aub	HGNC:18443	OMIM:610314	PIWIL3	7		
FBgn0000146	aub	HGNC:18444	OMIM:610315	PIWIL4	5		
FBgn0004872	piwi	HGNC:17644	OMIM:610312	PIWIL2	6		
FBgn0004872	piwi	HGNC:9007	OMIM:605571	PIWIL1	8		
FBgn0004872	piwi	HGNC:18443	OMIM:610314	PIWIL3	9		
FBgn0004872	piwi	HGNC:18444	OMIM:610315	PIWIL4	6		
FBgn0010612	ATPsynG	HGNC:14247	OMIM:617473	ATP5MG	15		
FBgn0010612	ATPsynG	HGNC:13213		ATP5MGL	11		
FBgn0000018	abo	HGNC:25477	OMIM:608727	DET1	13		
FBgn0053129	CG33129	HGNC:25983	OMIM:615301	TMEM214	13		
FBgn0032314	CG7309	HGNC:14430	OMIM:606411	SLC13A3	6	618384	618384[LEUKOENCEPHALOPATHY, ACUTE REVERSIBLE, WITH INCREASED URINARY ALPHA-KETOGLUTARATE; ARLIAK]
FBgn0032314	CG7309	HGNC:23089	OMIM:608305	SLC13A5	5	615905	615905[DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 25 WITH AMELOGENESIS IMPERFECTA; DEE25]
FBgn0032314	CG7309	HGNC:10916	OMIM:606193	SLC13A1	6		
FBgn0032314	CG7309	HGNC:15827	OMIM:604309	SLC13A4	6		
FBgn0032314	CG7309	HGNC:10917	OMIM:604148	SLC13A2	5		
FBgn0024227	aurB	HGNC:11391	OMIM:603495	AURKC	7	243060	243060[SPERMATOGENIC FAILURE 5; SPGF5]
FBgn0024227	aurB	HGNC:11390	OMIM:604970	AURKB	7		
FBgn0024227	aurB	HGNC:11393	OMIM:603072	AURKA	5	114500	114500[COLORECTAL CANCER; CRC]
FBgn0027453	Dnz1	HGNC:20749	OMIM:617972	ZDHHC20	3		
FBgn0027453	Dnz1	HGNC:18470	OMIM:617150	ZDHHC3	3		
FBgn0027453	Dnz1	HGNC:18459	OMIM:614604	ZDHHC7	3		
FBgn0027453	Dnz1	HGNC:20342	OMIM:300576	ZDHHC15	3		
FBgn0027453	Dnz1	HGNC:18469	OMIM:618621	ZDHHC2	3		
FBgn0027453	Dnz1	HGNC:20750	OMIM:614605	ZDHHC21	4		
FBgn0069354	Porin2	HGNC:12669	OMIM:604492	VDAC1	7		
FBgn0069354	Porin2	HGNC:12672	OMIM:193245	VDAC2	7		
FBgn0069354	Porin2	HGNC:12674	OMIM:610029	VDAC3	8		
FBgn0032305	CG6700	HGNC:15500	OMIM:616575	LENG8	11		
FBgn0032298	CG6724	HGNC:14098	OMIM:616620	WDR12	14		
FBgn0032339	Wdr59	HGNC:25706	OMIM:617418	WDR59	12		
FBgn0032348	CG4751	HGNC:25934		MPND	7		
FBgn0040211	hgo	HGNC:4892	OMIM:607474	HGD	15	203500	203500[ALKAPTONURIA; AKU]
FBgn0032358	Ppt2	HGNC:9326	OMIM:603298	PPT2	13		
FBgn0020270	mre11	HGNC:7230	OMIM:600814	MRE11	15	604391	604391[ATAXIA-TELANGIECTASIA-LIKE DISORDER 1; ATLD1]
FBgn0040232	cmet	HGNC:1856	OMIM:117143	CENPE	9	616051	616051[MICROCEPHALY 13, PRIMARY, AUTOSOMAL RECESSIVE; MCPH13]
FBgn0032350	CG6287	HGNC:2495	OMIM:602619	CTBP2	3		
FBgn0032350	CG6287	HGNC:8923	OMIM:606879	PHGDH	14	256520,601815	256520[NEU-LAXOVA SYNDROME 1; NLS1],601815[PHOSPHOGLYCERATE DEHYDROGENASE DEFICIENCY; PHGDHD]
FBgn0010197	Gyc32E	HGNC:7943	OMIM:108960	NPR1	4		
FBgn0010197	Gyc32E	HGNC:7944	OMIM:108961	NPR2	5	602875,615923,616255	602875[ACROMESOMELIC DYSPLASIA 1; AMD1],615923[EPIPHYSEAL CHONDRODYSPLASIA, MIURA TYPE; ECDM],616255[SHORT STATURE WITH NONSPECIFIC SKELETAL ABNORMALITIES; SNSK]
FBgn0010197	Gyc32E	HGNC:4691	OMIM:300041	GUCY2F	5		
FBgn0010197	Gyc32E	HGNC:4689	OMIM:600179	GUCY2D	3	204000,215500,601777,618555	204000[LEBER CONGENITAL AMAUROSIS 1; LCA1],215500[CHOROIDAL DYSTROPHY, CENTRAL AREOLAR, 1; CACD1],601777[CONE-ROD DYSTROPHY 6; CORD6],618555[NIGHT BLINDNESS, CONGENITAL STATIONARY, TYPE1I; CSNB1I]
FBgn0010197	Gyc32E	HGNC:4688	OMIM:601330	GUCY2C	4	614616,614665	614616[DIARRHEA 6; DIAR6],614665[MECONIUM ILEUS]
FBgn0028700	RfC38	HGNC:9971	OMIM:600405	RFC3	13		
FBgn0032346	Csl4	HGNC:17286	OMIM:606493	EXOSC1	15	619304	619304[PONTOCEREBELLAR HYPOPLASIA, TYPE 1F; PCH1F]
FBgn0032345	Dnaaf4	HGNC:21493	OMIM:608706	DNAAF4	7	127700,615482	127700[DYSLEXIA, SUSCEPTIBILITY TO, 1; DYX1],615482[CILIARY DYSKINESIA, PRIMARY, 25; CILD25]
FBgn0027582	CG6230	HGNC:24215	OMIM:619118	ATP13A1	15		
FBgn0032343	Idua	HGNC:5391	OMIM:252800	IDUA	14	607014,607015,607016	607014[HURLER SYNDROME],607015[HURLER-SCHEIE SYNDROME],607016[SCHEIE SYNDROME]
FBgn0032341	Reps	HGNC:15578	OMIM:614825	REPS1	12	617916	617916[NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 7; NBIA7]
FBgn0032341	Reps	HGNC:9963	OMIM:300317	REPS2	10		
FBgn0000287	salr	HGNC:10524	OMIM:602218	SALL1	10	107480	107480[TOWNES-BROCKS SYNDROME 1; TBS1]
FBgn0000287	salr	HGNC:10527	OMIM:605079	SALL3	8		
FBgn0000287	salr	HGNC:10526	OMIM:602219	SALL2	8	216820	216820[COLOBOMA, OCULAR, AUTOSOMAL RECESSIVE]
FBgn0000287	salr	HGNC:15924	OMIM:607343	SALL4	9	147750,607323	147750[IVIC SYNDROME; IVIC],607323[DUANE-RADIAL RAY SYNDROME; DRRS]
FBgn0032363	Dlg5	HGNC:2904	OMIM:604090	DLG5	12		
FBgn0032372	CG4988	HGNC:24063	OMIM:137030	GALM	12	618881	618881[GALACTOSEMIA IV; GALAC4]
FBgn0032373	Vha100-5	HGNC:865	OMIM:192130	ATP6V0A1	7	619970,619971	619970[DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 104; DEE104],619971[NEURODEVELOPMENTAL DISORDER WITH EPILEPSY AND BRAIN ATROPHY; NEDEBA]
FBgn0032373	Vha100-5	HGNC:18481	OMIM:611716	ATP6V0A2	6	219200,278250	219200[CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IIA; ARCL2A],278250[WRINKLY SKIN SYNDROME; WSS]
FBgn0032373	Vha100-5	HGNC:866	OMIM:605239	ATP6V0A4	7	602722	602722[RENAL TUBULAR ACIDOSIS, DISTAL, 3, WITH OR WITHOUT SENSORINEURAL HEARING LOSS; DRTA3]
FBgn0032373	Vha100-5	HGNC:11647	OMIM:604592	TCIRG1	5	259700	259700[OSTEOPETROSIS, AUTOSOMAL RECESSIVE 1; OPTB1]
FBgn0032378	CycY	HGNC:26868		CCNYL1	11		
FBgn0032378	CycY	HGNC:23354	OMIM:612786	CCNY	12		
FBgn0032378	CycY	HGNC:33206		CCNYL3	3		
FBgn0032378	CycY	HGNC:23495		CCNYL2	3		
FBgn0020309	crol	HGNC:24737	OMIM:613904	ZNF569	3		
FBgn0032368	spag4	HGNC:11214	OMIM:603038	SPAG4	3		
FBgn0032368	spag4	HGNC:18587	OMIM:607723	SUN1	3		
FBgn0032368	spag4	HGNC:22429	OMIM:618984	SUN3	3		
FBgn0032368	spag4	HGNC:14210	OMIM:613569	SUN2	3		
FBgn0032368	spag4	HGNC:16252	OMIM:613942	SUN5	3	617187	617187[SPERMATOGENIC FAILURE 16; SPGF16]
FBgn0051704	CG31704	HGNC:11244	OMIM:167790	SPINK1	4	167800,608189	167800[PANCREATITIS, HEREDITARY; PCTT],608189[TROPICAL CALCIFIC PANCREATITIS]
FBgn0051704	CG31704	HGNC:32951	OMIM:613511	SPINK9	4		
FBgn0051704	CG31704	HGNC:11245	OMIM:605753	SPINK2	6	618091	618091[SPERMATOGENIC FAILURE 29; SPGF29]
FBgn0051704	CG31704	HGNC:24643	OMIM:617288	SPINK7	4		
FBgn0032381	Mal-B1	HGNC:11026	OMIM:158070	SLC3A2	3		
FBgn0032381	Mal-B1	HGNC:11025	OMIM:104614	SLC3A1	12	220100	220100[CYSTINURIA]
FBgn0032382	Mal-B2	HGNC:11026	OMIM:158070	SLC3A2	4		
FBgn0032382	Mal-B2	HGNC:11025	OMIM:104614	SLC3A1	12	220100	220100[CYSTINURIA]
FBgn0032387	CG16965	HGNC:26210	OMIM:617032	PGGHG	14		
FBgn0051866	Ada1-2	HGNC:30631	OMIM:612763	TADA1	13		
FBgn0051864	Qtzl	HGNC:15910	OMIM:603485	NFS1	3	619386	619386[COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 52; COXPD52]
FBgn0051865	Ada1-1	HGNC:30631	OMIM:612763	TADA1	12		
FBgn0032393	Nfs1	HGNC:15910	OMIM:603485	NFS1	13	619386	619386[COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 52; COXPD52]
FBgn0014019	Rh5	HGNC:14449	OMIM:606665	OPN4	5		
FBgn0010497	dmGlut	HGNC:20151	OMIM:607557	SLC17A8	4	605583	605583[DEAFNESS, AUTOSOMAL DOMINANT 25; DFNA25]
FBgn0010497	dmGlut	HGNC:10933	OMIM:604322	SLC17A5	4	269920,604369	269920[INFANTILE SIALIC ACID STORAGE DISEASE; ISSD],604369[SALLA DISEASE; SD]
FBgn0010497	dmGlut	HGNC:16703	OMIM:607563	SLC17A6	4		
FBgn0010497	dmGlut	HGNC:16704	OMIM:605208	SLC17A7	4		
FBgn0010497	dmGlut	HGNC:10929	OMIM:182308	SLC17A1	4		
FBgn0010497	dmGlut	HGNC:10932	OMIM:604216	SLC17A4	5		
FBgn0010497	dmGlut	HGNC:10930	OMIM:611049	SLC17A2	5		
FBgn0010497	dmGlut	HGNC:10931	OMIM:611034	SLC17A3	6	612671	612671[URIC ACID CONCENTRATION, SERUM, QUANTITATIVE TRAIT LOCUS 4; UAQTL4]
FBgn0042126	CG18788	HGNC:20151	OMIM:607557	SLC17A8	3	605583	605583[DEAFNESS, AUTOSOMAL DOMINANT 25; DFNA25]
FBgn0042126	CG18788	HGNC:10933	OMIM:604322	SLC17A5	3	269920,604369	269920[INFANTILE SIALIC ACID STORAGE DISEASE; ISSD],604369[SALLA DISEASE; SD]
FBgn0042126	CG18788	HGNC:16703	OMIM:607563	SLC17A6	3		
FBgn0042126	CG18788	HGNC:16704	OMIM:605208	SLC17A7	3		
FBgn0042126	CG18788	HGNC:10929	OMIM:182308	SLC17A1	3		
FBgn0042126	CG18788	HGNC:10932	OMIM:604216	SLC17A4	4		
FBgn0042126	CG18788	HGNC:10930	OMIM:611049	SLC17A2	4		
FBgn0042126	CG18788	HGNC:10931	OMIM:611034	SLC17A3	4	612671	612671[URIC ACID CONCENTRATION, SERUM, QUANTITATIVE TRAIT LOCUS 4; UAQTL4]
FBgn0032402	PLCXD	HGNC:23148	OMIM:300974	PLCXD1	4		
FBgn0032402	PLCXD	HGNC:26462	OMIM:617015	PLCXD2	4		
FBgn0032402	PLCXD	HGNC:31822	OMIM:617016	PLCXD3	4		
FBgn0032404	RpL7-like	HGNC:21370	OMIM:617417	RPL7L1	3		
FBgn0032404	RpL7-like	HGNC:10363	OMIM:604166	RPL7	4		
FBgn0027505	Rab3-GAP	HGNC:17168	OMIM:609275	RAB3GAP2	15	212720,614225	212720[MARTSOLF SYNDROME 1; MARTS1],614225[WARBURG MICRO SYNDROME 2; WARBM2]
FBgn0032400	CG6770	HGNC:44164		NUPR2	5		
FBgn0032400	CG6770	HGNC:29990	OMIM:614812	NUPR1	8		
FBgn0032398	CG6766	HGNC:25222	OMIM:611229	ERLEC1	14		
FBgn0032398	CG6766	HGNC:16994	OMIM:609677	OS9	3		
FBgn0032397	Tom70	HGNC:11985	OMIM:606081	TOMM70	15		
FBgn0032395	Wdr81	HGNC:26600	OMIM:614218	WDR81	14	610185,617967	610185[CEREBELLAR ATAXIA, MENTAL RETARDATION, AND DYSEQUILIBRIUM SYNDROME 2; CAMRQ2],617967[HYDROCEPHALUS, CONGENITAL, 3, WITH BRAIN ANOMALIES; HYC3]
FBgn0032394	Hacd1	HGNC:24175	OMIM:615940	HACD3	3		
FBgn0032394	Hacd1	HGNC:9639	OMIM:610467	HACD1	13	619967	619967[MYOPATHY, CONGENITAL, NONPROGRESSIVE; MYONP]
FBgn0032394	Hacd1	HGNC:9640	OMIM:615939	HACD2	14		
FBgn0032394	Hacd1	HGNC:20920	OMIM:615941	HACD4	3		
FBgn0042125	CG18787	HGNC:17010	OMIM:619998	NUP42	6		
FBgn0042127	CG18789	HGNC:17010	OMIM:619998	NUP42	5		
FBgn0000588	esc	HGNC:3188	OMIM:605984	EED	13	617561	617561[COHEN-GIBSON SYNDROME; COGIS]
FBgn0032407	Pex19	HGNC:9713	OMIM:600279	PEX19	12	614886	614886[PEROXISOME BIOGENESIS DISORDER 12A (ZELLWEGER); PBD12A]
FBgn0028707	Mt2	HGNC:2977	OMIM:602478	TRDMT1	13		
FBgn0032409	Ced-12	HGNC:17289	OMIM:606422	ELMO3	10		
FBgn0032409	Ced-12	HGNC:17233	OMIM:606421	ELMO2	11	606893	606893[VASCULAR MALFORMATION, PRIMARY INTRAOSSEOUS; VMPI]
FBgn0032409	Ced-12	HGNC:16286	OMIM:606420	ELMO1	13		
FBgn0027081	ThrRS	HGNC:11572	OMIM:187790	TARS	14	618546	618546[TRICHOTHIODYSTROPHY 7, NONPHOTOSENSITIVE; TTD7]
FBgn0027081	ThrRS	HGNC:24728		TARSL2	11		
FBgn0027081	ThrRS	HGNC:30740	OMIM:612805	TARS2	6	615918	615918[COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 21; COXPD21]
FBgn0051760	CG31760	HGNC:31371	OMIM:614515	GPR179	7	614565	614565[NIGHT BLINDNESS, CONGENITAL STATIONARY, TYPE 1E; CSNB1E]
FBgn0051760	CG31760	HGNC:23689	OMIM:614573	GPR158	6		
FBgn0051860	ZnT33D	HGNC:20303	OMIM:611145	SLC30A8	8	125853	125853[TYPE 2 DIABETES MELLITUS; T2D]
FBgn0051860	ZnT33D	HGNC:11015	OMIM:602095	SLC30A4	3		
FBgn0051860	ZnT33D	HGNC:11013	OMIM:609617	SLC30A2	10	608118	608118[ZINC DEFICIENCY, TRANSIENT NEONATAL; TNZD]
FBgn0051860	ZnT33D	HGNC:11014	OMIM:602878	SLC30A3	9		
FBgn0000114	bru1	HGNC:14058	OMIM:612680	CELF5	3		
FBgn0000114	bru1	HGNC:11967	OMIM:612678	CELF3	4		
FBgn0000114	bru1	HGNC:14059	OMIM:612681	CELF6	4		
FBgn0000114	bru1	HGNC:2550	OMIM:602538	CELF2	14	619561	619561[DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 97; DEE97]
FBgn0000114	bru1	HGNC:2549	OMIM:601074	CELF1	14		
FBgn0000114	bru1	HGNC:14015	OMIM:612679	CELF4	4		
FBgn0051759	CG31759	HGNC:18042	OMIM:618069	CNOT6L	3		
FBgn0051759	CG31759	HGNC:14099	OMIM:608951	CNOT6	3		
FBgn0051759	CG31759	HGNC:25386	OMIM:616519	PDE12	12		
FBgn0051759	CG31759	HGNC:14254	OMIM:608468	NOCT	3		
FBgn0032424	CG17010	HGNC:30325	OMIM:611132	RBKS	12		
FBgn0032415	rho-6	HGNC:16083	OMIM:608962	RHBDL2	3		
FBgn0032415	rho-6	HGNC:20561	OMIM:614403	RHBDF1	3		
FBgn0032415	rho-6	HGNC:10007	OMIM:603264	RHBDL1	5		
FBgn0032415	rho-6	HGNC:16502	OMIM:619017	RHBDL3	6		
FBgn0015797	Rab6	HGNC:16525	OMIM:612909	RAB6C	7		
FBgn0015797	Rab6	HGNC:14902	OMIM:615852	RAB6B	10		
FBgn0015797	Rab6	HGNC:9786	OMIM:179513	RAB6A	13		
FBgn0015797	Rab6	HGNC:18293		RAB41	6		
FBgn0015797	Rab6	HGNC:30272		RAB6D	3		
FBgn0029137	Patsas	HGNC:18412	OMIM:607799	ZDHHC17	5		
FBgn0029137	Patsas	HGNC:18413	OMIM:612815	ZDHHC13	3		
FBgn0029137	Patsas	HGNC:18471		ZDHHC4	3		
FBgn0032408	CG6712	HGNC:30350		RPF1	14		
FBgn0041195	Pkd2	HGNC:9011	OMIM:604532	PKD2L1	11		
FBgn0041195	Pkd2	HGNC:9012	OMIM:604669	PKD2L2	9		
FBgn0041195	Pkd2	HGNC:9009	OMIM:173910	PKD2	11	613095	613095[POLYCYSTIC KIDNEY DISEASE 2 WITH OR WITHOUT POLYCYSTIC LIVER DISEASE; PKD2]
FBgn0032428	Fam92	HGNC:24781	OMIM:617274	CIBAR2	9		
FBgn0032428	Fam92	HGNC:30452	OMIM:617273	FAM92A	12	618219	618219[POLYDACTYLY, POSTAXIAL, TYPE A9; PAPA9]
FBgn0032430	Trm1	HGNC:25980	OMIM:611669	TRMT1	15	618302	618302[INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 68; MRT68]
FBgn0032430	Trm1	HGNC:16782	OMIM:611673	TRMT1L	3		
FBgn0020443	eRF3	HGNC:4622	OMIM:300418	GSPT2	12		
FBgn0020443	eRF3	HGNC:4621	OMIM:139259	GSPT1	14		
FBgn0032435	Oatp33Eb	HGNC:23612	OMIM:609013	SLCO4C1	3		
FBgn0032435	Oatp33Eb	HGNC:10953	OMIM:612436	SLCO4A1	4		
FBgn0032435	Oatp33Eb	HGNC:23613	OMIM:613365	SLCO6A1	3		
FBgn0032435	Oatp33Eb	HGNC:10962	OMIM:604988	SLCO2B1	3		
FBgn0032435	Oatp33Eb	HGNC:10956	OMIM:602883	SLCO1A2	4		
FBgn0032435	Oatp33Eb	HGNC:10959	OMIM:604843	SLCO1B1	3	237450	237450[HYPERBILIRUBINEMIA, ROTOR TYPE; HBLRR]
FBgn0032435	Oatp33Eb	HGNC:10961	OMIM:605495	SLCO1B3	3	237450	237450[HYPERBILIRUBINEMIA, ROTOR TYPE; HBLRR]
FBgn0032435	Oatp33Eb	HGNC:13819	OMIM:613389	SLCO1C1	4		
FBgn0032435	Oatp33Eb	HGNC:32934	OMIM:619875	SLCO1B7	3		
FBgn0032439	Ref2	HGNC:19071	OMIM:604171	ALYREF	6		
FBgn0051858	t-cup	HGNC:16090	OMIM:300435	PGRMC1	4		
FBgn0051858	t-cup	HGNC:16089	OMIM:607735	PGRMC2	5		
FBgn0032434	CG5421	HGNC:868	OMIM:300197	ATP6AP1	3	300972	300972[IMMUNODEFICIENCY 47; IMD47]
FBgn0032434	CG5421	HGNC:28091		ATP6AP1L	3		
FBgn0032433	Oatp33Ea	HGNC:23612	OMIM:609013	SLCO4C1	3		
FBgn0032433	Oatp33Ea	HGNC:10953	OMIM:612436	SLCO4A1	3		
FBgn0032433	Oatp33Ea	HGNC:23613	OMIM:613365	SLCO6A1	3		
FBgn0032433	Oatp33Ea	HGNC:10955	OMIM:601460	SLCO2A1	3	167100,614441	167100[HYPERTROPHIC OSTEOARTHROPATHY, PRIMARY, AUTOSOMAL DOMINANT; PHOAD],614441[HYPERTROPHIC OSTEOARTHROPATHY, PRIMARY, AUTOSOMAL RECESSIVE, 2; PHOAR2]
FBgn0032433	Oatp33Ea	HGNC:10962	OMIM:604988	SLCO2B1	3		
FBgn0032433	Oatp33Ea	HGNC:10952	OMIM:612435	SLCO3A1	4		
FBgn0032433	Oatp33Ea	HGNC:10956	OMIM:602883	SLCO1A2	4		
FBgn0032433	Oatp33Ea	HGNC:10959	OMIM:604843	SLCO1B1	3	237450	237450[HYPERBILIRUBINEMIA, ROTOR TYPE; HBLRR]
FBgn0032433	Oatp33Ea	HGNC:10961	OMIM:605495	SLCO1B3	3	237450	237450[HYPERBILIRUBINEMIA, ROTOR TYPE; HBLRR]
FBgn0032433	Oatp33Ea	HGNC:13819	OMIM:613389	SLCO1C1	4		
FBgn0032433	Oatp33Ea	HGNC:32934	OMIM:619875	SLCO1B7	3		
FBgn0032431	CG5435	HGNC:32331	OMIM:618682	C1orf194	10		
FBgn0032429	CG5446	HGNC:5203	OMIM:604553	HSBP1	12		
FBgn0032429	CG5446	HGNC:37243		HSBP1L1	4		
FBgn0004394	pdm2	HGNC:9217	OMIM:300039	POU3F4	3	304400	304400[DEAFNESS, X-LINKED 2; DFNX2]
FBgn0004394	pdm2	HGNC:9214	OMIM:602479	POU3F1	3		
FBgn0004394	pdm2	HGNC:9212	OMIM:164175	POU2F1	4		
FBgn0004394	pdm2	HGNC:9221	OMIM:164177	POU5F1	3		
FBgn0004394	pdm2	HGNC:9216	OMIM:602480	POU3F3	3	618604	618604[SNIJDERS BLOK-FISHER SYNDROME; SNIBFIS]
FBgn0004394	pdm2	HGNC:19864	OMIM:607394	POU2F3	7		
FBgn0004394	pdm2	HGNC:9223	OMIM:615739	POU5F1B	3		
FBgn0004394	pdm2	HGNC:9213	OMIM:164176	POU2F2	6		
FBgn0004394	pdm2	HGNC:26367		POU5F2	3		
FBgn0032445	CG6153	HGNC:25022	OMIM:618784	PITHD1	14		
FBgn0032447	PICK1	HGNC:9394	OMIM:605926	PICK1	13		
FBgn0032451	spict	HGNC:17044	OMIM:608146	NIPA2	12		
FBgn0032451	spict	HGNC:28018	OMIM:609383	NIPAL4	10	612281	612281[ICHTHYOSIS, CONGENITAL, AUTOSOMAL RECESSIVE 6; ARCI6]
FBgn0032451	spict	HGNC:27194		NIPAL1	11		
FBgn0032451	spict	HGNC:17043	OMIM:608145	NIPA1	4	600363	600363[SPASTIC PARAPLEGIA 6, AUTOSOMAL DOMINANT; SPG6]
FBgn0032451	spict	HGNC:25233		NIPAL3	4		
FBgn0032451	spict	HGNC:25854		NIPAL2	3		
FBgn0032453	CG6180	HGNC:8630	OMIM:604591	PEBP1	10		
FBgn0032453	CG6180	HGNC:28319	OMIM:612473	PEBP4	5		
FBgn0032457	CG15483	HGNC:15685	OMIM:605517	B4GAT1	7	615287	615287[MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 13; MDDGA13]
FBgn0032457	CG15483	HGNC:16522	OMIM:609709	LARGE2	4		
FBgn0032457	CG15483	HGNC:6511	OMIM:603590	LARGE1	3	608840,613154	608840[MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH IMPAIRED INTELLECTUAL DEVELOPMENT), TYPE B, 6; MDDGB6],613154[MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 6; MDDGA6]
FBgn0032450	CG5776	HGNC:8070	OMIM:602426	NVL	3		
FBgn0032450	CG5776	HGNC:12666	OMIM:601023	VCP	4	167320,613954,616687	167320[INCLUSION BODY MYOPATHY WITH EARLY-ONSET PAGET DISEASE WITH OR WITHOUT FRONTOTEMPORAL DEMENTIA 1; IBMPFD1],613954[FRONTOTEMPORAL DEMENTIA AND/OR AMYOTROPHIC LATERAL SCLEROSIS 6; FTDALS6],616687[CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2Y; CMT2Y]
FBgn0032450	CG5776	HGNC:18119	OMIM:613940	SPATA5	11	616577	616577[NEURODEVELOPMENTAL DISORDER WITH HEARING LOSS, SEIZURES, AND BRAIN ABNORMALITIES; NEDHSB]
FBgn0032450	CG5776	HGNC:28762	OMIM:619578	SPATA5L1	3	619615,619616	619615[DEAFNESS, AUTOSOMAL RECESSIVE 119; DFNB119],619616[NEURODEVELOPMENTAL DISORDER WITH HEARING LOSS AND SPASTICITY; NEDHLS]
FBgn0032449	CG17036	HGNC:10937	OMIM:600424	SLC19A1	11	601775	601775[MEGALOBLASTIC ANEMIA, FOLATE-RESPONSIVE; MEGAF]
FBgn0032449	CG17036	HGNC:10938	OMIM:603941	SLC19A2	15	249270	249270[THIAMINE-RESPONSIVE MEGALOBLASTIC ANEMIA SYNDROME; TRMA]
FBgn0032449	CG17036	HGNC:16266	OMIM:606152	SLC19A3	12	607483	607483[THIAMINE METABOLISM DYSFUNCTION SYNDROME 2 (BIOTIN- OR THIAMINE-RESPONSIVE TYPE); THMD2]
FBgn0032449	CG17036	HGNC:25344		C2orf83	3		
FBgn0032446	IFT43	HGNC:29669	OMIM:614068	IFT43	11	614099,617866,617871	614099[CRANIOECTODERMAL DYSPLASIA 3; CED3],617866[SHORT-RIB THORACIC DYSPLASIA 18 WITH POLYDACTYLY; SRTD18],617871[RETINITIS PIGMENTOSA 81; RP81]
FBgn0032444	CCT4	HGNC:1617	OMIM:605142	CCT4	13		
FBgn0032442	Nepl7	HGNC:8918	OMIM:300550	PHEX	3	307800	307800[HYPOPHOSPHATEMIC RICKETS, X-LINKED DOMINANT; XLHR]
FBgn0032442	Nepl7	HGNC:14668	OMIM:618104	MMEL1	3		
FBgn0032442	Nepl7	HGNC:7154	OMIM:120520	MME	3	617017,617018	617017[CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2T; CMT2T],617018[SPINOCEREBELLAR ATAXIA 43; SCA43]
FBgn0032442	Nepl7	HGNC:13275	OMIM:610145	ECE2	3		
FBgn0032442	Nepl7	HGNC:3147	OMIM:605896	ECEL1	3	615065	615065[ARTHROGRYPOSIS, DISTAL, TYPE 5D; DA5D]
FBgn0032442	Nepl7	HGNC:3146	OMIM:600423	ECE1	3	145500,613870	145500[HYPERTENSION, ESSENTIAL],613870[HIRSCHSPRUNG DISEASE, CARDIAC DEFECTS, AND AUTONOMIC DYSFUNCTION; HCAD]
FBgn0032442	Nepl7	HGNC:6308	OMIM:613883	KEL	6	110900	110900[BLOOD GROUP--KELL SYSTEM; KEL]
FBgn0040509	ACXB	HGNC:235	OMIM:600292	ADCY4	5		
FBgn0040509	ACXB	HGNC:238	OMIM:600385	ADCY7	5		
FBgn0040509	ACXB	HGNC:233	OMIM:103071	ADCY2	6		
FBgn0040510	ACXA	HGNC:235	OMIM:600292	ADCY4	5		
FBgn0040510	ACXA	HGNC:238	OMIM:600385	ADCY7	5		
FBgn0040510	ACXA	HGNC:233	OMIM:103071	ADCY2	5		
FBgn0040506	ACXE	HGNC:235	OMIM:600292	ADCY4	5		
FBgn0040506	ACXE	HGNC:238	OMIM:600385	ADCY7	5		
FBgn0040506	ACXE	HGNC:233	OMIM:103071	ADCY2	5		
FBgn0040506	ACXE	HGNC:239	OMIM:103070	ADCY8	3		
FBgn0032464	Vha68-3	HGNC:851	OMIM:607027	ATP6V1A	8	617403,618012	617403[CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IID; ARCL2D],618012[DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 93; DEE93]
FBgn0021796	Tor	HGNC:3942	OMIM:601231	MTOR	15	607341,616638	607341[FOCAL CORTICAL DYSPLASIA, TYPE II; FCORD2],616638[SMITH-KINGSMORE SYNDROME; SKS]
FBgn0032470	Ttc30	HGNC:26425		TTC30B	13		
FBgn0032470	Ttc30	HGNC:25853		TTC30A	11		
FBgn0032467	Ube4B	HGNC:12500	OMIM:613565	UBE4B	14		
FBgn0032465	Yip1d1	HGNC:24877	OMIM:611483	YIPF5	15	619278	619278[MICROCEPHALY, EPILEPSY, AND DIABETES SYNDROME 2; MEDS2]
FBgn0032465	Yip1d1	HGNC:26825	OMIM:619754	YIPF7	12		
FBgn0032471	CG5122	HGNC:2342	OMIM:600184	CRAT	7	617917	617917[NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 8; NBIA8]
FBgn0032471	CG5122	HGNC:1912	OMIM:118490	CHAT	4	254210	254210[MYASTHENIC SYNDROME, CONGENITAL, 6, PRESYNAPTIC; CMS6]
FBgn0028410	Pk34A	HGNC:4617	OMIM:605004	GSK3B	3		
FBgn0028410	Pk34A	HGNC:4616	OMIM:606784	GSK3A	4		
FBgn0032473	kmg	HGNC:21684	OMIM:617371	ZNF462	3	618619	618619[WEISS-KRUSZKA SYNDROME; WSKA]
FBgn0024291	Sirt1	HGNC:14931	OMIM:604481	SIRT3	4		
FBgn0024291	Sirt1	HGNC:14929	OMIM:604479	SIRT1	12		
FBgn0024291	Sirt1	HGNC:10886	OMIM:604480	SIRT2	3		
FBgn0032476	CG5439	HGNC:30542		SNX29	9		
FBgn0032477	Alg7	HGNC:2995	OMIM:191350	DPAGT1	14	608093,614750	608093[CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Ij; CDG1J],614750[MYASTHENIC SYNDROME, CONGENITAL, 13; CMS13]
FBgn0032478	Rsph1	HGNC:12371	OMIM:609314	RSPH1	11	615481	615481[CILIARY DYSKINESIA, PRIMARY, 24; CILD24]
FBgn0032480	Edem2	HGNC:18967	OMIM:607673	EDEM1	3		
FBgn0032480	Edem2	HGNC:16787	OMIM:610214	EDEM3	13	619493	619493[CONGENITAL DISORDER OF GLYCOSYLATION, TYPE 2v; CDG2V]
FBgn0032482	Pect	HGNC:8756	OMIM:602679	PCYT2	14	618770	618770[SPASTIC PARAPLEGIA 82, AUTOSOMAL RECESSIVE; SPG82]
FBgn0032486	mRF1	HGNC:21051	OMIM:613542	MTRF1L	14		
FBgn0032486	mRF1	HGNC:7469	OMIM:604601	MTRF1	8		
FBgn0032488	CG16812	HGNC:26723		C19orf47	10		
FBgn0032492	Prosalpha6T	HGNC:9530	OMIM:602854	PSMA1	15		
FBgn0051851	Naa20B	HGNC:15908	OMIM:610833	NAA20	5	619717	619717[INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 73; MRT73]
FBgn0032499	Uvrag	HGNC:12640	OMIM:602493	UVRAG	10		
FBgn0051729	CG31729	HGNC:13540	OMIM:609126	ATP9A	12		
FBgn0051729	CG31729	HGNC:13541	OMIM:614446	ATP9B	13		
FBgn0032509	CG6523	HGNC:15987	OMIM:612754	GLRX3	13		
FBgn0051852	Tap42	HGNC:5461	OMIM:300139	IGBP1	15	300472	300472[CORPUS CALLOSUM, AGENESIS OF, WITH IMPAIRED INTELLECTUAL DEVELOPMENT, OCULAR COLOBOMA, AND MICROGNATHIA]
FBgn0051855	CG31855	HGNC:28360		DDA1	13		
FBgn0032513	CG6565	HGNC:18063	OMIM:616712	STARD7	13	607876	607876[EPILEPSY, FAMILIAL ADULT MYOCLONIC, 2; FAME2]
FBgn0025724	beta'COP	HGNC:2232	OMIM:606990	COPB2	13	617800,619884	617800[MICROCEPHALY 19, PRIMARY, AUTOSOMAL RECESSIVE; MCPH19],619884[OSTEOPOROSIS, CHILDHOOD- OR JUVENILE-ONSET, WITH DEVELOPMENTAL DELAY; OPDD]
FBgn0032514	CG9302	HGNC:24811	OMIM:616942	PDIA5	14		
FBgn0032512	Bdp1	HGNC:13652	OMIM:607012	BDP1	8	618257	618257[DEAFNESS, AUTOSOMAL RECESSIVE 112; DFNB112]
FBgn0032511	ND-B22	HGNC:7704	OMIM:601445	NDUFB9	15	618245	618245[MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 24; MC1DN24]
FBgn0022069	Nnp-1	HGNC:23818	OMIM:610654	RRP1B	12		
FBgn0022069	Nnp-1	HGNC:18785	OMIM:610653	RRP1	12		
FBgn0028406	Drep4	HGNC:2773	OMIM:601883	DFFB	13		
FBgn0051730	CG31730	HGNC:15908	OMIM:610833	NAA20	5	619717	619717[INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 73; MRT73]
FBgn0032487	Ski6	HGNC:18189	OMIM:606491	EXOSC4	14		
FBgn0032485	CG9426	HGNC:6108	OMIM:147485	IPP	13		
FBgn0032484	kek4	HGNC:28947		LRRC24	3		
FBgn0051849	Mgat3	HGNC:7046	OMIM:604621	MGAT3	13		
FBgn0032475	Sfmbt	HGNC:19866	OMIM:618705	MBTD1	12		
FBgn0032475	Sfmbt	HGNC:18594	OMIM:611865	L3MBTL2	10		
FBgn0032474	DnaJ-H	HGNC:14885		DNAJA4	3		
FBgn0032474	DnaJ-H	HGNC:14884	OMIM:611322	DNAJA2	3		
FBgn0032517	CG7099	HGNC:4664	OMIM:603246	GTF3C1	11		
FBgn0032522	CG16848	HGNC:24671	OMIM:610595	FLAD1	11	255100	255100[LIPID STORAGE MYOPATHY DUE TO FLAVIN ADENINE DINUCLEOTIDE SYNTHETASE DEFICIENCY; LSMFLAD]
FBgn0026760	Tehao	HGNC:11851	OMIM:603031	TLR5	3	601744,608556,615557	601744[SYSTEMIC LUPUS ERYTHEMATOSUS, SUSCEPTIBILITY TO, 1; SLEB1],608556[LEGIONNAIRE DISEASE, SUSCEPTIBILITY TO],615557[MELIOIDOSIS, SUSCEPTIBILITY TO]
FBgn0026760	Tehao	HGNC:11850	OMIM:603030	TLR4	4		
FBgn0026760	Tehao	HGNC:15634	OMIM:606270	TLR10	3		
FBgn0026760	Tehao	HGNC:11848	OMIM:603028	TLR2	3	114500,246300,607948	114500[COLORECTAL CANCER; CRC],246300[LEPROSY, SUSCEPTIBILITY TO, 3; LPRS3],607948[MYCOBACTERIUM TUBERCULOSIS, SUSCEPTIBILITY TO]
FBgn0026760	Tehao	HGNC:11847	OMIM:601194	TLR1	3	613223	613223[LEPROSY, SUSCEPTIBILITY TO, 5; LPRS5]
FBgn0026760	Tehao	HGNC:16711	OMIM:605403	TLR6	3		
FBgn0028546	ics	HGNC:10464	OMIM:179555	RSU1	14		
FBgn0028513	CG9254	HGNC:20151	OMIM:607557	SLC17A8	3	605583	605583[DEAFNESS, AUTOSOMAL DOMINANT 25; DFNA25]
FBgn0028513	CG9254	HGNC:10933	OMIM:604322	SLC17A5	4	269920,604369	269920[INFANTILE SIALIC ACID STORAGE DISEASE; ISSD],604369[SALLA DISEASE; SD]
FBgn0028513	CG9254	HGNC:16703	OMIM:607563	SLC17A6	3		
FBgn0028513	CG9254	HGNC:16704	OMIM:605208	SLC17A7	3		
FBgn0028513	CG9254	HGNC:10929	OMIM:182308	SLC17A1	4		
FBgn0028513	CG9254	HGNC:10932	OMIM:604216	SLC17A4	5		
FBgn0028513	CG9254	HGNC:10930	OMIM:611049	SLC17A2	5		
FBgn0028513	CG9254	HGNC:10931	OMIM:611034	SLC17A3	5	612671	612671[URIC ACID CONCENTRATION, SERUM, QUANTITATIVE TRAIT LOCUS 4; UAQTL4]
FBgn0032525	Hsp60D	HGNC:5261	OMIM:118190	HSPD1	7	605280,612233	605280[SPASTIC PARAPLEGIA 13, AUTOSOMAL DOMINANT; SPG13],612233[LEUKODYSTROPHY, HYPOMYELINATING, 4; HLD4]
FBgn0032524	Hacd2	HGNC:24175	OMIM:615940	HACD3	14		
FBgn0032524	Hacd2	HGNC:20920	OMIM:615941	HACD4	6		
FBgn0032520	CG10859	HGNC:18744	OMIM:605483	DNAI2	6	612444	612444[CILIARY DYSKINESIA, PRIMARY, 9; CILD9]
FBgn0032519	CG16957	HGNC:16090	OMIM:300435	PGRMC1	8		
FBgn0032519	CG16957	HGNC:16089	OMIM:607735	PGRMC2	7		
FBgn0032518	RpL24	HGNC:10325	OMIM:604180	RPL24	14		
FBgn0032516	Ing5	HGNC:6063	OMIM:604215	ING2	4		
FBgn0032516	Ing5	HGNC:19421	OMIM:608525	ING5	14		
FBgn0032516	Ing5	HGNC:6062	OMIM:601566	ING1	4	275355	275355[SQUAMOUS CELL CARCINOMA, HEAD AND NECK; HNSCC]
FBgn0032516	Ing5	HGNC:19423	OMIM:608524	ING4	14		
FBgn0032516	Ing5	HGNC:14587	OMIM:607493	ING3	3		
FBgn0028527	CG18507	HGNC:24513		TMEM268	7		
FBgn0028848	Gpo3	HGNC:4456	OMIM:138430	GPD2	4	125853	125853[TYPE 2 DIABETES MELLITUS; T2D]
FBgn0028541	TM9SF4	HGNC:11865	OMIM:604678	TM9SF2	5		
FBgn0028541	TM9SF4	HGNC:30797	OMIM:617727	TM9SF4	14		
FBgn0024846	p38b	HGNC:6876	OMIM:600289	MAPK14	15		
FBgn0024846	p38b	HGNC:6875	OMIM:602899	MAPK13	6		
FBgn0024846	p38b	HGNC:6874	OMIM:602399	MAPK12	5		
FBgn0024846	p38b	HGNC:6873	OMIM:602898	MAPK11	12		
FBgn0028539	Eato	HGNC:37	OMIM:605414	ABCA7	4	608907	608907[ALZHEIMER DISEASE 9, SUSCEPTIBILITY TO; AD9]
FBgn0028539	Eato	HGNC:29	OMIM:600046	ABCA1	4	205400,604091	205400[TANGIER DISEASE; TGD],604091[HYPOALPHALIPOPROTEINEMIA, PRIMARY, 1]
FBgn0028539	Eato	HGNC:32	OMIM:600047	ABCA2	4	618808	618808[INTELLECTUAL DEVELOPMENTAL DISORDER WITH POOR GROWTH AND WITH OR WITHOUT SEIZURES OR ATAXIA; IDPOGSA]
FBgn0028539	Eato	HGNC:34	OMIM:601691	ABCA4	3	153800,248200,601718,604116	153800[MACULAR DEGENERATION, AGE-RELATED, 2; ARMD2],248200[STARGARDT DISEASE 1; STGD1],601718[RETINITIS PIGMENTOSA 19; RP19],604116[CONE-ROD DYSTROPHY 3; CORD3]
FBgn0028539	Eato	HGNC:33	OMIM:601615	ABCA3	5	610921	610921[SURFACTANT METABOLISM DYSFUNCTION, PULMONARY, 3; SMDP3]
FBgn0028539	Eato	HGNC:14637	OMIM:607800	ABCA12	5	242500,601277	242500[ICHTHYOSIS, CONGENITAL, AUTOSOMAL RECESSIVE 4B; ARCI4B],601277[ICHTHYOSIS, CONGENITAL, AUTOSOMAL RECESSIVE 4A; ARCI4A]
FBgn0028539	Eato	HGNC:30	OMIM:612508	ABCA10	4		
FBgn0028539	Eato	HGNC:39	OMIM:612507	ABCA9	4		
FBgn0028539	Eato	HGNC:38	OMIM:612505	ABCA8	4		
FBgn0028539	Eato	HGNC:36	OMIM:612504	ABCA6	4		
FBgn0028539	Eato	HGNC:35	OMIM:612503	ABCA5	4	135400	135400[HYPERTRICHOSIS, CONGENITAL GENERALIZED, WITH OR WITHOUT GINGIVAL HYPERPLASIA; HTC3]
FBgn0028539	Eato	HGNC:14638	OMIM:607807	ABCA13	4		
FBgn0028931	CG16863	HGNC:447	OMIM:300178	ZBED1	6		
FBgn0028931	CG16863	HGNC:33273	OMIM:613512	ZBED6	3		
FBgn0028538	Sec71	HGNC:15853	OMIM:605371	ARFGEF2	13	608097	608097[PERIVENTRICULAR HETEROTOPIA WITH MICROCEPHALY, AUTOSOMAL RECESSIVE; ARPHM]
FBgn0028538	Sec71	HGNC:4181	OMIM:603698	GBF1	3	606483	606483[CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2GG; CMT2GG]
FBgn0028538	Sec71	HGNC:15772	OMIM:604141	ARFGEF1	14	619964	619964[DEVELOPMENTAL DELAY, IMPAIRED SPEECH, AND BEHAVIORAL ABNORMALITIES, WITH OR WITHOUT SEIZURES; DEDISB]
FBgn0027844	CAH1	HGNC:1373	OMIM:611492	CA2	10	259730	259730[OSTEOPETROSIS, AUTOSOMAL RECESSIVE 3; OPTB3]
FBgn0027844	CAH1	HGNC:1381	OMIM:114770	CA7	10		
FBgn0027844	CAH1	HGNC:1368	OMIM:114800	CA1	8		
FBgn0027844	CAH1	HGNC:1377	OMIM:114761	CA5A	8	615751	615751[CARBONIC ANHYDRASE VA DEFICIENCY, HYPERAMMONEMIA DUE TO; CA5AD]
FBgn0027844	CAH1	HGNC:14914	OMIM:611436	CA13	10		
FBgn0027844	CAH1	HGNC:1374	OMIM:114750	CA3	8		
FBgn0027844	CAH1	HGNC:1375	OMIM:114760	CA4	3		
FBgn0027844	CAH1	HGNC:1378	OMIM:300230	CA5B	9		
FBgn0028919	CG16865	HGNC:26239	OMIM:301012	CXorf56	14	301013	301013[INTELLECTUAL DEVELOPMENTAL DISORDER, X-LINKED 107; XLID107]
FBgn0001965	Sos	HGNC:11188	OMIM:601247	SOS2	12	616559	616559[NOONAN SYNDROME 9; NS9]
FBgn0001965	Sos	HGNC:11187	OMIM:182530	SOS1	14	135300,610733	135300[FIBROMATOSIS, GINGIVAL, 1; GINGF1],610733[NOONAN SYNDROME 4; NS4]
FBgn0015271	Orc5	HGNC:8491	OMIM:602331	ORC5	14		
FBgn0026373	Polr2C	HGNC:9189	OMIM:180663	POLR2C	15		
FBgn0028509	CenG1A	HGNC:23463		AGAP9	4		
FBgn0028509	CenG1A	HGNC:16922	OMIM:608651	AGAP1	13		
FBgn0028509	CenG1A	HGNC:23459		AGAP4	7		
FBgn0028509	CenG1A	HGNC:23467		AGAP5	6		
FBgn0028509	CenG1A	HGNC:16923	OMIM:616813	AGAP3	11		
FBgn0028509	CenG1A	HGNC:16921	OMIM:605476	AGAP2	9		
FBgn0028509	CenG1A	HGNC:23466		AGAP6	6		
FBgn0028509	CenG1A	HGNC:29421		AGAP11	4		
FBgn0028509	CenG1A	HGNC:23659		AGAP10P	3		
FBgn0028509	CenG1A	HGNC:23465		AGAP7P	4		
FBgn0012037	Ance	HGNC:13557	OMIM:300335	ACE2	6		
FBgn0012037	Ance	HGNC:2707	OMIM:106180	ACE	10	267430,612624,614519	267430[RENAL TUBULAR DYSGENESIS; RTD],612624[MICROVASCULAR COMPLICATIONS OF DIABETES, SUSCEPTIBILITY TO, 3; MVCD3],614519[HEMORRHAGE, INTRACEREBRAL, SUSCEPTIBILITY TO; ICH]
FBgn0032535	Ance-2	HGNC:13557	OMIM:300335	ACE2	4		
FBgn0032535	Ance-2	HGNC:2707	OMIM:106180	ACE	6	267430,612624,614519	267430[RENAL TUBULAR DYSGENESIS; RTD],612624[MICROVASCULAR COMPLICATIONS OF DIABETES, SUSCEPTIBILITY TO, 3; MVCD3],614519[HEMORRHAGE, INTRACEREBRAL, SUSCEPTIBILITY TO; ICH]
FBgn0025115	Acyp	HGNC:179	OMIM:600875	ACYP1	7		
FBgn0025115	Acyp	HGNC:180	OMIM:102595	ACYP2	8		
FBgn0028544	Vajk3	HGNC:29212	OMIM:617886	ZNF512B	3		
FBgn0019890	Smg5	HGNC:24644	OMIM:610962	SMG5	13		
FBgn0001961	Arpc1	HGNC:704	OMIM:604223	ARPC1B	13	617718	617718[IMMUNODEFICIENCY 71 WITH INFLAMMATORY DISEASE AND CONGENITAL THROMBOCYTOPENIA; IMD71]
FBgn0001961	Arpc1	HGNC:703	OMIM:604220	ARPC1A	14		
FBgn0004406	PolG1	HGNC:9179	OMIM:174763	POLG	14	157640,203700,258450,607459,613662	157640[PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL DOMINANT 1; PEOA1],203700[MITOCHONDRIAL DNA DEPLETION SYNDROME 4A (ALPERS TYPE); MTDPS4A],258450[PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL RECESSIVE 1; PEOB1],607459[SENSORY ATAXIC NEUROPATHY, DYSARTHRIA, AND OPHTHALMOPARESIS; SANDO],613662[MITOCHONDRIAL DNA DEPLETION SYNDROME 4B (MNGIE TYPE); MTDPS4B]
FBgn0028658	Adat1	HGNC:227	OMIM:602065	ADARB2	4		
FBgn0028658	Adat1	HGNC:226	OMIM:601218	ADARB1	4	618862	618862[NEURODEVELOPMENTAL DISORDER WITH HYPOTONIA, MICROCEPHALY, AND SEIZURES; NEDHYMS]
FBgn0028658	Adat1	HGNC:228	OMIM:604230	ADAT1	9		
FBgn0028658	Adat1	HGNC:30714	OMIM:619532	ADAD2	3		
FBgn0028658	Adat1	HGNC:30713	OMIM:614130	ADAD1	3		
FBgn0028932	CG16890	HGNC:1162	OMIM:608866	FRA10AC1	14		
FBgn0028847	CG9014	HGNC:18401		RNF41	5		
FBgn0028847	CG9014	HGNC:23235		RNF151	5		
FBgn0051814	DIP-kappa	HGNC:17302	OMIM:613173	NEGR1	6		
FBgn0051814	DIP-kappa	HGNC:34550	OMIM:618861	IGLON5	7		
FBgn0051814	DIP-kappa	HGNC:6705	OMIM:603241	LSAMP	8		
FBgn0051814	DIP-kappa	HGNC:8143	OMIM:600632	OPCML	7	167000	167000[OVARIAN CANCER]
FBgn0051814	DIP-kappa	HGNC:17941	OMIM:607938	NTM	8		
FBgn0028940	Cyp28a5	HGNC:2638	OMIM:605325	CYP3A5	4	145500	145500[HYPERTENSION, ESSENTIAL]
FBgn0028940	Cyp28a5	HGNC:17450	OMIM:606534	CYP3A43	4		
FBgn0028940	Cyp28a5	HGNC:11609	OMIM:274180	TBXAS1	4	231095	231095[GHOSAL HEMATODIAPHYSEAL DYSPLASIA; GHDD]
FBgn0028940	Cyp28a5	HGNC:2637	OMIM:124010	CYP3A4	4	619073	619073[VITAMIN D-DEPENDENT RICKETS, TYPE 3; VDDR3]
FBgn0028940	Cyp28a5	HGNC:51504		CYP3A7-CYP3A51P	4		
FBgn0027348	bgm	HGNC:24174	OMIM:614363	ACSBG2	14		
FBgn0027348	bgm	HGNC:29567	OMIM:614362	ACSBG1	12		
FBgn0028875	nAChRalpha5	HGNC:15781	OMIM:609756	CHRFAM7A	11		
FBgn0028875	nAChRalpha5	HGNC:1960	OMIM:118511	CHRNA7	8		
FBgn0028872	CG18095	HGNC:5468	OMIM:601489	IGFALS	3	615961	615961[ACID-LABILE SUBUNIT DEFICIENCY; ACLSD]
FBgn0003255	rk	HGNC:4504	OMIM:606667	LGR5	9		
FBgn0003255	rk	HGNC:13299	OMIM:606666	LGR4	7	615311,619613	615311[BONE MINERAL DENSITY QUANTITATIVE TRAIT LOCUS 17; BMND17],619613[DELAYED PUBERTY, SELF-LIMITED; DPSL]
FBgn0003255	rk	HGNC:19719	OMIM:606653	LGR6	6		
FBgn0052971	CG32971	HGNC:11477	OMIM:185641	MED22	6		
FBgn0028916	CG33090	HGNC:18986	OMIM:609471	GBA2	15	614409	614409[SPASTIC PARAPLEGIA 46, AUTOSOMAL RECESSIVE; SPG46]
FBgn0028531	CG15286	HGNC:20589	OMIM:614719	KCMF1	5		
FBgn0015791	Rab14	HGNC:16524	OMIM:612673	RAB14	13		
FBgn0001970	Pgant35A	HGNC:19875	OMIM:615130	GALNT11	14		
FBgn0001970	Pgant35A	HGNC:21725	OMIM:615133	GALNTL5	5		
FBgn0028844	CG15283	HGNC:20957	OMIM:619198	SDHAF4	10		
FBgn0004858	elB	HGNC:25883	OMIM:617045	ZNF703	9		
FBgn0004858	elB	HGNC:23589	OMIM:613902	ZNF503	8		
FBgn0020258	ppk	HGNC:101	OMIM:611741	ASIC3	6		
FBgn0020258	ppk	HGNC:100	OMIM:602866	ASIC1	7		
FBgn0020258	ppk	HGNC:21263	OMIM:606715	ASIC4	6		
FBgn0020258	ppk	HGNC:99	OMIM:601784	ASIC2	7		
FBgn0020258	ppk	HGNC:17537	OMIM:616693	ASIC5	7		
FBgn0020258	ppk	HGNC:10600	OMIM:600760	SCNN1B	3	177200,211400,264350	177200[LIDDLE SYNDROME 1; LIDLS1],211400[BRONCHIECTASIS WITH OR WITHOUT ELEVATED SWEAT CHLORIDE 1; BESC1],264350[PSEUDOHYPOALDOSTERONISM, TYPE I, AUTOSOMAL RECESSIVE; PHA1B]
FBgn0020258	ppk	HGNC:10602	OMIM:600761	SCNN1G	3	264350,613071,618114	264350[PSEUDOHYPOALDOSTERONISM, TYPE I, AUTOSOMAL RECESSIVE; PHA1B],613071[BRONCHIECTASIS WITH OR WITHOUT ELEVATED SWEAT CHLORIDE 3; BESC3],618114[LIDDLE SYNDROME 2; LIDLS2]
FBgn0005771	noc	HGNC:25883	OMIM:617045	ZNF703	12		
FBgn0005771	noc	HGNC:23589	OMIM:613902	ZNF503	13		
FBgn0028913	CG3473	HGNC:31710		UBE2NL	6		
FBgn0028913	CG3473	HGNC:12492	OMIM:603679	UBE2N	10		
FBgn0051835	CG31835	HGNC:20589	OMIM:614719	KCMF1	5		
FBgn0028838	CSN1a	HGNC:4549	OMIM:601934	GPS1	7		
FBgn0028868	CG4701	HGNC:25903	OMIM:614452	ATAD1	13	618011	618011[HYPEREKPLEXIA 4; HKPX4]
FBgn0028887	CG3491	HGNC:29158	OMIM:615729	SBNO2	9		
FBgn0028887	CG3491	HGNC:22973	OMIM:614274	SBNO1	6		
FBgn0028886	CG15279	HGNC:11049	OMIM:126455	SLC6A3	3	188890,613135	188890[TOBACCO ADDICTION, SUSCEPTIBILITY TO],613135[PARKINSONISM-DYSTONIA 1, INFANTILE-ONSET; PKDYS1]
FBgn0028886	CG15279	HGNC:11044	OMIM:607952	SLC6A11	3		
FBgn0028886	CG15279	HGNC:31399	OMIM:610299	SLC6A17	4	616269	616269[INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 48; MRT48]
FBgn0028886	CG15279	HGNC:11045	OMIM:603080	SLC6A12	3		
FBgn0028886	CG15279	HGNC:11054	OMIM:606205	SLC6A7	4		
FBgn0028886	CG15279	HGNC:11048	OMIM:163970	SLC6A2	3	604715	604715[ORTHOSTATIC INTOLERANCE]
FBgn0028886	CG15279	HGNC:13621	OMIM:607971	SLC6A15	4		
FBgn0028886	CG15279	HGNC:11050	OMIM:182138	SLC6A4	3	164230,607834	164230[OBSESSIVE-COMPULSIVE DISORDER; OCD],607834[ANXIETY]
FBgn0028886	CG15279	HGNC:11055	OMIM:300036	SLC6A8	3	300352	300352[CEREBRAL CREATINE DEFICIENCY SYNDROME 1; CCDS1]
FBgn0028886	CG15279	HGNC:11056	OMIM:601019	SLC6A9	4	617301	617301[GLYCINE ENCEPHALOPATHY WITH NORMAL SERUM GLYCINE]
FBgn0028886	CG15279	HGNC:11051	OMIM:604159	SLC6A5	3	614618	614618[HYPEREKPLEXIA 3; HKPX3]
FBgn0028886	CG15279	HGNC:11047	OMIM:300444	SLC6A14	3		
FBgn0028886	CG15279	HGNC:11052	OMIM:186854	SLC6A6	3	145350	145350[HYPOTAURINEMIC RETINAL DEGENERATION AND CARDIOMYOPATHY; HTRDC]
FBgn0028886	CG15279	HGNC:11046	OMIM:615097	SLC6A13	3		
FBgn0028886	CG15279	HGNC:11042	OMIM:137165	SLC6A1	3	616421	616421[MYOCLONIC-ATONIC EPILEPSY; MAE]
FBgn0028886	CG15279	HGNC:13622	OMIM:607972	SLC6A16	4		
FBgn0040228	DCTN5-p25	HGNC:24594	OMIM:612962	DCTN5	13		
FBgn0028926	NC2beta	HGNC:3017	OMIM:601482	DR1	13		
FBgn0260446	GABA-B-R1	HGNC:4070	OMIM:603540	GABBR1	13		
FBgn0053310	CG33310	HGNC:804	OMIM:182330	ATP1B1	7	145500	145500[HYPERTENSION, ESSENTIAL]
FBgn0053310	CG33310	HGNC:806	OMIM:601867	ATP1B3	4		
FBgn0053310	CG33310	HGNC:805	OMIM:182331	ATP1B2	5		
FBgn0053310	CG33310	HGNC:820	OMIM:137217	ATP4B	4		
FBgn0053310	CG33310	HGNC:808	OMIM:301073	ATP1B4	5		
FBgn0004837	Su(H)	HGNC:13761	OMIM:616104	RBPJL	5		
FBgn0004837	Su(H)	HGNC:5724	OMIM:147183	RBPJ	14	614814	614814[ADAMS-OLIVER SYNDROME 3; AOS3]
FBgn0028879	CG15270	HGNC:21625	OMIM:610108	ANO1	3		
FBgn0028879	CG15270	HGNC:31677	OMIM:605096	ANO7	3		
FBgn0028879	CG15270	HGNC:29329	OMIM:610216	ANO8	11		
FBgn0028879	CG15270	HGNC:27337	OMIM:608662	ANO5	3	166260,611307,613319	166260[GNATHODIAPHYSEAL DYSPLASIA; GDD],611307[MUSCULAR DYSTROPHY, LIMB-GIRDLE, AUTOSOMAL RECESSIVE 12; LGMDR12],613319[MIYOSHI MUSCULAR DYSTROPHY 3; MMD3]
FBgn0028879	CG15270	HGNC:23837	OMIM:610111	ANO4	3		
FBgn0028879	CG15270	HGNC:25519	OMIM:613726	ANO10	4	613728	613728[SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 10; SCAR10]
FBgn0001978	stc	HGNC:7803	OMIM:603255	NFX1	14		
FBgn0028862	dao	HGNC:21067	OMIM:619134	SMYD4	6		
FBgn0028516	ZnT35C	HGNC:20303	OMIM:611145	SLC30A8	7	125853	125853[TYPE 2 DIABETES MELLITUS; T2D]
FBgn0028516	ZnT35C	HGNC:11015	OMIM:602095	SLC30A4	4		
FBgn0028516	ZnT35C	HGNC:11013	OMIM:609617	SLC30A2	11	608118	608118[ZINC DEFICIENCY, TRANSIENT NEONATAL; TNZD]
FBgn0028516	ZnT35C	HGNC:11014	OMIM:602878	SLC30A3	7		
FBgn0024183	vig	HGNC:17062	OMIM:617369	HABP4	7		
FBgn0024183	vig	HGNC:17860	OMIM:607378	SERBP1	12		
FBgn0010422	TfIIS	HGNC:11615	OMIM:604128	TCEA3	13		
FBgn0010422	TfIIS	HGNC:11614	OMIM:604784	TCEA2	11		
FBgn0010422	TfIIS	HGNC:11612	OMIM:601425	TCEA1	14		
FBgn0010422	TfIIS	HGNC:28277	OMIM:301084	TCEANC	5		
FBgn0000317	ck	HGNC:7607	OMIM:606541	MYO7B	8		
FBgn0000317	ck	HGNC:7606	OMIM:276903	MYO7A	15	276900,600060,601317	276900[USHER SYNDROME, TYPE I; USH1],600060[DEAFNESS, AUTOSOMAL RECESSIVE 2; DFNB2],601317[DEAFNESS, AUTOSOMAL DOMINANT 11; DFNA11]
FBgn0001977	CIAPIN1	HGNC:28050	OMIM:608943	CIAPIN1	14		
FBgn0051832	CG31832	HGNC:3624	OMIM:601624	FCN2	3		
FBgn0051832	CG31832	HGNC:3623	OMIM:601252	FCN1	3		
FBgn0051832	CG31832	HGNC:25922	OMIM:613357	FIBCD1	3		
FBgn0051832	CG31832	HGNC:3625	OMIM:604973	FCN3	3	613860	613860[FICOLIN 3 DEFICIENCY]
FBgn0028852	CG15262	HGNC:7878	OMIM:604909	CNOT2	10	618608	618608[INTELLECTUAL DEVELOPMENTAL DISORDER WITH NASAL SPEECH, DYSMORPHIC FACIES, AND VARIABLE SKELETAL ANOMALIES; IDNADFS]
FBgn0028892	CG4161	HGNC:17872	OMIM:616332	ARMT1	13		
FBgn0003448	sna	HGNC:11128	OMIM:604238	SNAI1	4		
FBgn0003448	sna	HGNC:11094	OMIM:602150	SNAI2	5	172800,608890	172800[PIEBALD TRAIT; PBT],608890[WAARDENBURG SYNDROME, TYPE 2D; WS2D]
FBgn0003448	sna	HGNC:18411	OMIM:612741	SNAI3	4		
FBgn0001983	wor	HGNC:11128	OMIM:604238	SNAI1	3		
FBgn0001983	wor	HGNC:11094	OMIM:602150	SNAI2	6	172800,608890	172800[PIEBALD TRAIT; PBT],608890[WAARDENBURG SYNDROME, TYPE 2D; WS2D]
FBgn0001983	wor	HGNC:18411	OMIM:612741	SNAI3	4		
FBgn0041103	nht	HGNC:11537	OMIM:601796	TAF4	3		
FBgn0041103	nht	HGNC:11538	OMIM:601689	TAF4B	3	615841	615841[SPERMATOGENIC FAILURE 13; SPGF13]
FBgn0028370	kek3	HGNC:15586	OMIM:610486	LRRC4	3		
FBgn0028370	kek3	HGNC:25042		LRRC4B	4		
FBgn0028370	kek3	HGNC:29317	OMIM:608817	LRRC4C	5		
FBgn0028947	CG11865	HGNC:7015	OMIM:600388	MEP1A	3		
FBgn0028947	CG11865	HGNC:31704	OMIM:608860	ASTL	3	619643	619643[OOCYTE MATURATION DEFECT 11; OOMD11]
FBgn0028945	CG7631	HGNC:31704	OMIM:608860	ASTL	5	619643	619643[OOCYTE MATURATION DEFECT 11; OOMD11]
FBgn0001986	Mtr4	HGNC:18734	OMIM:618122	MTREX	14		
FBgn0001986	Mtr4	HGNC:10898	OMIM:600478	SKIV2L	3	614602	614602[TRICHOHEPATOENTERIC SYNDROME 2; THES2]
FBgn0028507	CG3793	HGNC:17557	OMIM:610286	LCMT1	14		
FBgn0028507	CG3793	HGNC:17558	OMIM:611246	LCMT2	6		
FBgn0041627	Ku80	HGNC:12833	OMIM:194364	XRCC5	13		
FBgn0001987	Gli	HGNC:26459	OMIM:618678	CES5A	3		
FBgn0001987	Gli	HGNC:1863	OMIM:114835	CES1	3	618057	618057[DRUG METABOLISM, ALTERED, CES1-RELATED]
FBgn0001987	Gli	HGNC:1848	OMIM:114840	CEL	4	609812	609812[MATURITY-ONSET DIABETES OF THE YOUNG, TYPE 8, WITH EXOCRINE DYSFUNCTION; MODY8]
FBgn0001987	Gli	HGNC:1864	OMIM:605278	CES2	3		
FBgn0001987	Gli	HGNC:1865	OMIM:605279	CES3	3		
FBgn0001987	Gli	HGNC:15529	OMIM:400028	NLGN4Y	3		
FBgn0001987	Gli	HGNC:14291	OMIM:600568	NLGN1	4	618830	618830[AUTISM, SUSCEPTIBILITY TO, 20; AUTS20]
FBgn0001987	Gli	HGNC:14289	OMIM:300336	NLGN3	4	300425,300494	300425[AUTISM, SUSCEPTIBILITY TO, X-LINKED 1; AUTSX1],300494[ASPERGER SYNDROME, X-LINKED, SUSCEPTIBILITY TO, 1; ASPGX1]
FBgn0001987	Gli	HGNC:14287	OMIM:300427	NLGN4X	4	300495,300497	300495[AUTISM, SUSCEPTIBILITY TO, X-LINKED 2; AUTSX2],300497[ASPERGER SYNDROME, X-LINKED, SUSCEPTIBILITY TO, 2; ASPGX2]
FBgn0001987	Gli	HGNC:14290	OMIM:606479	NLGN2	5		
FBgn0028863	stol	HGNC:1399	OMIM:114204	CACNA2D1	4		
FBgn0028863	stol	HGNC:1400	OMIM:607082	CACNA2D2	4	618501	618501[CEREBELLAR ATROPHY WITH SEIZURES AND VARIABLE DEVELOPMENTAL DELAY; CASVDD]
FBgn0028863	stol	HGNC:15460	OMIM:606399	CACNA2D3	10		
FBgn0028863	stol	HGNC:20202	OMIM:608171	CACNA2D4	11	610478	610478[RETINAL CONE DYSTROPHY 4; RCD4]
FBgn0028948	CG15253	HGNC:7020	OMIM:600389	MEP1B	3		
FBgn0028948	CG15253	HGNC:31704	OMIM:608860	ASTL	4	619643	619643[OOCYTE MATURATION DEFECT 11; OOMD11]
FBgn0028949	CG15254	HGNC:31704	OMIM:608860	ASTL	4	619643	619643[OOCYTE MATURATION DEFECT 11; OOMD11]
FBgn0028944	Semp1	HGNC:31704	OMIM:608860	ASTL	5	619643	619643[OOCYTE MATURATION DEFECT 11; OOMD11]
FBgn0028950	CG15255	HGNC:7015	OMIM:600388	MEP1A	3		
FBgn0028950	CG15255	HGNC:7020	OMIM:600389	MEP1B	3		
FBgn0028950	CG15255	HGNC:31704	OMIM:608860	ASTL	4	619643	619643[OOCYTE MATURATION DEFECT 11; OOMD11]
FBgn0028903	CG13243	HGNC:25062	OMIM:619387	CATIP	5	619379	619379[SPERMATOGENIC FAILURE 54; SPGF54]
FBgn0028902	Tektin-A	HGNC:26554	OMIM:618686	TEKT5	5		
FBgn0028902	Tektin-A	HGNC:14293	OMIM:612683	TEKT3	5		
FBgn0028902	Tektin-A	HGNC:31012		TEKT4	9		
FBgn0028902	Tektin-A	HGNC:15534	OMIM:609002	TEKT1	4		
FBgn0051735	CG31735	HGNC:25184	OMIM:611032	SPATA17	7		
FBgn0028857	CG12448	HGNC:25184	OMIM:611032	SPATA17	7		
FBgn0028856	CG18063	HGNC:25184	OMIM:611032	SPATA17	6		
FBgn0028858	CG10839	HGNC:23247	OMIM:610062	DNAL1	10	614017	614017[CILIARY DYSKINESIA, PRIMARY, 16; CILD16]
FBgn0028858	CG10839	HGNC:25965		LRRC49	3		
FBgn0000182	BicC	HGNC:19351	OMIM:614295	BICC1	11	601331	601331[RENAL DYSPLASIA, CYSTIC, SUSCEPTIBILITY TO; CYSRD]
FBgn0051821	CG31821	HGNC:29507	OMIM:619723	SCPEP1	9		
FBgn0051823	CG31823	HGNC:29507	OMIM:619723	SCPEP1	11		
FBgn0051823	CG31823	HGNC:14399	OMIM:609780	CPVL	4		
FBgn0041183	Tep1	HGNC:21685	OMIM:608859	CD109	11		
FBgn0041183	Tep1	HGNC:1318	OMIM:120700	C3	4	611378,612925,613779	611378[MACULAR DEGENERATION, AGE-RELATED, 9; ARMD9],612925[HEMOLYTIC UREMIC SYNDROME, ATYPICAL, SUSCEPTIBILITY TO, 5; AHUS5],613779[COMPLEMENT COMPONENT 3 DEFICIENCY, AUTOSOMAL RECESSIVE; C3D]
FBgn0041183	Tep1	HGNC:1323	OMIM:120810	C4A	4	614374,614380	614374[BLOOD GROUP, CHIDO/RODGERS SYSTEM],614380[COMPLEMENT COMPONENT 4A DEFICIENCY; C4AD]
FBgn0041183	Tep1	HGNC:1324	OMIM:120820	C4B	4	614379	614379[COMPLEMENT COMPONENT 4B DEFICIENCY; C4BD]
FBgn0041183	Tep1	HGNC:1331	OMIM:120900	C5	5	609536,615749	609536[COMPLEMENT COMPONENT 5 DEFICIENCY; C5D],615749[ECULIZUMAB, POOR RESPONSE TO]
FBgn0041183	Tep1	HGNC:9750	OMIM:176420	PZP	5		
FBgn0041183	Tep1	HGNC:7	OMIM:103950	A2M	5		
FBgn0041183	Tep1	HGNC:23336	OMIM:610627	A2ML1	5	166760	166760[OTITIS MEDIA, SUSCEPTIBILITY TO; OMS]
FBgn0041183	Tep1	HGNC:23228	OMIM:608841	CPAMD8	3	617319	617319[ANTERIOR SEGMENT DYSGENESIS 8; ASGD8]
FBgn0028935	CG7653	HGNC:500	OMIM:151530	ANPEP	3		
FBgn0028935	CG7653	HGNC:30748	OMIM:606950	TRHDE	3		
FBgn0028935	CG7653	HGNC:18173	OMIM:606832	ERAP1	4		
FBgn0028935	CG7653	HGNC:26904	OMIM:610046	LVRN	3		
FBgn0028935	CG7653	HGNC:7900	OMIM:606793	NPEPPS	3		
FBgn0028935	CG7653	HGNC:29499	OMIM:609497	ERAP2	4		
FBgn0028935	CG7653	HGNC:6656	OMIM:151300	LNPEP	4		
FBgn0028897	CG4935	HGNC:32672	OMIM:616850	WDR83	14		
FBgn0040079	pkaap	HGNC:368	OMIM:604694	AKAP10	14		
FBgn0028896	CG17329	HGNC:25539	OMIM:614151	RFWD3	5	617784	617784[FANCONI ANEMIA, COMPLEMENTATION GROUP W; FANCW]
FBgn0001992	Cyp303a1	HGNC:2615	OMIM:123930	CYP2B6	5	614546	614546[EFAVIRENZ, POOR METABOLISM OF]
FBgn0001992	Cyp303a1	HGNC:2621	OMIM:124020	CYP2C19	3	609535	609535[DRUG METABOLISM, POOR, CYP2C19-RELATED]
FBgn0001992	Cyp303a1	HGNC:2622	OMIM:601129	CYP2C8	3	618018	618018[DRUG METABOLISM, ALTERED, CYP2C8-RELATED]
FBgn0001992	Cyp303a1	HGNC:2623	OMIM:601130	CYP2C9	3	122700	122700[COUMARIN RESISTANCE]
FBgn0001992	Cyp303a1	HGNC:2620	OMIM:601131	CYP2C18	3		
FBgn0001992	Cyp303a1	HGNC:2634	OMIM:601258	CYP2J2	3		
FBgn0011708	Syx5	HGNC:11440	OMIM:603189	STX5	14		
FBgn0001086	fzy	HGNC:24824	OMIM:603619	FZR1	4		
FBgn0001086	fzy	HGNC:1723	OMIM:603618	CDC20	14		
FBgn0001086	fzy	HGNC:24222		CDC20B	6		
FBgn0014092	CG4278	HGNC:13390	OMIM:605778	NIF3L1	13		
FBgn0025678	CaBP1	HGNC:30168	OMIM:611099	PDIA6	15		
FBgn0000307	chif	HGNC:17364	OMIM:604281	DBF4	8		
FBgn0000307	chif	HGNC:17883	OMIM:611661	DBF4B	9		
FBgn0001995	mRpL4	HGNC:14276	OMIM:611823	MRPL4	14		
FBgn0000250	cact	HGNC:7797	OMIM:164008	NFKBIA	10	612132	612132[ECTODERMAL DYSPLASIA AND IMMUNODEFICIENCY 2; EDAID2]
FBgn0000250	cact	HGNC:7798	OMIM:604495	NFKBIB	3		
FBgn0000339	cni	HGNC:25013	OMIM:617483	CNIH4	5		
FBgn0000339	cni	HGNC:19431	OMIM:611287	CNIH1	14		
FBgn0000339	cni	HGNC:26802		CNIH3	11		
FBgn0000339	cni	HGNC:28744	OMIM:611288	CNIH2	11		
FBgn0015338	CG5861	HGNC:30414	OMIM:613585	TMEM147	13		
FBgn0028894	GMF	HGNC:4374	OMIM:604104	GMFG	13		
FBgn0028894	GMF	HGNC:4373	OMIM:601713	GMFB	13		
FBgn0028375	heix	HGNC:30791	OMIM:611632	UBIAD1	14	121800	121800[SCHNYDER CORNEAL DYSTROPHY; SCCD]
FBgn0001994	crp	HGNC:11745	OMIM:600743	TFAP4	11		
FBgn0002673	twe	HGNC:1725	OMIM:116947	CDC25A	11		
FBgn0002673	twe	HGNC:1726	OMIM:116949	CDC25B	10		
FBgn0002673	twe	HGNC:1727	OMIM:157680	CDC25C	10		
FBgn0024734	PRL-1	HGNC:9634	OMIM:601585	PTP4A1	11		
FBgn0024734	PRL-1	HGNC:9635	OMIM:601584	PTP4A2	12		
FBgn0024734	PRL-1	HGNC:9636	OMIM:606449	PTP4A3	8		
FBgn0020416	Idgf1	HGNC:8524	OMIM:603578	OVGP1	4		
FBgn0020416	Idgf1	HGNC:1932	OMIM:601525	CHI3L1	4	181500,611960	181500[SCHIZOPHRENIA; SCZD],611960[ASTHMA-RELATED TRAITS, SUSCEPTIBILITY TO, 7; ASRT7]
FBgn0020416	Idgf1	HGNC:1936	OMIM:600031	CHIT1	4	614122	614122[CHITOTRIOSIDASE DEFICIENCY; CHITD]
FBgn0020416	Idgf1	HGNC:17432	OMIM:606080	CHIA	3		
FBgn0020416	Idgf1	HGNC:1933	OMIM:601526	CHI3L2	3		
FBgn0020415	Idgf2	HGNC:8524	OMIM:603578	OVGP1	4		
FBgn0020415	Idgf2	HGNC:1932	OMIM:601525	CHI3L1	4	181500,611960	181500[SCHIZOPHRENIA; SCZD],611960[ASTHMA-RELATED TRAITS, SUSCEPTIBILITY TO, 7; ASRT7]
FBgn0020415	Idgf2	HGNC:1936	OMIM:600031	CHIT1	4	614122	614122[CHITOTRIOSIDASE DEFICIENCY; CHITD]
FBgn0020415	Idgf2	HGNC:17432	OMIM:606080	CHIA	3		
FBgn0020415	Idgf2	HGNC:1933	OMIM:601526	CHI3L2	3		
FBgn0020414	Idgf3	HGNC:8524	OMIM:603578	OVGP1	4		
FBgn0020414	Idgf3	HGNC:1932	OMIM:601525	CHI3L1	4	181500,611960	181500[SCHIZOPHRENIA; SCZD],611960[ASTHMA-RELATED TRAITS, SUSCEPTIBILITY TO, 7; ASRT7]
FBgn0020414	Idgf3	HGNC:1936	OMIM:600031	CHIT1	4	614122	614122[CHITOTRIOSIDASE DEFICIENCY; CHITD]
FBgn0020414	Idgf3	HGNC:17432	OMIM:606080	CHIA	3		
FBgn0020414	Idgf3	HGNC:1933	OMIM:601526	CHI3L2	3		
FBgn0032585	Nepl8	HGNC:6308	OMIM:613883	KEL	3	110900	110900[BLOOD GROUP--KELL SYSTEM; KEL]
FBgn0032586	Tpr2	HGNC:12392	OMIM:601964	DNAJC7	13		
FBgn0051812	Tsen2	HGNC:28422	OMIM:608753	TSEN2	12	612389	612389[PONTOCEREBELLAR HYPOPLASIA, TYPE 2B; PCH2B]
FBgn0032597	Nubp1	HGNC:8042	OMIM:610779	NUBP2	4		
FBgn0032597	Nubp1	HGNC:8041	OMIM:600280	NUBP1	15		
FBgn0032597	Nubp1	HGNC:20278	OMIM:613621	NUBPL	3	618242	618242[MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 21; MC1DN21]
FBgn0032600	BuGZ	HGNC:12998	OMIM:603428	ZNF207	10		
FBgn0032603	CG17928	HGNC:3574	OMIM:606148	FADS1	3		
FBgn0032603	CG17928	HGNC:3575	OMIM:606149	FADS2	3		
FBgn0032603	CG17928	HGNC:3576	OMIM:606150	FADS3	3		
FBgn0040262	Ugt37C2	HGNC:12531	OMIM:606435	UGT1A10	3		
FBgn0040262	Ugt37C2	HGNC:12545	OMIM:603064	UGT2B11	5		
FBgn0040262	Ugt37C2	HGNC:12530	OMIM:191740	UGT1A1	5	143500,218800,237900,601816,606785	143500[GILBERT SYNDROME],218800[CRIGLER-NAJJAR SYNDROME, TYPE I],237900[HYPERBILIRUBINEMIA, TRANSIENT FAMILIAL NEONATAL; HBLRTFN],601816[BILIRUBIN, SERUM LEVEL OF, QUANTITATIVE TRAIT LOCUS 1; BILIQTL1],606785[CRIGLER-NAJJAR SYNDROME, TYPE II]
FBgn0040262	Ugt37C2	HGNC:12555	OMIM:601291	UGT8	5		
FBgn0040262	Ugt37C2	HGNC:12539	OMIM:606432	UGT1A7	3		
FBgn0040262	Ugt37C2	HGNC:13479	OMIM:606497	UGT2B28	5		
FBgn0040262	Ugt37C2	HGNC:27266	OMIM:616384	UGT3A2	4		
FBgn0040262	Ugt37C2	HGNC:12544	OMIM:600070	UGT2B10	6		
FBgn0040262	Ugt37C2	HGNC:12537	OMIM:606430	UGT1A5	3		
FBgn0040262	Ugt37C2	HGNC:12546	OMIM:600069	UGT2B15	5		
FBgn0040262	Ugt37C2	HGNC:12541	OMIM:606434	UGT1A9	3		
FBgn0040262	Ugt37C2	HGNC:28528	OMIM:616382	UGT2A3	6		
FBgn0040262	Ugt37C2	HGNC:12535	OMIM:606428	UGT1A3	6		
FBgn0040262	Ugt37C2	HGNC:12536	OMIM:606429	UGT1A4	3		
FBgn0040262	Ugt37C2	HGNC:12540	OMIM:606433	UGT1A8	3		
FBgn0040262	Ugt37C2	HGNC:26625	OMIM:616383	UGT3A1	4		
FBgn0040262	Ugt37C2	HGNC:12547	OMIM:601903	UGT2B17	5	612560	612560[BONE MINERAL DENSITY QUANTITATIVE TRAIT LOCUS 12; BMND12]
FBgn0040262	Ugt37C2	HGNC:12553	OMIM:600067	UGT2B4	6		
FBgn0040262	Ugt37C2	HGNC:12538	OMIM:606431	UGT1A6	4		
FBgn0040262	Ugt37C2	HGNC:12554	OMIM:600068	UGT2B7	5		
FBgn0040262	Ugt37C2	HGNC:28183	OMIM:619809	UGT2A2	5		
FBgn0040261	Ugt37E1	HGNC:12531	OMIM:606435	UGT1A10	3		
FBgn0040261	Ugt37E1	HGNC:12545	OMIM:603064	UGT2B11	5		
FBgn0040261	Ugt37E1	HGNC:12530	OMIM:191740	UGT1A1	5	143500,218800,237900,601816,606785	143500[GILBERT SYNDROME],218800[CRIGLER-NAJJAR SYNDROME, TYPE I],237900[HYPERBILIRUBINEMIA, TRANSIENT FAMILIAL NEONATAL; HBLRTFN],601816[BILIRUBIN, SERUM LEVEL OF, QUANTITATIVE TRAIT LOCUS 1; BILIQTL1],606785[CRIGLER-NAJJAR SYNDROME, TYPE II]
FBgn0040261	Ugt37E1	HGNC:12555	OMIM:601291	UGT8	5		
FBgn0040261	Ugt37E1	HGNC:12539	OMIM:606432	UGT1A7	3		
FBgn0040261	Ugt37E1	HGNC:13479	OMIM:606497	UGT2B28	5		
FBgn0040261	Ugt37E1	HGNC:27266	OMIM:616384	UGT3A2	4		
FBgn0040261	Ugt37E1	HGNC:12544	OMIM:600070	UGT2B10	5		
FBgn0040261	Ugt37E1	HGNC:12537	OMIM:606430	UGT1A5	3		
FBgn0040261	Ugt37E1	HGNC:12546	OMIM:600069	UGT2B15	5		
FBgn0040261	Ugt37E1	HGNC:12541	OMIM:606434	UGT1A9	3		
FBgn0040261	Ugt37E1	HGNC:28528	OMIM:616382	UGT2A3	5		
FBgn0040261	Ugt37E1	HGNC:12535	OMIM:606428	UGT1A3	6		
FBgn0040261	Ugt37E1	HGNC:12536	OMIM:606429	UGT1A4	3		
FBgn0040261	Ugt37E1	HGNC:12540	OMIM:606433	UGT1A8	3		
FBgn0040261	Ugt37E1	HGNC:26625	OMIM:616383	UGT3A1	4		
FBgn0040261	Ugt37E1	HGNC:12547	OMIM:601903	UGT2B17	5	612560	612560[BONE MINERAL DENSITY QUANTITATIVE TRAIT LOCUS 12; BMND12]
FBgn0040261	Ugt37E1	HGNC:12553	OMIM:600067	UGT2B4	5		
FBgn0040261	Ugt37E1	HGNC:12538	OMIM:606431	UGT1A6	3		
FBgn0040261	Ugt37E1	HGNC:12554	OMIM:600068	UGT2B7	5		
FBgn0040261	Ugt37E1	HGNC:28183	OMIM:619809	UGT2A2	4		
FBgn0040260	Ugt37D1	HGNC:12531	OMIM:606435	UGT1A10	3		
FBgn0040260	Ugt37D1	HGNC:12545	OMIM:603064	UGT2B11	5		
FBgn0040260	Ugt37D1	HGNC:12530	OMIM:191740	UGT1A1	5	143500,218800,237900,601816,606785	143500[GILBERT SYNDROME],218800[CRIGLER-NAJJAR SYNDROME, TYPE I],237900[HYPERBILIRUBINEMIA, TRANSIENT FAMILIAL NEONATAL; HBLRTFN],601816[BILIRUBIN, SERUM LEVEL OF, QUANTITATIVE TRAIT LOCUS 1; BILIQTL1],606785[CRIGLER-NAJJAR SYNDROME, TYPE II]
FBgn0040260	Ugt37D1	HGNC:12555	OMIM:601291	UGT8	5		
FBgn0040260	Ugt37D1	HGNC:12539	OMIM:606432	UGT1A7	3		
FBgn0040260	Ugt37D1	HGNC:13479	OMIM:606497	UGT2B28	5		
FBgn0040260	Ugt37D1	HGNC:27266	OMIM:616384	UGT3A2	4		
FBgn0040260	Ugt37D1	HGNC:12544	OMIM:600070	UGT2B10	5		
FBgn0040260	Ugt37D1	HGNC:12537	OMIM:606430	UGT1A5	3		
FBgn0040260	Ugt37D1	HGNC:12546	OMIM:600069	UGT2B15	5		
FBgn0040260	Ugt37D1	HGNC:12541	OMIM:606434	UGT1A9	3		
FBgn0040260	Ugt37D1	HGNC:28528	OMIM:616382	UGT2A3	5		
FBgn0040260	Ugt37D1	HGNC:12535	OMIM:606428	UGT1A3	6		
FBgn0040260	Ugt37D1	HGNC:12536	OMIM:606429	UGT1A4	3		
FBgn0040260	Ugt37D1	HGNC:12540	OMIM:606433	UGT1A8	3		
FBgn0040260	Ugt37D1	HGNC:26625	OMIM:616383	UGT3A1	4		
FBgn0040260	Ugt37D1	HGNC:12547	OMIM:601903	UGT2B17	5	612560	612560[BONE MINERAL DENSITY QUANTITATIVE TRAIT LOCUS 12; BMND12]
FBgn0040260	Ugt37D1	HGNC:12553	OMIM:600067	UGT2B4	5		
FBgn0040260	Ugt37D1	HGNC:12538	OMIM:606431	UGT1A6	3		
FBgn0040260	Ugt37D1	HGNC:12554	OMIM:600068	UGT2B7	5		
FBgn0040260	Ugt37D1	HGNC:28183	OMIM:619809	UGT2A2	4		
FBgn0004797	mdy	HGNC:11177	OMIM:102642	SOAT1	3		
FBgn0004797	mdy	HGNC:11178	OMIM:601311	SOAT2	3		
FBgn0004797	mdy	HGNC:2843	OMIM:604900	DGAT1	13	615863	615863[DIARRHEA 7, PROTEIN-LOSING ENTEROPATHY TYPE; DIAR7]
FBgn0051739	AspRS-m	HGNC:25538	OMIM:610956	DARS2	14	611105	611105[LEUKOENCEPHALOPATHY WITH BRAINSTEM AND SPINAL CORD INVOLVEMENT AND LACTATE ELEVATION; LBSL]
FBgn0032615	CG6012	HGNC:18646	OMIM:609574	HSD17B12	4		
FBgn0032615	CG6012	HGNC:16475	OMIM:619067	HSDL1	7		
FBgn0032615	CG6012	HGNC:5212	OMIM:605573	HSD17B3	6	264300	264300[17-BETA HYDROXYSTEROID DEHYDROGENASE III DEFICIENCY]
FBgn0051809	CG31809	HGNC:18646	OMIM:609574	HSD17B12	6		
FBgn0051809	CG31809	HGNC:16475	OMIM:619067	HSDL1	11		
FBgn0051809	CG31809	HGNC:5212	OMIM:605573	HSD17B3	4	264300	264300[17-BETA HYDROXYSTEROID DEHYDROGENASE III DEFICIENCY]
FBgn0051810	CG31810	HGNC:18646	OMIM:609574	HSD17B12	5		
FBgn0051810	CG31810	HGNC:16475	OMIM:619067	HSDL1	12		
FBgn0051810	CG31810	HGNC:5212	OMIM:605573	HSD17B3	4	264300	264300[17-BETA HYDROXYSTEROID DEHYDROGENASE III DEFICIENCY]
FBgn0032614	CG13284	HGNC:18646	OMIM:609574	HSD17B12	6		
FBgn0032614	CG13284	HGNC:16475	OMIM:619067	HSDL1	10		
FBgn0032614	CG13284	HGNC:5212	OMIM:605573	HSD17B3	5	264300	264300[17-BETA HYDROXYSTEROID DEHYDROGENASE III DEFICIENCY]
FBgn0032613	Nepl9	HGNC:8918	OMIM:300550	PHEX	3	307800	307800[HYPOPHOSPHATEMIC RICKETS, X-LINKED DOMINANT; XLHR]
FBgn0032612	CG13282	HGNC:9155	OMIM:246600	PNLIP	3	614338	614338[PANCREATIC LIPASE DEFICIENCY; PNLIPD]
FBgn0032612	CG13282	HGNC:9156	OMIM:604422	PNLIPRP1	3		
FBgn0032612	CG13282	HGNC:23492		PNLIPRP3	3		
FBgn0032612	CG13282	HGNC:18821	OMIM:609252	LIPI	3		
FBgn0022213	Cse1	HGNC:2431	OMIM:601342	CSE1L	13		
FBgn0032609	CG13280	HGNC:17887	OMIM:606377	DHDH	8		
FBgn0032602	ppk17	HGNC:101	OMIM:611741	ASIC3	3		
FBgn0032602	ppk17	HGNC:99	OMIM:601784	ASIC2	3		
FBgn0032602	ppk17	HGNC:10599	OMIM:600228	SCNN1A	3	264350,613021,618126	264350[PSEUDOHYPOALDOSTERONISM, TYPE I, AUTOSOMAL RECESSIVE; PHA1B],613021[BRONCHIECTASIS WITH OR WITHOUT ELEVATED SWEAT CHLORIDE 2; BESC2],618126[LIDDLE SYNDROME 3; LIDLS3]
FBgn0032602	ppk17	HGNC:10600	OMIM:600760	SCNN1B	3	177200,211400,264350	177200[LIDDLE SYNDROME 1; LIDLS1],211400[BRONCHIECTASIS WITH OR WITHOUT ELEVATED SWEAT CHLORIDE 1; BESC1],264350[PSEUDOHYPOALDOSTERONISM, TYPE I, AUTOSOMAL RECESSIVE; PHA1B]
FBgn0032602	ppk17	HGNC:10601	OMIM:601328	SCNN1D	3		
FBgn0032602	ppk17	HGNC:10602	OMIM:600761	SCNN1G	3	264350,613071,618114	264350[PSEUDOHYPOALDOSTERONISM, TYPE I, AUTOSOMAL RECESSIVE; PHA1B],613071[BRONCHIECTASIS WITH OR WITHOUT ELEVATED SWEAT CHLORIDE 3; BESC3],618114[LIDDLE SYNDROME 2; LIDLS2]
FBgn0015391	glu	HGNC:14013	OMIM:605575	SMC4	13		
FBgn0032596	Prosbeta4	HGNC:9539	OMIM:602175	PSMB2	14		
FBgn0032595	CG17996	HGNC:28783	OMIM:615166	CMC1	13		
FBgn0027779	VhaSFD	HGNC:18303	OMIM:608861	ATP6V1H	15		
FBgn0051807	CG31807	HGNC:25539	OMIM:614151	RFWD3	3	617784	617784[FANCONI ANEMIA, COMPLEMENTATION GROUP W; FANCW]
FBgn0032593	Trpgamma	HGNC:12336	OMIM:603651	TRPC4	14		
FBgn0032593	Trpgamma	HGNC:12337	OMIM:300334	TRPC5	12		
FBgn0032593	Trpgamma	HGNC:12333	OMIM:602343	TRPC1	7		
FBgn0032593	Trpgamma	HGNC:12335	OMIM:602345	TRPC3	4	616410	616410[SPINOCEREBELLAR ATAXIA 41; SCA41]
FBgn0032593	Trpgamma	HGNC:12338	OMIM:603652	TRPC6	4	603965	603965[FOCAL SEGMENTAL GLOMERULOSCLEROSIS 2; FSGS2]
FBgn0032593	Trpgamma	HGNC:20754		TRPC7	4		
FBgn0032618	CG31743	HGNC:21755	OMIM:610124	CHST13	11		
FBgn0032618	CG31743	HGNC:17423	OMIM:610129	CHST12	3		
FBgn0032618	CG31743	HGNC:19898	OMIM:610191	CHST9	3		
FBgn0032618	CG31743	HGNC:15993	OMIM:610190	CHST8	3	616265	616265[PEELING SKIN SYNDROME 3; PSS3]
FBgn0032618	CG31743	HGNC:17422	OMIM:610128	CHST11	12	618167	618167[OSTEOCHONDRODYSPLASIA, BRACHYDACTYLY, AND OVERLAPPING MALFORMED DIGITS; OCBMD]
FBgn0026150	ApepP	HGNC:12822	OMIM:602443	XPNPEP1	15		
FBgn0026150	ApepP	HGNC:12823	OMIM:300145	XPNPEP2	6	300909	300909[ANGIOEDEMA INDUCED BY ACE INHIBITORS, SUSCEPTIBILITY TO; AEACEI]
FBgn0032620	CG12288	HGNC:28965	OMIM:619915	RBM34	11		
FBgn0040985	CG6115	HGNC:27052		ETFRF1	13		
FBgn0052832	CG32832	HGNC:24515	OMIM:614737	MPC2	9		
FBgn0032633	Lrch	HGNC:20309	OMIM:610368	LRCH1	10		
FBgn0032633	Lrch	HGNC:29292		LRCH2	11		
FBgn0032633	Lrch	HGNC:28637		LRCH3	11		
FBgn0032633	Lrch	HGNC:6691		LRCH4	7		
FBgn0032632	CG6380	HGNC:9288	OMIM:601792	PPP1R2	8		
FBgn0032632	CG6380	HGNC:16324	OMIM:301017	PPP1R2C	6		
FBgn0032632	CG6380	HGNC:16318		PPP1R2B	4		
FBgn0032632	CG6380	HGNC:9289		PPP1R2P1	3		
FBgn0020503	CLIP-190	HGNC:10461	OMIM:179838	CLIP1	12		
FBgn0020503	CLIP-190	HGNC:2586	OMIM:603432	CLIP2	11		
FBgn0020503	CLIP-190	HGNC:24314	OMIM:607382	CLIP3	3		
FBgn0032635	CG15141	HGNC:20344	OMIM:613816	UBR7	14	619189	619189[LI-CAMPEAU SYNDROME; LICAS]
FBgn0032640	Sgt	HGNC:23567		SGTB	13		
FBgn0032640	Sgt	HGNC:10819	OMIM:603419	SGTA	12		
FBgn0032642	Lamtor3	HGNC:15606	OMIM:603296	LAMTOR3	14		
FBgn0032644	CG5131	HGNC:29452	OMIM:619760	ATP23	14		
FBgn0013810	Dhc36C	HGNC:2951	OMIM:603336	DNAH6	3		
FBgn0013810	Dhc36C	HGNC:2949	OMIM:603334	DNAH3	4		
FBgn0013810	Dhc36C	HGNC:2952	OMIM:603337	DNAH8	3	619095	619095[SPERMATOGENIC FAILURE 46; SPGF46]
FBgn0013810	Dhc36C	HGNC:2940	OMIM:603332	DNAH1	3	617576,617577	617576[SPERMATOGENIC FAILURE 18; SPGF18],617577[CILIARY DYSKINESIA, PRIMARY, 37; CILD37]
FBgn0013810	Dhc36C	HGNC:18661	OMIM:610061	DNAH7	13		
FBgn0013810	Dhc36C	HGNC:2953	OMIM:603330	DNAH9	3	618300	618300[CILIARY DYSKINESIA, PRIMARY, 40; CILD40]
FBgn0013810	Dhc36C	HGNC:2942	OMIM:603339	DNAH11	3	611884	611884[CILIARY DYSKINESIA, PRIMARY, 7; CILD7]
FBgn0013810	Dhc36C	HGNC:2950	OMIM:603335	DNAH5	3	608644	608644[CILIARY DYSKINESIA, PRIMARY, 3; CILD3]
FBgn0013810	Dhc36C	HGNC:2948	OMIM:603333	DNAH2	3	619094	619094[SPERMATOGENIC FAILURE 45; SPGF45]
FBgn0013810	Dhc36C	HGNC:2941	OMIM:605884	DNAH10	3	619515	619515[SPERMATOGENIC FAILURE 56; SPGF56]
FBgn0013810	Dhc36C	HGNC:2946	OMIM:610063	DNAH17	3	618643	618643[SPERMATOGENIC FAILURE 39; SPGF39]
FBgn0013810	Dhc36C	HGNC:2943	OMIM:603340	DNAH12	4		
FBgn0032651	Oli	HGNC:11963	OMIM:613483	BHLHE22	12		
FBgn0032651	Oli	HGNC:16093	OMIM:609331	BHLHE23	12		
FBgn0032651	Oli	HGNC:9398	OMIM:606386	OLIG2	3		
FBgn0032651	Oli	HGNC:18003	OMIM:609323	OLIG3	3		
FBgn0032651	Oli	HGNC:16983	OMIM:606385	OLIG1	3		
FBgn0032654	CG15147	HGNC:18251	OMIM:607914	SELENOH	4		
FBgn0032652	CG6870	HGNC:2570	OMIM:613218	CYB5A	7	250790	250790[METHEMOGLOBINEMIA AND AMBIGUOUS GENITALIA; METAG]
FBgn0032652	CG6870	HGNC:24374	OMIM:611964	CYB5B	6		
FBgn0032650	CG7094	HGNC:2451	OMIM:600505	CSNK1A1	8		
FBgn0032650	CG7094	HGNC:20289		CSNK1A1L	6		
FBgn0032650	CG7094	HGNC:2452	OMIM:600864	CSNK1D	3	615224	615224[ADVANCED SLEEP PHASE SYNDROME, FAMILIAL, 2; FASPS2]
FBgn0032649	CG15145	HGNC:24010	OMIM:609910	MAATS1	9	619177	619177[SPERMATOGENIC FAILURE 51; SPGF51]
FBgn0032648	CG15144	HGNC:24010	OMIM:609910	MAATS1	8	619177	619177[SPERMATOGENIC FAILURE 51; SPGF51]
FBgn0032647	CG15143	HGNC:24010	OMIM:609910	MAATS1	8	619177	619177[SPERMATOGENIC FAILURE 51; SPGF51]
FBgn0032646	mEFTs	HGNC:12367	OMIM:604723	TSFM	14	610505	610505[COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 3; COXPD3]
FBgn0032645	CG15142	HGNC:14002	OMIM:602198	CDK2AP1	3		
FBgn0032645	CG15142	HGNC:30833		CDK2AP2	3		
FBgn0003187	qua	HGNC:30906	OMIM:619666	VILL	5		
FBgn0003187	qua	HGNC:12690	OMIM:193040	VIL1	5		
FBgn0003187	qua	HGNC:14188	OMIM:613397	AVIL	5	618594	618594[NEPHROTIC SYNDROME, TYPE 21; NPHS21]
FBgn0003187	qua	HGNC:4620	OMIM:137350	GSN	5	105120	105120[AMYLOIDOSIS, FINNISH TYPE]
FBgn0003187	qua	HGNC:21695	OMIM:613416	SCIN	4		
FBgn0003187	qua	HGNC:1474	OMIM:153615	CAPG	4		
FBgn0032643	GCS2beta	HGNC:9411	OMIM:177060	PRKCSH	15	174050	174050[POLYCYSTIC LIVER DISEASE 1 WITH OR WITHOUT KIDNEY CYSTS; PCLD1]
FBgn0024689	fws	HGNC:14857	OMIM:606821	COG5	13	613612	613612[CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIi; CDG2I]
FBgn0000183	BicD	HGNC:17208	OMIM:609797	BICD2	14	615290,618291	615290[SPINAL MUSCULAR ATROPHY, LOWER EXTREMITY-PREDOMINANT, 2A, CHILDHOOD ONSET, AUTOSOMAL DOMINANT; SMALED2A],618291[SPINAL MUSCULAR ATROPHY, LOWER EXTREMITY-PREDOMINANT, 2B, PRENATAL ONSET, AUTOSOMAL DOMINANT; SMALED2B]
FBgn0000183	BicD	HGNC:1049	OMIM:602204	BICD1	13		
FBgn0011274	Dif	HGNC:7795	OMIM:164012	NFKB2	3	615577	615577[IMMUNODEFICIENCY, COMMON VARIABLE, 10; CVID10]
FBgn0011274	Dif	HGNC:7794	OMIM:164011	NFKB1	3	616576	616576[IMMUNODEFICIENCY, COMMON VARIABLE, 12, WITH AUTOIMMUNITY; CVID12]
FBgn0011274	Dif	HGNC:9954	OMIM:164910	REL	7	619652	619652[IMMUNODEFICIENCY 92; IMD92]
FBgn0011274	Dif	HGNC:9955	OMIM:164014	RELA	8	618287	618287[MUCOCUTANEOUS ULCERATION, CHRONIC; CMCU]
FBgn0011274	Dif	HGNC:9956	OMIM:604758	RELB	8	617585	617585[IMMUNODEFICIENCY 53; IMD53]
FBgn0051803	Rsph9	HGNC:21057	OMIM:612648	RSPH9	13	612650	612650[CILIARY DYSKINESIA, PRIMARY, 12; CILD12]
FBgn0032634	Polr2J	HGNC:23208	OMIM:609881	POLR2J2	7		
FBgn0032634	Polr2J	HGNC:33853		POLR2J3	8		
FBgn0032634	Polr2J	HGNC:9197	OMIM:604150	POLR2J	15		
FBgn0051742	Prosbeta5R2	HGNC:31963	OMIM:611137	PSMB11	8		
FBgn0051742	Prosbeta5R2	HGNC:9545	OMIM:177046	PSMB8	9	256040	256040[PROTEASOME-ASSOCIATED AUTOINFLAMMATORY SYNDROME 1; PRAAS1]
FBgn0051742	Prosbeta5R2	HGNC:9542	OMIM:600306	PSMB5	10		
FBgn0000120	Arr1	HGNC:712	OMIM:107941	ARRB2	6		
FBgn0000120	Arr1	HGNC:710	OMIM:301770	ARR3	4	301010	301010[MYOPIA 26, X-LINKED, FEMALE-LIMITED; MYP26]
FBgn0000120	Arr1	HGNC:10521	OMIM:181031	SAG	5	258100,613758	258100[OGUCHI DISEASE 1],613758[RETINITIS PIGMENTOSA 47; RP47]
FBgn0000120	Arr1	HGNC:711	OMIM:107940	ARRB1	5		
FBgn0002939	ninaD	HGNC:1663	OMIM:173510	CD36	4	608404,610938,611162	608404[PLATELET GLYCOPROTEIN IV DEFICIENCY],610938[CORONARY HEART DISEASE, SUSCEPTIBILITY TO, 7; CHDS7],611162[MALARIA, SUSCEPTIBILITY TO]
FBgn0002939	ninaD	HGNC:1664	OMIM:601040	SCARB1	6	610762	610762[HIGH DENSITY LIPOPROTEIN CHOLESTEROL LEVEL QUANTITATIVE TRAIT LOCUS 6; HDLCQ6]
FBgn0002939	ninaD	HGNC:1665	OMIM:602257	SCARB2	4	254900	254900[EPILEPSY, PROGRESSIVE MYOCLONIC, 4, WITH OR WITHOUT RENAL FAILURE; EPM4]
FBgn0051741	CG31741	HGNC:1663	OMIM:173510	CD36	4	608404,610938,611162	608404[PLATELET GLYCOPROTEIN IV DEFICIENCY],610938[CORONARY HEART DISEASE, SUSCEPTIBILITY TO, 7; CHDS7],611162[MALARIA, SUSCEPTIBILITY TO]
FBgn0051741	CG31741	HGNC:1664	OMIM:601040	SCARB1	6	610762	610762[HIGH DENSITY LIPOPROTEIN CHOLESTEROL LEVEL QUANTITATIVE TRAIT LOCUS 6; HDLCQ6]
FBgn0051741	CG31741	HGNC:1665	OMIM:602257	SCARB2	4	254900	254900[EPILEPSY, PROGRESSIVE MYOCLONIC, 4, WITH OR WITHOUT RENAL FAILURE; EPM4]
FBgn0032664	Slc25A46b	HGNC:25198	OMIM:610826	SLC25A46	14	616505,619303	616505[NEUROPATHY, HEREDITARY MOTOR AND SENSORY, TYPE VIB, WITH OPTIC ATROPHY; HMSN6B],619303[PONTOCEREBELLAR HYPOPLASIA, TYPE 1E; PCH1E]
FBgn0041184	Socs36E	HGNC:19392	OMIM:616337	SOCS4	7		
FBgn0041184	Socs36E	HGNC:16852	OMIM:607094	SOCS5	7		
FBgn0032660	elfless	HGNC:10067	OMIM:602850	RNF4	3		
FBgn0023096	btv	HGNC:2961	OMIM:600112	DYNC1H1	3	158600,614228,614563	158600[SPINAL MUSCULAR ATROPHY, LOWER EXTREMITY-PREDOMINANT, 1, AUTOSOMAL DOMINANT; SMALED1],614228[CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2O; CMT2O],614563[INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL DOMINANT 13; MRD13]
FBgn0023096	btv	HGNC:2962	OMIM:603297	DYNC2H1	14	613091	613091[SHORT-RIB THORACIC DYSPLASIA 3 WITH OR WITHOUT POLYDACTYLY; SRTD3]
FBgn0032669	CG15155	HGNC:21349	OMIM:614763	GLYATL3	5		
FBgn0032669	CG15155	HGNC:30519	OMIM:614761	GLYATL1	3		
FBgn0032669	CG15155	HGNC:24178	OMIM:614762	GLYATL2	3		
FBgn0032669	CG15155	HGNC:13734	OMIM:607424	GLYAT	3		
FBgn0032669	CG15155	HGNC:37865		GLYATL1B	3		
FBgn0032670	CG5783	HGNC:21349	OMIM:614763	GLYATL3	6		
FBgn0032670	CG5783	HGNC:30519	OMIM:614761	GLYATL1	5		
FBgn0032670	CG5783	HGNC:24178	OMIM:614762	GLYATL2	5		
FBgn0032670	CG5783	HGNC:13734	OMIM:607424	GLYAT	6		
FBgn0032670	CG5783	HGNC:37865		GLYATL1B	3		
FBgn0032677	CG5790	HGNC:1745	OMIM:603311	CDC7	13		
FBgn0000636	Fas3	HGNC:17664	OMIM:607147	NECTIN3	3		
FBgn0051787	CG31787	HGNC:28889		TMED3	3		
FBgn0051787	CG31787	HGNC:17291	OMIM:605395	TMED1	8		
FBgn0051787	CG31787	HGNC:24251	OMIM:616876	TMED5	9		
FBgn0051802	CG31802	HGNC:1867	OMIM:300006	CETN2	6		
FBgn0051802	CG31802	HGNC:1868	OMIM:602907	CETN3	4		
FBgn0051802	CG31802	HGNC:1866	OMIM:603187	CETN1	5		
FBgn0032671	JMJD4	HGNC:25724		JMJD4	12		
FBgn0032680	Ntf-2r	HGNC:13722	OMIM:605813	NUTF2	13		
FBgn0032684	Ugt301D1	HGNC:12531	OMIM:606435	UGT1A10	5		
FBgn0032684	Ugt301D1	HGNC:12545	OMIM:603064	UGT2B11	7		
FBgn0032684	Ugt301D1	HGNC:12530	OMIM:191740	UGT1A1	7	143500,218800,237900,601816,606785	143500[GILBERT SYNDROME],218800[CRIGLER-NAJJAR SYNDROME, TYPE I],237900[HYPERBILIRUBINEMIA, TRANSIENT FAMILIAL NEONATAL; HBLRTFN],601816[BILIRUBIN, SERUM LEVEL OF, QUANTITATIVE TRAIT LOCUS 1; BILIQTL1],606785[CRIGLER-NAJJAR SYNDROME, TYPE II]
FBgn0032684	Ugt301D1	HGNC:12555	OMIM:601291	UGT8	6		
FBgn0032684	Ugt301D1	HGNC:12539	OMIM:606432	UGT1A7	5		
FBgn0032684	Ugt301D1	HGNC:13479	OMIM:606497	UGT2B28	6		
FBgn0032684	Ugt301D1	HGNC:27266	OMIM:616384	UGT3A2	3		
FBgn0032684	Ugt301D1	HGNC:12544	OMIM:600070	UGT2B10	7		
FBgn0032684	Ugt301D1	HGNC:12537	OMIM:606430	UGT1A5	5		
FBgn0032684	Ugt301D1	HGNC:12546	OMIM:600069	UGT2B15	7		
FBgn0032684	Ugt301D1	HGNC:12541	OMIM:606434	UGT1A9	5		
FBgn0032684	Ugt301D1	HGNC:28528	OMIM:616382	UGT2A3	7		
FBgn0032684	Ugt301D1	HGNC:12535	OMIM:606428	UGT1A3	6		
FBgn0032684	Ugt301D1	HGNC:12536	OMIM:606429	UGT1A4	5		
FBgn0032684	Ugt301D1	HGNC:12540	OMIM:606433	UGT1A8	5		
FBgn0032684	Ugt301D1	HGNC:26625	OMIM:616383	UGT3A1	3		
FBgn0032684	Ugt301D1	HGNC:12547	OMIM:601903	UGT2B17	7	612560	612560[BONE MINERAL DENSITY QUANTITATIVE TRAIT LOCUS 12; BMND12]
FBgn0032684	Ugt301D1	HGNC:12553	OMIM:600067	UGT2B4	7		
FBgn0032684	Ugt301D1	HGNC:12538	OMIM:606431	UGT1A6	5		
FBgn0032684	Ugt301D1	HGNC:12554	OMIM:600068	UGT2B7	7		
FBgn0032684	Ugt301D1	HGNC:28183	OMIM:619809	UGT2A2	6		
FBgn0032685	CG10211	HGNC:6678	OMIM:150205	LPO	3		
FBgn0032685	CG10211	HGNC:7218	OMIM:606989	MPO	4	104300,254600	104300[ALZHEIMER DISEASE, FAMILIAL, 1; AD1],254600[MYELOPEROXIDASE DEFICIENCY; MPOD]
FBgn0032685	CG10211	HGNC:3423	OMIM:131399	EPX	3	261500	261500[EOSINOPHIL PEROXIDASE DEFICIENCY; EPXD]
FBgn0032688	CG15160	HGNC:29039	OMIM:614695	RPRD2	11		
FBgn0032688	CG15160	HGNC:16209	OMIM:614694	RPRD1B	3		
FBgn0032688	CG15160	HGNC:25560	OMIM:610347	RPRD1A	3		
FBgn0032690	CG10333	HGNC:17347	OMIM:612172	DDX23	15		
FBgn0032693	Cyp310a1	HGNC:2638	OMIM:605325	CYP3A5	3	145500	145500[HYPERTENSION, ESSENTIAL]
FBgn0032693	Cyp310a1	HGNC:17450	OMIM:606534	CYP3A43	3		
FBgn0032693	Cyp310a1	HGNC:11609	OMIM:274180	TBXAS1	3	231095	231095[GHOSAL HEMATODIAPHYSEAL DYSPLASIA; GHDD]
FBgn0032693	Cyp310a1	HGNC:2637	OMIM:124010	CYP3A4	3	619073	619073[VITAMIN D-DEPENDENT RICKETS, TYPE 3; VDDR3]
FBgn0032693	Cyp310a1	HGNC:51504		CYP3A7-CYP3A51P	3		
FBgn0032692	IFT46	HGNC:26146		IFT46	10		
FBgn0032691	Atac2	HGNC:15904	OMIM:617501	KAT14	13		
FBgn0032689	CG10413	HGNC:17435	OMIM:616861	SLC12A9	15		
FBgn0003270	amos	HGNC:797	OMIM:601461	ATOH1	6		
FBgn0003270	amos	HGNC:13907	OMIM:609875	ATOH7	5	221900	221900[PERSISTENT HYPERPLASTIC PRIMARY VITREOUS, AUTOSOMAL RECESSIVE; PHPVAR]
FBgn0032683	kon	HGNC:2466	OMIM:601172	CSPG4	13		
FBgn0032681	CG10283	HGNC:18111	OMIM:611051	CCDC50	7	607453	607453[DEAFNESS, AUTOSOMAL DOMINANT 44; DFNA44]
FBgn0032698	CG10336	HGNC:30750	OMIM:610716	TIPIN	10		
FBgn0032700	CG10338	HGNC:25848		C16orf58	12		
FBgn0032701	CG10341	HGNC:25126	OMIM:617868	NAF1	12		
FBgn0032703	CG10343	HGNC:23750		RWDD4	14		
FBgn0032705	Grip71	HGNC:7723	OMIM:600372	NEDD1	6		
FBgn0027074	Ugt36F1	HGNC:12531	OMIM:606435	UGT1A10	3		
FBgn0027074	Ugt36F1	HGNC:12545	OMIM:603064	UGT2B11	5		
FBgn0027074	Ugt36F1	HGNC:12530	OMIM:191740	UGT1A1	5	143500,218800,237900,601816,606785	143500[GILBERT SYNDROME],218800[CRIGLER-NAJJAR SYNDROME, TYPE I],237900[HYPERBILIRUBINEMIA, TRANSIENT FAMILIAL NEONATAL; HBLRTFN],601816[BILIRUBIN, SERUM LEVEL OF, QUANTITATIVE TRAIT LOCUS 1; BILIQTL1],606785[CRIGLER-NAJJAR SYNDROME, TYPE II]
FBgn0027074	Ugt36F1	HGNC:12555	OMIM:601291	UGT8	5		
FBgn0027074	Ugt36F1	HGNC:12539	OMIM:606432	UGT1A7	3		
FBgn0027074	Ugt36F1	HGNC:13479	OMIM:606497	UGT2B28	5		
FBgn0027074	Ugt36F1	HGNC:27266	OMIM:616384	UGT3A2	4		
FBgn0027074	Ugt36F1	HGNC:12544	OMIM:600070	UGT2B10	5		
FBgn0027074	Ugt36F1	HGNC:12537	OMIM:606430	UGT1A5	3		
FBgn0027074	Ugt36F1	HGNC:12546	OMIM:600069	UGT2B15	5		
FBgn0027074	Ugt36F1	HGNC:12541	OMIM:606434	UGT1A9	3		
FBgn0027074	Ugt36F1	HGNC:28528	OMIM:616382	UGT2A3	5		
FBgn0027074	Ugt36F1	HGNC:12535	OMIM:606428	UGT1A3	5		
FBgn0027074	Ugt36F1	HGNC:12536	OMIM:606429	UGT1A4	3		
FBgn0027074	Ugt36F1	HGNC:12540	OMIM:606433	UGT1A8	3		
FBgn0027074	Ugt36F1	HGNC:26625	OMIM:616383	UGT3A1	4		
FBgn0027074	Ugt36F1	HGNC:12547	OMIM:601903	UGT2B17	5	612560	612560[BONE MINERAL DENSITY QUANTITATIVE TRAIT LOCUS 12; BMND12]
FBgn0027074	Ugt36F1	HGNC:12553	OMIM:600067	UGT2B4	5		
FBgn0027074	Ugt36F1	HGNC:12538	OMIM:606431	UGT1A6	3		
FBgn0027074	Ugt36F1	HGNC:12554	OMIM:600068	UGT2B7	5		
FBgn0027074	Ugt36F1	HGNC:28183	OMIM:619809	UGT2A2	4		
FBgn0032713	Ugt36D1	HGNC:12531	OMIM:606435	UGT1A10	3		
FBgn0032713	Ugt36D1	HGNC:12545	OMIM:603064	UGT2B11	5		
FBgn0032713	Ugt36D1	HGNC:12530	OMIM:191740	UGT1A1	5	143500,218800,237900,601816,606785	143500[GILBERT SYNDROME],218800[CRIGLER-NAJJAR SYNDROME, TYPE I],237900[HYPERBILIRUBINEMIA, TRANSIENT FAMILIAL NEONATAL; HBLRTFN],601816[BILIRUBIN, SERUM LEVEL OF, QUANTITATIVE TRAIT LOCUS 1; BILIQTL1],606785[CRIGLER-NAJJAR SYNDROME, TYPE II]
FBgn0032713	Ugt36D1	HGNC:12555	OMIM:601291	UGT8	5		
FBgn0032713	Ugt36D1	HGNC:12539	OMIM:606432	UGT1A7	3		
FBgn0032713	Ugt36D1	HGNC:13479	OMIM:606497	UGT2B28	5		
FBgn0032713	Ugt36D1	HGNC:27266	OMIM:616384	UGT3A2	4		
FBgn0032713	Ugt36D1	HGNC:12544	OMIM:600070	UGT2B10	5		
FBgn0032713	Ugt36D1	HGNC:12537	OMIM:606430	UGT1A5	3		
FBgn0032713	Ugt36D1	HGNC:12546	OMIM:600069	UGT2B15	5		
FBgn0032713	Ugt36D1	HGNC:12541	OMIM:606434	UGT1A9	3		
FBgn0032713	Ugt36D1	HGNC:28528	OMIM:616382	UGT2A3	5		
FBgn0032713	Ugt36D1	HGNC:12535	OMIM:606428	UGT1A3	5		
FBgn0032713	Ugt36D1	HGNC:12536	OMIM:606429	UGT1A4	3		
FBgn0032713	Ugt36D1	HGNC:12540	OMIM:606433	UGT1A8	3		
FBgn0032713	Ugt36D1	HGNC:26625	OMIM:616383	UGT3A1	4		
FBgn0032713	Ugt36D1	HGNC:12547	OMIM:601903	UGT2B17	5	612560	612560[BONE MINERAL DENSITY QUANTITATIVE TRAIT LOCUS 12; BMND12]
FBgn0032713	Ugt36D1	HGNC:12553	OMIM:600067	UGT2B4	5		
FBgn0032713	Ugt36D1	HGNC:12538	OMIM:606431	UGT1A6	3		
FBgn0032713	Ugt36D1	HGNC:12554	OMIM:600068	UGT2B7	5		
FBgn0032713	Ugt36D1	HGNC:28183	OMIM:619809	UGT2A2	4		
FBgn0027070	Ugt36E1	HGNC:12531	OMIM:606435	UGT1A10	4		
FBgn0027070	Ugt36E1	HGNC:12545	OMIM:603064	UGT2B11	6		
FBgn0027070	Ugt36E1	HGNC:12530	OMIM:191740	UGT1A1	6	143500,218800,237900,601816,606785	143500[GILBERT SYNDROME],218800[CRIGLER-NAJJAR SYNDROME, TYPE I],237900[HYPERBILIRUBINEMIA, TRANSIENT FAMILIAL NEONATAL; HBLRTFN],601816[BILIRUBIN, SERUM LEVEL OF, QUANTITATIVE TRAIT LOCUS 1; BILIQTL1],606785[CRIGLER-NAJJAR SYNDROME, TYPE II]
FBgn0027070	Ugt36E1	HGNC:12555	OMIM:601291	UGT8	7		
FBgn0027070	Ugt36E1	HGNC:12539	OMIM:606432	UGT1A7	4		
FBgn0027070	Ugt36E1	HGNC:13479	OMIM:606497	UGT2B28	6		
FBgn0027070	Ugt36E1	HGNC:27266	OMIM:616384	UGT3A2	4		
FBgn0027070	Ugt36E1	HGNC:12544	OMIM:600070	UGT2B10	6		
FBgn0027070	Ugt36E1	HGNC:12537	OMIM:606430	UGT1A5	4		
FBgn0027070	Ugt36E1	HGNC:12546	OMIM:600069	UGT2B15	6		
FBgn0027070	Ugt36E1	HGNC:12541	OMIM:606434	UGT1A9	4		
FBgn0027070	Ugt36E1	HGNC:28528	OMIM:616382	UGT2A3	6		
FBgn0027070	Ugt36E1	HGNC:12535	OMIM:606428	UGT1A3	6		
FBgn0027070	Ugt36E1	HGNC:12536	OMIM:606429	UGT1A4	4		
FBgn0027070	Ugt36E1	HGNC:12540	OMIM:606433	UGT1A8	4		
FBgn0027070	Ugt36E1	HGNC:26625	OMIM:616383	UGT3A1	4		
FBgn0027070	Ugt36E1	HGNC:12547	OMIM:601903	UGT2B17	6	612560	612560[BONE MINERAL DENSITY QUANTITATIVE TRAIT LOCUS 12; BMND12]
FBgn0027070	Ugt36E1	HGNC:12553	OMIM:600067	UGT2B4	6		
FBgn0027070	Ugt36E1	HGNC:12538	OMIM:606431	UGT1A6	4		
FBgn0027070	Ugt36E1	HGNC:12554	OMIM:600068	UGT2B7	6		
FBgn0027070	Ugt36E1	HGNC:28183	OMIM:619809	UGT2A2	5		
FBgn0015808	ScpX	HGNC:10606	OMIM:184755	SCP2	14	613724	613724[LEUKOENCEPHALOPATHY WITH DYSTONIA AND MOTOR NEUROPATHY; LKDMN]
FBgn0015808	ScpX	HGNC:16211		SCP2D1	3		
FBgn0003896	tup	HGNC:18524	OMIM:609481	ISL2	11		
FBgn0003896	tup	HGNC:6132	OMIM:600366	ISL1	14		
FBgn0032717	CG10600	HGNC:24765		RSBN1L	10		
FBgn0032717	CG10600	HGNC:25642	OMIM:615858	RSBN1	10		
FBgn0032715	CG17597	HGNC:10606	OMIM:184755	SCP2	12	613724	613724[LEUKOENCEPHALOPATHY WITH DYSTONIA AND MOTOR NEUROPATHY; LKDMN]
FBgn0045852	ham	HGNC:14000	OMIM:605557	PRDM16	10	615373	615373[LEFT VENTRICULAR NONCOMPACTION 8; LVNC8]
FBgn0045852	ham	HGNC:3498	OMIM:165215	MECOM	12	616738	616738[RADIOULNAR SYNOSTOSIS WITH AMEGAKARYOCYTIC THROMBOCYTOPENIA 2; RUSAT2]
FBgn0032707	CG10348	HGNC:14000	OMIM:605557	PRDM16	5	615373	615373[LEFT VENTRICULAR NONCOMPACTION 8; LVNC8]
FBgn0032707	CG10348	HGNC:3498	OMIM:165215	MECOM	7	616738	616738[RADIOULNAR SYNOSTOSIS WITH AMEGAKARYOCYTIC THROMBOCYTOPENIA 2; RUSAT2]
FBgn0032706	Irk3	HGNC:6270	OMIM:600932	KCNJ9	4		
FBgn0032706	Irk3	HGNC:6262	OMIM:605722	KCNJ16	4	619406	619406[HYPOKALEMIC TUBULOPATHY AND DEAFNESS; HKTD]
FBgn0032706	Irk3	HGNC:6263	OMIM:600681	KCNJ2	3	170390,609622,613980	170390[ANDERSEN CARDIODYSRHYTHMIC PERIODIC PARALYSIS],609622[SHORT QT SYNDROME 3; SQT3],613980[ATRIAL FIBRILLATION, FAMILIAL, 9; ATFB9]
FBgn0032706	Irk3	HGNC:6255	OMIM:600359	KCNJ1	4	241200	241200[BARTTER SYNDROME, TYPE 2, ANTENATAL; BARTS2]
FBgn0032706	Irk3	HGNC:6258	OMIM:602323	KCNJ12	3		
FBgn0032706	Irk3	HGNC:6267	OMIM:600877	KCNJ6	3	614098	614098[KEPPEN-LUBINSKY SYNDROME; KPLBS]
FBgn0032706	Irk3	HGNC:6265	OMIM:600504	KCNJ4	3		
FBgn0032706	Irk3	HGNC:6264	OMIM:601534	KCNJ3	3		
FBgn0032706	Irk3	HGNC:39080	OMIM:613236	KCNJ18	3	613239	613239[THYROTOXIC PERIODIC PARALYSIS, SUSCEPTIBILITY TO, 2; TTPP2]
FBgn0032706	Irk3	HGNC:6260	OMIM:603953	KCNJ14	3		
FBgn0032706	Irk3	HGNC:6269	OMIM:600935	KCNJ8	3		
FBgn0032706	Irk3	HGNC:6257	OMIM:600937	KCNJ11	3	125853,601820,610582,616329,618856	125853[TYPE 2 DIABETES MELLITUS; T2D],601820[HYPERINSULINEMIC HYPOGLYCEMIA, FAMILIAL, 2; HHF2],610582[DIABETES MELLITUS, TRANSIENT NEONATAL, 3],616329[MATURITY-ONSET DIABETES OF THE YOUNG, TYPE 13; MODY13],618856[DIABETES MELLITUS, PERMANENT NEONATAL, 2; PNDM2]
FBgn0032706	Irk3	HGNC:6256	OMIM:602208	KCNJ10	5	600791,612780	600791[DEAFNESS, AUTOSOMAL RECESSIVE 4, WITH ENLARGED VESTIBULAR AQUEDUCT; DFNB4],612780[SEIZURES, SENSORINEURAL DEAFNESS, ATAXIA, MENTAL RETARDATION, AND ELECTROLYTE IMBALANCE; SESAMES]
FBgn0032706	Irk3	HGNC:6261	OMIM:602106	KCNJ15	5		
FBgn0032706	Irk3	HGNC:6259	OMIM:603208	KCNJ13	4	193230,614186	193230[VITREORETINAL DEGENERATION, SNOWFLAKE TYPE; SVD],614186[LEBER CONGENITAL AMAUROSIS 16; LCA16]
FBgn0025608	Faf2	HGNC:24666	OMIM:616935	FAF2	14		
FBgn0025608	Faf2	HGNC:30307	OMIM:602155	UBXN8	3		
FBgn0032704	Jwa	HGNC:16937	OMIM:605709	ARL6IP5	14		
FBgn0032704	Jwa	HGNC:28911	OMIM:300840	PRAF2	11		
FBgn0032702	CG10376	HGNC:19388	OMIM:619309	PPM1F	13		
FBgn0032702	CG10376	HGNC:19322	OMIM:619308	PPM1E	12		
FBgn0032702	CG10376	HGNC:9275	OMIM:606108	PPM1A	3		
FBgn0032702	CG10376	HGNC:25415	OMIM:611065	PPM1K	3	615135	615135[MAPLE SYRUP URINE DISEASE, MILD VARIANT; MSUDMV]
FBgn0005617	msl-1	HGNC:27905	OMIM:614801	MSL1	9		
FBgn0015553	tos	HGNC:3511	OMIM:606063	EXO1	11		
FBgn0032724	CG10428	HGNC:25806	OMIM:615912	GSTCD	15		
FBgn0032728	Tango6	HGNC:25749		TANGO6	9		
FBgn0032732	EMC5	HGNC:28100		MMGT1	13		
FBgn0051792	CG31792	HGNC:55	OMIM:605250	ABCC4	12		
FBgn0051792	CG31792	HGNC:52	OMIM:612509	ABCC10	5		
FBgn0051792	CG31792	HGNC:53	OMIM:601107	ABCC2	5	237500	237500[DUBIN-JOHNSON SYNDROME; DJS]
FBgn0051792	CG31792	HGNC:51	OMIM:158343	ABCC1	5	618915	618915[DEAFNESS, AUTOSOMAL DOMINANT 77; DFNA77]
FBgn0051792	CG31792	HGNC:59	OMIM:600509	ABCC8	5	125853,240800,256450,610374,618857	125853[TYPE 2 DIABETES MELLITUS; T2D],240800[HYPOGLYCEMIA, LEUCINE-INDUCED; LIH],256450[HYPERINSULINEMIC HYPOGLYCEMIA, FAMILIAL, 1; HHF1],610374[DIABETES MELLITUS, TRANSIENT NEONATAL, 2; TNDM2],618857[DIABETES MELLITUS, PERMANENT NEONATAL, 3; PNDM3]
FBgn0051792	CG31792	HGNC:14640	OMIM:607041	ABCC12	5		
FBgn0051792	CG31792	HGNC:60	OMIM:601439	ABCC9	5	239850,608569,614050,619719	239850[CANTU SYNDROME],608569[CARDIOMYOPATHY, DILATED, 1O; CMD1O],614050[ATRIAL FIBRILLATION, FAMILIAL, 12; ATFB12],619719[INTELLECTUAL DISABILITY AND MYOPATHY SYNDROME; IDMYS]
FBgn0051792	CG31792	HGNC:57	OMIM:603234	ABCC6	5	177850,264800,614473	177850[PSEUDOXANTHOMA ELASTICUM, FORME FRUSTE],264800[PSEUDOXANTHOMA ELASTICUM; PXE],614473[ARTERIAL CALCIFICATION, GENERALIZED, OF INFANCY, 2; GACI2]
FBgn0051792	CG31792	HGNC:56	OMIM:605251	ABCC5	6		
FBgn0051792	CG31792	HGNC:14639	OMIM:607040	ABCC11	5	117800	117800[APOCRINE GLAND SECRETION, VARIATION IN]
FBgn0051792	CG31792	HGNC:54	OMIM:604323	ABCC3	5		
FBgn0051792	CG31792	HGNC:1884	OMIM:602421	CFTR	5	167800,211400,219700,277180	167800[PANCREATITIS, HEREDITARY; PCTT],211400[BRONCHIECTASIS WITH OR WITHOUT ELEVATED SWEAT CHLORIDE 1; BESC1],219700[CYSTIC FIBROSIS; CF],277180[VAS DEFERENS, CONGENITAL BILATERAL APLASIA OF; CBAVD]
FBgn0051793	CG31793	HGNC:55	OMIM:605250	ABCC4	10		
FBgn0051793	CG31793	HGNC:52	OMIM:612509	ABCC10	4		
FBgn0051793	CG31793	HGNC:53	OMIM:601107	ABCC2	4	237500	237500[DUBIN-JOHNSON SYNDROME; DJS]
FBgn0051793	CG31793	HGNC:51	OMIM:158343	ABCC1	4	618915	618915[DEAFNESS, AUTOSOMAL DOMINANT 77; DFNA77]
FBgn0051793	CG31793	HGNC:59	OMIM:600509	ABCC8	4	125853,240800,256450,610374,618857	125853[TYPE 2 DIABETES MELLITUS; T2D],240800[HYPOGLYCEMIA, LEUCINE-INDUCED; LIH],256450[HYPERINSULINEMIC HYPOGLYCEMIA, FAMILIAL, 1; HHF1],610374[DIABETES MELLITUS, TRANSIENT NEONATAL, 2; TNDM2],618857[DIABETES MELLITUS, PERMANENT NEONATAL, 3; PNDM3]
FBgn0051793	CG31793	HGNC:14640	OMIM:607041	ABCC12	4		
FBgn0051793	CG31793	HGNC:60	OMIM:601439	ABCC9	4	239850,608569,614050,619719	239850[CANTU SYNDROME],608569[CARDIOMYOPATHY, DILATED, 1O; CMD1O],614050[ATRIAL FIBRILLATION, FAMILIAL, 12; ATFB12],619719[INTELLECTUAL DISABILITY AND MYOPATHY SYNDROME; IDMYS]
FBgn0051793	CG31793	HGNC:57	OMIM:603234	ABCC6	4	177850,264800,614473	177850[PSEUDOXANTHOMA ELASTICUM, FORME FRUSTE],264800[PSEUDOXANTHOMA ELASTICUM; PXE],614473[ARTERIAL CALCIFICATION, GENERALIZED, OF INFANCY, 2; GACI2]
FBgn0051793	CG31793	HGNC:56	OMIM:605251	ABCC5	5		
FBgn0051793	CG31793	HGNC:14639	OMIM:607040	ABCC11	4	117800	117800[APOCRINE GLAND SECRETION, VARIATION IN]
FBgn0051793	CG31793	HGNC:54	OMIM:604323	ABCC3	4		
FBgn0051793	CG31793	HGNC:1884	OMIM:602421	CFTR	4	167800,211400,219700,277180	167800[PANCREATITIS, HEREDITARY; PCTT],211400[BRONCHIECTASIS WITH OR WITHOUT ELEVATED SWEAT CHLORIDE 1; BESC1],219700[CYSTIC FIBROSIS; CF],277180[VAS DEFERENS, CONGENITAL BILATERAL APLASIA OF; CBAVD]
FBgn0028569	robl37BC	HGNC:15467	OMIM:607168	DYNLRB2	5		
FBgn0028569	robl37BC	HGNC:15468	OMIM:607167	DYNLRB1	4		
FBgn0032741	Sidpn	HGNC:24149	OMIM:608060	HES4	4		
FBgn0032741	Sidpn	HGNC:5192	OMIM:139605	HES1	4		
FBgn0032741	Sidpn	HGNC:16005	OMIM:609970	HES2	5		
FBgn0032741	Sidpn	HGNC:19764	OMIM:607348	HES5	3		
FBgn0002022	Catsup	HGNC:4927	OMIM:601416	SLC39A7	14	619693	619693[AGAMMAGLOBULINEMIA 9, AUTOSOMAL RECESSIVE; AGM9]
FBgn0002022	Catsup	HGNC:20859	OMIM:608735	SLC39A13	4	612350	612350[EHLERS-DANLOS SYNDROME, SPONDYLODYSPLASTIC TYPE, 3; EDSSPD3]
FBgn0032746	CG10470	HGNC:18188	OMIM:614123	TMCO1	14	213980	213980[CRANIOFACIAL DYSMORPHISM, SKELETAL ANOMALIES, AND IMPAIRED INTELLECTUAL DEVELOPMENT SYNDROME 1; CFSMR1]
FBgn0032748	CG10492	HGNC:22916		ZCCHC2	5		
FBgn0032748	CG10492	HGNC:24134		ZCCHC14	4		
FBgn0032749	Phlpp	HGNC:20610	OMIM:609396	PHLPP1	10		
FBgn0032749	Phlpp	HGNC:29149	OMIM:611066	PHLPP2	9		
FBgn0032750	CG10495	HGNC:21517		DUS4L	14		
FBgn0000075	amd	HGNC:4855	OMIM:142704	HDC	3	137580	137580[GILLES DE LA TOURETTE SYNDROME; GTS]
FBgn0000075	amd	HGNC:2719	OMIM:107930	DDC	7	608643	608643[AROMATIC L-AMINO ACID DECARBOXYLASE DEFICIENCY; AADCD]
FBgn0002036	CG10561	HGNC:15862	OMIM:615854	SMOX	6		
FBgn0002036	CG10561	HGNC:20837	OMIM:615853	PAOX	6		
FBgn0010300	brat	HGNC:10064	OMIM:605493	TRIM3	7		
FBgn0010300	brat	HGNC:15974	OMIM:614141	TRIM2	6	615490	615490[CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2R; CMT2R]
FBgn0002031	Phb1	HGNC:8912	OMIM:176705	PHB1	13	114480	114480[BREAST CANCER]
FBgn0002031	Phb1	HGNC:30306	OMIM:610704	PHB2	3		
FBgn0000422	Ddc	HGNC:4855	OMIM:142704	HDC	4	137580	137580[GILLES DE LA TOURETTE SYNDROME; GTS]
FBgn0000422	Ddc	HGNC:2719	OMIM:107930	DDC	14	608643	608643[AROMATIC L-AMINO ACID DECARBOXYLASE DEFICIENCY; AADCD]
FBgn0002023	Lim3	HGNC:21734	OMIM:602146	LHX4	9	262700	262700[PITUITARY HORMONE DEFICIENCY, COMBINED, 4; CPHD4]
FBgn0002023	Lim3	HGNC:6595	OMIM:600577	LHX3	8	221750	221750[PITUITARY HORMONE DEFICIENCY, COMBINED, 3; CPHD3]
FBgn0032754	CG10700	HGNC:26398	OMIM:617298	AIFM3	14		
FBgn0032752	CG10702	HGNC:5465	OMIM:147370	IGF1R	4	270450	270450[INSULIN-LIKE GROWTH FACTOR I, RESISTANCE TO; IGF1RES]
FBgn0032752	CG10702	HGNC:6091	OMIM:147670	INSR	4	246200,262190,609968,610549	246200[DONOHUE SYNDROME],262190[PINEAL HYPERPLASIA, INSULIN-RESISTANT DIABETES MELLITUS, AND SOMATIC ABNORMALITIES],609968[HYPERINSULINEMIC HYPOGLYCEMIA, FAMILIAL, 5; HHF5],610549[DIABETES MELLITUS, INSULIN-RESISTANT, WITH ACANTHOSIS NIGRICANS]
FBgn0032752	CG10702	HGNC:6093	OMIM:147671	INSRR	5		
FBgn0002021	l(2)37Bb	HGNC:26927	OMIM:613622	FOXRED1	11	618241	618241[MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 19; MC1DN19]
FBgn0032744	Ttc19	HGNC:26006	OMIM:613814	TTC19	12	615157	615157[MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 2; MC3DN2]
FBgn0051800	CG31800	HGNC:28795		C1orf50	11		
FBgn0001202	hook	HGNC:19885	OMIM:607824	HOOK2	10		
FBgn0001202	hook	HGNC:23576	OMIM:607825	HOOK3	14		
FBgn0001202	hook	HGNC:19884	OMIM:607820	HOOK1	10		
FBgn0032731	Swip-1	HGNC:28670	OMIM:616450	EFHD2	15		
FBgn0032731	Swip-1	HGNC:29556	OMIM:611617	EFHD1	13		
FBgn0032729	L2HGDH	HGNC:20499	OMIM:609584	L2HGDH	14	236792	236792[L-2-HYDROXYGLUTARIC ACIDURIA; L2HGA]
FBgn0015772	Nak	HGNC:18041	OMIM:617648	BMP2K	7		
FBgn0015772	Nak	HGNC:19679	OMIM:616405	AAK1	10		
FBgn0032727	CG10623	HGNC:7468	OMIM:156570	MTR	4	250940,601634	250940[HOMOCYSTINURIA-MEGALOBLASTIC ANEMIA, cblG COMPLEMENTATION TYPE; HMAG],601634[NEURAL TUBE DEFECTS, FOLATE-SENSITIVE; NTDFS]
FBgn0032727	CG10623	HGNC:1048	OMIM:605932	BHMT2	3		
FBgn0032726	CG10621	HGNC:7468	OMIM:156570	MTR	4	250940,601634	250940[HOMOCYSTINURIA-MEGALOBLASTIC ANEMIA, cblG COMPLEMENTATION TYPE; HMAG],601634[NEURAL TUBE DEFECTS, FOLATE-SENSITIVE; NTDFS]
FBgn0032726	CG10621	HGNC:1048	OMIM:605932	BHMT2	3		
FBgn0032725	Nedd8	HGNC:10417	OMIM:191343	RPS27A	3		
FBgn0032725	Nedd8	HGNC:7732	OMIM:603171	NEDD8	14		
FBgn0032723	ssp3	HGNC:13081	OMIM:611611	SCAPER	13	618195	618195[INTELLECTUAL DEVELOPMENTAL DISORDER AND RETINITIS PIGMENTOSA; IDDRP]
FBgn0010309	pigeon	HGNC:28042	OMIM:613552	GSAP	12		
FBgn0015380	drl	HGNC:10481	OMIM:600524	RYK	12		
FBgn0032769	CG10750	HGNC:37100		CFAP73	9		
FBgn0032769	CG10750	HGNC:26528		CCDC42	8		
FBgn0032771	CG17349	HGNC:19152	OMIM:608427	PACRG	6		
FBgn0032771	CG17349	HGNC:28442		PACRGL	3		
FBgn0016675	Lectin-galC1	HGNC:14554	OMIM:609964	CLEC4D	3		
FBgn0032779	Alp12	HGNC:438	OMIM:171760	ALPL	8	146300,241500,241510	146300[HYPOPHOSPHATASIA, ADULT; HPPA],241500[HYPOPHOSPHATASIA, INFANTILE; HPPI],241510[HYPOPHOSPHATASIA, CHILDHOOD; HPPC]
FBgn0032779	Alp12	HGNC:441	OMIM:171810	ALPG	7		
FBgn0032779	Alp12	HGNC:439	OMIM:171800	ALPP	8		
FBgn0032779	Alp12	HGNC:437	OMIM:171740	ALPI	7		
FBgn0032781	RtcB	HGNC:26935	OMIM:613901	RTCB	14		
FBgn0032782	Rab9	HGNC:14090	OMIM:300285	RAB9B	9		
FBgn0032782	Rab9	HGNC:9792	OMIM:300284	RAB9A	9		
FBgn0032783	CG10237	HGNC:12404	OMIM:600415	TTPA	3	277460	277460[ATAXIA WITH VITAMIN E DEFICIENCY; AVED]
FBgn0032783	CG10237	HGNC:16114		TTPAL	10		
FBgn0032783	CG10237	HGNC:10024	OMIM:180090	RLBP1	3	136880,607475,607476	136880[FUNDUS ALBIPUNCTATUS],607475[BOTHNIA RETINAL DYSTROPHY],607476[NEWFOUNDLAND ROD-CONE DYSTROPHY; NFRCD]
FBgn0032783	CG10237	HGNC:23046	OMIM:616945	CLVS2	4		
FBgn0032783	CG10237	HGNC:23139	OMIM:611292	CLVS1	3		
FBgn0032775	CG17544	HGNC:121	OMIM:603402	ACOX3	10		
FBgn0032775	CG17544	HGNC:25621		ACOXL	3		
FBgn0024245	dnt	HGNC:10481	OMIM:600524	RYK	12		
FBgn0032768	CG17564	HGNC:37100		CFAP73	8		
FBgn0032768	CG17564	HGNC:26528		CCDC42	8		
FBgn0010097	gammaTub37C	HGNC:12417	OMIM:191135	TUBG1	13	615412	615412[CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 4; CDCBM4]
FBgn0010097	gammaTub37C	HGNC:12419	OMIM:605785	TUBG2	12		
FBgn0003346	RanGAP	HGNC:9854	OMIM:602362	RANGAP1	13		
FBgn0032785	CG10026	HGNC:12404	OMIM:600415	TTPA	5	277460	277460[ATAXIA WITH VITAMIN E DEFICIENCY; AVED]
FBgn0032785	CG10026	HGNC:16114		TTPAL	4		
FBgn0032785	CG10026	HGNC:10024	OMIM:180090	RLBP1	3	136880,607475,607476	136880[FUNDUS ALBIPUNCTATUS],607475[BOTHNIA RETINAL DYSTROPHY],607476[NEWFOUNDLAND ROD-CONE DYSTROPHY; NFRCD]
FBgn0032785	CG10026	HGNC:23046	OMIM:616945	CLVS2	3		
FBgn0032785	CG10026	HGNC:23139	OMIM:611292	CLVS1	3		
FBgn0000964	tj	HGNC:6776	OMIM:177075	MAF	9	601088,610202	601088[AYME-GRIPP SYNDROME; AYGRP],610202[CATARACT 21, MULTIPLE TYPES; CTRCT21]
FBgn0000964	tj	HGNC:23145	OMIM:610303	MAFA	8	147630	147630[INSULINOMATOSIS AND DIABETES MELLITUS; INSDM]
FBgn0000964	tj	HGNC:6780	OMIM:604877	MAFF	4		
FBgn0000964	tj	HGNC:6408	OMIM:608968	MAFB	9	166300,617041	166300[MULTICENTRIC CARPOTARSAL OSTEOLYSIS SYNDROME; MCTO],617041[DUANE RETRACTION SYNDROME 3 WITH OR WITHOUT DEAFNESS; DURS3]
FBgn0000964	tj	HGNC:6782	OMIM:600197	MAFK	4		
FBgn0000964	tj	HGNC:6781	OMIM:602020	MAFG	3		
FBgn0000964	tj	HGNC:8002	OMIM:162080	NRL	7	613750	613750[RETINITIS PIGMENTOSA 27; RP27]
FBgn0032791	CG18094	HGNC:32036		NUDT19	9		
FBgn0002044	swm	HGNC:29243		RBM27	13		
FBgn0002044	swm	HGNC:20327		RBM26	14		
FBgn0040268	Top3alpha	HGNC:11992	OMIM:601243	TOP3A	14	618097,618098	618097[MICROCEPHALY, GROWTH RESTRICTION, AND INCREASED SISTER CHROMATID EXCHANGE 2; MGRISCE2],618098[PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL RECESSIVE 5; PEOB5]
FBgn0032800	CG10137	HGNC:24866	OMIM:616690	CEP104	14	616781,619988	616781[JOUBERT SYNDROME 25; JBTS25],619988[INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 77; MRT77]
FBgn0053116	CG33116	HGNC:24289	OMIM:616751	CEPT1	3		
FBgn0053116	CG33116	HGNC:29361	OMIM:607915	SELENOI	14	618768	618768[SPASTIC PARAPLEGIA 81, AUTOSOMAL RECESSIVE; SPG81]
FBgn0041180	Tep4	HGNC:21685	OMIM:608859	CD109	11		
FBgn0041180	Tep4	HGNC:1318	OMIM:120700	C3	4	611378,612925,613779	611378[MACULAR DEGENERATION, AGE-RELATED, 9; ARMD9],612925[HEMOLYTIC UREMIC SYNDROME, ATYPICAL, SUSCEPTIBILITY TO, 5; AHUS5],613779[COMPLEMENT COMPONENT 3 DEFICIENCY, AUTOSOMAL RECESSIVE; C3D]
FBgn0041180	Tep4	HGNC:1323	OMIM:120810	C4A	4	614374,614380	614374[BLOOD GROUP, CHIDO/RODGERS SYSTEM],614380[COMPLEMENT COMPONENT 4A DEFICIENCY; C4AD]
FBgn0041180	Tep4	HGNC:1324	OMIM:120820	C4B	4	614379	614379[COMPLEMENT COMPONENT 4B DEFICIENCY; C4BD]
FBgn0041180	Tep4	HGNC:1331	OMIM:120900	C5	5	609536,615749	609536[COMPLEMENT COMPONENT 5 DEFICIENCY; C5D],615749[ECULIZUMAB, POOR RESPONSE TO]
FBgn0041180	Tep4	HGNC:9750	OMIM:176420	PZP	5		
FBgn0041180	Tep4	HGNC:7	OMIM:103950	A2M	5		
FBgn0041180	Tep4	HGNC:23336	OMIM:610627	A2ML1	5	166760	166760[OTITIS MEDIA, SUSCEPTIBILITY TO; OMS]
FBgn0041180	Tep4	HGNC:23228	OMIM:608841	CPAMD8	3	617319	617319[ANTERIOR SEGMENT DYSGENESIS 8; ASGD8]
FBgn0032809	CG13078	HGNC:30253	OMIM:607068	CYB561D2	7		
FBgn0032809	CG13078	HGNC:26804		CYB561D1	7		
FBgn0032810	CG13077	HGNC:30253	OMIM:607068	CYB561D2	7		
FBgn0032810	CG13077	HGNC:26804		CYB561D1	7		
FBgn0000464	Lar	HGNC:9681	OMIM:601576	PTPRS	10		
FBgn0000464	Lar	HGNC:9668	OMIM:601598	PTPRD	12		
FBgn0000464	Lar	HGNC:9670	OMIM:179590	PTPRF	11	616001	616001[BREASTS AND/OR NIPPLES, APLASIA OR HYPOPLASIA OF, 2; BNAH2]
FBgn0005590	scw	HGNC:1072	OMIM:112265	BMP5	8		
FBgn0005590	scw	HGNC:1073	OMIM:112266	BMP6	7		
FBgn0005590	scw	HGNC:1074	OMIM:112267	BMP7	7		
FBgn0005590	scw	HGNC:21650		BMP8A	7		
FBgn0005590	scw	HGNC:1075	OMIM:602284	BMP8B	6		
FBgn0032813	PCNA2	HGNC:8729	OMIM:176740	PCNA	9	615919	615919[ATAXIA-TELANGIECTASIA-LIKE DISORDER 2; ATLD2]
FBgn0032811	Pmvk	HGNC:9141	OMIM:607622	PMVK	14	175800	175800[POROKERATOSIS 1, MULTIPLE TYPES; POROK1]
FBgn0032801	CG10165	HGNC:30253	OMIM:607068	CYB561D2	9		
FBgn0032801	CG10165	HGNC:26804		CYB561D1	5		
FBgn0032799	Dpm1	HGNC:3005	OMIM:603503	DPM1	14	608799	608799[CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Ie; CDG1E]
FBgn0032797	Hasp	HGNC:2334	OMIM:120620	CR1	4	607486,611162	607486[KNOPS BLOOD GROUP SYSTEM; KN],611162[MALARIA, SUSCEPTIBILITY TO]
FBgn0032797	Hasp	HGNC:15985	OMIM:611691	SVEP1	5		
FBgn0032797	Hasp	HGNC:4883	OMIM:134370	CFH	3	126700,235400,609814,610698	126700[BASAL LAMINAR DRUSEN],235400[HEMOLYTIC UREMIC SYNDROME, ATYPICAL, SUSCEPTIBILITY TO, 1; AHUS1],609814[COMPLEMENT FACTOR H DEFICIENCY; CFHD],610698[MACULAR DEGENERATION, AGE-RELATED, 4; ARMD4]
FBgn0032796	cyst	HGNC:682	OMIM:607560	ARHGEF2	10	617523	617523[NEURODEVELOPMENTAL DISORDER WITH MIDBRAIN AND HINDBRAIN MALFORMATIONS; NEDMHM]
FBgn0032796	cyst	HGNC:371	OMIM:604686	AKAP13	7		
FBgn0032796	cyst	HGNC:17090	OMIM:616432	ARHGEF18	12	617433	617433[RETINITIS PIGMENTOSA 78; RP78]
FBgn0032796	cyst	HGNC:30322	OMIM:612790	ARHGEF28	9		
FBgn0032793	CG10189	HGNC:28005	OMIM:617057	CTU2	12	618142	618142[MICROCEPHALY, FACIAL DYSMORPHISM, RENAL AGENESIS, AND AMBIGUOUS GENITALIA SYNDROME; MFRG]
FBgn0032790	CG10194	HGNC:32036		NUDT19	14		
FBgn0032787	CG10195	HGNC:32036		NUDT19	9		
FBgn0024230	Hs2st	HGNC:5193	OMIM:604844	HS2ST1	14	619194	619194[NEUROFACIOSKELETAL SYNDROME WITH OR WITHOUT RENAL AGENESIS; NFSRA]
FBgn0032816	Nf-YB	HGNC:7805	OMIM:189904	NFYB	13		
FBgn0032819	CG10463	HGNC:26920		DUS3L	14		
FBgn0032822	CG10466	HGNC:24282		RBMX2	11		
FBgn0032833	COX4	HGNC:16232	OMIM:607976	COX4I2	12	612714	612714[EXOCRINE PANCREATIC INSUFFICIENCY, DYSERYTHROPOIETIC ANEMIA, AND CALVARIAL HYPEROSTOSIS]
FBgn0032833	COX4	HGNC:2265	OMIM:123864	COX4I1	13	619060	619060[MITOCHONDRIAL COMPLEX IV DEFICIENCY, NUCLEAR TYPE 16; MC4DN16]
FBgn0032827	CG10481	HGNC:12827	OMIM:605237	XPR1	6	616413	616413[BASAL GANGLIA CALCIFICATION, IDIOPATHIC, 6; IBGC6]
FBgn0004811	fs(2)ltoPP43	HGNC:25807	OMIM:619192	SLC7A6OS	8	619191	619191[EPILEPSY, PROGRESSIVE MYOCLONIC, 12; EPM12]
FBgn0032821	CdGAPr	HGNC:17399	OMIM:608541	ARHGAP32	9		
FBgn0032821	CdGAPr	HGNC:23085	OMIM:614902	ARHGAP33	9		
FBgn0032821	CdGAPr	HGNC:29216	OMIM:610911	ARHGAP31	5	100300	100300[ADAMS-OLIVER SYNDROME 1; AOS1]
FBgn0032821	CdGAPr	HGNC:27414	OMIM:614264	ARHGAP30	4		
FBgn0032820	fbp	HGNC:3607	OMIM:603027	FBP2	14	619864	619864[LEUKODYSTROPHY, CHILDHOOD-ONSET, REMITTING; CORLK]
FBgn0032820	fbp	HGNC:3606	OMIM:611570	FBP1	13	229700	229700[FRUCTOSE-1,6-BISPHOSPHATASE DEFICIENCY; FBP1D]
FBgn0032818	CG10628	HGNC:25106	OMIM:610920	GTPBP10	14		
FBgn0032818	CG10628	HGNC:16239	OMIM:610919	MTG2	3		
FBgn0019686	lok	HGNC:16627	OMIM:604373	CHEK2	13	114480,114500,176807,259500,609265	114480[BREAST CANCER],114500[COLORECTAL CANCER; CRC],176807[PROSTATE CANCER],259500[OSTEOGENIC SARCOMA],609265[LI-FRAUMENI SYNDROME 2; LFS2]
FBgn0045064	bwa	HGNC:18356	OMIM:613491	ACER1	5		
FBgn0045064	bwa	HGNC:23675	OMIM:613492	ACER2	14		
FBgn0045064	bwa	HGNC:16066	OMIM:617036	ACER3	4	617762	617762[LEUKODYSTROPHY, PROGRESSIVE, EARLY CHILDHOOD-ONSET; PLDECO]
FBgn0004374	neb	HGNC:6317	OMIM:603060	KIF1C	3	611302	611302[SPASTIC ATAXIA 2, AUTOSOMAL RECESSIVE; SPAX2]
FBgn0004374	neb	HGNC:19181	OMIM:611279	KIF14	10	616258,617914	616258[MECKEL SYNDROME 12; MKS12],617914[MICROCEPHALY 20, PRIMARY, AUTOSOMAL RECESSIVE; MCPH20]
FBgn0032846	Pyroxd1	HGNC:26162	OMIM:617220	PYROXD1	13	617258	617258[MYOPATHY, MYOFIBRILLAR, 8; MFM8]
FBgn0032848	nesd	HGNC:29547	OMIM:611027	SHCBP1	12		
FBgn0032848	nesd	HGNC:16788	OMIM:619514	SHCBP1L	7		
FBgn0032850	Kua	HGNC:33521		TMEM189-UBE2V1	9		
FBgn0032850	Kua	HGNC:16735	OMIM:610994	TMEM189	5		
FBgn0032849	mRpS18B	HGNC:14516	OMIM:611982	MRPS18B	11		
FBgn0032847	Taf13	HGNC:11546	OMIM:600774	TAF13	14	617432	617432[INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 60; MRT60]
FBgn0032845	CG10747	HGNC:23148	OMIM:300974	PLCXD1	7		
FBgn0032845	CG10747	HGNC:26462	OMIM:617015	PLCXD2	14		
FBgn0032845	CG10747	HGNC:31822	OMIM:617016	PLCXD3	13		
FBgn0003978	vls	HGNC:29652	OMIM:611734	WDR77	10		
FBgn0014127	barr	HGNC:1112	OMIM:602332	NCAPH	13	617985	617985[MICROCEPHALY 23, PRIMARY, AUTOSOMAL RECESSIVE; MCPH23]
FBgn0003475	spir	HGNC:30622	OMIM:609216	SPIRE1	13		
FBgn0003475	spir	HGNC:30623	OMIM:609217	SPIRE2	11		
FBgn0015803	RtGEF	HGNC:685	OMIM:300267	ARHGEF6	10		
FBgn0015803	RtGEF	HGNC:15607	OMIM:605477	ARHGEF7	10		
FBgn0032857	CG10947	HGNC:26276	OMIM:609559	CAMKMT	12		
FBgn0026756	Ugt37A1	HGNC:12531	OMIM:606435	UGT1A10	3		
FBgn0026756	Ugt37A1	HGNC:12545	OMIM:603064	UGT2B11	5		
FBgn0026756	Ugt37A1	HGNC:12530	OMIM:191740	UGT1A1	5	143500,218800,237900,601816,606785	143500[GILBERT SYNDROME],218800[CRIGLER-NAJJAR SYNDROME, TYPE I],237900[HYPERBILIRUBINEMIA, TRANSIENT FAMILIAL NEONATAL; HBLRTFN],601816[BILIRUBIN, SERUM LEVEL OF, QUANTITATIVE TRAIT LOCUS 1; BILIQTL1],606785[CRIGLER-NAJJAR SYNDROME, TYPE II]
FBgn0026756	Ugt37A1	HGNC:12555	OMIM:601291	UGT8	5		
FBgn0026756	Ugt37A1	HGNC:12539	OMIM:606432	UGT1A7	3		
FBgn0026756	Ugt37A1	HGNC:13479	OMIM:606497	UGT2B28	5		
FBgn0026756	Ugt37A1	HGNC:27266	OMIM:616384	UGT3A2	4		
FBgn0026756	Ugt37A1	HGNC:12544	OMIM:600070	UGT2B10	5		
FBgn0026756	Ugt37A1	HGNC:12537	OMIM:606430	UGT1A5	3		
FBgn0026756	Ugt37A1	HGNC:12546	OMIM:600069	UGT2B15	5		
FBgn0026756	Ugt37A1	HGNC:12541	OMIM:606434	UGT1A9	3		
FBgn0026756	Ugt37A1	HGNC:28528	OMIM:616382	UGT2A3	5		
FBgn0026756	Ugt37A1	HGNC:12535	OMIM:606428	UGT1A3	6		
FBgn0026756	Ugt37A1	HGNC:12536	OMIM:606429	UGT1A4	3		
FBgn0026756	Ugt37A1	HGNC:12540	OMIM:606433	UGT1A8	3		
FBgn0026756	Ugt37A1	HGNC:26625	OMIM:616383	UGT3A1	4		
FBgn0026756	Ugt37A1	HGNC:12547	OMIM:601903	UGT2B17	5	612560	612560[BONE MINERAL DENSITY QUANTITATIVE TRAIT LOCUS 12; BMND12]
FBgn0026756	Ugt37A1	HGNC:12553	OMIM:600067	UGT2B4	5		
FBgn0026756	Ugt37A1	HGNC:12538	OMIM:606431	UGT1A6	3		
FBgn0026756	Ugt37A1	HGNC:12554	OMIM:600068	UGT2B7	5		
FBgn0026756	Ugt37A1	HGNC:28183	OMIM:619809	UGT2A2	4		
FBgn0011638	La	HGNC:11316	OMIM:109090	SSB	15		
FBgn0032853	CG10651	HGNC:8946	OMIM:607076	PI15	3		
FBgn0032853	CG10651	HGNC:16249		R3HDML	3		
FBgn0032853	CG10651	HGNC:21245		PI16	5		
FBgn0032853	CG10651	HGNC:17001	OMIM:602692	GLIPR1	3		
FBgn0032853	CG10651	HGNC:28392	OMIM:610395	GLIPR1L1	4		
FBgn0032853	CG10651	HGNC:25248	OMIM:612434	CRISPLD2	3		
FBgn0032853	CG10651	HGNC:16904	OMIM:618062	CRISP3	4		
FBgn0032853	CG10651	HGNC:304	OMIM:601193	CRISP1	4		
FBgn0032853	CG10651	HGNC:12024	OMIM:187430	CRISP2	4		
FBgn0032853	CG10651	HGNC:33849	OMIM:616572	CLEC18B	3		
FBgn0032853	CG10651	HGNC:30388	OMIM:616571	CLEC18A	3		
FBgn0032870	CG2608	HGNC:11216	OMIM:610056	SPAG7	14		
FBgn0042133	CG18810	HGNC:27387		ZDHHC24	9		
FBgn0042133	CG18810	HGNC:20106		ZDHHC22	6		
FBgn0032871	CG2611	HGNC:15876	OMIM:617019	TMEM230	6		
FBgn0032873	CG2614	HGNC:24248	OMIM:617987	EEF1AKNMT	15	605429	605429[DEAFNESS, AUTOSOMAL RECESSIVE 26, MODIFIER OF; DFNB26M]
FBgn0032877	CG2617	HGNC:14646	OMIM:606130	RNF26	6		
FBgn0032880	TM9SF2	HGNC:11865	OMIM:604678	TM9SF2	13		
FBgn0032880	TM9SF2	HGNC:30797	OMIM:617727	TM9SF4	5		
FBgn0032879	CarT	HGNC:8494	OMIM:604047	SLC22A13	3		
FBgn0032879	CarT	HGNC:10970	OMIM:607582	SLC22A6	3		
FBgn0032879	CarT	HGNC:20302	OMIM:608276	SLC22A16	3		
FBgn0032879	CarT	HGNC:10968	OMIM:604190	SLC22A4	4	180300	180300[RHEUMATOID ARTHRITIS; RA]
FBgn0032879	CarT	HGNC:10969	OMIM:603377	SLC22A5	5	212140	212140[CARNITINE DEFICIENCY, SYSTEMIC PRIMARY; CDSP]
FBgn0032879	CarT	HGNC:8495	OMIM:604048	SLC22A14	3		
FBgn0032879	CarT	HGNC:10971	OMIM:604995	SLC22A7	3		
FBgn0032879	CarT	HGNC:10972	OMIM:607581	SLC22A8	3		
FBgn0032879	CarT	HGNC:10966	OMIM:602608	SLC22A2	3		
FBgn0032879	CarT	HGNC:32935	OMIM:610792	SLC22A25	3		
FBgn0032879	CarT	HGNC:10963	OMIM:602607	SLC22A1	3		
FBgn0032879	CarT	HGNC:10967	OMIM:604842	SLC22A3	3		
FBgn0032879	CarT	HGNC:17989	OMIM:607096	SLC22A12	3	220150	220150[HYPOURICEMIA, RENAL, 1; RHUC1]
FBgn0032879	CarT	HGNC:18120	OMIM:607097	SLC22A11	3		
FBgn0032879	CarT	HGNC:16261	OMIM:607579	SLC22A9	3		
FBgn0032879	CarT	HGNC:28542	OMIM:611698	SLC22A24	3		
FBgn0032879	CarT	HGNC:18057	OMIM:607580	SLC22A10	3		
FBgn0032878	CG9316	HGNC:21658	OMIM:609080	FBXL13	3		
FBgn0014859	Hr38	HGNC:7980	OMIM:139139	NR4A1	10		
FBgn0014859	Hr38	HGNC:7981	OMIM:601828	NR4A2	13	619911	619911[INTELLECTUAL DEVELOPMENTAL DISORDER WITH LANGUAGE IMPAIRMENT AND EARLY-ONSET DOPA-RESPONSIVE DYSTONIA-PARKINSONISM; IDLDP]
FBgn0014859	Hr38	HGNC:7982	OMIM:600542	NR4A3	11	612237	612237[CHONDROSARCOMA, EXTRASKELETAL MYXOID]
FBgn0032876	Cen	HGNC:1799	OMIM:117340	CDR2	9		
FBgn0032876	Cen	HGNC:29999		CDR2L	8		
FBgn0051678	CG31678	HGNC:1240	OMIM:619434	SUCO	11		
FBgn0016054	phr6-4	HGNC:2384	OMIM:601933	CRY1	7	614163	614163[DELAYED SLEEP PHASE DISORDER, SUSCEPTIBILITY TO; DSPD]
FBgn0016054	phr6-4	HGNC:2385	OMIM:603732	CRY2	8		
FBgn0032882	Ns4	HGNC:4413	OMIM:143024	GNL1	14		
FBgn0011202	dia	HGNC:18143	OMIM:606627	DAAM2	3	619263	619263[NEPHROTIC SYNDROME, TYPE 24; NPHS24]
FBgn0011202	dia	HGNC:18142	OMIM:606626	DAAM1	3		
FBgn0011202	dia	HGNC:2876	OMIM:602121	DIAPH1	12	124900,616632	124900[DEAFNESS, AUTOSOMAL DOMINANT 1, WITH OR WITHOUT THROMBOCYTOPENIA; DFNA1],616632[SEIZURES, CORTICAL BLINDNESS, AND MICROCEPHALY SYNDROME; SCBMS]
FBgn0011202	dia	HGNC:2877	OMIM:300108	DIAPH2	14	300511	300511[PREMATURE OVARIAN FAILURE 2A; POF2A]
FBgn0011202	dia	HGNC:15480	OMIM:614567	DIAPH3	12	609129	609129[AUDITORY NEUROPATHY, AUTOSOMAL DOMINANT 1; AUNA1]
FBgn0000251	cad	HGNC:1808	OMIM:300025	CDX4	7		
FBgn0000251	cad	HGNC:1805	OMIM:600746	CDX1	9		
FBgn0000251	cad	HGNC:1806	OMIM:600297	CDX2	10		
FBgn0032884	Pomp	HGNC:20330	OMIM:613386	POMP	13	601952,618048	601952[KERATOSIS LINEARIS WITH ICHTHYOSIS CONGENITA AND SCLEROSING KERATODERMA; KLICK],618048[PROTEASOME-ASSOCIATED AUTOINFLAMMATORY SYNDROME 2; PRAAS2]
FBgn0032886	CG9328	HGNC:23726		FAM107B	10		
FBgn0032886	CG9328	HGNC:30827	OMIM:608295	FAM107A	8		
FBgn0032889	CG9331	HGNC:4570	OMIM:604296	GRHPR	8	260000	260000[HYPEROXALURIA, PRIMARY, TYPE II; HP2]
FBgn0051673	CG31673	HGNC:4570	OMIM:604296	GRHPR	7	260000	260000[HYPEROXALURIA, PRIMARY, TYPE II; HP2]
FBgn0051674	CG31674	HGNC:4570	OMIM:604296	GRHPR	8	260000	260000[HYPEROXALURIA, PRIMARY, TYPE II; HP2]
FBgn0032908	CG9270	HGNC:55	OMIM:605250	ABCC4	12		
FBgn0032908	CG9270	HGNC:52	OMIM:612509	ABCC10	5		
FBgn0032908	CG9270	HGNC:53	OMIM:601107	ABCC2	5	237500	237500[DUBIN-JOHNSON SYNDROME; DJS]
FBgn0032908	CG9270	HGNC:51	OMIM:158343	ABCC1	5	618915	618915[DEAFNESS, AUTOSOMAL DOMINANT 77; DFNA77]
FBgn0032908	CG9270	HGNC:59	OMIM:600509	ABCC8	6	125853,240800,256450,610374,618857	125853[TYPE 2 DIABETES MELLITUS; T2D],240800[HYPOGLYCEMIA, LEUCINE-INDUCED; LIH],256450[HYPERINSULINEMIC HYPOGLYCEMIA, FAMILIAL, 1; HHF1],610374[DIABETES MELLITUS, TRANSIENT NEONATAL, 2; TNDM2],618857[DIABETES MELLITUS, PERMANENT NEONATAL, 3; PNDM3]
FBgn0032908	CG9270	HGNC:14640	OMIM:607041	ABCC12	5		
FBgn0032908	CG9270	HGNC:60	OMIM:601439	ABCC9	5	239850,608569,614050,619719	239850[CANTU SYNDROME],608569[CARDIOMYOPATHY, DILATED, 1O; CMD1O],614050[ATRIAL FIBRILLATION, FAMILIAL, 12; ATFB12],619719[INTELLECTUAL DISABILITY AND MYOPATHY SYNDROME; IDMYS]
FBgn0032908	CG9270	HGNC:57	OMIM:603234	ABCC6	5	177850,264800,614473	177850[PSEUDOXANTHOMA ELASTICUM, FORME FRUSTE],264800[PSEUDOXANTHOMA ELASTICUM; PXE],614473[ARTERIAL CALCIFICATION, GENERALIZED, OF INFANCY, 2; GACI2]
FBgn0032908	CG9270	HGNC:56	OMIM:605251	ABCC5	5		
FBgn0032908	CG9270	HGNC:14639	OMIM:607040	ABCC11	5	117800	117800[APOCRINE GLAND SECRETION, VARIATION IN]
FBgn0032908	CG9270	HGNC:54	OMIM:604323	ABCC3	5		
FBgn0032908	CG9270	HGNC:1884	OMIM:602421	CFTR	5	167800,211400,219700,277180	167800[PANCREATITIS, HEREDITARY; PCTT],211400[BRONCHIECTASIS WITH OR WITHOUT ELEVATED SWEAT CHLORIDE 1; BESC1],219700[CYSTIC FIBROSIS; CF],277180[VAS DEFERENS, CONGENITAL BILATERAL APLASIA OF; CBAVD]
FBgn0032901	sky	HGNC:29203	OMIM:613577	TBC1D24	14	220500,605021,608105,614617,615338,616044	220500[DEAFNESS, ONYCHODYSTROPHY, OSTEODYSTROPHY, MENTAL RETARDATION, AND SEIZURES SYNDROME; DOORS],605021[MYOCLONIC EPILEPSY, FAMILIAL INFANTILE; FIME],608105[EPILEPSY, ROLANDIC, WITH PAROXYSMAL EXERCISE-INDUCED DYSTONIA AND WRITER&apos;S CRAMP; EPRPDC],614617[DEAFNESS, AUTOSOMAL RECESSIVE 86; DFNB86],615338[DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 16; DEE16],616044[DEAFNESS, AUTOSOMAL DOMINANT 65; DFNA65]
FBgn0028986	Spn38F	HGNC:8955	OMIM:601799	SERPINB9	4		
FBgn0028986	Spn38F	HGNC:8945	OMIM:605587	SERPINI2	3		
FBgn0028986	Spn38F	HGNC:8943	OMIM:602445	SERPINI1	4	604218	604218[ENCEPHALOPATHY, FAMILIAL, WITH NEUROSERPIN INCLUSION BODIES; FENIB]
FBgn0028986	Spn38F	HGNC:10569	OMIM:600517	SERPINB3	7		
FBgn0028986	Spn38F	HGNC:3311	OMIM:130135	SERPINB1	7		
FBgn0028986	Spn38F	HGNC:775	OMIM:107300	SERPINC1	4	613118	613118[ANTITHROMBIN III DEFICIENCY; AT3D]
FBgn0028986	Spn38F	HGNC:8584	OMIM:173390	SERPINB2	3		
FBgn0028986	Spn38F	HGNC:10570	OMIM:600518	SERPINB4	8		
FBgn0028986	Spn38F	HGNC:8952	OMIM:601697	SERPINB8	4	617115	617115[PEELING SKIN SYNDROME 5; PSS5]
FBgn0028986	Spn38F	HGNC:14220	OMIM:615662	SERPINB12	4		
FBgn0028986	Spn38F	HGNC:8942	OMIM:602058	SERPINB10	4		
FBgn0028986	Spn38F	HGNC:8950	OMIM:173321	SERPINB6	5	613453	613453[DEAFNESS, AUTOSOMAL RECESSIVE 91; DFNB91]
FBgn0028986	Spn38F	HGNC:8944	OMIM:604445	SERPINB13	5		
FBgn0028986	Spn38F	HGNC:13902	OMIM:603357	SERPINB7	3	615598	615598[PALMOPLANTAR KERATODERMA, NAGASHIMA TYPE; PPKN]
FBgn0028986	Spn38F	HGNC:14221	OMIM:615682	SERPINB11	5		
FBgn0032891	Oseg5	HGNC:29262	OMIM:611177	IFT80	14	611263	611263[SHORT-RIB THORACIC DYSPLASIA 2 WITH OR WITHOUT POLYDACTYLY; SRTD2]
FBgn0032891	Oseg5	HGNC:30834	OMIM:616148	TRIM59	3		
FBgn0032891	Oseg5	HGNC:0		TRIM59-IFT80	3		
FBgn0032883	Rhau	HGNC:2750	OMIM:603115	DHX9	4		
FBgn0032883	Rhau	HGNC:20086		DHX57	4		
FBgn0032883	Rhau	HGNC:14410	OMIM:612767	DHX36	15		
FBgn0032883	Rhau	HGNC:15815	OMIM:612720	DHX29	4		
FBgn0032883	Rhau	HGNC:16716	OMIM:616423	DHX30	3	617804	617804[NEURODEVELOPMENTAL DISORDER WITH SEVERE MOTOR IMPAIRMENT AND ABSENT LANGUAGE; NEDMIAL]
FBgn0032881	Amacr	HGNC:451	OMIM:604489	AMACR	13	214950,614307	214950[BILE ACID SYNTHESIS DEFECT, CONGENITAL, 4; CBAS4],614307[ALPHA-METHYLACYL-CoA RACEMASE DEFICIENCY; AMACRD]
FBgn0010395	Itgbn	HGNC:6163	OMIM:604160	ITGB8	4		
FBgn0010395	Itgbn	HGNC:6160	OMIM:147561	ITGB5	4		
FBgn0010395	Itgbn	HGNC:6161	OMIM:147558	ITGB6	4	616221	616221[AMELOGENESIS IMPERFECTA, TYPE IH; AI1H]
FBgn0010395	Itgbn	HGNC:6155	OMIM:600065	ITGB2	6	116920	116920[LEUKOCYTE ADHESION DEFICIENCY, TYPE I; LAD1]
FBgn0010395	Itgbn	HGNC:6153	OMIM:135630	ITGB1	7		
FBgn0010395	Itgbn	HGNC:6158	OMIM:147557	ITGB4	6	226730,619816	226730[EPIDERMOLYSIS BULLOSA, JUNCTIONAL 5B, WITH PYLORIC ATRESIA; JEB5B],619816[EPIDERMOLYSIS BULLOSA, JUNCTIONAL 5A, INTERMEDIATE; JEB5A]
FBgn0010395	Itgbn	HGNC:6162	OMIM:147559	ITGB7	6		
FBgn0010395	Itgbn	HGNC:6156	OMIM:173470	ITGB3	5	608446,619267,619271	608446[MYOCARDIAL INFARCTION, SUSCEPTIBILITY TO],619267[GLANZMANN THROMBASTHENIA 2; GT2],619271[BLEEDING DISORDER, PLATELET-TYPE, 24; BDPLT24]
FBgn0032911	tadr	HGNC:29326	OMIM:615720	SLC7A14	3	615725	615725[RETINITIS PIGMENTOSA 68; RP68]
FBgn0032916	CG9257	HGNC:28973	OMIM:613802	MLEC	13		
FBgn0040297	Nhe2	HGNC:11071	OMIM:107310	SLC9A1	5	616291	616291[LICHTENSTEIN-KNORR SYNDROME; LIKNS]
FBgn0040297	Nhe2	HGNC:11072	OMIM:600530	SLC9A2	6		
FBgn0040297	Nhe2	HGNC:11073	OMIM:182307	SLC9A3	12	616868	616868[DIARRHEA 8, SECRETORY SODIUM, CONGENITAL; DIAR8]
FBgn0040297	Nhe2	HGNC:11078	OMIM:600477	SLC9A5	12		
FBgn0040297	Nhe2	HGNC:11077	OMIM:600531	SLC9A4	5		
FBgn0032919	pths	HGNC:18682	OMIM:615428	DDX47	13		
FBgn0032921	Mpp6	HGNC:7214	OMIM:605500	MPHOSPH6	12		
FBgn0032923	Pld3	HGNC:23792	OMIM:618488	PLD4	10		
FBgn0032923	Pld3	HGNC:17158	OMIM:615698	PLD3	15	617770	617770[SPINOCEREBELLAR ATAXIA 46; SCA46]
FBgn0032923	Pld3	HGNC:26879		PLD5	6		
FBgn0032925	CG9246	HGNC:24517	OMIM:610770	NOC2L	14		
FBgn0010100	mAcon1	HGNC:118	OMIM:100850	ACO2	14	614559,616289	614559[INFANTILE CEREBELLAR-RETINAL DEGENERATION; ICRD],616289[OPTIC ATROPHY 9; OPA9]
FBgn0010100	mAcon1	HGNC:6115	OMIM:147582	IREB2	3	618451	618451[NEURODEGENERATION, EARLY-ONSET, WITH CHOREOATHETOID MOVEMENTS AND MICROCYTIC ANEMIA; NDCAMA]
FBgn0032929	Mcm10	HGNC:18043	OMIM:609357	MCM10	14	619313	619313[IMMUNODEFICIENCY 80 WITH OR WITHOUT CONGENITAL CARDIOMYOPATHY; IMD80]
FBgn0026255	clumsy	HGNC:4580	OMIM:138244	GRIK2	7	611092,619580	611092[INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 6; MRT6],619580[NEURODEVELOPMENTAL DISORDER WITH IMPAIRED LANGUAGE AND ATAXIA AND WITH OR WITHOUT SEIZURES; NEDLAS]
FBgn0026255	clumsy	HGNC:4581	OMIM:138243	GRIK3	7		
FBgn0026255	clumsy	HGNC:4583	OMIM:600283	GRIK5	5		
FBgn0026255	clumsy	HGNC:4579	OMIM:138245	GRIK1	7		
FBgn0026255	clumsy	HGNC:4582	OMIM:600282	GRIK4	6		
FBgn0026255	clumsy	HGNC:4576	OMIM:602368	GRID2	4	616204	616204[SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 18; SCAR18]
FBgn0026255	clumsy	HGNC:4575	OMIM:610659	GRID1	3		
FBgn0026577	CG8677	HGNC:18118	OMIM:608522	RSF1	7		
FBgn0021856	l(2)k14505	HGNC:18802	OMIM:608918	ATPAF2	13	604273	604273[MITOCHONDRIAL COMPLEX V (ATP SYNTHASE) DEFICIENCY, NUCLEAR TYPE 1; MC5DN1]
FBgn0032938	CG8671	HGNC:27637		FAM102B	12		
FBgn0032938	CG8671	HGNC:31419	OMIM:610891	FAM102A	13		
FBgn0032935	Atg18b	HGNC:25471	OMIM:609224	WIPI1	8		
FBgn0032935	Atg18b	HGNC:32225	OMIM:609225	WIPI2	8	618453	618453[INTELLECTUAL DEVELOPMENTAL DISORDER WITH SHORT STATURE AND VARIABLE SKELETAL ANOMALIES; IDDSSA]
FBgn0032934	CG8679	HGNC:26812	OMIM:619348	ANKLE1	10		
FBgn0051988	CG31988	HGNC:9718	OMIM:602505	PXN	5		
FBgn0051988	CG31988	HGNC:11767	OMIM:602353	TGFB1I1	5		
FBgn0051988	CG31988	HGNC:14061	OMIM:605390	LPXN	5		
FBgn0051624	CG31624	HGNC:9718	OMIM:602505	PXN	5		
FBgn0051624	CG31624	HGNC:11767	OMIM:602353	TGFB1I1	5		
FBgn0051624	CG31624	HGNC:14061	OMIM:605390	LPXN	5		
FBgn0011829	Ret	HGNC:9967	OMIM:164761	RET	11	142623,155240,162300,171300,171400	142623[HIRSCHSPRUNG DISEASE, SUSCEPTIBILITY TO, 1; HSCR1],155240[THYROID CARCINOMA, FAMILIAL MEDULLARY; MTC],162300[MULTIPLE ENDOCRINE NEOPLASIA, TYPE IIB; MEN2B],171300[PHEOCHROMOCYTOMA],171400[MULTIPLE ENDOCRINE NEOPLASIA, TYPE IIA; MEN2A]
FBgn0000239	bur	HGNC:4378	OMIM:600358	GMPS	13		
FBgn0032924	Nbr	HGNC:26023		EXD3	14		
FBgn0032922	Coq3	HGNC:18175	OMIM:605196	COQ3	14		
FBgn0024371	E2f2	HGNC:3113	OMIM:189971	E2F1	3		
FBgn0024371	E2f2	HGNC:3114	OMIM:600426	E2F2	3		
FBgn0024371	E2f2	HGNC:3115	OMIM:600427	E2F3	4		
FBgn0024371	E2f2	HGNC:3118	OMIM:600659	E2F4	6		
FBgn0024371	E2f2	HGNC:3119	OMIM:600967	E2F5	9		
FBgn0023388	Dap160	HGNC:6183	OMIM:602442	ITSN1	14		
FBgn0023388	Dap160	HGNC:6184	OMIM:604464	ITSN2	13		
FBgn0032910	CG9265	HGNC:18685	OMIM:612127	HSD17B13	5		
FBgn0032910	CG9265	HGNC:17693	OMIM:612830	DHRS3	5		
FBgn0032910	CG9265	HGNC:30311	OMIM:608989	SDR16C5	10		
FBgn0032910	CG9265	HGNC:22960	OMIM:612831	HSD17B11	7		
FBgn0032910	CG9265	HGNC:19975	OMIM:607599	RDH10	7		
FBgn0023091	dimm	HGNC:22265	OMIM:608606	BHLHA15	7		
FBgn0032943	Tsp39D	HGNC:1692	OMIM:155740	CD63	9		
FBgn0023090	dtr	HGNC:30539	OMIM:613190	DNAAF1	7	613193	613193[CILIARY DYSKINESIA, PRIMARY, 13; CILD13]
FBgn0032945	CG8665	HGNC:26777	OMIM:613584	ALDH1L2	14		
FBgn0032945	CG8665	HGNC:3978	OMIM:600249	ALDH1L1	14		
FBgn0032945	CG8665	HGNC:15472	OMIM:603687	ALDH1A2	3	620025	620025[DIAPHRAGMATIC HERNIA 4, WITH CARDIOVASCULAR DEFECTS; DIH4]
FBgn0032945	CG8665	HGNC:402	OMIM:100640	ALDH1A1	3		
FBgn0032946	nrv3	HGNC:804	OMIM:182330	ATP1B1	14	145500	145500[HYPERTENSION, ESSENTIAL]
FBgn0032946	nrv3	HGNC:806	OMIM:601867	ATP1B3	10		
FBgn0032946	nrv3	HGNC:805	OMIM:182331	ATP1B2	11		
FBgn0032946	nrv3	HGNC:820	OMIM:137217	ATP4B	7		
FBgn0032946	nrv3	HGNC:808	OMIM:301073	ATP1B4	9		
FBgn0032940	Mondo	HGNC:12744	OMIM:605678	MLXIPL	12		
FBgn0032940	Mondo	HGNC:17055	OMIM:608090	MLXIP	13		
FBgn0037501	Ir84a	HGNC:4572	OMIM:138247	GRIA2	3	618917	618917[NEURODEVELOPMENTAL DISORDER WITH LANGUAGE IMPAIRMENT AND BEHAVIORAL ABNORMALITIES; NEDLIB]
FBgn0037501	Ir84a	HGNC:4573	OMIM:305915	GRIA3	3	300699	300699[INTELLECTUAL DEVELOPMENTAL DISORDER, X-LINKED, SYNDROMIC, WU TYPE; MRXSW]
FBgn0037501	Ir84a	HGNC:4571	OMIM:138248	GRIA1	3	619927,619931	619927[INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL DOMINANT 67; MRD67],619931[INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 76; MRT76]
FBgn0037501	Ir84a	HGNC:4574	OMIM:138246	GRIA4	3	617864	617864[NEURODEVELOPMENTAL DISORDER WITH OR WITHOUT SEIZURES AND GAIT ABNORMALITIES; NEDSGA]
FBgn0003885	alphaTub84D	HGNC:12408	OMIM:602528	TUBA3C	7		
FBgn0003885	alphaTub84D	HGNC:24071	OMIM:617878	TUBA3D	10	617928	617928[KERATOCONUS 9; KTCN9]
FBgn0003885	alphaTub84D	HGNC:20768		TUBA1C	6		
FBgn0003885	alphaTub84D	HGNC:20765	OMIM:619918	TUBA3E	7		
FBgn0003885	alphaTub84D	HGNC:12407	OMIM:191110	TUBA4A	4	616208	616208[AMYOTROPHIC LATERAL SCLEROSIS 22 WITH OR WITHOUT FRONTOTEMPORAL DEMENTIA; ALS22]
FBgn0003885	alphaTub84D	HGNC:18809	OMIM:602530	TUBA1B	6		
FBgn0003885	alphaTub84D	HGNC:20766	OMIM:602529	TUBA1A	7	611603	611603[LISSENCEPHALY 3; LIS3]
FBgn0003885	alphaTub84D	HGNC:12410	OMIM:605742	TUBA8	3	619840	619840[MACROTHROMBOCYTOPENIA, ISOLATED, 2, AUTOSOMAL DOMINANT; MACTHC2]
FBgn0003885	alphaTub84D	HGNC:23534		TUBAL3	4		
FBgn0015570	alpha-Est2	HGNC:26741		CES4A	5		
FBgn0015570	alpha-Est2	HGNC:11764	OMIM:188450	TG	3	274700,608175	274700[THYROID DYSHORMONOGENESIS 3; TDH3],608175[AUTOIMMUNE THYROID DISEASE, SUSCEPTIBILITY TO, 3; AITD3]
FBgn0015570	alpha-Est2	HGNC:108	OMIM:100740	ACHE	5	112100	112100[YT BLOOD GROUP ANTIGEN]
FBgn0015570	alpha-Est2	HGNC:983	OMIM:177400	BCHE	3	617936	617936[BUTYRYLCHOLINESTERASE DEFICIENCY; BCHED]
FBgn0015570	alpha-Est2	HGNC:26459	OMIM:618678	CES5A	5		
FBgn0015570	alpha-Est2	HGNC:1863	OMIM:114835	CES1	5	618057	618057[DRUG METABOLISM, ALTERED, CES1-RELATED]
FBgn0015570	alpha-Est2	HGNC:1848	OMIM:114840	CEL	3	609812	609812[MATURITY-ONSET DIABETES OF THE YOUNG, TYPE 8, WITH EXOCRINE DYSFUNCTION; MODY8]
FBgn0015570	alpha-Est2	HGNC:1864	OMIM:605278	CES2	5		
FBgn0015570	alpha-Est2	HGNC:1865	OMIM:605279	CES3	5		
FBgn0015570	alpha-Est2	HGNC:14291	OMIM:600568	NLGN1	3	618830	618830[AUTISM, SUSCEPTIBILITY TO, 20; AUTS20]
FBgn0015570	alpha-Est2	HGNC:14289	OMIM:300336	NLGN3	3	300425,300494	300425[AUTISM, SUSCEPTIBILITY TO, X-LINKED 1; AUTSX1],300494[ASPERGER SYNDROME, X-LINKED, SUSCEPTIBILITY TO, 1; ASPGX1]
FBgn0015570	alpha-Est2	HGNC:14287	OMIM:300427	NLGN4X	3	300495,300497	300495[AUTISM, SUSCEPTIBILITY TO, X-LINKED 2; AUTSX2],300497[ASPERGER SYNDROME, X-LINKED, SUSCEPTIBILITY TO, 2; ASPGX2]
FBgn0015570	alpha-Est2	HGNC:14290	OMIM:606479	NLGN2	3		
FBgn0051146	Nlg1	HGNC:1848	OMIM:114840	CEL	3	609812	609812[MATURITY-ONSET DIABETES OF THE YOUNG, TYPE 8, WITH EXOCRINE DYSFUNCTION; MODY8]
FBgn0051146	Nlg1	HGNC:15529	OMIM:400028	NLGN4Y	6		
FBgn0051146	Nlg1	HGNC:14291	OMIM:600568	NLGN1	7	618830	618830[AUTISM, SUSCEPTIBILITY TO, 20; AUTS20]
FBgn0051146	Nlg1	HGNC:14289	OMIM:300336	NLGN3	7	300425,300494	300425[AUTISM, SUSCEPTIBILITY TO, X-LINKED 1; AUTSX1],300494[ASPERGER SYNDROME, X-LINKED, SUSCEPTIBILITY TO, 1; ASPGX1]
FBgn0051146	Nlg1	HGNC:14287	OMIM:300427	NLGN4X	7	300495,300497	300495[AUTISM, SUSCEPTIBILITY TO, X-LINKED 2; AUTSX2],300497[ASPERGER SYNDROME, X-LINKED, SUSCEPTIBILITY TO, 2; ASPGX2]
FBgn0051146	Nlg1	HGNC:14290	OMIM:606479	NLGN2	6		
FBgn0015568	alpha-Est1	HGNC:26741		CES4A	5		
FBgn0015568	alpha-Est1	HGNC:11764	OMIM:188450	TG	3	274700,608175	274700[THYROID DYSHORMONOGENESIS 3; TDH3],608175[AUTOIMMUNE THYROID DISEASE, SUSCEPTIBILITY TO, 3; AITD3]
FBgn0015568	alpha-Est1	HGNC:108	OMIM:100740	ACHE	5	112100	112100[YT BLOOD GROUP ANTIGEN]
FBgn0015568	alpha-Est1	HGNC:983	OMIM:177400	BCHE	3	617936	617936[BUTYRYLCHOLINESTERASE DEFICIENCY; BCHED]
FBgn0015568	alpha-Est1	HGNC:26459	OMIM:618678	CES5A	5		
FBgn0015568	alpha-Est1	HGNC:1863	OMIM:114835	CES1	5	618057	618057[DRUG METABOLISM, ALTERED, CES1-RELATED]
FBgn0015568	alpha-Est1	HGNC:1848	OMIM:114840	CEL	3	609812	609812[MATURITY-ONSET DIABETES OF THE YOUNG, TYPE 8, WITH EXOCRINE DYSFUNCTION; MODY8]
FBgn0015568	alpha-Est1	HGNC:1864	OMIM:605278	CES2	5		
FBgn0015568	alpha-Est1	HGNC:1865	OMIM:605279	CES3	5		
FBgn0015568	alpha-Est1	HGNC:14291	OMIM:600568	NLGN1	3	618830	618830[AUTISM, SUSCEPTIBILITY TO, 20; AUTS20]
FBgn0015568	alpha-Est1	HGNC:14289	OMIM:300336	NLGN3	3	300425,300494	300425[AUTISM, SUSCEPTIBILITY TO, X-LINKED 1; AUTSX1],300494[ASPERGER SYNDROME, X-LINKED, SUSCEPTIBILITY TO, 1; ASPGX1]
FBgn0015568	alpha-Est1	HGNC:14287	OMIM:300427	NLGN4X	3	300495,300497	300495[AUTISM, SUSCEPTIBILITY TO, X-LINKED 2; AUTSX2],300497[ASPERGER SYNDROME, X-LINKED, SUSCEPTIBILITY TO, 2; ASPGX2]
FBgn0015568	alpha-Est1	HGNC:14290	OMIM:606479	NLGN2	3		
FBgn0015571	alpha-Est3	HGNC:26741		CES4A	4		
FBgn0015571	alpha-Est3	HGNC:108	OMIM:100740	ACHE	3	112100	112100[YT BLOOD GROUP ANTIGEN]
FBgn0015571	alpha-Est3	HGNC:26459	OMIM:618678	CES5A	4		
FBgn0015571	alpha-Est3	HGNC:1863	OMIM:114835	CES1	4	618057	618057[DRUG METABOLISM, ALTERED, CES1-RELATED]
FBgn0015571	alpha-Est3	HGNC:1864	OMIM:605278	CES2	4		
FBgn0015571	alpha-Est3	HGNC:1865	OMIM:605279	CES3	4		
FBgn0015572	alpha-Est4	HGNC:26741		CES4A	5		
FBgn0015572	alpha-Est4	HGNC:11764	OMIM:188450	TG	3	274700,608175	274700[THYROID DYSHORMONOGENESIS 3; TDH3],608175[AUTOIMMUNE THYROID DISEASE, SUSCEPTIBILITY TO, 3; AITD3]
FBgn0015572	alpha-Est4	HGNC:108	OMIM:100740	ACHE	4	112100	112100[YT BLOOD GROUP ANTIGEN]
FBgn0015572	alpha-Est4	HGNC:983	OMIM:177400	BCHE	4	617936	617936[BUTYRYLCHOLINESTERASE DEFICIENCY; BCHED]
FBgn0015572	alpha-Est4	HGNC:26459	OMIM:618678	CES5A	5		
FBgn0015572	alpha-Est4	HGNC:1863	OMIM:114835	CES1	5	618057	618057[DRUG METABOLISM, ALTERED, CES1-RELATED]
FBgn0015572	alpha-Est4	HGNC:1848	OMIM:114840	CEL	3	609812	609812[MATURITY-ONSET DIABETES OF THE YOUNG, TYPE 8, WITH EXOCRINE DYSFUNCTION; MODY8]
FBgn0015572	alpha-Est4	HGNC:1864	OMIM:605278	CES2	5		
FBgn0015572	alpha-Est4	HGNC:1865	OMIM:605279	CES3	5		
FBgn0015572	alpha-Est4	HGNC:14291	OMIM:600568	NLGN1	3	618830	618830[AUTISM, SUSCEPTIBILITY TO, 20; AUTS20]
FBgn0015572	alpha-Est4	HGNC:14289	OMIM:300336	NLGN3	3	300425,300494	300425[AUTISM, SUSCEPTIBILITY TO, X-LINKED 1; AUTSX1],300494[ASPERGER SYNDROME, X-LINKED, SUSCEPTIBILITY TO, 1; ASPGX1]
FBgn0015572	alpha-Est4	HGNC:14287	OMIM:300427	NLGN4X	3	300495,300497	300495[AUTISM, SUSCEPTIBILITY TO, X-LINKED 2; AUTSX2],300497[ASPERGER SYNDROME, X-LINKED, SUSCEPTIBILITY TO, 2; ASPGX2]
FBgn0015572	alpha-Est4	HGNC:14290	OMIM:606479	NLGN2	3		
FBgn0015831	Rtnl2	HGNC:10468	OMIM:603183	RTN2	4	604805	604805[SPASTIC PARAPLEGIA 12, AUTOSOMAL DOMINANT; SPG12]
FBgn0015831	Rtnl2	HGNC:10469	OMIM:604249	RTN3	4		
FBgn0015831	Rtnl2	HGNC:14085	OMIM:604475	RTN4	4		
FBgn0015831	Rtnl2	HGNC:10467	OMIM:600865	RTN1	4		
FBgn0015574	alpha-Est6	HGNC:26741		CES4A	5		
FBgn0015574	alpha-Est6	HGNC:11764	OMIM:188450	TG	3	274700,608175	274700[THYROID DYSHORMONOGENESIS 3; TDH3],608175[AUTOIMMUNE THYROID DISEASE, SUSCEPTIBILITY TO, 3; AITD3]
FBgn0015574	alpha-Est6	HGNC:108	OMIM:100740	ACHE	5	112100	112100[YT BLOOD GROUP ANTIGEN]
FBgn0015574	alpha-Est6	HGNC:983	OMIM:177400	BCHE	3	617936	617936[BUTYRYLCHOLINESTERASE DEFICIENCY; BCHED]
FBgn0015574	alpha-Est6	HGNC:26459	OMIM:618678	CES5A	5		
FBgn0015574	alpha-Est6	HGNC:1863	OMIM:114835	CES1	5	618057	618057[DRUG METABOLISM, ALTERED, CES1-RELATED]
FBgn0015574	alpha-Est6	HGNC:1848	OMIM:114840	CEL	3	609812	609812[MATURITY-ONSET DIABETES OF THE YOUNG, TYPE 8, WITH EXOCRINE DYSFUNCTION; MODY8]
FBgn0015574	alpha-Est6	HGNC:1864	OMIM:605278	CES2	5		
FBgn0015574	alpha-Est6	HGNC:1865	OMIM:605279	CES3	5		
FBgn0015574	alpha-Est6	HGNC:14291	OMIM:600568	NLGN1	3	618830	618830[AUTISM, SUSCEPTIBILITY TO, 20; AUTS20]
FBgn0015574	alpha-Est6	HGNC:14289	OMIM:300336	NLGN3	3	300425,300494	300425[AUTISM, SUSCEPTIBILITY TO, X-LINKED 1; AUTSX1],300494[ASPERGER SYNDROME, X-LINKED, SUSCEPTIBILITY TO, 1; ASPGX1]
FBgn0015574	alpha-Est6	HGNC:14287	OMIM:300427	NLGN4X	3	300495,300497	300495[AUTISM, SUSCEPTIBILITY TO, X-LINKED 2; AUTSX2],300497[ASPERGER SYNDROME, X-LINKED, SUSCEPTIBILITY TO, 2; ASPGX2]
FBgn0015574	alpha-Est6	HGNC:14290	OMIM:606479	NLGN2	3		
FBgn0015575	alpha-Est7	HGNC:26741		CES4A	5		
FBgn0015575	alpha-Est7	HGNC:11764	OMIM:188450	TG	3	274700,608175	274700[THYROID DYSHORMONOGENESIS 3; TDH3],608175[AUTOIMMUNE THYROID DISEASE, SUSCEPTIBILITY TO, 3; AITD3]
FBgn0015575	alpha-Est7	HGNC:108	OMIM:100740	ACHE	4	112100	112100[YT BLOOD GROUP ANTIGEN]
FBgn0015575	alpha-Est7	HGNC:983	OMIM:177400	BCHE	3	617936	617936[BUTYRYLCHOLINESTERASE DEFICIENCY; BCHED]
FBgn0015575	alpha-Est7	HGNC:26459	OMIM:618678	CES5A	5		
FBgn0015575	alpha-Est7	HGNC:1863	OMIM:114835	CES1	5	618057	618057[DRUG METABOLISM, ALTERED, CES1-RELATED]
FBgn0015575	alpha-Est7	HGNC:1848	OMIM:114840	CEL	3	609812	609812[MATURITY-ONSET DIABETES OF THE YOUNG, TYPE 8, WITH EXOCRINE DYSFUNCTION; MODY8]
FBgn0015575	alpha-Est7	HGNC:1864	OMIM:605278	CES2	5		
FBgn0015575	alpha-Est7	HGNC:1865	OMIM:605279	CES3	6		
FBgn0015575	alpha-Est7	HGNC:14291	OMIM:600568	NLGN1	3	618830	618830[AUTISM, SUSCEPTIBILITY TO, 20; AUTS20]
FBgn0015575	alpha-Est7	HGNC:14289	OMIM:300336	NLGN3	3	300425,300494	300425[AUTISM, SUSCEPTIBILITY TO, X-LINKED 1; AUTSX1],300494[ASPERGER SYNDROME, X-LINKED, SUSCEPTIBILITY TO, 1; ASPGX1]
FBgn0015575	alpha-Est7	HGNC:14287	OMIM:300427	NLGN4X	3	300495,300497	300495[AUTISM, SUSCEPTIBILITY TO, X-LINKED 2; AUTSX2],300497[ASPERGER SYNDROME, X-LINKED, SUSCEPTIBILITY TO, 2; ASPGX2]
FBgn0015575	alpha-Est7	HGNC:14290	OMIM:606479	NLGN2	3		
FBgn0017456	Ubc84D	HGNC:12490	OMIM:603890	UBE2L6	4		
FBgn0017456	Ubc84D	HGNC:12488	OMIM:603721	UBE2L3	6		
FBgn0017456	Ubc84D	HGNC:13477		UBE2L5	3		
FBgn0015576	alpha-Est8	HGNC:26741		CES4A	4		
FBgn0015576	alpha-Est8	HGNC:11764	OMIM:188450	TG	3	274700,608175	274700[THYROID DYSHORMONOGENESIS 3; TDH3],608175[AUTOIMMUNE THYROID DISEASE, SUSCEPTIBILITY TO, 3; AITD3]
FBgn0015576	alpha-Est8	HGNC:108	OMIM:100740	ACHE	4	112100	112100[YT BLOOD GROUP ANTIGEN]
FBgn0015576	alpha-Est8	HGNC:983	OMIM:177400	BCHE	3	617936	617936[BUTYRYLCHOLINESTERASE DEFICIENCY; BCHED]
FBgn0015576	alpha-Est8	HGNC:26459	OMIM:618678	CES5A	4		
FBgn0015576	alpha-Est8	HGNC:1863	OMIM:114835	CES1	5	618057	618057[DRUG METABOLISM, ALTERED, CES1-RELATED]
FBgn0015576	alpha-Est8	HGNC:1848	OMIM:114840	CEL	3	609812	609812[MATURITY-ONSET DIABETES OF THE YOUNG, TYPE 8, WITH EXOCRINE DYSFUNCTION; MODY8]
FBgn0015576	alpha-Est8	HGNC:1864	OMIM:605278	CES2	4		
FBgn0015576	alpha-Est8	HGNC:1865	OMIM:605279	CES3	4		
FBgn0015576	alpha-Est8	HGNC:14291	OMIM:600568	NLGN1	3	618830	618830[AUTISM, SUSCEPTIBILITY TO, 20; AUTS20]
FBgn0015576	alpha-Est8	HGNC:14289	OMIM:300336	NLGN3	3	300425,300494	300425[AUTISM, SUSCEPTIBILITY TO, X-LINKED 1; AUTSX1],300494[ASPERGER SYNDROME, X-LINKED, SUSCEPTIBILITY TO, 1; ASPGX1]
FBgn0015576	alpha-Est8	HGNC:14287	OMIM:300427	NLGN4X	3	300495,300497	300495[AUTISM, SUSCEPTIBILITY TO, X-LINKED 2; AUTSX2],300497[ASPERGER SYNDROME, X-LINKED, SUSCEPTIBILITY TO, 2; ASPGX2]
FBgn0015576	alpha-Est8	HGNC:14290	OMIM:606479	NLGN2	3		
FBgn0037506	Mics1	HGNC:17281	OMIM:619205	GHITM	13		
FBgn0015577	alpha-Est9	HGNC:26741		CES4A	5		
FBgn0015577	alpha-Est9	HGNC:11764	OMIM:188450	TG	3	274700,608175	274700[THYROID DYSHORMONOGENESIS 3; TDH3],608175[AUTOIMMUNE THYROID DISEASE, SUSCEPTIBILITY TO, 3; AITD3]
FBgn0015577	alpha-Est9	HGNC:108	OMIM:100740	ACHE	4	112100	112100[YT BLOOD GROUP ANTIGEN]
FBgn0015577	alpha-Est9	HGNC:983	OMIM:177400	BCHE	4	617936	617936[BUTYRYLCHOLINESTERASE DEFICIENCY; BCHED]
FBgn0015577	alpha-Est9	HGNC:26459	OMIM:618678	CES5A	5		
FBgn0015577	alpha-Est9	HGNC:1863	OMIM:114835	CES1	5	618057	618057[DRUG METABOLISM, ALTERED, CES1-RELATED]
FBgn0015577	alpha-Est9	HGNC:1848	OMIM:114840	CEL	3	609812	609812[MATURITY-ONSET DIABETES OF THE YOUNG, TYPE 8, WITH EXOCRINE DYSFUNCTION; MODY8]
FBgn0015577	alpha-Est9	HGNC:1864	OMIM:605278	CES2	6		
FBgn0015577	alpha-Est9	HGNC:1865	OMIM:605279	CES3	5		
FBgn0015577	alpha-Est9	HGNC:14291	OMIM:600568	NLGN1	3	618830	618830[AUTISM, SUSCEPTIBILITY TO, 20; AUTS20]
FBgn0015577	alpha-Est9	HGNC:14289	OMIM:300336	NLGN3	3	300425,300494	300425[AUTISM, SUSCEPTIBILITY TO, X-LINKED 1; AUTSX1],300494[ASPERGER SYNDROME, X-LINKED, SUSCEPTIBILITY TO, 1; ASPGX1]
FBgn0015577	alpha-Est9	HGNC:14287	OMIM:300427	NLGN4X	3	300495,300497	300495[AUTISM, SUSCEPTIBILITY TO, X-LINKED 2; AUTSX2],300497[ASPERGER SYNDROME, X-LINKED, SUSCEPTIBILITY TO, 2; ASPGX2]
FBgn0015577	alpha-Est9	HGNC:14290	OMIM:606479	NLGN2	3		
FBgn0015569	alpha-Est10	HGNC:26741		CES4A	5		
FBgn0015569	alpha-Est10	HGNC:11764	OMIM:188450	TG	3	274700,608175	274700[THYROID DYSHORMONOGENESIS 3; TDH3],608175[AUTOIMMUNE THYROID DISEASE, SUSCEPTIBILITY TO, 3; AITD3]
FBgn0015569	alpha-Est10	HGNC:108	OMIM:100740	ACHE	4	112100	112100[YT BLOOD GROUP ANTIGEN]
FBgn0015569	alpha-Est10	HGNC:983	OMIM:177400	BCHE	3	617936	617936[BUTYRYLCHOLINESTERASE DEFICIENCY; BCHED]
FBgn0015569	alpha-Est10	HGNC:26459	OMIM:618678	CES5A	5		
FBgn0015569	alpha-Est10	HGNC:1863	OMIM:114835	CES1	5	618057	618057[DRUG METABOLISM, ALTERED, CES1-RELATED]
FBgn0015569	alpha-Est10	HGNC:1848	OMIM:114840	CEL	3	609812	609812[MATURITY-ONSET DIABETES OF THE YOUNG, TYPE 8, WITH EXOCRINE DYSFUNCTION; MODY8]
FBgn0015569	alpha-Est10	HGNC:1864	OMIM:605278	CES2	5		
FBgn0015569	alpha-Est10	HGNC:1865	OMIM:605279	CES3	6		
FBgn0015569	alpha-Est10	HGNC:14291	OMIM:600568	NLGN1	3	618830	618830[AUTISM, SUSCEPTIBILITY TO, 20; AUTS20]
FBgn0015569	alpha-Est10	HGNC:14289	OMIM:300336	NLGN3	3	300425,300494	300425[AUTISM, SUSCEPTIBILITY TO, X-LINKED 1; AUTSX1],300494[ASPERGER SYNDROME, X-LINKED, SUSCEPTIBILITY TO, 1; ASPGX1]
FBgn0015569	alpha-Est10	HGNC:14287	OMIM:300427	NLGN4X	3	300495,300497	300495[AUTISM, SUSCEPTIBILITY TO, X-LINKED 2; AUTSX2],300497[ASPERGER SYNDROME, X-LINKED, SUSCEPTIBILITY TO, 2; ASPGX2]
FBgn0015569	alpha-Est10	HGNC:14290	OMIM:606479	NLGN2	3		
FBgn0037504	CG1142	HGNC:24013	OMIM:611199	DNTTIP2	8		
FBgn0040670	e(y)2b	HGNC:24449	OMIM:619015	ENY2	8		
FBgn0037472	CG10098	HGNC:30381	OMIM:614966	SCRN2	12		
FBgn0037472	CG10098	HGNC:22192	OMIM:614965	SCRN1	12		
FBgn0037472	CG10098	HGNC:30382	OMIM:614967	SCRN3	14		
FBgn0037475	Fer1	HGNC:23734	OMIM:607194	PTF1A	12	609069,615935	609069[PANCREATIC AND CEREBELLAR AGENESIS; PACA],615935[PANCREATIC AGENESIS 2; PAGEN2]
FBgn0037478	CG2656	HGNC:30186		GPN3	15		
FBgn0011020	Sas-4	HGNC:17272	OMIM:609279	CENPJ	11	608393,613676	608393[MICROCEPHALY 6, PRIMARY, AUTOSOMAL RECESSIVE; MCPH6],613676[SECKEL SYNDROME 4; SCKL4]
FBgn0011020	Sas-4	HGNC:11657	OMIM:608365	TCP10L	3		
FBgn0011020	Sas-4	HGNC:11656	OMIM:187020	TCP10	3		
FBgn0011020	Sas-4	HGNC:21254		TCP10L2	4		
FBgn0037490	CG10053	HGNC:26768		GPATCH11	14		
FBgn0037492	Dtwd2	HGNC:19334		DTWD2	14		
FBgn0028400	Syt4	HGNC:11510	OMIM:600104	SYT2	3	616040,619461	616040[MYASTHENIC SYNDROME, CONGENITAL, 7A, PRESYNAPTIC, AND DISTAL MOTOR NEUROPATHY, AUTOSOMAL DOMINANT; CMS7A],619461[MYASTHENIC SYNDROME, CONGENITAL, 7B, PRESYNAPTIC, AUTOSOMAL RECESSIVE; CMS7B]
FBgn0028400	Syt4	HGNC:19265	OMIM:613528	SYT9	3		
FBgn0028400	Syt4	HGNC:11512	OMIM:600103	SYT4	10		
FBgn0028400	Syt4	HGNC:19239	OMIM:608741	SYT11	10		
FBgn0028400	Syt4	HGNC:11509	OMIM:185605	SYT1	3	618218	618218[BAKER-GORDON SYNDROME; BAGOS]
FBgn0028400	Syt4	HGNC:11514	OMIM:604146	SYT7	3		
FBgn0028400	Syt4	HGNC:11511	OMIM:600327	SYT3	3		
FBgn0028400	Syt4	HGNC:19266		SYT10	3		
FBgn0028400	Syt4	HGNC:11513	OMIM:600782	SYT5	3		
FBgn0028400	Syt4	HGNC:14962	OMIM:607716	SYT13	3		
FBgn0028400	Syt4	HGNC:19264	OMIM:607719	SYT8	3		
FBgn0028400	Syt4	HGNC:0		LOC102724488	3		
FBgn0045843	RacGAP84C	HGNC:9804	OMIM:604980	RACGAP1	8	619789	619789[ANEMIA, CONGENITAL DYSERYTHROPOIETIC, TYPE IIIb, AUTOSOMAL RECESSIVE; CDAN3B]
FBgn0037498	CG10029	HGNC:18311	OMIM:609170	ERP44	9		
FBgn0001112	Gld	HGNC:24288		CHDH	7		
FBgn0037491	CG1227	HGNC:11394	OMIM:604719	STK16	14		
FBgn0037489	CG1234	HGNC:24034	OMIM:610769	NOC3L	13		
FBgn0037486	CG14605	HGNC:11011	OMIM:606813	SLC2A6	5		
FBgn0037486	CG14605	HGNC:13812	OMIM:605245	SLC2A8	6		
FBgn0037486	CG14605	HGNC:11006	OMIM:138160	SLC2A2	3	125853,227810	125853[TYPE 2 DIABETES MELLITUS; T2D],227810[FANCONI-BICKEL SYNDROME; FBS]
FBgn0037486	CG14605	HGNC:18067	OMIM:610372	SLC2A12	3		
FBgn0037485	CG14606	HGNC:11011	OMIM:606813	SLC2A6	5		
FBgn0037485	CG14606	HGNC:13812	OMIM:605245	SLC2A8	6		
FBgn0037485	CG14606	HGNC:11006	OMIM:138160	SLC2A2	3	125853,227810	125853[TYPE 2 DIABETES MELLITUS; T2D],227810[FANCONI-BICKEL SYNDROME; FBS]
FBgn0037485	CG14606	HGNC:18067	OMIM:610372	SLC2A12	3		
FBgn0037482	CG10055	HGNC:25543	OMIM:613663	SHQ1	11	619921,619922	619921[DYSTONIA 35, CHILDHOOD-ONSET; DYT35],619922[NEURODEVELOPMENTAL DISORDER WITH DYSTONIA AND SEIZURES; NEDDS]
FBgn0037481	MAGE	HGNC:16353	OMIM:300470	MAGED2	6	300971	300971[BARTTER SYNDROME, TYPE 5, ANTENATAL, TRANSIENT; BARTS5]
FBgn0037481	MAGE	HGNC:6814	OMIM:605283	MAGEL2	6	615547	615547[SCHAAF-YANG SYNDROME; SHFYNG]
FBgn0037481	MAGE	HGNC:6812	OMIM:300223	MAGEC1	5		
FBgn0037481	MAGE	HGNC:7677	OMIM:608243	NSMCE3	11	617241	617241[LUNG DISEASE, IMMUNODEFICIENCY, AND CHROMOSOME BREAKAGE SYNDROME; LICS]
FBgn0037481	MAGE	HGNC:24935	OMIM:300760	MAGEE2	7		
FBgn0037481	MAGE	HGNC:6813	OMIM:300224	MAGED1	5		
FBgn0037481	MAGE	HGNC:24934	OMIM:300759	MAGEE1	7		
FBgn0037481	MAGE	HGNC:23795	OMIM:300466	MAGEB5	8		
FBgn0037481	MAGE	HGNC:7675	OMIM:602117	NDN	8		
FBgn0037481	MAGE	HGNC:13574	OMIM:300468	MAGEC2	8		
FBgn0037481	MAGE	HGNC:24092	OMIM:300548	MAGEH1	6		
FBgn0037481	MAGE	HGNC:17418	OMIM:300763	MAGEB17	9		
FBgn0037481	MAGE	HGNC:6811	OMIM:300153	MAGEB4	9		
FBgn0037481	MAGE	HGNC:6800	OMIM:300173	MAGEA2	3		
FBgn0037481	MAGE	HGNC:29639	OMIM:609267	MAGEF1	10		
FBgn0037481	MAGE	HGNC:19340	OMIM:300549	MAGEA2B	8		
FBgn0037481	MAGE	HGNC:23793	OMIM:300702	MAGED4	5		
FBgn0037481	MAGE	HGNC:6806	OMIM:300341	MAGEA8	8		
FBgn0037481	MAGE	HGNC:6799	OMIM:300177	MAGEA12	7		
FBgn0037481	MAGE	HGNC:22880	OMIM:300765	MAGED4B	5		
FBgn0037481	MAGE	HGNC:6810	OMIM:300152	MAGEB3	9		
FBgn0037481	MAGE	HGNC:6804	OMIM:300176	MAGEA6	8		
FBgn0037481	MAGE	HGNC:6796	OMIM:300016	MAGEA1	8		
FBgn0037481	MAGE	HGNC:23798	OMIM:300469	MAGEC3	6		
FBgn0037481	MAGE	HGNC:25377	OMIM:300761	MAGEB10	8		
FBgn0037481	MAGE	HGNC:21188	OMIM:300762	MAGEB16	9		
FBgn0037481	MAGE	HGNC:6798	OMIM:300344	MAGEA11	8		
FBgn0037481	MAGE	HGNC:6808	OMIM:300097	MAGEB1	9		
FBgn0037481	MAGE	HGNC:6809	OMIM:300098	MAGEB2	10		
FBgn0037481	MAGE	HGNC:28515	OMIM:301064	MAGEB18	8		
FBgn0037481	MAGE	HGNC:23796	OMIM:300467	MAGEB6	9		
FBgn0037481	MAGE	HGNC:6797	OMIM:300343	MAGEA10	8		
FBgn0037481	MAGE	HGNC:6801	OMIM:300174	MAGEA3	8		
FBgn0037481	MAGE	HGNC:12326	OMIM:300132	TRO	7		
FBgn0037481	MAGE	HGNC:6802	OMIM:300175	MAGEA4	8		
FBgn0037481	MAGE	HGNC:35154		MAGEA13P	4		
FBgn0037481	MAGE	HGNC:31909	OMIM:300764	MAGEA9B	8		
FBgn0037473	CG10068	HGNC:25334	OMIM:615456	ELMOD1	10		
FBgn0037473	CG10068	HGNC:28111	OMIM:610196	ELMOD2	14		
FBgn0037473	CG10068	HGNC:26158	OMIM:615427	ELMOD3	3	615429,619500	615429[DEAFNESS, AUTOSOMAL RECESSIVE 88; DFNB88],619500[DEAFNESS, AUTOSOMAL DOMINANT 81; DFNA81]
FBgn0014863	Mlp84B	HGNC:2469	OMIM:123876	CSRP1	9		
FBgn0014863	Mlp84B	HGNC:2472	OMIM:600824	CSRP3	10	607482,612124	607482[CARDIOMYOPATHY, DILATED, 1M; CMD1M],612124[CARDIOMYOPATHY, FAMILIAL HYPERTROPHIC, 12; CMH12]
FBgn0014863	Mlp84B	HGNC:2470	OMIM:601871	CSRP2	9		
FBgn0000071	Ama	HGNC:17302	OMIM:613173	NEGR1	5		
FBgn0000071	Ama	HGNC:34550	OMIM:618861	IGLON5	6		
FBgn0000071	Ama	HGNC:6705	OMIM:603241	LSAMP	8		
FBgn0000071	Ama	HGNC:8143	OMIM:600632	OPCML	7	167000	167000[OVARIAN CANCER]
FBgn0000071	Ama	HGNC:17941	OMIM:607938	NTM	6		
FBgn0000439	Dfd	HGNC:5126	OMIM:142974	HOXC4	5		
FBgn0000439	Dfd	HGNC:5115	OMIM:142965	HOXB4	4		
FBgn0000439	Dfd	HGNC:5138	OMIM:142981	HOXD4	4		
FBgn0000439	Dfd	HGNC:5105	OMIM:142953	HOXA4	4		
FBgn0024289	Sodh1	HGNC:11184	OMIM:182500	SORD	15	618912	618912[SORBITOL DEHYDROGENASE DEFICIENCY WITH PERIPHERAL NEUROPATHY; SORDD]
FBgn0037466	CG1965	HGNC:1317	OMIM:189901	GCFC2	10		
FBgn0037466	CG1965	HGNC:13579	OMIM:617621	PAXBP1	14		
FBgn0037468	CG1943	HGNC:14137	OMIM:619241	JPT2	4		
FBgn0037469	Dpck	HGNC:26238		DCAKD	15		
FBgn0003884	alphaTub84B	HGNC:12408	OMIM:602528	TUBA3C	8		
FBgn0003884	alphaTub84B	HGNC:24071	OMIM:617878	TUBA3D	11	617928	617928[KERATOCONUS 9; KTCN9]
FBgn0003884	alphaTub84B	HGNC:20768		TUBA1C	7		
FBgn0003884	alphaTub84B	HGNC:20765	OMIM:619918	TUBA3E	8		
FBgn0003884	alphaTub84B	HGNC:12407	OMIM:191110	TUBA4A	4	616208	616208[AMYOTROPHIC LATERAL SCLEROSIS 22 WITH OR WITHOUT FRONTOTEMPORAL DEMENTIA; ALS22]
FBgn0003884	alphaTub84B	HGNC:18809	OMIM:602530	TUBA1B	7		
FBgn0003884	alphaTub84B	HGNC:20766	OMIM:602529	TUBA1A	8	611603	611603[LISSENCEPHALY 3; LIS3]
FBgn0003884	alphaTub84B	HGNC:12410	OMIM:605742	TUBA8	3	619840	619840[MACROTHROMBOCYTOPENIA, ISOLATED, 2, AUTOSOMAL DOMINANT; MACTHC2]
FBgn0003884	alphaTub84B	HGNC:23534		TUBAL3	4		
FBgn0037470	Tailor	HGNC:25532	OMIM:613669	MTPAP	3	613672	613672[SPASTIC ATAXIA 4, AUTOSOMAL RECESSIVE; SPAX4]
FBgn0037470	Tailor	HGNC:26184	OMIM:610641	TUT1	3		
FBgn0010774	Ref1	HGNC:19071	OMIM:604171	ALYREF	12		
FBgn0037467	Ufl1	HGNC:23039	OMIM:613372	UFL1	15		
FBgn0037465	CG1105	HGNC:16952	OMIM:606599	TXNIP	8		
FBgn0037465	CG1105	HGNC:25225		ARRDC2	8		
FBgn0037465	CG1105	HGNC:29263	OMIM:612464	ARRDC3	8		
FBgn0037465	CG1105	HGNC:28087	OMIM:619788	ARRDC4	7		
FBgn0037465	CG1105	HGNC:28633	OMIM:619768	ARRDC1	5		
FBgn0037465	CG1105	HGNC:31407		ARRDC5	4		
FBgn0003339	Scr	HGNC:5106	OMIM:142952	HOXA5	7		
FBgn0003339	Scr	HGNC:5126	OMIM:142974	HOXC4	3		
FBgn0003339	Scr	HGNC:5115	OMIM:142965	HOXB4	3		
FBgn0003339	Scr	HGNC:5138	OMIM:142981	HOXD4	3		
FBgn0003339	Scr	HGNC:5127	OMIM:142973	HOXC5	5		
FBgn0003339	Scr	HGNC:5116	OMIM:142960	HOXB5	6		
FBgn0003339	Scr	HGNC:5105	OMIM:142953	HOXA4	3		
FBgn0004054	zen2	HGNC:5114	OMIM:142966	HOXB3	3		
FBgn0004054	zen2	HGNC:5104	OMIM:142954	HOXA3	3		
FBgn0004054	zen2	HGNC:5137	OMIM:142980	HOXD3	3		
FBgn0051482	CG31482	HGNC:18007	OMIM:607141	GLIPR2	13		
FBgn0051482	CG31482	HGNC:18206		CRISPLD1	3		
FBgn0051482	CG31482	HGNC:25248	OMIM:612434	CRISPLD2	3		
FBgn0037462	sunz	HGNC:25678	OMIM:619564	EFCAB1	5		
FBgn0051286	CG31286	HGNC:8946	OMIM:607076	PI15	3		
FBgn0051286	CG31286	HGNC:16249		R3HDML	3		
FBgn0051286	CG31286	HGNC:18007	OMIM:607141	GLIPR2	4		
FBgn0051286	CG31286	HGNC:28592	OMIM:610394	GLIPR1L2	3		
FBgn0051286	CG31286	HGNC:17001	OMIM:602692	GLIPR1	3		
FBgn0051286	CG31286	HGNC:28392	OMIM:610395	GLIPR1L1	3		
FBgn0051286	CG31286	HGNC:18206		CRISPLD1	3		
FBgn0051286	CG31286	HGNC:25248	OMIM:612434	CRISPLD2	3		
FBgn0051286	CG31286	HGNC:304	OMIM:601193	CRISP1	3		
FBgn0051286	CG31286	HGNC:12024	OMIM:187430	CRISP2	3		
FBgn0051286	CG31286	HGNC:33849	OMIM:616572	CLEC18B	3		
FBgn0051286	CG31286	HGNC:30388	OMIM:616571	CLEC18A	3		
FBgn0010355	Taf1	HGNC:11535	OMIM:313650	TAF1	14	300966,314250	300966[INTELLECTUAL DEVELOPMENTAL DISORDER, X-LINKED, SYNDROMIC 33; MRXS33],314250[DYSTONIA 3, TORSION, X-LINKED; DYT3]
FBgn0010355	Taf1	HGNC:18056	OMIM:607798	TAF1L	13		
FBgn0024912	agt	HGNC:7059	OMIM:156569	MGMT	9		
FBgn0026566	CG1307	HGNC:24265	OMIM:608625	PTRH2	14	616263	616263[NEUROLOGIC, ENDOCRINE, AND PANCREATIC DISEASE, MULTISYSTEM, INFANTILE-ONSET 1; IMNEPD1]
FBgn0026565	Ass	HGNC:758	OMIM:603470	ASS1	15	215700	215700[CITRULLINEMIA, CLASSIC]
FBgn0037461	CG15177	HGNC:25678	OMIM:619564	EFCAB1	5		
FBgn0037460	sowi	HGNC:25678	OMIM:619564	EFCAB1	5		
FBgn0037454	CG1137	HGNC:25168		IQCD	7		
FBgn0037431	CG17917	HGNC:8630	OMIM:604591	PEBP1	7		
FBgn0037431	CG17917	HGNC:28319	OMIM:612473	PEBP4	4		
FBgn0037432	CG10298	HGNC:8630	OMIM:604591	PEBP1	13		
FBgn0037432	CG10298	HGNC:28319	OMIM:612473	PEBP4	6		
FBgn0037433	CG17919	HGNC:8630	OMIM:604591	PEBP1	10		
FBgn0037433	CG17919	HGNC:28319	OMIM:612473	PEBP4	6		
FBgn0037435	CG18048	HGNC:25502		TRMT13	14		
FBgn0037439	CG10286	HGNC:26087	OMIM:614951	HEATR3	14		
FBgn0010282	TfIIFalpha	HGNC:4652	OMIM:189968	GTF2F1	13		
FBgn0037442	gzl	HGNC:17726	OMIM:612063	ZNRF4	5		
FBgn0037442	gzl	HGNC:10057	OMIM:609247	RNF13	10	618379	618379[DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 73; DEE73]
FBgn0037442	gzl	HGNC:24544	OMIM:610431	RNF167	10		
FBgn0037447	Neurochondrin	HGNC:17597	OMIM:608458	NCDN	14	619373	619373[NEURODEVELOPMENTAL DISORDER WITH INFANTILE EPILEPTIC SPASMS; NEDIES]
FBgn0037445	CG9727	HGNC:9986	OMIM:601863	RFX5	8	209920	209920[BARE LYMPHOCYTE SYNDROME, TYPE II]
FBgn0037445	CG9727	HGNC:25777	OMIM:612660	RFX7	7		
FBgn0037443	Dmtn	HGNC:24239	OMIM:619429	TMCC2	13		
FBgn0037443	Dmtn	HGNC:29199	OMIM:617459	TMCC3	10		
FBgn0037443	Dmtn	HGNC:2563	OMIM:300092	TEX28	5		
FBgn0037443	Dmtn	HGNC:29116	OMIM:616242	TMCC1	13		
FBgn0037440	CRAT	HGNC:2342	OMIM:600184	CRAT	11	617917	617917[NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 8; NBIA8]
FBgn0037440	CRAT	HGNC:1912	OMIM:118490	CHAT	5	254210	254210[MYASTHENIC SYNDROME, CONGENITAL, 6, PRESYNAPTIC; CMS6]
FBgn0037512	CG2616	HGNC:29680	OMIM:610821	SLC25A40	13		
FBgn0037512	CG2616	HGNC:24279	OMIM:610820	SLC25A39	12		
FBgn0037517	CG10086	HGNC:16952	OMIM:606599	TXNIP	6		
FBgn0037517	CG10086	HGNC:25225		ARRDC2	5		
FBgn0037517	CG10086	HGNC:29263	OMIM:612464	ARRDC3	5		
FBgn0037517	CG10086	HGNC:28087	OMIM:619788	ARRDC4	6		
FBgn0037517	CG10086	HGNC:28633	OMIM:619768	ARRDC1	4		
FBgn0037517	CG10086	HGNC:31407		ARRDC5	4		
FBgn0037518	CG2641	HGNC:16952	OMIM:606599	TXNIP	8		
FBgn0037518	CG2641	HGNC:25225		ARRDC2	7		
FBgn0037518	CG2641	HGNC:29263	OMIM:612464	ARRDC3	7		
FBgn0037518	CG2641	HGNC:28087	OMIM:619788	ARRDC4	7		
FBgn0037518	CG2641	HGNC:28633	OMIM:619768	ARRDC1	4		
FBgn0037518	CG2641	HGNC:31407		ARRDC5	4		
FBgn0051472	sgll	HGNC:30260	OMIM:603287	PNPO	14	610090	610090[PYRIDOXAMINE 5-PRIME-PHOSPHATE OXIDASE DEFICIENCY; PNPOD]
FBgn0051473	CG31473	HGNC:30260	OMIM:603287	PNPO	7	610090	610090[PYRIDOXAMINE 5-PRIME-PHOSPHATE OXIDASE DEFICIENCY; PNPOD]
FBgn0037526	ArgRS-m	HGNC:21406	OMIM:611524	RARS2	15	611523	611523[PONTOCEREBELLAR HYPOPLASIA, TYPE 6; PCH6]
FBgn0037526	ArgRS-m	HGNC:9870	OMIM:107820	RARS	3	616140	616140[LEUKODYSTROPHY, HYPOMYELINATING, 9; HLD9]
FBgn0024909	Taf7	HGNC:11548	OMIM:300314	TAF7L	11		
FBgn0024909	Taf7	HGNC:11541	OMIM:600573	TAF7	12		
FBgn0002542	lds	HGNC:12398	OMIM:604718	TTF2	12		
FBgn0002542	lds	HGNC:11099	OMIM:603257	HLTF	3		
FBgn0000504	dsx	HGNC:2934	OMIM:602424	DMRT1	3		
FBgn0000504	dsx	HGNC:13913	OMIM:614805	DMRTB1	3		
FBgn0000504	dsx	HGNC:13911	OMIM:614806	DMRTC2	3		
FBgn0037531	CG10445	HGNC:12398	OMIM:604718	TTF2	8		
FBgn0014930	CG2846	HGNC:30324	OMIM:613010	RFK	15		
FBgn0004901	Prat	HGNC:9238	OMIM:172450	PPAT	15		
FBgn0037530	EMC1	HGNC:28957	OMIM:616846	EMC1	13	616875	616875[CEREBELLAR ATROPHY, VISUAL IMPAIRMENT, AND PSYCHOMOTOR RETARDATION; CAVIPMR]
FBgn0037529	mRpS9	HGNC:14501	OMIM:611975	MRPS9	14		
FBgn0037521	CG2993	HGNC:16952	OMIM:606599	TXNIP	6		
FBgn0037521	CG2993	HGNC:25225		ARRDC2	5		
FBgn0037521	CG2993	HGNC:29263	OMIM:612464	ARRDC3	5		
FBgn0037521	CG2993	HGNC:28087	OMIM:619788	ARRDC4	6		
FBgn0037521	CG2993	HGNC:28633	OMIM:619768	ARRDC1	4		
FBgn0037521	CG2993	HGNC:31407		ARRDC5	4		
FBgn0037520	CG18268	HGNC:16952	OMIM:606599	TXNIP	4		
FBgn0037520	CG18268	HGNC:25225		ARRDC2	3		
FBgn0037520	CG18268	HGNC:29263	OMIM:612464	ARRDC3	4		
FBgn0037520	CG18268	HGNC:28087	OMIM:619788	ARRDC4	4		
FBgn0037520	CG18268	HGNC:31407		ARRDC5	3		
FBgn0037519	CG3014	HGNC:16952	OMIM:606599	TXNIP	5		
FBgn0037519	CG3014	HGNC:25225		ARRDC2	4		
FBgn0037519	CG3014	HGNC:29263	OMIM:612464	ARRDC3	4		
FBgn0037519	CG3014	HGNC:28087	OMIM:619788	ARRDC4	5		
FBgn0037519	CG3014	HGNC:28633	OMIM:619768	ARRDC1	4		
FBgn0037519	CG3014	HGNC:31407		ARRDC5	4		
FBgn0042101	CG18744	HGNC:16952	OMIM:606599	TXNIP	5		
FBgn0042101	CG18744	HGNC:25225		ARRDC2	4		
FBgn0042101	CG18744	HGNC:29263	OMIM:612464	ARRDC3	4		
FBgn0042101	CG18744	HGNC:28087	OMIM:619788	ARRDC4	5		
FBgn0042101	CG18744	HGNC:28633	OMIM:619768	ARRDC1	4		
FBgn0042101	CG18744	HGNC:31407		ARRDC5	4		
FBgn0042103	CG18746	HGNC:16952	OMIM:606599	TXNIP	7		
FBgn0042103	CG18746	HGNC:25225		ARRDC2	6		
FBgn0042103	CG18746	HGNC:29263	OMIM:612464	ARRDC3	6		
FBgn0042103	CG18746	HGNC:28087	OMIM:619788	ARRDC4	7		
FBgn0042103	CG18746	HGNC:28633	OMIM:619768	ARRDC1	4		
FBgn0042103	CG18746	HGNC:31407		ARRDC5	4		
FBgn0042105	CG18748	HGNC:16952	OMIM:606599	TXNIP	7		
FBgn0042105	CG18748	HGNC:25225		ARRDC2	6		
FBgn0042105	CG18748	HGNC:29263	OMIM:612464	ARRDC3	6		
FBgn0042105	CG18748	HGNC:28087	OMIM:619788	ARRDC4	7		
FBgn0042105	CG18748	HGNC:28633	OMIM:619768	ARRDC1	4		
FBgn0042105	CG18748	HGNC:31407		ARRDC5	4		
FBgn0042102	CG18745	HGNC:16952	OMIM:606599	TXNIP	7		
FBgn0042102	CG18745	HGNC:25225		ARRDC2	6		
FBgn0042102	CG18745	HGNC:29263	OMIM:612464	ARRDC3	7		
FBgn0042102	CG18745	HGNC:28087	OMIM:619788	ARRDC4	7		
FBgn0042102	CG18745	HGNC:28633	OMIM:619768	ARRDC1	5		
FBgn0042102	CG18745	HGNC:31407		ARRDC5	4		
FBgn0042104	CG18747	HGNC:16952	OMIM:606599	TXNIP	7		
FBgn0042104	CG18747	HGNC:25225		ARRDC2	6		
FBgn0042104	CG18747	HGNC:29263	OMIM:612464	ARRDC3	6		
FBgn0042104	CG18747	HGNC:28087	OMIM:619788	ARRDC4	7		
FBgn0042104	CG18747	HGNC:28633	OMIM:619768	ARRDC1	4		
FBgn0042104	CG18747	HGNC:31407		ARRDC5	4		
FBgn0037513	pyd3	HGNC:16297	OMIM:606673	UPB1	15	613161	613161[BETA-UREIDOPROPIONASE DEFICIENCY; UPB1D]
FBgn0037535	PIG-H	HGNC:8964	OMIM:600154	PIGH	8	618010	618010[GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 17; GPIBD17]
FBgn0037536	CG2698	HGNC:1363		TMEM245	14		
FBgn0037538	CG3223	HGNC:28221	OMIM:609748	UBL7	5		
FBgn0037540	Pbp95	HGNC:11137	OMIM:602777	SNAPC4	9		
FBgn0037543	CG10903	HGNC:16405	OMIM:615733	BUD23	14		
FBgn0037547	CG7910	HGNC:26440	OMIM:300654	FAAH2	7		
FBgn0037547	CG7910	HGNC:3553	OMIM:602935	FAAH	6	606581	606581[POLYSUBSTANCE ABUSE, SUSCEPTIBILITY TO; PSAB]
FBgn0037548	CG7900	HGNC:26440	OMIM:300654	FAAH2	6		
FBgn0037548	CG7900	HGNC:3553	OMIM:602935	FAAH	5	606581	606581[POLYSUBSTANCE ABUSE, SUSCEPTIBILITY TO; PSAB]
FBgn0037551	Arl8	HGNC:25192	OMIM:616597	ARL8A	12		
FBgn0037551	Arl8	HGNC:25564	OMIM:616596	ARL8B	13		
FBgn0037554	PolI	HGNC:9181	OMIM:603968	POLH	3	278750	278750[XERODERMA PIGMENTOSUM, VARIANT TYPE; XPV]
FBgn0037554	PolI	HGNC:9182	OMIM:605252	POLI	13		
FBgn0040528	CG15864	HGNC:8546	OMIM:176710	P4HA1	4		
FBgn0040528	CG15864	HGNC:30135	OMIM:608987	P4HA3	5		
FBgn0040528	CG15864	HGNC:8547	OMIM:600608	P4HA2	4	617238	617238[MYOPIA 25, AUTOSOMAL DOMINANT; MYP25]
FBgn0037556	CG9636	HGNC:28352	OMIM:614142	CUEDC2	14		
FBgn0001138	grn	HGNC:4173	OMIM:600576	GATA4	4	187500,607941,614429,614430,615542	187500[TETRALOGY OF FALLOT; TOF],607941[ATRIAL SEPTAL DEFECT 2; ASD2],614429[VENTRICULAR SEPTAL DEFECT 1; VSD1],614430[ATRIOVENTRICULAR SEPTAL DEFECT 4; AVSD4],615542[TESTICULAR ANOMALIES WITH OR WITHOUT CONGENITAL HEART DISEASE; TACHD]
FBgn0001138	grn	HGNC:4170	OMIM:305371	GATA1	8	190685,300367,300835,301083,314050	190685[DOWN SYNDROME],300367[THROMBOCYTOPENIA, X-LINKED, WITH OR WITHOUT DYSERYTHROPOIETIC ANEMIA; XLTDA],300835[ANEMIA, X-LINKED, WITH OR WITHOUT NEUTROPENIA AND/OR PLATELET ABNORMALITIES; XLANP],301083[ADENOSINE DEAMINASE, ELEVATED, HEMOLYTIC ANEMIA DUE TO; HAEADA],314050[THROMBOCYTOPENIA WITH BETA-THALASSEMIA, X-LINKED; XLTT]
FBgn0001138	grn	HGNC:15802	OMIM:611496	GATA5	4	617912	617912[CONGENITAL HEART DEFECTS, MULTIPLE TYPES, 5; CHTD5]
FBgn0001138	grn	HGNC:4172	OMIM:131320	GATA3	10	146255	146255[HYPOPARATHYROIDISM, SENSORINEURAL DEAFNESS, AND RENAL DYSPLASIA SYNDROME; HDRS]
FBgn0001138	grn	HGNC:4174	OMIM:601656	GATA6	4	187500,217095,600001,614474,614475	187500[TETRALOGY OF FALLOT; TOF],217095[CONOTRUNCAL HEART MALFORMATIONS; CTHM],600001[HEART DEFECTS, CONGENITAL, AND OTHER CONGENITAL ANOMALIES; HDCA],614474[ATRIOVENTRICULAR SEPTAL DEFECT 5; AVSD5],614475[ATRIAL SEPTAL DEFECT 9; ASD9]
FBgn0001138	grn	HGNC:4171	OMIM:137295	GATA2	10	601626,614038,614172,614286	601626[LEUKEMIA, ACUTE MYELOID; AML],614038[LYMPHEDEMA, PRIMARY, WITH MYELODYSPLASIA],614172[IMMUNODEFICIENCY 21; IMD21],614286[MYELODYSPLASTIC SYNDROME; MDS]
FBgn0037544	CG11035	HGNC:16410	OMIM:618202	DNAJC30	10	619382	619382[LEBER HEREDITARY OPTIC NEUROPATHY, AUTOSOMAL RECESSIVE; LHONAR]
FBgn0037541	CG2747	HGNC:29273	OMIM:619627	HEATR5B	14		
FBgn0037541	CG2747	HGNC:20276		HEATR5A	12		
FBgn0037539	CG10435	HGNC:12461	OMIM:609787	UBAP1	8	618418	618418[SPASTIC PARAPLEGIA 80, AUTOSOMAL DOMINANT; SPG80]
FBgn0037539	CG10435	HGNC:40028		UBAP1L	3		
FBgn0040524	CG11052	HGNC:179	OMIM:600875	ACYP1	6		
FBgn0040524	CG11052	HGNC:180	OMIM:102595	ACYP2	7		
FBgn0037537	CG2767	HGNC:386	OMIM:603966	AKR1C3	4		
FBgn0037537	CG2767	HGNC:384	OMIM:600449	AKR1C1	4		
FBgn0037537	CG2767	HGNC:387	OMIM:600451	AKR1C4	4	614279	614279[46,XY SEX REVERSAL 8; SRXY8]
FBgn0037537	CG2767	HGNC:380	OMIM:103830	AKR1A1	5		
FBgn0037537	CG2767	HGNC:381	OMIM:103880	AKR1B1	5		
FBgn0037537	CG2767	HGNC:382	OMIM:604707	AKR1B10	4		
FBgn0037537	CG2767	HGNC:388	OMIM:604741	AKR1D1	5	235555	235555[BILE ACID SYNTHESIS DEFECT, CONGENITAL, 2; CBAS2]
FBgn0037537	CG2767	HGNC:385	OMIM:600450	AKR1C2	4	614279	614279[46,XY SEX REVERSAL 8; SRXY8]
FBgn0037537	CG2767	HGNC:23437	OMIM:617451	AKR1E2	4		
FBgn0037537	CG2767	HGNC:37281	OMIM:616336	AKR1B15	4		
FBgn0037534	Elovl7	HGNC:26292	OMIM:614451	ELOVL7	15		
FBgn0037534	Elovl7	HGNC:14416	OMIM:611814	ELOVL2	5		
FBgn0037534	Elovl7	HGNC:14415	OMIM:605512	ELOVL4	5	133190,600110,614457	133190[SPINOCEREBELLAR ATAXIA 34; SCA34],600110[STARGARDT DISEASE 3; STGD3],614457[ICHTHYOSIS, SPASTIC QUADRIPLEGIA, AND MENTAL RETARDATION; ISQMR]
FBgn0037534	Elovl7	HGNC:14418	OMIM:611813	ELOVL1	11	618527	618527[ICHTHYOTIC KERATODERMA, SPASTICITY, HYPOMYELINATION, AND DYSMORPHIC FACIAL FEATURES; IKSHD]
FBgn0037534	Elovl7	HGNC:21308	OMIM:611805	ELOVL5	4	615957	615957[SPINOCEREBELLAR ATAXIA 38; SCA38]
FBgn0037533	CD98hc	HGNC:11026	OMIM:158070	SLC3A2	6		
FBgn0014861	Mcm2	HGNC:6944	OMIM:116945	MCM2	13	616968	616968[DEAFNESS, AUTOSOMAL DOMINANT 70; DFNA70]
FBgn0010433	ato	HGNC:797	OMIM:601461	ATOH1	4		
FBgn0010433	ato	HGNC:13907	OMIM:609875	ATOH7	5	221900	221900[PERSISTENT HYPERPLASTIC PRIMARY VITREOUS, AUTOSOMAL RECESSIVE; PHPVAR]
FBgn0037562	Nazo	HGNC:25443	OMIM:614297	C19orf12	9	614298,615043	614298[NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 4; NBIA4],615043[SPASTIC PARAPLEGIA 43, AUTOSOMAL RECESSIVE; SPG43]
FBgn0037566	mRpL1	HGNC:14275	OMIM:611821	MRPL1	12		
FBgn0037573	CG7483	HGNC:18683	OMIM:608546	EIF4A3	15	268305	268305[ROBIN SEQUENCE WITH CLEFT MANDIBLE AND LIMB ANOMALIES]
FBgn0062412	Ctr1B	HGNC:11016	OMIM:603085	SLC31A1	7		
FBgn0062412	Ctr1B	HGNC:11017	OMIM:603088	SLC31A2	7		
FBgn0004908	Arl2	HGNC:693	OMIM:601175	ARL2	14	619082	619082[MICROCORNEA, ROD-CONE DYSTROPHY, CATARACT, AND POSTERIOR STAPHYLOMA 1; MRCS1]
FBgn0037579	COX7AL	HGNC:2287	OMIM:123995	COX7A1	10		
FBgn0037579	COX7AL	HGNC:2288	OMIM:123996	COX7A2	8		
FBgn0037579	COX7AL	HGNC:2289	OMIM:605771	COX7A2L	7		
FBgn0037580	DppIII	HGNC:3008	OMIM:606818	DPP3	14		
FBgn0037581	CG7352	HGNC:29636	OMIM:610766	MNS1	4	618948	618948[HETEROTAXY, VISCERAL, 9, AUTOSOMAL, WITH MALE INFERTILITY; HTX9]
FBgn0020249	stck	HGNC:16084	OMIM:607908	LIMS2	13	616827	616827[MUSCULAR DYSTROPHY, AUTOSOMAL RECESSIVE, WITH CARDIOMYOPATHY AND TRIANGULAR TONGUE; MDRCMTT]
FBgn0020249	stck	HGNC:6616	OMIM:602567	LIMS1	14		
FBgn0020249	stck	HGNC:30047		LIMS3	3		
FBgn0020249	stck	HGNC:39941		LIMS4	5		
FBgn0037578	PNKP	HGNC:9154	OMIM:605610	PNKP	14	605589,613402,616267	605589[CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2B2; CMT2B2],613402[MICROCEPHALY, SEIZURES, AND DEVELOPMENTAL DELAY; MCSZ],616267[ATAXIA-OCULOMOTOR APRAXIA 4; AOA4]
FBgn0040529	COX7A	HGNC:2287	OMIM:123995	COX7A1	11		
FBgn0040529	COX7A	HGNC:2288	OMIM:123996	COX7A2	10		
FBgn0040529	COX7A	HGNC:2289	OMIM:605771	COX7A2L	9		
FBgn0040529	COX7A	HGNC:2290	OMIM:123997	COX7A2P2	5		
FBgn0003129	Poxm	HGNC:8623	OMIM:167416	PAX9	11	604625	604625[TOOTH AGENESIS, SELECTIVE, 3; STHAG3]
FBgn0003129	Poxm	HGNC:8615	OMIM:167411	PAX1	11	615560	615560[OTOFACIOCERVICAL SYNDROME 2, WITH T-CELL DEFICIENCY; OTFCS2]
FBgn0037574	Coq2	HGNC:25223	OMIM:609825	COQ2	14	146500,607426	146500[MULTIPLE SYSTEM ATROPHY 1, SUSCEPTIBILITY TO; MSA1],607426[COENZYME Q10 DEFICIENCY, PRIMARY, 1; COQ10D1]
FBgn0037569	tex	HGNC:19072	OMIM:606929	THOC3	14		
FBgn0037561	CG9630	HGNC:20085		DDX55	15		
FBgn0010173	RPA1	HGNC:10289	OMIM:179835	RPA1	15	619767	619767[PULMONARY FIBROSIS AND/OR BONE MARROW FAILURE, TELOMERE-RELATED, 6; PFBMFT6]
FBgn0037592	CG11737	HGNC:26167	OMIM:616360	TMEM135	14		
FBgn0051454	CG31454	HGNC:26167	OMIM:616360	TMEM135	13		
FBgn0051259	CG31259	HGNC:26167	OMIM:616360	TMEM135	14		
FBgn0051460	CG31460	HGNC:28942	OMIM:619029	KRTCAP2	15		
FBgn0037602	SLIRP2	HGNC:20495	OMIM:610211	SLIRP	10		
FBgn0037603	Sys1	HGNC:16162	OMIM:612979	SYS1	13		
FBgn0037606	CG8032	HGNC:15862	OMIM:615854	SMOX	10		
FBgn0037606	CG8032	HGNC:20837	OMIM:615853	PAOX	13		
FBgn0037607	CG8036	HGNC:25313		TKTL2	14		
FBgn0037607	CG8036	HGNC:11834	OMIM:606781	TKT	14	617044	617044[SHORT STATURE, DEVELOPMENTAL DELAY, AND CONGENITAL HEART DEFECTS; SDDHD]
FBgn0037607	CG8036	HGNC:11835	OMIM:300044	TKTL1	10		
FBgn0000447	Dhod	HGNC:2867	OMIM:126064	DHODH	14	263750	263750[POSTAXIAL ACROFACIAL DYSOSTOSIS; POADS]
FBgn0024326	Mkk4	HGNC:6844	OMIM:601335	MAP2K4	15		
FBgn0024326	Mkk4	HGNC:6846	OMIM:601254	MAP2K6	3		
FBgn0051450	mRpS18A	HGNC:14515	OMIM:611981	MRPS18A	12		
FBgn0051453	pch2	HGNC:12307	OMIM:604507	TRIP13	15	617598,619011	617598[MOSAIC VARIEGATED ANEUPLOIDY SYNDROME 3; MVA3],619011[OOCYTE MATURATION DEFECT 9; OOMD9]
FBgn0037608	mRpL19	HGNC:14052	OMIM:611832	MRPL19	14		
FBgn0037610	CG8043	HGNC:27302	OMIM:615316	IBA57	14	615330,616451	615330[MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 3; MMDS3],616451[SPASTIC PARAPLEGIA 74, AUTOSOMAL RECESSIVE; SPG74]
FBgn0037611	CG11755	HGNC:33710		CDPF1	11		
FBgn0037612	CG8112	HGNC:11177	OMIM:102642	SOAT1	15		
FBgn0037612	CG8112	HGNC:11178	OMIM:601311	SOAT2	11		
FBgn0037612	CG8112	HGNC:2843	OMIM:604900	DGAT1	3	615863	615863[DIARRHEA 7, PROTEIN-LOSING ENTEROPATHY TYPE; DIAR7]
FBgn0037614	TMEM216	HGNC:25018	OMIM:613277	TMEM216	13	603194,608091	603194[MECKEL SYNDROME, TYPE 2; MKS2],608091[JOUBERT SYNDROME 2; JBTS2]
FBgn0037614	TMEM216	HGNC:27453		TMEM80	11		
FBgn0037615	CG11760	HGNC:25018	OMIM:613277	TMEM216	13	603194,608091	603194[MECKEL SYNDROME, TYPE 2; MKS2],608091[JOUBERT SYNDROME 2; JBTS2]
FBgn0037615	CG11760	HGNC:27453		TMEM80	11		
FBgn0037622	CG8202	HGNC:24641	OMIM:618981	VPS35L	14	619135	619135[RITSCHER-SCHINZEL SYNDROME 3; RTSC3]
FBgn0037624	CG8223	HGNC:7644	OMIM:603185	NASP	11		
FBgn0037630	Ir85a	HGNC:4576	OMIM:602368	GRID2	3	616204	616204[SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 18; SCAR18]
FBgn0037630	Ir85a	HGNC:4575	OMIM:610659	GRID1	3		
FBgn0037632	CCT7	HGNC:1622	OMIM:605140	CCT7	14		
FBgn0037638	CG8379	HGNC:25788		ARMH3	14		
FBgn0037637	IscU	HGNC:29882	OMIM:611911	ISCU	15	255125	255125[MYOPATHY WITH LACTIC ACIDOSIS, HEREDITARY; HML]
FBgn0037633	CG9839	HGNC:19401		PGBD4	11		
FBgn0037613	Cks85A	HGNC:2000	OMIM:116901	CKS2	9		
FBgn0037613	Cks85A	HGNC:19083	OMIM:116900	CKS1B	9		
FBgn0001180	hb	HGNC:14283	OMIM:606238	IKZF5	3	619130	619130[THROMBOCYTOPENIA 7; THC7]
FBgn0037609	Unc50	HGNC:16046	OMIM:617826	UNC50	14		
FBgn0037643	ScsbetaA	HGNC:11450	OMIM:603922	SUCLG2	4		
FBgn0037643	ScsbetaA	HGNC:11448	OMIM:603921	SUCLA2	14	612073	612073[MITOCHONDRIAL DNA DEPLETION SYNDROME 5 (ENCEPHALOMYOPATHIC WITH OR WITHOUT METHYLMALONIC ACIDURIA); MTDPS5]
FBgn0027503	CG11970	HGNC:7802	OMIM:164013	NFRKB	12		
FBgn0037648	CG11975	HGNC:25072	OMIM:609226	WDR45B	14	617977	617977[NEURODEVELOPMENTAL DISORDER WITH SPASTIC QUADRIPLEGIA AND BRAIN ABNORMALITIES WITH OR WITHOUT SEIZURES; NEDSBAS]
FBgn0037648	CG11975	HGNC:28912	OMIM:300526	WDR45	4	300894	300894[NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 5; NBIA5]
FBgn0037652	CG11980	HGNC:17590	OMIM:611366	C12orf10	12		
FBgn0037653	Iru	HGNC:21151	OMIM:615177	RNF126	12		
FBgn0037653	Iru	HGNC:28037	OMIM:612490	RNF181	3		
FBgn0037653	Iru	HGNC:18154	OMIM:619535	RNF115	12		
FBgn0037653	Iru	HGNC:17481	OMIM:619341	PJA2	3		
FBgn0037653	Iru	HGNC:16648	OMIM:300420	PJA1	3		
FBgn0037656	CG11986	HGNC:24446	OMIM:618288	HMCES	14		
FBgn0037657	hyx	HGNC:16783	OMIM:607393	CDC73	14	145000,145001,608266	145000[HYPERPARATHYROIDISM 1; HRPT1],145001[HYPERPARATHYROIDISM 2 WITH JAW TUMORS; HRPT2],608266[PARATHYROID CARCINOMA]
FBgn0037659	Kdm2	HGNC:13606	OMIM:605657	KDM2A	13		
FBgn0037659	Kdm2	HGNC:13610	OMIM:609078	KDM2B	11		
FBgn0037659	Kdm2	HGNC:25300	OMIM:609085	FBXL19	3		
FBgn0037661	Ada	HGNC:31853	OMIM:619346	ADAL	14		
FBgn0037661	Ada	HGNC:186	OMIM:608958	ADA	3	102700	102700[SEVERE COMBINED IMMUNODEFICIENCY, AUTOSOMAL RECESSIVE, T CELL-NEGATIVE, B CELL-NEGATIVE, NK CELL-NEGATIVE, DUE TO ADENOSINE DEAMINASE DEFICIENCY]
FBgn0037665	St2	HGNC:11456	OMIM:602385	SULT1C2	9		
FBgn0037665	St2	HGNC:14903	OMIM:608359	SULT4A1	6		
FBgn0037665	St2	HGNC:30004	OMIM:615819	SULT1A4	6		
FBgn0037665	St2	HGNC:33543	OMIM:617151	SULT1C3	6		
FBgn0037665	St2	HGNC:11459	OMIM:604125	SULT2B1	7	617571	617571[ICHTHYOSIS, CONGENITAL, AUTOSOMAL RECESSIVE 14; ARCI14]
FBgn0037665	St2	HGNC:11457	OMIM:608357	SULT1C4	9		
FBgn0037665	St2	HGNC:17845	OMIM:608436	SULT1B1	8		
FBgn0037665	St2	HGNC:11458	OMIM:125263	SULT2A1	8		
FBgn0037665	St2	HGNC:11377	OMIM:600043	SULT1E1	7		
FBgn0037665	St2	HGNC:11455	OMIM:600641	SULT1A3	4		
FBgn0037665	St2	HGNC:11453	OMIM:171150	SULT1A1	6		
FBgn0037665	St2	HGNC:33433	OMIM:617152	SULT6B1	5		
FBgn0037665	St2	HGNC:11454	OMIM:601292	SULT1A2	6		
FBgn0037671	ATP6AP2	HGNC:18305	OMIM:300556	ATP6AP2	13	300423,300911,301045	300423[INTELLECTUAL DEVELOPMENTAL DISORDER, X-LINKED, SYNDROMIC, HEDERA TYPE; MRXSH],300911[PARKINSONISM WITH SPASTICITY, X-LINKED; XPDS],301045[CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIr; CDG2R]
FBgn0010803	TrpRS	HGNC:12729	OMIM:191050	WARS	14	617721	617721[NEURONOPATHY, DISTAL HEREDITARY MOTOR, TYPE IX; HMN9]
FBgn0037672	sage	HGNC:14907	OMIM:612209	MSGN1	3		
FBgn0037672	sage	HGNC:29658	OMIM:608689	MESP1	5		
FBgn0037672	sage	HGNC:29659	OMIM:605195	MESP2	4	608681	608681[SPONDYLOCOSTAL DYSOSTOSIS 2, AUTOSOMAL RECESSIVE; SCDO2]
FBgn0037668	CG16736	HGNC:10980	OMIM:606794	SLC25A10	4	618972	618972[MITOCHONDRIAL DNA DEPLETION SYNDROME 19; MTDPS19]
FBgn0003165	pum	HGNC:14957	OMIM:607204	PUM1	11	617931	617931[SPINOCEREBELLAR ATAXIA 47; SCA47]
FBgn0003165	pum	HGNC:14958	OMIM:607205	PUM2	12		
FBgn0037660	beag	HGNC:5958	OMIM:600549	IK	13		
FBgn0010222	Nmdmc	HGNC:31865	OMIM:614047	MTHFD2L	12		
FBgn0010222	Nmdmc	HGNC:7434	OMIM:604887	MTHFD2	14		
FBgn0002932	neur	HGNC:7761	OMIM:603804	NEURL1	11		
FBgn0002932	neur	HGNC:35422	OMIM:615893	NEURL1B	11		
FBgn0002932	neur	HGNC:25162	OMIM:617206	NEURL3	3		
FBgn0040534	Sf3b5	HGNC:21083	OMIM:617847	SF3B5	14		
FBgn0037655	Kcmf1	HGNC:20589	OMIM:614719	KCMF1	10		
FBgn0026380	Prosbeta3	HGNC:9540	OMIM:602176	PSMB3	15		
FBgn0051100	CG31100	HGNC:11011	OMIM:606813	SLC2A6	4		
FBgn0051100	CG31100	HGNC:13812	OMIM:605245	SLC2A8	4		
FBgn0037647	RagA-B	HGNC:19901	OMIM:300725	RRAGB	15		
FBgn0037647	RagA-B	HGNC:16963	OMIM:612194	RRAGA	14		
FBgn0037644	CG11964	HGNC:15879	OMIM:611537	CTNNBL1	14	619846	619846[IMMUNODEFICIENCY 99 WITH HYPOGAMMAGLOBULINEMIA AND AUTOIMMUNE CYTOPENIAS; IMD99]
FBgn0037675	HP1e	HGNC:1555	OMIM:604478	CBX5	6		
FBgn0037675	HP1e	HGNC:1551	OMIM:604511	CBX1	6		
FBgn0037675	HP1e	HGNC:1553	OMIM:604477	CBX3	6		
FBgn0037683	CG18473	HGNC:9590	OMIM:604446	PTER	15		
FBgn0037684	Srr	HGNC:14398	OMIM:606477	SRR	8		
FBgn0037687	CG8132	HGNC:7828	OMIM:604618	NIT1	3		
FBgn0037687	CG8132	HGNC:29878	OMIM:616769	NIT2	14		
FBgn0037689	CG8135	HGNC:25287	OMIM:619490	LMBRD2	13	619694	619694[DEVELOPMENTAL DELAY WITH VARIABLE NEUROLOGIC AND BRAIN ABNORMALITIES; DENBA]
FBgn0011740	alpha-Man-IIa	HGNC:6824	OMIM:154582	MAN2A1	13		
FBgn0011740	alpha-Man-IIa	HGNC:6825	OMIM:600988	MAN2A2	12		
FBgn0037697	GstZ2	HGNC:4643	OMIM:603758	GSTZ1	12	617596	617596[MALEYLACETOACETATE ISOMERASE DEFICIENCY; MAAID]
FBgn0037696	GstZ1	HGNC:4643	OMIM:603758	GSTZ1	14	617596	617596[MALEYLACETOACETATE ISOMERASE DEFICIENCY; MAAID]
FBgn0037690	Task7	HGNC:6283	OMIM:605874	KCNK9	15	612292	612292[BIRK-BAREL SYNDROME; BIBARS]
FBgn0037690	Task7	HGNC:6278	OMIM:603220	KCNK3	13	615344	615344[PULMONARY HYPERTENSION, PRIMARY, 4; PPH4]
FBgn0037690	Task7	HGNC:13814	OMIM:607368	KCNK15	11		
FBgn0037690	Task7	HGNC:6277	OMIM:603219	KCNK2	3		
FBgn0037690	Task7	HGNC:6273	OMIM:605873	KCNK10	3		
FBgn0003889	betaTub85D	HGNC:20774	OMIM:602662	TUBB4A	6	128101,612438	128101[DYSTONIA 4, TORSION, AUTOSOMAL DOMINANT; DYT4],612438[LEUKODYSTROPHY, HYPOMYELINATING, 6; HLD6]
FBgn0003889	betaTub85D	HGNC:12412	OMIM:615101	TUBB2A	8	615763	615763[CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 5; CDCBM5]
FBgn0003889	betaTub85D	HGNC:20778	OMIM:191130	TUBB	7	156610,615771	156610[SKIN CREASES, CONGENITAL SYMMETRIC CIRCUMFERENTIAL, 1; CSCSC1],615771[CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 6; CDCBM6]
FBgn0003889	betaTub85D	HGNC:30829	OMIM:612850	TUBB2B	9	610031	610031[CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 7; CDCBM7]
FBgn0003889	betaTub85D	HGNC:20771	OMIM:602660	TUBB4B	8	617879	617879[LEBER CONGENITAL AMAUROSIS WITH EARLY-ONSET DEAFNESS; LCAEOD]
FBgn0003889	betaTub85D	HGNC:20772	OMIM:602661	TUBB3	4	600638,614039	600638[FIBROSIS OF EXTRAOCULAR MUSCLES, CONGENITAL, 3A, WITH OR WITHOUT EXTRAOCULAR INVOLVEMENT; CFEOM3A],614039[CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 1; CDCBM1]
FBgn0003889	betaTub85D	HGNC:16257	OMIM:612901	TUBB1	5	613112	613112[MACROTHROMBOCYTOPENIA, ISOLATED, 1, AUTOSOMAL DOMINANT; MACTHC1]
FBgn0003889	betaTub85D	HGNC:20776	OMIM:615103	TUBB6	5	617732	617732[FACIAL PALSY, CONGENITAL, WITH PTOSIS AND VELOPHARYNGEAL DYSFUNCTION; FPVEPD]
FBgn0003889	betaTub85D	HGNC:20773	OMIM:616768	TUBB8	5	616780	616780[OOCYTE MATURATION DEFECT 2; OOMD2]
FBgn0037688	CG9356	HGNC:1065	OMIM:608692	BLZF1	11		
FBgn0037686	RpL34b	HGNC:10340	OMIM:616862	RPL34	11		
FBgn0000723	FER	HGNC:3655	OMIM:176942	FER	12		
FBgn0000723	FER	HGNC:3657	OMIM:190030	FES	11		
FBgn0037679	Aduk	HGNC:19703	OMIM:613472	ULK3	14		
FBgn0037679	Aduk	HGNC:12558	OMIM:603168	ULK1	4		
FBgn0037679	Aduk	HGNC:13480	OMIM:608650	ULK2	4		
FBgn0037678	CG16749	HGNC:6358	OMIM:602673	KLK10	3		
FBgn0037678	CG16749	HGNC:20453	OMIM:610601	KLK15	3		
FBgn0037678	CG16749	HGNC:6366	OMIM:605643	KLK5	3		
FBgn0037678	CG16749	HGNC:6364	OMIM:176820	KLK3	3		
FBgn0037678	CG16749	HGNC:6367	OMIM:602652	KLK6	3		
FBgn0037678	CG16749	HGNC:6357	OMIM:147910	KLK1	3	615953	615953[KALLIKREIN, DECREASED URINARY ACTIVITY OF]
FBgn0037678	CG16749	HGNC:6359	OMIM:604434	KLK11	3		
FBgn0037677	CG12951	HGNC:6362	OMIM:606135	KLK14	4		
FBgn0037677	CG12951	HGNC:6369	OMIM:605644	KLK8	3		
FBgn0037677	CG12951	HGNC:6366	OMIM:605643	KLK5	4		
FBgn0037677	CG12951	HGNC:6364	OMIM:176820	KLK3	3		
FBgn0037677	CG12951	HGNC:6361	OMIM:605505	KLK13	3		
FBgn0037677	CG12951	HGNC:6367	OMIM:602652	KLK6	4		
FBgn0037677	CG12951	HGNC:6357	OMIM:147910	KLK1	4	615953	615953[KALLIKREIN, DECREASED URINARY ACTIVITY OF]
FBgn0037677	CG12951	HGNC:6363	OMIM:147960	KLK2	3		
FBgn0037677	CG12951	HGNC:6368	OMIM:604438	KLK7	3		
FBgn0037700	CG8149	HGNC:24432	OMIM:610049	SARNP	9		
FBgn0014022	Rlb1	HGNC:26333	OMIM:610479	SRFBP1	3		
FBgn0037703	Kdm3	HGNC:12313	OMIM:604503	JMJD1C	9		
FBgn0037703	Kdm3	HGNC:20815	OMIM:611512	KDM3A	10		
FBgn0037703	Kdm3	HGNC:1337	OMIM:609373	KDM3B	10	618846	618846[DIETS-JONGMANS SYNDROME; DIJOS]
FBgn0037703	Kdm3	HGNC:5172	OMIM:602302	HR	7	203655,209500	203655[ALOPECIA UNIVERSALIS CONGENITA; ALUNC],209500[ATRICHIA WITH PAPULAR LESIONS; APL]
FBgn0037702	CG8176	HGNC:29002	OMIM:613437	FCHO1	11	619164	619164[IMMUNODEFICIENCY 76; IMD76]
FBgn0037702	CG8176	HGNC:25180	OMIM:613438	FCHO2	11		
FBgn0037702	CG8176	HGNC:25412	OMIM:611540	SGIP1	8		
FBgn0037702	CG8176	HGNC:9581	OMIM:616046	PSTPIP2	3		
FBgn0037707	RnpS1	HGNC:10080	OMIM:606447	RNPS1	11		
FBgn0037709	CG8199	HGNC:986	OMIM:608348	BCKDHA	13	248600	248600[MAPLE SYRUP URINE DISEASE; MSUD]
FBgn0027950	MBD-like	HGNC:18532	OMIM:607964	MBD3L2	4		
FBgn0027950	MBD-like	HGNC:6918	OMIM:603573	MBD3	13		
FBgn0027950	MBD-like	HGNC:37205		MBD3L3	5		
FBgn0027950	MBD-like	HGNC:15774	OMIM:607963	MBD3L1	7		
FBgn0027950	MBD-like	HGNC:37206		MBD3L4	5		
FBgn0027950	MBD-like	HGNC:6917	OMIM:603547	MBD2	13		
FBgn0027950	MBD-like	HGNC:37204		MBD3L5	5		
FBgn0027950	MBD-like	HGNC:6916	OMIM:156535	MBD1	3		
FBgn0027950	MBD-like	HGNC:53435		MBD3L2B	4		
FBgn0037712	CG16789	HGNC:26195		IQCA1	14		
FBgn0037712	CG16789	HGNC:22831		IQCA1L	10		
FBgn0037718	P58IPK	HGNC:12392	OMIM:601964	DNAJC7	3		
FBgn0037718	P58IPK	HGNC:9439	OMIM:601184	DNAJC3	14	616192	616192[ATAXIA, COMBINED CEREBELLAR AND PERIPHERAL, WITH HEARING LOSS AND DIABETES MELLITUS; ACPHD]
FBgn0037720	CG8312	HGNC:26888		FAM43A	8		
FBgn0037720	CG8312	HGNC:31791		FAM43B	7		
FBgn0037723	SpdS	HGNC:11296	OMIM:182891	SRM	13		
FBgn0037727	Nepl12	HGNC:8918	OMIM:300550	PHEX	3	307800	307800[HYPOPHOSPHATEMIC RICKETS, X-LINKED DOMINANT; XLHR]
FBgn0037727	Nepl12	HGNC:14668	OMIM:618104	MMEL1	4		
FBgn0037727	Nepl12	HGNC:7154	OMIM:120520	MME	4	617017,617018	617017[CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2T; CMT2T],617018[SPINOCEREBELLAR ATAXIA 43; SCA43]
FBgn0037727	Nepl12	HGNC:13275	OMIM:610145	ECE2	3		
FBgn0037727	Nepl12	HGNC:3147	OMIM:605896	ECEL1	4	615065	615065[ARTHROGRYPOSIS, DISTAL, TYPE 5D; DA5D]
FBgn0037727	Nepl12	HGNC:3146	OMIM:600423	ECE1	4	145500,613870	145500[HYPERTENSION, ESSENTIAL],613870[HIRSCHSPRUNG DISEASE, CARDIAC DEFECTS, AND AUTONOMIC DYSFUNCTION; HCAD]
FBgn0037727	Nepl12	HGNC:6308	OMIM:613883	KEL	6	110900	110900[BLOOD GROUP--KELL SYSTEM; KEL]
FBgn0037728	p23	HGNC:16049	OMIM:607061	PTGES3	14		
FBgn0037728	p23	HGNC:43943		PTGES3L	3		
FBgn0037728	p23	HGNC:28417	OMIM:613212	AARSD1	5		
FBgn0028997	nmdyn-D7	HGNC:20461	OMIM:613465	NME7	15		
FBgn0003886	alphaTub85E	HGNC:12408	OMIM:602528	TUBA3C	4		
FBgn0003886	alphaTub85E	HGNC:24071	OMIM:617878	TUBA3D	5	617928	617928[KERATOCONUS 9; KTCN9]
FBgn0003886	alphaTub85E	HGNC:20768		TUBA1C	6		
FBgn0003886	alphaTub85E	HGNC:20765	OMIM:619918	TUBA3E	5		
FBgn0003886	alphaTub85E	HGNC:12407	OMIM:191110	TUBA4A	5	616208	616208[AMYOTROPHIC LATERAL SCLEROSIS 22 WITH OR WITHOUT FRONTOTEMPORAL DEMENTIA; ALS22]
FBgn0003886	alphaTub85E	HGNC:18809	OMIM:602530	TUBA1B	7		
FBgn0003886	alphaTub85E	HGNC:20766	OMIM:602529	TUBA1A	8	611603	611603[LISSENCEPHALY 3; LIS3]
FBgn0003886	alphaTub85E	HGNC:12410	OMIM:605742	TUBA8	3	619840	619840[MACROTHROMBOCYTOPENIA, ISOLATED, 2, AUTOSOMAL DOMINANT; MACTHC2]
FBgn0003886	alphaTub85E	HGNC:23534		TUBAL3	4		
FBgn0002431	hyd	HGNC:16806	OMIM:608413	UBR5	15		
FBgn0037734	trbd	HGNC:18224	OMIM:611749	ZRANB1	15		
FBgn0037734	trbd	HGNC:20718	OMIM:612024	OTUD7A	3		
FBgn0037734	trbd	HGNC:16683	OMIM:611748	OTUD7B	3		
FBgn0037734	trbd	HGNC:11896	OMIM:191163	TNFAIP3	3	616744	616744[AUTOINFLAMMATORY SYNDROME, FAMILIAL, BEHCET-LIKE 1; AIFBL1]
FBgn0051352	Unc-115a	HGNC:3382	OMIM:125305	DMTN	5		
FBgn0051352	Unc-115a	HGNC:78	OMIM:602330	ABLIM1	13		
FBgn0051352	Unc-115a	HGNC:29132	OMIM:611305	ABLIM3	12		
FBgn0051352	Unc-115a	HGNC:19195	OMIM:612544	ABLIM2	12		
FBgn0053105	p24-2	HGNC:24878		TMED9	10		
FBgn0053105	p24-2	HGNC:22301	OMIM:612038	TMED4	12		
FBgn0260463	Unc-115b	HGNC:3382	OMIM:125305	DMTN	4		
FBgn0260463	Unc-115b	HGNC:78	OMIM:602330	ABLIM1	8		
FBgn0260463	Unc-115b	HGNC:29132	OMIM:611305	ABLIM3	8		
FBgn0260463	Unc-115b	HGNC:19195	OMIM:612544	ABLIM2	7		
FBgn0069242	eca	HGNC:24878		TMED9	12		
FBgn0069242	eca	HGNC:22301	OMIM:612038	TMED4	14		
FBgn0037730	CG9444	HGNC:10920	OMIM:600544	SLC15A1	7		
FBgn0037730	CG9444	HGNC:10921	OMIM:602339	SLC15A2	7		
FBgn0037730	CG9444	HGNC:18068	OMIM:610408	SLC15A3	4		
FBgn0037730	CG9444	HGNC:23090	OMIM:615806	SLC15A4	3		
FBgn0037730	CG9444	HGNC:33455		SLC15A5	3		
FBgn0003334	Scm	HGNC:19003	OMIM:616396	SCMH1	11		
FBgn0003334	Scm	HGNC:10581	OMIM:300208	SCML2	10		
FBgn0003334	Scm	HGNC:21397		SCML4	5		
FBgn0003334	Scm	HGNC:10580	OMIM:300227	SCML1	3		
FBgn0005585	Calr	HGNC:1455	OMIM:109091	CALR	14	187950,254450	187950[THROMBOCYTHEMIA 1; THCYT1],254450[MYELOFIBROSIS]
FBgn0005585	Calr	HGNC:20407	OMIM:611414	CALR3	5		
FBgn0037721	CG9427	HGNC:5398	OMIM:604664	IFI30	8		
FBgn0027338	Kap-alpha3	HGNC:6395	OMIM:600685	KPNA2	3		
FBgn0027338	Kap-alpha3	HGNC:6396	OMIM:601892	KPNA3	12		
FBgn0027338	Kap-alpha3	HGNC:6397	OMIM:602970	KPNA4	14		
FBgn0027338	Kap-alpha3	HGNC:6399	OMIM:610563	KPNA6	5		
FBgn0027338	Kap-alpha3	HGNC:21839	OMIM:614107	KPNA7	3		
FBgn0027338	Kap-alpha3	HGNC:6394	OMIM:600686	KPNA1	5		
FBgn0027338	Kap-alpha3	HGNC:6398	OMIM:604545	KPNA5	5		
FBgn0037715	CG9399	HGNC:24515	OMIM:614737	MPC2	14		
FBgn0037714	CG9396	HGNC:24515	OMIM:614737	MPC2	13		
FBgn0037713	CG16790	HGNC:25792	OMIM:613276	USB1	14	604173	604173[POIKILODERMA WITH NEUTROPENIA; PN]
FBgn0037710	CG9393	HGNC:7504	OMIM:600605	MTX1	14		
FBgn0037710	CG9393	HGNC:24812	OMIM:619336	MTX3	11		
FBgn0037710	CG9393	HGNC:7506	OMIM:608555	MTX2	3	619127	619127[MANDIBULOACRAL DYSPLASIA PROGEROID SYNDROME; MDPS]
FBgn0024833	AP-1mu	HGNC:13667	OMIM:603535	AP1M1	14		
FBgn0024833	AP-1mu	HGNC:558	OMIM:607309	AP1M2	7		
FBgn0037708	CG9386	HGNC:26653	OMIM:614309	TRMT44	14		
FBgn0037705	mura	HGNC:18052	OMIM:612488	RNF38	7		
FBgn0037705	mura	HGNC:19180	OMIM:619283	RNF44	6		
FBgn0037705	mura	HGNC:13429	OMIM:300379	RLIM	4	300978	300978[TONNE-KALSCHEUER SYNDROME; TOKAS]
FBgn0037705	mura	HGNC:10069	OMIM:604242	RNF6	4	133239	133239[ESOPHAGEAL CANCER]
FBgn0037705	mura	HGNC:18126	OMIM:612062	ZNRF3	3		
FBgn0000244	by	HGNC:11973	OMIM:600076	TNS1	7		
FBgn0000244	by	HGNC:19737	OMIM:607717	TNS2	9		
FBgn0000244	by	HGNC:21616	OMIM:606825	TNS3	7		
FBgn0000244	by	HGNC:24352	OMIM:608385	TNS4	6		
FBgn0014023	mRpL47	HGNC:16652	OMIM:611852	MRPL47	14		
FBgn0003205	Ras85D	HGNC:10447	OMIM:165090	RRAS	3		
FBgn0003205	Ras85D	HGNC:6407	OMIM:190070	KRAS	12	108010,109800,114480,163200,211980,260350,600268,601626,609942,613659,614470,615278	108010[ARTERIOVENOUS MALFORMATIONS OF THE BRAIN],109800[BLADDER CANCER],114480[BREAST CANCER],163200[SCHIMMELPENNING-FEUERSTEIN-MIMS SYNDROME; SFM],211980[LUNG CANCER],260350[PANCREATIC CANCER],600268[OCULOECTODERMAL SYNDROME; OES],601626[LEUKEMIA, ACUTE MYELOID; AML],609942[NOONAN SYNDROME 3; NS3],613659[GASTRIC CANCER],614470[RAS-ASSOCIATED AUTOIMMUNE LEUKOPROLIFERATIVE DISORDER; RALD],615278[CARDIOFACIOCUTANEOUS SYNDROME 2; CFC2]
FBgn0003205	Ras85D	HGNC:7989	OMIM:164790	NRAS	10	114500,137550,162900,163200,188470,249400,613224,614470	114500[COLORECTAL CANCER; CRC],137550[MELANOCYTIC NEVUS SYNDROME, CONGENITAL; CMNS],162900[NEVUS, EPIDERMAL],163200[SCHIMMELPENNING-FEUERSTEIN-MIMS SYNDROME; SFM],188470[THYROID CANCER, NONMEDULLARY, 2; NMTC2],249400[MELANOSIS, NEUROCUTANEOUS; NCMS],613224[NOONAN SYNDROME 6; NS6],614470[RAS-ASSOCIATED AUTOIMMUNE LEUKOPROLIFERATIVE DISORDER; RALD]
FBgn0003205	Ras85D	HGNC:17271	OMIM:600098	RRAS2	4	618624	618624[NOONAN SYNDROME 12; NS12]
FBgn0003205	Ras85D	HGNC:5173	OMIM:190020	HRAS	13	109800,137550,162900,163200,188470,218040	109800[BLADDER CANCER],137550[MELANOCYTIC NEVUS SYNDROME, CONGENITAL; CMNS],162900[NEVUS, EPIDERMAL],163200[SCHIMMELPENNING-FEUERSTEIN-MIMS SYNDROME; SFM],188470[THYROID CANCER, NONMEDULLARY, 2; NMTC2],218040[COSTELLO SYNDROME; CSTLO]
FBgn0003205	Ras85D	HGNC:5174	OMIM:300437	ERAS	3		
FBgn0037698	CG16779	HGNC:18273	OMIM:610322	TRERF1	7		
FBgn0037698	CG16779	HGNC:25294	OMIM:619942	ZNF541	9		
FBgn0037698	CG16779	HGNC:19853		ELMSAN1	8		
FBgn0037737	Pnn	HGNC:9162	OMIM:603154	PNN	10		
FBgn0005777	PpD3	HGNC:9322	OMIM:600658	PPP5C	14		
FBgn0037743	Alg12	HGNC:19358	OMIM:607144	ALG12	13	607143	607143[CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Ig; CDG1G]
FBgn0037754	CG8500	HGNC:687	OMIM:605193	DIRAS3	3		
FBgn0037754	CG8500	HGNC:19323	OMIM:607863	DIRAS2	15		
FBgn0037754	CG8500	HGNC:19127	OMIM:607862	DIRAS1	11		
FBgn0037756	CG8507	HGNC:6701	OMIM:104225	LRPAP1	14	615431	615431[MYOPIA 23, AUTOSOMAL RECESSIVE; MYP23]
FBgn0037759	CG8526	HGNC:20123	OMIM:618472	ASPG	13		
FBgn0037761	CG8534	HGNC:26292	OMIM:614451	ELOVL7	5		
FBgn0037761	CG8534	HGNC:14416	OMIM:611814	ELOVL2	3		
FBgn0037761	CG8534	HGNC:15829	OMIM:611546	ELOVL6	3		
FBgn0037761	CG8534	HGNC:14415	OMIM:605512	ELOVL4	3	133190,600110,614457	133190[SPINOCEREBELLAR ATAXIA 34; SCA34],600110[STARGARDT DISEASE 3; STGD3],614457[ICHTHYOSIS, SPASTIC QUADRIPLEGIA, AND MENTAL RETARDATION; ISQMR]
FBgn0037761	CG8534	HGNC:14418	OMIM:611813	ELOVL1	5	618527	618527[ICHTHYOTIC KERATODERMA, SPASTICITY, HYPOMYELINATION, AND DYSMORPHIC FACIAL FEATURES; IKSHD]
FBgn0037761	CG8534	HGNC:21308	OMIM:611805	ELOVL5	3	615957	615957[SPINOCEREBELLAR ATAXIA 38; SCA38]
FBgn0037762	eloF	HGNC:26292	OMIM:614451	ELOVL7	6		
FBgn0037762	eloF	HGNC:14416	OMIM:611814	ELOVL2	4		
FBgn0037762	eloF	HGNC:14415	OMIM:605512	ELOVL4	4	133190,600110,614457	133190[SPINOCEREBELLAR ATAXIA 34; SCA34],600110[STARGARDT DISEASE 3; STGD3],614457[ICHTHYOSIS, SPASTIC QUADRIPLEGIA, AND MENTAL RETARDATION; ISQMR]
FBgn0037762	eloF	HGNC:14418	OMIM:611813	ELOVL1	7	618527	618527[ICHTHYOTIC KERATODERMA, SPASTICITY, HYPOMYELINATION, AND DYSMORPHIC FACIAL FEATURES; IKSHD]
FBgn0037762	eloF	HGNC:21308	OMIM:611805	ELOVL5	4	615957	615957[SPINOCEREBELLAR ATAXIA 38; SCA38]
FBgn0037770	Art4	HGNC:23393	OMIM:603934	CARM1	13		
FBgn0037765	CG9458	HGNC:26292	OMIM:614451	ELOVL7	5		
FBgn0037765	CG9458	HGNC:14416	OMIM:611814	ELOVL2	3		
FBgn0037765	CG9458	HGNC:15829	OMIM:611546	ELOVL6	3		
FBgn0037765	CG9458	HGNC:14415	OMIM:605512	ELOVL4	3	133190,600110,614457	133190[SPINOCEREBELLAR ATAXIA 34; SCA34],600110[STARGARDT DISEASE 3; STGD3],614457[ICHTHYOSIS, SPASTIC QUADRIPLEGIA, AND MENTAL RETARDATION; ISQMR]
FBgn0037765	CG9458	HGNC:14418	OMIM:611813	ELOVL1	5	618527	618527[ICHTHYOTIC KERATODERMA, SPASTICITY, HYPOMYELINATION, AND DYSMORPHIC FACIAL FEATURES; IKSHD]
FBgn0037765	CG9458	HGNC:21308	OMIM:611805	ELOVL5	3	615957	615957[SPINOCEREBELLAR ATAXIA 38; SCA38]
FBgn0037763	CG16904	HGNC:26292	OMIM:614451	ELOVL7	5		
FBgn0037763	CG16904	HGNC:14416	OMIM:611814	ELOVL2	3		
FBgn0037763	CG16904	HGNC:14415	OMIM:605512	ELOVL4	3	133190,600110,614457	133190[SPINOCEREBELLAR ATAXIA 34; SCA34],600110[STARGARDT DISEASE 3; STGD3],614457[ICHTHYOSIS, SPASTIC QUADRIPLEGIA, AND MENTAL RETARDATION; ISQMR]
FBgn0037763	CG16904	HGNC:14418	OMIM:611813	ELOVL1	5	618527	618527[ICHTHYOTIC KERATODERMA, SPASTICITY, HYPOMYELINATION, AND DYSMORPHIC FACIAL FEATURES; IKSHD]
FBgn0037763	CG16904	HGNC:21308	OMIM:611805	ELOVL5	3	615957	615957[SPINOCEREBELLAR ATAXIA 38; SCA38]
FBgn0037760	FBXO11	HGNC:13590	OMIM:607871	FBXO11	13	618089	618089[INTELLECTUAL DEVELOPMENTAL DISORDER WITH DYSMORPHIC FACIES AND BEHAVIORAL ABNORMALITIES; IDDFBA]
FBgn0037760	FBXO11	HGNC:13589	OMIM:609092	FBXO10	3		
FBgn0037758	CG9467	HGNC:21305	OMIM:613272	KCTD3	14		
FBgn0037758	CG9467	HGNC:19214	OMIM:617322	SHKBP1	13		
FBgn0037749	CG9471	HGNC:1063	OMIM:600941	BLVRB	15		
FBgn0024330	MED6	HGNC:19970	OMIM:602984	MED6	14		
FBgn0037742	Rpt3R	HGNC:9551	OMIM:602707	PSMC4	9		
FBgn0037741	Tti1	HGNC:29029	OMIM:614425	TTI1	14		
FBgn0037739	CG12948	HGNC:20270		C14orf119	9		
FBgn0027524	CG3909	HGNC:30300	OMIM:609540	WDR61	14		
FBgn0037778	mtTFB2	HGNC:18559	OMIM:607055	TFB2M	8		
FBgn0037780	ohgt	HGNC:30185	OMIM:609262	CRBN	13	607417	607417[INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 2; MRT2]
FBgn0051410	Npc2e	HGNC:14537	OMIM:601015	NPC2	7	607625	607625[NIEMANN-PICK DISEASE, TYPE C2; NPC2]
FBgn0037783	Npc2c	HGNC:14537	OMIM:601015	NPC2	7	607625	607625[NIEMANN-PICK DISEASE, TYPE C2; NPC2]
FBgn0041105	nerfin-2	HGNC:6090	OMIM:600010	INSM1	8		
FBgn0041105	nerfin-2	HGNC:17539	OMIM:614027	INSM2	7		
FBgn0037788	CAH7	HGNC:1369	OMIM:604642	CA10	4		
FBgn0037788	CAH7	HGNC:1380	OMIM:114780	CA6	5		
FBgn0037788	CAH7	HGNC:1371	OMIM:603263	CA12	5	143860	143860[HYPERCHLORHIDROSIS, ISOLATED; HYCHL]
FBgn0037788	CAH7	HGNC:1372	OMIM:604832	CA14	5		
FBgn0037788	CAH7	HGNC:1383	OMIM:603179	CA9	5		
FBgn0037788	CAH7	HGNC:1370	OMIM:604644	CA11	3		
FBgn0037788	CAH7	HGNC:1368	OMIM:114800	CA1	3		
FBgn0037788	CAH7	HGNC:1377	OMIM:114761	CA5A	3	615751	615751[CARBONIC ANHYDRASE VA DEFICIENCY, HYPERAMMONEMIA DUE TO; CA5AD]
FBgn0037788	CAH7	HGNC:14914	OMIM:611436	CA13	3		
FBgn0037788	CAH7	HGNC:1374	OMIM:114750	CA3	3		
FBgn0037788	CAH7	HGNC:1375	OMIM:114760	CA4	4		
FBgn0037788	CAH7	HGNC:1378	OMIM:300230	CA5B	3		
FBgn0051477	ATPsynepsilonL	HGNC:838	OMIM:606153	ATP5F1E	11	614053	614053[MITOCHONDRIAL COMPLEX V (ATP SYNTHASE) DEFICIENCY, NUCLEAR TYPE 3; MC5DN3]
FBgn0051477	ATPsynepsilonL	HGNC:34026		ATP5F1EP2	5		
FBgn0040238	Best1	HGNC:17105	OMIM:607337	BEST3	12		
FBgn0040238	Best1	HGNC:12703	OMIM:607854	BEST1	10	153700,193220,611809,613194	153700[MACULAR DYSTROPHY, VITELLIFORM, 2; VMD2],193220[VITREORETINOCHOROIDOPATHY; VRCP],611809[BESTROPHINOPATHY, AUTOSOMAL RECESSIVE; ARB],613194[RETINITIS PIGMENTOSA 50; RP50]
FBgn0040238	Best1	HGNC:17106	OMIM:607336	BEST4	11		
FBgn0040238	Best1	HGNC:17107	OMIM:607335	BEST2	11		
FBgn0037792	TAF1B	HGNC:11533	OMIM:604904	TAF1B	8		
FBgn0004889	tws	HGNC:9306	OMIM:605997	PPP2R2C	11		
FBgn0004889	tws	HGNC:9305	OMIM:604325	PPP2R2B	13	604326	604326[SPINOCEREBELLAR ATAXIA 12; SCA12]
FBgn0004889	tws	HGNC:23732	OMIM:613992	PPP2R2D	15		
FBgn0004889	tws	HGNC:9304	OMIM:604941	PPP2R2A	13		
FBgn0028734	Fmr1	HGNC:4024	OMIM:605339	FXR2	11		
FBgn0028734	Fmr1	HGNC:3775	OMIM:309550	FMR1	11	300623,300624,311360	300623[FRAGILE X TREMOR/ATAXIA SYNDROME; FXTAS],300624[FRAGILE X SYNDROME; FXS],311360[PREMATURE OVARIAN FAILURE 1; POF1]
FBgn0028734	Fmr1	HGNC:4023	OMIM:600819	FXR1	12	618822,618823	618822[MYOPATHY, CONGENITAL, WITH RESPIRATORY INSUFFICIENCY AND BONE FRACTURES; MYORIBF],618823[MYOPATHY, CONGENITAL PROXIMAL, WITH MINICORE LESIONS; MYOPMIL]
FBgn0037786	Alp13	HGNC:438	OMIM:171760	ALPL	6	146300,241500,241510	146300[HYPOPHOSPHATASIA, ADULT; HPPA],241500[HYPOPHOSPHATASIA, INFANTILE; HPPI],241510[HYPOPHOSPHATASIA, CHILDHOOD; HPPC]
FBgn0037786	Alp13	HGNC:441	OMIM:171810	ALPG	6		
FBgn0037786	Alp13	HGNC:439	OMIM:171800	ALPP	6		
FBgn0037786	Alp13	HGNC:437	OMIM:171740	ALPI	6		
FBgn0037782	Npc2d	HGNC:14537	OMIM:601015	NPC2	7	607625	607625[NIEMANN-PICK DISEASE, TYPE C2; NPC2]
FBgn0037781	Fancl	HGNC:20748	OMIM:608111	FANCL	12	614083	614083[FANCONI ANEMIA, COMPLEMENTATION GROUP L; FANCL]
FBgn0037777	CG11722	HGNC:21034	OMIM:611776	NDUFAF4	14	618237	618237[MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 15; MC1DN15]
FBgn0053208	Mical	HGNC:24693	OMIM:608881	MICAL2	8		
FBgn0053208	Mical	HGNC:24694	OMIM:608882	MICAL3	8		
FBgn0053208	Mical	HGNC:20619	OMIM:607129	MICAL1	4		
FBgn0037773	CG5359	HGNC:28482	OMIM:617353	DYNLT2B	8	617405	617405[SHORT-RIB THORACIC DYSPLASIA 17 WITH OR WITHOUT POLYDACTYLY; SRTD17]
FBgn0037801	CG3999	HGNC:4313	OMIM:238300	GLDC	14	605899	605899[GLYCINE ENCEPHALOPATHY; GCE]
FBgn0040078	pont	HGNC:10474	OMIM:603449	RUVBL1	15		
FBgn0037809	CG12818	HGNC:15502		LENG1	14		
FBgn0015396	jumu	HGNC:12765	OMIM:600838	FOXN1	5	601705,618806	601705[T-CELL IMMUNODEFICIENCY, CONGENITAL ALOPECIA, AND NAIL DYSTROPHY; TIDAND],618806[T-CELL LYMPHOPENIA, INFANTILE, WITH OR WITHOUT NAIL DYSTROPHY, AUTOSOMAL DOMINANT; TLIND]
FBgn0015396	jumu	HGNC:21399	OMIM:609429	FOXN4	7		
FBgn0020379	Rfx	HGNC:9984	OMIM:601337	RFX3	13		
FBgn0020379	Rfx	HGNC:9983	OMIM:142765	RFX2	12		
FBgn0020379	Rfx	HGNC:9982	OMIM:600006	RFX1	12		
FBgn0020379	Rfx	HGNC:9985	OMIM:603958	RFX4	4		
FBgn0037807	CG6293	HGNC:10974	OMIM:603790	SLC23A1	13		
FBgn0037807	CG6293	HGNC:10973	OMIM:603791	SLC23A2	14		
FBgn0037807	CG6293	HGNC:20601		SLC23A3	4		
FBgn0037802	Sirt6	HGNC:14934	OMIM:606211	SIRT6	13		
FBgn0037798	CG12817	HGNC:18451	OMIM:607788	MCFD2	6	613625	613625[FACTOR V AND FACTOR VIII, COMBINED DEFICIENCY OF, 2; F5F8D2]
FBgn0037798	CG12817	HGNC:16962	OMIM:606137	CGREF1	3		
FBgn0025879	Timp	HGNC:11823	OMIM:601915	TIMP4	9		
FBgn0025879	Timp	HGNC:11821	OMIM:188825	TIMP2	12		
FBgn0025879	Timp	HGNC:11822	OMIM:188826	TIMP3	13	136900	136900[SORSBY FUNDUS DYSTROPHY; SFD]
FBgn0025879	Timp	HGNC:11820	OMIM:305370	TIMP1	9		
FBgn0037815	Rrp46	HGNC:24662	OMIM:606492	EXOSC5	15	619576	619576[CEREBELLAR ATAXIA, BRAIN ABNORMALITIES, AND CARDIAC CONDUCTION DEFECTS; CABAC]
FBgn0037817	Cyp12e1	HGNC:2606	OMIM:609506	CYP27B1	5	264700	264700[VITAMIN D HYDROXYLATION-DEFICIENT RICKETS, TYPE 1A; VDDR1A]
FBgn0037817	Cyp12e1	HGNC:33480		CYP27C1	3		
FBgn0037817	Cyp12e1	HGNC:2605	OMIM:606530	CYP27A1	3	213700	213700[CEREBROTENDINOUS XANTHOMATOSIS; CTX]
FBgn0037817	Cyp12e1	HGNC:2602	OMIM:126065	CYP24A1	5	143880	143880[HYPERCALCEMIA, INFANTILE, 1; HCINF1]
FBgn0037816	CG6345	HGNC:15880	OMIM:608200	CDK5RAP1	14		
FBgn0037816	CG6345	HGNC:21050	OMIM:611259	CDKAL1	3		
FBgn0024957	Irp-1B	HGNC:117	OMIM:100880	ACO1	11		
FBgn0024957	Irp-1B	HGNC:118	OMIM:100850	ACO2	3	614559,616289	614559[INFANTILE CEREBELLAR-RETINAL DEGENERATION; ICRD],616289[OPTIC ATROPHY 9; OPA9]
FBgn0024957	Irp-1B	HGNC:6115	OMIM:147582	IREB2	6	618451	618451[NEURODEGENERATION, EARLY-ONSET, WITH CHOREOATHETOID MOVEMENTS AND MICROCYTIC ANEMIA; NDCAMA]
FBgn0037814	CG6325	HGNC:25095		DCAF15	9		
FBgn0037831	Cap-H2	HGNC:25071	OMIM:611230	NCAPH2	4		
FBgn0017577	Mcm5	HGNC:6948	OMIM:602696	MCM5	14	617564	617564[MEIER-GORLIN SYNDROME 8; MGORS8]
FBgn0037841	CG4565	HGNC:14129	OMIM:604599	EHMT2	3		
FBgn0037841	CG4565	HGNC:10762	OMIM:609834	SETMAR	9		
FBgn0037841	CG4565	HGNC:24650	OMIM:607001	EHMT1	3	610253	610253[KLEEFSTRA SYNDROME 1; KLEFS1]
FBgn0037841	CG4565	HGNC:17287	OMIM:606503	SUV39H2	3		
FBgn0037843	CG4511	HGNC:24110	OMIM:612564	TXNDC9	15		
FBgn0037848	Tsp86D	HGNC:13594		TSPAN17	3		
FBgn0037848	Tsp86D	HGNC:28743	OMIM:610120	TSPAN33	8		
FBgn0037848	Tsp86D	HGNC:23303		TSPAN14	3		
FBgn0037848	Tsp86D	HGNC:17753	OMIM:613136	TSPAN5	3		
FBgn0037849	CG4596	HGNC:25130		TMEM169	11		
FBgn0011768	Fdh	HGNC:256	OMIM:600086	ADH7	5		
FBgn0011768	Fdh	HGNC:249	OMIM:103700	ADH1A	7		
FBgn0011768	Fdh	HGNC:250	OMIM:103720	ADH1B	7	103780	103780[ALCOHOL DEPENDENCE]
FBgn0011768	Fdh	HGNC:252	OMIM:103740	ADH4	6		
FBgn0011768	Fdh	HGNC:255	OMIM:103735	ADH6	6		
FBgn0011768	Fdh	HGNC:253	OMIM:103710	ADH5	13	619151	619151[AMED SYNDROME, DIGENIC; AMEDS]
FBgn0011768	Fdh	HGNC:251	OMIM:103730	ADH1C	4	103780,168600	103780[ALCOHOL DEPENDENCE],168600[PARKINSON DISEASE, LATE-ONSET; PD]
FBgn0037846	CG6574	HGNC:10937	OMIM:600424	SLC19A1	11	601775	601775[MEGALOBLASTIC ANEMIA, FOLATE-RESPONSIVE; MEGAF]
FBgn0037846	CG6574	HGNC:10938	OMIM:603941	SLC19A2	13	249270	249270[THIAMINE-RESPONSIVE MEGALOBLASTIC ANEMIA SYNDROME; TRMA]
FBgn0037846	CG6574	HGNC:16266	OMIM:606152	SLC19A3	14	607483	607483[THIAMINE METABOLISM DYSFUNCTION SYNDROME 2 (BIOTIN- OR THIAMINE-RESPONSIVE TYPE); THMD2]
FBgn0037846	CG6574	HGNC:25344		C2orf83	3		
FBgn0037845	CG14694	HGNC:10937	OMIM:600424	SLC19A1	11	601775	601775[MEGALOBLASTIC ANEMIA, FOLATE-RESPONSIVE; MEGAF]
FBgn0037845	CG14694	HGNC:10938	OMIM:603941	SLC19A2	11	249270	249270[THIAMINE-RESPONSIVE MEGALOBLASTIC ANEMIA SYNDROME; TRMA]
FBgn0037845	CG14694	HGNC:16266	OMIM:606152	SLC19A3	13	607483	607483[THIAMINE METABOLISM DYSFUNCTION SYNDROME 2 (BIOTIN- OR THIAMINE-RESPONSIVE TYPE); THMD2]
FBgn0037845	CG14694	HGNC:25344		C2orf83	3		
FBgn0037842	CG6567	HGNC:20440	OMIM:616548	LYPLAL1	15		
FBgn0037837	CG14693	HGNC:16145		CNBD2	9		
FBgn0037834	Art1	HGNC:5188	OMIM:610086	PRMT8	12		
FBgn0037834	Art1	HGNC:5187	OMIM:602950	PRMT1	13		
FBgn0010421	TfIIFbeta	HGNC:4653	OMIM:189969	GTF2F2	15		
FBgn0051390	MED7	HGNC:2378	OMIM:605045	MED7	12		
FBgn0051272	CG31272	HGNC:8494	OMIM:604047	SLC22A13	4		
FBgn0051272	CG31272	HGNC:10970	OMIM:607582	SLC22A6	3		
FBgn0051272	CG31272	HGNC:20302	OMIM:608276	SLC22A16	3		
FBgn0051272	CG31272	HGNC:10968	OMIM:604190	SLC22A4	3	180300	180300[RHEUMATOID ARTHRITIS; RA]
FBgn0051272	CG31272	HGNC:10969	OMIM:603377	SLC22A5	3	212140	212140[CARNITINE DEFICIENCY, SYSTEMIC PRIMARY; CDSP]
FBgn0051272	CG31272	HGNC:8495	OMIM:604048	SLC22A14	4		
FBgn0051272	CG31272	HGNC:10971	OMIM:604995	SLC22A7	4		
FBgn0051272	CG31272	HGNC:10972	OMIM:607581	SLC22A8	4		
FBgn0051272	CG31272	HGNC:10966	OMIM:602608	SLC22A2	3		
FBgn0051272	CG31272	HGNC:32935	OMIM:610792	SLC22A25	3		
FBgn0051272	CG31272	HGNC:10963	OMIM:602607	SLC22A1	3		
FBgn0051272	CG31272	HGNC:10967	OMIM:604842	SLC22A3	3		
FBgn0051272	CG31272	HGNC:16874	OMIM:185861	SV2B	3		
FBgn0051272	CG31272	HGNC:20566	OMIM:185860	SV2A	4		
FBgn0051272	CG31272	HGNC:30670	OMIM:610291	SV2C	3		
FBgn0051272	CG31272	HGNC:17989	OMIM:607096	SLC22A12	3	220150	220150[HYPOURICEMIA, RENAL, 1; RHUC1]
FBgn0051272	CG31272	HGNC:18120	OMIM:607097	SLC22A11	3		
FBgn0051272	CG31272	HGNC:16261	OMIM:607579	SLC22A9	3		
FBgn0051272	CG31272	HGNC:28542	OMIM:611698	SLC22A24	3		
FBgn0051272	CG31272	HGNC:18057	OMIM:607580	SLC22A10	3		
FBgn0037829	CG14691	HGNC:8494	OMIM:604047	SLC22A13	4		
FBgn0037829	CG14691	HGNC:10970	OMIM:607582	SLC22A6	3		
FBgn0037829	CG14691	HGNC:20302	OMIM:608276	SLC22A16	3		
FBgn0037829	CG14691	HGNC:10968	OMIM:604190	SLC22A4	3	180300	180300[RHEUMATOID ARTHRITIS; RA]
FBgn0037829	CG14691	HGNC:10969	OMIM:603377	SLC22A5	3	212140	212140[CARNITINE DEFICIENCY, SYSTEMIC PRIMARY; CDSP]
FBgn0037829	CG14691	HGNC:8495	OMIM:604048	SLC22A14	4		
FBgn0037829	CG14691	HGNC:10971	OMIM:604995	SLC22A7	4		
FBgn0037829	CG14691	HGNC:10972	OMIM:607581	SLC22A8	4		
FBgn0037829	CG14691	HGNC:10966	OMIM:602608	SLC22A2	3		
FBgn0037829	CG14691	HGNC:32935	OMIM:610792	SLC22A25	3		
FBgn0037829	CG14691	HGNC:10963	OMIM:602607	SLC22A1	3		
FBgn0037829	CG14691	HGNC:10967	OMIM:604842	SLC22A3	3		
FBgn0037829	CG14691	HGNC:16874	OMIM:185861	SV2B	3		
FBgn0037829	CG14691	HGNC:20566	OMIM:185860	SV2A	4		
FBgn0037829	CG14691	HGNC:30670	OMIM:610291	SV2C	3		
FBgn0037829	CG14691	HGNC:17989	OMIM:607096	SLC22A12	3	220150	220150[HYPOURICEMIA, RENAL, 1; RHUC1]
FBgn0037829	CG14691	HGNC:18120	OMIM:607097	SLC22A11	3		
FBgn0037829	CG14691	HGNC:16261	OMIM:607579	SLC22A9	3		
FBgn0037829	CG14691	HGNC:28542	OMIM:611698	SLC22A24	3		
FBgn0037829	CG14691	HGNC:18057	OMIM:607580	SLC22A10	3		
FBgn0004841	TkR86C	HGNC:11527	OMIM:162321	TACR2	9		
FBgn0004841	TkR86C	HGNC:11528	OMIM:162332	TACR3	8	614840	614840[HYPOGONADOTROPIC HYPOGONADISM 11 WITH OR WITHOUT ANOSMIA; HH11]
FBgn0004841	TkR86C	HGNC:11526	OMIM:162323	TACR1	7		
FBgn0037828	tomboy20	HGNC:20947	OMIM:601848	TOMM20	11		
FBgn0037828	tomboy20	HGNC:33752		TOMM20L	9		
FBgn0037826	CG14689	HGNC:20097	OMIM:619923	PPP1R36	9		
FBgn0051373	CG31373	HGNC:30012	OMIM:618720	PDF	10		
FBgn0051278	CG31278	HGNC:30012	OMIM:618720	PDF	11		
FBgn0051467	CG31467	HGNC:20097	OMIM:619923	PPP1R36	8		
FBgn0051391	CG31391	HGNC:20097	OMIM:619923	PPP1R36	6		
FBgn0037819	Phyhd1	HGNC:23396		PHYHD1	13		
FBgn0037818	CG6465	HGNC:177	OMIM:104620	ACY1	13	609924	609924[AMINOACYLASE 1 DEFICIENCY; ACY1D]
FBgn0037818	CG6465	HGNC:26518	OMIM:617124	PM20D1	3		
FBgn0037818	CG6465	HGNC:24538	OMIM:618771	ABHD14A	3		
FBgn0037818	CG6465	HGNC:38856		ABHD14A-ACY1	4		
FBgn0037856	Leash	HGNC:16952	OMIM:606599	TXNIP	5		
FBgn0037856	Leash	HGNC:25225		ARRDC2	4		
FBgn0037856	Leash	HGNC:29263	OMIM:612464	ARRDC3	4		
FBgn0037856	Leash	HGNC:28087	OMIM:619788	ARRDC4	5		
FBgn0037856	Leash	HGNC:28633	OMIM:619768	ARRDC1	4		
FBgn0037856	Leash	HGNC:31407		ARRDC5	4		
FBgn0037857	Tengl4	HGNC:3346	OMIM:600440	ENDOG	6		
FBgn0037857	Tengl4	HGNC:3347	OMIM:604051	EXOG	3		
FBgn0037855	CG6621	HGNC:24697		TTC14	11		
FBgn0042094	Ak3	HGNC:363	OMIM:103030	AK4	10		
FBgn0042094	Ak3	HGNC:17376	OMIM:609290	AK3	15		
FBgn0037853	CG14696	HGNC:16952	OMIM:606599	TXNIP	5		
FBgn0037853	CG14696	HGNC:25225		ARRDC2	4		
FBgn0037853	CG14696	HGNC:29263	OMIM:612464	ARRDC3	5		
FBgn0037853	CG14696	HGNC:28087	OMIM:619788	ARRDC4	5		
FBgn0037853	CG14696	HGNC:28633	OMIM:619768	ARRDC1	5		
FBgn0037853	CG14696	HGNC:31407		ARRDC5	3		
FBgn0037852	Tpc1	HGNC:14409	OMIM:606521	SLC25A19	15	607196,613710	607196[MICROCEPHALY, AMISH TYPE; MCPHA],613710[THIAMINE METABOLISM DYSFUNCTION SYNDROME 4 (BILATERAL STRIATAL DEGENERATION AND PROGRESSIVE POLYNEUROPATHY TYPE); THMD4]
FBgn0037862	mAcon2	HGNC:118	OMIM:100850	ACO2	12	614559,616289	614559[INFANTILE CEREBELLAR-RETINAL DEGENERATION; ICRD],616289[OPTIC ATROPHY 9; OPA9]
FBgn0037862	mAcon2	HGNC:6115	OMIM:147582	IREB2	3	618451	618451[NEURODEGENERATION, EARLY-ONSET, WITH CHOREOATHETOID MOVEMENTS AND MICROCYTIC ANEMIA; NDCAMA]
FBgn0040257	Ugt302E1	HGNC:12531	OMIM:606435	UGT1A10	5		
FBgn0040257	Ugt302E1	HGNC:12545	OMIM:603064	UGT2B11	7		
FBgn0040257	Ugt302E1	HGNC:12530	OMIM:191740	UGT1A1	7	143500,218800,237900,601816,606785	143500[GILBERT SYNDROME],218800[CRIGLER-NAJJAR SYNDROME, TYPE I],237900[HYPERBILIRUBINEMIA, TRANSIENT FAMILIAL NEONATAL; HBLRTFN],601816[BILIRUBIN, SERUM LEVEL OF, QUANTITATIVE TRAIT LOCUS 1; BILIQTL1],606785[CRIGLER-NAJJAR SYNDROME, TYPE II]
FBgn0040257	Ugt302E1	HGNC:12555	OMIM:601291	UGT8	6		
FBgn0040257	Ugt302E1	HGNC:12539	OMIM:606432	UGT1A7	5		
FBgn0040257	Ugt302E1	HGNC:13479	OMIM:606497	UGT2B28	7		
FBgn0040257	Ugt302E1	HGNC:27266	OMIM:616384	UGT3A2	5		
FBgn0040257	Ugt302E1	HGNC:12544	OMIM:600070	UGT2B10	8		
FBgn0040257	Ugt302E1	HGNC:12537	OMIM:606430	UGT1A5	5		
FBgn0040257	Ugt302E1	HGNC:12546	OMIM:600069	UGT2B15	7		
FBgn0040257	Ugt302E1	HGNC:12541	OMIM:606434	UGT1A9	5		
FBgn0040257	Ugt302E1	HGNC:28528	OMIM:616382	UGT2A3	7		
FBgn0040257	Ugt302E1	HGNC:12535	OMIM:606428	UGT1A3	7		
FBgn0040257	Ugt302E1	HGNC:12536	OMIM:606429	UGT1A4	5		
FBgn0040257	Ugt302E1	HGNC:12540	OMIM:606433	UGT1A8	5		
FBgn0040257	Ugt302E1	HGNC:26625	OMIM:616383	UGT3A1	4		
FBgn0040257	Ugt302E1	HGNC:12547	OMIM:601903	UGT2B17	7	612560	612560[BONE MINERAL DENSITY QUANTITATIVE TRAIT LOCUS 12; BMND12]
FBgn0040257	Ugt302E1	HGNC:12553	OMIM:600067	UGT2B4	7		
FBgn0040257	Ugt302E1	HGNC:12538	OMIM:606431	UGT1A6	6		
FBgn0040257	Ugt302E1	HGNC:12554	OMIM:600068	UGT2B7	8		
FBgn0040257	Ugt302E1	HGNC:28183	OMIM:619809	UGT2A2	6		
FBgn0040259	Ugt302C1	HGNC:12531	OMIM:606435	UGT1A10	5		
FBgn0040259	Ugt302C1	HGNC:12545	OMIM:603064	UGT2B11	8		
FBgn0040259	Ugt302C1	HGNC:12530	OMIM:191740	UGT1A1	7	143500,218800,237900,601816,606785	143500[GILBERT SYNDROME],218800[CRIGLER-NAJJAR SYNDROME, TYPE I],237900[HYPERBILIRUBINEMIA, TRANSIENT FAMILIAL NEONATAL; HBLRTFN],601816[BILIRUBIN, SERUM LEVEL OF, QUANTITATIVE TRAIT LOCUS 1; BILIQTL1],606785[CRIGLER-NAJJAR SYNDROME, TYPE II]
FBgn0040259	Ugt302C1	HGNC:12555	OMIM:601291	UGT8	7		
FBgn0040259	Ugt302C1	HGNC:12539	OMIM:606432	UGT1A7	5		
FBgn0040259	Ugt302C1	HGNC:13479	OMIM:606497	UGT2B28	7		
FBgn0040259	Ugt302C1	HGNC:27266	OMIM:616384	UGT3A2	4		
FBgn0040259	Ugt302C1	HGNC:12544	OMIM:600070	UGT2B10	7		
FBgn0040259	Ugt302C1	HGNC:12537	OMIM:606430	UGT1A5	5		
FBgn0040259	Ugt302C1	HGNC:12546	OMIM:600069	UGT2B15	7		
FBgn0040259	Ugt302C1	HGNC:12541	OMIM:606434	UGT1A9	5		
FBgn0040259	Ugt302C1	HGNC:28528	OMIM:616382	UGT2A3	7		
FBgn0040259	Ugt302C1	HGNC:12535	OMIM:606428	UGT1A3	7		
FBgn0040259	Ugt302C1	HGNC:12536	OMIM:606429	UGT1A4	5		
FBgn0040259	Ugt302C1	HGNC:12540	OMIM:606433	UGT1A8	5		
FBgn0040259	Ugt302C1	HGNC:26625	OMIM:616383	UGT3A1	4		
FBgn0040259	Ugt302C1	HGNC:12547	OMIM:601903	UGT2B17	7	612560	612560[BONE MINERAL DENSITY QUANTITATIVE TRAIT LOCUS 12; BMND12]
FBgn0040259	Ugt302C1	HGNC:12553	OMIM:600067	UGT2B4	7		
FBgn0040259	Ugt302C1	HGNC:12538	OMIM:606431	UGT1A6	5		
FBgn0040259	Ugt302C1	HGNC:12554	OMIM:600068	UGT2B7	7		
FBgn0040259	Ugt302C1	HGNC:28183	OMIM:619809	UGT2A2	6		
FBgn0027584	CG4757	HGNC:26741		CES4A	5		
FBgn0027584	CG4757	HGNC:11764	OMIM:188450	TG	3	274700,608175	274700[THYROID DYSHORMONOGENESIS 3; TDH3],608175[AUTOIMMUNE THYROID DISEASE, SUSCEPTIBILITY TO, 3; AITD3]
FBgn0027584	CG4757	HGNC:108	OMIM:100740	ACHE	5	112100	112100[YT BLOOD GROUP ANTIGEN]
FBgn0027584	CG4757	HGNC:983	OMIM:177400	BCHE	3	617936	617936[BUTYRYLCHOLINESTERASE DEFICIENCY; BCHED]
FBgn0027584	CG4757	HGNC:26459	OMIM:618678	CES5A	5		
FBgn0027584	CG4757	HGNC:1863	OMIM:114835	CES1	5	618057	618057[DRUG METABOLISM, ALTERED, CES1-RELATED]
FBgn0027584	CG4757	HGNC:1848	OMIM:114840	CEL	3	609812	609812[MATURITY-ONSET DIABETES OF THE YOUNG, TYPE 8, WITH EXOCRINE DYSFUNCTION; MODY8]
FBgn0027584	CG4757	HGNC:1864	OMIM:605278	CES2	6		
FBgn0027584	CG4757	HGNC:1865	OMIM:605279	CES3	5		
FBgn0027584	CG4757	HGNC:15529	OMIM:400028	NLGN4Y	3		
FBgn0027584	CG4757	HGNC:14291	OMIM:600568	NLGN1	4	618830	618830[AUTISM, SUSCEPTIBILITY TO, 20; AUTS20]
FBgn0027584	CG4757	HGNC:14289	OMIM:300336	NLGN3	4	300425,300494	300425[AUTISM, SUSCEPTIBILITY TO, X-LINKED 1; AUTSX1],300494[ASPERGER SYNDROME, X-LINKED, SUSCEPTIBILITY TO, 1; ASPGX1]
FBgn0027584	CG4757	HGNC:14287	OMIM:300427	NLGN4X	4	300495,300497	300495[AUTISM, SUSCEPTIBILITY TO, X-LINKED 2; AUTSX2],300497[ASPERGER SYNDROME, X-LINKED, SUSCEPTIBILITY TO, 2; ASPGX2]
FBgn0027584	CG4757	HGNC:14290	OMIM:606479	NLGN2	4		
FBgn0040252	Ugt303A1	HGNC:12531	OMIM:606435	UGT1A10	4		
FBgn0040252	Ugt303A1	HGNC:12545	OMIM:603064	UGT2B11	6		
FBgn0040252	Ugt303A1	HGNC:12530	OMIM:191740	UGT1A1	6	143500,218800,237900,601816,606785	143500[GILBERT SYNDROME],218800[CRIGLER-NAJJAR SYNDROME, TYPE I],237900[HYPERBILIRUBINEMIA, TRANSIENT FAMILIAL NEONATAL; HBLRTFN],601816[BILIRUBIN, SERUM LEVEL OF, QUANTITATIVE TRAIT LOCUS 1; BILIQTL1],606785[CRIGLER-NAJJAR SYNDROME, TYPE II]
FBgn0040252	Ugt303A1	HGNC:12555	OMIM:601291	UGT8	5		
FBgn0040252	Ugt303A1	HGNC:12539	OMIM:606432	UGT1A7	4		
FBgn0040252	Ugt303A1	HGNC:13479	OMIM:606497	UGT2B28	6		
FBgn0040252	Ugt303A1	HGNC:27266	OMIM:616384	UGT3A2	4		
FBgn0040252	Ugt303A1	HGNC:12544	OMIM:600070	UGT2B10	6		
FBgn0040252	Ugt303A1	HGNC:12537	OMIM:606430	UGT1A5	4		
FBgn0040252	Ugt303A1	HGNC:12546	OMIM:600069	UGT2B15	6		
FBgn0040252	Ugt303A1	HGNC:12541	OMIM:606434	UGT1A9	4		
FBgn0040252	Ugt303A1	HGNC:28528	OMIM:616382	UGT2A3	6		
FBgn0040252	Ugt303A1	HGNC:12535	OMIM:606428	UGT1A3	6		
FBgn0040252	Ugt303A1	HGNC:12536	OMIM:606429	UGT1A4	4		
FBgn0040252	Ugt303A1	HGNC:12540	OMIM:606433	UGT1A8	4		
FBgn0040252	Ugt303A1	HGNC:26625	OMIM:616383	UGT3A1	4		
FBgn0040252	Ugt303A1	HGNC:12547	OMIM:601903	UGT2B17	6	612560	612560[BONE MINERAL DENSITY QUANTITATIVE TRAIT LOCUS 12; BMND12]
FBgn0040252	Ugt303A1	HGNC:12553	OMIM:600067	UGT2B4	6		
FBgn0040252	Ugt303A1	HGNC:12538	OMIM:606431	UGT1A6	4		
FBgn0040252	Ugt303A1	HGNC:12554	OMIM:600068	UGT2B7	6		
FBgn0040252	Ugt303A1	HGNC:28183	OMIM:619809	UGT2A2	5		
FBgn0037874	Tctp	HGNC:12022	OMIM:600763	TPT1	14		
FBgn0037874	Tctp	HGNC:24088		TPT1P8	5		
FBgn0037874	Tctp	HGNC:0		FLJ44635	6		
FBgn0020910	RpL3	HGNC:10351	OMIM:617416	RPL3L	9	619371	619371[CARDIOMYOPATHY, DILATED, 2D; CMD2D]
FBgn0020910	RpL3	HGNC:10332	OMIM:604163	RPL3	13		
FBgn0037879	scpr-C	HGNC:8946	OMIM:607076	PI15	4		
FBgn0037879	scpr-C	HGNC:16249		R3HDML	4		
FBgn0037879	scpr-C	HGNC:21245		PI16	3		
FBgn0037879	scpr-C	HGNC:28392	OMIM:610395	GLIPR1L1	5		
FBgn0037879	scpr-C	HGNC:25248	OMIM:612434	CRISPLD2	3		
FBgn0037879	scpr-C	HGNC:16904	OMIM:618062	CRISP3	3		
FBgn0037879	scpr-C	HGNC:304	OMIM:601193	CRISP1	3		
FBgn0037879	scpr-C	HGNC:12024	OMIM:187430	CRISP2	3		
FBgn0037879	scpr-C	HGNC:33849	OMIM:616572	CLEC18B	3		
FBgn0037879	scpr-C	HGNC:30388	OMIM:616571	CLEC18A	3		
FBgn0037880	CG17726	HGNC:28816	OMIM:615898	NDUFAF7	14		
FBgn0037883	Dph3	HGNC:27717	OMIM:608959	DPH3	14		
FBgn0037883	Dph3	HGNC:16136		DPH3P1	6		
FBgn0037889	scpr-A	HGNC:8946	OMIM:607076	PI15	4		
FBgn0037889	scpr-A	HGNC:16249		R3HDML	3		
FBgn0037889	scpr-A	HGNC:21245		PI16	3		
FBgn0037889	scpr-A	HGNC:28392	OMIM:610395	GLIPR1L1	4		
FBgn0037889	scpr-A	HGNC:16904	OMIM:618062	CRISP3	3		
FBgn0037889	scpr-A	HGNC:304	OMIM:601193	CRISP1	3		
FBgn0037889	scpr-A	HGNC:12024	OMIM:187430	CRISP2	3		
FBgn0037889	scpr-A	HGNC:33849	OMIM:616572	CLEC18B	3		
FBgn0037889	scpr-A	HGNC:30388	OMIM:616571	CLEC18A	3		
FBgn0037891	CG5214	HGNC:2911	OMIM:126063	DLST	14	618475	618475[PARAGANGLIOMAS 7; PGL7]
FBgn0037890	CG17734	HGNC:24318		HIGD1B	4		
FBgn0037890	CG17734	HGNC:29527	OMIM:618623	HIGD1A	7		
FBgn0037890	CG17734	HGNC:28044		HIGD1C	6		
FBgn0037888	scpr-B	HGNC:8946	OMIM:607076	PI15	3		
FBgn0037888	scpr-B	HGNC:16249		R3HDML	3		
FBgn0037888	scpr-B	HGNC:28392	OMIM:610395	GLIPR1L1	4		
FBgn0037888	scpr-B	HGNC:25248	OMIM:612434	CRISPLD2	3		
FBgn0037884	Arfip	HGNC:21496	OMIM:605928	ARFIP1	11		
FBgn0037884	Arfip	HGNC:17160	OMIM:601638	ARFIP2	15		
FBgn0037882	CG17187	HGNC:25556	OMIM:616844	DNAJC17	14		
FBgn0037881	GCC88	HGNC:19095	OMIM:607418	GCC1	14		
FBgn0037878	CG6693	HGNC:19123	OMIM:611206	DNAJC9	14		
FBgn0037875	ZnT86D	HGNC:19089	OMIM:607819	SLC30A5	5		
FBgn0037875	ZnT86D	HGNC:19306	OMIM:611149	SLC30A7	15		
FBgn0037873	SdhC	HGNC:10682	OMIM:602413	SDHC	15	605373,606764,606864	605373[PARAGANGLIOMAS 3; PGL3],606764[GASTROINTESTINAL STROMAL TUMOR; GIST],606864[PARAGANGLIOMA AND GASTRIC STROMAL SARCOMA]
FBgn0040250	Ugt304A1	HGNC:12531	OMIM:606435	UGT1A10	4		
FBgn0040250	Ugt304A1	HGNC:12545	OMIM:603064	UGT2B11	6		
FBgn0040250	Ugt304A1	HGNC:12530	OMIM:191740	UGT1A1	6	143500,218800,237900,601816,606785	143500[GILBERT SYNDROME],218800[CRIGLER-NAJJAR SYNDROME, TYPE I],237900[HYPERBILIRUBINEMIA, TRANSIENT FAMILIAL NEONATAL; HBLRTFN],601816[BILIRUBIN, SERUM LEVEL OF, QUANTITATIVE TRAIT LOCUS 1; BILIQTL1],606785[CRIGLER-NAJJAR SYNDROME, TYPE II]
FBgn0040250	Ugt304A1	HGNC:12555	OMIM:601291	UGT8	5		
FBgn0040250	Ugt304A1	HGNC:12539	OMIM:606432	UGT1A7	4		
FBgn0040250	Ugt304A1	HGNC:13479	OMIM:606497	UGT2B28	6		
FBgn0040250	Ugt304A1	HGNC:27266	OMIM:616384	UGT3A2	4		
FBgn0040250	Ugt304A1	HGNC:12544	OMIM:600070	UGT2B10	6		
FBgn0040250	Ugt304A1	HGNC:12537	OMIM:606430	UGT1A5	4		
FBgn0040250	Ugt304A1	HGNC:12546	OMIM:600069	UGT2B15	6		
FBgn0040250	Ugt304A1	HGNC:12541	OMIM:606434	UGT1A9	4		
FBgn0040250	Ugt304A1	HGNC:28528	OMIM:616382	UGT2A3	6		
FBgn0040250	Ugt304A1	HGNC:12535	OMIM:606428	UGT1A3	6		
FBgn0040250	Ugt304A1	HGNC:12536	OMIM:606429	UGT1A4	4		
FBgn0040250	Ugt304A1	HGNC:12540	OMIM:606433	UGT1A8	4		
FBgn0040250	Ugt304A1	HGNC:26625	OMIM:616383	UGT3A1	4		
FBgn0040250	Ugt304A1	HGNC:12547	OMIM:601903	UGT2B17	6	612560	612560[BONE MINERAL DENSITY QUANTITATIVE TRAIT LOCUS 12; BMND12]
FBgn0040250	Ugt304A1	HGNC:12553	OMIM:600067	UGT2B4	6		
FBgn0040250	Ugt304A1	HGNC:12538	OMIM:606431	UGT1A6	4		
FBgn0040250	Ugt304A1	HGNC:12554	OMIM:600068	UGT2B7	6		
FBgn0040250	Ugt304A1	HGNC:28183	OMIM:619809	UGT2A2	5		
FBgn0026315	Ugt35A1	HGNC:12531	OMIM:606435	UGT1A10	5		
FBgn0026315	Ugt35A1	HGNC:12545	OMIM:603064	UGT2B11	8		
FBgn0026315	Ugt35A1	HGNC:12530	OMIM:191740	UGT1A1	7	143500,218800,237900,601816,606785	143500[GILBERT SYNDROME],218800[CRIGLER-NAJJAR SYNDROME, TYPE I],237900[HYPERBILIRUBINEMIA, TRANSIENT FAMILIAL NEONATAL; HBLRTFN],601816[BILIRUBIN, SERUM LEVEL OF, QUANTITATIVE TRAIT LOCUS 1; BILIQTL1],606785[CRIGLER-NAJJAR SYNDROME, TYPE II]
FBgn0026315	Ugt35A1	HGNC:12555	OMIM:601291	UGT8	7		
FBgn0026315	Ugt35A1	HGNC:12539	OMIM:606432	UGT1A7	5		
FBgn0026315	Ugt35A1	HGNC:13479	OMIM:606497	UGT2B28	7		
FBgn0026315	Ugt35A1	HGNC:27266	OMIM:616384	UGT3A2	5		
FBgn0026315	Ugt35A1	HGNC:12544	OMIM:600070	UGT2B10	8		
FBgn0026315	Ugt35A1	HGNC:12537	OMIM:606430	UGT1A5	5		
FBgn0026315	Ugt35A1	HGNC:12546	OMIM:600069	UGT2B15	8		
FBgn0026315	Ugt35A1	HGNC:12541	OMIM:606434	UGT1A9	5		
FBgn0026315	Ugt35A1	HGNC:28528	OMIM:616382	UGT2A3	9		
FBgn0026315	Ugt35A1	HGNC:12535	OMIM:606428	UGT1A3	7		
FBgn0026315	Ugt35A1	HGNC:12536	OMIM:606429	UGT1A4	5		
FBgn0026315	Ugt35A1	HGNC:12540	OMIM:606433	UGT1A8	5		
FBgn0026315	Ugt35A1	HGNC:26625	OMIM:616383	UGT3A1	5		
FBgn0026315	Ugt35A1	HGNC:12547	OMIM:601903	UGT2B17	8	612560	612560[BONE MINERAL DENSITY QUANTITATIVE TRAIT LOCUS 12; BMND12]
FBgn0026315	Ugt35A1	HGNC:12553	OMIM:600067	UGT2B4	8		
FBgn0026315	Ugt35A1	HGNC:12538	OMIM:606431	UGT1A6	5		
FBgn0026315	Ugt35A1	HGNC:12554	OMIM:600068	UGT2B7	8		
FBgn0026315	Ugt35A1	HGNC:28183	OMIM:619809	UGT2A2	7		
FBgn0026314	Ugt35B1	HGNC:12531	OMIM:606435	UGT1A10	5		
FBgn0026314	Ugt35B1	HGNC:12545	OMIM:603064	UGT2B11	8		
FBgn0026314	Ugt35B1	HGNC:12530	OMIM:191740	UGT1A1	7	143500,218800,237900,601816,606785	143500[GILBERT SYNDROME],218800[CRIGLER-NAJJAR SYNDROME, TYPE I],237900[HYPERBILIRUBINEMIA, TRANSIENT FAMILIAL NEONATAL; HBLRTFN],601816[BILIRUBIN, SERUM LEVEL OF, QUANTITATIVE TRAIT LOCUS 1; BILIQTL1],606785[CRIGLER-NAJJAR SYNDROME, TYPE II]
FBgn0026314	Ugt35B1	HGNC:12555	OMIM:601291	UGT8	7		
FBgn0026314	Ugt35B1	HGNC:12539	OMIM:606432	UGT1A7	5		
FBgn0026314	Ugt35B1	HGNC:13479	OMIM:606497	UGT2B28	8		
FBgn0026314	Ugt35B1	HGNC:27266	OMIM:616384	UGT3A2	4		
FBgn0026314	Ugt35B1	HGNC:12544	OMIM:600070	UGT2B10	8		
FBgn0026314	Ugt35B1	HGNC:12537	OMIM:606430	UGT1A5	5		
FBgn0026314	Ugt35B1	HGNC:12546	OMIM:600069	UGT2B15	10		
FBgn0026314	Ugt35B1	HGNC:12541	OMIM:606434	UGT1A9	5		
FBgn0026314	Ugt35B1	HGNC:28528	OMIM:616382	UGT2A3	10		
FBgn0026314	Ugt35B1	HGNC:12535	OMIM:606428	UGT1A3	7		
FBgn0026314	Ugt35B1	HGNC:12536	OMIM:606429	UGT1A4	5		
FBgn0026314	Ugt35B1	HGNC:12540	OMIM:606433	UGT1A8	5		
FBgn0026314	Ugt35B1	HGNC:26625	OMIM:616383	UGT3A1	4		
FBgn0026314	Ugt35B1	HGNC:12547	OMIM:601903	UGT2B17	9	612560	612560[BONE MINERAL DENSITY QUANTITATIVE TRAIT LOCUS 12; BMND12]
FBgn0026314	Ugt35B1	HGNC:12553	OMIM:600067	UGT2B4	8		
FBgn0026314	Ugt35B1	HGNC:12538	OMIM:606431	UGT1A6	5		
FBgn0026314	Ugt35B1	HGNC:12554	OMIM:600068	UGT2B7	8		
FBgn0026314	Ugt35B1	HGNC:28183	OMIM:619809	UGT2A2	7		
FBgn0040255	Ugt35E2	HGNC:12531	OMIM:606435	UGT1A10	5		
FBgn0040255	Ugt35E2	HGNC:12545	OMIM:603064	UGT2B11	8		
FBgn0040255	Ugt35E2	HGNC:12530	OMIM:191740	UGT1A1	7	143500,218800,237900,601816,606785	143500[GILBERT SYNDROME],218800[CRIGLER-NAJJAR SYNDROME, TYPE I],237900[HYPERBILIRUBINEMIA, TRANSIENT FAMILIAL NEONATAL; HBLRTFN],601816[BILIRUBIN, SERUM LEVEL OF, QUANTITATIVE TRAIT LOCUS 1; BILIQTL1],606785[CRIGLER-NAJJAR SYNDROME, TYPE II]
FBgn0040255	Ugt35E2	HGNC:12555	OMIM:601291	UGT8	7		
FBgn0040255	Ugt35E2	HGNC:12539	OMIM:606432	UGT1A7	5		
FBgn0040255	Ugt35E2	HGNC:13479	OMIM:606497	UGT2B28	8		
FBgn0040255	Ugt35E2	HGNC:27266	OMIM:616384	UGT3A2	4		
FBgn0040255	Ugt35E2	HGNC:12544	OMIM:600070	UGT2B10	8		
FBgn0040255	Ugt35E2	HGNC:12537	OMIM:606430	UGT1A5	5		
FBgn0040255	Ugt35E2	HGNC:12546	OMIM:600069	UGT2B15	9		
FBgn0040255	Ugt35E2	HGNC:12541	OMIM:606434	UGT1A9	5		
FBgn0040255	Ugt35E2	HGNC:28528	OMIM:616382	UGT2A3	9		
FBgn0040255	Ugt35E2	HGNC:12535	OMIM:606428	UGT1A3	7		
FBgn0040255	Ugt35E2	HGNC:12536	OMIM:606429	UGT1A4	5		
FBgn0040255	Ugt35E2	HGNC:12540	OMIM:606433	UGT1A8	5		
FBgn0040255	Ugt35E2	HGNC:26625	OMIM:616383	UGT3A1	4		
FBgn0040255	Ugt35E2	HGNC:12547	OMIM:601903	UGT2B17	9	612560	612560[BONE MINERAL DENSITY QUANTITATIVE TRAIT LOCUS 12; BMND12]
FBgn0040255	Ugt35E2	HGNC:12553	OMIM:600067	UGT2B4	8		
FBgn0040255	Ugt35E2	HGNC:12538	OMIM:606431	UGT1A6	5		
FBgn0040255	Ugt35E2	HGNC:12554	OMIM:600068	UGT2B7	8		
FBgn0040255	Ugt35E2	HGNC:28183	OMIM:619809	UGT2A2	7		
FBgn0040253	Ugt35E1	HGNC:12531	OMIM:606435	UGT1A10	5		
FBgn0040253	Ugt35E1	HGNC:12545	OMIM:603064	UGT2B11	8		
FBgn0040253	Ugt35E1	HGNC:12530	OMIM:191740	UGT1A1	8	143500,218800,237900,601816,606785	143500[GILBERT SYNDROME],218800[CRIGLER-NAJJAR SYNDROME, TYPE I],237900[HYPERBILIRUBINEMIA, TRANSIENT FAMILIAL NEONATAL; HBLRTFN],601816[BILIRUBIN, SERUM LEVEL OF, QUANTITATIVE TRAIT LOCUS 1; BILIQTL1],606785[CRIGLER-NAJJAR SYNDROME, TYPE II]
FBgn0040253	Ugt35E1	HGNC:12555	OMIM:601291	UGT8	7		
FBgn0040253	Ugt35E1	HGNC:12539	OMIM:606432	UGT1A7	5		
FBgn0040253	Ugt35E1	HGNC:13479	OMIM:606497	UGT2B28	7		
FBgn0040253	Ugt35E1	HGNC:27266	OMIM:616384	UGT3A2	4		
FBgn0040253	Ugt35E1	HGNC:12544	OMIM:600070	UGT2B10	8		
FBgn0040253	Ugt35E1	HGNC:12537	OMIM:606430	UGT1A5	5		
FBgn0040253	Ugt35E1	HGNC:12546	OMIM:600069	UGT2B15	8		
FBgn0040253	Ugt35E1	HGNC:12541	OMIM:606434	UGT1A9	5		
FBgn0040253	Ugt35E1	HGNC:28528	OMIM:616382	UGT2A3	10		
FBgn0040253	Ugt35E1	HGNC:12535	OMIM:606428	UGT1A3	7		
FBgn0040253	Ugt35E1	HGNC:12536	OMIM:606429	UGT1A4	5		
FBgn0040253	Ugt35E1	HGNC:12540	OMIM:606433	UGT1A8	5		
FBgn0040253	Ugt35E1	HGNC:26625	OMIM:616383	UGT3A1	4		
FBgn0040253	Ugt35E1	HGNC:12547	OMIM:601903	UGT2B17	8	612560	612560[BONE MINERAL DENSITY QUANTITATIVE TRAIT LOCUS 12; BMND12]
FBgn0040253	Ugt35E1	HGNC:12553	OMIM:600067	UGT2B4	9		
FBgn0040253	Ugt35E1	HGNC:12538	OMIM:606431	UGT1A6	5		
FBgn0040253	Ugt35E1	HGNC:12554	OMIM:600068	UGT2B7	9		
FBgn0040253	Ugt35E1	HGNC:28183	OMIM:619809	UGT2A2	8		
FBgn0040251	Ugt302K1	HGNC:12531	OMIM:606435	UGT1A10	6		
FBgn0040251	Ugt302K1	HGNC:12545	OMIM:603064	UGT2B11	7		
FBgn0040251	Ugt302K1	HGNC:12530	OMIM:191740	UGT1A1	8	143500,218800,237900,601816,606785	143500[GILBERT SYNDROME],218800[CRIGLER-NAJJAR SYNDROME, TYPE I],237900[HYPERBILIRUBINEMIA, TRANSIENT FAMILIAL NEONATAL; HBLRTFN],601816[BILIRUBIN, SERUM LEVEL OF, QUANTITATIVE TRAIT LOCUS 1; BILIQTL1],606785[CRIGLER-NAJJAR SYNDROME, TYPE II]
FBgn0040251	Ugt302K1	HGNC:12555	OMIM:601291	UGT8	7		
FBgn0040251	Ugt302K1	HGNC:12539	OMIM:606432	UGT1A7	6		
FBgn0040251	Ugt302K1	HGNC:13479	OMIM:606497	UGT2B28	8		
FBgn0040251	Ugt302K1	HGNC:27266	OMIM:616384	UGT3A2	5		
FBgn0040251	Ugt302K1	HGNC:12544	OMIM:600070	UGT2B10	8		
FBgn0040251	Ugt302K1	HGNC:12537	OMIM:606430	UGT1A5	6		
FBgn0040251	Ugt302K1	HGNC:12546	OMIM:600069	UGT2B15	8		
FBgn0040251	Ugt302K1	HGNC:12541	OMIM:606434	UGT1A9	6		
FBgn0040251	Ugt302K1	HGNC:28528	OMIM:616382	UGT2A3	8		
FBgn0040251	Ugt302K1	HGNC:12535	OMIM:606428	UGT1A3	8		
FBgn0040251	Ugt302K1	HGNC:12536	OMIM:606429	UGT1A4	6		
FBgn0040251	Ugt302K1	HGNC:12540	OMIM:606433	UGT1A8	6		
FBgn0040251	Ugt302K1	HGNC:26625	OMIM:616383	UGT3A1	5		
FBgn0040251	Ugt302K1	HGNC:12547	OMIM:601903	UGT2B17	8	612560	612560[BONE MINERAL DENSITY QUANTITATIVE TRAIT LOCUS 12; BMND12]
FBgn0040251	Ugt302K1	HGNC:12553	OMIM:600067	UGT2B4	7		
FBgn0040251	Ugt302K1	HGNC:12538	OMIM:606431	UGT1A6	6		
FBgn0040251	Ugt302K1	HGNC:12554	OMIM:600068	UGT2B7	7		
FBgn0040251	Ugt302K1	HGNC:28183	OMIM:619809	UGT2A2	6		
FBgn0040256	Ugt35C1	HGNC:12531	OMIM:606435	UGT1A10	6		
FBgn0040256	Ugt35C1	HGNC:12545	OMIM:603064	UGT2B11	6		
FBgn0040256	Ugt35C1	HGNC:12530	OMIM:191740	UGT1A1	7	143500,218800,237900,601816,606785	143500[GILBERT SYNDROME],218800[CRIGLER-NAJJAR SYNDROME, TYPE I],237900[HYPERBILIRUBINEMIA, TRANSIENT FAMILIAL NEONATAL; HBLRTFN],601816[BILIRUBIN, SERUM LEVEL OF, QUANTITATIVE TRAIT LOCUS 1; BILIQTL1],606785[CRIGLER-NAJJAR SYNDROME, TYPE II]
FBgn0040256	Ugt35C1	HGNC:12555	OMIM:601291	UGT8	6		
FBgn0040256	Ugt35C1	HGNC:12539	OMIM:606432	UGT1A7	6		
FBgn0040256	Ugt35C1	HGNC:13479	OMIM:606497	UGT2B28	8		
FBgn0040256	Ugt35C1	HGNC:27266	OMIM:616384	UGT3A2	4		
FBgn0040256	Ugt35C1	HGNC:12544	OMIM:600070	UGT2B10	7		
FBgn0040256	Ugt35C1	HGNC:12537	OMIM:606430	UGT1A5	6		
FBgn0040256	Ugt35C1	HGNC:12546	OMIM:600069	UGT2B15	8		
FBgn0040256	Ugt35C1	HGNC:12541	OMIM:606434	UGT1A9	6		
FBgn0040256	Ugt35C1	HGNC:28528	OMIM:616382	UGT2A3	7		
FBgn0040256	Ugt35C1	HGNC:12535	OMIM:606428	UGT1A3	7		
FBgn0040256	Ugt35C1	HGNC:12536	OMIM:606429	UGT1A4	6		
FBgn0040256	Ugt35C1	HGNC:12540	OMIM:606433	UGT1A8	6		
FBgn0040256	Ugt35C1	HGNC:26625	OMIM:616383	UGT3A1	4		
FBgn0040256	Ugt35C1	HGNC:12547	OMIM:601903	UGT2B17	8	612560	612560[BONE MINERAL DENSITY QUANTITATIVE TRAIT LOCUS 12; BMND12]
FBgn0040256	Ugt35C1	HGNC:12553	OMIM:600067	UGT2B4	6		
FBgn0040256	Ugt35C1	HGNC:12538	OMIM:606431	UGT1A6	6		
FBgn0040256	Ugt35C1	HGNC:12554	OMIM:600068	UGT2B7	6		
FBgn0040256	Ugt35C1	HGNC:28183	OMIM:619809	UGT2A2	5		
FBgn0037860	SdhCL	HGNC:10682	OMIM:602413	SDHC	10	605373,606764,606864	605373[PARAGANGLIOMAS 3; PGL3],606764[GASTROINTESTINAL STROMAL TUMOR; GIST],606864[PARAGANGLIOMA AND GASTRIC STROMAL SARCOMA]
FBgn0037892	mRpL40	HGNC:14491	OMIM:605089	MRPL40	14		
FBgn0011774	Irbp	HGNC:4055	OMIM:152690	XRCC6	15		
FBgn0037894	Ipo9	HGNC:19425		IPO9	14		
FBgn0037897	CG5270	HGNC:20761	OMIM:612012	ZFYVE26	12	270700	270700[SPASTIC PARAPLEGIA 15, AUTOSOMAL RECESSIVE; SPG15]
FBgn0037898	Dtd	HGNC:16219	OMIM:610996	DTD1	13		
FBgn0037900	CG5276	HGNC:19721	OMIM:613165	CANT1	15	251450,617719	251450[DESBUQUOIS DYSPLASIA 1; DBQD1],617719[EPIPHYSEAL DYSPLASIA, MULTIPLE, 7; EDM7]
FBgn0037902	CG5281	HGNC:26607	OMIM:617167	SLC35G1	14		
FBgn0046225	CG17230	HGNC:28135	OMIM:612654	TCHP	6		
FBgn0037906	PGRP-LB	HGNC:30013	OMIM:608199	PGLYRP2	7		
FBgn0037906	PGRP-LB	HGNC:8904	OMIM:604963	PGLYRP1	5		
FBgn0037906	PGRP-LB	HGNC:30014	OMIM:608197	PGLYRP3	4		
FBgn0037906	PGRP-LB	HGNC:30015	OMIM:608198	PGLYRP4	4		
FBgn0037901	Exd2	HGNC:20217	OMIM:616940	EXD2	14		
FBgn0037899	RpL24-like	HGNC:18479	OMIM:613262	RSL24D1	14		
FBgn0037896	ninaG	HGNC:24288		CHDH	4		
FBgn0037895	bumpel	HGNC:11041	OMIM:604024	SLC5A6	5	618973,619903	618973[SODIUM-DEPENDENT MULTIVITAMIN TRANSPORTER DEFICIENCY; SMVTD],619903[PERIPHERAL MOTOR NEUROPATHY, CHILDHOOD-ONSET, BIOTIN-RESPONSIVE; COMNB]
FBgn0037895	bumpel	HGNC:11040	OMIM:601843	SLC5A5	6	274400	274400[THYROID DYSHORMONOGENESIS 1; TDH1]
FBgn0037895	bumpel	HGNC:28750	OMIM:612455	SLC5A12	7		
FBgn0037895	bumpel	HGNC:19119	OMIM:608044	SLC5A8	7		
FBgn0037895	bumpel	HGNC:11037	OMIM:182381	SLC5A2	3	233100	233100[RENAL GLUCOSURIA; GLYS]
FBgn0026064	KP78a	HGNC:6896	OMIM:606511	MARK1	3		
FBgn0026064	KP78a	HGNC:6897	OMIM:602678	MARK3	3	618283	618283[VISUAL IMPAIRMENT AND PROGRESSIVE PHTHISIS BULBI; VIPB]
FBgn0026063	KP78b	HGNC:6896	OMIM:606511	MARK1	3		
FBgn0026063	KP78b	HGNC:3332	OMIM:600526	MARK2	3		
FBgn0037911	CG10898	HGNC:26194	OMIM:615791	NUDT18	10		
FBgn0037916	CG5342	HGNC:8967	OMIM:606097	PIGN	8	614080	614080[MULTIPLE CONGENITAL ANOMALIES-HYPOTONIA-SEIZURES SYNDROME 1; MCAHS1]
FBgn0037917	wkd	HGNC:23609	OMIM:610020	TBC1D10A	12		
FBgn0037917	wkd	HGNC:24510	OMIM:613620	TBC1D10B	11		
FBgn0037917	wkd	HGNC:24702	OMIM:610831	TBC1D10C	10		
FBgn0037924	CG14712	HGNC:8062	OMIM:603948	NUP153	3		
FBgn0037926	Elp1	HGNC:5959	OMIM:603722	ELP1	15	155255,223900	155255[MEDULLOBLASTOMA; MDB],223900[NEUROPATHY, HEREDITARY SENSORY AND AUTONOMIC, TYPE III; HSAN3]
FBgn0037930	CG14715	HGNC:3718	OMIM:186946	FKBP2	14		
FBgn0037930	CG14715	HGNC:18624	OMIM:610571	FKBP11	3		
FBgn0037933	Ho	HGNC:5013	OMIM:141250	HMOX1	10	606963,614034	606963[PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; COPD],614034[HEME OXYGENASE 1 DEFICIENCY; HMOX1D]
FBgn0037933	Ho	HGNC:5014	OMIM:141251	HMOX2	12		
FBgn0037939	CG14718	HGNC:3508	OMIM:133450	EWSR1	6	612219	612219[EWING SARCOMA; ES]
FBgn0037939	CG14718	HGNC:4010	OMIM:137070	FUS	4	608030,614782	608030[AMYOTROPHIC LATERAL SCLEROSIS 6 WITH OR WITHOUT FRONTOTEMPORAL DEMENTIA; ALS6],614782[TREMOR, HEREDITARY ESSENTIAL, 4; ETM4]
FBgn0037939	CG14718	HGNC:11547	OMIM:601574	TAF15	4	612237	612237[CHONDROSARCOMA, EXTRASKELETAL MYXOID]
FBgn0037942	CG14721	HGNC:17358	OMIM:606370	TPK1	14	614458	614458[THIAMINE METABOLISM DYSFUNCTION SYNDROME 5 (EPISODIC ENCEPHALOPATHY TYPE); THMD5]
FBgn0037943	CG14722	HGNC:25971		WDR55	14		
FBgn0037944	CG6923	HGNC:31696		RNF165	6		
FBgn0037944	CG6923	HGNC:17384	OMIM:605840	RNF111	7		
FBgn0002906	Blm	HGNC:12791	OMIM:604611	WRN	3	277700	277700[WERNER SYNDROME; WRN]
FBgn0002906	Blm	HGNC:9950	OMIM:603781	RECQL5	4		
FBgn0002906	Blm	HGNC:1058	OMIM:604610	BLM	10	210900	210900[BLOOM SYNDROME; BLM]
FBgn0002906	Blm	HGNC:9948	OMIM:600537	RECQL	5		
FBgn0037937	Fer3	HGNC:16660	OMIM:617578	FERD3L	9		
FBgn0011290	Taf12	HGNC:11545	OMIM:600773	TAF12	12		
FBgn0051363	Jupiter	HGNC:14569	OMIM:619242	JPT1	3		
FBgn0051363	Jupiter	HGNC:14137	OMIM:619241	JPT2	3		
FBgn0037915	CG6790	HGNC:8967	OMIM:606097	PIGN	7	614080	614080[MULTIPLE CONGENITAL ANOMALIES-HYPOTONIA-SEIZURES SYNDROME 1; MCAHS1]
FBgn0037950	HisCl1	HGNC:4328	OMIM:600421	GLRA3	4		
FBgn0037950	HisCl1	HGNC:4329	OMIM:138492	GLRB	3	614619	614619[HYPEREKPLEXIA 2; HKPX2]
FBgn0037950	HisCl1	HGNC:4327	OMIM:305990	GLRA2	5	301076	301076[INTELLECTUAL DEVELOPMENTAL DISORDER, X-LINKED, SYNDROMIC, PILORGE TYPE; MRXSP]
FBgn0037950	HisCl1	HGNC:31715		GLRA4	5		
FBgn0037950	HisCl1	HGNC:4326	OMIM:138491	GLRA1	4	149400	149400[HYPEREKPLEXIA 1; HKPX1]
FBgn0019624	COX5A	HGNC:2267	OMIM:603773	COX5A	14	619064	619064[MITOCHONDRIAL COMPLEX IV DEFICIENCY, NUCLEAR TYPE 20; MC4DN20]
FBgn0003312	sad	HGNC:2606	OMIM:609506	CYP27B1	5	264700	264700[VITAMIN D HYDROXYLATION-DEFICIENT RICKETS, TYPE 1A; VDDR1A]
FBgn0003312	sad	HGNC:33480		CYP27C1	6		
FBgn0003312	sad	HGNC:2605	OMIM:606530	CYP27A1	5	213700	213700[CEREBROTENDINOUS XANTHOMATOSIS; CTX]
FBgn0003312	sad	HGNC:2602	OMIM:126065	CYP24A1	5	143880	143880[HYPERCALCEMIA, INFANTILE, 1; HCINF1]
FBgn0051368	CG31368	HGNC:29513	OMIM:610548	AQR	14		
FBgn0051211	CG31211	HGNC:21222	OMIM:616653	PNISR	8		
FBgn0013276	Hsp70Ab	HGNC:5232	OMIM:140550	HSPA1A	5		
FBgn0013276	Hsp70Ab	HGNC:5233	OMIM:603012	HSPA1B	5		
FBgn0013276	Hsp70Ab	HGNC:5234	OMIM:140559	HSPA1L	4		
FBgn0013276	Hsp70Ab	HGNC:5238	OMIM:138120	HSPA5	3		
FBgn0013276	Hsp70Ab	HGNC:5239	OMIM:140555	HSPA6	4		
FBgn0013276	Hsp70Ab	HGNC:5235	OMIM:140560	HSPA2	4		
FBgn0013276	Hsp70Ab	HGNC:5241	OMIM:600816	HSPA8	4		
FBgn0000147	aurA	HGNC:11391	OMIM:603495	AURKC	11	243060	243060[SPERMATOGENIC FAILURE 5; SPGF5]
FBgn0000147	aurA	HGNC:11390	OMIM:604970	AURKB	11		
FBgn0000147	aurA	HGNC:11393	OMIM:603072	AURKA	11	114500	114500[COLORECTAL CANCER; CRC]
FBgn0037970	GC2	HGNC:10988	OMIM:609303	SLC25A18	9		
FBgn0037970	GC2	HGNC:19954	OMIM:609302	SLC25A22	10	609304	609304[DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 3; DEE3]
FBgn0037975	CG3397	HGNC:389	OMIM:603418	AKR7A2	3		
FBgn0037975	CG3397	HGNC:390	OMIM:608477	AKR7A3	3		
FBgn0037974	CG12224	HGNC:389	OMIM:603418	AKR7A2	3		
FBgn0037974	CG12224	HGNC:390	OMIM:608477	AKR7A3	3		
FBgn0037973	CG18547	HGNC:6229	OMIM:601142	KCNAB2	3		
FBgn0037973	CG18547	HGNC:389	OMIM:603418	AKR7A2	3		
FBgn0037973	CG18547	HGNC:390	OMIM:608477	AKR7A3	3		
FBgn0013275	Hsp70Aa	HGNC:5232	OMIM:140550	HSPA1A	5		
FBgn0013275	Hsp70Aa	HGNC:5233	OMIM:603012	HSPA1B	6		
FBgn0013275	Hsp70Aa	HGNC:5234	OMIM:140559	HSPA1L	5		
FBgn0013275	Hsp70Aa	HGNC:5238	OMIM:138120	HSPA5	4		
FBgn0013275	Hsp70Aa	HGNC:5244	OMIM:600548	HSPA9	3	182170,616854	182170[ANEMIA, SIDEROBLASTIC, 4; SIDBA4],616854[EVEN-PLUS SYNDROME; EVPLS]
FBgn0013275	Hsp70Aa	HGNC:5239	OMIM:140555	HSPA6	5		
FBgn0013275	Hsp70Aa	HGNC:5235	OMIM:140560	HSPA2	5		
FBgn0013275	Hsp70Aa	HGNC:5241	OMIM:600816	HSPA8	5		
FBgn0037962	Dnali1	HGNC:14353	OMIM:602135	DNALI1	15		
FBgn0037958	CG6962	HGNC:32949	OMIM:610457	SMPD4	15	618622	618622[NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, ARTHROGRYPOSIS, AND STRUCTURAL BRAIN ANOMALIES; NEDMABA]
FBgn0037956	CG6959	HGNC:12004	OMIM:190920	TPBG	6		
FBgn0037956	CG6959	HGNC:44159		TPBGL	4		
FBgn0037955	Kyat	HGNC:33238	OMIM:610656	KYAT3	13		
FBgn0037955	Kyat	HGNC:1564	OMIM:600547	KYAT1	10		
FBgn0051116	ClC-a	HGNC:2026	OMIM:602024	CLCNKA	5	613090	613090[BARTTER SYNDROME, TYPE 4B, NEONATAL, WITH SENSORINEURAL DEAFNESS; BARTS4B]
FBgn0051116	ClC-a	HGNC:2020	OMIM:600570	CLCN2	13	605635,607628,615651	605635[HYPERALDOSTERONISM, FAMILIAL, TYPE II; HALD2],607628[EPILEPSY, IDIOPATHIC GENERALIZED, SUSCEPTIBILITY TO, 11; EIG11],615651[LEUKOENCEPHALOPATHY WITH ATAXIA; LKPAT]
FBgn0051116	ClC-a	HGNC:2019	OMIM:118425	CLCN1	10	160800,255700	160800[MYOTONIA CONGENITA, AUTOSOMAL DOMINANT],255700[MYOTONIA CONGENITA, AUTOSOMAL RECESSIVE]
FBgn0051116	ClC-a	HGNC:2027	OMIM:602023	CLCNKB	5	607364,613090	607364[BARTTER SYNDROME, TYPE 3; BARTS3],613090[BARTTER SYNDROME, TYPE 4B, NEONATAL, WITH SENSORINEURAL DEAFNESS; BARTS4B]
FBgn0025802	Sbf	HGNC:2135	OMIM:607697	SBF2	14	604563	604563[CHARCOT-MARIE-TOOTH DISEASE, TYPE 4B2; CMT4B2]
FBgn0025802	Sbf	HGNC:10542	OMIM:603560	SBF1	14	615284	615284[CHARCOT-MARIE-TOOTH DISEASE, TYPE 4B3; CMT4B3]
FBgn0037949	prd1	HGNC:29131	OMIM:609613	PLEKHM2	4		
FBgn0017581	Lk6	HGNC:7111	OMIM:605069	MKNK2	6		
FBgn0017581	Lk6	HGNC:7110	OMIM:606724	MKNK1	9		
FBgn0037979	GCC185	HGNC:23218	OMIM:612711	GCC2	10		
FBgn0037981	Spt3	HGNC:11466	OMIM:602947	SUPT3H	13		
FBgn0037995	Adk1	HGNC:257	OMIM:102750	ADK	8	614300	614300[HYPERMETHIONINEMIA DUE TO ADENOSINE KINASE DEFICIENCY]
FBgn0037994	eIF3d2	HGNC:3278	OMIM:603915	EIF3D	13		
FBgn0037989	ATP8B	HGNC:13534	OMIM:605867	ATP8B2	12		
FBgn0037989	ATP8B	HGNC:3706	OMIM:602397	ATP8B1	8	147480,211600,243300	147480[CHOLESTASIS, INTRAHEPATIC, OF PREGNANCY, 1; ICP1],211600[CHOLESTASIS, PROGRESSIVE FAMILIAL INTRAHEPATIC, 1; PFIC1],243300[CHOLESTASIS, BENIGN RECURRENT INTRAHEPATIC, 1; BRIC1]
FBgn0037989	ATP8B	HGNC:13536	OMIM:609123	ATP8B4	9		
FBgn0037989	ATP8B	HGNC:13554	OMIM:300516	ATP11C	4	301015	301015[HEMOLYTIC ANEMIA, CONGENITAL, X-LINKED; HACXL]
FBgn0037989	ATP8B	HGNC:13552	OMIM:605868	ATP11A	4	619810,619851	619810[DEAFNESS, AUTOSOMAL DOMINANT 84; DFNA84],619851[LEUKODYSTROPHY, HYPOMYELINATING, 24; HLD24]
FBgn0037989	ATP8B	HGNC:13533	OMIM:605870	ATP8A2	3	615268	615268[CEREBELLAR ATAXIA, MENTAL RETARDATION, AND DYSEQUILIBRIUM SYNDROME 4; CAMRQ4]
FBgn0037989	ATP8B	HGNC:13553	OMIM:605869	ATP11B	3		
FBgn0037989	ATP8B	HGNC:13549	OMIM:619815	ATP10D	3		
FBgn0037989	ATP8B	HGNC:13531	OMIM:609542	ATP8A1	3		
FBgn0037989	ATP8B	HGNC:13543	OMIM:619791	ATP10B	3		
FBgn0037989	ATP8B	HGNC:13535	OMIM:605866	ATP8B3	6		
FBgn0037988	CG14740	HGNC:2422	OMIM:118950	CS	7		
FBgn0037987	CG14739	HGNC:12484	OMIM:601082	UBE2H	5		
FBgn0051358	CG31358	HGNC:13394	OMIM:604766	NPHS2	4	600995	600995[NEPHROTIC SYNDROME, TYPE 2; NPHS2]
FBgn0051358	CG31358	HGNC:3383	OMIM:133090	STOM	4		
FBgn0051358	CG31358	HGNC:19420	OMIM:608327	STOML3	4		
FBgn0037980	DCAF12	HGNC:29395		DCAF12L1	12		
FBgn0037980	DCAF12	HGNC:19911		DCAF12	14		
FBgn0037980	DCAF12	HGNC:32950		DCAF12L2	11		
FBgn0037978	KLHL18	HGNC:29120	OMIM:619926	KLHL18	14		
FBgn0038008	CG3942	HGNC:26957	OMIM:614124	GPCPD1	10		
FBgn0003651	svp	HGNC:7977	OMIM:132880	NR2F6	4		
FBgn0003651	svp	HGNC:7975	OMIM:132890	NR2F1	9	615722	615722[BOSCH-BOONSTRA-SCHAAF OPTIC ATROPHY SYNDROME; BBSOAS]
FBgn0003651	svp	HGNC:7976	OMIM:107773	NR2F2	10	615779,618901	615779[CONGENITAL HEART DEFECTS, MULTIPLE TYPES, 4; CHTD4],618901[46,XX SEX REVERSAL 5; SRXX5]
FBgn0010038	GstD2	HGNC:4642	OMIM:600437	GSTT2	3		
FBgn0010038	GstD2	HGNC:33437		GSTT2B	3		
FBgn0010038	GstD2	HGNC:26930		GSTT4	3		
FBgn0010039	GstD3	HGNC:4642	OMIM:600437	GSTT2	3		
FBgn0010039	GstD3	HGNC:33437		GSTT2B	3		
FBgn0010039	GstD3	HGNC:26930		GSTT4	3		
FBgn0010040	GstD4	HGNC:4642	OMIM:600437	GSTT2	3		
FBgn0010040	GstD4	HGNC:33437		GSTT2B	3		
FBgn0010040	GstD4	HGNC:26930		GSTT4	3		
FBgn0010041	GstD5	HGNC:4642	OMIM:600437	GSTT2	3		
FBgn0010041	GstD5	HGNC:33437		GSTT2B	3		
FBgn0010041	GstD5	HGNC:26930		GSTT4	3		
FBgn0010042	GstD6	HGNC:4642	OMIM:600437	GSTT2	3		
FBgn0010042	GstD6	HGNC:33437		GSTT2B	3		
FBgn0010042	GstD6	HGNC:26930		GSTT4	3		
FBgn0010043	GstD7	HGNC:4642	OMIM:600437	GSTT2	3		
FBgn0010043	GstD7	HGNC:33437		GSTT2B	3		
FBgn0010043	GstD7	HGNC:26930		GSTT4	3		
FBgn0010044	GstD8	HGNC:4642	OMIM:600437	GSTT2	3		
FBgn0010044	GstD8	HGNC:33437		GSTT2B	3		
FBgn0010044	GstD8	HGNC:26930		GSTT4	3		
FBgn0053098	CG33098	HGNC:15754	OMIM:609905	MYL9	3	619365	619365[MEGACYSTIS-MICROCOLON-INTESTINAL HYPOPERISTALSIS SYNDROME 4; MMIHS4]
FBgn0053098	CG33098	HGNC:29827	OMIM:609211	MYL12B	3		
FBgn0053098	CG33098	HGNC:16701		MYL12A	3		
FBgn0053098	CG33098	HGNC:29824	OMIM:617378	MYLPF	3	619110	619110[ARTHROGRYPOSIS, DISTAL, TYPE 1C; DA1C]
FBgn0038038	Sccpdh2	HGNC:24275		SCCPDH	15		
FBgn0038039	CG5196	HGNC:19160	OMIM:618715	ZDHHC6	15		
FBgn0082831	pps	HGNC:2680	OMIM:604140	DIDO1	7		
FBgn0082831	pps	HGNC:8921	OMIM:607789	PHF3	6		
FBgn0082831	pps	HGNC:26338	OMIM:619038	SPOCD1	6		
FBgn0038043	CG17202	HGNC:7554	OMIM:606535	MYCBP	7		
FBgn0038045	NANS	HGNC:19237	OMIM:605202	NANS	15	610442	610442[SPONDYLOEPIMETAPHYSEAL DYSPLASIA, GENEVIEVE TYPE; SEMDG]
FBgn0038047	CG5245	HGNC:13019		ZNF226	3		
FBgn0038047	CG5245	HGNC:20817		ZNF429	3		
FBgn0038047	CG5245	HGNC:13111	OMIM:194554	ZNF45	3		
FBgn0038047	CG5245	HGNC:24750	OMIM:609571	ZNF699	3	619488	619488[DEGCAGS SYNDROME; DEGCAGS]
FBgn0038047	CG5245	HGNC:23384		ZNF483	3		
FBgn0038047	CG5245	HGNC:13144	OMIM:194548	ZNF74	3		
FBgn0038049	Srlp	HGNC:21489	OMIM:612136	ECHDC1	3		
FBgn0043043	Desat2	HGNC:21088	OMIM:608370	SCD5	13	619086	619086[DEAFNESS, AUTOSOMAL DOMINANT 79; DFNA79]
FBgn0043043	Desat2	HGNC:10571	OMIM:604031	SCD	13		
FBgn0029512	Aos1	HGNC:30660	OMIM:613294	SAE1	14		
FBgn0038046	CG5641	HGNC:6037	OMIM:603181	ILF2	15		
FBgn0004103	Pp1-87B	HGNC:9281	OMIM:176875	PPP1CA	13		
FBgn0004103	Pp1-87B	HGNC:9283	OMIM:176914	PPP1CC	14		
FBgn0004103	Pp1-87B	HGNC:9282	OMIM:600590	PPP1CB	4	617506	617506[NOONAN SYNDROME-LIKE DISORDER WITH LOOSE ANAGEN HAIR 2; NSLH2]
FBgn0038042	Scgbeta	HGNC:10806	OMIM:600900	SGCB	13	604286	604286[MUSCULAR DYSTROPHY, LIMB-GIRDLE, AUTOSOMAL RECESSIVE 4; LGMDR4]
FBgn0000455	Dip-C	HGNC:8840	OMIM:613230	PEPD	15	170100	170100[PROLIDASE DEFICIENCY]
FBgn0000455	Dip-C	HGNC:28052	OMIM:613553	XPNPEP3	4	613159	613159[NEPHRONOPHTHISIS-LIKE NEPHROPATHY 1; NPHPL1]
FBgn0038037	Cyp9f2	HGNC:2638	OMIM:605325	CYP3A5	8	145500	145500[HYPERTENSION, ESSENTIAL]
FBgn0038037	Cyp9f2	HGNC:17450	OMIM:606534	CYP3A43	8		
FBgn0038037	Cyp9f2	HGNC:11609	OMIM:274180	TBXAS1	6	231095	231095[GHOSAL HEMATODIAPHYSEAL DYSPLASIA; GHDD]
FBgn0038037	Cyp9f2	HGNC:2637	OMIM:124010	CYP3A4	9	619073	619073[VITAMIN D-DEPENDENT RICKETS, TYPE 3; VDDR3]
FBgn0038037	Cyp9f2	HGNC:51504		CYP3A7-CYP3A51P	6		
FBgn0038020	GstD9	HGNC:4642	OMIM:600437	GSTT2	3		
FBgn0038020	GstD9	HGNC:33437		GSTT2B	3		
FBgn0038020	GstD9	HGNC:26930		GSTT4	3		
FBgn0042206	GstD10	HGNC:4642	OMIM:600437	GSTT2	3		
FBgn0042206	GstD10	HGNC:33437		GSTT2B	3		
FBgn0042206	GstD10	HGNC:26930		GSTT4	3		
FBgn0038018	Tim17a1	HGNC:17315	OMIM:605057	TIMM17A	8		
FBgn0038018	Tim17a1	HGNC:17310	OMIM:300249	TIMM17B	9		
FBgn0038016	MBD-R2	HGNC:24280		PHF20L1	11		
FBgn0038016	MBD-R2	HGNC:16098	OMIM:610335	PHF20	10		
FBgn0038013	CG10038	HGNC:25365		FAM172A	12		
FBgn0038013	CG10038	HGNC:34336		FAM172BP	4		
FBgn0011270	Pglym87	HGNC:8889	OMIM:612931	PGAM2	14	261670	261670[GLYCOGEN STORAGE DISEASE X; GSD10]
FBgn0011270	Pglym87	HGNC:8888	OMIM:172250	PGAM1	12		
FBgn0011270	Pglym87	HGNC:21731	OMIM:300567	PGAM4	9		
FBgn0011270	Pglym87	HGNC:1093	OMIM:613896	BPGM	5	222800	222800[ERYTHROCYTOSIS, FAMILIAL, 8; ECYT8]
FBgn0037999	CG4860	HGNC:90	OMIM:606885	ACADS	8	201470	201470[ACYL-CoA DEHYDROGENASE, SHORT-CHAIN, DEFICIENCY OF; ACADSD]
FBgn0037999	CG4860	HGNC:91	OMIM:600301	ACADSB	4	610006	610006[2-METHYLBUTYRYL-CoA DEHYDROGENASE DEFICIENCY]
FBgn0037998	Cog1	HGNC:6545	OMIM:606973	COG1	14	611209	611209[CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIg; CDG2G]
FBgn0038053	CG18549	HGNC:25458		MFSD11	14		
FBgn0038055	trus	HGNC:8762	OMIM:600866	PDCD2	5		
FBgn0038055	trus	HGNC:28194	OMIM:615661	PDCD2L	13		
FBgn0038057	Polr3C	HGNC:30076	OMIM:617454	POLR3C	15		
FBgn0051354	Hsp70Bbb	HGNC:5232	OMIM:140550	HSPA1A	5		
FBgn0051354	Hsp70Bbb	HGNC:5233	OMIM:603012	HSPA1B	6		
FBgn0051354	Hsp70Bbb	HGNC:5234	OMIM:140559	HSPA1L	5		
FBgn0051354	Hsp70Bbb	HGNC:5238	OMIM:138120	HSPA5	4		
FBgn0051354	Hsp70Bbb	HGNC:5244	OMIM:600548	HSPA9	3	182170,616854	182170[ANEMIA, SIDEROBLASTIC, 4; SIDBA4],616854[EVEN-PLUS SYNDROME; EVPLS]
FBgn0051354	Hsp70Bbb	HGNC:5239	OMIM:140555	HSPA6	5		
FBgn0051354	Hsp70Bbb	HGNC:5235	OMIM:140560	HSPA2	5		
FBgn0051354	Hsp70Bbb	HGNC:5241	OMIM:600816	HSPA8	5		
FBgn0013278	Hsp70Bb	HGNC:5232	OMIM:140550	HSPA1A	5		
FBgn0013278	Hsp70Bb	HGNC:5233	OMIM:603012	HSPA1B	5		
FBgn0013278	Hsp70Bb	HGNC:5234	OMIM:140559	HSPA1L	4		
FBgn0013278	Hsp70Bb	HGNC:5238	OMIM:138120	HSPA5	3		
FBgn0013278	Hsp70Bb	HGNC:5239	OMIM:140555	HSPA6	4		
FBgn0013278	Hsp70Bb	HGNC:5235	OMIM:140560	HSPA2	4		
FBgn0013278	Hsp70Bb	HGNC:5241	OMIM:600816	HSPA8	4		
FBgn0013279	Hsp70Bc	HGNC:5232	OMIM:140550	HSPA1A	5		
FBgn0013279	Hsp70Bc	HGNC:5233	OMIM:603012	HSPA1B	5		
FBgn0013279	Hsp70Bc	HGNC:5234	OMIM:140559	HSPA1L	4		
FBgn0013279	Hsp70Bc	HGNC:5238	OMIM:138120	HSPA5	3		
FBgn0013279	Hsp70Bc	HGNC:5239	OMIM:140555	HSPA6	4		
FBgn0013279	Hsp70Bc	HGNC:5235	OMIM:140560	HSPA2	4		
FBgn0013279	Hsp70Bc	HGNC:5241	OMIM:600816	HSPA8	4		
FBgn0038065	Snx3	HGNC:14976	OMIM:300883	SNX12	14		
FBgn0038065	Snx3	HGNC:11174	OMIM:605930	SNX3	12		
FBgn0260444	Not10	HGNC:23817		CNOT10	14		
FBgn0042207	CG18530	HGNC:6617	OMIM:613497	LIPA	6	278000	278000[LYSOSOMAL ACID LIPASE DEFICIENCY]
FBgn0042207	CG18530	HGNC:23444	OMIM:613922	LIPK	6		
FBgn0042207	CG18530	HGNC:23455	OMIM:613923	LIPM	6		
FBgn0042207	CG18530	HGNC:6622	OMIM:601980	LIPF	6		
FBgn0042207	CG18530	HGNC:21773	OMIM:613921	LIPJ	5		
FBgn0042207	CG18530	HGNC:23452	OMIM:613924	LIPN	6	613943	613943[ICHTHYOSIS, CONGENITAL, AUTOSOMAL RECESSIVE 8; ARCI8]
FBgn0038067	CG11598	HGNC:6617	OMIM:613497	LIPA	6	278000	278000[LYSOSOMAL ACID LIPASE DEFICIENCY]
FBgn0038067	CG11598	HGNC:23444	OMIM:613922	LIPK	6		
FBgn0038067	CG11598	HGNC:23455	OMIM:613923	LIPM	6		
FBgn0038067	CG11598	HGNC:6622	OMIM:601980	LIPF	6		
FBgn0038067	CG11598	HGNC:21773	OMIM:613921	LIPJ	5		
FBgn0038067	CG11598	HGNC:23452	OMIM:613924	LIPN	6	613943	613943[ICHTHYOSIS, CONGENITAL, AUTOSOMAL RECESSIVE 8; ARCI8]
FBgn0038068	CG11600	HGNC:6617	OMIM:613497	LIPA	6	278000	278000[LYSOSOMAL ACID LIPASE DEFICIENCY]
FBgn0038068	CG11600	HGNC:23444	OMIM:613922	LIPK	6		
FBgn0038068	CG11600	HGNC:23455	OMIM:613923	LIPM	6		
FBgn0038068	CG11600	HGNC:6622	OMIM:601980	LIPF	6		
FBgn0038068	CG11600	HGNC:21773	OMIM:613921	LIPJ	5		
FBgn0038068	CG11600	HGNC:23452	OMIM:613924	LIPN	6	613943	613943[ICHTHYOSIS, CONGENITAL, AUTOSOMAL RECESSIVE 8; ARCI8]
FBgn0038069	CG11608	HGNC:6617	OMIM:613497	LIPA	6	278000	278000[LYSOSOMAL ACID LIPASE DEFICIENCY]
FBgn0038069	CG11608	HGNC:23444	OMIM:613922	LIPK	6		
FBgn0038069	CG11608	HGNC:23455	OMIM:613923	LIPM	6		
FBgn0038069	CG11608	HGNC:6622	OMIM:601980	LIPF	6		
FBgn0038069	CG11608	HGNC:21773	OMIM:613921	LIPJ	5		
FBgn0038069	CG11608	HGNC:23452	OMIM:613924	LIPN	6	613943	613943[ICHTHYOSIS, CONGENITAL, AUTOSOMAL RECESSIVE 8; ARCI8]
FBgn0038072	CG6225	HGNC:12822	OMIM:602443	XPNPEP1	5		
FBgn0038072	CG6225	HGNC:12823	OMIM:300145	XPNPEP2	6	300909	300909[ANGIOEDEMA INDUCED BY ACE INHIBITORS, SUSCEPTIBILITY TO; AEACEI]
FBgn0038074	Gnmt	HGNC:4415	OMIM:606628	GNMT	14	606664	606664[GLYCINE N-METHYLTRANSFERASE DEFICIENCY]
FBgn0011745	Arp1	HGNC:17780	OMIM:614835	ACTBL2	3		
FBgn0011745	Arp1	HGNC:168	OMIM:605144	ACTR1B	12		
FBgn0011745	Arp1	HGNC:132	OMIM:102630	ACTB	3	243310,607371	243310[BARAITSER-WINTER SYNDROME 1; BRWS1],607371[DYSTONIA, JUVENILE-ONSET; DJO]
FBgn0011745	Arp1	HGNC:130	OMIM:102620	ACTA2	3	611788,613834,614042	611788[AORTIC ANEURYSM, FAMILIAL THORACIC 6; AAT6],613834[MULTISYSTEMIC SMOOTH MUSCLE DYSFUNCTION SYNDROME; MSMDS],614042[MOYAMOYA DISEASE 5; MYMY5]
FBgn0011745	Arp1	HGNC:143	OMIM:102540	ACTC1	3	612098,612794,613424	612098[CARDIOMYOPATHY, FAMILIAL HYPERTROPHIC, 11; CMH11],612794[ATRIAL SEPTAL DEFECT 5; ASD5],613424[CARDIOMYOPATHY, DILATED, 1R; CMD1R]
FBgn0011745	Arp1	HGNC:167	OMIM:605143	ACTR1A	14		
FBgn0011745	Arp1	HGNC:37093		POTEI	3		
FBgn0011745	Arp1	HGNC:37094		POTEJ	3		
FBgn0011745	Arp1	HGNC:33905		POTEF	3		
FBgn0011745	Arp1	HGNC:33895	OMIM:608914	POTEE	3		
FBgn0011745	Arp1	HGNC:24022	OMIM:608534	ACTRT3	3		
FBgn0038079	NijC	HGNC:7824	OMIM:602062	NINJ1	10		
FBgn0038079	NijC	HGNC:7825	OMIM:607297	NINJ2	10		
FBgn0016693	Past1	HGNC:3243	OMIM:605890	EHD2	11		
FBgn0016693	Past1	HGNC:3245	OMIM:605892	EHD4	11		
FBgn0016693	Past1	HGNC:3244	OMIM:605891	EHD3	12		
FBgn0016693	Past1	HGNC:3242	OMIM:605888	EHD1	14		
FBgn0038080	CG12279	HGNC:35410	OMIM:616041	TSTD1	11		
FBgn0038080	CG12279	HGNC:40910		TSTD3	3		
FBgn0038082	Ugt37A2	HGNC:12531	OMIM:606435	UGT1A10	3		
FBgn0038082	Ugt37A2	HGNC:12545	OMIM:603064	UGT2B11	5		
FBgn0038082	Ugt37A2	HGNC:12530	OMIM:191740	UGT1A1	5	143500,218800,237900,601816,606785	143500[GILBERT SYNDROME],218800[CRIGLER-NAJJAR SYNDROME, TYPE I],237900[HYPERBILIRUBINEMIA, TRANSIENT FAMILIAL NEONATAL; HBLRTFN],601816[BILIRUBIN, SERUM LEVEL OF, QUANTITATIVE TRAIT LOCUS 1; BILIQTL1],606785[CRIGLER-NAJJAR SYNDROME, TYPE II]
FBgn0038082	Ugt37A2	HGNC:12555	OMIM:601291	UGT8	5		
FBgn0038082	Ugt37A2	HGNC:12539	OMIM:606432	UGT1A7	3		
FBgn0038082	Ugt37A2	HGNC:13479	OMIM:606497	UGT2B28	5		
FBgn0038082	Ugt37A2	HGNC:27266	OMIM:616384	UGT3A2	4		
FBgn0038082	Ugt37A2	HGNC:12544	OMIM:600070	UGT2B10	5		
FBgn0038082	Ugt37A2	HGNC:12537	OMIM:606430	UGT1A5	3		
FBgn0038082	Ugt37A2	HGNC:12546	OMIM:600069	UGT2B15	5		
FBgn0038082	Ugt37A2	HGNC:12541	OMIM:606434	UGT1A9	3		
FBgn0038082	Ugt37A2	HGNC:28528	OMIM:616382	UGT2A3	5		
FBgn0038082	Ugt37A2	HGNC:12535	OMIM:606428	UGT1A3	6		
FBgn0038082	Ugt37A2	HGNC:12536	OMIM:606429	UGT1A4	3		
FBgn0038082	Ugt37A2	HGNC:12540	OMIM:606433	UGT1A8	3		
FBgn0038082	Ugt37A2	HGNC:26625	OMIM:616383	UGT3A1	4		
FBgn0038082	Ugt37A2	HGNC:12547	OMIM:601903	UGT2B17	5	612560	612560[BONE MINERAL DENSITY QUANTITATIVE TRAIT LOCUS 12; BMND12]
FBgn0038082	Ugt37A2	HGNC:12553	OMIM:600067	UGT2B4	5		
FBgn0038082	Ugt37A2	HGNC:12538	OMIM:606431	UGT1A6	3		
FBgn0038082	Ugt37A2	HGNC:12554	OMIM:600068	UGT2B7	5		
FBgn0038082	Ugt37A2	HGNC:28183	OMIM:619809	UGT2A2	4		
FBgn0038083	Ugt37A3	HGNC:12531	OMIM:606435	UGT1A10	3		
FBgn0038083	Ugt37A3	HGNC:12545	OMIM:603064	UGT2B11	5		
FBgn0038083	Ugt37A3	HGNC:12530	OMIM:191740	UGT1A1	5	143500,218800,237900,601816,606785	143500[GILBERT SYNDROME],218800[CRIGLER-NAJJAR SYNDROME, TYPE I],237900[HYPERBILIRUBINEMIA, TRANSIENT FAMILIAL NEONATAL; HBLRTFN],601816[BILIRUBIN, SERUM LEVEL OF, QUANTITATIVE TRAIT LOCUS 1; BILIQTL1],606785[CRIGLER-NAJJAR SYNDROME, TYPE II]
FBgn0038083	Ugt37A3	HGNC:12555	OMIM:601291	UGT8	5		
FBgn0038083	Ugt37A3	HGNC:12539	OMIM:606432	UGT1A7	3		
FBgn0038083	Ugt37A3	HGNC:13479	OMIM:606497	UGT2B28	5		
FBgn0038083	Ugt37A3	HGNC:27266	OMIM:616384	UGT3A2	4		
FBgn0038083	Ugt37A3	HGNC:12544	OMIM:600070	UGT2B10	5		
FBgn0038083	Ugt37A3	HGNC:12537	OMIM:606430	UGT1A5	3		
FBgn0038083	Ugt37A3	HGNC:12546	OMIM:600069	UGT2B15	5		
FBgn0038083	Ugt37A3	HGNC:12541	OMIM:606434	UGT1A9	3		
FBgn0038083	Ugt37A3	HGNC:28528	OMIM:616382	UGT2A3	5		
FBgn0038083	Ugt37A3	HGNC:12535	OMIM:606428	UGT1A3	6		
FBgn0038083	Ugt37A3	HGNC:12536	OMIM:606429	UGT1A4	3		
FBgn0038083	Ugt37A3	HGNC:12540	OMIM:606433	UGT1A8	3		
FBgn0038083	Ugt37A3	HGNC:26625	OMIM:616383	UGT3A1	4		
FBgn0038083	Ugt37A3	HGNC:12547	OMIM:601903	UGT2B17	5	612560	612560[BONE MINERAL DENSITY QUANTITATIVE TRAIT LOCUS 12; BMND12]
FBgn0038083	Ugt37A3	HGNC:12553	OMIM:600067	UGT2B4	5		
FBgn0038083	Ugt37A3	HGNC:12538	OMIM:606431	UGT1A6	3		
FBgn0038083	Ugt37A3	HGNC:12554	OMIM:600068	UGT2B7	5		
FBgn0038083	Ugt37A3	HGNC:28183	OMIM:619809	UGT2A2	4		
FBgn0002719	Men	HGNC:6985	OMIM:604626	ME3	12		
FBgn0002719	Men	HGNC:6984	OMIM:154270	ME2	9		
FBgn0002719	Men	HGNC:6983	OMIM:154250	ME1	15		
FBgn0002905	PolQ	HGNC:18536	OMIM:606769	HELQ	3		
FBgn0002905	PolQ	HGNC:9186	OMIM:604419	POLQ	15		
FBgn0005355	Su(fu)	HGNC:16466	OMIM:607035	SUFU	14	109400,155255,607174,617757	109400[BASAL CELL NEVUS SYNDROME; BCNS],155255[MEDULLOBLASTOMA; MDB],607174[MENINGIOMA, FAMILIAL, SUSCEPTIBILITY TO],617757[JOUBERT SYNDROME 32; JBTS32]
FBgn0001296	kar	HGNC:17027	OMIM:607550	SLC16A10	13		
FBgn0001296	kar	HGNC:10923	OMIM:300095	SLC16A2	10	300523	300523[ALLAN-HERNDON-DUDLEY SYNDROME; AHDS]
FBgn0001296	kar	HGNC:23093	OMIM:615765	SLC16A11	3		
FBgn0026207	mbo	HGNC:8067	OMIM:602552	NUP88	14	618393	618393[FETAL AKINESIA DEFORMATION SEQUENCE 4; FADS4]
FBgn0038070	CG6753	HGNC:6617	OMIM:613497	LIPA	7	278000	278000[LYSOSOMAL ACID LIPASE DEFICIENCY]
FBgn0038070	CG6753	HGNC:23444	OMIM:613922	LIPK	7		
FBgn0038070	CG6753	HGNC:23455	OMIM:613923	LIPM	7		
FBgn0038070	CG6753	HGNC:6622	OMIM:601980	LIPF	7		
FBgn0038070	CG6753	HGNC:21773	OMIM:613921	LIPJ	6		
FBgn0038070	CG6753	HGNC:23452	OMIM:613924	LIPN	7	613943	613943[ICHTHYOSIS, CONGENITAL, AUTOSOMAL RECESSIVE 8; ARCI8]
FBgn0005671	Vha55	HGNC:853	OMIM:192132	ATP6V1B1	9	267300	267300[RENAL TUBULAR ACIDOSIS, DISTAL, 2, WITH PROGRESSIVE SENSORINEURAL HEARING LOSS; DRTA2]
FBgn0005671	Vha55	HGNC:854	OMIM:606939	ATP6V1B2	15	124480,616455	124480[DEAFNESS, CONGENITAL, WITH ONYCHODYSTROPHY, AUTOSOMAL DOMINANT; DDOD],616455[ZIMMERMANN-LABAND SYNDROME 2; ZLS2]
FBgn0013277	Hsp70Ba	HGNC:5232	OMIM:140550	HSPA1A	5		
FBgn0013277	Hsp70Ba	HGNC:5233	OMIM:603012	HSPA1B	6		
FBgn0013277	Hsp70Ba	HGNC:5234	OMIM:140559	HSPA1L	5		
FBgn0013277	Hsp70Ba	HGNC:5238	OMIM:138120	HSPA5	4		
FBgn0013277	Hsp70Ba	HGNC:5244	OMIM:600548	HSPA9	3	182170,616854	182170[ANEMIA, SIDEROBLASTIC, 4; SIDBA4],616854[EVEN-PLUS SYNDROME; EVPLS]
FBgn0013277	Hsp70Ba	HGNC:5239	OMIM:140555	HSPA6	5		
FBgn0013277	Hsp70Ba	HGNC:5235	OMIM:140560	HSPA2	5		
FBgn0013277	Hsp70Ba	HGNC:5241	OMIM:600816	HSPA8	5		
FBgn0038058	CG5608	HGNC:25507	OMIM:604632	VAC14	14	617054	617054[STRIATONIGRAL DEGENERATION, CHILDHOOD-ONSET; SNDC]
FBgn0038056	CG5961	HGNC:13588	OMIM:609091	FBXO9	15		
FBgn0038089	d-cup	HGNC:25678	OMIM:619564	EFCAB1	5		
FBgn0038090	CG10909	HGNC:3599	OMIM:134795	FBL	4		
FBgn0038088	CG10126	HGNC:1487	OMIM:114212	CAPS	5		
FBgn0038088	CG10126	HGNC:28375	OMIM:618799	CAPSL	13		
FBgn0051345	CG31345	HGNC:1487	OMIM:114212	CAPS	5		
FBgn0051345	CG31345	HGNC:28375	OMIM:618799	CAPSL	15		
FBgn0038099	CG7091	HGNC:20151	OMIM:607557	SLC17A8	3	605583	605583[DEAFNESS, AUTOSOMAL DOMINANT 25; DFNA25]
FBgn0038099	CG7091	HGNC:10933	OMIM:604322	SLC17A5	3	269920,604369	269920[INFANTILE SIALIC ACID STORAGE DISEASE; ISSD],604369[SALLA DISEASE; SD]
FBgn0038099	CG7091	HGNC:16703	OMIM:607563	SLC17A6	3		
FBgn0038099	CG7091	HGNC:16704	OMIM:605208	SLC17A7	3		
FBgn0038099	CG7091	HGNC:10929	OMIM:182308	SLC17A1	3		
FBgn0038099	CG7091	HGNC:10932	OMIM:604216	SLC17A4	3		
FBgn0038099	CG7091	HGNC:10930	OMIM:611049	SLC17A2	4		
FBgn0038099	CG7091	HGNC:10931	OMIM:611034	SLC17A3	4	612671	612671[URIC ACID CONCENTRATION, SERUM, QUANTITATIVE TRAIT LOCUS 4; UAQTL4]
FBgn0038100	Paip2	HGNC:17970	OMIM:605604	PAIP2	11		
FBgn0038100	Paip2	HGNC:29200	OMIM:611018	PAIP2B	12		
FBgn0051342	CG31342	HGNC:15756	OMIM:617358	SDCBP2	4		
FBgn0051342	CG31342	HGNC:10662	OMIM:602217	SDCBP	4		
FBgn0038106	CG7488	HGNC:3424	OMIM:607435	ERAL1	13	617565	617565[PERRAULT SYNDROME 6; PRLTS6]
FBgn0038108	CG7518	HGNC:16822		FAM193A	5		
FBgn0038108	CG7518	HGNC:25524	OMIM:615813	FAM193B	3		
FBgn0002354	l(3)87Df	HGNC:26970	OMIM:614698	COX20	11	619054	619054[MITOCHONDRIAL COMPLEX IV DEFICIENCY, NUCLEAR TYPE 11; MC4DN11]
FBgn0003308	ry	HGNC:553	OMIM:602841	AOX1	7		
FBgn0003308	ry	HGNC:12805	OMIM:607633	XDH	14	278300	278300[XANTHINURIA, TYPE I; XAN1]
FBgn0001217	Hsc70-2	HGNC:5232	OMIM:140550	HSPA1A	5		
FBgn0001217	Hsc70-2	HGNC:5233	OMIM:603012	HSPA1B	6		
FBgn0001217	Hsc70-2	HGNC:5234	OMIM:140559	HSPA1L	5		
FBgn0001217	Hsc70-2	HGNC:5238	OMIM:138120	HSPA5	4		
FBgn0001217	Hsc70-2	HGNC:5244	OMIM:600548	HSPA9	3	182170,616854	182170[ANEMIA, SIDEROBLASTIC, 4; SIDBA4],616854[EVEN-PLUS SYNDROME; EVPLS]
FBgn0001217	Hsc70-2	HGNC:5239	OMIM:140555	HSPA6	5		
FBgn0001217	Hsc70-2	HGNC:5235	OMIM:140560	HSPA2	5		
FBgn0001217	Hsc70-2	HGNC:5241	OMIM:600816	HSPA8	5		
FBgn0051157	CG31157	HGNC:26167	OMIM:616360	TMEM135	3		
FBgn0004666	sim	HGNC:10882	OMIM:603128	SIM1	9		
FBgn0004666	sim	HGNC:7894	OMIM:603346	NPAS1	5		
FBgn0004666	sim	HGNC:19311	OMIM:609430	NPAS3	3		
FBgn0004666	sim	HGNC:10883	OMIM:600892	SIM2	9		
FBgn0038118	timeout	HGNC:11813	OMIM:603887	TIMELESS	12	620015	620015[ADVANCE SLEEP PHASE SYNDROME, FAMILIAL, 4; FASPS4]
FBgn0038115	CG7966	HGNC:10719	OMIM:604188	SELENBP1	14	618148	618148[EXTRAORAL HALITOSIS DUE TO METHANETHIOL OXIDASE DEFICIENCY; EHMTO]
FBgn0038110	CG8031	HGNC:14014	OMIM:611786	MEMO1	14		
FBgn0038107	CG17327	HGNC:24265	OMIM:608625	PTRH2	4	616263	616263[NEUROLOGIC, ENDOCRINE, AND PANCREATIC DISEASE, MULTISYSTEM, INFANTILE-ONSET 1; IMNEPD1]
FBgn0040493	grsm	HGNC:16244		NPEPL1	13		
FBgn0038122	CG8138	HGNC:28554		CFAP299	13		
FBgn0038125	CG8141	HGNC:26783		RNF185	5		
FBgn0038125	CG8141	HGNC:10068	OMIM:602677	RNF5	6		
FBgn0038130	CG8630	HGNC:21088	OMIM:608370	SCD5	10	619086	619086[DEAFNESS, AUTOSOMAL DOMINANT 79; DFNA79]
FBgn0038130	CG8630	HGNC:10571	OMIM:604031	SCD	10		
FBgn0038135	CG8773	HGNC:500	OMIM:151530	ANPEP	6		
FBgn0038135	CG8773	HGNC:3355	OMIM:138297	ENPEP	12		
FBgn0038135	CG8773	HGNC:18173	OMIM:606832	ERAP1	5		
FBgn0038135	CG8773	HGNC:26904	OMIM:610046	LVRN	4		
FBgn0038135	CG8773	HGNC:7900	OMIM:606793	NPEPPS	4		
FBgn0038135	CG8773	HGNC:29499	OMIM:609497	ERAP2	5		
FBgn0038135	CG8773	HGNC:6656	OMIM:151300	LNPEP	4		
FBgn0038136	CG8774	HGNC:500	OMIM:151530	ANPEP	6		
FBgn0038136	CG8774	HGNC:3355	OMIM:138297	ENPEP	13		
FBgn0038136	CG8774	HGNC:18173	OMIM:606832	ERAP1	4		
FBgn0038136	CG8774	HGNC:26904	OMIM:610046	LVRN	4		
FBgn0038136	CG8774	HGNC:7900	OMIM:606793	NPEPPS	4		
FBgn0038136	CG8774	HGNC:29499	OMIM:609497	ERAP2	4		
FBgn0038136	CG8774	HGNC:6656	OMIM:151300	LNPEP	4		
FBgn0052473	CG32473	HGNC:500	OMIM:151530	ANPEP	6		
FBgn0052473	CG32473	HGNC:3355	OMIM:138297	ENPEP	11		
FBgn0052473	CG32473	HGNC:18173	OMIM:606832	ERAP1	4		
FBgn0052473	CG32473	HGNC:26904	OMIM:610046	LVRN	4		
FBgn0052473	CG32473	HGNC:7900	OMIM:606793	NPEPPS	4		
FBgn0052473	CG32473	HGNC:29499	OMIM:609497	ERAP2	4		
FBgn0052473	CG32473	HGNC:6656	OMIM:151300	LNPEP	4		
FBgn0038140	PK2-R1	HGNC:4518	OMIM:604153	NMUR1	9		
FBgn0038140	PK2-R1	HGNC:16454	OMIM:605108	NMUR2	9		
FBgn0038140	PK2-R1	HGNC:4267	OMIM:601898	GHSR	3	615925	615925[GROWTH HORMONE DEFICIENCY, ISOLATED PARTIAL; GHDP]
FBgn0038140	PK2-R1	HGNC:4495	OMIM:602885	MLNR	3		
FBgn0027610	Dic1	HGNC:10981	OMIM:604165	SLC25A11	3	618464	618464[PARAGANGLIOMAS 6; PGL6]
FBgn0027610	Dic1	HGNC:10980	OMIM:606794	SLC25A10	12	618972	618972[MITOCHONDRIAL DNA DEPLETION SYNDROME 19; MTDPS19]
FBgn0038145	Droj2	HGNC:5229	OMIM:602837	DNAJA1	13		
FBgn0038145	Droj2	HGNC:14885		DNAJA4	14		
FBgn0038145	Droj2	HGNC:14884	OMIM:611322	DNAJA2	5		
FBgn0038149	GILT1	HGNC:5398	OMIM:604664	IFI30	8		
FBgn0038146	CG9799	HGNC:30696	OMIM:609669	WDR36	13	609887	609887[GLAUCOMA 1, OPEN ANGLE, G; GLC1G]
FBgn0044511	mRpS21	HGNC:14046	OMIM:611984	MRPS21	13		
FBgn0023495	Lip3	HGNC:6617	OMIM:613497	LIPA	13	278000	278000[LYSOSOMAL ACID LIPASE DEFICIENCY]
FBgn0023495	Lip3	HGNC:23444	OMIM:613922	LIPK	12		
FBgn0023495	Lip3	HGNC:23455	OMIM:613923	LIPM	12		
FBgn0023495	Lip3	HGNC:6622	OMIM:601980	LIPF	12		
FBgn0023495	Lip3	HGNC:21773	OMIM:613921	LIPJ	9		
FBgn0023495	Lip3	HGNC:23452	OMIM:613924	LIPN	10	613943	613943[ICHTHYOSIS, CONGENITAL, AUTOSOMAL RECESSIVE 8; ARCI8]
FBgn0038134	wntD	HGNC:12788	OMIM:606360	WNT8A	4		
FBgn0038134	wntD	HGNC:12789	OMIM:601396	WNT8B	5		
FBgn0038129	TBC1D5	HGNC:19166	OMIM:615740	TBC1D5	9		
FBgn0000024	Ace	HGNC:26741		CES4A	3		
FBgn0000024	Ace	HGNC:108	OMIM:100740	ACHE	9	112100	112100[YT BLOOD GROUP ANTIGEN]
FBgn0000024	Ace	HGNC:983	OMIM:177400	BCHE	10	617936	617936[BUTYRYLCHOLINESTERASE DEFICIENCY; BCHED]
FBgn0000024	Ace	HGNC:26459	OMIM:618678	CES5A	3		
FBgn0000024	Ace	HGNC:1863	OMIM:114835	CES1	3	618057	618057[DRUG METABOLISM, ALTERED, CES1-RELATED]
FBgn0000024	Ace	HGNC:1864	OMIM:605278	CES2	3		
FBgn0000024	Ace	HGNC:1865	OMIM:605279	CES3	3		
FBgn0038127	CG8476	HGNC:5271	OMIM:604189	DNAJC4	3		
FBgn0038126	CG8483	HGNC:8946	OMIM:607076	PI15	6		
FBgn0038126	CG8483	HGNC:16249		R3HDML	4		
FBgn0038126	CG8483	HGNC:21245		PI16	5		
FBgn0038126	CG8483	HGNC:28592	OMIM:610394	GLIPR1L2	3		
FBgn0038126	CG8483	HGNC:17001	OMIM:602692	GLIPR1	4		
FBgn0038126	CG8483	HGNC:28392	OMIM:610395	GLIPR1L1	5		
FBgn0038126	CG8483	HGNC:18206		CRISPLD1	4		
FBgn0038126	CG8483	HGNC:25248	OMIM:612434	CRISPLD2	4		
FBgn0038126	CG8483	HGNC:16904	OMIM:618062	CRISP3	4		
FBgn0038126	CG8483	HGNC:304	OMIM:601193	CRISP1	4		
FBgn0038126	CG8483	HGNC:12024	OMIM:187430	CRISP2	5		
FBgn0038126	CG8483	HGNC:33849	OMIM:616572	CLEC18B	4		
FBgn0038126	CG8483	HGNC:30388	OMIM:616571	CLEC18A	4		
FBgn0000046	Act87E	HGNC:17780	OMIM:614835	ACTBL2	5		
FBgn0000046	Act87E	HGNC:168	OMIM:605144	ACTR1B	3		
FBgn0000046	Act87E	HGNC:129	OMIM:102610	ACTA1	3	161800,255310,616852	161800[NEMALINE MYOPATHY 3; NEM3],255310[MYOPATHY, CONGENITAL, WITH FIBER-TYPE DISPROPORTION; CFTD],616852[MYOPATHY, SCAPULOHUMEROPERONEAL; SHPM]
FBgn0000046	Act87E	HGNC:132	OMIM:102630	ACTB	7	243310,607371	243310[BARAITSER-WINTER SYNDROME 1; BRWS1],607371[DYSTONIA, JUVENILE-ONSET; DJO]
FBgn0000046	Act87E	HGNC:130	OMIM:102620	ACTA2	5	611788,613834,614042	611788[AORTIC ANEURYSM, FAMILIAL THORACIC 6; AAT6],613834[MULTISYSTEMIC SMOOTH MUSCLE DYSFUNCTION SYNDROME; MSMDS],614042[MOYAMOYA DISEASE 5; MYMY5]
FBgn0000046	Act87E	HGNC:143	OMIM:102540	ACTC1	4	612098,612794,613424	612098[CARDIOMYOPATHY, FAMILIAL HYPERTROPHIC, 11; CMH11],612794[ATRIAL SEPTAL DEFECT 5; ASD5],613424[CARDIOMYOPATHY, DILATED, 1R; CMD1R]
FBgn0000046	Act87E	HGNC:167	OMIM:605143	ACTR1A	3		
FBgn0000046	Act87E	HGNC:144	OMIM:102560	ACTG1	4	604717,614583	604717[DEAFNESS, AUTOSOMAL DOMINANT 20; DFNA20],614583[BARAITSER-WINTER SYNDROME 2; BRWS2]
FBgn0000046	Act87E	HGNC:145	OMIM:102545	ACTG2	3	155310,619431	155310[VISCERAL MYOPATHY 1; VSCM1],619431[MEGACYSTIS-MICROCOLON-INTESTINAL HYPOPERISTALSIS SYNDROME 5; MMIHS5]
FBgn0000046	Act87E	HGNC:37093		POTEI	5		
FBgn0000046	Act87E	HGNC:37094		POTEJ	5		
FBgn0000046	Act87E	HGNC:33905		POTEF	5		
FBgn0000046	Act87E	HGNC:33895	OMIM:608914	POTEE	4		
FBgn0000046	Act87E	HGNC:24022	OMIM:608534	ACTRT3	4		
FBgn0000046	Act87E	HGNC:24026	OMIM:608535	ACTRT2	3		
FBgn0000046	Act87E	HGNC:28494	OMIM:619251	ACTL9	3	619258	619258[SPERMATOGENIC FAILURE 53; SPGF53]
FBgn0000046	Act87E	HGNC:16127		ACTL10	3		
FBgn0004049	yrt	HGNC:13278	OMIM:612141	EPB41L4A	3		
FBgn0004049	yrt	HGNC:19818	OMIM:610340	EPB41L4B	10		
FBgn0004049	yrt	HGNC:19819	OMIM:611730	EPB41L5	11		
FBgn0015778	rin	HGNC:30291	OMIM:620020	G3BP2	10		
FBgn0015778	rin	HGNC:30292	OMIM:608431	G3BP1	12		
FBgn0038167	Lkb1	HGNC:11389	OMIM:602216	STK11	12	155600,175200,260350,273300	155600[MELANOMA, CUTANEOUS MALIGNANT, SUSCEPTIBILITY TO, 1; CMM1],175200[PEUTZ-JEGHERS SYNDROME; PJS],260350[PANCREATIC CANCER],273300[TESTICULAR GERM CELL TUMOR; TGCT]
FBgn0024555	flfl	HGNC:29267	OMIM:610352	PPP4R3B	14		
FBgn0024555	flfl	HGNC:20219	OMIM:610351	PPP4R3A	13		
FBgn0024555	flfl	HGNC:33146		PPP4R3C	6		
FBgn0038170	CG14367	HGNC:30540		CFAP36	13		
FBgn0002937	ninaB	HGNC:18503	OMIM:611740	BCO2	10		
FBgn0002937	ninaB	HGNC:10294	OMIM:180069	RPE65	12	204100,613794,618697	204100[LEBER CONGENITAL AMAUROSIS 2; LCA2],613794[RETINITIS PIGMENTOSA 20; RP20],618697[RETINITIS PIGMENTOSA 87 WITH CHOROIDAL INVOLVEMENT; RP87]
FBgn0002937	ninaB	HGNC:13815	OMIM:605748	BCO1	9	115300	115300[HYPERCAROTENEMIA AND VITAMIN A DEFICIENCY, AUTOSOMAL DOMINANT; HCVAD]
FBgn0038173	Adgf-C	HGNC:1839	OMIM:607575	ADA2	9	182410,615688	182410[SNEDDON SYNDROME; SNDNS],615688[VASCULITIS, AUTOINFLAMMATION, IMMUNODEFICIENCY, AND HEMATOLOGIC DEFECTS SYNDROME; VAIHS]
FBgn0038180	Cht5	HGNC:8524	OMIM:603578	OVGP1	4		
FBgn0038180	Cht5	HGNC:1932	OMIM:601525	CHI3L1	4	181500,611960	181500[SCHIZOPHRENIA; SCZD],611960[ASTHMA-RELATED TRAITS, SUSCEPTIBILITY TO, 7; ASRT7]
FBgn0038180	Cht5	HGNC:1936	OMIM:600031	CHIT1	3	614122	614122[CHITOTRIOSIDASE DEFICIENCY; CHITD]
FBgn0038180	Cht5	HGNC:17432	OMIM:606080	CHIA	4		
FBgn0038181	CG9297	HGNC:11295	OMIM:604992	SRL	12		
FBgn0260464	CG9288	HGNC:1364		ABITRAM	13		
FBgn0038183	CG9286	HGNC:978	OMIM:611883	BCCIP	14		
FBgn0000454	Dip-B	HGNC:16244		NPEPL1	3		
FBgn0038172	Adgf-D	HGNC:1839	OMIM:607575	ADA2	10	182410,615688	182410[SNEDDON SYNDROME; SNDNS],615688[VASCULITIS, AUTOINFLAMMATION, IMMUNODEFICIENCY, AND HEMATOLOGIC DEFECTS SYNDROME; VAIHS]
FBgn0028487	f-cup	HGNC:26004		LRRC40	13		
FBgn0038168	omd	HGNC:29352	OMIM:611349	INTS5	13		
FBgn0038166	CG9588	HGNC:9567	OMIM:603146	PSMD9	14		
FBgn0038165	Task6	HGNC:6283	OMIM:605874	KCNK9	13	612292	612292[BIRK-BAREL SYNDROME; BIBARS]
FBgn0038165	Task6	HGNC:6278	OMIM:603220	KCNK3	12	615344	615344[PULMONARY HYPERTENSION, PRIMARY, 4; PPH4]
FBgn0038165	Task6	HGNC:13814	OMIM:607368	KCNK15	11		
FBgn0038165	Task6	HGNC:6277	OMIM:603219	KCNK2	3		
FBgn0038165	Task6	HGNC:6273	OMIM:605873	KCNK10	3		
FBgn0004237	Hrb87F	HGNC:27067		HNRNPA1L2	9		
FBgn0004237	Hrb87F	HGNC:5033	OMIM:600124	HNRNPA2B1	11	615422	615422[INCLUSION BODY MYOPATHY WITH EARLY-ONSET PAGET DISEASE WITH OR WITHOUT FRONTOTEMPORAL DEMENTIA 2; IBMPFD2]
FBgn0004237	Hrb87F	HGNC:5031	OMIM:164017	HNRNPA1	9	615424,615426	615424[INCLUSION BODY MYOPATHY WITH EARLY-ONSET PAGET DISEASE WITH OR WITHOUT FRONTOTEMPORAL DEMENTIA 3; IBMPFD3],615426[AMYOTROPHIC LATERAL SCLEROSIS 20; ALS20]
FBgn0004237	Hrb87F	HGNC:24941	OMIM:605372	HNRNPA3	9		
FBgn0004237	Hrb87F	HGNC:5030	OMIM:609409	HNRNPA0	5		
FBgn0010258	Rbp4	HGNC:5031	OMIM:164017	HNRNPA1	3	615424,615426	615424[INCLUSION BODY MYOPATHY WITH EARLY-ONSET PAGET DISEASE WITH OR WITHOUT FRONTOTEMPORAL DEMENTIA 3; IBMPFD3],615426[AMYOTROPHIC LATERAL SCLEROSIS 20; ALS20]
FBgn0010258	Rbp4	HGNC:24941	OMIM:605372	HNRNPA3	3		
FBgn0000576	ems	HGNC:3341	OMIM:600035	EMX2	6	269160	269160[SCHIZENCEPHALY]
FBgn0000576	ems	HGNC:3340	OMIM:600034	EMX1	5		
FBgn0016672	Ipp	HGNC:6071	OMIM:147263	INPP1	14		
FBgn0015270	Orc2	HGNC:8488	OMIM:601182	ORC2	14		
FBgn0038195	CG3061	HGNC:25881	OMIM:617487	DNAJB14	12		
FBgn0038195	CG3061	HGNC:28429		DNAJC18	7		
FBgn0038195	CG3061	HGNC:14891	OMIM:608376	DNAJB12	14		
FBgn0038196	CG9922	HGNC:18418	OMIM:612784	HYPK	14		
FBgn0038190	CG9926	HGNC:4856	OMIM:600339	HDGF	3		
FBgn0038190	CG9926	HGNC:21095		HDGFL1	3		
FBgn0038189	Art6	HGNC:30163	OMIM:603190	PRMT3	3		
FBgn0038189	Art6	HGNC:18241	OMIM:608274	PRMT6	3		
FBgn0038189	Art6	HGNC:5188	OMIM:610086	PRMT8	4		
FBgn0038189	Art6	HGNC:5187	OMIM:602950	PRMT1	4		
FBgn0038188	Art9	HGNC:30163	OMIM:603190	PRMT3	3		
FBgn0038188	Art9	HGNC:5188	OMIM:610086	PRMT8	4		
FBgn0038188	Art9	HGNC:5187	OMIM:602950	PRMT1	5		
FBgn0008646	E5	HGNC:3341	OMIM:600035	EMX2	9	269160	269160[SCHIZENCEPHALY]
FBgn0008646	E5	HGNC:3340	OMIM:600034	EMX1	7		
FBgn0038186	CG14362	HGNC:16920	OMIM:602293	CIB1	3	618267	618267[EPIDERMODYSPLASIA VERRUCIFORMIS, SUSCEPTIBILITY TO, 3; EV3]
FBgn0038186	CG14362	HGNC:24927		CHP2	5		
FBgn0038186	CG14362	HGNC:33703	OMIM:610646	CIB4	3		
FBgn0038186	CG14362	HGNC:9318	OMIM:613821	PPP3R2	3		
FBgn0038186	CG14362	HGNC:17433	OMIM:606988	CHP1	5	618438	618438[SPASTIC ATAXIA 9, AUTOSOMAL RECESSIVE; SPAX9]
FBgn0038186	CG14362	HGNC:26065	OMIM:611585	TESC	6		
FBgn0051495	CG31495	HGNC:8016	OMIM:601633	NSF	6	619340	619340[DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 96; DEE96]
FBgn0038197	foxo	HGNC:7139	OMIM:300033	FOXO4	8		
FBgn0038197	foxo	HGNC:24814	OMIM:611457	FOXO6	6		
FBgn0038197	foxo	HGNC:3821	OMIM:602681	FOXO3	9		
FBgn0038197	foxo	HGNC:3819	OMIM:136533	FOXO1	8	268220	268220[RHABDOMYOSARCOMA 2; RMS2]
FBgn0038198	Npc2b	HGNC:14537	OMIM:601015	NPC2	7	607625	607625[NIEMANN-PICK DISEASE, TYPE C2; NPC2]
FBgn0038206	twf	HGNC:9621	OMIM:607433	TWF2	12		
FBgn0038206	twf	HGNC:9620	OMIM:610932	TWF1	14		
FBgn0027083	MetRS-m	HGNC:25133	OMIM:609728	MARS2	15	611390,616430	611390[SPASTIC ATAXIA 3, AUTOSOMAL RECESSIVE; SPAX3],616430[COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 25; COXPD25]
FBgn0011582	Dop1R1	HGNC:3020	OMIM:126449	DRD1	6		
FBgn0011582	Dop1R1	HGNC:3026	OMIM:126453	DRD5	9	143465,606798	143465[ATTENTION DEFICIT-HYPERACTIVITY DISORDER; ADHD],606798[BLEPHAROSPASM, BENIGN ESSENTIAL, SUSCEPTIBILITY TO]
FBgn0038209	Recs1	HGNC:4589	OMIM:138251	GRINA	6		
FBgn0038209	Recs1	HGNC:17067	OMIM:604306	FAIM2	4		
FBgn0038209	Recs1	HGNC:23410	OMIM:610364	TMBIM1	3		
FBgn0038209	Recs1	HGNC:24257	OMIM:616874	TMBIM4	4		
FBgn0010340	140up	HGNC:1321	OMIM:615534	TIMMDC1	13	618251	618251[MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 31; MC1DN31]
FBgn0020510	Abi	HGNC:29859	OMIM:606363	ABI3	5		
FBgn0020510	Abi	HGNC:11320	OMIM:603050	ABI1	12		
FBgn0020510	Abi	HGNC:24011	OMIM:606442	ABI2	14		
FBgn0038205	Kif19A	HGNC:27102	OMIM:614570	KIF18B	3		
FBgn0038205	Kif19A	HGNC:26735	OMIM:619610	KIF19	12		
FBgn0038205	Kif19A	HGNC:29441	OMIM:611271	KIF18A	4		
FBgn0038202	CG12402	HGNC:13605		LRRC29	3		
FBgn0038200	CG9920	HGNC:5269	OMIM:600141	HSPE1	12		
FBgn0038221	IFT54	HGNC:17861	OMIM:607380	TRAF3IP1	13	616629	616629[SENIOR-LOKEN SYNDROME 9; SLSN9]
FBgn0004855	Polr2I	HGNC:9196	OMIM:180662	POLR2I	15		
FBgn0051321	CG31321	HGNC:16055	OMIM:608956	SLC46A2	5		
FBgn0051321	CG31321	HGNC:30521	OMIM:611672	SLC46A1	5	229050	229050[FOLATE MALABSORPTION, HEREDITARY]
FBgn0051321	CG31321	HGNC:27501	OMIM:616764	SLC46A3	5		
FBgn0011474	Set8	HGNC:29489	OMIM:607240	KMT5A	9		
FBgn0038224	ATPsynE	HGNC:846	OMIM:601519	ATP5ME	11		
FBgn0003480	spn-B	HGNC:12830	OMIM:600675	XRCC3	15	114480,613972	114480[BREAST CANCER],613972[MELANOMA, CUTANEOUS MALIGNANT, SUSCEPTIBILITY TO, 6; CMM6]
FBgn0051320	HEATR2	HGNC:26013	OMIM:614864	DNAAF5	14	614874	614874[CILIARY DYSKINESIA, PRIMARY, 18; CILD18]
FBgn0038223	Afti	HGNC:25951	OMIM:619628	AFTPH	7		
FBgn0038234	mRpL11	HGNC:14042	OMIM:611826	MRPL11	14		
FBgn0020299	stumps	HGNC:30034	OMIM:607942	PIK3AP1	8		
FBgn0020299	stumps	HGNC:18233	OMIM:610292	BANK1	6		
FBgn0038246	CG14853	HGNC:44395		ERICH2	6		
FBgn0013981	His4r	HGNC:20510	OMIM:615069	HIST4H4	5		
FBgn0013981	His4r	HGNC:4787	OMIM:602827	H4C3	4	619758	619758[TESSADORI-VAN HAAFTEN NEURODEVELOPMENTAL SYNDROME 1; TEVANED1]
FBgn0013981	His4r	HGNC:29607		HIST2H4B	4		
FBgn0013981	His4r	HGNC:4789	OMIM:602829	HIST1H4B	4		
FBgn0013981	His4r	HGNC:4788	OMIM:602828	HIST1H4H	4		
FBgn0013981	His4r	HGNC:4782	OMIM:602823	HIST1H4D	5		
FBgn0013981	His4r	HGNC:4790	OMIM:602830	HIST1H4E	4	619950	619950[TESSADORI-VAN HAAFTEN NEURODEVELOPMENTAL SYNDROME 3; TEVANED3]
FBgn0013981	His4r	HGNC:4783	OMIM:602824	HIST1H4F	5		
FBgn0013981	His4r	HGNC:4794	OMIM:142750	HIST2H4A	5		
FBgn0013981	His4r	HGNC:4785	OMIM:602826	H4C11	4	619759	619759[TESSADORI-VAN HAAFTEN NEURODEVELOPMENTAL SYNDROME 2; TEVANED2]
FBgn0013981	His4r	HGNC:4791	OMIM:602831	HIST1H4L	5		
FBgn0013981	His4r	HGNC:4784	OMIM:602825	HIST1H4K	4		
FBgn0013981	His4r	HGNC:4793	OMIM:602833	H4C9	4	619951	619951[TESSADORI-VAN HAAFTEN NEURODEVELOPMENTAL SYNDROME 4; TEVANED4]
FBgn0013981	His4r	HGNC:4781	OMIM:602822	HIST1H4A	4		
FBgn0013981	His4r	HGNC:4792	OMIM:602832	HIST1H4G	4		
FBgn0038251	Hexim	HGNC:24953	OMIM:607328	HEXIM1	11		
FBgn0038251	Hexim	HGNC:28591	OMIM:615695	HEXIM2	8		
FBgn0025808	Rad17	HGNC:9807	OMIM:603139	RAD17	11		
FBgn0038248	CG7886	HGNC:25740	OMIM:617110	CEP78	9	617236	617236[CONE-ROD DYSTROPHY AND HEARING LOSS 1; CRDHL1]
FBgn0003169	put	HGNC:11773	OMIM:190182	TGFBR2	3	133239,610168,614331	133239[ESOPHAGEAL CANCER],610168[LOEYS-DIETZ SYNDROME 2; LDS2],614331[COLORECTAL CANCER, HEREDITARY NONPOLYPOSIS, TYPE 6; HNPCC6]
FBgn0003169	put	HGNC:174	OMIM:602730	ACVR2B	12	613751	613751[HETEROTAXY, VISCERAL, 4, AUTOSOMAL; HTX4]
FBgn0003169	put	HGNC:173	OMIM:102581	ACVR2A	12		
FBgn0038237	Pde6	HGNC:8773	OMIM:604961	PDE11A	7	610475	610475[PIGMENTED NODULAR ADRENOCORTICAL DISEASE, PRIMARY, 2; PPNAD2]
FBgn0038237	Pde6	HGNC:8784	OMIM:603310	PDE5A	5		
FBgn0038237	Pde6	HGNC:8785	OMIM:180071	PDE6A	3	613810	613810[RETINITIS PIGMENTOSA 43; RP43]
FBgn0038237	Pde6	HGNC:8787	OMIM:600827	PDE6C	3	613093	613093[CONE DYSTROPHY 4; COD4]
FBgn0038237	Pde6	HGNC:8786	OMIM:180072	PDE6B	3	163500,613801	163500[NIGHT BLINDNESS, CONGENITAL STATIONARY, AUTOSOMAL DOMINANT 2; CSNBAD2],613801[RETINITIS PIGMENTOSA 40; RP40]
FBgn0038235	CG8461	HGNC:21374	OMIM:613475	RRP36	14		
FBgn0038233	HtrA2	HGNC:14348	OMIM:606441	HTRA2	13	610297,617248	610297[PARKINSON DISEASE 13, AUTOSOMAL DOMINANT, SUSCEPTIBILITY TO; PARK13],617248[3-METHYLGLUTACONIC ACIDURIA, TYPE VIII; MGCA8]
FBgn0038233	HtrA2	HGNC:9476	OMIM:602194	HTRA1	11	600142,610149,616779	600142[CEREBRAL ARTERIOPATHY, AUTOSOMAL RECESSIVE, WITH SUBCORTICAL INFARCTS AND LEUKOENCEPHALOPATHY; CARASIL],610149[MACULAR DEGENERATION, AGE-RELATED, 7; ARMD7],616779[CEREBRAL ARTERIOPATHY, AUTOSOMAL DOMINANT, WITH SUBCORTICAL INFARCTS AND LEUKOENCEPHALOPATHY, TYPE 2; CADASIL2]
FBgn0038233	HtrA2	HGNC:26909	OMIM:610700	HTRA4	6		
FBgn0038233	HtrA2	HGNC:30406	OMIM:608785	HTRA3	10		
FBgn0038260	CG14855	HGNC:8494	OMIM:604047	SLC22A13	4		
FBgn0038260	CG14855	HGNC:10970	OMIM:607582	SLC22A6	4		
FBgn0038260	CG14855	HGNC:20302	OMIM:608276	SLC22A16	4		
FBgn0038260	CG14855	HGNC:10968	OMIM:604190	SLC22A4	4	180300	180300[RHEUMATOID ARTHRITIS; RA]
FBgn0038260	CG14855	HGNC:10969	OMIM:603377	SLC22A5	4	212140	212140[CARNITINE DEFICIENCY, SYSTEMIC PRIMARY; CDSP]
FBgn0038260	CG14855	HGNC:8495	OMIM:604048	SLC22A14	4		
FBgn0038260	CG14855	HGNC:10971	OMIM:604995	SLC22A7	5		
FBgn0038260	CG14855	HGNC:10972	OMIM:607581	SLC22A8	4		
FBgn0038260	CG14855	HGNC:10966	OMIM:602608	SLC22A2	4		
FBgn0038260	CG14855	HGNC:21106	OMIM:611697	SLC22A23	3		
FBgn0038260	CG14855	HGNC:32935	OMIM:610792	SLC22A25	4		
FBgn0038260	CG14855	HGNC:10963	OMIM:602607	SLC22A1	4		
FBgn0038260	CG14855	HGNC:10967	OMIM:604842	SLC22A3	4		
FBgn0038260	CG14855	HGNC:23095	OMIM:611461	SLC22A17	3		
FBgn0038260	CG14855	HGNC:20301	OMIM:608275	SLC22A15	3		
FBgn0038260	CG14855	HGNC:17989	OMIM:607096	SLC22A12	4	220150	220150[HYPOURICEMIA, RENAL, 1; RHUC1]
FBgn0038260	CG14855	HGNC:27091		SLC22A31	3		
FBgn0038260	CG14855	HGNC:18120	OMIM:607097	SLC22A11	4		
FBgn0038260	CG14855	HGNC:16261	OMIM:607579	SLC22A9	4		
FBgn0038260	CG14855	HGNC:28542	OMIM:611698	SLC22A24	4		
FBgn0038260	CG14855	HGNC:18057	OMIM:607580	SLC22A10	4		
FBgn0038261	CG14856	HGNC:8494	OMIM:604047	SLC22A13	4		
FBgn0038261	CG14856	HGNC:10970	OMIM:607582	SLC22A6	4		
FBgn0038261	CG14856	HGNC:20302	OMIM:608276	SLC22A16	4		
FBgn0038261	CG14856	HGNC:10968	OMIM:604190	SLC22A4	4	180300	180300[RHEUMATOID ARTHRITIS; RA]
FBgn0038261	CG14856	HGNC:10969	OMIM:603377	SLC22A5	4	212140	212140[CARNITINE DEFICIENCY, SYSTEMIC PRIMARY; CDSP]
FBgn0038261	CG14856	HGNC:8495	OMIM:604048	SLC22A14	4		
FBgn0038261	CG14856	HGNC:10971	OMIM:604995	SLC22A7	5		
FBgn0038261	CG14856	HGNC:10972	OMIM:607581	SLC22A8	4		
FBgn0038261	CG14856	HGNC:10966	OMIM:602608	SLC22A2	4		
FBgn0038261	CG14856	HGNC:21106	OMIM:611697	SLC22A23	3		
FBgn0038261	CG14856	HGNC:32935	OMIM:610792	SLC22A25	4		
FBgn0038261	CG14856	HGNC:10963	OMIM:602607	SLC22A1	4		
FBgn0038261	CG14856	HGNC:10967	OMIM:604842	SLC22A3	4		
FBgn0038261	CG14856	HGNC:23095	OMIM:611461	SLC22A17	3		
FBgn0038261	CG14856	HGNC:20301	OMIM:608275	SLC22A15	3		
FBgn0038261	CG14856	HGNC:17989	OMIM:607096	SLC22A12	4	220150	220150[HYPOURICEMIA, RENAL, 1; RHUC1]
FBgn0038261	CG14856	HGNC:27091		SLC22A31	3		
FBgn0038261	CG14856	HGNC:18120	OMIM:607097	SLC22A11	4		
FBgn0038261	CG14856	HGNC:16261	OMIM:607579	SLC22A9	4		
FBgn0038261	CG14856	HGNC:28542	OMIM:611698	SLC22A24	4		
FBgn0038261	CG14856	HGNC:18057	OMIM:607580	SLC22A10	4		
FBgn0038262	CG14857	HGNC:8494	OMIM:604047	SLC22A13	4		
FBgn0038262	CG14857	HGNC:10970	OMIM:607582	SLC22A6	4		
FBgn0038262	CG14857	HGNC:20302	OMIM:608276	SLC22A16	4		
FBgn0038262	CG14857	HGNC:10968	OMIM:604190	SLC22A4	4	180300	180300[RHEUMATOID ARTHRITIS; RA]
FBgn0038262	CG14857	HGNC:10969	OMIM:603377	SLC22A5	4	212140	212140[CARNITINE DEFICIENCY, SYSTEMIC PRIMARY; CDSP]
FBgn0038262	CG14857	HGNC:8495	OMIM:604048	SLC22A14	4		
FBgn0038262	CG14857	HGNC:10971	OMIM:604995	SLC22A7	5		
FBgn0038262	CG14857	HGNC:10972	OMIM:607581	SLC22A8	4		
FBgn0038262	CG14857	HGNC:10966	OMIM:602608	SLC22A2	4		
FBgn0038262	CG14857	HGNC:21106	OMIM:611697	SLC22A23	3		
FBgn0038262	CG14857	HGNC:32935	OMIM:610792	SLC22A25	4		
FBgn0038262	CG14857	HGNC:10963	OMIM:602607	SLC22A1	4		
FBgn0038262	CG14857	HGNC:10967	OMIM:604842	SLC22A3	4		
FBgn0038262	CG14857	HGNC:23095	OMIM:611461	SLC22A17	3		
FBgn0038262	CG14857	HGNC:20301	OMIM:608275	SLC22A15	3		
FBgn0038262	CG14857	HGNC:17989	OMIM:607096	SLC22A12	4	220150	220150[HYPOURICEMIA, RENAL, 1; RHUC1]
FBgn0038262	CG14857	HGNC:27091		SLC22A31	3		
FBgn0038262	CG14857	HGNC:18120	OMIM:607097	SLC22A11	4		
FBgn0038262	CG14857	HGNC:16261	OMIM:607579	SLC22A9	4		
FBgn0038262	CG14857	HGNC:28542	OMIM:611698	SLC22A24	4		
FBgn0038262	CG14857	HGNC:18057	OMIM:607580	SLC22A10	4		
FBgn0038268	CG3631	HGNC:23017	OMIM:611063	FAM20B	13		
FBgn0067628	CG33331	HGNC:25187	OMIM:614948	TAMM41	13		
FBgn0067629	CG33332	HGNC:20298		GPALPP1	14		
FBgn0038271	UQCR-C1	HGNC:9119	OMIM:603131	PMPCB	15	617954	617954[MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 6; MMDS6]
FBgn0038271	UQCR-C1	HGNC:12585	OMIM:191328	UQCRC1	7	619279	619279[PARKINSONISM WITH POLYNEUROPATHY; PKNPY]
FBgn0038275	CG3817	HGNC:24255	OMIM:611193	RRP15	13		
FBgn0038279	Sdr	HGNC:5465	OMIM:147370	IGF1R	4	270450	270450[INSULIN-LIKE GROWTH FACTOR I, RESISTANCE TO; IGF1RES]
FBgn0038279	Sdr	HGNC:6091	OMIM:147670	INSR	3	246200,262190,609968,610549	246200[DONOHUE SYNDROME],262190[PINEAL HYPERPLASIA, INSULIN-RESISTANT DIABETES MELLITUS, AND SOMATIC ABNORMALITIES],609968[HYPERINSULINEMIC HYPOGLYCEMIA, FAMILIAL, 5; HHF5],610549[DIABETES MELLITUS, INSULIN-RESISTANT, WITH ACANTHOSIS NIGRICANS]
FBgn0038279	Sdr	HGNC:6093	OMIM:147671	INSRR	3		
FBgn0028662	VhaPPA1-1	HGNC:861	OMIM:603717	ATP6V0B	15		
FBgn0038277	RpS5b	HGNC:10426	OMIM:603630	RPS5	10		
FBgn0038274	Nup93-2	HGNC:28958	OMIM:614351	NUP93	14	616892	616892[NEPHROTIC SYNDROME, TYPE 12; NPHS12]
FBgn0038272	Dph2	HGNC:3004	OMIM:603456	DPH2	14		
FBgn0004597	CycC	HGNC:1581	OMIM:123838	CCNC	13		
FBgn0038269	Rrp6	HGNC:9138	OMIM:605960	EXOSC10	14		
FBgn0038258	CG7362	HGNC:9021	OMIM:179050	PKM	5		
FBgn0038258	CG7362	HGNC:9020	OMIM:609712	PKLR	5	102900,266200	102900[ADENOSINE TRIPHOSPHATE, ELEVATED, OF ERYTHROCYTES],266200[PYRUVATE KINASE DEFICIENCY OF RED CELLS]
FBgn0038257	smp-30	HGNC:9989	OMIM:300212	RGN	15		
FBgn0011217	eff	HGNC:12474	OMIM:602961	UBE2D1	10		
FBgn0011217	eff	HGNC:12475	OMIM:602962	UBE2D2	13		
FBgn0011217	eff	HGNC:12476	OMIM:602963	UBE2D3	13		
FBgn0011217	eff	HGNC:21647		UBE2D4	10		
FBgn0038256	CG7530	HGNC:30130	OMIM:614577	PAQR3	14		
FBgn0038280	CG14861	HGNC:28670	OMIM:616450	EFHD2	7		
FBgn0038280	CG14861	HGNC:29556	OMIM:611617	EFHD1	6		
FBgn0038281	RpL10Aa	HGNC:10299	OMIM:615660	RPL10A	6		
FBgn0038296	Kpc1	HGNC:21148	OMIM:614472	RNF123	14		
FBgn0038296	Kpc1	HGNC:29420	OMIM:616585	RSPRY1	3	616723	616723[SPONDYLOEPIMETAPHYSEAL DYSPLASIA, FADEN-ALKURAYA TYPE; SEMDFA]
FBgn0038286	CG6966	HGNC:16933	OMIM:608767	FEM1C	13		
FBgn0038286	CG6966	HGNC:16934	OMIM:613538	FEM1A	12		
FBgn0038300	Mau2	HGNC:29140	OMIM:614560	MAU2	14		
FBgn0038302	CG4210	HGNC:27992		SATL1	7		
FBgn0038302	CG4210	HGNC:10540	OMIM:313020	SAT1	10		
FBgn0038302	CG4210	HGNC:23160	OMIM:611463	SAT2	14		
FBgn0038304	CG12241	HGNC:20310		GRTP1	3		
FBgn0038304	CG12241	HGNC:25228	OMIM:610440	SGSM3	15		
FBgn0038307	mRpS10	HGNC:14502	OMIM:611976	MRPS10	11		
FBgn0014879	Set	HGNC:24358	OMIM:300564	TSPYL2	5		
FBgn0014879	Set	HGNC:10760	OMIM:600960	SET	13	618106	618106[INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL DOMINANT 58; MRD58]
FBgn0014879	Set	HGNC:12381	OMIM:480100	TSPY1	5		
FBgn0014879	Set	HGNC:12382	OMIM:604714	TSPYL1	6	608800	608800[SUDDEN INFANT DEATH WITH DYSGENESIS OF THE TESTES SYNDROME; SIDDT]
FBgn0014879	Set	HGNC:21559	OMIM:619586	TSPYL4	6		
FBgn0014879	Set	HGNC:23924		TSPY2	5		
FBgn0014879	Set	HGNC:29367	OMIM:614721	TSPYL5	5		
FBgn0014879	Set	HGNC:14521		TSPYL6	6		
FBgn0014879	Set	HGNC:33876		TSPY3	4		
FBgn0014879	Set	HGNC:37287		TSPY4	5		
FBgn0014879	Set	HGNC:37473		TSPY10	4		
FBgn0014879	Set	HGNC:37471		TSPY8	4		
FBgn0014879	Set	HGNC:42937		SETSIP	8		
FBgn0016691	ATPsynO	HGNC:850	OMIM:600828	ATP5PO	13		
FBgn0038312	Zip88E	HGNC:12876	OMIM:604740	SLC39A1	6		
FBgn0038312	Zip88E	HGNC:17128	OMIM:612168	SLC39A3	8		
FBgn0038312	Zip88E	HGNC:17127	OMIM:612166	SLC39A2	5		
FBgn0038313	CG4338	HGNC:14175	OMIM:617058	TSR3	12		
FBgn0004117	Tm2	HGNC:12012	OMIM:191030	TPM3	11	255310,609284	255310[MYOPATHY, CONGENITAL, WITH FIBER-TYPE DISPROPORTION; CFTD],609284[NEMALINE MYOPATHY 1; NEM1]
FBgn0004117	Tm2	HGNC:12013	OMIM:600317	TPM4	11		
FBgn0004117	Tm2	HGNC:12011	OMIM:190990	TPM2	11	108120,609285	108120[ARTHROGRYPOSIS, DISTAL, TYPE 1A; DA1A],609285[NEMALINE MYOPATHY 4; NEM4]
FBgn0004117	Tm2	HGNC:12010	OMIM:191010	TPM1	11	115196,611878	115196[CARDIOMYOPATHY, FAMILIAL HYPERTROPHIC, 3; CMH3],611878[CARDIOMYOPATHY, DILATED, 1Y; CMD1Y]
FBgn0026441	ear	HGNC:7136	OMIM:159558	MLLT3	8		
FBgn0026441	ear	HGNC:7134	OMIM:159556	MLLT1	8		
FBgn0038319	mRpL9	HGNC:14277	OMIM:611824	MRPL9	14		
FBgn0038320	Cyfip	HGNC:13759	OMIM:606322	CYFIP1	14		
FBgn0038320	Cyfip	HGNC:13760	OMIM:606323	CYFIP2	14	618008	618008[DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 65; DEE65]
FBgn0021750	SerRS-m	HGNC:10537	OMIM:607529	SARS	4	617709	617709[NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, ATAXIA, AND SEIZURES; NEDMAS]
FBgn0021750	SerRS-m	HGNC:17697	OMIM:612804	SARS2	13	613845	613845[HYPERURICEMIA, PULMONARY HYPERTENSION, RENAL FAILURE, AND ALKALOSIS SYNDROME; HUPRAS]
FBgn0051301	CG31301	HGNC:19374	OMIM:300440	NKRF	11		
FBgn0038324	CG5038	HGNC:25904	OMIM:618203	TMTC4	14		
FBgn0038326	Hibch	HGNC:4908	OMIM:610690	HIBCH	13	250620	250620[3-HYDROXYISOBUTYRYL-CoA HYDROLASE DEFICIENCY; HIBCHD]
FBgn0038327	Trax	HGNC:12380	OMIM:602964	TSNAX	15		
FBgn0038331	Ccm3	HGNC:8761	OMIM:609118	PDCD10	14	603285	603285[CEREBRAL CAVERNOUS MALFORMATIONS 3; CCM3]
FBgn0041188	Atx2	HGNC:10555	OMIM:601517	ATXN2	9	168600,183090	168600[PARKINSON DISEASE, LATE-ONSET; PD],183090[SPINOCEREBELLAR ATAXIA 2; SCA2]
FBgn0041188	Atx2	HGNC:31326	OMIM:607931	ATXN2L	10		
FBgn0038337	CG6125	HGNC:14471	OMIM:610117	SLC26A11	6		
FBgn0038334	h-cup	HGNC:23098	OMIM:608858	FGFR1OP2	4		
FBgn0038334	h-cup	HGNC:26119	OMIM:611656	SIKE1	4		
FBgn0038332	CG6136	HGNC:24271	OMIM:610101	CUTC	15		
FBgn0038330	CG14868	HGNC:25405		CCDC149	11		
FBgn0026737	CG6171	HGNC:28724	OMIM:611035	APLF	9		
FBgn0026634	Cog2	HGNC:6546	OMIM:606974	COG2	14	617395	617395[CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIq; CDG2Q]
FBgn0038325	Atg4b	HGNC:16489	OMIM:300663	ATG4A	5		
FBgn0038325	Atg4b	HGNC:16040	OMIM:611339	ATG4C	12		
FBgn0038325	Atg4b	HGNC:20790	OMIM:611338	ATG4B	5		
FBgn0038325	Atg4b	HGNC:20789	OMIM:611340	ATG4D	13		
FBgn0019925	Surf4	HGNC:11476	OMIM:185660	SURF4	14		
FBgn0038321	Nagk	HGNC:17174	OMIM:606828	NAGK	14		
FBgn0011476	l(3)neo43	HGNC:20213	OMIM:618064	COX16	10	619355	619355[MITOCHONDRIAL COMPLEX IV DEFICIENCY, NUCLEAR TYPE 22; MC4DN22]
FBgn0027378	MRG15	HGNC:16989	OMIM:607303	MORF4L1	14		
FBgn0027378	MRG15	HGNC:16849	OMIM:300409	MORF4L2	11		
FBgn0045035	tefu	HGNC:795	OMIM:607585	ATM	12	114480,208900	114480[BREAST CANCER],208900[ATAXIA-TELANGIECTASIA; AT]
FBgn0038306	Art3	HGNC:30163	OMIM:603190	PRMT3	13		
FBgn0051155	Polr2G	HGNC:9194	OMIM:602013	POLR2G	14		
FBgn0038303	SIDL	HGNC:11868	OMIM:602103	TRAPPC10	15	620027	620027[NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, SHORT STATURE, AND SPEECH DELAY; NEDMISS]
FBgn0038303	SIDL	HGNC:0		LOC102724200	5		
FBgn0038299	Spn88Eb	HGNC:8943	OMIM:602445	SERPINI1	4	604218	604218[ENCEPHALOPATHY, FAMILIAL, WITH NEUROSERPIN INCLUSION BODIES; FENIB]
FBgn0038299	Spn88Eb	HGNC:10569	OMIM:600517	SERPINB3	3		
FBgn0038299	Spn88Eb	HGNC:3311	OMIM:130135	SERPINB1	4		
FBgn0038299	Spn88Eb	HGNC:775	OMIM:107300	SERPINC1	3	613118	613118[ANTITHROMBIN III DEFICIENCY; AT3D]
FBgn0038299	Spn88Eb	HGNC:8950	OMIM:173321	SERPINB6	3	613453	613453[DEAFNESS, AUTOSOMAL RECESSIVE 91; DFNB91]
FBgn0038299	Spn88Eb	HGNC:8944	OMIM:604445	SERPINB13	3		
FBgn0028984	Spn88Ea	HGNC:8955	OMIM:601799	SERPINB9	3		
FBgn0028984	Spn88Ea	HGNC:8945	OMIM:605587	SERPINI2	3		
FBgn0028984	Spn88Ea	HGNC:8943	OMIM:602445	SERPINI1	5	604218	604218[ENCEPHALOPATHY, FAMILIAL, WITH NEUROSERPIN INCLUSION BODIES; FENIB]
FBgn0028984	Spn88Ea	HGNC:10569	OMIM:600517	SERPINB3	4		
FBgn0028984	Spn88Ea	HGNC:3311	OMIM:130135	SERPINB1	5		
FBgn0028984	Spn88Ea	HGNC:10570	OMIM:600518	SERPINB4	3		
FBgn0028984	Spn88Ea	HGNC:8950	OMIM:173321	SERPINB6	4	613453	613453[DEAFNESS, AUTOSOMAL RECESSIVE 91; DFNB91]
FBgn0028984	Spn88Ea	HGNC:8944	OMIM:604445	SERPINB13	4		
FBgn0000047	Act88F	HGNC:17780	OMIM:614835	ACTBL2	5		
FBgn0000047	Act88F	HGNC:169	OMIM:604221	ACTR2	3		
FBgn0000047	Act88F	HGNC:168	OMIM:605144	ACTR1B	3		
FBgn0000047	Act88F	HGNC:129	OMIM:102610	ACTA1	3	161800,255310,616852	161800[NEMALINE MYOPATHY 3; NEM3],255310[MYOPATHY, CONGENITAL, WITH FIBER-TYPE DISPROPORTION; CFTD],616852[MYOPATHY, SCAPULOHUMEROPERONEAL; SHPM]
FBgn0000047	Act88F	HGNC:132	OMIM:102630	ACTB	6	243310,607371	243310[BARAITSER-WINTER SYNDROME 1; BRWS1],607371[DYSTONIA, JUVENILE-ONSET; DJO]
FBgn0000047	Act88F	HGNC:130	OMIM:102620	ACTA2	4	611788,613834,614042	611788[AORTIC ANEURYSM, FAMILIAL THORACIC 6; AAT6],613834[MULTISYSTEMIC SMOOTH MUSCLE DYSFUNCTION SYNDROME; MSMDS],614042[MOYAMOYA DISEASE 5; MYMY5]
FBgn0000047	Act88F	HGNC:143	OMIM:102540	ACTC1	4	612098,612794,613424	612098[CARDIOMYOPATHY, FAMILIAL HYPERTROPHIC, 11; CMH11],612794[ATRIAL SEPTAL DEFECT 5; ASD5],613424[CARDIOMYOPATHY, DILATED, 1R; CMD1R]
FBgn0000047	Act88F	HGNC:167	OMIM:605143	ACTR1A	3		
FBgn0000047	Act88F	HGNC:144	OMIM:102560	ACTG1	4	604717,614583	604717[DEAFNESS, AUTOSOMAL DOMINANT 20; DFNA20],614583[BARAITSER-WINTER SYNDROME 2; BRWS2]
FBgn0000047	Act88F	HGNC:145	OMIM:102545	ACTG2	3	155310,619431	155310[VISCERAL MYOPATHY 1; VSCM1],619431[MEGACYSTIS-MICROCOLON-INTESTINAL HYPOPERISTALSIS SYNDROME 5; MMIHS5]
FBgn0000047	Act88F	HGNC:37093		POTEI	5		
FBgn0000047	Act88F	HGNC:37094		POTEJ	5		
FBgn0000047	Act88F	HGNC:33905		POTEF	6		
FBgn0000047	Act88F	HGNC:33895	OMIM:608914	POTEE	5		
FBgn0000047	Act88F	HGNC:24022	OMIM:608534	ACTRT3	4		
FBgn0000047	Act88F	HGNC:24026	OMIM:608535	ACTRT2	3		
FBgn0000047	Act88F	HGNC:28494	OMIM:619251	ACTL9	3	619258	619258[SPERMATOGENIC FAILURE 53; SPGF53]
FBgn0000047	Act88F	HGNC:16127		ACTL10	3		
FBgn0038342	B9d1	HGNC:24123	OMIM:614144	B9D1	12	614209,617120	614209[MECKEL SYNDROME, TYPE 9; MKS9],617120[JOUBERT SYNDROME 27; JBTS27]
FBgn0019940	Rh6	HGNC:14449	OMIM:606665	OPN4	9		
FBgn0038344	obe	HGNC:18697	OMIM:614217	ASCC3	15		
FBgn0038344	obe	HGNC:30859	OMIM:601664	SNRNP200	4	610359	610359[RETINITIS PIGMENTOSA 33; RP33]
FBgn0038345	maca	HGNC:21220		SRSF12	3		
FBgn0038345	maca	HGNC:16713	OMIM:605221	SRSF10	3		
FBgn0038349	AOX3	HGNC:12805	OMIM:607633	XDH	3	278300	278300[XANTHINURIA, TYPE I; XAN1]
FBgn0051296	CG31296	HGNC:8946	OMIM:607076	PI15	3		
FBgn0051296	CG31296	HGNC:16249		R3HDML	3		
FBgn0051296	CG31296	HGNC:21245		PI16	4		
FBgn0051296	CG31296	HGNC:28392	OMIM:610395	GLIPR1L1	3		
FBgn0051296	CG31296	HGNC:25248	OMIM:612434	CRISPLD2	3		
FBgn0051296	CG31296	HGNC:304	OMIM:601193	CRISP1	3		
FBgn0051296	CG31296	HGNC:12024	OMIM:187430	CRISP2	3		
FBgn0051296	CG31296	HGNC:33849	OMIM:616572	CLEC18B	3		
FBgn0051296	CG31296	HGNC:30388	OMIM:616571	CLEC18A	3		
FBgn0038354	CG5404	HGNC:14471	OMIM:610117	SLC26A11	7		
FBgn0038355	CG4520	HGNC:25756		TOMM40L	5		
FBgn0038355	CG4520	HGNC:18001	OMIM:608061	TOMM40	6		
FBgn0038358	Ttc26	HGNC:21882	OMIM:617453	TTC26	14	619534	619534[BILIARY, RENAL, NEUROLOGIC, AND SKELETAL SYNDROME; BRENS]
FBgn0038359	CG5614	HGNC:26435	OMIM:617149	FOPNL	5		
FBgn0038360	CG9590	HGNC:25087		FAM114A1	12		
FBgn0038360	CG9590	HGNC:1333		FAM114A2	14		
FBgn0038361	Uros2	HGNC:12592	OMIM:606938	UROS	12	263700	263700[PORPHYRIA, CONGENITAL ERYTHROPOIETIC; CEP]
FBgn0038363	Acyp2	HGNC:179	OMIM:600875	ACYP1	10		
FBgn0038363	Acyp2	HGNC:180	OMIM:102595	ACYP2	9		
FBgn0038365	CG9593	HGNC:16039	OMIM:605910	ANGPTL4	3	615881	615881[PLASMA TRIGLYCERIDE LEVEL QUANTITATIVE TRAIT LOCUS; TGQTL]
FBgn0026616	alpha-Man-IIb	HGNC:6824	OMIM:154582	MAN2A1	5		
FBgn0026616	alpha-Man-IIb	HGNC:6825	OMIM:600988	MAN2A2	5		
FBgn0038369	Arpc3A	HGNC:706	OMIM:604225	ARPC3	14		
FBgn0003483	spn-E	HGNC:20122	OMIM:617963	TDRD9	14	618110	618110[SPERMATOGENIC FAILURE 30; SPGF30]
FBgn0038373	CG4546	HGNC:1996	OMIM:123295	CKMT2	8		
FBgn0038373	CG4546	HGNC:31736	OMIM:613415	CKMT1A	6		
FBgn0038373	CG4546	HGNC:1995	OMIM:123290	CKMT1B	4		
FBgn0038373	CG4546	HGNC:1991	OMIM:123280	CKB	6		
FBgn0038373	CG4546	HGNC:1994	OMIM:123310	CKM	6		
FBgn0051183	CG31183	HGNC:7943	OMIM:108960	NPR1	13		
FBgn0051183	CG31183	HGNC:7944	OMIM:108961	NPR2	13	602875,615923,616255	602875[ACROMESOMELIC DYSPLASIA 1; AMD1],615923[EPIPHYSEAL CHONDRODYSPLASIA, MIURA TYPE; ECDM],616255[SHORT STATURE WITH NONSPECIFIC SKELETAL ABNORMALITIES; SNSK]
FBgn0051183	CG31183	HGNC:4691	OMIM:300041	GUCY2F	3		
FBgn0051183	CG31183	HGNC:4688	OMIM:601330	GUCY2C	3	614616,614665	614616[DIARRHEA 6; DIAR6],614665[MECONIUM ILEUS]
FBgn0038376	Hmt-1	HGNC:48	OMIM:300135	ABCB7	3	301310	301310[ANEMIA, SIDEROBLASTIC, AND SPINOCEREBELLAR ATAXIA; ASAT]
FBgn0038376	Hmt-1	HGNC:47	OMIM:605452	ABCB6	15	111600,609153,614497,615402	111600[BLOOD GROUP, LANGEREIS SYSTEM; LAN],609153[PSEUDOHYPERKALEMIA, FAMILIAL, 2, DUE TO RED CELL LEAK; PSHK2],614497[MICROPHTHALMIA, ISOLATED, WITH COLOBOMA 7; MCOPCB7],615402[DYSCHROMATOSIS UNIVERSALIS HEREDITARIA 3; DUH3]
FBgn0038371	Pbp45	HGNC:11134	OMIM:600591	SNAPC1	10		
FBgn0017567	ND-23	HGNC:7715	OMIM:602141	NDUFS8	14	618222	618222[MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 2; MC1DN2]
FBgn0003227	rec	HGNC:16147	OMIM:608187	MCM8	12	612885	612885[PREMATURE OVARIAN FAILURE 10; POF10]
FBgn0051294	CG31294	HGNC:23700	OMIM:610732	TTC12	4	618801	618801[CILIARY DYSKINESIA, PRIMARY, 45; CILD45]
FBgn0038381	EndoU	HGNC:14369	OMIM:606720	ENDOU	12		
FBgn0038385	Fbxl7	HGNC:13604	OMIM:605656	FBXL7	11		
FBgn0038387	blp	HGNC:29679	OMIM:614336	PAM16	13	613320	613320[SPONDYLOMETAPHYSEAL DYSPLASIA, MEGARBANE-DAGHER-MELKI TYPE; SMDMDM]
FBgn0013334	Sap47	HGNC:16273		SYAP1	12		
FBgn0038389	CG5516	HGNC:25954		ZCCHC10	13		
FBgn0038390	Rbf2	HGNC:9893	OMIM:116957	RBL1	8		
FBgn0038390	Rbf2	HGNC:9894	OMIM:180203	RBL2	7	619690	619690[BRUNET-WAGNER NEURODEVELOPMENTAL SYNDROME; BRUWAG]
FBgn0038390	Rbf2	HGNC:9884	OMIM:614041	RB1	6	109800,180200,182280,259500	109800[BLADDER CANCER],180200[RETINOBLASTOMA; RB1],182280[SMALL CELL CANCER OF THE LUNG],259500[OSTEOGENIC SARCOMA]
FBgn0022787	Hel89B	HGNC:17307	OMIM:605191	BTAF1	12		
FBgn0038391	GATAe	HGNC:4173	OMIM:600576	GATA4	6	187500,607941,614429,614430,615542	187500[TETRALOGY OF FALLOT; TOF],607941[ATRIAL SEPTAL DEFECT 2; ASD2],614429[VENTRICULAR SEPTAL DEFECT 1; VSD1],614430[ATRIOVENTRICULAR SEPTAL DEFECT 4; AVSD4],615542[TESTICULAR ANOMALIES WITH OR WITHOUT CONGENITAL HEART DISEASE; TACHD]
FBgn0038391	GATAe	HGNC:4170	OMIM:305371	GATA1	3	190685,300367,300835,301083,314050	190685[DOWN SYNDROME],300367[THROMBOCYTOPENIA, X-LINKED, WITH OR WITHOUT DYSERYTHROPOIETIC ANEMIA; XLTDA],300835[ANEMIA, X-LINKED, WITH OR WITHOUT NEUTROPENIA AND/OR PLATELET ABNORMALITIES; XLANP],301083[ADENOSINE DEAMINASE, ELEVATED, HEMOLYTIC ANEMIA DUE TO; HAEADA],314050[THROMBOCYTOPENIA WITH BETA-THALASSEMIA, X-LINKED; XLTT]
FBgn0038391	GATAe	HGNC:15802	OMIM:611496	GATA5	5	617912	617912[CONGENITAL HEART DEFECTS, MULTIPLE TYPES, 5; CHTD5]
FBgn0038391	GATAe	HGNC:4172	OMIM:131320	GATA3	3	146255	146255[HYPOPARATHYROIDISM, SENSORINEURAL DEAFNESS, AND RENAL DYSPLASIA SYNDROME; HDRS]
FBgn0038391	GATAe	HGNC:4174	OMIM:601656	GATA6	4	187500,217095,600001,614474,614475	187500[TETRALOGY OF FALLOT; TOF],217095[CONOTRUNCAL HEART MALFORMATIONS; CTHM],600001[HEART DEFECTS, CONGENITAL, AND OTHER CONGENITAL ANOMALIES; HDCA],614474[ATRIOVENTRICULAR SEPTAL DEFECT 5; AVSD5],614475[ATRIAL SEPTAL DEFECT 9; ASD9]
FBgn0038391	GATAe	HGNC:4171	OMIM:137295	GATA2	3	601626,614038,614172,614286	601626[LEUKEMIA, ACUTE MYELOID; AML],614038[LYMPHEDEMA, PRIMARY, WITH MYELODYSPLASIA],614172[IMMUNODEFICIENCY 21; IMD21],614286[MYELODYSPLASTIC SYNDROME; MDS]
FBgn0003117	pnr	HGNC:4173	OMIM:600576	GATA4	10	187500,607941,614429,614430,615542	187500[TETRALOGY OF FALLOT; TOF],607941[ATRIAL SEPTAL DEFECT 2; ASD2],614429[VENTRICULAR SEPTAL DEFECT 1; VSD1],614430[ATRIOVENTRICULAR SEPTAL DEFECT 4; AVSD4],615542[TESTICULAR ANOMALIES WITH OR WITHOUT CONGENITAL HEART DISEASE; TACHD]
FBgn0003117	pnr	HGNC:4170	OMIM:305371	GATA1	4	190685,300367,300835,301083,314050	190685[DOWN SYNDROME],300367[THROMBOCYTOPENIA, X-LINKED, WITH OR WITHOUT DYSERYTHROPOIETIC ANEMIA; XLTDA],300835[ANEMIA, X-LINKED, WITH OR WITHOUT NEUTROPENIA AND/OR PLATELET ABNORMALITIES; XLANP],301083[ADENOSINE DEAMINASE, ELEVATED, HEMOLYTIC ANEMIA DUE TO; HAEADA],314050[THROMBOCYTOPENIA WITH BETA-THALASSEMIA, X-LINKED; XLTT]
FBgn0003117	pnr	HGNC:15802	OMIM:611496	GATA5	9	617912	617912[CONGENITAL HEART DEFECTS, MULTIPLE TYPES, 5; CHTD5]
FBgn0003117	pnr	HGNC:4172	OMIM:131320	GATA3	4	146255	146255[HYPOPARATHYROIDISM, SENSORINEURAL DEAFNESS, AND RENAL DYSPLASIA SYNDROME; HDRS]
FBgn0003117	pnr	HGNC:4174	OMIM:601656	GATA6	8	187500,217095,600001,614474,614475	187500[TETRALOGY OF FALLOT; TOF],217095[CONOTRUNCAL HEART MALFORMATIONS; CTHM],600001[HEART DEFECTS, CONGENITAL, AND OTHER CONGENITAL ANOMALIES; HDCA],614474[ATRIOVENTRICULAR SEPTAL DEFECT 5; AVSD5],614475[ATRIAL SEPTAL DEFECT 9; ASD9]
FBgn0003117	pnr	HGNC:4171	OMIM:137295	GATA2	4	601626,614038,614172,614286	601626[LEUKEMIA, ACUTE MYELOID; AML],614038[LYMPHEDEMA, PRIMARY, WITH MYELODYSPLASIA],614172[IMMUNODEFICIENCY 21; IMD21],614286[MYELODYSPLASTIC SYNDROME; MDS]
FBgn0038396	CG5013	HGNC:26988	OMIM:615262	METTL23	14	615942	615942[INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 44; MRT44]
FBgn0038396	CG5013	HGNC:30476	OMIM:615257	METTL21A	3		
FBgn0027948	msps	HGNC:28959	OMIM:611142	CKAP5	13		
FBgn0038398	sxe2	HGNC:17661	OMIM:607460	PLA1A	4		
FBgn0038398	sxe2	HGNC:18821	OMIM:609252	LIPI	3		
FBgn0038398	sxe2	HGNC:18483	OMIM:607365	LIPH	3	604379	604379[HYPOTRICHOSIS 7; HYPT7]
FBgn0010379	Akt	HGNC:392	OMIM:164731	AKT2	13	125853,240900	125853[TYPE 2 DIABETES MELLITUS; T2D],240900[HYPOINSULINEMIC HYPOGLYCEMIA WITH HEMIHYPERTROPHY; HIHGHH]
FBgn0010379	Akt	HGNC:13900	OMIM:607589	SGK2	4		
FBgn0010379	Akt	HGNC:10810	OMIM:602958	SGK1	4		
FBgn0010379	Akt	HGNC:393	OMIM:611223	AKT3	12	615937	615937[MEGALENCEPHALY-POLYMICROGYRIA-POLYDACTYLY-HYDROCEPHALUS SYNDROME 2; MPPH2]
FBgn0010379	Akt	HGNC:391	OMIM:164730	AKT1	10	114480,114500,167000,176920,615109	114480[BREAST CANCER],114500[COLORECTAL CANCER; CRC],167000[OVARIAN CANCER],176920[PROTEUS SYNDROME],615109[COWDEN SYNDROME 6; CWS6]
FBgn0038397	CG10185	HGNC:29229		NWD2	10		
FBgn0038397	CG10185	HGNC:27619	OMIM:616250	NWD1	5		
FBgn0024222	IKKbeta	HGNC:1974	OMIM:600664	CHUK	9	613630,619339	613630[FETAL ENCASEMENT SYNDROME],619339[BARTSOCAS-PAPAS SYNDROME 2; BPS2]
FBgn0024222	IKKbeta	HGNC:5960	OMIM:603258	IKBKB	9	615592,618204	615592[IMMUNODEFICIENCY 15B; IMD15B],618204[IMMUNODEFICIENCY 15A; IMD15A]
FBgn0002783	mor	HGNC:11105	OMIM:601734	SMARCC2	15	618362	618362[COFFIN-SIRIS SYNDROME 8; CSS8]
FBgn0002783	mor	HGNC:11104	OMIM:601732	SMARCC1	13		
FBgn0027657	glob1	HGNC:4827	OMIM:141900	HBB	4	140700,141749,603902,603903,611162,613985,617971,617980	140700[HEINZ BODY ANEMIAS],141749[FETAL HEMOGLOBIN QUANTITATIVE TRAIT LOCUS 1; HBFQTL1],603902[BETA-THALASSEMIA, DOMINANT INCLUSION BODY TYPE],603903[SICKLE CELL ANEMIA],611162[MALARIA, SUSCEPTIBILITY TO],613985[BETA-THALASSEMIA],617971[METHEMOGLOBINEMIA, BETA TYPE],617980[ERYTHROCYTOSIS, FAMILIAL, 6; ECYT6]
FBgn0027657	glob1	HGNC:4829	OMIM:142000	HBD	3		
FBgn0027657	glob1	HGNC:4830	OMIM:142100	HBE1	5		
FBgn0027657	glob1	HGNC:4831	OMIM:142200	HBG1	5	141749	141749[FETAL HEMOGLOBIN QUANTITATIVE TRAIT LOCUS 1; HBFQTL1]
FBgn0027657	glob1	HGNC:4832	OMIM:142250	HBG2	5	141749,613977	141749[FETAL HEMOGLOBIN QUANTITATIVE TRAIT LOCUS 1; HBFQTL1],613977[CYANOSIS, TRANSIENT NEONATAL; TNCY]
FBgn0027657	glob1	HGNC:4835	OMIM:142310	HBZ	4		
FBgn0027657	glob1	HGNC:6915	OMIM:160000	MB	4		
FBgn0027657	glob1	HGNC:16505	OMIM:608759	CYGB	9		
FBgn0027657	glob1	HGNC:4824	OMIM:141850	HBA2	4	140700,604131,613978,617981	140700[HEINZ BODY ANEMIAS],604131[ALPHA-THALASSEMIA],613978[HEMOGLOBIN H DISEASE; HBH],617981[ERYTHROCYTOSIS, FAMILIAL, 7; ECYT7]
FBgn0027657	glob1	HGNC:4826	OMIM:609639	HBM	4		
FBgn0027657	glob1	HGNC:4833	OMIM:142240	HBQ1	4		
FBgn0038380	CG14877	HGNC:7945	OMIM:108962	NPR3	5	619543	619543[BOUDIN-MORTIER SYNDROME; BOMOS]
FBgn0003319	Sb	HGNC:29808	OMIM:610050	TMPRSS13	3		
FBgn0003319	Sb	HGNC:9491	OMIM:600823	PRSS8	3		
FBgn0003319	Sb	HGNC:29970	OMIM:618962	OVCH2	3		
FBgn0038401	CG5916	HGNC:20310		GRTP1	14		
FBgn0038401	CG5916	HGNC:25228	OMIM:610440	SGSM3	3		
FBgn0038401	CG5916	HGNC:29183	OMIM:619152	TBC1D2B	3	619323	619323[NEURODEVELOPMENTAL DISORDER WITH SEIZURES AND GINGIVAL OVERGROWTH; NEDSGO]
FBgn0038401	CG5916	HGNC:18026	OMIM:609871	TBC1D2	3		
FBgn0063649	CG6006	HGNC:8494	OMIM:604047	SLC22A13	3		
FBgn0063649	CG6006	HGNC:10970	OMIM:607582	SLC22A6	4		
FBgn0063649	CG6006	HGNC:20302	OMIM:608276	SLC22A16	4		
FBgn0063649	CG6006	HGNC:10968	OMIM:604190	SLC22A4	3	180300	180300[RHEUMATOID ARTHRITIS; RA]
FBgn0063649	CG6006	HGNC:10969	OMIM:603377	SLC22A5	4	212140	212140[CARNITINE DEFICIENCY, SYSTEMIC PRIMARY; CDSP]
FBgn0063649	CG6006	HGNC:8495	OMIM:604048	SLC22A14	3		
FBgn0063649	CG6006	HGNC:10972	OMIM:607581	SLC22A8	3		
FBgn0063649	CG6006	HGNC:10966	OMIM:602608	SLC22A2	4		
FBgn0063649	CG6006	HGNC:32935	OMIM:610792	SLC22A25	3		
FBgn0063649	CG6006	HGNC:10963	OMIM:602607	SLC22A1	4		
FBgn0063649	CG6006	HGNC:10967	OMIM:604842	SLC22A3	4		
FBgn0063649	CG6006	HGNC:20301	OMIM:608275	SLC22A15	3		
FBgn0063649	CG6006	HGNC:17989	OMIM:607096	SLC22A12	4	220150	220150[HYPOURICEMIA, RENAL, 1; RHUC1]
FBgn0063649	CG6006	HGNC:18120	OMIM:607097	SLC22A11	4		
FBgn0063649	CG6006	HGNC:16261	OMIM:607579	SLC22A9	3		
FBgn0063649	CG6006	HGNC:18057	OMIM:607580	SLC22A10	3		
FBgn0038404	CG8925	HGNC:8494	OMIM:604047	SLC22A13	3		
FBgn0038404	CG8925	HGNC:10970	OMIM:607582	SLC22A6	4		
FBgn0038404	CG8925	HGNC:20302	OMIM:608276	SLC22A16	4		
FBgn0038404	CG8925	HGNC:10968	OMIM:604190	SLC22A4	3	180300	180300[RHEUMATOID ARTHRITIS; RA]
FBgn0038404	CG8925	HGNC:10969	OMIM:603377	SLC22A5	3	212140	212140[CARNITINE DEFICIENCY, SYSTEMIC PRIMARY; CDSP]
FBgn0038404	CG8925	HGNC:8495	OMIM:604048	SLC22A14	3		
FBgn0038404	CG8925	HGNC:10972	OMIM:607581	SLC22A8	3		
FBgn0038404	CG8925	HGNC:10966	OMIM:602608	SLC22A2	4		
FBgn0038404	CG8925	HGNC:32935	OMIM:610792	SLC22A25	3		
FBgn0038404	CG8925	HGNC:10963	OMIM:602607	SLC22A1	4		
FBgn0038404	CG8925	HGNC:10967	OMIM:604842	SLC22A3	4		
FBgn0038404	CG8925	HGNC:20301	OMIM:608275	SLC22A15	3		
FBgn0038404	CG8925	HGNC:17989	OMIM:607096	SLC22A12	4	220150	220150[HYPOURICEMIA, RENAL, 1; RHUC1]
FBgn0038404	CG8925	HGNC:18120	OMIM:607097	SLC22A11	4		
FBgn0038404	CG8925	HGNC:16261	OMIM:607579	SLC22A9	3		
FBgn0038404	CG8925	HGNC:18057	OMIM:607580	SLC22A10	3		
FBgn0020407	asun	HGNC:20174	OMIM:615079	INTS13	14		
FBgn0038412	Zip89B	HGNC:12876	OMIM:604740	SLC39A1	9		
FBgn0038412	Zip89B	HGNC:17128	OMIM:612168	SLC39A3	8		
FBgn0038412	Zip89B	HGNC:17127	OMIM:612166	SLC39A2	8		
FBgn0040271	Sulf1	HGNC:20392	OMIM:610013	SULF2	13		
FBgn0040271	Sulf1	HGNC:719	OMIM:300180	ARSE	3	302950	302950[CHONDRODYSPLASIA PUNCTATA 1, X-LINKED RECESSIVE; CDPX1]
FBgn0040271	Sulf1	HGNC:20391	OMIM:610012	SULF1	13		
FBgn0038407	CG6126	HGNC:25417	OMIM:611699	SVOP	3		
FBgn0038407	CG6126	HGNC:8494	OMIM:604047	SLC22A13	6		
FBgn0038407	CG6126	HGNC:10970	OMIM:607582	SLC22A6	5		
FBgn0038407	CG6126	HGNC:20302	OMIM:608276	SLC22A16	7		
FBgn0038407	CG6126	HGNC:10968	OMIM:604190	SLC22A4	5	180300	180300[RHEUMATOID ARTHRITIS; RA]
FBgn0038407	CG6126	HGNC:10969	OMIM:603377	SLC22A5	5	212140	212140[CARNITINE DEFICIENCY, SYSTEMIC PRIMARY; CDSP]
FBgn0038407	CG6126	HGNC:8495	OMIM:604048	SLC22A14	4		
FBgn0038407	CG6126	HGNC:10971	OMIM:604995	SLC22A7	5		
FBgn0038407	CG6126	HGNC:10972	OMIM:607581	SLC22A8	5		
FBgn0038407	CG6126	HGNC:10966	OMIM:602608	SLC22A2	4		
FBgn0038407	CG6126	HGNC:32935	OMIM:610792	SLC22A25	3		
FBgn0038407	CG6126	HGNC:10963	OMIM:602607	SLC22A1	4		
FBgn0038407	CG6126	HGNC:10967	OMIM:604842	SLC22A3	4		
FBgn0038407	CG6126	HGNC:20301	OMIM:608275	SLC22A15	3		
FBgn0038407	CG6126	HGNC:17989	OMIM:607096	SLC22A12	5	220150	220150[HYPOURICEMIA, RENAL, 1; RHUC1]
FBgn0038407	CG6126	HGNC:18120	OMIM:607097	SLC22A11	4		
FBgn0038407	CG6126	HGNC:16261	OMIM:607579	SLC22A9	3		
FBgn0038407	CG6126	HGNC:28542	OMIM:611698	SLC22A24	3		
FBgn0038407	CG6126	HGNC:18057	OMIM:607580	SLC22A10	3		
FBgn0024491	Bin1	HGNC:10530	OMIM:602949	SAP18	14		
FBgn0038402	Fer2	HGNC:16660	OMIM:617578	FERD3L	3		
FBgn0038400	Mic26-27	HGNC:28727	OMIM:300753	APOO	8		
FBgn0038400	Mic26-27	HGNC:24009	OMIM:300955	APOOL	10		
FBgn0027095	Manf	HGNC:15461	OMIM:601916	MANF	14		
FBgn0027095	Manf	HGNC:24913	OMIM:611233	CDNF	10		
FBgn0038424	Fntb	HGNC:3785	OMIM:134636	FNTB	10		
FBgn0038424	Fntb	HGNC:20099	OMIM:608577	CHURC1	3		
FBgn0038424	Fntb	HGNC:42960		CHURC1-FNTB	10		
FBgn0038425	CG14881	HGNC:26168		ARMC7	7		
FBgn0038425	CG14881	HGNC:30327	OMIM:606112	RPP14	3		
FBgn0038429	CG14882	HGNC:7473	OMIM:602568	MTRR	8	236270,601634	236270[HOMOCYSTINURIA-MEGALOBLASTIC ANEMIA, cblE COMPLEMENTATION TYPE; HMAE],601634[NEURAL TUBE DEFECTS, FOLATE-SENSITIVE; NTDFS]
FBgn0038432	CG14883	HGNC:29644	OMIM:605943	GDE1	12		
FBgn0038432	CG14883	HGNC:28638	OMIM:616318	GDPD3	3		
FBgn0027053	CSN5	HGNC:2240	OMIM:604850	COPS5	14		
FBgn0038435	Gyc89Da	HGNC:4687	OMIM:139397	GUCY1B1	3		
FBgn0038445	CG14891	HGNC:28155	OMIM:610287	FBXL15	3		
FBgn0038445	CG14891	HGNC:21658	OMIM:609080	FBXL13	3		
FBgn0038445	CG14891	HGNC:13605		LRRC29	3		
FBgn0038446	CG14903	HGNC:33782	OMIM:617342	PTRHD1	14		
FBgn0028381	Decay	HGNC:1504	OMIM:600636	CASP3	5		
FBgn0028381	Decay	HGNC:1508	OMIM:601761	CASP7	4		
FBgn0028381	Decay	HGNC:1507	OMIM:601532	CASP6	4		
FBgn0028381	Decay	HGNC:1503	OMIM:600639	CASP2	3		
FBgn0028381	Decay	HGNC:1511	OMIM:602234	CASP9	3		
FBgn0028381	Decay	HGNC:1509	OMIM:601763	CASP8	3	114480,114550,211980,607271	114480[BREAST CANCER],114550[HEPATOCELLULAR CARCINOMA],211980[LUNG CANCER],607271[CASPASE 8 DEFICIENCY]
FBgn0038438	Der-2	HGNC:14236	OMIM:610305	DERL3	12		
FBgn0038438	Der-2	HGNC:17943	OMIM:610304	DERL2	14		
FBgn0038438	Der-2	HGNC:28454	OMIM:608813	DERL1	4		
FBgn0038437	Sdhaf3	HGNC:21752	OMIM:615773	SDHAF3	13		
FBgn0044826	Pak3	HGNC:8592	OMIM:300142	PAK3	5	300558	300558[INTELLECTUAL DEVELOPMENTAL DISORDER, X-LINKED 30; XLID30]
FBgn0044826	Pak3	HGNC:16059	OMIM:605451	PAK4	3		
FBgn0044826	Pak3	HGNC:8591	OMIM:605022	PAK2	5	618458	618458[KNOBLOCH SYNDROME 2; KNO2]
FBgn0044826	Pak3	HGNC:15916	OMIM:608038	PAK5	3		
FBgn0044826	Pak3	HGNC:8590	OMIM:602590	PAK1	5	618158	618158[INTELLECTUAL DEVELOPMENTAL DISORDER WITH MACROCEPHALY, SEIZURES, AND SPEECH DELAY; IDDMSSD]
FBgn0044826	Pak3	HGNC:16061	OMIM:608110	PAK6	3		
FBgn0038428	CG14894	HGNC:12391	OMIM:601963	TTC1	14		
FBgn0038426	mRpS33	HGNC:16634	OMIM:611993	MRPS33	14		
FBgn0003513	ss	HGNC:346	OMIM:606517	AHRR	6		
FBgn0003513	ss	HGNC:348	OMIM:600253	AHR	10	618345	618345[RETINITIS PIGMENTOSA 85; RP85]
FBgn0038421	CG17931	HGNC:10757	OMIM:605054	SERF2	8		
FBgn0038421	CG17931	HGNC:10756		SERF1B	5		
FBgn0038421	CG17931	HGNC:10755	OMIM:603011	SERF1A	5		
FBgn0038449	CG17562	HGNC:26222	OMIM:616107	FAR1	6	616154,619338	616154[PEROXISOMAL FATTY ACYL-CoA REDUCTASE 1 DISORDER; PFCRD],619338[CATARACTS, SPASTIC PARAPARESIS, AND SPEECH DELAY; CSPSD]
FBgn0038449	CG17562	HGNC:25531	OMIM:616156	FAR2	6		
FBgn0038450	CG17560	HGNC:26222	OMIM:616107	FAR1	6	616154,619338	616154[PEROXISOMAL FATTY ACYL-CoA REDUCTASE 1 DISORDER; PFCRD],619338[CATARACTS, SPASTIC PARAPARESIS, AND SPEECH DELAY; CSPSD]
FBgn0038450	CG17560	HGNC:25531	OMIM:616156	FAR2	5		
FBgn0038451	CG14893	HGNC:26222	OMIM:616107	FAR1	6	616154,619338	616154[PEROXISOMAL FATTY ACYL-CoA REDUCTASE 1 DISORDER; PFCRD],619338[CATARACTS, SPASTIC PARAPARESIS, AND SPEECH DELAY; CSPSD]
FBgn0038451	CG14893	HGNC:25531	OMIM:616156	FAR2	7		
FBgn0015520	nonA-l	HGNC:20320	OMIM:612408	PSPC1	9		
FBgn0015520	nonA-l	HGNC:7871	OMIM:300084	NONO	10	300967	300967[INTELLECTUAL DEVELOPMENTAL DISORDER, X-LINKED, SYNDROMIC 34; MRXS34]
FBgn0015520	nonA-l	HGNC:10774	OMIM:605199	SFPQ	11		
FBgn0038453	Arl6IP1	HGNC:697	OMIM:607669	ARL6IP1	14	615685	615685[SPASTIC PARAPLEGIA 61, AUTOSOMAL RECESSIVE; SPG61]
FBgn0015019	CCT3	HGNC:1616	OMIM:600114	CCT3	14		
FBgn0015230	Glut3	HGNC:11011	OMIM:606813	SLC2A6	5		
FBgn0015230	Glut3	HGNC:13812	OMIM:605245	SLC2A8	6		
FBgn0015230	Glut3	HGNC:11006	OMIM:138160	SLC2A2	3	125853,227810	125853[TYPE 2 DIABETES MELLITUS; T2D],227810[FANCONI-BICKEL SYNDROME; FBS]
FBgn0015230	Glut3	HGNC:18067	OMIM:610372	SLC2A12	3		
FBgn0015230	Glut3	HGNC:13444	OMIM:606145	SLC2A10	3	208050	208050[ARTERIAL TORTUOSITY SYNDROME; ATORS]
FBgn0063261	CG31275	HGNC:15467	OMIM:607168	DYNLRB2	6		
FBgn0063261	CG31275	HGNC:15468	OMIM:607167	DYNLRB1	5		
FBgn0003944	Ubx	HGNC:5117	OMIM:142961	HOXB6	3		
FBgn0015351	Mettl4	HGNC:24726	OMIM:619626	METTL4	9		
FBgn0038454	CG10324	HGNC:30677	OMIM:301003	GPKOW	13		
FBgn0038452	CG14905	HGNC:26560	OMIM:615038	CCDC114	6	615067	615067[CILIARY DYSKINESIA, PRIMARY, 20; CILD20]
FBgn0038452	CG14905	HGNC:26669	OMIM:617969	CCDC63	13		
FBgn0022344	CG10340	HGNC:18803	OMIM:608917	ATPAF1	14		
FBgn0027562	CG10345	HGNC:1663	OMIM:173510	CD36	4	608404,610938,611162	608404[PLATELET GLYCOPROTEIN IV DEFICIENCY],610938[CORONARY HEART DISEASE, SUSCEPTIBILITY TO, 7; CHDS7],611162[MALARIA, SUSCEPTIBILITY TO]
FBgn0027562	CG10345	HGNC:1664	OMIM:601040	SCARB1	5	610762	610762[HIGH DENSITY LIPOPROTEIN CHOLESTEROL LEVEL QUANTITATIVE TRAIT LOCUS 6; HDLCQ6]
FBgn0027562	CG10345	HGNC:1665	OMIM:602257	SCARB2	4	254900	254900[EPILEPSY, PROGRESSIVE MYOCLONIC, 4, WITH OR WITHOUT RENAL FAILURE; EPM4]
FBgn0038458	VhaM9.7-d	HGNC:863	OMIM:603931	ATP6V0E1	10		
FBgn0038458	VhaM9.7-d	HGNC:21723	OMIM:611019	ATP6V0E2	8		
FBgn0038463	CG3534	HGNC:12839	OMIM:604049	XYLB	15		
FBgn0038466	CG8907	HGNC:21295	OMIM:614987	EPS8L1	9		
FBgn0038466	CG8907	HGNC:21297	OMIM:614989	EPS8L3	8	612841	612841[HYPOTRICHOSIS 5; HYPT5]
FBgn0038466	CG8907	HGNC:21296	OMIM:614988	EPS8L2	12	617637	617637[DEAFNESS, AUTOSOMAL RECESSIVE 106; DFNB106]
FBgn0038466	CG8907	HGNC:3420	OMIM:600206	EPS8	10	615974	615974[DEAFNESS, AUTOSOMAL RECESSIVE 102; DFNB102]
FBgn0038467	AdSL	HGNC:291	OMIM:608222	ADSL	14	103050	103050[ADENYLOSUCCINASE DEFICIENCY; ADSLD]
FBgn0038462	EMC2A	HGNC:28963	OMIM:607722	EMC2	14		
FBgn0038461	EMC2B	HGNC:28963	OMIM:607722	EMC2	12		
FBgn0015011	AhcyL2	HGNC:22204	OMIM:616520	AHCYL2	11		
FBgn0015011	AhcyL2	HGNC:344	OMIM:607826	AHCYL1	10		
FBgn0015011	AhcyL2	HGNC:343	OMIM:180960	AHCY	3	613752	613752[HYPERMETHIONINEMIA WITH S-ADENOSYLHOMOCYSTEINE HYDROLASE DEFICIENCY]
FBgn0015008	Actn3	HGNC:30615	OMIM:608793	SPECC1	3		
FBgn0015008	Actn3	HGNC:32394	OMIM:613664	SMTNL1	3		
FBgn0000015	Abd-B	HGNC:5120	OMIM:142964	HOXB9	4		
FBgn0000015	Abd-B	HGNC:5101	OMIM:142958	HOXA11	4	605432	605432[RADIOULNAR SYNOSTOSIS WITH AMEGAKARYOCYTIC THROMBOCYTOPENIA 1; RUSAT1]
FBgn0000015	Abd-B	HGNC:5133	OMIM:142984	HOXD10	4	192950	192950[VERTICAL TALUS, CONGENITAL; CVT]
FBgn0000015	Abd-B	HGNC:5122	OMIM:605560	HOXC10	3		
FBgn0000015	Abd-B	HGNC:5123	OMIM:605559	HOXC11	4		
FBgn0000015	Abd-B	HGNC:5134	OMIM:142986	HOXD11	4		
FBgn0000015	Abd-B	HGNC:5130	OMIM:142971	HOXC9	4		
FBgn0000015	Abd-B	HGNC:5140	OMIM:142982	HOXD9	3		
FBgn0000015	Abd-B	HGNC:5124	OMIM:142975	HOXC12	3		
FBgn0000015	Abd-B	HGNC:5109	OMIM:142956	HOXA9	4		
FBgn0000015	Abd-B	HGNC:5100	OMIM:142957	HOXA10	4		
FBgn0000014	abd-A	HGNC:5128	OMIM:142972	HOXC6	3		
FBgn0000014	abd-A	HGNC:5107	OMIM:142951	HOXA6	3		
FBgn0000014	abd-A	HGNC:5117	OMIM:142961	HOXB6	3		
FBgn0038471	Trm7-32	HGNC:13254	OMIM:300499	FTSJ1	13	309549	309549[INTELLECTUAL DEVELOPMENTAL DISORDER, X-LINKED 9; XLID9]
FBgn0051269	CG31269	HGNC:6359	OMIM:604434	KLK11	3		
FBgn0038486	CG5265	HGNC:2342	OMIM:600184	CRAT	10	617917	617917[NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 8; NBIA8]
FBgn0038486	CG5265	HGNC:1912	OMIM:118490	CHAT	4	254210	254210[MYASTHENIC SYNDROME, CONGENITAL, 6, PRESYNAPTIC; CMS6]
FBgn0038490	Smug	HGNC:17148	OMIM:607753	SMUG1	15		
FBgn0038491	CG5292	HGNC:21172	OMIM:615388	ADAT2	14		
FBgn0051262	CG31262	HGNC:11041	OMIM:604024	SLC5A6	4	618973,619903	618973[SODIUM-DEPENDENT MULTIVITAMIN TRANSPORTER DEFICIENCY; SMVTD],619903[PERIPHERAL MOTOR NEUROPATHY, CHILDHOOD-ONSET, BIOTIN-RESPONSIVE; COMNB]
FBgn0051262	CG31262	HGNC:11040	OMIM:601843	SLC5A5	6	274400	274400[THYROID DYSHORMONOGENESIS 1; TDH1]
FBgn0051262	CG31262	HGNC:28750	OMIM:612455	SLC5A12	6		
FBgn0051262	CG31262	HGNC:19119	OMIM:608044	SLC5A8	6		
FBgn0051262	CG31262	HGNC:11036	OMIM:182380	SLC5A1	3	606824	606824[GLUCOSE/GALACTOSE MALABSORPTION; GGM]
FBgn0051262	CG31262	HGNC:11037	OMIM:182381	SLC5A2	3	233100	233100[RENAL GLUCOSURIA; GLYS]
FBgn0051262	CG31262	HGNC:11038	OMIM:600444	SLC5A3	3		
FBgn0051262	CG31262	HGNC:11039	OMIM:618633	SLC5A4	3		
FBgn0051262	CG31262	HGNC:23091	OMIM:610238	SLC5A11	3		
FBgn0051262	CG31262	HGNC:23155	OMIM:618636	SLC5A10	3		
FBgn0051262	CG31262	HGNC:22146		SLC5A9	3		
FBgn0038488	m-cup	HGNC:16933	OMIM:608767	FEM1C	3		
FBgn0038488	m-cup	HGNC:16934	OMIM:613538	FEM1A	3		
FBgn0038488	m-cup	HGNC:3649	OMIM:613539	FEM1B	4		
FBgn0038475	Keap1	HGNC:23177	OMIM:606016	KEAP1	13		
FBgn0038473	Ns1	HGNC:25553	OMIM:300873	GNL3L	13		
FBgn0038473	Ns1	HGNC:29931	OMIM:608011	GNL3	8		
FBgn0038469	CG4009	HGNC:14966	OMIM:605158	PXDN	3	269400	269400[ANTERIOR SEGMENT DYSGENESIS 7; ASGD7]
FBgn0038469	CG4009	HGNC:12015	OMIM:606765	TPO	3	274500	274500[THYROID DYSHORMONOGENESIS 2A; TDH2A]
FBgn0038469	CG4009	HGNC:26359	OMIM:615904	PXDNL	3		
FBgn0038469	CG4009	HGNC:6678	OMIM:150205	LPO	3		
FBgn0038469	CG4009	HGNC:7218	OMIM:606989	MPO	3	104300,254600	104300[ALZHEIMER DISEASE, FAMILIAL, 1; AD1],254600[MYELOPEROXIDASE DEFICIENCY; MPOD]
FBgn0038469	CG4009	HGNC:3423	OMIM:131399	EPX	3	261500	261500[EOSINOPHIL PEROXIDASE DEFICIENCY; EPXD]
FBgn0038469	CG4009	HGNC:9605	OMIM:600262	PTGS2	3		
FBgn0038469	CG4009	HGNC:9604	OMIM:176805	PTGS1	4		
FBgn0028992	sds22	HGNC:9295	OMIM:602877	PPP1R7	11		
FBgn0038505	CG17283	HGNC:2530	OMIM:116890	CTSE	3		
FBgn0038505	CG17283	HGNC:8887	OMIM:169730	PGA5	3		
FBgn0038505	CG17283	HGNC:8886	OMIM:169720	PGA4	3		
FBgn0038505	CG17283	HGNC:9958	OMIM:179820	REN	5	267430,613092	267430[RENAL TUBULAR DYSGENESIS; RTD],613092[TUBULOINTERSTITIAL KIDNEY DISEASE, AUTOSOMAL DOMINANT, 4; ADTKD4]
FBgn0038505	CG17283	HGNC:8890	OMIM:169740	PGC	3		
FBgn0038505	CG17283	HGNC:13395	OMIM:605631	NAPSA	5		
FBgn0038505	CG17283	HGNC:2529	OMIM:116840	CTSD	4	610127	610127[CEROID LIPOFUSCINOSIS, NEURONAL, 10; CLN10]
FBgn0038506	CG5860	HGNC:2530	OMIM:116890	CTSE	5		
FBgn0038506	CG5860	HGNC:8887	OMIM:169730	PGA5	4		
FBgn0038506	CG5860	HGNC:8886	OMIM:169720	PGA4	3		
FBgn0038506	CG5860	HGNC:9958	OMIM:179820	REN	5	267430,613092	267430[RENAL TUBULAR DYSGENESIS; RTD],613092[TUBULOINTERSTITIAL KIDNEY DISEASE, AUTOSOMAL DOMINANT, 4; ADTKD4]
FBgn0038506	CG5860	HGNC:8890	OMIM:169740	PGC	4		
FBgn0038506	CG5860	HGNC:13395	OMIM:605631	NAPSA	5		
FBgn0038506	CG5860	HGNC:2529	OMIM:116840	CTSD	4	610127	610127[CEROID LIPOFUSCINOSIS, NEURONAL, 10; CLN10]
FBgn0038507	CG5863	HGNC:2530	OMIM:116890	CTSE	5		
FBgn0038507	CG5863	HGNC:8887	OMIM:169730	PGA5	4		
FBgn0038507	CG5863	HGNC:8886	OMIM:169720	PGA4	4		
FBgn0038507	CG5863	HGNC:9958	OMIM:179820	REN	5	267430,613092	267430[RENAL TUBULAR DYSGENESIS; RTD],613092[TUBULOINTERSTITIAL KIDNEY DISEASE, AUTOSOMAL DOMINANT, 4; ADTKD4]
FBgn0038507	CG5863	HGNC:8890	OMIM:169740	PGC	4		
FBgn0038507	CG5863	HGNC:13395	OMIM:605631	NAPSA	5		
FBgn0038507	CG5863	HGNC:2529	OMIM:116840	CTSD	4	610127	610127[CEROID LIPOFUSCINOSIS, NEURONAL, 10; CLN10]
FBgn0038511	cysu	HGNC:14966	OMIM:605158	PXDN	3	269400	269400[ANTERIOR SEGMENT DYSGENESIS 7; ASGD7]
FBgn0038511	cysu	HGNC:12015	OMIM:606765	TPO	3	274500	274500[THYROID DYSHORMONOGENESIS 2A; TDH2A]
FBgn0038511	cysu	HGNC:26359	OMIM:615904	PXDNL	3		
FBgn0038511	cysu	HGNC:6678	OMIM:150205	LPO	3		
FBgn0038511	cysu	HGNC:7218	OMIM:606989	MPO	3	104300,254600	104300[ALZHEIMER DISEASE, FAMILIAL, 1; AD1],254600[MYELOPEROXIDASE DEFICIENCY; MPOD]
FBgn0038511	cysu	HGNC:3423	OMIM:131399	EPX	4	261500	261500[EOSINOPHIL PEROXIDASE DEFICIENCY; EPXD]
FBgn0038504	Sur-8	HGNC:15454	OMIM:602775	SHOC2	14	607721	607721[NOONAN SYNDROME-LIKE DISORDER WITH LOOSE ANAGEN HAIR 1; NSLH1]
FBgn0038499	Brf	HGNC:11551	OMIM:604902	BRF1	14	616202	616202[CEREBELLOFACIODENTAL SYNDROME; CFDS]
FBgn0038516	P5cr-2	HGNC:9721	OMIM:179035	PYCR1	10	612940,614438	612940[CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IIB; ARCL2B],614438[CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IIIB; ARCL3B]
FBgn0038516	P5cr-2	HGNC:30262	OMIM:616406	PYCR2	9	616420	616420[LEUKODYSTROPHY, HYPOMYELINATING, 10; HLD10]
FBgn0038516	P5cr-2	HGNC:25846	OMIM:616408	PYCR3	12		
FBgn0025571	SF1	HGNC:12950	OMIM:601516	SF1	13		
FBgn0038524	sll	HGNC:16872	OMIM:610788	SLC35B2	12		
FBgn0038524	sll	HGNC:20798	OMIM:610790	SLC35B1	5		
FBgn0038531	CG14325	HGNC:11693	OMIM:186975	TCTE1	13		
FBgn0000063	Mps1	HGNC:12401	OMIM:604092	TTK	10		
FBgn0038536	CG7655	HGNC:8003	OMIM:620017	NRM	14		
FBgn0051249	CG31249	HGNC:23169	OMIM:610858	RTRAF	14		
FBgn0051251	CG31251	HGNC:22208	OMIM:610296	NUDCD3	12		
FBgn0038533	CG7523	HGNC:26775		TMEM192	13		
FBgn0038519	Prx3	HGNC:17169	OMIM:300927	PRDX4	5		
FBgn0038519	Prx3	HGNC:9352	OMIM:176763	PRDX1	4	277400	277400[METHYLMALONIC ACIDURIA AND HOMOCYSTINURIA, cblC TYPE; MAHCC]
FBgn0038519	Prx3	HGNC:9354	OMIM:604769	PRDX3	13	619862,619871	619862[SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 32; SCAR32],619871[CORNEAL DYSTROPHY, PUNCTIFORM AND POLYCHROMATIC PRE-DESCEMET; PPPCD]
FBgn0038519	Prx3	HGNC:9353	OMIM:600538	PRDX2	4		
FBgn0010926	l(3)07882	HGNC:16821	OMIM:611526	NOP14	14		
FBgn0038515	CG5823	HGNC:19268	OMIM:619756	UBE2J2	13		
FBgn0016650	Lgr1	HGNC:3969	OMIM:136435	FSHR	12	233300,276400,608115	233300[OVARIAN DYSGENESIS 1; ODG1],276400[TWINNING, DIZYGOTIC],608115[OVARIAN HYPERSTIMULATION SYNDROME; OHSS]
FBgn0016650	Lgr1	HGNC:12373	OMIM:603372	TSHR	11	275200,603373,609152	275200[HYPOTHYROIDISM, CONGENITAL, NONGOITROUS, 1; CHNG1],603373[HYPERTHYROIDISM, FAMILIAL GESTATIONAL],609152[HYPERTHYROIDISM, NONAUTOIMMUNE]
FBgn0016650	Lgr1	HGNC:6585	OMIM:152790	LHCGR	14	176410,238320	176410[PRECOCIOUS PUBERTY, MALE-LIMITED],238320[LEYDIG CELL HYPOPLASIA, TYPE I]
FBgn0038552	Alg1	HGNC:18294	OMIM:605907	ALG1	13	608540	608540[CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Ik; CDG1K]
FBgn0038552	Alg1	HGNC:33721		ALG1L	6		
FBgn0038552	Alg1	HGNC:37258		ALG1L2	6		
FBgn0038546	CG7379	HGNC:6063	OMIM:604215	ING2	10		
FBgn0038546	CG7379	HGNC:19421	OMIM:608525	ING5	4		
FBgn0038546	CG7379	HGNC:6062	OMIM:601566	ING1	11	275355	275355[SQUAMOUS CELL CARCINOMA, HEAD AND NECK; HNSCC]
FBgn0038546	CG7379	HGNC:19423	OMIM:608524	ING4	5		
FBgn0038546	CG7379	HGNC:14587	OMIM:607493	ING3	4		
FBgn0038539	Atg8b	HGNC:13291	OMIM:607452	GABARAPL2	4		
FBgn0038539	Atg8b	HGNC:13353	OMIM:609605	MAP1LC3C	3		
FBgn0038539	Atg8b	HGNC:4067	OMIM:605125	GABARAP	8		
FBgn0038539	Atg8b	HGNC:4068	OMIM:607420	GABARAPL1	4		
FBgn0000477	DNaseII	HGNC:28875	OMIM:608057	DNASE2B	11		
FBgn0000477	DNaseII	HGNC:2960	OMIM:126350	DNASE2	12	619858	619858[AUTOINFLAMMATORY-PANCYTOPENIA SYNDROME; AIPCS]
FBgn0038564	CG7785	HGNC:14297	OMIM:607866	SPRYD7	14		
FBgn0038565	CG7794	HGNC:12408	OMIM:602528	TUBA3C	3		
FBgn0038565	CG7794	HGNC:24071	OMIM:617878	TUBA3D	3	617928	617928[KERATOCONUS 9; KTCN9]
FBgn0038565	CG7794	HGNC:20768		TUBA1C	3		
FBgn0038565	CG7794	HGNC:12407	OMIM:191110	TUBA4A	3	616208	616208[AMYOTROPHIC LATERAL SCLEROSIS 22 WITH OR WITHOUT FRONTOTEMPORAL DEMENTIA; ALS22]
FBgn0038565	CG7794	HGNC:18809	OMIM:602530	TUBA1B	3		
FBgn0038565	CG7794	HGNC:20766	OMIM:602529	TUBA1A	3	611603	611603[LISSENCEPHALY 3; LIS3]
FBgn0038565	CG7794	HGNC:23534		TUBAL3	4		
FBgn0003499	sr	HGNC:3239	OMIM:129010	EGR2	6	145900,605253,607678	145900[HYPERTROPHIC NEUROPATHY OF DEJERINE-SOTTAS],605253[NEUROPATHY, CONGENITAL HYPOMYELINATING, 1, AUTOSOMAL RECESSIVE; CHN1],607678[CHARCOT-MARIE-TOOTH DISEASE, DEMYELINATING, TYPE 1D; CMT1D]
FBgn0003499	sr	HGNC:3238	OMIM:128990	EGR1	5		
FBgn0003499	sr	HGNC:3240	OMIM:602419	EGR3	5		
FBgn0010389	htl	HGNC:3691	OMIM:134935	FGFR4	11		
FBgn0010389	htl	HGNC:3688	OMIM:136350	FGFR1	11	101600,123150,147950,166250,190440,613001,615465	101600[PFEIFFER SYNDROME],123150[JACKSON-WEISS SYNDROME; JWS],147950[HYPOGONADOTROPIC HYPOGONADISM 2 WITH OR WITHOUT ANOSMIA; HH2],166250[OSTEOGLOPHONIC DYSPLASIA; OGD],190440[TRIGONOCEPHALY 1; TRIGNO1],613001[ENCEPHALOCRANIOCUTANEOUS LIPOMATOSIS; ECCL],615465[HARTSFIELD SYNDROME; HRTFDS]
FBgn0010389	htl	HGNC:3690	OMIM:134934	FGFR3	14	100800,109800,114500,146000,149730,162900,187600,187601,273300,602849,603956,610474,612247,616482	100800[ACHONDROPLASIA; ACH],109800[BLADDER CANCER],114500[COLORECTAL CANCER; CRC],146000[HYPOCHONDROPLASIA; HCH],149730[LACRIMOAURICULODENTODIGITAL SYNDROME; LADD],162900[NEVUS, EPIDERMAL],187600[THANATOPHORIC DYSPLASIA, TYPE I; TD1],187601[THANATOPHORIC DYSPLASIA, TYPE II; TD2],273300[TESTICULAR GERM CELL TUMOR; TGCT],602849[MUENKE SYNDROME; MNKES],603956[CERVICAL CANCER],610474[CAMPTODACTYLY, TALL STATURE, AND HEARING LOSS SYNDROME; CATSHLS],612247[CROUZON SYNDROME WITH ACANTHOSIS NIGRICANS; CAN],616482[ACHONDROPLASIA, SEVERE, WITH DEVELOPMENTAL DELAY AND ACANTHOSIS NIGRICANS; SADDAN]
FBgn0010389	htl	HGNC:3689	OMIM:176943	FGFR2	10	101200,101400,101600,123150,123500,123790,149730,207410,609579,613659,614592	101200[APERT SYNDROME],101400[SAETHRE-CHOTZEN SYNDROME; SCS],101600[PFEIFFER SYNDROME],123150[JACKSON-WEISS SYNDROME; JWS],123500[CROUZON SYNDROME],123790[BEARE-STEVENSON CUTIS GYRATA SYNDROME; BSTVS],149730[LACRIMOAURICULODENTODIGITAL SYNDROME; LADD],207410[ANTLEY-BIXLER SYNDROME WITHOUT GENITAL ANOMALIES OR DISORDERED STEROIDOGENESIS; ABS2],609579[SCAPHOCEPHALY, MAXILLARY RETRUSION, AND MENTAL RETARDATION],613659[GASTRIC CANCER],614592[BENT BONE DYSPLASIA SYNDROME; BBDS]
FBgn0022943	Cbp20	HGNC:7659	OMIM:605133	NCBP2	14		
FBgn0022943	Cbp20	HGNC:31795		NCBP2L	6		
FBgn0042693	wrd	HGNC:9312	OMIM:601646	PPP2R5D	13	616355	616355[INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL DOMINANT 35; MRD35]
FBgn0042693	wrd	HGNC:9313	OMIM:601647	PPP2R5E	4		
FBgn0042693	wrd	HGNC:9311	OMIM:601645	PPP2R5C	12		
FBgn0042693	wrd	HGNC:9309	OMIM:601643	PPP2R5A	5		
FBgn0042693	wrd	HGNC:9310	OMIM:601644	PPP2R5B	5		
FBgn0038576	Arp5	HGNC:14671	OMIM:619730	ACTR5	15		
FBgn0038578	MED17	HGNC:2375	OMIM:603810	MED17	14	613668	613668[MICROCEPHALY, POSTNATAL PROGRESSIVE, WITH SEIZURES AND BRAIN ATROPHY]
FBgn0028499	CG7985	HGNC:26307	OMIM:616864	HEXD	14		
FBgn0038582	CG7988	HGNC:33910	OMIM:602254	SRRD	14		
FBgn0038585	Non3	HGNC:20870	OMIM:618471	RPF2	14		
FBgn0020238	14-3-3epsilon	HGNC:12855	OMIM:601288	YWHAZ	4		
FBgn0020238	14-3-3epsilon	HGNC:12849	OMIM:601289	YWHAB	4		
FBgn0020238	14-3-3epsilon	HGNC:12851	OMIM:605066	YWHAE	14		
FBgn0038592	CG18599	HGNC:31839		NOTO	4		
FBgn0026250	eIF1A	HGNC:3250	OMIM:300186	EIF1AX	12		
FBgn0026250	eIF1A	HGNC:3252	OMIM:400014	EIF1AY	13		
FBgn0038597	CG8064	HGNC:12755	OMIM:604737	WDR3	14		
FBgn0024432	Dlc90F	HGNC:11694	OMIM:300302	DYNLT3	7		
FBgn0024432	Dlc90F	HGNC:11697	OMIM:601554	DYNLT1	15		
FBgn0038607	hmw	HGNC:29276	OMIM:616047	CFAP97	4		
FBgn0038609	Nup43	HGNC:21182	OMIM:608141	NUP43	14		
FBgn0038611	CG14309	HGNC:5164	OMIM:604724	HPSE	4		
FBgn0038611	CG14309	HGNC:18374	OMIM:613469	HPSE2	7	236730	236730[UROFACIAL SYNDROME 1; UFS1]
FBgn0038610	CG7675	HGNC:19979	OMIM:616796	RDH14	3		
FBgn0038610	CG7675	HGNC:17964	OMIM:607849	RDH11	4	616108	616108[RETINAL DYSTROPHY, JUVENILE CATARACTS, AND SHORT STATURE SYNDROME; RDJCSS]
FBgn0038610	CG7675	HGNC:19977	OMIM:608830	RDH12	4	612712	612712[LEBER CONGENITAL AMAUROSIS 13; LCA13]
FBgn0038610	CG7675	HGNC:28326	OMIM:616157	DHRS13	4		
FBgn0038610	CG7675	HGNC:19978		RDH13	4		
FBgn0038606	CG15803	HGNC:28881	OMIM:603199	PATJ	5		
FBgn0038606	CG15803	HGNC:7208	OMIM:603785	MPDZ	5	615219	615219[HYDROCEPHALUS, CONGENITAL, 2, WITH OR WITHOUT BRAIN OR EYE ANOMALIES; HYC2]
FBgn0038603	PKD	HGNC:9408	OMIM:607077	PRKD3	13		
FBgn0038603	PKD	HGNC:9407	OMIM:605435	PRKD1	13	617364	617364[CONGENITAL HEART DEFECTS AND ECTODERMAL DYSPLASIA; CHDED]
FBgn0038603	PKD	HGNC:17293	OMIM:607074	PRKD2	12		
FBgn0038601	Polr1E	HGNC:17631		POLR1E	7		
FBgn0038598	CG7131	HGNC:28566	OMIM:616292	SAXO1	7		
FBgn0038598	CG7131	HGNC:33727		SAXO2	9		
FBgn0038593	Vps39	HGNC:20593	OMIM:612188	VPS39	14		
FBgn0038590	CG12320	HGNC:15886	OMIM:617365	AAR2	11		
FBgn0038588	CG7156	HGNC:10439	OMIM:617517	RPS6KC1	10		
FBgn0038588	CG7156	HGNC:14978	OMIM:605964	SNX15	5		
FBgn0038588	CG7156	HGNC:20222		RPS6KL1	12		
FBgn0038586	CG7168	HGNC:24993	OMIM:616699	COMMD2	13		
FBgn0038583	CG7183	HGNC:28033	OMIM:616735	CCDC174	12	616816	616816[HYPOTONIA, INFANTILE, WITH PSYCHOMOTOR RETARDATION; IHPMR]
FBgn0011481	Ssdp	HGNC:15674	OMIM:607390	SSBP3	14		
FBgn0011481	Ssdp	HGNC:15676	OMIM:607391	SSBP4	12		
FBgn0011481	Ssdp	HGNC:15831	OMIM:607389	SSBP2	13		
FBgn0038577	CG12321	HGNC:24929	OMIM:609702	PSMG2	13	619183	619183[PROTEASOME-ASSOCIATED AUTOINFLAMMATORY SYNDROME 4; PRAAS4]
FBgn0038569	CG7218	HGNC:26887	OMIM:612758	TAPT1	13	616897	616897[OSTEOCHONDRODYSPLASIA, COMPLEX LETHAL, SYMOENS-BARNES-GISTELINCK TYPE; OCLSBG]
FBgn0038619	CG7685	HGNC:9411	OMIM:177060	PRKCSH	6	174050	174050[POLYCYSTIC LIVER DISEASE 1 WITH OR WITHOUT KIDNEY CYSTS; PCLD1]
FBgn0038627	CG7694	HGNC:21151	OMIM:615177	RNF126	3		
FBgn0038627	CG7694	HGNC:28037	OMIM:612490	RNF181	14		
FBgn0038627	CG7694	HGNC:18154	OMIM:619535	RNF115	3		
FBgn0038627	CG7694	HGNC:17481	OMIM:619341	PJA2	3		
FBgn0038627	CG7694	HGNC:16648	OMIM:300420	PJA1	3		
FBgn0038630	CG14305	HGNC:14968	OMIM:610709	TSSK1B	10		
FBgn0038630	CG14305	HGNC:11401	OMIM:610710	TSSK2	8		
FBgn0038630	CG14305	HGNC:30410	OMIM:610712	TSSK6	5		
FBgn0038630	CG14305	HGNC:15473	OMIM:607660	TSSK3	3		
FBgn0023083	fray	HGNC:17717	OMIM:607648	STK39	14		
FBgn0023083	fray	HGNC:8508	OMIM:604046	OXSR1	13		
FBgn0051122	CG31122	HGNC:26799	OMIM:619219	C2orf69	13	619423	619423[COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 53; COXPD53]
FBgn0038621	CG10864	HGNC:6277	OMIM:603219	KCNK2	3		
FBgn0038621	CG10864	HGNC:19439	OMIM:613655	KCNK18	9	613656	613656[MIGRAINE WITH OR WITHOUT AURA, SUSCEPTIBILITY TO, 13; MGR13]
FBgn0038621	CG10864	HGNC:6274	OMIM:607366	KCNK12	3		
FBgn0038617	Wdr37	HGNC:31406	OMIM:618586	WDR37	14	618652	618652[NEUROOCULOCARDIOGENITOURINARY SYNDROME; NOCGUS]
FBgn0028670	Vha100-2	HGNC:865	OMIM:192130	ATP6V0A1	8	619970,619971	619970[DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 104; DEE104],619971[NEURODEVELOPMENTAL DISORDER WITH EPILEPSY AND BRAIN ATROPHY; NEDEBA]
FBgn0028670	Vha100-2	HGNC:18481	OMIM:611716	ATP6V0A2	6	219200,278250	219200[CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IIA; ARCL2A],278250[WRINKLY SKIN SYNDROME; WSS]
FBgn0028670	Vha100-2	HGNC:866	OMIM:605239	ATP6V0A4	9	602722	602722[RENAL TUBULAR ACIDOSIS, DISTAL, 3, WITH OR WITHOUT SENSORINEURAL HEARING LOSS; DRTA3]
FBgn0028670	Vha100-2	HGNC:11647	OMIM:604592	TCIRG1	5	259700	259700[OSTEOPETROSIS, AUTOSOMAL RECESSIVE 1; OPTB1]
FBgn0038613	Vha100-4	HGNC:865	OMIM:192130	ATP6V0A1	6	619970,619971	619970[DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 104; DEE104],619971[NEURODEVELOPMENTAL DISORDER WITH EPILEPSY AND BRAIN ATROPHY; NEDEBA]
FBgn0038613	Vha100-4	HGNC:18481	OMIM:611716	ATP6V0A2	6	219200,278250	219200[CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IIA; ARCL2A],278250[WRINKLY SKIN SYNDROME; WSS]
FBgn0038613	Vha100-4	HGNC:866	OMIM:605239	ATP6V0A4	7	602722	602722[RENAL TUBULAR ACIDOSIS, DISTAL, 3, WITH OR WITHOUT SENSORINEURAL HEARING LOSS; DRTA3]
FBgn0038613	Vha100-4	HGNC:11647	OMIM:604592	TCIRG1	6	259700	259700[OSTEOPETROSIS, AUTOSOMAL RECESSIVE 1; OPTB1]
FBgn0044871	Gos28	HGNC:4430	OMIM:604026	GOSR1	14		
FBgn0051229	CG31229	HGNC:17317	OMIM:607251	TIMM22	15	618851	618851[COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 43; COXPD43]
FBgn0038640	CG7706	HGNC:13813	OMIM:602655	SLC4A1AP	12		
FBgn0038641	ChT	HGNC:14025	OMIM:608761	SLC5A7	13	158580,617143	158580[NEURONOPATHY, DISTAL HEREDITARY MOTOR, TYPE VIIA; HMN7A],617143[MYASTHENIC SYNDROME, CONGENITAL, 20, PRESYNAPTIC; CMS20]
FBgn0038653	Octalpha2R	HGNC:281	OMIM:104210	ADRA2A	7		
FBgn0038653	Octalpha2R	HGNC:282	OMIM:104260	ADRA2B	6		
FBgn0038653	Octalpha2R	HGNC:283	OMIM:104250	ADRA2C	5		
FBgn0038652	CG7720	HGNC:11041	OMIM:604024	SLC5A6	5	618973,619903	618973[SODIUM-DEPENDENT MULTIVITAMIN TRANSPORTER DEFICIENCY; SMVTD],619903[PERIPHERAL MOTOR NEUROPATHY, CHILDHOOD-ONSET, BIOTIN-RESPONSIVE; COMNB]
FBgn0038652	CG7720	HGNC:11040	OMIM:601843	SLC5A5	4	274400	274400[THYROID DYSHORMONOGENESIS 1; TDH1]
FBgn0038652	CG7720	HGNC:28750	OMIM:612455	SLC5A12	4		
FBgn0038652	CG7720	HGNC:19119	OMIM:608044	SLC5A8	4		
FBgn0038649	PGS1	HGNC:30029	OMIM:614942	PGS1	14		
FBgn0024329	Mekk1	HGNC:6856	OMIM:602425	MAP3K4	13		
FBgn0038655	CG14297	HGNC:122	OMIM:171500	ACP1	5		
FBgn0003248	Rh2	HGNC:14449	OMIM:606665	OPN4	11		
FBgn0038659	EndoA	HGNC:10831	OMIM:604465	SH3GL2	12		
FBgn0038659	EndoA	HGNC:10832	OMIM:603362	SH3GL3	15		
FBgn0038659	EndoA	HGNC:10830	OMIM:601768	SH3GL1	12	601626	601626[LEUKEMIA, ACUTE MYELOID; AML]
FBgn0022338	dnk	HGNC:11831	OMIM:188250	TK2	15	609560,617069	609560[MITOCHONDRIAL DNA DEPLETION SYNDROME 2 (MYOPATHIC TYPE); MTDPS2],617069[PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL RECESSIVE 3; PEOB3]
FBgn0038673	CG14286	HGNC:26104		C8orf33	8		
FBgn0027785	NP15.6	HGNC:20372	OMIM:300403	NDUFB11	12	300952,301021	300952[LINEAR SKIN DEFECTS WITH MULTIPLE CONGENITAL ANOMALIES 3; LSDMCA3],301021[MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 30; MC1DN30]
FBgn0015781	P5cr	HGNC:9721	OMIM:179035	PYCR1	5	612940,614438	612940[CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IIB; ARCL2B],614438[CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IIIB; ARCL3B]
FBgn0015781	P5cr	HGNC:30262	OMIM:616406	PYCR2	3	616420	616420[LEUKODYSTROPHY, HYPOMYELINATING, 10; HLD10]
FBgn0015781	P5cr	HGNC:25846	OMIM:616408	PYCR3	7		
FBgn0038675	CG6013	HGNC:25171		CCDC124	14		
FBgn0004876	cdi	HGNC:11731	OMIM:601782	TESK1	6		
FBgn0004876	cdi	HGNC:11732	OMIM:604746	TESK2	8		
FBgn0027784	Prp18	HGNC:17351	OMIM:604993	PRPF18	15		
FBgn0038672	CG6005	HGNC:24997	OMIM:616303	WDR91	9		
FBgn0038666	Smu1	HGNC:18247	OMIM:617811	SMU1	14		
FBgn0038665	euc	HGNC:16211		SCP2D1	3		
FBgn0038662	Mpc1	HGNC:21606	OMIM:614738	MPC1	14	614741	614741[MITOCHONDRIAL PYRUVATE CARRIER DEFICIENCY; MPYCD]
FBgn0038662	Mpc1	HGNC:44205		MPC1L	4		
FBgn0038660	Sgsh	HGNC:10818	OMIM:605270	SGSH	14	252900	252900[MUCOPOLYSACCHARIDOSIS, TYPE IIIA; MPS3A]
FBgn0016120	ATPsynD	HGNC:845	OMIM:618121	ATP5PD	15		
FBgn0038680	Cyp12a5	HGNC:2606	OMIM:609506	CYP27B1	4	264700	264700[VITAMIN D HYDROXYLATION-DEFICIENT RICKETS, TYPE 1A; VDDR1A]
FBgn0038680	Cyp12a5	HGNC:33480		CYP27C1	5		
FBgn0038680	Cyp12a5	HGNC:2605	OMIM:606530	CYP27A1	5	213700	213700[CEREBROTENDINOUS XANTHOMATOSIS; CTX]
FBgn0038680	Cyp12a5	HGNC:2602	OMIM:126065	CYP24A1	6	143880	143880[HYPERCALCEMIA, INFANTILE, 1; HCINF1]
FBgn0038681	Cyp12a4	HGNC:2606	OMIM:609506	CYP27B1	4	264700	264700[VITAMIN D HYDROXYLATION-DEFICIENT RICKETS, TYPE 1A; VDDR1A]
FBgn0038681	Cyp12a4	HGNC:33480		CYP27C1	4		
FBgn0038681	Cyp12a4	HGNC:2605	OMIM:606530	CYP27A1	4	213700	213700[CEREBROTENDINOUS XANTHOMATOSIS; CTX]
FBgn0038681	Cyp12a4	HGNC:2602	OMIM:126065	CYP24A1	7	143880	143880[HYPERCALCEMIA, INFANTILE, 1; HCINF1]
FBgn0002962	nos	HGNC:23044	OMIM:608226	NANOS1	9	615413	615413[SPERMATOGENIC FAILURE 12; SPGF12]
FBgn0002962	nos	HGNC:23292	OMIM:608228	NANOS2	8		
FBgn0002962	nos	HGNC:22048	OMIM:608229	NANOS3	7		
FBgn0010768	sqz	HGNC:18079		ZNF362	3		
FBgn0051475	myd	HGNC:24188	OMIM:614282	SDF4	14		
FBgn0025680	cry	HGNC:2384	OMIM:601933	CRY1	4	614163	614163[DELAYED SLEEP PHASE DISORDER, SUSCEPTIBILITY TO; DSPD]
FBgn0025680	cry	HGNC:2385	OMIM:603732	CRY2	5		
FBgn0038692	Polr2M	HGNC:14862	OMIM:606485	POLR2M	4		
FBgn0000463	Dl	HGNC:2910	OMIM:605185	DLL4	11	616589	616589[ADAMS-OLIVER SYNDROME 6; AOS6]
FBgn0000463	Dl	HGNC:2908	OMIM:606582	DLL1	13	618709	618709[NEURODEVELOPMENTAL DISORDER WITH NONSPECIFIC BRAIN ABNORMALITIES AND WITH OR WITHOUT SEIZURES; NEDBAS]
FBgn0038693	unc79	HGNC:19966	OMIM:616884	UNC79	14		
FBgn0038691	CG5250	HGNC:804	OMIM:182330	ATP1B1	5	145500	145500[HYPERTENSION, ESSENTIAL]
FBgn0038691	CG5250	HGNC:806	OMIM:601867	ATP1B3	3		
FBgn0038691	CG5250	HGNC:805	OMIM:182331	ATP1B2	3		
FBgn0038691	CG5250	HGNC:820	OMIM:137217	ATP4B	3		
FBgn0038691	CG5250	HGNC:808	OMIM:301073	ATP1B4	3		
FBgn0038690	CG11703	HGNC:804	OMIM:182330	ATP1B1	6	145500	145500[HYPERTENSION, ESSENTIAL]
FBgn0038690	CG11703	HGNC:806	OMIM:601867	ATP1B3	3		
FBgn0038690	CG11703	HGNC:805	OMIM:182331	ATP1B2	4		
FBgn0038690	CG11703	HGNC:820	OMIM:137217	ATP4B	3		
FBgn0038690	CG11703	HGNC:808	OMIM:301073	ATP1B4	4		
FBgn0038686	CG5555	HGNC:1099	OMIM:604986	BRAP	14		
FBgn0038678	mRpL55	HGNC:16686	OMIM:611859	MRPL55	11		
FBgn0038700	CG3734	HGNC:14892	OMIM:610537	DPP7	3		
FBgn0038700	CG3734	HGNC:9480	OMIM:607169	PRSS16	6		
FBgn0038701	CG18493	HGNC:9480	OMIM:607169	PRSS16	7		
FBgn0038702	CG3739	HGNC:9480	OMIM:607169	PRSS16	6		
FBgn0038704	CG5316	HGNC:15984	OMIM:606350	APTX	9	208920	208920[ATAXIA, EARLY-ONSET, WITH OCULOMOTOR APRAXIA AND HYPOALBUMINEMIA; EAOH]
FBgn0038705	CG11626	HGNC:14892	OMIM:610537	DPP7	3		
FBgn0038705	CG11626	HGNC:9480	OMIM:607169	PRSS16	4		
FBgn0038708	Scsalpha2	HGNC:11449	OMIM:611224	SUCLG1	11	245400	245400[MITOCHONDRIAL DNA DEPLETION SYNDROME 9 (ENCEPHALOMYOPATHIC TYPE WITH METHYLMALONIC ACIDURIA); MTDPS9]
FBgn0051244	CG31244	HGNC:24316	OMIM:612958	TACO1	6	619052	619052[MITOCHONDRIAL COMPLEX IV DEFICIENCY, NUCLEAR TYPE 8; MC4DN8]
FBgn0038715	CG7333	HGNC:8494	OMIM:604047	SLC22A13	4		
FBgn0038715	CG7333	HGNC:10970	OMIM:607582	SLC22A6	4		
FBgn0038715	CG7333	HGNC:20302	OMIM:608276	SLC22A16	4		
FBgn0038715	CG7333	HGNC:10968	OMIM:604190	SLC22A4	4	180300	180300[RHEUMATOID ARTHRITIS; RA]
FBgn0038715	CG7333	HGNC:10969	OMIM:603377	SLC22A5	4	212140	212140[CARNITINE DEFICIENCY, SYSTEMIC PRIMARY; CDSP]
FBgn0038715	CG7333	HGNC:8495	OMIM:604048	SLC22A14	4		
FBgn0038715	CG7333	HGNC:10971	OMIM:604995	SLC22A7	5		
FBgn0038715	CG7333	HGNC:10972	OMIM:607581	SLC22A8	4		
FBgn0038715	CG7333	HGNC:10966	OMIM:602608	SLC22A2	4		
FBgn0038715	CG7333	HGNC:21106	OMIM:611697	SLC22A23	3		
FBgn0038715	CG7333	HGNC:32935	OMIM:610792	SLC22A25	4		
FBgn0038715	CG7333	HGNC:10963	OMIM:602607	SLC22A1	4		
FBgn0038715	CG7333	HGNC:10967	OMIM:604842	SLC22A3	4		
FBgn0038715	CG7333	HGNC:23095	OMIM:611461	SLC22A17	3		
FBgn0038715	CG7333	HGNC:20301	OMIM:608275	SLC22A15	3		
FBgn0038715	CG7333	HGNC:17989	OMIM:607096	SLC22A12	4	220150	220150[HYPOURICEMIA, RENAL, 1; RHUC1]
FBgn0038715	CG7333	HGNC:27091		SLC22A31	3		
FBgn0038715	CG7333	HGNC:18120	OMIM:607097	SLC22A11	4		
FBgn0038715	CG7333	HGNC:16261	OMIM:607579	SLC22A9	4		
FBgn0038715	CG7333	HGNC:28542	OMIM:611698	SLC22A24	4		
FBgn0038715	CG7333	HGNC:18057	OMIM:607580	SLC22A10	4		
FBgn0038716	CG7342	HGNC:8494	OMIM:604047	SLC22A13	4		
FBgn0038716	CG7342	HGNC:10970	OMIM:607582	SLC22A6	4		
FBgn0038716	CG7342	HGNC:20302	OMIM:608276	SLC22A16	4		
FBgn0038716	CG7342	HGNC:10968	OMIM:604190	SLC22A4	4	180300	180300[RHEUMATOID ARTHRITIS; RA]
FBgn0038716	CG7342	HGNC:10969	OMIM:603377	SLC22A5	4	212140	212140[CARNITINE DEFICIENCY, SYSTEMIC PRIMARY; CDSP]
FBgn0038716	CG7342	HGNC:8495	OMIM:604048	SLC22A14	4		
FBgn0038716	CG7342	HGNC:10971	OMIM:604995	SLC22A7	5		
FBgn0038716	CG7342	HGNC:10972	OMIM:607581	SLC22A8	4		
FBgn0038716	CG7342	HGNC:10966	OMIM:602608	SLC22A2	4		
FBgn0038716	CG7342	HGNC:21106	OMIM:611697	SLC22A23	3		
FBgn0038716	CG7342	HGNC:32935	OMIM:610792	SLC22A25	4		
FBgn0038716	CG7342	HGNC:10963	OMIM:602607	SLC22A1	4		
FBgn0038716	CG7342	HGNC:10967	OMIM:604842	SLC22A3	4		
FBgn0038716	CG7342	HGNC:23095	OMIM:611461	SLC22A17	3		
FBgn0038716	CG7342	HGNC:20301	OMIM:608275	SLC22A15	3		
FBgn0038716	CG7342	HGNC:17989	OMIM:607096	SLC22A12	4	220150	220150[HYPOURICEMIA, RENAL, 1; RHUC1]
FBgn0038716	CG7342	HGNC:27091		SLC22A31	3		
FBgn0038716	CG7342	HGNC:18120	OMIM:607097	SLC22A11	4		
FBgn0038716	CG7342	HGNC:16261	OMIM:607579	SLC22A9	4		
FBgn0038716	CG7342	HGNC:28542	OMIM:611698	SLC22A24	4		
FBgn0038716	CG7342	HGNC:18057	OMIM:607580	SLC22A10	4		
FBgn0038718	CG17752	HGNC:8494	OMIM:604047	SLC22A13	4		
FBgn0038718	CG17752	HGNC:10970	OMIM:607582	SLC22A6	4		
FBgn0038718	CG17752	HGNC:20302	OMIM:608276	SLC22A16	4		
FBgn0038718	CG17752	HGNC:10968	OMIM:604190	SLC22A4	4	180300	180300[RHEUMATOID ARTHRITIS; RA]
FBgn0038718	CG17752	HGNC:10969	OMIM:603377	SLC22A5	4	212140	212140[CARNITINE DEFICIENCY, SYSTEMIC PRIMARY; CDSP]
FBgn0038718	CG17752	HGNC:8495	OMIM:604048	SLC22A14	4		
FBgn0038718	CG17752	HGNC:10971	OMIM:604995	SLC22A7	5		
FBgn0038718	CG17752	HGNC:10972	OMIM:607581	SLC22A8	4		
FBgn0038718	CG17752	HGNC:10966	OMIM:602608	SLC22A2	4		
FBgn0038718	CG17752	HGNC:21106	OMIM:611697	SLC22A23	3		
FBgn0038718	CG17752	HGNC:32935	OMIM:610792	SLC22A25	5		
FBgn0038718	CG17752	HGNC:10963	OMIM:602607	SLC22A1	4		
FBgn0038718	CG17752	HGNC:10967	OMIM:604842	SLC22A3	4		
FBgn0038718	CG17752	HGNC:23095	OMIM:611461	SLC22A17	3		
FBgn0038718	CG17752	HGNC:20301	OMIM:608275	SLC22A15	3		
FBgn0038718	CG17752	HGNC:17989	OMIM:607096	SLC22A12	4	220150	220150[HYPOURICEMIA, RENAL, 1; RHUC1]
FBgn0038718	CG17752	HGNC:27091		SLC22A31	3		
FBgn0038718	CG17752	HGNC:18120	OMIM:607097	SLC22A11	4		
FBgn0038718	CG17752	HGNC:16261	OMIM:607579	SLC22A9	4		
FBgn0038718	CG17752	HGNC:28542	OMIM:611698	SLC22A24	4		
FBgn0038718	CG17752	HGNC:18057	OMIM:607580	SLC22A10	4		
FBgn0038719	CG16727	HGNC:8494	OMIM:604047	SLC22A13	4		
FBgn0038719	CG16727	HGNC:10970	OMIM:607582	SLC22A6	4		
FBgn0038719	CG16727	HGNC:20302	OMIM:608276	SLC22A16	4		
FBgn0038719	CG16727	HGNC:10968	OMIM:604190	SLC22A4	4	180300	180300[RHEUMATOID ARTHRITIS; RA]
FBgn0038719	CG16727	HGNC:10969	OMIM:603377	SLC22A5	4	212140	212140[CARNITINE DEFICIENCY, SYSTEMIC PRIMARY; CDSP]
FBgn0038719	CG16727	HGNC:8495	OMIM:604048	SLC22A14	4		
FBgn0038719	CG16727	HGNC:10971	OMIM:604995	SLC22A7	5		
FBgn0038719	CG16727	HGNC:10972	OMIM:607581	SLC22A8	4		
FBgn0038719	CG16727	HGNC:10966	OMIM:602608	SLC22A2	4		
FBgn0038719	CG16727	HGNC:21106	OMIM:611697	SLC22A23	3		
FBgn0038719	CG16727	HGNC:32935	OMIM:610792	SLC22A25	4		
FBgn0038719	CG16727	HGNC:10963	OMIM:602607	SLC22A1	4		
FBgn0038719	CG16727	HGNC:10967	OMIM:604842	SLC22A3	4		
FBgn0038719	CG16727	HGNC:23095	OMIM:611461	SLC22A17	3		
FBgn0038719	CG16727	HGNC:20301	OMIM:608275	SLC22A15	3		
FBgn0038719	CG16727	HGNC:17989	OMIM:607096	SLC22A12	4	220150	220150[HYPOURICEMIA, RENAL, 1; RHUC1]
FBgn0038719	CG16727	HGNC:27091		SLC22A31	3		
FBgn0038719	CG16727	HGNC:18120	OMIM:607097	SLC22A11	4		
FBgn0038719	CG16727	HGNC:16261	OMIM:607579	SLC22A9	4		
FBgn0038719	CG16727	HGNC:28542	OMIM:611698	SLC22A24	5		
FBgn0038719	CG16727	HGNC:18057	OMIM:607580	SLC22A10	4		
FBgn0038722	Nup58	HGNC:20261	OMIM:607615	NUP58	12		
FBgn0003011	ort	HGNC:4328	OMIM:600421	GLRA3	4		
FBgn0003011	ort	HGNC:4329	OMIM:138492	GLRB	4	614619	614619[HYPEREKPLEXIA 2; HKPX2]
FBgn0003011	ort	HGNC:4327	OMIM:305990	GLRA2	4	301076	301076[INTELLECTUAL DEVELOPMENTAL DISORDER, X-LINKED, SYNDROMIC, PILORGE TYPE; MRXSP]
FBgn0003011	ort	HGNC:31715		GLRA4	5		
FBgn0003011	ort	HGNC:4326	OMIM:138491	GLRA1	3	149400	149400[HYPEREKPLEXIA 1; HKPX1]
FBgn0038725	CG6184	HGNC:29288	OMIM:617838	FAM234B	8		
FBgn0038725	CG6184	HGNC:14163		FAM234A	7		
FBgn0038723	CG6195	HGNC:3030	OMIM:602986	DRG2	15		
FBgn0038723	CG6195	HGNC:3029	OMIM:603952	DRG1	3		
FBgn0038721	subdued	HGNC:21625	OMIM:610108	ANO1	10		
FBgn0038721	subdued	HGNC:1183	OMIM:610109	ANO2	8		
FBgn0038721	subdued	HGNC:31677	OMIM:605096	ANO7	6		
FBgn0038721	subdued	HGNC:29329	OMIM:610216	ANO8	3		
FBgn0038721	subdued	HGNC:25240	OMIM:608663	ANO6	7	262890	262890[SCOTT SYNDROME; SCTS]
FBgn0038721	subdued	HGNC:27337	OMIM:608662	ANO5	9	166260,611307,613319	166260[GNATHODIAPHYSEAL DYSPLASIA; GDD],611307[MUSCULAR DYSTROPHY, LIMB-GIRDLE, AUTOSOMAL RECESSIVE 12; LGMDR12],613319[MIYOSHI MUSCULAR DYSTROPHY 3; MMD3]
FBgn0038721	subdued	HGNC:23837	OMIM:610111	ANO4	7		
FBgn0038721	subdued	HGNC:14004	OMIM:610110	ANO3	5	615034	615034[DYSTONIA 24; DYT24]
FBgn0038721	subdued	HGNC:20679	OMIM:619963	ANO9	4		
FBgn0038720	CG6231	HGNC:8494	OMIM:604047	SLC22A13	4		
FBgn0038720	CG6231	HGNC:10970	OMIM:607582	SLC22A6	4		
FBgn0038720	CG6231	HGNC:20302	OMIM:608276	SLC22A16	4		
FBgn0038720	CG6231	HGNC:10968	OMIM:604190	SLC22A4	4	180300	180300[RHEUMATOID ARTHRITIS; RA]
FBgn0038720	CG6231	HGNC:10969	OMIM:603377	SLC22A5	4	212140	212140[CARNITINE DEFICIENCY, SYSTEMIC PRIMARY; CDSP]
FBgn0038720	CG6231	HGNC:8495	OMIM:604048	SLC22A14	4		
FBgn0038720	CG6231	HGNC:10971	OMIM:604995	SLC22A7	5		
FBgn0038720	CG6231	HGNC:10972	OMIM:607581	SLC22A8	4		
FBgn0038720	CG6231	HGNC:10966	OMIM:602608	SLC22A2	4		
FBgn0038720	CG6231	HGNC:21106	OMIM:611697	SLC22A23	3		
FBgn0038720	CG6231	HGNC:32935	OMIM:610792	SLC22A25	4		
FBgn0038720	CG6231	HGNC:10963	OMIM:602607	SLC22A1	4		
FBgn0038720	CG6231	HGNC:10967	OMIM:604842	SLC22A3	4		
FBgn0038720	CG6231	HGNC:23095	OMIM:611461	SLC22A17	3		
FBgn0038720	CG6231	HGNC:20301	OMIM:608275	SLC22A15	3		
FBgn0038720	CG6231	HGNC:17989	OMIM:607096	SLC22A12	4	220150	220150[HYPOURICEMIA, RENAL, 1; RHUC1]
FBgn0038720	CG6231	HGNC:27091		SLC22A31	3		
FBgn0038720	CG6231	HGNC:18120	OMIM:607097	SLC22A11	4		
FBgn0038720	CG6231	HGNC:16261	OMIM:607579	SLC22A9	4		
FBgn0038720	CG6231	HGNC:28542	OMIM:611698	SLC22A24	4		
FBgn0038720	CG6231	HGNC:18057	OMIM:607580	SLC22A10	4		
FBgn0038735	MICU3	HGNC:27820	OMIM:610633	MICU3	14		
FBgn0038735	MICU3	HGNC:31830	OMIM:610632	MICU2	5		
FBgn0038737	Mrm2	HGNC:16352	OMIM:606906	MRM2	14	618567	618567[MITOCHONDRIAL DNA DEPLETION SYNDROME 17; MTDPS17]
FBgn0038739	CG4686	HGNC:28618	OMIM:617779	TMEM256	12		
FBgn0038742	Arc42	HGNC:90	OMIM:606885	ACADS	15	201470	201470[ACYL-CoA DEHYDROGENASE, SHORT-CHAIN, DEFICIENCY OF; ACADSD]
FBgn0038742	Arc42	HGNC:91	OMIM:600301	ACADSB	3	610006	610006[2-METHYLBUTYRYL-CoA DEHYDROGENASE DEFICIENCY]
FBgn0014006	Ask1	HGNC:6858	OMIM:604468	MAP3K6	8		
FBgn0014006	Ask1	HGNC:31689	OMIM:300820	MAP3K15	14		
FBgn0014006	Ask1	HGNC:6857	OMIM:602448	MAP3K5	12		
FBgn0038744	CG4733	HGNC:9307	OMIM:604944	PPP2R3A	8		
FBgn0038744	CG4733	HGNC:13417	OMIM:300339	PPP2R3B	9		
FBgn0038747	RhoGAP92B	HGNC:30259	OMIM:609246	PDXP	4		
FBgn0038747	RhoGAP92B	HGNC:29096	OMIM:617716	ARHGAP44	11		
FBgn0038747	RhoGAP92B	HGNC:18239	OMIM:608293	ARHGAP17	12		
FBgn0038747	RhoGAP92B	HGNC:10824	OMIM:617368	SH3BP1	9		
FBgn0038751	CG4770	HGNC:26222	OMIM:616107	FAR1	5	616154,619338	616154[PEROXISOMAL FATTY ACYL-CoA REDUCTASE 1 DISORDER; PFCRD],619338[CATARACTS, SPASTIC PARAPARESIS, AND SPEECH DELAY; CSPSD]
FBgn0038751	CG4770	HGNC:25531	OMIM:616156	FAR2	5		
FBgn0051213	CG31213	HGNC:37	OMIM:605414	ABCA7	3	608907	608907[ALZHEIMER DISEASE 9, SUSCEPTIBILITY TO; AD9]
FBgn0051213	CG31213	HGNC:32	OMIM:600047	ABCA2	3	618808	618808[INTELLECTUAL DEVELOPMENTAL DISORDER WITH POOR GROWTH AND WITH OR WITHOUT SEIZURES OR ATAXIA; IDPOGSA]
FBgn0051213	CG31213	HGNC:33	OMIM:601615	ABCA3	5	610921	610921[SURFACTANT METABOLISM DYSFUNCTION, PULMONARY, 3; SMDP3]
FBgn0051213	CG31213	HGNC:14637	OMIM:607800	ABCA12	4	242500,601277	242500[ICHTHYOSIS, CONGENITAL, AUTOSOMAL RECESSIVE 4B; ARCI4B],601277[ICHTHYOSIS, CONGENITAL, AUTOSOMAL RECESSIVE 4A; ARCI4A]
FBgn0051213	CG31213	HGNC:30	OMIM:612508	ABCA10	3		
FBgn0051213	CG31213	HGNC:39	OMIM:612507	ABCA9	3		
FBgn0051213	CG31213	HGNC:38	OMIM:612505	ABCA8	3		
FBgn0051213	CG31213	HGNC:36	OMIM:612504	ABCA6	3		
FBgn0051213	CG31213	HGNC:35	OMIM:612503	ABCA5	3	135400	135400[HYPERTRICHOSIS, CONGENITAL GENERALIZED, WITH OR WITHOUT GINGIVAL HYPERPLASIA; HTC3]
FBgn0051213	CG31213	HGNC:14638	OMIM:607807	ABCA13	3		
FBgn0038760	MED25	HGNC:28845	OMIM:610197	MED25	11	616449	616449[BASEL-VANAGAITE-SMIRIN-YOSEF SYNDROME; BVSYS]
FBgn0038760	MED25	HGNC:9632	OMIM:610195	PTOV1	5		
FBgn0038772	mdlc	HGNC:17267		RNF113B	14		
FBgn0038772	mdlc	HGNC:12974	OMIM:300951	RNF113A	14	300953	300953[TRICHOTHIODYSTROPHY 5, NONPHOTOSENSITIVE; TTD5]
FBgn0038771	CG4390	HGNC:3465	OMIM:133280	ESD	15		
FBgn0038769	Regnase-1	HGNC:21175	OMIM:611106	ZC3H12D	8		
FBgn0038769	Regnase-1	HGNC:17407	OMIM:300889	ZC3H12B	10		
FBgn0038769	Regnase-1	HGNC:29362	OMIM:615001	ZC3H12C	11		
FBgn0038769	Regnase-1	HGNC:26259	OMIM:610562	ZC3H12A	11		
FBgn0038769	Regnase-1	HGNC:20165		NYNRIN	3		
FBgn0038769	Regnase-1	HGNC:20166	OMIM:619579	KHNYN	4		
FBgn0038769	Regnase-1	HGNC:29850	OMIM:619138	N4BP1	4		
FBgn0038763	PIG-L	HGNC:8966	OMIM:605947	PIGL	13	280000	280000[COLOBOMA, CONGENITAL HEART DISEASE, ICHTHYOSIFORM DERMATOSIS, MENTAL RETARDATION, AND EAR ANOMALIES SYNDROME; CHIME]
FBgn0038755	Hs6st	HGNC:19133	OMIM:300545	HS6ST2	11	301025	301025[PAGANINI-MIOZZO SYNDROME; MRXSPM]
FBgn0038755	Hs6st	HGNC:5201	OMIM:604846	HS6ST1	14	614880	614880[HYPOGONADOTROPIC HYPOGONADISM 15 WITH OR WITHOUT ANOSMIA; HH15]
FBgn0038755	Hs6st	HGNC:19134	OMIM:609401	HS6ST3	13		
FBgn0038753	CG4459	HGNC:8494	OMIM:604047	SLC22A13	5		
FBgn0038753	CG4459	HGNC:10970	OMIM:607582	SLC22A6	4		
FBgn0038753	CG4459	HGNC:20302	OMIM:608276	SLC22A16	4		
FBgn0038753	CG4459	HGNC:10968	OMIM:604190	SLC22A4	4	180300	180300[RHEUMATOID ARTHRITIS; RA]
FBgn0038753	CG4459	HGNC:10969	OMIM:603377	SLC22A5	4	212140	212140[CARNITINE DEFICIENCY, SYSTEMIC PRIMARY; CDSP]
FBgn0038753	CG4459	HGNC:8495	OMIM:604048	SLC22A14	5		
FBgn0038753	CG4459	HGNC:10971	OMIM:604995	SLC22A7	4		
FBgn0038753	CG4459	HGNC:10972	OMIM:607581	SLC22A8	4		
FBgn0038753	CG4459	HGNC:10966	OMIM:602608	SLC22A2	4		
FBgn0038753	CG4459	HGNC:21106	OMIM:611697	SLC22A23	3		
FBgn0038753	CG4459	HGNC:32935	OMIM:610792	SLC22A25	4		
FBgn0038753	CG4459	HGNC:10963	OMIM:602607	SLC22A1	5		
FBgn0038753	CG4459	HGNC:10967	OMIM:604842	SLC22A3	4		
FBgn0038753	CG4459	HGNC:23095	OMIM:611461	SLC22A17	3		
FBgn0038753	CG4459	HGNC:20301	OMIM:608275	SLC22A15	3		
FBgn0038753	CG4459	HGNC:17989	OMIM:607096	SLC22A12	4	220150	220150[HYPOURICEMIA, RENAL, 1; RHUC1]
FBgn0038753	CG4459	HGNC:27091		SLC22A31	3		
FBgn0038753	CG4459	HGNC:18120	OMIM:607097	SLC22A11	4		
FBgn0038753	CG4459	HGNC:16261	OMIM:607579	SLC22A9	4		
FBgn0038753	CG4459	HGNC:28542	OMIM:611698	SLC22A24	4		
FBgn0038753	CG4459	HGNC:18057	OMIM:607580	SLC22A10	4		
FBgn0038752	CG4462	HGNC:8494	OMIM:604047	SLC22A13	5		
FBgn0038752	CG4462	HGNC:10970	OMIM:607582	SLC22A6	4		
FBgn0038752	CG4462	HGNC:20302	OMIM:608276	SLC22A16	4		
FBgn0038752	CG4462	HGNC:10968	OMIM:604190	SLC22A4	4	180300	180300[RHEUMATOID ARTHRITIS; RA]
FBgn0038752	CG4462	HGNC:10969	OMIM:603377	SLC22A5	4	212140	212140[CARNITINE DEFICIENCY, SYSTEMIC PRIMARY; CDSP]
FBgn0038752	CG4462	HGNC:8495	OMIM:604048	SLC22A14	5		
FBgn0038752	CG4462	HGNC:10971	OMIM:604995	SLC22A7	4		
FBgn0038752	CG4462	HGNC:10972	OMIM:607581	SLC22A8	4		
FBgn0038752	CG4462	HGNC:10966	OMIM:602608	SLC22A2	4		
FBgn0038752	CG4462	HGNC:21106	OMIM:611697	SLC22A23	3		
FBgn0038752	CG4462	HGNC:32935	OMIM:610792	SLC22A25	4		
FBgn0038752	CG4462	HGNC:10963	OMIM:602607	SLC22A1	5		
FBgn0038752	CG4462	HGNC:10967	OMIM:604842	SLC22A3	4		
FBgn0038752	CG4462	HGNC:23095	OMIM:611461	SLC22A17	3		
FBgn0038752	CG4462	HGNC:17989	OMIM:607096	SLC22A12	4	220150	220150[HYPOURICEMIA, RENAL, 1; RHUC1]
FBgn0038752	CG4462	HGNC:27091		SLC22A31	3		
FBgn0038752	CG4462	HGNC:18120	OMIM:607097	SLC22A11	4		
FBgn0038752	CG4462	HGNC:16261	OMIM:607579	SLC22A9	4		
FBgn0038752	CG4462	HGNC:28542	OMIM:611698	SLC22A24	4		
FBgn0038752	CG4462	HGNC:18057	OMIM:607580	SLC22A10	4		
FBgn0038750	CG4465	HGNC:8494	OMIM:604047	SLC22A13	5		
FBgn0038750	CG4465	HGNC:10970	OMIM:607582	SLC22A6	4		
FBgn0038750	CG4465	HGNC:20302	OMIM:608276	SLC22A16	4		
FBgn0038750	CG4465	HGNC:10968	OMIM:604190	SLC22A4	4	180300	180300[RHEUMATOID ARTHRITIS; RA]
FBgn0038750	CG4465	HGNC:10969	OMIM:603377	SLC22A5	4	212140	212140[CARNITINE DEFICIENCY, SYSTEMIC PRIMARY; CDSP]
FBgn0038750	CG4465	HGNC:8495	OMIM:604048	SLC22A14	5		
FBgn0038750	CG4465	HGNC:10971	OMIM:604995	SLC22A7	4		
FBgn0038750	CG4465	HGNC:10972	OMIM:607581	SLC22A8	4		
FBgn0038750	CG4465	HGNC:10966	OMIM:602608	SLC22A2	4		
FBgn0038750	CG4465	HGNC:21106	OMIM:611697	SLC22A23	3		
FBgn0038750	CG4465	HGNC:32935	OMIM:610792	SLC22A25	4		
FBgn0038750	CG4465	HGNC:10963	OMIM:602607	SLC22A1	5		
FBgn0038750	CG4465	HGNC:10967	OMIM:604842	SLC22A3	4		
FBgn0038750	CG4465	HGNC:23095	OMIM:611461	SLC22A17	3		
FBgn0038750	CG4465	HGNC:17989	OMIM:607096	SLC22A12	4	220150	220150[HYPOURICEMIA, RENAL, 1; RHUC1]
FBgn0038750	CG4465	HGNC:27091		SLC22A31	3		
FBgn0038750	CG4465	HGNC:18120	OMIM:607097	SLC22A11	4		
FBgn0038750	CG4465	HGNC:16261	OMIM:607579	SLC22A9	4		
FBgn0038750	CG4465	HGNC:28542	OMIM:611698	SLC22A24	4		
FBgn0038750	CG4465	HGNC:18057	OMIM:607580	SLC22A10	4		
FBgn0038746	Surf6	HGNC:11478	OMIM:185642	SURF6	9		
FBgn0038745	ClpX	HGNC:2088	OMIM:615611	CLPX	15	618015	618015[PROTOPORPHYRIA, ERYTHROPOIETIC, 2; EPP2]
FBgn0002940	ninaE	HGNC:14449	OMIM:606665	OPN4	12		
FBgn0038740	Mrp5	HGNC:55	OMIM:605250	ABCC4	14		
FBgn0038740	Mrp5	HGNC:52	OMIM:612509	ABCC10	5		
FBgn0038740	Mrp5	HGNC:53	OMIM:601107	ABCC2	5	237500	237500[DUBIN-JOHNSON SYNDROME; DJS]
FBgn0038740	Mrp5	HGNC:51	OMIM:158343	ABCC1	5	618915	618915[DEAFNESS, AUTOSOMAL DOMINANT 77; DFNA77]
FBgn0038740	Mrp5	HGNC:59	OMIM:600509	ABCC8	5	125853,240800,256450,610374,618857	125853[TYPE 2 DIABETES MELLITUS; T2D],240800[HYPOGLYCEMIA, LEUCINE-INDUCED; LIH],256450[HYPERINSULINEMIC HYPOGLYCEMIA, FAMILIAL, 1; HHF1],610374[DIABETES MELLITUS, TRANSIENT NEONATAL, 2; TNDM2],618857[DIABETES MELLITUS, PERMANENT NEONATAL, 3; PNDM3]
FBgn0038740	Mrp5	HGNC:14640	OMIM:607041	ABCC12	5		
FBgn0038740	Mrp5	HGNC:60	OMIM:601439	ABCC9	5	239850,608569,614050,619719	239850[CANTU SYNDROME],608569[CARDIOMYOPATHY, DILATED, 1O; CMD1O],614050[ATRIAL FIBRILLATION, FAMILIAL, 12; ATFB12],619719[INTELLECTUAL DISABILITY AND MYOPATHY SYNDROME; IDMYS]
FBgn0038740	Mrp5	HGNC:57	OMIM:603234	ABCC6	5	177850,264800,614473	177850[PSEUDOXANTHOMA ELASTICUM, FORME FRUSTE],264800[PSEUDOXANTHOMA ELASTICUM; PXE],614473[ARTERIAL CALCIFICATION, GENERALIZED, OF INFANCY, 2; GACI2]
FBgn0038740	Mrp5	HGNC:56	OMIM:605251	ABCC5	5		
FBgn0038740	Mrp5	HGNC:14639	OMIM:607040	ABCC11	5	117800	117800[APOCRINE GLAND SECRETION, VARIATION IN]
FBgn0038740	Mrp5	HGNC:54	OMIM:604323	ABCC3	5		
FBgn0038740	Mrp5	HGNC:1884	OMIM:602421	CFTR	5	167800,211400,219700,277180	167800[PANCREATITIS, HEREDITARY; PCTT],211400[BRONCHIECTASIS WITH OR WITHOUT ELEVATED SWEAT CHLORIDE 1; BESC1],219700[CYSTIC FIBROSIS; CF],277180[VAS DEFERENS, CONGENITAL BILATERAL APLASIA OF; CBAVD]
FBgn0038738	CG4572	HGNC:29507	OMIM:619723	SCPEP1	3		
FBgn0038738	CG4572	HGNC:14399	OMIM:609780	CPVL	13		
FBgn0038738	CG4572	HGNC:9251	OMIM:613111	CTSA	5	256540	256540[GALACTOSIALIDOSIS; GSL]
FBgn0038773	CG10887	HGNC:30401	OMIM:610507	LEO1	5		
FBgn0038774	CG5023	HGNC:2155	OMIM:600806	CNN1	7		
FBgn0038774	CG5023	HGNC:2156	OMIM:602373	CNN2	5		
FBgn0038774	CG5023	HGNC:2157	OMIM:602374	CNN3	5		
FBgn0038774	CG5023	HGNC:11553	OMIM:600818	TAGLN	5		
FBgn0038774	CG5023	HGNC:11554	OMIM:604634	TAGLN2	7		
FBgn0038774	CG5023	HGNC:29868	OMIM:607953	TAGLN3	8		
FBgn0003249	Rh3	HGNC:14449	OMIM:606665	OPN4	7		
FBgn0038788	Sirt2	HGNC:14931	OMIM:604481	SIRT3	5		
FBgn0038788	Sirt2	HGNC:14929	OMIM:604479	SIRT1	4		
FBgn0038788	Sirt2	HGNC:10886	OMIM:604480	SIRT2	13		
FBgn0038796	eIF3g2	HGNC:3274	OMIM:603913	EIF3G	14		
FBgn0038799	MFS9	HGNC:20151	OMIM:607557	SLC17A8	4	605583	605583[DEAFNESS, AUTOSOMAL DOMINANT 25; DFNA25]
FBgn0038799	MFS9	HGNC:10933	OMIM:604322	SLC17A5	7	269920,604369	269920[INFANTILE SIALIC ACID STORAGE DISEASE; ISSD],604369[SALLA DISEASE; SD]
FBgn0038799	MFS9	HGNC:16703	OMIM:607563	SLC17A6	4		
FBgn0038799	MFS9	HGNC:16704	OMIM:605208	SLC17A7	4		
FBgn0038799	MFS9	HGNC:10929	OMIM:182308	SLC17A1	3		
FBgn0038799	MFS9	HGNC:10932	OMIM:604216	SLC17A4	3		
FBgn0038799	MFS9	HGNC:10930	OMIM:611049	SLC17A2	4		
FBgn0038799	MFS9	HGNC:10931	OMIM:611034	SLC17A3	4	612671	612671[URIC ACID CONCENTRATION, SERUM, QUANTITATIVE TRAIT LOCUS 4; UAQTL4]
FBgn0038797	Dic2	HGNC:10980	OMIM:606794	SLC25A10	6	618972	618972[MITOCHONDRIAL DNA DEPLETION SYNDROME 19; MTDPS19]
FBgn0038795	Tmlh	HGNC:18308	OMIM:300777	TMLHE	14	300872	300872[AUTISM, SUSCEPTIBILITY TO, X-LINKED 6; AUTSX6]
FBgn0038795	Tmlh	HGNC:964	OMIM:603312	BBOX1	4		
FBgn0038803	CG5191	HGNC:26440	OMIM:300654	FAAH2	6		
FBgn0038803	CG5191	HGNC:3553	OMIM:602935	FAAH	4	606581	606581[POLYSUBSTANCE ABUSE, SUSCEPTIBILITY TO; PSAB]
FBgn0038806	CG5412	HGNC:24203	OMIM:607896	OVCA2	14		
FBgn0038808	Srp14	HGNC:11299	OMIM:600708	SRP14	11		
FBgn0038810	Srp72	HGNC:11303	OMIM:602122	SRP72	14	614675	614675[BONE MARROW FAILURE SYNDROME 1; BMFS1]
FBgn0023097	bon	HGNC:11812	OMIM:603406	TRIM24	9		
FBgn0023097	bon	HGNC:29005	OMIM:612000	TRIM66	4		
FBgn0023097	bon	HGNC:16384	OMIM:601742	TRIM28	5		
FBgn0023097	bon	HGNC:16290	OMIM:605769	TRIM33	9		
FBgn0038816	Lrrk	HGNC:18608	OMIM:610986	LRRK1	8	615198	615198[OSTEOSCLEROTIC METAPHYSEAL DYSPLASIA; OSMD]
FBgn0038816	Lrrk	HGNC:18618	OMIM:609007	LRRK2	6	607060	607060[PARKINSON DISEASE 8, AUTOSOMAL DOMINANT; PARK8]
FBgn0004107	Cdk2	HGNC:1774	OMIM:123831	CDK5	4	616342	616342[LISSENCEPHALY 7 WITH CEREBELLAR HYPOPLASIA; LIS7]
FBgn0004107	Cdk2	HGNC:8749	OMIM:311550	CDK16	3		
FBgn0004107	Cdk2	HGNC:1722	OMIM:116940	CDK1	4		
FBgn0004107	Cdk2	HGNC:8883	OMIM:610679	CDK14	3		
FBgn0004107	Cdk2	HGNC:8751	OMIM:169190	CDK18	3		
FBgn0004107	Cdk2	HGNC:1771	OMIM:116953	CDK2	11		
FBgn0004107	Cdk2	HGNC:1772	OMIM:123828	CDK3	7		
FBgn0004107	Cdk2	HGNC:8750	OMIM:603440	CDK17	3		
FBgn0004107	Cdk2	HGNC:14434	OMIM:616147	CDK15	3		
FBgn0024944	Oamb	HGNC:277	OMIM:104221	ADRA1A	3		
FBgn0038818	Nep4	HGNC:8918	OMIM:300550	PHEX	3	307800	307800[HYPOPHOSPHATEMIC RICKETS, X-LINKED DOMINANT; XLHR]
FBgn0038818	Nep4	HGNC:14668	OMIM:618104	MMEL1	8		
FBgn0038818	Nep4	HGNC:7154	OMIM:120520	MME	7	617017,617018	617017[CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2T; CMT2T],617018[SPINOCEREBELLAR ATAXIA 43; SCA43]
FBgn0038818	Nep4	HGNC:13275	OMIM:610145	ECE2	4		
FBgn0038818	Nep4	HGNC:3147	OMIM:605896	ECEL1	3	615065	615065[ARTHROGRYPOSIS, DISTAL, TYPE 5D; DA5D]
FBgn0038818	Nep4	HGNC:3146	OMIM:600423	ECE1	5	145500,613870	145500[HYPERTENSION, ESSENTIAL],613870[HIRSCHSPRUNG DISEASE, CARDIAC DEFECTS, AND AUTONOMIC DYSFUNCTION; HCAD]
FBgn0038818	Nep4	HGNC:6308	OMIM:613883	KEL	4	110900	110900[BLOOD GROUP--KELL SYSTEM; KEL]
FBgn0028422	GluRIID	HGNC:4580	OMIM:138244	GRIK2	7	611092,619580	611092[INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 6; MRT6],619580[NEURODEVELOPMENTAL DISORDER WITH IMPAIRED LANGUAGE AND ATAXIA AND WITH OR WITHOUT SEIZURES; NEDLAS]
FBgn0028422	GluRIID	HGNC:4581	OMIM:138243	GRIK3	8		
FBgn0028422	GluRIID	HGNC:4583	OMIM:600283	GRIK5	5		
FBgn0028422	GluRIID	HGNC:4579	OMIM:138245	GRIK1	7		
FBgn0028422	GluRIID	HGNC:4582	OMIM:600282	GRIK4	6		
FBgn0028422	GluRIID	HGNC:4576	OMIM:602368	GRID2	3	616204	616204[SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 18; SCAR18]
FBgn0028422	GluRIID	HGNC:4575	OMIM:610659	GRID1	3		
FBgn0051201	GluRIIE	HGNC:4580	OMIM:138244	GRIK2	7	611092,619580	611092[INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 6; MRT6],619580[NEURODEVELOPMENTAL DISORDER WITH IMPAIRED LANGUAGE AND ATAXIA AND WITH OR WITHOUT SEIZURES; NEDLAS]
FBgn0051201	GluRIIE	HGNC:4581	OMIM:138243	GRIK3	6		
FBgn0051201	GluRIIE	HGNC:4583	OMIM:600283	GRIK5	5		
FBgn0051201	GluRIIE	HGNC:4579	OMIM:138245	GRIK1	6		
FBgn0051201	GluRIIE	HGNC:4582	OMIM:600282	GRIK4	6		
FBgn0051201	GluRIIE	HGNC:4576	OMIM:602368	GRID2	3	616204	616204[SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 18; SCAR18]
FBgn0051201	GluRIIE	HGNC:4575	OMIM:610659	GRID1	3		
FBgn0015279	Pi3K92E	HGNC:8976	OMIM:602925	PIK3CB	12		
FBgn0015279	Pi3K92E	HGNC:8978	OMIM:601232	PIK3CG	5	619802	619802[IMMUNODEFICIENCY 97 WITH AUTOINFLAMMATION; IMD97]
FBgn0015279	Pi3K92E	HGNC:8975	OMIM:171834	PIK3CA	6	114480,114500,114550,155500,162900,167000,182000,211980,602501,612918,613089,613659,615108,619538	114480[BREAST CANCER],114500[COLORECTAL CANCER; CRC],114550[HEPATOCELLULAR CARCINOMA],155500[MACRODACTYLY],162900[NEVUS, EPIDERMAL],167000[OVARIAN CANCER],182000[KERATOSIS, SEBORRHEIC],211980[LUNG CANCER],602501[MEGALENCEPHALY-CAPILLARY MALFORMATION-POLYMICROGYRIA SYNDROME; MCAP],612918[CONGENITAL LIPOMATOUS OVERGROWTH, VASCULAR MALFORMATIONS, AND EPIDERMAL NEVI],613089[CAPILLARY MALFORMATION OF THE LOWER LIP, LYMPHATIC MALFORMATION OF FACE AND NECK, ASYMMETRY OF FACE AND LIMBS, AND PARTIAL/GENERALIZED OVERGROWTH],613659[GASTRIC CANCER],615108[COWDEN SYNDROME 5; CWS5],619538[CEREBRAL CAVERNOUS MALFORMATIONS 4; CCM4]
FBgn0015279	Pi3K92E	HGNC:8977	OMIM:602839	PIK3CD	15	613328,615513,619281	613328[ROIFMAN-CHITAYAT SYNDROME; ROCHIS],615513[IMMUNODEFICIENCY 14A, AUTOSOMAL DOMINANT; IMD14A],619281[IMMUNODEFICIENCY 14B, AUTOSOMAL RECESSIVE; IMD14B]
FBgn0015279	Pi3K92E	HGNC:8971	OMIM:603601	PIK3C2A	3	618440	618440[OCULOSKELETODENTAL SYNDROME; OCSKD]
FBgn0015279	Pi3K92E	HGNC:8972	OMIM:602838	PIK3C2B	3		
FBgn0015279	Pi3K92E	HGNC:8973	OMIM:609001	PIK3C2G	3		
FBgn0038814	CG15923	HGNC:28396	OMIM:609884	TMEM67	14	216360,602152,607361,610688,613550,615991	216360[COACH SYNDROME 1; COACH1],602152[RHYNS SYNDROME; RHYNS],607361[MECKEL SYNDROME, TYPE 3; MKS3],610688[JOUBERT SYNDROME 6; JBTS6],613550[NEPHRONOPHTHISIS 11; NPHP11],615991[BARDET-BIEDL SYNDROME 14; BBS14]
FBgn0038811	Pus1	HGNC:15508	OMIM:608109	PUS1	14	600462	600462[MYOPATHY, LACTIC ACIDOSIS, AND SIDEROBLASTIC ANEMIA 1; MLASA1]
FBgn0014029	Septin2	HGNC:33280	OMIM:612140	SEPTIN14	8		
FBgn0014029	Septin2	HGNC:1717	OMIM:603151	SEPTIN7	4		
FBgn0014029	Septin2	HGNC:9165	OMIM:603696	SEPTIN4	5		
FBgn0014029	Septin2	HGNC:15848	OMIM:300683	SEPTIN6	14		
FBgn0014029	Septin2	HGNC:2879	OMIM:612897	SEPTIN1	4		
FBgn0014029	Septin2	HGNC:25589	OMIM:612887	SEPTIN11	14		
FBgn0014029	Septin2	HGNC:7729	OMIM:601506	SEPTIN2	4		
FBgn0014029	Septin2	HGNC:9164	OMIM:602724	SEPTIN5	4		
FBgn0014029	Septin2	HGNC:16511	OMIM:608418	SEPTIN8	13		
FBgn0014029	Septin2	HGNC:14349	OMIM:611737	SEPTIN10	11		
FBgn0014029	Septin2	HGNC:7323	OMIM:604061	SEPTIN9	5	162100	162100[AMYOTROPHY, HEREDITARY NEURALGIC; HNA]
FBgn0014029	Septin2	HGNC:10750	OMIM:608314	SEPTIN3	5		
FBgn0014029	Septin2	HGNC:26348	OMIM:611562	SEPTIN12	4	614822	614822[SPERMATOGENIC FAILURE 10; SPGF10]
FBgn0023212	EloB	HGNC:11619	OMIM:600787	ELOB	11		
FBgn0038805	TFAM	HGNC:11741	OMIM:600438	TFAM	13	617156	617156[MITOCHONDRIAL DNA DEPLETION SYNDROME 15 (HEPATOCEREBRAL TYPE); MTDPS15]
FBgn0038804	CG10877	HGNC:16001	OMIM:609187	SUGCT	13	231690	231690[GLUTARIC ACIDURIA III; GA3]
FBgn0038826	Syp	HGNC:5047	OMIM:607201	HNRNPR	12		
FBgn0038826	Syp	HGNC:16918	OMIM:616686	SYNCRIP	12		
FBgn0019936	RpS20	HGNC:10405	OMIM:603682	RPS20	14		
FBgn0051223	CG31223	HGNC:1177	OMIM:604575	ZNHIT2	11		
FBgn0053094	Synd	HGNC:8572	OMIM:606513	PACSIN3	11		
FBgn0053094	Synd	HGNC:8570	OMIM:606512	PACSIN1	13		
FBgn0053094	Synd	HGNC:8571	OMIM:604960	PACSIN2	13		
FBgn0038833	CG15696	HGNC:2915	OMIM:126255	DLX2	3		
FBgn0038834	RpS30	HGNC:3597	OMIM:134690	FAU	10		
FBgn0038840	Grik	HGNC:4580	OMIM:138244	GRIK2	8	611092,619580	611092[INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 6; MRT6],619580[NEURODEVELOPMENTAL DISORDER WITH IMPAIRED LANGUAGE AND ATAXIA AND WITH OR WITHOUT SEIZURES; NEDLAS]
FBgn0038840	Grik	HGNC:4581	OMIM:138243	GRIK3	7		
FBgn0038840	Grik	HGNC:4583	OMIM:600283	GRIK5	5		
FBgn0038840	Grik	HGNC:4579	OMIM:138245	GRIK1	7		
FBgn0038840	Grik	HGNC:4582	OMIM:600282	GRIK4	6		
FBgn0038840	Grik	HGNC:4576	OMIM:602368	GRID2	3	616204	616204[SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 18; SCAR18]
FBgn0038840	Grik	HGNC:4575	OMIM:610659	GRID1	3		
FBgn0038839	Ktl	HGNC:22394	OMIM:618442	KCTD8	11		
FBgn0038839	Ktl	HGNC:14678	OMIM:610521	KCTD12	12		
FBgn0038839	Ktl	HGNC:29244	OMIM:613423	KCTD16	12		
FBgn0038837	KaiR1D	HGNC:4580	OMIM:138244	GRIK2	10	611092,619580	611092[INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 6; MRT6],619580[NEURODEVELOPMENTAL DISORDER WITH IMPAIRED LANGUAGE AND ATAXIA AND WITH OR WITHOUT SEIZURES; NEDLAS]
FBgn0038837	KaiR1D	HGNC:4581	OMIM:138243	GRIK3	9		
FBgn0038837	KaiR1D	HGNC:4583	OMIM:600283	GRIK5	5		
FBgn0038837	KaiR1D	HGNC:4579	OMIM:138245	GRIK1	9		
FBgn0038837	KaiR1D	HGNC:4582	OMIM:600282	GRIK4	5		
FBgn0027493	AdSS	HGNC:292	OMIM:103060	ADSS	13		
FBgn0027493	AdSS	HGNC:20093	OMIM:612498	ADSSL1	13	617030	617030[MYOPATHY, DISTAL, 5; MPD5]
FBgn0038830	CG17272	HGNC:1442	OMIM:114180	CALM1	3	614916,616247	614916[VENTRICULAR TACHYCARDIA, CATECHOLAMINERGIC POLYMORPHIC, 4; CPVT4],616247[LONG QT SYNDROME 14; LQT14]
FBgn0038830	CG17272	HGNC:18180	OMIM:605183	CALML5	3		
FBgn0038830	CG17272	HGNC:18445		CALML4	7		
FBgn0038829	CG17271	HGNC:18451	OMIM:607788	MCFD2	10	613625	613625[FACTOR V AND FACTOR VIII, COMBINED DEFICIENCY OF, 2; F5F8D2]
FBgn0038828	CG17270	HGNC:1187	OMIM:604576	ERG28	5		
FBgn0038827	Fancd2	HGNC:3585	OMIM:613984	FANCD2	13	227646	227646[FANCONI ANEMIA, COMPLEMENTATION GROUP D2; FANCD2]
FBgn0046689	Takl1	HGNC:6859	OMIM:602614	MAP3K7	4	157800,617137	157800[CARDIOSPONDYLOCARPOFACIAL SYNDROME; CSCF],617137[FRONTOMETAPHYSEAL DYSPLASIA 2; FMD2]
FBgn0013995	Calx	HGNC:11069	OMIM:601901	SLC8A2	12		
FBgn0013995	Calx	HGNC:11070	OMIM:607991	SLC8A3	13		
FBgn0013995	Calx	HGNC:11068	OMIM:182305	SLC8A1	13		
FBgn0026056	Rlip	HGNC:9841	OMIM:605801	RALBP1	14		
FBgn0038851	dmrt93B	HGNC:13908	OMIM:614804	DMRTA2	4		
FBgn0038851	dmrt93B	HGNC:13909	OMIM:614754	DMRT3	7		
FBgn0038851	dmrt93B	HGNC:13826	OMIM:614803	DMRTA1	4		
FBgn0038851	dmrt93B	HGNC:2935	OMIM:604935	DMRT2	3		
FBgn0038851	dmrt93B	HGNC:13911	OMIM:614806	DMRTC2	3		
FBgn0038855	Tbc1d22	HGNC:1309	OMIM:616879	TBC1D22A	11		
FBgn0038855	Tbc1d22	HGNC:21602	OMIM:616880	TBC1D22B	13		
FBgn0028468	rtet	HGNC:16894	OMIM:610977	MFSD10	14		
FBgn0015790	Rab11	HGNC:18238	OMIM:612942	RAB25	4		
FBgn0015790	Rab11	HGNC:9760	OMIM:605570	RAB11A	13		
FBgn0015790	Rab11	HGNC:9761	OMIM:604198	RAB11B	12	617807	617807[NEURODEVELOPMENTAL DISORDER WITH ATAXIC GAIT, ABSENT SPEECH, AND DECREASED CORTICAL WHITE MATTER; NDAGSCW]
FBgn0010770	ppan	HGNC:9227	OMIM:607793	PPAN	10		
FBgn0010770	ppan	HGNC:8540	OMIM:602697	P2RY11	3		
FBgn0010770	ppan	HGNC:33526		PPAN-P2RY11	10		
FBgn0038858	CG5793	HGNC:14169	OMIM:616320	FAHD1	11		
FBgn0038858	CG5793	HGNC:25318		FAHD2B	4		
FBgn0038858	CG5793	HGNC:24252		FAHD2A	4		
FBgn0038862	Usp8	HGNC:12631	OMIM:603158	USP8	13	219090	219090[PITUITARY ADENOMA 4, ACTH-SECRETING; PITA4]
FBgn0038862	Usp8	HGNC:20079		USP50	3		
FBgn0038862	Usp8	HGNC:12618	OMIM:604725	USP2	5		
FBgn0038861	Trm7-34	HGNC:13254	OMIM:300499	FTSJ1	10	309549	309549[INTELLECTUAL DEVELOPMENTAL DISORDER, X-LINKED 9; XLID9]
FBgn0038854	CG7044	HGNC:21701	OMIM:614506	BRAT1	7	614498,618056	614498[RIGIDITY AND MULTIFOCAL SEIZURE SYNDROME, LETHAL NEONATAL; RMFSL],618056[NEURODEVELOPMENTAL DISORDER WITH CEREBELLAR ATROPHY AND WITH OR WITHOUT SEIZURES; NEDCAS]
FBgn0038853	RhoGAP93B	HGNC:29351	OMIM:615880	ARHGAP39	12		
FBgn0038852	HHEX	HGNC:4901	OMIM:604420	HHEX	8		
FBgn0003257	r-l	HGNC:12563	OMIM:613891	UMPS	14	258900	258900[OROTIC ACIDURIA]
FBgn0025865	Cortactin	HGNC:3338	OMIM:164765	CTTN	13		
FBgn0025865	Cortactin	HGNC:4844	OMIM:601306	HCLS1	8		
FBgn0013812	Dhc93AB	HGNC:2951	OMIM:603336	DNAH6	3		
FBgn0013812	Dhc93AB	HGNC:2949	OMIM:603334	DNAH3	3		
FBgn0013812	Dhc93AB	HGNC:2952	OMIM:603337	DNAH8	3	619095	619095[SPERMATOGENIC FAILURE 46; SPGF46]
FBgn0013812	Dhc93AB	HGNC:2940	OMIM:603332	DNAH1	3	617576,617577	617576[SPERMATOGENIC FAILURE 18; SPGF18],617577[CILIARY DYSKINESIA, PRIMARY, 37; CILD37]
FBgn0013812	Dhc93AB	HGNC:18661	OMIM:610061	DNAH7	3		
FBgn0013812	Dhc93AB	HGNC:2953	OMIM:603330	DNAH9	14	618300	618300[CILIARY DYSKINESIA, PRIMARY, 40; CILD40]
FBgn0013812	Dhc93AB	HGNC:2942	OMIM:603339	DNAH11	8	611884	611884[CILIARY DYSKINESIA, PRIMARY, 7; CILD7]
FBgn0013812	Dhc93AB	HGNC:2950	OMIM:603335	DNAH5	3	608644	608644[CILIARY DYSKINESIA, PRIMARY, 3; CILD3]
FBgn0013812	Dhc93AB	HGNC:2948	OMIM:603333	DNAH2	4	619094	619094[SPERMATOGENIC FAILURE 45; SPGF45]
FBgn0013812	Dhc93AB	HGNC:2941	OMIM:605884	DNAH10	4	619515	619515[SPERMATOGENIC FAILURE 56; SPGF56]
FBgn0013812	Dhc93AB	HGNC:2946	OMIM:610063	DNAH17	11	618643	618643[SPERMATOGENIC FAILURE 39; SPGF39]
FBgn0013812	Dhc93AB	HGNC:2945	OMIM:603341	DNAH14	3		
FBgn0013812	Dhc93AB	HGNC:2943	OMIM:603340	DNAH12	3		
FBgn0038845	Alp5	HGNC:438	OMIM:171760	ALPL	12	146300,241500,241510	146300[HYPOPHOSPHATASIA, ADULT; HPPA],241500[HYPOPHOSPHATASIA, INFANTILE; HPPI],241510[HYPOPHOSPHATASIA, CHILDHOOD; HPPC]
FBgn0038845	Alp5	HGNC:441	OMIM:171810	ALPG	10		
FBgn0038845	Alp5	HGNC:439	OMIM:171800	ALPP	11		
FBgn0038845	Alp5	HGNC:437	OMIM:171740	ALPI	11		
FBgn0038868	CG5862	HGNC:16110	OMIM:616177	DDRGK1	11	602557	602557[SPONDYLOEPIMETAPHYSEAL DYSPLASIA, SHOHAT TYPE; SEMDSH]
FBgn0038870	Oga	HGNC:7056	OMIM:604039	OGA	14		
FBgn0038874	ETHR	HGNC:12299	OMIM:188545	TRHR	8	618573	618573[HYPOTHYROIDISM, CONGENITAL, NONGOITROUS, 7; CHNG7]
FBgn0038876	Idi	HGNC:23487	OMIM:615389	IDI2	11		
FBgn0038876	Idi	HGNC:5387	OMIM:604055	IDI1	12		
FBgn0004110	tin	HGNC:7836	OMIM:606727	NKX2-3	3		
FBgn0004110	tin	HGNC:2488	OMIM:600584	NKX2-5	3	108900,187500,217095,225250,614432,614435	108900[ATRIAL SEPTAL DEFECT 7 WITH OR WITHOUT ATRIOVENTRICULAR CONDUCTION DEFECTS; ASD7],187500[TETRALOGY OF FALLOT; TOF],217095[CONOTRUNCAL HEART MALFORMATIONS; CTHM],225250[HYPOTHYROIDISM, CONGENITAL, NONGOITROUS, 5; CHNG5],614432[VENTRICULAR SEPTAL DEFECT 3; VSD3],614435[HYPOPLASTIC LEFT HEART SYNDROME 2; HLHS2]
FBgn0004110	tin	HGNC:7835	OMIM:604612	NKX2-2	4		
FBgn0004110	tin	HGNC:32940	OMIM:611770	NKX2-6	3	217095	217095[CONOTRUNCAL HEART MALFORMATIONS; CTHM]
FBgn0004110	tin	HGNC:16364	OMIM:603245	NKX2-8	3		
FBgn0004862	bap	HGNC:951	OMIM:602183	NKX3-2	9	613330	613330[SPONDYLO-MEGAEPIPHYSEAL-METAPHYSEAL DYSPLASIA; SMMD]
FBgn0004862	bap	HGNC:7838	OMIM:602041	NKX3-1	4		
FBgn0038887	CG7907	HGNC:7658	OMIM:600469	NCBP1	5		
FBgn0011278	lbe	HGNC:16960	OMIM:604255	LBX1	10	619483	619483[CENTRAL HYPOVENTILATION SYNDROME, CONGENITAL, 3; CCHS3]
FBgn0011278	lbe	HGNC:15525	OMIM:607164	LBX2	8		
FBgn0008651	lbl	HGNC:16960	OMIM:604255	LBX1	9	619483	619483[CENTRAL HYPOVENTILATION SYNDROME, CONGENITAL, 3; CCHS3]
FBgn0008651	lbl	HGNC:15525	OMIM:607164	LBX2	7		
FBgn0038878	CG3301	HGNC:28639	OMIM:616159	DHRS11	11		
FBgn0038877	CG3308	HGNC:24220	OMIM:619364	TATDN1	4		
FBgn0038877	CG3308	HGNC:28988	OMIM:619330	TATDN2	5		
FBgn0038877	CG3308	HGNC:27010		TATDN3	3		
FBgn0043012	AP-2sigma	HGNC:565	OMIM:602242	AP2S1	14	600740	600740[HYPOCALCIURIC HYPERCALCEMIA, FAMILIAL, TYPE III; HHC3]
FBgn0043012	AP-2sigma	HGNC:560	OMIM:300629	AP1S2	3	304340	304340[PETTIGREW SYNDROME; PGS]
FBgn0043012	AP-2sigma	HGNC:559	OMIM:603531	AP1S1	3	609313	609313[MENTAL RETARDATION, ENTEROPATHY, DEAFNESS, PERIPHERAL NEUROPATHY, ICHTHYOSIS, AND KERATODERMA; MEDNIK]
FBgn0043012	AP-2sigma	HGNC:18971	OMIM:615781	AP1S3	3	616106	616106[PSORIASIS 15, PUSTULAR, SUSCEPTIBILITY TO; PSORS15]
FBgn0000527	e	HGNC:23993	OMIM:614365	AASDH	4		
FBgn0038871	CG3337	HGNC:27029	OMIM:618568	ATPSCKMT	13		
FBgn0038871	CG3337	HGNC:14152	OMIM:618566	ANTKMT	7		
FBgn0038869	Smyd5	HGNC:16258	OMIM:619114	SMYD5	14		
FBgn0038889	Fancm	HGNC:23168	OMIM:609644	FANCM	11	618086,618096	618086[SPERMATOGENIC FAILURE 28; SPGF28],618096[PREMATURE OVARIAN FAILURE 15; POF15]
FBgn0004863	C15	HGNC:13532	OMIM:604640	TLX3	11		
FBgn0004863	C15	HGNC:5056	OMIM:186770	TLX1	10		
FBgn0004863	C15	HGNC:5057	OMIM:604240	TLX2	10		
FBgn0038890	sp3	HGNC:17054	OMIM:609389	INPP5F	12		
FBgn0038893	Archease	HGNC:24094	OMIM:615891	ZBTB8OS	14		
FBgn0011766	E2f1	HGNC:3113	OMIM:189971	E2F1	8		
FBgn0011766	E2f1	HGNC:3114	OMIM:600426	E2F2	9		
FBgn0011766	E2f1	HGNC:3115	OMIM:600427	E2F3	9		
FBgn0011766	E2f1	HGNC:3118	OMIM:600659	E2F4	4		
FBgn0011766	E2f1	HGNC:3119	OMIM:600967	E2F5	3		
FBgn0011766	E2f1	HGNC:3120	OMIM:602944	E2F6	5		
FBgn0038892	CG15498	HGNC:26782		CFAP161	12		
FBgn0002941	slou	HGNC:24975	OMIM:617869	NKX1-1	7		
FBgn0002941	slou	HGNC:31652		NKX1-2	5		
FBgn0038897	CG5849	HGNC:500	OMIM:151530	ANPEP	3		
FBgn0038897	CG5849	HGNC:30748	OMIM:606950	TRHDE	3		
FBgn0038897	CG5849	HGNC:18173	OMIM:606832	ERAP1	4		
FBgn0038897	CG5849	HGNC:26904	OMIM:610046	LVRN	3		
FBgn0038897	CG5849	HGNC:7900	OMIM:606793	NPEPPS	3		
FBgn0038897	CG5849	HGNC:29499	OMIM:609497	ERAP2	4		
FBgn0038897	CG5849	HGNC:6656	OMIM:151300	LNPEP	4		
FBgn0051343	CG31343	HGNC:500	OMIM:151530	ANPEP	5		
FBgn0051343	CG31343	HGNC:30748	OMIM:606950	TRHDE	4		
FBgn0051343	CG31343	HGNC:3355	OMIM:138297	ENPEP	3		
FBgn0051343	CG31343	HGNC:18173	OMIM:606832	ERAP1	4		
FBgn0051343	CG31343	HGNC:26904	OMIM:610046	LVRN	4		
FBgn0051343	CG31343	HGNC:7900	OMIM:606793	NPEPPS	4		
FBgn0051343	CG31343	HGNC:29499	OMIM:609497	ERAP2	4		
FBgn0051343	CG31343	HGNC:6656	OMIM:151300	LNPEP	4		
FBgn0051233	CG31233	HGNC:500	OMIM:151530	ANPEP	5		
FBgn0051233	CG31233	HGNC:30748	OMIM:606950	TRHDE	4		
FBgn0051233	CG31233	HGNC:3355	OMIM:138297	ENPEP	3		
FBgn0051233	CG31233	HGNC:18173	OMIM:606832	ERAP1	4		
FBgn0051233	CG31233	HGNC:26904	OMIM:610046	LVRN	4		
FBgn0051233	CG31233	HGNC:7900	OMIM:606793	NPEPPS	4		
FBgn0051233	CG31233	HGNC:29499	OMIM:609497	ERAP2	4		
FBgn0051233	CG31233	HGNC:6656	OMIM:151300	LNPEP	4		
FBgn0051198	CG31198	HGNC:500	OMIM:151530	ANPEP	4		
FBgn0051198	CG31198	HGNC:30748	OMIM:606950	TRHDE	3		
FBgn0051198	CG31198	HGNC:3355	OMIM:138297	ENPEP	3		
FBgn0051198	CG31198	HGNC:26904	OMIM:610046	LVRN	3		
FBgn0038902	CG6800	HGNC:21420	OMIM:610076	CDK20	14		
FBgn0038902	CG6800	HGNC:1778	OMIM:601955	CDK7	3		
FBgn0051431	CG31431	HGNC:3693	OMIM:605830	FGFRL1	4		
FBgn0038912	CG6656	HGNC:29609	OMIM:611471	ACP6	4		
FBgn0038912	CG6656	HGNC:125	OMIM:171790	ACP3	6		
FBgn0038912	CG6656	HGNC:123	OMIM:171650	ACP2	6	200950	200950[ACID PHOSPHATASE DEFICIENCY]
FBgn0038912	CG6656	HGNC:14376	OMIM:606362	ACP4	5	617297	617297[AMELOGENESIS IMPERFECTA, TYPE IJ; AI1J]
FBgn0053092	P5CDh2	HGNC:406	OMIM:606811	ALDH4A1	5	239510	239510[HYPERPROLINEMIA, TYPE II; HYRPRO2]
FBgn0038917	CG6678	HGNC:30457	OMIM:617997	RCCD1	10		
FBgn0038918	Qsox3	HGNC:9756	OMIM:603120	QSOX1	11		
FBgn0038918	Qsox3	HGNC:30249	OMIM:612860	QSOX2	11		
FBgn0038919	Qsox2	HGNC:9756	OMIM:603120	QSOX1	13		
FBgn0038919	Qsox2	HGNC:30249	OMIM:612860	QSOX2	15		
FBgn0038916	dnd	HGNC:694	OMIM:604695	ARL3	12	618161,618173	618161[JOUBERT SYNDROME 35; JBTS35],618173[RETINITIS PIGMENTOSA 83; RP83]
FBgn0013759	CASK	HGNC:7220	OMIM:600723	MPP2	3		
FBgn0013759	CASK	HGNC:7219	OMIM:305360	MPP1	6		
FBgn0013759	CASK	HGNC:1497	OMIM:300172	CASK	11	300422,300749	300422[FG SYNDROME 4; FGS4],300749[INTELLECTUAL DEVELOPMENTAL DISORDER WITH MICROCEPHALY AND PONTINE AND CEREBELLAR HYPOPLASIA; MICPCH]
FBgn0013759	CASK	HGNC:18167	OMIM:606959	MPP6	3		
FBgn0038903	Polr1H	HGNC:13182	OMIM:607525	POLR1H	15		
FBgn0027575	GABA-B-R2	HGNC:4507	OMIM:607340	GABBR2	14	188890,617903,617904	188890[TOBACCO ADDICTION, SUSCEPTIBILITY TO],617903[NEURODEVELOPMENTAL DISORDER WITH POOR LANGUAGE AND LOSS OF HAND SKILLS; NDPLHS],617904[DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 59; DEE59]
FBgn0027575	GABA-B-R2	HGNC:20844	OMIM:610464	GPR156	4		
FBgn0038921	Theg	HGNC:43771		THEGL	3		
FBgn0038921	Theg	HGNC:13706	OMIM:609503	THEG	5		
FBgn0038923	mRpL35	HGNC:14489	OMIM:611841	MRPL35	12		
FBgn0019957	ND-42	HGNC:7684	OMIM:603835	NDUFA10	14	618243	618243[MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 22; MC1DN22]
FBgn0038928	Fadd	HGNC:3573	OMIM:602457	FADD	4	613759	613759[IMMUNODEFICIENCY 90 WITH ENCEPHALOPATHY, FUNCTIONAL HYPOSPLENIA, AND HEPATIC DYSFUNCTION; IMD90]
FBgn0038927	CG6015	HGNC:17350	OMIM:605585	CDC40	13	619302	619302[PONTOCEREBELLAR HYPOPLASIA, TYPE 15; PCH15]
FBgn0038926	CG13409	HGNC:20958	OMIM:613209	TMEM181	14		
FBgn0038925	Cchl	HGNC:4837	OMIM:300056	HCCS	13	309801	309801[LINEAR SKIN DEFECTS WITH MULTIPLE CONGENITAL ANOMALIES 1; LSDMCA1]
FBgn0038924	CG6028	HGNC:14169	OMIM:616320	FAHD1	3		
FBgn0038924	CG6028	HGNC:25318		FAHD2B	12		
FBgn0038924	CG6028	HGNC:24252		FAHD2A	14		
FBgn0019960	Mitofilin	HGNC:6047	OMIM:600378	IMMT	14		
FBgn0038922	Idh3b	HGNC:5386	OMIM:300089	IDH3G	4		
FBgn0038922	Idh3b	HGNC:5385	OMIM:604526	IDH3B	15	612572	612572[RETINITIS PIGMENTOSA 46; RP46]
FBgn0051163	SKIP	HGNC:21180		SAMD5	5		
FBgn0051163	SKIP	HGNC:19182	OMIM:607955	SASH1	5	127500,618373	127500[DYSCHROMATOSIS UNIVERSALIS HEREDITARIA 1; DUH1],618373[CANCER, ALOPECIA, PIGMENT DYSCRASIA, ONYCHODYSTROPHY, AND KERATODERMA; CAPOK]
FBgn0051163	SKIP	HGNC:15975	OMIM:300441	SASH3	6	301082	301082[IMMUNODEFICIENCY 102; IMD102]
FBgn0051163	SKIP	HGNC:10528	OMIM:607978	SAMSN1	6		
FBgn0038934	Gld2	HGNC:26776	OMIM:614121	TENT2	9		
FBgn0038938	CG7084	HGNC:8494	OMIM:604047	SLC22A13	3		
FBgn0038938	CG7084	HGNC:10970	OMIM:607582	SLC22A6	3		
FBgn0038938	CG7084	HGNC:20302	OMIM:608276	SLC22A16	3		
FBgn0038938	CG7084	HGNC:10968	OMIM:604190	SLC22A4	4	180300	180300[RHEUMATOID ARTHRITIS; RA]
FBgn0038938	CG7084	HGNC:10969	OMIM:603377	SLC22A5	4	212140	212140[CARNITINE DEFICIENCY, SYSTEMIC PRIMARY; CDSP]
FBgn0038938	CG7084	HGNC:8495	OMIM:604048	SLC22A14	3		
FBgn0038938	CG7084	HGNC:10971	OMIM:604995	SLC22A7	3		
FBgn0038938	CG7084	HGNC:10972	OMIM:607581	SLC22A8	3		
FBgn0038938	CG7084	HGNC:10966	OMIM:602608	SLC22A2	3		
FBgn0038938	CG7084	HGNC:32935	OMIM:610792	SLC22A25	3		
FBgn0038938	CG7084	HGNC:10963	OMIM:602607	SLC22A1	3		
FBgn0038938	CG7084	HGNC:10967	OMIM:604842	SLC22A3	3		
FBgn0038938	CG7084	HGNC:17989	OMIM:607096	SLC22A12	3	220150	220150[HYPOURICEMIA, RENAL, 1; RHUC1]
FBgn0038938	CG7084	HGNC:18120	OMIM:607097	SLC22A11	3		
FBgn0038938	CG7084	HGNC:16261	OMIM:607579	SLC22A9	3		
FBgn0038938	CG7084	HGNC:28542	OMIM:611698	SLC22A24	3		
FBgn0038938	CG7084	HGNC:18057	OMIM:607580	SLC22A10	3		
FBgn0038946	rdhB	HGNC:28639	OMIM:616159	DHRS11	7		
FBgn0038947	Sar1	HGNC:10534	OMIM:607691	SAR1A	11		
FBgn0038947	Sar1	HGNC:10535	OMIM:607690	SAR1B	12	246700	246700[CHYLOMICRON RETENTION DISEASE; CMRD]
FBgn0260467	CG7071	HGNC:18085	OMIM:616815	TMEM199	10	616829	616829[CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIp; CDG2P]
FBgn0038952	CG7069	HGNC:9021	OMIM:179050	PKM	5		
FBgn0038952	CG7069	HGNC:9020	OMIM:609712	PKLR	5	102900,266200	102900[ADENOSINE TRIPHOSPHATE, ELEVATED, OF ERYTHROCYTES],266200[PYRUVATE KINASE DEFICIENCY OF RED CELLS]
FBgn0038953	CG18596	HGNC:11568	OMIM:605052	TARBP1	12		
FBgn0038957	CG7059	HGNC:8889	OMIM:612931	PGAM2	6	261670	261670[GLYCOGEN STORAGE DISEASE X; GSD10]
FBgn0038957	CG7059	HGNC:8888	OMIM:172250	PGAM1	6		
FBgn0038957	CG7059	HGNC:21731	OMIM:300567	PGAM4	5		
FBgn0038957	CG7059	HGNC:1093	OMIM:613896	BPGM	6	222800	222800[ERYTHROCYTOSIS, FAMILIAL, 8; ECYT8]
FBgn0038960	CG13855	HGNC:21995		IQUB	14		
FBgn0038965	mats	HGNC:29802		MOB3A	4		
FBgn0038965	mats	HGNC:23825	OMIM:617652	MOB3B	5		
FBgn0038965	mats	HGNC:29800		MOB3C	4		
FBgn0038965	mats	HGNC:16015	OMIM:609281	MOB1A	12		
FBgn0038965	mats	HGNC:29801	OMIM:609282	MOB1B	14		
FBgn0038964	Nop56	HGNC:15911	OMIM:614154	NOP56	13	614153	614153[SPINOCEREBELLAR ATAXIA 36; SCA36]
FBgn0038961	CG13850	HGNC:17443	OMIM:611325	TBRG4	12		
FBgn0038961	CG13850	HGNC:28758	OMIM:617530	FASTKD3	4		
FBgn0038961	CG13850	HGNC:24676	OMIM:606965	FASTK	3		
FBgn0038956	CAH8	HGNC:1380	OMIM:114780	CA6	6		
FBgn0038956	CAH8	HGNC:1381	OMIM:114770	CA7	3		
FBgn0038956	CAH8	HGNC:1371	OMIM:603263	CA12	4	143860	143860[HYPERCHLORHIDROSIS, ISOLATED; HYCHL]
FBgn0038956	CAH8	HGNC:1372	OMIM:604832	CA14	3		
FBgn0038956	CAH8	HGNC:1383	OMIM:603179	CA9	4		
FBgn0038956	CAH8	HGNC:1370	OMIM:604644	CA11	3		
FBgn0038956	CAH8	HGNC:1368	OMIM:114800	CA1	4		
FBgn0038956	CAH8	HGNC:1377	OMIM:114761	CA5A	4	615751	615751[CARBONIC ANHYDRASE VA DEFICIENCY, HYPERAMMONEMIA DUE TO; CA5AD]
FBgn0038956	CAH8	HGNC:14914	OMIM:611436	CA13	4		
FBgn0038956	CAH8	HGNC:1374	OMIM:114750	CA3	4		
FBgn0038956	CAH8	HGNC:1375	OMIM:114760	CA4	4		
FBgn0038956	CAH8	HGNC:1378	OMIM:300230	CA5B	4		
FBgn0038951	Polr3F	HGNC:15763	OMIM:617455	POLR3F	15	619872	619872[IMMUNODEFICIENCY 101 (VARICELLA ZOSTER VIRUS-SPECIFIC); IMD101]
FBgn0038948	JMJD6	HGNC:19355	OMIM:604914	JMJD6	15		
FBgn0038972	CG7054	HGNC:8630	OMIM:604591	PEBP1	6		
FBgn0038972	CG7054	HGNC:28319	OMIM:612473	PEBP4	4		
FBgn0038973	Pebp1	HGNC:8630	OMIM:604591	PEBP1	6		
FBgn0038973	Pebp1	HGNC:28319	OMIM:612473	PEBP4	4		
FBgn0038975	Nrx-1	HGNC:8008	OMIM:600565	NRXN1	12	614325,614332	614325[PITT-HOPKINS-LIKE SYNDROME 2; PTHSL2],614332[CHROMOSOME 2p16.3 DELETION SYNDROME]
FBgn0038975	Nrx-1	HGNC:8010	OMIM:600567	NRXN3	11		
FBgn0038975	Nrx-1	HGNC:8009	OMIM:600566	NRXN2	12		
FBgn0038976	Pfdn5	HGNC:8869	OMIM:604899	PFDN5	12		
FBgn0038978	tHMG1	HGNC:4983	OMIM:163905	HMGB1	3		
FBgn0038978	tHMG1	HGNC:5000	OMIM:163906	HMGB2	3		
FBgn0038978	tHMG1	HGNC:5004	OMIM:300193	HMGB3	3	300915	300915[MICROPHTHALMIA, SYNDROMIC 13; MCOPS13]
FBgn0038979	tHMG2	HGNC:4983	OMIM:163905	HMGB1	4		
FBgn0038979	tHMG2	HGNC:5000	OMIM:163906	HMGB2	4		
FBgn0038979	tHMG2	HGNC:5004	OMIM:300193	HMGB3	4	300915	300915[MICROPHTHALMIA, SYNDROMIC 13; MCOPS13]
FBgn0053110	CG33110	HGNC:26292	OMIM:614451	ELOVL7	6		
FBgn0053110	CG33110	HGNC:14416	OMIM:611814	ELOVL2	3		
FBgn0053110	CG33110	HGNC:14415	OMIM:605512	ELOVL4	3	133190,600110,614457	133190[SPINOCEREBELLAR ATAXIA 34; SCA34],600110[STARGARDT DISEASE 3; STGD3],614457[ICHTHYOSIS, SPASTIC QUADRIPLEGIA, AND MENTAL RETARDATION; ISQMR]
FBgn0053110	CG33110	HGNC:14418	OMIM:611813	ELOVL1	7	618527	618527[ICHTHYOTIC KERATODERMA, SPASTICITY, HYPOMYELINATION, AND DYSMORPHIC FACIAL FEATURES; IKSHD]
FBgn0053110	CG33110	HGNC:21308	OMIM:611805	ELOVL5	3	615957	615957[SPINOCEREBELLAR ATAXIA 38; SCA38]
FBgn0028837	CSN6	HGNC:21749	OMIM:614729	COPS6	14		
FBgn0038989	CG6937	HGNC:17838	OMIM:611970	NIFK	9		
FBgn0051158	Efa6	HGNC:9507	OMIM:602327	PSD	10		
FBgn0051158	Efa6	HGNC:19093	OMIM:614440	PSD3	9		
FBgn0051158	Efa6	HGNC:19096	OMIM:614442	PSD4	8		
FBgn0051158	Efa6	HGNC:19092		PSD2	9		
FBgn0051159	mRRF2	HGNC:29682	OMIM:606544	GFM2	14	618397	618397[COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 39; COXPD39]
FBgn0020278	loco	HGNC:9996	OMIM:602513	RGS14	6		
FBgn0020278	loco	HGNC:9994	OMIM:602512	RGS12	11		
FBgn0020278	loco	HGNC:9992	OMIM:602856	RGS10	3		
FBgn0051156	CG31156	HGNC:25521		SRBD1	13		
FBgn0014949	btn	HGNC:7014	OMIM:600535	MEOX2	6		
FBgn0014949	btn	HGNC:7013	OMIM:600147	MEOX1	6	214300	214300[KLIPPEL-FEIL SYNDROME 2, AUTOSOMAL RECESSIVE; KFS2]
FBgn0024558	Dph5	HGNC:24270	OMIM:611075	DPH5	13		
FBgn0038986	sit	HGNC:26292	OMIM:614451	ELOVL7	6		
FBgn0038986	sit	HGNC:14416	OMIM:611814	ELOVL2	3		
FBgn0038986	sit	HGNC:14415	OMIM:605512	ELOVL4	5	133190,600110,614457	133190[SPINOCEREBELLAR ATAXIA 34; SCA34],600110[STARGARDT DISEASE 3; STGD3],614457[ICHTHYOSIS, SPASTIC QUADRIPLEGIA, AND MENTAL RETARDATION; ISQMR]
FBgn0038986	sit	HGNC:14418	OMIM:611813	ELOVL1	6	618527	618527[ICHTHYOTIC KERATODERMA, SPASTICITY, HYPOMYELINATION, AND DYSMORPHIC FACIAL FEATURES; IKSHD]
FBgn0038986	sit	HGNC:21308	OMIM:611805	ELOVL5	3	615957	615957[SPINOCEREBELLAR ATAXIA 38; SCA38]
FBgn0038984	AdipoR	HGNC:24040	OMIM:607945	ADIPOR1	14		
FBgn0038984	AdipoR	HGNC:30133	OMIM:614581	MMD2	3		
FBgn0038984	AdipoR	HGNC:24041	OMIM:607946	ADIPOR2	12		
FBgn0038984	AdipoR	HGNC:7153	OMIM:604467	MMD	3		
FBgn0038984	AdipoR	HGNC:29645	OMIM:607781	PAQR5	3		
FBgn0038984	AdipoR	HGNC:30132	OMIM:614579	PAQR6	3		
FBgn0038984	AdipoR	HGNC:15708	OMIM:607780	PAQR8	3		
FBgn0038984	AdipoR	HGNC:23146	OMIM:607779	PAQR7	3		
FBgn0038983	CG5326	HGNC:26292	OMIM:614451	ELOVL7	5		
FBgn0038983	CG5326	HGNC:14416	OMIM:611814	ELOVL2	3		
FBgn0038983	CG5326	HGNC:14415	OMIM:605512	ELOVL4	3	133190,600110,614457	133190[SPINOCEREBELLAR ATAXIA 34; SCA34],600110[STARGARDT DISEASE 3; STGD3],614457[ICHTHYOSIS, SPASTIC QUADRIPLEGIA, AND MENTAL RETARDATION; ISQMR]
FBgn0038983	CG5326	HGNC:14418	OMIM:611813	ELOVL1	5	618527	618527[ICHTHYOTIC KERATODERMA, SPASTICITY, HYPOMYELINATION, AND DYSMORPHIC FACIAL FEATURES; IKSHD]
FBgn0038983	CG5326	HGNC:21308	OMIM:611805	ELOVL5	3	615957	615957[SPINOCEREBELLAR ATAXIA 38; SCA38]
FBgn0003676	CCT1	HGNC:11655	OMIM:186980	TCP1	14		
FBgn0038974	CG5377	HGNC:1094	OMIM:603156	BPHL	14		
FBgn0028688	Rpn7	HGNC:9564	OMIM:617857	PSMD6	15		
FBgn0038968	CG12499	HGNC:17344	OMIM:608865	URB1	12		
FBgn0038966	pinta	HGNC:12404	OMIM:600415	TTPA	3	277460	277460[ATAXIA WITH VITAMIN E DEFICIENCY; AVED]
FBgn0038966	pinta	HGNC:16114		TTPAL	3		
FBgn0039002	CG17625	HGNC:21180		SAMD5	4		
FBgn0039004	Nup133	HGNC:18016	OMIM:607613	NUP133	14	618177,618349	618177[NEPHROTIC SYNDROME, TYPE 18; NPHS18],618349[GALLOWAY-MOWAT SYNDROME 8; GAMOS8]
FBgn0039006	Cyp6d4	HGNC:2638	OMIM:605325	CYP3A5	4	145500	145500[HYPERTENSION, ESSENTIAL]
FBgn0039006	Cyp6d4	HGNC:17450	OMIM:606534	CYP3A43	4		
FBgn0039006	Cyp6d4	HGNC:11609	OMIM:274180	TBXAS1	3	231095	231095[GHOSAL HEMATODIAPHYSEAL DYSPLASIA; GHDD]
FBgn0039006	Cyp6d4	HGNC:2637	OMIM:124010	CYP3A4	4	619073	619073[VITAMIN D-DEPENDENT RICKETS, TYPE 3; VDDR3]
FBgn0039006	Cyp6d4	HGNC:51504		CYP3A7-CYP3A51P	4		
FBgn0039008	CG6972	HGNC:24577	OMIM:614637	DESI1	3		
FBgn0039019	HP1c	HGNC:1555	OMIM:604478	CBX5	5		
FBgn0039019	HP1c	HGNC:1551	OMIM:604511	CBX1	5		
FBgn0039019	HP1c	HGNC:1553	OMIM:604477	CBX3	6		
FBgn0039025	Usp12-46	HGNC:20485	OMIM:603091	USP12	13		
FBgn0039025	Usp12-46	HGNC:20075	OMIM:612849	USP46	14		
FBgn0039029	CG4704	HGNC:1530	OMIM:605084	MICU1	7	615673	615673[MYOPATHY WITH EXTRAPYRAMIDAL SIGNS; MPXPS]
FBgn0039024	Nepl15	HGNC:8918	OMIM:300550	PHEX	3	307800	307800[HYPOPHOSPHATEMIC RICKETS, X-LINKED DOMINANT; XLHR]
FBgn0039024	Nepl15	HGNC:14668	OMIM:618104	MMEL1	4		
FBgn0039024	Nepl15	HGNC:7154	OMIM:120520	MME	4	617017,617018	617017[CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2T; CMT2T],617018[SPINOCEREBELLAR ATAXIA 43; SCA43]
FBgn0039024	Nepl15	HGNC:13275	OMIM:610145	ECE2	3		
FBgn0039024	Nepl15	HGNC:3147	OMIM:605896	ECEL1	4	615065	615065[ARTHROGRYPOSIS, DISTAL, TYPE 5D; DA5D]
FBgn0039024	Nepl15	HGNC:3146	OMIM:600423	ECE1	4	145500,613870	145500[HYPERTENSION, ESSENTIAL],613870[HIRSCHSPRUNG DISEASE, CARDIAC DEFECTS, AND AUTONOMIC DYSFUNCTION; HCAD]
FBgn0039024	Nepl15	HGNC:6308	OMIM:613883	KEL	5	110900	110900[BLOOD GROUP--KELL SYSTEM; KEL]
FBgn0039023	Nepl14	HGNC:8918	OMIM:300550	PHEX	4	307800	307800[HYPOPHOSPHATEMIC RICKETS, X-LINKED DOMINANT; XLHR]
FBgn0039023	Nepl14	HGNC:14668	OMIM:618104	MMEL1	3		
FBgn0039023	Nepl14	HGNC:7154	OMIM:120520	MME	3	617017,617018	617017[CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2T; CMT2T],617018[SPINOCEREBELLAR ATAXIA 43; SCA43]
FBgn0039023	Nepl14	HGNC:13275	OMIM:610145	ECE2	3		
FBgn0039023	Nepl14	HGNC:3147	OMIM:605896	ECEL1	3	615065	615065[ARTHROGRYPOSIS, DISTAL, TYPE 5D; DA5D]
FBgn0039023	Nepl14	HGNC:3146	OMIM:600423	ECE1	3	145500,613870	145500[HYPERTENSION, ESSENTIAL],613870[HIRSCHSPRUNG DISEASE, CARDIAC DEFECTS, AND AUTONOMIC DYSFUNCTION; HCAD]
FBgn0039023	Nepl14	HGNC:6308	OMIM:613883	KEL	5	110900	110900[BLOOD GROUP--KELL SYSTEM; KEL]
FBgn0039022	Nepl13	HGNC:8918	OMIM:300550	PHEX	3	307800	307800[HYPOPHOSPHATEMIC RICKETS, X-LINKED DOMINANT; XLHR]
FBgn0039022	Nepl13	HGNC:14668	OMIM:618104	MMEL1	3		
FBgn0039022	Nepl13	HGNC:7154	OMIM:120520	MME	3	617017,617018	617017[CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2T; CMT2T],617018[SPINOCEREBELLAR ATAXIA 43; SCA43]
FBgn0039022	Nepl13	HGNC:13275	OMIM:610145	ECE2	3		
FBgn0039022	Nepl13	HGNC:3147	OMIM:605896	ECEL1	3	615065	615065[ARTHROGRYPOSIS, DISTAL, TYPE 5D; DA5D]
FBgn0039022	Nepl13	HGNC:3146	OMIM:600423	ECE1	3	145500,613870	145500[HYPERTENSION, ESSENTIAL],613870[HIRSCHSPRUNG DISEASE, CARDIAC DEFECTS, AND AUTONOMIC DYSFUNCTION; HCAD]
FBgn0039022	Nepl13	HGNC:6308	OMIM:613883	KEL	5	110900	110900[BLOOD GROUP--KELL SYSTEM; KEL]
FBgn0051139	CG31139	HGNC:22954	OMIM:615618	POGLUT1	5	615696,617232	615696[DOWLING-DEGOS DISEASE 4; DDD4],617232[MUSCULAR DYSTROPHY, LIMB-GIRDLE, AUTOSOMAL RECESSIVE 21; LGMDR21]
FBgn0051139	CG31139	HGNC:19350	OMIM:611613	POGLUT2	3		
FBgn0039016	Dcr-1	HGNC:17098	OMIM:606241	DICER1	15	138800,180295,601200,618272	138800[GOITER, MULTINODULAR 1, WITH OR WITHOUT SERTOLI-LEYDIG CELL TUMORS; MNG1],180295[RHABDOMYOSARCOMA, EMBRYONAL, 2; RMSE2],601200[PLEUROPULMONARY BLASTOMA; PPB],618272[GLOBAL DEVELOPMENTAL DELAY, LUNG CYSTS, OVERGROWTH, AND WILMS TUMOR; GLOW]
FBgn0039015	Takl2	HGNC:6859	OMIM:602614	MAP3K7	6	157800,617137	157800[CARDIOSPONDYLOCARPOFACIAL SYNDROME; CSCF],617137[FRONTOMETAPHYSEAL DYSPLASIA 2; FMD2]
FBgn0039013	RNF220	HGNC:25552	OMIM:616136	RNF220	14	619688	619688[LEUKODYSTROPHY, HYPOMYELINATING, 23, WITH ATAXIA, DEAFNESS, LIVER DYSFUNCTION, AND DILATED CARDIOMYOPATHY; HLD23]
FBgn0024958	Irp-1A	HGNC:117	OMIM:100880	ACO1	12		
FBgn0024958	Irp-1A	HGNC:118	OMIM:100850	ACO2	3	614559,616289	614559[INFANTILE CEREBELLAR-RETINAL DEGENERATION; ICRD],616289[OPTIC ATROPHY 9; OPA9]
FBgn0024958	Irp-1A	HGNC:6115	OMIM:147582	IREB2	7	618451	618451[NEURODEGENERATION, EARLY-ONSET, WITH CHOREOATHETOID MOVEMENTS AND MICROCYTIC ANEMIA; NDCAMA]
FBgn0051151	wge	HGNC:29279	OMIM:617646	BAHCC1	7		
FBgn0051151	wge	HGNC:11962		TNRC18	7		
FBgn0039010	CG4907	HGNC:8967	OMIM:606097	PIGN	8	614080	614080[MULTIPLE CONGENITAL ANOMALIES-HYPOTONIA-SEIZURES SYNDROME 1; MCAHS1]
FBgn0039009	CG13842	HGNC:25889		CCDC142	6		
FBgn0039003	wfs1	HGNC:12762	OMIM:606201	WFS1	14	116400,125853,222300,600965,614296	116400[CATARACT 41; CTRCT41],125853[TYPE 2 DIABETES MELLITUS; T2D],222300[WOLFRAM SYNDROME 1; WFS1],600965[DEAFNESS, AUTOSOMAL DOMINANT 6; DFNA6],614296[WOLFRAM-LIKE SYNDROME, AUTOSOMAL DOMINANT; WFSL]
FBgn0046114	Gclm	HGNC:4312	OMIM:601176	GCLM	14	608446	608446[MYOCARDIAL INFARCTION, SUSCEPTIBILITY TO]
FBgn0017590	klg	HGNC:17302	OMIM:613173	NEGR1	3		
FBgn0017590	klg	HGNC:34550	OMIM:618861	IGLON5	3		
FBgn0017590	klg	HGNC:6705	OMIM:603241	LSAMP	3		
FBgn0017590	klg	HGNC:8143	OMIM:600632	OPCML	3	167000	167000[OVARIAN CANCER]
FBgn0017590	klg	HGNC:17941	OMIM:607938	NTM	3		
FBgn0039030	CG6660	HGNC:26292	OMIM:614451	ELOVL7	7		
FBgn0039030	CG6660	HGNC:14416	OMIM:611814	ELOVL2	4		
FBgn0039030	CG6660	HGNC:14415	OMIM:605512	ELOVL4	4	133190,600110,614457	133190[SPINOCEREBELLAR ATAXIA 34; SCA34],600110[STARGARDT DISEASE 3; STGD3],614457[ICHTHYOSIS, SPASTIC QUADRIPLEGIA, AND MENTAL RETARDATION; ISQMR]
FBgn0039030	CG6660	HGNC:14418	OMIM:611813	ELOVL1	6	618527	618527[ICHTHYOTIC KERATODERMA, SPASTICITY, HYPOMYELINATION, AND DYSMORPHIC FACIAL FEATURES; IKSHD]
FBgn0039030	CG6660	HGNC:21308	OMIM:611805	ELOVL5	4	615957	615957[SPINOCEREBELLAR ATAXIA 38; SCA38]
FBgn0039038	CG6688	HGNC:11076	OMIM:606553	SLC9A3R2	3		
FBgn0027526	Ublcp1	HGNC:28110	OMIM:609867	UBLCP1	14		
FBgn0039049	CG6726	HGNC:177	OMIM:104620	ACY1	11	609924	609924[AMINOACYLASE 1 DEFICIENCY; ACY1D]
FBgn0039049	CG6726	HGNC:24538	OMIM:618771	ABHD14A	3		
FBgn0039049	CG6726	HGNC:38856		ABHD14A-ACY1	3		
FBgn0039050	CG17110	HGNC:177	OMIM:104620	ACY1	12	609924	609924[AMINOACYLASE 1 DEFICIENCY; ACY1D]
FBgn0039050	CG17110	HGNC:38856		ABHD14A-ACY1	3		
FBgn0039051	CG17109	HGNC:177	OMIM:104620	ACY1	12	609924	609924[AMINOACYLASE 1 DEFICIENCY; ACY1D]
FBgn0039051	CG17109	HGNC:38856		ABHD14A-ACY1	3		
FBgn0039052	CG6733	HGNC:177	OMIM:104620	ACY1	13	609924	609924[AMINOACYLASE 1 DEFICIENCY; ACY1D]
FBgn0039052	CG6733	HGNC:26518	OMIM:617124	PM20D1	4		
FBgn0039052	CG6733	HGNC:38856		ABHD14A-ACY1	4		
FBgn0039053	CG6738	HGNC:177	OMIM:104620	ACY1	12	609924	609924[AMINOACYLASE 1 DEFICIENCY; ACY1D]
FBgn0039053	CG6738	HGNC:26518	OMIM:617124	PM20D1	3		
FBgn0039053	CG6738	HGNC:38856		ABHD14A-ACY1	3		
FBgn0039054	Cow	HGNC:11251	OMIM:602264	SPOCK1	9		
FBgn0039054	Cow	HGNC:13564	OMIM:607988	SPOCK2	10		
FBgn0039054	Cow	HGNC:13565	OMIM:607989	SPOCK3	11		
FBgn0053193	sav	HGNC:17795	OMIM:607203	SAV1	10		
FBgn0039045	Ctns	HGNC:2518	OMIM:606272	CTNS	15	219750,219800,219900	219750[CYSTINOSIS, ADULT NONNEPHROPATHIC],219800[CYSTINOSIS, NEPHROPATHIC; CTNS],219900[CYSTINOSIS, LATE-ONSET JUVENILE OR ADOLESCENT NEPHROPATHIC TYPE]
FBgn0039044	p53	HGNC:15979	OMIM:603273	TP63	8	103285,106260,129400,603543,604292,605289,618149	103285[ADULT SYNDROME],106260[ANKYLOBLEPHARON-ECTODERMAL DEFECTS-CLEFT LIP/PALATE; AEC],129400[RAPP-HODGKIN SYNDROME; RHS],603543[LIMB-MAMMARY SYNDROME; LMS],604292[ECTRODACTYLY, ECTODERMAL DYSPLASIA, AND CLEFT LIP/PALATE SYNDROME 3; EEC3],605289[SPLIT-HAND/FOOT MALFORMATION 4; SHFM4],618149[OROFACIAL CLEFT 8; OFC8]
FBgn0039044	p53	HGNC:12003	OMIM:601990	TP73	8	619466	619466[CILIARY DYSKINESIA, PRIMARY, 47, AND LISSENCEPHALY; CILD47]
FBgn0039044	p53	HGNC:11998	OMIM:191170	TP53	7	114480,114500,114550,137800,151623,202300,259500,260350,260500,607107,614740,618165	114480[BREAST CANCER],114500[COLORECTAL CANCER; CRC],114550[HEPATOCELLULAR CARCINOMA],137800[GLIOMA SUSCEPTIBILITY 1; GLM1],151623[LI-FRAUMENI SYNDROME; LFS],202300[ADRENOCORTICAL CARCINOMA, HEREDITARY; ADCC],259500[OSTEOGENIC SARCOMA],260350[PANCREATIC CANCER],260500[PAPILLOMA OF CHOROID PLEXUS; CPP],607107[NASOPHARYNGEAL CARCINOMA],614740[BASAL CELL CARCINOMA, SUSCEPTIBILITY TO, 7; BCC7],618165[BONE MARROW FAILURE SYNDROME 5; BMFS5]
FBgn0039043	CG17121	HGNC:18685	OMIM:612127	HSD17B13	4		
FBgn0039043	CG17121	HGNC:17693	OMIM:612830	DHRS3	4		
FBgn0039043	CG17121	HGNC:30311	OMIM:608989	SDR16C5	4		
FBgn0039043	CG17121	HGNC:22960	OMIM:612831	HSD17B11	4		
FBgn0039043	CG17121	HGNC:19975	OMIM:607599	RDH10	4		
FBgn0039040	CG13833	HGNC:18685	OMIM:612127	HSD17B13	4		
FBgn0039040	CG13833	HGNC:17693	OMIM:612830	DHRS3	4		
FBgn0039040	CG13833	HGNC:30311	OMIM:608989	SDR16C5	4		
FBgn0039040	CG13833	HGNC:22960	OMIM:612831	HSD17B11	4		
FBgn0039040	CG13833	HGNC:19975	OMIM:607599	RDH10	4		
FBgn0039039	lmd	HGNC:29525	OMIM:610378	GLIS1	6		
FBgn0039039	lmd	HGNC:28510	OMIM:610192	GLIS3	7	610199	610199[DIABETES MELLITUS, NEONATAL, WITH CONGENITAL HYPOTHYROIDISM; NDH]
FBgn0039056	CenB1A	HGNC:16922	OMIM:608651	AGAP1	3		
FBgn0039056	CenB1A	HGNC:16754		ACAP3	13		
FBgn0039056	CenB1A	HGNC:16467	OMIM:607763	ACAP1	12		
FBgn0039056	CenB1A	HGNC:16923	OMIM:616813	AGAP3	3		
FBgn0039056	CenB1A	HGNC:16469	OMIM:607766	ACAP2	13		
FBgn0039066	EloA	HGNC:11620	OMIM:600786	ELOA	12		
FBgn0039066	EloA	HGNC:31007		ELOA3B	9		
FBgn0039066	EloA	HGNC:30771	OMIM:609522	ELOA2	10		
FBgn0039066	EloA	HGNC:24617		ELOA3	6		
FBgn0039066	EloA	HGNC:33511		ELOA3D	10		
FBgn0039066	EloA	HGNC:52410		ELOA3C	4		
FBgn0039068	Pex11c	HGNC:20208	OMIM:607583	PEX11G	14		
FBgn0025781	Cdc16	HGNC:1720	OMIM:603461	CDC16	13		
FBgn0039069	CG6763	HGNC:7015	OMIM:600388	MEP1A	3		
FBgn0039069	CG6763	HGNC:7020	OMIM:600389	MEP1B	3		
FBgn0039069	CG6763	HGNC:31704	OMIM:608860	ASTL	6	619643	619643[OOCYTE MATURATION DEFECT 11; OOMD11]
FBgn0039071	bb8	HGNC:4336	OMIM:300144	GLUD2	7	168600	168600[PARKINSON DISEASE, LATE-ONSET; PD]
FBgn0039071	bb8	HGNC:4335	OMIM:138130	GLUD1	8	606762	606762[HYPERINSULINEMIC HYPOGLYCEMIA, FAMILIAL, 6; HHF6]
FBgn0039070	wam	HGNC:26560	OMIM:615038	CCDC114	4	615067	615067[CILIARY DYSKINESIA, PRIMARY, 20; CILD20]
FBgn0039070	wam	HGNC:26669	OMIM:617969	CCDC63	8		
FBgn0039067	wda	HGNC:17304		TAF5L	6		
FBgn0039064	CG4467	HGNC:18173	OMIM:606832	ERAP1	4		
FBgn0039064	CG4467	HGNC:7900	OMIM:606793	NPEPPS	3		
FBgn0039064	CG4467	HGNC:29499	OMIM:609497	ERAP2	4		
FBgn0039064	CG4467	HGNC:6656	OMIM:151300	LNPEP	4		
FBgn0011596	fzo	HGNC:16877	OMIM:608507	MFN2	7	601152,609260,617087	601152[NEUROPATHY, HEREDITARY MOTOR AND SENSORY, TYPE VIA, WITH OPTIC ATROPHY; HMSN6A],609260[CHARCOT-MARIE-TOOTH DISEASE, AXONAL, AUTOSOMAL DOMINANT, TYPE 2A2A; CMT2A2A],617087[CHARCOT-MARIE-TOOTH DISEASE, AXONAL, AUTOSOMAL RECESSIVE, TYPE 2A2B; CMT2A2B]
FBgn0011596	fzo	HGNC:18262	OMIM:608506	MFN1	6		
FBgn0039059	CG13829	HGNC:22082	OMIM:300913	VMA21	3	310440	310440[MYOPATHY, X-LINKED, WITH EXCESSIVE AUTOPHAGY; MEAX]
FBgn0039058	VhaAC39-2	HGNC:13724	OMIM:607028	ATP6V0D1	9		
FBgn0039058	VhaAC39-2	HGNC:18266	OMIM:618072	ATP6V0D2	8		
FBgn0004395	unk	HGNC:14184	OMIM:617463	UNKL	9		
FBgn0004395	unk	HGNC:29369	OMIM:616375	UNK	12		
FBgn0039055	Rassf	HGNC:9882	OMIM:605082	RASSF1	3		
FBgn0039055	Rassf	HGNC:2360	OMIM:123875	CRIP1	3		
FBgn0039055	Rassf	HGNC:9883	OMIM:609492	RASSF2	12		
FBgn0039055	Rassf	HGNC:20793	OMIM:610559	RASSF4	12		
FBgn0039055	Rassf	HGNC:20796	OMIM:612620	RASSF6	10		
FBgn0039055	Rassf	HGNC:14271	OMIM:607019	RASSF3	3		
FBgn0024509	Sec13	HGNC:10697	OMIM:600152	SEC13	13		
FBgn0002622	RpS3	HGNC:10420	OMIM:600454	RPS3	14		
FBgn0039087	Ugt303B2	HGNC:12531	OMIM:606435	UGT1A10	4		
FBgn0039087	Ugt303B2	HGNC:12545	OMIM:603064	UGT2B11	6		
FBgn0039087	Ugt303B2	HGNC:12530	OMIM:191740	UGT1A1	6	143500,218800,237900,601816,606785	143500[GILBERT SYNDROME],218800[CRIGLER-NAJJAR SYNDROME, TYPE I],237900[HYPERBILIRUBINEMIA, TRANSIENT FAMILIAL NEONATAL; HBLRTFN],601816[BILIRUBIN, SERUM LEVEL OF, QUANTITATIVE TRAIT LOCUS 1; BILIQTL1],606785[CRIGLER-NAJJAR SYNDROME, TYPE II]
FBgn0039087	Ugt303B2	HGNC:12555	OMIM:601291	UGT8	5		
FBgn0039087	Ugt303B2	HGNC:12539	OMIM:606432	UGT1A7	4		
FBgn0039087	Ugt303B2	HGNC:13479	OMIM:606497	UGT2B28	6		
FBgn0039087	Ugt303B2	HGNC:27266	OMIM:616384	UGT3A2	4		
FBgn0039087	Ugt303B2	HGNC:12544	OMIM:600070	UGT2B10	6		
FBgn0039087	Ugt303B2	HGNC:12537	OMIM:606430	UGT1A5	4		
FBgn0039087	Ugt303B2	HGNC:12546	OMIM:600069	UGT2B15	6		
FBgn0039087	Ugt303B2	HGNC:12541	OMIM:606434	UGT1A9	4		
FBgn0039087	Ugt303B2	HGNC:28528	OMIM:616382	UGT2A3	6		
FBgn0039087	Ugt303B2	HGNC:12535	OMIM:606428	UGT1A3	6		
FBgn0039087	Ugt303B2	HGNC:12536	OMIM:606429	UGT1A4	4		
FBgn0039087	Ugt303B2	HGNC:12540	OMIM:606433	UGT1A8	4		
FBgn0039087	Ugt303B2	HGNC:26625	OMIM:616383	UGT3A1	4		
FBgn0039087	Ugt303B2	HGNC:12547	OMIM:601903	UGT2B17	6	612560	612560[BONE MINERAL DENSITY QUANTITATIVE TRAIT LOCUS 12; BMND12]
FBgn0039087	Ugt303B2	HGNC:12553	OMIM:600067	UGT2B4	6		
FBgn0039087	Ugt303B2	HGNC:12538	OMIM:606431	UGT1A6	4		
FBgn0039087	Ugt303B2	HGNC:12554	OMIM:600068	UGT2B7	6		
FBgn0039087	Ugt303B2	HGNC:28183	OMIM:619809	UGT2A2	5		
FBgn0039086	Ugt303B1	HGNC:12531	OMIM:606435	UGT1A10	4		
FBgn0039086	Ugt303B1	HGNC:12545	OMIM:603064	UGT2B11	6		
FBgn0039086	Ugt303B1	HGNC:12530	OMIM:191740	UGT1A1	6	143500,218800,237900,601816,606785	143500[GILBERT SYNDROME],218800[CRIGLER-NAJJAR SYNDROME, TYPE I],237900[HYPERBILIRUBINEMIA, TRANSIENT FAMILIAL NEONATAL; HBLRTFN],601816[BILIRUBIN, SERUM LEVEL OF, QUANTITATIVE TRAIT LOCUS 1; BILIQTL1],606785[CRIGLER-NAJJAR SYNDROME, TYPE II]
FBgn0039086	Ugt303B1	HGNC:12555	OMIM:601291	UGT8	5		
FBgn0039086	Ugt303B1	HGNC:12539	OMIM:606432	UGT1A7	4		
FBgn0039086	Ugt303B1	HGNC:13479	OMIM:606497	UGT2B28	6		
FBgn0039086	Ugt303B1	HGNC:27266	OMIM:616384	UGT3A2	4		
FBgn0039086	Ugt303B1	HGNC:12544	OMIM:600070	UGT2B10	6		
FBgn0039086	Ugt303B1	HGNC:12537	OMIM:606430	UGT1A5	4		
FBgn0039086	Ugt303B1	HGNC:12546	OMIM:600069	UGT2B15	6		
FBgn0039086	Ugt303B1	HGNC:12541	OMIM:606434	UGT1A9	4		
FBgn0039086	Ugt303B1	HGNC:28528	OMIM:616382	UGT2A3	6		
FBgn0039086	Ugt303B1	HGNC:12535	OMIM:606428	UGT1A3	6		
FBgn0039086	Ugt303B1	HGNC:12536	OMIM:606429	UGT1A4	4		
FBgn0039086	Ugt303B1	HGNC:12540	OMIM:606433	UGT1A8	4		
FBgn0039086	Ugt303B1	HGNC:26625	OMIM:616383	UGT3A1	4		
FBgn0039086	Ugt303B1	HGNC:12547	OMIM:601903	UGT2B17	6	612560	612560[BONE MINERAL DENSITY QUANTITATIVE TRAIT LOCUS 12; BMND12]
FBgn0039086	Ugt303B1	HGNC:12553	OMIM:600067	UGT2B4	6		
FBgn0039086	Ugt303B1	HGNC:12538	OMIM:606431	UGT1A6	4		
FBgn0039086	Ugt303B1	HGNC:12554	OMIM:600068	UGT2B7	6		
FBgn0039086	Ugt303B1	HGNC:28183	OMIM:619809	UGT2A2	5		
FBgn0039085	Ugt303B3	HGNC:12531	OMIM:606435	UGT1A10	4		
FBgn0039085	Ugt303B3	HGNC:12545	OMIM:603064	UGT2B11	6		
FBgn0039085	Ugt303B3	HGNC:12530	OMIM:191740	UGT1A1	6	143500,218800,237900,601816,606785	143500[GILBERT SYNDROME],218800[CRIGLER-NAJJAR SYNDROME, TYPE I],237900[HYPERBILIRUBINEMIA, TRANSIENT FAMILIAL NEONATAL; HBLRTFN],601816[BILIRUBIN, SERUM LEVEL OF, QUANTITATIVE TRAIT LOCUS 1; BILIQTL1],606785[CRIGLER-NAJJAR SYNDROME, TYPE II]
FBgn0039085	Ugt303B3	HGNC:12555	OMIM:601291	UGT8	5		
FBgn0039085	Ugt303B3	HGNC:12539	OMIM:606432	UGT1A7	4		
FBgn0039085	Ugt303B3	HGNC:13479	OMIM:606497	UGT2B28	6		
FBgn0039085	Ugt303B3	HGNC:27266	OMIM:616384	UGT3A2	4		
FBgn0039085	Ugt303B3	HGNC:12544	OMIM:600070	UGT2B10	6		
FBgn0039085	Ugt303B3	HGNC:12537	OMIM:606430	UGT1A5	4		
FBgn0039085	Ugt303B3	HGNC:12546	OMIM:600069	UGT2B15	6		
FBgn0039085	Ugt303B3	HGNC:12541	OMIM:606434	UGT1A9	4		
FBgn0039085	Ugt303B3	HGNC:28528	OMIM:616382	UGT2A3	6		
FBgn0039085	Ugt303B3	HGNC:12535	OMIM:606428	UGT1A3	6		
FBgn0039085	Ugt303B3	HGNC:12536	OMIM:606429	UGT1A4	4		
FBgn0039085	Ugt303B3	HGNC:12540	OMIM:606433	UGT1A8	4		
FBgn0039085	Ugt303B3	HGNC:26625	OMIM:616383	UGT3A1	4		
FBgn0039085	Ugt303B3	HGNC:12547	OMIM:601903	UGT2B17	6	612560	612560[BONE MINERAL DENSITY QUANTITATIVE TRAIT LOCUS 12; BMND12]
FBgn0039085	Ugt303B3	HGNC:12553	OMIM:600067	UGT2B4	6		
FBgn0039085	Ugt303B3	HGNC:12538	OMIM:606431	UGT1A6	4		
FBgn0039085	Ugt303B3	HGNC:12554	OMIM:600068	UGT2B7	6		
FBgn0039085	Ugt303B3	HGNC:28183	OMIM:619809	UGT2A2	5		
FBgn0039084	CG10175	HGNC:26741		CES4A	5		
FBgn0039084	CG10175	HGNC:108	OMIM:100740	ACHE	4	112100	112100[YT BLOOD GROUP ANTIGEN]
FBgn0039084	CG10175	HGNC:983	OMIM:177400	BCHE	3	617936	617936[BUTYRYLCHOLINESTERASE DEFICIENCY; BCHED]
FBgn0039084	CG10175	HGNC:26459	OMIM:618678	CES5A	5		
FBgn0039084	CG10175	HGNC:1863	OMIM:114835	CES1	5	618057	618057[DRUG METABOLISM, ALTERED, CES1-RELATED]
FBgn0039084	CG10175	HGNC:1864	OMIM:605278	CES2	5		
FBgn0039084	CG10175	HGNC:1865	OMIM:605279	CES3	5		
FBgn0039081	Irk2	HGNC:6270	OMIM:600932	KCNJ9	7		
FBgn0039081	Irk2	HGNC:6262	OMIM:605722	KCNJ16	6	619406	619406[HYPOKALEMIC TUBULOPATHY AND DEAFNESS; HKTD]
FBgn0039081	Irk2	HGNC:6263	OMIM:600681	KCNJ2	9	170390,609622,613980	170390[ANDERSEN CARDIODYSRHYTHMIC PERIODIC PARALYSIS],609622[SHORT QT SYNDROME 3; SQT3],613980[ATRIAL FIBRILLATION, FAMILIAL, 9; ATFB9]
FBgn0039081	Irk2	HGNC:6255	OMIM:600359	KCNJ1	5	241200	241200[BARTTER SYNDROME, TYPE 2, ANTENATAL; BARTS2]
FBgn0039081	Irk2	HGNC:6258	OMIM:602323	KCNJ12	9		
FBgn0039081	Irk2	HGNC:6267	OMIM:600877	KCNJ6	6	614098	614098[KEPPEN-LUBINSKY SYNDROME; KPLBS]
FBgn0039081	Irk2	HGNC:6265	OMIM:600504	KCNJ4	9		
FBgn0039081	Irk2	HGNC:6264	OMIM:601534	KCNJ3	5		
FBgn0039081	Irk2	HGNC:39080	OMIM:613236	KCNJ18	8	613239	613239[THYROTOXIC PERIODIC PARALYSIS, SUSCEPTIBILITY TO, 2; TTPP2]
FBgn0039081	Irk2	HGNC:6260	OMIM:603953	KCNJ14	6		
FBgn0039081	Irk2	HGNC:6269	OMIM:600935	KCNJ8	4		
FBgn0039081	Irk2	HGNC:6257	OMIM:600937	KCNJ11	4	125853,601820,610582,616329,618856	125853[TYPE 2 DIABETES MELLITUS; T2D],601820[HYPERINSULINEMIC HYPOGLYCEMIA, FAMILIAL, 2; HHF2],610582[DIABETES MELLITUS, TRANSIENT NEONATAL, 3],616329[MATURITY-ONSET DIABETES OF THE YOUNG, TYPE 13; MODY13],618856[DIABETES MELLITUS, PERMANENT NEONATAL, 2; PNDM2]
FBgn0039081	Irk2	HGNC:6266	OMIM:600734	KCNJ5	6	613485,613677	613485[LONG QT SYNDROME 13; LQT13],613677[HYPERALDOSTERONISM, FAMILIAL, TYPE III; HALD3]
FBgn0039081	Irk2	HGNC:6256	OMIM:602208	KCNJ10	5	600791,612780	600791[DEAFNESS, AUTOSOMAL RECESSIVE 4, WITH ENLARGED VESTIBULAR AQUEDUCT; DFNB4],612780[SEIZURES, SENSORINEURAL DEAFNESS, ATAXIA, MENTAL RETARDATION, AND ELECTROLYTE IMBALANCE; SESAMES]
FBgn0039081	Irk2	HGNC:6261	OMIM:602106	KCNJ15	5		
FBgn0039081	Irk2	HGNC:6259	OMIM:603208	KCNJ13	5	193230,614186	193230[VITREORETINAL DEGENERATION, SNOWFLAKE TYPE; SVD],614186[LEBER CONGENITAL AMAUROSIS 16; LCA16]
FBgn0039075	CG4393	HGNC:20961	OMIM:608994	ANKS1A	11		
FBgn0039075	CG4393	HGNC:24600	OMIM:607815	ANKS1B	10		
FBgn0039073	CG4408	HGNC:2300	OMIM:603101	CPB2	6		
FBgn0039073	CG4408	HGNC:21011	OMIM:609563	CPO	6		
FBgn0039073	CG4408	HGNC:2298	OMIM:114851	CPA3	5		
FBgn0039073	CG4408	HGNC:2297	OMIM:600688	CPA2	6		
FBgn0039073	CG4408	HGNC:15740	OMIM:607635	CPA4	6		
FBgn0039073	CG4408	HGNC:2299	OMIM:114852	CPB1	6		
FBgn0039073	CG4408	HGNC:2296	OMIM:114850	CPA1	6		
FBgn0039073	CG4408	HGNC:17245	OMIM:609562	CPA6	6	614417,614418	614417[EPILEPSY, FAMILIAL TEMPORAL LOBE, 5; ETL5],614418[FEBRILE SEIZURES, FAMILIAL, 11; FEB11]
FBgn0039073	CG4408	HGNC:15722	OMIM:609561	CPA5	6		
FBgn0016119	ATPsynCF6	HGNC:847	OMIM:603152	ATP5PF	13		
FBgn0039098	GILT3	HGNC:5398	OMIM:604664	IFI30	7		
FBgn0039099	GILT2	HGNC:5398	OMIM:604664	IFI30	8		
FBgn0051148	Gba1a	HGNC:4177	OMIM:606463	GBA1	14	127750,168600,230800,230900,231000,231005,608013	127750[DEMENTIA, LEWY BODY; DLB],168600[PARKINSON DISEASE, LATE-ONSET; PD],230800[GAUCHER DISEASE, TYPE I; GD1],230900[GAUCHER DISEASE, TYPE II; GD2],231000[GAUCHER DISEASE, TYPE III; GD3],231005[GAUCHER DISEASE, TYPE IIIC; GD3C],608013[GAUCHER DISEASE, PERINATAL LETHAL]
FBgn0051413	Qsox4	HGNC:9756	OMIM:603120	QSOX1	8		
FBgn0051413	Qsox4	HGNC:30249	OMIM:612860	QSOX2	10		
FBgn0051414	Gba1b	HGNC:4177	OMIM:606463	GBA1	14	127750,168600,230800,230900,231000,231005,608013	127750[DEMENTIA, LEWY BODY; DLB],168600[PARKINSON DISEASE, LATE-ONSET; PD],230800[GAUCHER DISEASE, TYPE I; GD1],230900[GAUCHER DISEASE, TYPE II; GD2],231000[GAUCHER DISEASE, TYPE III; GD3],231005[GAUCHER DISEASE, TYPE IIIC; GD3C],608013[GAUCHER DISEASE, PERINATAL LETHAL]
FBgn0039106	CG10301	HGNC:12404	OMIM:600415	TTPA	3	277460	277460[ATAXIA WITH VITAMIN E DEFICIENCY; AVED]
FBgn0039106	CG10301	HGNC:16114		TTPAL	3		
FBgn0039106	CG10301	HGNC:10024	OMIM:180090	RLBP1	3	136880,607475,607476	136880[FUNDUS ALBIPUNCTATUS],607475[BOTHNIA RETINAL DYSTROPHY],607476[NEWFOUNDLAND ROD-CONE DYSTROPHY; NFRCD]
FBgn0039106	CG10301	HGNC:23046	OMIM:616945	CLVS2	3		
FBgn0039106	CG10301	HGNC:23139	OMIM:611292	CLVS1	3		
FBgn0039107	CG10300	HGNC:12404	OMIM:600415	TTPA	3	277460	277460[ATAXIA WITH VITAMIN E DEFICIENCY; AVED]
FBgn0039107	CG10300	HGNC:16114		TTPAL	3		
FBgn0039107	CG10300	HGNC:10024	OMIM:180090	RLBP1	3	136880,607475,607476	136880[FUNDUS ALBIPUNCTATUS],607475[BOTHNIA RETINAL DYSTROPHY],607476[NEWFOUNDLAND ROD-CONE DYSTROPHY; NFRCD]
FBgn0039107	CG10300	HGNC:23046	OMIM:616945	CLVS2	3		
FBgn0039107	CG10300	HGNC:23139	OMIM:611292	CLVS1	3		
FBgn0039109	CG10365	HGNC:32363	OMIM:617446	CHAC2	5		
FBgn0039109	CG10365	HGNC:28680	OMIM:614587	CHAC1	12		
FBgn0028684	Rpt5	HGNC:9549	OMIM:186852	PSMC3	13	619354	619354[DEAFNESS, CATARACT, IMPAIRED INTELLECTUAL DEVELOPMENT, AND POLYNEUROPATHY; DCIDP]
FBgn0039111	PTPMT1	HGNC:26965	OMIM:609538	PTPMT1	13		
FBgn0039112	SdhD	HGNC:10683	OMIM:602690	SDHD	12	168000,171300,606864,619167	168000[PARAGANGLIOMAS 1; PGL1],171300[PHEOCHROMOCYTOMA],606864[PARAGANGLIOMA AND GASTRIC STROMAL SARCOMA],619167[MITOCHONDRIAL COMPLEX II DEFICIENCY, NUCLEAR TYPE 3; MC2DN3]
FBgn0028475	Hrd3	HGNC:15897	OMIM:614289	SEL1L2	9		
FBgn0028475	Hrd3	HGNC:10717	OMIM:602329	SEL1L	15		
FBgn0039110	RanBP3	HGNC:26353	OMIM:616391	RANBP3L	9		
FBgn0039110	RanBP3	HGNC:9850	OMIM:603327	RANBP3	12		
FBgn0028691	Rpn9	HGNC:9558	OMIM:603481	PSMD13	15		
FBgn0002922	nau	HGNC:7566	OMIM:159991	MYF6	8		
FBgn0002922	nau	HGNC:7612	OMIM:159980	MYOG	7		
FBgn0002922	nau	HGNC:7611	OMIM:159970	MYOD1	10	618975	618975[MYOPATHY, CONGENITAL, WITH DIAPHRAGMATIC DEFECTS, RESPIRATORY INSUFFICIENCY, AND DYSMORPHIC FACIES; MYODRIF]
FBgn0002922	nau	HGNC:7565	OMIM:159990	MYF5	11	618155	618155[OPHTHALMOPLEGIA, EXTERNAL, WITH RIB AND VERTEBRAL ANOMALIES; EORVA]
FBgn0043005	prt	HGNC:10934	OMIM:193002	SLC18A1	4		
FBgn0043005	prt	HGNC:10935	OMIM:193001	SLC18A2	5	618049	618049[PARKINSONISM-DYSTONIA 2, INFANTILE-ONSET; PKDYS2]
FBgn0039104	CG10252	HGNC:26841		ODF3L2	11		
FBgn0039104	CG10252	HGNC:34388		ODF3B	6		
FBgn0039104	CG10252	HGNC:19905	OMIM:608356	ODF3	9		
FBgn0039104	CG10252	HGNC:28735		ODF3L1	6		
FBgn0027512	CG10254	HGNC:29554	OMIM:617649	UBE2O	12		
FBgn0051145	CG31145	HGNC:23015	OMIM:611062	FAM20A	7	204690	204690[AMELOGENESIS IMPERFECTA, TYPE IG; AI1G]
FBgn0051145	CG31145	HGNC:22140	OMIM:611061	FAM20C	10	259775	259775[RAINE SYNDROME; RNS]
FBgn0051141	CG31141	HGNC:26292	OMIM:614451	ELOVL7	5		
FBgn0051141	CG31141	HGNC:14416	OMIM:611814	ELOVL2	3		
FBgn0051141	CG31141	HGNC:14415	OMIM:605512	ELOVL4	3	133190,600110,614457	133190[SPINOCEREBELLAR ATAXIA 34; SCA34],600110[STARGARDT DISEASE 3; STGD3],614457[ICHTHYOSIS, SPASTIC QUADRIPLEGIA, AND MENTAL RETARDATION; ISQMR]
FBgn0051141	CG31141	HGNC:18047	OMIM:611815	ELOVL3	3		
FBgn0051141	CG31141	HGNC:14418	OMIM:611813	ELOVL1	5	618527	618527[ICHTHYOTIC KERATODERMA, SPASTICITY, HYPOMYELINATION, AND DYSMORPHIC FACIAL FEATURES; IKSHD]
FBgn0051141	CG31141	HGNC:21308	OMIM:611805	ELOVL5	3	615957	615957[SPINOCEREBELLAR ATAXIA 38; SCA38]
FBgn0039125	Ndc1	HGNC:25525	OMIM:610115	NDC1	13		
FBgn0039128	CG13599	HGNC:21059	OMIM:618136	MAD2L1BP	5		
FBgn0039130	CG5854	HGNC:6905	OMIM:605527	MAT2B	3		
FBgn0039132	AP-1sigma	HGNC:565	OMIM:602242	AP2S1	3	600740	600740[HYPOCALCIURIC HYPERCALCEMIA, FAMILIAL, TYPE III; HHC3]
FBgn0039132	AP-1sigma	HGNC:560	OMIM:300629	AP1S2	12	304340	304340[PETTIGREW SYNDROME; PGS]
FBgn0039132	AP-1sigma	HGNC:559	OMIM:603531	AP1S1	11	609313	609313[MENTAL RETARDATION, ENTEROPATHY, DEAFNESS, PERIPHERAL NEUROPATHY, ICHTHYOSIS, AND KERATODERMA; MEDNIK]
FBgn0039132	AP-1sigma	HGNC:18971	OMIM:615781	AP1S3	7	616106	616106[PSORIASIS 15, PUSTULAR, SUSCEPTIBILITY TO; PSORS15]
FBgn0051140	CG31140	HGNC:2856	OMIM:601207	DGKQ	14		
FBgn0039136	CG5902	HGNC:28658		AMMECR1L	11		
FBgn0039136	CG5902	HGNC:467	OMIM:300195	AMMECR1	13	300990	300990[MIDFACE HYPOPLASIA, HEARING IMPAIRMENT, ELLIPTOCYTOSIS, AND NEPHROCALCINOSIS; MFHIEN]
FBgn0015795	Rab7	HGNC:9788	OMIM:602298	RAB7A	13	600882	600882[CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2B; CMT2B]
FBgn0015795	Rab7	HGNC:9792	OMIM:300284	RAB9A	4		
FBgn0015795	Rab7	HGNC:30513		RAB7B	3		
FBgn0053108	CG33108	HGNC:24758		C19orf54	11		
FBgn0051184	LSm3	HGNC:17874	OMIM:607283	LSM3	14		
FBgn0020647	KrT95D	HGNC:30032	OMIM:607492	PACS1	13	615009	615009[SCHUURS-HOEIJMAKERS SYNDROME; SHMS]
FBgn0020647	KrT95D	HGNC:23794	OMIM:610423	PACS2	14	618067	618067[DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 66; DEE66]
FBgn0039137	Epp	HGNC:29884	OMIM:609201	UBASH3B	14		
FBgn0039137	Epp	HGNC:12462	OMIM:605736	UBASH3A	9		
FBgn0039135	CG13603	HGNC:20137		TMEM179	14		
FBgn0005674	GluProRS	HGNC:3418	OMIM:138295	EPRS	13	617951	617951[LEUKODYSTROPHY, HYPOMYELINATING, 15; HLD15]
FBgn0039131	CG12268	HGNC:26222	OMIM:616107	FAR1	7	616154,619338	616154[PEROXISOMAL FATTY ACYL-CoA REDUCTASE 1 DISORDER; PFCRD],619338[CATARACTS, SPASTIC PARAPARESIS, AND SPEECH DELAY; CSPSD]
FBgn0039131	CG12268	HGNC:25531	OMIM:616156	FAR2	7		
FBgn0039129	RpS19b	HGNC:10402	OMIM:603474	RPS19	12	105650	105650[DIAMOND-BLACKFAN ANEMIA 1; DBA1]
FBgn0015282	Rpt2	HGNC:9547	OMIM:602706	PSMC1	14		
FBgn0039126	CG13601	HGNC:8142	OMIM:606580	OPA3	13	165300,258501	165300[OPTIC ATROPHY 3, AUTOSOMAL DOMINANT; OPA3],258501[3-METHYLGLUTACONIC ACIDURIA, TYPE III; MGCA3]
FBgn0016754	sba	HGNC:20444	OMIM:611472	MBD5	7	156200	156200[INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL DOMINANT 1; MRD1]
FBgn0016754	sba	HGNC:20445	OMIM:619458	MBD6	3		
FBgn0039124	tbrd-1	HGNC:1104	OMIM:601541	BRD3	6		
FBgn0039124	tbrd-1	HGNC:1103	OMIM:601540	BRD2	8		
FBgn0039124	tbrd-1	HGNC:1105	OMIM:602144	BRDT	6	617644	617644[SPERMATOGENIC FAILURE 21; SPGF21]
FBgn0039124	tbrd-1	HGNC:13575	OMIM:608749	BRD4	5		
FBgn0013347	TfIIA-S	HGNC:4647	OMIM:600519	GTF2A2	13		
FBgn0025574	Pli	HGNC:30010	OMIM:609827	PELI3	13		
FBgn0025574	Pli	HGNC:8827	OMIM:614797	PELI1	14		
FBgn0025574	Pli	HGNC:8828	OMIM:614798	PELI2	14		
FBgn0039139	Mettl3	HGNC:17563	OMIM:612472	METTL3	14		
FBgn0039141	spas	HGNC:13286	OMIM:615383	FIGNL1	4		
FBgn0039141	spas	HGNC:11233	OMIM:604277	SPAST	15	182601	182601[SPASTIC PARAPLEGIA 4, AUTOSOMAL DOMINANT; SPG4]
FBgn0043455	CG5986	HGNC:26643		SDE2	9		
FBgn0026576	Pisd	HGNC:8999	OMIM:612770	PISD	12	618889	618889[LIBERFARB SYNDROME; LIBF]
FBgn0039145	CG6000	HGNC:35410	OMIM:616041	TSTD1	10		
FBgn0039145	CG6000	HGNC:40910		TSTD3	3		
FBgn0040283	SMC1	HGNC:11111	OMIM:300040	SMC1A	12	300590,301044	300590[CORNELIA DE LANGE SYNDROME 2; CDLS2],301044[DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 85 WITH OR WITHOUT MIDLINE BRAIN DEFECTS; DEE85]
FBgn0040283	SMC1	HGNC:11112	OMIM:608685	SMC1B	9		
FBgn0039147	CG10694	HGNC:9812	OMIM:600061	RAD23A	7		
FBgn0039147	CG10694	HGNC:9813	OMIM:600062	RAD23B	7		
FBgn0039149	CG18428	HGNC:18076	OMIM:607668	ARL6IP4	8		
FBgn0039152	Root	HGNC:1859	OMIM:609689	CEP250	7	618358	618358[CONE-ROD DYSTROPHY AND HEARING LOSS 2; CRDHL2]
FBgn0039152	Root	HGNC:51677		CROCC2	4		
FBgn0039152	Root	HGNC:21299	OMIM:615776	CROCC	12		
FBgn0026317	Tsc1	HGNC:12362	OMIM:605284	TSC1	13	191100,606690,607341	191100[TUBEROUS SCLEROSIS 1; TSC1],606690[LYMPHANGIOLEIOMYOMATOSIS; LAM],607341[FOCAL CORTICAL DYSPLASIA, TYPE II; FCORD2]
FBgn0039154	Npc2f	HGNC:14537	OMIM:601015	NPC2	5	607625	607625[NIEMANN-PICK DISEASE, TYPE C2; NPC2]
FBgn0039155	Kal1	HGNC:6211	OMIM:300836	ANOS1	11	308700	308700[HYPOGONADOTROPIC HYPOGONADISM 1 WITH OR WITHOUT ANOSMIA; HH1]
FBgn0039158	TBC1d7	HGNC:21066	OMIM:612655	TBC1D7	8	248000	248000[MACROCEPHALY/MEGALENCEPHALY SYNDROME, AUTOSOMAL RECESSIVE; MGCPH]
FBgn0039158	TBC1d7	HGNC:0		TBC1D7-LOC100130357	9		
FBgn0026598	Apc2	HGNC:583	OMIM:611731	APC	8	114500,114550,135290,175100,613659,619182	114500[COLORECTAL CANCER; CRC],114550[HEPATOCELLULAR CARCINOMA],135290[DESMOID DISEASE, HEREDITARY; DESMD],175100[FAMILIAL ADENOMATOUS POLYPOSIS 1; FAP1],613659[GASTRIC CANCER],619182[GASTRIC ADENOCARCINOMA AND PROXIMAL POLYPOSIS OF THE STOMACH; GAPPS]
FBgn0026598	Apc2	HGNC:24036	OMIM:612034	APC2	8	617169,618677	617169[INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 74; MRT74],618677[CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 10; CDCBM10]
FBgn0029503	mora	HGNC:14525	OMIM:604353	CHORDC1	14		
FBgn0029503	mora	HGNC:6154	OMIM:300332	ITGB1BP2	8		
FBgn0039165	CG6204	HGNC:29271	OMIM:618931	ZNFX1	10	619644	619644[IMMUNODEFICIENCY 91 AND HYPERINFLAMMATION; IMD91]
FBgn0039170	CG13609	HGNC:28845	OMIM:610197	MED25	6	616449	616449[BASEL-VANAGAITE-SMIRIN-YOSEF SYNDROME; BVSYS]
FBgn0039170	CG13609	HGNC:9632	OMIM:610195	PTOV1	13		
FBgn0043884	mask	HGNC:23575	OMIM:615929	ANKRD17	10	619504	619504[CHOPRA-AMIEL-GORDON SYNDROME; CAGS]
FBgn0043884	mask	HGNC:33530		ANKHD1-EIF4EBP3	9		
FBgn0039172	Spase22-23	HGNC:26212	OMIM:618854	SPCS3	14		
FBgn0039169	Spps	HGNC:11209	OMIM:600540	SP4	8		
FBgn0039169	Spps	HGNC:11205	OMIM:189906	SP1	6		
FBgn0039169	Spps	HGNC:11207	OMIM:601801	SP2	3		
FBgn0039169	Spps	HGNC:11208	OMIM:601804	SP3	7		
FBgn0039169	Spps	HGNC:14529	OMIM:609391	SP5	4		
FBgn0011725	twin	HGNC:18042	OMIM:618069	CNOT6L	15		
FBgn0011725	twin	HGNC:14099	OMIM:608951	CNOT6	13		
FBgn0039163	CG5515	HGNC:20993		RWDD1	14		
FBgn0039160	CG5510	HGNC:19263	OMIM:609552	LMAN2L	14	616887,617863	616887[INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 52; MRT52],617863[INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL DOMINANT 69; MRD69]
FBgn0039160	CG5510	HGNC:6631	OMIM:601567	LMAN1	3	227300	227300[FACTOR V AND FACTOR VIII, COMBINED DEFICIENCY OF, 1; F5F8D1]
FBgn0039160	CG5510	HGNC:16986	OMIM:609551	LMAN2	13		
FBgn0039159	mRpS24	HGNC:14510	OMIM:611986	MRPS24	14		
FBgn0015765	p38a	HGNC:6876	OMIM:600289	MAPK14	13		
FBgn0015765	p38a	HGNC:6875	OMIM:602899	MAPK13	6		
FBgn0015765	p38a	HGNC:6874	OMIM:602399	MAPK12	5		
FBgn0015765	p38a	HGNC:6873	OMIM:602898	MAPK11	12		
FBgn0051133	Slimp	HGNC:17697	OMIM:612804	SARS2	4	613845	613845[HYPERURICEMIA, PULMONARY HYPERTENSION, RENAL FAILURE, AND ALKALOSIS SYNDROME; HUPRAS]
FBgn0039153	GatB	HGNC:8849	OMIM:603645	GATB	14	618838	618838[COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 41; COXPD41]
FBgn0039150	CG13605	HGNC:25905		RNFT2	9		
FBgn0039150	CG13605	HGNC:30206	OMIM:615172	RNFT1	9		
FBgn0053100	eIF4EHP	HGNC:3293	OMIM:605895	EIF4E2	13		
FBgn0053100	eIF4EHP	HGNC:3287	OMIM:133440	EIF4E	3	615091	615091[AUTISM, SUSCEPTIBILITY TO, 19; AUTS19]
FBgn0053100	eIF4EHP	HGNC:33179		EIF4E1B	3		
FBgn0053100	eIF4EHP	HGNC:31837	OMIM:609896	EIF4E3	3		
FBgn0013343	Syx1A	HGNC:11433	OMIM:186590	STX1A	15		
FBgn0013343	Syx1A	HGNC:11438	OMIM:600876	STX3	9	619445,619446	619445[DIARRHEA 12, WITH MICROVILLUS ATROPHY; DIAR12],619446[RETINAL DYSTROPHY AND MICROVILLUS INCLUSION DISEASE; RDMVID]
FBgn0013343	Syx1A	HGNC:18539	OMIM:601485	STX1B	12	616172	616172[GENERALIZED EPILEPSY WITH FEBRILE SEIZURES PLUS, TYPE 9; GEFSP9]
FBgn0013343	Syx1A	HGNC:3403	OMIM:132350	STX2	9		
FBgn0013343	Syx1A	HGNC:11439	OMIM:186591	STX4	6		
FBgn0013343	Syx1A	HGNC:11429	OMIM:605014	STX11	5	603552	603552[HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS, FAMILIAL, 4; FHL4]
FBgn0013343	Syx1A	HGNC:19300		STX19	5		
FBgn0001230	Hsp68	HGNC:5232	OMIM:140550	HSPA1A	5		
FBgn0001230	Hsp68	HGNC:5233	OMIM:603012	HSPA1B	6		
FBgn0001230	Hsp68	HGNC:5234	OMIM:140559	HSPA1L	5		
FBgn0001230	Hsp68	HGNC:5238	OMIM:138120	HSPA5	4		
FBgn0001230	Hsp68	HGNC:5244	OMIM:600548	HSPA9	3	182170,616854	182170[ANEMIA, SIDEROBLASTIC, 4; SIDBA4],616854[EVEN-PLUS SYNDROME; EVPLS]
FBgn0001230	Hsp68	HGNC:5239	OMIM:140555	HSPA6	5		
FBgn0001230	Hsp68	HGNC:5235	OMIM:140560	HSPA2	5		
FBgn0001230	Hsp68	HGNC:5241	OMIM:600816	HSPA8	5		
FBgn0005649	Rox8	HGNC:11804	OMIM:603413	TIAL1	14		
FBgn0005649	Rox8	HGNC:11802	OMIM:603518	TIA1	12	604454,619133	604454[WELANDER DISTAL MYOPATHY; WDM],619133[AMYOTROPHIC LATERAL SCLEROSIS 26 WITH OR WITHOUT FRONTOTEMPORAL DEMENTIA; ALS26]
FBgn0039140	Miro	HGNC:21168	OMIM:613888	RHOT1	14		
FBgn0039140	Miro	HGNC:21169	OMIM:613889	RHOT2	12		
FBgn0019952	Orct	HGNC:25417	OMIM:611699	SVOP	3		
FBgn0019952	Orct	HGNC:8494	OMIM:604047	SLC22A13	7		
FBgn0019952	Orct	HGNC:10970	OMIM:607582	SLC22A6	6		
FBgn0019952	Orct	HGNC:20302	OMIM:608276	SLC22A16	7		
FBgn0019952	Orct	HGNC:10968	OMIM:604190	SLC22A4	8	180300	180300[RHEUMATOID ARTHRITIS; RA]
FBgn0019952	Orct	HGNC:10969	OMIM:603377	SLC22A5	7	212140	212140[CARNITINE DEFICIENCY, SYSTEMIC PRIMARY; CDSP]
FBgn0019952	Orct	HGNC:8495	OMIM:604048	SLC22A14	4		
FBgn0019952	Orct	HGNC:10971	OMIM:604995	SLC22A7	4		
FBgn0019952	Orct	HGNC:10972	OMIM:607581	SLC22A8	5		
FBgn0019952	Orct	HGNC:10966	OMIM:602608	SLC22A2	5		
FBgn0019952	Orct	HGNC:21106	OMIM:611697	SLC22A23	3		
FBgn0019952	Orct	HGNC:32935	OMIM:610792	SLC22A25	4		
FBgn0019952	Orct	HGNC:10963	OMIM:602607	SLC22A1	5		
FBgn0019952	Orct	HGNC:10967	OMIM:604842	SLC22A3	5		
FBgn0019952	Orct	HGNC:23095	OMIM:611461	SLC22A17	3		
FBgn0019952	Orct	HGNC:20301	OMIM:608275	SLC22A15	4		
FBgn0019952	Orct	HGNC:17989	OMIM:607096	SLC22A12	6	220150	220150[HYPOURICEMIA, RENAL, 1; RHUC1]
FBgn0019952	Orct	HGNC:27091		SLC22A31	3		
FBgn0019952	Orct	HGNC:18120	OMIM:607097	SLC22A11	5		
FBgn0019952	Orct	HGNC:16261	OMIM:607579	SLC22A9	4		
FBgn0019952	Orct	HGNC:28542	OMIM:611698	SLC22A24	3		
FBgn0019952	Orct	HGNC:18057	OMIM:607580	SLC22A10	4		
FBgn0039178	CG6356	HGNC:8494	OMIM:604047	SLC22A13	6		
FBgn0039178	CG6356	HGNC:10970	OMIM:607582	SLC22A6	5		
FBgn0039178	CG6356	HGNC:20302	OMIM:608276	SLC22A16	6		
FBgn0039178	CG6356	HGNC:10968	OMIM:604190	SLC22A4	4	180300	180300[RHEUMATOID ARTHRITIS; RA]
FBgn0039178	CG6356	HGNC:10969	OMIM:603377	SLC22A5	4	212140	212140[CARNITINE DEFICIENCY, SYSTEMIC PRIMARY; CDSP]
FBgn0039178	CG6356	HGNC:8495	OMIM:604048	SLC22A14	6		
FBgn0039178	CG6356	HGNC:10971	OMIM:604995	SLC22A7	4		
FBgn0039178	CG6356	HGNC:10972	OMIM:607581	SLC22A8	5		
FBgn0039178	CG6356	HGNC:10966	OMIM:602608	SLC22A2	5		
FBgn0039178	CG6356	HGNC:21106	OMIM:611697	SLC22A23	3		
FBgn0039178	CG6356	HGNC:32935	OMIM:610792	SLC22A25	4		
FBgn0039178	CG6356	HGNC:10963	OMIM:602607	SLC22A1	5		
FBgn0039178	CG6356	HGNC:10967	OMIM:604842	SLC22A3	5		
FBgn0039178	CG6356	HGNC:23095	OMIM:611461	SLC22A17	3		
FBgn0039178	CG6356	HGNC:20301	OMIM:608275	SLC22A15	4		
FBgn0039178	CG6356	HGNC:17989	OMIM:607096	SLC22A12	5	220150	220150[HYPOURICEMIA, RENAL, 1; RHUC1]
FBgn0039178	CG6356	HGNC:27091		SLC22A31	3		
FBgn0039178	CG6356	HGNC:18120	OMIM:607097	SLC22A11	5		
FBgn0039178	CG6356	HGNC:16261	OMIM:607579	SLC22A9	4		
FBgn0039178	CG6356	HGNC:28542	OMIM:611698	SLC22A24	4		
FBgn0039178	CG6356	HGNC:18057	OMIM:607580	SLC22A10	4		
FBgn0011785	BRWD3	HGNC:12760	OMIM:617824	BRWD1	9		
FBgn0011785	BRWD3	HGNC:17342	OMIM:300553	BRWD3	11	300659	300659[INTELLECTUAL DEVELOPMENTAL DISORDER, X-LINKED 93; XLID93]
FBgn0011785	BRWD3	HGNC:15673	OMIM:612870	PHIP	11	617991	617991[CHUNG-JANSEN SYNDROME; CHUJANS]
FBgn0039183	Dis3	HGNC:20604	OMIM:607533	DIS3	13		
FBgn0039184	CG6432	HGNC:16091	OMIM:614355	ACSS1	3		
FBgn0039184	CG6432	HGNC:15814	OMIM:605832	ACSS2	3		
FBgn0039184	CG6432	HGNC:24723	OMIM:614356	ACSS3	15		
FBgn0039187	CG6454	HGNC:29062	OMIM:618044	C2CD5	13		
FBgn0000036	nAChRalpha1	HGNC:1962	OMIM:118507	CHRNB2	5	605375	605375[EPILEPSY, NOCTURNAL FRONTAL LOBE, 3; ENFL3]
FBgn0000036	nAChRalpha1	HGNC:1959	OMIM:118505	CHRNA5	5	612052	612052[SMOKING AS A QUANTITATIVE TRAIT LOCUS 3; SQTL3]
FBgn0000036	nAChRalpha1	HGNC:1955	OMIM:100690	CHRNA1	4	253290,601462,608930	253290[MULTIPLE PTERYGIUM SYNDROME, LETHAL TYPE; LMPS],601462[MYASTHENIC SYNDROME, CONGENITAL, 1A, SLOW-CHANNEL; CMS1A],608930[MYASTHENIC SYNDROME, CONGENITAL, 1B, FAST-CHANNEL; CMS1B]
FBgn0000036	nAChRalpha1	HGNC:1957	OMIM:118503	CHRNA3	10	191800,612052	191800[BLADDER DYSFUNCTION, AUTONOMIC, WITH IMPAIRED PUPILLARY REFLEX AND SECONDARY CAKUT; BAIPRCK],612052[SMOKING AS A QUANTITATIVE TRAIT LOCUS 3; SQTL3]
FBgn0000036	nAChRalpha1	HGNC:1964	OMIM:118509	CHRNB4	4		
FBgn0000036	nAChRalpha1	HGNC:1958	OMIM:118504	CHRNA4	8	188890,600513	188890[TOBACCO ADDICTION, SUSCEPTIBILITY TO],600513[EPILEPSY, NOCTURNAL FRONTAL LOBE, 1; ENFL1]
FBgn0000036	nAChRalpha1	HGNC:15963	OMIM:606888	CHRNA6	10		
FBgn0000036	nAChRalpha1	HGNC:1956	OMIM:118502	CHRNA2	11	610353	610353[EPILEPSY, NOCTURNAL FRONTAL LOBE, 4; ENFL4]
FBgn0000036	nAChRalpha1	HGNC:1961	OMIM:100710	CHRNB1	3	616313,616314	616313[MYASTHENIC SYNDROME, CONGENITAL, 2A, SLOW-CHANNEL; CMS2A],616314[MYASTHENIC SYNDROME, CONGENITAL, 2C, ASSOCIATED WITH ACETYLCHOLINE RECEPTOR DEFICIENCY; CMS2C]
FBgn0000036	nAChRalpha1	HGNC:1963	OMIM:118508	CHRNB3	4		
FBgn0000036	nAChRalpha1	HGNC:1965	OMIM:100720	CHRND	3	253290,616321,616322,616323	253290[MULTIPLE PTERYGIUM SYNDROME, LETHAL TYPE; LMPS],616321[MYASTHENIC SYNDROME, CONGENITAL, 3A, SLOW-CHANNEL; CMS3A],616322[MYASTHENIC SYNDROME, CONGENITAL, 3B, FAST-CHANNEL; CMS3B],616323[MYASTHENIC SYNDROME, CONGENITAL, 3C, ASSOCIATED WITH ACETYLCHOLINE RECEPTOR DEFICIENCY; CMS3C]
FBgn0000036	nAChRalpha1	HGNC:1966	OMIM:100725	CHRNE	3	605809,608931,616324	605809[MYASTHENIC SYNDROME, CONGENITAL, 4A, SLOW-CHANNEL; CMS4A],608931[MYASTHENIC SYNDROME, CONGENITAL, 4C, ASSOCIATED WITH ACETYLCHOLINE RECEPTOR DEFICIENCY; CMS4C],616324[MYASTHENIC SYNDROME, CONGENITAL, 4B, FAST-CHANNEL; CMS4B]
FBgn0000036	nAChRalpha1	HGNC:1967	OMIM:100730	CHRNG	3	253290,265000	253290[MULTIPLE PTERYGIUM SYNDROME, LETHAL TYPE; LMPS],265000[MULTIPLE PTERYGIUM SYNDROME, ESCOBAR VARIANT; EVMPS]
FBgn0039189	CG18528	HGNC:14880	OMIM:608536	GTPBP3	15	616198	616198[COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 23; COXPD23]
FBgn0039188	Golgin84	HGNC:4428	OMIM:606918	GOLGA5	12		
FBgn0039182	Rrp5	HGNC:13408	OMIM:612333	PDCD11	12		
FBgn0028471	Nab2	HGNC:20509	OMIM:613279	ZC3H14	13	617125	617125[INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 56; MRT56]
FBgn0039180	CG5715	HGNC:7015	OMIM:600388	MEP1A	3		
FBgn0039180	CG5715	HGNC:7020	OMIM:600389	MEP1B	6		
FBgn0039180	CG5715	HGNC:31704	OMIM:608860	ASTL	9	619643	619643[OOCYTE MATURATION DEFECT 11; OOMD11]
FBgn0039175	beta-PheRS	HGNC:17800	OMIM:609690	FARSB	15	613658	613658[RAJAB INTERSTITIAL LUNG DISEASE WITH BRAIN CALCIFICATIONS 1; RILDBC1]
FBgn0000039	nAChRalpha2	HGNC:1962	OMIM:118507	CHRNB2	4	605375	605375[EPILEPSY, NOCTURNAL FRONTAL LOBE, 3; ENFL3]
FBgn0000039	nAChRalpha2	HGNC:1959	OMIM:118505	CHRNA5	5	612052	612052[SMOKING AS A QUANTITATIVE TRAIT LOCUS 3; SQTL3]
FBgn0000039	nAChRalpha2	HGNC:1955	OMIM:100690	CHRNA1	4	253290,601462,608930	253290[MULTIPLE PTERYGIUM SYNDROME, LETHAL TYPE; LMPS],601462[MYASTHENIC SYNDROME, CONGENITAL, 1A, SLOW-CHANNEL; CMS1A],608930[MYASTHENIC SYNDROME, CONGENITAL, 1B, FAST-CHANNEL; CMS1B]
FBgn0000039	nAChRalpha2	HGNC:1957	OMIM:118503	CHRNA3	9	191800,612052	191800[BLADDER DYSFUNCTION, AUTONOMIC, WITH IMPAIRED PUPILLARY REFLEX AND SECONDARY CAKUT; BAIPRCK],612052[SMOKING AS A QUANTITATIVE TRAIT LOCUS 3; SQTL3]
FBgn0000039	nAChRalpha2	HGNC:1964	OMIM:118509	CHRNB4	4		
FBgn0000039	nAChRalpha2	HGNC:1958	OMIM:118504	CHRNA4	8	188890,600513	188890[TOBACCO ADDICTION, SUSCEPTIBILITY TO],600513[EPILEPSY, NOCTURNAL FRONTAL LOBE, 1; ENFL1]
FBgn0000039	nAChRalpha2	HGNC:15963	OMIM:606888	CHRNA6	9		
FBgn0000039	nAChRalpha2	HGNC:1956	OMIM:118502	CHRNA2	11	610353	610353[EPILEPSY, NOCTURNAL FRONTAL LOBE, 4; ENFL4]
FBgn0000039	nAChRalpha2	HGNC:1961	OMIM:100710	CHRNB1	3	616313,616314	616313[MYASTHENIC SYNDROME, CONGENITAL, 2A, SLOW-CHANNEL; CMS2A],616314[MYASTHENIC SYNDROME, CONGENITAL, 2C, ASSOCIATED WITH ACETYLCHOLINE RECEPTOR DEFICIENCY; CMS2C]
FBgn0000039	nAChRalpha2	HGNC:1963	OMIM:118508	CHRNB3	4		
FBgn0000039	nAChRalpha2	HGNC:1965	OMIM:100720	CHRND	3	253290,616321,616322,616323	253290[MULTIPLE PTERYGIUM SYNDROME, LETHAL TYPE; LMPS],616321[MYASTHENIC SYNDROME, CONGENITAL, 3A, SLOW-CHANNEL; CMS3A],616322[MYASTHENIC SYNDROME, CONGENITAL, 3B, FAST-CHANNEL; CMS3B],616323[MYASTHENIC SYNDROME, CONGENITAL, 3C, ASSOCIATED WITH ACETYLCHOLINE RECEPTOR DEFICIENCY; CMS3C]
FBgn0000039	nAChRalpha2	HGNC:1966	OMIM:100725	CHRNE	3	605809,608931,616324	605809[MYASTHENIC SYNDROME, CONGENITAL, 4A, SLOW-CHANNEL; CMS4A],608931[MYASTHENIC SYNDROME, CONGENITAL, 4C, ASSOCIATED WITH ACETYLCHOLINE RECEPTOR DEFICIENCY; CMS4C],616324[MYASTHENIC SYNDROME, CONGENITAL, 4B, FAST-CHANNEL; CMS4B]
FBgn0000039	nAChRalpha2	HGNC:1967	OMIM:100730	CHRNG	3	253290,265000	253290[MULTIPLE PTERYGIUM SYNDROME, LETHAL TYPE; LMPS],265000[MULTIPLE PTERYGIUM SYNDROME, ESCOBAR VARIANT; EVMPS]
FBgn0039201	DZIP1	HGNC:20908	OMIM:608671	DZIP1	8	610840,619102	610840[MITRAL VALVE PROLAPSE 3; MVP3],619102[SPERMATOGENIC FAILURE 47; SPGF47]
FBgn0039201	DZIP1	HGNC:26551	OMIM:617570	DZIP1L	8	617610	617610[POLYCYSTIC KIDNEY DISEASE 5; PKD5]
FBgn0003134	Pp1alpha-96A	HGNC:9281	OMIM:176875	PPP1CA	11		
FBgn0003134	Pp1alpha-96A	HGNC:9283	OMIM:176914	PPP1CC	12		
FBgn0003134	Pp1alpha-96A	HGNC:9282	OMIM:600590	PPP1CB	4	617506	617506[NOONAN SYNDROME-LIKE DISORDER WITH LOOSE ANAGEN HAIR 2; NSLH2]
FBgn0039204	CG6607	HGNC:30595	OMIM:618159	PPP1R21	12	619383	619383[NEURODEVELOPMENTAL DISORDER WITH HYPOTONIA, FACIAL DYSMORPHISM, AND BRAIN ABNORMALITIES; NEDHFBA]
FBgn0039213	atl	HGNC:11231	OMIM:606439	ATL1	13	182600,613708	182600[SPASTIC PARAPLEGIA 3, AUTOSOMAL DOMINANT; SPG3A],613708[NEUROPATHY, HEREDITARY SENSORY, TYPE ID; HSN1D]
FBgn0039213	atl	HGNC:24047	OMIM:609368	ATL2	15		
FBgn0039213	atl	HGNC:24526	OMIM:609369	ATL3	12	615632	615632[NEUROPATHY, HEREDITARY SENSORY, TYPE IF; HSN1F]
FBgn0039213	atl	HGNC:4183	OMIM:600412	GBP2	3		
FBgn0039213	atl	HGNC:4184	OMIM:600413	GBP3	3		
FBgn0039213	atl	HGNC:20480	OMIM:612466	GBP4	3		
FBgn0039213	atl	HGNC:19895	OMIM:611467	GBP5	3		
FBgn0039213	atl	HGNC:25395	OMIM:612467	GBP6	3		
FBgn0039213	atl	HGNC:29606	OMIM:612468	GBP7	3		
FBgn0039213	atl	HGNC:12968	OMIM:601237	RNF112	3		
FBgn0000139	ash2	HGNC:744	OMIM:604782	ASH2L	14		
FBgn0051126	CG31126	HGNC:24263	OMIM:613181	BOLA1	14		
FBgn0051126	CG31126	HGNC:32479		BOLA2B	4		
FBgn0020018	Ppox	HGNC:9280	OMIM:600923	PPOX	14	176200	176200[VARIEGATE PORPHYRIA; VP]
FBgn0039214	puf	HGNC:20066	OMIM:615295	USP34	14		
FBgn0039212	Syx18	HGNC:15942	OMIM:606046	STX18	14		
FBgn0039210	CG13625	HGNC:28199		BUD13	14		
FBgn0039209	REPTOR	HGNC:24050	OMIM:617109	CREBRF	8		
FBgn0039205	CG13623	HGNC:19857	OMIM:615317	ISCA2	13	616370	616370[MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 4; MMDS4]
FBgn0004118	nAChRbeta2	HGNC:1962	OMIM:118507	CHRNB2	4	605375	605375[EPILEPSY, NOCTURNAL FRONTAL LOBE, 3; ENFL3]
FBgn0004118	nAChRbeta2	HGNC:1959	OMIM:118505	CHRNA5	4	612052	612052[SMOKING AS A QUANTITATIVE TRAIT LOCUS 3; SQTL3]
FBgn0004118	nAChRbeta2	HGNC:1955	OMIM:100690	CHRNA1	4	253290,601462,608930	253290[MULTIPLE PTERYGIUM SYNDROME, LETHAL TYPE; LMPS],601462[MYASTHENIC SYNDROME, CONGENITAL, 1A, SLOW-CHANNEL; CMS1A],608930[MYASTHENIC SYNDROME, CONGENITAL, 1B, FAST-CHANNEL; CMS1B]
FBgn0004118	nAChRbeta2	HGNC:1957	OMIM:118503	CHRNA3	11	191800,612052	191800[BLADDER DYSFUNCTION, AUTONOMIC, WITH IMPAIRED PUPILLARY REFLEX AND SECONDARY CAKUT; BAIPRCK],612052[SMOKING AS A QUANTITATIVE TRAIT LOCUS 3; SQTL3]
FBgn0004118	nAChRbeta2	HGNC:1964	OMIM:118509	CHRNB4	4		
FBgn0004118	nAChRbeta2	HGNC:1958	OMIM:118504	CHRNA4	8	188890,600513	188890[TOBACCO ADDICTION, SUSCEPTIBILITY TO],600513[EPILEPSY, NOCTURNAL FRONTAL LOBE, 1; ENFL1]
FBgn0004118	nAChRbeta2	HGNC:15963	OMIM:606888	CHRNA6	10		
FBgn0004118	nAChRbeta2	HGNC:1956	OMIM:118502	CHRNA2	11	610353	610353[EPILEPSY, NOCTURNAL FRONTAL LOBE, 4; ENFL4]
FBgn0004118	nAChRbeta2	HGNC:1961	OMIM:100710	CHRNB1	3	616313,616314	616313[MYASTHENIC SYNDROME, CONGENITAL, 2A, SLOW-CHANNEL; CMS2A],616314[MYASTHENIC SYNDROME, CONGENITAL, 2C, ASSOCIATED WITH ACETYLCHOLINE RECEPTOR DEFICIENCY; CMS2C]
FBgn0004118	nAChRbeta2	HGNC:1963	OMIM:118508	CHRNB3	4		
FBgn0004118	nAChRbeta2	HGNC:1965	OMIM:100720	CHRND	3	253290,616321,616322,616323	253290[MULTIPLE PTERYGIUM SYNDROME, LETHAL TYPE; LMPS],616321[MYASTHENIC SYNDROME, CONGENITAL, 3A, SLOW-CHANNEL; CMS3A],616322[MYASTHENIC SYNDROME, CONGENITAL, 3B, FAST-CHANNEL; CMS3B],616323[MYASTHENIC SYNDROME, CONGENITAL, 3C, ASSOCIATED WITH ACETYLCHOLINE RECEPTOR DEFICIENCY; CMS3C]
FBgn0004118	nAChRbeta2	HGNC:1966	OMIM:100725	CHRNE	3	605809,608931,616324	605809[MYASTHENIC SYNDROME, CONGENITAL, 4A, SLOW-CHANNEL; CMS4A],608931[MYASTHENIC SYNDROME, CONGENITAL, 4C, ASSOCIATED WITH ACETYLCHOLINE RECEPTOR DEFICIENCY; CMS4C],616324[MYASTHENIC SYNDROME, CONGENITAL, 4B, FAST-CHANNEL; CMS4B]
FBgn0004118	nAChRbeta2	HGNC:1967	OMIM:100730	CHRNG	3	253290,265000	253290[MULTIPLE PTERYGIUM SYNDROME, LETHAL TYPE; LMPS],265000[MULTIPLE PTERYGIUM SYNDROME, ESCOBAR VARIANT; EVMPS]
FBgn0039218	Polr2L	HGNC:9199	OMIM:601189	POLR2L	15		
FBgn0004885	tok	HGNC:1067	OMIM:112264	BMP1	11	614856	614856[OSTEOGENESIS IMPERFECTA, TYPE XIII; OI13]
FBgn0004885	tok	HGNC:11843	OMIM:606742	TLL1	11	613087	613087[ATRIAL SEPTAL DEFECT 6; ASD6]
FBgn0004885	tok	HGNC:11844	OMIM:606743	TLL2	10		
FBgn0003719	tld	HGNC:1067	OMIM:112264	BMP1	9	614856	614856[OSTEOGENESIS IMPERFECTA, TYPE XIII; OI13]
FBgn0003719	tld	HGNC:11843	OMIM:606742	TLL1	10	613087	613087[ATRIAL SEPTAL DEFECT 6; ASD6]
FBgn0003719	tld	HGNC:11844	OMIM:606743	TLL2	9		
FBgn0000140	asp	HGNC:19048	OMIM:605481	ASPM	11	608716	608716[MICROCEPHALY 5, PRIMARY, AUTOSOMAL RECESSIVE; MCPH5]
FBgn0039225	Ets96B	HGNC:3494	OMIM:601600	ETV5	6		
FBgn0039225	Ets96B	HGNC:3490	OMIM:600541	ETV1	7		
FBgn0039225	Ets96B	HGNC:3493	OMIM:600711	ETV4	6		
FBgn0039228	CG6980	HGNC:23700	OMIM:610732	TTC12	7	618801	618801[CILIARY DYSKINESIA, PRIMARY, 45; CILD45]
FBgn0013953	Esp	HGNC:14471	OMIM:610117	SLC26A11	10		
FBgn0013953	Esp	HGNC:14472	OMIM:610068	SLC26A6	3		
FBgn0013953	Esp	HGNC:9359	OMIM:604943	SLC26A5	3	613865	613865[DEAFNESS, AUTOSOMAL RECESSIVE 61; DFNB61]
FBgn0039233	CG7006	HGNC:24328	OMIM:619204	NIP7	14		
FBgn0039234	Nct	HGNC:17091	OMIM:605254	NCSTN	14	142690	142690[ACNE INVERSA, FAMILIAL, 1; ACNINV1]
FBgn0039241	CG11089	HGNC:794	OMIM:601731	ATIC	15	608688	608688[AICA-RIBOSURIA DUE TO ATIC DEFICIENCY]
FBgn0043799	CG31381	HGNC:20286	OMIM:617840	TRIT1	15	617873	617873[COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 35; COXPD35]
FBgn0039244	CG11069	HGNC:13887	OMIM:605460	ABCG8	3	210250,611465	210250[SITOSTEROLEMIA 1; STSL1],611465[GALLBLADDER DISEASE 4; GBD4]
FBgn0039244	CG11069	HGNC:13886	OMIM:605459	ABCG5	13	618666	618666[SITOSTEROLEMIA 2; STSL2]
FBgn0039249	CG11168	HGNC:20961	OMIM:608994	ANKS1A	11		
FBgn0039249	CG11168	HGNC:24600	OMIM:607815	ANKS1B	10		
FBgn0039251	Trf4-2	HGNC:16705	OMIM:605198	TENT4A	9		
FBgn0039251	Trf4-2	HGNC:30758	OMIM:605540	TENT4B	8		
FBgn0051121	CG31121	HGNC:73	OMIM:603076	ABCG1	3		
FBgn0051121	CG31121	HGNC:74	OMIM:603756	ABCG2	3	138900,614490	138900[URIC ACID CONCENTRATION, SERUM, QUANTITATIVE TRAIT LOCUS 1; UAQTL1],614490[BLOOD GROUP, JUNIOR SYSTEM; JR]
FBgn0051121	CG31121	HGNC:13887	OMIM:605460	ABCG8	4	210250,611465	210250[SITOSTEROLEMIA 1; STSL1],611465[GALLBLADDER DISEASE 4; GBD4]
FBgn0051121	CG31121	HGNC:13886	OMIM:605459	ABCG5	3	618666	618666[SITOSTEROLEMIA 2; STSL2]
FBgn0039240	CG3744	HGNC:16490	OMIM:606819	DPP8	13		
FBgn0039240	CG3744	HGNC:18648	OMIM:608258	DPP9	14		
FBgn0015625	CycB3	HGNC:18709	OMIM:300456	CCNB3	10		
FBgn0015625	CycB3	HGNC:1580	OMIM:602755	CCNB2	4		
FBgn0015625	CycB3	HGNC:1579	OMIM:123836	CCNB1	3		
FBgn0015625	CycB3	HGNC:1577	OMIM:604036	CCNA1	3		
FBgn0051105	ppk22	HGNC:101	OMIM:611741	ASIC3	5		
FBgn0051105	ppk22	HGNC:100	OMIM:602866	ASIC1	5		
FBgn0051105	ppk22	HGNC:21263	OMIM:606715	ASIC4	5		
FBgn0051105	ppk22	HGNC:99	OMIM:601784	ASIC2	4		
FBgn0051105	ppk22	HGNC:17537	OMIM:616693	ASIC5	5		
FBgn0051105	ppk22	HGNC:10599	OMIM:600228	SCNN1A	3	264350,613021,618126	264350[PSEUDOHYPOALDOSTERONISM, TYPE I, AUTOSOMAL RECESSIVE; PHA1B],613021[BRONCHIECTASIS WITH OR WITHOUT ELEVATED SWEAT CHLORIDE 2; BESC2],618126[LIDDLE SYNDROME 3; LIDLS3]
FBgn0051105	ppk22	HGNC:10600	OMIM:600760	SCNN1B	4	177200,211400,264350	177200[LIDDLE SYNDROME 1; LIDLS1],211400[BRONCHIECTASIS WITH OR WITHOUT ELEVATED SWEAT CHLORIDE 1; BESC1],264350[PSEUDOHYPOALDOSTERONISM, TYPE I, AUTOSOMAL RECESSIVE; PHA1B]
FBgn0051105	ppk22	HGNC:10601	OMIM:601328	SCNN1D	3		
FBgn0051105	ppk22	HGNC:10602	OMIM:600761	SCNN1G	4	264350,613071,618114	264350[PSEUDOHYPOALDOSTERONISM, TYPE I, AUTOSOMAL RECESSIVE; PHA1B],613071[BRONCHIECTASIS WITH OR WITHOUT ELEVATED SWEAT CHLORIDE 3; BESC3],618114[LIDDLE SYNDROME 2; LIDLS2]
FBgn0039235	CAH4	HGNC:1373	OMIM:611492	CA2	3	259730	259730[OSTEOPETROSIS, AUTOSOMAL RECESSIVE 3; OPTB3]
FBgn0039235	CAH4	HGNC:1369	OMIM:604642	CA10	3		
FBgn0039235	CAH4	HGNC:1380	OMIM:114780	CA6	6		
FBgn0039235	CAH4	HGNC:1381	OMIM:114770	CA7	4		
FBgn0039235	CAH4	HGNC:1371	OMIM:603263	CA12	4	143860	143860[HYPERCHLORHIDROSIS, ISOLATED; HYCHL]
FBgn0039235	CAH4	HGNC:1372	OMIM:604832	CA14	4		
FBgn0039235	CAH4	HGNC:1383	OMIM:603179	CA9	5		
FBgn0039235	CAH4	HGNC:1370	OMIM:604644	CA11	3		
FBgn0039235	CAH4	HGNC:1368	OMIM:114800	CA1	5		
FBgn0039235	CAH4	HGNC:1377	OMIM:114761	CA5A	4	615751	615751[CARBONIC ANHYDRASE VA DEFICIENCY, HYPERAMMONEMIA DUE TO; CA5AD]
FBgn0039235	CAH4	HGNC:14914	OMIM:611436	CA13	5		
FBgn0039235	CAH4	HGNC:1374	OMIM:114750	CA3	5		
FBgn0039235	CAH4	HGNC:1375	OMIM:114760	CA4	6		
FBgn0039235	CAH4	HGNC:1378	OMIM:300230	CA5B	5		
FBgn0051119	HDAC11	HGNC:19086	OMIM:607226	HDAC11	15		
FBgn0051357	Kaz	HGNC:13731	OMIM:606801	MAEA	14		
FBgn0051118	RabX4	HGNC:9762	OMIM:602672	RAB13	3		
FBgn0051118	RabX4	HGNC:7007	OMIM:165040	RAB8A	3		
FBgn0051118	RabX4	HGNC:30273	OMIM:613532	RAB8B	3		
FBgn0051118	RabX4	HGNC:9759	OMIM:612672	RAB10	3		
FBgn0051118	RabX4	HGNC:20150	OMIM:619547	RAB15	3		
FBgn0051118	RabX4	HGNC:31332	OMIM:616448	RAB12	3		
FBgn0045980	niki	HGNC:13387	OMIM:609799	NEK8	10	613824,615415	613824[NEPHRONOPHTHISIS 9; NPHP9],615415[RENAL-HEPATIC-PANCREATIC DYSPLASIA 2; RHPD2]
FBgn0045980	niki	HGNC:18593	OMIM:609779	NEK11	3		
FBgn0045980	niki	HGNC:18591	OMIM:609798	NEK9	9	614262,617022,617025	614262[ARTHROGRYPOSIS, PERTHES DISEASE, AND UPWARD GAZE PALSY; APUG],617022[LETHAL CONGENITAL CONTRACTURE SYNDROME 10; LCCS10],617025[NEVUS COMEDONICUS; NC]
FBgn0027617	CG5808	HGNC:15702	OMIM:607609	PPIL4	13		
FBgn0027539	lili	HGNC:13243	OMIM:605522	LMBR1	13	135750,174500,186200,188740,200500	135750[LAURIN-SANDROW SYNDROME; LSS],174500[POLYDACTYLY, PREAXIAL II; PPD2],186200[SYNDACTYLY, TYPE IV; SDTY4],188740[TIBIA, HYPOPLASIA OR APLASIA OF, WITH POLYDACTYLY; THYP],200500[ACHEIROPODY; ACHP]
FBgn0027539	lili	HGNC:18268	OMIM:610007	LMBR1L	14		
FBgn0039227	polybromo	HGNC:30064	OMIM:606083	PBRM1	14	144700	144700[RENAL CELL CARCINOMA, NONPAPILLARY; RCC]
FBgn0039223	CG5805	HGNC:29036	OMIM:610824	SLC25A44	14		
FBgn0039219	CG13630	HGNC:32583	OMIM:610267	METAP1D	3		
FBgn0039219	CG13630	HGNC:15789	OMIM:610151	METAP1	15		
FBgn0039252	CG11771	HGNC:11793	OMIM:601117	THOP1	8		
FBgn0039252	CG11771	HGNC:16058	OMIM:611530	NLN	6		
FBgn0039254	Nmnat	HGNC:16789	OMIM:608701	NMNAT2	6		
FBgn0039254	Nmnat	HGNC:20989	OMIM:608702	NMNAT3	13		
FBgn0039254	Nmnat	HGNC:17877	OMIM:608700	NMNAT1	12	608553,619260	608553[LEBER CONGENITAL AMAUROSIS 9; LCA9],619260[SPONDYLOEPIPHYSEAL DYSPLASIA, SENSORINEURAL HEARING LOSS, IMPAIRED INTELLECTUAL DEVELOPMENT, AND LEBER CONGENITAL AMAUROSIS; SHILCA]
FBgn0039258	beta4GalT7	HGNC:930	OMIM:604327	B4GALT7	15	130070	130070[EHLERS-DANLOS SYNDROME, SPONDYLODYSPLASTIC TYPE, 1; EDSSPD1]
FBgn0015240	Hr96	HGNC:7966	OMIM:602423	NR1H3	3		
FBgn0015240	Hr96	HGNC:7969	OMIM:603881	NR1I3	4		
FBgn0015240	Hr96	HGNC:12679	OMIM:601769	VDR	6	277440	277440[VITAMIN D-DEPENDENT RICKETS, TYPE 2A; VDDR2A]
FBgn0015240	Hr96	HGNC:7968	OMIM:603065	NR1I2	7		
FBgn0051115	CG31115	HGNC:7413	OMIM:156540	MTAP	9	112250	112250[DIAPHYSEAL MEDULLARY STENOSIS WITH MALIGNANT FIBROUS HISTIOCYTOMA; DMSMFH]
FBgn0045866	bai	HGNC:16998	OMIM:605406	TMED10	14		
FBgn0039270	PQBP1	HGNC:9330	OMIM:300463	PQBP1	8	309500	309500[RENPENNING SYNDROME 1; RENS1]
FBgn0039271	CG11839	HGNC:28291		ZNF830	13		
FBgn0039272	CG11836	HGNC:14134	OMIM:609341	TPSG1	3		
FBgn0039274	CG11920	HGNC:30856	OMIM:612981	IMP4	14		
FBgn0004897	fd96Ca	HGNC:3799	OMIM:619961	FOXB1	9		
FBgn0004897	fd96Ca	HGNC:23315	OMIM:619962	FOXB2	9		
FBgn0004898	fd96Cb	HGNC:3799	OMIM:619961	FOXB1	9		
FBgn0004898	fd96Cb	HGNC:23315	OMIM:619962	FOXB2	7		
FBgn0004898	fd96Cb	HGNC:3804	OMIM:611539	FOXD3	3	607836	607836[AUTOIMMUNE DISEASE, SUSCEPTIBILITY TO, 1; AIS1]
FBgn0004898	fd96Cb	HGNC:3805	OMIM:601092	FOXD4	3		
FBgn0046214	vig2	HGNC:17062	OMIM:617369	HABP4	7		
FBgn0046214	vig2	HGNC:17860	OMIM:607378	SERBP1	11		
FBgn0039282	Bili	HGNC:25462	OMIM:618337	FRMD8	11		
FBgn0039282	Bili	HGNC:24690		FRMD8P1	4		
FBgn0039280	Mocs2B	HGNC:7193	OMIM:603708	MOCS2	10	252160	252160[MOLYBDENUM COFACTOR DEFICIENCY, COMPLEMENTATION GROUP B; MOCODB]
FBgn0039273	shams	HGNC:33383	OMIM:613322	GXYLT2	12		
FBgn0039273	shams	HGNC:27482	OMIM:613321	GXYLT1	12		
FBgn0011336	Stt3B	HGNC:6172	OMIM:601134	STT3A	5	615596,619714	615596[CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Iw, AUTOSOMAL RECESSIVE; CDG1WAR],619714[CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Iw, AUTOSOMAL DOMINANT; CDG1WAD]
FBgn0011336	Stt3B	HGNC:30611	OMIM:608605	STT3B	14	615597	615597[CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Ix; CDG1X]
FBgn0039269	veli	HGNC:17787	OMIM:603380	LIN7A	10		
FBgn0039269	veli	HGNC:17789	OMIM:612332	LIN7C	12		
FBgn0039269	veli	HGNC:17788	OMIM:612331	LIN7B	13		
FBgn0051111	CG31111	HGNC:29551	OMIM:610614	TBRG1	11		
FBgn0039261	Ythdf	HGNC:31675	OMIM:610640	YTHDF2	10		
FBgn0039261	Ythdf	HGNC:15867	OMIM:616529	YTHDF1	9		
FBgn0039261	Ythdf	HGNC:26465	OMIM:618669	YTHDF3	7		
FBgn0039260	Smg6	HGNC:17809	OMIM:610963	SMG6	11		
FBgn0039259	EMC6	HGNC:28430		EMC6	14		
FBgn0029157	ssh	HGNC:30580	OMIM:606779	SSH2	9		
FBgn0029157	ssh	HGNC:30581	OMIM:606780	SSH3	9		
FBgn0029157	ssh	HGNC:30579	OMIM:606778	SSH1	8		
FBgn0020626	Osbp	HGNC:8503	OMIM:167040	OSBP	12		
FBgn0020626	Osbp	HGNC:8504	OMIM:606729	OSBP2	13		
FBgn0020626	Osbp	HGNC:16398	OMIM:606730	OSBPL1A	4		
FBgn0020626	Osbp	HGNC:15761	OMIM:606731	OSBPL2	4	616340	616340[DEAFNESS, AUTOSOMAL DOMINANT 67; DFNA67]
FBgn0020626	Osbp	HGNC:16370	OMIM:606732	OSBPL3	4		
FBgn0020626	Osbp	HGNC:16388	OMIM:606734	OSBPL6	3		
FBgn0020626	Osbp	HGNC:16387	OMIM:606735	OSBPL7	4		
FBgn0051108	TTLL5	HGNC:19963	OMIM:612268	TTLL5	11	615860	615860[CONE-ROD DYSTROPHY 19; CORD19]
FBgn0039290	CG13654	HGNC:17205	OMIM:619342	TMEM8A	9		
FBgn0039290	CG13654	HGNC:21427	OMIM:616888	TMEM8B	10		
FBgn0039290	CG13654	HGNC:33778	OMIM:615345	MYMK	4	254940	254940[CAREY-FINEMAN-ZITER SYNDROME 1; CFZS1]
FBgn0051106	CG31106	HGNC:8494	OMIM:604047	SLC22A13	4		
FBgn0051106	CG31106	HGNC:10970	OMIM:607582	SLC22A6	3		
FBgn0051106	CG31106	HGNC:20302	OMIM:608276	SLC22A16	3		
FBgn0051106	CG31106	HGNC:10968	OMIM:604190	SLC22A4	3	180300	180300[RHEUMATOID ARTHRITIS; RA]
FBgn0051106	CG31106	HGNC:10969	OMIM:603377	SLC22A5	3	212140	212140[CARNITINE DEFICIENCY, SYSTEMIC PRIMARY; CDSP]
FBgn0051106	CG31106	HGNC:8495	OMIM:604048	SLC22A14	4		
FBgn0051106	CG31106	HGNC:10971	OMIM:604995	SLC22A7	4		
FBgn0051106	CG31106	HGNC:10972	OMIM:607581	SLC22A8	4		
FBgn0051106	CG31106	HGNC:10966	OMIM:602608	SLC22A2	3		
FBgn0051106	CG31106	HGNC:32935	OMIM:610792	SLC22A25	3		
FBgn0051106	CG31106	HGNC:10963	OMIM:602607	SLC22A1	3		
FBgn0051106	CG31106	HGNC:10967	OMIM:604842	SLC22A3	3		
FBgn0051106	CG31106	HGNC:16874	OMIM:185861	SV2B	3		
FBgn0051106	CG31106	HGNC:17989	OMIM:607096	SLC22A12	3	220150	220150[HYPOURICEMIA, RENAL, 1; RHUC1]
FBgn0051106	CG31106	HGNC:18120	OMIM:607097	SLC22A11	3		
FBgn0051106	CG31106	HGNC:16261	OMIM:607579	SLC22A9	3		
FBgn0051106	CG31106	HGNC:28542	OMIM:611698	SLC22A24	3		
FBgn0051106	CG31106	HGNC:18057	OMIM:607580	SLC22A10	3		
FBgn0051103	CG31103	HGNC:8494	OMIM:604047	SLC22A13	4		
FBgn0051103	CG31103	HGNC:10970	OMIM:607582	SLC22A6	3		
FBgn0051103	CG31103	HGNC:20302	OMIM:608276	SLC22A16	3		
FBgn0051103	CG31103	HGNC:10968	OMIM:604190	SLC22A4	3	180300	180300[RHEUMATOID ARTHRITIS; RA]
FBgn0051103	CG31103	HGNC:10969	OMIM:603377	SLC22A5	3	212140	212140[CARNITINE DEFICIENCY, SYSTEMIC PRIMARY; CDSP]
FBgn0051103	CG31103	HGNC:8495	OMIM:604048	SLC22A14	4		
FBgn0051103	CG31103	HGNC:10971	OMIM:604995	SLC22A7	4		
FBgn0051103	CG31103	HGNC:10972	OMIM:607581	SLC22A8	4		
FBgn0051103	CG31103	HGNC:10966	OMIM:602608	SLC22A2	3		
FBgn0051103	CG31103	HGNC:32935	OMIM:610792	SLC22A25	3		
FBgn0051103	CG31103	HGNC:10963	OMIM:602607	SLC22A1	3		
FBgn0051103	CG31103	HGNC:10967	OMIM:604842	SLC22A3	3		
FBgn0051103	CG31103	HGNC:16874	OMIM:185861	SV2B	3		
FBgn0051103	CG31103	HGNC:20566	OMIM:185860	SV2A	4		
FBgn0051103	CG31103	HGNC:30670	OMIM:610291	SV2C	3		
FBgn0051103	CG31103	HGNC:17989	OMIM:607096	SLC22A12	3	220150	220150[HYPOURICEMIA, RENAL, 1; RHUC1]
FBgn0051103	CG31103	HGNC:18120	OMIM:607097	SLC22A11	3		
FBgn0051103	CG31103	HGNC:16261	OMIM:607579	SLC22A9	3		
FBgn0051103	CG31103	HGNC:28542	OMIM:611698	SLC22A24	3		
FBgn0051103	CG31103	HGNC:18057	OMIM:607580	SLC22A10	3		
FBgn0039293	Alg9	HGNC:15672	OMIM:606941	ALG9	11	263210,608776	263210[GILLESSEN-KAESBACH-NISHIMURA SYNDROME; GIKANIS],608776[CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Il; CDG1L]
FBgn0039301	Nup37	HGNC:29929	OMIM:609264	NUP37	14	618179	618179[MICROCEPHALY 24, PRIMARY, AUTOSOMAL RECESSIVE; MCPH24]
FBgn0039302	Nup358	HGNC:32419	OMIM:612709	RGPD6	8		
FBgn0039302	Nup358	HGNC:32418	OMIM:612708	RGPD5	5		
FBgn0039302	Nup358	HGNC:32414	OMIM:612704	RGPD1	8		
FBgn0039302	Nup358	HGNC:9849	OMIM:602752	RGPD8	8		
FBgn0039302	Nup358	HGNC:9848	OMIM:601181	RANBP2	9	608033	608033[ENCEPHALOPATHY, ACUTE, INFECTION-INDUCED, SUSCEPTIBILITY TO, 3; IIAE3]
FBgn0039302	Nup358	HGNC:32415	OMIM:612705	RGPD2	8		
FBgn0039302	Nup358	HGNC:32416	OMIM:612706	RGPD3	9		
FBgn0039302	Nup358	HGNC:32417	OMIM:612707	RGPD4	8		
FBgn0039302	Nup358	HGNC:9847	OMIM:601180	RANBP1	6		
FBgn0039303	CG11857	HGNC:30309		RER1	14		
FBgn0039305	CG11858	HGNC:8992	OMIM:300252	PIN4	13		
FBgn0039306	RIOK2	HGNC:18999	OMIM:617754	RIOK2	13		
FBgn0039335	Vps33B	HGNC:18179	OMIM:610034	VPS33A	4	617303	617303[MUCOPOLYSACCHARIDOSIS-PLUS SYNDROME; MPSPS]
FBgn0039335	Vps33B	HGNC:12712	OMIM:608552	VPS33B	7	208085,620009,620010	208085[ARTHROGRYPOSIS, RENAL DYSFUNCTION, AND CHOLESTASIS 1; ARCS1],620009[KERATODERMA-ICHTHYOSIS-DEAFNESS SYNDROME, AUTOSOMAL RECESSIVE; KDIDAR],620010[CHOLESTASIS, PROGRESSIVE FAMILIAL INTRAHEPATIC, 12; PFIC12]
FBgn0039337	MED28	HGNC:24628	OMIM:610311	MED28	13		
FBgn0039338	XNP	HGNC:886	OMIM:300032	ATRX	10	300448,301040,309580	300448[ALPHA-THALASSEMIA MYELODYSPLASIA SYNDROME; ATMDS],301040[ALPHA-THALASSEMIA/MENTAL RETARDATION SYNDROME, X-LINKED; ATRX],309580[INTELLECTUAL DISABILITY-HYPOTONIC FACIES SYNDROME, X-LINKED, 1; MRXHF1]
FBgn0039336	CG4553	HGNC:18077	OMIM:616718	NGRN	7		
FBgn0027090	GlnRS	HGNC:9751	OMIM:603727	QARS	14	615760	615760[MICROCEPHALY, PROGRESSIVE, WITH SEIZURES AND CEREBRAL AND CEREBELLAR ATROPHY; MSCCA]
FBgn0039304	CG10425	HGNC:4021	OMIM:136440	KDSR	15	617526	617526[ERYTHROKERATODERMIA VARIABILIS ET PROGRESSIVA 4; EKVP4]
FBgn0039300	RpS27	HGNC:10416	OMIM:603702	RPS27	14	617409	617409[DIAMOND-BLACKFAN ANEMIA 17; DBA17]
FBgn0039300	RpS27	HGNC:18476	OMIM:612055	RPS27L	11		
FBgn0039296	Sil1	HGNC:24624	OMIM:608005	SIL1	13	248800	248800[MARINESCO-SJOGREN SYNDROME; MSS]
FBgn0039291	CG13663	HGNC:21025		SAYSD1	11		
FBgn0022800	Cad96Ca	HGNC:6307	OMIM:191306	KDR	3	602089	602089[HEMANGIOMA, CAPILLARY INFANTILE]
FBgn0039339	CG5116	HGNC:30189	OMIM:300124	GTPBP6	14		
FBgn0039341	CG5112	HGNC:26440	OMIM:300654	FAAH2	8		
FBgn0039341	CG5112	HGNC:3553	OMIM:602935	FAAH	5	606581	606581[POLYSUBSTANCE ABUSE, SUSCEPTIBILITY TO; PSAB]
FBgn0039343	CG5111	HGNC:17623	OMIM:607981	NUB1	13		
FBgn0011666	msi	HGNC:7330	OMIM:603328	MSI1	3		
FBgn0011666	msi	HGNC:18585	OMIM:607897	MSI2	5		
FBgn0027508	Tnks	HGNC:15677	OMIM:607128	TNKS2	11		
FBgn0027508	Tnks	HGNC:11941	OMIM:603303	TNKS	12		
FBgn0039344	CG4582	HGNC:17661	OMIM:607460	PLA1A	3		
FBgn0039344	CG4582	HGNC:18821	OMIM:609252	LIPI	3		
FBgn0039344	CG4582	HGNC:18483	OMIM:607365	LIPH	3	604379	604379[HYPOTRICHOSIS 7; HYPT7]
FBgn0040212	Gnpat	HGNC:4416	OMIM:602744	GNPAT	14	222765	222765[RHIZOMELIC CHONDRODYSPLASIA PUNCTATA, TYPE 2; RCDP2]
FBgn0039354	Lgr3	HGNC:17318	OMIM:606655	RXFP2	14		
FBgn0039354	Lgr3	HGNC:19718	OMIM:606654	RXFP1	12		
FBgn0039358	Idh3g	HGNC:5386	OMIM:300089	IDH3G	14		
FBgn0039358	Idh3g	HGNC:5385	OMIM:604526	IDH3B	5	612572	612572[RETINITIS PIGMENTOSA 46; RP46]
FBgn0039373	CG5024	HGNC:13714	OMIM:607315	CABP5	3		
FBgn0039373	CG5024	HGNC:24193	OMIM:610171	CALML6	3		
FBgn0011273	Acam	HGNC:1445	OMIM:114182	CALM2	3	616249	616249[LONG QT SYNDROME 15; LQT15]
FBgn0011273	Acam	HGNC:1442	OMIM:114180	CALM1	3	614916,616247	614916[VENTRICULAR TACHYCARDIA, CATECHOLAMINERGIC POLYMORPHIC, 4; CPVT4],616247[LONG QT SYNDROME 14; LQT14]
FBgn0011273	Acam	HGNC:1449	OMIM:114183	CALM3	3	618782	618782[LONG QT SYNDROME 16; LQT16]
FBgn0011273	Acam	HGNC:18180	OMIM:605183	CALML5	3		
FBgn0039379	CG5886	HGNC:18578	OMIM:300677	TXLNG	10		
FBgn0039379	CG5886	HGNC:21617	OMIM:611438	TXLNB	11		
FBgn0039379	CG5886	HGNC:30685	OMIM:608676	TXLNA	12		
FBgn0039380	CG5890	HGNC:15522	OMIM:604661	KCNIP2	10		
FBgn0039380	CG5890	HGNC:30083	OMIM:608182	KCNIP4	10		
FBgn0039380	CG5890	HGNC:15523	OMIM:604662	KCNIP3	10		
FBgn0039380	CG5890	HGNC:15521	OMIM:604660	KCNIP1	13		
FBgn0039381	SppL	HGNC:30424	OMIM:608240	SPPL3	13		
FBgn0039381	SppL	HGNC:16435	OMIM:607106	HM13	3		
FBgn0027865	Tsp96F	HGNC:1709	OMIM:143030	CD9	4		
FBgn0027865	Tsp96F	HGNC:20659	OMIM:613133	TSPAN2	4		
FBgn0027865	Tsp96F	HGNC:1701	OMIM:186845	CD81	5	613496	613496[IMMUNODEFICIENCY, COMMON VARIABLE, 6; CVID6]
FBgn0039371	CG4960	HGNC:30078	OMIM:609346	REEP6	10	617304	617304[RETINITIS PIGMENTOSA 77; RP77]
FBgn0039371	CG4960	HGNC:30077	OMIM:125265	REEP5	13		
FBgn0039368	CG17196	HGNC:27387		ZDHHC24	9		
FBgn0039368	CG17196	HGNC:20106		ZDHHC22	3		
FBgn0039367	CG17197	HGNC:27387		ZDHHC24	7		
FBgn0066101	LpR1	HGNC:12698	OMIM:192977	VLDLR	11	224050	224050[CEREBELLAR ATAXIA, MENTAL RETARDATION, AND DYSEQUILIBRIUM SYNDROME 1; CAMRQ1]
FBgn0066101	LpR1	HGNC:6700	OMIM:602600	LRP8	9	608446	608446[MYOCARDIAL INFARCTION, SUSCEPTIBILITY TO]
FBgn0066101	LpR1	HGNC:6547	OMIM:606945	LDLR	9	143890	143890[HYPERCHOLESTEROLEMIA, FAMILIAL, 1; FHCL1]
FBgn0051092	LpR2	HGNC:12698	OMIM:192977	VLDLR	12	224050	224050[CEREBELLAR ATAXIA, MENTAL RETARDATION, AND DYSEQUILIBRIUM SYNDROME 1; CAMRQ1]
FBgn0051092	LpR2	HGNC:6700	OMIM:602600	LRP8	11	608446	608446[MYOCARDIAL INFARCTION, SUSCEPTIBILITY TO]
FBgn0051092	LpR2	HGNC:6547	OMIM:606945	LDLR	11	143890	143890[HYPERCHOLESTEROLEMIA, FAMILIAL, 1; FHCL1]
FBgn0039360	CLS	HGNC:16148	OMIM:608188	CRLS1	14		
FBgn0039359	RpL27	HGNC:10328	OMIM:607526	RPL27	12	617408	617408[DIAMOND-BLACKFAN ANEMIA 16; DBA16]
FBgn0039357	CG4743	HGNC:20661	OMIM:611037	SLC25A26	14	616794	616794[COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 28; COXPD28]
FBgn0028717	Lnk	HGNC:29605	OMIM:605093	SH2B3	7	133100,187950,254450	133100[ERYTHROCYTOSIS, FAMILIAL, 1; ECYT1],187950[THROMBOCYTHEMIA 1; THCYT1],254450[MYELOFIBROSIS]
FBgn0028717	Lnk	HGNC:17381	OMIM:605300	SH2B2	11		
FBgn0028717	Lnk	HGNC:30417	OMIM:608937	SH2B1	10		
FBgn0039385	CG5913	HGNC:24520		FAM98A	12		
FBgn0039385	CG5913	HGNC:26773	OMIM:616142	FAM98B	10		
FBgn0039385	CG5913	HGNC:27119		FAM98C	8		
FBgn0039386	CG5948	HGNC:11179	OMIM:147450	SOD1	3	105400,618598	105400[AMYOTROPHIC LATERAL SCLEROSIS 1; ALS1],618598[SPASTIC TETRAPLEGIA AND AXIAL HYPOTONIA, PROGRESSIVE; STAHP]
FBgn0039386	CG5948	HGNC:11181	OMIM:185490	SOD3	4		
FBgn0039387	Mco3	HGNC:2295	OMIM:117700	CP	3	604290	604290[ACERULOPLASMINEMIA]
FBgn0039387	Mco3	HGNC:30477	OMIM:618455	HEPHL1	3	261990	261990[ABNORMAL HAIR, JOINT LAXITY, AND DEVELOPMENTAL DELAY; HJDD]
FBgn0039387	Mco3	HGNC:4866	OMIM:300167	HEPH	3		
FBgn0051091	CG31091	HGNC:6617	OMIM:613497	LIPA	7	278000	278000[LYSOSOMAL ACID LIPASE DEFICIENCY]
FBgn0051091	CG31091	HGNC:23444	OMIM:613922	LIPK	7		
FBgn0051091	CG31091	HGNC:23455	OMIM:613923	LIPM	7		
FBgn0051091	CG31091	HGNC:6622	OMIM:601980	LIPF	7		
FBgn0051091	CG31091	HGNC:21773	OMIM:613921	LIPJ	6		
FBgn0051091	CG31091	HGNC:23452	OMIM:613924	LIPN	7	613943	613943[ICHTHYOSIS, CONGENITAL, AUTOSOMAL RECESSIVE 8; ARCI8]
FBgn0051089	CG31089	HGNC:6617	OMIM:613497	LIPA	8	278000	278000[LYSOSOMAL ACID LIPASE DEFICIENCY]
FBgn0051089	CG31089	HGNC:23444	OMIM:613922	LIPK	8		
FBgn0051089	CG31089	HGNC:23455	OMIM:613923	LIPM	8		
FBgn0051089	CG31089	HGNC:6622	OMIM:601980	LIPF	8		
FBgn0051089	CG31089	HGNC:21773	OMIM:613921	LIPJ	6		
FBgn0051089	CG31089	HGNC:23452	OMIM:613924	LIPN	7	613943	613943[ICHTHYOSIS, CONGENITAL, AUTOSOMAL RECESSIVE 8; ARCI8]
FBgn0000206	boss	HGNC:9836	OMIM:604138	GPRC5A	3		
FBgn0000206	boss	HGNC:13308	OMIM:605948	GPRC5B	3		
FBgn0002734	E(spl)mdelta-HLH	HGNC:24149	OMIM:608060	HES4	4		
FBgn0002734	E(spl)mdelta-HLH	HGNC:5192	OMIM:139605	HES1	4		
FBgn0002734	E(spl)mdelta-HLH	HGNC:16005	OMIM:609970	HES2	6		
FBgn0002734	E(spl)mdelta-HLH	HGNC:18254	OMIM:610331	HES6	6		
FBgn0002734	E(spl)mdelta-HLH	HGNC:19764	OMIM:607348	HES5	3		
FBgn0002734	E(spl)mdelta-HLH	HGNC:26226	OMIM:609971	HES3	3		
FBgn0002734	E(spl)mdelta-HLH	HGNC:15977	OMIM:608059	HES7	3	613686	613686[SPONDYLOCOSTAL DYSOSTOSIS 4, AUTOSOMAL RECESSIVE; SCDO4]
FBgn0002734	E(spl)mdelta-HLH	HGNC:1046	OMIM:604256	BHLHE40	3		
FBgn0002734	E(spl)mdelta-HLH	HGNC:16617	OMIM:606200	BHLHE41	3	612975	612975[SHORT SLEEP, FAMILIAL NATURAL, 1; FNSS1]
FBgn0002735	E(spl)mgamma-HLH	HGNC:24149	OMIM:608060	HES4	4		
FBgn0002735	E(spl)mgamma-HLH	HGNC:5192	OMIM:139605	HES1	4		
FBgn0002735	E(spl)mgamma-HLH	HGNC:16005	OMIM:609970	HES2	5		
FBgn0002735	E(spl)mgamma-HLH	HGNC:18254	OMIM:610331	HES6	6		
FBgn0002735	E(spl)mgamma-HLH	HGNC:26226	OMIM:609971	HES3	3		
FBgn0002735	E(spl)mgamma-HLH	HGNC:15977	OMIM:608059	HES7	3	613686	613686[SPONDYLOCOSTAL DYSOSTOSIS 4, AUTOSOMAL RECESSIVE; SCDO4]
FBgn0002735	E(spl)mgamma-HLH	HGNC:1046	OMIM:604256	BHLHE40	3		
FBgn0002735	E(spl)mgamma-HLH	HGNC:16617	OMIM:606200	BHLHE41	3	612975	612975[SHORT SLEEP, FAMILIAL NATURAL, 1; FNSS1]
FBgn0002609	E(spl)m3-HLH	HGNC:24149	OMIM:608060	HES4	4		
FBgn0002609	E(spl)m3-HLH	HGNC:5192	OMIM:139605	HES1	4		
FBgn0002609	E(spl)m3-HLH	HGNC:16005	OMIM:609970	HES2	4		
FBgn0002609	E(spl)m3-HLH	HGNC:18254	OMIM:610331	HES6	7		
FBgn0002609	E(spl)m3-HLH	HGNC:26226	OMIM:609971	HES3	3		
FBgn0002609	E(spl)m3-HLH	HGNC:15977	OMIM:608059	HES7	3	613686	613686[SPONDYLOCOSTAL DYSOSTOSIS 4, AUTOSOMAL RECESSIVE; SCDO4]
FBgn0002609	E(spl)m3-HLH	HGNC:1046	OMIM:604256	BHLHE40	3		
FBgn0002609	E(spl)m3-HLH	HGNC:16617	OMIM:606200	BHLHE41	3	612975	612975[SHORT SLEEP, FAMILIAL NATURAL, 1; FNSS1]
FBgn0002633	E(spl)m7-HLH	HGNC:24149	OMIM:608060	HES4	4		
FBgn0002633	E(spl)m7-HLH	HGNC:5192	OMIM:139605	HES1	4		
FBgn0002633	E(spl)m7-HLH	HGNC:16005	OMIM:609970	HES2	4		
FBgn0002633	E(spl)m7-HLH	HGNC:18254	OMIM:610331	HES6	6		
FBgn0002633	E(spl)m7-HLH	HGNC:26226	OMIM:609971	HES3	3		
FBgn0002633	E(spl)m7-HLH	HGNC:15977	OMIM:608059	HES7	3	613686	613686[SPONDYLOCOSTAL DYSOSTOSIS 4, AUTOSOMAL RECESSIVE; SCDO4]
FBgn0002633	E(spl)m7-HLH	HGNC:1046	OMIM:604256	BHLHE40	3		
FBgn0002633	E(spl)m7-HLH	HGNC:16617	OMIM:606200	BHLHE41	3	612975	612975[SHORT SLEEP, FAMILIAL NATURAL, 1; FNSS1]
FBgn0000591	E(spl)m8-HLH	HGNC:24149	OMIM:608060	HES4	4		
FBgn0000591	E(spl)m8-HLH	HGNC:5192	OMIM:139605	HES1	4		
FBgn0000591	E(spl)m8-HLH	HGNC:16005	OMIM:609970	HES2	5		
FBgn0000591	E(spl)m8-HLH	HGNC:18254	OMIM:610331	HES6	4		
FBgn0000591	E(spl)m8-HLH	HGNC:19764	OMIM:607348	HES5	3		
FBgn0000591	E(spl)m8-HLH	HGNC:26226	OMIM:609971	HES3	3		
FBgn0000591	E(spl)m8-HLH	HGNC:15977	OMIM:608059	HES7	3	613686	613686[SPONDYLOCOSTAL DYSOSTOSIS 4, AUTOSOMAL RECESSIVE; SCDO4]
FBgn0000591	E(spl)m8-HLH	HGNC:1046	OMIM:604256	BHLHE40	3		
FBgn0000591	E(spl)m8-HLH	HGNC:16617	OMIM:606200	BHLHE41	3	612975	612975[SHORT SLEEP, FAMILIAL NATURAL, 1; FNSS1]
FBgn0001139	gro	HGNC:11837	OMIM:600189	TLE1	11		
FBgn0001139	gro	HGNC:11840	OMIM:605132	TLE4	12		
FBgn0001139	gro	HGNC:11838	OMIM:601041	TLE2	11		
FBgn0001139	gro	HGNC:11839	OMIM:600190	TLE3	12		
FBgn0001139	gro	HGNC:307	OMIM:600188	TLE5	4		
FBgn0001139	gro	HGNC:30788	OMIM:612399	TLE6	4	616814	616814[PREIMPLANTATION EMBRYONIC LETHALITY 1; PREMBL1]
FBgn0039402	Vps2	HGNC:30216	OMIM:610893	CHMP2A	13		
FBgn0039404	CG14543	HGNC:25455	OMIM:300945	TSR2	13	300946	300946[DIAMOND-BLACKFAN ANEMIA 14 WITH MANDIBULOFACIAL DYSOSTOSIS; DBA14]
FBgn0039407	Trmt61	HGNC:23790		TRMT61A	15		
FBgn0039411	dysf	HGNC:18983	OMIM:608554	NPAS4	8		
FBgn0039408	CG14551	HGNC:37241	OMIM:619866	CFAP97D1	6		
FBgn0039406	RpL34a	HGNC:10340	OMIM:616862	RPL34	11		
FBgn0039405	PIG-P	HGNC:3046	OMIM:605938	PIGP	10	617599	617599[DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 55; DEE55]
FBgn0039403	Sld5	HGNC:28226	OMIM:610611	GINS4	13		
FBgn0028833	Cmpk	HGNC:361	OMIM:103000	AK1	4	612631	612631[ADENYLATE KINASE DEFICIENCY, HEMOLYTIC ANEMIA DUE TO]
FBgn0028833	Cmpk	HGNC:365	OMIM:608009	AK5	3		
FBgn0028833	Cmpk	HGNC:18170	OMIM:191710	CMPK1	13		
FBgn0002733	E(spl)mbeta-HLH	HGNC:24149	OMIM:608060	HES4	4		
FBgn0002733	E(spl)mbeta-HLH	HGNC:5192	OMIM:139605	HES1	5		
FBgn0002733	E(spl)mbeta-HLH	HGNC:16005	OMIM:609970	HES2	5		
FBgn0002733	E(spl)mbeta-HLH	HGNC:18254	OMIM:610331	HES6	6		
FBgn0002733	E(spl)mbeta-HLH	HGNC:26226	OMIM:609971	HES3	3		
FBgn0002733	E(spl)mbeta-HLH	HGNC:15977	OMIM:608059	HES7	3	613686	613686[SPONDYLOCOSTAL DYSOSTOSIS 4, AUTOSOMAL RECESSIVE; SCDO4]
FBgn0002733	E(spl)mbeta-HLH	HGNC:1046	OMIM:604256	BHLHE40	3		
FBgn0002733	E(spl)mbeta-HLH	HGNC:16617	OMIM:606200	BHLHE41	3	612975	612975[SHORT SLEEP, FAMILIAL NATURAL, 1; FNSS1]
FBgn0039415	CG6142	HGNC:24288		CHDH	6		
FBgn0039420	CG6154	HGNC:23028	OMIM:609925	DPEP2	9		
FBgn0039420	CG6154	HGNC:3002	OMIM:179780	DPEP1	14		
FBgn0039420	CG6154	HGNC:23029	OMIM:609926	DPEP3	9		
FBgn0000064	Ald1	HGNC:417	OMIM:612724	ALDOB	11	229600	229600[FRUCTOSE INTOLERANCE, HEREDITARY; HFI]
FBgn0000064	Ald1	HGNC:414	OMIM:103850	ALDOA	13	611881	611881[GLYCOGEN STORAGE DISEASE XII; GSD12]
FBgn0000064	Ald1	HGNC:418	OMIM:103870	ALDOC	13		
FBgn0039417	CG6073	HGNC:24161		HGH1	14		
FBgn0039425	Ald2	HGNC:417	OMIM:612724	ALDOB	10	229600	229600[FRUCTOSE INTOLERANCE, HEREDITARY; HFI]
FBgn0039425	Ald2	HGNC:414	OMIM:103850	ALDOA	9	611881	611881[GLYCOGEN STORAGE DISEASE XII; GSD12]
FBgn0039425	Ald2	HGNC:418	OMIM:103870	ALDOC	9		
FBgn0042711	Hex-t1	HGNC:23302	OMIM:617221	HKDC1	6	619614	619614[RETINITIS PIGMENTOSA 92; RP92]
FBgn0042711	Hex-t1	HGNC:4922	OMIM:142600	HK1	6	235700,605285,617460,618547	235700[HEMOLYTIC ANEMIA, NONSPHEROCYTIC, DUE TO HEXOKINASE DEFICIENCY],605285[NEUROPATHY, HEREDITARY MOTOR AND SENSORY, RUSSE TYPE; HMSNR],617460[RETINITIS PIGMENTOSA 79; RP79],618547[NEURODEVELOPMENTAL DISORDER WITH VISUAL DEFECTS AND BRAIN ANOMALIES; NEDVIBA]
FBgn0042711	Hex-t1	HGNC:4923	OMIM:601125	HK2	6		
FBgn0042711	Hex-t1	HGNC:4925	OMIM:142570	HK3	6		
FBgn0042711	Hex-t1	HGNC:4195	OMIM:138079	GCK	8	125851,125853,602485,606176	125851[MATURITY-ONSET DIABETES OF THE YOUNG, TYPE 2; MODY2],125853[TYPE 2 DIABETES MELLITUS; T2D],602485[HYPERINSULINEMIC HYPOGLYCEMIA, FAMILIAL, 3; HHF3],606176[DIABETES MELLITUS, PERMANENT NEONATAL, 1; PNDM1]
FBgn0042710	Hex-t2	HGNC:23302	OMIM:617221	HKDC1	7	619614	619614[RETINITIS PIGMENTOSA 92; RP92]
FBgn0042710	Hex-t2	HGNC:4922	OMIM:142600	HK1	8	235700,605285,617460,618547	235700[HEMOLYTIC ANEMIA, NONSPHEROCYTIC, DUE TO HEXOKINASE DEFICIENCY],605285[NEUROPATHY, HEREDITARY MOTOR AND SENSORY, RUSSE TYPE; HMSNR],617460[RETINITIS PIGMENTOSA 79; RP79],618547[NEURODEVELOPMENTAL DISORDER WITH VISUAL DEFECTS AND BRAIN ANOMALIES; NEDVIBA]
FBgn0042710	Hex-t2	HGNC:4923	OMIM:601125	HK2	7		
FBgn0042710	Hex-t2	HGNC:4925	OMIM:142570	HK3	8		
FBgn0042710	Hex-t2	HGNC:4195	OMIM:138079	GCK	10	125851,125853,602485,606176	125851[MATURITY-ONSET DIABETES OF THE YOUNG, TYPE 2; MODY2],125853[TYPE 2 DIABETES MELLITUS; T2D],602485[HYPERINSULINEMIC HYPOGLYCEMIA, FAMILIAL, 3; HHF3],606176[DIABETES MELLITUS, PERMANENT NEONATAL, 1; PNDM1]
FBgn0039427	CG5447	HGNC:24876	OMIM:609453	GOLGA7	12		
FBgn0039427	CG5447	HGNC:31668	OMIM:614189	GOLGA7B	13		
FBgn0039429	CG14238	HGNC:28550	OMIM:617803	TMEM26	11		
FBgn0039430	CG5455	HGNC:21061	OMIM:614725	SERAC1	6	614739	614739[3-METHYLGLUTACONIC ACIDURIA WITH DEAFNESS, ENCEPHALOPATHY, AND LEIGH-LIKE SYNDROME; MEGDEL]
FBgn0039424	ppk15	HGNC:101	OMIM:611741	ASIC3	3		
FBgn0039424	ppk15	HGNC:100	OMIM:602866	ASIC1	3		
FBgn0039424	ppk15	HGNC:21263	OMIM:606715	ASIC4	3		
FBgn0039424	ppk15	HGNC:17537	OMIM:616693	ASIC5	3		
FBgn0039421	Nil	HGNC:9278	OMIM:605119	PPM1G	3		
FBgn0039421	Nil	HGNC:9275	OMIM:606108	PPM1A	9		
FBgn0039421	Nil	HGNC:9276	OMIM:603770	PPM1B	9		
FBgn0039421	Nil	HGNC:26845		PPM1N	6		
FBgn0039451	CG6420	HGNC:2936	OMIM:609857	DMWD	10		
FBgn0039451	CG6420	HGNC:19667	OMIM:617741	WDR20	14		
FBgn0023179	amon	HGNC:8569	OMIM:167405	PCSK6	4		
FBgn0023179	amon	HGNC:8743	OMIM:162150	PCSK1	4	600955,612362	600955[PROPROTEIN CONVERTASE 1/3 DEFICIENCY],612362[BODY MASS INDEX QUANTITATIVE TRAIT LOCUS 12; BMIQ12]
FBgn0023179	amon	HGNC:8747	OMIM:600488	PCSK5	4		
FBgn0023179	amon	HGNC:8744	OMIM:162151	PCSK2	15		
FBgn0023179	amon	HGNC:8746	OMIM:600487	PCSK4	3		
FBgn0023179	amon	HGNC:8568	OMIM:136950	FURIN	4		
FBgn0023179	amon	HGNC:8748	OMIM:604872	PCSK7	4		
FBgn0039459	IntS12	HGNC:25067	OMIM:611355	INTS12	14		
FBgn0001197	His2Av	HGNC:4741	OMIM:142763	H2AZ1	12		
FBgn0001197	His2Av	HGNC:20664	OMIM:620008	H2AFV	13		
FBgn0039461	CG5500	HGNC:27901		OXLD1	11		
FBgn0039463	Spag1	HGNC:11212	OMIM:603395	SPAG1	9	615505	615505[CILIARY DYSKINESIA, PRIMARY, 28; CILD28]
FBgn0039463	Spag1	HGNC:15746	OMIM:616049	TOMM34	6		
FBgn0039466	CG5521	HGNC:16207	OMIM:618836	RALGAPA2	13		
FBgn0039466	CG5521	HGNC:17770	OMIM:608884	RALGAPA1	14	618797	618797[NEURODEVELOPMENTAL DISORDER WITH HYPOTONIA, NEONATAL RESPIRATORY INSUFFICIENCY, AND THERMODYSREGULATION; NEDHRIT]
FBgn0039471	CG6295	HGNC:9155	OMIM:246600	PNLIP	3	614338	614338[PANCREATIC LIPASE DEFICIENCY; PNLIPD]
FBgn0039471	CG6295	HGNC:17661	OMIM:607460	PLA1A	3		
FBgn0039471	CG6295	HGNC:9156	OMIM:604422	PNLIPRP1	3		
FBgn0039471	CG6295	HGNC:23492		PNLIPRP3	3		
FBgn0039471	CG6295	HGNC:6619	OMIM:151670	LIPC	3	125853,612797,614025	125853[TYPE 2 DIABETES MELLITUS; T2D],612797[HIGH DENSITY LIPOPROTEIN CHOLESTEROL LEVEL QUANTITATIVE TRAIT LOCUS 12; HDLCQ12],614025[HEPATIC LIPASE DEFICIENCY]
FBgn0039471	CG6295	HGNC:18821	OMIM:609252	LIPI	4		
FBgn0039471	CG6295	HGNC:18483	OMIM:607365	LIPH	3	604379	604379[HYPOTRICHOSIS 7; HYPT7]
FBgn0039470	CG6296	HGNC:9155	OMIM:246600	PNLIP	3	614338	614338[PANCREATIC LIPASE DEFICIENCY; PNLIPD]
FBgn0039470	CG6296	HGNC:17661	OMIM:607460	PLA1A	3		
FBgn0039470	CG6296	HGNC:9156	OMIM:604422	PNLIPRP1	3		
FBgn0039470	CG6296	HGNC:23492		PNLIPRP3	3		
FBgn0039470	CG6296	HGNC:6619	OMIM:151670	LIPC	3	125853,612797,614025	125853[TYPE 2 DIABETES MELLITUS; T2D],612797[HIGH DENSITY LIPOPROTEIN CHOLESTEROL LEVEL QUANTITATIVE TRAIT LOCUS 12; HDLCQ12],614025[HEPATIC LIPASE DEFICIENCY]
FBgn0039470	CG6296	HGNC:18821	OMIM:609252	LIPI	3		
FBgn0039470	CG6296	HGNC:18483	OMIM:607365	LIPH	3	604379	604379[HYPOTRICHOSIS 7; HYPT7]
FBgn0051076	CG31076	HGNC:23405	OMIM:614537	LRMDA	11	615179	615179[ALBINISM, OCULOCUTANEOUS, TYPE VII; OCA7]
FBgn0051075	CG31075	HGNC:404	OMIM:100650	ALDH2	7	610251	610251[ALCOHOL SENSITIVITY, ACUTE]
FBgn0051075	CG31075	HGNC:26777	OMIM:613584	ALDH1L2	3		
FBgn0051075	CG31075	HGNC:3978	OMIM:600249	ALDH1L1	3		
FBgn0051075	CG31075	HGNC:15472	OMIM:603687	ALDH1A2	6	620025	620025[DIAPHRAGMATIC HERNIA 4, WITH CARDIOVASCULAR DEFECTS; DIH4]
FBgn0051075	CG31075	HGNC:407	OMIM:100670	ALDH1B1	5		
FBgn0051075	CG31075	HGNC:402	OMIM:100640	ALDH1A1	7		
FBgn0051075	CG31075	HGNC:409	OMIM:600463	ALDH1A3	6	615113	615113[MICROPHTHALMIA, ISOLATED 8; MCOP8]
FBgn0051075	CG31075	HGNC:412	OMIM:602733	ALDH9A1	3		
FBgn0039465	Tsp97E	HGNC:10539	OMIM:181035	TSPAN31	12		
FBgn0039465	Tsp97E	HGNC:21643	OMIM:613139	TSPAN13	13		
FBgn0039464	CG6330	HGNC:23061	OMIM:617340	UPP2	14		
FBgn0039464	CG6330	HGNC:12576	OMIM:191730	UPP1	13		
FBgn0004510	Ets97D	HGNC:4071	OMIM:600609	GABPA	14		
FBgn0004510	Ets97D	HGNC:3491	OMIM:609358	ETV2	3		
FBgn0026562	SPARC	HGNC:11219	OMIM:182120	SPARC	14	616507	616507[OSTEOGENESIS IMPERFECTA, TYPE XVII; OI17]
FBgn0026562	SPARC	HGNC:11220	OMIM:606041	SPARCL1	10		
FBgn0027889	ball	HGNC:18996	OMIM:619771	VRK3	6		
FBgn0027889	ball	HGNC:12718	OMIM:602168	VRK1	14	607596	607596[PONTOCEREBELLAR HYPOPLASIA, TYPE 1A; PCH1A]
FBgn0027889	ball	HGNC:12719	OMIM:602169	VRK2	11		
FBgn0027574	CG5815	HGNC:26818		SPTY2D1	8		
FBgn0039489	CG5880	HGNC:20714	OMIM:616750	ZDHHC16	14		
FBgn0039490	CG5882	HGNC:26676	OMIM:619129	CFAP58	13	619144	619144[SPERMATOGENIC FAILURE 49; SPGF49]
FBgn0029155	Men-b	HGNC:6985	OMIM:604626	ME3	13		
FBgn0029155	Men-b	HGNC:6984	OMIM:154270	ME2	9		
FBgn0029155	Men-b	HGNC:6983	OMIM:154250	ME1	12		
FBgn0051065	ppk31	HGNC:101	OMIM:611741	ASIC3	3		
FBgn0051065	ppk31	HGNC:100	OMIM:602866	ASIC1	3		
FBgn0051065	ppk31	HGNC:21263	OMIM:606715	ASIC4	3		
FBgn0051065	ppk31	HGNC:17537	OMIM:616693	ASIC5	4		
FBgn0003482	spn-D	HGNC:9820	OMIM:602774	RAD51C	11	613390,613399	613390[FANCONI ANEMIA, COMPLEMENTATION GROUP O; FANCO],613399[BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 3; BROVCA3]
FBgn0003482	spn-D	HGNC:9822	OMIM:602948	RAD51B	3		
FBgn0005696	PolA2	HGNC:30073		POLA2	15		
FBgn0039498	CG17991	HGNC:26025	OMIM:610637	MARCHF5	9		
FBgn0042111	CG18766	HGNC:33741		MSANTD1	8		
FBgn0051064	CG31064	HGNC:19761	OMIM:610328	RUFY2	13		
FBgn0051064	CG31064	HGNC:19760	OMIM:610327	RUFY1	11		
FBgn0051064	CG31064	HGNC:30285	OMIM:611194	RUFY3	9		
FBgn0051064	CG31064	HGNC:16984	OMIM:605448	RUNDC3A	3		
FBgn0051064	CG31064	HGNC:30286	OMIM:617295	RUNDC3B	3		
FBgn0004197	Ser	HGNC:6188	OMIM:601920	JAG1	12	118450,187500,617992,619574	118450[ALAGILLE SYNDROME 1; ALGS1],187500[TETRALOGY OF FALLOT; TOF],617992[DEAFNESS, CONGENITAL HEART DEFECTS, AND POSTERIOR EMBRYOTOXON; DCHE],619574[CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2HH; CMT2HH]
FBgn0004197	Ser	HGNC:6189	OMIM:602570	JAG2	11	619566	619566[MUSCULAR DYSTROPHY, LIMB-GIRDLE, AUTOSOMAL RECESSIVE 27; LGMDR27]
FBgn0039492	CG6051	HGNC:29334	OMIM:614176	ZFYVE28	13		
FBgn0039491	CG6059	HGNC:26676	OMIM:619129	CFAP58	6	619144	619144[SPERMATOGENIC FAILURE 49; SPGF49]
FBgn0039488	CG6066	HGNC:29873	OMIM:300766	NKAP	12	301039	301039[INTELLECTUAL DEVELOPMENTAL DISORDER, X-LINKED, SYNDROMIC, HACKMANN-DI DONATO TYPE; MRXSHD]
FBgn0039488	CG6066	HGNC:21584		NKAPL	11		
FBgn0039487	gb	HGNC:11059	OMIM:607933	SLC7A11	5		
FBgn0039487	gb	HGNC:11058	OMIM:607959	SLC7A10	4		
FBgn0039487	gb	HGNC:11065	OMIM:603593	SLC7A7	5	222700	222700[LYSINURIC PROTEIN INTOLERANCE; LPI]
FBgn0039487	gb	HGNC:11064	OMIM:605641	SLC7A6	5		
FBgn0039487	gb	HGNC:11067	OMIM:604144	SLC7A9	5	220100	220100[CYSTINURIA]
FBgn0039487	gb	HGNC:11063	OMIM:600182	SLC7A5	5		
FBgn0039487	gb	HGNC:11066	OMIM:604235	SLC7A8	6		
FBgn0039487	gb	HGNC:23092	OMIM:617256	SLC7A13	3		
FBgn0039486	CAH9	HGNC:1373	OMIM:611492	CA2	3	259730	259730[OSTEOPETROSIS, AUTOSOMAL RECESSIVE 3; OPTB3]
FBgn0039486	CAH9	HGNC:1380	OMIM:114780	CA6	6		
FBgn0039486	CAH9	HGNC:1381	OMIM:114770	CA7	4		
FBgn0039486	CAH9	HGNC:1371	OMIM:603263	CA12	5	143860	143860[HYPERCHLORHIDROSIS, ISOLATED; HYCHL]
FBgn0039486	CAH9	HGNC:1372	OMIM:604832	CA14	4		
FBgn0039486	CAH9	HGNC:1383	OMIM:603179	CA9	6		
FBgn0039486	CAH9	HGNC:1370	OMIM:604644	CA11	3		
FBgn0039486	CAH9	HGNC:1368	OMIM:114800	CA1	5		
FBgn0039486	CAH9	HGNC:1377	OMIM:114761	CA5A	4	615751	615751[CARBONIC ANHYDRASE VA DEFICIENCY, HYPERAMMONEMIA DUE TO; CA5AD]
FBgn0039486	CAH9	HGNC:14914	OMIM:611436	CA13	5		
FBgn0039486	CAH9	HGNC:1374	OMIM:114750	CA3	5		
FBgn0039486	CAH9	HGNC:1375	OMIM:114760	CA4	5		
FBgn0039486	CAH9	HGNC:1378	OMIM:300230	CA5B	5		
FBgn0039478	Nep5	HGNC:8918	OMIM:300550	PHEX	3	307800	307800[HYPOPHOSPHATEMIC RICKETS, X-LINKED DOMINANT; XLHR]
FBgn0039478	Nep5	HGNC:14668	OMIM:618104	MMEL1	3		
FBgn0039478	Nep5	HGNC:7154	OMIM:120520	MME	4	617017,617018	617017[CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2T; CMT2T],617018[SPINOCEREBELLAR ATAXIA 43; SCA43]
FBgn0039478	Nep5	HGNC:13275	OMIM:610145	ECE2	3		
FBgn0039478	Nep5	HGNC:3147	OMIM:605896	ECEL1	3	615065	615065[ARTHROGRYPOSIS, DISTAL, TYPE 5D; DA5D]
FBgn0039478	Nep5	HGNC:3146	OMIM:600423	ECE1	3	145500,613870	145500[HYPERTENSION, ESSENTIAL],613870[HIRSCHSPRUNG DISEASE, CARDIAC DEFECTS, AND AUTONOMIC DYSFUNCTION; HCAD]
FBgn0039478	Nep5	HGNC:6308	OMIM:613883	KEL	3	110900	110900[BLOOD GROUP--KELL SYSTEM; KEL]
FBgn0039476	CG6271	HGNC:9155	OMIM:246600	PNLIP	3	614338	614338[PANCREATIC LIPASE DEFICIENCY; PNLIPD]
FBgn0039476	CG6271	HGNC:17661	OMIM:607460	PLA1A	3		
FBgn0039476	CG6271	HGNC:9156	OMIM:604422	PNLIPRP1	3		
FBgn0039476	CG6271	HGNC:23492		PNLIPRP3	3		
FBgn0039476	CG6271	HGNC:6619	OMIM:151670	LIPC	3	125853,612797,614025	125853[TYPE 2 DIABETES MELLITUS; T2D],612797[HIGH DENSITY LIPOPROTEIN CHOLESTEROL LEVEL QUANTITATIVE TRAIT LOCUS 12; HDLCQ12],614025[HEPATIC LIPASE DEFICIENCY]
FBgn0039476	CG6271	HGNC:18821	OMIM:609252	LIPI	3		
FBgn0039476	CG6271	HGNC:18483	OMIM:607365	LIPH	3	604379	604379[HYPOTRICHOSIS 7; HYPT7]
FBgn0039476	CG6271	HGNC:6677	OMIM:609708	LPL	3	144250,238600	144250[HYPERLIPIDEMIA, FAMILIAL COMBINED, 3; FCHL3],238600[HYPERLIPOPROTEINEMIA, TYPE I]
FBgn0039475	CG6277	HGNC:9155	OMIM:246600	PNLIP	3	614338	614338[PANCREATIC LIPASE DEFICIENCY; PNLIPD]
FBgn0039475	CG6277	HGNC:17661	OMIM:607460	PLA1A	3		
FBgn0039475	CG6277	HGNC:9156	OMIM:604422	PNLIPRP1	3		
FBgn0039475	CG6277	HGNC:23492		PNLIPRP3	3		
FBgn0039475	CG6277	HGNC:6619	OMIM:151670	LIPC	3	125853,612797,614025	125853[TYPE 2 DIABETES MELLITUS; T2D],612797[HIGH DENSITY LIPOPROTEIN CHOLESTEROL LEVEL QUANTITATIVE TRAIT LOCUS 12; HDLCQ12],614025[HEPATIC LIPASE DEFICIENCY]
FBgn0039475	CG6277	HGNC:18821	OMIM:609252	LIPI	3		
FBgn0039475	CG6277	HGNC:18483	OMIM:607365	LIPH	4	604379	604379[HYPOTRICHOSIS 7; HYPT7]
FBgn0039475	CG6277	HGNC:6623	OMIM:603684	LIPG	3		
FBgn0039474	CG6283	HGNC:9155	OMIM:246600	PNLIP	3	614338	614338[PANCREATIC LIPASE DEFICIENCY; PNLIPD]
FBgn0039474	CG6283	HGNC:17661	OMIM:607460	PLA1A	3		
FBgn0039474	CG6283	HGNC:9156	OMIM:604422	PNLIPRP1	3		
FBgn0039474	CG6283	HGNC:23492		PNLIPRP3	3		
FBgn0039474	CG6283	HGNC:6619	OMIM:151670	LIPC	3	125853,612797,614025	125853[TYPE 2 DIABETES MELLITUS; T2D],612797[HIGH DENSITY LIPOPROTEIN CHOLESTEROL LEVEL QUANTITATIVE TRAIT LOCUS 12; HDLCQ12],614025[HEPATIC LIPASE DEFICIENCY]
FBgn0039474	CG6283	HGNC:18821	OMIM:609252	LIPI	3		
FBgn0039474	CG6283	HGNC:18483	OMIM:607365	LIPH	3	604379	604379[HYPOTRICHOSIS 7; HYPT7]
FBgn0039474	CG6283	HGNC:6677	OMIM:609708	LPL	3	144250,238600	144250[HYPERLIPIDEMIA, FAMILIAL COMBINED, 3; FCHL3],238600[HYPERLIPOPROTEINEMIA, TYPE I]
FBgn0039473	CG17191	HGNC:9155	OMIM:246600	PNLIP	3	614338	614338[PANCREATIC LIPASE DEFICIENCY; PNLIPD]
FBgn0039473	CG17191	HGNC:17661	OMIM:607460	PLA1A	3		
FBgn0039473	CG17191	HGNC:9156	OMIM:604422	PNLIPRP1	4		
FBgn0039473	CG17191	HGNC:23492		PNLIPRP3	3		
FBgn0039473	CG17191	HGNC:6619	OMIM:151670	LIPC	3	125853,612797,614025	125853[TYPE 2 DIABETES MELLITUS; T2D],612797[HIGH DENSITY LIPOPROTEIN CHOLESTEROL LEVEL QUANTITATIVE TRAIT LOCUS 12; HDLCQ12],614025[HEPATIC LIPASE DEFICIENCY]
FBgn0039473	CG17191	HGNC:18821	OMIM:609252	LIPI	3		
FBgn0039473	CG17191	HGNC:18483	OMIM:607365	LIPH	3	604379	604379[HYPOTRICHOSIS 7; HYPT7]
FBgn0039472	CG17192	HGNC:17661	OMIM:607460	PLA1A	3		
FBgn0011289	TfIIA-L	HGNC:4646	OMIM:600520	GTF2A1	12		
FBgn0011289	TfIIA-L	HGNC:30651		STON1-GTF2A1L	5		
FBgn0011289	TfIIA-L	HGNC:30727	OMIM:605358	GTF2A1L	6		
FBgn0039505	CG5934	HGNC:20335		SCOC	11		
FBgn0046247	CG5938	HGNC:1935	OMIM:604332	CHIC2	14	601626	601626[LEUKEMIA, ACUTE MYELOID; AML]
FBgn0046247	CG5938	HGNC:1934	OMIM:300922	CHIC1	13		
FBgn0015737	Hmu	HGNC:13238	OMIM:615884	APMAP	12		
FBgn0039510	CG3339	HGNC:2951	OMIM:603336	DNAH6	3		
FBgn0039510	CG3339	HGNC:2949	OMIM:603334	DNAH3	3		
FBgn0039510	CG3339	HGNC:2952	OMIM:603337	DNAH8	3	619095	619095[SPERMATOGENIC FAILURE 46; SPGF46]
FBgn0039510	CG3339	HGNC:2940	OMIM:603332	DNAH1	3	617576,617577	617576[SPERMATOGENIC FAILURE 18; SPGF18],617577[CILIARY DYSKINESIA, PRIMARY, 37; CILD37]
FBgn0039510	CG3339	HGNC:18661	OMIM:610061	DNAH7	3		
FBgn0039510	CG3339	HGNC:2953	OMIM:603330	DNAH9	9	618300	618300[CILIARY DYSKINESIA, PRIMARY, 40; CILD40]
FBgn0039510	CG3339	HGNC:2942	OMIM:603339	DNAH11	8	611884	611884[CILIARY DYSKINESIA, PRIMARY, 7; CILD7]
FBgn0039510	CG3339	HGNC:2950	OMIM:603335	DNAH5	3	608644	608644[CILIARY DYSKINESIA, PRIMARY, 3; CILD3]
FBgn0039510	CG3339	HGNC:2948	OMIM:603333	DNAH2	4	619094	619094[SPERMATOGENIC FAILURE 45; SPGF45]
FBgn0039510	CG3339	HGNC:2941	OMIM:605884	DNAH10	4	619515	619515[SPERMATOGENIC FAILURE 56; SPGF56]
FBgn0039510	CG3339	HGNC:2946	OMIM:610063	DNAH17	8	618643	618643[SPERMATOGENIC FAILURE 39; SPGF39]
FBgn0039510	CG3339	HGNC:2945	OMIM:603341	DNAH14	3		
FBgn0039510	CG3339	HGNC:2943	OMIM:603340	DNAH12	3		
FBgn0039509	bigmax	HGNC:11645	OMIM:602976	MLX	14		
FBgn0002441	l(3)mbt	HGNC:10581	OMIM:300208	SCML2	3		
FBgn0002441	l(3)mbt	HGNC:15905	OMIM:608802	L3MBTL1	7		
FBgn0002441	l(3)mbt	HGNC:23035	OMIM:618844	L3MBTL3	8		
FBgn0002441	l(3)mbt	HGNC:26677	OMIM:617135	L3MBTL4	9		
FBgn0010328	woc	HGNC:12989	OMIM:602221	ZMYM2	9	619522	619522[NEURODEVELOPMENTAL-CRANIOFACIAL SYNDROME WITH VARIABLE RENAL AND CARDIAC ABNORMALITIES; NECRC]
FBgn0010328	woc	HGNC:13055	OMIM:613568	ZMYM4	10		
FBgn0010328	woc	HGNC:13054	OMIM:300061	ZMYM3	10		
FBgn0010328	woc	HGNC:13050	OMIM:613567	ZMYM6	4		
FBgn0010328	woc	HGNC:24713	OMIM:617387	QRICH1	4	617982	617982[VERVERI-BRADY SYNDROME; VERBRAS]
FBgn0010441	pll	HGNC:6112	OMIM:300283	IRAK1	8		
FBgn0010441	pll	HGNC:17967	OMIM:606883	IRAK4	9	607676	607676[IMMUNODEFICIENCY 67; IMD67]
FBgn0010441	pll	HGNC:6113	OMIM:603304	IRAK2	7		
FBgn0010441	pll	HGNC:17020	OMIM:604459	IRAK3	5	611064	611064[ASTHMA-RELATED TRAITS, SUSCEPTIBILITY TO, 5]
FBgn0039501	TTLL6B	HGNC:26664	OMIM:610849	TTLL6	11		
FBgn0039501	TTLL6B	HGNC:26242	OMIM:618813	TTLL7	4		
FBgn0039501	TTLL6B	HGNC:18113		TTLL11	3		
FBgn0039501	TTLL6B	HGNC:32484		TTLL13P	8		
FBgn0039500	CG5984	HGNC:3755	OMIM:603381	FLNB	3	108720,108721,112310,150250,272460	108720[ATELOSTEOGENESIS, TYPE I; AO1],108721[ATELOSTEOGENESIS, TYPE III; AO3],112310[BOOMERANG DYSPLASIA; BOOMD],150250[LARSEN SYNDROME; LRS],272460[SPONDYLOCARPOTARSAL SYNOSTOSIS SYNDROME; SCT]
FBgn0039518	CG13978	HGNC:8967	OMIM:606097	PIGN	8	614080	614080[MULTIPLE CONGENITAL ANOMALIES-HYPOTONIA-SEIZURES SYNDROME 1; MCAHS1]
FBgn0039519	Cyp6a18	HGNC:2638	OMIM:605325	CYP3A5	6	145500	145500[HYPERTENSION, ESSENTIAL]
FBgn0039519	Cyp6a18	HGNC:17450	OMIM:606534	CYP3A43	6		
FBgn0039519	Cyp6a18	HGNC:11609	OMIM:274180	TBXAS1	6	231095	231095[GHOSAL HEMATODIAPHYSEAL DYSPLASIA; GHDD]
FBgn0039519	Cyp6a18	HGNC:2637	OMIM:124010	CYP3A4	6	619073	619073[VITAMIN D-DEPENDENT RICKETS, TYPE 3; VDDR3]
FBgn0039519	Cyp6a18	HGNC:51504		CYP3A7-CYP3A51P	5		
FBgn0040080	pins	HGNC:29501	OMIM:609245	GPSM2	13	604213	604213[CHUDLEY-MCCULLOUGH SYNDROME; CMCS]
FBgn0040080	pins	HGNC:17858	OMIM:609491	GPSM1	12		
FBgn0039528	dsd	HGNC:29063	OMIM:612869	ATRNL1	11		
FBgn0039528	dsd	HGNC:885	OMIM:603130	ATRN	12		
FBgn0039527	CG5639	HGNC:20477	OMIM:605161	WFDC5	3		
FBgn0039527	CG5639	HGNC:15957		WFDC3	3		
FBgn0039527	CG5639	HGNC:8947	OMIM:182257	PI3	3		
FBgn0027492	wdb	HGNC:9312	OMIM:601646	PPP2R5D	4	616355	616355[INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL DOMINANT 35; MRD35]
FBgn0027492	wdb	HGNC:9313	OMIM:601647	PPP2R5E	13		
FBgn0027492	wdb	HGNC:9311	OMIM:601645	PPP2R5C	5		
FBgn0027492	wdb	HGNC:9309	OMIM:601643	PPP2R5A	12		
FBgn0027492	wdb	HGNC:9310	OMIM:601644	PPP2R5B	9		
FBgn0039525	CG5646	HGNC:1421	OMIM:613698	SLC25A20	3	212138	212138[CARNITINE-ACYLCARNITINE TRANSLOCASE DEFICIENCY; CACTD]
FBgn0039525	CG5646	HGNC:20116	OMIM:615064	SLC25A29	3		
FBgn0039525	CG5646	HGNC:30451	OMIM:616150	SLC25A48	3		
FBgn0039525	CG5646	HGNC:27442	OMIM:610825	SLC25A45	5		
FBgn0039525	CG5646	HGNC:20115	OMIM:609911	SLC25A47	3		
FBgn0004387	Klp98A	HGNC:15869	OMIM:618171	KIF16B	11		
FBgn0039522	CG13972	HGNC:25251	OMIM:612477	IQCG	11		
FBgn0005659	Ets98B	HGNC:17257	OMIM:608144	SPDEF	11		
FBgn0039555	mRpS22	HGNC:14508	OMIM:605810	MRPS22	14	611719,618117	611719[COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 5; COXPD5],618117[OVARIAN DYSGENESIS 7; ODG7]
FBgn0003279	RpL4	HGNC:10353	OMIM:180479	RPL4	14		
FBgn0027579	mino	HGNC:27168	OMIM:616431	GPAT2	9		
FBgn0027579	mino	HGNC:24865	OMIM:602395	GPAM	15		
FBgn0039560	BOD1	HGNC:28505		BOD1L2	6		
FBgn0039560	BOD1	HGNC:31792	OMIM:616746	BOD1L1	4		
FBgn0039560	BOD1	HGNC:25114	OMIM:616745	BOD1	8		
FBgn0039562	Gp93	HGNC:5258	OMIM:140572	HSP90AB1	4		
FBgn0039562	Gp93	HGNC:5253	OMIM:140571	HSP90AA1	4		
FBgn0039562	Gp93	HGNC:12028	OMIM:191175	HSP90B1	14		
FBgn0039564	Nep7	HGNC:8918	OMIM:300550	PHEX	3	307800	307800[HYPOPHOSPHATEMIC RICKETS, X-LINKED DOMINANT; XLHR]
FBgn0039564	Nep7	HGNC:14668	OMIM:618104	MMEL1	4		
FBgn0039564	Nep7	HGNC:7154	OMIM:120520	MME	5	617017,617018	617017[CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2T; CMT2T],617018[SPINOCEREBELLAR ATAXIA 43; SCA43]
FBgn0039564	Nep7	HGNC:13275	OMIM:610145	ECE2	3		
FBgn0039564	Nep7	HGNC:3147	OMIM:605896	ECEL1	4	615065	615065[ARTHROGRYPOSIS, DISTAL, TYPE 5D; DA5D]
FBgn0039564	Nep7	HGNC:3146	OMIM:600423	ECE1	4	145500,613870	145500[HYPERTENSION, ESSENTIAL],613870[HIRSCHSPRUNG DISEASE, CARDIAC DEFECTS, AND AUTONOMIC DYSFUNCTION; HCAD]
FBgn0039564	Nep7	HGNC:6308	OMIM:613883	KEL	5	110900	110900[BLOOD GROUP--KELL SYSTEM; KEL]
FBgn0039566	CG4849	HGNC:30858	OMIM:603892	EFTUD2	14	610536	610536[MANDIBULOFACIAL DYSOSTOSIS, GUION-ALMEIDA TYPE; MFDGA]
FBgn0003890	betaTub97EF	HGNC:20774	OMIM:602662	TUBB4A	4	128101,612438	128101[DYSTONIA 4, TORSION, AUTOSOMAL DOMINANT; DYT4],612438[LEUKODYSTROPHY, HYPOMYELINATING, 6; HLD6]
FBgn0003890	betaTub97EF	HGNC:12412	OMIM:615101	TUBB2A	6	615763	615763[CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 5; CDCBM5]
FBgn0003890	betaTub97EF	HGNC:20778	OMIM:191130	TUBB	4	156610,615771	156610[SKIN CREASES, CONGENITAL SYMMETRIC CIRCUMFERENTIAL, 1; CSCSC1],615771[CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 6; CDCBM6]
FBgn0003890	betaTub97EF	HGNC:30829	OMIM:612850	TUBB2B	4	610031	610031[CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 7; CDCBM7]
FBgn0003890	betaTub97EF	HGNC:20771	OMIM:602660	TUBB4B	4	617879	617879[LEBER CONGENITAL AMAUROSIS WITH EARLY-ONSET DEAFNESS; LCAEOD]
FBgn0003890	betaTub97EF	HGNC:20772	OMIM:602661	TUBB3	4	600638,614039	600638[FIBROSIS OF EXTRAOCULAR MUSCLES, CONGENITAL, 3A, WITH OR WITHOUT EXTRAOCULAR INVOLVEMENT; CFEOM3A],614039[CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 1; CDCBM1]
FBgn0003890	betaTub97EF	HGNC:16257	OMIM:612901	TUBB1	5	613112	613112[MACROTHROMBOCYTOPENIA, ISOLATED, 1, AUTOSOMAL DOMINANT; MACTHC1]
FBgn0003890	betaTub97EF	HGNC:20776	OMIM:615103	TUBB6	5	617732	617732[FACIAL PALSY, CONGENITAL, WITH PTOSIS AND VELOPHARYNGEAL DYSFUNCTION; FPVEPD]
FBgn0003890	betaTub97EF	HGNC:20773	OMIM:616768	TUBB8	5	616780	616780[OOCYTE MATURATION DEFECT 2; OOMD2]
FBgn0039565	CG4884	HGNC:17971	OMIM:618583	MTRES1	11		
FBgn0039561	mfrn	HGNC:23472	OMIM:609767	SLC25A28	12		
FBgn0039561	mfrn	HGNC:29786	OMIM:610387	SLC25A37	14		
FBgn0039559	NSD	HGNC:12766	OMIM:602952	NSD2	12	619695	619695[RAUCH-STEINDL SYNDROME; RAUST]
FBgn0039559	NSD	HGNC:12767	OMIM:607083	NSD3	13		
FBgn0039559	NSD	HGNC:14234	OMIM:606681	NSD1	10	117550	117550[SOTOS SYNDROME; SOTOS]
FBgn0051053	nenya	HGNC:20438		RNF212B	9		
FBgn0051053	nenya	HGNC:27729	OMIM:612041	RNF212	6	612042,619673	612042[RECOMBINATION RATE QUANTITATIVE TRAIT LOCUS 1; RRQTL1],619673[SPERMATOGENIC FAILURE 62; SPGF62]
FBgn0039558	BCAS2	HGNC:975	OMIM:605783	BCAS2	14		
FBgn0039557	CG12259	HGNC:18786	OMIM:300453	FAM50A	14	300261	300261[INTELLECTUAL DEVELOPMENTAL DISORDER, X-LINKED, SYNDROMIC, ARMFIELD TYPE; MRXSA]
FBgn0039557	CG12259	HGNC:18789	OMIM:614686	FAM50B	11		
FBgn0039576	UQCR-14L	HGNC:12582	OMIM:191330	UQCRB	14	615158	615158[MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 3; MC3DN3]
FBgn0039581	Moca-cyp	HGNC:14650	OMIM:606093	PPIG	10		
FBgn0039581	Moca-cyp	HGNC:9256	OMIM:123842	PPIC	3		
FBgn0039581	Moca-cyp	HGNC:33996		PPIAL4G	3		
FBgn0039581	Moca-cyp	HGNC:7833	OMIM:161565	NKTR	7		
FBgn0039581	Moca-cyp	HGNC:14651	OMIM:606095	PPIH	3		
FBgn0039581	Moca-cyp	HGNC:9257	OMIM:601753	PPID	3		
FBgn0039581	Moca-cyp	HGNC:9255	OMIM:123841	PPIB	3	259440	259440[OSTEOGENESIS IMPERFECTA, TYPE IX; OI9]
FBgn0039581	Moca-cyp	HGNC:9259	OMIM:604486	PPIF	3		
FBgn0039581	Moca-cyp	HGNC:33995		PPIAL4C	3		
FBgn0039581	Moca-cyp	HGNC:9253	OMIM:123840	PPIA	3		
FBgn0039581	Moca-cyp	HGNC:33999		PPIAL4F	3		
FBgn0039581	Moca-cyp	HGNC:53889		PPIAL4H	3		
FBgn0039585	CG1894	HGNC:5275	OMIM:601409	KAT5	3	619103	619103[NEURODEVELOPMENTAL DISORDER WITH DYSMORPHIC FACIES, SLEEP DISTURBANCE, AND BRAIN ABNORMALITIES; NEDFASB]
FBgn0039585	CG1894	HGNC:17933	OMIM:609912	KAT8	6	618974	618974[LI-GHORBANI-WEISZ-HUBSHMAN SYNDROME; LIGOWS]
FBgn0013813	Dhc98D	HGNC:2952	OMIM:603337	DNAH8	3	619095	619095[SPERMATOGENIC FAILURE 46; SPGF46]
FBgn0013813	Dhc98D	HGNC:2953	OMIM:603330	DNAH9	3	618300	618300[CILIARY DYSKINESIA, PRIMARY, 40; CILD40]
FBgn0013813	Dhc98D	HGNC:2942	OMIM:603339	DNAH11	3	611884	611884[CILIARY DYSKINESIA, PRIMARY, 7; CILD7]
FBgn0013813	Dhc98D	HGNC:2950	OMIM:603335	DNAH5	3	608644	608644[CILIARY DYSKINESIA, PRIMARY, 3; CILD3]
FBgn0013813	Dhc98D	HGNC:2948	OMIM:603333	DNAH2	3	619094	619094[SPERMATOGENIC FAILURE 45; SPGF45]
FBgn0013813	Dhc98D	HGNC:2941	OMIM:605884	DNAH10	14	619515	619515[SPERMATOGENIC FAILURE 56; SPGF56]
FBgn0013813	Dhc98D	HGNC:2946	OMIM:610063	DNAH17	3	618643	618643[SPERMATOGENIC FAILURE 39; SPGF39]
FBgn0039588	mIF2	HGNC:7441	OMIM:603766	MTIF2	15		
FBgn0003137	Ppn	HGNC:19706	OMIM:610113	ADAMTSL4	3	225100,225200	225100[ECTOPIA LENTIS 2, ISOLATED, AUTOSOMAL RECESSIVE; ECTOL2],225200[ECTOPIA LENTIS ET PUPILLAE]
FBgn0003137	Ppn	HGNC:25835	OMIM:614476	THSD4	3	619825	619825[AORTIC ANEURYSM, FAMILIAL THORACIC 12; AAT12]
FBgn0003137	Ppn	HGNC:17108	OMIM:607510	ADAMTS16	3		
FBgn0003137	Ppn	HGNC:17110	OMIM:607512	ADAMTS18	3	615458	615458[MICROCORNEA, MYOPIC CHORIORETINAL ATROPHY, AND TELECANTHUS; MMCAT]
FBgn0003137	Ppn	HGNC:1366	OMIM:604134	ADAMTS13	3	274150	274150[THROMBOTIC THROMBOCYTOPENIC PURPURA, HEREDITARY; TTP]
FBgn0003137	Ppn	HGNC:222	OMIM:605008	ADAMTS6	3		
FBgn0003137	Ppn	HGNC:13201	OMIM:608990	ADAMTS10	3	277600	277600[WEILL-MARCHESANI SYNDROME 1; WMS1]
FBgn0003137	Ppn	HGNC:19262	OMIM:617785	PAPLN	11		
FBgn0003137	Ppn	HGNC:14631	OMIM:612277	ADAMTSL2	3	231050	231050[GELEOPHYSIC DYSPLASIA 1; GPHYSD1]
FBgn0003137	Ppn	HGNC:219	OMIM:605011	ADAMTS3	3	618154	618154[HENNEKAM LYMPHANGIECTASIA-LYMPHEDEMA SYNDROME 3; HKLLS3]
FBgn0003137	Ppn	HGNC:218	OMIM:604539	ADAMTS2	3	225410	225410[EHLERS-DANLOS SYNDROME, DERMATOSPARAXIS TYPE; EDSDERMS]
FBgn0003137	Ppn	HGNC:14899	OMIM:607506	ADAMTS14	3		
FBgn0003137	Ppn	HGNC:27912		ADAMTSL5	3		
FBgn0039580	Gfat2	HGNC:4241	OMIM:138292	GFPT1	12	610542	610542[MYASTHENIC SYNDROME, CONGENITAL, 12; CMS12]
FBgn0039580	Gfat2	HGNC:4242	OMIM:603865	GFPT2	15		
FBgn0001215	Hrb98DE	HGNC:27067		HNRNPA1L2	9		
FBgn0001215	Hrb98DE	HGNC:5033	OMIM:600124	HNRNPA2B1	12	615422	615422[INCLUSION BODY MYOPATHY WITH EARLY-ONSET PAGET DISEASE WITH OR WITHOUT FRONTOTEMPORAL DEMENTIA 2; IBMPFD2]
FBgn0001215	Hrb98DE	HGNC:5031	OMIM:164017	HNRNPA1	9	615424,615426	615424[INCLUSION BODY MYOPATHY WITH EARLY-ONSET PAGET DISEASE WITH OR WITHOUT FRONTOTEMPORAL DEMENTIA 3; IBMPFD3],615426[AMYOTROPHIC LATERAL SCLEROSIS 20; ALS20]
FBgn0001215	Hrb98DE	HGNC:24941	OMIM:605372	HNRNPA3	9		
FBgn0001215	Hrb98DE	HGNC:5030	OMIM:609409	HNRNPA0	5		
FBgn0039589	CG9986	HGNC:1184	OMIM:616082	C12orf4	14	618221	618221[INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 66; MRT66]
FBgn0053346	CG33346	HGNC:3346	OMIM:600440	ENDOG	3		
FBgn0039593	Sid	HGNC:3346	OMIM:600440	ENDOG	3		
FBgn0027655	htt	HGNC:4851	OMIM:613004	HTT	12	143100,617435	143100[HUNTINGTON DISEASE; HD],617435[LOPES-MACIEL-RODAN SYNDROME; LOMARS]
FBgn0039596	CG10000	HGNC:23233	OMIM:615132	GALNT16	4		
FBgn0039596	CG10000	HGNC:19875	OMIM:615130	GALNT11	3		
FBgn0039596	CG10000	HGNC:22946	OMIM:608225	GALNT14	5		
FBgn0039596	CG10000	HGNC:4124	OMIM:602274	GALNT2	4	618885	618885[CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIt; CDG2T]
FBgn0039596	CG10000	HGNC:21725	OMIM:615133	GALNTL5	3		
FBgn0039595	AstA-R2	HGNC:4132	OMIM:600377	GALR1	4		
FBgn0039595	AstA-R2	HGNC:4133	OMIM:603691	GALR2	8		
FBgn0039595	AstA-R2	HGNC:4134	OMIM:603692	GALR3	7		
FBgn0039590	CG10011	HGNC:29223	OMIM:619856	ANKRD50	11		
FBgn0026400	Noa36	HGNC:15462	OMIM:609550	ZNF330	15		
FBgn0000659	fkh	HGNC:5021	OMIM:602294	FOXA1	10		
FBgn0000659	fkh	HGNC:5022	OMIM:600288	FOXA2	12		
FBgn0000659	fkh	HGNC:5023	OMIM:602295	FOXA3	7		
FBgn0039600	Prp39	HGNC:20314	OMIM:614907	PRPF39	10		
FBgn0039609	Nepl17	HGNC:8918	OMIM:300550	PHEX	3	307800	307800[HYPOPHOSPHATEMIC RICKETS, X-LINKED DOMINANT; XLHR]
FBgn0039609	Nepl17	HGNC:14668	OMIM:618104	MMEL1	3		
FBgn0039609	Nepl17	HGNC:7154	OMIM:120520	MME	3	617017,617018	617017[CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2T; CMT2T],617018[SPINOCEREBELLAR ATAXIA 43; SCA43]
FBgn0039609	Nepl17	HGNC:13275	OMIM:610145	ECE2	3		
FBgn0039609	Nepl17	HGNC:3147	OMIM:605896	ECEL1	3	615065	615065[ARTHROGRYPOSIS, DISTAL, TYPE 5D; DA5D]
FBgn0039609	Nepl17	HGNC:3146	OMIM:600423	ECE1	3	145500,613870	145500[HYPERTENSION, ESSENTIAL],613870[HIRSCHSPRUNG DISEASE, CARDIAC DEFECTS, AND AUTONOMIC DYSFUNCTION; HCAD]
FBgn0039609	Nepl17	HGNC:6308	OMIM:613883	KEL	5	110900	110900[BLOOD GROUP--KELL SYSTEM; KEL]
FBgn0039611	Nepl18	HGNC:8918	OMIM:300550	PHEX	3	307800	307800[HYPOPHOSPHATEMIC RICKETS, X-LINKED DOMINANT; XLHR]
FBgn0039611	Nepl18	HGNC:14668	OMIM:618104	MMEL1	4		
FBgn0039611	Nepl18	HGNC:7154	OMIM:120520	MME	5	617017,617018	617017[CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2T; CMT2T],617018[SPINOCEREBELLAR ATAXIA 43; SCA43]
FBgn0039611	Nepl18	HGNC:13275	OMIM:610145	ECE2	3		
FBgn0039611	Nepl18	HGNC:3147	OMIM:605896	ECEL1	4	615065	615065[ARTHROGRYPOSIS, DISTAL, TYPE 5D; DA5D]
FBgn0039611	Nepl18	HGNC:3146	OMIM:600423	ECE1	4	145500,613870	145500[HYPERTENSION, ESSENTIAL],613870[HIRSCHSPRUNG DISEASE, CARDIAC DEFECTS, AND AUTONOMIC DYSFUNCTION; HCAD]
FBgn0039611	Nepl18	HGNC:6308	OMIM:613883	KEL	5	110900	110900[BLOOD GROUP--KELL SYSTEM; KEL]
FBgn0039613	Nepl20	HGNC:8918	OMIM:300550	PHEX	3	307800	307800[HYPOPHOSPHATEMIC RICKETS, X-LINKED DOMINANT; XLHR]
FBgn0039613	Nepl20	HGNC:14668	OMIM:618104	MMEL1	4		
FBgn0039613	Nepl20	HGNC:7154	OMIM:120520	MME	4	617017,617018	617017[CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2T; CMT2T],617018[SPINOCEREBELLAR ATAXIA 43; SCA43]
FBgn0039613	Nepl20	HGNC:13275	OMIM:610145	ECE2	3		
FBgn0039613	Nepl20	HGNC:3147	OMIM:605896	ECEL1	4	615065	615065[ARTHROGRYPOSIS, DISTAL, TYPE 5D; DA5D]
FBgn0039613	Nepl20	HGNC:3146	OMIM:600423	ECE1	4	145500,613870	145500[HYPERTENSION, ESSENTIAL],613870[HIRSCHSPRUNG DISEASE, CARDIAC DEFECTS, AND AUTONOMIC DYSFUNCTION; HCAD]
FBgn0039613	Nepl20	HGNC:6308	OMIM:613883	KEL	6	110900	110900[BLOOD GROUP--KELL SYSTEM; KEL]
FBgn0027578	Nepl21	HGNC:8918	OMIM:300550	PHEX	3	307800	307800[HYPOPHOSPHATEMIC RICKETS, X-LINKED DOMINANT; XLHR]
FBgn0027578	Nepl21	HGNC:14668	OMIM:618104	MMEL1	4		
FBgn0027578	Nepl21	HGNC:7154	OMIM:120520	MME	4	617017,617018	617017[CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2T; CMT2T],617018[SPINOCEREBELLAR ATAXIA 43; SCA43]
FBgn0027578	Nepl21	HGNC:13275	OMIM:610145	ECE2	3		
FBgn0027578	Nepl21	HGNC:3147	OMIM:605896	ECEL1	4	615065	615065[ARTHROGRYPOSIS, DISTAL, TYPE 5D; DA5D]
FBgn0027578	Nepl21	HGNC:3146	OMIM:600423	ECE1	5	145500,613870	145500[HYPERTENSION, ESSENTIAL],613870[HIRSCHSPRUNG DISEASE, CARDIAC DEFECTS, AND AUTONOMIC DYSFUNCTION; HCAD]
FBgn0027578	Nepl21	HGNC:6308	OMIM:613883	KEL	5	110900	110900[BLOOD GROUP--KELL SYSTEM; KEL]
FBgn0039616	CG11828	HGNC:8546	OMIM:176710	P4HA1	4		
FBgn0039616	CG11828	HGNC:30135	OMIM:608987	P4HA3	5		
FBgn0039616	CG11828	HGNC:8547	OMIM:600608	P4HA2	4	617238	617238[MYOPIA 25, AUTOSOMAL DOMINANT; MYP25]
FBgn0039623	CG1951	HGNC:19286	OMIM:616365	SCYL2	15	618766	618766[ARTHROGRYPOSIS MULTIPLEX CONGENITA 4, NEUROGENIC, WITH AGENESIS OF THE CORPUS CALLOSUM; AMC4]
FBgn0041780	Ssl2	HGNC:13238	OMIM:615884	APMAP	13		
FBgn0039622	eIF4E6	HGNC:3293	OMIM:605895	EIF4E2	3		
FBgn0039622	eIF4E6	HGNC:3287	OMIM:133440	EIF4E	7	615091	615091[AUTISM, SUSCEPTIBILITY TO, 19; AUTS19]
FBgn0039622	eIF4E6	HGNC:33179		EIF4E1B	7		
FBgn0039622	eIF4E6	HGNC:31837	OMIM:609896	EIF4E3	4		
FBgn0039620	wat	HGNC:26222	OMIM:616107	FAR1	8	616154,619338	616154[PEROXISOMAL FATTY ACYL-CoA REDUCTASE 1 DISORDER; PFCRD],619338[CATARACTS, SPASTIC PARAPARESIS, AND SPEECH DELAY; CSPSD]
FBgn0039620	wat	HGNC:25531	OMIM:616156	FAR2	7		
FBgn0039617	DIP-gamma	HGNC:17302	OMIM:613173	NEGR1	6		
FBgn0039617	DIP-gamma	HGNC:34550	OMIM:618861	IGLON5	8		
FBgn0039617	DIP-gamma	HGNC:6705	OMIM:603241	LSAMP	6		
FBgn0039617	DIP-gamma	HGNC:8143	OMIM:600632	OPCML	8	167000	167000[OVARIAN CANCER]
FBgn0039617	DIP-gamma	HGNC:17941	OMIM:607938	NTM	7		
FBgn0053203	CG33203	HGNC:26386	OMIM:614578	PAQR4	13		
FBgn0039612	Nepl19	HGNC:8918	OMIM:300550	PHEX	3	307800	307800[HYPOPHOSPHATEMIC RICKETS, X-LINKED DOMINANT; XLHR]
FBgn0039612	Nepl19	HGNC:14668	OMIM:618104	MMEL1	4		
FBgn0039612	Nepl19	HGNC:7154	OMIM:120520	MME	4	617017,617018	617017[CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2T; CMT2T],617018[SPINOCEREBELLAR ATAXIA 43; SCA43]
FBgn0039612	Nepl19	HGNC:13275	OMIM:610145	ECE2	3		
FBgn0039612	Nepl19	HGNC:3147	OMIM:605896	ECEL1	4	615065	615065[ARTHROGRYPOSIS, DISTAL, TYPE 5D; DA5D]
FBgn0039612	Nepl19	HGNC:3146	OMIM:600423	ECE1	4	145500,613870	145500[HYPERTENSION, ESSENTIAL],613870[HIRSCHSPRUNG DISEASE, CARDIAC DEFECTS, AND AUTONOMIC DYSFUNCTION; HCAD]
FBgn0039612	Nepl19	HGNC:6308	OMIM:613883	KEL	5	110900	110900[BLOOD GROUP--KELL SYSTEM; KEL]
FBgn0015589	Apc	HGNC:583	OMIM:611731	APC	9	114500,114550,135290,175100,613659,619182	114500[COLORECTAL CANCER; CRC],114550[HEPATOCELLULAR CARCINOMA],135290[DESMOID DISEASE, HEREDITARY; DESMD],175100[FAMILIAL ADENOMATOUS POLYPOSIS 1; FAP1],613659[GASTRIC CANCER],619182[GASTRIC ADENOCARCINOMA AND PROXIMAL POLYPOSIS OF THE STOMACH; GAPPS]
FBgn0015589	Apc	HGNC:24036	OMIM:612034	APC2	8	617169,618677	617169[INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 74; MRT74],618677[CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 10; CDCBM10]
FBgn0024273	WASp	HGNC:12731	OMIM:300392	WAS	12	300299,301000,313900	300299[NEUTROPENIA, SEVERE CONGENITAL, X-LINKED; SCNX],301000[WISKOTT-ALDRICH SYNDROME; WAS],313900[THROMBOCYTOPENIA 1; THC1]
FBgn0024273	WASp	HGNC:12735	OMIM:605056	WASL	11		
FBgn0039601	CG1523	HGNC:23686		DCAF10	11		
FBgn0027873	Cpsf100	HGNC:2325	OMIM:606028	CPSF2	15		
FBgn0003093	Pkc98E	HGNC:9403	OMIM:605437	PRKCH	10	601367	601367[STROKE, ISCHEMIC]
FBgn0003093	Pkc98E	HGNC:9410	OMIM:600448	PRKCQ	4		
FBgn0003093	Pkc98E	HGNC:9401	OMIM:176975	PRKCE	14		
FBgn0003093	Pkc98E	HGNC:9399	OMIM:176977	PRKCD	4	615559	615559[AUTOIMMUNE LYMPHOPROLIFERATIVE SYNDROME, TYPE III; ALPS3]
FBgn0039627	CG11837	HGNC:30217	OMIM:612499	DIMT1	14		
FBgn0039631	Sirt7	HGNC:14935	OMIM:606212	SIRT7	11		
FBgn0039633	Bicra	HGNC:21111	OMIM:618502	BICRAL	3		
FBgn0039633	Bicra	HGNC:4332	OMIM:605690	BICRA	4	619325	619325[COFFIN-SIRIS SYNDROME 12; CSS12]
FBgn0039635	Pdhb	HGNC:8808	OMIM:179060	PDHB	15	614111	614111[PYRUVATE DEHYDROGENASE E1-BETA DEFICIENCY; PDHBD]
FBgn0039636	Atg14	HGNC:19962	OMIM:613515	ATG14	14		
FBgn0039637	Ctl2	HGNC:13941	OMIM:606107	SLC44A4	13	617606	617606[DEAFNESS, AUTOSOMAL DOMINANT 72; DFNA72]
FBgn0039637	Ctl2	HGNC:17292	OMIM:606106	SLC44A2	13		
FBgn0039637	Ctl2	HGNC:28524		SLC44A5	12		
FBgn0039637	Ctl2	HGNC:28689		SLC44A3	3		
FBgn0028671	Vha100-1	HGNC:865	OMIM:192130	ATP6V0A1	13	619970,619971	619970[DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 104; DEE104],619971[NEURODEVELOPMENTAL DISORDER WITH EPILEPSY AND BRAIN ATROPHY; NEDEBA]
FBgn0028671	Vha100-1	HGNC:18481	OMIM:611716	ATP6V0A2	6	219200,278250	219200[CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IIA; ARCL2A],278250[WRINKLY SKIN SYNDROME; WSS]
FBgn0028671	Vha100-1	HGNC:866	OMIM:605239	ATP6V0A4	9	602722	602722[RENAL TUBULAR ACIDOSIS, DISTAL, 3, WITH OR WITHOUT SENSORINEURAL HEARING LOSS; DRTA3]
FBgn0028671	Vha100-1	HGNC:11647	OMIM:604592	TCIRG1	5	259700	259700[OSTEOPETROSIS, AUTOSOMAL RECESSIVE 1; OPTB1]
FBgn0039640	superdeath	HGNC:500	OMIM:151530	ANPEP	11		
FBgn0039640	superdeath	HGNC:3355	OMIM:138297	ENPEP	5		
FBgn0039640	superdeath	HGNC:18173	OMIM:606832	ERAP1	4		
FBgn0039640	superdeath	HGNC:26904	OMIM:610046	LVRN	5		
FBgn0039640	superdeath	HGNC:7900	OMIM:606793	NPEPPS	4		
FBgn0039640	superdeath	HGNC:29499	OMIM:609497	ERAP2	4		
FBgn0039640	superdeath	HGNC:6656	OMIM:151300	LNPEP	4		
FBgn0028692	Rpn2	HGNC:9554	OMIM:617842	PSMD1	14		
FBgn0039644	rdog	HGNC:55	OMIM:605250	ABCC4	8		
FBgn0039644	rdog	HGNC:52	OMIM:612509	ABCC10	5		
FBgn0039644	rdog	HGNC:53	OMIM:601107	ABCC2	5	237500	237500[DUBIN-JOHNSON SYNDROME; DJS]
FBgn0039644	rdog	HGNC:51	OMIM:158343	ABCC1	5	618915	618915[DEAFNESS, AUTOSOMAL DOMINANT 77; DFNA77]
FBgn0039644	rdog	HGNC:59	OMIM:600509	ABCC8	5	125853,240800,256450,610374,618857	125853[TYPE 2 DIABETES MELLITUS; T2D],240800[HYPOGLYCEMIA, LEUCINE-INDUCED; LIH],256450[HYPERINSULINEMIC HYPOGLYCEMIA, FAMILIAL, 1; HHF1],610374[DIABETES MELLITUS, TRANSIENT NEONATAL, 2; TNDM2],618857[DIABETES MELLITUS, PERMANENT NEONATAL, 3; PNDM3]
FBgn0039644	rdog	HGNC:14640	OMIM:607041	ABCC12	5		
FBgn0039644	rdog	HGNC:60	OMIM:601439	ABCC9	5	239850,608569,614050,619719	239850[CANTU SYNDROME],608569[CARDIOMYOPATHY, DILATED, 1O; CMD1O],614050[ATRIAL FIBRILLATION, FAMILIAL, 12; ATFB12],619719[INTELLECTUAL DISABILITY AND MYOPATHY SYNDROME; IDMYS]
FBgn0039644	rdog	HGNC:57	OMIM:603234	ABCC6	5	177850,264800,614473	177850[PSEUDOXANTHOMA ELASTICUM, FORME FRUSTE],264800[PSEUDOXANTHOMA ELASTICUM; PXE],614473[ARTERIAL CALCIFICATION, GENERALIZED, OF INFANCY, 2; GACI2]
FBgn0039644	rdog	HGNC:56	OMIM:605251	ABCC5	6		
FBgn0039644	rdog	HGNC:14639	OMIM:607040	ABCC11	5	117800	117800[APOCRINE GLAND SECRETION, VARIATION IN]
FBgn0039644	rdog	HGNC:54	OMIM:604323	ABCC3	5		
FBgn0039644	rdog	HGNC:1884	OMIM:602421	CFTR	5	167800,211400,219700,277180	167800[PANCREATITIS, HEREDITARY; PCTT],211400[BRONCHIECTASIS WITH OR WITHOUT ELEVATED SWEAT CHLORIDE 1; BESC1],219700[CYSTIC FIBROSIS; CF],277180[VAS DEFERENS, CONGENITAL BILATERAL APLASIA OF; CBAVD]
FBgn0039645	CG11898	HGNC:55	OMIM:605250	ABCC4	8		
FBgn0039645	CG11898	HGNC:52	OMIM:612509	ABCC10	5		
FBgn0039645	CG11898	HGNC:53	OMIM:601107	ABCC2	5	237500	237500[DUBIN-JOHNSON SYNDROME; DJS]
FBgn0039645	CG11898	HGNC:51	OMIM:158343	ABCC1	5	618915	618915[DEAFNESS, AUTOSOMAL DOMINANT 77; DFNA77]
FBgn0039645	CG11898	HGNC:59	OMIM:600509	ABCC8	5	125853,240800,256450,610374,618857	125853[TYPE 2 DIABETES MELLITUS; T2D],240800[HYPOGLYCEMIA, LEUCINE-INDUCED; LIH],256450[HYPERINSULINEMIC HYPOGLYCEMIA, FAMILIAL, 1; HHF1],610374[DIABETES MELLITUS, TRANSIENT NEONATAL, 2; TNDM2],618857[DIABETES MELLITUS, PERMANENT NEONATAL, 3; PNDM3]
FBgn0039645	CG11898	HGNC:14640	OMIM:607041	ABCC12	5		
FBgn0039645	CG11898	HGNC:60	OMIM:601439	ABCC9	5	239850,608569,614050,619719	239850[CANTU SYNDROME],608569[CARDIOMYOPATHY, DILATED, 1O; CMD1O],614050[ATRIAL FIBRILLATION, FAMILIAL, 12; ATFB12],619719[INTELLECTUAL DISABILITY AND MYOPATHY SYNDROME; IDMYS]
FBgn0039645	CG11898	HGNC:57	OMIM:603234	ABCC6	5	177850,264800,614473	177850[PSEUDOXANTHOMA ELASTICUM, FORME FRUSTE],264800[PSEUDOXANTHOMA ELASTICUM; PXE],614473[ARTERIAL CALCIFICATION, GENERALIZED, OF INFANCY, 2; GACI2]
FBgn0039645	CG11898	HGNC:56	OMIM:605251	ABCC5	5		
FBgn0039645	CG11898	HGNC:14639	OMIM:607040	ABCC11	5	117800	117800[APOCRINE GLAND SECRETION, VARIATION IN]
FBgn0039645	CG11898	HGNC:54	OMIM:604323	ABCC3	5		
FBgn0039645	CG11898	HGNC:1884	OMIM:602421	CFTR	5	167800,211400,219700,277180	167800[PANCREATITIS, HEREDITARY; PCTT],211400[BRONCHIECTASIS WITH OR WITHOUT ELEVATED SWEAT CHLORIDE 1; BESC1],219700[CYSTIC FIBROSIS; CF],277180[VAS DEFERENS, CONGENITAL BILATERAL APLASIA OF; CBAVD]
FBgn0014427	CG11899	HGNC:19129	OMIM:610936	PSAT1	15	610992,616038	610992[PHOSPHOSERINE AMINOTRANSFERASE DEFICIENCY; PSATD],616038[NEU-LAXOVA SYNDROME 2; NLS2]
FBgn0029176	eEF1gamma	HGNC:3213	OMIM:130593	EEF1G	12		
FBgn0039654	Brd8	HGNC:19874	OMIM:602848	BRD8	10		
FBgn0028476	Usp1	HGNC:12607	OMIM:603478	USP1	8		
FBgn0003525	stg	HGNC:1725	OMIM:116947	CDC25A	12		
FBgn0003525	stg	HGNC:1726	OMIM:116949	CDC25B	10		
FBgn0003525	stg	HGNC:1727	OMIM:157680	CDC25C	9		
FBgn0051445	CG31445	HGNC:500	OMIM:151530	ANPEP	8		
FBgn0051445	CG31445	HGNC:30748	OMIM:606950	TRHDE	3		
FBgn0051445	CG31445	HGNC:3355	OMIM:138297	ENPEP	4		
FBgn0051445	CG31445	HGNC:18173	OMIM:606832	ERAP1	5		
FBgn0051445	CG31445	HGNC:26904	OMIM:610046	LVRN	5		
FBgn0051445	CG31445	HGNC:7900	OMIM:606793	NPEPPS	4		
FBgn0051445	CG31445	HGNC:29499	OMIM:609497	ERAP2	5		
FBgn0051445	CG31445	HGNC:6656	OMIM:151300	LNPEP	5		
FBgn0039656	CG11951	HGNC:500	OMIM:151530	ANPEP	5		
FBgn0039656	CG11951	HGNC:3355	OMIM:138297	ENPEP	4		
FBgn0039656	CG11951	HGNC:18173	OMIM:606832	ERAP1	4		
FBgn0039656	CG11951	HGNC:26904	OMIM:610046	LVRN	5		
FBgn0039656	CG11951	HGNC:7900	OMIM:606793	NPEPPS	3		
FBgn0039656	CG11951	HGNC:29499	OMIM:609497	ERAP2	4		
FBgn0039656	CG11951	HGNC:6656	OMIM:151300	LNPEP	4		
FBgn0039655	CG14507	HGNC:9030	OMIM:172410	PLA2G1B	9		
FBgn0039655	CG14507	HGNC:9031	OMIM:172411	PLA2G2A	5	114500	114500[COLORECTAL CANCER; CRC]
FBgn0039655	CG14507	HGNC:9038	OMIM:601192	PLA2G5	5	228980	228980[FLECK RETINA, FAMILIAL BENIGN; FRFB]
FBgn0039655	CG14507	HGNC:9029	OMIM:603603	PLA2G10	8		
FBgn0039655	CG14507	HGNC:9033	OMIM:605630	PLA2G2D	5		
FBgn0039655	CG14507	HGNC:13414	OMIM:618320	PLA2G2E	5		
FBgn0039655	CG14507	HGNC:30040	OMIM:616793	PLA2G2F	4		
FBgn0039655	CG14507	HGNC:9032		PLA2G2C	4		
FBgn0039655	CG14507	HGNC:8100	OMIM:601658	OC90	3		
FBgn0062442	Cisd2	HGNC:30880	OMIM:611932	CISD1	9		
FBgn0062442	Cisd2	HGNC:24212	OMIM:611507	CISD2	14	604928	604928[WOLFRAM SYNDROME 2; WFS2]
FBgn0039651	Cyt-c1L	HGNC:2579	OMIM:123980	CYC1	12	615453	615453[MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 6; MC3DN6]
FBgn0039650	Mesh1	HGNC:30522		HDDC3	11		
FBgn0041186	Slbp	HGNC:10904	OMIM:602422	SLBP	10		
FBgn0041588	eIF2D	HGNC:6583	OMIM:613709	EIF2D	14		
FBgn0039641	CG14511	HGNC:20584	OMIM:610923	SLC35B4	8		
FBgn0039639	Alg13	HGNC:30881	OMIM:300776	ALG13	7	300884	300884[DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 36; DEE36]
FBgn0039638	dgt6	HGNC:25948	OMIM:613433	HAUS6	7		
FBgn0005596	yem	HGNC:21931	OMIM:613841	UBN2	9		
FBgn0005596	yem	HGNC:12506	OMIM:609771	UBN1	8		
FBgn0039634	alpha-Man-Ib	HGNC:6822	OMIM:604345	MAN1A2	4		
FBgn0039634	alpha-Man-Ib	HGNC:6823	OMIM:604346	MAN1B1	13	614202	614202[RAFIQ SYNDROME; RAFQS]
FBgn0039634	alpha-Man-Ib	HGNC:19080	OMIM:616772	MAN1C1	3		
FBgn0039634	alpha-Man-Ib	HGNC:6821	OMIM:604344	MAN1A1	4		
FBgn0039626	Slu7	HGNC:16939	OMIM:605974	SLU7	14		
FBgn0039625	beta4GalNAcTB	HGNC:928	OMIM:604016	B4GALT5	4		
FBgn0039625	beta4GalNAcTB	HGNC:929	OMIM:604017	B4GALT6	3		
FBgn0039625	beta4GalNAcTB	HGNC:924	OMIM:137060	B4GALT1	4	607091	607091[CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IId; CDG2D]
FBgn0039625	beta4GalNAcTB	HGNC:925	OMIM:604013	B4GALT2	4		
FBgn0039625	beta4GalNAcTB	HGNC:926	OMIM:604014	B4GALT3	4		
FBgn0039625	beta4GalNAcTB	HGNC:927	OMIM:604015	B4GALT4	4		
FBgn0039664	CG2006	HGNC:30926		DTWD1	14		
FBgn0039667	FipoQ	HGNC:13604	OMIM:605656	FBXL7	3		
FBgn0039667	FipoQ	HGNC:21658	OMIM:609080	FBXL13	3		
FBgn0039667	FipoQ	HGNC:13599	OMIM:605653	FBXL3	3	606220	606220[INTELLECTUAL DEVELOPMENTAL DISORDER WITH SHORT STATURE, FACIAL ANOMALIES, AND SPEECH DEFECTS; IDDSFAS]
FBgn0039668	Trc8	HGNC:17023	OMIM:603046	RNF139	14	144700	144700[RENAL CELL CARCINOMA, NONPAPILLARY; RCC]
FBgn0040623	Spase12	HGNC:23401	OMIM:610358	SPCS1	11		
FBgn0039663	CG2321	HGNC:26056		C2orf42	11		
FBgn0015622	Cnx99A	HGNC:2060	OMIM:601858	CLGN	10		
FBgn0015622	Cnx99A	HGNC:1473	OMIM:114217	CANX	13		
FBgn0039669	ND-20L	HGNC:7714	OMIM:601825	NDUFS7	13	618224	618224[MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 3; MC1DN3]
FBgn0000492	Dr	HGNC:7392	OMIM:123101	MSX2	8	168500,168550,604757	168500[PARIETAL FORAMINA 1; PFM1],168550[PARIETAL FORAMINA WITH CLEIDOCRANIAL DYSPLASIA; PFMCCD],604757[CRANIOSYNOSTOSIS 2; CRS2]
FBgn0000492	Dr	HGNC:7391	OMIM:142983	MSX1	7	106600,189500,608874	106600[TOOTH AGENESIS, SELECTIVE, 1; STHAG1],189500[WITKOP SYNDROME],608874[OROFACIAL CLEFT 5; OFC5]
FBgn0039674	CG1907	HGNC:10981	OMIM:604165	SLC25A11	15	618464	618464[PARAGANGLIOMAS 6; PGL6]
FBgn0039674	CG1907	HGNC:10984	OMIM:300242	SLC25A14	3		
FBgn0039677	ppk30	HGNC:101	OMIM:611741	ASIC3	4		
FBgn0039677	ppk30	HGNC:100	OMIM:602866	ASIC1	4		
FBgn0039677	ppk30	HGNC:21263	OMIM:606715	ASIC4	4		
FBgn0039677	ppk30	HGNC:99	OMIM:601784	ASIC2	3		
FBgn0039677	ppk30	HGNC:17537	OMIM:616693	ASIC5	4		
FBgn0039679	ppk19	HGNC:101	OMIM:611741	ASIC3	4		
FBgn0039679	ppk19	HGNC:100	OMIM:602866	ASIC1	4		
FBgn0039679	ppk19	HGNC:21263	OMIM:606715	ASIC4	4		
FBgn0039679	ppk19	HGNC:99	OMIM:601784	ASIC2	3		
FBgn0039679	ppk19	HGNC:17537	OMIM:616693	ASIC5	5		
FBgn0039680	Cap-D2	HGNC:24305	OMIM:615638	NCAPD2	14	617983	617983[MICROCEPHALY 21, PRIMARY, AUTOSOMAL RECESSIVE; MCPH21]
FBgn0013972	Gycalpha99B	HGNC:4684	OMIM:601244	GUCY1A2	14		
FBgn0013972	Gycalpha99B	HGNC:4685	OMIM:139396	GUCY1A1	11	615750	615750[MOYAMOYA DISEASE 6 WITH OR WITHOUT ACHALASIA; MYMY6]
FBgn0039683	dmrt99B	HGNC:13908	OMIM:614804	DMRTA2	12		
FBgn0039683	dmrt99B	HGNC:13909	OMIM:614754	DMRT3	4		
FBgn0039683	dmrt99B	HGNC:13826	OMIM:614803	DMRTA1	9		
FBgn0039683	dmrt99B	HGNC:2934	OMIM:602424	DMRT1	3		
FBgn0039683	dmrt99B	HGNC:13913	OMIM:614805	DMRTB1	3		
FBgn0039683	dmrt99B	HGNC:13910	OMIM:300878	DMRTC1	3		
FBgn0039683	dmrt99B	HGNC:13911	OMIM:614806	DMRTC2	3		
FBgn0024841	Pcd	HGNC:24474	OMIM:609836	PCBD2	7		
FBgn0024841	Pcd	HGNC:8646	OMIM:126090	PCBD1	11	264070	264070[HYPERPHENYLALANINEMIA, BH4-DEFICIENT, D; HPABH4D]
FBgn0039688	Kul	HGNC:195	OMIM:603639	ADAM17	3	614328	614328[INFLAMMATORY SKIN AND BOWEL DISEASE, NEONATAL, 1; NISBD1]
FBgn0039688	Kul	HGNC:188	OMIM:602192	ADAM10	6	615537,615590	615537[RETICULATE ACROPIGMENTATION OF KITAMURA; RAK],615590[ALZHEIMER DISEASE 18; AD18]
FBgn0039687	Naa40	HGNC:25845	OMIM:619999	NAA40	15		
FBgn0039681	CG7582	HGNC:26890		TMEM86A	13		
FBgn0039681	CG7582	HGNC:28448	OMIM:617806	TMEM86B	10		
FBgn0025457	Bub3	HGNC:1151	OMIM:603719	BUB3	13		
FBgn0039673	CG7568	HGNC:26383		DAW1	13		
FBgn0039689	CIA30	HGNC:18828	OMIM:606934	NDUFAF1	14	618234	618234[MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 11; MC1DN11]
FBgn0039690	Gnpnat	HGNC:19980	OMIM:616510	GNPNAT1	14	616510	616510[GLUCOSAMINE-PHOSPHATE N-ACETYLTRANSFERASE 1; GNPNAT1]
FBgn0039691	IntS11	HGNC:26052	OMIM:611354	INTS11	13		
FBgn0019972	Drice	HGNC:1504	OMIM:600636	CASP3	11		
FBgn0019972	Drice	HGNC:1508	OMIM:601761	CASP7	12		
FBgn0019972	Drice	HGNC:1507	OMIM:601532	CASP6	5		
FBgn0039698	CG7789	HGNC:26019	OMIM:614010	IMPAD1	3	614078	614078[CHONDRODYSPLASIA WITH JOINT DISLOCATIONS, GPAPP TYPE]
FBgn0039698	CG7789	HGNC:1096	OMIM:604053	BPNT1	12		
FBgn0000247	ca	HGNC:30297	OMIM:609587	RCC2	3		
FBgn0000247	ca	HGNC:4868	OMIM:605837	HERC2	3	227220,615516	227220[SKIN/HAIR/EYE PIGMENTATION, VARIATION IN, 1; SHEP1],615516[INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 38; MRT38]
FBgn0000247	ca	HGNC:17499	OMIM:606051	SERGEF	5		
FBgn0000247	ca	HGNC:4867	OMIM:605109	HERC1	3	617011	617011[MACROCEPHALY, DYSMORPHIC FACIES, AND PSYCHOMOTOR RETARDATION; MDFPMR]
FBgn0000247	ca	HGNC:18243	OMIM:607867	RCBTB1	4	617175	617175[RETINAL DYSTROPHY WITH OR WITHOUT EXTRAOCULAR ANOMALIES; RDEOA]
FBgn0000247	ca	HGNC:10295	OMIM:312610	RPGR	3	300029,300455,300834,304020	300029[RETINITIS PIGMENTOSA 3; RP3],300455[RETINITIS PIGMENTOSA, X-LINKED, AND SINORESPIRATORY INFECTIONS, WITH OR WITHOUT DEAFNESS],300834[MACULAR DEGENERATION, X-LINKED ATROPHIC],304020[CONE-ROD DYSTROPHY, X-LINKED, 1; CORDX1]
FBgn0000247	ca	HGNC:30457	OMIM:617997	RCCD1	3		
FBgn0000247	ca	HGNC:1914	OMIM:603524	RCBTB2	4		
FBgn0039709	Cad99C	HGNC:14674	OMIM:605514	PCDH15	11	601067,602083,609533	601067[USHER SYNDROME, TYPE ID; USH1D],602083[USHER SYNDROME, TYPE IF; USH1F],609533[DEAFNESS, AUTOSOMAL RECESSIVE 23; DFNB23]
FBgn0039727	Vps13B	HGNC:23594	OMIM:608879	VPS13C	3	616840	616840[PARKINSON DISEASE 23, AUTOSOMAL RECESSIVE EARLY-ONSET; PARK23]
FBgn0039727	Vps13B	HGNC:23595	OMIM:608877	VPS13D	3	607317	607317[SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 4; SCAR4]
FBgn0039727	Vps13B	HGNC:1908	OMIM:605978	VPS13A	3	200150	200150[CHOREOACANTHOCYTOSIS; CHAC]
FBgn0039727	Vps13B	HGNC:2183	OMIM:607817	VPS13B	11	216550	216550[COHEN SYNDROME; COH1]
FBgn0004622	TkR99D	HGNC:11527	OMIM:162321	TACR2	10		
FBgn0004622	TkR99D	HGNC:11528	OMIM:162332	TACR3	12	614840	614840[HYPOGONADOTROPIC HYPOGONADISM 11 WITH OR WITHOUT ANOSMIA; HH11]
FBgn0004622	TkR99D	HGNC:11526	OMIM:162323	TACR1	9		
FBgn0039726	eIF2Balpha	HGNC:3257	OMIM:606686	EIF2B1	14	603896	603896[LEUKOENCEPHALOPATHY WITH VANISHING WHITE MATTER; VWM]
FBgn0051040	Cog7	HGNC:18622	OMIM:606978	COG7	14	608779	608779[CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIe; CDG2E]
FBgn0051202	alpha-Man-Ic	HGNC:6822	OMIM:604345	MAN1A2	8		
FBgn0051202	alpha-Man-Ic	HGNC:19080	OMIM:616772	MAN1C1	7		
FBgn0051202	alpha-Man-Ic	HGNC:6821	OMIM:604344	MAN1A1	7		
FBgn0003861	trp	HGNC:12336	OMIM:603651	TRPC4	9		
FBgn0003861	trp	HGNC:12337	OMIM:300334	TRPC5	9		
FBgn0003861	trp	HGNC:12333	OMIM:602343	TRPC1	7		
FBgn0003861	trp	HGNC:12335	OMIM:602345	TRPC3	4	616410	616410[SPINOCEREBELLAR ATAXIA 41; SCA41]
FBgn0003861	trp	HGNC:12338	OMIM:603652	TRPC6	4	603965	603965[FOCAL SEGMENTAL GLOMERULOSCLEROSIS 2; FSGS2]
FBgn0003861	trp	HGNC:20754		TRPC7	5		
FBgn0039710	dgt1	HGNC:26024	OMIM:615488	KANSL2	13		
FBgn0039705	Atg16	HGNC:21498	OMIM:610767	ATG16L1	14	611081	611081[INFLAMMATORY BOWEL DISEASE (CROHN DISEASE) 10; IBD10]
FBgn0039705	Atg16	HGNC:25464	OMIM:618716	ATG16L2	9		
FBgn0039702	Vps16B	HGNC:20347	OMIM:613401	VIPAS39	13	613404	613404[ARTHROGRYPOSIS, RENAL DYSFUNCTION, AND CHOLESTASIS 2; ARCS2]
FBgn0002924	ncd	HGNC:6389	OMIM:603763	KIFC1	11		
FBgn0002924	ncd	HGNC:6326	OMIM:604535	KIFC3	4		
FBgn0039697	Etfb	HGNC:3482	OMIM:130410	ETFB	13	231680	231680[MULTIPLE ACYL-CoA DEHYDROGENASE DEFICIENCY; MADD]
FBgn0039696	Rnb	HGNC:25781	OMIM:615549	ARMC5	10	615954	615954[ACTH-INDEPENDENT MACRONODULAR ADRENAL HYPERPLASIA 2; AIMAH2]
FBgn0039694	fig	HGNC:30695	OMIM:609668	PPTC7	9		
FBgn0020235	ATPsyngamma	HGNC:833	OMIM:108729	ATP5F1C	15		
FBgn0027518	Wdr24	HGNC:20852		WDR24	14		
FBgn0027583	CG7601	HGNC:24547	OMIM:616160	DHRS7B	14		
FBgn0027583	CG7601	HGNC:32423	OMIM:616161	DHRS7C	5		
FBgn0027583	CG7601	HGNC:14423	OMIM:608575	RDH8	3		
FBgn0039728	CG7896	HGNC:5468	OMIM:601489	IGFALS	3	615961	615961[ACID-LABILE SUBUNIT DEFICIENCY; ACLSD]
FBgn0039731	Sas-6	HGNC:25403	OMIM:609321	SASS6	12	616402	616402[MICROCEPHALY 14, PRIMARY, AUTOSOMAL RECESSIVE; MCPH14]
FBgn0039734	Tace	HGNC:195	OMIM:603639	ADAM17	14	614328	614328[INFLAMMATORY SKIN AND BOWEL DISEASE, NEONATAL, 1; NISBD1]
FBgn0016685	Nlp	HGNC:7910	OMIM:164040	NPM1	7	601626	601626[LEUKEMIA, ACUTE MYELOID; AML]
FBgn0016685	Nlp	HGNC:7930	OMIM:608073	NPM2	8		
FBgn0016685	Nlp	HGNC:7931	OMIM:606456	NPM3	12		
FBgn0026597	Axn	HGNC:903	OMIM:603816	AXIN1	12	114550,607864	114550[HEPATOCELLULAR CARCINOMA],607864[CAUDAL DUPLICATION ANOMALY]
FBgn0026597	Axn	HGNC:904	OMIM:604025	AXIN2	10	114500,608615	114500[COLORECTAL CANCER; CRC],608615[OLIGODONTIA-COLORECTAL CANCER SYNDROME; ODCRCS]
FBgn0039741	CG7943	HGNC:23324	OMIM:616153	SLC25A52	10		
FBgn0039741	CG7943	HGNC:23323	OMIM:619153	SLC25A51	12		
FBgn0039741	CG7943	HGNC:31894	OMIM:300941	SLC25A53	4		
FBgn0039743	Jasper	HGNC:4856	OMIM:600339	HDGF	8		
FBgn0039743	Jasper	HGNC:21095		HDGFL1	7		
FBgn0039743	Jasper	HGNC:24937	OMIM:616643	HDGFL3	7		
FBgn0039743	Jasper	HGNC:14680	OMIM:617884	HDGFL2	8		
FBgn0039743	Jasper	HGNC:9527	OMIM:603620	PSIP1	10		
FBgn0039744	Rpp14b	HGNC:30327	OMIM:606112	RPP14	6		
FBgn0260468	CG7950	HGNC:26467	OMIM:611077	CHCHD4	13		
FBgn0039748	CG15529	HGNC:30439		SH2D6	3		
FBgn0039748	CG15529	HGNC:14211	OMIM:604515	BLNK	4	613502	613502[AGAMMAGLOBULINEMIA 4, AUTOSOMAL RECESSIVE; AGM4]
FBgn0039756	CG9743	HGNC:21088	OMIM:608370	SCD5	7	619086	619086[DEAFNESS, AUTOSOMAL DOMINANT 79; DFNA79]
FBgn0039756	CG9743	HGNC:10571	OMIM:604031	SCD	7		
FBgn0039755	CG15531	HGNC:21088	OMIM:608370	SCD5	5	619086	619086[DEAFNESS, AUTOSOMAL DOMINANT 79; DFNA79]
FBgn0039755	CG15531	HGNC:10571	OMIM:604031	SCD	5		
FBgn0039754	CG9747	HGNC:21088	OMIM:608370	SCD5	6	619086	619086[DEAFNESS, AUTOSOMAL DOMINANT 79; DFNA79]
FBgn0039754	CG9747	HGNC:10571	OMIM:604031	SCD	6		
FBgn0039751	CG1983	HGNC:9457	OMIM:604436	PLPBP	13	617290	617290[EPILEPSY, EARLY-ONSET, VITAMIN B6-DEPENDENT; EPVB6D]
FBgn0051030	VhaAC45RP	HGNC:868	OMIM:300197	ATP6AP1	4	300972	300972[IMMUNODEFICIENCY 47; IMD47]
FBgn0051030	VhaAC45RP	HGNC:28091		ATP6AP1L	4		
FBgn0039747	AdoR	HGNC:268	OMIM:600445	ADORA3	5		
FBgn0039747	AdoR	HGNC:263	OMIM:102776	ADORA2A	6		
FBgn0039747	AdoR	HGNC:262	OMIM:102775	ADORA1	7		
FBgn0039747	AdoR	HGNC:264	OMIM:600446	ADORA2B	8		
FBgn0003479	spn-A	HGNC:2927	OMIM:602721	DMC1	3		
FBgn0003479	spn-A	HGNC:9817	OMIM:179617	RAD51	13	114480,614508,617244	114480[BREAST CANCER],614508[MIRROR MOVEMENTS 2; MRMV2],617244[FANCONI ANEMIA, COMPLEMENTATION GROUP R; FANCR]
FBgn0039742	CG15528	HGNC:17007	OMIM:606618	DUSP14	12		
FBgn0039742	CG15528	HGNC:20476	OMIM:300678	DUSP21	8		
FBgn0039742	CG15528	HGNC:18484	OMIM:611446	DUSP18	10		
FBgn0039742	CG15528	HGNC:33237		DUSP28	4		
FBgn0002626	RpL32	HGNC:10336		RPL32	13		
FBgn0001280	janA	HGNC:30033	OMIM:610167	PHPT1	13		
FBgn0001281	janB	HGNC:30033	OMIM:610167	PHPT1	6		
FBgn0041102	ocn	HGNC:30033	OMIM:610167	PHPT1	6		
FBgn0039739	RpS28a	HGNC:10418	OMIM:603685	RPS28	11	606164	606164[DIAMOND-BLACKFAN ANEMIA 15 WITH MANDIBULOFACIAL DYSOSTOSIS; DBA15]
FBgn0039735	Nph	HGNC:7910	OMIM:164040	NPM1	5	601626	601626[LEUKEMIA, ACUTE MYELOID; AML]
FBgn0039735	Nph	HGNC:7930	OMIM:608073	NPM2	7		
FBgn0039735	Nph	HGNC:7931	OMIM:606456	NPM3	9		
FBgn0039732	CG15525	HGNC:28332		CCDC12	13		
FBgn0039730	CG7903	HGNC:9901	OMIM:602571	RBM4	3		
FBgn0000032	Acph-1	HGNC:29609	OMIM:611471	ACP6	3		
FBgn0000032	Acph-1	HGNC:125	OMIM:171790	ACP3	11		
FBgn0000032	Acph-1	HGNC:123	OMIM:171650	ACP2	13	200950	200950[ACID PHOSPHATASE DEFICIENCY]
FBgn0000032	Acph-1	HGNC:14376	OMIM:606362	ACP4	9	617297	617297[AMELOGENESIS IMPERFECTA, TYPE IJ; AI1J]
FBgn0010113	hdc	HGNC:21041	OMIM:607977	HECA	12		
FBgn0015221	Fer2LCH	HGNC:17345	OMIM:608847	FTMT	3		
FBgn0039765	mRpS18C	HGNC:16633	OMIM:611983	MRPS18C	13		
FBgn0039768	CG15533	HGNC:11120	OMIM:607608	SMPD1	4	257200,607616	257200[NIEMANN-PICK DISEASE, TYPE A],607616[NIEMANN-PICK DISEASE, TYPE B]
FBgn0039767	CG2218	HGNC:17777	OMIM:619675	UBOX5	14		
FBgn0039764	CG15535	HGNC:25005	OMIM:619280	CCDC59	4		
FBgn0015222	Fer1HCH	HGNC:3987	OMIM:300308	FTHL17	3		
FBgn0015222	Fer1HCH	HGNC:17345	OMIM:608847	FTMT	3		
FBgn0015222	Fer1HCH	HGNC:3976	OMIM:134770	FTH1	3	615517	615517[HEMOCHROMATOSIS, TYPE 5; HFE5]
FBgn0039769	CG15534	HGNC:11120	OMIM:607608	SMPD1	4	257200,607616	257200[NIEMANN-PICK DISEASE, TYPE A],607616[NIEMANN-PICK DISEASE, TYPE B]
FBgn0039774	CDase	HGNC:18860	OMIM:611202	ASAH2	9		
FBgn0039774	CDase	HGNC:23456	OMIM:610987	ASAH2B	9		
FBgn0039776	PH4alphaEFB	HGNC:8546	OMIM:176710	P4HA1	14		
FBgn0039776	PH4alphaEFB	HGNC:30135	OMIM:608987	P4HA3	4		
FBgn0039776	PH4alphaEFB	HGNC:8547	OMIM:600608	P4HA2	11	617238	617238[MYOPIA 25, AUTOSOMAL DOMINANT; MYP25]
FBgn0039779	PH4alphaSG2	HGNC:8546	OMIM:176710	P4HA1	4		
FBgn0039779	PH4alphaSG2	HGNC:30135	OMIM:608987	P4HA3	7		
FBgn0039779	PH4alphaSG2	HGNC:8547	OMIM:600608	P4HA2	4	617238	617238[MYOPIA 25, AUTOSOMAL DOMINANT; MYP25]
FBgn0039782	CG15539	HGNC:8546	OMIM:176710	P4HA1	4		
FBgn0039782	CG15539	HGNC:30135	OMIM:608987	P4HA3	5		
FBgn0039782	CG15539	HGNC:8547	OMIM:600608	P4HA2	4	617238	617238[MYOPIA 25, AUTOSOMAL DOMINANT; MYP25]
FBgn0039784	CG9698	HGNC:8546	OMIM:176710	P4HA1	5		
FBgn0039784	CG9698	HGNC:30135	OMIM:608987	P4HA3	5		
FBgn0039784	CG9698	HGNC:8547	OMIM:600608	P4HA2	6	617238	617238[MYOPIA 25, AUTOSOMAL DOMINANT; MYP25]
FBgn0082582	tmod	HGNC:11871	OMIM:190930	TMOD1	13		
FBgn0082582	tmod	HGNC:6647	OMIM:602715	LMOD1	6	619362	619362[MEGACYSTIS-MICROCOLON-INTESTINAL HYPOPERISTALSIS SYNDROME 3; MMIHS3]
FBgn0082582	tmod	HGNC:11874	OMIM:605834	TMOD4	11		
FBgn0082582	tmod	HGNC:11872	OMIM:602928	TMOD2	11		
FBgn0082582	tmod	HGNC:6649	OMIM:616112	LMOD3	6	616165	616165[NEMALINE MYOPATHY 10; NEM10]
FBgn0082582	tmod	HGNC:6648	OMIM:608006	LMOD2	5	619897	619897[CARDIOMYOPATHY, DILATED, 2G; CMD2G]
FBgn0082582	tmod	HGNC:11873	OMIM:605112	TMOD3	10		
FBgn0039787	CG9702	HGNC:14471	OMIM:610117	SLC26A11	8		
FBgn0051019	CG31019	HGNC:25892	OMIM:616476	AGBL4	13		
FBgn0051019	CG31019	HGNC:17258	OMIM:606830	AGTPBP1	3	618276	618276[NEURODEGENERATION, CHILDHOOD-ONSET, WITH CEREBELLAR ATROPHY; CONDCA]
FBgn0051021	CG31021	HGNC:8546	OMIM:176710	P4HA1	4		
FBgn0051021	CG31021	HGNC:30135	OMIM:608987	P4HA3	3		
FBgn0051021	CG31021	HGNC:8547	OMIM:600608	P4HA2	4	617238	617238[MYOPIA 25, AUTOSOMAL DOMINANT; MYP25]
FBgn0051017	PH4alphaNE3	HGNC:8546	OMIM:176710	P4HA1	4		
FBgn0051017	PH4alphaNE3	HGNC:30135	OMIM:608987	P4HA3	5		
FBgn0051017	PH4alphaNE3	HGNC:8547	OMIM:600608	P4HA2	4	617238	617238[MYOPIA 25, AUTOSOMAL DOMINANT; MYP25]
FBgn0051017	PH4alphaNE3	HGNC:28858	OMIM:614584	P4HTM	3	618493	618493[HYPOTONIA, HYPOVENTILATION, IMPAIRED INTELLECTUAL DEVELOPMENT, DYSAUTONOMIA, EPILEPSY, AND EYE ABNORMALITIES; HIDEA]
FBgn0051015	PH4alphaPV	HGNC:8546	OMIM:176710	P4HA1	5		
FBgn0051015	PH4alphaPV	HGNC:30135	OMIM:608987	P4HA3	6		
FBgn0051015	PH4alphaPV	HGNC:8547	OMIM:600608	P4HA2	4	617238	617238[MYOPIA 25, AUTOSOMAL DOMINANT; MYP25]
FBgn0051013	CG31013	HGNC:8546	OMIM:176710	P4HA1	4		
FBgn0051013	CG31013	HGNC:30135	OMIM:608987	P4HA3	5		
FBgn0051013	CG31013	HGNC:8547	OMIM:600608	P4HA2	4	617238	617238[MYOPIA 25, AUTOSOMAL DOMINANT; MYP25]
FBgn0039790	CG2246	HGNC:9466	OMIM:601249	PRPSAP1	13		
FBgn0039790	CG2246	HGNC:9467	OMIM:603762	PRPSAP2	14		
FBgn0039789	CG9717	HGNC:14471	OMIM:610117	SLC26A11	9		
FBgn0039788	Rpt6R	HGNC:9552	OMIM:601681	PSMC5	9		
FBgn0027654	jdp	HGNC:28908	OMIM:606060	DNAJC12	11	617384	617384[HYPERPHENYLALANINEMIA, MILD, NON-BH4-DEFICIENT; HPANBH4]
FBgn0051524	CG31524	HGNC:8546	OMIM:176710	P4HA1	4		
FBgn0051524	CG31524	HGNC:30135	OMIM:608987	P4HA3	5		
FBgn0051524	CG31524	HGNC:8547	OMIM:600608	P4HA2	4	617238	617238[MYOPIA 25, AUTOSOMAL DOMINANT; MYP25]
FBgn0039783	PH4alphaNE2	HGNC:8546	OMIM:176710	P4HA1	3		
FBgn0039783	PH4alphaNE2	HGNC:30135	OMIM:608987	P4HA3	5		
FBgn0039783	PH4alphaNE2	HGNC:8547	OMIM:600608	P4HA2	3	617238	617238[MYOPIA 25, AUTOSOMAL DOMINANT; MYP25]
FBgn0051014	PH4alphaSG1	HGNC:8546	OMIM:176710	P4HA1	4		
FBgn0051014	PH4alphaSG1	HGNC:30135	OMIM:608987	P4HA3	8		
FBgn0051014	PH4alphaSG1	HGNC:8547	OMIM:600608	P4HA2	4	617238	617238[MYOPIA 25, AUTOSOMAL DOMINANT; MYP25]
FBgn0051371	CG31371	HGNC:8546	OMIM:176710	P4HA1	4		
FBgn0051371	CG31371	HGNC:30135	OMIM:608987	P4HA3	5		
FBgn0051371	CG31371	HGNC:8547	OMIM:600608	P4HA2	4	617238	617238[MYOPIA 25, AUTOSOMAL DOMINANT; MYP25]
FBgn0039780	PH4alphaNE1	HGNC:8546	OMIM:176710	P4HA1	5		
FBgn0039780	PH4alphaNE1	HGNC:30135	OMIM:608987	P4HA3	6		
FBgn0039780	PH4alphaNE1	HGNC:8547	OMIM:600608	P4HA2	4	617238	617238[MYOPIA 25, AUTOSOMAL DOMINANT; MYP25]
FBgn0026190	PH4alphaMP	HGNC:8546	OMIM:176710	P4HA1	3		
FBgn0026190	PH4alphaMP	HGNC:30135	OMIM:608987	P4HA3	5		
FBgn0026190	PH4alphaMP	HGNC:8547	OMIM:600608	P4HA2	4	617238	617238[MYOPIA 25, AUTOSOMAL DOMINANT; MYP25]
FBgn0039773	CG2224	HGNC:24105	OMIM:612352	STAMBPL1	13		
FBgn0039773	CG2224	HGNC:16950	OMIM:606247	STAMBP	14	614261	614261[MICROCEPHALY-CAPILLARY MALFORMATION SYNDROME; MICCAP]
FBgn0028646	aralar1	HGNC:10982	OMIM:603667	SLC25A12	15	612949	612949[DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 39; DEE39]
FBgn0028646	aralar1	HGNC:10983	OMIM:603859	SLC25A13	12	603471,605814	603471[CITRULLINEMIA, TYPE II, ADULT-ONSET; CTLN2],605814[CITRULLINEMIA, TYPE II, NEONATAL-ONSET]
FBgn0039770	CG15537	HGNC:2356	OMIM:122559	CRHBP	13		
FBgn0039797	eIF4H2	HGNC:12741	OMIM:603431	EIF4H	10		
FBgn0039799	CG15543	HGNC:26526	OMIM:615365	AK8	3		
FBgn0039802	dj-1beta	HGNC:16369	OMIM:602533	PARK7	13	606324	606324[PARKINSON DISEASE 7, AUTOSOMAL RECESSIVE EARLY-ONSET; PARK7]
FBgn0027598	cindr	HGNC:14258	OMIM:604241	CD2AP	8	607832	607832[FOCAL SEGMENTAL GLOMERULOSCLEROSIS 3, SUSCEPTIBILITY TO; FSGS3]
FBgn0027598	cindr	HGNC:13867	OMIM:300374	SH3KBP1	11	300310	300310[IMMUNODEFICIENCY 61; IMD61]
FBgn0027598	cindr	HGNC:26236		SH3D21	4		
FBgn0015032	Cyp4c3	HGNC:23198	OMIM:608614	CYP4V2	13	210370	210370[BIETTI CRYSTALLINE CORNEORETINAL DYSTROPHY; BCD]
FBgn0015032	Cyp4c3	HGNC:13265	OMIM:611517	CYP4F11	4		
FBgn0015032	Cyp4c3	HGNC:26820	OMIM:611495	CYP4F22	4	604777	604777[ICHTHYOSIS, CONGENITAL, AUTOSOMAL RECESSIVE 5; ARCI5]
FBgn0015032	Cyp4c3	HGNC:2645	OMIM:604426	CYP4F2	4		
FBgn0015032	Cyp4c3	HGNC:2646	OMIM:601270	CYP4F3	4		
FBgn0015032	Cyp4c3	HGNC:20244	OMIM:614999	CYP4X1	4		
FBgn0015032	Cyp4c3	HGNC:2642	OMIM:601310	CYP4A11	3		
FBgn0015032	Cyp4c3	HGNC:18857	OMIM:611485	CYP4F12	5		
FBgn0015032	Cyp4c3	HGNC:20575	OMIM:615341	CYP4A22	3		
FBgn0015032	Cyp4c3	HGNC:2644	OMIM:124075	CYP4B1	4		
FBgn0015032	Cyp4c3	HGNC:2648	OMIM:611545	CYP4F8	4		
FBgn0015032	Cyp4c3	HGNC:20583	OMIM:618953	CYP4Z1	3		
FBgn0015032	Cyp4c3	HGNC:2594	OMIM:107910	CYP19A1	4	139300,613546	139300[AROMATASE EXCESS SYNDROME; AEXS],613546[AROMATASE DEFICIENCY]
FBgn0000416	Sap-r	HGNC:9498	OMIM:176801	PSAP	12	249900,610539,611721,611722,619491	249900[METACHROMATIC LEUKODYSTROPHY DUE TO SAPOSIN B DEFICIENCY; MLDSAPB],610539[GAUCHER DISEASE, ATYPICAL, DUE TO SAPOSIN C DEFICIENCY; GDSAPC],611721[COMBINED SAPOSIN DEFICIENCY; PSAPD],611722[KRABBE DISEASE, ATYPICAL, DUE TO SAPOSIN A DEFICIENCY; KRBSAPA],619491[PARKINSON DISEASE 24, AUTOSOMAL DOMINANT, SUSCEPTIBILITY TO; PARK24]
FBgn0000416	Sap-r	HGNC:33131		PSAPL1	10		
FBgn0000416	Sap-r	HGNC:10801	OMIM:178640	SFTPB	6	265120	265120[SURFACTANT METABOLISM DYSFUNCTION, PULMONARY, 1; SMDP1]
FBgn0039809	CG15547	HGNC:7853	OMIM:603575	NME5	5		
FBgn0011739	wts	HGNC:6515	OMIM:604861	LATS2	9		
FBgn0011739	wts	HGNC:6514	OMIM:603473	LATS1	11		
FBgn0039801	Npc2h	HGNC:14537	OMIM:601015	NPC2	4	607625	607625[NIEMANN-PICK DISEASE, TYPE C2; NPC2]
FBgn0039800	Npc2g	HGNC:14537	OMIM:601015	NPC2	3	607625	607625[NIEMANN-PICK DISEASE, TYPE C2; NPC2]
FBgn0000274	Pka-C2	HGNC:9441	OMIM:300083	PRKX	3		
FBgn0000274	Pka-C2	HGNC:9382	OMIM:176893	PRKACG	7	616176	616176[BLEEDING DISORDER, PLATELET-TYPE, 19; BDPLT19]
FBgn0000274	Pka-C2	HGNC:9380	OMIM:601639	PRKACA	7	615830,619142	615830[PIGMENTED NODULAR ADRENOCORTICAL DISEASE, PRIMARY, 4; PPNAD4],619142[CARDIOACROFACIAL DYSPLASIA 1; CAFD1]
FBgn0000274	Pka-C2	HGNC:9381	OMIM:176892	PRKACB	6	619143	619143[CARDIOACROFACIAL DYSPLASIA 2; CAFD2]
FBgn0039796	CG12069	HGNC:9441	OMIM:300083	PRKX	3		
FBgn0039796	CG12069	HGNC:9382	OMIM:176893	PRKACG	7	616176	616176[BLEEDING DISORDER, PLATELET-TYPE, 19; BDPLT19]
FBgn0039796	CG12069	HGNC:9380	OMIM:601639	PRKACA	7	615830,619142	615830[PIGMENTED NODULAR ADRENOCORTICAL DISEASE, PRIMARY, 4; PPNAD4],619142[CARDIOACROFACIAL DYSPLASIA 1; CAFD1]
FBgn0039796	CG12069	HGNC:9381	OMIM:176892	PRKACB	6	619143	619143[CARDIOACROFACIAL DYSPLASIA 2; CAFD2]
FBgn0010015	CanA1	HGNC:9315	OMIM:114106	PPP3CB	10		
FBgn0010015	CanA1	HGNC:9316	OMIM:114107	PPP3CC	9		
FBgn0010015	CanA1	HGNC:9314	OMIM:114105	PPP3CA	9	617711,618265	617711[DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 91; DEE91],618265[ARTHROGRYPOSIS, CLEFT PALATE, CRANIOSYNOSTOSIS, AND IMPAIRED INTELLECTUAL DEVELOPMENT; ACCIID]
FBgn0016123	Alp4	HGNC:438	OMIM:171760	ALPL	6	146300,241500,241510	146300[HYPOPHOSPHATASIA, ADULT; HPPA],241500[HYPOPHOSPHATASIA, INFANTILE; HPPI],241510[HYPOPHOSPHATASIA, CHILDHOOD; HPPC]
FBgn0016123	Alp4	HGNC:441	OMIM:171810	ALPG	6		
FBgn0016123	Alp4	HGNC:439	OMIM:171800	ALPP	7		
FBgn0016123	Alp4	HGNC:437	OMIM:171740	ALPI	6		
FBgn0024288	Sox100B	HGNC:11199	OMIM:313430	SOX3	3	300123,312000	300123[INTELLECTUAL DEVELOPMENTAL DISORDER, X-LINKED, WITH PANHYPOPITUITARISM],312000[PANHYPOPITUITARISM, X-LINKED; PHPX]
FBgn0024288	Sox100B	HGNC:11198	OMIM:601947	SOX12	3		
FBgn0024288	Sox100B	HGNC:11196	OMIM:601297	SOX15	3		
FBgn0024288	Sox100B	HGNC:11203	OMIM:605923	SOX8	8		
FBgn0024288	Sox100B	HGNC:11194	OMIM:601618	SOX18	3	137940,607823	137940[HYPOTRICHOSIS-LYMPHEDEMA-TELANGIECTASIA-RENAL DEFECT SYNDROME; HLTRS],607823[HYPOTRICHOSIS-LYMPHEDEMA-TELANGIECTASIA SYNDROME; HLTS]
FBgn0024288	Sox100B	HGNC:11204	OMIM:608160	SOX9	4	114290	114290[CAMPOMELIC DYSPLASIA]
FBgn0024288	Sox100B	HGNC:11190	OMIM:602229	SOX10	5	609136,611584,613266	609136[PERIPHERAL DEMYELINATING NEUROPATHY, CENTRAL DYSMYELINATION, WAARDENBURG SYNDROME, AND HIRSCHSPRUNG DISEASE; PCWH],611584[WAARDENBURG SYNDROME, TYPE 2E; WS2E],613266[WAARDENBURG SYNDROME, TYPE 4C; WS4C]
FBgn0039821	CG15556	HGNC:18992	OMIM:301085	ADGRG4	3		
FBgn0039821	CG15556	HGNC:4516	OMIM:300572	ADGRG2	4	300985	300985[VAS DEFERENS, CONGENITAL BILATERAL APLASIA OF, X-LINKED; CBAVDX]
FBgn0039821	CG15556	HGNC:13841	OMIM:612243	ADGRG6	3	616503	616503[LETHAL CONGENITAL CONTRACTURE SYNDROME 9; LCCS9]
FBgn0039821	CG15556	HGNC:13728	OMIM:618441	ADGRG3	3		
FBgn0039821	CG15556	HGNC:19241	OMIM:612307	ADGRG7	6		
FBgn0039818	CG11318	HGNC:18992	OMIM:301085	ADGRG4	4		
FBgn0039818	CG11318	HGNC:4516	OMIM:300572	ADGRG2	5	300985	300985[VAS DEFERENS, CONGENITAL BILATERAL APLASIA OF, X-LINKED; CBAVDX]
FBgn0039818	CG11318	HGNC:13841	OMIM:612243	ADGRG6	3	616503	616503[LETHAL CONGENITAL CONTRACTURE SYNDROME 9; LCCS9]
FBgn0039818	CG11318	HGNC:19241	OMIM:612307	ADGRG7	7		
FBgn0002413	dco	HGNC:2451	OMIM:600505	CSNK1A1	5		
FBgn0002413	dco	HGNC:20289		CSNK1A1L	3		
FBgn0002413	dco	HGNC:2453	OMIM:600863	CSNK1E	7		
FBgn0002413	dco	HGNC:2452	OMIM:600864	CSNK1D	11	615224	615224[ADVANCED SLEEP PHASE SYNDROME, FAMILIAL, 2; FASPS2]
FBgn0002413	dco	HGNC:53829		TPTEP2-CSNK1E	8		
FBgn0010808	Chchd3	HGNC:21906	OMIM:613748	CHCHD3	11		
FBgn0010808	Chchd3	HGNC:28184	OMIM:615634	CHCHD6	6		
FBgn0004573	5-HT7	HGNC:5289	OMIM:182133	HTR1D	4		
FBgn0004573	5-HT7	HGNC:5292	OMIM:182134	HTR1F	3		
FBgn0004573	5-HT7	HGNC:5287	OMIM:182131	HTR1B	4		
FBgn0004573	5-HT7	HGNC:5286	OMIM:109760	HTR1A	4	614674	614674[PERIODIC FEVER, MENSTRUAL CYCLE-DEPENDENT]
FBgn0004573	5-HT7	HGNC:5302	OMIM:182137	HTR7	6		
FBgn0051008	CG31008	HGNC:21645	OMIM:616244	CHCHD2	5	616710	616710[PARKINSON DISEASE 22, AUTOSOMAL DOMINANT; PARK22]
FBgn0051008	CG31008	HGNC:15559	OMIM:615903	CHCHD10	5	615048,615911,616209	615048[SPINAL MUSCULAR ATROPHY, JOKELA TYPE; SMAJ],615911[FRONTOTEMPORAL DEMENTIA AND/OR AMYOTROPHIC LATERAL SCLEROSIS 2; FTDALS2],616209[MYOPATHY, ISOLATED MITOCHONDRIAL, AUTOSOMAL DOMINANT; IMMD]
FBgn0062411	Ctr1C	HGNC:11016	OMIM:603085	SLC31A1	9		
FBgn0062411	Ctr1C	HGNC:11017	OMIM:603088	SLC31A2	7		
FBgn0013973	Gycbeta100B	HGNC:4687	OMIM:139397	GUCY1B1	15		
FBgn0039827	CG1544	HGNC:8124	OMIM:613022	OGDH	4	203740	203740[OXOGLUTARATE DEHYDROGENASE DEFICIENCY; OGDHD]
FBgn0039827	CG1544	HGNC:23537	OMIM:614984	DHTKD1	15	204750,615025	204750[ALPHA-AMINOADIPIC AND ALPHA-KETOADIPIC ACIDURIA; AAKAD],615025[CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2Q; CMT2Q]
FBgn0039827	CG1544	HGNC:25590	OMIM:617513	OGDHL	4	619701	619701[YOON-BELLEN NEURODEVELOPMENTAL SYNDROME; YOBELN]
FBgn0039828	CG1542	HGNC:15531	OMIM:614443	EBNA1BP2	13		
FBgn0039831	CG12054	HGNC:28917	OMIM:606246	JAZF1	11		
FBgn0039835	mRpL32	HGNC:14035	OMIM:611839	MRPL32	12		
FBgn0039838	CAH6	HGNC:1373	OMIM:611492	CA2	3	259730	259730[OSTEOPETROSIS, AUTOSOMAL RECESSIVE 3; OPTB3]
FBgn0039838	CAH6	HGNC:1380	OMIM:114780	CA6	5		
FBgn0039838	CAH6	HGNC:1381	OMIM:114770	CA7	4		
FBgn0039838	CAH6	HGNC:1371	OMIM:603263	CA12	4	143860	143860[HYPERCHLORHIDROSIS, ISOLATED; HYCHL]
FBgn0039838	CAH6	HGNC:1372	OMIM:604832	CA14	3		
FBgn0039838	CAH6	HGNC:1383	OMIM:603179	CA9	4		
FBgn0039838	CAH6	HGNC:1370	OMIM:604644	CA11	3		
FBgn0039838	CAH6	HGNC:1368	OMIM:114800	CA1	5		
FBgn0039838	CAH6	HGNC:1377	OMIM:114761	CA5A	4	615751	615751[CARBONIC ANHYDRASE VA DEFICIENCY, HYPERAMMONEMIA DUE TO; CA5AD]
FBgn0039838	CAH6	HGNC:14914	OMIM:611436	CA13	5		
FBgn0039838	CAH6	HGNC:1374	OMIM:114750	CA3	5		
FBgn0039838	CAH6	HGNC:1375	OMIM:114760	CA4	7		
FBgn0039838	CAH6	HGNC:1378	OMIM:300230	CA5B	6		
FBgn0040628	CAH16	HGNC:1373	OMIM:611492	CA2	4	259730	259730[OSTEOPETROSIS, AUTOSOMAL RECESSIVE 3; OPTB3]
FBgn0040628	CAH16	HGNC:1380	OMIM:114780	CA6	5		
FBgn0040628	CAH16	HGNC:1381	OMIM:114770	CA7	5		
FBgn0040628	CAH16	HGNC:1371	OMIM:603263	CA12	4	143860	143860[HYPERCHLORHIDROSIS, ISOLATED; HYCHL]
FBgn0040628	CAH16	HGNC:1372	OMIM:604832	CA14	3		
FBgn0040628	CAH16	HGNC:1383	OMIM:603179	CA9	4		
FBgn0040628	CAH16	HGNC:1370	OMIM:604644	CA11	4		
FBgn0040628	CAH16	HGNC:1368	OMIM:114800	CA1	5		
FBgn0040628	CAH16	HGNC:1377	OMIM:114761	CA5A	4	615751	615751[CARBONIC ANHYDRASE VA DEFICIENCY, HYPERAMMONEMIA DUE TO; CA5AD]
FBgn0040628	CAH16	HGNC:14914	OMIM:611436	CA13	5		
FBgn0040628	CAH16	HGNC:1374	OMIM:114750	CA3	5		
FBgn0040628	CAH16	HGNC:1375	OMIM:114760	CA4	5		
FBgn0040628	CAH16	HGNC:1378	OMIM:300230	CA5B	5		
FBgn0040629	CAH5	HGNC:1373	OMIM:611492	CA2	3	259730	259730[OSTEOPETROSIS, AUTOSOMAL RECESSIVE 3; OPTB3]
FBgn0040629	CAH5	HGNC:1380	OMIM:114780	CA6	5		
FBgn0040629	CAH5	HGNC:1381	OMIM:114770	CA7	4		
FBgn0040629	CAH5	HGNC:1371	OMIM:603263	CA12	4	143860	143860[HYPERCHLORHIDROSIS, ISOLATED; HYCHL]
FBgn0040629	CAH5	HGNC:1372	OMIM:604832	CA14	4		
FBgn0040629	CAH5	HGNC:1383	OMIM:603179	CA9	5		
FBgn0040629	CAH5	HGNC:1370	OMIM:604644	CA11	3		
FBgn0040629	CAH5	HGNC:1368	OMIM:114800	CA1	5		
FBgn0040629	CAH5	HGNC:1377	OMIM:114761	CA5A	4	615751	615751[CARBONIC ANHYDRASE VA DEFICIENCY, HYPERAMMONEMIA DUE TO; CA5AD]
FBgn0040629	CAH5	HGNC:14914	OMIM:611436	CA13	5		
FBgn0040629	CAH5	HGNC:1374	OMIM:114750	CA3	5		
FBgn0040629	CAH5	HGNC:1375	OMIM:114760	CA4	5		
FBgn0040629	CAH5	HGNC:1378	OMIM:300230	CA5B	5		
FBgn0039839	ppk24	HGNC:101	OMIM:611741	ASIC3	6		
FBgn0039839	ppk24	HGNC:100	OMIM:602866	ASIC1	6		
FBgn0039839	ppk24	HGNC:21263	OMIM:606715	ASIC4	6		
FBgn0039839	ppk24	HGNC:99	OMIM:601784	ASIC2	5		
FBgn0039839	ppk24	HGNC:17537	OMIM:616693	ASIC5	5		
FBgn0039839	ppk24	HGNC:10599	OMIM:600228	SCNN1A	3	264350,613021,618126	264350[PSEUDOHYPOALDOSTERONISM, TYPE I, AUTOSOMAL RECESSIVE; PHA1B],613021[BRONCHIECTASIS WITH OR WITHOUT ELEVATED SWEAT CHLORIDE 2; BESC2],618126[LIDDLE SYNDROME 3; LIDLS3]
FBgn0039839	ppk24	HGNC:10600	OMIM:600760	SCNN1B	3	177200,211400,264350	177200[LIDDLE SYNDROME 1; LIDLS1],211400[BRONCHIECTASIS WITH OR WITHOUT ELEVATED SWEAT CHLORIDE 1; BESC1],264350[PSEUDOHYPOALDOSTERONISM, TYPE I, AUTOSOMAL RECESSIVE; PHA1B]
FBgn0039839	ppk24	HGNC:10601	OMIM:601328	SCNN1D	3		
FBgn0039839	ppk24	HGNC:10602	OMIM:600761	SCNN1G	3	264350,613071,618114	264350[PSEUDOHYPOALDOSTERONISM, TYPE I, AUTOSOMAL RECESSIVE; PHA1B],613071[BRONCHIECTASIS WITH OR WITHOUT ELEVATED SWEAT CHLORIDE 3; BESC3],618114[LIDDLE SYNDROME 2; LIDLS2]
FBgn0039840	pHCl-2	HGNC:4328	OMIM:600421	GLRA3	3		
FBgn0039840	pHCl-2	HGNC:4329	OMIM:138492	GLRB	3	614619	614619[HYPEREKPLEXIA 2; HKPX2]
FBgn0039840	pHCl-2	HGNC:4327	OMIM:305990	GLRA2	3	301076	301076[INTELLECTUAL DEVELOPMENTAL DISORDER, X-LINKED, SYNDROMIC, PILORGE TYPE; MRXSP]
FBgn0039840	pHCl-2	HGNC:31715		GLRA4	3		
FBgn0039840	pHCl-2	HGNC:4326	OMIM:138491	GLRA1	3	149400	149400[HYPEREKPLEXIA 1; HKPX1]
FBgn0039840	pHCl-2	HGNC:4089	OMIM:602729	GABRP	3		
FBgn0039836	CG1750	HGNC:29666	OMIM:611766	MTFMT	15	614947,618248	614947[COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 15; COXPD15],618248[MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 27; MC1DN27]
FBgn0051005	qless	HGNC:17759	OMIM:607429	PDSS1	13	614651	614651[COENZYME Q10 DEFICIENCY, PRIMARY, 2; COQ10D2]
FBgn0039830	ATPsynC	HGNC:843	OMIM:602736	ATP5MC3	9	619681	619681[DYSTONIA, EARLY-ONSET, AND/OR SPASTIC PARAPLEGIA; DYTSPG]
FBgn0039830	ATPsynC	HGNC:841	OMIM:603192	ATP5MC1	10		
FBgn0039830	ATPsynC	HGNC:842	OMIM:603193	ATP5MC2	12		
FBgn0039829	CG15561	HGNC:25982		GPATCH4	12		
FBgn0061476	Zwilch	HGNC:25468	OMIM:609984	ZWILCH	5		
FBgn0051004	mesh	HGNC:30667	OMIM:615825	SUSD2	13		
FBgn0051004	mesh	HGNC:7514	OMIM:158372	MUC4	3		
FBgn0046332	gskt	HGNC:4617	OMIM:605004	GSK3B	10		
FBgn0046332	gskt	HGNC:4616	OMIM:606784	GSK3A	8		
FBgn0039844	CG1607	HGNC:11059	OMIM:607933	SLC7A11	5		
FBgn0039844	CG1607	HGNC:11058	OMIM:607959	SLC7A10	7		
FBgn0039844	CG1607	HGNC:11065	OMIM:603593	SLC7A7	8	222700	222700[LYSINURIC PROTEIN INTOLERANCE; LPI]
FBgn0039844	CG1607	HGNC:11064	OMIM:605641	SLC7A6	10		
FBgn0039844	CG1607	HGNC:11067	OMIM:604144	SLC7A9	5	220100	220100[CYSTINURIA]
FBgn0039844	CG1607	HGNC:11063	OMIM:600182	SLC7A5	8		
FBgn0039844	CG1607	HGNC:11066	OMIM:604235	SLC7A8	8		
FBgn0039844	CG1607	HGNC:23092	OMIM:617256	SLC7A13	3		
FBgn0019990	Gcn2	HGNC:19687	OMIM:609280	EIF2AK4	14	234810	234810[PULMONARY VENOOCCLUSIVE DISEASE 2, AUTOSOMAL RECESSIVE; PVOD2]
FBgn0019990	Gcn2	HGNC:24921	OMIM:613635	EIF2AK1	3	618878	618878[LEUKOENCEPHALOPATHY, MOTOR DELAY, SPASTICITY, AND DYSARTHRIA SYNDROME; LEMSPAD]
FBgn0039850	CG11333	HGNC:26278	OMIM:612928	ISOC2	8		
FBgn0039850	CG11333	HGNC:24254		ISOC1	10		
FBgn0028968	gammaCOP	HGNC:2236	OMIM:615525	COPG1	12		
FBgn0028968	gammaCOP	HGNC:2237	OMIM:604355	COPG2	11		
FBgn0003268	rod	HGNC:17255	OMIM:607363	KNTC1	12		
FBgn0039854	CG1635	HGNC:17152	OMIM:300862	ACOT9	13		
FBgn0039855	CG1638	HGNC:17152	OMIM:300862	ACOT9	14		
FBgn0039856	CG1774	HGNC:17152	OMIM:300862	ACOT9	13		
FBgn0039858	CycG	HGNC:1592	OMIM:601578	CCNG1	9		
FBgn0039858	CycG	HGNC:1593	OMIM:603203	CCNG2	8		
FBgn0039858	CycG	HGNC:1595	OMIM:618783	CCNI	4		
FBgn0039858	CycG	HGNC:33869		CCNI2	3		
FBgn0039857	RpL6	HGNC:10362	OMIM:603703	RPL6	14		
FBgn0043900	pygo	HGNC:30256	OMIM:606902	PYGO1	5		
FBgn0043900	pygo	HGNC:30257	OMIM:606903	PYGO2	8		
FBgn0039849	CG11334	HGNC:28469	OMIM:615105	MRI1	14		
FBgn0039848	Loxl1	HGNC:6664	OMIM:153455	LOX	3	617168	617168[AORTIC ANEURYSM, FAMILIAL THORACIC 10; AAT10]
FBgn0039848	Loxl1	HGNC:13869	OMIM:607163	LOXL3	5	619781	619781[MYOPIA 28, AUTOSOMAL RECESSIVE; MYP28]
FBgn0039848	Loxl1	HGNC:6666	OMIM:606663	LOXL2	6		
FBgn0039848	Loxl1	HGNC:17171	OMIM:607318	LOXL4	4		
FBgn0039846	PNPase	HGNC:23166	OMIM:610316	PNPT1	15	608703,614932,614934	608703[SPINOCEREBELLAR ATAXIA 25; SCA25],614932[COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 13; COXPD13],614934[DEAFNESS, AUTOSOMAL RECESSIVE 70, WITH OR WITHOUT ADULT-ONSET NEURODEGENERATION; DFNB70]
FBgn0051002	Ugt35D1	HGNC:12531	OMIM:606435	UGT1A10	5		
FBgn0051002	Ugt35D1	HGNC:12545	OMIM:603064	UGT2B11	8		
FBgn0051002	Ugt35D1	HGNC:12530	OMIM:191740	UGT1A1	7	143500,218800,237900,601816,606785	143500[GILBERT SYNDROME],218800[CRIGLER-NAJJAR SYNDROME, TYPE I],237900[HYPERBILIRUBINEMIA, TRANSIENT FAMILIAL NEONATAL; HBLRTFN],601816[BILIRUBIN, SERUM LEVEL OF, QUANTITATIVE TRAIT LOCUS 1; BILIQTL1],606785[CRIGLER-NAJJAR SYNDROME, TYPE II]
FBgn0051002	Ugt35D1	HGNC:12555	OMIM:601291	UGT8	7		
FBgn0051002	Ugt35D1	HGNC:12539	OMIM:606432	UGT1A7	5		
FBgn0051002	Ugt35D1	HGNC:13479	OMIM:606497	UGT2B28	7		
FBgn0051002	Ugt35D1	HGNC:27266	OMIM:616384	UGT3A2	4		
FBgn0051002	Ugt35D1	HGNC:12544	OMIM:600070	UGT2B10	8		
FBgn0051002	Ugt35D1	HGNC:12537	OMIM:606430	UGT1A5	5		
FBgn0051002	Ugt35D1	HGNC:12546	OMIM:600069	UGT2B15	8		
FBgn0051002	Ugt35D1	HGNC:12541	OMIM:606434	UGT1A9	5		
FBgn0051002	Ugt35D1	HGNC:28528	OMIM:616382	UGT2A3	10		
FBgn0051002	Ugt35D1	HGNC:12535	OMIM:606428	UGT1A3	7		
FBgn0051002	Ugt35D1	HGNC:12536	OMIM:606429	UGT1A4	5		
FBgn0051002	Ugt35D1	HGNC:12540	OMIM:606433	UGT1A8	5		
FBgn0051002	Ugt35D1	HGNC:26625	OMIM:616383	UGT3A1	4		
FBgn0051002	Ugt35D1	HGNC:12547	OMIM:601903	UGT2B17	8	612560	612560[BONE MINERAL DENSITY QUANTITATIVE TRAIT LOCUS 12; BMND12]
FBgn0051002	Ugt35D1	HGNC:12553	OMIM:600067	UGT2B4	8		
FBgn0051002	Ugt35D1	HGNC:12538	OMIM:606431	UGT1A6	5		
FBgn0051002	Ugt35D1	HGNC:12554	OMIM:600068	UGT2B7	8		
FBgn0051002	Ugt35D1	HGNC:28183	OMIM:619809	UGT2A2	7		
FBgn0039861	pasha	HGNC:2847	OMIM:609030	DGCR8	12		
FBgn0039863	CG1815	HGNC:9397	OMIM:615713	ZMYND8	13		
FBgn0039863	CG1815	HGNC:16966	OMIM:608668	ZMYND11	3	616083	616083[INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL DOMINANT 30; MRD30]
FBgn0039868	CG11563	HGNC:26934	OMIM:612861	NOP16	10		
FBgn0000557	eEF1alpha2	HGNC:3189	OMIM:130590	EEF1A1	8		
FBgn0000557	eEF1alpha2	HGNC:3192	OMIM:602959	EEF1A2	11	616393,616409	616393[INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL DOMINANT 38; MRD38],616409[DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 33; DEE33]
FBgn0000557	eEF1alpha2	HGNC:3200		EEF1A1P5	3		
FBgn0039869	CG1890	HGNC:11579	OMIM:610058	TBCA	15		
FBgn0039870	CG1896	HGNC:8767	OMIM:608138	PDCD7	3		
FBgn0039875	sip3	HGNC:17023	OMIM:603046	RNF139	3	144700	144700[RENAL CELL CARCINOMA, NONPAPILLARY; RCC]
FBgn0039875	sip3	HGNC:20738	OMIM:608046	SYVN1	12		
FBgn0039875	sip3	HGNC:463	OMIM:603243	AMFR	3		
FBgn0005632	faf	HGNC:12632	OMIM:300072	USP9X	14	300919,300968	300919[INTELLECTUAL DEVELOPMENTAL DISORDER, X-LINKED 99; XLID99],300968[INTELLECTUAL DEVELOPMENTAL DISORDER, X-LINKED 99, SYNDROMIC, FEMALE-RESTRICTED; MRXS99F]
FBgn0005632	faf	HGNC:12633	OMIM:400005	USP9Y	10	415000	415000[SPERMATOGENIC FAILURE, Y-LINKED, 2; SPGFY2]
FBgn0005632	faf	HGNC:12623	OMIM:610569	USP24	4		
FBgn0027620	Acf	HGNC:960	OMIM:605680	BAZ1A	13		
FBgn0039882	Rift	HGNC:16187	OMIM:613350	SLC52A3	14	211500,211530	211500[FAZIO-LONDE DISEASE],211530[BROWN-VIALETTO-VAN LAERE SYNDROME 1; BVVLS1]
FBgn0039882	Rift	HGNC:30225	OMIM:607883	SLC52A1	7	615026	615026[RIBOFLAVIN DEFICIENCY; RBFVD]
FBgn0039882	Rift	HGNC:30224	OMIM:607882	SLC52A2	8	614707	614707[BROWN-VIALETTO-VAN LAERE SYNDROME 2; BVVLS2]
FBgn0039877	Mccc1	HGNC:6936	OMIM:609010	MCCC1	15	210200	210200[3-METHYLCROTONYL-CoA CARBOXYLASE 1 DEFICIENCY; MCC1D]
FBgn0039877	Mccc1	HGNC:8653	OMIM:232000	PCCA	5	606054	606054[PROPIONIC ACIDEMIA]
FBgn0039876	CG2126	HGNC:20184	OMIM:611176	JKAMP	14		
FBgn0039873	Smvt	HGNC:11041	OMIM:604024	SLC5A6	4	618973,619903	618973[SODIUM-DEPENDENT MULTIVITAMIN TRANSPORTER DEFICIENCY; SMVTD],619903[PERIPHERAL MOTOR NEUROPATHY, CHILDHOOD-ONSET, BIOTIN-RESPONSIVE; COMNB]
FBgn0039873	Smvt	HGNC:11040	OMIM:601843	SLC5A5	6	274400	274400[THYROID DYSHORMONOGENESIS 1; TDH1]
FBgn0039873	Smvt	HGNC:28750	OMIM:612455	SLC5A12	6		
FBgn0039873	Smvt	HGNC:19119	OMIM:608044	SLC5A8	6		
FBgn0039873	Smvt	HGNC:11036	OMIM:182380	SLC5A1	3	606824	606824[GLUCOSE/GALACTOSE MALABSORPTION; GGM]
FBgn0017448	CG2187	HGNC:11041	OMIM:604024	SLC5A6	4	618973,619903	618973[SODIUM-DEPENDENT MULTIVITAMIN TRANSPORTER DEFICIENCY; SMVTD],619903[PERIPHERAL MOTOR NEUROPATHY, CHILDHOOD-ONSET, BIOTIN-RESPONSIVE; COMNB]
FBgn0017448	CG2187	HGNC:11040	OMIM:601843	SLC5A5	7	274400	274400[THYROID DYSHORMONOGENESIS 1; TDH1]
FBgn0017448	CG2187	HGNC:28750	OMIM:612455	SLC5A12	6		
FBgn0017448	CG2187	HGNC:19119	OMIM:608044	SLC5A8	6		
FBgn0039872	salt	HGNC:11041	OMIM:604024	SLC5A6	4	618973,619903	618973[SODIUM-DEPENDENT MULTIVITAMIN TRANSPORTER DEFICIENCY; SMVTD],619903[PERIPHERAL MOTOR NEUROPATHY, CHILDHOOD-ONSET, BIOTIN-RESPONSIVE; COMNB]
FBgn0039872	salt	HGNC:11040	OMIM:601843	SLC5A5	6	274400	274400[THYROID DYSHORMONOGENESIS 1; TDH1]
FBgn0039872	salt	HGNC:28750	OMIM:612455	SLC5A12	6		
FBgn0039872	salt	HGNC:19119	OMIM:608044	SLC5A8	6		
FBgn0000150	awd	HGNC:33531		NME1-NME2	8		
FBgn0000150	awd	HGNC:7852	OMIM:601818	NME4	6		
FBgn0000150	awd	HGNC:7851	OMIM:601817	NME3	6		
FBgn0000150	awd	HGNC:7849	OMIM:156490	NME1	13		
FBgn0000150	awd	HGNC:7850	OMIM:156491	NME2	6		
FBgn0000150	awd	HGNC:31358		NME2P1	5		
FBgn0039867	CstF50	HGNC:2483	OMIM:600369	CSTF1	13		
FBgn0039864	CG11550	HGNC:16114		TTPAL	3		
FBgn0039859	Mnat9	HGNC:23133		NAT9	15		
FBgn0039883	RhoGAP100F	HGNC:25841		SYDE2	8		
FBgn0039883	RhoGAP100F	HGNC:25824	OMIM:617377	SYDE1	9		
FBgn0039886	CG2003	HGNC:20151	OMIM:607557	SLC17A8	3	605583	605583[DEAFNESS, AUTOSOMAL DOMINANT 25; DFNA25]
FBgn0039886	CG2003	HGNC:10933	OMIM:604322	SLC17A5	5	269920,604369	269920[INFANTILE SIALIC ACID STORAGE DISEASE; ISSD],604369[SALLA DISEASE; SD]
FBgn0039886	CG2003	HGNC:16704	OMIM:605208	SLC17A7	3		
FBgn0039886	CG2003	HGNC:10929	OMIM:182308	SLC17A1	5		
FBgn0039886	CG2003	HGNC:10932	OMIM:604216	SLC17A4	5		
FBgn0039886	CG2003	HGNC:10930	OMIM:611049	SLC17A2	4		
FBgn0039886	CG2003	HGNC:10931	OMIM:611034	SLC17A3	5	612671	612671[URIC ACID CONCENTRATION, SERUM, QUANTITATIVE TRAIT LOCUS 4; UAQTL4]
FBgn0039887	Pos	HGNC:10445	OMIM:612054	CNOT9	4		
FBgn0040206	krz	HGNC:712	OMIM:107941	ARRB2	13		
FBgn0040206	krz	HGNC:710	OMIM:301770	ARR3	6	301010	301010[MYOPIA 26, X-LINKED, FEMALE-LIMITED; MYP26]
FBgn0040206	krz	HGNC:10521	OMIM:181031	SAG	5	258100,613758	258100[OGUCHI DISEASE 1],613758[RETINITIS PIGMENTOSA 47; RP47]
FBgn0040206	krz	HGNC:711	OMIM:107940	ARRB1	13		
FBgn0011224	heph	HGNC:9583	OMIM:600693	PTBP1	13		
FBgn0011224	heph	HGNC:10253	OMIM:607527	PTBP3	13		
FBgn0011224	heph	HGNC:17662	OMIM:608449	PTBP2	13		
FBgn0032956	Cul2	HGNC:2552	OMIM:603135	CUL2	14		
FBgn0051619	nolo	HGNC:14633	OMIM:609199	ADAMTSL3	10		
FBgn0051619	nolo	HGNC:14632	OMIM:609198	ADAMTSL1	9		
FBgn0032961	CG1416	HGNC:20437		AHSA2P	4		
FBgn0032961	CG1416	HGNC:1189	OMIM:608466	AHSA1	13		
FBgn0003866	tsh	HGNC:13010	OMIM:614118	TSHZ2	8		
FBgn0003866	tsh	HGNC:10669	OMIM:614427	TSHZ1	8	607842	607842[AURAL ATRESIA, CONGENITAL; CAA]
FBgn0003866	tsh	HGNC:30700	OMIM:614119	TSHZ3	8		
FBgn0000559	eEF2	HGNC:30858	OMIM:603892	EFTUD2	3	610536	610536[MANDIBULOFACIAL DYSOSTOSIS, GUION-ALMEIDA TYPE; MFDGA]
FBgn0000559	eEF2	HGNC:3214	OMIM:130610	EEF2	15	609306	609306[SPINOCEREBELLAR ATAXIA 26; SCA26]
FBgn0051702	tplus3a	HGNC:28996	OMIM:611633	RTF1	6		
FBgn0032971	ttm3	HGNC:23656	OMIM:607381	TIMM50	12	617698	617698[3-METHYLGLUTACONIC ACIDURIA, TYPE IX; MGCA9]
FBgn0032973	CG6675	HGNC:9155	OMIM:246600	PNLIP	4	614338	614338[PANCREATIC LIPASE DEFICIENCY; PNLIPD]
FBgn0032973	CG6675	HGNC:17661	OMIM:607460	PLA1A	4		
FBgn0032973	CG6675	HGNC:9156	OMIM:604422	PNLIPRP1	4		
FBgn0032973	CG6675	HGNC:23492		PNLIPRP3	3		
FBgn0032973	CG6675	HGNC:6619	OMIM:151670	LIPC	3	125853,612797,614025	125853[TYPE 2 DIABETES MELLITUS; T2D],612797[HIGH DENSITY LIPOPROTEIN CHOLESTEROL LEVEL QUANTITATIVE TRAIT LOCUS 12; HDLCQ12],614025[HEPATIC LIPASE DEFICIENCY]
FBgn0032973	CG6675	HGNC:18821	OMIM:609252	LIPI	3		
FBgn0032973	CG6675	HGNC:18483	OMIM:607365	LIPH	3	604379	604379[HYPOTRICHOSIS 7; HYPT7]
FBgn0032973	CG6675	HGNC:9157	OMIM:604423	PNLIPRP2	3		
FBgn0025674	CycK	HGNC:1596	OMIM:603544	CCNK	11	618147	618147[INTELLECTUAL DEVELOPMENTAL DISORDER WITH HYPERTELORISM AND DISTINCTIVE FACIES; IDDHDF]
FBgn0032972	CG10834	HGNC:15467	OMIM:607168	DYNLRB2	5		
FBgn0032972	CG10834	HGNC:15468	OMIM:607167	DYNLRB1	5		
FBgn0051703	tplus3b	HGNC:28996	OMIM:611633	RTF1	6		
FBgn0051601	CG31601	HGNC:25091		ZC3H18	3		
FBgn0032969	CG2528	HGNC:9358	OMIM:600400	PREP	14		
FBgn0032981	CG3635	HGNC:6617	OMIM:613497	LIPA	9	278000	278000[LYSOSOMAL ACID LIPASE DEFICIENCY]
FBgn0032981	CG3635	HGNC:23444	OMIM:613922	LIPK	8		
FBgn0032981	CG3635	HGNC:23455	OMIM:613923	LIPM	8		
FBgn0032981	CG3635	HGNC:6622	OMIM:601980	LIPF	8		
FBgn0032981	CG3635	HGNC:21773	OMIM:613921	LIPJ	7		
FBgn0032981	CG3635	HGNC:23452	OMIM:613924	LIPN	8	613943	613943[ICHTHYOSIS, CONGENITAL, AUTOSOMAL RECESSIVE 8; ARCI8]
FBgn0032986	CG3262	HGNC:8042	OMIM:610779	NUBP2	3		
FBgn0032986	CG3262	HGNC:8041	OMIM:600280	NUBP1	3		
FBgn0032986	CG3262	HGNC:20278	OMIM:613621	NUBPL	14	618242	618242[MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 21; MC1DN21]
FBgn0032988	Tif-IA	HGNC:30346	OMIM:605121	RRN3	14		
FBgn0039972	Marf1	HGNC:29562	OMIM:614593	MARF1	8		
FBgn0032987	RpL21	HGNC:10313	OMIM:603636	RPL21	14	615885	615885[HYPOTRICHOSIS 12; HYPT12]
FBgn0033047	CG7882	HGNC:18301	OMIM:611039	SLC2A14	5		
FBgn0033047	CG7882	HGNC:11010	OMIM:138230	SLC2A5	6		
FBgn0033047	CG7882	HGNC:11005	OMIM:138140	SLC2A1	5	601042,606777,608885,612126,614847	601042[DYSTONIA 9; DYT9],606777[GLUT1 DEFICIENCY SYNDROME 1; GLUT1DS1],608885[STOMATIN-DEFICIENT CRYOHYDROCYTOSIS WITH NEUROLOGIC DEFECTS; SDCHCN],612126[GLUT1 DEFICIENCY SYNDROME 2; GLUT1DS2],614847[EPILEPSY, IDIOPATHIC GENERALIZED, SUSCEPTIBILITY TO, 12; EIG12]
FBgn0033047	CG7882	HGNC:13445	OMIM:610371	SLC2A7	6		
FBgn0033047	CG7882	HGNC:11009	OMIM:138190	SLC2A4	5		
FBgn0033047	CG7882	HGNC:13446	OMIM:606142	SLC2A9	5	612076	612076[HYPOURICEMIA, RENAL, 2; RHUC2]
FBgn0033047	CG7882	HGNC:11006	OMIM:138160	SLC2A2	5	125853,227810	125853[TYPE 2 DIABETES MELLITUS; T2D],227810[FANCONI-BICKEL SYNDROME; FBS]
FBgn0033047	CG7882	HGNC:11007	OMIM:138170	SLC2A3	5		
FBgn0033047	CG7882	HGNC:14239	OMIM:610367	SLC2A11	4		
FBgn0033050	Pngl	HGNC:17646	OMIM:610661	NGLY1	15	615273	615273[CONGENITAL DISORDER OF DEGLYCOSYLATION 1; CDDG1]
FBgn0033055	Tbce	HGNC:11582	OMIM:604934	TBCE	13	241410,244460,617207	241410[HYPOPARATHYROIDISM-RETARDATION-DYSMORPHISM SYNDROME; HRDS],244460[KENNY-CAFFEY SYNDROME, TYPE 1; KCS1],617207[ENCEPHALOPATHY, PROGRESSIVE, WITH AMYOTROPHY AND OPTIC ATROPHY; PEAMO]
FBgn0033058	CCHa2-R	HGNC:1113	OMIM:300107	BRS3	11		
FBgn0033058	CCHa2-R	HGNC:4609	OMIM:305670	GRPR	9		
FBgn0033058	CCHa2-R	HGNC:7843	OMIM:162341	NMBR	9		
FBgn0033060	CG7849	HGNC:17170	OMIM:610727	TRUB2	14		
FBgn0033065	Cyp6w1	HGNC:2638	OMIM:605325	CYP3A5	5	145500	145500[HYPERTENSION, ESSENTIAL]
FBgn0033065	Cyp6w1	HGNC:17450	OMIM:606534	CYP3A43	5		
FBgn0033065	Cyp6w1	HGNC:11609	OMIM:274180	TBXAS1	5	231095	231095[GHOSAL HEMATODIAPHYSEAL DYSPLASIA; GHDD]
FBgn0033065	Cyp6w1	HGNC:2637	OMIM:124010	CYP3A4	7	619073	619073[VITAMIN D-DEPENDENT RICKETS, TYPE 3; VDDR3]
FBgn0033065	Cyp6w1	HGNC:51504		CYP3A7-CYP3A51P	5		
FBgn0040502	CG8343	HGNC:22977	OMIM:609846	REG4	3		
FBgn0033069	eIF3f2	HGNC:3275	OMIM:603914	EIF3F	7	618295	618295[INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 67; MRT67]
FBgn0033074	tomboy40	HGNC:25756		TOMM40L	11		
FBgn0033074	tomboy40	HGNC:18001	OMIM:608061	TOMM40	14		
FBgn0021847	Ttc7	HGNC:19858		TTC7B	13		
FBgn0021847	Ttc7	HGNC:19750	OMIM:609332	TTC7A	11	243150	243150[GASTROINTESTINAL DEFECTS AND IMMUNODEFICIENCY SYNDROME 1; GIDID1]
FBgn0000546	EcR	HGNC:7966	OMIM:602423	NR1H3	10		
FBgn0000546	EcR	HGNC:7967	OMIM:603826	NR1H4	3	617049	617049[CHOLESTASIS, PROGRESSIVE FAMILIAL INTRAHEPATIC, 5; PFIC5]
FBgn0000546	EcR	HGNC:7965	OMIM:600380	NR1H2	9		
FBgn0033062	Ars2	HGNC:24101	OMIM:614469	SRRT	14		
FBgn0033061	SmydA-5	HGNC:15513	OMIM:608783	SMYD3	5		
FBgn0033061	SmydA-5	HGNC:20982	OMIM:610663	SMYD2	5		
FBgn0033061	SmydA-5	HGNC:20986	OMIM:606846	SMYD1	5		
FBgn0033054	CG14591	HGNC:26217		TMEM164	14		
FBgn0033052	SCAP	HGNC:30634	OMIM:601510	SCAP	13		
FBgn0033051	Strica	HGNC:1507	OMIM:601532	CASP6	3		
FBgn0000043	Act42A	HGNC:17780	OMIM:614835	ACTBL2	4		
FBgn0000043	Act42A	HGNC:168	OMIM:605144	ACTR1B	3		
FBgn0000043	Act42A	HGNC:129	OMIM:102610	ACTA1	3	161800,255310,616852	161800[NEMALINE MYOPATHY 3; NEM3],255310[MYOPATHY, CONGENITAL, WITH FIBER-TYPE DISPROPORTION; CFTD],616852[MYOPATHY, SCAPULOHUMEROPERONEAL; SHPM]
FBgn0000043	Act42A	HGNC:132	OMIM:102630	ACTB	11	243310,607371	243310[BARAITSER-WINTER SYNDROME 1; BRWS1],607371[DYSTONIA, JUVENILE-ONSET; DJO]
FBgn0000043	Act42A	HGNC:130	OMIM:102620	ACTA2	4	611788,613834,614042	611788[AORTIC ANEURYSM, FAMILIAL THORACIC 6; AAT6],613834[MULTISYSTEMIC SMOOTH MUSCLE DYSFUNCTION SYNDROME; MSMDS],614042[MOYAMOYA DISEASE 5; MYMY5]
FBgn0000043	Act42A	HGNC:143	OMIM:102540	ACTC1	4	612098,612794,613424	612098[CARDIOMYOPATHY, FAMILIAL HYPERTROPHIC, 11; CMH11],612794[ATRIAL SEPTAL DEFECT 5; ASD5],613424[CARDIOMYOPATHY, DILATED, 1R; CMD1R]
FBgn0000043	Act42A	HGNC:167	OMIM:605143	ACTR1A	3		
FBgn0000043	Act42A	HGNC:144	OMIM:102560	ACTG1	10	604717,614583	604717[DEAFNESS, AUTOSOMAL DOMINANT 20; DFNA20],614583[BARAITSER-WINTER SYNDROME 2; BRWS2]
FBgn0000043	Act42A	HGNC:145	OMIM:102545	ACTG2	3	155310,619431	155310[VISCERAL MYOPATHY 1; VSCM1],619431[MEGACYSTIS-MICROCOLON-INTESTINAL HYPOPERISTALSIS SYNDROME 5; MMIHS5]
FBgn0000043	Act42A	HGNC:37093		POTEI	6		
FBgn0000043	Act42A	HGNC:37094		POTEJ	5		
FBgn0000043	Act42A	HGNC:33905		POTEF	5		
FBgn0000043	Act42A	HGNC:33895	OMIM:608914	POTEE	4		
FBgn0000043	Act42A	HGNC:24022	OMIM:608534	ACTRT3	4		
FBgn0000043	Act42A	HGNC:24027	OMIM:300487	ACTRT1	3		
FBgn0000043	Act42A	HGNC:24026	OMIM:608535	ACTRT2	3		
FBgn0000043	Act42A	HGNC:24018		ACTL8	3		
FBgn0000043	Act42A	HGNC:28494	OMIM:619251	ACTL9	3	619258	619258[SPERMATOGENIC FAILURE 53; SPGF53]
FBgn0033048	CG7881	HGNC:20151	OMIM:607557	SLC17A8	3	605583	605583[DEAFNESS, AUTOSOMAL DOMINANT 25; DFNA25]
FBgn0033048	CG7881	HGNC:10933	OMIM:604322	SLC17A5	5	269920,604369	269920[INFANTILE SIALIC ACID STORAGE DISEASE; ISSD],604369[SALLA DISEASE; SD]
FBgn0033048	CG7881	HGNC:16704	OMIM:605208	SLC17A7	3		
FBgn0033048	CG7881	HGNC:10929	OMIM:182308	SLC17A1	5		
FBgn0033048	CG7881	HGNC:10932	OMIM:604216	SLC17A4	5		
FBgn0033048	CG7881	HGNC:10930	OMIM:611049	SLC17A2	4		
FBgn0033048	CG7881	HGNC:10931	OMIM:611034	SLC17A3	5	612671	612671[URIC ACID CONCENTRATION, SERUM, QUANTITATIVE TRAIT LOCUS 4; UAQTL4]
FBgn0027507	CG1344	HGNC:19285	OMIM:608192	SCYL3	13		
FBgn0033031	CG8245	HGNC:26186	OMIM:619722	TMEM53	14	619727	619727[CRANIOTUBULAR DYSPLASIA, IKEGAWA TYPE; CTDI]
FBgn0022288	l(2)09851	HGNC:21270	OMIM:610597	GRWD1	14		
FBgn0025693	ZnT41F	HGNC:20303	OMIM:611145	SLC30A8	4	125853	125853[TYPE 2 DIABETES MELLITUS; T2D]
FBgn0025693	ZnT41F	HGNC:11015	OMIM:602095	SLC30A4	6		
FBgn0025693	ZnT41F	HGNC:11013	OMIM:609617	SLC30A2	5	608118	608118[ZINC DEFICIENCY, TRANSIENT NEONATAL; TNZD]
FBgn0025693	ZnT41F	HGNC:11014	OMIM:602878	SLC30A3	4		
FBgn0033038	CG7791	HGNC:7104	OMIM:602241	MIPEP	13	617228	617228[COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 31; COXPD31]
FBgn0033038	CG7791	HGNC:11793	OMIM:601117	THOP1	3		
FBgn0033029	Not3	HGNC:7879	OMIM:604910	CNOT3	10	618672	618672[INTELLECTUAL DEVELOPMENTAL DISORDER WITH SPEECH DELAY, AUTISM, AND DYSMORPHIC FACIES; IDDSADF]
FBgn0050438	Ugt50B3	HGNC:12531	OMIM:606435	UGT1A10	4		
FBgn0050438	Ugt50B3	HGNC:12545	OMIM:603064	UGT2B11	7		
FBgn0050438	Ugt50B3	HGNC:12530	OMIM:191740	UGT1A1	5	143500,218800,237900,601816,606785	143500[GILBERT SYNDROME],218800[CRIGLER-NAJJAR SYNDROME, TYPE I],237900[HYPERBILIRUBINEMIA, TRANSIENT FAMILIAL NEONATAL; HBLRTFN],601816[BILIRUBIN, SERUM LEVEL OF, QUANTITATIVE TRAIT LOCUS 1; BILIQTL1],606785[CRIGLER-NAJJAR SYNDROME, TYPE II]
FBgn0050438	Ugt50B3	HGNC:12555	OMIM:601291	UGT8	10		
FBgn0050438	Ugt50B3	HGNC:12539	OMIM:606432	UGT1A7	4		
FBgn0050438	Ugt50B3	HGNC:13479	OMIM:606497	UGT2B28	5		
FBgn0050438	Ugt50B3	HGNC:27266	OMIM:616384	UGT3A2	3		
FBgn0050438	Ugt50B3	HGNC:12544	OMIM:600070	UGT2B10	6		
FBgn0050438	Ugt50B3	HGNC:12537	OMIM:606430	UGT1A5	4		
FBgn0050438	Ugt50B3	HGNC:12546	OMIM:600069	UGT2B15	6		
FBgn0050438	Ugt50B3	HGNC:12541	OMIM:606434	UGT1A9	4		
FBgn0050438	Ugt50B3	HGNC:28528	OMIM:616382	UGT2A3	6		
FBgn0050438	Ugt50B3	HGNC:12535	OMIM:606428	UGT1A3	5		
FBgn0050438	Ugt50B3	HGNC:12536	OMIM:606429	UGT1A4	4		
FBgn0050438	Ugt50B3	HGNC:12540	OMIM:606433	UGT1A8	4		
FBgn0050438	Ugt50B3	HGNC:26625	OMIM:616383	UGT3A1	3		
FBgn0050438	Ugt50B3	HGNC:12547	OMIM:601903	UGT2B17	6	612560	612560[BONE MINERAL DENSITY QUANTITATIVE TRAIT LOCUS 12; BMND12]
FBgn0050438	Ugt50B3	HGNC:12553	OMIM:600067	UGT2B4	6		
FBgn0050438	Ugt50B3	HGNC:12538	OMIM:606431	UGT1A6	4		
FBgn0050438	Ugt50B3	HGNC:12554	OMIM:600068	UGT2B7	6		
FBgn0050438	Ugt50B3	HGNC:28183	OMIM:619809	UGT2A2	5		
FBgn0039970	CG17508	HGNC:16102	OMIM:618722	FAM210B	8		
FBgn0033028	hrm	HGNC:10924	OMIM:603877	SLC16A3	5		
FBgn0033028	hrm	HGNC:16270	OMIM:610409	SLC16A8	5		
FBgn0033028	hrm	HGNC:26417		SLC16A14	5		
FBgn0033028	hrm	HGNC:23093	OMIM:615765	SLC16A11	4		
FBgn0033028	hrm	HGNC:23520	OMIM:614242	SLC16A9	5		
FBgn0033028	hrm	HGNC:10922	OMIM:600682	SLC16A1	5	245340,610021,616095	245340[ERYTHROCYTE LACTATE TRANSPORTER DEFECT],610021[HYPERINSULINEMIC HYPOGLYCEMIA, FAMILIAL, 7; HHF7],616095[MONOCARBOXYLATE TRANSPORTER 1 DEFICIENCY; MCT1D]
FBgn0033028	hrm	HGNC:10927	OMIM:603880	SLC16A6	4		
FBgn0033028	hrm	HGNC:10925	OMIM:603878	SLC16A4	4		
FBgn0033028	hrm	HGNC:31037		SLC16A13	5		
FBgn0033028	hrm	HGNC:10926	OMIM:603879	SLC16A5	5		
FBgn0033028	hrm	HGNC:10928	OMIM:603654	SLC16A7	5		
FBgn0033028	hrm	HGNC:23094	OMIM:611910	SLC16A12	6	612018	612018[CATARACT 47; CTRCT47]
FBgn0039969	Fis1	HGNC:21689	OMIM:609003	FIS1	12		
FBgn0033027	TpnC4	HGNC:18180	OMIM:605183	CALML5	3		
FBgn0033027	TpnC4	HGNC:24193	OMIM:610171	CALML6	4		
FBgn0050440	CG30440	HGNC:30319	OMIM:619946	MCF2L2	5		
FBgn0050440	CG30440	HGNC:6940	OMIM:311030	MCF2	6		
FBgn0050440	CG30440	HGNC:14576	OMIM:609499	MCF2L	6		
FBgn0042085	Bap170	HGNC:18037	OMIM:609539	ARID2	13	617808	617808[COFFIN-SIRIS SYNDROME 6; CSS6]
FBgn0029131	Debcl	HGNC:1087	OMIM:605404	BOK	10		
FBgn0033085	CG15908	HGNC:27012		C22orf39	11		
FBgn0033086	CG9410	HGNC:26515		COQ10A	13		
FBgn0033086	CG9410	HGNC:25819		COQ10B	12		
FBgn0033088	PGAP3	HGNC:23719	OMIM:611801	PGAP3	13	615716	615716[HYPERPHOSPHATASIA WITH MENTAL RETARDATION SYNDROME 4; HPMRS4]
FBgn0033092	Rpp25	HGNC:19909		RPP25L	13		
FBgn0033092	Rpp25	HGNC:30361	OMIM:619235	RPP25	9		
FBgn0033093	CG3270	HGNC:26927	OMIM:613622	FOXRED1	13	618241	618241[MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 19; MC1DN19]
FBgn0014009	Rab2	HGNC:20246	OMIM:607466	RAB2B	9		
FBgn0014009	Rab2	HGNC:9763	OMIM:179509	RAB2A	13		
FBgn0028579	phtf	HGNC:8939	OMIM:604950	PHTF1	12		
FBgn0028579	phtf	HGNC:13411	OMIM:616785	PHTF2	14		
FBgn0042083	Mccc2	HGNC:6937	OMIM:609014	MCCC2	14	210210	210210[3-METHYLCROTONYL-CoA CARBOXYLASE 2 DEFICIENCY; MCC2D]
FBgn0027066	Eb1	HGNC:6892	OMIM:605788	MAPRE3	12		
FBgn0027066	Eb1	HGNC:6891	OMIM:605789	MAPRE2	10	616734	616734[SKIN CREASES, CONGENITAL SYMMETRIC CIRCUMFERENTIAL, 2; CSCSC2]
FBgn0027066	Eb1	HGNC:6890	OMIM:603108	MAPRE1	14		
FBgn0000473	Cyp6a2	HGNC:2638	OMIM:605325	CYP3A5	6	145500	145500[HYPERTENSION, ESSENTIAL]
FBgn0000473	Cyp6a2	HGNC:17450	OMIM:606534	CYP3A43	6		
FBgn0000473	Cyp6a2	HGNC:11609	OMIM:274180	TBXAS1	6	231095	231095[GHOSAL HEMATODIAPHYSEAL DYSPLASIA; GHDD]
FBgn0000473	Cyp6a2	HGNC:2637	OMIM:124010	CYP3A4	6	619073	619073[VITAMIN D-DEPENDENT RICKETS, TYPE 3; VDDR3]
FBgn0000473	Cyp6a2	HGNC:51504		CYP3A7-CYP3A51P	5		
FBgn0033101	CG9436	HGNC:386	OMIM:603966	AKR1C3	4		
FBgn0033101	CG9436	HGNC:384	OMIM:600449	AKR1C1	5		
FBgn0033101	CG9436	HGNC:387	OMIM:600451	AKR1C4	5	614279	614279[46,XY SEX REVERSAL 8; SRXY8]
FBgn0033101	CG9436	HGNC:380	OMIM:103830	AKR1A1	6		
FBgn0033101	CG9436	HGNC:381	OMIM:103880	AKR1B1	7		
FBgn0033101	CG9436	HGNC:382	OMIM:604707	AKR1B10	6		
FBgn0033101	CG9436	HGNC:388	OMIM:604741	AKR1D1	6	235555	235555[BILE ACID SYNTHESIS DEFECT, CONGENITAL, 2; CBAS2]
FBgn0033101	CG9436	HGNC:385	OMIM:600450	AKR1C2	4	614279	614279[46,XY SEX REVERSAL 8; SRXY8]
FBgn0033101	CG9436	HGNC:23437	OMIM:617451	AKR1E2	5		
FBgn0033101	CG9436	HGNC:37281	OMIM:616336	AKR1B15	5		
FBgn0033100	CG3420	HGNC:27578	OMIM:611933	CISD3	12		
FBgn0033097	Zip42C.2	HGNC:12876	OMIM:604740	SLC39A1	9		
FBgn0033097	Zip42C.2	HGNC:17128	OMIM:612168	SLC39A3	9		
FBgn0033097	Zip42C.2	HGNC:17127	OMIM:612166	SLC39A2	6		
FBgn0033096	Zip42C.1	HGNC:12876	OMIM:604740	SLC39A1	9		
FBgn0033096	Zip42C.1	HGNC:17128	OMIM:612168	SLC39A3	10		
FBgn0033096	Zip42C.1	HGNC:17127	OMIM:612166	SLC39A2	8		
FBgn0033095	chk	HGNC:10924	OMIM:603877	SLC16A3	5		
FBgn0033095	chk	HGNC:16270	OMIM:610409	SLC16A8	5		
FBgn0033095	chk	HGNC:26417		SLC16A14	5		
FBgn0033095	chk	HGNC:10922	OMIM:600682	SLC16A1	5	245340,610021,616095	245340[ERYTHROCYTE LACTATE TRANSPORTER DEFECT],610021[HYPERINSULINEMIC HYPOGLYCEMIA, FAMILIAL, 7; HHF7],616095[MONOCARBOXYLATE TRANSPORTER 1 DEFICIENCY; MCT1D]
FBgn0033095	chk	HGNC:10927	OMIM:603880	SLC16A6	5		
FBgn0033095	chk	HGNC:10925	OMIM:603878	SLC16A4	3		
FBgn0033095	chk	HGNC:31037		SLC16A13	4		
FBgn0033095	chk	HGNC:10926	OMIM:603879	SLC16A5	5		
FBgn0033095	chk	HGNC:10928	OMIM:603654	SLC16A7	5		
FBgn0033095	chk	HGNC:23094	OMIM:611910	SLC16A12	5	612018	612018[CATARACT 47; CTRCT47]
FBgn0050446	Tdc2	HGNC:4855	OMIM:142704	HDC	3	137580	137580[GILLES DE LA TOURETTE SYNDROME; GTS]
FBgn0050446	Tdc2	HGNC:2719	OMIM:107930	DDC	6	608643	608643[AROMATIC L-AMINO ACID DECARBOXYLASE DEFICIENCY; AADCD]
FBgn0033089	CG17266	HGNC:14650	OMIM:606093	PPIG	3		
FBgn0033089	CG17266	HGNC:9256	OMIM:123842	PPIC	3		
FBgn0033089	CG17266	HGNC:33996		PPIAL4G	3		
FBgn0033089	CG17266	HGNC:7833	OMIM:161565	NKTR	3		
FBgn0033089	CG17266	HGNC:14651	OMIM:606095	PPIH	14		
FBgn0033089	CG17266	HGNC:9257	OMIM:601753	PPID	3		
FBgn0033089	CG17266	HGNC:9255	OMIM:123841	PPIB	3	259440	259440[OSTEOGENESIS IMPERFECTA, TYPE IX; OI9]
FBgn0033089	CG17266	HGNC:9259	OMIM:604486	PPIF	3		
FBgn0033089	CG17266	HGNC:33995		PPIAL4C	3		
FBgn0033089	CG17266	HGNC:9253	OMIM:123840	PPIA	3		
FBgn0033089	CG17266	HGNC:33999		PPIAL4F	3		
FBgn0033089	CG17266	HGNC:53889		PPIAL4H	3		
FBgn0033087	Hsepi	HGNC:17855	OMIM:612134	GLCE	15		
FBgn0033081	geminin	HGNC:17493	OMIM:602842	GMNN	13	616835	616835[MEIER-GORLIN SYNDROME 6; MGORS6]
FBgn0033081	geminin	HGNC:40050	OMIM:614086	MCIDAS	4	618695	618695[CILIARY DYSKINESIA, PRIMARY, 42; CILD42]
FBgn0033079	Fmo-2	HGNC:3772	OMIM:136131	FMO4	6		
FBgn0033079	Fmo-2	HGNC:3769	OMIM:136130	FMO1	7		
FBgn0033079	Fmo-2	HGNC:3773	OMIM:603957	FMO5	8		
FBgn0033079	Fmo-2	HGNC:3771	OMIM:136132	FMO3	7	602079	602079[TRIMETHYLAMINURIA; TMAU]
FBgn0033079	Fmo-2	HGNC:3770	OMIM:603955	FMO2	8		
FBgn0026761	Trap1	HGNC:16264	OMIM:606219	TRAP1	14		
FBgn0014028	SdhB	HGNC:10681	OMIM:185470	SDHB	15	115310,171300,606764,606864,619224	115310[PARAGANGLIOMAS 4; PGL4],171300[PHEOCHROMOCYTOMA],606764[GASTROINTESTINAL STROMAL TUMOR; GIST],606864[PARAGANGLIOMA AND GASTRIC STROMAL SARCOMA],619224[MITOCHONDRIAL COMPLEX II DEFICIENCY, NUCLEAR TYPE 4; MC2DN4]
FBgn0033113	Spn42Dc	HGNC:8955	OMIM:601799	SERPINB9	7		
FBgn0033113	Spn42Dc	HGNC:8945	OMIM:605587	SERPINI2	4		
FBgn0033113	Spn42Dc	HGNC:8943	OMIM:602445	SERPINI1	5	604218	604218[ENCEPHALOPATHY, FAMILIAL, WITH NEUROSERPIN INCLUSION BODIES; FENIB]
FBgn0033113	Spn42Dc	HGNC:10569	OMIM:600517	SERPINB3	5		
FBgn0033113	Spn42Dc	HGNC:3311	OMIM:130135	SERPINB1	7		
FBgn0033113	Spn42Dc	HGNC:8584	OMIM:173390	SERPINB2	3		
FBgn0033113	Spn42Dc	HGNC:8583	OMIM:173360	SERPINE1	3	613329	613329[PLASMINOGEN ACTIVATOR INHIBITOR-1 DEFICIENCY]
FBgn0033113	Spn42Dc	HGNC:10570	OMIM:600518	SERPINB4	4		
FBgn0033113	Spn42Dc	HGNC:8952	OMIM:601697	SERPINB8	5	617115	617115[PEELING SKIN SYNDROME 5; PSS5]
FBgn0033113	Spn42Dc	HGNC:8951	OMIM:177010	SERPINE2	3		
FBgn0033113	Spn42Dc	HGNC:14220	OMIM:615662	SERPINB12	4		
FBgn0033113	Spn42Dc	HGNC:15995	OMIM:615677	SERPINA9	3		
FBgn0033113	Spn42Dc	HGNC:8942	OMIM:602058	SERPINB10	5		
FBgn0033113	Spn42Dc	HGNC:24774		SERPINE3	3		
FBgn0033113	Spn42Dc	HGNC:8950	OMIM:173321	SERPINB6	6	613453	613453[DEAFNESS, AUTOSOMAL RECESSIVE 91; DFNB91]
FBgn0033113	Spn42Dc	HGNC:8944	OMIM:604445	SERPINB13	5		
FBgn0033113	Spn42Dc	HGNC:14221	OMIM:615682	SERPINB11	4		
FBgn0033113	Spn42Dc	HGNC:23037	OMIM:612086	HMSD	3		
FBgn0028988	Spn42Dd	HGNC:8955	OMIM:601799	SERPINB9	5		
FBgn0028988	Spn42Dd	HGNC:8945	OMIM:605587	SERPINI2	5		
FBgn0028988	Spn42Dd	HGNC:8943	OMIM:602445	SERPINI1	7	604218	604218[ENCEPHALOPATHY, FAMILIAL, WITH NEUROSERPIN INCLUSION BODIES; FENIB]
FBgn0028988	Spn42Dd	HGNC:10569	OMIM:600517	SERPINB3	7		
FBgn0028988	Spn42Dd	HGNC:3311	OMIM:130135	SERPINB1	8		
FBgn0028988	Spn42Dd	HGNC:775	OMIM:107300	SERPINC1	4	613118	613118[ANTITHROMBIN III DEFICIENCY; AT3D]
FBgn0028988	Spn42Dd	HGNC:8584	OMIM:173390	SERPINB2	3		
FBgn0028988	Spn42Dd	HGNC:8583	OMIM:173360	SERPINE1	3	613329	613329[PLASMINOGEN ACTIVATOR INHIBITOR-1 DEFICIENCY]
FBgn0028988	Spn42Dd	HGNC:10570	OMIM:600518	SERPINB4	7		
FBgn0028988	Spn42Dd	HGNC:8952	OMIM:601697	SERPINB8	5	617115	617115[PEELING SKIN SYNDROME 5; PSS5]
FBgn0028988	Spn42Dd	HGNC:8951	OMIM:177010	SERPINE2	4		
FBgn0028988	Spn42Dd	HGNC:14220	OMIM:615662	SERPINB12	5		
FBgn0028988	Spn42Dd	HGNC:8942	OMIM:602058	SERPINB10	5		
FBgn0028988	Spn42Dd	HGNC:24774		SERPINE3	3		
FBgn0028988	Spn42Dd	HGNC:8950	OMIM:173321	SERPINB6	8	613453	613453[DEAFNESS, AUTOSOMAL RECESSIVE 91; DFNB91]
FBgn0028988	Spn42Dd	HGNC:8944	OMIM:604445	SERPINB13	6		
FBgn0028988	Spn42Dd	HGNC:13902	OMIM:603357	SERPINB7	3	615598	615598[PALMOPLANTAR KERATODERMA, NAGASHIMA TYPE; PPKN]
FBgn0028988	Spn42Dd	HGNC:14221	OMIM:615682	SERPINB11	4		
FBgn0033115	Spn42De	HGNC:8955	OMIM:601799	SERPINB9	5		
FBgn0033115	Spn42De	HGNC:8945	OMIM:605587	SERPINI2	7		
FBgn0033115	Spn42De	HGNC:8943	OMIM:602445	SERPINI1	9	604218	604218[ENCEPHALOPATHY, FAMILIAL, WITH NEUROSERPIN INCLUSION BODIES; FENIB]
FBgn0033115	Spn42De	HGNC:10569	OMIM:600517	SERPINB3	6		
FBgn0033115	Spn42De	HGNC:3311	OMIM:130135	SERPINB1	7		
FBgn0033115	Spn42De	HGNC:775	OMIM:107300	SERPINC1	3	613118	613118[ANTITHROMBIN III DEFICIENCY; AT3D]
FBgn0033115	Spn42De	HGNC:8584	OMIM:173390	SERPINB2	3		
FBgn0033115	Spn42De	HGNC:8583	OMIM:173360	SERPINE1	3	613329	613329[PLASMINOGEN ACTIVATOR INHIBITOR-1 DEFICIENCY]
FBgn0033115	Spn42De	HGNC:8948	OMIM:147935	SERPINA4	3		
FBgn0033115	Spn42De	HGNC:10570	OMIM:600518	SERPINB4	6		
FBgn0033115	Spn42De	HGNC:8952	OMIM:601697	SERPINB8	4	617115	617115[PEELING SKIN SYNDROME 5; PSS5]
FBgn0033115	Spn42De	HGNC:8951	OMIM:177010	SERPINE2	4		
FBgn0033115	Spn42De	HGNC:14220	OMIM:615662	SERPINB12	4		
FBgn0033115	Spn42De	HGNC:15995	OMIM:615677	SERPINA9	4		
FBgn0033115	Spn42De	HGNC:8942	OMIM:602058	SERPINB10	5		
FBgn0033115	Spn42De	HGNC:4838	OMIM:142360	SERPIND1	3	612356	612356[HEPARIN COFACTOR II DEFICIENCY]
FBgn0033115	Spn42De	HGNC:24774		SERPINE3	3		
FBgn0033115	Spn42De	HGNC:8950	OMIM:173321	SERPINB6	6	613453	613453[DEAFNESS, AUTOSOMAL RECESSIVE 91; DFNB91]
FBgn0033115	Spn42De	HGNC:1540	OMIM:122500	SERPINA6	3	611489	611489[CORTICOSTEROID-BINDING GLOBULIN DEFICIENCY]
FBgn0033115	Spn42De	HGNC:8944	OMIM:604445	SERPINB13	5		
FBgn0033115	Spn42De	HGNC:14221	OMIM:615682	SERPINB11	3		
FBgn0033117	CG3358	HGNC:24220	OMIM:619364	TATDN1	13		
FBgn0033117	CG3358	HGNC:28988	OMIM:619330	TATDN2	3		
FBgn0053349	ppk25	HGNC:101	OMIM:611741	ASIC3	3		
FBgn0053349	ppk25	HGNC:100	OMIM:602866	ASIC1	3		
FBgn0053349	ppk25	HGNC:21263	OMIM:606715	ASIC4	4		
FBgn0053349	ppk25	HGNC:99	OMIM:601784	ASIC2	3		
FBgn0053349	ppk25	HGNC:17537	OMIM:616693	ASIC5	4		
FBgn0033122	CG17002	HGNC:4550	OMIM:601935	GPS2	11		
FBgn0029508	Tsp42Ea	HGNC:1692	OMIM:155740	CD63	3		
FBgn0029506	Tsp42Ee	HGNC:1692	OMIM:155740	CD63	3		
FBgn0029507	Tsp42Ed	HGNC:1692	OMIM:155740	CD63	4		
FBgn0022960	vimar	HGNC:9859	OMIM:179502	RAP1GDS1	15		
FBgn0050156	CG30156	HGNC:25881	OMIM:617487	DNAJB14	7		
FBgn0050156	CG30156	HGNC:28429		DNAJC18	6		
FBgn0050156	CG30156	HGNC:14891	OMIM:608376	DNAJB12	7		
FBgn0033121	Cyp6u1	HGNC:2638	OMIM:605325	CYP3A5	4	145500	145500[HYPERTENSION, ESSENTIAL]
FBgn0033121	Cyp6u1	HGNC:17450	OMIM:606534	CYP3A43	4		
FBgn0033121	Cyp6u1	HGNC:11609	OMIM:274180	TBXAS1	3	231095	231095[GHOSAL HEMATODIAPHYSEAL DYSPLASIA; GHDD]
FBgn0033121	Cyp6u1	HGNC:2637	OMIM:124010	CYP3A4	4	619073	619073[VITAMIN D-DEPENDENT RICKETS, TYPE 3; VDDR3]
FBgn0033121	Cyp6u1	HGNC:51504		CYP3A7-CYP3A51P	4		
FBgn0050157	Ufsp1	HGNC:25640	OMIM:611482	UFSP2	3	142669,617974,620028	142669[BEUKES HIP DYSPLASIA; BHD],617974[SPONDYLOEPIMETAPHYSEAL DYSPLASIA, DI ROCCO TYPE; SEMDDR],620028[DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 106; DEE106]
FBgn0050157	Ufsp1	HGNC:33821	OMIM:611481	UFSP1	10		
FBgn0033112	Spn42Db	HGNC:8955	OMIM:601799	SERPINB9	3		
FBgn0033112	Spn42Db	HGNC:8945	OMIM:605587	SERPINI2	5		
FBgn0033112	Spn42Db	HGNC:8943	OMIM:602445	SERPINI1	6	604218	604218[ENCEPHALOPATHY, FAMILIAL, WITH NEUROSERPIN INCLUSION BODIES; FENIB]
FBgn0033112	Spn42Db	HGNC:10569	OMIM:600517	SERPINB3	4		
FBgn0033112	Spn42Db	HGNC:3311	OMIM:130135	SERPINB1	4		
FBgn0033112	Spn42Db	HGNC:775	OMIM:107300	SERPINC1	3	613118	613118[ANTITHROMBIN III DEFICIENCY; AT3D]
FBgn0033112	Spn42Db	HGNC:8583	OMIM:173360	SERPINE1	3	613329	613329[PLASMINOGEN ACTIVATOR INHIBITOR-1 DEFICIENCY]
FBgn0033112	Spn42Db	HGNC:10570	OMIM:600518	SERPINB4	3		
FBgn0033112	Spn42Db	HGNC:8951	OMIM:177010	SERPINE2	3		
FBgn0033112	Spn42Db	HGNC:15995	OMIM:615677	SERPINA9	3		
FBgn0033112	Spn42Db	HGNC:24774		SERPINE3	3		
FBgn0033112	Spn42Db	HGNC:8950	OMIM:173321	SERPINB6	3	613453	613453[DEAFNESS, AUTOSOMAL RECESSIVE 91; DFNB91]
FBgn0033112	Spn42Db	HGNC:8944	OMIM:604445	SERPINB13	3		
FBgn0022224	ubl	HGNC:13736	OMIM:606849	UBL5	14		
FBgn0034513	CG13423	HGNC:1059	OMIM:602403	BLMH	5		
FBgn0034520	lms	HGNC:12660	OMIM:604294	VAX1	3	614402	614402[MICROPHTHALMIA, SYNDROMIC 11; MCOPS11]
FBgn0034527	CG9945	HGNC:20258	OMIM:613317	DCAF11	14		
FBgn0034529	FAM21	HGNC:23414	OMIM:613631	WASHC2C	11		
FBgn0034529	FAM21	HGNC:23416		WASHC2A	10		
FBgn0034532	CG13436	HGNC:21405		CFAP206	13		
FBgn0034534	maf-S	HGNC:6776	OMIM:177075	MAF	5	601088,610202	601088[AYME-GRIPP SYNDROME; AYGRP],610202[CATARACT 21, MULTIPLE TYPES; CTRCT21]
FBgn0034534	maf-S	HGNC:23145	OMIM:610303	MAFA	4	147630	147630[INSULINOMATOSIS AND DIABETES MELLITUS; INSDM]
FBgn0034534	maf-S	HGNC:6780	OMIM:604877	MAFF	11		
FBgn0034534	maf-S	HGNC:6408	OMIM:608968	MAFB	5	166300,617041	166300[MULTICENTRIC CARPOTARSAL OSTEOLYSIS SYNDROME; MCTO],617041[DUANE RETRACTION SYNDROME 3 WITH OR WITHOUT DEAFNESS; DURS3]
FBgn0034534	maf-S	HGNC:6782	OMIM:600197	MAFK	14		
FBgn0034534	maf-S	HGNC:6781	OMIM:602020	MAFG	10		
FBgn0034534	maf-S	HGNC:8002	OMIM:162080	NRL	4	613750	613750[RETINITIS PIGMENTOSA 27; RP27]
FBgn0034535	CG11110	HGNC:14598	OMIM:605977	IMMP2L	15		
FBgn0034535	CG11110	HGNC:26317	OMIM:612323	IMMP1L	3		
FBgn0034537	DMAP1	HGNC:18291	OMIM:605077	DMAP1	14		
FBgn0034543	galla-1	HGNC:26235	OMIM:618382	CIAO2A	13		
FBgn0034543	galla-1	HGNC:24261	OMIM:614778	CIAO2B	4		
FBgn0034546	CG13442	HGNC:28038	OMIM:613332	MARCHF2	6		
FBgn0034546	CG13442	HGNC:28728	OMIM:613333	MARCHF3	7		
FBgn0034542	Fem-1	HGNC:16933	OMIM:608767	FEM1C	3		
FBgn0034542	Fem-1	HGNC:16934	OMIM:613538	FEM1A	3		
FBgn0034542	Fem-1	HGNC:3649	OMIM:613539	FEM1B	14		
FBgn0034539	CG11159	HGNC:28387	OMIM:612750	LYZL4	7		
FBgn0034539	CG11159	HGNC:31353	OMIM:300593	SPACA5	5		
FBgn0034539	CG11159	HGNC:19142		SPACA5B	8		
FBgn0034539	CG11159	HGNC:29613	OMIM:612748	LYZL2	9		
FBgn0034539	CG11159	HGNC:16260	OMIM:612749	SPACA3	9		
FBgn0034539	CG11159	HGNC:6480	OMIM:149750	LALBA	6		
FBgn0034539	CG11159	HGNC:6740	OMIM:153450	LYZ	8	105200	105200[AMYLOIDOSIS, FAMILIAL VISCERAL]
FBgn0034539	CG11159	HGNC:30502		LYZL1	9		
FBgn0034539	CG11159	HGNC:29614	OMIM:612751	LYZL6	7		
FBgn0034538	CG16799	HGNC:28387	OMIM:612750	LYZL4	7		
FBgn0034538	CG16799	HGNC:31353	OMIM:300593	SPACA5	4		
FBgn0034538	CG16799	HGNC:19142		SPACA5B	8		
FBgn0034538	CG16799	HGNC:29613	OMIM:612748	LYZL2	10		
FBgn0034538	CG16799	HGNC:16260	OMIM:612749	SPACA3	9		
FBgn0034538	CG16799	HGNC:6480	OMIM:149750	LALBA	6		
FBgn0034538	CG16799	HGNC:6740	OMIM:153450	LYZ	8	105200	105200[AMYLOIDOSIS, FAMILIAL VISCERAL]
FBgn0034538	CG16799	HGNC:30502		LYZL1	11		
FBgn0034538	CG16799	HGNC:29614	OMIM:612751	LYZL6	7		
FBgn0034528	CG11180	HGNC:30046	OMIM:606505	PINX1	7		
FBgn0050147	Hil	HGNC:26576	OMIM:605739	KY	10	617114	617114[MYOPATHY, MYOFIBRILLAR, 7; MFM7]
FBgn0034521	Mgat1	HGNC:7044	OMIM:160995	MGAT1	14		
FBgn0034491	Hsl	HGNC:6621	OMIM:151750	LIPE	14	615980	615980[LIPODYSTROPHY, FAMILIAL PARTIAL, TYPE 6; FPLD6]
FBgn0010411	RpS18	HGNC:10401	OMIM:180473	RPS18	14		
FBgn0034493	CG8908	HGNC:37	OMIM:605414	ABCA7	4	608907	608907[ALZHEIMER DISEASE 9, SUSCEPTIBILITY TO; AD9]
FBgn0034493	CG8908	HGNC:29	OMIM:600046	ABCA1	4	205400,604091	205400[TANGIER DISEASE; TGD],604091[HYPOALPHALIPOPROTEINEMIA, PRIMARY, 1]
FBgn0034493	CG8908	HGNC:32	OMIM:600047	ABCA2	4	618808	618808[INTELLECTUAL DEVELOPMENTAL DISORDER WITH POOR GROWTH AND WITH OR WITHOUT SEIZURES OR ATAXIA; IDPOGSA]
FBgn0034493	CG8908	HGNC:34	OMIM:601691	ABCA4	3	153800,248200,601718,604116	153800[MACULAR DEGENERATION, AGE-RELATED, 2; ARMD2],248200[STARGARDT DISEASE 1; STGD1],601718[RETINITIS PIGMENTOSA 19; RP19],604116[CONE-ROD DYSTROPHY 3; CORD3]
FBgn0034493	CG8908	HGNC:33	OMIM:601615	ABCA3	7	610921	610921[SURFACTANT METABOLISM DYSFUNCTION, PULMONARY, 3; SMDP3]
FBgn0034493	CG8908	HGNC:14637	OMIM:607800	ABCA12	5	242500,601277	242500[ICHTHYOSIS, CONGENITAL, AUTOSOMAL RECESSIVE 4B; ARCI4B],601277[ICHTHYOSIS, CONGENITAL, AUTOSOMAL RECESSIVE 4A; ARCI4A]
FBgn0034493	CG8908	HGNC:30	OMIM:612508	ABCA10	4		
FBgn0034493	CG8908	HGNC:39	OMIM:612507	ABCA9	4		
FBgn0034493	CG8908	HGNC:38	OMIM:612505	ABCA8	4		
FBgn0034493	CG8908	HGNC:36	OMIM:612504	ABCA6	4		
FBgn0034493	CG8908	HGNC:35	OMIM:612503	ABCA5	4	135400	135400[HYPERTRICHOSIS, CONGENITAL GENERALIZED, WITH OR WITHOUT GINGIVAL HYPERPLASIA; HTC3]
FBgn0034493	CG8908	HGNC:14638	OMIM:607807	ABCA13	4		
FBgn0026136	CkIIbeta2	HGNC:2460	OMIM:115441	CSNK2B	6	618732	618732[POIRIER-BIENVENU NEURODEVELOPMENTAL SYNDROME; POBINDS]
FBgn0034510	CG13426	HGNC:18277	OMIM:609215	SEC61G	8		
FBgn0034503	MED8	HGNC:19971	OMIM:607956	MED8	14		
FBgn0034500	CG11200	HGNC:12799	OMIM:605131	WWOX	3	133239,614322,616211	133239[ESOPHAGEAL CANCER],614322[SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 12; SCAR12],616211[DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 28; DEE28]
FBgn0034500	CG11200	HGNC:18399	OMIM:301034	DHRSX	8		
FBgn0034498	CG16868	HGNC:29314		CACHD1	14		
FBgn0034497	Mpcp1	HGNC:10989	OMIM:600370	SLC25A3	15	610773	610773[MITOCHONDRIAL PHOSPHATE CARRIER DEFICIENCY; MPCD]
FBgn0034494	CG10444	HGNC:11041	OMIM:604024	SLC5A6	12	618973,619903	618973[SODIUM-DEPENDENT MULTIVITAMIN TRANSPORTER DEFICIENCY; SMVTD],619903[PERIPHERAL MOTOR NEUROPATHY, CHILDHOOD-ONSET, BIOTIN-RESPONSIVE; COMNB]
FBgn0034494	CG10444	HGNC:11040	OMIM:601843	SLC5A5	8	274400	274400[THYROID DYSHORMONOGENESIS 1; TDH1]
FBgn0034494	CG10444	HGNC:28750	OMIM:612455	SLC5A12	12		
FBgn0034494	CG10444	HGNC:19119	OMIM:608044	SLC5A8	11		
FBgn0005655	PCNA	HGNC:8729	OMIM:176740	PCNA	14	615919	615919[ATAXIA-TELANGIECTASIA-LIKE DISORDER 2; ATLD2]
FBgn0034481	CG11041	HGNC:28166	OMIM:619617	EFCAB2	7		
FBgn0034487	Efhc1.2	HGNC:26233	OMIM:300817	EFHC2	15		
FBgn0034487	Efhc1.2	HGNC:16406	OMIM:608815	EFHC1	5	254770,607631	254770[EPILEPSY, MYOCLONIC JUVENILE; EJM],607631[EPILEPSY, JUVENILE ABSENCE, SUSCEPTIBILITY TO, 1; EJA1]
FBgn0025720	Ate1	HGNC:782	OMIM:607103	ATE1	14		
FBgn0034490	CG9864	HGNC:20151	OMIM:607557	SLC17A8	3	605583	605583[DEAFNESS, AUTOSOMAL DOMINANT 25; DFNA25]
FBgn0034490	CG9864	HGNC:10933	OMIM:604322	SLC17A5	3	269920,604369	269920[INFANTILE SIALIC ACID STORAGE DISEASE; ISSD],604369[SALLA DISEASE; SD]
FBgn0034490	CG9864	HGNC:16703	OMIM:607563	SLC17A6	3		
FBgn0034490	CG9864	HGNC:16704	OMIM:605208	SLC17A7	3		
FBgn0034490	CG9864	HGNC:10929	OMIM:182308	SLC17A1	3		
FBgn0034490	CG9864	HGNC:10932	OMIM:604216	SLC17A4	3		
FBgn0034490	CG9864	HGNC:10930	OMIM:611049	SLC17A2	4		
FBgn0034490	CG9864	HGNC:10931	OMIM:611034	SLC17A3	4	612671	612671[URIC ACID CONCENTRATION, SERUM, QUANTITATIVE TRAIT LOCUS 4; UAQTL4]
FBgn0034489	ppk6	HGNC:101	OMIM:611741	ASIC3	5		
FBgn0034489	ppk6	HGNC:100	OMIM:602866	ASIC1	5		
FBgn0034489	ppk6	HGNC:21263	OMIM:606715	ASIC4	5		
FBgn0034489	ppk6	HGNC:99	OMIM:601784	ASIC2	4		
FBgn0034489	ppk6	HGNC:17537	OMIM:616693	ASIC5	4		
FBgn0034489	ppk6	HGNC:10599	OMIM:600228	SCNN1A	3	264350,613021,618126	264350[PSEUDOHYPOALDOSTERONISM, TYPE I, AUTOSOMAL RECESSIVE; PHA1B],613021[BRONCHIECTASIS WITH OR WITHOUT ELEVATED SWEAT CHLORIDE 2; BESC2],618126[LIDDLE SYNDROME 3; LIDLS3]
FBgn0034489	ppk6	HGNC:10600	OMIM:600760	SCNN1B	4	177200,211400,264350	177200[LIDDLE SYNDROME 1; LIDLS1],211400[BRONCHIECTASIS WITH OR WITHOUT ELEVATED SWEAT CHLORIDE 1; BESC1],264350[PSEUDOHYPOALDOSTERONISM, TYPE I, AUTOSOMAL RECESSIVE; PHA1B]
FBgn0034489	ppk6	HGNC:10601	OMIM:601328	SCNN1D	3		
FBgn0034489	ppk6	HGNC:10602	OMIM:600761	SCNN1G	3	264350,613071,618114	264350[PSEUDOHYPOALDOSTERONISM, TYPE I, AUTOSOMAL RECESSIVE; PHA1B],613071[BRONCHIECTASIS WITH OR WITHOUT ELEVATED SWEAT CHLORIDE 3; BESC3],618114[LIDDLE SYNDROME 2; LIDLS2]
FBgn0034488	Hacl	HGNC:17856	OMIM:604300	HACL1	15		
FBgn0034483	CG16894	HGNC:16710	OMIM:608483	AKTIP	12		
FBgn0034472	CG8517	HGNC:12435	OMIM:187700	TXN	3		
FBgn0034472	CG8517	HGNC:17772	OMIM:609063	TXN2	14	616811	616811[COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 29; COXPD29]
FBgn0034476	Toll-7	HGNC:15631	OMIM:300365	TLR7	3	301051,301080	301051[IMMUNODEFICIENCY 74, COVID19-RELATED, X-LINKED; IMD74],301080[SYSTEMIC LUPUS ERYTHEMATOSUS 17; SLEB17]
FBgn0034476	Toll-7	HGNC:11849	OMIM:603029	TLR3	4	609423,613002	609423[HUMAN IMMUNODEFICIENCY VIRUS TYPE 1, SUSCEPTIBILITY TO],613002[IMMUNODEFICIENCY 83, SUSCEPTIBILITY TO VIRAL INFECTIONS; IMD83]
FBgn0034476	Toll-7	HGNC:15633	OMIM:605474	TLR9	3		
FBgn0002716	mei-W68	HGNC:11250	OMIM:605114	SPO11	14		
FBgn0026378	Rep	HGNC:1940	OMIM:300390	CHM	15	303100	303100[CHOROIDEREMIA; CHM]
FBgn0026378	Rep	HGNC:1941	OMIM:118825	CHML	13		
FBgn0034454	CG15120	HGNC:19152	OMIM:608427	PACRG	14		
FBgn0034455	CG11007	HGNC:30739	OMIM:616715	TMX2	14	618730	618730[NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, CORTICAL MALFORMATIONS, AND SPASTICITY; NEDMCMS]
FBgn0034459	TTLL6A	HGNC:26664	OMIM:610849	TTLL6	9		
FBgn0034459	TTLL6A	HGNC:32484		TTLL13P	7		
FBgn0028372	Kpc2	HGNC:30221	OMIM:608129	UBAC1	14		
FBgn0015949	hrg	HGNC:14981	OMIM:605553	PAPOLA	13		
FBgn0015949	hrg	HGNC:14982	OMIM:616865	PAPOLG	13		
FBgn0015949	hrg	HGNC:15970	OMIM:607436	PAPOLB	12		
FBgn0034452	Oseg6	HGNC:18340	OMIM:608151	WDR19	14	614376,614377,614378,616307,619867	614376[SHORT-RIB THORACIC DYSPLASIA 5 WITH OR WITHOUT POLYDACTYLY; SRTD5],614377[NEPHRONOPHTHISIS 13; NPHP13],614378[CRANIOECTODERMAL DYSPLASIA 4; CED4],616307[SENIOR-LOKEN SYNDROME 8; SLSN8],619867[SPERMATOGENIC FAILURE 72; SPGF72]
FBgn0034451	TBCB	HGNC:1989	OMIM:601303	TBCB	13		
FBgn0034422	CG7137	HGNC:29030	OMIM:615818	RRP8	11		
FBgn0010434	cora	HGNC:3379	OMIM:603237	EPB41L2	8		
FBgn0010434	cora	HGNC:3378	OMIM:602879	EPB41L1	9	614257	614257[CHROMOSOME 20q11-q12 DELETION SYNDROME]
FBgn0010434	cora	HGNC:3380	OMIM:605331	EPB41L3	8		
FBgn0010434	cora	HGNC:3377	OMIM:130500	EPB41	8	611804	611804[ELLIPTOCYTOSIS 1; EL1]
FBgn0004003	wbl	HGNC:13799	OMIM:602287	ERP29	15		
FBgn0034423	tbrd-2	HGNC:1104	OMIM:601541	BRD3	3		
FBgn0034423	tbrd-2	HGNC:1103	OMIM:601540	BRD2	4		
FBgn0034423	tbrd-2	HGNC:1105	OMIM:602144	BRDT	4	617644	617644[SPERMATOGENIC FAILURE 21; SPGF21]
FBgn0034423	tbrd-2	HGNC:13575	OMIM:608749	BRD4	4		
FBgn0013954	Fkbp12	HGNC:3711	OMIM:186945	FKBP1A	12		
FBgn0013954	Fkbp12	HGNC:3712	OMIM:600620	FKBP1B	12		
FBgn0013954	Fkbp12	HGNC:21376		FKBP1C	5		
FBgn0034432	Acadvl	HGNC:21497	OMIM:611103	ACAD9	5	611126	611126[MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 20; MC1DN20]
FBgn0034432	Acadvl	HGNC:92	OMIM:609575	ACADVL	15	201475	201475[ACYL-CoA DEHYDROGENASE, VERY LONG-CHAIN, DEFICIENCY OF; ACADVLD]
FBgn0034436	CG11961	HGNC:23703	OMIM:611156	ERMP1	13		
FBgn0034437	CG10051	HGNC:23703	OMIM:611156	ERMP1	13		
FBgn0034439	CG10062	HGNC:23703	OMIM:611156	ERMP1	13		
FBgn0034440	CG10073	HGNC:23703	OMIM:611156	ERMP1	13		
FBgn0034441	CG10081	HGNC:23703	OMIM:611156	ERMP1	13		
FBgn0034442	CG11257	HGNC:20147	OMIM:608343	CYB5R4	15		
FBgn0012051	CalpA	HGNC:1479	OMIM:114230	CAPN2	9		
FBgn0012051	CalpA	HGNC:1476	OMIM:114220	CAPN1	9	616907	616907[SPASTIC PARAPLEGIA 76, AUTOSOMAL RECESSIVE; SPG76]
FBgn0012051	CalpA	HGNC:1478	OMIM:604822	CAPN11	8		
FBgn0012051	CalpA	HGNC:1480	OMIM:114240	CAPN3	9	253600,618129	253600[MUSCULAR DYSTROPHY, LIMB-GIRDLE, AUTOSOMAL RECESSIVE 1; LGMDR1],618129[MUSCULAR DYSTROPHY, LIMB-GIRDLE, AUTOSOMAL DOMINANT 4; LGMDD4]
FBgn0012051	CalpA	HGNC:16664	OMIM:610229	CAPN14	4		
FBgn0012051	CalpA	HGNC:1485	OMIM:618777	CAPN8	9		
FBgn0012051	CalpA	HGNC:13249	OMIM:608839	CAPN12	4		
FBgn0012051	CalpA	HGNC:1486	OMIM:606401	CAPN9	13		
FBgn0012051	CalpA	HGNC:16663	OMIM:610228	CAPN13	4		
FBgn0012051	CalpA	HGNC:1477	OMIM:605286	CAPN10	3	601283	601283[TYPE 2 DIABETES MELLITUS 1; T2D1]
FBgn0012051	CalpA	HGNC:1482	OMIM:602537	CAPN5	3	193235	193235[VITREORETINOPATHY, NEOVASCULAR INFLAMMATORY; VRNI]
FBgn0040273	Spt5	HGNC:11469	OMIM:602102	SUPT5H	12		
FBgn0013325	RpL11	HGNC:10301	OMIM:604175	RPL11	14	612562	612562[DIAMOND-BLACKFAN ANEMIA 7; DBA7]
FBgn0034446	Arl6	HGNC:13210	OMIM:608845	ARL6	14	209900,600151,613575	209900[BARDET-BIEDL SYNDROME 1; BBS1],600151[BARDET-BIEDL SYNDROME 3; BBS3],613575[RETINITIS PIGMENTOSA 55; RP55]
FBgn0034447	CG7744	HGNC:33719		TMEM201	7		
FBgn0020440	Fak	HGNC:9612	OMIM:601212	PTK2B	8		
FBgn0020440	Fak	HGNC:9611	OMIM:600758	PTK2	12		
FBgn0034438	CG9416	HGNC:23703	OMIM:611156	ERMP1	14		
FBgn0034433	EndoB	HGNC:10833	OMIM:609287	SH3GLB1	13		
FBgn0034433	EndoB	HGNC:10834	OMIM:609288	SH3GLB2	12		
FBgn0034430	mip40	HGNC:33234		LIN37	12		
FBgn0034427	CG10474	HGNC:318	OMIM:613228	AGA	13	208400	208400[ASPARTYLGLUCOSAMINURIA; AGU]
FBgn0034411	CG18605	HGNC:21653	OMIM:609507	TOPORS	3	609923	609923[RETINITIS PIGMENTOSA 31; RP31]
FBgn0004168	5-HT1A	HGNC:5289	OMIM:182133	HTR1D	3		
FBgn0004168	5-HT1A	HGNC:5292	OMIM:182134	HTR1F	3		
FBgn0004168	5-HT1A	HGNC:5287	OMIM:182131	HTR1B	3		
FBgn0004168	5-HT1A	HGNC:5291	OMIM:182132	HTR1E	3		
FBgn0004168	5-HT1A	HGNC:5286	OMIM:109760	HTR1A	7	614674	614674[PERIODIC FEVER, MENSTRUAL CYCLE-DEPENDENT]
FBgn0027535	botv	HGNC:3518	OMIM:605744	EXTL3	14	617425	617425[IMMUNOSKELETAL DYSPLASIA WITH NEURODEVELOPMENTAL ABNORMALITIES; ISDNA]
FBgn0034419	CG15111	HGNC:19837		ABHD12B	9		
FBgn0034419	CG15111	HGNC:15868	OMIM:613599	ABHD12	12	612674	612674[POLYNEUROPATHY, HEARING LOSS, ATAXIA, RETINITIS PIGMENTOSA, AND CATARACT; PHARC]
FBgn0034418	CG15118	HGNC:27880	OMIM:615126	ANKRD13D	14		
FBgn0034418	CG15118	HGNC:26363	OMIM:615124	ANKRD13B	12		
FBgn0034418	CG15118	HGNC:21268	OMIM:615123	ANKRD13A	12		
FBgn0028669	Vha100-3	HGNC:865	OMIM:192130	ATP6V0A1	5	619970,619971	619970[DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 104; DEE104],619971[NEURODEVELOPMENTAL DISORDER WITH EPILEPSY AND BRAIN ATROPHY; NEDEBA]
FBgn0028669	Vha100-3	HGNC:18481	OMIM:611716	ATP6V0A2	5	219200,278250	219200[CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IIA; ARCL2A],278250[WRINKLY SKIN SYNDROME; WSS]
FBgn0028669	Vha100-3	HGNC:866	OMIM:605239	ATP6V0A4	5	602722	602722[RENAL TUBULAR ACIDOSIS, DISTAL, 3, WITH OR WITHOUT SENSORINEURAL HEARING LOSS; DRTA3]
FBgn0028669	Vha100-3	HGNC:11647	OMIM:604592	TCIRG1	5	259700	259700[OSTEOPETROSIS, AUTOSOMAL RECESSIVE 1; OPTB1]
FBgn0053147	Hs3st-A	HGNC:5194	OMIM:603244	HS3ST1	6		
FBgn0053147	Hs3st-A	HGNC:19419	OMIM:609407	HS3ST5	9		
FBgn0053147	Hs3st-A	HGNC:5200	OMIM:604059	HS3ST4	3		
FBgn0053147	Hs3st-A	HGNC:14178	OMIM:619210	HS3ST6	3	619367	619367[ANGIOEDEMA, HEREDITARY, 8; HAE8]
FBgn0034387	Cyp12b2	HGNC:2606	OMIM:609506	CYP27B1	6	264700	264700[VITAMIN D HYDROXYLATION-DEFICIENT RICKETS, TYPE 1A; VDDR1A]
FBgn0034387	Cyp12b2	HGNC:33480		CYP27C1	3		
FBgn0034387	Cyp12b2	HGNC:2605	OMIM:606530	CYP27A1	3	213700	213700[CEREBROTENDINOUS XANTHOMATOSIS; CTX]
FBgn0034387	Cyp12b2	HGNC:2602	OMIM:126065	CYP24A1	7	143880	143880[HYPERCALCEMIA, INFANTILE, 1; HCINF1]
FBgn0010551	Phb2	HGNC:8912	OMIM:176705	PHB1	3	114480	114480[BREAST CANCER]
FBgn0010551	Phb2	HGNC:30306	OMIM:610704	PHB2	14		
FBgn0034402	CG15084	HGNC:28118		YJU2B	13		
FBgn0034402	CG15084	HGNC:25518		YJU2	3		
FBgn0034406	Jheh3	HGNC:3401	OMIM:132810	EPHX1	14		
FBgn0010053	Jheh1	HGNC:3401	OMIM:132810	EPHX1	14		
FBgn0034403	CG18190	HGNC:6892	OMIM:605788	MAPRE3	7		
FBgn0034403	CG18190	HGNC:6891	OMIM:605789	MAPRE2	8	616734	616734[SKIN CREASES, CONGENITAL SYMMETRIC CIRCUMFERENTIAL, 2; CSCSC2]
FBgn0034403	CG18190	HGNC:6890	OMIM:603108	MAPRE1	7		
FBgn0034401	MetRS	HGNC:6898	OMIM:156560	MARS	13	615486,616280,619692	615486[INTERSTITIAL LUNG AND LIVER DISEASE; ILLD],616280[CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2U; CMT2U],619692[TRICHOTHIODYSTROPHY 9, NONPHOTOSENSITIVE; TTD9]
FBgn0034400	CG15099	HGNC:1291	OMIM:604803	DOP1B	13		
FBgn0034400	CG15099	HGNC:21194	OMIM:616823	DOP1A	14		
FBgn0034396	CG15097	HGNC:24023	OMIM:619262	KLHL17	11		
FBgn0034394	CG15096	HGNC:20151	OMIM:607557	SLC17A8	4	605583	605583[DEAFNESS, AUTOSOMAL DOMINANT 25; DFNA25]
FBgn0034394	CG15096	HGNC:10933	OMIM:604322	SLC17A5	4	269920,604369	269920[INFANTILE SIALIC ACID STORAGE DISEASE; ISSD],604369[SALLA DISEASE; SD]
FBgn0034394	CG15096	HGNC:16703	OMIM:607563	SLC17A6	3		
FBgn0034394	CG15096	HGNC:16192	OMIM:612107	SLC17A9	3	616063	616063[POROKERATOSIS 8, DISSEMINATED SUPERFICIAL ACTINIC TYPE; POROK8]
FBgn0034394	CG15096	HGNC:16704	OMIM:605208	SLC17A7	4		
FBgn0034394	CG15096	HGNC:10929	OMIM:182308	SLC17A1	4		
FBgn0034394	CG15096	HGNC:10932	OMIM:604216	SLC17A4	4		
FBgn0034394	CG15096	HGNC:10930	OMIM:611049	SLC17A2	5		
FBgn0034394	CG15096	HGNC:10931	OMIM:611034	SLC17A3	5	612671	612671[URIC ACID CONCENTRATION, SERUM, QUANTITATIVE TRAIT LOCUS 4; UAQTL4]
FBgn0010651	MFS14	HGNC:20151	OMIM:607557	SLC17A8	5	605583	605583[DEAFNESS, AUTOSOMAL DOMINANT 25; DFNA25]
FBgn0010651	MFS14	HGNC:10933	OMIM:604322	SLC17A5	5	269920,604369	269920[INFANTILE SIALIC ACID STORAGE DISEASE; ISSD],604369[SALLA DISEASE; SD]
FBgn0010651	MFS14	HGNC:16703	OMIM:607563	SLC17A6	4		
FBgn0010651	MFS14	HGNC:16704	OMIM:605208	SLC17A7	5		
FBgn0010651	MFS14	HGNC:10929	OMIM:182308	SLC17A1	4		
FBgn0010651	MFS14	HGNC:10932	OMIM:604216	SLC17A4	5		
FBgn0010651	MFS14	HGNC:10930	OMIM:611049	SLC17A2	5		
FBgn0010651	MFS14	HGNC:10931	OMIM:611034	SLC17A3	5	612671	612671[URIC ACID CONCENTRATION, SERUM, QUANTITATIVE TRAIT LOCUS 4; UAQTL4]
FBgn0034392	MFS15	HGNC:20151	OMIM:607557	SLC17A8	4	605583	605583[DEAFNESS, AUTOSOMAL DOMINANT 25; DFNA25]
FBgn0034392	MFS15	HGNC:10933	OMIM:604322	SLC17A5	5	269920,604369	269920[INFANTILE SIALIC ACID STORAGE DISEASE; ISSD],604369[SALLA DISEASE; SD]
FBgn0034392	MFS15	HGNC:16703	OMIM:607563	SLC17A6	3		
FBgn0034392	MFS15	HGNC:16704	OMIM:605208	SLC17A7	4		
FBgn0034392	MFS15	HGNC:10929	OMIM:182308	SLC17A1	4		
FBgn0034392	MFS15	HGNC:10932	OMIM:604216	SLC17A4	4		
FBgn0034392	MFS15	HGNC:10930	OMIM:611049	SLC17A2	5		
FBgn0034392	MFS15	HGNC:10931	OMIM:611034	SLC17A3	5	612671	612671[URIC ACID CONCENTRATION, SERUM, QUANTITATIVE TRAIT LOCUS 4; UAQTL4]
FBgn0034390	CG15093	HGNC:4907	OMIM:608475	HIBADH	14		
FBgn0034383	CG17821	HGNC:26292	OMIM:614451	ELOVL7	5		
FBgn0034383	CG17821	HGNC:14416	OMIM:611814	ELOVL2	3		
FBgn0034383	CG17821	HGNC:14415	OMIM:605512	ELOVL4	3	133190,600110,614457	133190[SPINOCEREBELLAR ATAXIA 34; SCA34],600110[STARGARDT DISEASE 3; STGD3],614457[ICHTHYOSIS, SPASTIC QUADRIPLEGIA, AND MENTAL RETARDATION; ISQMR]
FBgn0034383	CG17821	HGNC:18047	OMIM:611815	ELOVL3	3		
FBgn0034383	CG17821	HGNC:14418	OMIM:611813	ELOVL1	5	618527	618527[ICHTHYOTIC KERATODERMA, SPASTICITY, HYPOMYELINATION, AND DYSMORPHIC FACIAL FEATURES; IKSHD]
FBgn0034383	CG17821	HGNC:21308	OMIM:611805	ELOVL5	3	615957	615957[SPINOCEREBELLAR ATAXIA 38; SCA38]
FBgn0034382	CG18609	HGNC:26292	OMIM:614451	ELOVL7	6		
FBgn0034382	CG18609	HGNC:14416	OMIM:611814	ELOVL2	4		
FBgn0034382	CG18609	HGNC:15829	OMIM:611546	ELOVL6	3		
FBgn0034382	CG18609	HGNC:14415	OMIM:605512	ELOVL4	4	133190,600110,614457	133190[SPINOCEREBELLAR ATAXIA 34; SCA34],600110[STARGARDT DISEASE 3; STGD3],614457[ICHTHYOSIS, SPASTIC QUADRIPLEGIA, AND MENTAL RETARDATION; ISQMR]
FBgn0034382	CG18609	HGNC:14418	OMIM:611813	ELOVL1	6	618527	618527[ICHTHYOTIC KERATODERMA, SPASTICITY, HYPOMYELINATION, AND DYSMORPHIC FACIAL FEATURES; IKSHD]
FBgn0034382	CG18609	HGNC:21308	OMIM:611805	ELOVL5	4	615957	615957[SPINOCEREBELLAR ATAXIA 38; SCA38]
FBgn0034381	List	HGNC:11049	OMIM:126455	SLC6A3	3	188890,613135	188890[TOBACCO ADDICTION, SUSCEPTIBILITY TO],613135[PARKINSONISM-DYSTONIA 1, INFANTILE-ONSET; PKDYS1]
FBgn0034381	List	HGNC:11044	OMIM:607952	SLC6A11	3		
FBgn0034381	List	HGNC:31399	OMIM:610299	SLC6A17	4	616269	616269[INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 48; MRT48]
FBgn0034381	List	HGNC:11045	OMIM:603080	SLC6A12	3		
FBgn0034381	List	HGNC:11054	OMIM:606205	SLC6A7	5		
FBgn0034381	List	HGNC:11048	OMIM:163970	SLC6A2	3	604715	604715[ORTHOSTATIC INTOLERANCE]
FBgn0034381	List	HGNC:13621	OMIM:607971	SLC6A15	4		
FBgn0034381	List	HGNC:11050	OMIM:182138	SLC6A4	3	164230,607834	164230[OBSESSIVE-COMPULSIVE DISORDER; OCD],607834[ANXIETY]
FBgn0034381	List	HGNC:11055	OMIM:300036	SLC6A8	3	300352	300352[CEREBRAL CREATINE DEFICIENCY SYNDROME 1; CCDS1]
FBgn0034381	List	HGNC:11056	OMIM:601019	SLC6A9	4	617301	617301[GLYCINE ENCEPHALOPATHY WITH NORMAL SERUM GLYCINE]
FBgn0034381	List	HGNC:11051	OMIM:604159	SLC6A5	3	614618	614618[HYPEREKPLEXIA 3; HKPX3]
FBgn0034381	List	HGNC:11047	OMIM:300444	SLC6A14	3		
FBgn0034381	List	HGNC:11052	OMIM:186854	SLC6A6	3	145350	145350[HYPOTAURINEMIC RETINAL DEGENERATION AND CARDIOMYOPATHY; HTRDC]
FBgn0034381	List	HGNC:11046	OMIM:615097	SLC6A13	3		
FBgn0034381	List	HGNC:11042	OMIM:137165	SLC6A1	3	616421	616421[MYOCLONIC-ATONIC EPILEPSY; MAE]
FBgn0034381	List	HGNC:13622	OMIM:607972	SLC6A16	4		
FBgn0034380	Vps51	HGNC:1172	OMIM:615738	VPS51	13	618606	618606[PONTOCEREBELLAR HYPOPLASIA, TYPE 13; PCH13]
FBgn0034372	Gint3	HGNC:14928	OMIM:611946	UBXN6	13		
FBgn0034371	Ntan1	HGNC:29909	OMIM:615367	NTAN1	15		
FBgn0050122	CG30122	HGNC:25451		HNRNPUL2	8		
FBgn0050122	CG30122	HGNC:5048	OMIM:602869	HNRNPU	10	617391	617391[DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 54; DEE54]
FBgn0050122	CG30122	HGNC:17011	OMIM:605800	HNRNPUL1	11		
FBgn0034368	zda	HGNC:3724	OMIM:604840	FKBP8	13		
FBgn0064237	Idgf5	HGNC:8524	OMIM:603578	OVGP1	4		
FBgn0064237	Idgf5	HGNC:1932	OMIM:601525	CHI3L1	4	181500,611960	181500[SCHIZOPHRENIA; SCZD],611960[ASTHMA-RELATED TRAITS, SUSCEPTIBILITY TO, 7; ASRT7]
FBgn0064237	Idgf5	HGNC:1936	OMIM:600031	CHIT1	4	614122	614122[CHITOTRIOSIDASE DEFICIENCY; CHITD]
FBgn0064237	Idgf5	HGNC:17432	OMIM:606080	CHIA	3		
FBgn0064237	Idgf5	HGNC:1933	OMIM:601526	CHI3L2	3		
FBgn0034335	GstE1	HGNC:4641	OMIM:600436	GSTT1	3		
FBgn0034335	GstE1	HGNC:4642	OMIM:600437	GSTT2	4		
FBgn0034335	GstE1	HGNC:33437		GSTT2B	4		
FBgn0034335	GstE1	HGNC:26930		GSTT4	3		
FBgn0063498	GstE2	HGNC:4641	OMIM:600436	GSTT1	3		
FBgn0063498	GstE2	HGNC:4642	OMIM:600437	GSTT2	4		
FBgn0063498	GstE2	HGNC:33437		GSTT2B	4		
FBgn0063498	GstE2	HGNC:26930		GSTT4	3		
FBgn0063497	GstE3	HGNC:4641	OMIM:600436	GSTT1	3		
FBgn0063497	GstE3	HGNC:4642	OMIM:600437	GSTT2	4		
FBgn0063497	GstE3	HGNC:33437		GSTT2B	4		
FBgn0063497	GstE3	HGNC:26930		GSTT4	3		
FBgn0063496	GstE4	HGNC:4641	OMIM:600436	GSTT1	3		
FBgn0063496	GstE4	HGNC:4642	OMIM:600437	GSTT2	4		
FBgn0063496	GstE4	HGNC:33437		GSTT2B	4		
FBgn0063496	GstE4	HGNC:26930		GSTT4	3		
FBgn0063495	GstE5	HGNC:4641	OMIM:600436	GSTT1	3		
FBgn0063495	GstE5	HGNC:4642	OMIM:600437	GSTT2	4		
FBgn0063495	GstE5	HGNC:33437		GSTT2B	4		
FBgn0063495	GstE5	HGNC:26930		GSTT4	3		
FBgn0063494	GstE6	HGNC:4641	OMIM:600436	GSTT1	3		
FBgn0063494	GstE6	HGNC:4642	OMIM:600437	GSTT2	4		
FBgn0063494	GstE6	HGNC:33437		GSTT2B	4		
FBgn0063494	GstE6	HGNC:26930		GSTT4	3		
FBgn0063493	GstE7	HGNC:4641	OMIM:600436	GSTT1	3		
FBgn0063493	GstE7	HGNC:4642	OMIM:600437	GSTT2	4		
FBgn0063493	GstE7	HGNC:33437		GSTT2B	4		
FBgn0063493	GstE7	HGNC:26930		GSTT4	3		
FBgn0063492	GstE8	HGNC:4641	OMIM:600436	GSTT1	3		
FBgn0063492	GstE8	HGNC:4642	OMIM:600437	GSTT2	4		
FBgn0063492	GstE8	HGNC:33437		GSTT2B	4		
FBgn0063492	GstE8	HGNC:26930		GSTT4	3		
FBgn0063491	GstE9	HGNC:4641	OMIM:600436	GSTT1	3		
FBgn0063491	GstE9	HGNC:4642	OMIM:600437	GSTT2	4		
FBgn0063491	GstE9	HGNC:33437		GSTT2B	4		
FBgn0063491	GstE9	HGNC:26930		GSTT4	3		
FBgn0027835	Dp1	HGNC:4857	OMIM:142695	HDLBP	15		
FBgn0034345	CG5174	HGNC:12005	OMIM:604068	TPD52	11		
FBgn0034345	CG5174	HGNC:12006	OMIM:604069	TPD52L1	12		
FBgn0034345	CG5174	HGNC:12007	OMIM:603747	TPD52L2	13		
FBgn0034345	CG5174	HGNC:23382	OMIM:617567	TPD52L3	9		
FBgn0034346	PIG-O	HGNC:23215	OMIM:614730	PIGO	14	614749	614749[HYPERPHOSPHATASIA WITH MENTAL RETARDATION SYNDROME 2; HPMRS2]
FBgn0034350	Lamtor2	HGNC:29796	OMIM:610389	LAMTOR2	13	610798	610798[IMMUNODEFICIENCY DUE TO DEFECT IN MAPBP-INTERACTING PROTEIN]
FBgn0034351	rswl	HGNC:26022	OMIM:615423	TRMT10C	14	616974	616974[COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 30; COXPD30]
FBgn0034354	GstE11	HGNC:4642	OMIM:600437	GSTT2	3		
FBgn0034354	GstE11	HGNC:33437		GSTT2B	3		
FBgn0034354	GstE11	HGNC:26930		GSTT4	3		
FBgn0034356	Pepck2	HGNC:8725	OMIM:614095	PCK2	14	261650	261650[PHOSPHOENOLPYRUVATE CARBOXYKINASE DEFICIENCY, MITOCHONDRIAL; PCKDM]
FBgn0034356	Pepck2	HGNC:8724	OMIM:614168	PCK1	13	261680	261680[PHOSPHOENOLPYRUVATE CARBOXYKINASE DEFICIENCY, CYTOSOLIC; PCKDC]
FBgn0003067	Pepck1	HGNC:8725	OMIM:614095	PCK2	13	261650	261650[PHOSPHOENOLPYRUVATE CARBOXYKINASE DEFICIENCY, MITOCHONDRIAL; PCKDM]
FBgn0003067	Pepck1	HGNC:8724	OMIM:614168	PCK1	12	261680	261680[PHOSPHOENOLPYRUVATE CARBOXYKINASE DEFICIENCY, CYTOSOLIC; PCKDC]
FBgn0034360	CG10927	HGNC:25151	OMIM:615302	ADAT3	14	615286	615286[NEURODEVELOPMENTAL DISORDER WITH BRAIN ABNORMALITIES, POOR GROWTH, AND DYSMORPHIC FACIES; NEDBGF]
FBgn0034362	CG5323	HGNC:25911	OMIM:616275	FAM136A	12		
FBgn0034363	CG5327	HGNC:25911	OMIM:616275	FAM136A	12		
FBgn0034365	CG5335	HGNC:6565	OMIM:602518	LGALS4	3		
FBgn0034365	CG5335	HGNC:6569	OMIM:606099	LGALS8	5		
FBgn0034365	CG5335	HGNC:6570	OMIM:601879	LGALS9	5		
FBgn0034365	CG5335	HGNC:25012	OMIM:617902	LGALSL	3		
FBgn0034365	CG5335	HGNC:15788	OMIM:606096	LGALS12	3		
FBgn0034365	CG5335	HGNC:24842		LGALS9B	4		
FBgn0034365	CG5335	HGNC:33874		LGALS9C	5		
FBgn0034365	CG5335	HGNC:6563	OMIM:153619	LGALS3	3		
FBgn0000566	Cth	HGNC:2501	OMIM:607657	CTH	14	219500	219500[CYSTATHIONINURIA]
FBgn0034366	Atg7	HGNC:16935	OMIM:608760	ATG7	14	619422	619422[SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 31; SCAR31]
FBgn0034364	CG5493	HGNC:1795	OMIM:603943	CDO1	15		
FBgn0034361	mRpS28	HGNC:14513	OMIM:611990	MRPS28	12	618958	618958[COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 47; COXPD47]
FBgn0050115	GEFmeso	HGNC:20364	OMIM:617940	PLEKHG3	5		
FBgn0050115	GEFmeso	HGNC:20884		PLEKHG1	7		
FBgn0050115	GEFmeso	HGNC:29515	OMIM:611893	PLEKHG2	8	616763	616763[LEUKODYSTROPHY AND ACQUIRED MICROCEPHALY WITH OR WITHOUT DYSTONIA; LDAMD]
FBgn0034352	Dnaaf3	HGNC:30492	OMIM:614566	DNAAF3	14	606763	606763[CILIARY DYSKINESIA, PRIMARY, 2; CILD2]
FBgn0063499	GstE10	HGNC:4641	OMIM:600436	GSTT1	3		
FBgn0063499	GstE10	HGNC:4642	OMIM:600437	GSTT2	4		
FBgn0063499	GstE10	HGNC:33437		GSTT2B	4		
FBgn0063499	GstE10	HGNC:26930		GSTT4	3		
FBgn0034300	CG5098	HGNC:11631	OMIM:603107	TCF20	6	618430	618430[DEVELOPMENTAL DELAY WITH VARIABLE INTELLECTUAL IMPAIRMENT AND BEHAVIORAL ABNORMALITIES; DDVIBA]
FBgn0034300	CG5098	HGNC:9834	OMIM:607642	RAI1	4	182290	182290[SMITH-MAGENIS SYNDROME; SMS]
FBgn0028983	Spn55B	HGNC:8955	OMIM:601799	SERPINB9	7		
FBgn0028983	Spn55B	HGNC:8945	OMIM:605587	SERPINI2	5		
FBgn0028983	Spn55B	HGNC:8943	OMIM:602445	SERPINI1	8	604218	604218[ENCEPHALOPATHY, FAMILIAL, WITH NEUROSERPIN INCLUSION BODIES; FENIB]
FBgn0028983	Spn55B	HGNC:10569	OMIM:600517	SERPINB3	8		
FBgn0028983	Spn55B	HGNC:3311	OMIM:130135	SERPINB1	11		
FBgn0028983	Spn55B	HGNC:775	OMIM:107300	SERPINC1	3	613118	613118[ANTITHROMBIN III DEFICIENCY; AT3D]
FBgn0028983	Spn55B	HGNC:8584	OMIM:173390	SERPINB2	5		
FBgn0028983	Spn55B	HGNC:8949	OMIM:154790	SERPINB5	3		
FBgn0028983	Spn55B	HGNC:8583	OMIM:173360	SERPINE1	3	613329	613329[PLASMINOGEN ACTIVATOR INHIBITOR-1 DEFICIENCY]
FBgn0028983	Spn55B	HGNC:10570	OMIM:600518	SERPINB4	6		
FBgn0028983	Spn55B	HGNC:8952	OMIM:601697	SERPINB8	6	617115	617115[PEELING SKIN SYNDROME 5; PSS5]
FBgn0028983	Spn55B	HGNC:8951	OMIM:177010	SERPINE2	4		
FBgn0028983	Spn55B	HGNC:14220	OMIM:615662	SERPINB12	4		
FBgn0028983	Spn55B	HGNC:15995	OMIM:615677	SERPINA9	3		
FBgn0028983	Spn55B	HGNC:8942	OMIM:602058	SERPINB10	7		
FBgn0028983	Spn55B	HGNC:24774		SERPINE3	3		
FBgn0028983	Spn55B	HGNC:8950	OMIM:173321	SERPINB6	9	613453	613453[DEAFNESS, AUTOSOMAL RECESSIVE 91; DFNB91]
FBgn0028983	Spn55B	HGNC:1540	OMIM:122500	SERPINA6	3	611489	611489[CORTICOSTEROID-BINDING GLOBULIN DEFICIENCY]
FBgn0028983	Spn55B	HGNC:8944	OMIM:604445	SERPINB13	6		
FBgn0028983	Spn55B	HGNC:14221	OMIM:615682	SERPINB11	7		
FBgn0003044	Pcl	HGNC:24566	OMIM:609740	PHF19	11		
FBgn0003044	Pcl	HGNC:8919	OMIM:602881	PHF1	10		
FBgn0003044	Pcl	HGNC:29535	OMIM:609882	MTF2	11		
FBgn0000057	adp	HGNC:29175	OMIM:619763	WDTC1	14		
FBgn0000057	adp	HGNC:24891	OMIM:615820	DCAF8	3	610100	610100[GIANT AXONAL NEUROPATHY 2, AUTOSOMAL DOMINANT; GAN2]
FBgn0034307	CG10914	HGNC:28473	OMIM:614919	NOA1	15		
FBgn0034308	Naus	HGNC:25330	OMIM:615100	CTTNBP2NL	10		
FBgn0034308	Naus	HGNC:15679	OMIM:609772	CTTNBP2	3		
FBgn0000658	fj	HGNC:17166	OMIM:612206	FJX1	13		
FBgn0034327	CG14505	HGNC:20343	OMIM:616605	GSKIP	9		
FBgn0027836	Dgp-1	HGNC:4669	OMIM:602245	GTPBP1	15		
FBgn0027836	Dgp-1	HGNC:4670	OMIM:607434	GTPBP2	3	617988	617988[JABERI-ELAHI SYNDROME; JABELS]
FBgn0034310	Nup75	HGNC:8734	OMIM:170285	NUP85	14	618176	618176[NEPHROTIC SYNDROME, TYPE 17; NPHS17]
FBgn0034304	CG5742	HGNC:25374	OMIM:615125	ANKRD13C	14		
FBgn0062440	EMRE	HGNC:25055	OMIM:615588	SMDT1	12		
FBgn0001222	Hsf	HGNC:5225	OMIM:140581	HSF2	8		
FBgn0001222	Hsf	HGNC:5224	OMIM:140580	HSF1	11		
FBgn0001222	Hsf	HGNC:5227	OMIM:602438	HSF4	7	116800	116800[CATARACT 5, MULTIPLE TYPES; CTRCT5]
FBgn0001222	Hsf	HGNC:29603		HSFX1	3		
FBgn0003520	stau	HGNC:11370	OMIM:601716	STAU1	10		
FBgn0003520	stau	HGNC:11371	OMIM:605920	STAU2	11		
FBgn0034299	CG5757	HGNC:3061	OMIM:188345	DTYMK	14	619847	619847[NEURODEGENERATION, CHILDHOOD-ONSET, WITH PROGRESSIVE MICROCEPHALY; CONPM]
FBgn0041585	Orai	HGNC:28185	OMIM:610930	ORAI3	10		
FBgn0041585	Orai	HGNC:25896	OMIM:610277	ORAI1	9	612782,615883	612782[IMMUNODEFICIENCY 9; IMD9],615883[MYOPATHY, TUBULAR AGGREGATE, 2; TAM2]
FBgn0041585	Orai	HGNC:21667	OMIM:610929	ORAI2	10		
FBgn0015522	olf186-M	HGNC:11319	OMIM:118990	ITPRID2	3		
FBgn0034281	CG14490	HGNC:29807		MORN3	12		
FBgn0034281	CG14490	HGNC:25852		MORN1	3		
FBgn0011589	Elk	HGNC:18864	OMIM:608260	KCNH8	12		
FBgn0011589	Elk	HGNC:6253	OMIM:604528	KCNH4	10		
FBgn0011589	Elk	HGNC:18863	OMIM:608169	KCNH7	3		
FBgn0011589	Elk	HGNC:6251	OMIM:152427	KCNH2	3	609620,613688	609620[SHORT QT SYNDROME 1; SQT1],613688[LONG QT SYNDROME 2; LQT2]
FBgn0011589	Elk	HGNC:6252	OMIM:604527	KCNH3	11		
FBgn0003140	PpY-55A	HGNC:9281	OMIM:176875	PPP1CA	4		
FBgn0003140	PpY-55A	HGNC:9283	OMIM:176914	PPP1CC	5		
FBgn0003140	PpY-55A	HGNC:9282	OMIM:600590	PPP1CB	4	617506	617506[NOONAN SYNDROME-LIKE DISORDER WITH LOOSE ANAGEN HAIR 2; NSLH2]
FBgn0034282	Mapmodulin	HGNC:16673	OMIM:609611	ANP32E	13		
FBgn0034282	Mapmodulin	HGNC:13233	OMIM:600832	ANP32A	13		
FBgn0034282	Mapmodulin	HGNC:16677	OMIM:619823	ANP32B	14		
FBgn0034282	Mapmodulin	HGNC:16676	OMIM:606878	ANP32D	6		
FBgn0034282	Mapmodulin	HGNC:16675	OMIM:606877	ANP32C	7		
FBgn0034242	CG14480	HGNC:29856	OMIM:617766	FAM192A	13		
FBgn0040294	POSH	HGNC:26299	OMIM:613377	SH3RF2	6		
FBgn0040294	POSH	HGNC:17650	OMIM:618642	SH3RF1	13		
FBgn0040294	POSH	HGNC:24699	OMIM:618933	SH3RF3	12		
FBgn0016701	Rab4	HGNC:9781	OMIM:179511	RAB4A	13		
FBgn0016701	Rab4	HGNC:9782	OMIM:612945	RAB4B	13		
FBgn0029079	icln	HGNC:2080	OMIM:602158	CLNS1A	12		
FBgn0029006	Smurf	HGNC:7727	OMIM:602278	NEDD4	3		
FBgn0029006	Smurf	HGNC:16809	OMIM:605532	SMURF2	14		
FBgn0029006	Smurf	HGNC:7728	OMIM:606384	NEDD4L	3	617201	617201[PERIVENTRICULAR NODULAR HETEROTOPIA 7; PVNH7]
FBgn0029006	Smurf	HGNC:13890	OMIM:606409	ITCH	4	613385	613385[AUTOIMMUNE DISEASE, MULTISYSTEM, WITH FACIAL DYSMORPHISM; ADMFD]
FBgn0029006	Smurf	HGNC:16807	OMIM:605568	SMURF1	12		
FBgn0029006	Smurf	HGNC:17004	OMIM:602307	WWP1	3		
FBgn0029006	Smurf	HGNC:16804	OMIM:602308	WWP2	4		
FBgn0034251	ND-51L1	HGNC:7716	OMIM:161015	NDUFV1	10	618225	618225[MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 4; MC1DN4]
FBgn0034258	eIF3c	HGNC:26347		EIF3CL	13		
FBgn0034258	eIF3c	HGNC:3279	OMIM:603916	EIF3C	9		
FBgn0050108	CG30108	HGNC:26937	OMIM:614943	TRIAP1	13		
FBgn0050109	CG30109	HGNC:26937	OMIM:614943	TRIAP1	13		
FBgn0034261	HPS4	HGNC:15844	OMIM:606682	HPS4	9	614073	614073[HERMANSKY-PUDLAK SYNDROME 4; HPS4]
FBgn0034266	CG4975	HGNC:10549	OMIM:611150	ATXN10	9	603516	603516[SPINOCEREBELLAR ATAXIA 10; SCA10]
FBgn0034271	Vps50	HGNC:25956	OMIM:616465	VPS50	14	619685	619685[NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, SEIZURES, AND NEONATAL CHOLESTASIS; NEDMSC]
FBgn0003545	sub	HGNC:6392	OMIM:605064	KIF23	3	105600	105600[ANEMIA, CONGENITAL DYSERYTHROPOIETIC, TYPE IIIa; CDAN3A]
FBgn0003545	sub	HGNC:7212	OMIM:605498	KIF20B	4		
FBgn0003545	sub	HGNC:9787	OMIM:605664	KIF20A	8	619433	619433[CARDIOMYOPATHY, FAMILIAL RESTRICTIVE, 6; RCM6]
FBgn0034270	PIG-A	HGNC:8957	OMIM:311770	PIGA	15	300818,300868,301072	300818[PAROXYSMAL NOCTURNAL HEMOGLOBINURIA 1; PNH1],300868[MULTIPLE CONGENITAL ANOMALIES-HYPOTONIA-SEIZURES SYNDROME 2; MCAHS2],301072[NEURODEVELOPMENTAL DISORDER WITH EPILEPSY AND HEMOCHROMATOSIS; NEDEPH]
FBgn0034269	Hyccin	HGNC:24587	OMIM:610531	HYCC1	12	610532	610532[LEUKODYSTROPHY, HYPOMYELINATING, 5; HLD5]
FBgn0034269	Hyccin	HGNC:28593		HYCC2	10		
FBgn0034265	Snx16	HGNC:14980	OMIM:614903	SNX16	8		
FBgn0028494	CG6424	HGNC:1335	OMIM:609371	FAM13B	6		
FBgn0028494	CG6424	HGNC:19367	OMIM:613299	FAM13A	7		
FBgn0028494	CG6424	HGNC:19371		FAM13C	6		
FBgn0027872	rdgBbeta	HGNC:21045	OMIM:605134	PITPNC1	14		
FBgn0016059	Sema1b	HGNC:10728	OMIM:601124	SEMA3F	3		
FBgn0016059	Sema1b	HGNC:10727	OMIM:608166	SEMA3E	3	214800	214800[CHARGE SYNDROME]
FBgn0016059	Sema1b	HGNC:10723	OMIM:603961	SEMA3A	3	614897	614897[HYPOGONADOTROPIC HYPOGONADISM 16 WITH OR WITHOUT ANOSMIA; HH16]
FBgn0016059	Sema1b	HGNC:10732	OMIM:601866	SEMA4D	3		
FBgn0016059	Sema1b	HGNC:10725	OMIM:602645	SEMA3C	3		
FBgn0016059	Sema1b	HGNC:30400		SEMA3G	3		
FBgn0016059	Sema1b	HGNC:10726	OMIM:609907	SEMA3D	3		
FBgn0016059	Sema1b	HGNC:10740	OMIM:609294	SEMA6C	6		
FBgn0016059	Sema1b	HGNC:10739	OMIM:608873	SEMA6B	7	618876	618876[EPILEPSY, PROGRESSIVE MYOCLONIC, 11; EPM11]
FBgn0016059	Sema1b	HGNC:10738	OMIM:605885	SEMA6A	7		
FBgn0016059	Sema1b	HGNC:16770	OMIM:609295	SEMA6D	7		
FBgn0016059	Sema1b	HGNC:10724	OMIM:601281	SEMA3B	3		
FBgn0034259	P32	HGNC:1243	OMIM:601269	C1QBP	13	617713	617713[COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 33; COXPD33]
FBgn0050106	CCHa1-R	HGNC:1113	OMIM:300107	BRS3	7		
FBgn0050106	CCHa1-R	HGNC:4609	OMIM:305670	GRPR	9		
FBgn0050106	CCHa1-R	HGNC:7843	OMIM:162341	NMBR	9		
FBgn0034255	Oxp	HGNC:1555	OMIM:604478	CBX5	4		
FBgn0034255	Oxp	HGNC:1551	OMIM:604511	CBX1	4		
FBgn0034255	Oxp	HGNC:1553	OMIM:604477	CBX3	4		
FBgn0004400	rhi	HGNC:1555	OMIM:604478	CBX5	5		
FBgn0004400	rhi	HGNC:1551	OMIM:604511	CBX1	5		
FBgn0004400	rhi	HGNC:1553	OMIM:604477	CBX3	5		
FBgn0050105	CG30105	HGNC:24116	OMIM:610330	RNASEH2C	9	610329	610329[AICARDI-GOUTIERES SYNDROME 3; AGS3]
FBgn0034249	RhoGAP54D	HGNC:23724	OMIM:611587	ARHGAP19	12		
FBgn0034248	CG14483	HGNC:40038	OMIM:614770	PET100	13	619055	619055[MITOCHONDRIAL COMPLEX IV DEFICIENCY, NUCLEAR TYPE 12; MC4DN12]
FBgn0034247	CG6484	HGNC:11011	OMIM:606813	SLC2A6	6		
FBgn0034247	CG6484	HGNC:13812	OMIM:605245	SLC2A8	9		
FBgn0034247	CG6484	HGNC:11006	OMIM:138160	SLC2A2	3	125853,227810	125853[TYPE 2 DIABETES MELLITUS; T2D],227810[FANCONI-BICKEL SYNDROME; FBS]
FBgn0034247	CG6484	HGNC:18067	OMIM:610372	SLC2A12	3		
FBgn0034247	CG6484	HGNC:13444	OMIM:606145	SLC2A10	3	208050	208050[ARTERIAL TORTUOSITY SYNDROME; ATORS]
FBgn0034246	Dcr-2	HGNC:17098	OMIM:606241	DICER1	7	138800,180295,601200,618272	138800[GOITER, MULTINODULAR 1, WITH OR WITHOUT SERTOLI-LEYDIG CELL TUMORS; MNG1],180295[RHABDOMYOSARCOMA, EMBRYONAL, 2; RMSE2],601200[PLEUROPULMONARY BLASTOMA; PPB],618272[GLOBAL DEVELOPMENTAL DELAY, LUNG CYSTS, OVERGROWTH, AND WILMS TUMOR; GLOW]
FBgn0034245	UQCR-6.4	HGNC:30862	OMIM:609711	UQCR11	7		
FBgn0034243	Ns2	HGNC:29925	OMIM:609365	GNL2	14		
FBgn0010620	CG10939	HGNC:11076	OMIM:606553	SLC9A3R2	8		
FBgn0010620	CG10939	HGNC:8821	OMIM:603831	PDZK1	6		
FBgn0010620	CG10939	HGNC:19891	OMIM:607146	PDZD3	6		
FBgn0010620	CG10939	HGNC:11075	OMIM:604990	SLC9A3R1	9	612287	612287[NEPHROLITHIASIS/OSTEOPOROSIS, HYPOPHOSPHATEMIC, 2; NPHLOP2]
FBgn0016697	Prosalpha5	HGNC:9534	OMIM:176844	PSMA5	14		
FBgn0022029	l(2)k01209	HGNC:12562	OMIM:609329	UCK2	4		
FBgn0022029	l(2)k01209	HGNC:28334	OMIM:300656	UPRT	3		
FBgn0022029	l(2)k01209	HGNC:14859	OMIM:609328	UCK1	4		
FBgn0022029	l(2)k01209	HGNC:15938	OMIM:610866	UCKL1	13		
FBgn0034215	Mtap	HGNC:7413	OMIM:156540	MTAP	13	112250	112250[DIAPHYSEAL MEDULLARY STENOSIS WITH MALIGNANT FIBROUS HISTIOCYTOMA; DMSMFH]
FBgn0034218	CG18467	HGNC:15857	OMIM:611625	GID8	7		
FBgn0024196	robl	HGNC:15467	OMIM:607168	DYNLRB2	14		
FBgn0024196	robl	HGNC:15468	OMIM:607167	DYNLRB1	10		
FBgn0022987	qkr54B	HGNC:18117	OMIM:610421	KHDRBS3	12		
FBgn0022987	qkr54B	HGNC:18116	OMIM:602489	KHDRBS1	11		
FBgn0022987	qkr54B	HGNC:18114	OMIM:610487	KHDRBS2	11		
FBgn0034225	veil	HGNC:8021	OMIM:129190	NT5E	13	211800	211800[CALCIFICATION OF JOINTS AND ARTERIES; CALJA]
FBgn0050104	NT5E-2	HGNC:8021	OMIM:129190	NT5E	13	211800	211800[CALCIFICATION OF JOINTS AND ARTERIES; CALJA]
FBgn0050103	CG30103	HGNC:8021	OMIM:129190	NT5E	10	211800	211800[CALCIFICATION OF JOINTS AND ARTERIES; CALJA]
FBgn0034229	CG4847	HGNC:2538	OMIM:603308	CTSV	3		
FBgn0034229	CG4847	HGNC:2537	OMIM:116880	CTSL	3		
FBgn0034230	CG4853	HGNC:24246	OMIM:614531	RASGEF1A	7		
FBgn0034230	CG4853	HGNC:24881	OMIM:614532	RASGEF1B	10		
FBgn0034230	CG4853	HGNC:27400		RASGEF1C	8		
FBgn0034232	CG4866	HGNC:14497	OMIM:612980	IMP3	14		
FBgn0034237	eIF3b	HGNC:3280	OMIM:603917	EIF3B	14		
FBgn0028382	cyp33	HGNC:33996		PPIAL4G	3		
FBgn0028382	cyp33	HGNC:9259	OMIM:604486	PPIF	3		
FBgn0028382	cyp33	HGNC:33995		PPIAL4C	3		
FBgn0028382	cyp33	HGNC:9253	OMIM:123840	PPIA	3		
FBgn0028382	cyp33	HGNC:9258	OMIM:602435	PPIE	11		
FBgn0028382	cyp33	HGNC:33999		PPIAL4F	3		
FBgn0028382	cyp33	HGNC:53889		PPIAL4H	3		
FBgn0034240	MESR4	HGNC:19421	OMIM:608525	ING5	3		
FBgn0034240	MESR4	HGNC:19423	OMIM:608524	ING4	3		
FBgn0010409	RpL18A	HGNC:10311	OMIM:604178	RPL18A	14		
FBgn0034231	APC10	HGNC:24077	OMIM:613745	ANAPC10	15		
FBgn0034223	Tes	HGNC:17019	OMIM:608500	PRICKLE1	3	612437	612437[EPILEPSY, PROGRESSIVE MYOCLONIC, 1B; EPM1B]
FBgn0034223	Tes	HGNC:6633	OMIM:604859	LMCD1	8		
FBgn0034223	Tes	HGNC:14620	OMIM:606085	TES	9		
FBgn0027506	EDTP	HGNC:26190	OMIM:611089	MTMR14	12	160150	160150[MYOPATHY, CENTRONUCLEAR, 1; CNM1]
FBgn0025716	Bap55	HGNC:160	OMIM:612458	ACTL6B	13	618468,618470	618468[DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 76; DEE76],618470[INTELLECTUAL DEVELOPMENTAL DISORDER WITH SEVERE SPEECH AND AMBULATION DEFECTS; IDDSSAD]
FBgn0025716	Bap55	HGNC:24124	OMIM:604958	ACTL6A	13		
FBgn0034214	CG6550	HGNC:15880	OMIM:608200	CDK5RAP1	3		
FBgn0034214	CG6550	HGNC:21050	OMIM:611259	CDKAL1	14		
FBgn0034179	CG6805	HGNC:8956	OMIM:606481	INPP5J	11		
FBgn0034179	CG6805	HGNC:33882	OMIM:607875	INPP5K	12	617404	617404[MUSCULAR DYSTROPHY, CONGENITAL, WITH CATARACTS AND INTELLECTUAL DISABILITY; MDCCAID]
FBgn0023172	RhoGEF2	HGNC:681	OMIM:601855	ARHGEF1	10	618459	618459[IMMUNODEFICIENCY 62; IMD62]
FBgn0023172	RhoGEF2	HGNC:14580	OMIM:605708	ARHGEF11	10		
FBgn0023172	RhoGEF2	HGNC:14193	OMIM:604763	ARHGEF12	11		
FBgn0034182	SmydA-7	HGNC:15513	OMIM:608783	SMYD3	3		
FBgn0034182	SmydA-7	HGNC:20982	OMIM:610663	SMYD2	3		
FBgn0034182	SmydA-7	HGNC:20986	OMIM:606846	SMYD1	3		
FBgn0034183	SmydA-6	HGNC:15513	OMIM:608783	SMYD3	4		
FBgn0034183	SmydA-6	HGNC:20982	OMIM:610663	SMYD2	3		
FBgn0034183	SmydA-6	HGNC:20986	OMIM:606846	SMYD1	3		
FBgn0034184	CG9646	HGNC:1314	OMIM:619709	KIAA0930	9		
FBgn0026721	fat-spondin	HGNC:11252	OMIM:604989	SPON1	10		
FBgn0026721	fat-spondin	HGNC:11253	OMIM:605918	SPON2	3		
FBgn0034187	Mov10	HGNC:7200	OMIM:610742	MOV10	8		
FBgn0034187	Mov10	HGNC:7201	OMIM:605794	MOV10L1	5	619878	619878[SPERMATOGENIC FAILURE 73; SPGF73]
FBgn0034187	Mov10	HGNC:445	OMIM:608465	SETX	3	602433,606002	602433[AMYOTROPHIC LATERAL SCLEROSIS 4, JUVENILE; ALS4],606002[SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE, WITH AXONAL NEUROPATHY 2; SCAN2]
FBgn0034191	CG6984	HGNC:23489		ECHDC3	15		
FBgn0034194	CG15611	HGNC:12303	OMIM:601893	TRIO	3	617061,618825	617061[INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL DOMINANT 44, WITH MICROCEPHALY; MRD44],618825[INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL DOMINANT 63, WITH MACROCEPHALY; MRD63]
FBgn0034194	CG15611	HGNC:4814	OMIM:604605	KALRN	3		
FBgn0034194	CG15611	HGNC:30275	OMIM:610215	ARHGEF25	5		
FBgn0000078	Amy-d	HGNC:478	OMIM:104660	AMY2B	12		
FBgn0000078	Amy-d	HGNC:474	OMIM:104700	AMY1A	6		
FBgn0000078	Amy-d	HGNC:477	OMIM:104650	AMY2A	8		
FBgn0000078	Amy-d	HGNC:475	OMIM:104701	AMY1B	6		
FBgn0000078	Amy-d	HGNC:476	OMIM:104702	AMY1C	8		
FBgn0034200	Gbp2	HGNC:27992		SATL1	3		
FBgn0034202	CG17287	HGNC:20749	OMIM:617972	ZDHHC20	8		
FBgn0034202	CG17287	HGNC:18459	OMIM:614604	ZDHHC7	3		
FBgn0034202	CG17287	HGNC:20342	OMIM:300576	ZDHHC15	10		
FBgn0034202	CG17287	HGNC:18469	OMIM:618621	ZDHHC2	7		
FBgn0034202	CG17287	HGNC:20750	OMIM:614605	ZDHHC21	4		
FBgn0034196	CG15605	HGNC:20993		RWDD1	3		
FBgn0034195	Spn53F	HGNC:8945	OMIM:605587	SERPINI2	3		
FBgn0034195	Spn53F	HGNC:8943	OMIM:602445	SERPINI1	4	604218	604218[ENCEPHALOPATHY, FAMILIAL, WITH NEUROSERPIN INCLUSION BODIES; FENIB]
FBgn0034195	Spn53F	HGNC:3311	OMIM:130135	SERPINB1	3		
FBgn0034195	Spn53F	HGNC:8583	OMIM:173360	SERPINE1	3	613329	613329[PLASMINOGEN ACTIVATOR INHIBITOR-1 DEFICIENCY]
FBgn0034195	Spn53F	HGNC:8951	OMIM:177010	SERPINE2	3		
FBgn0000079	Amy-p	HGNC:478	OMIM:104660	AMY2B	13		
FBgn0000079	Amy-p	HGNC:474	OMIM:104700	AMY1A	6		
FBgn0000079	Amy-p	HGNC:477	OMIM:104650	AMY2A	9		
FBgn0000079	Amy-p	HGNC:475	OMIM:104701	AMY1B	5		
FBgn0000079	Amy-p	HGNC:476	OMIM:104702	AMY1C	9		
FBgn0010591	Sply	HGNC:10817	OMIM:603729	SGPL1	15	617575	617575[NEPHROTIC SYNDROME, TYPE 14; NPHS14]
FBgn0050460	CG30460	HGNC:24277		ZC2HC1A	4		
FBgn0034186	CG8950	HGNC:4666	OMIM:604888	GTF3C3	14		
FBgn0034181	CG8963	HGNC:16945	OMIM:605184	PAIP1	11		
FBgn0034180	Ehbp1	HGNC:30682	OMIM:619583	EHBP1L1	8		
FBgn0034180	Ehbp1	HGNC:29144	OMIM:609922	EHBP1	12	611868	611868[PROSTATE CANCER, HEREDITARY, 12; HPC12]
FBgn0034156	CG5348	HGNC:26175	OMIM:609841	SLC8B1	12		
FBgn0011743	Arp53D	HGNC:17780	OMIM:614835	ACTBL2	4		
FBgn0011743	Arp53D	HGNC:168	OMIM:605144	ACTR1B	3		
FBgn0011743	Arp53D	HGNC:132	OMIM:102630	ACTB	3	243310,607371	243310[BARAITSER-WINTER SYNDROME 1; BRWS1],607371[DYSTONIA, JUVENILE-ONSET; DJO]
FBgn0011743	Arp53D	HGNC:130	OMIM:102620	ACTA2	3	611788,613834,614042	611788[AORTIC ANEURYSM, FAMILIAL THORACIC 6; AAT6],613834[MULTISYSTEMIC SMOOTH MUSCLE DYSFUNCTION SYNDROME; MSMDS],614042[MOYAMOYA DISEASE 5; MYMY5]
FBgn0011743	Arp53D	HGNC:143	OMIM:102540	ACTC1	3	612098,612794,613424	612098[CARDIOMYOPATHY, FAMILIAL HYPERTROPHIC, 11; CMH11],612794[ATRIAL SEPTAL DEFECT 5; ASD5],613424[CARDIOMYOPATHY, DILATED, 1R; CMD1R]
FBgn0011743	Arp53D	HGNC:167	OMIM:605143	ACTR1A	3		
FBgn0011743	Arp53D	HGNC:37093		POTEI	3		
FBgn0011743	Arp53D	HGNC:37094		POTEJ	3		
FBgn0011743	Arp53D	HGNC:33905		POTEF	3		
FBgn0011743	Arp53D	HGNC:33895	OMIM:608914	POTEE	3		
FBgn0011743	Arp53D	HGNC:24022	OMIM:608534	ACTRT3	4		
FBgn0011743	Arp53D	HGNC:24027	OMIM:300487	ACTRT1	3		
FBgn0011743	Arp53D	HGNC:24026	OMIM:608535	ACTRT2	3		
FBgn0011743	Arp53D	HGNC:28494	OMIM:619251	ACTL9	3	619258	619258[SPERMATOGENIC FAILURE 53; SPGF53]
FBgn0011743	Arp53D	HGNC:16127		ACTL10	3		
FBgn0034158	RalGPS	HGNC:30279	OMIM:617819	RALGPS2	12		
FBgn0034158	RalGPS	HGNC:16851	OMIM:614444	RALGPS1	12		
FBgn0034160	CG5550	HGNC:3624	OMIM:601624	FCN2	5		
FBgn0034160	CG5550	HGNC:3623	OMIM:601252	FCN1	5		
FBgn0034160	CG5550	HGNC:25922	OMIM:613357	FIBCD1	5		
FBgn0034160	CG5550	HGNC:3695	OMIM:605776	FGL1	3		
FBgn0034160	CG5550	HGNC:3625	OMIM:604973	FCN3	4	613860	613860[FICOLIN 3 DEFICIENCY]
FBgn0034160	CG5550	HGNC:7035	OMIM:600596	MFAP4	5		
FBgn0025830	IntS8	HGNC:26048	OMIM:611351	INTS8	14	618572	618572[NEURODEVELOPMENTAL DISORDER WITH CEREBELLAR HYPOPLASIA AND SPASTICITY; NEDCHS]
FBgn0028737	eEF1beta	HGNC:3208	OMIM:600655	EEF1B2	15		
FBgn0028737	eEF1beta	HGNC:3211	OMIM:130592	EEF1D	4		
FBgn0034166	CG6472	HGNC:9155	OMIM:246600	PNLIP	5	614338	614338[PANCREATIC LIPASE DEFICIENCY; PNLIPD]
FBgn0034166	CG6472	HGNC:17661	OMIM:607460	PLA1A	3		
FBgn0034166	CG6472	HGNC:9156	OMIM:604422	PNLIPRP1	5		
FBgn0034166	CG6472	HGNC:23492		PNLIPRP3	4		
FBgn0034166	CG6472	HGNC:6619	OMIM:151670	LIPC	5	125853,612797,614025	125853[TYPE 2 DIABETES MELLITUS; T2D],612797[HIGH DENSITY LIPOPROTEIN CHOLESTEROL LEVEL QUANTITATIVE TRAIT LOCUS 12; HDLCQ12],614025[HEPATIC LIPASE DEFICIENCY]
FBgn0034166	CG6472	HGNC:18821	OMIM:609252	LIPI	3		
FBgn0034166	CG6472	HGNC:18483	OMIM:607365	LIPH	3	604379	604379[HYPOTRICHOSIS 7; HYPT7]
FBgn0034166	CG6472	HGNC:9157	OMIM:604423	PNLIPRP2	3		
FBgn0004784	inaC	HGNC:9412	OMIM:176982	PRKCZ	3		
FBgn0004784	inaC	HGNC:9404	OMIM:600539	PRKCI	3		
FBgn0004784	inaC	HGNC:9395	OMIM:176970	PRKCB	8		
FBgn0004784	inaC	HGNC:9402	OMIM:176980	PRKCG	8	605361	605361[SPINOCEREBELLAR ATAXIA 14; SCA14]
FBgn0004784	inaC	HGNC:9393	OMIM:176960	PRKCA	8		
FBgn0003091	Pkc53E	HGNC:9403	OMIM:605437	PRKCH	3	601367	601367[STROKE, ISCHEMIC]
FBgn0003091	Pkc53E	HGNC:9412	OMIM:176982	PRKCZ	3		
FBgn0003091	Pkc53E	HGNC:9404	OMIM:600539	PRKCI	3		
FBgn0003091	Pkc53E	HGNC:9401	OMIM:176975	PRKCE	3		
FBgn0003091	Pkc53E	HGNC:9395	OMIM:176970	PRKCB	13		
FBgn0003091	Pkc53E	HGNC:9402	OMIM:176980	PRKCG	10	605361	605361[SPINOCEREBELLAR ATAXIA 14; SCA14]
FBgn0003091	Pkc53E	HGNC:9393	OMIM:176960	PRKCA	15		
FBgn0034172	CG6665	HGNC:29876	OMIM:617428	C1orf43	12		
FBgn0004580	Cbp53E	HGNC:1435	OMIM:114051	CALB2	11		
FBgn0004580	Cbp53E	HGNC:16941	OMIM:609202	SCGN	9		
FBgn0004580	Cbp53E	HGNC:1434	OMIM:114050	CALB1	10		
FBgn0034177	AsnRS-m	HGNC:7643	OMIM:108410	NARS	3	619091,619092	619091[NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, IMPAIRED LANGUAGE, AND GAIT ABNORMALITIES; NEDMILG],619092[NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, IMPAIRED LANGUAGE, EPILEPSY, AND GAIT ABNORMALITIES; NEDMILEG]
FBgn0034177	AsnRS-m	HGNC:26274	OMIM:612803	NARS2	15	616239,618434	616239[COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 24; COXPD24],618434[DEAFNESS, AUTOSOMAL RECESSIVE 94; DFNB94]
FBgn0026402	NiPp1	HGNC:9296	OMIM:602636	PPP1R8	14		
FBgn0034176	ste24a	HGNC:12877	OMIM:606480	ZMPSTE24	15	275210,608612	275210[RESTRICTIVE DERMOPATHY 1; RSDM1],608612[MANDIBULOACRAL DYSPLASIA WITH TYPE B LIPODYSTROPHY; MADB]
FBgn0034175	ste24b	HGNC:12877	OMIM:606480	ZMPSTE24	7	275210,608612	275210[RESTRICTIVE DERMOPATHY 1; RSDM1],608612[MANDIBULOACRAL DYSPLASIA WITH TYPE B LIPODYSTROPHY; MADB]
FBgn0034173	CG9010	HGNC:24864	OMIM:609169	GAPDHS	5		
FBgn0034173	CG9010	HGNC:4141	OMIM:138400	GAPDH	6		
FBgn0014870	Psi	HGNC:4004	OMIM:603444	FUBP1	11		
FBgn0014870	Psi	HGNC:4005	OMIM:603536	FUBP3	10		
FBgn0014870	Psi	HGNC:6316	OMIM:603445	KHSRP	9		
FBgn0025832	Fen1	HGNC:3650	OMIM:600393	FEN1	12		
FBgn0026754	Ugt37C1	HGNC:12531	OMIM:606435	UGT1A10	4		
FBgn0026754	Ugt37C1	HGNC:12545	OMIM:603064	UGT2B11	5		
FBgn0026754	Ugt37C1	HGNC:12530	OMIM:191740	UGT1A1	6	143500,218800,237900,601816,606785	143500[GILBERT SYNDROME],218800[CRIGLER-NAJJAR SYNDROME, TYPE I],237900[HYPERBILIRUBINEMIA, TRANSIENT FAMILIAL NEONATAL; HBLRTFN],601816[BILIRUBIN, SERUM LEVEL OF, QUANTITATIVE TRAIT LOCUS 1; BILIQTL1],606785[CRIGLER-NAJJAR SYNDROME, TYPE II]
FBgn0026754	Ugt37C1	HGNC:12555	OMIM:601291	UGT8	6		
FBgn0026754	Ugt37C1	HGNC:12539	OMIM:606432	UGT1A7	4		
FBgn0026754	Ugt37C1	HGNC:13479	OMIM:606497	UGT2B28	6		
FBgn0026754	Ugt37C1	HGNC:27266	OMIM:616384	UGT3A2	7		
FBgn0026754	Ugt37C1	HGNC:12544	OMIM:600070	UGT2B10	6		
FBgn0026754	Ugt37C1	HGNC:12537	OMIM:606430	UGT1A5	4		
FBgn0026754	Ugt37C1	HGNC:12546	OMIM:600069	UGT2B15	6		
FBgn0026754	Ugt37C1	HGNC:12541	OMIM:606434	UGT1A9	4		
FBgn0026754	Ugt37C1	HGNC:28528	OMIM:616382	UGT2A3	5		
FBgn0026754	Ugt37C1	HGNC:12535	OMIM:606428	UGT1A3	7		
FBgn0026754	Ugt37C1	HGNC:12536	OMIM:606429	UGT1A4	4		
FBgn0026754	Ugt37C1	HGNC:12540	OMIM:606433	UGT1A8	4		
FBgn0026754	Ugt37C1	HGNC:26625	OMIM:616383	UGT3A1	6		
FBgn0026754	Ugt37C1	HGNC:12547	OMIM:601903	UGT2B17	6	612560	612560[BONE MINERAL DENSITY QUANTITATIVE TRAIT LOCUS 12; BMND12]
FBgn0026754	Ugt37C1	HGNC:12553	OMIM:600067	UGT2B4	5		
FBgn0026754	Ugt37C1	HGNC:12538	OMIM:606431	UGT1A6	4		
FBgn0026754	Ugt37C1	HGNC:12554	OMIM:600068	UGT2B7	6		
FBgn0026754	Ugt37C1	HGNC:28183	OMIM:619809	UGT2A2	4		
FBgn0010213	Sod2	HGNC:11180	OMIM:147460	SOD2	13	612634	612634[MICROVASCULAR COMPLICATIONS OF DIABETES, SUSCEPTIBILITY TO, 6; MVCD6]
FBgn0034132	S-Lap8	HGNC:18449	OMIM:170250	LAP3	9		
FBgn0034132	S-Lap8	HGNC:16244		NPEPL1	3		
FBgn0011260	Sema2a	HGNC:10736	OMIM:609297	SEMA5A	3		
FBgn0011260	Sema2a	HGNC:10737	OMIM:609298	SEMA5B	3		
FBgn0011260	Sema2a	HGNC:10728	OMIM:601124	SEMA3F	7		
FBgn0011260	Sema2a	HGNC:10741	OMIM:607961	SEMA7A	3	614745,619874	614745[BLOOD GROUP, JOHN MILTON HAGEN SYSTEM; JMH],619874[CHOLESTASIS, PROGRESSIVE FAMILIAL INTRAHEPATIC, 11; PFIC11]
FBgn0011260	Sema2a	HGNC:10727	OMIM:608166	SEMA3E	6	214800	214800[CHARGE SYNDROME]
FBgn0011260	Sema2a	HGNC:10723	OMIM:603961	SEMA3A	8	614897	614897[HYPOGONADOTROPIC HYPOGONADISM 16 WITH OR WITHOUT ANOSMIA; HH16]
FBgn0011260	Sema2a	HGNC:10734	OMIM:603706	SEMA4F	4		
FBgn0011260	Sema2a	HGNC:10732	OMIM:601866	SEMA4D	7		
FBgn0011260	Sema2a	HGNC:10730	OMIM:617029	SEMA4B	4		
FBgn0011260	Sema2a	HGNC:10725	OMIM:602645	SEMA3C	7		
FBgn0011260	Sema2a	HGNC:10731	OMIM:604462	SEMA4C	5		
FBgn0011260	Sema2a	HGNC:30400		SEMA3G	6		
FBgn0011260	Sema2a	HGNC:10735	OMIM:618991	SEMA4G	5		
FBgn0011260	Sema2a	HGNC:10729	OMIM:607292	SEMA4A	5	610282,610283	610282[RETINITIS PIGMENTOSA 35; RP35],610283[CONE-ROD DYSTROPHY 10; CORD10]
FBgn0011260	Sema2a	HGNC:10726	OMIM:609907	SEMA3D	7		
FBgn0011260	Sema2a	HGNC:10740	OMIM:609294	SEMA6C	3		
FBgn0011260	Sema2a	HGNC:10739	OMIM:608873	SEMA6B	3	618876	618876[EPILEPSY, PROGRESSIVE MYOCLONIC, 11; EPM11]
FBgn0011260	Sema2a	HGNC:10738	OMIM:605885	SEMA6A	3		
FBgn0011260	Sema2a	HGNC:16770	OMIM:609295	SEMA6D	3		
FBgn0011260	Sema2a	HGNC:10724	OMIM:601281	SEMA3B	6		
FBgn0034135	Syn2	HGNC:13740	OMIM:608714	SNTG1	14		
FBgn0034135	Syn2	HGNC:13741	OMIM:608715	SNTG2	13		
FBgn0034137	CG4945	HGNC:17699		SBK1	11		
FBgn0034137	CG4945	HGNC:34416		SBK2	9		
FBgn0034137	CG4945	HGNC:44121		SBK3	5		
FBgn0016131	Cdk4	HGNC:1773	OMIM:123829	CDK4	11	609048	609048[MELANOMA, CUTANEOUS MALIGNANT, SUSCEPTIBILITY TO, 3; CMM3]
FBgn0016131	Cdk4	HGNC:1777	OMIM:603368	CDK6	11	616080	616080[MICROCEPHALY 12, PRIMARY, AUTOSOMAL RECESSIVE; MCPH12]
FBgn0003274	RpLP2	HGNC:10377	OMIM:180530	RPLP2	12		
FBgn0034145	CG5065	HGNC:26222	OMIM:616107	FAR1	10	616154,619338	616154[PEROXISOMAL FATTY ACYL-CoA REDUCTASE 1 DISORDER; PFCRD],619338[CATARACTS, SPASTIC PARAPARESIS, AND SPEECH DELAY; CSPSD]
FBgn0034145	CG5065	HGNC:25531	OMIM:616156	FAR2	11		
FBgn0013763	Idgf6	HGNC:8524	OMIM:603578	OVGP1	4		
FBgn0013763	Idgf6	HGNC:1932	OMIM:601525	CHI3L1	4	181500,611960	181500[SCHIZOPHRENIA; SCZD],611960[ASTHMA-RELATED TRAITS, SUSCEPTIBILITY TO, 7; ASRT7]
FBgn0013763	Idgf6	HGNC:1936	OMIM:600031	CHIT1	4	614122	614122[CHITOTRIOSIDASE DEFICIENCY; CHITD]
FBgn0013763	Idgf6	HGNC:17432	OMIM:606080	CHIA	3		
FBgn0013763	Idgf6	HGNC:1933	OMIM:601526	CHI3L2	3		
FBgn0050463	Pgant9	HGNC:4123	OMIM:602273	GALNT1	3		
FBgn0050463	Pgant9	HGNC:19877	OMIM:610290	GALNT12	6	608812	608812[COLORECTAL CANCER, SUSCEPTIBILITY TO, 1; CRCS1]
FBgn0050463	Pgant9	HGNC:4125	OMIM:601756	GALNT3	4	211900	211900[TUMORAL CALCINOSIS, HYPERPHOSPHATEMIC, FAMILIAL, 1; HFTC1]
FBgn0050463	Pgant9	HGNC:4126	OMIM:603565	GALNT4	3		
FBgn0050463	Pgant9	HGNC:4127	OMIM:615129	GALNT5	5		
FBgn0050463	Pgant9	HGNC:23242	OMIM:608369	GALNT13	4		
FBgn0050463	Pgant9	HGNC:4128	OMIM:605148	GALNT6	4		
FBgn0050463	Pgant9	HGNC:42957		POC1B-GALNT4	5		
FBgn0050463	Pgant9	HGNC:30488	OMIM:615136	GALNT18	3		
FBgn0050463	Pgant9	HGNC:4130	OMIM:606250	GALNT8	3		
FBgn0050463	Pgant9	HGNC:4131	OMIM:606251	GALNT9	3		
FBgn0050463	Pgant9	HGNC:16347	OMIM:615137	GALNT17	3		
FBgn0050463	Pgant9	HGNC:21531	OMIM:615131	GALNT15	4		
FBgn0024315	Picot	HGNC:20151	OMIM:607557	SLC17A8	3	605583	605583[DEAFNESS, AUTOSOMAL DOMINANT 25; DFNA25]
FBgn0024315	Picot	HGNC:10933	OMIM:604322	SLC17A5	5	269920,604369	269920[INFANTILE SIALIC ACID STORAGE DISEASE; ISSD],604369[SALLA DISEASE; SD]
FBgn0024315	Picot	HGNC:16703	OMIM:607563	SLC17A6	3		
FBgn0024315	Picot	HGNC:16704	OMIM:605208	SLC17A7	3		
FBgn0024315	Picot	HGNC:10929	OMIM:182308	SLC17A1	4		
FBgn0024315	Picot	HGNC:10932	OMIM:604216	SLC17A4	5		
FBgn0024315	Picot	HGNC:10930	OMIM:611049	SLC17A2	4		
FBgn0024315	Picot	HGNC:10931	OMIM:611034	SLC17A3	4	612671	612671[URIC ACID CONCENTRATION, SERUM, QUANTITATIVE TRAIT LOCUS 4; UAQTL4]
FBgn0024319	Nach	HGNC:101	OMIM:611741	ASIC3	6		
FBgn0024319	Nach	HGNC:100	OMIM:602866	ASIC1	6		
FBgn0024319	Nach	HGNC:21263	OMIM:606715	ASIC4	5		
FBgn0024319	Nach	HGNC:99	OMIM:601784	ASIC2	5		
FBgn0024319	Nach	HGNC:17537	OMIM:616693	ASIC5	4		
FBgn0024319	Nach	HGNC:10600	OMIM:600760	SCNN1B	4	177200,211400,264350	177200[LIDDLE SYNDROME 1; LIDLS1],211400[BRONCHIECTASIS WITH OR WITHOUT ELEVATED SWEAT CHLORIDE 1; BESC1],264350[PSEUDOHYPOALDOSTERONISM, TYPE I, AUTOSOMAL RECESSIVE; PHA1B]
FBgn0024319	Nach	HGNC:10602	OMIM:600761	SCNN1G	5	264350,613071,618114	264350[PSEUDOHYPOALDOSTERONISM, TYPE I, AUTOSOMAL RECESSIVE; PHA1B],613071[BRONCHIECTASIS WITH OR WITHOUT ELEVATED SWEAT CHLORIDE 3; BESC3],618114[LIDDLE SYNDROME 2; LIDLS2]
FBgn0020506	Amyrel	HGNC:478	OMIM:104660	AMY2B	9		
FBgn0020506	Amyrel	HGNC:474	OMIM:104700	AMY1A	4		
FBgn0020506	Amyrel	HGNC:477	OMIM:104650	AMY2A	7		
FBgn0020506	Amyrel	HGNC:475	OMIM:104701	AMY1B	4		
FBgn0020506	Amyrel	HGNC:476	OMIM:104702	AMY1C	7		
FBgn0040505	Alk	HGNC:6721	OMIM:151520	LTK	11		
FBgn0040505	Alk	HGNC:427	OMIM:105590	ALK	12	613014	613014[NEUROBLASTOMA, SUSCEPTIBILITY TO, 3; NBLST3]
FBgn0034143	CG8303	HGNC:26222	OMIM:616107	FAR1	5	616154,619338	616154[PEROXISOMAL FATTY ACYL-CoA REDUCTASE 1 DISORDER; PFCRD],619338[CATARACTS, SPASTIC PARAPARESIS, AND SPEECH DELAY; CSPSD]
FBgn0034143	CG8303	HGNC:25531	OMIM:616156	FAR2	5		
FBgn0034142	CG8306	HGNC:26222	OMIM:616107	FAR1	6	616154,619338	616154[PEROXISOMAL FATTY ACYL-CoA REDUCTASE 1 DISORDER; PFCRD],619338[CATARACTS, SPASTIC PARAPARESIS, AND SPEECH DELAY; CSPSD]
FBgn0034142	CG8306	HGNC:25531	OMIM:616156	FAR2	6		
FBgn0034141	Dolk	HGNC:23406	OMIM:610746	DOLK	13	610768	610768[CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Im; CDG1M]
FBgn0034138	RpS15	HGNC:10388	OMIM:180535	RPS15	13		
FBgn0034136	DAT	HGNC:11049	OMIM:126455	SLC6A3	10	188890,613135	188890[TOBACCO ADDICTION, SUSCEPTIBILITY TO],613135[PARKINSONISM-DYSTONIA 1, INFANTILE-ONSET; PKDYS1]
FBgn0034136	DAT	HGNC:11044	OMIM:607952	SLC6A11	3		
FBgn0034136	DAT	HGNC:31399	OMIM:610299	SLC6A17	3	616269	616269[INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 48; MRT48]
FBgn0034136	DAT	HGNC:11045	OMIM:603080	SLC6A12	3		
FBgn0034136	DAT	HGNC:11054	OMIM:606205	SLC6A7	3		
FBgn0034136	DAT	HGNC:11048	OMIM:163970	SLC6A2	14	604715	604715[ORTHOSTATIC INTOLERANCE]
FBgn0034136	DAT	HGNC:13621	OMIM:607971	SLC6A15	3		
FBgn0034136	DAT	HGNC:11050	OMIM:182138	SLC6A4	5	164230,607834	164230[OBSESSIVE-COMPULSIVE DISORDER; OCD],607834[ANXIETY]
FBgn0034136	DAT	HGNC:11055	OMIM:300036	SLC6A8	3	300352	300352[CEREBRAL CREATINE DEFICIENCY SYNDROME 1; CCDS1]
FBgn0034136	DAT	HGNC:11056	OMIM:601019	SLC6A9	3	617301	617301[GLYCINE ENCEPHALOPATHY WITH NORMAL SERUM GLYCINE]
FBgn0034136	DAT	HGNC:11052	OMIM:186854	SLC6A6	3	145350	145350[HYPOTAURINEMIC RETINAL DEGENERATION AND CARDIOMYOPATHY; HTRDC]
FBgn0034136	DAT	HGNC:11046	OMIM:615097	SLC6A13	3		
FBgn0034136	DAT	HGNC:11042	OMIM:137165	SLC6A1	3	616421	616421[MYOCLONIC-ATONIC EPILEPSY; MAE]
FBgn0034136	DAT	HGNC:13622	OMIM:607972	SLC6A16	3		
FBgn0034094	Tsf3	HGNC:11740	OMIM:190000	TF	6	209300	209300[ATRANSFERRINEMIA]
FBgn0034094	Tsf3	HGNC:6720	OMIM:150210	LTF	5		
FBgn0034094	Tsf3	HGNC:7037	OMIM:155750	MELTF	5		
FBgn0034095	CG15701	HGNC:21862	OMIM:615462	WDR60	8	615503	615503[SHORT-RIB THORACIC DYSPLASIA 8 WITH OR WITHOUT POLYDACTYLY; SRTD8]
FBgn0050100	CG30100	HGNC:26784	OMIM:613541	C12orf65	12	613559,615035	613559[COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 7; COXPD7],615035[SPASTIC PARAPLEGIA 55, AUTOSOMAL RECESSIVE; SPG55]
FBgn0034110	Atg9	HGNC:22408	OMIM:612204	ATG9A	12		
FBgn0034110	Atg9	HGNC:21899	OMIM:612205	ATG9B	6		
FBgn0010611	Hmgs	HGNC:5008	OMIM:600234	HMGCS2	12	605911	605911[3-HYDROXY-3-METHYLGLUTARYL-CoA SYNTHASE-2 DEFICIENCY; HMGCS2D]
FBgn0010611	Hmgs	HGNC:5007	OMIM:142940	HMGCS1	15		
FBgn0034118	Nup62	HGNC:25960		NUP62CL	4		
FBgn0034118	Nup62	HGNC:8066	OMIM:605815	NUP62	10	271930	271930[STRIATONIGRAL DEGENERATION, INFANTILE; SNDI]
FBgn0034129	Parp16	HGNC:26040		PARP16	10		
FBgn0034127	CG7848	HGNC:6985	OMIM:604626	ME3	7		
FBgn0034127	CG7848	HGNC:6984	OMIM:154270	ME2	7		
FBgn0034127	CG7848	HGNC:6983	OMIM:154250	ME1	8		
FBgn0034117	CG7997	HGNC:4296	OMIM:300644	GLA	12	301500	301500[FABRY DISEASE]
FBgn0034117	CG7997	HGNC:7631	OMIM:104170	NAGA	12	609241,609242	609241[SCHINDLER DISEASE, TYPE I],609242[KANZAKI DISEASE]
FBgn0034113	CG8060	HGNC:17853	OMIM:606457	IBTK	13		
FBgn0034109	CG7747	HGNC:9261	OMIM:607588	PPIL2	15		
FBgn0034105	CG7755	HGNC:5386	OMIM:300089	IDH3G	4		
FBgn0024249	cato	HGNC:797	OMIM:601461	ATOH1	5		
FBgn0024249	cato	HGNC:13907	OMIM:609875	ATOH7	4	221900	221900[PERSISTENT HYPERPLASTIC PRIMARY VITREOUS, AUTOSOMAL RECESSIVE; PHPVAR]
FBgn0001308	Khc	HGNC:6324	OMIM:602809	KIF5B	15		
FBgn0001308	Khc	HGNC:6323	OMIM:602821	KIF5A	12	604187,617235,617921	604187[SPASTIC PARAPLEGIA 10, AUTOSOMAL DOMINANT; SPG10],617235[MYOCLONUS, INTRACTABLE, NEONATAL; NEIMY],617921[AMYOTROPHIC LATERAL SCLEROSIS, SUSCEPTIBILITY TO, 25; ALS25]
FBgn0001308	Khc	HGNC:6325	OMIM:604593	KIF5C	12	615282	615282[CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 2; CDCBM2]
FBgn0025519	fidipidine	HGNC:25611		CCDC93	14		
FBgn0034096	CG7786	HGNC:2697	OMIM:124097	DBP	6		
FBgn0034096	CG7786	HGNC:4977	OMIM:142385	HLF	6		
FBgn0034096	CG7786	HGNC:11722	OMIM:188595	TEF	6		
FBgn0034093	CG15706	HGNC:24711	OMIM:613476	MFSD6	3		
FBgn0034093	CG15706	HGNC:26656		MFSD6L	4		
FBgn0034092	CG7798	HGNC:28387	OMIM:612750	LYZL4	6		
FBgn0034092	CG7798	HGNC:31353	OMIM:300593	SPACA5	3		
FBgn0034092	CG7798	HGNC:19142		SPACA5B	5		
FBgn0034092	CG7798	HGNC:29613	OMIM:612748	LYZL2	5		
FBgn0034092	CG7798	HGNC:16260	OMIM:612749	SPACA3	6		
FBgn0034092	CG7798	HGNC:6480	OMIM:149750	LALBA	5		
FBgn0034092	CG7798	HGNC:6740	OMIM:153450	LYZ	10	105200	105200[AMYLOIDOSIS, FAMILIAL VISCERAL]
FBgn0034092	CG7798	HGNC:30502		LYZL1	5		
FBgn0034092	CG7798	HGNC:29614	OMIM:612751	LYZL6	6		
FBgn0034091	mrj	HGNC:14888	OMIM:611332	DNAJB6	11	603511	603511[MUSCULAR DYSTROPHY, LIMB-GIRDLE, AUTOSOMAL DOMINANT 1; LGMDD1]
FBgn0034091	mrj	HGNC:24986	OMIM:611336	DNAJB7	10		
FBgn0034091	mrj	HGNC:23699	OMIM:611337	DNAJB8	9		
FBgn0034091	mrj	HGNC:5228	OMIM:604139	DNAJB2	11	614881	614881[SPINAL MUSCULAR ATROPHY, DISTAL, AUTOSOMAL RECESSIVE, 5; DSMA5]
FBgn0034091	mrj	HGNC:32397		DNAJB3	4		
FBgn0050093	COX6AL	HGNC:2277	OMIM:602072	COX6A1	11	616039	616039[CHARCOT-MARIE-TOOTH DISEASE, RECESSIVE INTERMEDIATE D; CMTRID]
FBgn0050093	COX6AL	HGNC:2279	OMIM:602009	COX6A2	10	619062	619062[MITOCHONDRIAL COMPLEX IV DEFICIENCY, NUCLEAR TYPE 18; MC4DN18]
FBgn0034059	CG8320	HGNC:25015		TMEM208	14		
FBgn0034060	Tmem131	HGNC:30366	OMIM:615659	TMEM131	11		
FBgn0034060	Tmem131	HGNC:29146	OMIM:616243	TMEM131L	5		
FBgn0034063	CG8389	HGNC:10923	OMIM:300095	SLC16A2	3	300523	300523[ALLAN-HERNDON-DUDLEY SYNDROME; AHDS]
FBgn0034063	CG8389	HGNC:10924	OMIM:603877	SLC16A3	4		
FBgn0034063	CG8389	HGNC:16270	OMIM:610409	SLC16A8	4		
FBgn0034063	CG8389	HGNC:26417		SLC16A14	4		
FBgn0034063	CG8389	HGNC:23093	OMIM:615765	SLC16A11	3		
FBgn0034063	CG8389	HGNC:23520	OMIM:614242	SLC16A9	3		
FBgn0034063	CG8389	HGNC:10922	OMIM:600682	SLC16A1	4	245340,610021,616095	245340[ERYTHROCYTE LACTATE TRANSPORTER DEFECT],610021[HYPERINSULINEMIC HYPOGLYCEMIA, FAMILIAL, 7; HHF7],616095[MONOCARBOXYLATE TRANSPORTER 1 DEFICIENCY; MCT1D]
FBgn0034063	CG8389	HGNC:10927	OMIM:603880	SLC16A6	3		
FBgn0034063	CG8389	HGNC:10925	OMIM:603878	SLC16A4	3		
FBgn0034063	CG8389	HGNC:31037		SLC16A13	4		
FBgn0034063	CG8389	HGNC:10926	OMIM:603879	SLC16A5	4		
FBgn0034063	CG8389	HGNC:10928	OMIM:603654	SLC16A7	4		
FBgn0034063	CG8389	HGNC:23094	OMIM:611910	SLC16A12	4	612018	612018[CATARACT 47; CTRCT47]
FBgn0034065	Rrp42	HGNC:28112	OMIM:606488	EXOSC7	15		
FBgn0034067	CG8399	HGNC:27622	OMIM:611578	FRRS1	15		
FBgn0034067	CG8399	HGNC:1362	OMIM:604574	FRRS1L	4	616981	616981[DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 37; DEE37]
FBgn0034069	CG8401	HGNC:28687		C16orf89	5		
FBgn0034070	SP2353	HGNC:26810	OMIM:617683	EGFLAM	10		
FBgn0014020	Rho1	HGNC:669	OMIM:165380	RHOC	12		
FBgn0014020	Rho1	HGNC:668	OMIM:165370	RHOB	9		
FBgn0014020	Rho1	HGNC:667	OMIM:165390	RHOA	13	618727	618727[ECTODERMAL DYSPLASIA WITH FACIAL DYSMORPHISM AND ACRAL, OCULAR, AND BRAIN ANOMALIES; EDFAOB]
FBgn0014020	Rho1	HGNC:670	OMIM:605781	RHOD	3		
FBgn0034075	Asph	HGNC:757	OMIM:600582	ASPH	10	601552	601552[FACIAL DYSMORPHISM, LENS DISLOCATION, ANTERIOR SEGMENT ABNORMALITIES, AND SPONTANEOUS FILTERING BLEBS; FDLAB]
FBgn0034075	Asph	HGNC:27380		ASPHD1	3		
FBgn0034075	Asph	HGNC:30437		ASPHD2	3		
FBgn0034076	Jhedup	HGNC:26741		CES4A	6		
FBgn0034076	Jhedup	HGNC:11764	OMIM:188450	TG	3	274700,608175	274700[THYROID DYSHORMONOGENESIS 3; TDH3],608175[AUTOIMMUNE THYROID DISEASE, SUSCEPTIBILITY TO, 3; AITD3]
FBgn0034076	Jhedup	HGNC:108	OMIM:100740	ACHE	4	112100	112100[YT BLOOD GROUP ANTIGEN]
FBgn0034076	Jhedup	HGNC:983	OMIM:177400	BCHE	3	617936	617936[BUTYRYLCHOLINESTERASE DEFICIENCY; BCHED]
FBgn0034076	Jhedup	HGNC:26459	OMIM:618678	CES5A	6		
FBgn0034076	Jhedup	HGNC:1863	OMIM:114835	CES1	6	618057	618057[DRUG METABOLISM, ALTERED, CES1-RELATED]
FBgn0034076	Jhedup	HGNC:1848	OMIM:114840	CEL	3	609812	609812[MATURITY-ONSET DIABETES OF THE YOUNG, TYPE 8, WITH EXOCRINE DYSFUNCTION; MODY8]
FBgn0034076	Jhedup	HGNC:1864	OMIM:605278	CES2	5		
FBgn0034076	Jhedup	HGNC:1865	OMIM:605279	CES3	6		
FBgn0034076	Jhedup	HGNC:14291	OMIM:600568	NLGN1	3	618830	618830[AUTISM, SUSCEPTIBILITY TO, 20; AUTS20]
FBgn0034076	Jhedup	HGNC:14289	OMIM:300336	NLGN3	3	300425,300494	300425[AUTISM, SUSCEPTIBILITY TO, X-LINKED 1; AUTSX1],300494[ASPERGER SYNDROME, X-LINKED, SUSCEPTIBILITY TO, 1; ASPGX1]
FBgn0034076	Jhedup	HGNC:14287	OMIM:300427	NLGN4X	3	300495,300497	300495[AUTISM, SUSCEPTIBILITY TO, X-LINKED 2; AUTSX2],300497[ASPERGER SYNDROME, X-LINKED, SUSCEPTIBILITY TO, 2; ASPGX2]
FBgn0034076	Jhedup	HGNC:14290	OMIM:606479	NLGN2	3		
FBgn0010052	Jhe	HGNC:26741		CES4A	7		
FBgn0010052	Jhe	HGNC:11764	OMIM:188450	TG	4	274700,608175	274700[THYROID DYSHORMONOGENESIS 3; TDH3],608175[AUTOIMMUNE THYROID DISEASE, SUSCEPTIBILITY TO, 3; AITD3]
FBgn0010052	Jhe	HGNC:108	OMIM:100740	ACHE	4	112100	112100[YT BLOOD GROUP ANTIGEN]
FBgn0010052	Jhe	HGNC:983	OMIM:177400	BCHE	3	617936	617936[BUTYRYLCHOLINESTERASE DEFICIENCY; BCHED]
FBgn0010052	Jhe	HGNC:26459	OMIM:618678	CES5A	6		
FBgn0010052	Jhe	HGNC:1863	OMIM:114835	CES1	6	618057	618057[DRUG METABOLISM, ALTERED, CES1-RELATED]
FBgn0010052	Jhe	HGNC:1848	OMIM:114840	CEL	3	609812	609812[MATURITY-ONSET DIABETES OF THE YOUNG, TYPE 8, WITH EXOCRINE DYSFUNCTION; MODY8]
FBgn0010052	Jhe	HGNC:1864	OMIM:605278	CES2	5		
FBgn0010052	Jhe	HGNC:1865	OMIM:605279	CES3	6		
FBgn0010052	Jhe	HGNC:14291	OMIM:600568	NLGN1	3	618830	618830[AUTISM, SUSCEPTIBILITY TO, 20; AUTS20]
FBgn0010052	Jhe	HGNC:14289	OMIM:300336	NLGN3	3	300425,300494	300425[AUTISM, SUSCEPTIBILITY TO, X-LINKED 1; AUTSX1],300494[ASPERGER SYNDROME, X-LINKED, SUSCEPTIBILITY TO, 1; ASPGX1]
FBgn0010052	Jhe	HGNC:14287	OMIM:300427	NLGN4X	3	300495,300497	300495[AUTISM, SUSCEPTIBILITY TO, X-LINKED 2; AUTSX2],300497[ASPERGER SYNDROME, X-LINKED, SUSCEPTIBILITY TO, 2; ASPGX2]
FBgn0010052	Jhe	HGNC:14290	OMIM:606479	NLGN2	3		
FBgn0001124	Got1	HGNC:4433	OMIM:138150	GOT2	5	618721	618721[DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 82; DEE82]
FBgn0001124	Got1	HGNC:4432	OMIM:138180	GOT1	13	614419	614419[ASPARTATE AMINOTRANSFERASE, SERUM LEVEL OF, QUANTITATIVE TRAIT LOCUS 1]
FBgn0001124	Got1	HGNC:28487		GOT1L1	5		
FBgn0027091	CysRS	HGNC:1493	OMIM:123859	CARS1	15	618891	618891[MICROCEPHALY, DEVELOPMENTAL DELAY, AND BRITTLE HAIR SYNDROME; MDBH]
FBgn0027091	CysRS	HGNC:25695	OMIM:612800	CARS2	3	616672	616672[COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 27; COXPD27]
FBgn0034083	lbk	HGNC:20889	OMIM:608869	LRIG2	10	615112	615112[UROFACIAL SYNDROME 2; UFS2]
FBgn0034083	lbk	HGNC:17360	OMIM:608868	LRIG1	11		
FBgn0034083	lbk	HGNC:30991	OMIM:608870	LRIG3	11		
FBgn0015754	Lis-1	HGNC:8574	OMIM:601545	PAFAH1B1	14	607432	607432[LISSENCEPHALY 1; LIS1]
FBgn0034087	clu	HGNC:29094	OMIM:616184	CLUH	13		
FBgn0015295	Shark	HGNC:11491	OMIM:600085	SYK	5	619381	619381[IMMUNODEFICIENCY 82 WITH SYSTEMIC INFLAMMATION; IMD82]
FBgn0015295	Shark	HGNC:12858	OMIM:176947	ZAP70	7	269840,617006	269840[IMMUNODEFICIENCY 48; IMD48],617006[AUTOIMMUNE DISEASE, MULTISYSTEM, INFANTILE-ONSET, 2; ADMIO2]
FBgn0034086	CG8441	HGNC:21894	OMIM:617458	PRKRIP1	11		
FBgn0034084	CG8435	HGNC:28118		YJU2B	4		
FBgn0034084	CG8435	HGNC:25518		YJU2	13		
FBgn0034073	CG8414	HGNC:26265		NOL9	9		
FBgn0034068	casp	HGNC:3578	OMIM:604460	FAF1	14		
FBgn0034066	EMC7	HGNC:24301		EMC7	13		
FBgn0010590	Prosbeta1	HGNC:9543	OMIM:600307	PSMB6	13		
FBgn0010590	Prosbeta1	HGNC:9546	OMIM:177045	PSMB9	8	617591	617591[PROTEASOME-ASSOCIATED AUTOINFLAMMATORY SYNDROME 3; PRAAS3]
FBgn0034061	Ufc1	HGNC:26941	OMIM:610554	UFC1	15	618076	618076[NEURODEVELOPMENTAL DISORDER WITH SPASTICITY AND POOR GROWTH; NEDSG]
FBgn0020236	ATPCL	HGNC:115	OMIM:108728	ACLY	15		
FBgn0034058	Pex11ab	HGNC:8853	OMIM:603867	PEX11B	14	614920	614920[PEROXISOME BIOGENESIS DISORDER 14B; PEX14B]
FBgn0034058	Pex11ab	HGNC:8852	OMIM:603866	PEX11A	12		
FBgn0034057	CG8314	HGNC:18470	OMIM:617150	ZDHHC3	15		
FBgn0034057	CG8314	HGNC:18459	OMIM:614604	ZDHHC7	9		
FBgn0034046	tun	HGNC:25490		WDYHV1	15		
FBgn0034050	bug	HGNC:20652	OMIM:617778	TXNDC15	11	619879	619879[MECKEL SYNDROME 14; MKS14]
FBgn0034052	CG8299	HGNC:9486	OMIM:613578	PRSS3	3		
FBgn0034052	CG8299	HGNC:9475	OMIM:276000	PRSS1	3	167800	167800[PANCREATITIS, HEREDITARY; PCTT]
FBgn0034051	Mlf	HGNC:7126	OMIM:601401	MLF2	11		
FBgn0034051	Mlf	HGNC:7125	OMIM:601402	MLF1	10		
FBgn0015247	Diap2	HGNC:593	OMIM:603352	BIRC5	3		
FBgn0015247	Diap2	HGNC:13702	OMIM:605737	BIRC7	7		
FBgn0015247	Diap2	HGNC:14878		BIRC8	5		
FBgn0015247	Diap2	HGNC:591	OMIM:601721	BIRC3	12		
FBgn0015247	Diap2	HGNC:590	OMIM:601712	BIRC2	13		
FBgn0015247	Diap2	HGNC:592	OMIM:300079	XIAP	11	300635	300635[LYMPHOPROLIFERATIVE SYNDROME, X-LINKED, 2; XLP2]
FBgn0015247	Diap2	HGNC:7634	OMIM:600355	NAIP	4		
FBgn0050085	Rif1	HGNC:23207	OMIM:608952	RIF1	7		
FBgn0022160	Gpo1	HGNC:4456	OMIM:138430	GPD2	13	125853	125853[TYPE 2 DIABETES MELLITUS; T2D]
FBgn0034045	CG8249	HGNC:11011	OMIM:606813	SLC2A6	5		
FBgn0034045	CG8249	HGNC:13812	OMIM:605245	SLC2A8	7		
FBgn0034045	CG8249	HGNC:11006	OMIM:138160	SLC2A2	3	125853,227810	125853[TYPE 2 DIABETES MELLITUS; T2D],227810[FANCONI-BICKEL SYNDROME; FBS]
FBgn0034045	CG8249	HGNC:18067	OMIM:610372	SLC2A12	3		
FBgn0034045	CG8249	HGNC:13444	OMIM:606145	SLC2A10	3	208050	208050[ARTERIAL TORTUOSITY SYNDROME; ATORS]
FBgn0034025	Pgant1	HGNC:4123	OMIM:602273	GALNT1	3		
FBgn0034025	Pgant1	HGNC:19877	OMIM:610290	GALNT12	4	608812	608812[COLORECTAL CANCER, SUSCEPTIBILITY TO, 1; CRCS1]
FBgn0034025	Pgant1	HGNC:4127	OMIM:615129	GALNT5	4		
FBgn0034025	Pgant1	HGNC:23242	OMIM:608369	GALNT13	3		
FBgn0034025	Pgant1	HGNC:4128	OMIM:605148	GALNT6	3		
FBgn0034025	Pgant1	HGNC:42957		POC1B-GALNT4	3		
FBgn0034025	Pgant1	HGNC:21531	OMIM:615131	GALNT15	3		
FBgn0050467	CG30467	HGNC:25158		SAAL1	7		
FBgn0022097	Vha36-1	HGNC:13527	OMIM:609398	ATP6V1D	14		
FBgn0034029	eIF2Bgamma	HGNC:3259	OMIM:606273	EIF2B3	13	603896	603896[LEUKOENCEPHALOPATHY WITH VANISHING WHITE MATTER; VWM]
FBgn0034035	Gmppa	HGNC:22923	OMIM:615495	GMPPA	15	615510	615510[ALACRIMA, ACHALASIA, AND MENTAL RETARDATION SYNDROME; AAMR]
FBgn0034035	Gmppa	HGNC:22932	OMIM:615320	GMPPB	3	615350,615351,615352	615350[MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 14; MDDGA14],615351[MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH IMPAIRED INTELLECTUAL DEVELOPMENT), TYPE B, 14; MDDGB14],615352[MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (LIMB-GIRDLE), TYPE C, 14; MDDGC14]
FBgn0023441	fus	HGNC:26152	OMIM:612960	ESRP2	10		
FBgn0023441	fus	HGNC:25966	OMIM:612959	ESRP1	12	618013	618013[DEAFNESS, AUTOSOMAL RECESSIVE 109; DFNB109]
FBgn0023441	fus	HGNC:4610	OMIM:604851	GRSF1	3		
FBgn0023441	fus	HGNC:5039	OMIM:601037	HNRNPF	3		
FBgn0023441	fus	HGNC:5043	OMIM:602324	HNRNPH3	3		
FBgn0034033	CG8204	HGNC:12309	OMIM:604500	ZNHIT3	14	260565	260565[PEHO SYNDROME; PEHO]
FBgn0013762	Cdk5	HGNC:1774	OMIM:123831	CDK5	14	616342	616342[LISSENCEPHALY 7 WITH CEREBELLAR HYPOPLASIA; LIS7]
FBgn0013762	Cdk5	HGNC:1722	OMIM:116940	CDK1	3		
FBgn0013762	Cdk5	HGNC:1771	OMIM:116953	CDK2	4		
FBgn0024754	Flo1	HGNC:3757	OMIM:606998	FLOT1	13		
FBgn0034032	CG8195	HGNC:23617	OMIM:619997	SLC35F5	14		
FBgn0034027	CG8187	HGNC:22412		FAM185A	12		
FBgn0019968	Khc-73	HGNC:16636	OMIM:605995	KIF1B	3	118210,171300,256700	118210[CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2A1; CMT2A1],171300[PHEOCHROMOCYTOMA],256700[NEUROBLASTOMA, SUSCEPTIBILITY TO, 1; NBLST1]
FBgn0019968	Khc-73	HGNC:14405	OMIM:607350	KIF13B	12		
FBgn0019968	Khc-73	HGNC:14566	OMIM:605433	KIF13A	13		
FBgn0013467	igl	HGNC:11210	OMIM:608621	SPA17	3		
FBgn0033996	CG11807	HGNC:19184	OMIM:607172	STK11IP	3		
FBgn0033996	CG11807	HGNC:18006	OMIM:615507	NISCH	10		
FBgn0034002	CG8079	HGNC:24684	OMIM:608464	AGGF1	13		
FBgn0034005	ItgaPS4	HGNC:6140	OMIM:192975	ITGA4	5		
FBgn0034005	ItgaPS4	HGNC:6145	OMIM:603963	ITGA9	5		
FBgn0034005	ItgaPS4	HGNC:6152	OMIM:151510	ITGAX	3		
FBgn0034005	ItgaPS4	HGNC:6148	OMIM:153370	ITGAL	3		
FBgn0034005	ItgaPS4	HGNC:6134	OMIM:192968	ITGA1	3		
FBgn0034005	ItgaPS4	HGNC:6137	OMIM:192974	ITGA2	3		
FBgn0034005	ItgaPS4	HGNC:6135	OMIM:604042	ITGA10	3		
FBgn0034005	ItgaPS4	HGNC:6136	OMIM:604789	ITGA11	3		
FBgn0034005	ItgaPS4	HGNC:6149	OMIM:120980	ITGAM	3		
FBgn0034005	ItgaPS4	HGNC:6143	OMIM:600536	ITGA7	3	613204	613204[MUSCULAR DYSTROPHY, CONGENITAL, DUE TO INTEGRIN ALPHA-7 DEFICIENCY]
FBgn0034005	ItgaPS4	HGNC:6142	OMIM:147556	ITGA6	3	619817	619817[EPIDERMOLYSIS BULLOSA, JUNCTIONAL 6, WITH PYLORIC ATRESIA; JEB6]
FBgn0034005	ItgaPS4	HGNC:6144	OMIM:604063	ITGA8	3	191830	191830[RENAL HYPODYSPLASIA/APLASIA 1; RHDA1]
FBgn0034005	ItgaPS4	HGNC:6139	OMIM:605025	ITGA3	3	614748	614748[EPIDERMOLYSIS BULLOSA, JUNCTIONAL 7, WITH INTERSTITIAL LUNG DISEASE AND NEPHROTIC SYNDROME; JEB7]
FBgn0034005	ItgaPS4	HGNC:6146	OMIM:602453	ITGAD	3		
FBgn0034005	ItgaPS4	HGNC:6147	OMIM:604682	ITGAE	3		
FBgn0004698	Xpc	HGNC:12816	OMIM:613208	XPC	11	278720	278720[XERODERMA PIGMENTOSUM, COMPLEMENTATION GROUP C; XPC]
FBgn0013750	Arf6	HGNC:659	OMIM:600464	ARF6	15		
FBgn0034012	Hr51	HGNC:7974	OMIM:604485	NR2E3	12	268100,611131	268100[ENHANCED S-CONE SYNDROME; ESCS],611131[RETINITIS PIGMENTOSA 37; RP37]
FBgn0034013	unc-5	HGNC:12569	OMIM:603610	UNC5C	15		
FBgn0034013	unc-5	HGNC:12567	OMIM:607869	UNC5A	13		
FBgn0034013	unc-5	HGNC:18634	OMIM:616466	UNC5D	12		
FBgn0034013	unc-5	HGNC:12568	OMIM:607870	UNC5B	13		
FBgn0034013	unc-5	HGNC:21203	OMIM:617464	UNC5CL	4		
FBgn0000996	dup	HGNC:24576	OMIM:605525	CDT1	12	613804	613804[MEIER-GORLIN SYNDROME 4; MGORS4]
FBgn0011660	Pms2	HGNC:9122	OMIM:600259	PMS2	13	614337,619101	614337[COLORECTAL CANCER, HEREDITARY NONPOLYPOSIS, TYPE 4; HNPCC4],619101[MISMATCH REPAIR CANCER SYNDROME 4; MMRCS4]
FBgn0011660	Pms2	HGNC:9121	OMIM:600258	PMS1	3		
FBgn0034008	CG8152	HGNC:13920	OMIM:142610	GPANK1	14		
FBgn0034007	ND-51L2	HGNC:7716	OMIM:161015	NDUFV1	7	618225	618225[MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 4; MC1DN4]
FBgn0001187	Hex-C	HGNC:23302	OMIM:617221	HKDC1	8	619614	619614[RETINITIS PIGMENTOSA 92; RP92]
FBgn0001187	Hex-C	HGNC:4922	OMIM:142600	HK1	9	235700,605285,617460,618547	235700[HEMOLYTIC ANEMIA, NONSPHEROCYTIC, DUE TO HEXOKINASE DEFICIENCY],605285[NEUROPATHY, HEREDITARY MOTOR AND SENSORY, RUSSE TYPE; HMSNR],617460[RETINITIS PIGMENTOSA 79; RP79],618547[NEURODEVELOPMENTAL DISORDER WITH VISUAL DEFECTS AND BRAIN ANOMALIES; NEDVIBA]
FBgn0001187	Hex-C	HGNC:4923	OMIM:601125	HK2	8		
FBgn0001187	Hex-C	HGNC:4925	OMIM:142570	HK3	8		
FBgn0001187	Hex-C	HGNC:4195	OMIM:138079	GCK	12	125851,125853,602485,606176	125851[MATURITY-ONSET DIABETES OF THE YOUNG, TYPE 2; MODY2],125853[TYPE 2 DIABETES MELLITUS; T2D],602485[HYPERINSULINEMIC HYPOGLYCEMIA, FAMILIAL, 3; HHF3],606176[DIABETES MELLITUS, PERMANENT NEONATAL, 1; PNDM1]
FBgn0034001	mRpL41	HGNC:14492	OMIM:611846	MRPL41	11		
FBgn0033999	CG8093	HGNC:6617	OMIM:613497	LIPA	12	278000	278000[LYSOSOMAL ACID LIPASE DEFICIENCY]
FBgn0033999	CG8093	HGNC:23444	OMIM:613922	LIPK	12		
FBgn0033999	CG8093	HGNC:23455	OMIM:613923	LIPM	13		
FBgn0033999	CG8093	HGNC:6622	OMIM:601980	LIPF	12		
FBgn0033999	CG8093	HGNC:21773	OMIM:613921	LIPJ	9		
FBgn0033999	CG8093	HGNC:23452	OMIM:613924	LIPN	10	613943	613943[ICHTHYOSIS, CONGENITAL, AUTOSOMAL RECESSIVE 8; ARCI8]
FBgn0033998	row	HGNC:25953		ZNF280D	5		
FBgn0033998	row	HGNC:25955		ZNF280C	5		
FBgn0033998	row	HGNC:18597		ZNF280A	3		
FBgn0033998	row	HGNC:23022		ZNF280B	3		
FBgn0033998	row	HGNC:18801	OMIM:614787	POGZ	6	616364	616364[WHITE-SUTTON SYNDROME; WHSUS]
FBgn0033995	GPHR	HGNC:13840	OMIM:612806	GPR89B	14		
FBgn0033995	GPHR	HGNC:31984	OMIM:612821	GPR89A	12		
FBgn0033982	Cyp317a1	HGNC:2638	OMIM:605325	CYP3A5	4	145500	145500[HYPERTENSION, ESSENTIAL]
FBgn0033982	Cyp317a1	HGNC:17450	OMIM:606534	CYP3A43	4		
FBgn0033982	Cyp317a1	HGNC:11609	OMIM:274180	TBXAS1	3	231095	231095[GHOSAL HEMATODIAPHYSEAL DYSPLASIA; GHDD]
FBgn0033982	Cyp317a1	HGNC:2637	OMIM:124010	CYP3A4	4	619073	619073[VITAMIN D-DEPENDENT RICKETS, TYPE 3; VDDR3]
FBgn0033982	Cyp317a1	HGNC:51504		CYP3A7-CYP3A51P	4		
FBgn0033984	Lap1	HGNC:18531	OMIM:614453	LRRC7	8		
FBgn0033984	Lap1	HGNC:15842	OMIM:606944	ERBIN	8		
FBgn0033985	CG10257	HGNC:18703	OMIM:617535	FAIM	14		
FBgn0033987	ckn	HGNC:18200	OMIM:612185	CASKIN2	4		
FBgn0033987	ckn	HGNC:20879	OMIM:612184	CASKIN1	4		
FBgn0033988	pcs	HGNC:29360		SH3BP5L	8		
FBgn0033988	pcs	HGNC:10827	OMIM:605612	SH3BP5	7		
FBgn0033994	CG7544	HGNC:28484		METTL16	12		
FBgn0033989	CG7639	HGNC:24276	OMIM:612058	SAMM50	13		
FBgn0033983	Agps	HGNC:327	OMIM:603051	AGPS	14	600121	600121[RHIZOMELIC CHONDRODYSPLASIA PUNCTATA, TYPE 3; RCDP3]
FBgn0027596	Kank	HGNC:19309	OMIM:607704	KANK1	10	612900	612900[CEREBRAL PALSY, SPASTIC QUADRIPLEGIC, 2; CPSQ2]
FBgn0027596	Kank	HGNC:29300	OMIM:614610	KANK2	10	616099,617783	616099[PALMOPLANTAR KERATODERMA AND WOOLLY HAIR; PPKWH],617783[NEPHROTIC SYNDROME, TYPE 16; NPHS16]
FBgn0027596	Kank	HGNC:24796	OMIM:614611	KANK3	7		
FBgn0027596	Kank	HGNC:27263	OMIM:614612	KANK4	7		
FBgn0033955	Targ	HGNC:17027	OMIM:607550	SLC16A10	4		
FBgn0033955	Targ	HGNC:10923	OMIM:300095	SLC16A2	3	300523	300523[ALLAN-HERNDON-DUDLEY SYNDROME; AHDS]
FBgn0033955	Targ	HGNC:10924	OMIM:603877	SLC16A3	4		
FBgn0033955	Targ	HGNC:16270	OMIM:610409	SLC16A8	5		
FBgn0033955	Targ	HGNC:26417		SLC16A14	5		
FBgn0033955	Targ	HGNC:23093	OMIM:615765	SLC16A11	4		
FBgn0033955	Targ	HGNC:23520	OMIM:614242	SLC16A9	4		
FBgn0033955	Targ	HGNC:10922	OMIM:600682	SLC16A1	5	245340,610021,616095	245340[ERYTHROCYTE LACTATE TRANSPORTER DEFECT],610021[HYPERINSULINEMIC HYPOGLYCEMIA, FAMILIAL, 7; HHF7],616095[MONOCARBOXYLATE TRANSPORTER 1 DEFICIENCY; MCT1D]
FBgn0033955	Targ	HGNC:10927	OMIM:603880	SLC16A6	4		
FBgn0033955	Targ	HGNC:10925	OMIM:603878	SLC16A4	4		
FBgn0033955	Targ	HGNC:31037		SLC16A13	5		
FBgn0033955	Targ	HGNC:10926	OMIM:603879	SLC16A5	5		
FBgn0033955	Targ	HGNC:10928	OMIM:603654	SLC16A7	5		
FBgn0033955	Targ	HGNC:23094	OMIM:611910	SLC16A12	5	612018	612018[CATARACT 47; CTRCT47]
FBgn0050476	ave	HGNC:31750	OMIM:618073	SAMD12	9	601068	601068[EPILEPSY, FAMILIAL ADULT MYOCLONIC, 1; FAME1]
FBgn0050476	ave	HGNC:16129		SAMD10	9		
FBgn0033961	ND-B15	HGNC:7699	OMIM:603840	NDUFB4	8		
FBgn0028434	Ercc1	HGNC:3433	OMIM:126380	ERCC1	13	610758	610758[CEREBROOCULOFACIOSKELETAL SYNDROME 4; COFS4]
FBgn0033973	HPS1	HGNC:5163	OMIM:604982	HPS1	12	203300	203300[HERMANSKY-PUDLAK SYNDROME 1; HPS1]
FBgn0013773	Cyp6a22	HGNC:2638	OMIM:605325	CYP3A5	6	145500	145500[HYPERTENSION, ESSENTIAL]
FBgn0013773	Cyp6a22	HGNC:17450	OMIM:606534	CYP3A43	6		
FBgn0013773	Cyp6a22	HGNC:11609	OMIM:274180	TBXAS1	5	231095	231095[GHOSAL HEMATODIAPHYSEAL DYSPLASIA; GHDD]
FBgn0013773	Cyp6a22	HGNC:2637	OMIM:124010	CYP3A4	6	619073	619073[VITAMIN D-DEPENDENT RICKETS, TYPE 3; VDDR3]
FBgn0013773	Cyp6a22	HGNC:51504		CYP3A7-CYP3A51P	5		
FBgn0015714	Cyp6a17	HGNC:2638	OMIM:605325	CYP3A5	7	145500	145500[HYPERTENSION, ESSENTIAL]
FBgn0015714	Cyp6a17	HGNC:17450	OMIM:606534	CYP3A43	7		
FBgn0015714	Cyp6a17	HGNC:11609	OMIM:274180	TBXAS1	5	231095	231095[GHOSAL HEMATODIAPHYSEAL DYSPLASIA; GHDD]
FBgn0015714	Cyp6a17	HGNC:2637	OMIM:124010	CYP3A4	6	619073	619073[VITAMIN D-DEPENDENT RICKETS, TYPE 3; VDDR3]
FBgn0015714	Cyp6a17	HGNC:51504		CYP3A7-CYP3A51P	5		
FBgn0033978	Cyp6a23	HGNC:2638	OMIM:605325	CYP3A5	6	145500	145500[HYPERTENSION, ESSENTIAL]
FBgn0033978	Cyp6a23	HGNC:17450	OMIM:606534	CYP3A43	6		
FBgn0033978	Cyp6a23	HGNC:11609	OMIM:274180	TBXAS1	6	231095	231095[GHOSAL HEMATODIAPHYSEAL DYSPLASIA; GHDD]
FBgn0033978	Cyp6a23	HGNC:2637	OMIM:124010	CYP3A4	7	619073	619073[VITAMIN D-DEPENDENT RICKETS, TYPE 3; VDDR3]
FBgn0033978	Cyp6a23	HGNC:51504		CYP3A7-CYP3A51P	5		
FBgn0033979	Cyp6a19	HGNC:2638	OMIM:605325	CYP3A5	6	145500	145500[HYPERTENSION, ESSENTIAL]
FBgn0033979	Cyp6a19	HGNC:17450	OMIM:606534	CYP3A43	6		
FBgn0033979	Cyp6a19	HGNC:11609	OMIM:274180	TBXAS1	5	231095	231095[GHOSAL HEMATODIAPHYSEAL DYSPLASIA; GHDD]
FBgn0033979	Cyp6a19	HGNC:2637	OMIM:124010	CYP3A4	6	619073	619073[VITAMIN D-DEPENDENT RICKETS, TYPE 3; VDDR3]
FBgn0033979	Cyp6a19	HGNC:51504		CYP3A7-CYP3A51P	5		
FBgn0033980	Cyp6a20	HGNC:2638	OMIM:605325	CYP3A5	5	145500	145500[HYPERTENSION, ESSENTIAL]
FBgn0033980	Cyp6a20	HGNC:17450	OMIM:606534	CYP3A43	5		
FBgn0033980	Cyp6a20	HGNC:11609	OMIM:274180	TBXAS1	5	231095	231095[GHOSAL HEMATODIAPHYSEAL DYSPLASIA; GHDD]
FBgn0033980	Cyp6a20	HGNC:2637	OMIM:124010	CYP3A4	5	619073	619073[VITAMIN D-DEPENDENT RICKETS, TYPE 3; VDDR3]
FBgn0033980	Cyp6a20	HGNC:51504		CYP3A7-CYP3A51P	5		
FBgn0013772	Cyp6a8	HGNC:2638	OMIM:605325	CYP3A5	6	145500	145500[HYPERTENSION, ESSENTIAL]
FBgn0013772	Cyp6a8	HGNC:17450	OMIM:606534	CYP3A43	6		
FBgn0013772	Cyp6a8	HGNC:11609	OMIM:274180	TBXAS1	5	231095	231095[GHOSAL HEMATODIAPHYSEAL DYSPLASIA; GHDD]
FBgn0013772	Cyp6a8	HGNC:2637	OMIM:124010	CYP3A4	6	619073	619073[VITAMIN D-DEPENDENT RICKETS, TYPE 3; VDDR3]
FBgn0013772	Cyp6a8	HGNC:51504		CYP3A7-CYP3A51P	5		
FBgn0013771	Cyp6a9	HGNC:2638	OMIM:605325	CYP3A5	6	145500	145500[HYPERTENSION, ESSENTIAL]
FBgn0013771	Cyp6a9	HGNC:17450	OMIM:606534	CYP3A43	6		
FBgn0013771	Cyp6a9	HGNC:11609	OMIM:274180	TBXAS1	5	231095	231095[GHOSAL HEMATODIAPHYSEAL DYSPLASIA; GHDD]
FBgn0013771	Cyp6a9	HGNC:2637	OMIM:124010	CYP3A4	6	619073	619073[VITAMIN D-DEPENDENT RICKETS, TYPE 3; VDDR3]
FBgn0013771	Cyp6a9	HGNC:51504		CYP3A7-CYP3A51P	5		
FBgn0033972	Ciao1	HGNC:14280	OMIM:604333	CIAO1	14		
FBgn0027783	SMC2	HGNC:14011	OMIM:605576	SMC2	14		
FBgn0016684	NaPi-T	HGNC:20151	OMIM:607557	SLC17A8	3	605583	605583[DEAFNESS, AUTOSOMAL DOMINANT 25; DFNA25]
FBgn0016684	NaPi-T	HGNC:10933	OMIM:604322	SLC17A5	3	269920,604369	269920[INFANTILE SIALIC ACID STORAGE DISEASE; ISSD],604369[SALLA DISEASE; SD]
FBgn0016684	NaPi-T	HGNC:16703	OMIM:607563	SLC17A6	3		
FBgn0016684	NaPi-T	HGNC:16704	OMIM:605208	SLC17A7	3		
FBgn0016684	NaPi-T	HGNC:10929	OMIM:182308	SLC17A1	3		
FBgn0016684	NaPi-T	HGNC:10932	OMIM:604216	SLC17A4	3		
FBgn0016684	NaPi-T	HGNC:10930	OMIM:611049	SLC17A2	4		
FBgn0016684	NaPi-T	HGNC:10931	OMIM:611034	SLC17A3	4	612671	612671[URIC ACID CONCENTRATION, SERUM, QUANTITATIVE TRAIT LOCUS 4; UAQTL4]
FBgn0033969	Pgm2b	HGNC:8906	OMIM:172000	PGM2	11		
FBgn0033969	Pgm2b	HGNC:20898	OMIM:611610	PGM2L1	11		
FBgn0001319	kn	HGNC:19087	OMIM:607407	EBF3	14	617330	617330[HYPOTONIA, ATAXIA, AND DELAYED DEVELOPMENT SYNDROME; HADDS]
FBgn0001319	kn	HGNC:3126	OMIM:164343	EBF1	12		
FBgn0001319	kn	HGNC:29278	OMIM:609935	EBF4	11		
FBgn0001319	kn	HGNC:19090	OMIM:609934	EBF2	11		
FBgn0020767	Spred	HGNC:20249	OMIM:609291	SPRED1	11	611431	611431[LEGIUS SYNDROME; LGSS]
FBgn0020767	Spred	HGNC:31041	OMIM:609293	SPRED3	7		
FBgn0020767	Spred	HGNC:17722	OMIM:609292	SPRED2	14	619745	619745[NOONAN SYNDROME 14; NS14]
FBgn0028689	Rpn6	HGNC:9556	OMIM:604449	PSMD11	14		
FBgn0033958	jef	HGNC:24711	OMIM:613476	MFSD6	13		
FBgn0020269	mspo	HGNC:11252	OMIM:604989	SPON1	3		
FBgn0020269	mspo	HGNC:11253	OMIM:605918	SPON2	11		
FBgn0033952	Adgf-E	HGNC:1839	OMIM:607575	ADA2	11	182410,615688	182410[SNEDDON SYNDROME; SNDNS],615688[VASCULITIS, AUTOINFLAMMATION, IMMUNODEFICIENCY, AND HEMATOLOGIC DEFECTS SYNDROME; VAIHS]
FBgn0033932	Dh44-R1	HGNC:2357	OMIM:122561	CRHR1	9		
FBgn0033932	Dh44-R1	HGNC:2358	OMIM:602034	CRHR2	13		
FBgn0033932	Dh44-R1	HGNC:51483		LINC02210-CRHR1	8		
FBgn0033933	CG10104	HGNC:2530	OMIM:116890	CTSE	3		
FBgn0033933	CG10104	HGNC:8887	OMIM:169730	PGA5	3		
FBgn0033933	CG10104	HGNC:8886	OMIM:169720	PGA4	3		
FBgn0033933	CG10104	HGNC:9958	OMIM:179820	REN	6	267430,613092	267430[RENAL TUBULAR DYSGENESIS; RTD],613092[TUBULOINTERSTITIAL KIDNEY DISEASE, AUTOSOMAL DOMINANT, 4; ADTKD4]
FBgn0033933	CG10104	HGNC:8890	OMIM:169740	PGC	3		
FBgn0033933	CG10104	HGNC:13395	OMIM:605631	NAPSA	6		
FBgn0033933	CG10104	HGNC:2529	OMIM:116840	CTSD	6	610127	610127[CEROID LIPOFUSCINOSIS, NEURONAL, 10; CLN10]
FBgn0033935	Sin1	HGNC:18752	OMIM:610558	MAPKAP1	15		
FBgn0033936	Achl	HGNC:24012	OMIM:611300	LARP6	9		
FBgn0033943	CG12869	HGNC:26741		CES4A	4		
FBgn0033943	CG12869	HGNC:108	OMIM:100740	ACHE	3	112100	112100[YT BLOOD GROUP ANTIGEN]
FBgn0033943	CG12869	HGNC:983	OMIM:177400	BCHE	3	617936	617936[BUTYRYLCHOLINESTERASE DEFICIENCY; BCHED]
FBgn0033943	CG12869	HGNC:26459	OMIM:618678	CES5A	4		
FBgn0033943	CG12869	HGNC:1863	OMIM:114835	CES1	4	618057	618057[DRUG METABOLISM, ALTERED, CES1-RELATED]
FBgn0033943	CG12869	HGNC:1864	OMIM:605278	CES2	3		
FBgn0033943	CG12869	HGNC:1865	OMIM:605279	CES3	4		
FBgn0050077	Blos1	HGNC:4200	OMIM:601444	BLOC1S1	13		
FBgn0010638	Sec61beta	HGNC:16993	OMIM:609214	SEC61B	14		
FBgn0033949	Had2	HGNC:18246	OMIM:609877	CRYL1	12		
FBgn0033948	CG12863	HGNC:22917	OMIM:611792	ZCCHC4	14		
FBgn0019938	Polr1A	HGNC:17264	OMIM:616404	POLR1A	13	616462	616462[ACROFACIAL DYSOSTOSIS, CINCINNATI TYPE; AFDCIN]
FBgn0010397	LamC	HGNC:6637	OMIM:150340	LMNB1	11	169500,619179	169500[LEUKODYSTROPHY, DEMYELINATING, ADULT-ONSET, AUTOSOMAL DOMINANT; ADLD],619179[MICROCEPHALY 26, PRIMARY, AUTOSOMAL DOMINANT; MCPH26]
FBgn0010397	LamC	HGNC:6636	OMIM:150330	LMNA	12	115200,151660,176670,181350,212112,248370,605588,610140,613205,616516,619793	115200[CARDIOMYOPATHY, DILATED, 1A; CMD1A],151660[LIPODYSTROPHY, FAMILIAL PARTIAL, TYPE 2; FPLD2],176670[HUTCHINSON-GILFORD PROGERIA SYNDROME; HGPS],181350[EMERY-DREIFUSS MUSCULAR DYSTROPHY 2, AUTOSOMAL DOMINANT; EDMD2],212112[CARDIOMYOPATHY, DILATED, WITH HYPERGONADOTROPIC HYPOGONADISM],248370[MANDIBULOACRAL DYSPLASIA WITH TYPE A LIPODYSTROPHY; MADA],605588[CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2B1; CMT2B1],610140[HEART-HAND SYNDROME, SLOVENIAN TYPE],613205[MUSCULAR DYSTROPHY, CONGENITAL, LMNA-RELATED],616516[EMERY-DREIFUSS MUSCULAR DYSTROPHY 3, AUTOSOMAL RECESSIVE; EDMD3],619793[RESTRICTIVE DERMOPATHY 2; RSDM2]
FBgn0010397	LamC	HGNC:6638	OMIM:150341	LMNB2	12	608709,616540,619180	608709[LIPODYSTROPHY, PARTIAL, ACQUIRED, SUSCEPTIBILITY TO; APLD],616540[EPILEPSY, PROGRESSIVE MYOCLONIC, 9; EPM9],619180[MICROCEPHALY 27, PRIMARY, AUTOSOMAL DOMINANT; MCPH27]
FBgn0033899	CG13016	HGNC:25510		TMEM39B	12		
FBgn0033899	CG13016	HGNC:25600		TMEM39A	14		
FBgn0033901	O-fut1	HGNC:14988	OMIM:607491	POFUT1	13	615327	615327[DOWLING-DEGOS DISEASE 2; DDD2]
FBgn0033903	CG8323	HGNC:31921	OMIM:610818	SLC25A35	12		
FBgn0033903	CG8323	HGNC:27653	OMIM:610817	SLC25A34	13		
FBgn0033904	CG18327	HGNC:31921	OMIM:610818	SLC25A35	12		
FBgn0033904	CG18327	HGNC:27653	OMIM:610817	SLC25A34	13		
FBgn0033905	CG18324	HGNC:31921	OMIM:610818	SLC25A35	11		
FBgn0033905	CG18324	HGNC:27653	OMIM:610817	SLC25A34	12		
FBgn0033906	ReepB	HGNC:30078	OMIM:609346	REEP6	11	617304	617304[RETINITIS PIGMENTOSA 77; RP77]
FBgn0033906	ReepB	HGNC:30077	OMIM:125265	REEP5	14		
FBgn0033913	CG8468	HGNC:17027	OMIM:607550	SLC16A10	3		
FBgn0033913	CG8468	HGNC:10923	OMIM:300095	SLC16A2	3	300523	300523[ALLAN-HERNDON-DUDLEY SYNDROME; AHDS]
FBgn0033913	CG8468	HGNC:10924	OMIM:603877	SLC16A3	5		
FBgn0033913	CG8468	HGNC:16270	OMIM:610409	SLC16A8	7		
FBgn0033913	CG8468	HGNC:26417		SLC16A14	6		
FBgn0033913	CG8468	HGNC:23093	OMIM:615765	SLC16A11	5		
FBgn0033913	CG8468	HGNC:23520	OMIM:614242	SLC16A9	4		
FBgn0033913	CG8468	HGNC:10922	OMIM:600682	SLC16A1	6	245340,610021,616095	245340[ERYTHROCYTE LACTATE TRANSPORTER DEFECT],610021[HYPERINSULINEMIC HYPOGLYCEMIA, FAMILIAL, 7; HHF7],616095[MONOCARBOXYLATE TRANSPORTER 1 DEFICIENCY; MCT1D]
FBgn0033913	CG8468	HGNC:10927	OMIM:603880	SLC16A6	5		
FBgn0033913	CG8468	HGNC:10925	OMIM:603878	SLC16A4	5		
FBgn0033913	CG8468	HGNC:31037		SLC16A13	6		
FBgn0033913	CG8468	HGNC:10926	OMIM:603879	SLC16A5	6		
FBgn0033913	CG8468	HGNC:10928	OMIM:603654	SLC16A7	6		
FBgn0033913	CG8468	HGNC:23094	OMIM:611910	SLC16A12	6	612018	612018[CATARACT 47; CTRCT47]
FBgn0033916	Usp20-33	HGNC:12619	OMIM:615143	USP20	13		
FBgn0033916	Usp20-33	HGNC:20059	OMIM:615146	USP33	10		
FBgn0033917	SmydA-1	HGNC:15513	OMIM:608783	SMYD3	4		
FBgn0033917	SmydA-1	HGNC:20982	OMIM:610663	SMYD2	3		
FBgn0033917	SmydA-1	HGNC:20986	OMIM:606846	SMYD1	3		
FBgn0033918	CG8531	HGNC:25570	OMIM:614827	DNAJC11	14		
FBgn0027538	beta4GalNAcTA	HGNC:928	OMIM:604016	B4GALT5	4		
FBgn0027538	beta4GalNAcTA	HGNC:929	OMIM:604017	B4GALT6	3		
FBgn0027538	beta4GalNAcTA	HGNC:924	OMIM:137060	B4GALT1	10	607091	607091[CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IId; CDG2D]
FBgn0027538	beta4GalNAcTA	HGNC:925	OMIM:604013	B4GALT2	12		
FBgn0027538	beta4GalNAcTA	HGNC:926	OMIM:604014	B4GALT3	11		
FBgn0027538	beta4GalNAcTA	HGNC:927	OMIM:604015	B4GALT4	9		
FBgn0033924	CG8613	HGNC:26125	OMIM:613939	SPATA20	15		
FBgn0033929	Tfb1	HGNC:4655	OMIM:189972	GTF2H1	15		
FBgn0033921	tej	HGNC:20614	OMIM:617748	TDRD5	8		
FBgn0033921	tej	HGNC:30831	OMIM:611258	TDRD7	3	613887	613887[CATARACT 36; CTRCT36]
FBgn0001220	Hsc70-5	HGNC:5233	OMIM:603012	HSPA1B	3		
FBgn0001220	Hsc70-5	HGNC:5234	OMIM:140559	HSPA1L	3		
FBgn0001220	Hsc70-5	HGNC:5238	OMIM:138120	HSPA5	3		
FBgn0001220	Hsc70-5	HGNC:5244	OMIM:600548	HSPA9	15	182170,616854	182170[ANEMIA, SIDEROBLASTIC, 4; SIDBA4],616854[EVEN-PLUS SYNDROME; EVPLS]
FBgn0001220	Hsc70-5	HGNC:5239	OMIM:140555	HSPA6	3		
FBgn0001220	Hsc70-5	HGNC:5235	OMIM:140560	HSPA2	3		
FBgn0001220	Hsc70-5	HGNC:5241	OMIM:600816	HSPA8	3		
FBgn0033915	Snrk	HGNC:30598	OMIM:612760	SNRK	11		
FBgn0033912	RpS23	HGNC:10410	OMIM:603683	RPS23	14	617412	617412[BRACHYCEPHALY, TRICHOMEGALY, AND DEVELOPMENTAL DELAY; BTDD]
FBgn0005613	Sox15	HGNC:11193	OMIM:604747	SOX14	4		
FBgn0005613	Sox15	HGNC:18196	OMIM:612202	SOX7	5		
FBgn0005613	Sox15	HGNC:11200	OMIM:184430	SOX4	3	618506	618506[COFFIN-SIRIS SYNDROME 10; CSS10]
FBgn0005613	Sox15	HGNC:11199	OMIM:313430	SOX3	4	300123,312000	300123[INTELLECTUAL DEVELOPMENTAL DISORDER, X-LINKED, WITH PANHYPOPITUITARISM],312000[PANHYPOPITUITARISM, X-LINKED; PHPX]
FBgn0005613	Sox15	HGNC:11195	OMIM:184429	SOX2	3	206900	206900[MICROPHTHALMIA, SYNDROMIC 3; MCOPS3]
FBgn0005613	Sox15	HGNC:11197	OMIM:604974	SOX21	4		
FBgn0005613	Sox15	HGNC:11198	OMIM:601947	SOX12	5		
FBgn0005613	Sox15	HGNC:11191	OMIM:600898	SOX11	3	615866	615866[COFFIN-SIRIS SYNDROME 9; CSS9]
FBgn0005613	Sox15	HGNC:11189	OMIM:602148	SOX1	3		
FBgn0005613	Sox15	HGNC:11196	OMIM:601297	SOX15	4		
FBgn0005613	Sox15	HGNC:11194	OMIM:601618	SOX18	6	137940,607823	137940[HYPOTRICHOSIS-LYMPHEDEMA-TELANGIECTASIA-RENAL DEFECT SYNDROME; HLTRS],607823[HYPOTRICHOSIS-LYMPHEDEMA-TELANGIECTASIA SYNDROME; HLTS]
FBgn0005613	Sox15	HGNC:18122	OMIM:610928	SOX17	5	613674	613674[VESICOURETERAL REFLUX 3; VUR3]
FBgn0005613	Sox15	HGNC:11311	OMIM:480000	SRY	3	400044,400045	400044[46,XY SEX REVERSAL 1; SRXY1],400045[46,XX SEX REVERSAL 1; SRXX1]
FBgn0033907	mRpS16	HGNC:14048	OMIM:609204	MRPS16	14	610498	610498[COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 2; COXPD2]
FBgn0033902	eIF3m	HGNC:24460	OMIM:609641	EIF3M	13		
FBgn0033900	CysRS-m	HGNC:1493	OMIM:123859	CARS1	3	618891	618891[MICROCEPHALY, DEVELOPMENTAL DELAY, AND BRITTLE HAIR SYNDROME; MDBH]
FBgn0033900	CysRS-m	HGNC:25695	OMIM:612800	CARS2	15	616672	616672[COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 27; COXPD27]
FBgn0040751	CG13018	HGNC:33848	OMIM:613920	COA5	13	616500	616500[MITOCHONDRIAL COMPLEX IV DEFICIENCY, NUCLEAR TYPE 9; MC4DN9]
FBgn0033897	Rcd1	HGNC:25473	OMIM:617742	KANSL3	10		
FBgn0013770	Cp1	HGNC:2538	OMIM:603308	CTSV	10		
FBgn0013770	Cp1	HGNC:2537	OMIM:116880	CTSL	8		
FBgn0013770	Cp1	HGNC:2536	OMIM:601105	CTSK	3	265800	265800[PYCNODYSOSTOSIS]
FBgn0013770	Cp1	HGNC:2545	OMIM:116845	CTSS	3		
FBgn0033891	CG8067	HGNC:15899	OMIM:612360	NDUFAF5	14	618238	618238[MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 16; MC1DN16]
FBgn0033893	CG18371	HGNC:179	OMIM:600875	ACYP1	9		
FBgn0033893	CG18371	HGNC:180	OMIM:102595	ACYP2	10		
FBgn0040752	Prosap	HGNC:14294	OMIM:606230	SHANK3	8	606232,613950	606232[PHELAN-MCDERMID SYNDROME; PHMDS],613950[SCHIZOPHRENIA 15; SCZD15]
FBgn0040752	Prosap	HGNC:15474	OMIM:604999	SHANK1	11		
FBgn0040752	Prosap	HGNC:14295	OMIM:603290	SHANK2	10	613436	613436[AUTISM, SUSCEPTIBILITY TO, 17; AUTS17]
FBgn0020620	RN-tre	HGNC:16858	OMIM:605405	USP6NL	11		
FBgn0020620	RN-tre	HGNC:12629	OMIM:604334	USP6	3		
FBgn0020620	RN-tre	HGNC:29860	OMIM:610810	TBC1D3G	6		
FBgn0020620	RN-tre	HGNC:18257	OMIM:610809	TBC1D3F	8		
FBgn0020620	RN-tre	HGNC:27011	OMIM:610144	TBC1D3B	8		
FBgn0020620	RN-tre	HGNC:19031	OMIM:607741	TBC1D3	8		
FBgn0020620	RN-tre	HGNC:30708	OMIM:610811	TBC1D3H	9		
FBgn0020620	RN-tre	HGNC:26858		TBC1D28	6		
FBgn0020620	RN-tre	HGNC:24889	OMIM:610806	TBC1D3C	7		
FBgn0020620	RN-tre	HGNC:51245		TBC1D3K	6		
FBgn0020620	RN-tre	HGNC:51246		TBC1D3L	3		
FBgn0020620	RN-tre	HGNC:28944	OMIM:610807	TBC1D3D	6		
FBgn0020620	RN-tre	HGNC:27071	OMIM:610808	TBC1D3E	6		
FBgn0020620	RN-tre	HGNC:32709		TBC1D3I	6		
FBgn0020620	RN-tre	HGNC:28745		TBC1D26	6		
FBgn0033890	Ctf4	HGNC:23170	OMIM:608126	WDHD1	14		
FBgn0033889	CG6701	HGNC:7200	OMIM:610742	MOV10	6		
FBgn0033889	CG6701	HGNC:7201	OMIM:605794	MOV10L1	3	619878	619878[SPERMATOGENIC FAILURE 73; SPGF73]
FBgn0033889	CG6701	HGNC:445	OMIM:608465	SETX	3	602433,606002	602433[AMYOTROPHIC LATERAL SCLEROSIS 4, JUVENILE; ALS4],606002[SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE, WITH AXONAL NEUROPATHY 2; SCAN2]
FBgn0033887	St4	HGNC:11456	OMIM:602385	SULT1C2	8		
FBgn0033887	St4	HGNC:14903	OMIM:608359	SULT4A1	6		
FBgn0033887	St4	HGNC:30004	OMIM:615819	SULT1A4	7		
FBgn0033887	St4	HGNC:33543	OMIM:617151	SULT1C3	7		
FBgn0033887	St4	HGNC:11459	OMIM:604125	SULT2B1	7	617571	617571[ICHTHYOSIS, CONGENITAL, AUTOSOMAL RECESSIVE 14; ARCI14]
FBgn0033887	St4	HGNC:11457	OMIM:608357	SULT1C4	9		
FBgn0033887	St4	HGNC:17845	OMIM:608436	SULT1B1	7		
FBgn0033887	St4	HGNC:11458	OMIM:125263	SULT2A1	7		
FBgn0033887	St4	HGNC:11377	OMIM:600043	SULT1E1	7		
FBgn0033887	St4	HGNC:11455	OMIM:600641	SULT1A3	5		
FBgn0033887	St4	HGNC:11453	OMIM:171150	SULT1A1	7		
FBgn0033887	St4	HGNC:33433	OMIM:617152	SULT6B1	5		
FBgn0033887	St4	HGNC:11454	OMIM:601292	SULT1A2	7		
FBgn0033886	Rpn13	HGNC:15759	OMIM:610650	ADRM1	13		
FBgn0033885	DJ-1alpha	HGNC:16369	OMIM:602533	PARK7	14	606324	606324[PARKINSON DISEASE 7, AUTOSOMAL RECESSIVE EARLY-ONSET; PARK7]
FBgn0013733	shot	HGNC:1090	OMIM:113810	DST	11	614653,615425	614653[NEUROPATHY, HEREDITARY SENSORY AND AUTONOMIC, TYPE VI; HSAN6],615425[EPIDERMOLYSIS BULLOSA SIMPLEX 3, LOCALIZED OR GENERALIZED INTERMEDIATE, WITH BP230 DEFICIENCY; EBS3]
FBgn0013733	shot	HGNC:3052	OMIM:125647	DSP	3	605676,607450,607655,609638,612908,615821	605676[CARDIOMYOPATHY, DILATED, WITH WOOLLY HAIR AND KERATODERMA; DCWHK],607450[ARRHYTHMOGENIC RIGHT VENTRICULAR DYSPLASIA, FAMILIAL, 8; ARVD8],607655[SKIN FRAGILITY-WOOLLY HAIR SYNDROME; SFWHS],609638[EPIDERMOLYSIS BULLOSA, LETHAL ACANTHOLYTIC; EBLA],612908[KERATOSIS PALMOPLANTARIS STRIATA II; PPKS2],615821[CARDIOMYOPATHY, DILATED, WITH WOOLLY HAIR, KERATODERMA, AND TOOTH AGENESIS; DCWHKTA]
FBgn0013733	shot	HGNC:9069	OMIM:601282	PLEC	4	131950,226670,612138,613723,616487	131950[EPIDERMOLYSIS BULLOSA SIMPLEX 5A, OGNA TYPE; EBS5A],226670[EPIDERMOLYSIS BULLOSA SIMPLEX 5B, WITH MUSCULAR DYSTROPHY; EBS5B],612138[EPIDERMOLYSIS BULLOSA SIMPLEX 5C, WITH PYLORIC ATRESIA; EBS5C],613723[MUSCULAR DYSTROPHY, LIMB-GIRDLE, AUTOSOMAL RECESSIVE 17; LGMDR17],616487[EPIDERMOLYSIS BULLOSA SIMPLEX 5D, GENERALIZED INTERMEDIATE, AUTOSOMAL RECESSIVE; EBS5D]
FBgn0013733	shot	HGNC:13664	OMIM:608271	MACF1	10	618325	618325[LISSENCEPHALY 9 WITH COMPLEX BRAINSTEM MALFORMATION; LIS9]
FBgn0033883	CG16935	HGNC:19691	OMIM:608205	MECR	15	617282	617282[DYSTONIA, CHILDHOOD-ONSET, WITH OPTIC ATROPHY AND BASAL GANGLIA ABNORMALITIES; DYTOABG]
FBgn0033859	fand	HGNC:14089	OMIM:610850	XAB2	14		
FBgn0033860	S-Lap5	HGNC:18449	OMIM:170250	LAP3	9		
FBgn0033874	CG6347	HGNC:2538	OMIM:603308	CTSV	4		
FBgn0033874	CG6347	HGNC:2537	OMIM:116880	CTSL	4		
FBgn0033880	CG6553	HGNC:27046	OMIM:617986	LDLRAD3	3		
FBgn0033879	Echs1	HGNC:3151	OMIM:602292	ECHS1	15	616277	616277[MITOCHONDRIAL SHORT-CHAIN ENOYL-CoA HYDRATASE 1 DEFICIENCY; ECHS1D]
FBgn0033876	Syngr	HGNC:11502	OMIM:608373	SYNGR4	6		
FBgn0033876	Syngr	HGNC:11499	OMIM:603926	SYNGR2	11		
FBgn0033876	Syngr	HGNC:11498	OMIM:603925	SYNGR1	14		
FBgn0033876	Syngr	HGNC:11501	OMIM:603927	SYNGR3	11		
FBgn0000662	fl(2)d	HGNC:16846	OMIM:605442	WTAP	11		
FBgn0033868	S-Lap7	HGNC:18449	OMIM:170250	LAP3	9		
FBgn0033865	CG6220	HGNC:16783	OMIM:607393	CDC73	6	145000,145001,608266	145000[HYPERPARATHYROIDISM 1; HRPT1],145001[HYPERPARATHYROIDISM 2 WITH JAW TUMORS; HRPT2],608266[PARATHYROID CARCINOMA]
FBgn0019928	Ser8	HGNC:9486	OMIM:613578	PRSS3	4		
FBgn0019928	Ser8	HGNC:9475	OMIM:276000	PRSS1	4	167800	167800[PANCREATITIS, HEREDITARY; PCTT]
FBgn0033845	mars	HGNC:16864	OMIM:617859	DLGAP5	7		
FBgn0033846	mip120	HGNC:7446	OMIM:604374	TESMIN	6		
FBgn0033846	mip120	HGNC:25397	OMIM:613367	LIN54	10		
FBgn0024556	mEFTu1	HGNC:12420	OMIM:602389	TUFM	13	610678	610678[COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 4; COXPD4]
FBgn0014877	Roe1	HGNC:21060	OMIM:618545	GRPEL2	8		
FBgn0014877	Roe1	HGNC:19696	OMIM:606173	GRPEL1	14		
FBgn0033856	CG13334	HGNC:28335	OMIM:618928	LDHAL6A	7		
FBgn0033856	CG13334	HGNC:6544	OMIM:150150	LDHC	7		
FBgn0033856	CG13334	HGNC:21481		LDHAL6B	6		
FBgn0033856	CG13334	HGNC:6541	OMIM:150100	LDHB	8	614128	614128[LACTATE DEHYDROGENASE B DEFICIENCY; LDHBD]
FBgn0033856	CG13334	HGNC:6535	OMIM:150000	LDHA	7	612933	612933[GLYCOGEN STORAGE DISEASE XI; GSD11]
FBgn0027581	CG6191	HGNC:16143	OMIM:618772	CABLES2	8		
FBgn0027581	CG6191	HGNC:25097	OMIM:609194	CABLES1	10		
FBgn0053156	Nadk1b	HGNC:29831	OMIM:611616	NADK	14		
FBgn0033853	Nadk1a	HGNC:29831	OMIM:611616	NADK	14		
FBgn0004638	drk	HGNC:4566	OMIM:108355	GRB2	14		
FBgn0004638	drk	HGNC:4562	OMIM:604330	GRAP	6	618456	618456[DEAFNESS, AUTOSOMAL RECESSIVE 114; DFNB114]
FBgn0004638	drk	HGNC:37240		GRAPL	4		
FBgn0004638	drk	HGNC:4563	OMIM:604518	GRAP2	4		
FBgn0033844	bbc	HGNC:24289	OMIM:616751	CEPT1	13		
FBgn0033844	bbc	HGNC:17852	OMIM:616747	CHPT1	11		
FBgn0033844	bbc	HGNC:29361	OMIM:607915	SELENOI	4	618768	618768[SPASTIC PARAPLEGIA 81, AUTOSOMAL RECESSIVE; SPG81]
FBgn0033842	cbc	HGNC:16999	OMIM:608757	CLP1	13	615803	615803[PONTOCEREBELLAR HYPOPLASIA, TYPE 10; PCH10]
FBgn0000119	arr	HGNC:6698	OMIM:603507	LRP6	13	610947,616724	610947[CORONARY ARTERY DISEASE, AUTOSOMAL DOMINANT 2; ADCAD2],616724[TOOTH AGENESIS, SELECTIVE, 7; STHAG7]
FBgn0000119	arr	HGNC:6697	OMIM:603506	LRP5	12	144750,166710,259770,601813,601884,607634,607636,617875	144750[ENDOSTEAL HYPEROSTOSIS, AUTOSOMAL DOMINANT],166710[OSTEOPOROSIS],259770[OSTEOPOROSIS-PSEUDOGLIOMA SYNDROME; OPPG],601813[EXUDATIVE VITREORETINOPATHY 4; EVR4],601884[BONE MINERAL DENSITY QUANTITATIVE TRAIT LOCUS 1; BMND1],607634[OSTEOPETROSIS, AUTOSOMAL DOMINANT 1; OPTA1],607636[MOVED TO 144750],617875[POLYCYSTIC LIVER DISEASE 4 WITH OR WITHOUT KIDNEY CYSTS; PCLD4]
FBgn0000119	arr	HGNC:6696	OMIM:604270	LRP4	4	212780,614305,616304	212780[CENANI-LENZ SYNDACTYLY SYNDROME; CLSS],614305[SCLEROSTEOSIS 2; SOST2],616304[MYASTHENIC SYNDROME, CONGENITAL, 17; CMS17]
FBgn0000119	arr	HGNC:6694	OMIM:600073	LRP2	3	222448	222448[DONNAI-BARROW SYNDROME]
FBgn0000119	arr	HGNC:6692	OMIM:107770	LRP1	3	604093	604093[KERATOSIS PILARIS ATROPHICANS; KPA]
FBgn0000119	arr	HGNC:6693	OMIM:608766	LRP1B	3		
FBgn0000119	arr	HGNC:25323		LRP5L	4		
FBgn0050062	CG30062	HGNC:28387	OMIM:612750	LYZL4	6		
FBgn0050062	CG30062	HGNC:31353	OMIM:300593	SPACA5	4		
FBgn0050062	CG30062	HGNC:19142		SPACA5B	5		
FBgn0050062	CG30062	HGNC:29613	OMIM:612748	LYZL2	5		
FBgn0050062	CG30062	HGNC:16260	OMIM:612749	SPACA3	6		
FBgn0050062	CG30062	HGNC:6480	OMIM:149750	LALBA	5		
FBgn0050062	CG30062	HGNC:6740	OMIM:153450	LYZ	6	105200	105200[AMYLOIDOSIS, FAMILIAL VISCERAL]
FBgn0050062	CG30062	HGNC:30502		LYZL1	5		
FBgn0050062	CG30062	HGNC:29614	OMIM:612751	LYZL6	6		
FBgn0260475	CG30059	HGNC:4422	OMIM:607664	GNS	10	252940	252940[MUCOPOLYSACCHARIDOSIS, TYPE IIID; MPS3D]
FBgn0260475	CG30059	HGNC:20392	OMIM:610013	SULF2	3		
FBgn0260475	CG30059	HGNC:719	OMIM:300180	ARSE	3	302950	302950[CHONDRODYSPLASIA PUNCTATA 1, X-LINKED RECESSIVE; CDPX1]
FBgn0260475	CG30059	HGNC:20391	OMIM:610012	SULF1	3		
FBgn0033836	CG18278	HGNC:4422	OMIM:607664	GNS	13	252940	252940[MUCOPOLYSACCHARIDOSIS, TYPE IIID; MPS3D]
FBgn0033836	CG18278	HGNC:20392	OMIM:610013	SULF2	4		
FBgn0033836	CG18278	HGNC:719	OMIM:300180	ARSE	3	302950	302950[CHONDRODYSPLASIA PUNCTATA 1, X-LINKED RECESSIVE; CDPX1]
FBgn0033836	CG18278	HGNC:20391	OMIM:610012	SULF1	4		
FBgn0033830	CG10814	HGNC:18308	OMIM:300777	TMLHE	3	300872	300872[AUTISM, SUSCEPTIBILITY TO, X-LINKED 6; AUTSX6]
FBgn0033830	CG10814	HGNC:964	OMIM:603312	BBOX1	13		
FBgn0020391	Nrk	HGNC:7525	OMIM:601296	MUSK	12	208150,616325	208150[FETAL AKINESIA DEFORMATION SEQUENCE 1; FADS1],616325[MYASTHENIC SYNDROME, CONGENITAL, 9, ASSOCIATED WITH ACETYLCHOLINE RECEPTOR DEFICIENCY; CMS9]
FBgn0020391	Nrk	HGNC:10256	OMIM:602336	ROR1	3	617654	617654[DEAFNESS, AUTOSOMAL RECESSIVE 108; DFNB108]
FBgn0020391	Nrk	HGNC:10257	OMIM:602337	ROR2	3	113000,268310	113000[BRACHYDACTYLY, TYPE B1; BDB1],268310[ROBINOW SYNDROME, AUTOSOMAL RECESSIVE 1; RRS1]
FBgn0053138	AGBE	HGNC:4180	OMIM:607839	GBE1	14	232500,263570	232500[GLYCOGEN STORAGE DISEASE IV; GSD4],263570[POLYGLUCOSAN BODY NEUROPATHY, ADULT FORM; APBN]
FBgn0027079	ValRS	HGNC:12651	OMIM:192150	VARS	15	617802	617802[NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, SEIZURES, AND CORTICAL ATROPHY; NDMSCA]
FBgn0027079	ValRS	HGNC:21642	OMIM:612802	VARS2	5	615917	615917[COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 20; COXPD20]
FBgn0033808	CG4627	HGNC:24530		TMEM186	13		
FBgn0040754	CG17059	HGNC:21314	OMIM:619349	COPS9	11		
FBgn0011763	Dp	HGNC:11751	OMIM:602160	TFDP2	11		
FBgn0011763	Dp	HGNC:11749	OMIM:189902	TFDP1	11		
FBgn0011763	Dp	HGNC:24603	OMIM:300772	TFDP3	9		
FBgn0033813	fsd	HGNC:20173		TMEM183A	11		
FBgn0033813	fsd	HGNC:33205	OMIM:611365	TMEM183B	7		
FBgn0033815	CG4676	HGNC:27387		ZDHHC24	13		
FBgn0033815	CG4676	HGNC:20106		ZDHHC22	3		
FBgn0033819	CG4714	HGNC:26900	OMIM:619347	CCDC96	3		
FBgn0033816	CG4679	HGNC:24717	OMIM:614918	PTCD3	14	619057	619057[COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 51; COXPD51]
FBgn0033814	Qsox1	HGNC:9756	OMIM:603120	QSOX1	14		
FBgn0033814	Qsox1	HGNC:30249	OMIM:612860	QSOX2	14		
FBgn0033812	Pex13	HGNC:8855	OMIM:601789	PEX13	14	614883,614885	614883[PEROXISOME BIOGENESIS DISORDER 11A (ZELLWEGER); PBD11A],614885[PEROXISOME BIOGENESIS DISORDER 11B; PBD11B]
FBgn0043010	Fsn	HGNC:29148	OMIM:609112	FBXO45	13		
FBgn0005654	Orc3	HGNC:8489	OMIM:604972	ORC3	12		
FBgn0053182	Kdm4B	HGNC:29136	OMIM:609765	KDM4B	9	619320	619320[INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL DOMINANT 65; MRD65]
FBgn0053182	Kdm4B	HGNC:17071	OMIM:605469	KDM4C	10		
FBgn0053182	Kdm4B	HGNC:25498	OMIM:609766	KDM4D	7		
FBgn0053182	Kdm4B	HGNC:22978	OMIM:609764	KDM4A	10		
FBgn0053182	Kdm4B	HGNC:37098	OMIM:616581	KDM4E	7		
FBgn0033799	GLaz	HGNC:612	OMIM:107740	APOD	4		
FBgn0020370	TppII	HGNC:12016	OMIM:190470	TPP2	15	619220	619220[IMMUNODEFICIENCY 78 WITH AUTOIMMUNITY AND DEVELOPMENTAL DELAY; IMD78]
FBgn0033794	CG13326	HGNC:30964	OMIM:611226	ARMC3	9		
FBgn0000181	bic	HGNC:30547		BTF3L4	13		
FBgn0000181	bic	HGNC:1125	OMIM:602542	BTF3	12		
FBgn0002069	AspRS	HGNC:2678	OMIM:603084	DARS	15	615281	615281[HYPOMYELINATION WITH BRAINSTEM AND SPINAL CORD INVOLVEMENT AND LEG SPASTICITY; HBSL]
FBgn0003975	vg	HGNC:20985	OMIM:300583	VGLL1	4		
FBgn0003975	vg	HGNC:20232	OMIM:609979	VGLL2	8		
FBgn0003975	vg	HGNC:24327	OMIM:609980	VGLL3	7		
FBgn0033782	sug	HGNC:29450	OMIM:608539	GLIS2	10	611498	611498[NEPHRONOPHTHISIS 7; NPHP7]
FBgn0033785	Sans	HGNC:16356	OMIM:607696	USH1G	14	606943	606943[USHER SYNDROME, TYPE IG; USH1G]
FBgn0033785	Sans	HGNC:26795	OMIM:609901	ANKS4B	10		
FBgn0033791	Drl-2	HGNC:10481	OMIM:600524	RYK	8		
FBgn0005624	Psc	HGNC:17615	OMIM:610231	PCGF1	5		
FBgn0005624	Psc	HGNC:12929	OMIM:600346	PCGF2	5	618371	618371[TURNPENNY-FRY SYNDROME; TPFS]
FBgn0005624	Psc	HGNC:21156	OMIM:607816	PCGF6	3		
FBgn0005624	Psc	HGNC:28264	OMIM:617407	PCGF5	5		
FBgn0005624	Psc	HGNC:48326		COMMD3-BMI1	5		
FBgn0005624	Psc	HGNC:1066	OMIM:164831	BMI1	6		
FBgn0005624	Psc	HGNC:10066	OMIM:617543	PCGF3	3		
FBgn0004512	Mdr49	HGNC:40	OMIM:171050	ABCB1	8	120080,612244	120080[COLCHICINE RESISTANCE],612244[INFLAMMATORY BOWEL DISEASE 13; IBD13]
FBgn0004512	Mdr49	HGNC:45	OMIM:171060	ABCB4	9	600803,602347,614972	600803[GALLBLADDER DISEASE 1; GBD1],602347[CHOLESTASIS, PROGRESSIVE FAMILIAL INTRAHEPATIC, 3; PFIC3],614972[CHOLESTASIS, INTRAHEPATIC, OF PREGNANCY 3; ICP3]
FBgn0004512	Mdr49	HGNC:42	OMIM:603201	ABCB11	9	601847,605479	601847[CHOLESTASIS, PROGRESSIVE FAMILIAL INTRAHEPATIC, 2; PFIC2],605479[CHOLESTASIS, BENIGN RECURRENT INTRAHEPATIC, 2; BRIC2]
FBgn0004512	Mdr49	HGNC:46	OMIM:611785	ABCB5	8		
FBgn0033784	SCCRO3	HGNC:18184	OMIM:605905	DCUN1D1	3		
FBgn0033784	SCCRO3	HGNC:28409	OMIM:616522	DCUN1D5	3		
FBgn0033784	SCCRO3	HGNC:28734	OMIM:616167	DCUN1D3	13		
FBgn0033784	SCCRO3	HGNC:20328		DCUN1D2	3		
FBgn0033783	CG17019	HGNC:17297	OMIM:608299	RNF34	12		
FBgn0033783	CG17019	HGNC:24821	OMIM:609735	RFFL	12		
FBgn0025692	Lfg	HGNC:4589	OMIM:138251	GRINA	8		
FBgn0025692	Lfg	HGNC:17067	OMIM:604306	FAIM2	5		
FBgn0025692	Lfg	HGNC:23410	OMIM:610364	TMBIM1	4		
FBgn0025692	Lfg	HGNC:24257	OMIM:616874	TMBIM4	6		
FBgn0033778	Balat	HGNC:25417	OMIM:611699	SVOP	3		
FBgn0033778	Balat	HGNC:8494	OMIM:604047	SLC22A13	5		
FBgn0033778	Balat	HGNC:10970	OMIM:607582	SLC22A6	5		
FBgn0033778	Balat	HGNC:20302	OMIM:608276	SLC22A16	5		
FBgn0033778	Balat	HGNC:10968	OMIM:604190	SLC22A4	7	180300	180300[RHEUMATOID ARTHRITIS; RA]
FBgn0033778	Balat	HGNC:10969	OMIM:603377	SLC22A5	7	212140	212140[CARNITINE DEFICIENCY, SYSTEMIC PRIMARY; CDSP]
FBgn0033778	Balat	HGNC:8495	OMIM:604048	SLC22A14	4		
FBgn0033778	Balat	HGNC:10971	OMIM:604995	SLC22A7	5		
FBgn0033778	Balat	HGNC:10972	OMIM:607581	SLC22A8	5		
FBgn0033778	Balat	HGNC:10966	OMIM:602608	SLC22A2	4		
FBgn0033778	Balat	HGNC:21106	OMIM:611697	SLC22A23	3		
FBgn0033778	Balat	HGNC:32935	OMIM:610792	SLC22A25	5		
FBgn0033778	Balat	HGNC:10963	OMIM:602607	SLC22A1	4		
FBgn0033778	Balat	HGNC:10967	OMIM:604842	SLC22A3	4		
FBgn0033778	Balat	HGNC:23095	OMIM:611461	SLC22A17	3		
FBgn0033778	Balat	HGNC:17989	OMIM:607096	SLC22A12	5	220150	220150[HYPOURICEMIA, RENAL, 1; RHUC1]
FBgn0033778	Balat	HGNC:27091		SLC22A31	3		
FBgn0033778	Balat	HGNC:18120	OMIM:607097	SLC22A11	4		
FBgn0033778	Balat	HGNC:16261	OMIM:607579	SLC22A9	4		
FBgn0033778	Balat	HGNC:28542	OMIM:611698	SLC22A24	4		
FBgn0033778	Balat	HGNC:18057	OMIM:607580	SLC22A10	4		
FBgn0050486	CG30486	HGNC:8946	OMIM:607076	PI15	3		
FBgn0050486	CG30486	HGNC:16249		R3HDML	3		
FBgn0050486	CG30486	HGNC:21245		PI16	5		
FBgn0050486	CG30486	HGNC:17001	OMIM:602692	GLIPR1	3		
FBgn0050486	CG30486	HGNC:28392	OMIM:610395	GLIPR1L1	4		
FBgn0050486	CG30486	HGNC:25248	OMIM:612434	CRISPLD2	3		
FBgn0050486	CG30486	HGNC:16904	OMIM:618062	CRISP3	4		
FBgn0050486	CG30486	HGNC:304	OMIM:601193	CRISP1	4		
FBgn0050486	CG30486	HGNC:12024	OMIM:187430	CRISP2	4		
FBgn0050486	CG30486	HGNC:33849	OMIM:616572	CLEC18B	4		
FBgn0050486	CG30486	HGNC:30388	OMIM:616571	CLEC18A	3		
FBgn0050488	antr	HGNC:8946	OMIM:607076	PI15	3		
FBgn0050488	antr	HGNC:16249		R3HDML	3		
FBgn0050488	antr	HGNC:21245		PI16	4		
FBgn0050488	antr	HGNC:28392	OMIM:610395	GLIPR1L1	4		
FBgn0050488	antr	HGNC:25248	OMIM:612434	CRISPLD2	3		
FBgn0050488	antr	HGNC:16904	OMIM:618062	CRISP3	3		
FBgn0050488	antr	HGNC:304	OMIM:601193	CRISP1	3		
FBgn0050488	antr	HGNC:12024	OMIM:187430	CRISP2	3		
FBgn0050488	antr	HGNC:33849	OMIM:616572	CLEC18B	3		
FBgn0050488	antr	HGNC:30388	OMIM:616571	CLEC18A	3		
FBgn0033775	Cyp9h1	HGNC:2638	OMIM:605325	CYP3A5	7	145500	145500[HYPERTENSION, ESSENTIAL]
FBgn0033775	Cyp9h1	HGNC:17450	OMIM:606534	CYP3A43	6		
FBgn0033775	Cyp9h1	HGNC:11609	OMIM:274180	TBXAS1	5	231095	231095[GHOSAL HEMATODIAPHYSEAL DYSPLASIA; GHDD]
FBgn0033775	Cyp9h1	HGNC:2637	OMIM:124010	CYP3A4	6	619073	619073[VITAMIN D-DEPENDENT RICKETS, TYPE 3; VDDR3]
FBgn0033775	Cyp9h1	HGNC:51504		CYP3A7-CYP3A51P	5		
FBgn0011592	fra	HGNC:2701	OMIM:120470	DCC	12	114500,133239,157600,617542	114500[COLORECTAL CANCER; CRC],133239[ESOPHAGEAL CANCER],157600[MIRROR MOVEMENTS 1; MRMV1],617542[GAZE PALSY, FAMILIAL HORIZONTAL, WITH PROGRESSIVE SCOLIOSIS 2, WITH IMPAIRED INTELLECTUAL DEVELOPMENT; HGPPS2]
FBgn0011592	fra	HGNC:7754	OMIM:601907	NEO1	13		
FBgn0033753	Cyp301a1	HGNC:2606	OMIM:609506	CYP27B1	4	264700	264700[VITAMIN D HYDROXYLATION-DEFICIENT RICKETS, TYPE 1A; VDDR1A]
FBgn0033753	Cyp301a1	HGNC:33480		CYP27C1	4		
FBgn0033753	Cyp301a1	HGNC:2605	OMIM:606530	CYP27A1	4	213700	213700[CEREBROTENDINOUS XANTHOMATOSIS; CTX]
FBgn0033753	Cyp301a1	HGNC:2602	OMIM:126065	CYP24A1	5	143880	143880[HYPERCALCEMIA, INFANTILE, 1; HCINF1]
FBgn0033755	ClC-b	HGNC:2025	OMIM:602727	CLCN7	15	166600,611490,618541	166600[OSTEOPETROSIS, AUTOSOMAL DOMINANT 2; OPTA2],611490[OSTEOPETROSIS,  AUTOSOMAL RECESSIVE 4; OPTB4],618541[HYPOPIGMENTATION, ORGANOMEGALY, AND DELAYED MYELINATION AND DEVELOPMENT; HOD]
FBgn0027356	Amph	HGNC:471	OMIM:600418	AMPH	11		
FBgn0027356	Amph	HGNC:1052	OMIM:601248	BIN1	12	255200	255200[MYOPATHY, CENTRONUCLEAR, 2; CNM2]
FBgn0027356	Amph	HGNC:1053	OMIM:605936	BIN2	7		
FBgn0027356	Amph	HGNC:1054	OMIM:606396	BIN3	3		
FBgn0004435	Galphaq	HGNC:4379	OMIM:139313	GNA11	11	145981,615361	145981[HYPOCALCIURIC HYPERCALCEMIA, FAMILIAL, TYPE II; HHC2],615361[HYPOCALCEMIA, AUTOSOMAL DOMINANT 2; HYPOC2]
FBgn0004435	Galphaq	HGNC:4390	OMIM:600998	GNAQ	12	163000,185300	163000[CAPILLARY MALFORMATIONS, CONGENITAL; CMC],185300[STURGE-WEBER SYNDROME; SWS]
FBgn0004435	Galphaq	HGNC:4394	OMIM:139340	GNAT2	3	613856	613856[ACHROMATOPSIA 4; ACHM4]
FBgn0004435	Galphaq	HGNC:4395	OMIM:139160	GNAZ	3		
FBgn0004435	Galphaq	HGNC:4382	OMIM:604397	GNA14	7		
FBgn0004435	Galphaq	HGNC:22800	OMIM:139395	GNAT3	3		
FBgn0004435	Galphaq	HGNC:4383	OMIM:139314	GNA15	3		
FBgn0050054	CG30054	HGNC:4387	OMIM:139370	GNAI3	3	602483	602483[AURICULOCONDYLAR SYNDROME 1; ARCND1]
FBgn0050054	CG30054	HGNC:4379	OMIM:139313	GNA11	7	145981,615361	145981[HYPOCALCIURIC HYPERCALCEMIA, FAMILIAL, TYPE II; HHC2],615361[HYPOCALCEMIA, AUTOSOMAL DOMINANT 2; HYPOC2]
FBgn0050054	CG30054	HGNC:4381	OMIM:604406	GNA13	4		
FBgn0050054	CG30054	HGNC:4390	OMIM:600998	GNAQ	7	163000,185300	163000[CAPILLARY MALFORMATIONS, CONGENITAL; CMC],185300[STURGE-WEBER SYNDROME; SWS]
FBgn0050054	CG30054	HGNC:4385	OMIM:139360	GNAI2	3	192605	192605[VENTRICULAR TACHYCARDIA, FAMILIAL]
FBgn0050054	CG30054	HGNC:4394	OMIM:139340	GNAT2	3	613856	613856[ACHROMATOPSIA 4; ACHM4]
FBgn0050054	CG30054	HGNC:4388	OMIM:139312	GNAL	3	615073	615073[DYSTONIA 25; DYT25]
FBgn0050054	CG30054	HGNC:4380	OMIM:604394	GNA12	3		
FBgn0050054	CG30054	HGNC:4395	OMIM:139160	GNAZ	4		
FBgn0050054	CG30054	HGNC:4382	OMIM:604397	GNA14	5		
FBgn0050054	CG30054	HGNC:22800	OMIM:139395	GNAT3	4		
FBgn0050054	CG30054	HGNC:4393	OMIM:139330	GNAT1	3	610444,616389	610444[NIGHT BLINDNESS, CONGENITAL STATIONARY, AUTOSOMAL DOMINANT 3; CSNBAD3],616389[NIGHT BLINDNESS, CONGENITAL STATIONARY, TYPE 1G; CSNB1G]
FBgn0050054	CG30054	HGNC:4383	OMIM:139314	GNA15	6		
FBgn0050054	CG30054	HGNC:4392	OMIM:139320	GNAS	3	103580,166350,174800,219080,603233,612462,612463,617686	103580[PSEUDOHYPOPARATHYROIDISM, TYPE IA; PHP1A],166350[OSSEOUS HETEROPLASIA, PROGRESSIVE; POH],174800[MCCUNE-ALBRIGHT SYNDROME; MAS],219080[ACTH-INDEPENDENT MACRONODULAR ADRENAL HYPERPLASIA; AIMAH1],603233[PSEUDOHYPOPARATHYROIDISM, TYPE IB; PHP1B],612462[PSEUDOHYPOPARATHYROIDISM, TYPE IC; PHP1C],612463[PSEUDOPSEUDOHYPOPARATHYROIDISM; PPHP],617686[PITUITARY ADENOMA 3, MULTIPLE TYPES; PITA3]
FBgn0050054	CG30054	HGNC:4389	OMIM:139311	GNAO1	3	615473,617493	615473[DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 17; DEE17],617493[NEURODEVELOPMENTAL DISORDER WITH INVOLUNTARY MOVEMENTS; NEDIM]
FBgn0033756	CG17760	HGNC:4387	OMIM:139370	GNAI3	3	602483	602483[AURICULOCONDYLAR SYNDROME 1; ARCND1]
FBgn0033756	CG17760	HGNC:4379	OMIM:139313	GNA11	7	145981,615361	145981[HYPOCALCIURIC HYPERCALCEMIA, FAMILIAL, TYPE II; HHC2],615361[HYPOCALCEMIA, AUTOSOMAL DOMINANT 2; HYPOC2]
FBgn0033756	CG17760	HGNC:4381	OMIM:604406	GNA13	4		
FBgn0033756	CG17760	HGNC:4390	OMIM:600998	GNAQ	8	163000,185300	163000[CAPILLARY MALFORMATIONS, CONGENITAL; CMC],185300[STURGE-WEBER SYNDROME; SWS]
FBgn0033756	CG17760	HGNC:4385	OMIM:139360	GNAI2	3	192605	192605[VENTRICULAR TACHYCARDIA, FAMILIAL]
FBgn0033756	CG17760	HGNC:4394	OMIM:139340	GNAT2	3	613856	613856[ACHROMATOPSIA 4; ACHM4]
FBgn0033756	CG17760	HGNC:4388	OMIM:139312	GNAL	3	615073	615073[DYSTONIA 25; DYT25]
FBgn0033756	CG17760	HGNC:4380	OMIM:604394	GNA12	3		
FBgn0033756	CG17760	HGNC:4395	OMIM:139160	GNAZ	4		
FBgn0033756	CG17760	HGNC:4382	OMIM:604397	GNA14	5		
FBgn0033756	CG17760	HGNC:22800	OMIM:139395	GNAT3	4		
FBgn0033756	CG17760	HGNC:4393	OMIM:139330	GNAT1	3	610444,616389	610444[NIGHT BLINDNESS, CONGENITAL STATIONARY, AUTOSOMAL DOMINANT 3; CSNBAD3],616389[NIGHT BLINDNESS, CONGENITAL STATIONARY, TYPE 1G; CSNB1G]
FBgn0033756	CG17760	HGNC:4383	OMIM:139314	GNA15	5		
FBgn0033756	CG17760	HGNC:4392	OMIM:139320	GNAS	3	103580,166350,174800,219080,603233,612462,612463,617686	103580[PSEUDOHYPOPARATHYROIDISM, TYPE IA; PHP1A],166350[OSSEOUS HETEROPLASIA, PROGRESSIVE; POH],174800[MCCUNE-ALBRIGHT SYNDROME; MAS],219080[ACTH-INDEPENDENT MACRONODULAR ADRENAL HYPERPLASIA; AIMAH1],603233[PSEUDOHYPOPARATHYROIDISM, TYPE IB; PHP1B],612462[PSEUDOHYPOPARATHYROIDISM, TYPE IC; PHP1C],612463[PSEUDOPSEUDOHYPOPARATHYROIDISM; PPHP],617686[PITUITARY ADENOMA 3, MULTIPLE TYPES; PITA3]
FBgn0033756	CG17760	HGNC:4389	OMIM:139311	GNAO1	3	615473,617493	615473[DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 17; DEE17],617493[NEURODEVELOPMENTAL DISORDER WITH INVOLUNTARY MOVEMENTS; NEDIM]
FBgn0028683	spt4	HGNC:11467	OMIM:603555	SUPT4H1	14		
FBgn0011604	Iswi	HGNC:11101	OMIM:603375	SMARCA5	12		
FBgn0011604	Iswi	HGNC:11097	OMIM:300012	SMARCA1	14		
FBgn0033762	ZnT49B	HGNC:1329	OMIM:604604	SLC30A9	15	617595	617595[BIRK-LANDAU-PEREZ SYNDROME; BILAPES]
FBgn0033763	CG8646	HGNC:26286	OMIM:610010	ARSJ	8		
FBgn0033763	CG8646	HGNC:714	OMIM:611542	ARSB	8	253200	253200[MUCOPOLYSACCHARIDOSIS, TYPE VI; MPS6]
FBgn0033763	CG8646	HGNC:32521	OMIM:610009	ARSI	9		
FBgn0026741	mRpL18	HGNC:14477	OMIM:611831	MRPL18	14		
FBgn0020930	Dgkepsilon	HGNC:2852	OMIM:601440	DGKE	13	615008	615008[NEPHROTIC SYNDROME, TYPE 7; NPHS7]
FBgn0033774	CG12374	HGNC:2300	OMIM:603101	CPB2	6		
FBgn0033774	CG12374	HGNC:21011	OMIM:609563	CPO	6		
FBgn0033774	CG12374	HGNC:2298	OMIM:114851	CPA3	5		
FBgn0033774	CG12374	HGNC:2297	OMIM:600688	CPA2	8		
FBgn0033774	CG12374	HGNC:15740	OMIM:607635	CPA4	7		
FBgn0033774	CG12374	HGNC:2299	OMIM:114852	CPB1	7		
FBgn0033774	CG12374	HGNC:2296	OMIM:114850	CPA1	7		
FBgn0033774	CG12374	HGNC:17245	OMIM:609562	CPA6	6	614417,614418	614417[EPILEPSY, FAMILIAL TEMPORAL LOBE, 5; ETL5],614418[FEBRILE SEIZURES, FAMILIAL, 11; FEB11]
FBgn0033774	CG12374	HGNC:15722	OMIM:609561	CPA5	7		
FBgn0003326	sca	HGNC:485	OMIM:601922	ANGPT2	3	619369	619369[LYMPHATIC MALFORMATION 10; LMPHM10]
FBgn0003326	sca	HGNC:3624	OMIM:601624	FCN2	3		
FBgn0003326	sca	HGNC:484	OMIM:601667	ANGPT1	3	619361	619361[ANGIOEDEMA, HEREDITARY, 5; HAE5]
FBgn0003326	sca	HGNC:487	OMIM:603705	ANGPT4	3		
FBgn0003326	sca	HGNC:3623	OMIM:601252	FCN1	3		
FBgn0003326	sca	HGNC:3625	OMIM:604973	FCN3	3	613860	613860[FICOLIN 3 DEFICIENCY]
FBgn0003326	sca	HGNC:7035	OMIM:600596	MFAP4	4		
FBgn0011227	ox	HGNC:30863	OMIM:610843	UQCR10	11		
FBgn0026619	Taz	HGNC:11577	OMIM:300394	TAFAZZIN	13	302060	302060[BARTH SYNDROME; BTHS]
FBgn0033773	Mos	HGNC:7199	OMIM:190060	MOS	12		
FBgn0033769	CG8768	HGNC:20275	OMIM:616162	SDR39U1	14		
FBgn0033766	Nup188	HGNC:17859	OMIM:615587	NUP188	11	618804	618804[SANDESTIG-STEFANOVA SYNDROME; SANDSTEF]
FBgn0033761	CG8778	HGNC:890	OMIM:600529	AUH	13	250950	250950[3-METHYLGLUTACONIC ACIDURIA, TYPE I; MGCA1]
FBgn0033761	CG8778	HGNC:23408		ECHDC2	11		
FBgn0033760	CG8785	HGNC:19659	OMIM:608332	SLC36A3	7		
FBgn0033760	CG8785	HGNC:18762	OMIM:608331	SLC36A2	7	138500,242600	138500[HYPERGLYCINURIA],242600[IMINOGLYCINURIA]
FBgn0033760	CG8785	HGNC:19660	OMIM:613760	SLC36A4	8		
FBgn0033760	CG8785	HGNC:18761	OMIM:606561	SLC36A1	7		
FBgn0033757	muskelin	HGNC:7109	OMIM:605623	MKLN1	13		
FBgn0022764	Sin3A	HGNC:19354	OMIM:607777	SIN3B	13		
FBgn0022764	Sin3A	HGNC:19353	OMIM:607776	SIN3A	13	613406	613406[WITTEVEEN-KOLK SYNDROME; WITKOS]
FBgn0033754	Ak6	HGNC:11542	OMIM:600822	TAF9	8		
FBgn0033754	Ak6	HGNC:49151	OMIM:619357	AK6	4		
FBgn0033710	CG17739	HGNC:11252	OMIM:604989	SPON1	13		
FBgn0033710	CG17739	HGNC:11253	OMIM:605918	SPON2	3		
FBgn0050203	CG30203	HGNC:11252	OMIM:604989	SPON1	7		
FBgn0050046	CG30046	HGNC:11252	OMIM:604989	SPON1	7		
FBgn0033716	Den1	HGNC:22992	OMIM:608659	SENP8	14		
FBgn0050047	CG30047	HGNC:23703	OMIM:611156	ERMP1	14		
FBgn0050049	CG30049	HGNC:23703	OMIM:611156	ERMP1	13		
FBgn0050043	CG30043	HGNC:23703	OMIM:611156	ERMP1	13		
FBgn0053012	CG33012	HGNC:23703	OMIM:611156	ERMP1	13		
FBgn0033720	CG13160	HGNC:23703	OMIM:611156	ERMP1	12		
FBgn0033734	CG8520	HGNC:16411	OMIM:617469	AFG1L	15		
FBgn0033735	Dera	HGNC:24269	OMIM:619668	DERA	15		
FBgn0050051	Tmem18	HGNC:25257	OMIM:613220	TMEM18	13		
FBgn0010238	Lac	HGNC:17302	OMIM:613173	NEGR1	9		
FBgn0010238	Lac	HGNC:34550	OMIM:618861	IGLON5	5		
FBgn0010238	Lac	HGNC:6705	OMIM:603241	LSAMP	5		
FBgn0010238	Lac	HGNC:8143	OMIM:600632	OPCML	5	167000	167000[OVARIAN CANCER]
FBgn0010238	Lac	HGNC:17941	OMIM:607938	NTM	5		
FBgn0033741	CG8545	HGNC:7867	OMIM:164031	NOP2	10		
FBgn0033742	Nepl10	HGNC:8918	OMIM:300550	PHEX	3	307800	307800[HYPOPHOSPHATEMIC RICKETS, X-LINKED DOMINANT; XLHR]
FBgn0033742	Nepl10	HGNC:14668	OMIM:618104	MMEL1	3		
FBgn0033742	Nepl10	HGNC:7154	OMIM:120520	MME	3	617017,617018	617017[CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2T; CMT2T],617018[SPINOCEREBELLAR ATAXIA 43; SCA43]
FBgn0033742	Nepl10	HGNC:13275	OMIM:610145	ECE2	3		
FBgn0033742	Nepl10	HGNC:3147	OMIM:605896	ECEL1	3	615065	615065[ARTHROGRYPOSIS, DISTAL, TYPE 5D; DA5D]
FBgn0033742	Nepl10	HGNC:3146	OMIM:600423	ECE1	3	145500,613870	145500[HYPERTENSION, ESSENTIAL],613870[HIRSCHSPRUNG DISEASE, CARDIAC DEFECTS, AND AUTONOMIC DYSFUNCTION; HCAD]
FBgn0033742	Nepl10	HGNC:6308	OMIM:613883	KEL	4	110900	110900[BLOOD GROUP--KELL SYSTEM; KEL]
FBgn0033744	Dh44-R2	HGNC:2357	OMIM:122561	CRHR1	9		
FBgn0033744	Dh44-R2	HGNC:2358	OMIM:602034	CRHR2	12		
FBgn0033744	Dh44-R2	HGNC:51483		LINC02210-CRHR1	7		
FBgn0033752	CG8569	HGNC:16966	OMIM:608668	ZMYND11	11	616083	616083[INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL DOMINANT 30; MRD30]
FBgn0033749	achi	HGNC:15764	OMIM:607294	TGIF2	5		
FBgn0033749	achi	HGNC:44664		TGIF2-RAB5IF	3		
FBgn0033749	achi	HGNC:18570	OMIM:300411	TGIF2LX	5		
FBgn0033749	achi	HGNC:18569	OMIM:400025	TGIF2LY	5		
FBgn0033749	achi	HGNC:11776	OMIM:602630	TGIF1	9	142946	142946[HOLOPROSENCEPHALY 4; HPE4]
FBgn0033748	vis	HGNC:7001	OMIM:601740	MEIS2	3	600987	600987[CLEFT PALATE, CARDIAC DEFECTS, AND MENTAL RETARDATION; CPCMR]
FBgn0033748	vis	HGNC:7000	OMIM:601739	MEIS1	3		
FBgn0033748	vis	HGNC:15764	OMIM:607294	TGIF2	5		
FBgn0033748	vis	HGNC:44664		TGIF2-RAB5IF	3		
FBgn0033748	vis	HGNC:18570	OMIM:300411	TGIF2LX	5		
FBgn0033748	vis	HGNC:18569	OMIM:400025	TGIF2LY	5		
FBgn0033748	vis	HGNC:11776	OMIM:602630	TGIF1	9	142946	142946[HOLOPROSENCEPHALY 4; HPE4]
FBgn0033748	vis	HGNC:16714	OMIM:613066	PKNOX2	3		
FBgn0045063	fdl	HGNC:4878	OMIM:606869	HEXA	7	272800	272800[TAY-SACHS DISEASE; TSD]
FBgn0045063	fdl	HGNC:4879	OMIM:606873	HEXB	8	268800	268800[SANDHOFF DISEASE]
FBgn0033738	DUBAI	HGNC:20067	OMIM:618322	USP38	13		
FBgn0033738	DUBAI	HGNC:20061		USP35	13		
FBgn0033737	Nup54	HGNC:17359	OMIM:607607	NUP54	12		
FBgn0033733	CG8834	HGNC:11000	OMIM:604196	SLC27A6	3		
FBgn0033717	CG8839	HGNC:26440	OMIM:300654	FAAH2	15		
FBgn0033717	CG8839	HGNC:3553	OMIM:602935	FAAH	4	606581	606581[POLYSUBSTANCE ABUSE, SUSCEPTIBILITY TO; PSAB]
FBgn0033713	CG8841	HGNC:15736	OMIM:605752	HID1	14	619983	619983[DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 105 WITH HYPOPITUITARISM; DEE105]
FBgn0033708	CG8850	HGNC:11049	OMIM:126455	SLC6A3	3	188890,613135	188890[TOBACCO ADDICTION, SUSCEPTIBILITY TO],613135[PARKINSONISM-DYSTONIA 1, INFANTILE-ONSET; PKDYS1]
FBgn0033708	CG8850	HGNC:11044	OMIM:607952	SLC6A11	3		
FBgn0033708	CG8850	HGNC:31399	OMIM:610299	SLC6A17	4	616269	616269[INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 48; MRT48]
FBgn0033708	CG8850	HGNC:11045	OMIM:603080	SLC6A12	3		
FBgn0033708	CG8850	HGNC:11054	OMIM:606205	SLC6A7	4		
FBgn0033708	CG8850	HGNC:11048	OMIM:163970	SLC6A2	3	604715	604715[ORTHOSTATIC INTOLERANCE]
FBgn0033708	CG8850	HGNC:13621	OMIM:607971	SLC6A15	4		
FBgn0033708	CG8850	HGNC:11050	OMIM:182138	SLC6A4	4	164230,607834	164230[OBSESSIVE-COMPULSIVE DISORDER; OCD],607834[ANXIETY]
FBgn0033708	CG8850	HGNC:11055	OMIM:300036	SLC6A8	3	300352	300352[CEREBRAL CREATINE DEFICIENCY SYNDROME 1; CCDS1]
FBgn0033708	CG8850	HGNC:11056	OMIM:601019	SLC6A9	4	617301	617301[GLYCINE ENCEPHALOPATHY WITH NORMAL SERUM GLYCINE]
FBgn0033708	CG8850	HGNC:11051	OMIM:604159	SLC6A5	3	614618	614618[HYPEREKPLEXIA 3; HKPX3]
FBgn0033708	CG8850	HGNC:11047	OMIM:300444	SLC6A14	3		
FBgn0033708	CG8850	HGNC:11052	OMIM:186854	SLC6A6	3	145350	145350[HYPOTAURINEMIC RETINAL DEGENERATION AND CARDIOMYOPATHY; HTRDC]
FBgn0033708	CG8850	HGNC:11046	OMIM:615097	SLC6A13	3		
FBgn0033708	CG8850	HGNC:11042	OMIM:137165	SLC6A1	3	616421	616421[MYOCLONIC-ATONIC EPILEPSY; MAE]
FBgn0033708	CG8850	HGNC:13622	OMIM:607972	SLC6A16	4		
FBgn0033677	CG8321	HGNC:24048	OMIM:616495	ARL6IP6	5		
FBgn0024732	Drep1	HGNC:1977	OMIM:604441	CIDEB	6		
FBgn0024732	Drep1	HGNC:1976	OMIM:604440	CIDEA	7		
FBgn0024732	Drep1	HGNC:2772	OMIM:601882	DFFA	4		
FBgn0024732	Drep1	HGNC:24229	OMIM:612120	CIDEC	7	615238	615238[LIPODYSTROPHY, FAMILIAL PARTIAL, TYPE 5; FPLD5]
FBgn0028407	Drep3	HGNC:1977	OMIM:604441	CIDEB	6		
FBgn0028407	Drep3	HGNC:1976	OMIM:604440	CIDEA	7		
FBgn0028407	Drep3	HGNC:2772	OMIM:601882	DFFA	3		
FBgn0028407	Drep3	HGNC:24229	OMIM:612120	CIDEC	7	615238	615238[LIPODYSTROPHY, FAMILIAL PARTIAL, TYPE 5; FPLD5]
FBgn0033680	CG13186	HGNC:18251	OMIM:607914	SELENOH	7		
FBgn0027495	Smyd4-4	HGNC:21067	OMIM:619134	SMYD4	8		
FBgn0033686	Hen1	HGNC:26400	OMIM:612178	HENMT1	12		
FBgn0033687	CG8407	HGNC:2955	OMIM:610565	DNAL4	15	616059	616059[MIRROR MOVEMENTS 3; MRMV3]
FBgn0023167	SmD3	HGNC:11160	OMIM:601062	SNRPD3	12		
FBgn0010621	CCT5	HGNC:1618	OMIM:610150	CCT5	14	256840	256840[NEUROPATHY, HEREDITARY SENSORY, WITH SPASTIC PARAPLEGIA, AUTOSOMAL RECESSIVE]
FBgn0033692	wash	HGNC:24361	OMIM:613632	WASHC1	10		
FBgn0033692	wash	HGNC:24362		WASH3P	5		
FBgn0033692	wash	HGNC:31685		WASH6P	5		
FBgn0025454	Cyp6g1	HGNC:2638	OMIM:605325	CYP3A5	5	145500	145500[HYPERTENSION, ESSENTIAL]
FBgn0025454	Cyp6g1	HGNC:17450	OMIM:606534	CYP3A43	5		
FBgn0025454	Cyp6g1	HGNC:11609	OMIM:274180	TBXAS1	4	231095	231095[GHOSAL HEMATODIAPHYSEAL DYSPLASIA; GHDD]
FBgn0025454	Cyp6g1	HGNC:2637	OMIM:124010	CYP3A4	5	619073	619073[VITAMIN D-DEPENDENT RICKETS, TYPE 3; VDDR3]
FBgn0025454	Cyp6g1	HGNC:51504		CYP3A7-CYP3A51P	5		
FBgn0033697	Cyp6t3	HGNC:2638	OMIM:605325	CYP3A5	3	145500	145500[HYPERTENSION, ESSENTIAL]
FBgn0033697	Cyp6t3	HGNC:17450	OMIM:606534	CYP3A43	3		
FBgn0033697	Cyp6t3	HGNC:11609	OMIM:274180	TBXAS1	3	231095	231095[GHOSAL HEMATODIAPHYSEAL DYSPLASIA; GHDD]
FBgn0033697	Cyp6t3	HGNC:2637	OMIM:124010	CYP3A4	3	619073	619073[VITAMIN D-DEPENDENT RICKETS, TYPE 3; VDDR3]
FBgn0033697	Cyp6t3	HGNC:51504		CYP3A7-CYP3A51P	3		
FBgn0033705	CG13168	HGNC:25168		IQCD	6		
FBgn0033706	Vha36-2	HGNC:13527	OMIM:609398	ATP6V1D	6		
FBgn0000253	Cam	HGNC:1445	OMIM:114182	CALM2	6	616249	616249[LONG QT SYNDROME 15; LQT15]
FBgn0000253	Cam	HGNC:1442	OMIM:114180	CALM1	10	614916,616247	614916[VENTRICULAR TACHYCARDIA, CATECHOLAMINERGIC POLYMORPHIC, 4; CPVT4],616247[LONG QT SYNDROME 14; LQT14]
FBgn0000253	Cam	HGNC:1449	OMIM:114183	CALM3	10	618782	618782[LONG QT SYNDROME 16; LQT16]
FBgn0000253	Cam	HGNC:1452	OMIM:114184	CALML3	5		
FBgn0000253	Cam	HGNC:18180	OMIM:605183	CALML5	4		
FBgn0033699	RpS11	HGNC:10384	OMIM:180471	RPS11	13		
FBgn0033698	CG8858	HGNC:29020	OMIM:616694	ECPAS	14		
FBgn0033696	Cyp6g2	HGNC:2638	OMIM:605325	CYP3A5	5	145500	145500[HYPERTENSION, ESSENTIAL]
FBgn0033696	Cyp6g2	HGNC:17450	OMIM:606534	CYP3A43	5		
FBgn0033696	Cyp6g2	HGNC:11609	OMIM:274180	TBXAS1	5	231095	231095[GHOSAL HEMATODIAPHYSEAL DYSPLASIA; GHDD]
FBgn0033696	Cyp6g2	HGNC:2637	OMIM:124010	CYP3A4	5	619073	619073[VITAMIN D-DEPENDENT RICKETS, TYPE 3; VDDR3]
FBgn0033696	Cyp6g2	HGNC:51504		CYP3A7-CYP3A51P	5		
FBgn0000426	SmF	HGNC:11162	OMIM:603541	SNRPF	12		
FBgn0033691	CG8860	HGNC:18277	OMIM:609215	SEC61G	14		
FBgn0033690	EndoG	HGNC:3346	OMIM:600440	ENDOG	15		
FBgn0033690	EndoG	HGNC:3347	OMIM:604051	EXOG	4		
FBgn0014184	Oda	HGNC:8095	OMIM:601579	OAZ1	8		
FBgn0014184	Oda	HGNC:8097	OMIM:605138	OAZ3	7		
FBgn0014184	Oda	HGNC:8096	OMIM:604152	OAZ2	9		
FBgn0033688	Prp8	HGNC:17340	OMIM:607300	PRPF8	15	600059	600059[RETINITIS PIGMENTOSA 13; RP13]
FBgn0027504	bsd	HGNC:18996	OMIM:619771	VRK3	5		
FBgn0027504	bsd	HGNC:12718	OMIM:602168	VRK1	4	607596	607596[PONTOCEREBELLAR HYPOPLASIA, TYPE 1A; PCH1A]
FBgn0027504	bsd	HGNC:12719	OMIM:602169	VRK2	4		
FBgn0033685	OSCP1	HGNC:29971	OMIM:608854	OSCP1	11		
FBgn0026176	SkpB	HGNC:10899	OMIM:601434	SKP1	9		
FBgn0033679	CG8888	HGNC:1027	OMIM:603063	BDH1	7		
FBgn0033679	CG8888	HGNC:5209	OMIM:614232	HSD11B2	4	218030	218030[APPARENT MINERALOCORTICOID EXCESS; AME]
FBgn0033679	CG8888	HGNC:16888	OMIM:612131	DHRS9	6		
FBgn0033679	CG8888	HGNC:23316	OMIM:606623	HSD17B6	7		
FBgn0033679	CG8888	HGNC:29674		RDH16	8		
FBgn0033679	CG8888	HGNC:29958	OMIM:609769	SDR9C7	8	617574	617574[ICHTHYOSIS, CONGENITAL, AUTOSOMAL RECESSIVE 13; ARCI13]
FBgn0033679	CG8888	HGNC:5211	OMIM:109685	HSD17B2	4		
FBgn0033679	CG8888	HGNC:9940	OMIM:601617	RDH5	5	136880	136880[FUNDUS ALBIPUNCTATUS]
FBgn0004839	otk	HGNC:9618	OMIM:601890	PTK7	14		
FBgn0033653	CG13192	HGNC:4397	OMIM:610778	GNB1L	13		
FBgn0033657	Sln	HGNC:17027	OMIM:607550	SLC16A10	3		
FBgn0033657	Sln	HGNC:10923	OMIM:300095	SLC16A2	3	300523	300523[ALLAN-HERNDON-DUDLEY SYNDROME; AHDS]
FBgn0033657	Sln	HGNC:10924	OMIM:603877	SLC16A3	5		
FBgn0033657	Sln	HGNC:16270	OMIM:610409	SLC16A8	6		
FBgn0033657	Sln	HGNC:26417		SLC16A14	5		
FBgn0033657	Sln	HGNC:23093	OMIM:615765	SLC16A11	5		
FBgn0033657	Sln	HGNC:23520	OMIM:614242	SLC16A9	4		
FBgn0033657	Sln	HGNC:10922	OMIM:600682	SLC16A1	6	245340,610021,616095	245340[ERYTHROCYTE LACTATE TRANSPORTER DEFECT],610021[HYPERINSULINEMIC HYPOGLYCEMIA, FAMILIAL, 7; HHF7],616095[MONOCARBOXYLATE TRANSPORTER 1 DEFICIENCY; MCT1D]
FBgn0033657	Sln	HGNC:10927	OMIM:603880	SLC16A6	5		
FBgn0033657	Sln	HGNC:10925	OMIM:603878	SLC16A4	5		
FBgn0033657	Sln	HGNC:31037		SLC16A13	6		
FBgn0033657	Sln	HGNC:10926	OMIM:603879	SLC16A5	6		
FBgn0033657	Sln	HGNC:10928	OMIM:603654	SLC16A7	6		
FBgn0033657	Sln	HGNC:23094	OMIM:611910	SLC16A12	6	612018	612018[CATARACT 47; CTRCT47]
FBgn0013756	Mtor	HGNC:12017	OMIM:189940	TPR	13		
FBgn0033665	Zip48C	HGNC:14463	OMIM:616508	SLC39A11	15		
FBgn0026573	ADD1	HGNC:886	OMIM:300032	ATRX	4	300448,301040,309580	300448[ALPHA-THALASSEMIA MYELODYSPLASIA SYNDROME; ATMDS],301040[ALPHA-THALASSEMIA/MENTAL RETARDATION SYNDROME, X-LINKED; ATRX],309580[INTELLECTUAL DISABILITY-HYPOTONIC FACIES SYNDROME, X-LINKED, 1; MRXHF1]
FBgn0033673	CG8298	HGNC:4291	OMIM:600148	GK2	7		
FBgn0033673	CG8298	HGNC:4289	OMIM:300474	GK	8	307030	307030[GLYCEROL KINASE DEFICIENCY; GKD]
FBgn0033672	rho-7	HGNC:18253	OMIM:607858	PARL	13		
FBgn0011704	RnrS	HGNC:10452	OMIM:180390	RRM2	14		
FBgn0011704	RnrS	HGNC:17296	OMIM:604712	RRM2B	11	268315,612075,613077	268315[ROD-CONE DYSTROPHY, SENSORINEURAL DEAFNESS, AND FANCONI-TYPE RENAL DYSFUNCTION; RCDFRD],612075[MITOCHONDRIAL DNA DEPLETION SYNDROME 8A (ENCEPHALOMYOPATHIC TYPE WITH RENAL TUBULOPATHY); MTDPS8A],613077[PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL DOMINANT 5; PEOA5]
FBgn0053145	GalT1	HGNC:918	OMIM:603094	B3GALNT1	6	111400,615021	111400[BLOOD GROUP, P1PK SYSTEM],615021[BLOOD GROUP, GLOBOSIDE SYSTEM; GLOB]
FBgn0053145	GalT1	HGNC:916	OMIM:603093	B3GALT1	8		
FBgn0053145	GalT1	HGNC:15684	OMIM:615333	B3GNT5	3		
FBgn0053145	GalT1	HGNC:917	OMIM:603018	B3GALT2	8		
FBgn0053145	GalT1	HGNC:920	OMIM:604066	B3GALT5	6		
FBgn0053145	GalT1	HGNC:15629	OMIM:605581	B3GNT2	4		
FBgn0053145	GalT1	HGNC:15683	OMIM:605864	B3GNT4	5		
FBgn0053145	GalT1	HGNC:28714		B3GNT9	5		
FBgn0053145	GalT1	HGNC:18811	OMIM:615313	B3GNT7	3		
FBgn0053145	GalT1	HGNC:24141	OMIM:615315	B3GNT6	5		
FBgn0053145	GalT1	HGNC:24139	OMIM:615357	B3GNT8	4		
FBgn0053145	GalT1	HGNC:13528	OMIM:605863	B3GNT3	5		
FBgn0050037	CG30037	HGNC:918	OMIM:603094	B3GALNT1	6	111400,615021	111400[BLOOD GROUP, P1PK SYSTEM],615021[BLOOD GROUP, GLOBOSIDE SYSTEM; GLOB]
FBgn0050037	CG30037	HGNC:916	OMIM:603093	B3GALT1	8		
FBgn0050037	CG30037	HGNC:15684	OMIM:615333	B3GNT5	3		
FBgn0050037	CG30037	HGNC:917	OMIM:603018	B3GALT2	7		
FBgn0050037	CG30037	HGNC:920	OMIM:604066	B3GALT5	6		
FBgn0050037	CG30037	HGNC:15629	OMIM:605581	B3GNT2	5		
FBgn0050037	CG30037	HGNC:15683	OMIM:605864	B3GNT4	5		
FBgn0050037	CG30037	HGNC:28714		B3GNT9	5		
FBgn0050037	CG30037	HGNC:18811	OMIM:615313	B3GNT7	3		
FBgn0050037	CG30037	HGNC:24141	OMIM:615315	B3GNT6	5		
FBgn0050037	CG30037	HGNC:24139	OMIM:615357	B3GNT8	4		
FBgn0050037	CG30037	HGNC:13528	OMIM:605863	B3GNT3	5		
FBgn0050036	CG30036	HGNC:918	OMIM:603094	B3GALNT1	6	111400,615021	111400[BLOOD GROUP, P1PK SYSTEM],615021[BLOOD GROUP, GLOBOSIDE SYSTEM; GLOB]
FBgn0050036	CG30036	HGNC:916	OMIM:603093	B3GALT1	8		
FBgn0050036	CG30036	HGNC:15684	OMIM:615333	B3GNT5	4		
FBgn0050036	CG30036	HGNC:917	OMIM:603018	B3GALT2	7		
FBgn0050036	CG30036	HGNC:920	OMIM:604066	B3GALT5	6		
FBgn0050036	CG30036	HGNC:15629	OMIM:605581	B3GNT2	4		
FBgn0050036	CG30036	HGNC:15683	OMIM:605864	B3GNT4	5		
FBgn0050036	CG30036	HGNC:28714		B3GNT9	5		
FBgn0050036	CG30036	HGNC:18811	OMIM:615313	B3GNT7	3		
FBgn0050036	CG30036	HGNC:24141	OMIM:615315	B3GNT6	5		
FBgn0050036	CG30036	HGNC:24139	OMIM:615357	B3GNT8	4		
FBgn0050036	CG30036	HGNC:13528	OMIM:605863	B3GNT3	5		
FBgn0033669	PI31	HGNC:9571	OMIM:617858	PSMF1	14		
FBgn0033663	ERp60	HGNC:8548	OMIM:176790	P4HB	5	112240	112240[COLE-CARPENTER SYNDROME 1; CLCRP1]
FBgn0033663	ERp60	HGNC:14180	OMIM:608012	PDIA2	3		
FBgn0033663	ERp60	HGNC:4606	OMIM:602046	PDIA3	14		
FBgn0033663	ERp60	HGNC:27338	OMIM:618588	PDILT	3		
FBgn0033663	ERp60	HGNC:30167	OMIM:620018	PDIA4	5		
FBgn0033661	CG13185	HGNC:18302	OMIM:618200	MDN1	13		
FBgn0033659	Damm	HGNC:1504	OMIM:600636	CASP3	3		
FBgn0033659	Damm	HGNC:1508	OMIM:601761	CASP7	3		
FBgn0033659	Damm	HGNC:1507	OMIM:601532	CASP6	4		
FBgn0033656	S2P	HGNC:15455	OMIM:300294	MBTPS2	15	300918,301014,308205,308800	300918[OLMSTED SYNDROME, X-LINKED; OLMSX],301014[OSTEOGENESIS IMPERFECTA, TYPE XIX; OI19],308205[IFAP SYNDROME 1, WITH OR WITHOUT BRESHECK SYNDROME; IFAP1],308800[KERATOSIS FOLLICULARIS SPINULOSA DECALVANS, X-LINKED; KFSDX]
FBgn0033654	Sobp	HGNC:29256	OMIM:613667	SOBP	11	613671	613671[MENTAL RETARDATION, ANTERIOR MAXILLARY PROTRUSION, AND STRABISMUS; MRAMS]
FBgn0050035	Tret1-1	HGNC:11011	OMIM:606813	SLC2A6	8		
FBgn0050035	Tret1-1	HGNC:13812	OMIM:605245	SLC2A8	11		
FBgn0050035	Tret1-1	HGNC:11005	OMIM:138140	SLC2A1	3	601042,606777,608885,612126,614847	601042[DYSTONIA 9; DYT9],606777[GLUT1 DEFICIENCY SYNDROME 1; GLUT1DS1],608885[STOMATIN-DEFICIENT CRYOHYDROCYTOSIS WITH NEUROLOGIC DEFECTS; SDCHCN],612126[GLUT1 DEFICIENCY SYNDROME 2; GLUT1DS2],614847[EPILEPSY, IDIOPATHIC GENERALIZED, SUSCEPTIBILITY TO, 12; EIG12]
FBgn0050035	Tret1-1	HGNC:11009	OMIM:138190	SLC2A4	3		
FBgn0050035	Tret1-1	HGNC:11007	OMIM:138170	SLC2A3	3		
FBgn0050035	Tret1-1	HGNC:13444	OMIM:606145	SLC2A10	3	208050	208050[ARTERIAL TORTUOSITY SYNDROME; ATORS]
FBgn0050035	Tret1-1	HGNC:15956	OMIM:611036	SLC2A13	4		
FBgn0033644	Tret1-2	HGNC:11011	OMIM:606813	SLC2A6	8		
FBgn0033644	Tret1-2	HGNC:13812	OMIM:605245	SLC2A8	15		
FBgn0033644	Tret1-2	HGNC:11010	OMIM:138230	SLC2A5	3		
FBgn0033644	Tret1-2	HGNC:11006	OMIM:138160	SLC2A2	3	125853,227810	125853[TYPE 2 DIABETES MELLITUS; T2D],227810[FANCONI-BICKEL SYNDROME; FBS]
FBgn0033644	Tret1-2	HGNC:18067	OMIM:610372	SLC2A12	3		
FBgn0033644	Tret1-2	HGNC:13444	OMIM:606145	SLC2A10	3	208050	208050[ARTERIAL TORTUOSITY SYNDROME; ATORS]
FBgn0033644	Tret1-2	HGNC:15956	OMIM:611036	SLC2A13	3		
FBgn0040491	Buffy	HGNC:1087	OMIM:605404	BOK	12		
FBgn0062449	CG13197	HGNC:3066	OMIM:603092	DUSP11	13		
FBgn0010516	wal	HGNC:3481	OMIM:608053	ETFA	12	231680	231680[MULTIPLE ACYL-CoA DEHYDROGENASE DEFICIENCY; MADD]
FBgn0044020	Roc2	HGNC:9928	OMIM:603814	RBX1	4		
FBgn0044020	Roc2	HGNC:10070	OMIM:603863	RNF7	15		
FBgn0033639	CG9003	HGNC:13598	OMIM:605652	FBXL2	11		
FBgn0033639	CG9003	HGNC:24679	OMIM:609086	FBXL20	13		
FBgn0033638	atos	HGNC:25609		FAM214A	8		
FBgn0033638	atos	HGNC:25666		ATOSB	5		
FBgn0033636	tou	HGNC:962	OMIM:605682	BAZ2A	9		
FBgn0033636	tou	HGNC:963	OMIM:605683	BAZ2B	10		
FBgn0003396	shn	HGNC:13561	OMIM:606649	HIVEP3	6		
FBgn0003396	shn	HGNC:4920	OMIM:194540	HIVEP1	7		
FBgn0003396	shn	HGNC:4921	OMIM:143054	HIVEP2	8	616977	616977[INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL DOMINANT 43; MRD43]
FBgn0037084	Syx6	HGNC:11428	OMIM:603765	STX10	11		
FBgn0037084	Syx6	HGNC:11441	OMIM:603944	STX6	13		
FBgn0033584	CG7737	HGNC:15862	OMIM:615854	SMOX	6		
FBgn0033584	CG7737	HGNC:20837	OMIM:615853	PAOX	6		
FBgn0033599	CG13223	HGNC:26175	OMIM:609841	SLC8B1	11		
FBgn0041174	Vhl	HGNC:30666	OMIM:619650	VHLL	9		
FBgn0041174	Vhl	HGNC:12687	OMIM:608537	VHL	10	144700,171300,193300,263400	144700[RENAL CELL CARCINOMA, NONPAPILLARY; RCC],171300[PHEOCHROMOCYTOMA],193300[VON HIPPEL-LINDAU SYNDROME; VHLS],263400[ERYTHROCYTOSIS, FAMILIAL, 2; ECYT2]
FBgn0033615	CG7741	HGNC:25613	OMIM:616120	CWF19L1	15	616127	616127[SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 17; SCAR17]
FBgn0043470	lambdaTry	HGNC:9486	OMIM:613578	PRSS3	4		
FBgn0043470	lambdaTry	HGNC:9475	OMIM:276000	PRSS1	4	167800	167800[PANCREATITIS, HEREDITARY; PCTT]
FBgn0010357	betaTry	HGNC:9486	OMIM:613578	PRSS3	3		
FBgn0010357	betaTry	HGNC:9475	OMIM:276000	PRSS1	3	167800	167800[PANCREATITIS, HEREDITARY; PCTT]
FBgn0050031	CG30031	HGNC:9486	OMIM:613578	PRSS3	4		
FBgn0050031	CG30031	HGNC:9475	OMIM:276000	PRSS1	4	167800	167800[PANCREATITIS, HEREDITARY; PCTT]
FBgn0024188	san	HGNC:29533	OMIM:610834	NAA50	13		
FBgn0033635	Prip	HGNC:633	OMIM:107776	AQP1	7	110450	110450[BLOOD GROUP, COLTON SYSTEM; CO]
FBgn0033635	Prip	HGNC:7103	OMIM:154050	MIP	4	615274	615274[CATARACT 15, MULTIPLE TYPES; CTRCT15]
FBgn0033635	Prip	HGNC:634	OMIM:107777	AQP2	4	125800	125800[DIABETES INSIPIDUS, NEPHROGENIC, 2, AUTOSOMAL; NDI2]
FBgn0033635	Prip	HGNC:638	OMIM:600442	AQP5	3	600231	600231[PALMOPLANTAR KERATODERMA, BOTHNIAN TYPE; PPKB]
FBgn0033635	Prip	HGNC:637	OMIM:600308	AQP4	5		
FBgn0033635	Prip	HGNC:642	OMIM:603750	AQP8	3		
FBgn0033635	Prip	HGNC:639	OMIM:601383	AQP6	3		
FBgn0033635	Prip	HGNC:636	OMIM:600170	AQP3	3	607457	607457[GIL BLOOD GROUP]
FBgn0033635	Prip	HGNC:643	OMIM:602914	AQP9	3		
FBgn0000581	E(Pc)	HGNC:19876	OMIM:610999	EPC1	10		
FBgn0000581	E(Pc)	HGNC:24543	OMIM:611000	EPC2	10		
FBgn0050022	CG30022	HGNC:23287	OMIM:608451	ETHE1	14	602473	602473[ENCEPHALOPATHY, ETHYLMALONIC; EE]
FBgn0033629	Tsp47F	HGNC:1692	OMIM:155740	CD63	8		
FBgn0033629	Tsp47F	HGNC:11854	OMIM:300096	TSPAN7	3	300210	300210[INTELLECTUAL DEVELOPMENTAL DISORDER, X-LINKED 58; XLID58]
FBgn0033629	Tsp47F	HGNC:11858	OMIM:300191	TSPAN6	6		
FBgn0021795	Tapdelta	HGNC:11326	OMIM:300090	SSR4	14	300934	300934[CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Iy; CDG1Y]
FBgn0001276	ix	HGNC:23074	OMIM:612914	MED29	11		
FBgn0033624	CG12384	HGNC:2672	OMIM:600954	DAP	10		
FBgn0033624	CG12384	HGNC:21490		DAPL1	5		
FBgn0033623	CG13202	HGNC:32700	OMIM:614677	CCDC103	6	614679	614679[CILIARY DYSKINESIA, PRIMARY, 17; CILD17]
FBgn0050025	CG30025	HGNC:9486	OMIM:613578	PRSS3	4		
FBgn0050025	CG30025	HGNC:9475	OMIM:276000	PRSS1	4	167800	167800[PANCREATITIS, HEREDITARY; PCTT]
FBgn0010425	epsilonTry	HGNC:9486	OMIM:613578	PRSS3	4		
FBgn0010425	epsilonTry	HGNC:9475	OMIM:276000	PRSS1	4	167800	167800[PANCREATITIS, HEREDITARY; PCTT]
FBgn0003863	alphaTry	HGNC:9486	OMIM:613578	PRSS3	3		
FBgn0003863	alphaTry	HGNC:9475	OMIM:276000	PRSS1	3	167800	167800[PANCREATITIS, HEREDITARY; PCTT]
FBgn0011555	thetaTry	HGNC:9486	OMIM:613578	PRSS3	3		
FBgn0011555	thetaTry	HGNC:9475	OMIM:276000	PRSS1	3	167800	167800[PANCREATITIS, HEREDITARY; PCTT]
FBgn0043471	kappaTry	HGNC:26906	OMIM:610560	PRSS36	3		
FBgn0043471	kappaTry	HGNC:34407	OMIM:610561	PRSS53	3		
FBgn0025373	Fpps	HGNC:3631	OMIM:134629	FDPS	15	616631	616631[POROKERATOSIS 9, MULTIPLE TYPES; POROK9]
FBgn0040763	CG18336	HGNC:34242		FAM166B	3		
FBgn0015582	dare	HGNC:3642	OMIM:103270	FDXR	15	617717	617717[AUDITORY NEUROPATHY AND OPTIC ATROPHY; ANOA]
FBgn0033610	CG18335	HGNC:34242		FAM166B	12		
FBgn0033610	CG18335	HGNC:33818		FAM166A	4		
FBgn0033609	Fbl6	HGNC:13603	OMIM:609076	FBXL6	12		
FBgn0033607	CG9062	HGNC:30914	OMIM:612167	WDR48	14		
FBgn0033605	CG9067	HGNC:30887	OMIM:610970	TRAPPC2L	13	618331	618331[ENCEPHALOPATHY, PROGRESSIVE, EARLY-ONSET, WITH EPISODIC RHABDOMYOLYSIS; PEERB]
FBgn0010423	TpnC47D	HGNC:24193	OMIM:610171	CALML6	3		
FBgn0050021	metro	HGNC:13680	OMIM:606575	MPP4	8		
FBgn0050021	metro	HGNC:26542	OMIM:610973	MPP7	13		
FBgn0050021	metro	HGNC:7221	OMIM:601114	MPP3	11		
FBgn0050021	metro	HGNC:18669	OMIM:606958	MPP5	3		
FBgn0033582	CG9084	HGNC:16495	OMIM:607611	PLSCR3	4		
FBgn0033582	CG9084	HGNC:19952		PLSCR5	4		
FBgn0033582	CG9084	HGNC:9092	OMIM:604170	PLSCR1	5		
FBgn0033582	CG9084	HGNC:16497	OMIM:607612	PLSCR4	4		
FBgn0033582	CG9084	HGNC:16494	OMIM:607610	PLSCR2	4		
FBgn0033572	polyph	HGNC:19659	OMIM:608332	SLC36A3	5		
FBgn0033572	polyph	HGNC:18762	OMIM:608331	SLC36A2	5	138500,242600	138500[HYPERGLYCINURIA],242600[IMINOGLYCINURIA]
FBgn0033572	polyph	HGNC:19660	OMIM:613760	SLC36A4	5		
FBgn0033572	polyph	HGNC:18761	OMIM:606561	SLC36A1	5		
FBgn0033572	polyph	HGNC:25582	OMIM:614236	SLC38A7	3		
FBgn0033578	BBS4	HGNC:969	OMIM:600374	BBS4	13	615982	615982[BARDET-BIEDL SYNDROME 4; BBS4]
FBgn0033579	CG13229	HGNC:19995	OMIM:618448	GPR139	3		
FBgn0040765	luna	HGNC:6350	OMIM:604865	KLF7	8		
FBgn0040765	luna	HGNC:6349	OMIM:602903	KLF5	5		
FBgn0040765	luna	HGNC:2235	OMIM:602053	KLF6	8	176807,613659	176807[PROSTATE CANCER],613659[GASTRIC CANCER]
FBgn0033574	Spn47C	HGNC:8955	OMIM:601799	SERPINB9	4		
FBgn0033574	Spn47C	HGNC:8945	OMIM:605587	SERPINI2	4		
FBgn0033574	Spn47C	HGNC:8943	OMIM:602445	SERPINI1	5	604218	604218[ENCEPHALOPATHY, FAMILIAL, WITH NEUROSERPIN INCLUSION BODIES; FENIB]
FBgn0033574	Spn47C	HGNC:10569	OMIM:600517	SERPINB3	3		
FBgn0033574	Spn47C	HGNC:3311	OMIM:130135	SERPINB1	4		
FBgn0033574	Spn47C	HGNC:8583	OMIM:173360	SERPINE1	3	613329	613329[PLASMINOGEN ACTIVATOR INHIBITOR-1 DEFICIENCY]
FBgn0033574	Spn47C	HGNC:8951	OMIM:177010	SERPINE2	3		
FBgn0033574	Spn47C	HGNC:8950	OMIM:173321	SERPINB6	3	613453	613453[DEAFNESS, AUTOSOMAL RECESSIVE 91; DFNB91]
FBgn0033574	Spn47C	HGNC:8944	OMIM:604445	SERPINB13	3		
FBgn0033542	CAH13	HGNC:1382	OMIM:114815	CA8	3	613227	613227[CEREBELLAR ATAXIA, MENTAL RETARDATION, AND DYSEQUILIBRIUM SYNDROME 3; CAMRQ3]
FBgn0033542	CAH13	HGNC:1369	OMIM:604642	CA10	3		
FBgn0033542	CAH13	HGNC:1380	OMIM:114780	CA6	3		
FBgn0033542	CAH13	HGNC:1371	OMIM:603263	CA12	3	143860	143860[HYPERCHLORHIDROSIS, ISOLATED; HYCHL]
FBgn0033542	CAH13	HGNC:1372	OMIM:604832	CA14	3		
FBgn0033542	CAH13	HGNC:1383	OMIM:603179	CA9	3		
FBgn0033542	CAH13	HGNC:1370	OMIM:604644	CA11	3		
FBgn0033542	CAH13	HGNC:1368	OMIM:114800	CA1	4		
FBgn0033542	CAH13	HGNC:1377	OMIM:114761	CA5A	3	615751	615751[CARBONIC ANHYDRASE VA DEFICIENCY, HYPERAMMONEMIA DUE TO; CA5AD]
FBgn0033542	CAH13	HGNC:14914	OMIM:611436	CA13	3		
FBgn0033542	CAH13	HGNC:1374	OMIM:114750	CA3	3		
FBgn0033542	CAH13	HGNC:1375	OMIM:114760	CA4	3		
FBgn0033542	CAH13	HGNC:1378	OMIM:300230	CA5B	3		
FBgn0033544	CG7220	HGNC:25616	OMIM:614277	UBE2W	15		
FBgn0033547	CG12935	HGNC:28464		TMEM223	14		
FBgn0033549	mms4	HGNC:27289	OMIM:610886	EME2	9		
FBgn0033549	mms4	HGNC:24965	OMIM:610885	EME1	13		
FBgn0033551	CG7222	HGNC:24264	OMIM:614638	DESI2	13		
FBgn0029134	Prosbeta5	HGNC:31963	OMIM:611137	PSMB11	7		
FBgn0029134	Prosbeta5	HGNC:9545	OMIM:177046	PSMB8	11	256040	256040[PROTEASOME-ASSOCIATED AUTOINFLAMMATORY SYNDROME 1; PRAAS1]
FBgn0029134	Prosbeta5	HGNC:9542	OMIM:600306	PSMB5	14		
FBgn0033555	RpS15Ab	HGNC:10389	OMIM:603674	RPS15A	14	618313	618313[DIAMOND-BLACKFAN ANEMIA 20; DBA20]
FBgn0033557	CG12325	HGNC:9711	OMIM:601475	PWP2	7		
FBgn0033557	CG12325	HGNC:0		LOC102724159	11		
FBgn0033571	Polr2E	HGNC:9192	OMIM:180664	POLR2E	14		
FBgn0033570	ND-B14	HGNC:7690	OMIM:602138	NDUFA6	15	618253	618253[MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 33; MC1DN33]
FBgn0017414	cag	HGNC:14523	OMIM:612972	TIGD1	4		
FBgn0017414	cag	HGNC:18336		TIGD5	3		
FBgn0017414	cag	HGNC:1852	OMIM:117140	CENPB	6		
FBgn0017414	cag	HGNC:6199	OMIM:603210	JRK	3		
FBgn0017414	cag	HGNC:6200	OMIM:603211	JRKL	3		
FBgn0017414	cag	HGNC:18332		TIGD6	5		
FBgn0017414	cag	HGNC:18331	OMIM:612969	TIGD7	3		
FBgn0017414	cag	HGNC:18333	OMIM:612973	TIGD2	3		
FBgn0017414	cag	HGNC:18335		TIGD4	5		
FBgn0017414	cag	HGNC:18334	OMIM:619084	TIGD3	4		
FBgn0010356	Taf5	HGNC:17304		TAF5L	5		
FBgn0010356	Taf5	HGNC:11539	OMIM:601787	TAF5	14		
FBgn0050016	CG30016	HGNC:12405	OMIM:176300	TTR	10	105210,115430,145680	105210[AMYLOIDOSIS, HEREDITARY, TRANSTHYRETIN-RELATED],115430[CARPAL TUNNEL SYNDROME; CTS1],145680[HYPERTHYROXINEMIA, DYSTRANSTHYRETINEMIC; DTTRH]
FBgn0027525	LTV1	HGNC:21173		LTV1	14		
FBgn0033558	CG12344	HGNC:4328	OMIM:600421	GLRA3	3		
FBgn0033558	CG12344	HGNC:4329	OMIM:138492	GLRB	3	614619	614619[HYPEREKPLEXIA 2; HKPX2]
FBgn0033558	CG12344	HGNC:4327	OMIM:305990	GLRA2	4	301076	301076[INTELLECTUAL DEVELOPMENTAL DISORDER, X-LINKED, SYNDROMIC, PILORGE TYPE; MRXSP]
FBgn0033558	CG12344	HGNC:31715		GLRA4	3		
FBgn0033558	CG12344	HGNC:4326	OMIM:138491	GLRA1	3	149400	149400[HYPEREKPLEXIA 1; HKPX1]
FBgn0033556	CG12343	HGNC:19824	OMIM:607090	SYF2	14		
FBgn0033554	Lsm10	HGNC:17562	OMIM:617909	LSM10	12		
FBgn0033550	CG12341	HGNC:34244		TMEM170B	10		
FBgn0033550	CG12341	HGNC:29577		TMEM170A	13		
FBgn0033548	CG7637	HGNC:14378	OMIM:606471	NOP10	14	224230	224230[DYSKERATOSIS CONGENITA, AUTOSOMAL RECESSIVE 1; DKCB1]
FBgn0027499	wde	HGNC:20092	OMIM:613644	ATF7IP	12		
FBgn0027499	wde	HGNC:20397	OMIM:613645	ATF7IP2	4		
FBgn0053144	CG33144	HGNC:20457	OMIM:619454	RNF144A	10		
FBgn0053144	CG33144	HGNC:21578	OMIM:618869	RNF144B	5		
FBgn0024956	Mat1	HGNC:7181	OMIM:602659	MNAT1	15		
FBgn0033543	Daao1	HGNC:2671	OMIM:124050	DAO	10		
FBgn0033543	Daao1	HGNC:2727	OMIM:124450	DDO	13		
FBgn0005586	Rab3	HGNC:9777	OMIM:179490	RAB3A	12		
FBgn0005586	Rab3	HGNC:9778	OMIM:179510	RAB3B	11		
FBgn0005586	Rab3	HGNC:9779	OMIM:604350	RAB3D	9		
FBgn0005586	Rab3	HGNC:30269	OMIM:612829	RAB3C	12		
FBgn0033518	Prx6c	HGNC:9352	OMIM:176763	PRDX1	3	277400	277400[METHYLMALONIC ACIDURIA AND HOMOCYSTINURIA, cblC TYPE; MAHCC]
FBgn0033518	Prx6c	HGNC:16753	OMIM:602316	PRDX6	10		
FBgn0033518	Prx6c	HGNC:9353	OMIM:600538	PRDX2	3		
FBgn0053474	CG33474	HGNC:20208	OMIM:607583	PEX11G	11		
FBgn0033520	Prx6b	HGNC:9352	OMIM:176763	PRDX1	3	277400	277400[METHYLMALONIC ACIDURIA AND HOMOCYSTINURIA, cblC TYPE; MAHCC]
FBgn0033520	Prx6b	HGNC:16753	OMIM:602316	PRDX6	9		
FBgn0033520	Prx6b	HGNC:9353	OMIM:600538	PRDX2	3		
FBgn0001122	Galphao	HGNC:4387	OMIM:139370	GNAI3	3	602483	602483[AURICULOCONDYLAR SYNDROME 1; ARCND1]
FBgn0001122	Galphao	HGNC:4385	OMIM:139360	GNAI2	4	192605	192605[VENTRICULAR TACHYCARDIA, FAMILIAL]
FBgn0001122	Galphao	HGNC:4394	OMIM:139340	GNAT2	3	613856	613856[ACHROMATOPSIA 4; ACHM4]
FBgn0001122	Galphao	HGNC:4395	OMIM:139160	GNAZ	3		
FBgn0001122	Galphao	HGNC:22800	OMIM:139395	GNAT3	3		
FBgn0001122	Galphao	HGNC:4384	OMIM:139310	GNAI1	4	619854	619854[NEURODEVELOPMENTAL DISORDER WITH HYPOTONIA, IMPAIRED SPEECH, AND BEHAVIORAL ABNORMALITIES; NEDHISB]
FBgn0001122	Galphao	HGNC:4389	OMIM:139311	GNAO1	14	615473,617493	615473[DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 17; DEE17],617493[NEURODEVELOPMENTAL DISORDER WITH INVOLUNTARY MOVEMENTS; NEDIM]
FBgn0033527	CG11777	HGNC:9262	OMIM:615811	PPIL3	14		
FBgn0033529	CG17765	HGNC:8765	OMIM:601057	PDCD6	3		
FBgn0033529	CG17765	HGNC:30009	OMIM:610033	PEF1	12		
FBgn0033529	CG17765	HGNC:11292	OMIM:182520	SRI	4		
FBgn0033529	CG17765	HGNC:15990	OMIM:607030	GCA	3		
FBgn0033528	trsn	HGNC:12379	OMIM:600575	TSN	14		
FBgn0033526	Caf1-105	HGNC:1911	OMIM:601245	CHAF1B	13		
FBgn0033524	Cyp49a1	HGNC:2606	OMIM:609506	CYP27B1	6	264700	264700[VITAMIN D HYDROXYLATION-DEFICIENT RICKETS, TYPE 1A; VDDR1A]
FBgn0033524	Cyp49a1	HGNC:33480		CYP27C1	6		
FBgn0033524	Cyp49a1	HGNC:2605	OMIM:606530	CYP27A1	6	213700	213700[CEREBROTENDINOUS XANTHOMATOSIS; CTX]
FBgn0033524	Cyp49a1	HGNC:2602	OMIM:126065	CYP24A1	8	143880	143880[HYPERCALCEMIA, INFANTILE, 1; HCINF1]
FBgn0033524	Cyp49a1	HGNC:2590	OMIM:118485	CYP11A1	3	613743	613743[ADRENAL INSUFFICIENCY, CONGENITAL, WITH 46,XY SEX REVERSAL, PARTIAL OR COMPLETE]
FBgn0033523	CG12895	HGNC:26034	OMIM:613019	SDHAF2	15	601650	601650[PARAGANGLIOMAS 2; PGL2]
FBgn0033521	CG12896	HGNC:9352	OMIM:176763	PRDX1	3	277400	277400[METHYLMALONIC ACIDURIA AND HOMOCYSTINURIA, cblC TYPE; MAHCC]
FBgn0033521	CG12896	HGNC:16753	OMIM:602316	PRDX6	10		
FBgn0033521	CG12896	HGNC:9353	OMIM:600538	PRDX2	3		
FBgn0033519	CG11825	HGNC:24318		HIGD1B	10		
FBgn0033519	CG11825	HGNC:29527	OMIM:618623	HIGD1A	12		
FBgn0033519	CG11825	HGNC:28044		HIGD1C	12		
FBgn0033490	CG12917	HGNC:3346	OMIM:600440	ENDOG	3		
FBgn0033490	CG12917	HGNC:3347	OMIM:604051	EXOG	3		
FBgn0005619	Hdc	HGNC:4855	OMIM:142704	HDC	13	137580	137580[GILLES DE LA TOURETTE SYNDROME; GTS]
FBgn0005619	Hdc	HGNC:2719	OMIM:107930	DDC	3	608643	608643[AROMATIC L-AMINO ACID DECARBOXYLASE DEFICIENCY; AADCD]
FBgn0033500	Csgalnact	HGNC:24292	OMIM:616616	CSGALNACT2	14		
FBgn0033500	Csgalnact	HGNC:24290	OMIM:616615	CSGALNACT1	14	618870	618870[SKELETAL DYSPLASIA, MILD, WITH JOINT LAXITY AND ADVANCED BONE AGE; SDJLABA]
FBgn0033504	CAP	HGNC:30907	OMIM:610795	SORBS3	7		
FBgn0033504	CAP	HGNC:14565	OMIM:605264	SORBS1	5		
FBgn0033504	CAP	HGNC:24098	OMIM:616349	SORBS2	5		
FBgn0033507	CG12909	HGNC:26021	OMIM:617684	LYAR	10		
FBgn0026403	Ndg	HGNC:7821	OMIM:131390	NID1	12		
FBgn0026403	Ndg	HGNC:13389	OMIM:605399	NID2	11		
FBgn0028426	RNaseZ	HGNC:14198	OMIM:605367	ELAC2	14	614731,615440	614731[PROSTATE CANCER, HEREDITARY, 2; HPC2],615440[COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 17; COXPD17]
FBgn0003660	Syb	HGNC:12647	OMIM:603177	VAMP8	5		
FBgn0003660	Syb	HGNC:12642	OMIM:185880	VAMP1	10	108600,618323	108600[SPASTIC ATAXIA 1, AUTOSOMAL DOMINANT; SPAX1],618323[MYASTHENIC SYNDROME, CONGENITAL, 25, PRESYNAPTIC; CMS25]
FBgn0003660	Syb	HGNC:12644	OMIM:603657	VAMP3	7		
FBgn0003660	Syb	HGNC:12643	OMIM:185881	VAMP2	10	618760	618760[NEURODEVELOPMENTAL DISORDER WITH HYPOTONIA AND AUTISTIC FEATURES WITH OR WITHOUT HYPERKINETIC MOVEMENTS; NEDHAHM]
FBgn0003660	Syb	HGNC:12645	OMIM:606909	VAMP4	4		
FBgn0003660	Syb	HGNC:12646	OMIM:607029	VAMP5	3		
FBgn0000448	Hr3	HGNC:10258	OMIM:600825	RORA	9	618060	618060[INTELLECTUAL DEVELOPMENTAL DISORDER WITH OR WITHOUT EPILEPSY OR CEREBELLAR ATAXIA; IDDECA]
FBgn0000448	Hr3	HGNC:10259	OMIM:601972	RORB	11	618357	618357[EPILEPSY, IDIOPATHIC GENERALIZED, SUSCEPTIBILITY TO, 15; EIG15]
FBgn0000448	Hr3	HGNC:10260	OMIM:602943	RORC	9	616622	616622[IMMUNODEFICIENCY 42; IMD42]
FBgn0033494	KCNQ	HGNC:6298	OMIM:603537	KCNQ4	9	600101	600101[DEAFNESS, AUTOSOMAL DOMINANT 2A; DFNA2A]
FBgn0033494	KCNQ	HGNC:6297	OMIM:602232	KCNQ3	7	121201	121201[SEIZURES, BENIGN FAMILIAL NEONATAL, 2; BFNS2]
FBgn0033494	KCNQ	HGNC:6294	OMIM:607542	KCNQ1	7	192500,220400,607554,609621	192500[LONG QT SYNDROME 1; LQT1],220400[JERVELL AND LANGE-NIELSEN SYNDROME 1; JLNS1],607554[ATRIAL FIBRILLATION, FAMILIAL, 3; ATFB3],609621[SHORT QT SYNDROME 2; SQT2]
FBgn0033494	KCNQ	HGNC:6296	OMIM:602235	KCNQ2	7	121200,613720	121200[SEIZURES, BENIGN FAMILIAL NEONATAL, 1; BFNS1],613720[DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 7; DEE7]
FBgn0033494	KCNQ	HGNC:6299	OMIM:607357	KCNQ5	9	617601	617601[INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL DOMINANT 46; MRD46]
FBgn0033454	CG1671	HGNC:11587	OMIM:605915	TBL3	14		
FBgn0050010	CG30010	HGNC:33826		C8orf82	14		
FBgn0033457	Ntmt	HGNC:31932		METTL11B	10		
FBgn0033457	Ntmt	HGNC:23373	OMIM:613560	NTMT1	13		
FBgn0050008	CG30008	HGNC:26292	OMIM:614451	ELOVL7	5		
FBgn0050008	CG30008	HGNC:14416	OMIM:611814	ELOVL2	3		
FBgn0050008	CG30008	HGNC:14415	OMIM:605512	ELOVL4	3	133190,600110,614457	133190[SPINOCEREBELLAR ATAXIA 34; SCA34],600110[STARGARDT DISEASE 3; STGD3],614457[ICHTHYOSIS, SPASTIC QUADRIPLEGIA, AND MENTAL RETARDATION; ISQMR]
FBgn0050008	CG30008	HGNC:14418	OMIM:611813	ELOVL1	5	618527	618527[ICHTHYOTIC KERATODERMA, SPASTICITY, HYPOMYELINATION, AND DYSMORPHIC FACIAL FEATURES; IKSHD]
FBgn0050008	CG30008	HGNC:21308	OMIM:611805	ELOVL5	3	615957	615957[SPINOCEREBELLAR ATAXIA 38; SCA38]
FBgn0027619	eIF3j	HGNC:3270	OMIM:603910	EIF3J	13		
FBgn0033471	CG12134	HGNC:20489		WDR89	14		
FBgn0000606	eve	HGNC:3506	OMIM:142996	EVX1	6		
FBgn0000606	eve	HGNC:3507	OMIM:142991	EVX2	6		
FBgn0033473	CG12128	HGNC:26933	OMIM:617614	SPOUT1	13		
FBgn0033475	CG12129	HGNC:24268	OMIM:614215	ASCC1	12	614266,616867	614266[BARRETT ESOPHAGUS],616867[SPINAL MUSCULAR ATROPHY WITH CONGENITAL BONE FRACTURES 2; SMABF2]
FBgn0040773	COX7C	HGNC:2292	OMIM:603774	COX7C	12		
FBgn0033480	mRpL42	HGNC:14493	OMIM:611847	MRPL42	11		
FBgn0033483	egr	HGNC:11928	OMIM:604472	TNFSF13	3		
FBgn0033483	egr	HGNC:11929	OMIM:603969	TNFSF13B	3		
FBgn0033483	egr	HGNC:33537		TNFSF12-TNFSF13	3		
FBgn0033483	egr	HGNC:3157	OMIM:300451	EDA	6	305100,313500	305100[ECTODERMAL DYSPLASIA 1, HYPOHIDROTIC, X-LINKED; XHED],313500[TOOTH AGENESIS, SELECTIVE, X-LINKED, 1; STHAGX1]
FBgn0001291	Jra	HGNC:6204	OMIM:165160	JUN	11		
FBgn0001291	Jra	HGNC:6206	OMIM:165162	JUND	11		
FBgn0001291	Jra	HGNC:6205	OMIM:165161	JUNB	9		
FBgn0003071	Pfk	HGNC:8876	OMIM:171860	PFKL	13		
FBgn0003071	Pfk	HGNC:8877	OMIM:610681	PFKM	15	232800	232800[GLYCOGEN STORAGE DISEASE VII; GSD7]
FBgn0003071	Pfk	HGNC:8878	OMIM:171840	PFKP	13		
FBgn0033486	dmpd	HGNC:29046	OMIM:609100	FBXO28	6	619777	619777[DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 100; DEE100]
FBgn0010531	Ccs	HGNC:1613	OMIM:603864	CCS	14		
FBgn0033485	RpLP0-like	HGNC:18477		MRTO4	14		
FBgn0033482	CG1371	HGNC:30060	OMIM:609157	NOMO1	14		
FBgn0033482	CG1371	HGNC:25242	OMIM:609159	NOMO3	14		
FBgn0033482	CG1371	HGNC:22652	OMIM:609158	NOMO2	13		
FBgn0033482	CG1371	HGNC:0		LOC102723728	4		
FBgn0013435	Cdc2rk	HGNC:1730	OMIM:116951	CDK11A	3		
FBgn0013435	Cdc2rk	HGNC:1770	OMIM:603464	CDK10	15	617694	617694[AL KAISSI SYNDROME; ALKAS]
FBgn0013435	Cdc2rk	HGNC:1729	OMIM:176873	CDK11B	3		
FBgn0033479	PIG-N	HGNC:8967	OMIM:606097	PIGN	14	614080	614080[MULTIPLE CONGENITAL ANOMALIES-HYPOTONIA-SEIZURES SYNDROME 1; MCAHS1]
FBgn0033476	oys	HGNC:21579	OMIM:611732	MBOAT1	13		
FBgn0033476	oys	HGNC:25193	OMIM:611949	MBOAT2	15		
FBgn0033476	oys	HGNC:32311	OMIM:611940	MBOAT4	6		
FBgn0033474	CG1407	HGNC:20749	OMIM:617972	ZDHHC20	14		
FBgn0033474	CG1407	HGNC:18459	OMIM:614604	ZDHHC7	3		
FBgn0033474	CG1407	HGNC:20342	OMIM:300576	ZDHHC15	12		
FBgn0033474	CG1407	HGNC:18469	OMIM:618621	ZDHHC2	12		
FBgn0033474	CG1407	HGNC:20750	OMIM:614605	ZDHHC21	3		
FBgn0022382	Pka-R2	HGNC:9391	OMIM:176910	PRKAR2A	13		
FBgn0022382	Pka-R2	HGNC:9388	OMIM:188830	PRKAR1A	4	101800,160980,255960,610489	101800[ACRODYSOSTOSIS 1 WITH OR WITHOUT HORMONE RESISTANCE; ACRDYS1],160980[CARNEY COMPLEX, TYPE 1; CNC1],255960[MYXOMA, INTRACARDIAC],610489[PIGMENTED NODULAR ADRENOCORTICAL DISEASE, PRIMARY, 1; PPNAD1]
FBgn0022382	Pka-R2	HGNC:9390	OMIM:176911	PRKAR1B	4	619680	619680[MARBACH-SCHAAF NEURODEVELOPMENTAL SYNDROME; MASNS]
FBgn0022382	Pka-R2	HGNC:9392	OMIM:176912	PRKAR2B	11		
FBgn0033468	CG1418	HGNC:9794	OMIM:604925	RABAC1	15		
FBgn0033467	Pdrg1	HGNC:16119	OMIM:610789	PDRG1	13		
FBgn0011656	Mef2	HGNC:6993	OMIM:600660	MEF2A	11	608320	608320[CORONARY ARTERY DISEASE, AUTOSOMAL DOMINANT, 1; ADCAD1]
FBgn0011656	Mef2	HGNC:39979		BORCS8-MEF2B	3		
FBgn0011656	Mef2	HGNC:6996	OMIM:600662	MEF2C	11	613443	613443[NEURODEVELOPMENTAL DISORDER WITH HYPOTONIA, STEREOTYPIC HAND MOVEMENTS, AND IMPAIRED LANGUAGE; NEDHSIL]
FBgn0011656	Mef2	HGNC:6997	OMIM:600663	MEF2D	10		
FBgn0011656	Mef2	HGNC:6995	OMIM:600661	MEF2B	5		
FBgn0033464	CG1441	HGNC:26222	OMIM:616107	FAR1	6	616154,619338	616154[PEROXISOMAL FATTY ACYL-CoA REDUCTASE 1 DISORDER; PFCRD],619338[CATARACTS, SPASTIC PARAPARESIS, AND SPEECH DELAY; CSPSD]
FBgn0033464	CG1441	HGNC:25531	OMIM:616156	FAR2	5		
FBgn0033463	CG1513	HGNC:16386	OMIM:606737	OSBPL9	14		
FBgn0033463	CG1513	HGNC:16397	OMIM:606739	OSBPL11	3		
FBgn0033463	CG1513	HGNC:16392	OMIM:606733	OSBPL5	3		
FBgn0033463	CG1513	HGNC:16396	OMIM:606736	OSBPL8	3		
FBgn0033460	Sec24AB	HGNC:10703	OMIM:607183	SEC24A	12		
FBgn0033460	Sec24AB	HGNC:10704	OMIM:607184	SEC24B	12		
FBgn0027580	PCB	HGNC:8636	OMIM:608786	PC	14	266150	266150[PYRUVATE CARBOXYLASE DEFICIENCY]
FBgn0050000	GstT1	HGNC:4641	OMIM:600436	GSTT1	8		
FBgn0050000	GstT1	HGNC:4642	OMIM:600437	GSTT2	9		
FBgn0050000	GstT1	HGNC:33437		GSTT2B	6		
FBgn0050000	GstT1	HGNC:26930		GSTT4	4		
FBgn0050005	GstT2	HGNC:4641	OMIM:600436	GSTT1	5		
FBgn0050005	GstT2	HGNC:4642	OMIM:600437	GSTT2	7		
FBgn0050005	GstT2	HGNC:33437		GSTT2B	6		
FBgn0050005	GstT2	HGNC:26930		GSTT4	4		
FBgn0033440	CG10459	HGNC:30796	OMIM:605986	STRAP	3		
FBgn0005614	trpl	HGNC:12336	OMIM:603651	TRPC4	10		
FBgn0005614	trpl	HGNC:12337	OMIM:300334	TRPC5	10		
FBgn0005614	trpl	HGNC:12333	OMIM:602343	TRPC1	7		
FBgn0005614	trpl	HGNC:12335	OMIM:602345	TRPC3	4	616410	616410[SPINOCEREBELLAR ATAXIA 41; SCA41]
FBgn0005614	trpl	HGNC:12338	OMIM:603652	TRPC6	4	603965	603965[FOCAL SEGMENTAL GLOMERULOSCLEROSIS 2; FSGS2]
FBgn0005614	trpl	HGNC:20754		TRPC7	4		
FBgn0033443	CG1698	HGNC:11049	OMIM:126455	SLC6A3	3	188890,613135	188890[TOBACCO ADDICTION, SUSCEPTIBILITY TO],613135[PARKINSONISM-DYSTONIA 1, INFANTILE-ONSET; PKDYS1]
FBgn0033443	CG1698	HGNC:11044	OMIM:607952	SLC6A11	4		
FBgn0033443	CG1698	HGNC:31399	OMIM:610299	SLC6A17	4	616269	616269[INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 48; MRT48]
FBgn0033443	CG1698	HGNC:11045	OMIM:603080	SLC6A12	3		
FBgn0033443	CG1698	HGNC:11054	OMIM:606205	SLC6A7	4		
FBgn0033443	CG1698	HGNC:11048	OMIM:163970	SLC6A2	3	604715	604715[ORTHOSTATIC INTOLERANCE]
FBgn0033443	CG1698	HGNC:13621	OMIM:607971	SLC6A15	4		
FBgn0033443	CG1698	HGNC:11050	OMIM:182138	SLC6A4	3	164230,607834	164230[OBSESSIVE-COMPULSIVE DISORDER; OCD],607834[ANXIETY]
FBgn0033443	CG1698	HGNC:11055	OMIM:300036	SLC6A8	3	300352	300352[CEREBRAL CREATINE DEFICIENCY SYNDROME 1; CCDS1]
FBgn0033443	CG1698	HGNC:11056	OMIM:601019	SLC6A9	4	617301	617301[GLYCINE ENCEPHALOPATHY WITH NORMAL SERUM GLYCINE]
FBgn0033443	CG1698	HGNC:11051	OMIM:604159	SLC6A5	3	614618	614618[HYPEREKPLEXIA 3; HKPX3]
FBgn0033443	CG1698	HGNC:11047	OMIM:300444	SLC6A14	3		
FBgn0033443	CG1698	HGNC:11052	OMIM:186854	SLC6A6	3	145350	145350[HYPOTAURINEMIC RETINAL DEGENERATION AND CARDIOMYOPATHY; HTRDC]
FBgn0033443	CG1698	HGNC:11046	OMIM:615097	SLC6A13	3		
FBgn0033443	CG1698	HGNC:11042	OMIM:137165	SLC6A1	3	616421	616421[MYOCLONIC-ATONIC EPILEPSY; MAE]
FBgn0033443	CG1698	HGNC:13622	OMIM:607972	SLC6A16	4		
FBgn0040092	lectin-46Cb	HGNC:14556	OMIM:613579	CLEC6A	3		
FBgn0040092	lectin-46Cb	HGNC:13257	OMIM:605306	CLEC4A	3		
FBgn0040092	lectin-46Cb	HGNC:14555	OMIM:609962	CLEC4E	3		
FBgn0040092	lectin-46Cb	HGNC:13258	OMIM:606677	CLEC4C	3		
FBgn0040092	lectin-46Cb	HGNC:14554	OMIM:609964	CLEC4D	3		
FBgn0040092	lectin-46Cb	HGNC:13523	OMIM:605872	CLEC4M	3		
FBgn0040092	lectin-46Cb	HGNC:34520	OMIM:616838	CLEC17A	3		
FBgn0040092	lectin-46Cb	HGNC:26705	OMIM:612252	CLEC9A	4		
FBgn0040093	lectin-46Ca	HGNC:13523	OMIM:605872	CLEC4M	3		
FBgn0033451	Marc	HGNC:26189	OMIM:614126	MTARC1	13		
FBgn0033451	Marc	HGNC:26064	OMIM:614127	MARC2	13		
FBgn0023180	Orc6	HGNC:17151	OMIM:607213	ORC6	13	613803	613803[MEIER-GORLIN SYNDROME 3; MGORS3]
FBgn0033450	Lsm11	HGNC:30860	OMIM:617910	LSM11	12	619486	619486[AICARDI-GOUTIERES SYNDROME 8; AGS8]
FBgn0033447	dila	HGNC:29511	OMIM:613479	CEP131	9		
FBgn0027589	CG1688	HGNC:19439	OMIM:613655	KCNK18	5	613656	613656[MIGRAINE WITH OR WITHOUT AURA, SUSCEPTIBILITY TO, 13; MGR13]
FBgn0027589	CG1688	HGNC:6282	OMIM:603940	KCNK7	3		
FBgn0023143	Uba1	HGNC:12471	OMIM:191325	UBA7	7		
FBgn0023143	Uba1	HGNC:25581	OMIM:611361	UBA6	4		
FBgn0023143	Uba1	HGNC:12469	OMIM:314370	UBA1	13	301054,301830	301054[VEXAS SYNDROME; VEXAS],301830[SPINAL MUSCULAR ATROPHY, X-LINKED 2; SMAX2]
FBgn0033438	Mmp2	HGNC:7157	OMIM:185261	MMP11	3		
FBgn0033438	Mmp2	HGNC:7162	OMIM:602262	MMP16	4		
FBgn0033438	Mmp2	HGNC:14246	OMIM:608482	MMP25	4		
FBgn0033438	Mmp2	HGNC:7163	OMIM:602285	MMP17	4		
FBgn0033438	Mmp2	HGNC:7167	OMIM:604629	MMP20	3	612529	612529[AMELOGENESIS IMPERFECTA, HYPOMATURATION TYPE, IIA2; AI2A2]
FBgn0033438	Mmp2	HGNC:7161	OMIM:602261	MMP15	5		
FBgn0033438	Mmp2	HGNC:7172	OMIM:604871	MMP24	4		
FBgn0033438	Mmp2	HGNC:7160	OMIM:600754	MMP14	4	277950	277950[WINCHESTER SYNDROME; WNCHRS]
FBgn0033438	Mmp2	HGNC:7155	OMIM:120353	MMP1	3	226600,606963	226600[EPIDERMOLYSIS BULLOSA DYSTROPHICA, AUTOSOMAL RECESSIVE; RDEB],606963[PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; COPD]
FBgn0033438	Mmp2	HGNC:7175	OMIM:120355	MMP8	3		
FBgn0033438	Mmp2	HGNC:7174	OMIM:178990	MMP7	3		
FBgn0033438	Mmp2	HGNC:14249	OMIM:605470	MMP26	3		
FBgn0033437	CG12926	HGNC:12404	OMIM:600415	TTPA	3	277460	277460[ATAXIA WITH VITAMIN E DEFICIENCY; AVED]
FBgn0033437	CG12926	HGNC:16114		TTPAL	3		
FBgn0033437	CG12926	HGNC:10024	OMIM:180090	RLBP1	3	136880,607475,607476	136880[FUNDUS ALBIPUNCTATUS],607475[BOTHNIA RETINAL DYSTROPHY],607476[NEWFOUNDLAND ROD-CONE DYSTROPHY; NFRCD]
FBgn0033437	CG12926	HGNC:23046	OMIM:616945	CLVS2	3		
FBgn0033437	CG12926	HGNC:23139	OMIM:611292	CLVS1	3		
FBgn0016970	l(2)k10201	HGNC:28445		ZNF511	11		
FBgn0041087	wun2	HGNC:9230	OMIM:607126	PLPP2	11		
FBgn0041087	wun2	HGNC:9229	OMIM:607125	PLPP3	12		
FBgn0041087	wun2	HGNC:9228	OMIM:607124	PLPP1	12		
FBgn0041087	wun2	HGNC:23531		PLPP4	3		
FBgn0041087	wun2	HGNC:25026	OMIM:610626	PLPP5	4		
FBgn0041087	wun2	HGNC:23496	OMIM:607813	PLPPR4	3		
FBgn0041087	wun2	HGNC:25993	OMIM:619590	PLPPR1	3		
FBgn0041087	wun2	HGNC:29566	OMIM:619591	PLPPR2	3		
FBgn0041087	wun2	HGNC:23497	OMIM:610391	PLPPR3	3		
FBgn0041087	wun2	HGNC:31703	OMIM:617287	PLPPR5	3		
FBgn0033413	prel	HGNC:30255	OMIM:605733	PRELID1	14		
FBgn0017558	Pdk	HGNC:8812	OMIM:602527	PDK4	12		
FBgn0017558	Pdk	HGNC:8810	OMIM:602525	PDK2	13		
FBgn0017558	Pdk	HGNC:8811	OMIM:300906	PDK3	14	300905	300905[CHARCOT-MARIE-TOOTH DISEASE, X-LINKED DOMINANT, 6; CMTX6]
FBgn0017558	Pdk	HGNC:8809	OMIM:602524	PDK1	13		
FBgn0004360	Wnt2	HGNC:12786	OMIM:601570	WNT7A	12	228930,276820	228930[FIBULAR APLASIA OR HYPOPLASIA, FEMORAL BOWING AND POLY-, SYN-, AND OLIGODACTYLY],276820[ULNA AND FIBULA, ABSENCE OF, WITH SEVERE LIMB DEFICIENCY]
FBgn0004360	Wnt2	HGNC:16267	OMIM:606267	WNT16	3		
FBgn0004360	Wnt2	HGNC:12781	OMIM:601968	WNT2B	4	618168	618168[DIARRHEA 9; DIAR9]
FBgn0004360	Wnt2	HGNC:12780	OMIM:147870	WNT2	3		
FBgn0004360	Wnt2	HGNC:12787	OMIM:601967	WNT7B	14		
FBgn0004360	Wnt2	HGNC:12783	OMIM:603490	WNT4	4	158330,611812	158330[MULLERIAN APLASIA AND HYPERANDROGENISM],611812[46,XX SEX REVERSAL WITH DYSGENESIS OF KIDNEYS, ADRENALS, AND LUNGS; SERKAL]
FBgn0004360	Wnt2	HGNC:16265	OMIM:606361	WNT5B	3		
FBgn0033423	Alp6	HGNC:438	OMIM:171760	ALPL	11	146300,241500,241510	146300[HYPOPHOSPHATASIA, ADULT; HPPA],241500[HYPOPHOSPHATASIA, INFANTILE; HPPI],241510[HYPOPHOSPHATASIA, CHILDHOOD; HPPC]
FBgn0033423	Alp6	HGNC:441	OMIM:171810	ALPG	11		
FBgn0033423	Alp6	HGNC:439	OMIM:171800	ALPP	11		
FBgn0033423	Alp6	HGNC:437	OMIM:171740	ALPI	12		
FBgn0033426	Nt5c	HGNC:30826	OMIM:611076	NT5DC3	13		
FBgn0033426	Nt5c	HGNC:25717		NT5DC2	11		
FBgn0033428	Urod	HGNC:12591	OMIM:613521	UROD	14	176100	176100[PORPHYRIA CUTANEA TARDA]
FBgn0033431	CG1827	HGNC:318	OMIM:613228	AGA	14	208400	208400[ASPARTYLGLUCOSAMINURIA; AGU]
FBgn0033434	CG1902	HGNC:12404	OMIM:600415	TTPA	3	277460	277460[ATAXIA WITH VITAMIN E DEFICIENCY; AVED]
FBgn0033434	CG1902	HGNC:16114		TTPAL	3		
FBgn0033434	CG1902	HGNC:10024	OMIM:180090	RLBP1	3	136880,607475,607476	136880[FUNDUS ALBIPUNCTATUS],607475[BOTHNIA RETINAL DYSTROPHY],607476[NEWFOUNDLAND ROD-CONE DYSTROPHY; NFRCD]
FBgn0033434	CG1902	HGNC:23046	OMIM:616945	CLVS2	3		
FBgn0033434	CG1902	HGNC:23139	OMIM:611292	CLVS1	3		
FBgn0050338	CG30338	HGNC:21385		RWDD2A	12		
FBgn0050338	CG30338	HGNC:1302	OMIM:617843	RWDD2B	12		
FBgn0050339	CG30339	HGNC:12404	OMIM:600415	TTPA	3	277460	277460[ATAXIA WITH VITAMIN E DEFICIENCY; AVED]
FBgn0050339	CG30339	HGNC:16114		TTPAL	3		
FBgn0050339	CG30339	HGNC:10024	OMIM:180090	RLBP1	3	136880,607475,607476	136880[FUNDUS ALBIPUNCTATUS],607475[BOTHNIA RETINAL DYSTROPHY],607476[NEWFOUNDLAND ROD-CONE DYSTROPHY; NFRCD]
FBgn0050339	CG30339	HGNC:23046	OMIM:616945	CLVS2	3		
FBgn0050339	CG30339	HGNC:23139	OMIM:611292	CLVS1	3		
FBgn0033429	CG12929	HGNC:28837		TMEM234	12		
FBgn0033427	Smyd4-1	HGNC:21067	OMIM:619134	SMYD4	8		
FBgn0029092	ced-6	HGNC:18649	OMIM:608165	GULP1	9		
FBgn0016078	wun	HGNC:9230	OMIM:607126	PLPP2	9		
FBgn0016078	wun	HGNC:9229	OMIM:607125	PLPP3	12		
FBgn0016078	wun	HGNC:9228	OMIM:607124	PLPP1	14		
FBgn0016078	wun	HGNC:23531		PLPP4	3		
FBgn0016078	wun	HGNC:25026	OMIM:610626	PLPP5	3		
FBgn0016078	wun	HGNC:23496	OMIM:607813	PLPPR4	3		
FBgn0016078	wun	HGNC:25993	OMIM:619590	PLPPR1	3		
FBgn0016078	wun	HGNC:29566	OMIM:619591	PLPPR2	3		
FBgn0016078	wun	HGNC:23497	OMIM:610391	PLPPR3	3		
FBgn0016078	wun	HGNC:31703	OMIM:617287	PLPPR5	3		
FBgn0028473	Non1	HGNC:21535	OMIM:619169	GTPBP4	15		
FBgn0033408	CG8800	HGNC:23247	OMIM:610062	DNAL1	14	614017	614017[CILIARY DYSKINESIA, PRIMARY, 16; CILD16]
FBgn0025709	CNT2	HGNC:16484	OMIM:608269	SLC28A3	12		
FBgn0025709	CNT2	HGNC:11001	OMIM:606207	SLC28A1	13	618477	618477[URIDINE-CYTIDINEURIA; URCTU]
FBgn0025709	CNT2	HGNC:11002	OMIM:606208	SLC28A2	14		
FBgn0033371	CNT1	HGNC:16484	OMIM:608269	SLC28A3	11		
FBgn0033371	CNT1	HGNC:11001	OMIM:606207	SLC28A1	12	618477	618477[URIDINE-CYTIDINEURIA; URCTU]
FBgn0033371	CNT1	HGNC:11002	OMIM:606208	SLC28A2	14		
FBgn0010220	Dbp45A	HGNC:18684		DDX49	14		
FBgn0010220	Dbp45A	HGNC:18682	OMIM:615428	DDX47	3		
FBgn0033376	CG8777	HGNC:23639	OMIM:614589	TTC37	14	222470	222470[TRICHOHEPATOENTERIC SYNDROME 1; THES1]
FBgn0015838	Vang	HGNC:15512	OMIM:610132	VANGL1	13	182940,600145	182940[NEURAL TUBE DEFECTS, SUSCEPTIBILITY TO; NTD],600145[SACRAL DEFECT WITH ANTERIOR MENINGOCELE]
FBgn0015838	Vang	HGNC:15511	OMIM:600533	VANGL2	12	182940	182940[NEURAL TUBE DEFECTS, SUSCEPTIBILITY TO; NTD]
FBgn0033378	tsu	HGNC:9905	OMIM:605313	RBM8A	13	274000	274000[THROMBOCYTOPENIA-ABSENT RADIUS SYNDROME; TAR]
FBgn0003612	Su(var)2-10	HGNC:17311	OMIM:603567	PIAS2	12		
FBgn0003612	Su(var)2-10	HGNC:16861	OMIM:605987	PIAS3	12		
FBgn0003612	Su(var)2-10	HGNC:17002	OMIM:605989	PIAS4	11		
FBgn0003612	Su(var)2-10	HGNC:2752	OMIM:603566	PIAS1	14		
FBgn0033381	GstE13	HGNC:4642	OMIM:600437	GSTT2	3		
FBgn0033381	GstE13	HGNC:33437		GSTT2B	3		
FBgn0033381	GstE13	HGNC:26930		GSTT4	3		
FBgn0033382	Hydr1	HGNC:18718	OMIM:612197	ABHD3	15		
FBgn0033382	Hydr1	HGNC:17553	OMIM:612195	ABHD1	13		
FBgn0050342	Prp38	HGNC:25930	OMIM:617031	PRPF38A	13		
FBgn0050344	CG30344	HGNC:16055	OMIM:608956	SLC46A2	5		
FBgn0050344	CG30344	HGNC:30521	OMIM:611672	SLC46A1	8	229050	229050[FOLATE MALABSORPTION, HEREDITARY]
FBgn0050344	CG30344	HGNC:27501	OMIM:616764	SLC46A3	7		
FBgn0050345	CG30345	HGNC:16055	OMIM:608956	SLC46A2	6		
FBgn0050345	CG30345	HGNC:30521	OMIM:611672	SLC46A1	9	229050	229050[FOLATE MALABSORPTION, HEREDITARY]
FBgn0050345	CG30345	HGNC:27501	OMIM:616764	SLC46A3	9		
FBgn0033389	Rad51D	HGNC:9823	OMIM:602954	RAD51D	11	614291	614291[BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 4; BROVCA4]
FBgn0015561	unpg	HGNC:4186	OMIM:601135	GBX2	10		
FBgn0015561	unpg	HGNC:4185	OMIM:603354	GBX1	10		
FBgn0033395	Cyp4p2	HGNC:23198	OMIM:608614	CYP4V2	6	210370	210370[BIETTI CRYSTALLINE CORNEORETINAL DYSTROPHY; BCD]
FBgn0033395	Cyp4p2	HGNC:13265	OMIM:611517	CYP4F11	4		
FBgn0033395	Cyp4p2	HGNC:26820	OMIM:611495	CYP4F22	4	604777	604777[ICHTHYOSIS, CONGENITAL, AUTOSOMAL RECESSIVE 5; ARCI5]
FBgn0033395	Cyp4p2	HGNC:2645	OMIM:604426	CYP4F2	5		
FBgn0033395	Cyp4p2	HGNC:2646	OMIM:601270	CYP4F3	5		
FBgn0033395	Cyp4p2	HGNC:20244	OMIM:614999	CYP4X1	4		
FBgn0033395	Cyp4p2	HGNC:2642	OMIM:601310	CYP4A11	3		
FBgn0033395	Cyp4p2	HGNC:18857	OMIM:611485	CYP4F12	4		
FBgn0033395	Cyp4p2	HGNC:20575	OMIM:615341	CYP4A22	3		
FBgn0033395	Cyp4p2	HGNC:2644	OMIM:124075	CYP4B1	4		
FBgn0033395	Cyp4p2	HGNC:2648	OMIM:611545	CYP4F8	4		
FBgn0033395	Cyp4p2	HGNC:20583	OMIM:618953	CYP4Z1	3		
FBgn0033395	Cyp4p2	HGNC:2594	OMIM:107910	CYP19A1	4	139300,613546	139300[AROMATASE EXCESS SYNDROME; AEXS],613546[AROMATASE DEFICIENCY]
FBgn0015037	Cyp4p1	HGNC:23198	OMIM:608614	CYP4V2	6	210370	210370[BIETTI CRYSTALLINE CORNEORETINAL DYSTROPHY; BCD]
FBgn0015037	Cyp4p1	HGNC:13265	OMIM:611517	CYP4F11	4		
FBgn0015037	Cyp4p1	HGNC:26820	OMIM:611495	CYP4F22	4	604777	604777[ICHTHYOSIS, CONGENITAL, AUTOSOMAL RECESSIVE 5; ARCI5]
FBgn0015037	Cyp4p1	HGNC:2645	OMIM:604426	CYP4F2	4		
FBgn0015037	Cyp4p1	HGNC:2646	OMIM:601270	CYP4F3	4		
FBgn0015037	Cyp4p1	HGNC:20244	OMIM:614999	CYP4X1	4		
FBgn0015037	Cyp4p1	HGNC:2642	OMIM:601310	CYP4A11	3		
FBgn0015037	Cyp4p1	HGNC:18857	OMIM:611485	CYP4F12	4		
FBgn0015037	Cyp4p1	HGNC:20575	OMIM:615341	CYP4A22	4		
FBgn0015037	Cyp4p1	HGNC:2644	OMIM:124075	CYP4B1	4		
FBgn0015037	Cyp4p1	HGNC:2648	OMIM:611545	CYP4F8	4		
FBgn0015037	Cyp4p1	HGNC:20583	OMIM:618953	CYP4Z1	4		
FBgn0015037	Cyp4p1	HGNC:2594	OMIM:107910	CYP19A1	4	139300,613546	139300[AROMATASE EXCESS SYNDROME; AEXS],613546[AROMATASE DEFICIENCY]
FBgn0033397	Cyp4p3	HGNC:23198	OMIM:608614	CYP4V2	6	210370	210370[BIETTI CRYSTALLINE CORNEORETINAL DYSTROPHY; BCD]
FBgn0033397	Cyp4p3	HGNC:13265	OMIM:611517	CYP4F11	4		
FBgn0033397	Cyp4p3	HGNC:26820	OMIM:611495	CYP4F22	4	604777	604777[ICHTHYOSIS, CONGENITAL, AUTOSOMAL RECESSIVE 5; ARCI5]
FBgn0033397	Cyp4p3	HGNC:2645	OMIM:604426	CYP4F2	4		
FBgn0033397	Cyp4p3	HGNC:2646	OMIM:601270	CYP4F3	4		
FBgn0033397	Cyp4p3	HGNC:20244	OMIM:614999	CYP4X1	4		
FBgn0033397	Cyp4p3	HGNC:2642	OMIM:601310	CYP4A11	3		
FBgn0033397	Cyp4p3	HGNC:18857	OMIM:611485	CYP4F12	4		
FBgn0033397	Cyp4p3	HGNC:20575	OMIM:615341	CYP4A22	3		
FBgn0033397	Cyp4p3	HGNC:2644	OMIM:124075	CYP4B1	4		
FBgn0033397	Cyp4p3	HGNC:2648	OMIM:611545	CYP4F8	4		
FBgn0033397	Cyp4p3	HGNC:20583	OMIM:618953	CYP4Z1	3		
FBgn0033397	Cyp4p3	HGNC:2594	OMIM:107910	CYP19A1	4	139300,613546	139300[AROMATASE EXCESS SYNDROME; AEXS],613546[AROMATASE DEFICIENCY]
FBgn0033401	Cog6	HGNC:18621	OMIM:606977	COG6	13	614576,615328	614576[CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIl; CDG2L],615328[SHAHEEN SYNDROME; SHNS]
FBgn0028408	Drep2	HGNC:1977	OMIM:604441	CIDEB	5		
FBgn0028408	Drep2	HGNC:1976	OMIM:604440	CIDEA	5		
FBgn0028408	Drep2	HGNC:24229	OMIM:612120	CIDEC	5	615238	615238[LIPODYSTROPHY, FAMILIAL PARTIAL, TYPE 5; FPLD5]
FBgn0033402	Myd88	HGNC:7562	OMIM:602170	MYD88	12	153600,612260	153600[MACROGLOBULINEMIA, WALDENSTROM, SUSCEPTIBILITY TO, 1; WM1],612260[IMMUNODEFICIENCY 68; IMD68]
FBgn0026326	Mad1	HGNC:6762	OMIM:602686	MAD1L1	12	176807	176807[PROSTATE CANCER]
FBgn0033400	CG2063	HGNC:30785	OMIM:610218	SAP30BP	12		
FBgn0020621	Pkn	HGNC:9405	OMIM:601032	PKN1	12		
FBgn0020621	Pkn	HGNC:9406	OMIM:602549	PKN2	13		
FBgn0020621	Pkn	HGNC:17999	OMIM:610714	PKN3	10		
FBgn0033392	Gnptab	HGNC:29670	OMIM:607840	GNPTAB	13	252500,252600	252500[MUCOLIPIDOSIS II ALPHA/BETA],252600[MUCOLIPIDOSIS III ALPHA/BETA]
FBgn0033391	CG8026	HGNC:29683	OMIM:138480	SLC25A32	12	616839	616839[EXERCISE INTOLERANCE, RIBOFLAVIN-RESPONSIVE; RREI]
FBgn0015477	Rme-8	HGNC:30343	OMIM:614334	DNAJC13	14		
FBgn0033388	CG8046	HGNC:16055	OMIM:608956	SLC46A2	5		
FBgn0033388	CG8046	HGNC:30521	OMIM:611672	SLC46A1	7	229050	229050[FOLATE MALABSORPTION, HEREDITARY]
FBgn0033388	CG8046	HGNC:27501	OMIM:616764	SLC46A3	7		
FBgn0033387	CG8008	HGNC:16055	OMIM:608956	SLC46A2	5		
FBgn0033387	CG8008	HGNC:30521	OMIM:611672	SLC46A1	7	229050	229050[FOLATE MALABSORPTION, HEREDITARY]
FBgn0033387	CG8008	HGNC:27501	OMIM:616764	SLC46A3	7		
FBgn0027561	CG18659	HGNC:29324	OMIM:613633	DENND1A	8		
FBgn0027561	CG18659	HGNC:28404	OMIM:613292	DENND1B	10		
FBgn0027561	CG18659	HGNC:26225	OMIM:613634	DENND1C	8		
FBgn0033379	Mys45A	HGNC:25537		SDAD1	14		
FBgn0033377	Pgm2a	HGNC:8906	OMIM:172000	PGM2	12		
FBgn0033377	Pgm2a	HGNC:20898	OMIM:611610	PGM2L1	12		
FBgn0033375	CG8078	HGNC:29590	OMIM:612694	CTU1	14		
FBgn0033373	Nadk2	HGNC:26404	OMIM:615787	NADK2	12	616034	616034[2,4-DIENOYL-CoA REDUCTASE DEFICIENCY; DECRD]
FBgn0024189	sns	HGNC:7908	OMIM:602716	NPHS1	14	256300	256300[NEPHROTIC SYNDROME, TYPE 1; NPHS1]
FBgn0011286	RyR	HGNC:10484	OMIM:180902	RYR2	14	115000,600996,604772	115000[VENTRICULAR ARRHYTHMIAS DUE TO CARDIAC RYANODINE RECEPTOR CALCIUM RELEASE DEFICIENCY SYNDROME; VACRDS],600996[ARRHYTHMOGENIC RIGHT VENTRICULAR DYSPLASIA, FAMILIAL, 2; ARVD2],604772[VENTRICULAR TACHYCARDIA, CATECHOLAMINERGIC POLYMORPHIC, 1, WITH OR WITHOUT ATRIAL DYSFUNCTION AND/OR DILATED CARDIOMYOPATHY; CPVT1]
FBgn0011286	RyR	HGNC:10485	OMIM:180903	RYR3	12		
FBgn0011286	RyR	HGNC:10483	OMIM:180901	RYR1	14	117000,145600,255320,619542	117000[CENTRAL CORE DISEASE OF MUSCLE; CCD],145600[MALIGNANT HYPERTHERMIA, SUSCEPTIBILITY TO, 1; MHS1],255320[MINICORE MYOPATHY WITH EXTERNAL OPHTHALMOPLEGIA],619542[KING-DENBOROUGH SYNDROME; KDS]
FBgn0021825	DCTN2-p50	HGNC:2712	OMIM:607376	DCTN2	15		
FBgn0033339	Sec31	HGNC:17052	OMIM:610257	SEC31A	14	618651	618651[HALPERIN-BIRK SYNDROME; HLBKS]
FBgn0033339	Sec31	HGNC:23197	OMIM:610258	SEC31B	13		
FBgn0004921	Ggamma1	HGNC:4403	OMIM:604390	GNG11	4		
FBgn0004921	Ggamma1	HGNC:4408	OMIM:600874	GNG5	8		
FBgn0004921	Ggamma1	HGNC:4405	OMIM:608941	GNG3	5		
FBgn0004921	Ggamma1	HGNC:4412	OMIM:139391	GNGT2	3		
FBgn0004921	Ggamma1	HGNC:4402	OMIM:604389	GNG10	8		
FBgn0004921	Ggamma1	HGNC:4410	OMIM:604430	GNG7	10		
FBgn0004921	Ggamma1	HGNC:4404	OMIM:606981	GNG2	7		
FBgn0004921	Ggamma1	HGNC:19664		GNG8	6		
FBgn0004921	Ggamma1	HGNC:4407	OMIM:604388	GNG4	6		
FBgn0004921	Ggamma1	HGNC:19663	OMIM:615405	GNG12	9		
FBgn0004921	Ggamma1	HGNC:37501		DNAJC25-GNG10	3		
FBgn0004921	Ggamma1	HGNC:4411	OMIM:189970	GNGT1	3		
FBgn0004921	Ggamma1	HGNC:53439		GNG14	4		
FBgn0050349	CG30349	HGNC:28945	OMIM:616195	WDR43	13		
FBgn0002552	lin	HGNC:30922	OMIM:610350	LINS1	4	614340	614340[INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 27; MRT27]
FBgn0033349	CG8243	HGNC:25082	OMIM:616916	SMAP2	12		
FBgn0033349	CG8243	HGNC:19651	OMIM:611372	SMAP1	11		
FBgn0033350	CG8237	HGNC:16372	OMIM:618409	FAM8A1	12		
FBgn0033352	PAN2	HGNC:20074	OMIM:617447	PAN2	14		
FBgn0033355	CG13748	HGNC:11248	OMIM:613941	SPINT3	3		
FBgn0033355	CG13748	HGNC:11761	OMIM:600033	TFPI2	3		
FBgn0033357	Tom7	HGNC:21648	OMIM:607980	TOMM7	11		
FBgn0011300	babo	HGNC:171	OMIM:102576	ACVR1	4	135100	135100[FIBRODYSPLASIA OSSIFICANS PROGRESSIVA; FOP]
FBgn0011300	babo	HGNC:172	OMIM:601300	ACVR1B	10		
FBgn0011300	babo	HGNC:1077	OMIM:603248	BMPR1B	3	112600,609441,616849	112600[BRACHYDACTYLY, TYPE A2; BDA2],609441[ACROMESOMELIC DYSPLASIA 3; AMD3],616849[BRACHYDACTYLY, TYPE A1, D; BDA1D]
FBgn0011300	babo	HGNC:18123	OMIM:608981	ACVR1C	12		
FBgn0011300	babo	HGNC:1076	OMIM:601299	BMPR1A	3	174900,610069	174900[JUVENILE POLYPOSIS SYNDROME; JPS],610069[POLYPOSIS SYNDROME, HEREDITARY MIXED, 2; HMPS2]
FBgn0011300	babo	HGNC:175	OMIM:601284	ACVRL1	4	600376	600376[TELANGIECTASIA, HEREDITARY HEMORRHAGIC, TYPE 2; HHT2]
FBgn0011300	babo	HGNC:11772	OMIM:190181	TGFBR1	14	132800,609192	132800[MULTIPLE SELF-HEALING SQUAMOUS EPITHELIOMA, SUSCEPTIBILITY TO; MSSE],609192[LOEYS-DIETZ SYNDROME 1; LDS1]
FBgn0033369	CG8197	HGNC:28408	OMIM:619037	LRRC34	3		
FBgn0033368	CG13743	HGNC:26836	OMIM:616526	SLC38A11	15		
FBgn0033368	CG13743	HGNC:13448	OMIM:605180	SLC38A2	3		
FBgn0033366	Ance-4	HGNC:13557	OMIM:300335	ACE2	3		
FBgn0033366	Ance-4	HGNC:2707	OMIM:106180	ACE	4	267430,612624,614519	267430[RENAL TUBULAR DYSGENESIS; RTD],612624[MICROVASCULAR COMPLICATIONS OF DIABETES, SUSCEPTIBILITY TO, 3; MVCD3],614519[HEMORRHAGE, INTRACEREBRAL, SUSCEPTIBILITY TO; ICH]
FBgn0033362	CG8172	HGNC:14368	OMIM:609343	PRSS22	3		
FBgn0033362	CG8172	HGNC:9485	OMIM:608159	PRSS21	3		
FBgn0027607	CG8230	HGNC:21317	OMIM:607461	DYM	14	223800,607326	223800[DYGGVE-MELCHIOR-CLAUSEN DISEASE; DMC],607326[SMITH-MCCORT DYSPLASIA 1; SMC1]
FBgn0033354	FANCI	HGNC:25568	OMIM:611360	FANCI	13	609053	609053[FANCONI ANEMIA, COMPLEMENTATION GROUP I; FANCI]
FBgn0033351	AIMP1	HGNC:10648	OMIM:603605	AIMP1	15	260600	260600[LEUKODYSTROPHY, HYPOMYELINATING, 3; HLD3]
FBgn0003074	Pgi	HGNC:4458	OMIM:172400	GPI	15	613470	613470[HEMOLYTIC ANEMIA, NONSPHEROCYTIC, DUE TO GLUCOSE PHOSPHATE ISOMERASE DEFICIENCY]
FBgn0033344	CG8252	HGNC:24061	OMIM:300462	AKAP14	3		
FBgn0033341	MrgBP	HGNC:15866	OMIM:611157	MRGBP	13		
FBgn0033337	CG8272	HGNC:13605		LRRC29	8		
FBgn0033304	Cyp6a13	HGNC:2638	OMIM:605325	CYP3A5	5	145500	145500[HYPERTENSION, ESSENTIAL]
FBgn0033304	Cyp6a13	HGNC:17450	OMIM:606534	CYP3A43	5		
FBgn0033304	Cyp6a13	HGNC:11609	OMIM:274180	TBXAS1	4	231095	231095[GHOSAL HEMATODIAPHYSEAL DYSPLASIA; GHDD]
FBgn0033304	Cyp6a13	HGNC:2637	OMIM:124010	CYP3A4	5	619073	619073[VITAMIN D-DEPENDENT RICKETS, TYPE 3; VDDR3]
FBgn0033304	Cyp6a13	HGNC:51504		CYP3A7-CYP3A51P	6		
FBgn0033313	Cirl	HGNC:3337	OMIM:606100	ADGRE2	3	125630	125630[VIBRATORY URTICARIA; VBU]
FBgn0033313	Cirl	HGNC:1711	OMIM:601211	ADGRE5	3		
FBgn0033313	Cirl	HGNC:20973	OMIM:616416	ADGRL1	10		
FBgn0033313	Cirl	HGNC:18582	OMIM:607018	ADGRL2	9		
FBgn0033313	Cirl	HGNC:20974	OMIM:616417	ADGRL3	10		
FBgn0033313	Cirl	HGNC:20822	OMIM:616419	ADGRL4	4		
FBgn0022027	Vps25	HGNC:28122	OMIM:610907	VPS25	14		
FBgn0033316	Gle1	HGNC:4315	OMIM:603371	GLE1	11	253310,611890	253310[LETHAL CONGENITAL CONTRACTURE SYNDROME 1; LCCS1],611890[CONGENITAL ARTHROGRYPOSIS WITH ANTERIOR HORN CELL DISEASE; CAAHD]
FBgn0050354	UQCR-11L	HGNC:12590	OMIM:613844	UQCRH	14		
FBgn0050354	UQCR-11L	HGNC:51714		UQCRHL	8		
FBgn0033323	CG12376	HGNC:26175	OMIM:609841	SLC8B1	13		
FBgn0043576	PGRP-SC1a	HGNC:30013	OMIM:608199	PGLYRP2	3		
FBgn0043576	PGRP-SC1a	HGNC:8904	OMIM:604963	PGLYRP1	5		
FBgn0043576	PGRP-SC1a	HGNC:30014	OMIM:608197	PGLYRP3	3		
FBgn0043576	PGRP-SC1a	HGNC:30015	OMIM:608198	PGLYRP4	4		
FBgn0033327	PGRP-SC1b	HGNC:30013	OMIM:608199	PGLYRP2	3		
FBgn0033327	PGRP-SC1b	HGNC:8904	OMIM:604963	PGLYRP1	9		
FBgn0033327	PGRP-SC1b	HGNC:30014	OMIM:608197	PGLYRP3	4		
FBgn0033327	PGRP-SC1b	HGNC:30015	OMIM:608198	PGLYRP4	5		
FBgn0043575	PGRP-SC2	HGNC:8904	OMIM:604963	PGLYRP1	11		
FBgn0043575	PGRP-SC2	HGNC:30014	OMIM:608197	PGLYRP3	5		
FBgn0043575	PGRP-SC2	HGNC:30015	OMIM:608198	PGLYRP4	6		
FBgn0005695	gcl	HGNC:23843	OMIM:618627	GMCL1	13		
FBgn0005695	gcl	HGNC:26340		BTBD16	3		
FBgn0005695	gcl	HGNC:19717	OMIM:618629	GMCL2	8		
FBgn0040777	CG14767	HGNC:6924	OMIM:618837	LAPTM4A	12		
FBgn0040777	CG14767	HGNC:13646	OMIM:613296	LAPTM4B	8		
FBgn0040777	CG14767	HGNC:29612	OMIM:601476	LAPTM5	4		
FBgn0033326	CG14743	HGNC:26175	OMIM:609841	SLC8B1	12		
FBgn0033324	CG14744	HGNC:26175	OMIM:609841	SLC8B1	14		
FBgn0033322	CG8584	HGNC:16890	OMIM:608592	CTDSPL	3		
FBgn0033322	CG8584	HGNC:17077	OMIM:608711	CTDSP2	3		
FBgn0033322	CG8584	HGNC:21614	OMIM:605323	CTDSP1	3		
FBgn0033322	CG8584	HGNC:19085	OMIM:610684	CTDNEP1	5		
FBgn0033317	CG8635	HGNC:29528	OMIM:619704	ZC3H15	15		
FBgn0033315	beta3GalTII	HGNC:17978	OMIM:615291	B3GALT6	15	271640,609465,615349	271640[SPONDYLOEPIMETAPHYSEAL DYSPLASIA WITH JOINT LAXITY, TYPE 1, WITH OR WITHOUT FRACTURES; SEMDJL1],609465[AL-GAZALI SYNDROME; ALGAZ],615349[EHLERS-DANLOS SYNDROME, SPONDYLODYSPLASTIC TYPE, 2; EDSSPD2]
FBgn0033312	CG8642	HGNC:3624	OMIM:601624	FCN2	5		
FBgn0033312	CG8642	HGNC:3623	OMIM:601252	FCN1	4		
FBgn0033312	CG8642	HGNC:25922	OMIM:613357	FIBCD1	7		
FBgn0033312	CG8642	HGNC:3695	OMIM:605776	FGL1	3		
FBgn0033312	CG8642	HGNC:3625	OMIM:604973	FCN3	4	613860	613860[FICOLIN 3 DEFICIENCY]
FBgn0033312	CG8642	HGNC:7035	OMIM:600596	MFAP4	4		
FBgn0033309	Lnpk	HGNC:21610	OMIM:610236	LNPK	14	618090	618090[NEURODEVELOPMENTAL DISORDER WITH EPILEPSY AND HYPOPLASIA OF THE CORPUS CALLOSUM; NEDEHCC]
FBgn0033302	Cyp6a14	HGNC:2638	OMIM:605325	CYP3A5	4	145500	145500[HYPERTENSION, ESSENTIAL]
FBgn0033302	Cyp6a14	HGNC:17450	OMIM:606534	CYP3A43	4		
FBgn0033302	Cyp6a14	HGNC:11609	OMIM:274180	TBXAS1	4	231095	231095[GHOSAL HEMATODIAPHYSEAL DYSPLASIA; GHDD]
FBgn0033302	Cyp6a14	HGNC:2637	OMIM:124010	CYP3A4	5	619073	619073[VITAMIN D-DEPENDENT RICKETS, TYPE 3; VDDR3]
FBgn0033302	Cyp6a14	HGNC:51504		CYP3A7-CYP3A51P	5		
FBgn0028836	CSN7	HGNC:16758	OMIM:616009	COPS7A	13		
FBgn0028836	CSN7	HGNC:16760	OMIM:616010	COPS7B	14		
FBgn0014469	Cyp4e2	HGNC:23198	OMIM:608614	CYP4V2	6	210370	210370[BIETTI CRYSTALLINE CORNEORETINAL DYSTROPHY; BCD]
FBgn0014469	Cyp4e2	HGNC:13265	OMIM:611517	CYP4F11	4		
FBgn0014469	Cyp4e2	HGNC:26820	OMIM:611495	CYP4F22	4	604777	604777[ICHTHYOSIS, CONGENITAL, AUTOSOMAL RECESSIVE 5; ARCI5]
FBgn0014469	Cyp4e2	HGNC:2645	OMIM:604426	CYP4F2	4		
FBgn0014469	Cyp4e2	HGNC:2646	OMIM:601270	CYP4F3	4		
FBgn0014469	Cyp4e2	HGNC:20244	OMIM:614999	CYP4X1	4		
FBgn0014469	Cyp4e2	HGNC:2642	OMIM:601310	CYP4A11	3		
FBgn0014469	Cyp4e2	HGNC:18857	OMIM:611485	CYP4F12	4		
FBgn0014469	Cyp4e2	HGNC:20575	OMIM:615341	CYP4A22	4		
FBgn0014469	Cyp4e2	HGNC:2644	OMIM:124075	CYP4B1	4		
FBgn0014469	Cyp4e2	HGNC:2648	OMIM:611545	CYP4F8	4		
FBgn0014469	Cyp4e2	HGNC:20583	OMIM:618953	CYP4Z1	4		
FBgn0014469	Cyp4e2	HGNC:2594	OMIM:107910	CYP19A1	4	139300,613546	139300[AROMATASE EXCESS SYNDROME; AEXS],613546[AROMATASE DEFICIENCY]
FBgn0015034	Cyp4e1	HGNC:23198	OMIM:608614	CYP4V2	6	210370	210370[BIETTI CRYSTALLINE CORNEORETINAL DYSTROPHY; BCD]
FBgn0015034	Cyp4e1	HGNC:13265	OMIM:611517	CYP4F11	4		
FBgn0015034	Cyp4e1	HGNC:26820	OMIM:611495	CYP4F22	4	604777	604777[ICHTHYOSIS, CONGENITAL, AUTOSOMAL RECESSIVE 5; ARCI5]
FBgn0015034	Cyp4e1	HGNC:2645	OMIM:604426	CYP4F2	4		
FBgn0015034	Cyp4e1	HGNC:2646	OMIM:601270	CYP4F3	4		
FBgn0015034	Cyp4e1	HGNC:20244	OMIM:614999	CYP4X1	4		
FBgn0015034	Cyp4e1	HGNC:2642	OMIM:601310	CYP4A11	3		
FBgn0015034	Cyp4e1	HGNC:18857	OMIM:611485	CYP4F12	4		
FBgn0015034	Cyp4e1	HGNC:20575	OMIM:615341	CYP4A22	4		
FBgn0015034	Cyp4e1	HGNC:2644	OMIM:124075	CYP4B1	4		
FBgn0015034	Cyp4e1	HGNC:2648	OMIM:611545	CYP4F8	4		
FBgn0015034	Cyp4e1	HGNC:20583	OMIM:618953	CYP4Z1	4		
FBgn0015034	Cyp4e1	HGNC:2594	OMIM:107910	CYP19A1	4	139300,613546	139300[AROMATASE EXCESS SYNDROME; AEXS],613546[AROMATASE DEFICIENCY]
FBgn0002569	Mal-A2	HGNC:11026	OMIM:158070	SLC3A2	3		
FBgn0002569	Mal-A2	HGNC:11025	OMIM:104614	SLC3A1	10	220100	220100[CYSTINURIA]
FBgn0033294	Mal-A4	HGNC:11026	OMIM:158070	SLC3A2	4		
FBgn0033294	Mal-A4	HGNC:11025	OMIM:104614	SLC3A1	11	220100	220100[CYSTINURIA]
FBgn0050359	Mal-A5	HGNC:11026	OMIM:158070	SLC3A2	3		
FBgn0050359	Mal-A5	HGNC:11025	OMIM:104614	SLC3A1	10	220100	220100[CYSTINURIA]
FBgn0050360	Mal-A6	HGNC:11026	OMIM:158070	SLC3A2	4		
FBgn0050360	Mal-A6	HGNC:11025	OMIM:104614	SLC3A1	10	220100	220100[CYSTINURIA]
FBgn0033297	Mal-A8	HGNC:11026	OMIM:158070	SLC3A2	3		
FBgn0033297	Mal-A8	HGNC:11025	OMIM:104614	SLC3A1	11	220100	220100[CYSTINURIA]
FBgn0050361	mtt	HGNC:4598	OMIM:604096	GRM6	3	257270	257270[NIGHT BLINDNESS, CONGENITAL STATIONARY, TYPE 1B; CSNB1B]
FBgn0050361	mtt	HGNC:4596	OMIM:604100	GRM4	3		
FBgn0050361	mtt	HGNC:4599	OMIM:604101	GRM7	3	618922	618922[NEURODEVELOPMENTAL DISORDER WITH SEIZURES, HYPOTONIA, AND BRAIN IMAGING ABNORMALITIES; NEDSHBA]
FBgn0050361	mtt	HGNC:4600	OMIM:601116	GRM8	4		
FBgn0050361	mtt	HGNC:4595	OMIM:601115	GRM3	4		
FBgn0050361	mtt	HGNC:4594	OMIM:604099	GRM2	4		
FBgn0050361	mtt	HGNC:4593	OMIM:604473	GRM1	4	614831,617691	614831[SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 13; SCAR13],617691[SPINOCEREBELLAR ATAXIA 44; SCA44]
FBgn0050361	mtt	HGNC:4597	OMIM:604102	GRM5	4		
FBgn0033296	Mal-A7	HGNC:11026	OMIM:158070	SLC3A2	5		
FBgn0033296	Mal-A7	HGNC:11025	OMIM:104614	SLC3A1	10	220100	220100[CYSTINURIA]
FBgn0002571	Mal-A3	HGNC:11026	OMIM:158070	SLC3A2	3		
FBgn0002571	Mal-A3	HGNC:11025	OMIM:104614	SLC3A1	10	220100	220100[CYSTINURIA]
FBgn0002570	Mal-A1	HGNC:11025	OMIM:104614	SLC3A1	9	220100	220100[CYSTINURIA]
FBgn0033292	Cyp4ad1	HGNC:23198	OMIM:608614	CYP4V2	5	210370	210370[BIETTI CRYSTALLINE CORNEORETINAL DYSTROPHY; BCD]
FBgn0033292	Cyp4ad1	HGNC:13265	OMIM:611517	CYP4F11	4		
FBgn0033292	Cyp4ad1	HGNC:26820	OMIM:611495	CYP4F22	4	604777	604777[ICHTHYOSIS, CONGENITAL, AUTOSOMAL RECESSIVE 5; ARCI5]
FBgn0033292	Cyp4ad1	HGNC:2645	OMIM:604426	CYP4F2	4		
FBgn0033292	Cyp4ad1	HGNC:2646	OMIM:601270	CYP4F3	4		
FBgn0033292	Cyp4ad1	HGNC:20244	OMIM:614999	CYP4X1	4		
FBgn0033292	Cyp4ad1	HGNC:2642	OMIM:601310	CYP4A11	3		
FBgn0033292	Cyp4ad1	HGNC:18857	OMIM:611485	CYP4F12	4		
FBgn0033292	Cyp4ad1	HGNC:20575	OMIM:615341	CYP4A22	4		
FBgn0033292	Cyp4ad1	HGNC:2644	OMIM:124075	CYP4B1	4		
FBgn0033292	Cyp4ad1	HGNC:2648	OMIM:611545	CYP4F8	4		
FBgn0033292	Cyp4ad1	HGNC:20583	OMIM:618953	CYP4Z1	4		
FBgn0033292	Cyp4ad1	HGNC:2594	OMIM:107910	CYP19A1	4	139300,613546	139300[AROMATASE EXCESS SYNDROME; AEXS],613546[AROMATASE DEFICIENCY]
FBgn0033289	CG2121	HGNC:12570	OMIM:607995	UNC93A	11		
FBgn0028563	sut1	HGNC:18301	OMIM:611039	SLC2A14	5		
FBgn0028563	sut1	HGNC:11010	OMIM:138230	SLC2A5	6		
FBgn0028563	sut1	HGNC:11005	OMIM:138140	SLC2A1	5	601042,606777,608885,612126,614847	601042[DYSTONIA 9; DYT9],606777[GLUT1 DEFICIENCY SYNDROME 1; GLUT1DS1],608885[STOMATIN-DEFICIENT CRYOHYDROCYTOSIS WITH NEUROLOGIC DEFECTS; SDCHCN],612126[GLUT1 DEFICIENCY SYNDROME 2; GLUT1DS2],614847[EPILEPSY, IDIOPATHIC GENERALIZED, SUSCEPTIBILITY TO, 12; EIG12]
FBgn0028563	sut1	HGNC:13445	OMIM:610371	SLC2A7	7		
FBgn0028563	sut1	HGNC:11009	OMIM:138190	SLC2A4	5		
FBgn0028563	sut1	HGNC:13446	OMIM:606142	SLC2A9	5	612076	612076[HYPOURICEMIA, RENAL, 2; RHUC2]
FBgn0028563	sut1	HGNC:11006	OMIM:138160	SLC2A2	5	125853,227810	125853[TYPE 2 DIABETES MELLITUS; T2D],227810[FANCONI-BICKEL SYNDROME; FBS]
FBgn0028563	sut1	HGNC:11007	OMIM:138170	SLC2A3	5		
FBgn0028563	sut1	HGNC:14239	OMIM:610367	SLC2A11	4		
FBgn0028562	sut2	HGNC:18301	OMIM:611039	SLC2A14	5		
FBgn0028562	sut2	HGNC:11010	OMIM:138230	SLC2A5	6		
FBgn0028562	sut2	HGNC:11005	OMIM:138140	SLC2A1	5	601042,606777,608885,612126,614847	601042[DYSTONIA 9; DYT9],606777[GLUT1 DEFICIENCY SYNDROME 1; GLUT1DS1],608885[STOMATIN-DEFICIENT CRYOHYDROCYTOSIS WITH NEUROLOGIC DEFECTS; SDCHCN],612126[GLUT1 DEFICIENCY SYNDROME 2; GLUT1DS2],614847[EPILEPSY, IDIOPATHIC GENERALIZED, SUSCEPTIBILITY TO, 12; EIG12]
FBgn0028562	sut2	HGNC:13445	OMIM:610371	SLC2A7	7		
FBgn0028562	sut2	HGNC:11009	OMIM:138190	SLC2A4	5		
FBgn0028562	sut2	HGNC:13446	OMIM:606142	SLC2A9	5	612076	612076[HYPOURICEMIA, RENAL, 2; RHUC2]
FBgn0028562	sut2	HGNC:11006	OMIM:138160	SLC2A2	5	125853,227810	125853[TYPE 2 DIABETES MELLITUS; T2D],227810[FANCONI-BICKEL SYNDROME; FBS]
FBgn0028562	sut2	HGNC:11007	OMIM:138170	SLC2A3	5		
FBgn0028562	sut2	HGNC:14239	OMIM:610367	SLC2A11	4		
FBgn0028561	sut3	HGNC:13812	OMIM:605245	SLC2A8	3		
FBgn0028561	sut3	HGNC:18301	OMIM:611039	SLC2A14	6		
FBgn0028561	sut3	HGNC:11010	OMIM:138230	SLC2A5	6		
FBgn0028561	sut3	HGNC:11005	OMIM:138140	SLC2A1	5	601042,606777,608885,612126,614847	601042[DYSTONIA 9; DYT9],606777[GLUT1 DEFICIENCY SYNDROME 1; GLUT1DS1],608885[STOMATIN-DEFICIENT CRYOHYDROCYTOSIS WITH NEUROLOGIC DEFECTS; SDCHCN],612126[GLUT1 DEFICIENCY SYNDROME 2; GLUT1DS2],614847[EPILEPSY, IDIOPATHIC GENERALIZED, SUSCEPTIBILITY TO, 12; EIG12]
FBgn0028561	sut3	HGNC:13445	OMIM:610371	SLC2A7	6		
FBgn0028561	sut3	HGNC:11009	OMIM:138190	SLC2A4	5		
FBgn0028561	sut3	HGNC:13446	OMIM:606142	SLC2A9	5	612076	612076[HYPOURICEMIA, RENAL, 2; RHUC2]
FBgn0028561	sut3	HGNC:11006	OMIM:138160	SLC2A2	5	125853,227810	125853[TYPE 2 DIABETES MELLITUS; T2D],227810[FANCONI-BICKEL SYNDROME; FBS]
FBgn0028561	sut3	HGNC:11007	OMIM:138170	SLC2A3	6		
FBgn0028561	sut3	HGNC:14239	OMIM:610367	SLC2A11	4		
FBgn0033257	sand	HGNC:19439	OMIM:613655	KCNK18	10	613656	613656[MIGRAINE WITH OR WITHOUT AURA, SUSCEPTIBILITY TO, 13; MGR13]
FBgn0033259	Tmem63	HGNC:29118	OMIM:618685	TMEM63A	13	618688	618688[LEUKODYSTROPHY, HYPOMYELINATING, 19, TRANSIENT INFANTILE; HLD19]
FBgn0033259	Tmem63	HGNC:17735	OMIM:619952	TMEM63B	12		
FBgn0033259	Tmem63	HGNC:23787	OMIM:619953	TMEM63C	12	619966	619966[SPASTIC PARAPLEGIA 87, AUTOSOMAL RECESSIVE; SPG87]
FBgn0033264	Nup50	HGNC:8065	OMIM:604646	NUP50	13		
FBgn0033266	Socs44A	HGNC:19392	OMIM:616337	SOCS4	3		
FBgn0033266	Socs44A	HGNC:16852	OMIM:607094	SOCS5	3		
FBgn0033266	Socs44A	HGNC:1984	OMIM:602441	CISH	4	607948,611162,614383	607948[MYCOBACTERIUM TUBERCULOSIS, SUSCEPTIBILITY TO],611162[MALARIA, SUSCEPTIBILITY TO],614383[BACTEREMIA, SUSCEPTIBILITY TO, 2; BACTS2]
FBgn0033266	Socs44A	HGNC:19383	OMIM:603597	SOCS1	5	619375	619375[AUTOINFLAMMATORY SYNDROME, FAMILIAL, WITH OR WITHOUT IMMUNODEFICIENCY; AISIMD]
FBgn0033266	Socs44A	HGNC:19382	OMIM:605117	SOCS2	4		
FBgn0033266	Socs44A	HGNC:19391	OMIM:604176	SOCS3	4		
FBgn0033266	Socs44A	HGNC:16833	OMIM:605118	SOCS6	6		
FBgn0033266	Socs44A	HGNC:29846	OMIM:608788	SOCS7	4		
FBgn0005648	Pabp2	HGNC:8565	OMIM:602279	PABPN1	14	164300	164300[OCULOPHARYNGEAL MUSCULAR DYSTROPHY; OPMD]
FBgn0005648	Pabp2	HGNC:37237		PABPN1L	6		
FBgn0005648	Pabp2	HGNC:42959		BCL2L2-PABPN1	3		
FBgn0021995	Rs1	HGNC:15837	OMIM:616621	DDX27	13		
FBgn0033273	Gasz	HGNC:1350	OMIM:605797	ASZ1	6		
FBgn0011659	Mlh1	HGNC:7127	OMIM:120436	MLH1	14	158320,276300,609310	158320[MUIR-TORRE SYNDROME; MRTES],276300[MISMATCH REPAIR CANCER SYNDROME 1; MMRCS1],609310[COLORECTAL CANCER, HEREDITARY NONPOLYPOSIS, TYPE 2; HNPCC2]
FBgn0053087	LRP1	HGNC:6696	OMIM:604270	LRP4	3	212780,614305,616304	212780[CENANI-LENZ SYNDACTYLY SYNDROME; CLSS],614305[SCLEROSTEOSIS 2; SOST2],616304[MYASTHENIC SYNDROME, CONGENITAL, 17; CMS17]
FBgn0053087	LRP1	HGNC:6694	OMIM:600073	LRP2	6	222448	222448[DONNAI-BARROW SYNDROME]
FBgn0053087	LRP1	HGNC:6692	OMIM:107770	LRP1	11	604093	604093[KERATOSIS PILARIS ATROPHICANS; KPA]
FBgn0053087	LRP1	HGNC:6693	OMIM:608766	LRP1B	10		
FBgn0013726	pnut	HGNC:33280	OMIM:612140	SEPTIN14	3		
FBgn0013726	pnut	HGNC:1717	OMIM:603151	SEPTIN7	15		
FBgn0013726	pnut	HGNC:9165	OMIM:603696	SEPTIN4	4		
FBgn0013726	pnut	HGNC:15848	OMIM:300683	SEPTIN6	4		
FBgn0013726	pnut	HGNC:2879	OMIM:612897	SEPTIN1	3		
FBgn0013726	pnut	HGNC:25589	OMIM:612887	SEPTIN11	4		
FBgn0013726	pnut	HGNC:7729	OMIM:601506	SEPTIN2	4		
FBgn0013726	pnut	HGNC:9164	OMIM:602724	SEPTIN5	4		
FBgn0013726	pnut	HGNC:16511	OMIM:608418	SEPTIN8	4		
FBgn0013726	pnut	HGNC:14349	OMIM:611737	SEPTIN10	4		
FBgn0013726	pnut	HGNC:7323	OMIM:604061	SEPTIN9	4	162100	162100[AMYOTROPHY, HEREDITARY NEURALGIC; HNA]
FBgn0013726	pnut	HGNC:10750	OMIM:608314	SEPTIN3	4		
FBgn0013726	pnut	HGNC:26348	OMIM:611562	SEPTIN12	4	614822	614822[SPERMATOGENIC FAILURE 10; SPGF10]
FBgn0010109	dpn	HGNC:24149	OMIM:608060	HES4	7		
FBgn0010109	dpn	HGNC:5192	OMIM:139605	HES1	7		
FBgn0010109	dpn	HGNC:16005	OMIM:609970	HES2	5		
FBgn0033274	CG14757	HGNC:26034	OMIM:613019	SDHAF2	15	601650	601650[PARAGANGLIOMAS 2; PGL2]
FBgn0050373	CG30373	HGNC:27558		C16orf91	4		
FBgn0033272	RagC-D	HGNC:19903	OMIM:608268	RRAGD	12		
FBgn0033272	RagC-D	HGNC:19902	OMIM:608267	RRAGC	15		
FBgn0033271	CG8708	HGNC:24337	OMIM:610555	C1GALT1	11		
FBgn0033271	CG8708	HGNC:24338	OMIM:300611	C1GALT1C1	3	300622	300622[TN POLYAGGLUTINATION SYNDROME; TNPS]
FBgn0010504	kermit	HGNC:18183	OMIM:608792	GIPC3	14	601869	601869[DEAFNESS, AUTOSOMAL RECESSIVE 15; DFNB15]
FBgn0010504	kermit	HGNC:18177	OMIM:619089	GIPC2	12		
FBgn0010504	kermit	HGNC:1226	OMIM:605072	GIPC1	13	618940	618940[OCULOPHARYNGODISTAL MYOPATHY 2; OPDM2]
FBgn0033260	Cul4	HGNC:2555	OMIM:300304	CUL4B	13	300354	300354[INTELLECTUAL DEVELOPMENTAL DISORDER, X-LINKED, SYNDROMIC, CABEZAS TYPE; MRXSC]
FBgn0033260	Cul4	HGNC:2553	OMIM:603136	CUL3	3	614496,619239	614496[PSEUDOHYPOALDOSTERONISM, TYPE IIE; PHA2E],619239[NEURODEVELOPMENTAL DISORDER WITH OR WITHOUT AUTISM OR SEIZURES; NEDAUS]
FBgn0033260	Cul4	HGNC:2554	OMIM:603137	CUL4A	14		
FBgn0025469	slv	HGNC:30657	OMIM:613683	SLC50A1	11		
FBgn0021814	Vps28	HGNC:18178	OMIM:611952	VPS28	13		
FBgn0033252	CG12769	HGNC:13177	OMIM:606234	IKZF2	3		
FBgn0002891	PolZ1	HGNC:9968	OMIM:602776	REV3L	12		
FBgn0003317	sax	HGNC:171	OMIM:102576	ACVR1	12	135100	135100[FIBRODYSPLASIA OSSIFICANS PROGRESSIVA; FOP]
FBgn0003317	sax	HGNC:172	OMIM:601300	ACVR1B	3		
FBgn0003317	sax	HGNC:1077	OMIM:603248	BMPR1B	3	112600,609441,616849	112600[BRACHYDACTYLY, TYPE A2; BDA2],609441[ACROMESOMELIC DYSPLASIA 3; AMD3],616849[BRACHYDACTYLY, TYPE A1, D; BDA1D]
FBgn0003317	sax	HGNC:18123	OMIM:608981	ACVR1C	4		
FBgn0003317	sax	HGNC:1076	OMIM:601299	BMPR1A	3	174900,610069	174900[JUVENILE POLYPOSIS SYNDROME; JPS],610069[POLYPOSIS SYNDROME, HEREDITARY MIXED, 2; HMPS2]
FBgn0003317	sax	HGNC:175	OMIM:601284	ACVRL1	10	600376	600376[TELANGIECTASIA, HEREDITARY HEMORRHAGIC, TYPE 2; HHT2]
FBgn0003317	sax	HGNC:11772	OMIM:190181	TGFBR1	4	132800,609192	132800[MULTIPLE SELF-HEALING SQUAMOUS EPITHELIOMA, SUSCEPTIBILITY TO; MSSE],609192[LOEYS-DIETZ SYNDROME 1; LDS1]
FBgn0033226	puml	HGNC:20154	OMIM:619728	ABHD4	15		
FBgn0033226	puml	HGNC:21396	OMIM:604780	ABHD5	12	275630	275630[CHANARIN-DORFMAN SYNDROME; CDS]
FBgn0033229	CG12822	HGNC:30967		TRMO	11		
FBgn0040780	Atg10	HGNC:20315	OMIM:610800	ATG10	9		
FBgn0015509	Cul1	HGNC:2551	OMIM:603134	CUL1	14		
FBgn0033234	MFS12	HGNC:20151	OMIM:607557	SLC17A8	4	605583	605583[DEAFNESS, AUTOSOMAL DOMINANT 25; DFNA25]
FBgn0033234	MFS12	HGNC:10933	OMIM:604322	SLC17A5	4	269920,604369	269920[INFANTILE SIALIC ACID STORAGE DISEASE; ISSD],604369[SALLA DISEASE; SD]
FBgn0033234	MFS12	HGNC:16703	OMIM:607563	SLC17A6	3		
FBgn0033234	MFS12	HGNC:16704	OMIM:605208	SLC17A7	4		
FBgn0033234	MFS12	HGNC:10929	OMIM:182308	SLC17A1	5		
FBgn0033234	MFS12	HGNC:10932	OMIM:604216	SLC17A4	6		
FBgn0033234	MFS12	HGNC:10930	OMIM:611049	SLC17A2	5		
FBgn0033234	MFS12	HGNC:10931	OMIM:611034	SLC17A3	6	612671	612671[URIC ACID CONCENTRATION, SERUM, QUANTITATIVE TRAIT LOCUS 4; UAQTL4]
FBgn0026722	drosha	HGNC:17904	OMIM:608828	DROSHA	14		
FBgn0050379	CG30379	HGNC:4589	OMIM:138251	GRINA	5		
FBgn0050379	CG30379	HGNC:17067	OMIM:604306	FAIM2	4		
FBgn0050379	CG30379	HGNC:23410	OMIM:610364	TMBIM1	4		
FBgn0050379	CG30379	HGNC:24257	OMIM:616874	TMBIM4	3		
FBgn0033238	azot	HGNC:1445	OMIM:114182	CALM2	3	616249	616249[LONG QT SYNDROME 15; LQT15]
FBgn0033238	azot	HGNC:1442	OMIM:114180	CALM1	4	614916,616247	614916[VENTRICULAR TACHYCARDIA, CATECHOLAMINERGIC POLYMORPHIC, 4; CPVT4],616247[LONG QT SYNDROME 14; LQT14]
FBgn0033238	azot	HGNC:1449	OMIM:114183	CALM3	3	618782	618782[LONG QT SYNDROME 16; LQT16]
FBgn0033238	azot	HGNC:18180	OMIM:605183	CALML5	4		
FBgn0050378	CG30378	HGNC:13714	OMIM:607315	CABP5	3		
FBgn0033240	CG2906	HGNC:26228		METTL25	3		
FBgn0033240	CG2906	HGNC:24273		RRNAD1	13		
FBgn0027548	nito	HGNC:24303	OMIM:612602	RBM15B	13		
FBgn0027548	nito	HGNC:14959	OMIM:606077	RBM15	12	606077	606077[RNA-BINDING MOTIF PROTEIN 15; RBM15]
FBgn0027054	CSN4	HGNC:16702	OMIM:616008	COPS4	15		
FBgn0033247	Nup44A	HGNC:30379	OMIM:609263	SEH1L	14		
FBgn0013307	Odc1	HGNC:8109	OMIM:165640	ODC1	14	619075	619075[BACHMANN-BUPP SYNDROME; BABS]
FBgn0013307	Odc1	HGNC:16432	OMIM:607909	AZIN1	10		
FBgn0013307	Odc1	HGNC:29957	OMIM:608353	AZIN2	11		
FBgn0013308	Odc2	HGNC:8109	OMIM:165640	ODC1	13	619075	619075[BACHMANN-BUPP SYNDROME; BABS]
FBgn0013308	Odc2	HGNC:16432	OMIM:607909	AZIN1	10		
FBgn0013308	Odc2	HGNC:29957	OMIM:608353	AZIN2	11		
FBgn0027788	Hey	HGNC:4881	OMIM:604674	HEY2	9		
FBgn0027788	Hey	HGNC:4880	OMIM:602953	HEY1	7		
FBgn0027788	Hey	HGNC:4882	OMIM:609034	HEYL	7		
FBgn0033248	Dic3	HGNC:10980	OMIM:606794	SLC25A10	6	618972	618972[MITOCHONDRIAL DNA DEPLETION SYNDROME 19; MTDPS19]
FBgn0033246	ACC	HGNC:85	OMIM:601557	ACACB	13		
FBgn0033246	ACC	HGNC:84	OMIM:200350	ACACA	14	613933	613933[ACETYL-CoA CARBOXYLASE DEFICIENCY; ACACAD]
FBgn0033244	CG8726	HGNC:23326	OMIM:611450	PXK	15		
FBgn0033243	CG14763	HGNC:28482	OMIM:617353	DYNLT2B	3	617405	617405[SHORT-RIB THORACIC DYSPLASIA 17 WITH OR WITHOUT POLYDACTYLY; SRTD17]
FBgn0033243	CG14763	HGNC:11695	OMIM:186977	TCTE3	5		
FBgn0033243	CG14763	HGNC:32315	OMIM:611713	TCTEX1D4	3		
FBgn0026361	Septin5	HGNC:33280	OMIM:612140	SEPTIN14	7		
FBgn0026361	Septin5	HGNC:1717	OMIM:603151	SEPTIN7	3		
FBgn0026361	Septin5	HGNC:9165	OMIM:603696	SEPTIN4	3		
FBgn0026361	Septin5	HGNC:15848	OMIM:300683	SEPTIN6	10		
FBgn0026361	Septin5	HGNC:2879	OMIM:612897	SEPTIN1	3		
FBgn0026361	Septin5	HGNC:25589	OMIM:612887	SEPTIN11	12		
FBgn0026361	Septin5	HGNC:7729	OMIM:601506	SEPTIN2	3		
FBgn0026361	Septin5	HGNC:9164	OMIM:602724	SEPTIN5	3		
FBgn0026361	Septin5	HGNC:16511	OMIM:608418	SEPTIN8	10		
FBgn0026361	Septin5	HGNC:14349	OMIM:611737	SEPTIN10	11		
FBgn0026361	Septin5	HGNC:7323	OMIM:604061	SEPTIN9	3	162100	162100[AMYOTROPHY, HEREDITARY NEURALGIC; HNA]
FBgn0026361	Septin5	HGNC:10750	OMIM:608314	SEPTIN3	3		
FBgn0026361	Septin5	HGNC:26348	OMIM:611562	SEPTIN12	3	614822	614822[SPERMATOGENIC FAILURE 10; SPGF10]
FBgn0033241	CG2915	HGNC:2300	OMIM:603101	CPB2	7		
FBgn0033241	CG2915	HGNC:21011	OMIM:609563	CPO	7		
FBgn0033241	CG2915	HGNC:2298	OMIM:114851	CPA3	8		
FBgn0033241	CG2915	HGNC:2297	OMIM:600688	CPA2	6		
FBgn0033241	CG2915	HGNC:15740	OMIM:607635	CPA4	7		
FBgn0033241	CG2915	HGNC:2299	OMIM:114852	CPB1	7		
FBgn0033241	CG2915	HGNC:2296	OMIM:114850	CPA1	6		
FBgn0033241	CG2915	HGNC:17245	OMIM:609562	CPA6	7	614417,614418	614417[EPILEPSY, FAMILIAL TEMPORAL LOBE, 5; ETL5],614418[FEBRILE SEIZURES, FAMILIAL, 11; FEB11]
FBgn0033241	CG2915	HGNC:15722	OMIM:609561	CPA5	6		
FBgn0033235	CG8728	HGNC:18667	OMIM:613036	PMPCA	15	213200	213200[SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 2; SCAR2]
FBgn0023171	rnh1	HGNC:18466	OMIM:604123	RNASEH1	15	616479	616479[PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL RECESSIVE 2; PEOB2]
FBgn0050381	PIG-X	HGNC:26046	OMIM:610276	PIGX	10		
FBgn0033233	Kdm4A	HGNC:29136	OMIM:609765	KDM4B	11	619320	619320[INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL DOMINANT 65; MRD65]
FBgn0033233	Kdm4A	HGNC:17071	OMIM:605469	KDM4C	11		
FBgn0033233	Kdm4A	HGNC:25498	OMIM:609766	KDM4D	9		
FBgn0033233	Kdm4A	HGNC:22978	OMIM:609764	KDM4A	11		
FBgn0033233	Kdm4A	HGNC:37098	OMIM:616581	KDM4E	9		
FBgn0033232	CG12159	HGNC:26073		FAM174C	3		
FBgn0050382	Prosalpha1R	HGNC:9535	OMIM:602855	PSMA6	12	608446	608446[MYOCARDIAL INFARCTION, SUSCEPTIBILITY TO]
FBgn0029093	cathD	HGNC:2530	OMIM:116890	CTSE	5		
FBgn0029093	cathD	HGNC:8887	OMIM:169730	PGA5	3		
FBgn0029093	cathD	HGNC:8886	OMIM:169720	PGA4	3		
FBgn0029093	cathD	HGNC:9958	OMIM:179820	REN	6	267430,613092	267430[RENAL TUBULAR DYSGENESIS; RTD],613092[TUBULOINTERSTITIAL KIDNEY DISEASE, AUTOSOMAL DOMINANT, 4; ADTKD4]
FBgn0029093	cathD	HGNC:8890	OMIM:169740	PGC	3		
FBgn0029093	cathD	HGNC:13395	OMIM:605631	NAPSA	8		
FBgn0029093	cathD	HGNC:2529	OMIM:116840	CTSD	12	610127	610127[CEROID LIPOFUSCINOSIS, NEURONAL, 10; CLN10]
FBgn0033225	TTLL12	HGNC:28974	OMIM:619410	TTLL12	15		
FBgn0033224	Nop17l	HGNC:26075	OMIM:611480	PIH1D1	4		
FBgn0033224	Nop17l	HGNC:20188	OMIM:612517	DNAAF2	11	612518	612518[CILIARY DYSKINESIA, PRIMARY, 10; CILD10]
FBgn0033187	PIG-G	HGNC:25985	OMIM:616918	PIGG	15	616917,619812	616917[NEURODEVELOPMENTAL DISORDER WITH OR WITHOUT HYPOTONIA, SEIZURES, AND CEREBELLAR ATROPHY; NEDHSCA],619812[BLOOD GROUP, EMM SYSTEM; EMM]
FBgn0033190	Gpo2	HGNC:4456	OMIM:138430	GPD2	9	125853	125853[TYPE 2 DIABETES MELLITUS; T2D]
FBgn0033192	Corin	HGNC:19012	OMIM:605236	CORIN	5	614595	614595[PREECLAMPSIA/ECLAMPSIA 5; PEE5]
FBgn0033194	Vps13	HGNC:23594	OMIM:608879	VPS13C	10	616840	616840[PARKINSON DISEASE 23, AUTOSOMAL RECESSIVE EARLY-ONSET; PARK23]
FBgn0033194	Vps13	HGNC:23595	OMIM:608877	VPS13D	3	607317	607317[SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 4; SCAR4]
FBgn0033194	Vps13	HGNC:1908	OMIM:605978	VPS13A	13	200150	200150[CHOREOACANTHOCYTOSIS; CHAC]
FBgn0050491	CG30491	HGNC:19979	OMIM:616796	RDH14	4		
FBgn0050491	CG30491	HGNC:17964	OMIM:607849	RDH11	9	616108	616108[RETINAL DYSTROPHY, JUVENILE CATARACTS, AND SHORT STATURE SYNDROME; RDJCSS]
FBgn0050491	CG30491	HGNC:19977	OMIM:608830	RDH12	9	612712	612712[LEBER CONGENITAL AMAUROSIS 13; LCA13]
FBgn0050491	CG30491	HGNC:28326	OMIM:616157	DHRS13	3		
FBgn0050491	CG30491	HGNC:19978		RDH13	10		
FBgn0050495	CG30495	HGNC:19979	OMIM:616796	RDH14	3		
FBgn0050495	CG30495	HGNC:17964	OMIM:607849	RDH11	9	616108	616108[RETINAL DYSTROPHY, JUVENILE CATARACTS, AND SHORT STATURE SYNDROME; RDJCSS]
FBgn0050495	CG30495	HGNC:19977	OMIM:608830	RDH12	8	612712	612712[LEBER CONGENITAL AMAUROSIS 13; LCA13]
FBgn0050495	CG30495	HGNC:28326	OMIM:616157	DHRS13	3		
FBgn0050495	CG30495	HGNC:19978		RDH13	8		
FBgn0033203	CG2070	HGNC:19979	OMIM:616796	RDH14	4		
FBgn0033203	CG2070	HGNC:17964	OMIM:607849	RDH11	10	616108	616108[RETINAL DYSTROPHY, JUVENILE CATARACTS, AND SHORT STATURE SYNDROME; RDJCSS]
FBgn0033203	CG2070	HGNC:19977	OMIM:608830	RDH12	10	612712	612712[LEBER CONGENITAL AMAUROSIS 13; LCA13]
FBgn0033203	CG2070	HGNC:28326	OMIM:616157	DHRS13	3		
FBgn0033203	CG2070	HGNC:19978		RDH13	9		
FBgn0033204	CG2065	HGNC:19979	OMIM:616796	RDH14	4		
FBgn0033204	CG2065	HGNC:17964	OMIM:607849	RDH11	10	616108	616108[RETINAL DYSTROPHY, JUVENILE CATARACTS, AND SHORT STATURE SYNDROME; RDJCSS]
FBgn0033204	CG2065	HGNC:19977	OMIM:608830	RDH12	10	612712	612712[LEBER CONGENITAL AMAUROSIS 13; LCA13]
FBgn0033204	CG2065	HGNC:18399	OMIM:301034	DHRSX	3		
FBgn0033204	CG2065	HGNC:28326	OMIM:616157	DHRS13	3		
FBgn0033204	CG2065	HGNC:19978		RDH13	9		
FBgn0033205	Rdh1	HGNC:19979	OMIM:616796	RDH14	4		
FBgn0033205	Rdh1	HGNC:17964	OMIM:607849	RDH11	10	616108	616108[RETINAL DYSTROPHY, JUVENILE CATARACTS, AND SHORT STATURE SYNDROME; RDJCSS]
FBgn0033205	Rdh1	HGNC:19977	OMIM:608830	RDH12	9	612712	612712[LEBER CONGENITAL AMAUROSIS 13; LCA13]
FBgn0033205	Rdh1	HGNC:28326	OMIM:616157	DHRS13	3		
FBgn0033205	Rdh1	HGNC:19978		RDH13	9		
FBgn0033209	CG12107	HGNC:15870	OMIM:619960	RAB5IF	12	616994	616994[CRANIOFACIAL DYSMORPHISM, SKELETAL ANOMALIES, AND IMPAIRED INTELLECTUAL DEVELOPMENT SYNDROME 2; CFSMR2]
FBgn0033209	CG12107	HGNC:44664		TGIF2-RAB5IF	8		
FBgn0050493	Coq9	HGNC:25302	OMIM:612837	COQ9	14	614654	614654[COENZYME Q10 DEFICIENCY, PRIMARY, 5; COQ10D5]
FBgn0050496	CG30496	HGNC:14373	OMIM:601749	GLMN	13	138000	138000[GLOMUVENOUS MALFORMATIONS; GVM]
FBgn0033214	CG1941	HGNC:18210	OMIM:610268	MOGAT1	10		
FBgn0033214	CG1941	HGNC:23249	OMIM:610184	MOGAT3	9		
FBgn0033214	CG1941	HGNC:16940	OMIM:606983	DGAT2	11		
FBgn0033214	CG1941	HGNC:23252	OMIM:300924	AWAT1	9		
FBgn0033214	CG1941	HGNC:23248	OMIM:610270	MOGAT2	14		
FBgn0033214	CG1941	HGNC:23250	OMIM:300926	DGAT2L6	10		
FBgn0033214	CG1941	HGNC:23251	OMIM:300925	AWAT2	10		
FBgn0033215	Dgat2	HGNC:18210	OMIM:610268	MOGAT1	10		
FBgn0033215	Dgat2	HGNC:23249	OMIM:610184	MOGAT3	9		
FBgn0033215	Dgat2	HGNC:16940	OMIM:606983	DGAT2	11		
FBgn0033215	Dgat2	HGNC:23252	OMIM:300924	AWAT1	9		
FBgn0033215	Dgat2	HGNC:23248	OMIM:610270	MOGAT2	15		
FBgn0033215	Dgat2	HGNC:23250	OMIM:300926	DGAT2L6	10		
FBgn0033215	Dgat2	HGNC:23251	OMIM:300925	AWAT2	9		
FBgn0033216	CG1946	HGNC:18210	OMIM:610268	MOGAT1	10		
FBgn0033216	CG1946	HGNC:23249	OMIM:610184	MOGAT3	9		
FBgn0033216	CG1946	HGNC:16940	OMIM:606983	DGAT2	11		
FBgn0033216	CG1946	HGNC:23252	OMIM:300924	AWAT1	9		
FBgn0033216	CG1946	HGNC:23248	OMIM:610270	MOGAT2	14		
FBgn0033216	CG1946	HGNC:23250	OMIM:300926	DGAT2L6	10		
FBgn0033216	CG1946	HGNC:23251	OMIM:300925	AWAT2	9		
FBgn0015614	CanB2	HGNC:9317	OMIM:601302	PPP3R1	12		
FBgn0015614	CanB2	HGNC:9318	OMIM:613821	PPP3R2	8		
FBgn0000337	cn	HGNC:6381	OMIM:603538	KMO	14		
FBgn0042135	Gdap2	HGNC:18010	OMIM:618128	GDAP2	14	618369	618369[SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 27; SCAR27]
FBgn0003733	tor	HGNC:11724	OMIM:600221	TEK	3	600195,617272	600195[VENOUS MALFORMATIONS, MULTIPLE CUTANEOUS AND MUCOSAL; VMCM],617272[GLAUCOMA 3, PRIMARY CONGENITAL, E; GLC3E]
FBgn0033212	LRR	HGNC:27089	OMIM:610859	CARMIL2	9	618131	618131[IMMUNODEFICIENCY 58; IMD58]
FBgn0033212	LRR	HGNC:20272	OMIM:614716	CARMIL3	13		
FBgn0033212	LRR	HGNC:21581	OMIM:609593	CARMIL1	15		
FBgn0033210	U2A	HGNC:11152	OMIM:603521	SNRPA1	13		
FBgn0033208	mRpL52	HGNC:16655	OMIM:611856	MRPL52	13		
FBgn0033206	DCTN4-p62	HGNC:15518	OMIM:614758	DCTN4	13		
FBgn0033199	CG17985	HGNC:26571		LYSMD4	11		
FBgn0033199	CG17985	HGNC:26969		LYSMD3	12		
FBgn0028687	Rpt1	HGNC:9548	OMIM:154365	PSMC2	14		
FBgn0033196	CG1358	HGNC:24682	OMIM:609144	FLVCR1	12	609033	609033[POSTERIOR COLUMN ATAXIA WITH RETINITIS PIGMENTOSA; AXPC1]
FBgn0033196	CG1358	HGNC:20105	OMIM:610865	FLVCR2	13	225790	225790[PROLIFERATIVE VASCULOPATHY AND HYDRANENCEPHALY-HYDROCEPHALY SYNDROME; PVHH]
FBgn0033196	CG1358	HGNC:26177		SLC49A3	3		
FBgn0004132	boca	HGNC:13520	OMIM:607783	MESD	13	618644	618644[OSTEOGENESIS IMPERFECTA, TYPE XX; OI20]
FBgn0050499	Rpe	HGNC:10293	OMIM:180480	RPE	14		
FBgn0050499	Rpe	HGNC:45241		RPEL1	8		
FBgn0033191	CG1598	HGNC:752	OMIM:601913	GET3	13		
FBgn0033160	Dhx15	HGNC:17211	OMIM:605584	DHX38	4	618220	618220[RETINITIS PIGMENTOSA 84; RP84]
FBgn0033160	Dhx15	HGNC:2738	OMIM:603403	DHX15	15		
FBgn0033160	Dhx15	HGNC:2739	OMIM:603405	DHX16	4	618733	618733[NEUROMUSCULAR OCULOAUDITORY SYNDROME; NMOAS]
FBgn0033160	Dhx15	HGNC:15861		DHX35	3		
FBgn0033160	Dhx15	HGNC:16718	OMIM:614405	DHX33	3		
FBgn0033160	Dhx15	HGNC:2749	OMIM:600396	DHX8	4		
FBgn0033160	Dhx15	HGNC:18018	OMIM:607570	DHX40	3		
FBgn0033160	Dhx15	HGNC:16717	OMIM:607960	DHX32	4		
FBgn0033160	Dhx15	HGNC:20410		DQX1	4		
FBgn0003460	so	HGNC:10887	OMIM:601205	SIX1	11	605192,608389	605192[DEAFNESS, AUTOSOMAL DOMINANT 23; DFNA23],608389[BRANCHIOOTIC SYNDROME 3; BOS3]
FBgn0003460	so	HGNC:10888	OMIM:604994	SIX2	9		
FBgn0033169	CG11123	HGNC:19826	OMIM:618308	NOP9	14		
FBgn0033174	CG11125	HGNC:25246		ENKD1	7		
FBgn0033184	mEFTu2	HGNC:12420	OMIM:602389	TUFM	5	610678	610678[COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 4; COXPD4]
FBgn0015929	dpa	HGNC:6947	OMIM:602638	MCM4	13	609981	609981[IMMUNODEFICIENCY 54; IMD54]
FBgn0033183	CG1620	HGNC:29210		MIER2	9		
FBgn0033183	CG1620	HGNC:29657	OMIM:616848	MIER1	12		
FBgn0033183	CG1620	HGNC:26678		MIER3	10		
FBgn0010548	Aldh-III	HGNC:405	OMIM:100660	ALDH3A1	9		
FBgn0010548	Aldh-III	HGNC:411	OMIM:601917	ALDH3B2	10		
FBgn0010548	Aldh-III	HGNC:410	OMIM:600466	ALDH3B1	10		
FBgn0010548	Aldh-III	HGNC:403	OMIM:609523	ALDH3A2	8	270200	270200[SJOGREN-LARSSON SYNDROME; SLS]
FBgn0033179	p47	HGNC:27035	OMIM:610686	UBXN2B	10		
FBgn0033179	p47	HGNC:15912	OMIM:606610	NSFL1C	14		
FBgn0033179	p47	HGNC:27265		UBXN2A	8		
FBgn0033177	CG11141	HGNC:17022	OMIM:607521	HPS5	3	614074	614074[HERMANSKY-PUDLAK SYNDROME 5; HPS5]
FBgn0033177	CG11141	HGNC:19957	OMIM:615000	TECPR2	8	615031	615031[NEUROPATHY, HEREDITARY SENSORY AND AUTONOMIC, TYPE IX, WITH DEVELOPMENTAL DELAY; HSAN9]
FBgn0050502	fa2h	HGNC:21197	OMIM:611026	FA2H	13	612319	612319[SPASTIC PARAPLEGIA 35, AUTOSOMAL RECESSIVE, WITH OR WITHOUT NEURODEGENERATION; SPG35]
FBgn0040513	kappaB-Ras	HGNC:17899	OMIM:604496	NKIRAS1	13		
FBgn0040513	kappaB-Ras	HGNC:17898	OMIM:604497	NKIRAS2	9		
FBgn0050503	CG30503	HGNC:17934	OMIM:611651	PLA2G3	5		
FBgn0033166	Eaf	HGNC:20907	OMIM:608315	EAF1	11		
FBgn0033166	Eaf	HGNC:23115	OMIM:607659	EAF2	10		
FBgn0000352	cos	HGNC:18632	OMIM:611253	KIF27	3		
FBgn0000352	cos	HGNC:30497	OMIM:611254	KIF7	3	200990,607131,614120	200990[ACROCALLOSAL SYNDROME; ACLS],607131[AL-GAZALI-BAKALINOVA SYNDROME; AGBK],614120[HYDROLETHALUS SYNDROME 2; HLS2]
FBgn0033159	Dscam1	HGNC:3039	OMIM:602523	DSCAM	11		
FBgn0033159	Dscam1	HGNC:14656	OMIM:611782	DSCAML1	13		
FBgn0033140	CG12836	HGNC:11695	OMIM:186977	TCTE3	3		
FBgn0024294	Spn43Aa	HGNC:8955	OMIM:601799	SERPINB9	5		
FBgn0024294	Spn43Aa	HGNC:8945	OMIM:605587	SERPINI2	3		
FBgn0024294	Spn43Aa	HGNC:8943	OMIM:602445	SERPINI1	5	604218	604218[ENCEPHALOPATHY, FAMILIAL, WITH NEUROSERPIN INCLUSION BODIES; FENIB]
FBgn0024294	Spn43Aa	HGNC:10569	OMIM:600517	SERPINB3	5		
FBgn0024294	Spn43Aa	HGNC:3311	OMIM:130135	SERPINB1	6		
FBgn0024294	Spn43Aa	HGNC:775	OMIM:107300	SERPINC1	3	613118	613118[ANTITHROMBIN III DEFICIENCY; AT3D]
FBgn0024294	Spn43Aa	HGNC:10570	OMIM:600518	SERPINB4	4		
FBgn0024294	Spn43Aa	HGNC:8952	OMIM:601697	SERPINB8	3	617115	617115[PEELING SKIN SYNDROME 5; PSS5]
FBgn0024294	Spn43Aa	HGNC:14220	OMIM:615662	SERPINB12	3		
FBgn0024294	Spn43Aa	HGNC:8942	OMIM:602058	SERPINB10	3		
FBgn0024294	Spn43Aa	HGNC:8950	OMIM:173321	SERPINB6	5	613453	613453[DEAFNESS, AUTOSOMAL RECESSIVE 91; DFNB91]
FBgn0024294	Spn43Aa	HGNC:1540	OMIM:122500	SERPINA6	3	611489	611489[CORTICOSTEROID-BINDING GLOBULIN DEFICIENCY]
FBgn0024294	Spn43Aa	HGNC:8944	OMIM:604445	SERPINB13	4		
FBgn0003090	pk	HGNC:17019	OMIM:608500	PRICKLE1	11	612437	612437[EPILEPSY, PROGRESSIVE MYOCLONIC, 1B; EPM1B]
FBgn0003090	pk	HGNC:6645	OMIM:300111	PRICKLE3	10	308905	308905[LEBER HEREDITARY OPTIC NEUROPATHY, MODIFIER OF; LOAM]
FBgn0003090	pk	HGNC:20340	OMIM:608501	PRICKLE2	12		
FBgn0033153	Gadd45	HGNC:4095	OMIM:126335	GADD45A	10		
FBgn0033153	Gadd45	HGNC:4097	OMIM:604949	GADD45G	12		
FBgn0033153	Gadd45	HGNC:4096	OMIM:604948	GADD45B	10		
FBgn0026602	Adk3	HGNC:257	OMIM:102750	ADK	5	614300	614300[HYPERMETHIONINEMIA DUE TO ADENOSINE KINASE DEFICIENCY]
FBgn0002930	nec	HGNC:8945	OMIM:605587	SERPINI2	3		
FBgn0002930	nec	HGNC:8943	OMIM:602445	SERPINI1	4	604218	604218[ENCEPHALOPATHY, FAMILIAL, WITH NEUROSERPIN INCLUSION BODIES; FENIB]
FBgn0002930	nec	HGNC:3311	OMIM:130135	SERPINB1	3		
FBgn0002930	nec	HGNC:775	OMIM:107300	SERPINC1	3	613118	613118[ANTITHROMBIN III DEFICIENCY; AT3D]
FBgn0002930	nec	HGNC:8583	OMIM:173360	SERPINE1	3	613329	613329[PLASMINOGEN ACTIVATOR INHIBITOR-1 DEFICIENCY]
FBgn0002930	nec	HGNC:8951	OMIM:177010	SERPINE2	3		
FBgn0002930	nec	HGNC:24774		SERPINE3	3		
FBgn0015039	Cyp9b2	HGNC:2638	OMIM:605325	CYP3A5	7	145500	145500[HYPERTENSION, ESSENTIAL]
FBgn0015039	Cyp9b2	HGNC:17450	OMIM:606534	CYP3A43	6		
FBgn0015039	Cyp9b2	HGNC:11609	OMIM:274180	TBXAS1	4	231095	231095[GHOSAL HEMATODIAPHYSEAL DYSPLASIA; GHDD]
FBgn0015039	Cyp9b2	HGNC:2637	OMIM:124010	CYP3A4	6	619073	619073[VITAMIN D-DEPENDENT RICKETS, TYPE 3; VDDR3]
FBgn0015039	Cyp9b2	HGNC:51504		CYP3A7-CYP3A51P	5		
FBgn0015038	Cyp9b1	HGNC:2638	OMIM:605325	CYP3A5	8	145500	145500[HYPERTENSION, ESSENTIAL]
FBgn0015038	Cyp9b1	HGNC:17450	OMIM:606534	CYP3A43	7		
FBgn0015038	Cyp9b1	HGNC:11609	OMIM:274180	TBXAS1	4	231095	231095[GHOSAL HEMATODIAPHYSEAL DYSPLASIA; GHDD]
FBgn0015038	Cyp9b1	HGNC:2637	OMIM:124010	CYP3A4	6	619073	619073[VITAMIN D-DEPENDENT RICKETS, TYPE 3; VDDR3]
FBgn0015038	Cyp9b1	HGNC:51504		CYP3A7-CYP3A51P	5		
FBgn0027558	Pgant3	HGNC:4123	OMIM:602273	GALNT1	5		
FBgn0027558	Pgant3	HGNC:4127	OMIM:615129	GALNT5	3		
FBgn0027558	Pgant3	HGNC:23242	OMIM:608369	GALNT13	3		
FBgn0016126	CaMKI	HGNC:1459	OMIM:604998	CAMK1	11		
FBgn0016126	CaMKI	HGNC:19341	OMIM:607957	CAMK1D	13		
FBgn0016126	CaMKI	HGNC:14585	OMIM:614994	CAMK1G	10		
FBgn0016126	CaMKI	HGNC:13415	OMIM:300680	PNCK	10		
FBgn0016126	CaMKI	HGNC:28788	OMIM:614993	CAMKV	3		
FBgn0016126	CaMKI	HGNC:1464	OMIM:114080	CAMK4	3		
FBgn0040324	Ephrin	HGNC:3225	OMIM:601535	EFNA5	4		
FBgn0040324	Ephrin	HGNC:3228	OMIM:602297	EFNB3	8		
FBgn0040324	Ephrin	HGNC:3221	OMIM:191164	EFNA1	4		
FBgn0040324	Ephrin	HGNC:3222	OMIM:602756	EFNA2	4		
FBgn0040324	Ephrin	HGNC:3223	OMIM:601381	EFNA3	4		
FBgn0040324	Ephrin	HGNC:3224	OMIM:601380	EFNA4	4		
FBgn0040324	Ephrin	HGNC:3226	OMIM:300035	EFNB1	8	304110	304110[CRANIOFRONTONASAL SYNDROME; CFNS]
FBgn0040324	Ephrin	HGNC:3227	OMIM:600527	EFNB2	9		
FBgn0039911	CG1909	HGNC:9863	OMIM:601592	RAPSN	14	616326,618388	616326[MYASTHENIC SYNDROME, CONGENITAL, 11, ASSOCIATED WITH ACETYLCHOLINE RECEPTOR DEFICIENCY; CMS11],618388[FETAL AKINESIA DEFORMATION SEQUENCE 2; FADS2]
FBgn0024728	Slip1	HGNC:21167	OMIM:300634	PDZD4	11		
FBgn0024728	Slip1	HGNC:30552	OMIM:609730	PDZRN4	11		
FBgn0024728	Slip1	HGNC:17704	OMIM:609729	PDZRN3	11		
FBgn0039920	CG11360	HGNC:25297	OMIM:611008	MEX3B	11		
FBgn0039920	CG11360	HGNC:16734	OMIM:611009	MEX3D	9		
FBgn0039920	CG11360	HGNC:33482	OMIM:611007	MEX3A	7		
FBgn0039920	CG11360	HGNC:28040	OMIM:611005	MEX3C	11		
FBgn0026199	myo	HGNC:4216	OMIM:603936	GDF11	7	619122	619122[VERTEBRAL HYPERSEGMENTATION AND OROFACIAL ANOMALIES; VHO]
FBgn0026199	myo	HGNC:4223	OMIM:601788	MSTN	8	614160	614160[MUSCLE HYPERTROPHY; MSLHP]
FBgn0026199	myo	HGNC:11766	OMIM:190180	TGFB1	3	131300,219700,618213	131300[CAMURATI-ENGELMANN DISEASE; CAEND],219700[CYSTIC FIBROSIS; CF],618213[INFLAMMATORY BOWEL DISEASE, IMMUNODEFICIENCY, AND ENCEPHALOPATHY; IBDIMDE]
FBgn0026199	myo	HGNC:11768	OMIM:190220	TGFB2	3	614816	614816[LOEYS-DIETZ SYNDROME 4; LDS4]
FBgn0039916	Ekar	HGNC:4580	OMIM:138244	GRIK2	9	611092,619580	611092[INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 6; MRT6],619580[NEURODEVELOPMENTAL DISORDER WITH IMPAIRED LANGUAGE AND ATAXIA AND WITH OR WITHOUT SEIZURES; NEDLAS]
FBgn0039916	Ekar	HGNC:4581	OMIM:138243	GRIK3	9		
FBgn0039916	Ekar	HGNC:4583	OMIM:600283	GRIK5	7		
FBgn0039916	Ekar	HGNC:4579	OMIM:138245	GRIK1	10		
FBgn0039916	Ekar	HGNC:4582	OMIM:600282	GRIK4	9		
FBgn0039916	Ekar	HGNC:4576	OMIM:602368	GRID2	3	616204	616204[SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 18; SCAR18]
FBgn0039916	Ekar	HGNC:4575	OMIM:610659	GRID1	3		
FBgn0028996	onecut	HGNC:8139	OMIM:604894	ONECUT2	9		
FBgn0028996	onecut	HGNC:13399	OMIM:611294	ONECUT3	6		
FBgn0028996	onecut	HGNC:8138	OMIM:604164	ONECUT1	10		
FBgn0039909	ND-49	HGNC:7708	OMIM:602985	NDUFS2	15	618228	618228[MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 6; MC1DN6]
FBgn0026869	Tdg	HGNC:11700	OMIM:601423	TDG	10		
FBgn0039908	Asator	HGNC:19141	OMIM:611695	TTBK2	7	604432	604432[SPINOCEREBELLAR ATAXIA 11; SCA11]
FBgn0039908	Asator	HGNC:19140	OMIM:619415	TTBK1	6		
FBgn0026262	Taf3	HGNC:17303	OMIM:606576	TAF3	9		
FBgn0039907	lgs	HGNC:1008	OMIM:602597	BCL9	3		
FBgn0024811	Crk	HGNC:2363	OMIM:602007	CRKL	13		
FBgn0024811	Crk	HGNC:2362	OMIM:164762	CRK	14		
FBgn0026777	Rad23	HGNC:9812	OMIM:600061	RAD23A	13		
FBgn0026777	Rad23	HGNC:9813	OMIM:600062	RAD23B	15		
FBgn0052850	Rnf11	HGNC:10056	OMIM:612598	RNF11	14		
FBgn0039904	Hcf	HGNC:24972	OMIM:607926	HCFC2	9		
FBgn0039904	Hcf	HGNC:4839	OMIM:300019	HCFC1	8	309541	309541[METHYLMALONIC ACIDURIA AND HOMOCYSTINURIA, cblX TYPE; MAHCX]
FBgn0039902	Zip102B	HGNC:20182	OMIM:619116	SLC39A9	15		
FBgn0042696	NfI	HGNC:7788	OMIM:164005	NFIX	10	602535,614753	602535[MARSHALL-SMITH SYNDROME; MRSHSS],614753[MALAN SYNDROME; MALNS]
FBgn0042696	NfI	HGNC:7784	OMIM:600727	NFIA	12	613735	613735[BRAIN MALFORMATIONS WITH OR WITHOUT URINARY TRACT DEFECTS; BRMUTD]
FBgn0042696	NfI	HGNC:7785	OMIM:600728	NFIB	11	618286	618286[MACROCEPHALY, ACQUIRED, WITH IMPAIRED INTELLECTUAL DEVELOPMENT; MACID]
FBgn0042696	NfI	HGNC:7786	OMIM:600729	NFIC	11		
FBgn0051999	CG31999	HGNC:6716	OMIM:602090	LTBP3	3	601216,617809	601216[DENTAL ANOMALIES AND SHORT STATURE; DASS],617809[GELEOPHYSIC DYSPLASIA 3; GPHYSD3]
FBgn0051999	CG31999	HGNC:3600	OMIM:135820	FBLN1	10	608180	608180[SYNPOLYDACTYLY 2; SPD2]
FBgn0051999	CG31999	HGNC:3601	OMIM:135821	FBLN2	8		
FBgn0051998	CG31998	HGNC:37280		PRRT4	3		
FBgn0039890	Abcd1	HGNC:66	OMIM:601081	ABCD2	14		
FBgn0039890	Abcd1	HGNC:61	OMIM:300371	ABCD1	12	300100	300100[ADRENOLEUKODYSTROPHY; ALD]
FBgn0039890	Abcd1	HGNC:67	OMIM:170995	ABCD3	5	616278	616278[BILE ACID SYNTHESIS DEFECT, CONGENITAL, 5; CBAS5]
FBgn0039890	Abcd1	HGNC:68	OMIM:603214	ABCD4	3	614857	614857[METHYLMALONIC ACIDURIA AND HOMOCYSTINURIA, cblJ TYPE; MAHCJ]
FBgn0039889	Arl4	HGNC:695	OMIM:604786	ARL4A	13		
FBgn0039889	Arl4	HGNC:698	OMIM:604787	ARL4C	11		
FBgn0039889	Arl4	HGNC:656	OMIM:600732	ARL4D	7		
FBgn0052006	CG32006	HGNC:3801	OMIM:602402	FOXC2	3	153400	153400[LYMPHEDEMA-DISTICHIASIS SYNDROME; LPHDST]
FBgn0011747	Ank	HGNC:492	OMIM:612641	ANK1	9	182900	182900[SPHEROCYTOSIS, TYPE 1; SPH1]
FBgn0011747	Ank	HGNC:493	OMIM:106410	ANK2	7	600919	600919[CARDIAC ARRHYTHMIA, ANKYRIN-B-RELATED]
FBgn0011747	Ank	HGNC:494	OMIM:600465	ANK3	7	615493	615493[INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 37; MRT37]
FBgn0017545	RpS3A	HGNC:10421	OMIM:180478	RPS3A	12		
FBgn0004859	ci	HGNC:4319	OMIM:165240	GLI3	11	146510,174200,174700,175700	146510[PALLISTER-HALL SYNDROME; PHS],174200[POLYDACTYLY, POSTAXIAL, TYPE A1; PAPA1],174700[POLYDACTYLY, PREAXIAL IV; PPD4],175700[GREIG CEPHALOPOLYSYNDACTYLY SYNDROME; GCPS]
FBgn0004859	ci	HGNC:4317	OMIM:165220	GLI1	8	174400,618123	174400[POLYDACTYLY, PREAXIAL I; PPD1],618123[POLYDACTYLY, POSTAXIAL, TYPE A8; PAPA8]
FBgn0004859	ci	HGNC:4318	OMIM:165230	GLI2	10	610829,615849	610829[HOLOPROSENCEPHALY 9; HPE9],615849[CULLER-JONES SYNDROME; CJS]
FBgn0025740	PlexB	HGNC:9099	OMIM:601055	PLXNA1	6	619955	619955[DWORSCHAK-PUNETHA NEURODEVELOPMENTAL SYNDROME; DWOPNED]
FBgn0025740	PlexB	HGNC:9101	OMIM:300022	PLXNA3	6		
FBgn0025740	PlexB	HGNC:9102	OMIM:604280	PLXNA4	6		
FBgn0025740	PlexB	HGNC:9100	OMIM:601054	PLXNA2	7		
FBgn0025740	PlexB	HGNC:9104	OMIM:604293	PLXNB2	8		
FBgn0025740	PlexB	HGNC:9105	OMIM:300214	PLXNB3	8		
FBgn0025740	PlexB	HGNC:9107	OMIM:604282	PLXND1	6		
FBgn0025740	PlexB	HGNC:9103	OMIM:601053	PLXNB1	8		
FBgn0025740	PlexB	HGNC:9106	OMIM:604259	PLXNC1	5		
FBgn0019985	mGluR	HGNC:4598	OMIM:604096	GRM6	4	257270	257270[NIGHT BLINDNESS, CONGENITAL STATIONARY, TYPE 1B; CSNB1B]
FBgn0019985	mGluR	HGNC:4596	OMIM:604100	GRM4	4		
FBgn0019985	mGluR	HGNC:4599	OMIM:604101	GRM7	4	618922	618922[NEURODEVELOPMENTAL DISORDER WITH SEIZURES, HYPOTONIA, AND BRAIN IMAGING ABNORMALITIES; NEDSHBA]
FBgn0019985	mGluR	HGNC:4600	OMIM:601116	GRM8	4		
FBgn0019985	mGluR	HGNC:4595	OMIM:601115	GRM3	15		
FBgn0019985	mGluR	HGNC:4594	OMIM:604099	GRM2	13		
FBgn0019985	mGluR	HGNC:4593	OMIM:604473	GRM1	3	614831,617691	614831[SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 13; SCAR13],617691[SPINOCEREBELLAR ATAXIA 44; SCA44]
FBgn0019985	mGluR	HGNC:4597	OMIM:604102	GRM5	3		
FBgn0019650	toy	HGNC:8620	OMIM:607108	PAX6	12	106210,120200,120430,136520,148190,165550,604229	106210[ANIRIDIA 1; AN1],120200[COLOBOMA, OCULAR, AUTOSOMAL DOMINANT],120430[COLOBOMA OF OPTIC NERVE],136520[FOVEAL HYPOPLASIA 1; FVH1],148190[KERATITIS, HEREDITARY],165550[OPTIC NERVE HYPOPLASIA, BILATERAL],604229[ANTERIOR SEGMENT DYSGENESIS 5; ASGD5]
FBgn0019650	toy	HGNC:8618	OMIM:167413	PAX4	3	125853,612225,612227	125853[TYPE 2 DIABETES MELLITUS; T2D],612225[MATURITY-ONSET DIABETES OF THE YOUNG, TYPE 9; MODY9],612227[DIABETES MELLITUS, KETOSIS-PRONE; KPD]
FBgn0010217	ATPsynbeta	HGNC:830	OMIM:102910	ATP5F1B	12		
FBgn0013749	Arf4	HGNC:652	OMIM:103180	ARF1	4	618185	618185[PERIVENTRICULAR NODULAR HETEROTOPIA 8; PVNH8]
FBgn0013749	Arf4	HGNC:655	OMIM:601177	ARF4	14		
FBgn0013749	Arf4	HGNC:658	OMIM:103188	ARF5	11		
FBgn0013749	Arf4	HGNC:654	OMIM:103190	ARF3	4		
FBgn0002521	pho	HGNC:30949	OMIM:614572	ZFP42	5		
FBgn0002521	pho	HGNC:31684	OMIM:300570	YY2	8		
FBgn0002521	pho	HGNC:12856	OMIM:600013	YY1	11	617557	617557[GABRIELE-DE VRIES SYNDROME; GADEVS]
FBgn0039928	Cals	HGNC:18371	OMIM:611324	CLSTN3	12		
FBgn0039928	Cals	HGNC:17447	OMIM:611321	CLSTN1	13		
FBgn0039928	Cals	HGNC:17448	OMIM:611323	CLSTN2	15		
FBgn0024913	Actbeta	HGNC:6067	OMIM:147390	INHBB	10		
FBgn0024913	Actbeta	HGNC:6068	OMIM:601233	INHBC	8		
FBgn0024913	Actbeta	HGNC:24029	OMIM:612031	INHBE	8		
FBgn0024913	Actbeta	HGNC:6066	OMIM:147290	INHBA	10		
FBgn0011642	Zyx	HGNC:13200	OMIM:602002	ZYX	3		
FBgn0011642	Zyx	HGNC:12311	OMIM:602933	TRIP6	7		
FBgn0011642	Zyx	HGNC:6679	OMIM:600700	LPP	8	601626	601626[LEUKEMIA, ACUTE MYELOID; AML]
FBgn0039930	CG11077	HGNC:7224	OMIM:137960	MPV17	13	256810,618400	256810[MITOCHONDRIAL DNA DEPLETION SYNDROME 6 (HEPATOCEREBRAL TYPE); MTDPS6],618400[CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2EE; CMT2EE]
FBgn0039930	CG11077	HGNC:28177	OMIM:616133	MPV17L2	4		
FBgn0039930	CG11077	HGNC:9716	OMIM:617399	PXMP2	3		
FBgn0039932	fuss	HGNC:21326	OMIM:611273	SKOR1	5		
FBgn0039932	fuss	HGNC:32695	OMIM:617138	SKOR2	6		
FBgn0052016	4E-T	HGNC:16687	OMIM:607445	EIF4ENIF1	7		
FBgn0023213	eIF4G1	HGNC:3298	OMIM:603929	EIF4G3	11		
FBgn0023213	eIF4G1	HGNC:3297	OMIM:602325	EIF4G2	3		
FBgn0023213	eIF4G1	HGNC:3296	OMIM:600495	EIF4G1	11	614251	614251[PARKINSON DISEASE 18, AUTOSOMAL DOMINANT, SUSCEPTIBILITY TO; PARK18]
FBgn0039936	Gyf	HGNC:11960	OMIM:612003	GIGYF2	10	607688	607688[PARKINSON DISEASE 11, AUTOSOMAL DOMINANT, SUSCEPTIBILITY TO; PARK11]
FBgn0039936	Gyf	HGNC:9126	OMIM:612064	GIGYF1	9		
FBgn0039937	fd102C	HGNC:3735	OMIM:602939	FOXS1	3		
FBgn0039937	fd102C	HGNC:3817	OMIM:603252	FOXL1	4		
FBgn0039937	fd102C	HGNC:3804	OMIM:611539	FOXD3	3	607836	607836[AUTOIMMUNE DISEASE, SUSCEPTIBILITY TO, 1; AIS1]
FBgn0039937	fd102C	HGNC:3805	OMIM:601092	FOXD4	3		
FBgn0039937	fd102C	HGNC:3816	OMIM:602291	FOXJ1	3	618699	618699[CILIARY DYSKINESIA, PRIMARY, 43; CILD43]
FBgn0039938	Sox102F	HGNC:16421	OMIM:607257	SOX6	9	618971	618971[TOLCHIN-LE CAIGNEC SYNDROME; TOLCAS]
FBgn0039938	Sox102F	HGNC:11192	OMIM:604748	SOX13	7		
FBgn0039938	Sox102F	HGNC:11201	OMIM:604975	SOX5	11	616803	616803[LAMB-SHAFFER SYNDROME; LAMSHF]
FBgn0039923	MED26	HGNC:2376	OMIM:605043	MED26	6		
FBgn0031208	CR11023	HGNC:28407	OMIM:612845	SENP5	3		
FBgn0031208	CR11023	HGNC:17927	OMIM:612157	SENP1	9		
FBgn0031208	CR11023	HGNC:23116	OMIM:608261	SENP2	8		
FBgn0031208	CR11023	HGNC:17862	OMIM:612844	SENP3	5		
FBgn0024698	Cpsf160	HGNC:2324	OMIM:606027	CPSF1	13	618827	618827[MYOPIA 27, AUTOSOMAL DOMINANT; MYP27]
FBgn0030538	betaNACtes1	HGNC:30547		BTF3L4	3		
FBgn0030538	betaNACtes1	HGNC:1125	OMIM:602542	BTF3	3		
FBgn0010473	tutl	HGNC:32326	OMIM:613773	IGSF9B	9		
FBgn0010473	tutl	HGNC:18132	OMIM:609738	IGSF9	12		
FBgn0003386	Shaw	HGNC:6236	OMIM:176265	KCNC4	12		
FBgn0003386	Shaw	HGNC:6233	OMIM:176258	KCNC1	13	616187	616187[EPILEPSY, PROGRESSIVE MYOCLONIC 7; EPM7]
FBgn0003386	Shaw	HGNC:6235	OMIM:176264	KCNC3	11	605259	605259[SPINOCEREBELLAR ATAXIA 13; SCA13]
FBgn0003386	Shaw	HGNC:6234	OMIM:176256	KCNC2	13	619913	619913[DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 103; DEE103]
FBgn0051481	pb	HGNC:5113	OMIM:142967	HOXB2	8		
FBgn0051481	pb	HGNC:5103	OMIM:604685	HOXA2	8	612290	612290[MICROTIA, HEARING IMPAIRMENT, AND CLEFT PALATE]
FBgn0004577	Pxd	HGNC:14966	OMIM:605158	PXDN	4	269400	269400[ANTERIOR SEGMENT DYSGENESIS 7; ASGD7]
FBgn0004577	Pxd	HGNC:12015	OMIM:606765	TPO	3	274500	274500[THYROID DYSHORMONOGENESIS 2A; TDH2A]
FBgn0004577	Pxd	HGNC:26359	OMIM:615904	PXDNL	4		
FBgn0004577	Pxd	HGNC:6678	OMIM:150205	LPO	3		
FBgn0004577	Pxd	HGNC:7218	OMIM:606989	MPO	3	104300,254600	104300[ALZHEIMER DISEASE, FAMILIAL, 1; AD1],254600[MYELOPEROXIDASE DEFICIENCY; MPOD]
FBgn0004577	Pxd	HGNC:3423	OMIM:131399	EPX	3	261500	261500[EOSINOPHIL PEROXIDASE DEFICIENCY; EPXD]
FBgn0010453	Wnt4	HGNC:12774	OMIM:164820	WNT1	3	615220,615221	615220[OSTEOGENESIS IMPERFECTA, TYPE XV; OI15],615221[BONE MINERAL DENSITY QUANTITATIVE TRAIT LOCUS 16; BMND16]
FBgn0010453	Wnt4	HGNC:12776	OMIM:603699	WNT11	3		
FBgn0010453	Wnt4	HGNC:12778	OMIM:602863	WNT9A	4		
FBgn0010453	Wnt4	HGNC:12779	OMIM:602864	WNT9B	6		
FBgn0010549	l(2)03659	HGNC:55	OMIM:605250	ABCC4	11		
FBgn0010549	l(2)03659	HGNC:52	OMIM:612509	ABCC10	4		
FBgn0010549	l(2)03659	HGNC:53	OMIM:601107	ABCC2	4	237500	237500[DUBIN-JOHNSON SYNDROME; DJS]
FBgn0010549	l(2)03659	HGNC:51	OMIM:158343	ABCC1	4	618915	618915[DEAFNESS, AUTOSOMAL DOMINANT 77; DFNA77]
FBgn0010549	l(2)03659	HGNC:59	OMIM:600509	ABCC8	4	125853,240800,256450,610374,618857	125853[TYPE 2 DIABETES MELLITUS; T2D],240800[HYPOGLYCEMIA, LEUCINE-INDUCED; LIH],256450[HYPERINSULINEMIC HYPOGLYCEMIA, FAMILIAL, 1; HHF1],610374[DIABETES MELLITUS, TRANSIENT NEONATAL, 2; TNDM2],618857[DIABETES MELLITUS, PERMANENT NEONATAL, 3; PNDM3]
FBgn0010549	l(2)03659	HGNC:14640	OMIM:607041	ABCC12	4		
FBgn0010549	l(2)03659	HGNC:60	OMIM:601439	ABCC9	4	239850,608569,614050,619719	239850[CANTU SYNDROME],608569[CARDIOMYOPATHY, DILATED, 1O; CMD1O],614050[ATRIAL FIBRILLATION, FAMILIAL, 12; ATFB12],619719[INTELLECTUAL DISABILITY AND MYOPATHY SYNDROME; IDMYS]
FBgn0010549	l(2)03659	HGNC:57	OMIM:603234	ABCC6	5	177850,264800,614473	177850[PSEUDOXANTHOMA ELASTICUM, FORME FRUSTE],264800[PSEUDOXANTHOMA ELASTICUM; PXE],614473[ARTERIAL CALCIFICATION, GENERALIZED, OF INFANCY, 2; GACI2]
FBgn0010549	l(2)03659	HGNC:56	OMIM:605251	ABCC5	4		
FBgn0010549	l(2)03659	HGNC:14639	OMIM:607040	ABCC11	4	117800	117800[APOCRINE GLAND SECRETION, VARIATION IN]
FBgn0010549	l(2)03659	HGNC:54	OMIM:604323	ABCC3	4		
FBgn0010549	l(2)03659	HGNC:1884	OMIM:602421	CFTR	5	167800,211400,219700,277180	167800[PANCREATITIS, HEREDITARY; PCTT],211400[BRONCHIECTASIS WITH OR WITHOUT ELEVATED SWEAT CHLORIDE 1; BESC1],219700[CYSTIC FIBROSIS; CF],277180[VAS DEFERENS, CONGENITAL BILATERAL APLASIA OF; CBAVD]
FBgn0014342	mia	HGNC:11540	OMIM:602955	TAF6	6	617126	617126[ALAZAMI-YUAN SYNDROME; ALYUS]
FBgn0032721	CG10602	HGNC:6710	OMIM:151570	LTA4H	15		
FBgn0032720	mRpL13	HGNC:14278	OMIM:610200	MRPL13	14		
FBgn0036290	CG10638	HGNC:386	OMIM:603966	AKR1C3	4		
FBgn0036290	CG10638	HGNC:384	OMIM:600449	AKR1C1	4		
FBgn0036290	CG10638	HGNC:387	OMIM:600451	AKR1C4	4	614279	614279[46,XY SEX REVERSAL 8; SRXY8]
FBgn0036290	CG10638	HGNC:380	OMIM:103830	AKR1A1	5		
FBgn0036290	CG10638	HGNC:381	OMIM:103880	AKR1B1	6		
FBgn0036290	CG10638	HGNC:382	OMIM:604707	AKR1B10	6		
FBgn0036290	CG10638	HGNC:388	OMIM:604741	AKR1D1	6	235555	235555[BILE ACID SYNTHESIS DEFECT, CONGENITAL, 2; CBAS2]
FBgn0036290	CG10638	HGNC:385	OMIM:600450	AKR1C2	4	614279	614279[46,XY SEX REVERSAL 8; SRXY8]
FBgn0036290	CG10638	HGNC:23437	OMIM:617451	AKR1E2	5		
FBgn0036290	CG10638	HGNC:37281	OMIM:616336	AKR1B15	5		
FBgn0036255	Atg12	HGNC:588	OMIM:609608	ATG12	14		
FBgn0025885	Inos	HGNC:29821	OMIM:611670	ISYNA1	13		
FBgn0014018	Rel	HGNC:7795	OMIM:164012	NFKB2	6	615577	615577[IMMUNODEFICIENCY, COMMON VARIABLE, 10; CVID10]
FBgn0014018	Rel	HGNC:7794	OMIM:164011	NFKB1	7	616576	616576[IMMUNODEFICIENCY, COMMON VARIABLE, 12, WITH AUTOIMMUNITY; CVID12]
FBgn0030151	CG1354	HGNC:28833	OMIM:611175	OLA1	13		
FBgn0039817	CG15553	HGNC:16055	OMIM:608956	SLC46A2	5		
FBgn0039817	CG15553	HGNC:30521	OMIM:611672	SLC46A1	8	229050	229050[FOLATE MALABSORPTION, HEREDITARY]
FBgn0039817	CG15553	HGNC:27501	OMIM:616764	SLC46A3	8		
FBgn0003141	pr	HGNC:9689	OMIM:612719	PTS	14	261640	261640[HYPERPHENYLALANINEMIA, BH4-DEFICIENT, A; HPABH4A]
FBgn0036039	Naa60	HGNC:25875	OMIM:614246	NAA60	13		
FBgn0038535	alt	HGNC:10448	OMIM:601418	RRBP1	3		
FBgn0053503	Cyp12d1-d	HGNC:2606	OMIM:609506	CYP27B1	4	264700	264700[VITAMIN D HYDROXYLATION-DEFICIENT RICKETS, TYPE 1A; VDDR1A]
FBgn0053503	Cyp12d1-d	HGNC:33480		CYP27C1	4		
FBgn0053503	Cyp12d1-d	HGNC:2605	OMIM:606530	CYP27A1	4	213700	213700[CEREBROTENDINOUS XANTHOMATOSIS; CTX]
FBgn0053503	Cyp12d1-d	HGNC:2602	OMIM:126065	CYP24A1	6	143880	143880[HYPERCALCEMIA, INFANTILE, 1; HCINF1]
FBgn0050489	Cyp12d1-p	HGNC:2606	OMIM:609506	CYP27B1	4	264700	264700[VITAMIN D HYDROXYLATION-DEFICIENT RICKETS, TYPE 1A; VDDR1A]
FBgn0050489	Cyp12d1-p	HGNC:33480		CYP27C1	5		
FBgn0050489	Cyp12d1-p	HGNC:2605	OMIM:606530	CYP27A1	5	213700	213700[CEREBROTENDINOUS XANTHOMATOSIS; CTX]
FBgn0050489	Cyp12d1-p	HGNC:2602	OMIM:126065	CYP24A1	6	143880	143880[HYPERCALCEMIA, INFANTILE, 1; HCINF1]
FBgn0000109	Aprt	HGNC:626	OMIM:102600	APRT	14	614723	614723[ADENINE PHOSPHORIBOSYLTRANSFERASE DEFICIENCY; APRTD]
FBgn0039757	RpS7	HGNC:10440	OMIM:603658	RPS7	14	612563	612563[DIAMOND-BLACKFAN ANEMIA 8; DBA8]
FBgn0042173	CG18853	HGNC:30967		TRMO	6		
FBgn0003892	ptc	HGNC:9586	OMIM:603673	PTCH2	14	109400,155255,605462	109400[BASAL CELL NEVUS SYNDROME; BCNS],155255[MEDULLOBLASTOMA; MDB],605462[BASAL CELL CARCINOMA, SUSCEPTIBILITY TO, 1; BCC1]
FBgn0003892	ptc	HGNC:9585	OMIM:601309	PTCH1	14	109400,605462,610828	109400[BASAL CELL NEVUS SYNDROME; BCNS],605462[BASAL CELL CARCINOMA, SUSCEPTIBILITY TO, 1; BCC1],610828[HOLOPROSENCEPHALY 7; HPE7]
FBgn0005278	Sam-S	HGNC:6904	OMIM:601468	MAT2A	14		
FBgn0005278	Sam-S	HGNC:6903	OMIM:610550	MAT1A	12	250850	250850[METHIONINE ADENOSYLTRANSFERASE I/III DEFICIENCY]
FBgn0052000	anne	HGNC:30213	OMIM:610513	ATP13A2	9	606693,617225	606693[KUFOR-RAKEB SYNDROME; KRS],617225[SPASTIC PARAPLEGIA 78, AUTOSOMAL RECESSIVE; SPG78]
FBgn0052000	anne	HGNC:24113	OMIM:610232	ATP13A3	13	265400	265400[PULMONARY HYPERTENSION, PRIMARY, 5; PPH5]
FBgn0052000	anne	HGNC:31789	OMIM:619119	ATP13A5	9		
FBgn0052000	anne	HGNC:25422	OMIM:609556	ATP13A4	12		
FBgn0021760	chb	HGNC:17078	OMIM:605853	CLASP2	13		
FBgn0021760	chb	HGNC:17088	OMIM:605852	CLASP1	14		
FBgn0036640	nxf2	HGNC:8073	OMIM:300316	NXF3	7		
FBgn0036640	nxf2	HGNC:23984		NXF2B	6		
FBgn0036640	nxf2	HGNC:8071	OMIM:602647	NXF1	7		
FBgn0036640	nxf2	HGNC:8072	OMIM:300315	NXF2	4		
FBgn0036640	nxf2	HGNC:8075	OMIM:300319	NXF5	7		
FBgn0067783	DPCoAC	HGNC:28380	OMIM:610823	SLC25A42	14	618416	618416[METABOLIC CRISES, RECURRENT, WITH VARIABLE ENCEPHALOMYOPATHIC FEATURES AND NEUROLOGIC REGRESSION; MECREN]
FBgn0067783	DPCoAC	HGNC:10986	OMIM:139080	SLC25A16	5		
FBgn0035981	CG4452	HGNC:28530		FAM76A	13		
FBgn0035981	CG4452	HGNC:28492		FAM76B	12		
FBgn0001098	Gdh	HGNC:4336	OMIM:300144	GLUD2	13	168600	168600[PARKINSON DISEASE, LATE-ONSET; PD]
FBgn0001098	Gdh	HGNC:4335	OMIM:138130	GLUD1	15	606762	606762[HYPERINSULINEMIC HYPOGLYCEMIA, FAMILIAL, 6; HHF6]
FBgn0002174	CG5504	HGNC:11808	OMIM:608382	DNAJA3	15		
FBgn0017418	ari-1	HGNC:690	OMIM:605615	ARIH2	3		
FBgn0017418	ari-1	HGNC:689	OMIM:605624	ARIH1	14		
FBgn0002921	Atpalpha	HGNC:13816	OMIM:182360	ATP12A	6		
FBgn0002921	Atpalpha	HGNC:801	OMIM:182350	ATP1A3	12	128235,601338,614820,619606	128235[DYSTONIA 12; DYT12],601338[CEREBELLAR ATAXIA, AREFLEXIA, PES CAVUS, OPTIC ATROPHY, AND SENSORINEURAL HEARING LOSS; CAPOS],614820[ALTERNATING HEMIPLEGIA OF CHILDHOOD 2; AHC2],619606[DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 99; DEE99]
FBgn0002921	Atpalpha	HGNC:799	OMIM:182310	ATP1A1	13	618036,618314	618036[CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2DD; CMT2DD],618314[HYPOMAGNESEMIA, SEIZURES, AND MENTAL RETARDATION 2; HOMGSMR2]
FBgn0002921	Atpalpha	HGNC:800	OMIM:182340	ATP1A2	11	104290,602481,619602,619605	104290[ALTERNATING HEMIPLEGIA OF CHILDHOOD 1; AHC1],602481[MIGRAINE, FAMILIAL HEMIPLEGIC, 2; FHM2],619602[FETAL AKINESIA, RESPIRATORY INSUFFICIENCY, MICROCEPHALY, POLYMICROGYRIA, AND DYSMORPHIC FACIES; FARIMPD],619605[DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 98; DEE98]
FBgn0002921	Atpalpha	HGNC:819	OMIM:137216	ATP4A	5		
FBgn0002921	Atpalpha	HGNC:14073	OMIM:607321	ATP1A4	7		
FBgn0000083	AnxB9	HGNC:541	OMIM:106490	ANXA3	3		
FBgn0000083	AnxB9	HGNC:536	OMIM:602573	ANXA13	4		
FBgn0000083	AnxB9	HGNC:545	OMIM:186360	ANXA7	10		
FBgn0000083	AnxB9	HGNC:544	OMIM:114070	ANXA6	3		
FBgn0000083	AnxB9	HGNC:542	OMIM:106491	ANXA4	5		
FBgn0000083	AnxB9	HGNC:535	OMIM:602572	ANXA11	10	617839,619733	617839[AMYOTROPHIC LATERAL SCLEROSIS 23; ALS23],619733[INCLUSION BODY MYOPATHY AND BRAIN WHITE MATTER ABNORMALITIES; IBMWMA]
FBgn0000083	AnxB9	HGNC:533	OMIM:151690	ANXA1	3		
FBgn0000083	AnxB9	HGNC:534	OMIM:608008	ANXA10	4		
FBgn0000083	AnxB9	HGNC:537	OMIM:151740	ANXA2	3		
FBgn0000083	AnxB9	HGNC:547	OMIM:603319	ANXA9	3		
FBgn0000083	AnxB9	HGNC:23334		ANXA8L1	3		
FBgn0000083	AnxB9	HGNC:546	OMIM:602396	ANXA8	4		
FBgn0011672	Mvl	HGNC:10908	OMIM:600523	SLC11A2	14	206100	206100[ANEMIA, HYPOCHROMIC MICROCYTIC, WITH IRON OVERLOAD 1; AHMIO1]
FBgn0011672	Mvl	HGNC:10907	OMIM:600266	SLC11A1	11	607948,610446	607948[MYCOBACTERIUM TUBERCULOSIS, SUSCEPTIBILITY TO],610446[BURULI ULCER, SUSCEPTIBILITY TO]
FBgn0036414	nan	HGNC:14006	OMIM:606680	TRPV6	10	618188	618188[HYPERPARATHYROIDISM, TRANSIENT NEONATAL; HRPTTN]
FBgn0036414	nan	HGNC:12716	OMIM:602076	TRPV1	7		
FBgn0036414	nan	HGNC:18082	OMIM:606676	TRPV2	5		
FBgn0036414	nan	HGNC:3145	OMIM:606679	TRPV5	10		
FBgn0036414	nan	HGNC:18083	OMIM:605427	TRPV4	7	113500,156530,168400,181405,184095,184252,600175,606071,606835,613508,617383	113500[BRACHYOLMIA TYPE 3; BCYM3],156530[METATROPIC DYSPLASIA; MTD],168400[PARASTREMMATIC DWARFISM],181405[SCAPULOPERONEAL SPINAL MUSCULAR ATROPHY; SPSMA],184095[SPONDYLOEPIPHYSEAL DYSPLASIA, MAROTEAUX TYPE],184252[SPONDYLOMETAPHYSEAL DYSPLASIA, KOZLOWSKI TYPE; SMDK],600175[NEURONOPATHY, DISTAL HEREDITARY MOTOR, TYPE VIII; HMN8],606071[HEREDITARY MOTOR AND SENSORY NEUROPATHY, TYPE IIC; HMSN2C],606835[DIGITAL ARTHROPATHY-BRACHYDACTYLY, FAMILIAL; FDAB],613508[SODIUM SERUM LEVEL QUANTITATIVE TRAIT LOCUS 1; SSQTL1],617383[AVASCULAR NECROSIS OF FEMORAL HEAD, PRIMARY, 2; ANFH2]
FBgn0036414	nan	HGNC:18084	OMIM:607066	TRPV3	7	614594,616400	614594[OLMSTED SYNDROME 1; OLMS1],616400[PALMOPLANTAR KERATODERMA, NONEPIDERMOLYTIC, FOCAL 2; FNEPPK2]
FBgn0053489	CG33489	HGNC:26330		EFHB	8		
FBgn0053490	CG33490	HGNC:26330		EFHB	9		
FBgn0036544	sff	HGNC:11405	OMIM:609236	BRSK2	12		
FBgn0036544	sff	HGNC:18994	OMIM:609235	BRSK1	13		
FBgn0034274	CG10931	HGNC:12757	OMIM:609012	WDR5	5		
FBgn0034274	CG10931	HGNC:17826		WDR5B	5		
FBgn0034275	CG5002	HGNC:14471	OMIM:610117	SLC26A11	14		
FBgn0034275	CG5002	HGNC:14472	OMIM:610068	SLC26A6	4		
FBgn0034275	CG5002	HGNC:9359	OMIM:604943	SLC26A5	4	613865	613865[DEAFNESS, AUTOSOMAL RECESSIVE 61; DFNB61]
FBgn0034275	CG5002	HGNC:8818	OMIM:605646	SLC26A4	3	274600,600791	274600[PENDRED SYNDROME; PDS],600791[DEAFNESS, AUTOSOMAL RECESSIVE 4, WITH ENLARGED VESTIBULAR AQUEDUCT; DFNB4]
FBgn0022740	HLH54F	HGNC:11632	OMIM:603306	TCF21	7		
FBgn0022740	HLH54F	HGNC:7321	OMIM:603628	MSC	6		
FBgn0027572	ACOX1	HGNC:119	OMIM:609751	ACOX1	12	264470,618960	264470[PEROXISOMAL ACYL-CoA OXIDASE DEFICIENCY],618960[MITCHELL SYNDROME; MITCH]
FBgn0027572	ACOX1	HGNC:120	OMIM:601641	ACOX2	7	617308	617308[BILE ACID SYNTHESIS DEFECT, CONGENITAL, 6; CBAS6]
FBgn0026309	aft	HGNC:25635	OMIM:616190	CMTR2	12		
FBgn0028744	CG5033	HGNC:15519	OMIM:610596	BOP1	13		
FBgn0028743	Dhit	HGNC:14600	OMIM:607193	RGS20	10		
FBgn0028743	Dhit	HGNC:14088	OMIM:607191	RGS17	12		
FBgn0028743	Dhit	HGNC:13735	OMIM:605071	RGS19	7		
FBgn0026316	Ubc10	HGNC:12490	OMIM:603890	UBE2L6	4		
FBgn0026316	Ubc10	HGNC:12488	OMIM:603721	UBE2L3	12		
FBgn0026316	Ubc10	HGNC:13477		UBE2L5	6		
FBgn0034279	CG18635	HGNC:25508	OMIM:619940	XKR8	3		
FBgn0034279	CG18635	HGNC:29394		XKR4	5		
FBgn0034279	CG18635	HGNC:27806		XKR6	5		
FBgn0034279	CG18635	HGNC:23062		XKR7	5		
FBgn0034279	CG18635	HGNC:20782		XKR5	3		
FBgn0034279	CG18635	HGNC:20937		XKR9	3		
FBgn0034277	OstDelta	HGNC:10382	OMIM:180490	RPN2	14		
FBgn0034276	Sardh	HGNC:10536	OMIM:604455	SARDH	13	268900	268900[SARCOSINEMIA; SARCOS]
FBgn0034276	Sardh	HGNC:24475	OMIM:605849	DMGDH	4	605850	605850[DIMETHYLGLYCINE DEHYDROGENASE DEFICIENCY; DMGDHD]
FBgn0035917	Zasp66	HGNC:15710	OMIM:605906	LDB3	3	601493,609452	601493[CARDIOMYOPATHY, DILATED, 1C, WITH OR WITHOUT LEFT VENTRICULAR NONCOMPACTION; CMD1C],609452[MYOPATHY, MYOFIBRILLAR, 4; MFM4]
FBgn0036101	NijA	HGNC:7824	OMIM:602062	NINJ1	7		
FBgn0036101	NijA	HGNC:7825	OMIM:607297	NINJ2	4		
FBgn0032388	CG6686	HGNC:10538	OMIM:605941	SART1	12		
FBgn0030887	CG6867	HGNC:24558		OLFML2B	3		
FBgn0030887	CG6867	HGNC:7610	OMIM:601652	MYOC	5	137750	137750[GLAUCOMA 1, OPEN ANGLE, A; GLC1A]
FBgn0030887	CG6867	HGNC:17187	OMIM:605366	OLFM1	4		
FBgn0030887	CG6867	HGNC:17189	OMIM:617492	OLFM2	3		
FBgn0030887	CG6867	HGNC:17990	OMIM:607567	OLFM3	3		
FBgn0030887	CG6867	HGNC:27270	OMIM:615899	OLFML2A	4		
FBgn0030887	CG6867	HGNC:29514	OMIM:608603	GLDN	7	617194	617194[LETHAL CONGENITAL CONTRACTURE SYNDROME 11; LCCS11]
FBgn0030887	CG6867	HGNC:24956	OMIM:610088	OLFML3	3		
FBgn0030887	CG6867	HGNC:24473		OLFML1	3		
FBgn0030887	CG6867	HGNC:17190	OMIM:614061	OLFM4	3		
FBgn0030892	Swt1	HGNC:16785	OMIM:619513	SWT1	8		
FBgn0020429	GluRIIB	HGNC:4580	OMIM:138244	GRIK2	4	611092,619580	611092[INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 6; MRT6],619580[NEURODEVELOPMENTAL DISORDER WITH IMPAIRED LANGUAGE AND ATAXIA AND WITH OR WITHOUT SEIZURES; NEDLAS]
FBgn0020429	GluRIIB	HGNC:4581	OMIM:138243	GRIK3	4		
FBgn0020429	GluRIIB	HGNC:4583	OMIM:600283	GRIK5	3		
FBgn0020429	GluRIIB	HGNC:4579	OMIM:138245	GRIK1	4		
FBgn0020429	GluRIIB	HGNC:4582	OMIM:600282	GRIK4	4		
FBgn0020429	GluRIIB	HGNC:16767	OMIM:606650	GRIN3A	3		
FBgn0020429	GluRIIB	HGNC:4576	OMIM:602368	GRID2	3	616204	616204[SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 18; SCAR18]
FBgn0020429	GluRIIB	HGNC:4575	OMIM:610659	GRID1	3		
FBgn0036790	AstC-R1	HGNC:11330	OMIM:182451	SSTR1	7		
FBgn0036790	AstC-R1	HGNC:11333	OMIM:182454	SSTR4	7		
FBgn0036790	AstC-R1	HGNC:11331	OMIM:182452	SSTR2	9		
FBgn0036790	AstC-R1	HGNC:4522	OMIM:600730	NPBWR1	3		
FBgn0036790	AstC-R1	HGNC:11332	OMIM:182453	SSTR3	7		
FBgn0036790	AstC-R1	HGNC:11334	OMIM:182455	SSTR5	7		
FBgn0010424	TpnC73F	HGNC:24193	OMIM:610171	CALML6	3		
FBgn0036911	Fibp	HGNC:3705	OMIM:608296	FIBP	14	617107	617107[THAUVIN-ROBINET-FAIVRE SYNDROME; TROFAS]
FBgn0015721	ktub	HGNC:12424	OMIM:602309	TULP2	5		
FBgn0015721	ktub	HGNC:12406	OMIM:601197	TUB	11	616188	616188[RETINAL DYSTROPHY AND OBESITY; RDOB]
FBgn0015721	ktub	HGNC:12423	OMIM:602280	TULP1	7	600132,613843	600132[RETINITIS PIGMENTOSA 14; RP14],613843[LEBER CONGENITAL AMAUROSIS 15; LCA15]
FBgn0015721	ktub	HGNC:12425	OMIM:604730	TULP3	11	619902	619902[HEPATORENOCARDIAC DEGENERATIVE FIBROSIS; HRCDF]
FBgn0040227	eIF3d1	HGNC:3278	OMIM:603915	EIF3D	14		
FBgn0025790	TBPH	HGNC:11571	OMIM:605078	TARDBP	14	612069	612069[AMYOTROPHIC LATERAL SCLEROSIS 10 WITH OR WITHOUT FRONTOTEMPORAL DEMENTIA; ALS10]
FBgn0032699	CG10383	HGNC:21061	OMIM:614725	SERAC1	11	614739	614739[3-METHYLGLUTACONIC ACIDURIA WITH DEAFNESS, ENCEPHALOPATHY, AND LEIGH-LIKE SYNDROME; MEGDEL]
FBgn0036302	sowah	HGNC:32960		SOWAHD	5		
FBgn0036302	sowah	HGNC:26149		SOWAHC	7		
FBgn0036302	sowah	HGNC:32958		SOWAHB	6		
FBgn0036302	sowah	HGNC:27033		SOWAHA	7		
FBgn0016034	mael	HGNC:25929	OMIM:611368	MAEL	13		
FBgn0031883	Caper	HGNC:15923	OMIM:604739	RBM39	11		
FBgn0031883	Caper	HGNC:20155		RBM23	7		
FBgn0031835	Dpp10	HGNC:3009	OMIM:102720	DPP4	3		
FBgn0031835	Dpp10	HGNC:3010	OMIM:126141	DPP6	8	612956,616311	612956[VENTRICULAR FIBRILLATION, PAROXYSMAL FAMILIAL, 2; VF2],616311[INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL DOMINANT 33; MRD33]
FBgn0031835	Dpp10	HGNC:3590	OMIM:600403	FAP	4		
FBgn0031835	Dpp10	HGNC:20823	OMIM:608209	DPP10	9		
FBgn0031115	CG11710	HGNC:12310	OMIM:604501	TRIP4	15	616866,617066	616866[SPINAL MUSCULAR ATROPHY WITH CONGENITAL BONE FRACTURES 1; SMABF1],617066[MUSCULAR DYSTROPHY, CONGENITAL, DAVIGNON-CHAUVEAU TYPE; MDCDC]
FBgn0028425	JhI-21	HGNC:11059	OMIM:607933	SLC7A11	5		
FBgn0028425	JhI-21	HGNC:11058	OMIM:607959	SLC7A10	5		
FBgn0028425	JhI-21	HGNC:11065	OMIM:603593	SLC7A7	7	222700	222700[LYSINURIC PROTEIN INTOLERANCE; LPI]
FBgn0028425	JhI-21	HGNC:11064	OMIM:605641	SLC7A6	7		
FBgn0028425	JhI-21	HGNC:11067	OMIM:604144	SLC7A9	6	220100	220100[CYSTINURIA]
FBgn0028425	JhI-21	HGNC:11063	OMIM:600182	SLC7A5	9		
FBgn0028425	JhI-21	HGNC:11066	OMIM:604235	SLC7A8	7		
FBgn0028425	JhI-21	HGNC:23092	OMIM:617256	SLC7A13	3		
FBgn0003380	Sh	HGNC:6224	OMIM:176267	KCNA5	7	612240	612240[ATRIAL FIBRILLATION, FAMILIAL, 7; ATFB7]
FBgn0003380	Sh	HGNC:6218	OMIM:176260	KCNA1	11	160120	160120[EPISODIC ATAXIA, TYPE 1; EA1]
FBgn0003380	Sh	HGNC:6219	OMIM:602420	KCNA10	6		
FBgn0003380	Sh	HGNC:6225	OMIM:176257	KCNA6	6		
FBgn0003380	Sh	HGNC:6226	OMIM:176268	KCNA7	6		
FBgn0003380	Sh	HGNC:6222	OMIM:176266	KCNA4	8	618284	618284[MICROCEPHALY, CATARACTS, IMPAIRED INTELLECTUAL DEVELOPMENT, AND DYSTONIA WITH ABNORMAL STRIATUM; MCIDDS]
FBgn0003380	Sh	HGNC:6221	OMIM:176263	KCNA3	10		
FBgn0003380	Sh	HGNC:6220	OMIM:176262	KCNA2	10	616366	616366[DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 32; DEE32]
FBgn0037153	olf413	HGNC:21063	OMIM:609000	MOXD1	10		
FBgn0038448	CG12783	HGNC:8494	OMIM:604047	SLC22A13	4		
FBgn0038448	CG12783	HGNC:10970	OMIM:607582	SLC22A6	3		
FBgn0038448	CG12783	HGNC:20302	OMIM:608276	SLC22A16	3		
FBgn0038448	CG12783	HGNC:10968	OMIM:604190	SLC22A4	3	180300	180300[RHEUMATOID ARTHRITIS; RA]
FBgn0038448	CG12783	HGNC:10969	OMIM:603377	SLC22A5	3	212140	212140[CARNITINE DEFICIENCY, SYSTEMIC PRIMARY; CDSP]
FBgn0038448	CG12783	HGNC:8495	OMIM:604048	SLC22A14	4		
FBgn0038448	CG12783	HGNC:10971	OMIM:604995	SLC22A7	4		
FBgn0038448	CG12783	HGNC:10972	OMIM:607581	SLC22A8	4		
FBgn0038448	CG12783	HGNC:10966	OMIM:602608	SLC22A2	3		
FBgn0038448	CG12783	HGNC:32935	OMIM:610792	SLC22A25	3		
FBgn0038448	CG12783	HGNC:10963	OMIM:602607	SLC22A1	3		
FBgn0038448	CG12783	HGNC:10967	OMIM:604842	SLC22A3	3		
FBgn0038448	CG12783	HGNC:17989	OMIM:607096	SLC22A12	3	220150	220150[HYPOURICEMIA, RENAL, 1; RHUC1]
FBgn0038448	CG12783	HGNC:18120	OMIM:607097	SLC22A11	3		
FBgn0038448	CG12783	HGNC:16261	OMIM:607579	SLC22A9	3		
FBgn0038448	CG12783	HGNC:28542	OMIM:611698	SLC22A24	3		
FBgn0038448	CG12783	HGNC:18057	OMIM:607580	SLC22A10	3		
FBgn0027780	Aasdh	HGNC:23993	OMIM:614365	AASDH	15		
FBgn0028560	sut4	HGNC:11011	OMIM:606813	SLC2A6	7		
FBgn0028560	sut4	HGNC:13812	OMIM:605245	SLC2A8	7		
FBgn0028560	sut4	HGNC:11006	OMIM:138160	SLC2A2	3	125853,227810	125853[TYPE 2 DIABETES MELLITUS; T2D],227810[FANCONI-BICKEL SYNDROME; FBS]
FBgn0028560	sut4	HGNC:18067	OMIM:610372	SLC2A12	3		
FBgn0028560	sut4	HGNC:13444	OMIM:606145	SLC2A10	3	208050	208050[ARTERIAL TORTUOSITY SYNDROME; ATORS]
FBgn0028560	sut4	HGNC:15956	OMIM:611036	SLC2A13	3		
FBgn0003464	sol	HGNC:11182	OMIM:603267	CAPN15	12	619318	619318[OCULOGASTROINTESTINAL NEURODEVELOPMENTAL SYNDROME; OGIN]
FBgn0023023	CRMP	HGNC:3015	OMIM:601168	DPYSL3	11		
FBgn0023023	CRMP	HGNC:2365	OMIM:602462	CRMP1	10		
FBgn0023023	CRMP	HGNC:3016	OMIM:608407	DPYSL4	10		
FBgn0023023	CRMP	HGNC:20637	OMIM:608383	DPYSL5	10	619435	619435[RITSCHER-SCHINZEL SYNDROME 4; RTSC4]
FBgn0023023	CRMP	HGNC:3014	OMIM:602463	DPYSL2	10		
FBgn0023023	CRMP	HGNC:3013	OMIM:613326	DPYS	14	222748	222748[DIHYDROPYRIMIDINASE DEFICIENCY; DPYSD]
FBgn0037986	CG14736	HGNC:13394	OMIM:604766	NPHS2	4	600995	600995[NEPHROTIC SYNDROME, TYPE 2; NPHS2]
FBgn0037986	CG14736	HGNC:3383	OMIM:133090	STOM	4		
FBgn0037986	CG14736	HGNC:19420	OMIM:608327	STOML3	4		
FBgn0029588	CR14798	HGNC:21306	OMIM:613305	ALKBH7	3		
FBgn0020371	Tim17b2	HGNC:17315	OMIM:605057	TIMM17A	10		
FBgn0020371	Tim17b2	HGNC:17310	OMIM:300249	TIMM17B	11		
FBgn0030657	cerv	HGNC:26513	OMIM:617246	NSMCE2	10	617253	617253[SECKEL SYNDROME 10; SCKL10]
FBgn0043070	MESK2	HGNC:7679	OMIM:605262	NDRG1	12	601455	601455[CHARCOT-MARIE-TOOTH DISEASE, TYPE 4D; CMT4D]
FBgn0043070	MESK2	HGNC:14462	OMIM:605273	NDRG3	13		
FBgn0043070	MESK2	HGNC:14460	OMIM:605272	NDRG2	10		
FBgn0043070	MESK2	HGNC:14466	OMIM:614463	NDRG4	10		
FBgn0029941	CG1677	HGNC:25091		ZC3H18	11		
FBgn0036574	elg1	HGNC:25752	OMIM:609534	ATAD5	10		
FBgn0003118	pnt	HGNC:3488	OMIM:164720	ETS1	9		
FBgn0003118	pnt	HGNC:3489	OMIM:164740	ETS2	8		
FBgn0004595	pros	HGNC:9459	OMIM:601546	PROX1	10		
FBgn0004595	pros	HGNC:26715	OMIM:615094	PROX2	8		
FBgn0016038	Vsp37A	HGNC:24928	OMIM:609927	VPS37A	7	614898	614898[SPASTIC PARAPLEGIA 53, AUTOSOMAL RECESSIVE; SPG53]
FBgn0033566	CG18004	HGNC:26905		INO80E	10		
FBgn0003189	r	HGNC:1424	OMIM:114010	CAD	14	616457	616457[DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 50; DEE50]
FBgn0003189	r	HGNC:2323	OMIM:608307	CPS1	5	237300,615371	237300[CARBAMOYL PHOSPHATE SYNTHETASE I DEFICIENCY, HYPERAMMONEMIA DUE TO],615371[PULMONARY HYPERTENSION, NEONATAL, SUSCEPTIBILITY TO; PHN]
FBgn0032202	REPTOR-BP	HGNC:2350	OMIM:603476	CREBL2	12		
FBgn0002773	Mlc2	HGNC:15754	OMIM:609905	MYL9	3	619365	619365[MEGACYSTIS-MICROCOLON-INTESTINAL HYPOPERISTALSIS SYNDROME 4; MMIHS4]
FBgn0002773	Mlc2	HGNC:29825	OMIM:617177	MYL10	3		
FBgn0002773	Mlc2	HGNC:16701		MYL12A	3		
FBgn0002773	Mlc2	HGNC:7586	OMIM:160782	MYL5	3		
FBgn0002773	Mlc2	HGNC:7583	OMIM:160781	MYL2	4	608758,619424	608758[CARDIOMYOPATHY, FAMILIAL HYPERTROPHIC, 10; CMH10],619424[MYOPATHY, MYOFIBRILLAR, 12, INFANTILE-ONSET, WITH CARDIOMYOPATHY; MFM12]
FBgn0002773	Mlc2	HGNC:21719	OMIM:613993	MYL7	4		
FBgn0002773	Mlc2	HGNC:29824	OMIM:617378	MYLPF	3	619110	619110[ARTHROGRYPOSIS, DISTAL, TYPE 1C; DA1C]
FBgn0031450	Hrs	HGNC:4897	OMIM:604375	HGS	14		
FBgn0050011	gem	HGNC:11748	OMIM:189889	TFCP2	12		
FBgn0050011	gem	HGNC:12507	OMIM:609784	UBP1	10		
FBgn0050011	gem	HGNC:17925	OMIM:609785	TFCP2L1	11		
FBgn0050011	gem	HGNC:17923	OMIM:609786	GRHL1	3		
FBgn0050011	gem	HGNC:25839	OMIM:608317	GRHL3	3	606713	606713[VAN DER WOUDE SYNDROME 2; VWS2]
FBgn0050159	CG30159	HGNC:26434	OMIM:619654	C3orf33	6		
FBgn0050423	CG30423	HGNC:6555	OMIM:607338	LEPROTL1	12		
FBgn0050423	CG30423	HGNC:29477	OMIM:613461	LEPROT	12		
FBgn0038194	Cyp6d5	HGNC:2638	OMIM:605325	CYP3A5	4	145500	145500[HYPERTENSION, ESSENTIAL]
FBgn0038194	Cyp6d5	HGNC:17450	OMIM:606534	CYP3A43	4		
FBgn0038194	Cyp6d5	HGNC:11609	OMIM:274180	TBXAS1	3	231095	231095[GHOSAL HEMATODIAPHYSEAL DYSPLASIA; GHDD]
FBgn0038194	Cyp6d5	HGNC:2637	OMIM:124010	CYP3A4	4	619073	619073[VITAMIN D-DEPENDENT RICKETS, TYPE 3; VDDR3]
FBgn0038194	Cyp6d5	HGNC:51504		CYP3A7-CYP3A51P	4		
FBgn0051665	wry	HGNC:7884	OMIM:164951	NOTCH4	4		
FBgn0051665	wry	HGNC:24456	OMIM:607299	DNER	3		
FBgn0005666	bt	HGNC:15719	OMIM:608616	OBSCN	4		
FBgn0005666	bt	HGNC:12403	OMIM:188840	TTN	9	600334,603689,604145,608807,611705,613765	600334[TIBIAL MUSCULAR DYSTROPHY, TARDIVE; TMD],603689[MYOPATHY, MYOFIBRILLAR, 9, WITH EARLY RESPIRATORY FAILURE; MFM9],604145[CARDIOMYOPATHY, DILATED, 1G; CMD1G],608807[MUSCULAR DYSTROPHY, LIMB-GIRDLE, AUTOSOMAL RECESSIVE 10; LGMDR10],611705[SALIH MYOPATHY; SALMY],613765[CARDIOMYOPATHY, FAMILIAL HYPERTROPHIC, 9; CMH9]
FBgn0052442	Arv1	HGNC:29561	OMIM:611647	ARV1	11	617020	617020[DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 38; DEE38]
FBgn0052495	Gss2	HGNC:4624	OMIM:601002	GSS	9	231900,266130	231900[GLUTATHIONE SYNTHETASE DEFICIENCY OF ERYTHROCYTES, HEMOLYTIC ANEMIA DUE TO; GSSDE],266130[GLUTATHIONE SYNTHETASE DEFICIENCY; GSSD]
FBgn0052568	CG32568	HGNC:9312	OMIM:601646	PPP2R5D	3	616355	616355[INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL DOMINANT 35; MRD35]
FBgn0052568	CG32568	HGNC:9313	OMIM:601647	PPP2R5E	4		
FBgn0052568	CG32568	HGNC:9311	OMIM:601645	PPP2R5C	3		
FBgn0052568	CG32568	HGNC:9309	OMIM:601643	PPP2R5A	3		
FBgn0052568	CG32568	HGNC:9310	OMIM:601644	PPP2R5B	3		
FBgn0023531	CG32809	HGNC:25428	OMIM:617367	KIAA1217	9		
FBgn0023531	CG32809	HGNC:29506	OMIM:610786	SRCIN1	9		
FBgn0053198	pen-2	HGNC:30100	OMIM:607632	PSENEN	14	613736	613736[ACNE INVERSA, FAMILIAL, 2, WITH OR WITHOUT DOWLING-DEGOS DISEASE; ACNINV2]
FBgn0035802	Pura	HGNC:24501	OMIM:609526	PLEKHG4	13		
FBgn0035802	Pura	HGNC:25516	OMIM:610018	ARHGEF40	7		
FBgn0035802	Pura	HGNC:29399		PLEKHG4B	12		
FBgn0035802	Pura	HGNC:29372		KIAA1755	3		
FBgn0032120	CG33298	HGNC:13542	OMIM:605855	ATP10A	12		
FBgn0032120	CG33298	HGNC:13549	OMIM:619815	ATP10D	13		
FBgn0032120	CG33298	HGNC:13543	OMIM:619791	ATP10B	13		
FBgn0041723	rho-5	HGNC:20788	OMIM:614404	RHBDF2	7	148500	148500[TYLOSIS WITH ESOPHAGEAL CANCER; TOC]
FBgn0041723	rho-5	HGNC:20561	OMIM:614403	RHBDF1	9		
FBgn0003016	osp	HGNC:17009	OMIM:609761	TRIOBP	6	609823	609823[DEAFNESS, AUTOSOMAL RECESSIVE 28; DFNB28]
FBgn0003016	osp	HGNC:30321	OMIM:612935	MPRIP	9		
FBgn0035028	Start1	HGNC:17579	OMIM:607048	STARD3	12		
FBgn0035028	Start1	HGNC:11359	OMIM:600617	STAR	4	201710	201710[LIPOID CONGENITAL ADRENAL HYPERPLASIA; LCAH]
FBgn0035028	Start1	HGNC:19169	OMIM:611759	STARD3NL	8		
FBgn0035028	Start1	HGNC:18066	OMIM:607051	STARD6	3		
FBgn0015925	csul	HGNC:10894	OMIM:604045	PRMT5	14		
FBgn0013305	Nmda1	HGNC:4589	OMIM:138251	GRINA	10		
FBgn0013305	Nmda1	HGNC:17067	OMIM:604306	FAIM2	5		
FBgn0013305	Nmda1	HGNC:23410	OMIM:610364	TMBIM1	4		
FBgn0013305	Nmda1	HGNC:24257	OMIM:616874	TMBIM4	5		
FBgn0021761	Nup154	HGNC:8063	OMIM:606694	NUP155	14	615770	615770[ATRIAL FIBRILLATION, FAMILIAL, 15; ATFB15]
FBgn0038474	mRpS11	HGNC:14050	OMIM:611977	MRPS11	12		
FBgn0025456	CREG	HGNC:2351	OMIM:618055	CREG1	14		
FBgn0025456	CREG	HGNC:14272	OMIM:618540	CREG2	7		
FBgn0026379	Pten	HGNC:9588	OMIM:601728	PTEN	13	158350,176807,605309,607174,613028	158350[COWDEN SYNDROME 1; CWS1],176807[PROSTATE CANCER],605309[MACROCEPHALY/AUTISM SYNDROME],607174[MENINGIOMA, FAMILIAL, SUSCEPTIBILITY TO],613028[GLIOMA SUSCEPTIBILITY 2; GLM2]
FBgn0039207	Cftr	HGNC:55	OMIM:605250	ABCC4	7		
FBgn0039207	Cftr	HGNC:52	OMIM:612509	ABCC10	4		
FBgn0039207	Cftr	HGNC:53	OMIM:601107	ABCC2	4	237500	237500[DUBIN-JOHNSON SYNDROME; DJS]
FBgn0039207	Cftr	HGNC:51	OMIM:158343	ABCC1	4	618915	618915[DEAFNESS, AUTOSOMAL DOMINANT 77; DFNA77]
FBgn0039207	Cftr	HGNC:59	OMIM:600509	ABCC8	4	125853,240800,256450,610374,618857	125853[TYPE 2 DIABETES MELLITUS; T2D],240800[HYPOGLYCEMIA, LEUCINE-INDUCED; LIH],256450[HYPERINSULINEMIC HYPOGLYCEMIA, FAMILIAL, 1; HHF1],610374[DIABETES MELLITUS, TRANSIENT NEONATAL, 2; TNDM2],618857[DIABETES MELLITUS, PERMANENT NEONATAL, 3; PNDM3]
FBgn0039207	Cftr	HGNC:14640	OMIM:607041	ABCC12	4		
FBgn0039207	Cftr	HGNC:60	OMIM:601439	ABCC9	4	239850,608569,614050,619719	239850[CANTU SYNDROME],608569[CARDIOMYOPATHY, DILATED, 1O; CMD1O],614050[ATRIAL FIBRILLATION, FAMILIAL, 12; ATFB12],619719[INTELLECTUAL DISABILITY AND MYOPATHY SYNDROME; IDMYS]
FBgn0039207	Cftr	HGNC:57	OMIM:603234	ABCC6	4	177850,264800,614473	177850[PSEUDOXANTHOMA ELASTICUM, FORME FRUSTE],264800[PSEUDOXANTHOMA ELASTICUM; PXE],614473[ARTERIAL CALCIFICATION, GENERALIZED, OF INFANCY, 2; GACI2]
FBgn0039207	Cftr	HGNC:56	OMIM:605251	ABCC5	4		
FBgn0039207	Cftr	HGNC:14639	OMIM:607040	ABCC11	4	117800	117800[APOCRINE GLAND SECRETION, VARIATION IN]
FBgn0039207	Cftr	HGNC:54	OMIM:604323	ABCC3	5		
FBgn0039207	Cftr	HGNC:1884	OMIM:602421	CFTR	4	167800,211400,219700,277180	167800[PANCREATITIS, HEREDITARY; PCTT],211400[BRONCHIECTASIS WITH OR WITHOUT ELEVATED SWEAT CHLORIDE 1; BESC1],219700[CYSTIC FIBROSIS; CF],277180[VAS DEFERENS, CONGENITAL BILATERAL APLASIA OF; CBAVD]
FBgn0032455	Pih1D1	HGNC:26075	OMIM:611480	PIH1D1	3		
FBgn0038886	Ugt49B2	HGNC:12531	OMIM:606435	UGT1A10	6		
FBgn0038886	Ugt49B2	HGNC:12545	OMIM:603064	UGT2B11	9		
FBgn0038886	Ugt49B2	HGNC:12530	OMIM:191740	UGT1A1	8	143500,218800,237900,601816,606785	143500[GILBERT SYNDROME],218800[CRIGLER-NAJJAR SYNDROME, TYPE I],237900[HYPERBILIRUBINEMIA, TRANSIENT FAMILIAL NEONATAL; HBLRTFN],601816[BILIRUBIN, SERUM LEVEL OF, QUANTITATIVE TRAIT LOCUS 1; BILIQTL1],606785[CRIGLER-NAJJAR SYNDROME, TYPE II]
FBgn0038886	Ugt49B2	HGNC:12555	OMIM:601291	UGT8	8		
FBgn0038886	Ugt49B2	HGNC:12539	OMIM:606432	UGT1A7	6		
FBgn0038886	Ugt49B2	HGNC:13479	OMIM:606497	UGT2B28	8		
FBgn0038886	Ugt49B2	HGNC:27266	OMIM:616384	UGT3A2	5		
FBgn0038886	Ugt49B2	HGNC:12544	OMIM:600070	UGT2B10	10		
FBgn0038886	Ugt49B2	HGNC:12537	OMIM:606430	UGT1A5	6		
FBgn0038886	Ugt49B2	HGNC:12546	OMIM:600069	UGT2B15	9		
FBgn0038886	Ugt49B2	HGNC:12541	OMIM:606434	UGT1A9	6		
FBgn0038886	Ugt49B2	HGNC:28528	OMIM:616382	UGT2A3	8		
FBgn0038886	Ugt49B2	HGNC:12535	OMIM:606428	UGT1A3	8		
FBgn0038886	Ugt49B2	HGNC:12536	OMIM:606429	UGT1A4	6		
FBgn0038886	Ugt49B2	HGNC:12540	OMIM:606433	UGT1A8	6		
FBgn0038886	Ugt49B2	HGNC:26625	OMIM:616383	UGT3A1	5		
FBgn0038886	Ugt49B2	HGNC:12547	OMIM:601903	UGT2B17	9	612560	612560[BONE MINERAL DENSITY QUANTITATIVE TRAIT LOCUS 12; BMND12]
FBgn0038886	Ugt49B2	HGNC:12553	OMIM:600067	UGT2B4	8		
FBgn0038886	Ugt49B2	HGNC:12538	OMIM:606431	UGT1A6	7		
FBgn0038886	Ugt49B2	HGNC:12554	OMIM:600068	UGT2B7	8		
FBgn0038886	Ugt49B2	HGNC:28183	OMIM:619809	UGT2A2	7		
FBgn0039215	CG6695	HGNC:17731	OMIM:618532	CLASRP	10		
FBgn0039714	Zip99C	HGNC:4927	OMIM:601416	SLC39A7	4	619693	619693[AGAMMAGLOBULINEMIA 9, AUTOSOMAL RECESSIVE; AGM9]
FBgn0039714	Zip99C	HGNC:20859	OMIM:608735	SLC39A13	15	612350	612350[EHLERS-DANLOS SYNDROME, SPONDYLODYSPLASTIC TYPE, 3; EDSSPD3]
FBgn0002567	Rab32	HGNC:9776	OMIM:606281	RAB38	6		
FBgn0002567	Rab32	HGNC:9772	OMIM:612906	RAB32	9		
FBgn0032001	CG8360	HGNC:1712	OMIM:123920	CDA	13		
FBgn0025682	scf	HGNC:1458	OMIM:603420	CALU	14		
FBgn0025682	scf	HGNC:21145	OMIM:619032	RCN3	8		
FBgn0025682	scf	HGNC:9934	OMIM:602735	RCN1	10		
FBgn0032907	Nthl1	HGNC:8028	OMIM:602656	NTHL1	14	616415	616415[FAMILIAL ADENOMATOUS POLYPOSIS 3; FAP3]
FBgn0031813	Acox3	HGNC:121	OMIM:603402	ACOX3	14		
FBgn0031813	Acox3	HGNC:25621		ACOXL	4		
FBgn0026620	tacc	HGNC:11524	OMIM:605303	TACC3	7		
FBgn0026620	tacc	HGNC:11522	OMIM:605301	TACC1	7		
FBgn0026620	tacc	HGNC:11523	OMIM:605302	TACC2	6		
FBgn0003721	Tm1	HGNC:12012	OMIM:191030	TPM3	11	255310,609284	255310[MYOPATHY, CONGENITAL, WITH FIBER-TYPE DISPROPORTION; CFTD],609284[NEMALINE MYOPATHY 1; NEM1]
FBgn0003721	Tm1	HGNC:12013	OMIM:600317	TPM4	11		
FBgn0003721	Tm1	HGNC:12011	OMIM:190990	TPM2	11	108120,609285	108120[ARTHROGRYPOSIS, DISTAL, TYPE 1A; DA1A],609285[NEMALINE MYOPATHY 4; NEM4]
FBgn0003721	Tm1	HGNC:12010	OMIM:191010	TPM1	13	115196,611878	115196[CARDIOMYOPATHY, FAMILIAL HYPERTROPHIC, 3; CMH3],611878[CARDIOMYOPATHY, DILATED, 1Y; CMD1Y]
FBgn0034405	Jheh2	HGNC:3401	OMIM:132810	EPHX1	15		
FBgn0039915	Gat	HGNC:11049	OMIM:126455	SLC6A3	3	188890,613135	188890[TOBACCO ADDICTION, SUSCEPTIBILITY TO],613135[PARKINSONISM-DYSTONIA 1, INFANTILE-ONSET; PKDYS1]
FBgn0039915	Gat	HGNC:11044	OMIM:607952	SLC6A11	6		
FBgn0039915	Gat	HGNC:31399	OMIM:610299	SLC6A17	3	616269	616269[INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 48; MRT48]
FBgn0039915	Gat	HGNC:11045	OMIM:603080	SLC6A12	6		
FBgn0039915	Gat	HGNC:11054	OMIM:606205	SLC6A7	3		
FBgn0039915	Gat	HGNC:11048	OMIM:163970	SLC6A2	3	604715	604715[ORTHOSTATIC INTOLERANCE]
FBgn0039915	Gat	HGNC:13621	OMIM:607971	SLC6A15	3		
FBgn0039915	Gat	HGNC:11050	OMIM:182138	SLC6A4	3	164230,607834	164230[OBSESSIVE-COMPULSIVE DISORDER; OCD],607834[ANXIETY]
FBgn0039915	Gat	HGNC:11055	OMIM:300036	SLC6A8	4	300352	300352[CEREBRAL CREATINE DEFICIENCY SYNDROME 1; CCDS1]
FBgn0039915	Gat	HGNC:11056	OMIM:601019	SLC6A9	3	617301	617301[GLYCINE ENCEPHALOPATHY WITH NORMAL SERUM GLYCINE]
FBgn0039915	Gat	HGNC:11052	OMIM:186854	SLC6A6	5	145350	145350[HYPOTAURINEMIC RETINAL DEGENERATION AND CARDIOMYOPATHY; HTRDC]
FBgn0039915	Gat	HGNC:11046	OMIM:615097	SLC6A13	6		
FBgn0039915	Gat	HGNC:11042	OMIM:137165	SLC6A1	14	616421	616421[MYOCLONIC-ATONIC EPILEPSY; MAE]
FBgn0039915	Gat	HGNC:13622	OMIM:607972	SLC6A16	3		
FBgn0020445	E23	HGNC:73	OMIM:603076	ABCG1	3		
FBgn0020445	E23	HGNC:74	OMIM:603756	ABCG2	3	138900,614490	138900[URIC ACID CONCENTRATION, SERUM, QUANTITATIVE TRAIT LOCUS 1; UAQTL1],614490[BLOOD GROUP, JUNIOR SYSTEM; JR]
FBgn0020445	E23	HGNC:13887	OMIM:605460	ABCG8	3	210250,611465	210250[SITOSTEROLEMIA 1; STSL1],611465[GALLBLADDER DISEASE 4; GBD4]
FBgn0020445	E23	HGNC:13886	OMIM:605459	ABCG5	3	618666	618666[SITOSTEROLEMIA 2; STSL2]
FBgn0004509	Fur1	HGNC:8569	OMIM:167405	PCSK6	4		
FBgn0004509	Fur1	HGNC:8743	OMIM:162150	PCSK1	4	600955,612362	600955[PROPROTEIN CONVERTASE 1/3 DEFICIENCY],612362[BODY MASS INDEX QUANTITATIVE TRAIT LOCUS 12; BMIQ12]
FBgn0004509	Fur1	HGNC:8747	OMIM:600488	PCSK5	3		
FBgn0004509	Fur1	HGNC:8744	OMIM:162151	PCSK2	3		
FBgn0004509	Fur1	HGNC:8746	OMIM:600487	PCSK4	6		
FBgn0004509	Fur1	HGNC:8568	OMIM:136950	FURIN	10		
FBgn0004509	Fur1	HGNC:8748	OMIM:604872	PCSK7	4		
FBgn0000117	arm	HGNC:2514	OMIM:116806	CTNNB1	14	114500,114550,132600,155255,167000,615075,617572	114500[COLORECTAL CANCER; CRC],114550[HEPATOCELLULAR CARCINOMA],132600[PILOMATRIXOMA],155255[MEDULLOBLASTOMA; MDB],167000[OVARIAN CANCER],615075[NEURODEVELOPMENTAL DISORDER WITH SPASTIC DIPLEGIA AND VISUAL DEFECTS; NEDSDV],617572[EXUDATIVE VITREORETINOPATHY 7; EVR7]
FBgn0000117	arm	HGNC:6207	OMIM:173325	JUP	10	601214,611528	601214[NAXOS DISEASE; NXD],611528[ARRHYTHMOGENIC RIGHT VENTRICULAR DYSPLASIA, FAMILIAL, 12; ARVD12]
FBgn0022361	Pur-alpha	HGNC:9701	OMIM:600473	PURA	13	616158	616158[NEURODEVELOPMENTAL DISORDER WITH NEONATAL RESPIRATORY INSUFFICIENCY, HYPOTONIA, AND FEEDING DIFFICULTIES; NEDRIHF]
FBgn0022361	Pur-alpha	HGNC:17930	OMIM:618041	PURG	10		
FBgn0022361	Pur-alpha	HGNC:9702	OMIM:608887	PURB	12		
FBgn0023175	Prosalpha7	HGNC:9532	OMIM:176843	PSMA3	15		
FBgn0010329	Tbh	HGNC:2689	OMIM:609312	DBH	15	223360	223360[ORTHOSTATIC HYPOTENSION 1; ORTHYP1]
FBgn0010329	Tbh	HGNC:21063	OMIM:609000	MOXD1	3		
FBgn0011754	PhKgamma	HGNC:8931	OMIM:172471	PHKG2	13	613027	613027[GLYCOGEN STORAGE DISEASE IXc; GSD9C]
FBgn0011754	PhKgamma	HGNC:8930	OMIM:172470	PHKG1	11		
FBgn0001991	Ca-alpha1D	HGNC:19082	OMIM:611549	NALCN	3	615419,616266	615419[HYPOTONIA, INFANTILE, WITH PSYCHOMOTOR RETARDATION AND CHARACTERISTIC FACIES 1; IHPRF1],616266[CONGENITAL CONTRACTURES OF THE LIMBS AND FACE, HYPOTONIA, AND DEVELOPMENTAL DELAY; CLIFAHDD]
FBgn0001991	Ca-alpha1D	HGNC:1397	OMIM:114208	CACNA1S	13	170400,188580,601887	170400[HYPOKALEMIC PERIODIC PARALYSIS, TYPE 1; HOKPP1],188580[THYROTOXIC PERIODIC PARALYSIS, SUSCEPTIBILITY TO, 1; TTPP1],601887[MALIGNANT HYPERTHERMIA, SUSCEPTIBILITY TO, 5; MHS5]
FBgn0001991	Ca-alpha1D	HGNC:1388	OMIM:601011	CACNA1A	6	108500,141500,183086,617106	108500[EPISODIC ATAXIA, TYPE 2; EA2],141500[MIGRAINE, FAMILIAL HEMIPLEGIC, 1; FHM1],183086[SPINOCEREBELLAR ATAXIA 6; SCA6],617106[DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 42; DEE42]
FBgn0001991	Ca-alpha1D	HGNC:1389	OMIM:601012	CACNA1B	5	618497	618497[NEURODEVELOPMENTAL DISORDER WITH SEIZURES AND NONEPILEPTIC HYPERKINETIC MOVEMENTS; NEDNEH]
FBgn0001991	Ca-alpha1D	HGNC:1392	OMIM:601013	CACNA1E	4	618285	618285[DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 69; DEE69]
FBgn0001991	Ca-alpha1D	HGNC:1390	OMIM:114205	CACNA1C	12	601005,611875,618447	601005[TIMOTHY SYNDROME; TS],611875[BRUGADA SYNDROME 3; BRGDA3],618447[LONG QT SYNDROME 8; LQT8]
FBgn0001991	Ca-alpha1D	HGNC:1393	OMIM:300110	CACNA1F	11	300071,300476,300600	300071[NIGHT BLINDNESS, CONGENITAL STATIONARY, TYPE 2A; CSNB2A],300476[CONE-ROD DYSTROPHY, X-LINKED, 3; CORDX3],300600[ALAND ISLAND EYE DISEASE; AIED]
FBgn0001991	Ca-alpha1D	HGNC:1391	OMIM:114206	CACNA1D	13	614896,615474	614896[SINOATRIAL NODE DYSFUNCTION AND DEAFNESS; SANDD],615474[PRIMARY ALDOSTERONISM, SEIZURES, AND NEUROLOGIC ABNORMALITIES; PASNA]
FBgn0001991	Ca-alpha1D	HGNC:10596	OMIM:600702	SCN8A	3	614306,614558,617080,618364	614306[COGNITIVE IMPAIRMENT WITH OR WITHOUT CEREBELLAR ATAXIA; CIAT],614558[DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 13; DEE13],617080[SEIZURES, BENIGN FAMILIAL INFANTILE, 5; BFIS5],618364[MYOCLONUS, FAMILIAL, 2; MYOCL2]
FBgn0032456	MRP	HGNC:55	OMIM:605250	ABCC4	5		
FBgn0032456	MRP	HGNC:52	OMIM:612509	ABCC10	5		
FBgn0032456	MRP	HGNC:53	OMIM:601107	ABCC2	7	237500	237500[DUBIN-JOHNSON SYNDROME; DJS]
FBgn0032456	MRP	HGNC:51	OMIM:158343	ABCC1	11	618915	618915[DEAFNESS, AUTOSOMAL DOMINANT 77; DFNA77]
FBgn0032456	MRP	HGNC:59	OMIM:600509	ABCC8	5	125853,240800,256450,610374,618857	125853[TYPE 2 DIABETES MELLITUS; T2D],240800[HYPOGLYCEMIA, LEUCINE-INDUCED; LIH],256450[HYPERINSULINEMIC HYPOGLYCEMIA, FAMILIAL, 1; HHF1],610374[DIABETES MELLITUS, TRANSIENT NEONATAL, 2; TNDM2],618857[DIABETES MELLITUS, PERMANENT NEONATAL, 3; PNDM3]
FBgn0032456	MRP	HGNC:14640	OMIM:607041	ABCC12	5		
FBgn0032456	MRP	HGNC:60	OMIM:601439	ABCC9	5	239850,608569,614050,619719	239850[CANTU SYNDROME],608569[CARDIOMYOPATHY, DILATED, 1O; CMD1O],614050[ATRIAL FIBRILLATION, FAMILIAL, 12; ATFB12],619719[INTELLECTUAL DISABILITY AND MYOPATHY SYNDROME; IDMYS]
FBgn0032456	MRP	HGNC:57	OMIM:603234	ABCC6	7	177850,264800,614473	177850[PSEUDOXANTHOMA ELASTICUM, FORME FRUSTE],264800[PSEUDOXANTHOMA ELASTICUM; PXE],614473[ARTERIAL CALCIFICATION, GENERALIZED, OF INFANCY, 2; GACI2]
FBgn0032456	MRP	HGNC:56	OMIM:605251	ABCC5	5		
FBgn0032456	MRP	HGNC:14639	OMIM:607040	ABCC11	5	117800	117800[APOCRINE GLAND SECRETION, VARIATION IN]
FBgn0032456	MRP	HGNC:54	OMIM:604323	ABCC3	14		
FBgn0032456	MRP	HGNC:1884	OMIM:602421	CFTR	3	167800,211400,219700,277180	167800[PANCREATITIS, HEREDITARY; PCTT],211400[BRONCHIECTASIS WITH OR WITHOUT ELEVATED SWEAT CHLORIDE 1; BESC1],219700[CYSTIC FIBROSIS; CF],277180[VAS DEFERENS, CONGENITAL BILATERAL APLASIA OF; CBAVD]
FBgn0034053	Cyp4aa1	HGNC:23198	OMIM:608614	CYP4V2	4	210370	210370[BIETTI CRYSTALLINE CORNEORETINAL DYSTROPHY; BCD]
FBgn0034053	Cyp4aa1	HGNC:2594	OMIM:107910	CYP19A1	3	139300,613546	139300[AROMATASE EXCESS SYNDROME; AEXS],613546[AROMATASE DEFICIENCY]
FBgn0039114	Lsd-1	HGNC:248	OMIM:103195	PLIN2	7		
FBgn0039114	Lsd-1	HGNC:9076	OMIM:170290	PLIN1	5	613877	613877[LIPODYSTROPHY, FAMILIAL PARTIAL, TYPE 4; FPLD4]
FBgn0039114	Lsd-1	HGNC:16893	OMIM:602702	PLIN3	7		
FBgn0039114	Lsd-1	HGNC:33196	OMIM:613248	PLIN5	6		
FBgn0039116	CG10375	HGNC:15470		DNAJC8	14		
FBgn0015513	mbc	HGNC:19192	OMIM:607679	DOCK4	4		
FBgn0015513	mbc	HGNC:2988	OMIM:603122	DOCK2	12	616433	616433[IMMUNODEFICIENCY 40; IMD40]
FBgn0015513	mbc	HGNC:2987	OMIM:601403	DOCK1	13		
FBgn0015513	mbc	HGNC:23476	OMIM:616904	DOCK5	11		
FBgn0015513	mbc	HGNC:2989	OMIM:603123	DOCK3	5	618292	618292[NEURODEVELOPMENTAL DISORDER WITH IMPAIRED INTELLECTUAL DEVELOPMENT, HYPOTONIA, AND ATAXIA; NEDIDHA]
FBgn0039120	Nup98-96	HGNC:8068	OMIM:601021	NUP98	12		
FBgn0039117	tst	HGNC:18734	OMIM:618122	MTREX	3		
FBgn0039117	tst	HGNC:10898	OMIM:600478	SKIV2L	13	614602	614602[TRICHOHEPATOENTERIC SYNDROME 2; THES2]
FBgn0039115	CG10214	HGNC:17851	OMIM:607149	REXO2	15		
FBgn0035477	CG14982	HGNC:25860		FAM110D	3		
FBgn0035477	CG14982	HGNC:16188	OMIM:611393	FAM110A	3		
FBgn0035477	CG14982	HGNC:28587	OMIM:611394	FAM110B	3		
FBgn0035477	CG14982	HGNC:33340	OMIM:611395	FAM110C	3		
FBgn0004880	scrt	HGNC:15952		SCRT2	7		
FBgn0004880	scrt	HGNC:15950	OMIM:605858	SCRT1	8		
FBgn0035482	CG14985	HGNC:25207		MITD1	13		
FBgn0004895	FoxL1	HGNC:3735	OMIM:602939	FOXS1	4		
FBgn0004895	FoxL1	HGNC:3803	OMIM:602211	FOXD2	3		
FBgn0004895	FoxL1	HGNC:3806	OMIM:602617	FOXE1	3	241850,616534	241850[HYPOTHYROIDISM, THYROIDAL OR ATHYROIDAL, WITH SPIKY HAIR AND CLEFT PALATE],616534[THYROID CANCER, NONMEDULLARY, 4; NMTC4]
FBgn0004895	FoxL1	HGNC:18521	OMIM:611084	FOXD4L1	3		
FBgn0004895	FoxL1	HGNC:3817	OMIM:603252	FOXL1	6		
FBgn0004895	FoxL1	HGNC:3804	OMIM:611539	FOXD3	4	607836	607836[AUTOIMMUNE DISEASE, SUSCEPTIBILITY TO, 1; AIS1]
FBgn0004895	FoxL1	HGNC:18523	OMIM:611086	FOXD4L3	3		
FBgn0004895	FoxL1	HGNC:3805	OMIM:601092	FOXD4	4		
FBgn0004895	FoxL1	HGNC:18522		FOXD4L5	3		
FBgn0004895	FoxL1	HGNC:23762	OMIM:611085	FOXD4L4	3		
FBgn0004895	FoxL1	HGNC:31986		FOXD4L6	3		
FBgn0004895	FoxL1	HGNC:3800	OMIM:601090	FOXC1	3	601631,602482	601631[ANTERIOR SEGMENT DYSGENESIS 3; ASGD3],602482[AXENFELD-RIEGER SYNDROME, TYPE 3; RIEG3]
FBgn0004895	FoxL1	HGNC:3808	OMIM:601094	FOXE3	3	610256,612968,617349	610256[ANTERIOR SEGMENT DYSGENESIS 2; ASGD2],612968[CATARACT 34, MULTIPLE TYPES; CTRCT34],617349[AORTIC ANEURYSM, FAMILIAL THORACIC 11, SUSCEPTIBILITY TO; AAT11]
FBgn0004895	FoxL1	HGNC:3816	OMIM:602291	FOXJ1	3	618699	618699[CILIARY DYSKINESIA, PRIMARY, 43; CILD43]
FBgn0004895	FoxL1	HGNC:20951	OMIM:612788	FOXQ1	3		
FBgn0035483	Mul1	HGNC:25762	OMIM:612037	MUL1	13		
FBgn0035484	CG11594	HGNC:25610	OMIM:611370	FGGY	14		
FBgn0035481	CG12605	HGNC:15952		SCRT2	7		
FBgn0035481	CG12605	HGNC:15950	OMIM:605858	SCRT1	8		
FBgn0035479	CG14983	HGNC:25539	OMIM:614151	RFWD3	3	617784	617784[FANCONI ANEMIA, COMPLEMENTATION GROUP W; FANCW]
FBgn0027552	CG10863	HGNC:386	OMIM:603966	AKR1C3	4		
FBgn0027552	CG10863	HGNC:384	OMIM:600449	AKR1C1	4		
FBgn0027552	CG10863	HGNC:387	OMIM:600451	AKR1C4	4	614279	614279[46,XY SEX REVERSAL 8; SRXY8]
FBgn0027552	CG10863	HGNC:380	OMIM:103830	AKR1A1	5		
FBgn0027552	CG10863	HGNC:381	OMIM:103880	AKR1B1	6		
FBgn0027552	CG10863	HGNC:382	OMIM:604707	AKR1B10	7		
FBgn0027552	CG10863	HGNC:388	OMIM:604741	AKR1D1	5	235555	235555[BILE ACID SYNTHESIS DEFECT, CONGENITAL, 2; CBAS2]
FBgn0027552	CG10863	HGNC:385	OMIM:600450	AKR1C2	4	614279	614279[46,XY SEX REVERSAL 8; SRXY8]
FBgn0027552	CG10863	HGNC:23437	OMIM:617451	AKR1E2	5		
FBgn0027552	CG10863	HGNC:37281	OMIM:616336	AKR1B15	5		
FBgn0035476	CG12766	HGNC:386	OMIM:603966	AKR1C3	4		
FBgn0035476	CG12766	HGNC:384	OMIM:600449	AKR1C1	4		
FBgn0035476	CG12766	HGNC:387	OMIM:600451	AKR1C4	4	614279	614279[46,XY SEX REVERSAL 8; SRXY8]
FBgn0035476	CG12766	HGNC:380	OMIM:103830	AKR1A1	6		
FBgn0035476	CG12766	HGNC:381	OMIM:103880	AKR1B1	7		
FBgn0035476	CG12766	HGNC:382	OMIM:604707	AKR1B10	6		
FBgn0035476	CG12766	HGNC:388	OMIM:604741	AKR1D1	6	235555	235555[BILE ACID SYNTHESIS DEFECT, CONGENITAL, 2; CBAS2]
FBgn0035476	CG12766	HGNC:385	OMIM:600450	AKR1C2	4	614279	614279[46,XY SEX REVERSAL 8; SRXY8]
FBgn0035476	CG12766	HGNC:23437	OMIM:617451	AKR1E2	5		
FBgn0035476	CG12766	HGNC:37281	OMIM:616336	AKR1B15	5		
FBgn0035475	CG10866	HGNC:26139		TMEM267	14		
FBgn0030545	CG11590	HGNC:21101	OMIM:616953	CUTA	12		
FBgn0026713	Prp16	HGNC:17211	OMIM:605584	DHX38	13	618220	618220[RETINITIS PIGMENTOSA 84; RP84]
FBgn0026713	Prp16	HGNC:2738	OMIM:603403	DHX15	4		
FBgn0026713	Prp16	HGNC:2739	OMIM:603405	DHX16	4	618733	618733[NEUROMUSCULAR OCULOAUDITORY SYNDROME; NMOAS]
FBgn0026713	Prp16	HGNC:15861		DHX35	4		
FBgn0026713	Prp16	HGNC:16718	OMIM:614405	DHX33	3		
FBgn0026713	Prp16	HGNC:2749	OMIM:600396	DHX8	4		
FBgn0026713	Prp16	HGNC:18018	OMIM:607570	DHX40	3		
FBgn0026713	Prp16	HGNC:16717	OMIM:607960	DHX32	3		
FBgn0026713	Prp16	HGNC:20410		DQX1	3		
FBgn0030552	mRpL38	HGNC:14033	OMIM:611844	MRPL38	13		
FBgn0030554	CG1434	HGNC:26014	OMIM:609707	DUS2	14		
FBgn0030558	Tat	HGNC:11573	OMIM:613018	TAT	14	276600	276600[TYROSINEMIA, TYPE II; TYRSN2]
FBgn0002917	na	HGNC:19082	OMIM:611549	NALCN	15	615419,616266	615419[HYPOTONIA, INFANTILE, WITH PSYCHOMOTOR RETARDATION AND CHARACTERISTIC FACIES 1; IHPRF1],616266[CONGENITAL CONTRACTURES OF THE LIMBS AND FACE, HYPOTONIA, AND DEVELOPMENTAL DELAY; CLIFAHDD]
FBgn0002917	na	HGNC:1397	OMIM:114208	CACNA1S	3	170400,188580,601887	170400[HYPOKALEMIC PERIODIC PARALYSIS, TYPE 1; HOKPP1],188580[THYROTOXIC PERIODIC PARALYSIS, SUSCEPTIBILITY TO, 1; TTPP1],601887[MALIGNANT HYPERTHERMIA, SUSCEPTIBILITY TO, 5; MHS5]
FBgn0002917	na	HGNC:1388	OMIM:601011	CACNA1A	3	108500,141500,183086,617106	108500[EPISODIC ATAXIA, TYPE 2; EA2],141500[MIGRAINE, FAMILIAL HEMIPLEGIC, 1; FHM1],183086[SPINOCEREBELLAR ATAXIA 6; SCA6],617106[DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 42; DEE42]
FBgn0002917	na	HGNC:1390	OMIM:114205	CACNA1C	3	601005,611875,618447	601005[TIMOTHY SYNDROME; TS],611875[BRUGADA SYNDROME 3; BRGDA3],618447[LONG QT SYNDROME 8; LQT8]
FBgn0002917	na	HGNC:1391	OMIM:114206	CACNA1D	3	614896,615474	614896[SINOATRIAL NODE DYSFUNCTION AND DEAFNESS; SANDD],615474[PRIMARY ALDOSTERONISM, SEIZURES, AND NEUROLOGIC ABNORMALITIES; PASNA]
FBgn0002917	na	HGNC:10596	OMIM:600702	SCN8A	3	614306,614558,617080,618364	614306[COGNITIVE IMPAIRMENT WITH OR WITHOUT CEREBELLAR ATAXIA; CIAT],614558[DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 13; DEE13],617080[SEIZURES, BENIGN FAMILIAL INFANTILE, 5; BFIS5],618364[MYOCLONUS, FAMILIAL, 2; MYOCL2]
FBgn0030562	CG9400	HGNC:8946	OMIM:607076	PI15	3		
FBgn0030562	CG9400	HGNC:16249		R3HDML	3		
FBgn0030562	CG9400	HGNC:21245		PI16	4		
FBgn0030562	CG9400	HGNC:28392	OMIM:610395	GLIPR1L1	4		
FBgn0030562	CG9400	HGNC:16904	OMIM:618062	CRISP3	3		
FBgn0030562	CG9400	HGNC:304	OMIM:601193	CRISP1	3		
FBgn0030562	CG9400	HGNC:12024	OMIM:187430	CRISP2	3		
FBgn0030562	CG9400	HGNC:33849	OMIM:616572	CLEC18B	3		
FBgn0030562	CG9400	HGNC:30388	OMIM:616571	CLEC18A	3		
FBgn0030559	CG13404	HGNC:23633	OMIM:618444	PLGRKT	13		
FBgn0030556	mRNA-cap	HGNC:10073	OMIM:603512	RNGTT	14		
FBgn0030555	Fbxl4	HGNC:13601	OMIM:605654	FBXL4	14	615471	615471[MITOCHONDRIAL DNA DEPLETION SYNDROME 13 (ENCEPHALOMYOPATHIC TYPE); MTDPS13]
FBgn0003053	peb	HGNC:10449	OMIM:602209	RREB1	11		
FBgn0029718	mRpL30	HGNC:14036	OMIM:611838	MRPL30	10		
FBgn0022942	Cbp80	HGNC:7658	OMIM:600469	NCBP1	14		
FBgn0029720	CG3009	HGNC:17934	OMIM:611651	PLA2G3	6		
FBgn0025615	Torsin	HGNC:11996	OMIM:608052	TOR2A	10		
FBgn0025615	Torsin	HGNC:11997	OMIM:607555	TOR3A	8		
FBgn0025615	Torsin	HGNC:3098	OMIM:605204	TOR1A	15	128100,618947	128100[DYSTONIA 1, TORSION, AUTOSOMAL DOMINANT; DYT1],618947[ARTHROGRYPOSIS MULTIPLEX CONGENITA 5; AMC5]
FBgn0025615	Torsin	HGNC:11995	OMIM:608050	TOR1B	13		
FBgn0025615	Torsin	HGNC:25981		TOR4A	5		
FBgn0011277	HLH4C	HGNC:7817	OMIM:162360	NHLH1	7		
FBgn0011277	HLH4C	HGNC:7818	OMIM:162361	NHLH2	5	619755	619755[HYPOGONADOTROPIC HYPOGONADISM 27 WITHOUT ANOSMIA; HH27]
FBgn0025612	CG3062	HGNC:32325	OMIM:616119	CFAP126	9		
FBgn0023395	Chd3	HGNC:1919	OMIM:603277	CHD4	7	617159	617159[SIFRIM-HITZ-WEISS SYNDROME; SIHIWES]
FBgn0023395	Chd3	HGNC:1918	OMIM:602120	CHD3	7	618205	618205[SNIJDERS BLOK-CAMPEAU SYNDROME; SNIBCPS]
FBgn0023395	Chd3	HGNC:16816	OMIM:610771	CHD5	7	619873	619873[PARENTI-MIGNOT NEURODEVELOPMENTAL SYNDROME; PMNDS]
FBgn0036877	CG9452	HGNC:29609	OMIM:611471	ACP6	3		
FBgn0036877	CG9452	HGNC:125	OMIM:171790	ACP3	7		
FBgn0036877	CG9452	HGNC:123	OMIM:171650	ACP2	8	200950	200950[ACID PHOSPHATASE DEFICIENCY]
FBgn0036877	CG9452	HGNC:14376	OMIM:606362	ACP4	6	617297	617297[AMELOGENESIS IMPERFECTA, TYPE IJ; AI1J]
FBgn0036876	CG9451	HGNC:29609	OMIM:611471	ACP6	4		
FBgn0036876	CG9451	HGNC:125	OMIM:171790	ACP3	6		
FBgn0036876	CG9451	HGNC:123	OMIM:171650	ACP2	6	200950	200950[ACID PHOSPHATASE DEFICIENCY]
FBgn0036876	CG9451	HGNC:14376	OMIM:606362	ACP4	5	617297	617297[AMELOGENESIS IMPERFECTA, TYPE IJ; AI1J]
FBgn0036875	CG9449	HGNC:29609	OMIM:611471	ACP6	4		
FBgn0036875	CG9449	HGNC:125	OMIM:171790	ACP3	9		
FBgn0036875	CG9449	HGNC:123	OMIM:171650	ACP2	8	200950	200950[ACID PHOSPHATASE DEFICIENCY]
FBgn0036875	CG9449	HGNC:14376	OMIM:606362	ACP4	7	617297	617297[AMELOGENESIS IMPERFECTA, TYPE IJ; AI1J]
FBgn0036874	brv1	HGNC:9015	OMIM:604670	PKDREJ	3		
FBgn0036874	brv1	HGNC:9011	OMIM:604532	PKD2L1	3		
FBgn0036874	brv1	HGNC:9012	OMIM:604669	PKD2L2	3		
FBgn0036874	brv1	HGNC:18053	OMIM:609721	PKD1L1	3	617205	617205[HETEROTAXY, VISCERAL, 8, AUTOSOMAL; HTX8]
FBgn0036874	brv1	HGNC:21716	OMIM:607895	PKD1L3	3		
FBgn0031126	Cyp6v1	HGNC:2638	OMIM:605325	CYP3A5	5	145500	145500[HYPERTENSION, ESSENTIAL]
FBgn0031126	Cyp6v1	HGNC:17450	OMIM:606534	CYP3A43	5		
FBgn0031126	Cyp6v1	HGNC:11609	OMIM:274180	TBXAS1	4	231095	231095[GHOSAL HEMATODIAPHYSEAL DYSPLASIA; GHDD]
FBgn0031126	Cyp6v1	HGNC:2637	OMIM:124010	CYP3A4	5	619073	619073[VITAMIN D-DEPENDENT RICKETS, TYPE 3; VDDR3]
FBgn0031126	Cyp6v1	HGNC:51504		CYP3A7-CYP3A51P	5		
FBgn0030162	CG1986	HGNC:6619	OMIM:151670	LIPC	3	125853,612797,614025	125853[TYPE 2 DIABETES MELLITUS; T2D],612797[HIGH DENSITY LIPOPROTEIN CHOLESTEROL LEVEL QUANTITATIVE TRAIT LOCUS 12; HDLCQ12],614025[HEPATIC LIPASE DEFICIENCY]
FBgn0053502	CG33502	HGNC:16287	OMIM:608100	NFU1	7	605711	605711[MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 1; MMDS1]
FBgn0052819	CG32819	HGNC:26554	OMIM:618686	TEKT5	11		
FBgn0052819	CG32819	HGNC:14293	OMIM:612683	TEKT3	14		
FBgn0052819	CG32819	HGNC:31012		TEKT4	4		
FBgn0052819	CG32819	HGNC:15534	OMIM:609002	TEKT1	3		
FBgn0040028	CG17450	HGNC:26554	OMIM:618686	TEKT5	8		
FBgn0040028	CG17450	HGNC:14293	OMIM:612683	TEKT3	11		
FBgn0040028	CG17450	HGNC:31012		TEKT4	4		
FBgn0040028	CG17450	HGNC:15534	OMIM:609002	TEKT1	3		
FBgn0052820	CG32820	HGNC:26554	OMIM:618686	TEKT5	5		
FBgn0052820	CG32820	HGNC:14293	OMIM:612683	TEKT3	7		
FBgn0027588	GCS2alpha	HGNC:4138	OMIM:104160	GANAB	14	600666	600666[POLYCYSTIC KIDNEY DISEASE 3 WITH OR WITHOUT POLYCYSTIC LIVER DISEASE; PKD3]
FBgn0027588	GCS2alpha	HGNC:4139	OMIM:104180	GANC	10		
FBgn0052230	ND-MLRQ	HGNC:29836		NDUFA4L2	9		
FBgn0052230	ND-MLRQ	HGNC:7687	OMIM:603833	NDUFA4	12	619065	619065[MITOCHONDRIAL COMPLEX IV DEFICIENCY, NUCLEAR TYPE 21; MC4DN21]
FBgn0010215	alpha-Cat	HGNC:2509	OMIM:116805	CTNNA1	12	608970	608970[MACULAR DYSTROPHY, PATTERNED, 2; MDPT2]
FBgn0010215	alpha-Cat	HGNC:2511	OMIM:607667	CTNNA3	7	615616	615616[ARRHYTHMOGENIC RIGHT VENTRICULAR DYSPLASIA, FAMILIAL, 13; ARVD13]
FBgn0010215	alpha-Cat	HGNC:2510	OMIM:114025	CTNNA2	13	618174	618174[CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 9; CDCBM9]
FBgn0039530	Tusp	HGNC:15530	OMIM:619442	TULP4	13		
FBgn0039532	Mtl	HGNC:9802	OMIM:602049	RAC2	4	608203,618986,618987	608203[IMMUNODEFICIENCY 73A WITH DEFECTIVE NEUTROPHIL CHEMOTAXIS AND LEUKOCYTOSIS; IMD73A],618986[IMMUNODEFICIENCY 73B WITH DEFECTIVE NEUTROPHIL CHEMOTAXIS AND LYMPHOPENIA; IMD73B],618987[IMMUNODEFICIENCY 73C WITH DEFECTIVE NEUTROPHIL CHEMOTAXIS AND HYPOGAMMAGLOBULINEMIA; IMD73C]
FBgn0039532	Mtl	HGNC:9801	OMIM:602048	RAC1	4	617751	617751[INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL DOMINANT 48; MRD48]
FBgn0039532	Mtl	HGNC:9803	OMIM:602050	RAC3	4	618577	618577[NEURODEVELOPMENTAL DISORDER WITH STRUCTURAL BRAIN ANOMALIES AND DYSMORPHIC FACIES; NEDBAF]
FBgn0039532	Mtl	HGNC:672	OMIM:179505	RHOG	5		
FBgn0039532	Mtl	HGNC:17736	OMIM:605857	RHOQ	3		
FBgn0039532	Mtl	HGNC:17794	OMIM:606366	RHOU	3		
FBgn0039532	Mtl	HGNC:686	OMIM:602037	RHOH	4	618307	618307[EPIDERMODYSPLASIA VERRUCIFORMIS, SUSCEPTIBILITY TO, 4; EV4]
FBgn0039532	Mtl	HGNC:1736	OMIM:116952	CDC42	3	616737	616737[TAKENOUCHI-KOSAKI SYNDROME; TKS]
FBgn0027494	RpS10a	HGNC:10383	OMIM:603632	RPS10	13	613308	613308[DIAMOND-BLACKFAN ANEMIA 9; DBA9]
FBgn0027494	RpS10a	HGNC:49181		RPS10-NUDT3	4		
FBgn0027494	RpS10a	HGNC:15795		RPS10P5	5		
FBgn0039536	unc80	HGNC:26582	OMIM:612636	UNC80	15	616801	616801[HYPOTONIA, INFANTILE, WITH PSYCHOMOTOR RETARDATION AND CHARACTERISTIC FACIES 2; IHPRF2]
FBgn0039537	Hsdl2	HGNC:18572		HSDL2	15		
FBgn0045862	btz	HGNC:17040	OMIM:606504	CASC3	9		
FBgn0039543	CROT	HGNC:2366	OMIM:606090	CROT	14		
FBgn0003330	Sce	HGNC:10061	OMIM:608985	RNF2	13	619460	619460[LUO-SCHOCH-YAMAMOTO SYNDROME; LUSYAM]
FBgn0003330	Sce	HGNC:10018	OMIM:602045	RING1	12		
FBgn0002772	Mlc1	HGNC:29823	OMIM:609930	MYL6B	4		
FBgn0002772	Mlc1	HGNC:7587	OMIM:609931	MYL6	4		
FBgn0002772	Mlc1	HGNC:7584	OMIM:160790	MYL3	4	608751	608751[CARDIOMYOPATHY, FAMILIAL HYPERTROPHIC, 8; CMH8]
FBgn0002772	Mlc1	HGNC:7582	OMIM:160780	MYL1	4	618414	618414[MYOPATHY, CONGENITAL, WITH FAST-TWITCH (TYPE II) FIBER ATROPHY; MYOFTA]
FBgn0002772	Mlc1	HGNC:7585	OMIM:160770	MYL4	4	617280	617280[ATRIAL FIBRILLATION, FAMILIAL, 18; ATFB18]
FBgn0039531	CG5611	HGNC:23408		ECHDC2	3		
FBgn0260484	HIP	HGNC:11343	OMIM:606796	ST13	14		
FBgn0260484	HIP	HGNC:18556		ST13P5	6		
FBgn0260484	HIP	HGNC:18487		ST13P4	4		
FBgn0029679	CG2901	HGNC:12827	OMIM:605237	XPR1	6	616413	616413[BASAL GANGLIA CALCIFICATION, IDIOPATHIC, 6; IBGC6]
FBgn0031644	CG15625	HGNC:18631		SAMD15	6		
FBgn0031645	CG3036	HGNC:20151	OMIM:607557	SLC17A8	3	605583	605583[DEAFNESS, AUTOSOMAL DOMINANT 25; DFNA25]
FBgn0031645	CG3036	HGNC:10933	OMIM:604322	SLC17A5	4	269920,604369	269920[INFANTILE SIALIC ACID STORAGE DISEASE; ISSD],604369[SALLA DISEASE; SD]
FBgn0031645	CG3036	HGNC:16703	OMIM:607563	SLC17A6	3		
FBgn0031645	CG3036	HGNC:16704	OMIM:605208	SLC17A7	3		
FBgn0031645	CG3036	HGNC:10929	OMIM:182308	SLC17A1	3		
FBgn0031645	CG3036	HGNC:10932	OMIM:604216	SLC17A4	3		
FBgn0031645	CG3036	HGNC:10930	OMIM:611049	SLC17A2	4		
FBgn0031645	CG3036	HGNC:10931	OMIM:611034	SLC17A3	4	612671	612671[URIC ACID CONCENTRATION, SERUM, QUANTITATIVE TRAIT LOCUS 4; UAQTL4]
FBgn0039331	ND-49L	HGNC:7708	OMIM:602985	NDUFS2	8	618228	618228[MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 6; MC1DN6]
FBgn0032859	Arpc2	HGNC:705	OMIM:604224	ARPC2	14		
FBgn0051687	CG31687	HGNC:1724	OMIM:603462	CDC23	12		
FBgn0032863	Cdc23	HGNC:1724	OMIM:603462	CDC23	14		
FBgn0032864	CG2493	HGNC:9344	OMIM:176785	PRCP	14		
FBgn0032864	CG2493	HGNC:14892	OMIM:610537	DPP7	3		
FBgn0042175	CG18858	HGNC:17163	OMIM:609362	PLA2G15	15		
FBgn0042175	CG18858	HGNC:6522	OMIM:606967	LCAT	11	136120,245900	136120[FISH-EYE DISEASE; FED],245900[LECITHIN:CHOLESTEROL ACYLTRANSFERASE DEFICIENCY]
FBgn0051683	CG31683	HGNC:17163	OMIM:609362	PLA2G15	14		
FBgn0051683	CG31683	HGNC:6522	OMIM:606967	LCAT	11	136120,245900	136120[FISH-EYE DISEASE; FED],245900[LECITHIN:CHOLESTEROL ACYLTRANSFERASE DEFICIENCY]
FBgn0032860	CG15130	HGNC:30800	OMIM:607237	TMIE	9	600971	600971[DEAFNESS, AUTOSOMAL RECESSIVE 6; DFNB6]
FBgn0031688	Cyp28d2	HGNC:2638	OMIM:605325	CYP3A5	4	145500	145500[HYPERTENSION, ESSENTIAL]
FBgn0031688	Cyp28d2	HGNC:17450	OMIM:606534	CYP3A43	4		
FBgn0031688	Cyp28d2	HGNC:11609	OMIM:274180	TBXAS1	4	231095	231095[GHOSAL HEMATODIAPHYSEAL DYSPLASIA; GHDD]
FBgn0031688	Cyp28d2	HGNC:2637	OMIM:124010	CYP3A4	4	619073	619073[VITAMIN D-DEPENDENT RICKETS, TYPE 3; VDDR3]
FBgn0031688	Cyp28d2	HGNC:51504		CYP3A7-CYP3A51P	4		
FBgn0031692	TpnC25D	HGNC:24193	OMIM:610171	CALML6	3		
FBgn0031690	CG7742	HGNC:25624		TBC1D19	15		
FBgn0033540	Elp2	HGNC:18248	OMIM:616054	ELP2	14	617270	617270[INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 58; MRT58]
FBgn0033539	Git	HGNC:4272	OMIM:608434	GIT1	11		
FBgn0033539	Git	HGNC:4273	OMIM:608564	GIT2	13		
FBgn0031196	Cluap1	HGNC:19009	OMIM:616787	CLUAP1	13		
FBgn0031194	CG17598	HGNC:26506	OMIM:608979	PPM1M	8		
FBgn0031194	CG17598	HGNC:20785	OMIM:609957	PPM1J	11		
FBgn0031194	CG17598	HGNC:18583	OMIM:616016	PPM1H	13		
FBgn0010316	dap	HGNC:1784	OMIM:116899	CDKN1A	3		
FBgn0010316	dap	HGNC:1785	OMIM:600778	CDKN1B	3	610755	610755[MULTIPLE ENDOCRINE NEOPLASIA, TYPE IV; MEN4]
FBgn0033633	Smyd4-3	HGNC:21067	OMIM:619134	SMYD4	12		
FBgn0015872	Drip	HGNC:633	OMIM:107776	AQP1	7	110450	110450[BLOOD GROUP, COLTON SYSTEM; CO]
FBgn0015872	Drip	HGNC:7103	OMIM:154050	MIP	6	615274	615274[CATARACT 15, MULTIPLE TYPES; CTRCT15]
FBgn0015872	Drip	HGNC:634	OMIM:107777	AQP2	8	125800	125800[DIABETES INSIPIDUS, NEPHROGENIC, 2, AUTOSOMAL; NDI2]
FBgn0015872	Drip	HGNC:638	OMIM:600442	AQP5	8	600231	600231[PALMOPLANTAR KERATODERMA, BOTHNIAN TYPE; PPKB]
FBgn0015872	Drip	HGNC:637	OMIM:600308	AQP4	10		
FBgn0015872	Drip	HGNC:642	OMIM:603750	AQP8	3		
FBgn0015872	Drip	HGNC:639	OMIM:601383	AQP6	4		
FBgn0015872	Drip	HGNC:636	OMIM:600170	AQP3	4	607457	607457[GIL BLOOD GROUP]
FBgn0015872	Drip	HGNC:640	OMIM:602974	AQP7	3	614411	614411[GLYCEROL QUANTITATIVE TRAIT LOCUS; GLYCQTL]
FBgn0015872	Drip	HGNC:16029	OMIM:606578	AQP10	3		
FBgn0015872	Drip	HGNC:643	OMIM:602914	AQP9	5		
FBgn0033015	d4	HGNC:20225	OMIM:601670	DPF1	12		
FBgn0033015	d4	HGNC:17427	OMIM:601672	DPF3	12		
FBgn0033015	d4	HGNC:9964	OMIM:601671	DPF2	12	618027	618027[COFFIN-SIRIS SYNDROME 7; CSS7]
FBgn0033019	CG10395	HGNC:13324	OMIM:616456	INO80B	11		
FBgn0033020	COX4L	HGNC:16232	OMIM:607976	COX4I2	12	612714	612714[EXOCRINE PANCREATIC INSUFFICIENCY, DYSERYTHROPOIETIC ANEMIA, AND CALVARIAL HYPEROSTOSIS]
FBgn0033020	COX4L	HGNC:2265	OMIM:123864	COX4I1	15	619060	619060[MITOCHONDRIAL COMPLEX IV DEFICIENCY, NUCLEAR TYPE 16; MC4DN16]
FBgn0033021	CG10417	HGNC:9278	OMIM:605119	PPM1G	14		
FBgn0033021	CG10417	HGNC:9275	OMIM:606108	PPM1A	3		
FBgn0033021	CG10417	HGNC:9276	OMIM:603770	PPM1B	3		
FBgn0050441	IFT20	HGNC:30989	OMIM:614394	IFT20	13		
FBgn0033017	CG10465	HGNC:23236	OMIM:613421	KCTD10	15		
FBgn0033017	CG10465	HGNC:11894	OMIM:191161	TNFAIP1	11		
FBgn0033017	CG10465	HGNC:22234	OMIM:608947	KCTD13	11		
FBgn0052133	Ptip	HGNC:8624	OMIM:608254	PAXIP1	9		
FBgn0052133	Ptip	HGNC:21163	OMIM:607593	MDC1	3		
FBgn0053196	dpy	HGNC:18794	OMIM:608529	FBN3	3		
FBgn0053196	dpy	HGNC:3603	OMIM:134797	FBN1	3	102370,129600,154700,184900,604308,608328,614185,616914	102370[ACROMICRIC DYSPLASIA; ACMICD],129600[ECTOPIA LENTIS 1, ISOLATED, AUTOSOMAL DOMINANT; ECTOL1],154700[MARFAN SYNDROME; MFS],184900[STIFF SKIN SYNDROME; SSKS],604308[MASS SYNDROME],608328[WEILL-MARCHESANI SYNDROME 2; WMS2],614185[GELEOPHYSIC DYSPLASIA 2; GPHYSD2],616914[MARFANOID-PROGEROID-LIPODYSTROPHY SYNDROME; MFLS]
FBgn0053196	dpy	HGNC:3604	OMIM:612570	FBN2	4	121050,616118	121050[CONTRACTURAL ARACHNODACTYLY, CONGENITAL; CCA],616118[MACULAR DEGENERATION, EARLY-ONSET; EOMD]
FBgn0033005	CG3107	HGNC:17663	OMIM:618211	PITRM1	15	619405	619405[SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 30; SCAR30]
FBgn0033010	Atf6	HGNC:791	OMIM:605537	ATF6	11	616517	616517[ACHROMATOPSIA 7; ACHM7]
FBgn0033010	Atf6	HGNC:2349	OMIM:600984	ATF6B	10		
FBgn0026238	gus	HGNC:29522	OMIM:611658	SPSB2	4		
FBgn0026238	gus	HGNC:30630	OMIM:611660	SPSB4	14		
FBgn0026238	gus	HGNC:30628	OMIM:611657	SPSB1	12		
FBgn0013348	TpnC41C	HGNC:18180	OMIM:605183	CALML5	3		
FBgn0013348	TpnC41C	HGNC:24193	OMIM:610171	CALML6	3		
FBgn0032949	Lamp1	HGNC:6499	OMIM:153330	LAMP1	10		
FBgn0032949	Lamp1	HGNC:6501	OMIM:309060	LAMP2	7	300257	300257[DANON DISEASE]
FBgn0032949	Lamp1	HGNC:14582	OMIM:605883	LAMP3	5		
FBgn0032949	Lamp1	HGNC:1693	OMIM:153634	CD68	4		
FBgn0030717	Slc25A46a	HGNC:25198	OMIM:610826	SLC25A46	14	616505,619303	616505[NEUROPATHY, HEREDITARY MOTOR AND SENSORY, TYPE VIB, WITH OPTIC ATROPHY; HMSN6B],619303[PONTOCEREBELLAR HYPOPLASIA, TYPE 1E; PCH1E]
FBgn0000611	exd	HGNC:8632	OMIM:176310	PBX1	13	617641	617641[CONGENITAL ANOMALIES OF KIDNEY AND URINARY TRACT SYNDROME WITH OR WITHOUT HEARING LOSS, ABNORMAL EARS, OR DEVELOPMENTAL DELAY; CAKUTHED]
FBgn0000611	exd	HGNC:8634	OMIM:176312	PBX3	13		
FBgn0000611	exd	HGNC:8633	OMIM:176311	PBX2	13		
FBgn0000611	exd	HGNC:13403	OMIM:608127	PBX4	8		
FBgn0030720	CG8939	HGNC:17136	OMIM:618411	FTSJ3	13		
FBgn0030721	CG12698	HGNC:16145		CNBD2	7		
FBgn0030725	CG8958	HGNC:16145		CNBD2	7		
FBgn0028397	Tob	HGNC:11980	OMIM:607396	TOB2	8		
FBgn0028397	Tob	HGNC:11979	OMIM:605523	TOB1	10		
FBgn0030724	Nipsnap	HGNC:7827	OMIM:603249	NIPSNAP1	13		
FBgn0030724	Nipsnap	HGNC:23641	OMIM:608872	NIPSNAP3B	3		
FBgn0030724	Nipsnap	HGNC:4179	OMIM:603004	NIPSNAP2	15		
FBgn0030724	Nipsnap	HGNC:23619	OMIM:608871	NIPSNAP3A	3		
FBgn0030722	CG12395	HGNC:15874	OMIM:610674	SPEF1	11		
FBgn0003969	vap	HGNC:9871	OMIM:139150	RASA1	13	605462,608354	605462[BASAL CELL CARCINOMA, SUSCEPTIBILITY TO, 1; BCC1],608354[CAPILLARY MALFORMATION-ARTERIOVENOUS MALFORMATION 1; CMAVM1]
FBgn0030719	eIF5	HGNC:3299	OMIM:601710	EIF5	13		
FBgn0030718	ND-20	HGNC:7714	OMIM:601825	NDUFS7	14	618224	618224[MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 3; MC1DN3]
FBgn0030716	CG9170	HGNC:29182	OMIM:614848	CEP164	6	614845	614845[NEPHRONOPHTHISIS 15; NPHP15]
FBgn0053236	Ste:CG33236	HGNC:2460	OMIM:115441	CSNK2B	4	618732	618732[POIRIER-BIENVENU NEURODEVELOPMENTAL SYNDROME; POBINDS]
FBgn0053237	Ste:CG33237	HGNC:2460	OMIM:115441	CSNK2B	5	618732	618732[POIRIER-BIENVENU NEURODEVELOPMENTAL SYNDROME; POBINDS]
FBgn0053238	Ste:CG33238	HGNC:2460	OMIM:115441	CSNK2B	4	618732	618732[POIRIER-BIENVENU NEURODEVELOPMENTAL SYNDROME; POBINDS]
FBgn0053239	Ste:CG33239	HGNC:2460	OMIM:115441	CSNK2B	4	618732	618732[POIRIER-BIENVENU NEURODEVELOPMENTAL SYNDROME; POBINDS]
FBgn0053240	Ste:CG33240	HGNC:2460	OMIM:115441	CSNK2B	3	618732	618732[POIRIER-BIENVENU NEURODEVELOPMENTAL SYNDROME; POBINDS]
FBgn0053241	Ste:CG33241	HGNC:2460	OMIM:115441	CSNK2B	3	618732	618732[POIRIER-BIENVENU NEURODEVELOPMENTAL SYNDROME; POBINDS]
FBgn0053242	Ste:CG33242	HGNC:2460	OMIM:115441	CSNK2B	4	618732	618732[POIRIER-BIENVENU NEURODEVELOPMENTAL SYNDROME; POBINDS]
FBgn0053243	Ste:CG33243	HGNC:2460	OMIM:115441	CSNK2B	4	618732	618732[POIRIER-BIENVENU NEURODEVELOPMENTAL SYNDROME; POBINDS]
FBgn0053244	Ste:CG33244	HGNC:2460	OMIM:115441	CSNK2B	3	618732	618732[POIRIER-BIENVENU NEURODEVELOPMENTAL SYNDROME; POBINDS]
FBgn0053245	Ste:CG33245	HGNC:2460	OMIM:115441	CSNK2B	3	618732	618732[POIRIER-BIENVENU NEURODEVELOPMENTAL SYNDROME; POBINDS]
FBgn0053246	Ste:CG33246	HGNC:2460	OMIM:115441	CSNK2B	4	618732	618732[POIRIER-BIENVENU NEURODEVELOPMENTAL SYNDROME; POBINDS]
FBgn0053247	Ste:CG33247	HGNC:2460	OMIM:115441	CSNK2B	4	618732	618732[POIRIER-BIENVENU NEURODEVELOPMENTAL SYNDROME; POBINDS]
FBgn0029174	Fkbp59	HGNC:3721	OMIM:602623	FKBP5	10	608516	608516[MAJOR DEPRESSIVE DISORDER; MDD]
FBgn0029174	Fkbp59	HGNC:3720	OMIM:600611	FKBP4	11		
FBgn0032153	CG4537	HGNC:14312	OMIM:604594	CRIPT	14	615789	615789[SHORT STATURE WITH MICROCEPHALY AND DISTINCTIVE FACIES; SSMCF]
FBgn0010520	Bka	HGNC:20220		FCF1	14		
FBgn0024285	Srp54	HGNC:17882	OMIM:609268	SREK1	9		
FBgn0024285	Srp54	HGNC:10782	OMIM:602010	SRSF11	8		
FBgn0040064	yip2	HGNC:83	OMIM:604770	ACAA2	15		
FBgn0040064	yip2	HGNC:93	OMIM:607809	ACAT1	3	203750	203750[ALPHA-METHYLACETOACETIC ACIDURIA]
FBgn0032160	CG4598	HGNC:2703	OMIM:600305	ECI1	13		
FBgn0032161	CG4594	HGNC:2703	OMIM:600305	ECI1	12		
FBgn0032162	CG4592	HGNC:2703	OMIM:600305	ECI1	12		
FBgn0032167	CG5853	HGNC:73	OMIM:603076	ABCG1	10		
FBgn0032167	CG5853	HGNC:13884	OMIM:607784	ABCG4	9		
FBgn0032167	CG5853	HGNC:74	OMIM:603756	ABCG2	5	138900,614490	138900[URIC ACID CONCENTRATION, SERUM, QUANTITATIVE TRAIT LOCUS 1; UAQTL1],614490[BLOOD GROUP, JUNIOR SYSTEM; JR]
FBgn0032167	CG5853	HGNC:13887	OMIM:605460	ABCG8	3	210250,611465	210250[SITOSTEROLEMIA 1; STSL1],611465[GALLBLADDER DISEASE 4; GBD4]
FBgn0051712	CG31712	HGNC:25482	OMIM:614046	ARGLU1	11		
FBgn0032163	TbCMF46	HGNC:25384	OMIM:618758	DRC3	14		
FBgn0025700	CG5885	HGNC:11325	OMIM:606213	SSR3	14		
FBgn0032156	CG13124	HGNC:23925	OMIM:613178	CTIF	5		
FBgn0032156	CG13124	HGNC:24030	OMIM:612072	MIF4GD	7		
FBgn0004867	RpS2	HGNC:10404	OMIM:603624	RPS2	13		
FBgn0032154	mtDNA-helicase	HGNC:1160	OMIM:606075	TWNK	14	271245,609286,616138	271245[MITOCHONDRIAL DNA DEPLETION SYNDROME 7 (HEPATOCEREBRAL TYPE); MTDPS7],609286[PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL DOMINANT 3; PEOA3],616138[PERRAULT SYNDROME 5; PRLTS5]
FBgn0031092	Ech1	HGNC:3149	OMIM:600696	ECH1	15		
FBgn0031094	CG9578	HGNC:30231	OMIM:611807	TIPRL	14		
FBgn0015789	Rab10	HGNC:9762	OMIM:602672	RAB13	4		
FBgn0015789	Rab10	HGNC:7007	OMIM:165040	RAB8A	6		
FBgn0015789	Rab10	HGNC:30273	OMIM:613532	RAB8B	6		
FBgn0015789	Rab10	HGNC:9759	OMIM:612672	RAB10	12		
FBgn0031099	CG17065	HGNC:24262		AMDHD2	13		
FBgn0031098	CG17068	HGNC:15504	OMIM:608531	BTBD2	4		
FBgn0031098	CG17068	HGNC:1120	OMIM:608530	BTBD1	3		
FBgn0031098	CG17068	HGNC:15854	OMIM:615566	BTBD3	3		
FBgn0031098	CG17068	HGNC:19897		BTBD6	3		
FBgn0003654	sw	HGNC:2964	OMIM:603331	DYNC1I2	13	618492	618492[NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY AND STRUCTURAL BRAIN ANOMALIES; NEDMIBA]
FBgn0003654	sw	HGNC:2963	OMIM:603772	DYNC1I1	12		
FBgn0053499	Sdic4	HGNC:2964	OMIM:603331	DYNC1I2	11	618492	618492[NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY AND STRUCTURAL BRAIN ANOMALIES; NEDMIBA]
FBgn0053499	Sdic4	HGNC:2963	OMIM:603772	DYNC1I1	12		
FBgn0052823	Sdic3	HGNC:2964	OMIM:603331	DYNC1I2	7	618492	618492[NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY AND STRUCTURAL BRAIN ANOMALIES; NEDMIBA]
FBgn0052823	Sdic3	HGNC:2963	OMIM:603772	DYNC1I1	6		
FBgn0053497	Sdic2	HGNC:2964	OMIM:603331	DYNC1I2	6	618492	618492[NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY AND STRUCTURAL BRAIN ANOMALIES; NEDMIBA]
FBgn0053497	Sdic2	HGNC:2963	OMIM:603772	DYNC1I1	6		
FBgn0067861	Sdic1	HGNC:2964	OMIM:603331	DYNC1I2	12	618492	618492[NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY AND STRUCTURAL BRAIN ANOMALIES; NEDMIBA]
FBgn0067861	Sdic1	HGNC:2963	OMIM:603772	DYNC1I1	11		
FBgn0000084	AnxB10	HGNC:543	OMIM:131230	ANXA5	3	614391	614391[PREGNANCY LOSS, RECURRENT, SUSCEPTIBILITY TO, 3; RPRGL3]
FBgn0000084	AnxB10	HGNC:544	OMIM:114070	ANXA6	3		
FBgn0000084	AnxB10	HGNC:535	OMIM:602572	ANXA11	3	617839,619733	617839[AMYOTROPHIC LATERAL SCLEROSIS 23; ALS23],619733[INCLUSION BODY MYOPATHY AND BRAIN WHITE MATTER ABNORMALITIES; IBMWMA]
FBgn0000084	AnxB10	HGNC:534	OMIM:608008	ANXA10	4		
FBgn0000084	AnxB10	HGNC:547	OMIM:603319	ANXA9	3		
FBgn0000084	AnxB10	HGNC:23334		ANXA8L1	5		
FBgn0000084	AnxB10	HGNC:546	OMIM:602396	ANXA8	5		
FBgn0031093	CG9581	HGNC:8840	OMIM:613230	PEPD	4	170100	170100[PROLIDASE DEFICIENCY]
FBgn0031093	CG9581	HGNC:28052	OMIM:613553	XPNPEP3	14	613159	613159[NEPHRONOPHTHISIS-LIKE NEPHROPATHY 1; NPHPL1]
FBgn0031091	Phf7	HGNC:20338	OMIM:611299	G2E3	6		
FBgn0031091	Phf7	HGNC:18145	OMIM:300414	PHF6	4	301900	301900[BORJESON-FORSSMAN-LEHMANN SYNDROME; BFLS]
FBgn0031091	Phf7	HGNC:17024	OMIM:607796	PHF11	4		
FBgn0031091	Phf7	HGNC:18458		PHF7	10		
FBgn0031090	Rab35	HGNC:9774	OMIM:604199	RAB35	10		
FBgn0061200	Nup153	HGNC:8062	OMIM:603948	NUP153	10		
FBgn0025743	mbt	HGNC:8592	OMIM:300142	PAK3	3	300558	300558[INTELLECTUAL DEVELOPMENTAL DISORDER, X-LINKED 30; XLID30]
FBgn0025743	mbt	HGNC:16059	OMIM:605451	PAK4	13		
FBgn0025743	mbt	HGNC:8591	OMIM:605022	PAK2	3	618458	618458[KNOBLOCH SYNDROME 2; KNO2]
FBgn0025743	mbt	HGNC:15916	OMIM:608038	PAK5	11		
FBgn0025743	mbt	HGNC:8590	OMIM:602590	PAK1	3	618158	618158[INTELLECTUAL DEVELOPMENTAL DISORDER WITH MACROCEPHALY, SEIZURES, AND SPEECH DELAY; IDDMSSD]
FBgn0025743	mbt	HGNC:16061	OMIM:608110	PAK6	5		
FBgn0025743	mbt	HGNC:52276		BUB1B-PAK6	3		
FBgn0030761	CG9784	HGNC:8956	OMIM:606481	INPP5J	9		
FBgn0030761	CG9784	HGNC:33882	OMIM:607875	INPP5K	11	617404	617404[MUSCULAR DYSTROPHY, CONGENITAL, WITH CATARACTS AND INTELLECTUAL DISABILITY; MDCCAID]
FBgn0015615	SMC3	HGNC:2468	OMIM:606062	SMC3	12	610759	610759[CORNELIA DE LANGE SYNDROME 3 WITH OR WITHOUT MIDLINE BRAIN DEFECTS; CDLS3]
FBgn0011826	Pp2B-14D	HGNC:9315	OMIM:114106	PPP3CB	12		
FBgn0011826	Pp2B-14D	HGNC:9316	OMIM:114107	PPP3CC	12		
FBgn0011826	Pp2B-14D	HGNC:9314	OMIM:114105	PPP3CA	14	617711,618265	617711[DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 91; DEE91],618265[ARTHROGRYPOSIS, CLEFT PALATE, CRANIOSYNOSTOSIS, AND IMPAIRED INTELLECTUAL DEVELOPMENT; ACCIID]
FBgn0011742	Arp2	HGNC:169	OMIM:604221	ACTR2	14		
FBgn0030756	CG9903	HGNC:10905	OMIM:182396	SLC10A1	6	619256	619256[HYPERCHOLANEMIA, FAMILIAL, 2; FHCA2]
FBgn0030756	CG9903	HGNC:10906	OMIM:601295	SLC10A2	11	613291	613291[BILE ACID MALABSORPTION, PRIMARY, 1; PBAM1]
FBgn0030756	CG9903	HGNC:22980	OMIM:618563	SLC10A4	6		
FBgn0030756	CG9903	HGNC:30603	OMIM:613366	SLC10A6	7		
FBgn0030756	CG9903	HGNC:22979	OMIM:312090	SLC10A3	8		
FBgn0030756	CG9903	HGNC:22981	OMIM:618582	SLC10A5	10		
FBgn0034478	CG10822	HGNC:15467	OMIM:607168	DYNLRB2	5		
FBgn0034478	CG10822	HGNC:15468	OMIM:607167	DYNLRB1	4		
FBgn0041150	hoe1	HGNC:8101	OMIM:611409	OCA2	12	203200,227220	203200[ALBINISM, OCULOCUTANEOUS, TYPE II; OCA2],227220[SKIN/HAIR/EYE PIGMENTATION, VARIATION IN, 1; SHEP1]
FBgn0034072	Dg	HGNC:2666	OMIM:128239	DAG1	10	613818,616538	613818[MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (LIMB-GIRDLE), TYPE C, 9; MDDGC9],616538[MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 9; MDDGA9]
FBgn0033155	Br140	HGNC:1102	OMIM:604589	BRD1	13		
FBgn0033155	Br140	HGNC:16063	OMIM:602409	MLLT10	3	601626	601626[LEUKEMIA, ACUTE MYELOID; AML]
FBgn0033155	Br140	HGNC:14255	OMIM:602410	BRPF1	14	617333	617333[INTELLECTUAL DEVELOPMENTAL DISORDER WITH DYSMORPHIC FACIES AND PTOSIS; IDDDFP]
FBgn0033155	Br140	HGNC:14256	OMIM:616856	BRPF3	13		
FBgn0025360	Optix	HGNC:10892	OMIM:606326	SIX6	9	212550	212550[OPTIC DISC ANOMALIES WITH RETINAL AND/OR MACULAR DYSTROPHY; ODRMD]
FBgn0025360	Optix	HGNC:10889	OMIM:603714	SIX3	9	157170,269160	157170[HOLOPROSENCEPHALY 2; HPE2],269160[SCHIZENCEPHALY]
FBgn0025360	Optix	HGNC:10887	OMIM:601205	SIX1	3	605192,608389	605192[DEAFNESS, AUTOSOMAL DOMINANT 23; DFNA23],608389[BRANCHIOOTIC SYNDROME 3; BOS3]
FBgn0025360	Optix	HGNC:10888	OMIM:604994	SIX2	4		
FBgn0015000	betaggt-I	HGNC:8895	OMIM:602031	PGGT1B	14		
FBgn0031655	Marcal1	HGNC:25249	OMIM:615655	ZRANB3	4		
FBgn0031655	Marcal1	HGNC:11102	OMIM:606622	SMARCAL1	13	242900	242900[SCHIMKE IMMUNOOSSEOUS DYSPLASIA; SIOD]
FBgn0031657	Polr1C	HGNC:20194	OMIM:610060	POLR1C	15	248390,616494	248390[TREACHER COLLINS SYNDROME 3; TCS3],616494[LEUKODYSTROPHY, HYPOMYELINATING, 11; HLD11]
FBgn0031662	CG3792	HGNC:7207	OMIM:604041	MPDU1	13	609180	609180[CONGENITAL DISORDER OF GLYCOSYLATION, TYPE If; CDG1F]
FBgn0033911	VGAT	HGNC:11018	OMIM:616440	SLC32A1	15		
FBgn0034071	CG8405	HGNC:17039	OMIM:611011	TMEM259	11		
FBgn0034479	CG8654	HGNC:25417	OMIM:611699	SVOP	3		
FBgn0034479	CG8654	HGNC:8494	OMIM:604047	SLC22A13	7		
FBgn0034479	CG8654	HGNC:10970	OMIM:607582	SLC22A6	5		
FBgn0034479	CG8654	HGNC:20302	OMIM:608276	SLC22A16	5		
FBgn0034479	CG8654	HGNC:10968	OMIM:604190	SLC22A4	4	180300	180300[RHEUMATOID ARTHRITIS; RA]
FBgn0034479	CG8654	HGNC:10969	OMIM:603377	SLC22A5	4	212140	212140[CARNITINE DEFICIENCY, SYSTEMIC PRIMARY; CDSP]
FBgn0034479	CG8654	HGNC:8495	OMIM:604048	SLC22A14	5		
FBgn0034479	CG8654	HGNC:10971	OMIM:604995	SLC22A7	4		
FBgn0034479	CG8654	HGNC:10972	OMIM:607581	SLC22A8	5		
FBgn0034479	CG8654	HGNC:10966	OMIM:602608	SLC22A2	4		
FBgn0034479	CG8654	HGNC:32935	OMIM:610792	SLC22A25	4		
FBgn0034479	CG8654	HGNC:10963	OMIM:602607	SLC22A1	4		
FBgn0034479	CG8654	HGNC:10967	OMIM:604842	SLC22A3	4		
FBgn0034479	CG8654	HGNC:20301	OMIM:608275	SLC22A15	3		
FBgn0034479	CG8654	HGNC:17989	OMIM:607096	SLC22A12	6	220150	220150[HYPOURICEMIA, RENAL, 1; RHUC1]
FBgn0034479	CG8654	HGNC:18120	OMIM:607097	SLC22A11	4		
FBgn0034479	CG8654	HGNC:16261	OMIM:607579	SLC22A9	3		
FBgn0034479	CG8654	HGNC:28542	OMIM:611698	SLC22A24	4		
FBgn0034479	CG8654	HGNC:18057	OMIM:607580	SLC22A10	4		
FBgn0031651	mRpL24	HGNC:14037	OMIM:611836	MRPL24	14		
FBgn0031652	jet	HGNC:28155	OMIM:610287	FBXL15	13		
FBgn0015834	eIF3i	HGNC:3272	OMIM:603911	EIF3I	14		
FBgn0031661	Gmd	HGNC:4369	OMIM:602884	GMDS	15		
FBgn0031663	CG8891	HGNC:6176	OMIM:147520	ITPA	15	613850,616647	613850[INOSINE TRIPHOSPHATASE DEFICIENCY],616647[DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 35; DEE35]
FBgn0031664	CG8892	HGNC:29119	OMIM:616379	UBXN7	12		
FBgn0031659	CG14043	HGNC:23419	OMIM:609367	KIF1BP	14	609460	609460[GOLDBERG-SHPRINTZEN SYNDROME; GOSHS]
FBgn0037028	CG3618	HGNC:29288	OMIM:617838	FAM234B	4		
FBgn0037028	CG3618	HGNC:14163		FAM234A	3		
FBgn0031660	mRpL28	HGNC:14484	OMIM:604853	MRPL28	13		
FBgn0061515	endos	HGNC:16967	OMIM:605487	ARPP19	12		
FBgn0061515	endos	HGNC:3360	OMIM:603061	ENSA	10		
FBgn0051961	TBCC	HGNC:11580	OMIM:602971	TBCC	14		
FBgn0051961	TBCC	HGNC:10274	OMIM:300757	RP2	3	312600	312600[RETINITIS PIGMENTOSA 2; RP2]
FBgn0053505	U3-55K	HGNC:16829	OMIM:620013	RRP9	14		
FBgn0053506	CG33506	HGNC:28143		TMEM177	13		
FBgn0053508	ppk13	HGNC:101	OMIM:611741	ASIC3	3		
FBgn0053508	ppk13	HGNC:100	OMIM:602866	ASIC1	4		
FBgn0053508	ppk13	HGNC:21263	OMIM:606715	ASIC4	4		
FBgn0053508	ppk13	HGNC:99	OMIM:601784	ASIC2	4		
FBgn0053508	ppk13	HGNC:17537	OMIM:616693	ASIC5	4		
FBgn0053513	Nmdar2	HGNC:4585	OMIM:138253	GRIN2A	11	245570	245570[EPILEPSY, FOCAL, WITH SPEECH DISORDER AND WITH OR WITHOUT IMPAIRED INTELLECTUAL DEVELOPMENT; FESD]
FBgn0053513	Nmdar2	HGNC:4586	OMIM:138252	GRIN2B	11	613970,616139	613970[INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL DOMINANT 6, WITH OR WITHOUT SEIZURES; MRD6],616139[DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 27; DEE27]
FBgn0053513	Nmdar2	HGNC:4587	OMIM:138254	GRIN2C	12		
FBgn0053513	Nmdar2	HGNC:4588	OMIM:602717	GRIN2D	14	617162	617162[DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 46; DEE46]
FBgn0053514	CG33514	HGNC:12404	OMIM:600415	TTPA	3	277460	277460[ATAXIA WITH VITAMIN E DEFICIENCY; AVED]
FBgn0053514	CG33514	HGNC:16114		TTPAL	3		
FBgn0053514	CG33514	HGNC:10024	OMIM:180090	RLBP1	3	136880,607475,607476	136880[FUNDUS ALBIPUNCTATUS],607475[BOTHNIA RETINAL DYSTROPHY],607476[NEWFOUNDLAND ROD-CONE DYSTROPHY; NFRCD]
FBgn0053514	CG33514	HGNC:23046	OMIM:616945	CLVS2	3		
FBgn0053514	CG33514	HGNC:23139	OMIM:611292	CLVS1	3		
FBgn0053519	Unc-89	HGNC:15719	OMIM:608616	OBSCN	3		
FBgn0053519	Unc-89	HGNC:19194	OMIM:608548	HMCN1	3	603075	603075[MACULAR DEGENERATION, AGE-RELATED, 1; ARMD1]
FBgn0053519	Unc-89	HGNC:21293		HMCN2	3		
FBgn0053519	Unc-89	HGNC:16901	OMIM:615950	SPEG	6	615959	615959[MYOPATHY, CENTRONUCLEAR, 5; CNM5]
FBgn0053523	CG33523	HGNC:28381	OMIM:301086	MOSPD2	14		
FBgn0053531	Ddr	HGNC:2730	OMIM:600408	DDR1	10		
FBgn0053531	Ddr	HGNC:2731	OMIM:191311	DDR2	13	271665,618175	271665[SPONDYLOMETAEPIPHYSEAL DYSPLASIA, SHORT LIMB-HAND TYPE],618175[WARBURG-CINOTTI SYNDROME; WRCN]
FBgn0053533	lectin-37Db	HGNC:2220	OMIM:607620	COLEC10	4	248340	248340[3MC SYNDROME 3; 3MC3]
FBgn0053543	CG33543	HGNC:34550	OMIM:618861	IGLON5	3		
FBgn0053543	CG33543	HGNC:7657	OMIM:602040	NCAM2	3		
FBgn0053543	CG33543	HGNC:7656	OMIM:116930	NCAM1	3		
FBgn0053543	CG33543	HGNC:6705	OMIM:603241	LSAMP	3		
FBgn0053543	CG33543	HGNC:8143	OMIM:600632	OPCML	3	167000	167000[OVARIAN CANCER]
FBgn0053543	CG33543	HGNC:17941	OMIM:607938	NTM	3		
FBgn0053526	PNUTS	HGNC:9284	OMIM:603771	PPP1R10	10		
FBgn0053547	Rim	HGNC:17283	OMIM:606630	RIMS2	10	618970	618970[CONE-ROD SYNAPTIC DISORDER SYNDROME, CONGENITAL NONPROGRESSIVE; CRSDS]
FBgn0053547	Rim	HGNC:21292	OMIM:611600	RIMS3	7		
FBgn0053547	Rim	HGNC:17282	OMIM:606629	RIMS1	10	603649	603649[CONE-ROD DYSTROPHY 7; CORD7]
FBgn0053547	Rim	HGNC:16183	OMIM:611601	RIMS4	6		
FBgn0002183	dre4	HGNC:11465	OMIM:605012	SUPT16H	14	619480	619480[NEURODEVELOPMENTAL DISORDER WITH DYSMORPHIC FACIES AND THIN CORPUS CALLOSUM; NEDDFAC]
FBgn0030018	slpr	HGNC:6861	OMIM:600136	MAP3K9	8		
FBgn0030018	slpr	HGNC:6850	OMIM:600050	MAP3K11	8		
FBgn0030018	slpr	HGNC:29798	OMIM:614793	MAP3K21	6		
FBgn0030018	slpr	HGNC:6849	OMIM:600137	MAP3K10	8		
FBgn0010263	Rbp9	HGNC:3313	OMIM:601673	ELAVL2	12		
FBgn0010263	Rbp9	HGNC:3312	OMIM:603466	ELAVL1	9		
FBgn0010263	Rbp9	HGNC:3314	OMIM:603458	ELAVL3	10		
FBgn0010263	Rbp9	HGNC:3315	OMIM:168360	ELAVL4	12		
FBgn0052484	Sk2	HGNC:19256	OMIM:610307	CERK	4		
FBgn0052484	Sk2	HGNC:11240	OMIM:603730	SPHK1	13		
FBgn0052484	Sk2	HGNC:18859	OMIM:607092	SPHK2	11		
FBgn0052484	Sk2	HGNC:21699	OMIM:608381	CERKL	3	608380	608380[RETINITIS PIGMENTOSA 26; RP26]
FBgn0004648	svr	HGNC:2311	OMIM:114860	CPM	3		
FBgn0004648	svr	HGNC:2301	OMIM:603102	CPD	12		
FBgn0004648	svr	HGNC:2303	OMIM:114855	CPE	4	619326	619326[BDV SYNDROME; BDVS]
FBgn0004648	svr	HGNC:2312	OMIM:603103	CPN1	3	212070	212070[CARBOXYPEPTIDASE N DEFICIENCY]
FBgn0020493	Dad	HGNC:6772	OMIM:602931	SMAD6	9	179300,614823,617439	179300[RADIOULNAR SYNOSTOSIS, NONSYNDROMIC, SUSCEPTIBILITY TO; RUS],614823[AORTIC VALVE DISEASE 2; AOVD2],617439[CRANIOSYNOSTOSIS 7; CRS7]
FBgn0020493	Dad	HGNC:6773	OMIM:602932	SMAD7	10	612229	612229[COLORECTAL CANCER, SUSCEPTIBILITY TO, 3; CRCS3]
FBgn0001301	kel	HGNC:6354	OMIM:605775	KLHL3	10	614495	614495[PSEUDOHYPOALDOSTERONISM, TYPE IID; PHA2D]
FBgn0001301	kel	HGNC:6353	OMIM:605774	KLHL2	9		
FBgn0031689	Cyp28d1	HGNC:2638	OMIM:605325	CYP3A5	4	145500	145500[HYPERTENSION, ESSENTIAL]
FBgn0031689	Cyp28d1	HGNC:17450	OMIM:606534	CYP3A43	4		
FBgn0031689	Cyp28d1	HGNC:11609	OMIM:274180	TBXAS1	4	231095	231095[GHOSAL HEMATODIAPHYSEAL DYSPLASIA; GHDD]
FBgn0031689	Cyp28d1	HGNC:2637	OMIM:124010	CYP3A4	4	619073	619073[VITAMIN D-DEPENDENT RICKETS, TYPE 3; VDDR3]
FBgn0031689	Cyp28d1	HGNC:51504		CYP3A7-CYP3A51P	4		
FBgn0053548	SmydA-8	HGNC:15513	OMIM:608783	SMYD3	4		
FBgn0053548	SmydA-8	HGNC:20982	OMIM:610663	SMYD2	4		
FBgn0053548	SmydA-8	HGNC:20986	OMIM:606846	SMYD1	5		
FBgn0053552	CG33552	HGNC:25539	OMIM:614151	RFWD3	3	617784	617784[FANCONI ANEMIA, COMPLEMENTATION GROUP W; FANCW]
FBgn0053554	Nipped-A	HGNC:12347	OMIM:603015	TRRAP	13	618454,618778	618454[DEVELOPMENTAL DELAY WITH OR WITHOUT DYSMORPHIC FACIES AND AUTISM; DEDDFA],618778[DEAFNESS, AUTOSOMAL DOMINANT 75; DFNA75]
FBgn0053556	form3	HGNC:18143	OMIM:606627	DAAM2	3	619263	619263[NEPHROTIC SYNDROME, TYPE 24; NPHS24]
FBgn0053556	form3	HGNC:18142	OMIM:606626	DAAM1	3		
FBgn0053556	form3	HGNC:23791	OMIM:610982	INF2	7	613237,614455	613237[FOCAL SEGMENTAL GLOMERULOSCLEROSIS 5; FSGS5],614455[CHARCOT-MARIE-TOOTH DISEASE, DOMINANT INTERMEDIATE E; CMTDIE]
FBgn0053556	form3	HGNC:29363		FHDC1	7		
FBgn0053557	CG33557	HGNC:32322	OMIM:609067	SCX	9		
FBgn0053557	CG33557	HGNC:11627	OMIM:601010	TCF15	9		
FBgn0000575	emc	HGNC:5361	OMIM:600386	ID2	9		
FBgn0000575	emc	HGNC:5362	OMIM:600277	ID3	8		
FBgn0000575	emc	HGNC:5360	OMIM:600349	ID1	10		
FBgn0000575	emc	HGNC:5363	OMIM:600581	ID4	10		
FBgn0010317	CycJ	HGNC:1577	OMIM:604036	CCNA1	3		
FBgn0010317	CycJ	HGNC:25876		CCNJL	8		
FBgn0010317	CycJ	HGNC:23434		CCNJ	8		
FBgn0003231	ref(2)P	HGNC:11280	OMIM:601530	SQSTM1	8	167250,616437,617145,617158	167250[PAGET DISEASE OF BONE 3; PDB3],616437[FRONTOTEMPORAL DEMENTIA AND/OR AMYOTROPHIC LATERAL SCLEROSIS 3; FTDALS3],617145[NEURODEGENERATION WITH ATAXIA, DYSTONIA, AND GAZE PALSY, CHILDHOOD-ONSET; NADGP],617158[MYOPATHY, DISTAL, WITH RIMMED VACUOLES; DMRV]
FBgn0003984	vn	HGNC:7997	OMIM:142445	NRG1	4	603013	603013[SCHIZOPHRENIA 6; SCZD6]
FBgn0003984	vn	HGNC:7998	OMIM:603818	NRG2	5		
FBgn0003429	slo	HGNC:18867	OMIM:615215	KCNU1	9		
FBgn0003429	slo	HGNC:6284	OMIM:600150	KCNMA1	13	609446,617643,618596,618729	609446[PAROXYSMAL NONKINESIGENIC DYSKINESIA, 3, WITH OR WITHOUT GENERALIZED EPILEPSY; PNKD3],617643[CEREBELLAR ATROPHY, DEVELOPMENTAL DELAY, AND SEIZURES; CADEDS],618596[EPILEPSY, IDIOPATHIC GENERALIZED, SUSCEPTIBILITY TO, 16; EIG16],618729[LIANG-WANG SYNDROME; LIWAS]
FBgn0004587	B52	HGNC:10791	OMIM:601943	SRSF9	3		
FBgn0004587	B52	HGNC:10788	OMIM:601944	SRSF6	11		
FBgn0004587	B52	HGNC:10787	OMIM:600914	SRSF5	4		
FBgn0004587	B52	HGNC:10780	OMIM:600812	SRSF1	3		
FBgn0004587	B52	HGNC:10786	OMIM:601940	SRSF4	11		
FBgn0004882	orb	HGNC:21744	OMIM:607342	CPEB1	8		
FBgn0005561	sv	HGNC:8619	OMIM:167414	PAX5	8	615545	615545[LEUKEMIA, ACUTE LYMPHOBLASTIC, SUSCEPTIBILITY TO, 3; ALL3]
FBgn0005561	sv	HGNC:8622	OMIM:167415	PAX8	7	218700	218700[HYPOTHYROIDISM, CONGENITAL, NONGOITROUS, 2; CHNG2]
FBgn0005561	sv	HGNC:8616	OMIM:167409	PAX2	9	120330,616002	120330[PAPILLORENAL SYNDROME; PAPRS],616002[FOCAL SEGMENTAL GLOMERULOSCLEROSIS 7; FSGS7]
FBgn0033170	sPLA2	HGNC:17934	OMIM:611651	PLA2G3	5		
FBgn0039927	CG11155	HGNC:4580	OMIM:138244	GRIK2	7	611092,619580	611092[INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 6; MRT6],619580[NEURODEVELOPMENTAL DISORDER WITH IMPAIRED LANGUAGE AND ATAXIA AND WITH OR WITHOUT SEIZURES; NEDLAS]
FBgn0039927	CG11155	HGNC:4581	OMIM:138243	GRIK3	7		
FBgn0039927	CG11155	HGNC:4583	OMIM:600283	GRIK5	5		
FBgn0039927	CG11155	HGNC:4579	OMIM:138245	GRIK1	8		
FBgn0039927	CG11155	HGNC:4582	OMIM:600282	GRIK4	6		
FBgn0039927	CG11155	HGNC:4575	OMIM:610659	GRID1	4		
FBgn0034990	CG11406	HGNC:6617	OMIM:613497	LIPA	6	278000	278000[LYSOSOMAL ACID LIPASE DEFICIENCY]
FBgn0034990	CG11406	HGNC:23444	OMIM:613922	LIPK	6		
FBgn0034990	CG11406	HGNC:23455	OMIM:613923	LIPM	6		
FBgn0034990	CG11406	HGNC:6622	OMIM:601980	LIPF	6		
FBgn0034990	CG11406	HGNC:21773	OMIM:613921	LIPJ	5		
FBgn0034990	CG11406	HGNC:23452	OMIM:613924	LIPN	6	613943	613943[ICHTHYOSIS, CONGENITAL, AUTOSOMAL RECESSIVE 8; ARCI8]
FBgn0015770	MstProx	HGNC:11851	OMIM:603031	TLR5	3	601744,608556,615557	601744[SYSTEMIC LUPUS ERYTHEMATOSUS, SUSCEPTIBILITY TO, 1; SLEB1],608556[LEGIONNAIRE DISEASE, SUSCEPTIBILITY TO],615557[MELIOIDOSIS, SUSCEPTIBILITY TO]
FBgn0015770	MstProx	HGNC:11850	OMIM:603030	TLR4	3		
FBgn0015770	MstProx	HGNC:15634	OMIM:606270	TLR10	3		
FBgn0015770	MstProx	HGNC:11848	OMIM:603028	TLR2	3	114500,246300,607948	114500[COLORECTAL CANCER; CRC],246300[LEPROSY, SUSCEPTIBILITY TO, 3; LPRS3],607948[MYCOBACTERIUM TUBERCULOSIS, SUSCEPTIBILITY TO]
FBgn0015770	MstProx	HGNC:11847	OMIM:601194	TLR1	3	613223	613223[LEPROSY, SUSCEPTIBILITY TO, 5; LPRS5]
FBgn0015770	MstProx	HGNC:16711	OMIM:605403	TLR6	3		
FBgn0041164	armi	HGNC:7200	OMIM:610742	MOV10	6		
FBgn0041164	armi	HGNC:7201	OMIM:605794	MOV10L1	10	619878	619878[SPERMATOGENIC FAILURE 73; SPGF73]
FBgn0037313	CG1161	HGNC:1168		TMEM9B	12		
FBgn0037313	CG1161	HGNC:18823	OMIM:616877	TMEM9	14		
FBgn0041707	7B2	HGNC:10816	OMIM:173120	SCG5	12		
FBgn0002774	mle	HGNC:2750	OMIM:603115	DHX9	15		
FBgn0002774	mle	HGNC:20086		DHX57	4		
FBgn0002774	mle	HGNC:14410	OMIM:612767	DHX36	4		
FBgn0002774	mle	HGNC:15815	OMIM:612720	DHX29	4		
FBgn0002774	mle	HGNC:16716	OMIM:616423	DHX30	3	617804	617804[NEURODEVELOPMENTAL DISORDER WITH SEVERE MOTOR IMPAIRMENT AND ABSENT LANGUAGE; NEDMIAL]
FBgn0004102	oc	HGNC:8522	OMIM:600037	OTX2	6	610125,613986	610125[MICROPHTHALMIA, SYNDROMIC 5; MCOPS5],613986[PITUITARY HORMONE DEFICIENCY, COMBINED, 6; CPHD6]
FBgn0004102	oc	HGNC:2383	OMIM:602225	CRX	5	120970,613829	120970[CONE-ROD DYSTROPHY 2; CORD2],613829[LEBER CONGENITAL AMAUROSIS 7; LCA7]
FBgn0004102	oc	HGNC:8521	OMIM:600036	OTX1	7		
FBgn0004102	oc	HGNC:30146	OMIM:611164	ARGFX	3		
FBgn0033807	AQP	HGNC:19940	OMIM:609914	AQP11	9		
FBgn0033807	AQP	HGNC:19941	OMIM:609789	AQP12A	12		
FBgn0033807	AQP	HGNC:6096		AQP12B	12		
FBgn0003124	polo	HGNC:19699	OMIM:607023	PLK2	5		
FBgn0003124	polo	HGNC:2154	OMIM:602913	PLK3	4		
FBgn0003124	polo	HGNC:9077	OMIM:602098	PLK1	15		
FBgn0000303	ChAT	HGNC:2342	OMIM:600184	CRAT	4	617917	617917[NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 8; NBIA8]
FBgn0000303	ChAT	HGNC:1912	OMIM:118490	CHAT	14	254210	254210[MYASTHENIC SYNDROME, CONGENITAL, 6, PRESYNAPTIC; CMS6]
FBgn0004606	zfh1	HGNC:14881	OMIM:605802	ZEB2	10	235730	235730[MOWAT-WILSON SYNDROME; MOWS]
FBgn0004606	zfh1	HGNC:11642	OMIM:189909	ZEB1	9	609141,613270	609141[CORNEAL DYSTROPHY, POSTERIOR POLYMORPHOUS, 3; PPCD3],613270[CORNEAL DYSTROPHY, FUCHS ENDOTHELIAL, 6; FECD6]
FBgn0003720	tll	HGNC:7973	OMIM:603849	NR2E1	13		
FBgn0038651	Epg5	HGNC:29331	OMIM:615068	EPG5	13	242840	242840[VICI SYNDROME; VICIS]
FBgn0004607	zfh2	HGNC:30939	OMIM:606940	ZFHX4	12	178300	178300[PTOSIS, HEREDITARY CONGENITAL 1; PTOS1]
FBgn0004607	zfh2	HGNC:777	OMIM:104155	ZFHX3	12	176807	176807[PROSTATE CANCER]
FBgn0004607	zfh2	HGNC:20152	OMIM:617828	ZFHX2	7	147430	147430[MARSILI SYNDROME; MARSIS]
FBgn0005558	ey	HGNC:8620	OMIM:607108	PAX6	7	106210,120200,120430,136520,148190,165550,604229	106210[ANIRIDIA 1; AN1],120200[COLOBOMA, OCULAR, AUTOSOMAL DOMINANT],120430[COLOBOMA OF OPTIC NERVE],136520[FOVEAL HYPOPLASIA 1; FVH1],148190[KERATITIS, HEREDITARY],165550[OPTIC NERVE HYPOPLASIA, BILATERAL],604229[ANTERIOR SEGMENT DYSGENESIS 5; ASGD5]
FBgn0005558	ey	HGNC:8618	OMIM:167413	PAX4	4	125853,612225,612227	125853[TYPE 2 DIABETES MELLITUS; T2D],612225[MATURITY-ONSET DIABETES OF THE YOUNG, TYPE 9; MODY9],612227[DIABETES MELLITUS, KETOSIS-PRONE; KPD]
FBgn0023416	Ac3	HGNC:236	OMIM:600293	ADCY5	3	606703,619647,619651	606703[DYSKINESIA WITH OROFACIAL INVOLVEMENT, AUTOSOMAL DOMINANT; DSKOD],619647[DYSKINESIA WITH OROFACIAL INVOLVEMENT, AUTOSOMAL RECESSIVE; DSKOR],619651[NEURODEVELOPMENTAL DISORDER WITH HYPERKINETIC MOVEMENTS AND DYSKINESIA; NEDHYD]
FBgn0023416	Ac3	HGNC:234	OMIM:600291	ADCY3	12	617885	617885[BODY MASS INDEX QUANTITATIVE TRAIT LOCUS 19; BMIQ19]
FBgn0023416	Ac3	HGNC:237	OMIM:600294	ADCY6	3	616287	616287[LETHAL CONGENITAL CONTRACTURE SYNDROME 8; LCCS8]
FBgn0000259	CkIIbeta	HGNC:2460	OMIM:115441	CSNK2B	13	618732	618732[POIRIER-BIENVENU NEURODEVELOPMENTAL SYNDROME; POBINDS]
FBgn0000241	bw	HGNC:73	OMIM:603076	ABCG1	3		
FBgn0000241	bw	HGNC:74	OMIM:603756	ABCG2	3	138900,614490	138900[URIC ACID CONCENTRATION, SERUM, QUANTITATIVE TRAIT LOCUS 1; UAQTL1],614490[BLOOD GROUP, JUNIOR SYSTEM; JR]
FBgn0004907	14-3-3zeta	HGNC:12853	OMIM:113508	YWHAH	6		
FBgn0004907	14-3-3zeta	HGNC:12852	OMIM:605356	YWHAG	6	617665	617665[DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 56; DEE56]
FBgn0004907	14-3-3zeta	HGNC:12854	OMIM:609009	YWHAQ	5		
FBgn0004907	14-3-3zeta	HGNC:12855	OMIM:601288	YWHAZ	13		
FBgn0004907	14-3-3zeta	HGNC:12849	OMIM:601289	YWHAB	11		
FBgn0004907	14-3-3zeta	HGNC:10773	OMIM:601290	SFN	5		
FBgn0004907	14-3-3zeta	HGNC:12851	OMIM:605066	YWHAE	4		
FBgn0039914	mav	HGNC:11769	OMIM:190230	TGFB3	3	107970,615582	107970[ARRHYTHMOGENIC RIGHT VENTRICULAR DYSPLASIA, FAMILIAL, 1; ARVD1],615582[LOEYS-DIETZ SYNDROME 5; LDS5]
FBgn0039914	mav	HGNC:7865	OMIM:601265	NODAL	3	270100	270100[HETEROTAXY, VISCERAL, 5, AUTOSOMAL; HTX5]
FBgn0039914	mav	HGNC:30142	OMIM:605312	GDF15	3		
FBgn0004369	Ptp99A	HGNC:9685	OMIM:176891	PTPRZ1	7		
FBgn0004369	Ptp99A	HGNC:9671	OMIM:176886	PTPRG	9		
FBgn0040107	lectin-21Ca	HGNC:2052	OMIM:613588	CLEC3A	3		
FBgn0040107	lectin-21Ca	HGNC:17213	OMIM:612502	COLEC11	3	265050	265050[3MC SYNDROME 2; 3MC2]
FBgn0029676	HIP-R	HGNC:11343	OMIM:606796	ST13	8		
FBgn0026059	Mhcl	HGNC:18150	OMIM:607295	MYO18B	7	616549	616549[KLIPPEL-FEIL SYNDROME 4, AUTOSOMAL RECESSIVE, WITH NEMALINE MYOPATHY AND FACIAL DYSMORPHISM; KFS4]
FBgn0026059	Mhcl	HGNC:31104	OMIM:609517	MYO18A	13		
FBgn0005427	ewg	HGNC:7996	OMIM:600879	NRF1	11		
FBgn0000053	Gart	HGNC:4163	OMIM:138440	GART	14		
FBgn0000567	Eip74EF	HGNC:3316	OMIM:189973	ELF1	4		
FBgn0000567	Eip74EF	HGNC:3317	OMIM:619798	ELF2	7		
FBgn0000567	Eip74EF	HGNC:3319	OMIM:300775	ELF4	4	301074	301074[AUTOINFLAMMATORY SYNDROME, FAMILIAL, X-LINKED, BEHCET-LIKE 2; AIFBL2]
FBgn0052333	CG32333	HGNC:21084		FAM135A	13		
FBgn0052333	CG32333	HGNC:28029		FAM135B	13		
FBgn0041605	cpx	HGNC:2310	OMIM:605033	CPLX2	8		
FBgn0041605	cpx	HGNC:2309	OMIM:605032	CPLX1	9	617976	617976[DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 63; DEE63]
FBgn0052576	CG32576	HGNC:20175	OMIM:615078	GOLT1B	13		
FBgn0052576	CG32576	HGNC:24766		GOLT1A	10		
FBgn0052602	Muc12Ea	HGNC:7508	OMIM:158340	MUC1	3	174000	174000[TUBULOINTERSTITIAL KIDNEY DISEASE, AUTOSOMAL DOMINANT, 2; ADTKD2]
FBgn0039396	CCAP-R	HGNC:23631	OMIM:608595	NPSR1	9	608584	608584[ASTHMA-RELATED TRAITS, SUSCEPTIBILITY TO, 2]
FBgn0039396	CCAP-R	HGNC:8529	OMIM:167055	OXTR	3		
FBgn0039396	CCAP-R	HGNC:895	OMIM:600821	AVPR1A	3		
FBgn0039396	CCAP-R	HGNC:896	OMIM:600264	AVPR1B	4		
FBgn0039396	CCAP-R	HGNC:897	OMIM:300538	AVPR2	5	300539,304800	300539[NEPHROGENIC SYNDROME OF INAPPROPRIATE ANTIDIURESIS; NSIAD],304800[DIABETES INSIPIDUS, NEPHROGENIC, 1, X-LINKED; NDI1]
FBgn0053558	mim	HGNC:25094	OMIM:616951	MTSS2	6		
FBgn0053558	mim	HGNC:20443	OMIM:608486	MTSS1	7		
FBgn0001148	gsb	HGNC:8621	OMIM:167410	PAX7	7	268220,618578	268220[RHABDOMYOSARCOMA 2; RMS2],618578[MYOPATHY, CONGENITAL, PROGRESSIVE, WITH SCOLIOSIS; MYOSCO]
FBgn0001148	gsb	HGNC:8617	OMIM:606597	PAX3	8	122880,148820,193500,268220	122880[CRANIOFACIAL-DEAFNESS-HAND SYNDROME; CDHS],148820[WAARDENBURG SYNDROME, TYPE 3; WS3],193500[WAARDENBURG SYNDROME, TYPE 1; WS1],268220[RHABDOMYOSARCOMA 2; RMS2]
FBgn0014141	cher	HGNC:3754	OMIM:300017	FLNA	14	300048,300049,300244,300321,304120,305620,309350,311300,314400	300048[INTESTINAL PSEUDOOBSTRUCTION, NEURONAL, CHRONIC IDIOPATHIC, X-LINKED],300049[PERIVENTRICULAR NODULAR HETEROTOPIA 1; PVNH1],300244[TERMINAL OSSEOUS DYSPLASIA; TOD],300321[FG SYNDROME 2; FGS2],304120[OTOPALATODIGITAL SYNDROME, TYPE II; OPD2],305620[FRONTOMETAPHYSEAL DYSPLASIA 1; FMD1],309350[MELNICK-NEEDLES SYNDROME; MNS],311300[OTOPALATODIGITAL SYNDROME, TYPE I; OPD1],314400[CARDIAC VALVULAR DYSPLASIA, X-LINKED; CVD1]
FBgn0014141	cher	HGNC:3756	OMIM:102565	FLNC	11	609524,614065,617047	609524[MYOPATHY, MYOFIBRILLAR, 5; MFM5],614065[MYOPATHY, DISTAL, 4; MPD4],617047[CARDIOMYOPATHY, FAMILIAL HYPERTROPHIC, 26; CMH26]
FBgn0014141	cher	HGNC:3755	OMIM:603381	FLNB	12	108720,108721,112310,150250,272460	108720[ATELOSTEOGENESIS, TYPE I; AO1],108721[ATELOSTEOGENESIS, TYPE III; AO3],112310[BOOMERANG DYSPLASIA; BOOMD],150250[LARSEN SYNDROME; LRS],272460[SPONDYLOCARPOTARSAL SYNOSTOSIS SYNDROME; SCT]
FBgn0010382	CycE	HGNC:1589	OMIM:123837	CCNE1	11		
FBgn0010382	CycE	HGNC:1590	OMIM:603775	CCNE2	9		
FBgn0010382	CycE	HGNC:1577	OMIM:604036	CCNA1	3		
FBgn0010382	CycE	HGNC:25876		CCNJL	3		
FBgn0010382	CycE	HGNC:25805		CNTD2	3		
FBgn0004575	Syn	HGNC:11494	OMIM:313440	SYN1	11	300115,300491	300115[INTELLECTUAL DEVELOPMENTAL DISORDER, X-LINKED 50; XLID50],300491[EPILEPSY, X-LINKED, WITH VARIABLE LEARNING DISABILITIES AND BEHAVIOR DISORDERS; EPILX]
FBgn0004575	Syn	HGNC:11496	OMIM:602705	SYN3	13		
FBgn0004575	Syn	HGNC:11495	OMIM:600755	SYN2	10	181500	181500[SCHIZOPHRENIA; SCZD]
FBgn0000042	Act5C	HGNC:17780	OMIM:614835	ACTBL2	4		
FBgn0000042	Act5C	HGNC:168	OMIM:605144	ACTR1B	3		
FBgn0000042	Act5C	HGNC:129	OMIM:102610	ACTA1	3	161800,255310,616852	161800[NEMALINE MYOPATHY 3; NEM3],255310[MYOPATHY, CONGENITAL, WITH FIBER-TYPE DISPROPORTION; CFTD],616852[MYOPATHY, SCAPULOHUMEROPERONEAL; SHPM]
FBgn0000042	Act5C	HGNC:132	OMIM:102630	ACTB	11	243310,607371	243310[BARAITSER-WINTER SYNDROME 1; BRWS1],607371[DYSTONIA, JUVENILE-ONSET; DJO]
FBgn0000042	Act5C	HGNC:130	OMIM:102620	ACTA2	4	611788,613834,614042	611788[AORTIC ANEURYSM, FAMILIAL THORACIC 6; AAT6],613834[MULTISYSTEMIC SMOOTH MUSCLE DYSFUNCTION SYNDROME; MSMDS],614042[MOYAMOYA DISEASE 5; MYMY5]
FBgn0000042	Act5C	HGNC:143	OMIM:102540	ACTC1	4	612098,612794,613424	612098[CARDIOMYOPATHY, FAMILIAL HYPERTROPHIC, 11; CMH11],612794[ATRIAL SEPTAL DEFECT 5; ASD5],613424[CARDIOMYOPATHY, DILATED, 1R; CMD1R]
FBgn0000042	Act5C	HGNC:167	OMIM:605143	ACTR1A	3		
FBgn0000042	Act5C	HGNC:144	OMIM:102560	ACTG1	10	604717,614583	604717[DEAFNESS, AUTOSOMAL DOMINANT 20; DFNA20],614583[BARAITSER-WINTER SYNDROME 2; BRWS2]
FBgn0000042	Act5C	HGNC:145	OMIM:102545	ACTG2	3	155310,619431	155310[VISCERAL MYOPATHY 1; VSCM1],619431[MEGACYSTIS-MICROCOLON-INTESTINAL HYPOPERISTALSIS SYNDROME 5; MMIHS5]
FBgn0000042	Act5C	HGNC:37093		POTEI	5		
FBgn0000042	Act5C	HGNC:37094		POTEJ	5		
FBgn0000042	Act5C	HGNC:33905		POTEF	5		
FBgn0000042	Act5C	HGNC:33895	OMIM:608914	POTEE	4		
FBgn0000042	Act5C	HGNC:24022	OMIM:608534	ACTRT3	4		
FBgn0000042	Act5C	HGNC:24027	OMIM:300487	ACTRT1	3		
FBgn0000042	Act5C	HGNC:24026	OMIM:608535	ACTRT2	3		
FBgn0000042	Act5C	HGNC:24018		ACTL8	3		
FBgn0000042	Act5C	HGNC:28494	OMIM:619251	ACTL9	3	619258	619258[SPERMATOGENIC FAILURE 53; SPGF53]
FBgn0034976	CG4049	HGNC:29123	OMIM:620006	RAD54L2	15		
FBgn0034982	Naa35	HGNC:24340	OMIM:619438	NAA35	13		
FBgn0020385	pug	HGNC:7432	OMIM:172460	MTHFD1	14	601634,617780	601634[NEURAL TUBE DEFECTS, FOLATE-SENSITIVE; NTDFS],617780[COMBINED IMMUNODEFICIENCY AND MEGALOBLASTIC ANEMIA WITH OR WITHOUT HYPERHOMOCYSTEINEMIA; CIMAH]
FBgn0020385	pug	HGNC:21055	OMIM:611427	MTHFD1L	7		
FBgn0037822	CG14683	HGNC:26606	OMIM:618711	METTL15	14		
FBgn0037822	CG14683	HGNC:31926		METTL15P1	3		
FBgn0038295	Gyc88E	HGNC:4687	OMIM:139397	GUCY1B1	3		
FBgn0004227	nonA	HGNC:20320	OMIM:612408	PSPC1	10		
FBgn0004227	nonA	HGNC:7871	OMIM:300084	NONO	11	300967	300967[INTELLECTUAL DEVELOPMENTAL DISORDER, X-LINKED, SYNDROMIC 34; MRXS34]
FBgn0004227	nonA	HGNC:10774	OMIM:605199	SFPQ	12		
FBgn0015546	spel1	HGNC:7325	OMIM:609309	MSH2	14	120435,158320,619096	120435[LYNCH SYNDROME I],158320[MUIR-TORRE SYNDROME; MRTES],619096[MISMATCH REPAIR CANCER SYNDROME 2; MMRCS2]
FBgn0016917	Stat92E	HGNC:11366	OMIM:601511	STAT5A	12		
FBgn0016917	Stat92E	HGNC:11368	OMIM:601512	STAT6	9		
FBgn0016917	Stat92E	HGNC:11367	OMIM:604260	STAT5B	13	102578,245590,618985	102578[ACUTE PROMYELOCYTIC LEUKEMIA, INDUCER OF; PML],245590[GROWTH HORMONE INSENSITIVITY SYNDROME WITH IMMUNE DYSREGULATION 1, AUTOSOMAL RECESSIVE; GHISID1],618985[GROWTH HORMONE INSENSITIVITY SYNDROME WITH IMMUNE DYSREGULATION 2, AUTOSOMAL DOMINANT; GHISID2]
FBgn0016917	Stat92E	HGNC:11364	OMIM:102582	STAT3	3	147060,615952	147060[HYPER-IgE RECURRENT INFECTION SYNDROME 1, AUTOSOMAL DOMINANT; HIES1],615952[AUTOIMMUNE DISEASE, MULTISYSTEM, INFANTILE-ONSET, 1; ADMIO1]
FBgn0016917	Stat92E	HGNC:11365	OMIM:600558	STAT4	3	612253	612253[SYSTEMIC LUPUS ERYTHEMATOSUS, SUSCEPTIBILITY TO, 11; SLEB11]
FBgn0016917	Stat92E	HGNC:11362	OMIM:600555	STAT1	4	613796,614162,614892	613796[IMMUNODEFICIENCY 31B; IMD31B],614162[IMMUNODEFICIENCY 31C; IMD31C],614892[IMMUNODEFICIENCY 31A; IMD31A]
FBgn0016917	Stat92E	HGNC:11363	OMIM:600556	STAT2	3	616636,618886	616636[IMMUNODEFICIENCY 44; IMD44],618886[PSEUDO-TORCH SYNDROME 3; PTORCH3]
FBgn0032117	FucTB	HGNC:19234	OMIM:616931	FUT10	15		
FBgn0032117	FucTB	HGNC:19233	OMIM:616932	FUT11	6		
FBgn0032117	FucTB	HGNC:4017	OMIM:136836	FUT6	3	613852	613852[FUCOSYLTRANSFERASE 6 DEFICIENCY]
FBgn0014135	bnl	HGNC:3665	OMIM:131220	FGF1	4		
FBgn0014135	bnl	HGNC:3676	OMIM:134920	FGF2	3		
FBgn0014135	bnl	HGNC:3681	OMIM:164950	FGF3	4	610706	610706[DEAFNESS, CONGENITAL, WITH INNER EAR AGENESIS, MICROTIA, AND MICRODONTIA]
FBgn0014135	bnl	HGNC:3682	OMIM:164980	FGF4	5		
FBgn0014135	bnl	HGNC:3683	OMIM:165190	FGF5	5	190330	190330[TRICHOMEGALY; TCMGLY]
FBgn0014135	bnl	HGNC:3684	OMIM:134921	FGF6	5		
FBgn0014135	bnl	HGNC:3685	OMIM:148180	FGF7	4		
FBgn0014135	bnl	HGNC:3687	OMIM:600921	FGF9	5	612961	612961[MULTIPLE SYNOSTOSES SYNDROME 3; SYNS3]
FBgn0014135	bnl	HGNC:3666	OMIM:602115	FGF10	5	149730,180920	149730[LACRIMOAURICULODENTODIGITAL SYNDROME; LADD],180920[APLASIA OF LACRIMAL AND SALIVARY GLANDS; ALSG]
FBgn0014135	bnl	HGNC:3672	OMIM:300827	FGF16	6	309630	309630[METACARPAL 4-5 FUSION; MF4]
FBgn0014135	bnl	HGNC:3677	OMIM:605558	FGF20	7	615721	615721[RENAL HYPODYSPLASIA/APLASIA 2; RHDA2]
FBgn0014135	bnl	HGNC:3679	OMIM:605831	FGF22	5		
FBgn0014135	bnl	HGNC:3686	OMIM:600483	FGF8	3	612702	612702[HYPOGONADOTROPIC HYPOGONADISM 6 WITH OR WITHOUT ANOSMIA; HH6]
FBgn0014135	bnl	HGNC:3667	OMIM:601514	FGF11	5		
FBgn0014135	bnl	HGNC:3668	OMIM:601513	FGF12	4	617166	617166[DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 47; DEE47]
FBgn0014135	bnl	HGNC:3670	OMIM:300070	FGF13	5	301058	301058[DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 90; DEE90]
FBgn0014135	bnl	HGNC:3671	OMIM:601515	FGF14	4	609307	609307[SPINOCEREBELLAR ATAXIA 27; SCA27]
FBgn0014135	bnl	HGNC:3680	OMIM:605380	FGF23	3	193100,617993	193100[HYPOPHOSPHATEMIC RICKETS, AUTOSOMAL DOMINANT; ADHR],617993[TUMORAL CALCINOSIS, HYPERPHOSPHATEMIC, FAMILIAL, 2; HFTC2]
FBgn0014135	bnl	HGNC:3674	OMIM:603726	FGF18	3		
FBgn0014135	bnl	HGNC:3673	OMIM:603725	FGF17	3	615270	615270[HYPOGONADOTROPIC HYPOGONADISM 20 WITH OR WITHOUT ANOSMIA; HH20]
FBgn0014135	bnl	HGNC:3675	OMIM:603891	FGF19	3		
FBgn0014135	bnl	HGNC:3678	OMIM:609436	FGF21	3		
FBgn0033809	CG4630	HGNC:8494	OMIM:604047	SLC22A13	5		
FBgn0033809	CG4630	HGNC:10970	OMIM:607582	SLC22A6	5		
FBgn0033809	CG4630	HGNC:20302	OMIM:608276	SLC22A16	4		
FBgn0033809	CG4630	HGNC:10968	OMIM:604190	SLC22A4	5	180300	180300[RHEUMATOID ARTHRITIS; RA]
FBgn0033809	CG4630	HGNC:10969	OMIM:603377	SLC22A5	5	212140	212140[CARNITINE DEFICIENCY, SYSTEMIC PRIMARY; CDSP]
FBgn0033809	CG4630	HGNC:8495	OMIM:604048	SLC22A14	5		
FBgn0033809	CG4630	HGNC:10971	OMIM:604995	SLC22A7	3		
FBgn0033809	CG4630	HGNC:10972	OMIM:607581	SLC22A8	4		
FBgn0033809	CG4630	HGNC:10966	OMIM:602608	SLC22A2	4		
FBgn0033809	CG4630	HGNC:32935	OMIM:610792	SLC22A25	4		
FBgn0033809	CG4630	HGNC:10963	OMIM:602607	SLC22A1	5		
FBgn0033809	CG4630	HGNC:10967	OMIM:604842	SLC22A3	6		
FBgn0033809	CG4630	HGNC:17989	OMIM:607096	SLC22A12	5	220150	220150[HYPOURICEMIA, RENAL, 1; RHUC1]
FBgn0033809	CG4630	HGNC:18120	OMIM:607097	SLC22A11	5		
FBgn0033809	CG4630	HGNC:16261	OMIM:607579	SLC22A9	4		
FBgn0033809	CG4630	HGNC:28542	OMIM:611698	SLC22A24	4		
FBgn0033809	CG4630	HGNC:18057	OMIM:607580	SLC22A10	4		
FBgn0033810	CG4646	HGNC:26059		CZIB	14		
FBgn0035964	Dhpr	HGNC:9752	OMIM:612676	QDPR	15	261630	261630[HYPERPHENYLALANINEMIA, BH4-DEFICIENT, C; HPABH4C]
FBgn0039348	Npl4	HGNC:18261	OMIM:606590	NPLOC4	14		
FBgn0039349	Ssadh	HGNC:408	OMIM:610045	ALDH5A1	15	271980	271980[SUCCINIC SEMIALDEHYDE DEHYDROGENASE DEFICIENCY; SSADHD]
FBgn0002789	Mp20	HGNC:2155	OMIM:600806	CNN1	7		
FBgn0002789	Mp20	HGNC:2156	OMIM:602373	CNN2	7		
FBgn0002789	Mp20	HGNC:2157	OMIM:602374	CNN3	5		
FBgn0002789	Mp20	HGNC:11553	OMIM:600818	TAGLN	7		
FBgn0002789	Mp20	HGNC:11554	OMIM:604634	TAGLN2	8		
FBgn0002789	Mp20	HGNC:29868	OMIM:607953	TAGLN3	9		
FBgn0027375	RecQ5	HGNC:12791	OMIM:604611	WRN	3	277700	277700[WERNER SYNDROME; WRN]
FBgn0027375	RecQ5	HGNC:9950	OMIM:603781	RECQL5	13		
FBgn0027375	RecQ5	HGNC:1058	OMIM:604610	BLM	3	210900	210900[BLOOM SYNDROME; BLM]
FBgn0027375	RecQ5	HGNC:9948	OMIM:600537	RECQL	4		
FBgn0005677	dac	HGNC:2663	OMIM:603803	DACH1	12		
FBgn0005677	dac	HGNC:16814	OMIM:300608	DACH2	11		
FBgn0035956	Doc2	HGNC:11605	OMIM:602427	TBX6	9	122600	122600[SPONDYLOCOSTAL DYSOSTOSIS 5; SCDO5]
FBgn0035956	Doc2	HGNC:11598	OMIM:606061	TBX20	3	611363	611363[ATRIAL SEPTAL DEFECT 4; ASD4]
FBgn0035956	Doc2	HGNC:11594	OMIM:604127	TBX15	3	260660	260660[COUSIN SYNDROME]
FBgn0035956	Doc2	HGNC:11600	OMIM:300307	TBX22	3	302905,303400	302905[ABRUZZO-ERICKSON SYNDROME; ABERS],303400[CLEFT PALATE WITH OR WITHOUT ANKYLOGLOSSIA, X-LINKED; CPX]
FBgn0038950	CG5382	HGNC:12868	OMIM:619397	ZFPL1	13		
FBgn0011225	jar	HGNC:7605	OMIM:600970	MYO6	14	606346,607821	606346[DEAFNESS, AUTOSOMAL DOMINANT 22; DFNA22],607821[DEAFNESS, AUTOSOMAL RECESSIVE 37; DFNB37]
FBgn0038872	Nelf-A	HGNC:12768	OMIM:606026	NELFA	8		
FBgn0036180	Duba	HGNC:25402	OMIM:300713	OTUD5	11	301056	301056[MULTIPLE CONGENITAL ANOMALIES-NEURODEVELOPMENTAL SYNDROME, X-LINKED; MCAND]
FBgn0004924	Top1	HGNC:11986	OMIM:126420	TOP1	13		
FBgn0004924	Top1	HGNC:29787	OMIM:606387	TOP1MT	10		
FBgn0004903	Rb97D	HGNC:27067		HNRNPA1L2	5		
FBgn0004903	Rb97D	HGNC:5033	OMIM:600124	HNRNPA2B1	8	615422	615422[INCLUSION BODY MYOPATHY WITH EARLY-ONSET PAGET DISEASE WITH OR WITHOUT FRONTOTEMPORAL DEMENTIA 2; IBMPFD2]
FBgn0004903	Rb97D	HGNC:5031	OMIM:164017	HNRNPA1	5	615424,615426	615424[INCLUSION BODY MYOPATHY WITH EARLY-ONSET PAGET DISEASE WITH OR WITHOUT FRONTOTEMPORAL DEMENTIA 3; IBMPFD3],615426[AMYOTROPHIC LATERAL SCLEROSIS 20; ALS20]
FBgn0004903	Rb97D	HGNC:24941	OMIM:605372	HNRNPA3	5		
FBgn0004903	Rb97D	HGNC:5030	OMIM:609409	HNRNPA0	5		
FBgn0001168	h	HGNC:24149	OMIM:608060	HES4	9		
FBgn0001168	h	HGNC:5192	OMIM:139605	HES1	7		
FBgn0001168	h	HGNC:16005	OMIM:609970	HES2	5		
FBgn0032369	CG6614	HGNC:30726	OMIM:618661	CFAP70	5	618670	618670[SPERMATOGENIC FAILURE 41; SPGF41]
FBgn0003145	prd	HGNC:8621	OMIM:167410	PAX7	7	268220,618578	268220[RHABDOMYOSARCOMA 2; RMS2],618578[MYOPATHY, CONGENITAL, PROGRESSIVE, WITH SCOLIOSIS; MYOSCO]
FBgn0003145	prd	HGNC:8617	OMIM:606597	PAX3	8	122880,148820,193500,268220	122880[CRANIOFACIAL-DEAFNESS-HAND SYNDROME; CDHS],148820[WAARDENBURG SYNDROME, TYPE 3; WS3],193500[WAARDENBURG SYNDROME, TYPE 1; WS1],268220[RHABDOMYOSARCOMA 2; RMS2]
FBgn0000008	a	HGNC:18486	OMIM:610697	PDZD2	4		
FBgn0000261	Cat	HGNC:1516	OMIM:115500	CAT	14	614097	614097[ACATALASEMIA]
FBgn0004169	up	HGNC:11948	OMIM:191041	TNNT1	9	605355	605355[NEMALINE MYOPATHY 5; NEM5]
FBgn0004169	up	HGNC:11949	OMIM:191045	TNNT2	10	115195,601494,612422	115195[CARDIOMYOPATHY, FAMILIAL HYPERTROPHIC, 2; CMH2],601494[CARDIOMYOPATHY, DILATED, 1D; CMD1D],612422[CARDIOMYOPATHY, FAMILIAL RESTRICTIVE, 3; RCM3]
FBgn0004169	up	HGNC:11950	OMIM:600692	TNNT3	9	618435	618435[ARTHROGRYPOSIS, DISTAL, TYPE 2B2; DA2B2]
FBgn0023076	Clk	HGNC:7895	OMIM:603347	NPAS2	10		
FBgn0023076	Clk	HGNC:2082	OMIM:601851	CLOCK	10		
FBgn0023076	Clk	HGNC:20686	OMIM:300993	PASD1	4		
FBgn0001208	Hn	HGNC:8582	OMIM:612349	PAH	14	261600	261600[PHENYLKETONURIA; PKU]
FBgn0036165	chrb	HGNC:24944	OMIM:607729	DDIT4	9		
FBgn0036165	chrb	HGNC:30555	OMIM:607730	DDIT4L	12		
FBgn0020496	CtBP	HGNC:2495	OMIM:602619	CTBP2	14		
FBgn0020496	CtBP	HGNC:2494	OMIM:602618	CTBP1	12	617915	617915[HYPOTONIA, ATAXIA, DEVELOPMENTAL DELAY, AND TOOTH ENAMEL DEFECT SYNDROME; HADDTS]
FBgn0020496	CtBP	HGNC:8923	OMIM:606879	PHGDH	3	256520,601815	256520[NEU-LAXOVA SYNDROME 1; NLS1],601815[PHOSPHOGLYCERATE DEHYDROGENASE DEFICIENCY; PHGDHD]
FBgn0027841	CstF64	HGNC:2484	OMIM:300907	CSTF2	10		
FBgn0027841	CstF64	HGNC:17086	OMIM:611968	CSTF2T	10		
FBgn0039713	RpS8	HGNC:10441	OMIM:600357	RPS8	14		
FBgn0039738	Mgat2	HGNC:7045	OMIM:602616	MGAT2	11	212066	212066[CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIa; CDG2A]
FBgn0015269	Nf1	HGNC:7765	OMIM:613113	NF1	13	162200,162210,193520,601321,607785	162200[NEUROFIBROMATOSIS, TYPE I; NF1],162210[NEUROFIBROMATOSIS, FAMILIAL SPINAL],193520[WATSON SYNDROME; WTSN],601321[NEUROFIBROMATOSIS-NOONAN SYNDROME; NFNS],607785[JUVENILE MYELOMONOCYTIC LEUKEMIA; JMML]
FBgn0037747	Naa80	HGNC:30252	OMIM:607073	NAA80	11		
FBgn0003862	trx	HGNC:7132	OMIM:159555	KMT2A	8	605130	605130[WIEDEMANN-STEINER SYNDROME; WDSTS]
FBgn0003862	trx	HGNC:15840	OMIM:606834	KMT2B	9	617284,619934	617284[DYSTONIA 28, CHILDHOOD-ONSET; DYT28],619934[INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL DOMINANT 68; MRD68]
FBgn0010226	GstS1	HGNC:17890	OMIM:602598	HPGDS	11		
FBgn0010226	GstS1	HGNC:4628	OMIM:605449	GSTA3	3		
FBgn0010226	GstS1	HGNC:4632	OMIM:138350	GSTM1	4		
FBgn0010226	GstS1	HGNC:4634	OMIM:138380	GSTM2	3		
FBgn0010226	GstS1	HGNC:4635	OMIM:138390	GSTM3	3		
FBgn0010226	GstS1	HGNC:4636	OMIM:138333	GSTM4	5		
FBgn0010226	GstS1	HGNC:4637	OMIM:138385	GSTM5	3		
FBgn0010226	GstS1	HGNC:4638	OMIM:134660	GSTP1	3		
FBgn0000577	en	HGNC:3343	OMIM:131310	EN2	9		
FBgn0000577	en	HGNC:3342	OMIM:131290	EN1	10	619218	619218[ENDOVE SYNDROME, LIMB-BRAIN TYPE; ENDOVESLB]
FBgn0000028	acj6	HGNC:9219	OMIM:113725	POU4F2	12		
FBgn0000028	acj6	HGNC:9220	OMIM:602460	POU4F3	12	602459	602459[DEAFNESS, AUTOSOMAL DOMINANT 15; DFNA15]
FBgn0000028	acj6	HGNC:9218	OMIM:601632	POU4F1	10	619352	619352[ATAXIA, INTENTION TREMOR, AND HYPOTONIA SYNDROME, CHILDHOOD-ONSET; ATITHS]
FBgn0022710	Ac13E	HGNC:240	OMIM:603302	ADCY9	14		
FBgn0012034	AcCoAS	HGNC:16091	OMIM:614355	ACSS1	6		
FBgn0012034	AcCoAS	HGNC:15814	OMIM:605832	ACSS2	14		
FBgn0012034	AcCoAS	HGNC:24723	OMIM:614356	ACSS3	3		
FBgn0027866	CG9776	HGNC:13578	OMIM:617512	ZNF318	8		
FBgn0038201	PK1-R	HGNC:4518	OMIM:604153	NMUR1	12		
FBgn0038201	PK1-R	HGNC:16454	OMIM:605108	NMUR2	12		
FBgn0038201	PK1-R	HGNC:4267	OMIM:601898	GHSR	3	615925	615925[GROWTH HORMONE DEFICIENCY, ISOLATED PARTIAL; GHDP]
FBgn0038201	PK1-R	HGNC:4495	OMIM:602885	MLNR	3		
FBgn0000721	for	HGNC:9416	OMIM:601591	PRKG2	5	619636,619638	619636[ACROMESOMELIC DYSPLASIA 4; AMD4],619638[SPONDYLOMETAPHYSEAL DYSPLASIA, PAGNAMENTA TYPE; SMDP]
FBgn0000721	for	HGNC:9414	OMIM:176894	PRKG1	13	615436	615436[AORTIC ANEURYSM, FAMILIAL THORACIC 8; AAT8]
FBgn0034420	CG10737	HGNC:1266	OMIM:617581	C2CD2	6		
FBgn0034420	CG10737	HGNC:29000	OMIM:617582	C2CD2L	3		
FBgn0003218	rdgB	HGNC:21044	OMIM:608920	PITPNM2	13		
FBgn0003218	rdgB	HGNC:9003	OMIM:608794	PITPNM1	11		
FBgn0003218	rdgB	HGNC:21043	OMIM:608921	PITPNM3	8	600977	600977[CONE-ROD DYSTROPHY 5; CORD5]
FBgn0024836	stan	HGNC:3231	OMIM:604265	CELSR2	13		
FBgn0024836	stan	HGNC:1850	OMIM:604523	CELSR1	13	619319	619319[LYMPHATIC MALFORMATION 9; LMPHM9]
FBgn0024836	stan	HGNC:3230	OMIM:604264	CELSR3	12		
FBgn0025936	Eph	HGNC:3394	OMIM:601839	EPHB3	10		
FBgn0025936	Eph	HGNC:19987	OMIM:611123	EPHA10	8		
FBgn0025936	Eph	HGNC:3396	OMIM:602757	EPHB6	8		
FBgn0025936	Eph	HGNC:3393	OMIM:600997	EPHB2	12	603688,618462	603688[PROSTATE CANCER/BRAIN CANCER SUSCEPTIBILITY],618462[BLEEDING DISORDER, PLATELET-TYPE, 22; BDPLT22]
FBgn0025936	Eph	HGNC:3390	OMIM:602190	EPHA7	11		
FBgn0025936	Eph	HGNC:3387	OMIM:179611	EPHA3	10		
FBgn0025936	Eph	HGNC:3386	OMIM:176946	EPHA2	10	116600	116600[CATARACT 6, MULTIPLE TYPES; CTRCT6]
FBgn0025936	Eph	HGNC:3391	OMIM:176945	EPHA8	10		
FBgn0025936	Eph	HGNC:3389	OMIM:600004	EPHA5	11		
FBgn0025936	Eph	HGNC:3385	OMIM:179610	EPHA1	6		
FBgn0025936	Eph	HGNC:19296	OMIM:600066	EPHA6	10		
FBgn0025936	Eph	HGNC:3395	OMIM:600011	EPHB4	10	617300,618196	617300[LYMPHATIC MALFORMATION 7; LMPHM7],618196[CAPILLARY MALFORMATION-ARTERIOVENOUS MALFORMATION 2; CMAVM2]
FBgn0025936	Eph	HGNC:3388	OMIM:602188	EPHA4	11		
FBgn0025936	Eph	HGNC:3392	OMIM:600600	EPHB1	13		
FBgn0000578	ena	HGNC:20234	OMIM:616912	EVL	9		
FBgn0000578	ena	HGNC:18271	OMIM:609061	ENAH	8		
FBgn0000578	ena	HGNC:12652	OMIM:601703	VASP	7		
FBgn0031649	hoe2	HGNC:8101	OMIM:611409	OCA2	11	203200,227220	203200[ALBINISM, OCULOCUTANEOUS, TYPE II; OCA2],227220[SKIN/HAIR/EYE PIGMENTATION, VARIATION IN, 1; SHEP1]
FBgn0032668	CG17681	HGNC:21349	OMIM:614763	GLYATL3	6		
FBgn0032668	CG17681	HGNC:30519	OMIM:614761	GLYATL1	4		
FBgn0032668	CG17681	HGNC:24178	OMIM:614762	GLYATL2	4		
FBgn0032668	CG17681	HGNC:13734	OMIM:607424	GLYAT	4		
FBgn0032668	CG17681	HGNC:37865		GLYATL1B	3		
FBgn0041210	HDAC4	HGNC:14067	OMIM:606542	HDAC7	8		
FBgn0041210	HDAC4	HGNC:14063	OMIM:605314	HDAC4	11	619797	619797[NEURODEVELOPMENTAL DISORDER WITH CENTRAL HYPOTONIA AND DYSMORPHIC FACIES; NEDCHF]
FBgn0041210	HDAC4	HGNC:14064	OMIM:300272	HDAC6	3	300863	300863[CHONDRODYSPLASIA WITH PLATYSPONDYLY, DISTINCTIVE BRACHYDACTYLY, HYDROCEPHALY, AND MICROPHTHALMIA]
FBgn0041210	HDAC4	HGNC:18128	OMIM:608544	HDAC10	3		
FBgn0041210	HDAC4	HGNC:14068	OMIM:605315	HDAC5	10		
FBgn0041210	HDAC4	HGNC:14065	OMIM:606543	HDAC9	9		
FBgn0001269	inv	HGNC:3343	OMIM:131310	EN2	8		
FBgn0001269	inv	HGNC:3342	OMIM:131290	EN1	9	619218	619218[ENDOVE SYNDROME, LIMB-BRAIN TYPE; ENDOVESLB]
FBgn0027608	CG2082	HGNC:7679	OMIM:605262	NDRG1	7	601455	601455[CHARCOT-MARIE-TOOTH DISEASE, TYPE 4D; CMT4D]
FBgn0027608	CG2082	HGNC:14462	OMIM:605273	NDRG3	7		
FBgn0027608	CG2082	HGNC:14460	OMIM:605272	NDRG2	6		
FBgn0027608	CG2082	HGNC:14466	OMIM:614463	NDRG4	6		
FBgn0039900	Syt7	HGNC:11510	OMIM:600104	SYT2	3	616040,619461	616040[MYASTHENIC SYNDROME, CONGENITAL, 7A, PRESYNAPTIC, AND DISTAL MOTOR NEUROPATHY, AUTOSOMAL DOMINANT; CMS7A],619461[MYASTHENIC SYNDROME, CONGENITAL, 7B, PRESYNAPTIC, AUTOSOMAL RECESSIVE; CMS7B]
FBgn0039900	Syt7	HGNC:19265	OMIM:613528	SYT9	3		
FBgn0039900	Syt7	HGNC:11512	OMIM:600103	SYT4	3		
FBgn0039900	Syt7	HGNC:19239	OMIM:608741	SYT11	3		
FBgn0039900	Syt7	HGNC:11509	OMIM:185605	SYT1	3	618218	618218[BAKER-GORDON SYNDROME; BAGOS]
FBgn0039900	Syt7	HGNC:11514	OMIM:604146	SYT7	11		
FBgn0039900	Syt7	HGNC:11511	OMIM:600327	SYT3	3		
FBgn0039900	Syt7	HGNC:19266		SYT10	3		
FBgn0039900	Syt7	HGNC:11513	OMIM:600782	SYT5	3		
FBgn0039900	Syt7	HGNC:19264	OMIM:607719	SYT8	3		
FBgn0039900	Syt7	HGNC:0		LOC102724488	3		
FBgn0031474	CG2991	HGNC:28728	OMIM:613333	MARCHF3	3		
FBgn0025726	unc-13	HGNC:12566	OMIM:605836	UNC13B	8		
FBgn0025726	unc-13	HGNC:23149	OMIM:614568	UNC13C	7		
FBgn0025726	unc-13	HGNC:23150	OMIM:609894	UNC13A	10		
FBgn0051721	Trim9	HGNC:31859	OMIM:610584	TRIM67	11		
FBgn0051721	Trim9	HGNC:16288	OMIM:606555	TRIM9	12		
FBgn0051992	gw	HGNC:11969	OMIM:610739	TNRC6A	8	618074	618074[EPILEPSY, FAMILIAL ADULT MYOCLONIC, 6; FAME6]
FBgn0051992	gw	HGNC:29190	OMIM:610740	TNRC6B	8	619243	619243[GLOBAL DEVELOPMENTAL DELAY WITH SPEECH AND BEHAVIORAL ABNORMALITIES; GDSBA]
FBgn0051992	gw	HGNC:29318	OMIM:610741	TNRC6C	10		
FBgn0028341	Ptpmeg2	HGNC:9661	OMIM:600768	PTPN9	11		
FBgn0029870	Marf	HGNC:16877	OMIM:608507	MFN2	13	601152,609260,617087	601152[NEUROPATHY, HEREDITARY MOTOR AND SENSORY, TYPE VIA, WITH OPTIC ATROPHY; HMSN6A],609260[CHARCOT-MARIE-TOOTH DISEASE, AXONAL, AUTOSOMAL DOMINANT, TYPE 2A2A; CMT2A2A],617087[CHARCOT-MARIE-TOOTH DISEASE, AXONAL, AUTOSOMAL RECESSIVE, TYPE 2A2B; CMT2A2B]
FBgn0029870	Marf	HGNC:18262	OMIM:608506	MFN1	11		
FBgn0035001	Slik	HGNC:11388	OMIM:603919	STK10	13		
FBgn0035001	Slik	HGNC:11088	OMIM:616563	SLK	11		
FBgn0026533	Dek	HGNC:2768	OMIM:125264	DEK	9	125264	125264[DEK ONCOGENE; DEK]
FBgn0036534	DCP2	HGNC:24452	OMIM:609844	DCP2	9		
FBgn0036144	GlcAT-P	HGNC:923	OMIM:606374	B3GAT3	3	245600	245600[MULTIPLE JOINT DISLOCATIONS, SHORT STATURE, AND CRANIOFACIAL DYSMORPHISM WITH OR WITHOUT CONGENITAL HEART DEFECTS; JDSCD]
FBgn0036144	GlcAT-P	HGNC:922	OMIM:607497	B3GAT2	3		
FBgn0036144	GlcAT-P	HGNC:921	OMIM:151290	B3GAT1	4		
FBgn0038139	PK2-R2	HGNC:4518	OMIM:604153	NMUR1	9		
FBgn0038139	PK2-R2	HGNC:16454	OMIM:605108	NMUR2	9		
FBgn0038139	PK2-R2	HGNC:4267	OMIM:601898	GHSR	3	615925	615925[GROWTH HORMONE DEFICIENCY, ISOLATED PARTIAL; GHDP]
FBgn0038139	PK2-R2	HGNC:4495	OMIM:602885	MLNR	3		
FBgn0027529	tapas	HGNC:30831	OMIM:611258	TDRD7	8	613887	613887[CATARACT 36; CTRCT36]
FBgn0031802	ppk7	HGNC:101	OMIM:611741	ASIC3	4		
FBgn0031802	ppk7	HGNC:100	OMIM:602866	ASIC1	5		
FBgn0031802	ppk7	HGNC:21263	OMIM:606715	ASIC4	6		
FBgn0031802	ppk7	HGNC:99	OMIM:601784	ASIC2	3		
FBgn0031802	ppk7	HGNC:17537	OMIM:616693	ASIC5	5		
FBgn0031802	ppk7	HGNC:10600	OMIM:600760	SCNN1B	4	177200,211400,264350	177200[LIDDLE SYNDROME 1; LIDLS1],211400[BRONCHIECTASIS WITH OR WITHOUT ELEVATED SWEAT CHLORIDE 1; BESC1],264350[PSEUDOHYPOALDOSTERONISM, TYPE I, AUTOSOMAL RECESSIVE; PHA1B]
FBgn0031802	ppk7	HGNC:10602	OMIM:600761	SCNN1G	3	264350,613071,618114	264350[PSEUDOHYPOALDOSTERONISM, TYPE I, AUTOSOMAL RECESSIVE; PHA1B],613071[BRONCHIECTASIS WITH OR WITHOUT ELEVATED SWEAT CHLORIDE 3; BESC3],618114[LIDDLE SYNDROME 2; LIDLS2]
FBgn0030641	CG6299	HGNC:24867	OMIM:608949	GLTP	12		
FBgn0030641	CG6299	HGNC:30037	OMIM:608639	PLEKHA8	5		
FBgn0029736	CG4041	HGNC:28261	OMIM:616899	TBCK	14	616900	616900[HYPOTONIA, INFANTILE, WITH PSYCHOMOTOR RETARDATION AND CHARACTERISTIC FACIES 3; IHPRF3]
FBgn0030662	Chsy	HGNC:17198	OMIM:608183	CHSY1	15	605282	605282[TEMTAMY PREAXIAL BRACHYDACTYLY SYNDROME; TPBS]
FBgn0030662	Chsy	HGNC:24293	OMIM:609963	CHSY3	13		
FBgn0035978	UGP	HGNC:12527	OMIM:191760	UGP2	14	618744	618744[DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 83; DEE83]
FBgn0031530	Pgant2	HGNC:23233	OMIM:615132	GALNT16	4		
FBgn0031530	Pgant2	HGNC:22946	OMIM:608225	GALNT14	5		
FBgn0031530	Pgant2	HGNC:4124	OMIM:602274	GALNT2	15	618885	618885[CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIt; CDG2T]
FBgn0031530	Pgant2	HGNC:21531	OMIM:615131	GALNT15	3		
FBgn0037100	CapaR	HGNC:4518	OMIM:604153	NMUR1	11		
FBgn0037100	CapaR	HGNC:16454	OMIM:605108	NMUR2	14		
FBgn0037100	CapaR	HGNC:4267	OMIM:601898	GHSR	3	615925	615925[GROWTH HORMONE DEFICIENCY, ISOLATED PARTIAL; GHDP]
FBgn0037100	CapaR	HGNC:4495	OMIM:602885	MLNR	3		
FBgn0034417	CG15117	HGNC:4696	OMIM:611499	GUSB	14	253220	253220[MUCOPOLYSACCHARIDOSIS, TYPE VII; MPS7]
FBgn0031294	IA-2	HGNC:9677	OMIM:601698	PTPRN2	10		
FBgn0031294	IA-2	HGNC:9676	OMIM:601773	PTPRN	11		
FBgn0000542	ec	HGNC:29255	OMIM:617431	USP53	4	619658	619658[CHOLESTASIS, PROGRESSIVE FAMILIAL INTRAHEPATIC, 7, WITH OR WITHOUT HEARING LOSS; PFIC7]
FBgn0000542	ec	HGNC:23513		USP54	6		
FBgn0050372	Asap	HGNC:2720	OMIM:605953	ASAP1	11		
FBgn0050372	Asap	HGNC:2721	OMIM:603817	ASAP2	12		
FBgn0050372	Asap	HGNC:14987	OMIM:616594	ASAP3	7		
FBgn0030844	ppk23	HGNC:101	OMIM:611741	ASIC3	3		
FBgn0030844	ppk23	HGNC:100	OMIM:602866	ASIC1	4		
FBgn0030844	ppk23	HGNC:21263	OMIM:606715	ASIC4	3		
FBgn0030844	ppk23	HGNC:99	OMIM:601784	ASIC2	3		
FBgn0030844	ppk23	HGNC:17537	OMIM:616693	ASIC5	4		
FBgn0031536	Cog3	HGNC:18619	OMIM:606975	COG3	14		
FBgn0039675	ppk21	HGNC:101	OMIM:611741	ASIC3	4		
FBgn0039675	ppk21	HGNC:100	OMIM:602866	ASIC1	3		
FBgn0039675	ppk21	HGNC:21263	OMIM:606715	ASIC4	5		
FBgn0039675	ppk21	HGNC:99	OMIM:601784	ASIC2	3		
FBgn0039675	ppk21	HGNC:17537	OMIM:616693	ASIC5	5		
FBgn0039676	ppk20	HGNC:101	OMIM:611741	ASIC3	4		
FBgn0039676	ppk20	HGNC:100	OMIM:602866	ASIC1	4		
FBgn0039676	ppk20	HGNC:21263	OMIM:606715	ASIC4	4		
FBgn0039676	ppk20	HGNC:99	OMIM:601784	ASIC2	3		
FBgn0039676	ppk20	HGNC:17537	OMIM:616693	ASIC5	4		
FBgn0020279	lig	HGNC:29877	OMIM:616472	UBAP2L	10		
FBgn0020279	lig	HGNC:14185		UBAP2	11		
FBgn0015777	nrv2	HGNC:804	OMIM:182330	ATP1B1	12	145500	145500[HYPERTENSION, ESSENTIAL]
FBgn0015777	nrv2	HGNC:806	OMIM:601867	ATP1B3	9		
FBgn0015777	nrv2	HGNC:805	OMIM:182331	ATP1B2	10		
FBgn0015777	nrv2	HGNC:820	OMIM:137217	ATP4B	6		
FBgn0015777	nrv2	HGNC:808	OMIM:301073	ATP1B4	10		
FBgn0029105	alpha-Catr	HGNC:2512	OMIM:604785	CTNNAL1	14		
FBgn0038570	Prx5	HGNC:9355	OMIM:606583	PRDX5	13		
FBgn0038571	CG7215	HGNC:32309	OMIM:611127	UBL4B	6		
FBgn0038571	CG7215	HGNC:12505	OMIM:312070	UBL4A	10		
FBgn0031039	Shawn	HGNC:29680	OMIM:610821	SLC25A40	9		
FBgn0031039	Shawn	HGNC:24279	OMIM:610820	SLC25A39	8		
FBgn0031038	Tyler	HGNC:29680	OMIM:610821	SLC25A40	7		
FBgn0031038	Tyler	HGNC:24279	OMIM:610820	SLC25A39	7		
FBgn0050481	mRpL53	HGNC:16684	OMIM:611857	MRPL53	8		
FBgn0013576	mtd	HGNC:21081	OMIM:609752	NCOA7	12		
FBgn0013576	mtd	HGNC:15822	OMIM:605609	OXR1	12	213000	213000[CEREBELLAR HYPOPLASIA/ATROPHY, EPILEPSY, AND GLOBAL DEVELOPMENTAL DELAY; CHEGDD]
FBgn0013576	mtd	HGNC:16112		TLDC2	5		
FBgn0043002	Chrac-14	HGNC:13546	OMIM:607267	POLE3	13		
FBgn0002887	mus201	HGNC:3437	OMIM:133530	ERCC5	10	278780,616570	278780[XERODERMA PIGMENTOSUM, COMPLEMENTATION GROUP G; XPG],616570[CEREBROOCULOFACIOSKELETAL SYNDROME 3; COFS3]
FBgn0002887	mus201	HGNC:43690		BIVM-ERCC5	4		
FBgn0035253	Srrm234	HGNC:16639	OMIM:606032	SRRM2	6		
FBgn0035253	Srrm234	HGNC:26729		SRRM3	4		
FBgn0064115	GatC	HGNC:25068	OMIM:617210	GATC	13	618839	618839[COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 42; COXPD42]
FBgn0004407	PolG2	HGNC:9180	OMIM:604983	POLG2	9	610131,618528,619425	610131[PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL DOMINANT 4; PEOA4],618528[MITOCHONDRIAL DNA DEPLETION SYNDROME 16 (HEPATIC TYPE); MTDPS16],619425[MITOCHONDRIAL DNA DEPLETION SYNDROME 16B (NEUROOPHTHALMIC TYPE); MTDPS16B]
FBgn0053653	Cadps	HGNC:16018	OMIM:609978	CADPS2	11		
FBgn0053653	Cadps	HGNC:1426	OMIM:604667	CADPS	14		
FBgn0034618	CG9485	HGNC:321	OMIM:610860	AGL	15	232400	232400[GLYCOGEN STORAGE DISEASE III; GSD3]
FBgn0037555	Ada2b	HGNC:30781	OMIM:608790	TADA2B	15		
FBgn0037555	Ada2b	HGNC:11531	OMIM:602276	TADA2A	5		
FBgn0000153	b	HGNC:4092	OMIM:605363	GAD1	5	619124	619124[DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 89; DEE89]
FBgn0000153	b	HGNC:4093	OMIM:138275	GAD2	5		
FBgn0000153	b	HGNC:18966	OMIM:616569	CSAD	13		
FBgn0000153	b	HGNC:27949	OMIM:615601	GADL1	11		
FBgn0001223	Hsp22	HGNC:2388	OMIM:123580	CRYAA	4	604219	604219[CATARACT 9, MULTIPLE TYPES; CTRCT9]
FBgn0001223	Hsp22	HGNC:26511	OMIM:610695	HSPB6	3		
FBgn0001223	Hsp22	HGNC:5247	OMIM:602179	HSPB2	3		
FBgn0001223	Hsp22	HGNC:2389	OMIM:123590	CRYAB	4	608810,613763,613869,615184	608810[MYOPATHY, MYOFIBRILLAR, 2; MFM2],613763[CATARACT 16, MULTIPLE TYPES; CTRCT16],613869[MYOPATHY, MYOFIBRILLAR, FATAL INFANTILE HYPERTONIC, ALPHA-B CRYSTALLIN-RELATED],615184[CARDIOMYOPATHY, DILATED, 1II; CMD1II]
FBgn0001223	Hsp22	HGNC:30171	OMIM:608014	HSPB8	3	158590,608673	158590[NEURONOPATHY, DISTAL HEREDITARY MOTOR, TYPE IIA; HMN2A],608673[CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2L; CMT2L]
FBgn0001223	Hsp22	HGNC:5246	OMIM:602195	HSPB1	3	606595,608634	606595[CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2F; CMT2F],608634[NEURONOPATHY, DISTAL HEREDITARY MOTOR, TYPE IIB; HMN2B]
FBgn0001223	Hsp22	HGNC:0		CRYAA2	4		
FBgn0001228	CG4456	HGNC:35410	OMIM:616041	TSTD1	9		
FBgn0001228	CG4456	HGNC:40910		TSTD3	3		
FBgn0033380	Phax	HGNC:10241	OMIM:604924	PHAX	12		
FBgn0061359	Mvk	HGNC:7530	OMIM:251170	MVK	10	175900,260920,610377	175900[POROKERATOSIS 3, MULTIPLE TYPES; POROK3],260920[HYPER-IgD SYNDROME; HIDS],610377[MEVALONIC ACIDURIA; MEVA]
FBgn0061360	CG33672	HGNC:29488	OMIM:613182	BOLA2	6		
FBgn0061360	CG33672	HGNC:24263	OMIM:613181	BOLA1	3		
FBgn0061360	CG33672	HGNC:24415	OMIM:613183	BOLA3	3	614299	614299[MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 2 WITH HYPERGLYCINEMIA; MMDS2]
FBgn0061360	CG33672	HGNC:32479		BOLA2B	10		
FBgn0053673	CG33673	HGNC:4589	OMIM:138251	GRINA	3		
FBgn0053673	CG33673	HGNC:17067	OMIM:604306	FAIM2	4		
FBgn0053673	CG33673	HGNC:23410	OMIM:610364	TMBIM1	3		
FBgn0053673	CG33673	HGNC:24257	OMIM:616874	TMBIM4	3		
FBgn0067622	LSm-4	HGNC:17902	OMIM:608216	COMMD5	8		
FBgn0032240	CG17768	HGNC:17259	OMIM:607284	LSM4	11		
FBgn0029504	CHES-1-like	HGNC:5281	OMIM:143089	FOXN2	4		
FBgn0029504	CHES-1-like	HGNC:1928	OMIM:602628	FOXN3	6		
FBgn0041775	tral	HGNC:24489	OMIM:610677	LSM14A	12		
FBgn0041775	tral	HGNC:15887		LSM14B	11		
FBgn0003507	srp	HGNC:4173	OMIM:600576	GATA4	4	187500,607941,614429,614430,615542	187500[TETRALOGY OF FALLOT; TOF],607941[ATRIAL SEPTAL DEFECT 2; ASD2],614429[VENTRICULAR SEPTAL DEFECT 1; VSD1],614430[ATRIOVENTRICULAR SEPTAL DEFECT 4; AVSD4],615542[TESTICULAR ANOMALIES WITH OR WITHOUT CONGENITAL HEART DISEASE; TACHD]
FBgn0003507	srp	HGNC:4170	OMIM:305371	GATA1	5	190685,300367,300835,301083,314050	190685[DOWN SYNDROME],300367[THROMBOCYTOPENIA, X-LINKED, WITH OR WITHOUT DYSERYTHROPOIETIC ANEMIA; XLTDA],300835[ANEMIA, X-LINKED, WITH OR WITHOUT NEUTROPENIA AND/OR PLATELET ABNORMALITIES; XLANP],301083[ADENOSINE DEAMINASE, ELEVATED, HEMOLYTIC ANEMIA DUE TO; HAEADA],314050[THROMBOCYTOPENIA WITH BETA-THALASSEMIA, X-LINKED; XLTT]
FBgn0003507	srp	HGNC:15802	OMIM:611496	GATA5	4	617912	617912[CONGENITAL HEART DEFECTS, MULTIPLE TYPES, 5; CHTD5]
FBgn0003507	srp	HGNC:4172	OMIM:131320	GATA3	5	146255	146255[HYPOPARATHYROIDISM, SENSORINEURAL DEAFNESS, AND RENAL DYSPLASIA SYNDROME; HDRS]
FBgn0003507	srp	HGNC:4174	OMIM:601656	GATA6	5	187500,217095,600001,614474,614475	187500[TETRALOGY OF FALLOT; TOF],217095[CONOTRUNCAL HEART MALFORMATIONS; CTHM],600001[HEART DEFECTS, CONGENITAL, AND OTHER CONGENITAL ANOMALIES; HDCA],614474[ATRIOVENTRICULAR SEPTAL DEFECT 5; AVSD5],614475[ATRIAL SEPTAL DEFECT 9; ASD9]
FBgn0003507	srp	HGNC:4171	OMIM:137295	GATA2	5	601626,614038,614172,614286	601626[LEUKEMIA, ACUTE MYELOID; AML],614038[LYMPHEDEMA, PRIMARY, WITH MYELODYSPLASIA],614172[IMMUNODEFICIENCY 21; IMD21],614286[MYELODYSPLASTIC SYNDROME; MDS]
FBgn0003507	srp	HGNC:12340	OMIM:604386	TRPS1	3	190350,190351	190350[TRICHORHINOPHALANGEAL SYNDROME, TYPE I; TRPS1],190351[TRICHORHINOPHALANGEAL SYNDROME, TYPE III; TRPS3]
FBgn0002524	lace	HGNC:11278	OMIM:605713	SPTLC2	15	613640	613640[NEUROPATHY, HEREDITARY SENSORY AND AUTONOMIC, TYPE IC; HSAN1C]
FBgn0002524	lace	HGNC:16253	OMIM:611120	SPTLC3	12		
FBgn0037716	Son	HGNC:11183	OMIM:182465	SON	6	617140	617140[ZTTK SYNDROME; ZTTKS]
FBgn0002522	lab	HGNC:5132	OMIM:142987	HOXD1	5		
FBgn0002522	lab	HGNC:5099	OMIM:142955	HOXA1	7	601536	601536[ATHABASKAN BRAINSTEM DYSGENESIS SYNDROME; ABDS]
FBgn0002522	lab	HGNC:5111	OMIM:142968	HOXB1	6	614744	614744[FACIAL PARESIS, HEREDITARY CONGENITAL, 3; HCFP3]
FBgn0039157	Myo95E	HGNC:13880	OMIM:600642	MYO1G	3		
FBgn0039157	Myo95E	HGNC:7595	OMIM:601478	MYO1A	6		
FBgn0039157	Myo95E	HGNC:7597	OMIM:606538	MYO1C	3		
FBgn0039157	Myo95E	HGNC:7598	OMIM:606539	MYO1D	3		
FBgn0039157	Myo95E	HGNC:7596	OMIM:606537	MYO1B	8		
FBgn0011676	Nos	HGNC:7872	OMIM:163731	NOS1	12		
FBgn0011676	Nos	HGNC:7873	OMIM:163730	NOS2	10	611162	611162[MALARIA, SUSCEPTIBILITY TO]
FBgn0011676	Nos	HGNC:7876	OMIM:163729	NOS3	11	104300,145500,189800,601367	104300[ALZHEIMER DISEASE, FAMILIAL, 1; AD1],145500[HYPERTENSION, ESSENTIAL],189800[PREECLAMPSIA/ECLAMPSIA 1; PEE1],601367[STROKE, ISCHEMIC]
FBgn0037913	fabp	HGNC:3559	OMIM:600434	FABP4	10		
FBgn0037913	fabp	HGNC:3563		FABP9	9		
FBgn0037913	fabp	HGNC:15847	OMIM:611866	RBP5	3		
FBgn0037913	fabp	HGNC:2338	OMIM:180230	CRABP1	3		
FBgn0037913	fabp	HGNC:3557	OMIM:134651	FABP3	11		
FBgn0037913	fabp	HGNC:3562	OMIM:602965	FABP7	11		
FBgn0037913	fabp	HGNC:9117	OMIM:170715	PMP2	11	618279	618279[CHARCOT-MARIE-TOOTH DISEASE, DEMYELINATING, TYPE 1G; CMT1G]
FBgn0037913	fabp	HGNC:9920	OMIM:180280	RBP2	3		
FBgn0037913	fabp	HGNC:9919	OMIM:180260	RBP1	3		
FBgn0037913	fabp	HGNC:2339	OMIM:180231	CRABP2	3		
FBgn0037913	fabp	HGNC:3560	OMIM:605168	FABP5	8		
FBgn0037913	fabp	HGNC:34524	OMIM:618923	FABP12	9		
FBgn0037913	fabp	HGNC:30316	OMIM:608604	RBP7	3		
FBgn0037913	fabp	HGNC:3555	OMIM:134650	FABP1	3		
FBgn0037913	fabp	HGNC:3561	OMIM:600422	FABP6	3		
FBgn0037912	sea	HGNC:10979	OMIM:190315	SLC25A1	11	615182,618197	615182[COMBINED D-2- AND L-2-HYDROXYGLUTARIC ACIDURIA; D2L2AD],618197[MYASTHENIC SYNDROME, CONGENITAL, 23, PRESYNAPTIC; CMS23]
FBgn0031403	CG15387	HGNC:29521	OMIM:615140	C12orf57	12	218340	218340[TEMTAMY SYNDROME; TEMTYS]
FBgn0026239	gukh	HGNC:7820	OMIM:300457	NHS	4	302200,302350	302200[CATARACT 40; CTRCT40],302350[NANCE-HORAN SYNDROME; NHS]
FBgn0051016	CG31016	HGNC:8546	OMIM:176710	P4HA1	4		
FBgn0051016	CG31016	HGNC:30135	OMIM:608987	P4HA3	6		
FBgn0051016	CG31016	HGNC:8547	OMIM:600608	P4HA2	4	617238	617238[MYOPIA 25, AUTOSOMAL DOMINANT; MYP25]
FBgn0052423	shep	HGNC:9907	OMIM:602310	RBMS1	10		
FBgn0052423	shep	HGNC:9909	OMIM:602387	RBMS2	10		
FBgn0052423	shep	HGNC:13427	OMIM:605786	RBMS3	11		
FBgn0033884	CG13344	HGNC:14662	OMIM:616014	RNF25	13		
FBgn0040233	cana	HGNC:1856	OMIM:117143	CENPE	8	616051	616051[MICROCEPHALY 13, PRIMARY, AUTOSOMAL RECESSIVE; MCPH13]
FBgn0052831	CG33695	HGNC:28737	OMIM:617215	C17orf49	9		
FBgn0052843	Dh31-R	HGNC:1440	OMIM:114131	CALCR	11	166710	166710[OSTEOPOROSIS]
FBgn0052843	Dh31-R	HGNC:16709	OMIM:114190	CALCRL	14	618773	618773[LYMPHATIC MALFORMATION 8; LMPHM8]
FBgn0016919	nompB	HGNC:20606	OMIM:600595	IFT88	13		
FBgn0001624	dlg1	HGNC:2900	OMIM:601014	DLG1	13		
FBgn0001624	dlg1	HGNC:2902	OMIM:300189	DLG3	10	300850	300850[INTELLECTUAL DEVELOPMENTAL DISORDER, X-LINKED 90; XLID90]
FBgn0001624	dlg1	HGNC:2903	OMIM:602887	DLG4	12	618793	618793[INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL DOMINANT 62; MRD62]
FBgn0001624	dlg1	HGNC:2901	OMIM:603583	DLG2	11		
FBgn0039378	alpha4GT2	HGNC:18149	OMIM:607922	A4GALT	13	111400	111400[BLOOD GROUP, P1PK SYSTEM]
FBgn0039378	alpha4GT2	HGNC:17968	OMIM:616709	A4GNT	10		
FBgn0064116	anox	HGNC:23339	OMIM:616352	ACBD6	12		
FBgn0064117	SLIRP1	HGNC:20495	OMIM:610211	SLIRP	7		
FBgn0260458	PGRP-LD	HGNC:30013	OMIM:608199	PGLYRP2	3		
FBgn0260458	PGRP-LD	HGNC:8904	OMIM:604963	PGLYRP1	5		
FBgn0260458	PGRP-LD	HGNC:30014	OMIM:608197	PGLYRP3	5		
FBgn0260458	PGRP-LD	HGNC:30015	OMIM:608198	PGLYRP4	5		
FBgn0044419	Pmi	HGNC:16823	OMIM:618817	TMEM11	13		
FBgn0042182	CG18749	HGNC:8546	OMIM:176710	P4HA1	3		
FBgn0042182	CG18749	HGNC:30135	OMIM:608987	P4HA3	4		
FBgn0042182	CG18749	HGNC:8547	OMIM:600608	P4HA2	3	617238	617238[MYOPIA 25, AUTOSOMAL DOMINANT; MYP25]
FBgn0064126	CG33722	HGNC:13825	OMIM:606236	ASPSCR1	12	606243	606243[ALVEOLAR SOFT PART SARCOMA; ASPS]
FBgn0260439	Pp2A-29B	HGNC:9303	OMIM:603113	PPP2R1B	12	211980	211980[LUNG CANCER]
FBgn0260439	Pp2A-29B	HGNC:9302	OMIM:605983	PPP2R1A	15	616362	616362[INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL DOMINANT 36; MRD36]
FBgn0014163	fax	HGNC:20742		FAXC	9		
FBgn0040076	primo-2	HGNC:122	OMIM:171500	ACP1	11		
FBgn0051469	Argp	HGNC:122	OMIM:171500	ACP1	9		
FBgn0040077	primo-1	HGNC:122	OMIM:171500	ACP1	12		
FBgn0037550	CG9667	HGNC:29201	OMIM:612764	ISY1	6		
FBgn0037550	CG9667	HGNC:42969		ISY1-RAB43	10		
FBgn0014857	His3.3A	HGNC:4764	OMIM:601128	H3-3A	5	619720	619720[BRYANT-LI-BHOJ NEURODEVELOPMENTAL SYNDROME 1; BRYLIB1]
FBgn0014857	His3.3A	HGNC:20505		HIST2H3A	3		
FBgn0014857	His3.3A	HGNC:4766	OMIM:602810	HIST1H3A	3		
FBgn0014857	His3.3A	HGNC:25311		HIST2H3D	5		
FBgn0014857	His3.3A	HGNC:4773	OMIM:602816	H3C7	4		
FBgn0014857	His3.3A	HGNC:20503	OMIM:142780	HIST2H3C	3		
FBgn0014857	His3.3A	HGNC:4771	OMIM:602814	HIST1H3I	3		
FBgn0014857	His3.3A	HGNC:4768	OMIM:602812	H3C3	3		
FBgn0014857	His3.3A	HGNC:4765	OMIM:601058	H3-3B	10	619721	619721[BRYANT-LI-BHOJ NEURODEVELOPMENTAL SYNDROME 2; BRYLIB2]
FBgn0014857	His3.3A	HGNC:4774	OMIM:602817	HIST1H3J	3		
FBgn0014857	His3.3A	HGNC:4776	OMIM:602819	H3C2	3		
FBgn0014857	His3.3A	HGNC:4769	OMIM:602813	HIST1H3E	3		
FBgn0014857	His3.3A	HGNC:4778	OMIM:602820	HIST3H3	3		
FBgn0014857	His3.3A	HGNC:4767	OMIM:602811	HIST1H3D	3		
FBgn0014857	His3.3A	HGNC:4775	OMIM:602818	H3C10	3		
FBgn0014857	His3.3A	HGNC:33164	OMIM:616134	H3F3C	3		
FBgn0034518	CG13430	HGNC:11878	OMIM:606565	TMPRSS4	3		
FBgn0034519	BORCS7	HGNC:23516	OMIM:616600	BORCS7	9		
FBgn0003742	tra2	HGNC:16645	OMIM:602718	TRA2A	12		
FBgn0003742	tra2	HGNC:10781	OMIM:602719	TRA2B	11		
FBgn0036789	AstC-R2	HGNC:11330	OMIM:182451	SSTR1	7		
FBgn0036789	AstC-R2	HGNC:11333	OMIM:182454	SSTR4	8		
FBgn0036789	AstC-R2	HGNC:8153	OMIM:165195	OPRD1	3		
FBgn0036789	AstC-R2	HGNC:8154	OMIM:165196	OPRK1	3		
FBgn0036789	AstC-R2	HGNC:11331	OMIM:182452	SSTR2	9		
FBgn0036789	AstC-R2	HGNC:11332	OMIM:182453	SSTR3	7		
FBgn0036789	AstC-R2	HGNC:11334	OMIM:182455	SSTR5	7		
FBgn0038880	SIFaR	HGNC:17425	OMIM:607448	NPFFR1	8		
FBgn0038880	SIFaR	HGNC:4525	OMIM:607449	NPFFR2	8		
FBgn0029890	Fum2	HGNC:3700	OMIM:136850	FH	11	150800,606812	150800[HEREDITARY LEIOMYOMATOSIS AND RENAL CELL CANCER; HLRCC],606812[FUMARASE DEFICIENCY; FMRD]
FBgn0029891	Pink1	HGNC:14581	OMIM:608309	PINK1	10	605909	605909[PARKINSON DISEASE 6, AUTOSOMAL RECESSIVE EARLY-ONSET; PARK6]
FBgn0029888	ND-ASHI	HGNC:7703	OMIM:602140	NDUFB8	15	618252	618252[MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 32; MC1DN32]
FBgn0001099	gdl	HGNC:18551	OMIM:609459	DGCR6L	11		
FBgn0001099	gdl	HGNC:2846	OMIM:601279	DGCR6	7		
FBgn0001099	gdl	HGNC:0		LOC102724770	9		
FBgn0053774	CG33774	HGNC:32483	OMIM:618932	OST4	6		
FBgn0035497	CG14995	HGNC:1260	OMIM:603191	CFAP410	12	602271,617547	602271[SPONDYLOMETAPHYSEAL DYSPLASIA, AXIAL; SMDAX],617547[RETINAL DYSTROPHY WITH OR WITHOUT MACULAR STAPHYLOMA; RDMS]
FBgn0061362	Polr3K	HGNC:14121	OMIM:606007	POLR3K	13	619310	619310[LEUKODYSTROPHY, HYPOMYELINATING, 21; HLD21]
FBgn0061361	Tcs1	HGNC:28905	OMIM:612276	YRDC	13	619609	619609[GALLOWAY-MOWAT SYNDROME 10; GAMOS10]
FBgn0050462	ste24c	HGNC:12877	OMIM:606480	ZMPSTE24	6	275210,608612	275210[RESTRICTIVE DERMOPATHY 1; RSDM1],608612[MANDIBULOACRAL DYSPLASIA WITH TYPE B LIPODYSTROPHY; MADB]
FBgn0020912	Ptx1	HGNC:9005	OMIM:601542	PITX2	11	137600,180500,180550	137600[ANTERIOR SEGMENT DYSGENESIS 4; ASGD4],180500[AXENFELD-RIEGER SYNDROME, TYPE 1; RIEG1],180550[RING DERMOID OF CORNEA; RDC]
FBgn0020912	Ptx1	HGNC:9006	OMIM:602669	PITX3	8	107250,610623	107250[ANTERIOR SEGMENT DYSGENESIS 1; ASGD1],610623[CATARACT 11, MULTIPLE TYPES; CTRCT11]
FBgn0020912	Ptx1	HGNC:9004	OMIM:602149	PITX1	8	119800,186550	119800[CLUBFOOT, CONGENITAL, WITH OR WITHOUT DEFICIENCY OF LONG BONES AND/OR MIRROR-IMAGE POLYDACTYLY; CCF],186550[LIEBENBERG SYNDROME; LBNBG]
FBgn0035240	CG33791	HGNC:8124	OMIM:613022	OGDH	8	203740	203740[OXOGLUTARATE DEHYDROGENASE DEFICIENCY; OGDHD]
FBgn0035240	CG33791	HGNC:23537	OMIM:614984	DHTKD1	3	204750,615025	204750[ALPHA-AMINOADIPIC AND ALPHA-KETOADIPIC ACIDURIA; AAKAD],615025[CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2Q; CMT2Q]
FBgn0035240	CG33791	HGNC:25590	OMIM:617513	OGDHL	8	619701	619701[YOON-BELLEN NEURODEVELOPMENTAL SYNDROME; YOBELN]
FBgn0033693	CG13175	HGNC:17589	OMIM:607224	LTO1	7		
FBgn0051072	Lerp	HGNC:5467	OMIM:147280	IGF2R	8	114550	114550[HEPATOCELLULAR CARCINOMA]
FBgn0032077	CG9515	HGNC:751	OMIM:300162	ASMTL	9		
FBgn0032076	Argl	HGNC:746	OMIM:608310	ASL	12	207900	207900[ARGININOSUCCINIC ACIDURIA]
FBgn0001235	hth	HGNC:7001	OMIM:601740	MEIS2	11	600987	600987[CLEFT PALATE, CARDIAC DEFECTS, AND MENTAL RETARDATION; CPCMR]
FBgn0001235	hth	HGNC:7000	OMIM:601739	MEIS1	11		
FBgn0001235	hth	HGNC:29537	OMIM:619443	MEIS3	9		
FBgn0001235	hth	HGNC:11776	OMIM:602630	TGIF1	3	142946	142946[HOLOPROSENCEPHALY 4; HPE4]
FBgn0001235	hth	HGNC:16714	OMIM:613066	PKNOX2	3		
FBgn0000056	Adhr	HGNC:5154	OMIM:601688	HPGD	5	119900,259100	119900[DIGITAL CLUBBING, ISOLATED CONGENITAL; DIGC],259100[HYPERTROPHIC OSTEOARTHROPATHY, PRIMARY, AUTOSOMAL RECESSIVE, 1; PHOAR1]
FBgn0053096	CG33096	HGNC:28756	OMIM:617942	ABHD17A	11		
FBgn0053096	CG33096	HGNC:24278	OMIM:617943	ABHD17B	11		
FBgn0053096	CG33096	HGNC:26925	OMIM:617944	ABHD17C	12		
FBgn0053801	His1:CG33801	HGNC:4714	OMIM:142708	H1F0	5		
FBgn0053801	His1:CG33801	HGNC:4717	OMIM:142210	HIST1H1D	6		
FBgn0053801	His1:CG33801	HGNC:4716	OMIM:142710	HIST1H1C	6		
FBgn0053801	His1:CG33801	HGNC:4719	OMIM:142711	HIST1H1B	7		
FBgn0053801	His1:CG33801	HGNC:4715	OMIM:142709	HIST1H1A	5		
FBgn0053801	His1:CG33801	HGNC:4718	OMIM:142220	HIST1H1E	7	617537	617537[RAHMAN SYNDROME; RMNS]
FBgn0053801	His1:CG33801	HGNC:4720	OMIM:142712	HIST1H1T	6		
FBgn0053801	His1:CG33801	HGNC:4722	OMIM:602785	H1FX	4		
FBgn0053803	His3:CG33803	HGNC:4764	OMIM:601128	H3-3A	3	619720	619720[BRYANT-LI-BHOJ NEURODEVELOPMENTAL SYNDROME 1; BRYLIB1]
FBgn0053803	His3:CG33803	HGNC:4772	OMIM:602815	HIST1H3G	3		
FBgn0053803	His3:CG33803	HGNC:20505		HIST2H3A	4		
FBgn0053803	His3:CG33803	HGNC:4766	OMIM:602810	HIST1H3A	4		
FBgn0053803	His3:CG33803	HGNC:25311		HIST2H3D	4		
FBgn0053803	His3:CG33803	HGNC:4773	OMIM:602816	H3C7	4		
FBgn0053803	His3:CG33803	HGNC:20503	OMIM:142780	HIST2H3C	4		
FBgn0053803	His3:CG33803	HGNC:4771	OMIM:602814	HIST1H3I	4		
FBgn0053803	His3:CG33803	HGNC:4768	OMIM:602812	H3C3	4		
FBgn0053803	His3:CG33803	HGNC:4765	OMIM:601058	H3-3B	3	619721	619721[BRYANT-LI-BHOJ NEURODEVELOPMENTAL SYNDROME 2; BRYLIB2]
FBgn0053803	His3:CG33803	HGNC:4774	OMIM:602817	HIST1H3J	4		
FBgn0053803	His3:CG33803	HGNC:4776	OMIM:602819	H3C2	4		
FBgn0053803	His3:CG33803	HGNC:4769	OMIM:602813	HIST1H3E	4		
FBgn0053803	His3:CG33803	HGNC:4767	OMIM:602811	HIST1H3D	4		
FBgn0053803	His3:CG33803	HGNC:4775	OMIM:602818	H3C10	4		
FBgn0051617	His1:CG31617	HGNC:4714	OMIM:142708	H1F0	3		
FBgn0051617	His1:CG31617	HGNC:4719	OMIM:142711	HIST1H1B	3		
FBgn0051617	His1:CG31617	HGNC:4718	OMIM:142220	HIST1H1E	3	617537	617537[RAHMAN SYNDROME; RMNS]
FBgn0051618	His2A:CG31618	HGNC:4733	OMIM:602794	HIST1H2AC	3		
FBgn0051618	His2A:CG31618	HGNC:20507	OMIM:615015	HIST3H2A	3		
FBgn0051618	His2A:CG31618	HGNC:4738	OMIM:602797	H2AC20	3		
FBgn0051618	His2A:CG31618	HGNC:18729	OMIM:613499	HIST1H2AA	3		
FBgn0051618	His2A:CG31618	HGNC:29668		HIST2H2AA4	3		
FBgn0051613	His3:CG31613	HGNC:4764	OMIM:601128	H3-3A	3	619720	619720[BRYANT-LI-BHOJ NEURODEVELOPMENTAL SYNDROME 1; BRYLIB1]
FBgn0051613	His3:CG31613	HGNC:4772	OMIM:602815	HIST1H3G	3		
FBgn0051613	His3:CG31613	HGNC:20505		HIST2H3A	4		
FBgn0051613	His3:CG31613	HGNC:4766	OMIM:602810	HIST1H3A	4		
FBgn0051613	His3:CG31613	HGNC:25311		HIST2H3D	5		
FBgn0051613	His3:CG31613	HGNC:4773	OMIM:602816	H3C7	4		
FBgn0051613	His3:CG31613	HGNC:20503	OMIM:142780	HIST2H3C	4		
FBgn0051613	His3:CG31613	HGNC:4771	OMIM:602814	HIST1H3I	4		
FBgn0051613	His3:CG31613	HGNC:4768	OMIM:602812	H3C3	4		
FBgn0051613	His3:CG31613	HGNC:4765	OMIM:601058	H3-3B	3	619721	619721[BRYANT-LI-BHOJ NEURODEVELOPMENTAL SYNDROME 2; BRYLIB2]
FBgn0051613	His3:CG31613	HGNC:4774	OMIM:602817	HIST1H3J	4		
FBgn0051613	His3:CG31613	HGNC:4776	OMIM:602819	H3C2	5		
FBgn0051613	His3:CG31613	HGNC:4769	OMIM:602813	HIST1H3E	4		
FBgn0051613	His3:CG31613	HGNC:4767	OMIM:602811	HIST1H3D	4		
FBgn0051613	His3:CG31613	HGNC:4775	OMIM:602818	H3C10	4		
FBgn0053806	His3:CG33806	HGNC:4764	OMIM:601128	H3-3A	3	619720	619720[BRYANT-LI-BHOJ NEURODEVELOPMENTAL SYNDROME 1; BRYLIB1]
FBgn0053806	His3:CG33806	HGNC:4772	OMIM:602815	HIST1H3G	3		
FBgn0053806	His3:CG33806	HGNC:20505		HIST2H3A	4		
FBgn0053806	His3:CG33806	HGNC:4766	OMIM:602810	HIST1H3A	4		
FBgn0053806	His3:CG33806	HGNC:25311		HIST2H3D	4		
FBgn0053806	His3:CG33806	HGNC:4773	OMIM:602816	H3C7	4		
FBgn0053806	His3:CG33806	HGNC:20503	OMIM:142780	HIST2H3C	4		
FBgn0053806	His3:CG33806	HGNC:4771	OMIM:602814	HIST1H3I	4		
FBgn0053806	His3:CG33806	HGNC:4768	OMIM:602812	H3C3	4		
FBgn0053806	His3:CG33806	HGNC:4765	OMIM:601058	H3-3B	3	619721	619721[BRYANT-LI-BHOJ NEURODEVELOPMENTAL SYNDROME 2; BRYLIB2]
FBgn0053806	His3:CG33806	HGNC:4774	OMIM:602817	HIST1H3J	4		
FBgn0053806	His3:CG33806	HGNC:4776	OMIM:602819	H3C2	4		
FBgn0053806	His3:CG33806	HGNC:4769	OMIM:602813	HIST1H3E	4		
FBgn0053806	His3:CG33806	HGNC:4767	OMIM:602811	HIST1H3D	4		
FBgn0053806	His3:CG33806	HGNC:4775	OMIM:602818	H3C10	4		
FBgn0053807	His1:CG33807	HGNC:4714	OMIM:142708	H1F0	5		
FBgn0053807	His1:CG33807	HGNC:4717	OMIM:142210	HIST1H1D	6		
FBgn0053807	His1:CG33807	HGNC:4716	OMIM:142710	HIST1H1C	6		
FBgn0053807	His1:CG33807	HGNC:4719	OMIM:142711	HIST1H1B	7		
FBgn0053807	His1:CG33807	HGNC:4715	OMIM:142709	HIST1H1A	5		
FBgn0053807	His1:CG33807	HGNC:4718	OMIM:142220	HIST1H1E	7	617537	617537[RAHMAN SYNDROME; RMNS]
FBgn0053807	His1:CG33807	HGNC:4720	OMIM:142712	HIST1H1T	5		
FBgn0053807	His1:CG33807	HGNC:4722	OMIM:602785	H1FX	4		
FBgn0053808	His2A:CG33808	HGNC:4733	OMIM:602794	HIST1H2AC	3		
FBgn0053808	His2A:CG33808	HGNC:20507	OMIM:615015	HIST3H2A	3		
FBgn0053808	His2A:CG33808	HGNC:4738	OMIM:602797	H2AC20	3		
FBgn0053808	His2A:CG33808	HGNC:18729	OMIM:613499	HIST1H2AA	3		
FBgn0053808	His2A:CG33808	HGNC:29668		HIST2H2AA4	3		
FBgn0053809	His3:CG33809	HGNC:4764	OMIM:601128	H3-3A	3	619720	619720[BRYANT-LI-BHOJ NEURODEVELOPMENTAL SYNDROME 1; BRYLIB1]
FBgn0053809	His3:CG33809	HGNC:4772	OMIM:602815	HIST1H3G	3		
FBgn0053809	His3:CG33809	HGNC:20505		HIST2H3A	5		
FBgn0053809	His3:CG33809	HGNC:4766	OMIM:602810	HIST1H3A	4		
FBgn0053809	His3:CG33809	HGNC:25311		HIST2H3D	5		
FBgn0053809	His3:CG33809	HGNC:4773	OMIM:602816	H3C7	4		
FBgn0053809	His3:CG33809	HGNC:20503	OMIM:142780	HIST2H3C	4		
FBgn0053809	His3:CG33809	HGNC:4771	OMIM:602814	HIST1H3I	4		
FBgn0053809	His3:CG33809	HGNC:4768	OMIM:602812	H3C3	4		
FBgn0053809	His3:CG33809	HGNC:4765	OMIM:601058	H3-3B	3	619721	619721[BRYANT-LI-BHOJ NEURODEVELOPMENTAL SYNDROME 2; BRYLIB2]
FBgn0053809	His3:CG33809	HGNC:4774	OMIM:602817	HIST1H3J	4		
FBgn0053809	His3:CG33809	HGNC:4776	OMIM:602819	H3C2	4		
FBgn0053809	His3:CG33809	HGNC:4769	OMIM:602813	HIST1H3E	4		
FBgn0053809	His3:CG33809	HGNC:4767	OMIM:602811	HIST1H3D	4		
FBgn0053809	His3:CG33809	HGNC:4775	OMIM:602818	H3C10	4		
FBgn0053812	His3:CG33812	HGNC:4764	OMIM:601128	H3-3A	3	619720	619720[BRYANT-LI-BHOJ NEURODEVELOPMENTAL SYNDROME 1; BRYLIB1]
FBgn0053812	His3:CG33812	HGNC:4772	OMIM:602815	HIST1H3G	3		
FBgn0053812	His3:CG33812	HGNC:20505		HIST2H3A	4		
FBgn0053812	His3:CG33812	HGNC:4766	OMIM:602810	HIST1H3A	4		
FBgn0053812	His3:CG33812	HGNC:25311		HIST2H3D	4		
FBgn0053812	His3:CG33812	HGNC:4773	OMIM:602816	H3C7	4		
FBgn0053812	His3:CG33812	HGNC:20503	OMIM:142780	HIST2H3C	5		
FBgn0053812	His3:CG33812	HGNC:4771	OMIM:602814	HIST1H3I	4		
FBgn0053812	His3:CG33812	HGNC:4768	OMIM:602812	H3C3	4		
FBgn0053812	His3:CG33812	HGNC:4765	OMIM:601058	H3-3B	3	619721	619721[BRYANT-LI-BHOJ NEURODEVELOPMENTAL SYNDROME 2; BRYLIB2]
FBgn0053812	His3:CG33812	HGNC:4774	OMIM:602817	HIST1H3J	4		
FBgn0053812	His3:CG33812	HGNC:4776	OMIM:602819	H3C2	4		
FBgn0053812	His3:CG33812	HGNC:4769	OMIM:602813	HIST1H3E	4		
FBgn0053812	His3:CG33812	HGNC:4767	OMIM:602811	HIST1H3D	4		
FBgn0053812	His3:CG33812	HGNC:4775	OMIM:602818	H3C10	4		
FBgn0053814	His2A:CG33814	HGNC:4733	OMIM:602794	HIST1H2AC	3		
FBgn0053814	His2A:CG33814	HGNC:20507	OMIM:615015	HIST3H2A	3		
FBgn0053814	His2A:CG33814	HGNC:4738	OMIM:602797	H2AC20	3		
FBgn0053814	His2A:CG33814	HGNC:18729	OMIM:613499	HIST1H2AA	3		
FBgn0053814	His2A:CG33814	HGNC:29668		HIST2H2AA4	3		
FBgn0053815	His3:CG33815	HGNC:4764	OMIM:601128	H3-3A	3	619720	619720[BRYANT-LI-BHOJ NEURODEVELOPMENTAL SYNDROME 1; BRYLIB1]
FBgn0053815	His3:CG33815	HGNC:4772	OMIM:602815	HIST1H3G	3		
FBgn0053815	His3:CG33815	HGNC:20505		HIST2H3A	5		
FBgn0053815	His3:CG33815	HGNC:4766	OMIM:602810	HIST1H3A	4		
FBgn0053815	His3:CG33815	HGNC:25311		HIST2H3D	4		
FBgn0053815	His3:CG33815	HGNC:4773	OMIM:602816	H3C7	4		
FBgn0053815	His3:CG33815	HGNC:20503	OMIM:142780	HIST2H3C	4		
FBgn0053815	His3:CG33815	HGNC:4771	OMIM:602814	HIST1H3I	4		
FBgn0053815	His3:CG33815	HGNC:4768	OMIM:602812	H3C3	4		
FBgn0053815	His3:CG33815	HGNC:4765	OMIM:601058	H3-3B	3	619721	619721[BRYANT-LI-BHOJ NEURODEVELOPMENTAL SYNDROME 2; BRYLIB2]
FBgn0053815	His3:CG33815	HGNC:4774	OMIM:602817	HIST1H3J	4		
FBgn0053815	His3:CG33815	HGNC:4776	OMIM:602819	H3C2	4		
FBgn0053815	His3:CG33815	HGNC:4769	OMIM:602813	HIST1H3E	4		
FBgn0053815	His3:CG33815	HGNC:4767	OMIM:602811	HIST1H3D	4		
FBgn0053815	His3:CG33815	HGNC:4775	OMIM:602818	H3C10	4		
FBgn0053817	His2A:CG33817	HGNC:4733	OMIM:602794	HIST1H2AC	3		
FBgn0053817	His2A:CG33817	HGNC:20507	OMIM:615015	HIST3H2A	3		
FBgn0053817	His2A:CG33817	HGNC:4738	OMIM:602797	H2AC20	3		
FBgn0053817	His2A:CG33817	HGNC:18729	OMIM:613499	HIST1H2AA	3		
FBgn0053817	His2A:CG33817	HGNC:29668		HIST2H2AA4	3		
FBgn0053818	His3:CG33818	HGNC:4764	OMIM:601128	H3-3A	3	619720	619720[BRYANT-LI-BHOJ NEURODEVELOPMENTAL SYNDROME 1; BRYLIB1]
FBgn0053818	His3:CG33818	HGNC:4772	OMIM:602815	HIST1H3G	3		
FBgn0053818	His3:CG33818	HGNC:20505		HIST2H3A	4		
FBgn0053818	His3:CG33818	HGNC:4766	OMIM:602810	HIST1H3A	4		
FBgn0053818	His3:CG33818	HGNC:25311		HIST2H3D	4		
FBgn0053818	His3:CG33818	HGNC:4773	OMIM:602816	H3C7	5		
FBgn0053818	His3:CG33818	HGNC:20503	OMIM:142780	HIST2H3C	4		
FBgn0053818	His3:CG33818	HGNC:4771	OMIM:602814	HIST1H3I	4		
FBgn0053818	His3:CG33818	HGNC:4768	OMIM:602812	H3C3	4		
FBgn0053818	His3:CG33818	HGNC:4765	OMIM:601058	H3-3B	3	619721	619721[BRYANT-LI-BHOJ NEURODEVELOPMENTAL SYNDROME 2; BRYLIB2]
FBgn0053818	His3:CG33818	HGNC:4774	OMIM:602817	HIST1H3J	4		
FBgn0053818	His3:CG33818	HGNC:4776	OMIM:602819	H3C2	4		
FBgn0053818	His3:CG33818	HGNC:4769	OMIM:602813	HIST1H3E	4		
FBgn0053818	His3:CG33818	HGNC:4767	OMIM:602811	HIST1H3D	4		
FBgn0053818	His3:CG33818	HGNC:4775	OMIM:602818	H3C10	4		
FBgn0053820	His2A:CG33820	HGNC:4733	OMIM:602794	HIST1H2AC	3		
FBgn0053820	His2A:CG33820	HGNC:20507	OMIM:615015	HIST3H2A	3		
FBgn0053820	His2A:CG33820	HGNC:4738	OMIM:602797	H2AC20	3		
FBgn0053820	His2A:CG33820	HGNC:18729	OMIM:613499	HIST1H2AA	3		
FBgn0053820	His2A:CG33820	HGNC:29668		HIST2H2AA4	3		
FBgn0053821	His3:CG33821	HGNC:4764	OMIM:601128	H3-3A	3	619720	619720[BRYANT-LI-BHOJ NEURODEVELOPMENTAL SYNDROME 1; BRYLIB1]
FBgn0053821	His3:CG33821	HGNC:4772	OMIM:602815	HIST1H3G	3		
FBgn0053821	His3:CG33821	HGNC:20505		HIST2H3A	4		
FBgn0053821	His3:CG33821	HGNC:4766	OMIM:602810	HIST1H3A	4		
FBgn0053821	His3:CG33821	HGNC:25311		HIST2H3D	4		
FBgn0053821	His3:CG33821	HGNC:4773	OMIM:602816	H3C7	4		
FBgn0053821	His3:CG33821	HGNC:20503	OMIM:142780	HIST2H3C	5		
FBgn0053821	His3:CG33821	HGNC:4771	OMIM:602814	HIST1H3I	4		
FBgn0053821	His3:CG33821	HGNC:4768	OMIM:602812	H3C3	4		
FBgn0053821	His3:CG33821	HGNC:4765	OMIM:601058	H3-3B	3	619721	619721[BRYANT-LI-BHOJ NEURODEVELOPMENTAL SYNDROME 2; BRYLIB2]
FBgn0053821	His3:CG33821	HGNC:4774	OMIM:602817	HIST1H3J	4		
FBgn0053821	His3:CG33821	HGNC:4776	OMIM:602819	H3C2	4		
FBgn0053821	His3:CG33821	HGNC:4769	OMIM:602813	HIST1H3E	4		
FBgn0053821	His3:CG33821	HGNC:4767	OMIM:602811	HIST1H3D	4		
FBgn0053821	His3:CG33821	HGNC:4775	OMIM:602818	H3C10	4		
FBgn0053823	His2A:CG33823	HGNC:4733	OMIM:602794	HIST1H2AC	3		
FBgn0053823	His2A:CG33823	HGNC:20507	OMIM:615015	HIST3H2A	3		
FBgn0053823	His2A:CG33823	HGNC:4738	OMIM:602797	H2AC20	3		
FBgn0053823	His2A:CG33823	HGNC:18729	OMIM:613499	HIST1H2AA	3		
FBgn0053823	His2A:CG33823	HGNC:29668		HIST2H2AA4	3		
FBgn0053824	His3:CG33824	HGNC:4764	OMIM:601128	H3-3A	3	619720	619720[BRYANT-LI-BHOJ NEURODEVELOPMENTAL SYNDROME 1; BRYLIB1]
FBgn0053824	His3:CG33824	HGNC:4772	OMIM:602815	HIST1H3G	3		
FBgn0053824	His3:CG33824	HGNC:20505		HIST2H3A	4		
FBgn0053824	His3:CG33824	HGNC:4766	OMIM:602810	HIST1H3A	4		
FBgn0053824	His3:CG33824	HGNC:25311		HIST2H3D	4		
FBgn0053824	His3:CG33824	HGNC:4773	OMIM:602816	H3C7	4		
FBgn0053824	His3:CG33824	HGNC:20503	OMIM:142780	HIST2H3C	6		
FBgn0053824	His3:CG33824	HGNC:4771	OMIM:602814	HIST1H3I	4		
FBgn0053824	His3:CG33824	HGNC:4768	OMIM:602812	H3C3	4		
FBgn0053824	His3:CG33824	HGNC:4765	OMIM:601058	H3-3B	3	619721	619721[BRYANT-LI-BHOJ NEURODEVELOPMENTAL SYNDROME 2; BRYLIB2]
FBgn0053824	His3:CG33824	HGNC:4774	OMIM:602817	HIST1H3J	4		
FBgn0053824	His3:CG33824	HGNC:4776	OMIM:602819	H3C2	4		
FBgn0053824	His3:CG33824	HGNC:4769	OMIM:602813	HIST1H3E	4		
FBgn0053824	His3:CG33824	HGNC:4767	OMIM:602811	HIST1H3D	4		
FBgn0053824	His3:CG33824	HGNC:4775	OMIM:602818	H3C10	4		
FBgn0053825	His1:CG33825	HGNC:4714	OMIM:142708	H1F0	6		
FBgn0053825	His1:CG33825	HGNC:4717	OMIM:142210	HIST1H1D	6		
FBgn0053825	His1:CG33825	HGNC:4716	OMIM:142710	HIST1H1C	7		
FBgn0053825	His1:CG33825	HGNC:4719	OMIM:142711	HIST1H1B	8		
FBgn0053825	His1:CG33825	HGNC:4715	OMIM:142709	HIST1H1A	5		
FBgn0053825	His1:CG33825	HGNC:4718	OMIM:142220	HIST1H1E	8	617537	617537[RAHMAN SYNDROME; RMNS]
FBgn0053825	His1:CG33825	HGNC:4720	OMIM:142712	HIST1H1T	6		
FBgn0053825	His1:CG33825	HGNC:4722	OMIM:602785	H1FX	4		
FBgn0053826	His2A:CG33826	HGNC:4733	OMIM:602794	HIST1H2AC	3		
FBgn0053826	His2A:CG33826	HGNC:20507	OMIM:615015	HIST3H2A	3		
FBgn0053826	His2A:CG33826	HGNC:4738	OMIM:602797	H2AC20	3		
FBgn0053826	His2A:CG33826	HGNC:18729	OMIM:613499	HIST1H2AA	3		
FBgn0053826	His2A:CG33826	HGNC:29668		HIST2H2AA4	3		
FBgn0053827	His3:CG33827	HGNC:4764	OMIM:601128	H3-3A	3	619720	619720[BRYANT-LI-BHOJ NEURODEVELOPMENTAL SYNDROME 1; BRYLIB1]
FBgn0053827	His3:CG33827	HGNC:4772	OMIM:602815	HIST1H3G	3		
FBgn0053827	His3:CG33827	HGNC:20505		HIST2H3A	4		
FBgn0053827	His3:CG33827	HGNC:4766	OMIM:602810	HIST1H3A	4		
FBgn0053827	His3:CG33827	HGNC:25311		HIST2H3D	4		
FBgn0053827	His3:CG33827	HGNC:4773	OMIM:602816	H3C7	4		
FBgn0053827	His3:CG33827	HGNC:20503	OMIM:142780	HIST2H3C	4		
FBgn0053827	His3:CG33827	HGNC:4771	OMIM:602814	HIST1H3I	4		
FBgn0053827	His3:CG33827	HGNC:4768	OMIM:602812	H3C3	4		
FBgn0053827	His3:CG33827	HGNC:4765	OMIM:601058	H3-3B	3	619721	619721[BRYANT-LI-BHOJ NEURODEVELOPMENTAL SYNDROME 2; BRYLIB2]
FBgn0053827	His3:CG33827	HGNC:4774	OMIM:602817	HIST1H3J	4		
FBgn0053827	His3:CG33827	HGNC:4776	OMIM:602819	H3C2	4		
FBgn0053827	His3:CG33827	HGNC:4769	OMIM:602813	HIST1H3E	4		
FBgn0053827	His3:CG33827	HGNC:4767	OMIM:602811	HIST1H3D	4		
FBgn0053827	His3:CG33827	HGNC:4775	OMIM:602818	H3C10	4		
FBgn0053829	His2A:CG33829	HGNC:4733	OMIM:602794	HIST1H2AC	3		
FBgn0053829	His2A:CG33829	HGNC:20507	OMIM:615015	HIST3H2A	3		
FBgn0053829	His2A:CG33829	HGNC:4738	OMIM:602797	H2AC20	3		
FBgn0053829	His2A:CG33829	HGNC:18729	OMIM:613499	HIST1H2AA	3		
FBgn0053829	His2A:CG33829	HGNC:29668		HIST2H2AA4	3		
FBgn0053830	His3:CG33830	HGNC:4764	OMIM:601128	H3-3A	3	619720	619720[BRYANT-LI-BHOJ NEURODEVELOPMENTAL SYNDROME 1; BRYLIB1]
FBgn0053830	His3:CG33830	HGNC:4772	OMIM:602815	HIST1H3G	3		
FBgn0053830	His3:CG33830	HGNC:20505		HIST2H3A	4		
FBgn0053830	His3:CG33830	HGNC:4766	OMIM:602810	HIST1H3A	4		
FBgn0053830	His3:CG33830	HGNC:25311		HIST2H3D	4		
FBgn0053830	His3:CG33830	HGNC:4773	OMIM:602816	H3C7	4		
FBgn0053830	His3:CG33830	HGNC:20503	OMIM:142780	HIST2H3C	4		
FBgn0053830	His3:CG33830	HGNC:4771	OMIM:602814	HIST1H3I	4		
FBgn0053830	His3:CG33830	HGNC:4768	OMIM:602812	H3C3	4		
FBgn0053830	His3:CG33830	HGNC:4765	OMIM:601058	H3-3B	3	619721	619721[BRYANT-LI-BHOJ NEURODEVELOPMENTAL SYNDROME 2; BRYLIB2]
FBgn0053830	His3:CG33830	HGNC:4774	OMIM:602817	HIST1H3J	5		
FBgn0053830	His3:CG33830	HGNC:4776	OMIM:602819	H3C2	4		
FBgn0053830	His3:CG33830	HGNC:4769	OMIM:602813	HIST1H3E	4		
FBgn0053830	His3:CG33830	HGNC:4767	OMIM:602811	HIST1H3D	4		
FBgn0053830	His3:CG33830	HGNC:4775	OMIM:602818	H3C10	4		
FBgn0053832	His2A:CG33832	HGNC:4727	OMIM:602791	HIST1H2AJ	6		
FBgn0053832	His2A:CG33832	HGNC:4733	OMIM:602794	HIST1H2AC	9		
FBgn0053832	His2A:CG33832	HGNC:20507	OMIM:615015	HIST3H2A	9		
FBgn0053832	His2A:CG33832	HGNC:4738	OMIM:602797	H2AC20	8		
FBgn0053832	His2A:CG33832	HGNC:4729	OMIM:602792	HIST1H2AD	7		
FBgn0053832	His2A:CG33832	HGNC:4737	OMIM:615012	HIST1H2AG	8		
FBgn0053832	His2A:CG33832	HGNC:14456		H2AFJ	7		
FBgn0053832	His2A:CG33832	HGNC:18729	OMIM:613499	HIST1H2AA	8		
FBgn0053832	His2A:CG33832	HGNC:4734	OMIM:602795	HIST1H2AB	8		
FBgn0053832	His2A:CG33832	HGNC:4739	OMIM:601772	H2AFX	8		
FBgn0053832	His2A:CG33832	HGNC:13671	OMIM:615013	HIST1H2AH	7		
FBgn0053832	His2A:CG33832	HGNC:20508	OMIM:615014	HIST2H2AB	8		
FBgn0053832	His2A:CG33832	HGNC:29668		HIST2H2AA4	8		
FBgn0053833	His3:CG33833	HGNC:4764	OMIM:601128	H3-3A	3	619720	619720[BRYANT-LI-BHOJ NEURODEVELOPMENTAL SYNDROME 1; BRYLIB1]
FBgn0053833	His3:CG33833	HGNC:4772	OMIM:602815	HIST1H3G	3		
FBgn0053833	His3:CG33833	HGNC:20505		HIST2H3A	4		
FBgn0053833	His3:CG33833	HGNC:4766	OMIM:602810	HIST1H3A	5		
FBgn0053833	His3:CG33833	HGNC:25311		HIST2H3D	4		
FBgn0053833	His3:CG33833	HGNC:4773	OMIM:602816	H3C7	4		
FBgn0053833	His3:CG33833	HGNC:20503	OMIM:142780	HIST2H3C	4		
FBgn0053833	His3:CG33833	HGNC:4771	OMIM:602814	HIST1H3I	4		
FBgn0053833	His3:CG33833	HGNC:4768	OMIM:602812	H3C3	4		
FBgn0053833	His3:CG33833	HGNC:4765	OMIM:601058	H3-3B	3	619721	619721[BRYANT-LI-BHOJ NEURODEVELOPMENTAL SYNDROME 2; BRYLIB2]
FBgn0053833	His3:CG33833	HGNC:4774	OMIM:602817	HIST1H3J	4		
FBgn0053833	His3:CG33833	HGNC:4776	OMIM:602819	H3C2	4		
FBgn0053833	His3:CG33833	HGNC:4769	OMIM:602813	HIST1H3E	4		
FBgn0053833	His3:CG33833	HGNC:4767	OMIM:602811	HIST1H3D	4		
FBgn0053833	His3:CG33833	HGNC:4775	OMIM:602818	H3C10	4		
FBgn0053834	His1:CG33834	HGNC:4714	OMIM:142708	H1F0	5		
FBgn0053834	His1:CG33834	HGNC:4717	OMIM:142210	HIST1H1D	5		
FBgn0053834	His1:CG33834	HGNC:4716	OMIM:142710	HIST1H1C	6		
FBgn0053834	His1:CG33834	HGNC:4719	OMIM:142711	HIST1H1B	6		
FBgn0053834	His1:CG33834	HGNC:4715	OMIM:142709	HIST1H1A	5		
FBgn0053834	His1:CG33834	HGNC:4718	OMIM:142220	HIST1H1E	7	617537	617537[RAHMAN SYNDROME; RMNS]
FBgn0053834	His1:CG33834	HGNC:4720	OMIM:142712	HIST1H1T	5		
FBgn0053834	His1:CG33834	HGNC:4722	OMIM:602785	H1FX	4		
FBgn0053835	His2A:CG33835	HGNC:4733	OMIM:602794	HIST1H2AC	3		
FBgn0053835	His2A:CG33835	HGNC:20507	OMIM:615015	HIST3H2A	3		
FBgn0053835	His2A:CG33835	HGNC:4738	OMIM:602797	H2AC20	3		
FBgn0053835	His2A:CG33835	HGNC:18729	OMIM:613499	HIST1H2AA	3		
FBgn0053835	His2A:CG33835	HGNC:29668		HIST2H2AA4	3		
FBgn0053836	His3:CG33836	HGNC:4764	OMIM:601128	H3-3A	3	619720	619720[BRYANT-LI-BHOJ NEURODEVELOPMENTAL SYNDROME 1; BRYLIB1]
FBgn0053836	His3:CG33836	HGNC:4772	OMIM:602815	HIST1H3G	3		
FBgn0053836	His3:CG33836	HGNC:20505		HIST2H3A	4		
FBgn0053836	His3:CG33836	HGNC:4766	OMIM:602810	HIST1H3A	4		
FBgn0053836	His3:CG33836	HGNC:25311		HIST2H3D	4		
FBgn0053836	His3:CG33836	HGNC:4773	OMIM:602816	H3C7	4		
FBgn0053836	His3:CG33836	HGNC:20503	OMIM:142780	HIST2H3C	4		
FBgn0053836	His3:CG33836	HGNC:4771	OMIM:602814	HIST1H3I	4		
FBgn0053836	His3:CG33836	HGNC:4768	OMIM:602812	H3C3	4		
FBgn0053836	His3:CG33836	HGNC:4765	OMIM:601058	H3-3B	3	619721	619721[BRYANT-LI-BHOJ NEURODEVELOPMENTAL SYNDROME 2; BRYLIB2]
FBgn0053836	His3:CG33836	HGNC:4774	OMIM:602817	HIST1H3J	4		
FBgn0053836	His3:CG33836	HGNC:4776	OMIM:602819	H3C2	4		
FBgn0053836	His3:CG33836	HGNC:4769	OMIM:602813	HIST1H3E	5		
FBgn0053836	His3:CG33836	HGNC:4767	OMIM:602811	HIST1H3D	4		
FBgn0053836	His3:CG33836	HGNC:4775	OMIM:602818	H3C10	4		
FBgn0053838	His2A:CG33838	HGNC:4733	OMIM:602794	HIST1H2AC	3		
FBgn0053838	His2A:CG33838	HGNC:20507	OMIM:615015	HIST3H2A	3		
FBgn0053838	His2A:CG33838	HGNC:4738	OMIM:602797	H2AC20	3		
FBgn0053838	His2A:CG33838	HGNC:18729	OMIM:613499	HIST1H2AA	3		
FBgn0053838	His2A:CG33838	HGNC:29668		HIST2H2AA4	3		
FBgn0053839	His3:CG33839	HGNC:4764	OMIM:601128	H3-3A	3	619720	619720[BRYANT-LI-BHOJ NEURODEVELOPMENTAL SYNDROME 1; BRYLIB1]
FBgn0053839	His3:CG33839	HGNC:4772	OMIM:602815	HIST1H3G	3		
FBgn0053839	His3:CG33839	HGNC:20505		HIST2H3A	4		
FBgn0053839	His3:CG33839	HGNC:4766	OMIM:602810	HIST1H3A	4		
FBgn0053839	His3:CG33839	HGNC:25311		HIST2H3D	4		
FBgn0053839	His3:CG33839	HGNC:4773	OMIM:602816	H3C7	4		
FBgn0053839	His3:CG33839	HGNC:20503	OMIM:142780	HIST2H3C	4		
FBgn0053839	His3:CG33839	HGNC:4771	OMIM:602814	HIST1H3I	4		
FBgn0053839	His3:CG33839	HGNC:4768	OMIM:602812	H3C3	4		
FBgn0053839	His3:CG33839	HGNC:4765	OMIM:601058	H3-3B	3	619721	619721[BRYANT-LI-BHOJ NEURODEVELOPMENTAL SYNDROME 2; BRYLIB2]
FBgn0053839	His3:CG33839	HGNC:4774	OMIM:602817	HIST1H3J	4		
FBgn0053839	His3:CG33839	HGNC:4776	OMIM:602819	H3C2	4		
FBgn0053839	His3:CG33839	HGNC:4769	OMIM:602813	HIST1H3E	4		
FBgn0053839	His3:CG33839	HGNC:4767	OMIM:602811	HIST1H3D	4		
FBgn0053839	His3:CG33839	HGNC:4775	OMIM:602818	H3C10	4		
FBgn0053839	His3:CG33839	HGNC:33164	OMIM:616134	H3F3C	3		
FBgn0053841	His2A:CG33841	HGNC:4733	OMIM:602794	HIST1H2AC	3		
FBgn0053841	His2A:CG33841	HGNC:20507	OMIM:615015	HIST3H2A	3		
FBgn0053841	His2A:CG33841	HGNC:4738	OMIM:602797	H2AC20	3		
FBgn0053841	His2A:CG33841	HGNC:18729	OMIM:613499	HIST1H2AA	3		
FBgn0053841	His2A:CG33841	HGNC:29668		HIST2H2AA4	3		
FBgn0053842	His3:CG33842	HGNC:4764	OMIM:601128	H3-3A	3	619720	619720[BRYANT-LI-BHOJ NEURODEVELOPMENTAL SYNDROME 1; BRYLIB1]
FBgn0053842	His3:CG33842	HGNC:4772	OMIM:602815	HIST1H3G	3		
FBgn0053842	His3:CG33842	HGNC:20505		HIST2H3A	4		
FBgn0053842	His3:CG33842	HGNC:4766	OMIM:602810	HIST1H3A	4		
FBgn0053842	His3:CG33842	HGNC:25311		HIST2H3D	4		
FBgn0053842	His3:CG33842	HGNC:4773	OMIM:602816	H3C7	4		
FBgn0053842	His3:CG33842	HGNC:20503	OMIM:142780	HIST2H3C	4		
FBgn0053842	His3:CG33842	HGNC:4771	OMIM:602814	HIST1H3I	4		
FBgn0053842	His3:CG33842	HGNC:4768	OMIM:602812	H3C3	4		
FBgn0053842	His3:CG33842	HGNC:4765	OMIM:601058	H3-3B	3	619721	619721[BRYANT-LI-BHOJ NEURODEVELOPMENTAL SYNDROME 2; BRYLIB2]
FBgn0053842	His3:CG33842	HGNC:4774	OMIM:602817	HIST1H3J	4		
FBgn0053842	His3:CG33842	HGNC:4776	OMIM:602819	H3C2	4		
FBgn0053842	His3:CG33842	HGNC:4769	OMIM:602813	HIST1H3E	4		
FBgn0053842	His3:CG33842	HGNC:4767	OMIM:602811	HIST1H3D	4		
FBgn0053842	His3:CG33842	HGNC:4775	OMIM:602818	H3C10	4		
FBgn0053844	His2A:CG33844	HGNC:4733	OMIM:602794	HIST1H2AC	3		
FBgn0053844	His2A:CG33844	HGNC:20507	OMIM:615015	HIST3H2A	3		
FBgn0053844	His2A:CG33844	HGNC:4738	OMIM:602797	H2AC20	3		
FBgn0053844	His2A:CG33844	HGNC:18729	OMIM:613499	HIST1H2AA	3		
FBgn0053844	His2A:CG33844	HGNC:29668		HIST2H2AA4	3		
FBgn0053845	His3:CG33845	HGNC:4764	OMIM:601128	H3-3A	3	619720	619720[BRYANT-LI-BHOJ NEURODEVELOPMENTAL SYNDROME 1; BRYLIB1]
FBgn0053845	His3:CG33845	HGNC:4772	OMIM:602815	HIST1H3G	4		
FBgn0053845	His3:CG33845	HGNC:20505		HIST2H3A	4		
FBgn0053845	His3:CG33845	HGNC:4766	OMIM:602810	HIST1H3A	4		
FBgn0053845	His3:CG33845	HGNC:25311		HIST2H3D	4		
FBgn0053845	His3:CG33845	HGNC:4773	OMIM:602816	H3C7	4		
FBgn0053845	His3:CG33845	HGNC:20503	OMIM:142780	HIST2H3C	4		
FBgn0053845	His3:CG33845	HGNC:4771	OMIM:602814	HIST1H3I	4		
FBgn0053845	His3:CG33845	HGNC:4768	OMIM:602812	H3C3	4		
FBgn0053845	His3:CG33845	HGNC:4765	OMIM:601058	H3-3B	3	619721	619721[BRYANT-LI-BHOJ NEURODEVELOPMENTAL SYNDROME 2; BRYLIB2]
FBgn0053845	His3:CG33845	HGNC:4774	OMIM:602817	HIST1H3J	4		
FBgn0053845	His3:CG33845	HGNC:4776	OMIM:602819	H3C2	4		
FBgn0053845	His3:CG33845	HGNC:4769	OMIM:602813	HIST1H3E	4		
FBgn0053845	His3:CG33845	HGNC:4767	OMIM:602811	HIST1H3D	4		
FBgn0053845	His3:CG33845	HGNC:4775	OMIM:602818	H3C10	4		
FBgn0053847	His2A:CG33847	HGNC:4733	OMIM:602794	HIST1H2AC	3		
FBgn0053847	His2A:CG33847	HGNC:20507	OMIM:615015	HIST3H2A	3		
FBgn0053847	His2A:CG33847	HGNC:4738	OMIM:602797	H2AC20	3		
FBgn0053847	His2A:CG33847	HGNC:18729	OMIM:613499	HIST1H2AA	3		
FBgn0053847	His2A:CG33847	HGNC:29668		HIST2H2AA4	3		
FBgn0053848	His3:CG33848	HGNC:4764	OMIM:601128	H3-3A	3	619720	619720[BRYANT-LI-BHOJ NEURODEVELOPMENTAL SYNDROME 1; BRYLIB1]
FBgn0053848	His3:CG33848	HGNC:4772	OMIM:602815	HIST1H3G	3		
FBgn0053848	His3:CG33848	HGNC:20505		HIST2H3A	4		
FBgn0053848	His3:CG33848	HGNC:4766	OMIM:602810	HIST1H3A	4		
FBgn0053848	His3:CG33848	HGNC:25311		HIST2H3D	9		
FBgn0053848	His3:CG33848	HGNC:4773	OMIM:602816	H3C7	5		
FBgn0053848	His3:CG33848	HGNC:20503	OMIM:142780	HIST2H3C	5		
FBgn0053848	His3:CG33848	HGNC:4771	OMIM:602814	HIST1H3I	4		
FBgn0053848	His3:CG33848	HGNC:4768	OMIM:602812	H3C3	4		
FBgn0053848	His3:CG33848	HGNC:4765	OMIM:601058	H3-3B	5	619721	619721[BRYANT-LI-BHOJ NEURODEVELOPMENTAL SYNDROME 2; BRYLIB2]
FBgn0053848	His3:CG33848	HGNC:4774	OMIM:602817	HIST1H3J	4		
FBgn0053848	His3:CG33848	HGNC:4776	OMIM:602819	H3C2	4		
FBgn0053848	His3:CG33848	HGNC:4769	OMIM:602813	HIST1H3E	4		
FBgn0053848	His3:CG33848	HGNC:4778	OMIM:602820	HIST3H3	3		
FBgn0053848	His3:CG33848	HGNC:4767	OMIM:602811	HIST1H3D	5		
FBgn0053848	His3:CG33848	HGNC:4775	OMIM:602818	H3C10	4		
FBgn0053848	His3:CG33848	HGNC:33164	OMIM:616134	H3F3C	4		
FBgn0053850	His2A:CG33850	HGNC:4733	OMIM:602794	HIST1H2AC	3		
FBgn0053850	His2A:CG33850	HGNC:20507	OMIM:615015	HIST3H2A	3		
FBgn0053850	His2A:CG33850	HGNC:4738	OMIM:602797	H2AC20	3		
FBgn0053850	His2A:CG33850	HGNC:18729	OMIM:613499	HIST1H2AA	3		
FBgn0053850	His2A:CG33850	HGNC:29668		HIST2H2AA4	3		
FBgn0053851	His3:CG33851	HGNC:4764	OMIM:601128	H3-3A	3	619720	619720[BRYANT-LI-BHOJ NEURODEVELOPMENTAL SYNDROME 1; BRYLIB1]
FBgn0053851	His3:CG33851	HGNC:4772	OMIM:602815	HIST1H3G	3		
FBgn0053851	His3:CG33851	HGNC:20505		HIST2H3A	4		
FBgn0053851	His3:CG33851	HGNC:4766	OMIM:602810	HIST1H3A	4		
FBgn0053851	His3:CG33851	HGNC:25311		HIST2H3D	5		
FBgn0053851	His3:CG33851	HGNC:4773	OMIM:602816	H3C7	4		
FBgn0053851	His3:CG33851	HGNC:20503	OMIM:142780	HIST2H3C	4		
FBgn0053851	His3:CG33851	HGNC:4771	OMIM:602814	HIST1H3I	4		
FBgn0053851	His3:CG33851	HGNC:4768	OMIM:602812	H3C3	4		
FBgn0053851	His3:CG33851	HGNC:4765	OMIM:601058	H3-3B	3	619721	619721[BRYANT-LI-BHOJ NEURODEVELOPMENTAL SYNDROME 2; BRYLIB2]
FBgn0053851	His3:CG33851	HGNC:4774	OMIM:602817	HIST1H3J	4		
FBgn0053851	His3:CG33851	HGNC:4776	OMIM:602819	H3C2	4		
FBgn0053851	His3:CG33851	HGNC:4769	OMIM:602813	HIST1H3E	4		
FBgn0053851	His3:CG33851	HGNC:4767	OMIM:602811	HIST1H3D	4		
FBgn0053851	His3:CG33851	HGNC:4775	OMIM:602818	H3C10	4		
FBgn0053853	His2A:CG33853	HGNC:4733	OMIM:602794	HIST1H2AC	3		
FBgn0053853	His2A:CG33853	HGNC:20507	OMIM:615015	HIST3H2A	3		
FBgn0053853	His2A:CG33853	HGNC:4738	OMIM:602797	H2AC20	3		
FBgn0053853	His2A:CG33853	HGNC:18729	OMIM:613499	HIST1H2AA	3		
FBgn0053853	His2A:CG33853	HGNC:20508	OMIM:615014	HIST2H2AB	3		
FBgn0053853	His2A:CG33853	HGNC:29668		HIST2H2AA4	3		
FBgn0053854	His3:CG33854	HGNC:4764	OMIM:601128	H3-3A	3	619720	619720[BRYANT-LI-BHOJ NEURODEVELOPMENTAL SYNDROME 1; BRYLIB1]
FBgn0053854	His3:CG33854	HGNC:4772	OMIM:602815	HIST1H3G	3		
FBgn0053854	His3:CG33854	HGNC:20505		HIST2H3A	5		
FBgn0053854	His3:CG33854	HGNC:4766	OMIM:602810	HIST1H3A	4		
FBgn0053854	His3:CG33854	HGNC:25311		HIST2H3D	4		
FBgn0053854	His3:CG33854	HGNC:4773	OMIM:602816	H3C7	4		
FBgn0053854	His3:CG33854	HGNC:20503	OMIM:142780	HIST2H3C	4		
FBgn0053854	His3:CG33854	HGNC:4771	OMIM:602814	HIST1H3I	4		
FBgn0053854	His3:CG33854	HGNC:4768	OMIM:602812	H3C3	4		
FBgn0053854	His3:CG33854	HGNC:4765	OMIM:601058	H3-3B	3	619721	619721[BRYANT-LI-BHOJ NEURODEVELOPMENTAL SYNDROME 2; BRYLIB2]
FBgn0053854	His3:CG33854	HGNC:4774	OMIM:602817	HIST1H3J	4		
FBgn0053854	His3:CG33854	HGNC:4776	OMIM:602819	H3C2	4		
FBgn0053854	His3:CG33854	HGNC:4769	OMIM:602813	HIST1H3E	4		
FBgn0053854	His3:CG33854	HGNC:4767	OMIM:602811	HIST1H3D	4		
FBgn0053854	His3:CG33854	HGNC:4775	OMIM:602818	H3C10	5		
FBgn0053856	His2A:CG33856	HGNC:4733	OMIM:602794	HIST1H2AC	3		
FBgn0053856	His2A:CG33856	HGNC:20507	OMIM:615015	HIST3H2A	3		
FBgn0053856	His2A:CG33856	HGNC:4738	OMIM:602797	H2AC20	3		
FBgn0053856	His2A:CG33856	HGNC:18729	OMIM:613499	HIST1H2AA	3		
FBgn0053856	His2A:CG33856	HGNC:20508	OMIM:615014	HIST2H2AB	3		
FBgn0053856	His2A:CG33856	HGNC:29668		HIST2H2AA4	3		
FBgn0053857	His3:CG33857	HGNC:4764	OMIM:601128	H3-3A	4	619720	619720[BRYANT-LI-BHOJ NEURODEVELOPMENTAL SYNDROME 1; BRYLIB1]
FBgn0053857	His3:CG33857	HGNC:4772	OMIM:602815	HIST1H3G	3		
FBgn0053857	His3:CG33857	HGNC:20505		HIST2H3A	5		
FBgn0053857	His3:CG33857	HGNC:4766	OMIM:602810	HIST1H3A	4		
FBgn0053857	His3:CG33857	HGNC:25311		HIST2H3D	4		
FBgn0053857	His3:CG33857	HGNC:4773	OMIM:602816	H3C7	4		
FBgn0053857	His3:CG33857	HGNC:20503	OMIM:142780	HIST2H3C	5		
FBgn0053857	His3:CG33857	HGNC:4771	OMIM:602814	HIST1H3I	4		
FBgn0053857	His3:CG33857	HGNC:4768	OMIM:602812	H3C3	4		
FBgn0053857	His3:CG33857	HGNC:4765	OMIM:601058	H3-3B	4	619721	619721[BRYANT-LI-BHOJ NEURODEVELOPMENTAL SYNDROME 2; BRYLIB2]
FBgn0053857	His3:CG33857	HGNC:4774	OMIM:602817	HIST1H3J	4		
FBgn0053857	His3:CG33857	HGNC:4776	OMIM:602819	H3C2	4		
FBgn0053857	His3:CG33857	HGNC:4769	OMIM:602813	HIST1H3E	4		
FBgn0053857	His3:CG33857	HGNC:4767	OMIM:602811	HIST1H3D	4		
FBgn0053857	His3:CG33857	HGNC:4775	OMIM:602818	H3C10	4		
FBgn0053859	His2A:CG33859	HGNC:4727	OMIM:602791	HIST1H2AJ	5		
FBgn0053859	His2A:CG33859	HGNC:4733	OMIM:602794	HIST1H2AC	8		
FBgn0053859	His2A:CG33859	HGNC:20507	OMIM:615015	HIST3H2A	8		
FBgn0053859	His2A:CG33859	HGNC:4738	OMIM:602797	H2AC20	7		
FBgn0053859	His2A:CG33859	HGNC:4729	OMIM:602792	HIST1H2AD	6		
FBgn0053859	His2A:CG33859	HGNC:4737	OMIM:615012	HIST1H2AG	8		
FBgn0053859	His2A:CG33859	HGNC:14456		H2AFJ	7		
FBgn0053859	His2A:CG33859	HGNC:18729	OMIM:613499	HIST1H2AA	7		
FBgn0053859	His2A:CG33859	HGNC:4734	OMIM:602795	HIST1H2AB	7		
FBgn0053859	His2A:CG33859	HGNC:4739	OMIM:601772	H2AFX	7		
FBgn0053859	His2A:CG33859	HGNC:13671	OMIM:615013	HIST1H2AH	6		
FBgn0053859	His2A:CG33859	HGNC:20508	OMIM:615014	HIST2H2AB	8		
FBgn0053859	His2A:CG33859	HGNC:29668		HIST2H2AA4	7		
FBgn0053860	His3:CG33860	HGNC:4764	OMIM:601128	H3-3A	3	619720	619720[BRYANT-LI-BHOJ NEURODEVELOPMENTAL SYNDROME 1; BRYLIB1]
FBgn0053860	His3:CG33860	HGNC:4772	OMIM:602815	HIST1H3G	3		
FBgn0053860	His3:CG33860	HGNC:20505		HIST2H3A	6		
FBgn0053860	His3:CG33860	HGNC:4766	OMIM:602810	HIST1H3A	4		
FBgn0053860	His3:CG33860	HGNC:25311		HIST2H3D	5		
FBgn0053860	His3:CG33860	HGNC:4773	OMIM:602816	H3C7	4		
FBgn0053860	His3:CG33860	HGNC:20503	OMIM:142780	HIST2H3C	4		
FBgn0053860	His3:CG33860	HGNC:4771	OMIM:602814	HIST1H3I	4		
FBgn0053860	His3:CG33860	HGNC:4768	OMIM:602812	H3C3	4		
FBgn0053860	His3:CG33860	HGNC:4765	OMIM:601058	H3-3B	3	619721	619721[BRYANT-LI-BHOJ NEURODEVELOPMENTAL SYNDROME 2; BRYLIB2]
FBgn0053860	His3:CG33860	HGNC:4774	OMIM:602817	HIST1H3J	4		
FBgn0053860	His3:CG33860	HGNC:4776	OMIM:602819	H3C2	4		
FBgn0053860	His3:CG33860	HGNC:4769	OMIM:602813	HIST1H3E	4		
FBgn0053860	His3:CG33860	HGNC:4778	OMIM:602820	HIST3H3	3		
FBgn0053860	His3:CG33860	HGNC:4767	OMIM:602811	HIST1H3D	4		
FBgn0053860	His3:CG33860	HGNC:4775	OMIM:602818	H3C10	4		
FBgn0053861	His1:CG33861	HGNC:4714	OMIM:142708	H1F0	4		
FBgn0053861	His1:CG33861	HGNC:4717	OMIM:142210	HIST1H1D	4		
FBgn0053861	His1:CG33861	HGNC:4716	OMIM:142710	HIST1H1C	5		
FBgn0053861	His1:CG33861	HGNC:4719	OMIM:142711	HIST1H1B	6		
FBgn0053861	His1:CG33861	HGNC:4715	OMIM:142709	HIST1H1A	3		
FBgn0053861	His1:CG33861	HGNC:4718	OMIM:142220	HIST1H1E	6	617537	617537[RAHMAN SYNDROME; RMNS]
FBgn0053861	His1:CG33861	HGNC:4720	OMIM:142712	HIST1H1T	3		
FBgn0053861	His1:CG33861	HGNC:4722	OMIM:602785	H1FX	3		
FBgn0053862	His2A:CG33862	HGNC:4733	OMIM:602794	HIST1H2AC	3		
FBgn0053862	His2A:CG33862	HGNC:20507	OMIM:615015	HIST3H2A	3		
FBgn0053862	His2A:CG33862	HGNC:4738	OMIM:602797	H2AC20	3		
FBgn0053862	His2A:CG33862	HGNC:18729	OMIM:613499	HIST1H2AA	3		
FBgn0053862	His2A:CG33862	HGNC:29668		HIST2H2AA4	3		
FBgn0053863	His3:CG33863	HGNC:4764	OMIM:601128	H3-3A	3	619720	619720[BRYANT-LI-BHOJ NEURODEVELOPMENTAL SYNDROME 1; BRYLIB1]
FBgn0053863	His3:CG33863	HGNC:4772	OMIM:602815	HIST1H3G	4		
FBgn0053863	His3:CG33863	HGNC:20505		HIST2H3A	4		
FBgn0053863	His3:CG33863	HGNC:4766	OMIM:602810	HIST1H3A	5		
FBgn0053863	His3:CG33863	HGNC:25311		HIST2H3D	4		
FBgn0053863	His3:CG33863	HGNC:4773	OMIM:602816	H3C7	5		
FBgn0053863	His3:CG33863	HGNC:20503	OMIM:142780	HIST2H3C	4		
FBgn0053863	His3:CG33863	HGNC:4771	OMIM:602814	HIST1H3I	5		
FBgn0053863	His3:CG33863	HGNC:4768	OMIM:602812	H3C3	6		
FBgn0053863	His3:CG33863	HGNC:4765	OMIM:601058	H3-3B	3	619721	619721[BRYANT-LI-BHOJ NEURODEVELOPMENTAL SYNDROME 2; BRYLIB2]
FBgn0053863	His3:CG33863	HGNC:4774	OMIM:602817	HIST1H3J	5		
FBgn0053863	His3:CG33863	HGNC:4776	OMIM:602819	H3C2	5		
FBgn0053863	His3:CG33863	HGNC:4769	OMIM:602813	HIST1H3E	5		
FBgn0053863	His3:CG33863	HGNC:4778	OMIM:602820	HIST3H3	3		
FBgn0053863	His3:CG33863	HGNC:4767	OMIM:602811	HIST1H3D	5		
FBgn0053863	His3:CG33863	HGNC:4775	OMIM:602818	H3C10	5		
FBgn0053865	His2A:CG33865	HGNC:4733	OMIM:602794	HIST1H2AC	3		
FBgn0053865	His2A:CG33865	HGNC:20507	OMIM:615015	HIST3H2A	3		
FBgn0053865	His2A:CG33865	HGNC:4738	OMIM:602797	H2AC20	3		
FBgn0053865	His2A:CG33865	HGNC:18729	OMIM:613499	HIST1H2AA	3		
FBgn0053865	His2A:CG33865	HGNC:29668		HIST2H2AA4	3		
FBgn0053866	His3:CG33866	HGNC:4764	OMIM:601128	H3-3A	3	619720	619720[BRYANT-LI-BHOJ NEURODEVELOPMENTAL SYNDROME 1; BRYLIB1]
FBgn0053866	His3:CG33866	HGNC:4772	OMIM:602815	HIST1H3G	3		
FBgn0053866	His3:CG33866	HGNC:20505		HIST2H3A	5		
FBgn0053866	His3:CG33866	HGNC:4766	OMIM:602810	HIST1H3A	4		
FBgn0053866	His3:CG33866	HGNC:25311		HIST2H3D	4		
FBgn0053866	His3:CG33866	HGNC:4773	OMIM:602816	H3C7	4		
FBgn0053866	His3:CG33866	HGNC:20503	OMIM:142780	HIST2H3C	4		
FBgn0053866	His3:CG33866	HGNC:4771	OMIM:602814	HIST1H3I	5		
FBgn0053866	His3:CG33866	HGNC:4768	OMIM:602812	H3C3	4		
FBgn0053866	His3:CG33866	HGNC:4765	OMIM:601058	H3-3B	3	619721	619721[BRYANT-LI-BHOJ NEURODEVELOPMENTAL SYNDROME 2; BRYLIB2]
FBgn0053866	His3:CG33866	HGNC:4774	OMIM:602817	HIST1H3J	4		
FBgn0053866	His3:CG33866	HGNC:4776	OMIM:602819	H3C2	4		
FBgn0053866	His3:CG33866	HGNC:4769	OMIM:602813	HIST1H3E	4		
FBgn0053866	His3:CG33866	HGNC:4767	OMIM:602811	HIST1H3D	4		
FBgn0053866	His3:CG33866	HGNC:4775	OMIM:602818	H3C10	4		
FBgn0053868	His2B:CG33868	HGNC:4747	OMIM:602799	HIST1H2BD	3		
FBgn0053868	His2B:CG33868	HGNC:4746	OMIM:602798	HIST1H2BG	3		
FBgn0053868	His2B:CG33868	HGNC:4760	OMIM:601831	H2BC21	3		
FBgn0053868	His2B:CG33868	HGNC:4755	OMIM:602806	HIST1H2BH	3		
FBgn0053868	His2B:CG33868	HGNC:4751	OMIM:602803	HIST1H2BB	3		
FBgn0053868	His2B:CG33868	HGNC:4757	OMIM:602847	HIST1H2BC	3		
FBgn0053868	His2B:CG33868	HGNC:4750	OMIM:602802	HIST1H2BM	3		
FBgn0053868	His2B:CG33868	HGNC:4748	OMIM:602800	HIST1H2BL	3		
FBgn0053868	His2B:CG33868	HGNC:4753	OMIM:602805	HIST1H2BE	3		
FBgn0053868	His2B:CG33868	HGNC:4756	OMIM:602807	HIST1H2BI	3		
FBgn0053868	His2B:CG33868	HGNC:24700		HIST2H2BF	3		
FBgn0053868	His2B:CG33868	HGNC:13954	OMIM:615045	HIST1H2BK	3		
FBgn0053868	His2B:CG33868	HGNC:4758	OMIM:602808	HIST1H2BO	4		
FBgn0053868	His2B:CG33868	HGNC:4749	OMIM:602801	HIST1H2BN	3		
FBgn0053868	His2B:CG33868	HGNC:18730	OMIM:609904	HIST1H2BA	5		
FBgn0053868	His2B:CG33868	HGNC:4761	OMIM:615044	HIST1H2BJ	3		
FBgn0053868	His2B:CG33868	HGNC:20514	OMIM:615046	HIST3H2BB	4		
FBgn0053869	His4:CG33869	HGNC:20510	OMIM:615069	HIST4H4	5		
FBgn0053869	His4:CG33869	HGNC:4787	OMIM:602827	H4C3	4	619758	619758[TESSADORI-VAN HAAFTEN NEURODEVELOPMENTAL SYNDROME 1; TEVANED1]
FBgn0053869	His4:CG33869	HGNC:29607		HIST2H4B	10		
FBgn0053869	His4:CG33869	HGNC:4789	OMIM:602829	HIST1H4B	3		
FBgn0053869	His4:CG33869	HGNC:4788	OMIM:602828	HIST1H4H	4		
FBgn0053869	His4:CG33869	HGNC:4782	OMIM:602823	HIST1H4D	4		
FBgn0053869	His4:CG33869	HGNC:4790	OMIM:602830	HIST1H4E	4	619950	619950[TESSADORI-VAN HAAFTEN NEURODEVELOPMENTAL SYNDROME 3; TEVANED3]
FBgn0053869	His4:CG33869	HGNC:4783	OMIM:602824	HIST1H4F	4		
FBgn0053869	His4:CG33869	HGNC:4794	OMIM:142750	HIST2H4A	4		
FBgn0053869	His4:CG33869	HGNC:4785	OMIM:602826	H4C11	4	619759	619759[TESSADORI-VAN HAAFTEN NEURODEVELOPMENTAL SYNDROME 2; TEVANED2]
FBgn0053869	His4:CG33869	HGNC:4791	OMIM:602831	HIST1H4L	4		
FBgn0053869	His4:CG33869	HGNC:4784	OMIM:602825	HIST1H4K	4		
FBgn0053869	His4:CG33869	HGNC:4793	OMIM:602833	H4C9	4	619951	619951[TESSADORI-VAN HAAFTEN NEURODEVELOPMENTAL SYNDROME 4; TEVANED4]
FBgn0053869	His4:CG33869	HGNC:4781	OMIM:602822	HIST1H4A	4		
FBgn0053869	His4:CG33869	HGNC:4792	OMIM:602832	HIST1H4G	5		
FBgn0053870	His2B:CG33870	HGNC:4747	OMIM:602799	HIST1H2BD	3		
FBgn0053870	His2B:CG33870	HGNC:4746	OMIM:602798	HIST1H2BG	3		
FBgn0053870	His2B:CG33870	HGNC:4760	OMIM:601831	H2BC21	3		
FBgn0053870	His2B:CG33870	HGNC:4755	OMIM:602806	HIST1H2BH	3		
FBgn0053870	His2B:CG33870	HGNC:4751	OMIM:602803	HIST1H2BB	3		
FBgn0053870	His2B:CG33870	HGNC:4757	OMIM:602847	HIST1H2BC	3		
FBgn0053870	His2B:CG33870	HGNC:4750	OMIM:602802	HIST1H2BM	3		
FBgn0053870	His2B:CG33870	HGNC:4748	OMIM:602800	HIST1H2BL	3		
FBgn0053870	His2B:CG33870	HGNC:4753	OMIM:602805	HIST1H2BE	3		
FBgn0053870	His2B:CG33870	HGNC:4756	OMIM:602807	HIST1H2BI	3		
FBgn0053870	His2B:CG33870	HGNC:24700		HIST2H2BF	3		
FBgn0053870	His2B:CG33870	HGNC:13954	OMIM:615045	HIST1H2BK	3		
FBgn0053870	His2B:CG33870	HGNC:4758	OMIM:602808	HIST1H2BO	4		
FBgn0053870	His2B:CG33870	HGNC:4749	OMIM:602801	HIST1H2BN	3		
FBgn0053870	His2B:CG33870	HGNC:18730	OMIM:609904	HIST1H2BA	5		
FBgn0053870	His2B:CG33870	HGNC:4761	OMIM:615044	HIST1H2BJ	3		
FBgn0053870	His2B:CG33870	HGNC:20514	OMIM:615046	HIST3H2BB	4		
FBgn0053871	His4:CG33871	HGNC:20510	OMIM:615069	HIST4H4	5		
FBgn0053871	His4:CG33871	HGNC:4787	OMIM:602827	H4C3	4	619758	619758[TESSADORI-VAN HAAFTEN NEURODEVELOPMENTAL SYNDROME 1; TEVANED1]
FBgn0053871	His4:CG33871	HGNC:29607		HIST2H4B	4		
FBgn0053871	His4:CG33871	HGNC:4789	OMIM:602829	HIST1H4B	5		
FBgn0053871	His4:CG33871	HGNC:4788	OMIM:602828	HIST1H4H	4		
FBgn0053871	His4:CG33871	HGNC:4782	OMIM:602823	HIST1H4D	5		
FBgn0053871	His4:CG33871	HGNC:4790	OMIM:602830	HIST1H4E	4	619950	619950[TESSADORI-VAN HAAFTEN NEURODEVELOPMENTAL SYNDROME 3; TEVANED3]
FBgn0053871	His4:CG33871	HGNC:4783	OMIM:602824	HIST1H4F	5		
FBgn0053871	His4:CG33871	HGNC:4794	OMIM:142750	HIST2H4A	5		
FBgn0053871	His4:CG33871	HGNC:4785	OMIM:602826	H4C11	4	619759	619759[TESSADORI-VAN HAAFTEN NEURODEVELOPMENTAL SYNDROME 2; TEVANED2]
FBgn0053871	His4:CG33871	HGNC:4791	OMIM:602831	HIST1H4L	4		
FBgn0053871	His4:CG33871	HGNC:4784	OMIM:602825	HIST1H4K	4		
FBgn0053871	His4:CG33871	HGNC:4793	OMIM:602833	H4C9	4	619951	619951[TESSADORI-VAN HAAFTEN NEURODEVELOPMENTAL SYNDROME 4; TEVANED4]
FBgn0053871	His4:CG33871	HGNC:4781	OMIM:602822	HIST1H4A	4		
FBgn0053871	His4:CG33871	HGNC:4792	OMIM:602832	HIST1H4G	4		
FBgn0053872	His2B:CG33872	HGNC:4747	OMIM:602799	HIST1H2BD	3		
FBgn0053872	His2B:CG33872	HGNC:4746	OMIM:602798	HIST1H2BG	3		
FBgn0053872	His2B:CG33872	HGNC:4760	OMIM:601831	H2BC21	3		
FBgn0053872	His2B:CG33872	HGNC:4755	OMIM:602806	HIST1H2BH	3		
FBgn0053872	His2B:CG33872	HGNC:4751	OMIM:602803	HIST1H2BB	3		
FBgn0053872	His2B:CG33872	HGNC:4757	OMIM:602847	HIST1H2BC	3		
FBgn0053872	His2B:CG33872	HGNC:4750	OMIM:602802	HIST1H2BM	3		
FBgn0053872	His2B:CG33872	HGNC:4748	OMIM:602800	HIST1H2BL	3		
FBgn0053872	His2B:CG33872	HGNC:4753	OMIM:602805	HIST1H2BE	3		
FBgn0053872	His2B:CG33872	HGNC:4756	OMIM:602807	HIST1H2BI	3		
FBgn0053872	His2B:CG33872	HGNC:24700		HIST2H2BF	3		
FBgn0053872	His2B:CG33872	HGNC:13954	OMIM:615045	HIST1H2BK	3		
FBgn0053872	His2B:CG33872	HGNC:4758	OMIM:602808	HIST1H2BO	4		
FBgn0053872	His2B:CG33872	HGNC:4749	OMIM:602801	HIST1H2BN	3		
FBgn0053872	His2B:CG33872	HGNC:18730	OMIM:609904	HIST1H2BA	5		
FBgn0053872	His2B:CG33872	HGNC:4761	OMIM:615044	HIST1H2BJ	3		
FBgn0053872	His2B:CG33872	HGNC:20514	OMIM:615046	HIST3H2BB	4		
FBgn0053873	His4:CG33873	HGNC:20510	OMIM:615069	HIST4H4	5		
FBgn0053873	His4:CG33873	HGNC:4787	OMIM:602827	H4C3	4	619758	619758[TESSADORI-VAN HAAFTEN NEURODEVELOPMENTAL SYNDROME 1; TEVANED1]
FBgn0053873	His4:CG33873	HGNC:29607		HIST2H4B	4		
FBgn0053873	His4:CG33873	HGNC:4789	OMIM:602829	HIST1H4B	4		
FBgn0053873	His4:CG33873	HGNC:4788	OMIM:602828	HIST1H4H	4		
FBgn0053873	His4:CG33873	HGNC:4782	OMIM:602823	HIST1H4D	5		
FBgn0053873	His4:CG33873	HGNC:4790	OMIM:602830	HIST1H4E	4	619950	619950[TESSADORI-VAN HAAFTEN NEURODEVELOPMENTAL SYNDROME 3; TEVANED3]
FBgn0053873	His4:CG33873	HGNC:4783	OMIM:602824	HIST1H4F	5		
FBgn0053873	His4:CG33873	HGNC:4794	OMIM:142750	HIST2H4A	5		
FBgn0053873	His4:CG33873	HGNC:4785	OMIM:602826	H4C11	5	619759	619759[TESSADORI-VAN HAAFTEN NEURODEVELOPMENTAL SYNDROME 2; TEVANED2]
FBgn0053873	His4:CG33873	HGNC:4791	OMIM:602831	HIST1H4L	4		
FBgn0053873	His4:CG33873	HGNC:4784	OMIM:602825	HIST1H4K	4		
FBgn0053873	His4:CG33873	HGNC:4793	OMIM:602833	H4C9	4	619951	619951[TESSADORI-VAN HAAFTEN NEURODEVELOPMENTAL SYNDROME 4; TEVANED4]
FBgn0053873	His4:CG33873	HGNC:4781	OMIM:602822	HIST1H4A	4		
FBgn0053873	His4:CG33873	HGNC:4792	OMIM:602832	HIST1H4G	4		
FBgn0053874	His2B:CG33874	HGNC:4747	OMIM:602799	HIST1H2BD	3		
FBgn0053874	His2B:CG33874	HGNC:4746	OMIM:602798	HIST1H2BG	3		
FBgn0053874	His2B:CG33874	HGNC:4760	OMIM:601831	H2BC21	3		
FBgn0053874	His2B:CG33874	HGNC:4755	OMIM:602806	HIST1H2BH	3		
FBgn0053874	His2B:CG33874	HGNC:4751	OMIM:602803	HIST1H2BB	3		
FBgn0053874	His2B:CG33874	HGNC:4757	OMIM:602847	HIST1H2BC	3		
FBgn0053874	His2B:CG33874	HGNC:4750	OMIM:602802	HIST1H2BM	3		
FBgn0053874	His2B:CG33874	HGNC:4748	OMIM:602800	HIST1H2BL	3		
FBgn0053874	His2B:CG33874	HGNC:4753	OMIM:602805	HIST1H2BE	3		
FBgn0053874	His2B:CG33874	HGNC:4756	OMIM:602807	HIST1H2BI	3		
FBgn0053874	His2B:CG33874	HGNC:24700		HIST2H2BF	3		
FBgn0053874	His2B:CG33874	HGNC:13954	OMIM:615045	HIST1H2BK	3		
FBgn0053874	His2B:CG33874	HGNC:4758	OMIM:602808	HIST1H2BO	4		
FBgn0053874	His2B:CG33874	HGNC:4749	OMIM:602801	HIST1H2BN	3		
FBgn0053874	His2B:CG33874	HGNC:18730	OMIM:609904	HIST1H2BA	5		
FBgn0053874	His2B:CG33874	HGNC:4761	OMIM:615044	HIST1H2BJ	3		
FBgn0053874	His2B:CG33874	HGNC:20514	OMIM:615046	HIST3H2BB	4		
FBgn0053875	His4:CG33875	HGNC:20510	OMIM:615069	HIST4H4	5		
FBgn0053875	His4:CG33875	HGNC:4787	OMIM:602827	H4C3	4	619758	619758[TESSADORI-VAN HAAFTEN NEURODEVELOPMENTAL SYNDROME 1; TEVANED1]
FBgn0053875	His4:CG33875	HGNC:29607		HIST2H4B	4		
FBgn0053875	His4:CG33875	HGNC:4789	OMIM:602829	HIST1H4B	4		
FBgn0053875	His4:CG33875	HGNC:4788	OMIM:602828	HIST1H4H	4		
FBgn0053875	His4:CG33875	HGNC:4782	OMIM:602823	HIST1H4D	5		
FBgn0053875	His4:CG33875	HGNC:4790	OMIM:602830	HIST1H4E	4	619950	619950[TESSADORI-VAN HAAFTEN NEURODEVELOPMENTAL SYNDROME 3; TEVANED3]
FBgn0053875	His4:CG33875	HGNC:4783	OMIM:602824	HIST1H4F	5		
FBgn0053875	His4:CG33875	HGNC:4794	OMIM:142750	HIST2H4A	5		
FBgn0053875	His4:CG33875	HGNC:4785	OMIM:602826	H4C11	4	619759	619759[TESSADORI-VAN HAAFTEN NEURODEVELOPMENTAL SYNDROME 2; TEVANED2]
FBgn0053875	His4:CG33875	HGNC:4791	OMIM:602831	HIST1H4L	4		
FBgn0053875	His4:CG33875	HGNC:4784	OMIM:602825	HIST1H4K	4		
FBgn0053875	His4:CG33875	HGNC:4793	OMIM:602833	H4C9	4	619951	619951[TESSADORI-VAN HAAFTEN NEURODEVELOPMENTAL SYNDROME 4; TEVANED4]
FBgn0053875	His4:CG33875	HGNC:4781	OMIM:602822	HIST1H4A	4		
FBgn0053875	His4:CG33875	HGNC:4792	OMIM:602832	HIST1H4G	4		
FBgn0053876	His2B:CG33876	HGNC:4747	OMIM:602799	HIST1H2BD	3		
FBgn0053876	His2B:CG33876	HGNC:4746	OMIM:602798	HIST1H2BG	3		
FBgn0053876	His2B:CG33876	HGNC:4760	OMIM:601831	H2BC21	3		
FBgn0053876	His2B:CG33876	HGNC:4755	OMIM:602806	HIST1H2BH	3		
FBgn0053876	His2B:CG33876	HGNC:4751	OMIM:602803	HIST1H2BB	3		
FBgn0053876	His2B:CG33876	HGNC:4757	OMIM:602847	HIST1H2BC	3		
FBgn0053876	His2B:CG33876	HGNC:4750	OMIM:602802	HIST1H2BM	3		
FBgn0053876	His2B:CG33876	HGNC:4748	OMIM:602800	HIST1H2BL	3		
FBgn0053876	His2B:CG33876	HGNC:4753	OMIM:602805	HIST1H2BE	3		
FBgn0053876	His2B:CG33876	HGNC:4756	OMIM:602807	HIST1H2BI	3		
FBgn0053876	His2B:CG33876	HGNC:24700		HIST2H2BF	3		
FBgn0053876	His2B:CG33876	HGNC:13954	OMIM:615045	HIST1H2BK	3		
FBgn0053876	His2B:CG33876	HGNC:4758	OMIM:602808	HIST1H2BO	4		
FBgn0053876	His2B:CG33876	HGNC:4749	OMIM:602801	HIST1H2BN	3		
FBgn0053876	His2B:CG33876	HGNC:18730	OMIM:609904	HIST1H2BA	5		
FBgn0053876	His2B:CG33876	HGNC:4761	OMIM:615044	HIST1H2BJ	3		
FBgn0053876	His2B:CG33876	HGNC:20514	OMIM:615046	HIST3H2BB	4		
FBgn0053877	His4:CG33877	HGNC:20510	OMIM:615069	HIST4H4	4		
FBgn0053877	His4:CG33877	HGNC:4787	OMIM:602827	H4C3	4	619758	619758[TESSADORI-VAN HAAFTEN NEURODEVELOPMENTAL SYNDROME 1; TEVANED1]
FBgn0053877	His4:CG33877	HGNC:29607		HIST2H4B	4		
FBgn0053877	His4:CG33877	HGNC:4789	OMIM:602829	HIST1H4B	3		
FBgn0053877	His4:CG33877	HGNC:4788	OMIM:602828	HIST1H4H	4		
FBgn0053877	His4:CG33877	HGNC:4782	OMIM:602823	HIST1H4D	4		
FBgn0053877	His4:CG33877	HGNC:4790	OMIM:602830	HIST1H4E	4	619950	619950[TESSADORI-VAN HAAFTEN NEURODEVELOPMENTAL SYNDROME 3; TEVANED3]
FBgn0053877	His4:CG33877	HGNC:4783	OMIM:602824	HIST1H4F	4		
FBgn0053877	His4:CG33877	HGNC:4794	OMIM:142750	HIST2H4A	4		
FBgn0053877	His4:CG33877	HGNC:4785	OMIM:602826	H4C11	4	619759	619759[TESSADORI-VAN HAAFTEN NEURODEVELOPMENTAL SYNDROME 2; TEVANED2]
FBgn0053877	His4:CG33877	HGNC:4791	OMIM:602831	HIST1H4L	4		
FBgn0053877	His4:CG33877	HGNC:4784	OMIM:602825	HIST1H4K	4		
FBgn0053877	His4:CG33877	HGNC:4793	OMIM:602833	H4C9	4	619951	619951[TESSADORI-VAN HAAFTEN NEURODEVELOPMENTAL SYNDROME 4; TEVANED4]
FBgn0053877	His4:CG33877	HGNC:4781	OMIM:602822	HIST1H4A	4		
FBgn0053877	His4:CG33877	HGNC:4792	OMIM:602832	HIST1H4G	3		
FBgn0053878	His2B:CG33878	HGNC:4747	OMIM:602799	HIST1H2BD	3		
FBgn0053878	His2B:CG33878	HGNC:4746	OMIM:602798	HIST1H2BG	3		
FBgn0053878	His2B:CG33878	HGNC:4760	OMIM:601831	H2BC21	3		
FBgn0053878	His2B:CG33878	HGNC:4755	OMIM:602806	HIST1H2BH	3		
FBgn0053878	His2B:CG33878	HGNC:4751	OMIM:602803	HIST1H2BB	3		
FBgn0053878	His2B:CG33878	HGNC:4757	OMIM:602847	HIST1H2BC	3		
FBgn0053878	His2B:CG33878	HGNC:4750	OMIM:602802	HIST1H2BM	3		
FBgn0053878	His2B:CG33878	HGNC:4748	OMIM:602800	HIST1H2BL	3		
FBgn0053878	His2B:CG33878	HGNC:4753	OMIM:602805	HIST1H2BE	3		
FBgn0053878	His2B:CG33878	HGNC:4756	OMIM:602807	HIST1H2BI	3		
FBgn0053878	His2B:CG33878	HGNC:24700		HIST2H2BF	3		
FBgn0053878	His2B:CG33878	HGNC:13954	OMIM:615045	HIST1H2BK	3		
FBgn0053878	His2B:CG33878	HGNC:4758	OMIM:602808	HIST1H2BO	4		
FBgn0053878	His2B:CG33878	HGNC:4749	OMIM:602801	HIST1H2BN	3		
FBgn0053878	His2B:CG33878	HGNC:18730	OMIM:609904	HIST1H2BA	5		
FBgn0053878	His2B:CG33878	HGNC:4761	OMIM:615044	HIST1H2BJ	3		
FBgn0053878	His2B:CG33878	HGNC:20514	OMIM:615046	HIST3H2BB	4		
FBgn0053879	His4:CG33879	HGNC:20510	OMIM:615069	HIST4H4	4		
FBgn0053879	His4:CG33879	HGNC:4787	OMIM:602827	H4C3	4	619758	619758[TESSADORI-VAN HAAFTEN NEURODEVELOPMENTAL SYNDROME 1; TEVANED1]
FBgn0053879	His4:CG33879	HGNC:29607		HIST2H4B	4		
FBgn0053879	His4:CG33879	HGNC:4789	OMIM:602829	HIST1H4B	3		
FBgn0053879	His4:CG33879	HGNC:4788	OMIM:602828	HIST1H4H	4		
FBgn0053879	His4:CG33879	HGNC:4782	OMIM:602823	HIST1H4D	4		
FBgn0053879	His4:CG33879	HGNC:4790	OMIM:602830	HIST1H4E	4	619950	619950[TESSADORI-VAN HAAFTEN NEURODEVELOPMENTAL SYNDROME 3; TEVANED3]
FBgn0053879	His4:CG33879	HGNC:4783	OMIM:602824	HIST1H4F	4		
FBgn0053879	His4:CG33879	HGNC:4794	OMIM:142750	HIST2H4A	4		
FBgn0053879	His4:CG33879	HGNC:4785	OMIM:602826	H4C11	4	619759	619759[TESSADORI-VAN HAAFTEN NEURODEVELOPMENTAL SYNDROME 2; TEVANED2]
FBgn0053879	His4:CG33879	HGNC:4791	OMIM:602831	HIST1H4L	4		
FBgn0053879	His4:CG33879	HGNC:4784	OMIM:602825	HIST1H4K	4		
FBgn0053879	His4:CG33879	HGNC:4793	OMIM:602833	H4C9	4	619951	619951[TESSADORI-VAN HAAFTEN NEURODEVELOPMENTAL SYNDROME 4; TEVANED4]
FBgn0053879	His4:CG33879	HGNC:4781	OMIM:602822	HIST1H4A	4		
FBgn0053879	His4:CG33879	HGNC:4792	OMIM:602832	HIST1H4G	3		
FBgn0053880	His2B:CG33880	HGNC:4747	OMIM:602799	HIST1H2BD	3		
FBgn0053880	His2B:CG33880	HGNC:4746	OMIM:602798	HIST1H2BG	3		
FBgn0053880	His2B:CG33880	HGNC:4760	OMIM:601831	H2BC21	3		
FBgn0053880	His2B:CG33880	HGNC:4755	OMIM:602806	HIST1H2BH	3		
FBgn0053880	His2B:CG33880	HGNC:4751	OMIM:602803	HIST1H2BB	3		
FBgn0053880	His2B:CG33880	HGNC:4757	OMIM:602847	HIST1H2BC	3		
FBgn0053880	His2B:CG33880	HGNC:4750	OMIM:602802	HIST1H2BM	3		
FBgn0053880	His2B:CG33880	HGNC:4748	OMIM:602800	HIST1H2BL	3		
FBgn0053880	His2B:CG33880	HGNC:4753	OMIM:602805	HIST1H2BE	3		
FBgn0053880	His2B:CG33880	HGNC:4756	OMIM:602807	HIST1H2BI	3		
FBgn0053880	His2B:CG33880	HGNC:24700		HIST2H2BF	3		
FBgn0053880	His2B:CG33880	HGNC:13954	OMIM:615045	HIST1H2BK	3		
FBgn0053880	His2B:CG33880	HGNC:4758	OMIM:602808	HIST1H2BO	4		
FBgn0053880	His2B:CG33880	HGNC:4749	OMIM:602801	HIST1H2BN	3		
FBgn0053880	His2B:CG33880	HGNC:18730	OMIM:609904	HIST1H2BA	5		
FBgn0053880	His2B:CG33880	HGNC:4761	OMIM:615044	HIST1H2BJ	3		
FBgn0053880	His2B:CG33880	HGNC:20514	OMIM:615046	HIST3H2BB	4		
FBgn0053881	His4:CG33881	HGNC:20510	OMIM:615069	HIST4H4	4		
FBgn0053881	His4:CG33881	HGNC:4787	OMIM:602827	H4C3	4	619758	619758[TESSADORI-VAN HAAFTEN NEURODEVELOPMENTAL SYNDROME 1; TEVANED1]
FBgn0053881	His4:CG33881	HGNC:29607		HIST2H4B	4		
FBgn0053881	His4:CG33881	HGNC:4789	OMIM:602829	HIST1H4B	3		
FBgn0053881	His4:CG33881	HGNC:4788	OMIM:602828	HIST1H4H	4		
FBgn0053881	His4:CG33881	HGNC:4782	OMIM:602823	HIST1H4D	4		
FBgn0053881	His4:CG33881	HGNC:4790	OMIM:602830	HIST1H4E	4	619950	619950[TESSADORI-VAN HAAFTEN NEURODEVELOPMENTAL SYNDROME 3; TEVANED3]
FBgn0053881	His4:CG33881	HGNC:4783	OMIM:602824	HIST1H4F	4		
FBgn0053881	His4:CG33881	HGNC:4794	OMIM:142750	HIST2H4A	4		
FBgn0053881	His4:CG33881	HGNC:4785	OMIM:602826	H4C11	4	619759	619759[TESSADORI-VAN HAAFTEN NEURODEVELOPMENTAL SYNDROME 2; TEVANED2]
FBgn0053881	His4:CG33881	HGNC:4791	OMIM:602831	HIST1H4L	4		
FBgn0053881	His4:CG33881	HGNC:4784	OMIM:602825	HIST1H4K	4		
FBgn0053881	His4:CG33881	HGNC:4793	OMIM:602833	H4C9	4	619951	619951[TESSADORI-VAN HAAFTEN NEURODEVELOPMENTAL SYNDROME 4; TEVANED4]
FBgn0053881	His4:CG33881	HGNC:4781	OMIM:602822	HIST1H4A	4		
FBgn0053881	His4:CG33881	HGNC:4792	OMIM:602832	HIST1H4G	3		
FBgn0053882	His2B:CG33882	HGNC:4747	OMIM:602799	HIST1H2BD	3		
FBgn0053882	His2B:CG33882	HGNC:4746	OMIM:602798	HIST1H2BG	3		
FBgn0053882	His2B:CG33882	HGNC:4760	OMIM:601831	H2BC21	3		
FBgn0053882	His2B:CG33882	HGNC:4755	OMIM:602806	HIST1H2BH	3		
FBgn0053882	His2B:CG33882	HGNC:4751	OMIM:602803	HIST1H2BB	3		
FBgn0053882	His2B:CG33882	HGNC:4757	OMIM:602847	HIST1H2BC	3		
FBgn0053882	His2B:CG33882	HGNC:4750	OMIM:602802	HIST1H2BM	3		
FBgn0053882	His2B:CG33882	HGNC:4748	OMIM:602800	HIST1H2BL	3		
FBgn0053882	His2B:CG33882	HGNC:4753	OMIM:602805	HIST1H2BE	3		
FBgn0053882	His2B:CG33882	HGNC:4756	OMIM:602807	HIST1H2BI	3		
FBgn0053882	His2B:CG33882	HGNC:24700		HIST2H2BF	3		
FBgn0053882	His2B:CG33882	HGNC:13954	OMIM:615045	HIST1H2BK	3		
FBgn0053882	His2B:CG33882	HGNC:4758	OMIM:602808	HIST1H2BO	4		
FBgn0053882	His2B:CG33882	HGNC:4749	OMIM:602801	HIST1H2BN	3		
FBgn0053882	His2B:CG33882	HGNC:18730	OMIM:609904	HIST1H2BA	5		
FBgn0053882	His2B:CG33882	HGNC:4761	OMIM:615044	HIST1H2BJ	3		
FBgn0053882	His2B:CG33882	HGNC:20514	OMIM:615046	HIST3H2BB	4		
FBgn0053883	His4:CG33883	HGNC:20510	OMIM:615069	HIST4H4	5		
FBgn0053883	His4:CG33883	HGNC:4787	OMIM:602827	H4C3	4	619758	619758[TESSADORI-VAN HAAFTEN NEURODEVELOPMENTAL SYNDROME 1; TEVANED1]
FBgn0053883	His4:CG33883	HGNC:29607		HIST2H4B	4		
FBgn0053883	His4:CG33883	HGNC:4789	OMIM:602829	HIST1H4B	4		
FBgn0053883	His4:CG33883	HGNC:4788	OMIM:602828	HIST1H4H	4		
FBgn0053883	His4:CG33883	HGNC:4782	OMIM:602823	HIST1H4D	5		
FBgn0053883	His4:CG33883	HGNC:4790	OMIM:602830	HIST1H4E	4	619950	619950[TESSADORI-VAN HAAFTEN NEURODEVELOPMENTAL SYNDROME 3; TEVANED3]
FBgn0053883	His4:CG33883	HGNC:4783	OMIM:602824	HIST1H4F	5		
FBgn0053883	His4:CG33883	HGNC:4794	OMIM:142750	HIST2H4A	5		
FBgn0053883	His4:CG33883	HGNC:4785	OMIM:602826	H4C11	4	619759	619759[TESSADORI-VAN HAAFTEN NEURODEVELOPMENTAL SYNDROME 2; TEVANED2]
FBgn0053883	His4:CG33883	HGNC:4791	OMIM:602831	HIST1H4L	4		
FBgn0053883	His4:CG33883	HGNC:4784	OMIM:602825	HIST1H4K	4		
FBgn0053883	His4:CG33883	HGNC:4793	OMIM:602833	H4C9	4	619951	619951[TESSADORI-VAN HAAFTEN NEURODEVELOPMENTAL SYNDROME 4; TEVANED4]
FBgn0053883	His4:CG33883	HGNC:4781	OMIM:602822	HIST1H4A	4		
FBgn0053883	His4:CG33883	HGNC:4792	OMIM:602832	HIST1H4G	4		
FBgn0053884	His2B:CG33884	HGNC:4747	OMIM:602799	HIST1H2BD	9		
FBgn0053884	His2B:CG33884	HGNC:4746	OMIM:602798	HIST1H2BG	4		
FBgn0053884	His2B:CG33884	HGNC:4760	OMIM:601831	H2BC21	9		
FBgn0053884	His2B:CG33884	HGNC:4755	OMIM:602806	HIST1H2BH	9		
FBgn0053884	His2B:CG33884	HGNC:4751	OMIM:602803	HIST1H2BB	8		
FBgn0053884	His2B:CG33884	HGNC:4757	OMIM:602847	HIST1H2BC	4		
FBgn0053884	His2B:CG33884	HGNC:4750	OMIM:602802	HIST1H2BM	8		
FBgn0053884	His2B:CG33884	HGNC:4748	OMIM:602800	HIST1H2BL	9		
FBgn0053884	His2B:CG33884	HGNC:4753	OMIM:602805	HIST1H2BE	3		
FBgn0053884	His2B:CG33884	HGNC:4756	OMIM:602807	HIST1H2BI	3		
FBgn0053884	His2B:CG33884	HGNC:24700		HIST2H2BF	8		
FBgn0053884	His2B:CG33884	HGNC:13954	OMIM:615045	HIST1H2BK	9		
FBgn0053884	His2B:CG33884	HGNC:4758	OMIM:602808	HIST1H2BO	10		
FBgn0053884	His2B:CG33884	HGNC:4749	OMIM:602801	HIST1H2BN	8		
FBgn0053884	His2B:CG33884	HGNC:18730	OMIM:609904	HIST1H2BA	10		
FBgn0053884	His2B:CG33884	HGNC:4761	OMIM:615044	HIST1H2BJ	9		
FBgn0053884	His2B:CG33884	HGNC:20514	OMIM:615046	HIST3H2BB	9		
FBgn0053884	His2B:CG33884	HGNC:27252	OMIM:300507	H2BFWT	5		
FBgn0053884	His2B:CG33884	HGNC:27867		H2BFM	5		
FBgn0053884	His2B:CG33884	HGNC:4762		H2BFS	3		
FBgn0053884	His2B:CG33884	HGNC:20517		HIST2H2BD	3		
FBgn0053884	His2B:CG33884	HGNC:0		LOC102724334	5		
FBgn0053885	His4:CG33885	HGNC:20510	OMIM:615069	HIST4H4	5		
FBgn0053885	His4:CG33885	HGNC:4787	OMIM:602827	H4C3	4	619758	619758[TESSADORI-VAN HAAFTEN NEURODEVELOPMENTAL SYNDROME 1; TEVANED1]
FBgn0053885	His4:CG33885	HGNC:29607		HIST2H4B	4		
FBgn0053885	His4:CG33885	HGNC:4789	OMIM:602829	HIST1H4B	4		
FBgn0053885	His4:CG33885	HGNC:4788	OMIM:602828	HIST1H4H	4		
FBgn0053885	His4:CG33885	HGNC:4782	OMIM:602823	HIST1H4D	5		
FBgn0053885	His4:CG33885	HGNC:4790	OMIM:602830	HIST1H4E	4	619950	619950[TESSADORI-VAN HAAFTEN NEURODEVELOPMENTAL SYNDROME 3; TEVANED3]
FBgn0053885	His4:CG33885	HGNC:4783	OMIM:602824	HIST1H4F	5		
FBgn0053885	His4:CG33885	HGNC:4794	OMIM:142750	HIST2H4A	5		
FBgn0053885	His4:CG33885	HGNC:4785	OMIM:602826	H4C11	4	619759	619759[TESSADORI-VAN HAAFTEN NEURODEVELOPMENTAL SYNDROME 2; TEVANED2]
FBgn0053885	His4:CG33885	HGNC:4791	OMIM:602831	HIST1H4L	4		
FBgn0053885	His4:CG33885	HGNC:4784	OMIM:602825	HIST1H4K	4		
FBgn0053885	His4:CG33885	HGNC:4793	OMIM:602833	H4C9	5	619951	619951[TESSADORI-VAN HAAFTEN NEURODEVELOPMENTAL SYNDROME 4; TEVANED4]
FBgn0053885	His4:CG33885	HGNC:4781	OMIM:602822	HIST1H4A	4		
FBgn0053885	His4:CG33885	HGNC:4792	OMIM:602832	HIST1H4G	4		
FBgn0053886	His2B:CG33886	HGNC:4747	OMIM:602799	HIST1H2BD	3		
FBgn0053886	His2B:CG33886	HGNC:4746	OMIM:602798	HIST1H2BG	3		
FBgn0053886	His2B:CG33886	HGNC:4760	OMIM:601831	H2BC21	3		
FBgn0053886	His2B:CG33886	HGNC:4755	OMIM:602806	HIST1H2BH	3		
FBgn0053886	His2B:CG33886	HGNC:4751	OMIM:602803	HIST1H2BB	3		
FBgn0053886	His2B:CG33886	HGNC:4757	OMIM:602847	HIST1H2BC	3		
FBgn0053886	His2B:CG33886	HGNC:4750	OMIM:602802	HIST1H2BM	3		
FBgn0053886	His2B:CG33886	HGNC:4748	OMIM:602800	HIST1H2BL	3		
FBgn0053886	His2B:CG33886	HGNC:4753	OMIM:602805	HIST1H2BE	3		
FBgn0053886	His2B:CG33886	HGNC:4756	OMIM:602807	HIST1H2BI	3		
FBgn0053886	His2B:CG33886	HGNC:24700		HIST2H2BF	3		
FBgn0053886	His2B:CG33886	HGNC:13954	OMIM:615045	HIST1H2BK	3		
FBgn0053886	His2B:CG33886	HGNC:4758	OMIM:602808	HIST1H2BO	4		
FBgn0053886	His2B:CG33886	HGNC:4749	OMIM:602801	HIST1H2BN	3		
FBgn0053886	His2B:CG33886	HGNC:18730	OMIM:609904	HIST1H2BA	5		
FBgn0053886	His2B:CG33886	HGNC:4761	OMIM:615044	HIST1H2BJ	3		
FBgn0053886	His2B:CG33886	HGNC:20514	OMIM:615046	HIST3H2BB	4		
FBgn0053887	His4:CG33887	HGNC:20510	OMIM:615069	HIST4H4	5		
FBgn0053887	His4:CG33887	HGNC:4787	OMIM:602827	H4C3	4	619758	619758[TESSADORI-VAN HAAFTEN NEURODEVELOPMENTAL SYNDROME 1; TEVANED1]
FBgn0053887	His4:CG33887	HGNC:29607		HIST2H4B	4		
FBgn0053887	His4:CG33887	HGNC:4789	OMIM:602829	HIST1H4B	4		
FBgn0053887	His4:CG33887	HGNC:4788	OMIM:602828	HIST1H4H	4		
FBgn0053887	His4:CG33887	HGNC:4782	OMIM:602823	HIST1H4D	5		
FBgn0053887	His4:CG33887	HGNC:4790	OMIM:602830	HIST1H4E	4	619950	619950[TESSADORI-VAN HAAFTEN NEURODEVELOPMENTAL SYNDROME 3; TEVANED3]
FBgn0053887	His4:CG33887	HGNC:4783	OMIM:602824	HIST1H4F	5		
FBgn0053887	His4:CG33887	HGNC:4794	OMIM:142750	HIST2H4A	5		
FBgn0053887	His4:CG33887	HGNC:4785	OMIM:602826	H4C11	4	619759	619759[TESSADORI-VAN HAAFTEN NEURODEVELOPMENTAL SYNDROME 2; TEVANED2]
FBgn0053887	His4:CG33887	HGNC:4791	OMIM:602831	HIST1H4L	4		
FBgn0053887	His4:CG33887	HGNC:4784	OMIM:602825	HIST1H4K	4		
FBgn0053887	His4:CG33887	HGNC:4793	OMIM:602833	H4C9	4	619951	619951[TESSADORI-VAN HAAFTEN NEURODEVELOPMENTAL SYNDROME 4; TEVANED4]
FBgn0053887	His4:CG33887	HGNC:4781	OMIM:602822	HIST1H4A	5		
FBgn0053887	His4:CG33887	HGNC:4792	OMIM:602832	HIST1H4G	4		
FBgn0053888	His2B:CG33888	HGNC:4747	OMIM:602799	HIST1H2BD	3		
FBgn0053888	His2B:CG33888	HGNC:4746	OMIM:602798	HIST1H2BG	3		
FBgn0053888	His2B:CG33888	HGNC:4760	OMIM:601831	H2BC21	3		
FBgn0053888	His2B:CG33888	HGNC:4755	OMIM:602806	HIST1H2BH	3		
FBgn0053888	His2B:CG33888	HGNC:4751	OMIM:602803	HIST1H2BB	3		
FBgn0053888	His2B:CG33888	HGNC:4757	OMIM:602847	HIST1H2BC	3		
FBgn0053888	His2B:CG33888	HGNC:4750	OMIM:602802	HIST1H2BM	3		
FBgn0053888	His2B:CG33888	HGNC:4748	OMIM:602800	HIST1H2BL	3		
FBgn0053888	His2B:CG33888	HGNC:4753	OMIM:602805	HIST1H2BE	3		
FBgn0053888	His2B:CG33888	HGNC:4756	OMIM:602807	HIST1H2BI	3		
FBgn0053888	His2B:CG33888	HGNC:24700		HIST2H2BF	3		
FBgn0053888	His2B:CG33888	HGNC:13954	OMIM:615045	HIST1H2BK	3		
FBgn0053888	His2B:CG33888	HGNC:4758	OMIM:602808	HIST1H2BO	4		
FBgn0053888	His2B:CG33888	HGNC:4749	OMIM:602801	HIST1H2BN	3		
FBgn0053888	His2B:CG33888	HGNC:18730	OMIM:609904	HIST1H2BA	5		
FBgn0053888	His2B:CG33888	HGNC:4761	OMIM:615044	HIST1H2BJ	3		
FBgn0053888	His2B:CG33888	HGNC:20514	OMIM:615046	HIST3H2BB	4		
FBgn0053889	His4:CG33889	HGNC:20510	OMIM:615069	HIST4H4	5		
FBgn0053889	His4:CG33889	HGNC:4787	OMIM:602827	H4C3	4	619758	619758[TESSADORI-VAN HAAFTEN NEURODEVELOPMENTAL SYNDROME 1; TEVANED1]
FBgn0053889	His4:CG33889	HGNC:29607		HIST2H4B	4		
FBgn0053889	His4:CG33889	HGNC:4789	OMIM:602829	HIST1H4B	4		
FBgn0053889	His4:CG33889	HGNC:4788	OMIM:602828	HIST1H4H	4		
FBgn0053889	His4:CG33889	HGNC:4782	OMIM:602823	HIST1H4D	5		
FBgn0053889	His4:CG33889	HGNC:4790	OMIM:602830	HIST1H4E	4	619950	619950[TESSADORI-VAN HAAFTEN NEURODEVELOPMENTAL SYNDROME 3; TEVANED3]
FBgn0053889	His4:CG33889	HGNC:4783	OMIM:602824	HIST1H4F	5		
FBgn0053889	His4:CG33889	HGNC:4794	OMIM:142750	HIST2H4A	5		
FBgn0053889	His4:CG33889	HGNC:4785	OMIM:602826	H4C11	4	619759	619759[TESSADORI-VAN HAAFTEN NEURODEVELOPMENTAL SYNDROME 2; TEVANED2]
FBgn0053889	His4:CG33889	HGNC:4791	OMIM:602831	HIST1H4L	4		
FBgn0053889	His4:CG33889	HGNC:4784	OMIM:602825	HIST1H4K	4		
FBgn0053889	His4:CG33889	HGNC:4793	OMIM:602833	H4C9	4	619951	619951[TESSADORI-VAN HAAFTEN NEURODEVELOPMENTAL SYNDROME 4; TEVANED4]
FBgn0053889	His4:CG33889	HGNC:4781	OMIM:602822	HIST1H4A	4		
FBgn0053889	His4:CG33889	HGNC:4792	OMIM:602832	HIST1H4G	4		
FBgn0053890	His2B:CG33890	HGNC:4747	OMIM:602799	HIST1H2BD	3		
FBgn0053890	His2B:CG33890	HGNC:4746	OMIM:602798	HIST1H2BG	3		
FBgn0053890	His2B:CG33890	HGNC:4760	OMIM:601831	H2BC21	3		
FBgn0053890	His2B:CG33890	HGNC:4755	OMIM:602806	HIST1H2BH	3		
FBgn0053890	His2B:CG33890	HGNC:4751	OMIM:602803	HIST1H2BB	3		
FBgn0053890	His2B:CG33890	HGNC:4757	OMIM:602847	HIST1H2BC	3		
FBgn0053890	His2B:CG33890	HGNC:4750	OMIM:602802	HIST1H2BM	3		
FBgn0053890	His2B:CG33890	HGNC:4748	OMIM:602800	HIST1H2BL	3		
FBgn0053890	His2B:CG33890	HGNC:4753	OMIM:602805	HIST1H2BE	3		
FBgn0053890	His2B:CG33890	HGNC:4756	OMIM:602807	HIST1H2BI	3		
FBgn0053890	His2B:CG33890	HGNC:24700		HIST2H2BF	3		
FBgn0053890	His2B:CG33890	HGNC:13954	OMIM:615045	HIST1H2BK	3		
FBgn0053890	His2B:CG33890	HGNC:4758	OMIM:602808	HIST1H2BO	4		
FBgn0053890	His2B:CG33890	HGNC:4749	OMIM:602801	HIST1H2BN	3		
FBgn0053890	His2B:CG33890	HGNC:18730	OMIM:609904	HIST1H2BA	5		
FBgn0053890	His2B:CG33890	HGNC:4761	OMIM:615044	HIST1H2BJ	3		
FBgn0053890	His2B:CG33890	HGNC:20514	OMIM:615046	HIST3H2BB	4		
FBgn0053891	His4:CG33891	HGNC:20510	OMIM:615069	HIST4H4	5		
FBgn0053891	His4:CG33891	HGNC:4787	OMIM:602827	H4C3	4	619758	619758[TESSADORI-VAN HAAFTEN NEURODEVELOPMENTAL SYNDROME 1; TEVANED1]
FBgn0053891	His4:CG33891	HGNC:29607		HIST2H4B	4		
FBgn0053891	His4:CG33891	HGNC:4789	OMIM:602829	HIST1H4B	4		
FBgn0053891	His4:CG33891	HGNC:4788	OMIM:602828	HIST1H4H	4		
FBgn0053891	His4:CG33891	HGNC:4782	OMIM:602823	HIST1H4D	6		
FBgn0053891	His4:CG33891	HGNC:4790	OMIM:602830	HIST1H4E	4	619950	619950[TESSADORI-VAN HAAFTEN NEURODEVELOPMENTAL SYNDROME 3; TEVANED3]
FBgn0053891	His4:CG33891	HGNC:4783	OMIM:602824	HIST1H4F	5		
FBgn0053891	His4:CG33891	HGNC:4794	OMIM:142750	HIST2H4A	5		
FBgn0053891	His4:CG33891	HGNC:4785	OMIM:602826	H4C11	4	619759	619759[TESSADORI-VAN HAAFTEN NEURODEVELOPMENTAL SYNDROME 2; TEVANED2]
FBgn0053891	His4:CG33891	HGNC:4791	OMIM:602831	HIST1H4L	4		
FBgn0053891	His4:CG33891	HGNC:4784	OMIM:602825	HIST1H4K	4		
FBgn0053891	His4:CG33891	HGNC:4793	OMIM:602833	H4C9	4	619951	619951[TESSADORI-VAN HAAFTEN NEURODEVELOPMENTAL SYNDROME 4; TEVANED4]
FBgn0053891	His4:CG33891	HGNC:4781	OMIM:602822	HIST1H4A	4		
FBgn0053891	His4:CG33891	HGNC:4792	OMIM:602832	HIST1H4G	4		
FBgn0053892	His2B:CG33892	HGNC:4747	OMIM:602799	HIST1H2BD	3		
FBgn0053892	His2B:CG33892	HGNC:4746	OMIM:602798	HIST1H2BG	3		
FBgn0053892	His2B:CG33892	HGNC:4760	OMIM:601831	H2BC21	3		
FBgn0053892	His2B:CG33892	HGNC:4755	OMIM:602806	HIST1H2BH	3		
FBgn0053892	His2B:CG33892	HGNC:4751	OMIM:602803	HIST1H2BB	3		
FBgn0053892	His2B:CG33892	HGNC:4757	OMIM:602847	HIST1H2BC	3		
FBgn0053892	His2B:CG33892	HGNC:4750	OMIM:602802	HIST1H2BM	3		
FBgn0053892	His2B:CG33892	HGNC:4748	OMIM:602800	HIST1H2BL	3		
FBgn0053892	His2B:CG33892	HGNC:4753	OMIM:602805	HIST1H2BE	3		
FBgn0053892	His2B:CG33892	HGNC:4756	OMIM:602807	HIST1H2BI	3		
FBgn0053892	His2B:CG33892	HGNC:24700		HIST2H2BF	3		
FBgn0053892	His2B:CG33892	HGNC:13954	OMIM:615045	HIST1H2BK	3		
FBgn0053892	His2B:CG33892	HGNC:4758	OMIM:602808	HIST1H2BO	4		
FBgn0053892	His2B:CG33892	HGNC:4749	OMIM:602801	HIST1H2BN	3		
FBgn0053892	His2B:CG33892	HGNC:18730	OMIM:609904	HIST1H2BA	5		
FBgn0053892	His2B:CG33892	HGNC:4761	OMIM:615044	HIST1H2BJ	3		
FBgn0053892	His2B:CG33892	HGNC:20514	OMIM:615046	HIST3H2BB	4		
FBgn0053893	His4:CG33893	HGNC:20510	OMIM:615069	HIST4H4	5		
FBgn0053893	His4:CG33893	HGNC:4787	OMIM:602827	H4C3	4	619758	619758[TESSADORI-VAN HAAFTEN NEURODEVELOPMENTAL SYNDROME 1; TEVANED1]
FBgn0053893	His4:CG33893	HGNC:29607		HIST2H4B	4		
FBgn0053893	His4:CG33893	HGNC:4789	OMIM:602829	HIST1H4B	4		
FBgn0053893	His4:CG33893	HGNC:4788	OMIM:602828	HIST1H4H	4		
FBgn0053893	His4:CG33893	HGNC:4782	OMIM:602823	HIST1H4D	5		
FBgn0053893	His4:CG33893	HGNC:4790	OMIM:602830	HIST1H4E	4	619950	619950[TESSADORI-VAN HAAFTEN NEURODEVELOPMENTAL SYNDROME 3; TEVANED3]
FBgn0053893	His4:CG33893	HGNC:4783	OMIM:602824	HIST1H4F	5		
FBgn0053893	His4:CG33893	HGNC:4794	OMIM:142750	HIST2H4A	5		
FBgn0053893	His4:CG33893	HGNC:4785	OMIM:602826	H4C11	4	619759	619759[TESSADORI-VAN HAAFTEN NEURODEVELOPMENTAL SYNDROME 2; TEVANED2]
FBgn0053893	His4:CG33893	HGNC:4791	OMIM:602831	HIST1H4L	4		
FBgn0053893	His4:CG33893	HGNC:4784	OMIM:602825	HIST1H4K	4		
FBgn0053893	His4:CG33893	HGNC:4793	OMIM:602833	H4C9	4	619951	619951[TESSADORI-VAN HAAFTEN NEURODEVELOPMENTAL SYNDROME 4; TEVANED4]
FBgn0053893	His4:CG33893	HGNC:4781	OMIM:602822	HIST1H4A	4		
FBgn0053893	His4:CG33893	HGNC:4792	OMIM:602832	HIST1H4G	4		
FBgn0053894	His2B:CG33894	HGNC:4747	OMIM:602799	HIST1H2BD	3		
FBgn0053894	His2B:CG33894	HGNC:4746	OMIM:602798	HIST1H2BG	3		
FBgn0053894	His2B:CG33894	HGNC:4760	OMIM:601831	H2BC21	3		
FBgn0053894	His2B:CG33894	HGNC:4755	OMIM:602806	HIST1H2BH	3		
FBgn0053894	His2B:CG33894	HGNC:4751	OMIM:602803	HIST1H2BB	3		
FBgn0053894	His2B:CG33894	HGNC:4757	OMIM:602847	HIST1H2BC	3		
FBgn0053894	His2B:CG33894	HGNC:4750	OMIM:602802	HIST1H2BM	3		
FBgn0053894	His2B:CG33894	HGNC:4748	OMIM:602800	HIST1H2BL	3		
FBgn0053894	His2B:CG33894	HGNC:4753	OMIM:602805	HIST1H2BE	3		
FBgn0053894	His2B:CG33894	HGNC:4756	OMIM:602807	HIST1H2BI	3		
FBgn0053894	His2B:CG33894	HGNC:24700		HIST2H2BF	3		
FBgn0053894	His2B:CG33894	HGNC:13954	OMIM:615045	HIST1H2BK	3		
FBgn0053894	His2B:CG33894	HGNC:4758	OMIM:602808	HIST1H2BO	4		
FBgn0053894	His2B:CG33894	HGNC:4749	OMIM:602801	HIST1H2BN	3		
FBgn0053894	His2B:CG33894	HGNC:18730	OMIM:609904	HIST1H2BA	5		
FBgn0053894	His2B:CG33894	HGNC:4761	OMIM:615044	HIST1H2BJ	3		
FBgn0053894	His2B:CG33894	HGNC:20514	OMIM:615046	HIST3H2BB	4		
FBgn0053895	His4:CG33895	HGNC:20510	OMIM:615069	HIST4H4	5		
FBgn0053895	His4:CG33895	HGNC:4787	OMIM:602827	H4C3	4	619758	619758[TESSADORI-VAN HAAFTEN NEURODEVELOPMENTAL SYNDROME 1; TEVANED1]
FBgn0053895	His4:CG33895	HGNC:29607		HIST2H4B	4		
FBgn0053895	His4:CG33895	HGNC:4789	OMIM:602829	HIST1H4B	4		
FBgn0053895	His4:CG33895	HGNC:4788	OMIM:602828	HIST1H4H	4		
FBgn0053895	His4:CG33895	HGNC:4782	OMIM:602823	HIST1H4D	5		
FBgn0053895	His4:CG33895	HGNC:4790	OMIM:602830	HIST1H4E	4	619950	619950[TESSADORI-VAN HAAFTEN NEURODEVELOPMENTAL SYNDROME 3; TEVANED3]
FBgn0053895	His4:CG33895	HGNC:4783	OMIM:602824	HIST1H4F	5		
FBgn0053895	His4:CG33895	HGNC:4794	OMIM:142750	HIST2H4A	5		
FBgn0053895	His4:CG33895	HGNC:4785	OMIM:602826	H4C11	4	619759	619759[TESSADORI-VAN HAAFTEN NEURODEVELOPMENTAL SYNDROME 2; TEVANED2]
FBgn0053895	His4:CG33895	HGNC:4791	OMIM:602831	HIST1H4L	4		
FBgn0053895	His4:CG33895	HGNC:4784	OMIM:602825	HIST1H4K	5		
FBgn0053895	His4:CG33895	HGNC:4793	OMIM:602833	H4C9	4	619951	619951[TESSADORI-VAN HAAFTEN NEURODEVELOPMENTAL SYNDROME 4; TEVANED4]
FBgn0053895	His4:CG33895	HGNC:4781	OMIM:602822	HIST1H4A	4		
FBgn0053895	His4:CG33895	HGNC:4792	OMIM:602832	HIST1H4G	4		
FBgn0053896	His2B:CG33896	HGNC:4747	OMIM:602799	HIST1H2BD	3		
FBgn0053896	His2B:CG33896	HGNC:4746	OMIM:602798	HIST1H2BG	3		
FBgn0053896	His2B:CG33896	HGNC:4760	OMIM:601831	H2BC21	3		
FBgn0053896	His2B:CG33896	HGNC:4755	OMIM:602806	HIST1H2BH	3		
FBgn0053896	His2B:CG33896	HGNC:4751	OMIM:602803	HIST1H2BB	3		
FBgn0053896	His2B:CG33896	HGNC:4757	OMIM:602847	HIST1H2BC	3		
FBgn0053896	His2B:CG33896	HGNC:4750	OMIM:602802	HIST1H2BM	3		
FBgn0053896	His2B:CG33896	HGNC:4748	OMIM:602800	HIST1H2BL	3		
FBgn0053896	His2B:CG33896	HGNC:4753	OMIM:602805	HIST1H2BE	3		
FBgn0053896	His2B:CG33896	HGNC:4756	OMIM:602807	HIST1H2BI	3		
FBgn0053896	His2B:CG33896	HGNC:24700		HIST2H2BF	3		
FBgn0053896	His2B:CG33896	HGNC:13954	OMIM:615045	HIST1H2BK	3		
FBgn0053896	His2B:CG33896	HGNC:4758	OMIM:602808	HIST1H2BO	4		
FBgn0053896	His2B:CG33896	HGNC:4749	OMIM:602801	HIST1H2BN	3		
FBgn0053896	His2B:CG33896	HGNC:18730	OMIM:609904	HIST1H2BA	5		
FBgn0053896	His2B:CG33896	HGNC:4761	OMIM:615044	HIST1H2BJ	3		
FBgn0053896	His2B:CG33896	HGNC:20514	OMIM:615046	HIST3H2BB	4		
FBgn0053897	His4:CG33897	HGNC:20510	OMIM:615069	HIST4H4	5		
FBgn0053897	His4:CG33897	HGNC:4787	OMIM:602827	H4C3	5	619758	619758[TESSADORI-VAN HAAFTEN NEURODEVELOPMENTAL SYNDROME 1; TEVANED1]
FBgn0053897	His4:CG33897	HGNC:29607		HIST2H4B	4		
FBgn0053897	His4:CG33897	HGNC:4789	OMIM:602829	HIST1H4B	4		
FBgn0053897	His4:CG33897	HGNC:4788	OMIM:602828	HIST1H4H	4		
FBgn0053897	His4:CG33897	HGNC:4782	OMIM:602823	HIST1H4D	5		
FBgn0053897	His4:CG33897	HGNC:4790	OMIM:602830	HIST1H4E	4	619950	619950[TESSADORI-VAN HAAFTEN NEURODEVELOPMENTAL SYNDROME 3; TEVANED3]
FBgn0053897	His4:CG33897	HGNC:4783	OMIM:602824	HIST1H4F	5		
FBgn0053897	His4:CG33897	HGNC:4794	OMIM:142750	HIST2H4A	5		
FBgn0053897	His4:CG33897	HGNC:4785	OMIM:602826	H4C11	4	619759	619759[TESSADORI-VAN HAAFTEN NEURODEVELOPMENTAL SYNDROME 2; TEVANED2]
FBgn0053897	His4:CG33897	HGNC:4791	OMIM:602831	HIST1H4L	4		
FBgn0053897	His4:CG33897	HGNC:4784	OMIM:602825	HIST1H4K	4		
FBgn0053897	His4:CG33897	HGNC:4793	OMIM:602833	H4C9	4	619951	619951[TESSADORI-VAN HAAFTEN NEURODEVELOPMENTAL SYNDROME 4; TEVANED4]
FBgn0053897	His4:CG33897	HGNC:4781	OMIM:602822	HIST1H4A	4		
FBgn0053897	His4:CG33897	HGNC:4792	OMIM:602832	HIST1H4G	4		
FBgn0053898	His2B:CG33898	HGNC:4747	OMIM:602799	HIST1H2BD	3		
FBgn0053898	His2B:CG33898	HGNC:4746	OMIM:602798	HIST1H2BG	3		
FBgn0053898	His2B:CG33898	HGNC:4760	OMIM:601831	H2BC21	3		
FBgn0053898	His2B:CG33898	HGNC:4755	OMIM:602806	HIST1H2BH	3		
FBgn0053898	His2B:CG33898	HGNC:4751	OMIM:602803	HIST1H2BB	3		
FBgn0053898	His2B:CG33898	HGNC:4757	OMIM:602847	HIST1H2BC	3		
FBgn0053898	His2B:CG33898	HGNC:4750	OMIM:602802	HIST1H2BM	3		
FBgn0053898	His2B:CG33898	HGNC:4748	OMIM:602800	HIST1H2BL	3		
FBgn0053898	His2B:CG33898	HGNC:4753	OMIM:602805	HIST1H2BE	3		
FBgn0053898	His2B:CG33898	HGNC:4756	OMIM:602807	HIST1H2BI	3		
FBgn0053898	His2B:CG33898	HGNC:24700		HIST2H2BF	3		
FBgn0053898	His2B:CG33898	HGNC:13954	OMIM:615045	HIST1H2BK	3		
FBgn0053898	His2B:CG33898	HGNC:4758	OMIM:602808	HIST1H2BO	4		
FBgn0053898	His2B:CG33898	HGNC:4749	OMIM:602801	HIST1H2BN	3		
FBgn0053898	His2B:CG33898	HGNC:18730	OMIM:609904	HIST1H2BA	5		
FBgn0053898	His2B:CG33898	HGNC:4761	OMIM:615044	HIST1H2BJ	3		
FBgn0053898	His2B:CG33898	HGNC:20514	OMIM:615046	HIST3H2BB	4		
FBgn0053899	His4:CG33899	HGNC:20510	OMIM:615069	HIST4H4	5		
FBgn0053899	His4:CG33899	HGNC:4787	OMIM:602827	H4C3	4	619758	619758[TESSADORI-VAN HAAFTEN NEURODEVELOPMENTAL SYNDROME 1; TEVANED1]
FBgn0053899	His4:CG33899	HGNC:29607		HIST2H4B	4		
FBgn0053899	His4:CG33899	HGNC:4789	OMIM:602829	HIST1H4B	4		
FBgn0053899	His4:CG33899	HGNC:4788	OMIM:602828	HIST1H4H	4		
FBgn0053899	His4:CG33899	HGNC:4782	OMIM:602823	HIST1H4D	5		
FBgn0053899	His4:CG33899	HGNC:4790	OMIM:602830	HIST1H4E	4	619950	619950[TESSADORI-VAN HAAFTEN NEURODEVELOPMENTAL SYNDROME 3; TEVANED3]
FBgn0053899	His4:CG33899	HGNC:4783	OMIM:602824	HIST1H4F	5		
FBgn0053899	His4:CG33899	HGNC:4794	OMIM:142750	HIST2H4A	5		
FBgn0053899	His4:CG33899	HGNC:4785	OMIM:602826	H4C11	4	619759	619759[TESSADORI-VAN HAAFTEN NEURODEVELOPMENTAL SYNDROME 2; TEVANED2]
FBgn0053899	His4:CG33899	HGNC:4791	OMIM:602831	HIST1H4L	4		
FBgn0053899	His4:CG33899	HGNC:4784	OMIM:602825	HIST1H4K	4		
FBgn0053899	His4:CG33899	HGNC:4793	OMIM:602833	H4C9	4	619951	619951[TESSADORI-VAN HAAFTEN NEURODEVELOPMENTAL SYNDROME 4; TEVANED4]
FBgn0053899	His4:CG33899	HGNC:4781	OMIM:602822	HIST1H4A	4		
FBgn0053899	His4:CG33899	HGNC:4792	OMIM:602832	HIST1H4G	4		
FBgn0053900	His2B:CG33900	HGNC:4747	OMIM:602799	HIST1H2BD	3		
FBgn0053900	His2B:CG33900	HGNC:4746	OMIM:602798	HIST1H2BG	3		
FBgn0053900	His2B:CG33900	HGNC:4760	OMIM:601831	H2BC21	3		
FBgn0053900	His2B:CG33900	HGNC:4755	OMIM:602806	HIST1H2BH	3		
FBgn0053900	His2B:CG33900	HGNC:4751	OMIM:602803	HIST1H2BB	3		
FBgn0053900	His2B:CG33900	HGNC:4757	OMIM:602847	HIST1H2BC	3		
FBgn0053900	His2B:CG33900	HGNC:4750	OMIM:602802	HIST1H2BM	3		
FBgn0053900	His2B:CG33900	HGNC:4748	OMIM:602800	HIST1H2BL	3		
FBgn0053900	His2B:CG33900	HGNC:4753	OMIM:602805	HIST1H2BE	3		
FBgn0053900	His2B:CG33900	HGNC:4756	OMIM:602807	HIST1H2BI	3		
FBgn0053900	His2B:CG33900	HGNC:24700		HIST2H2BF	3		
FBgn0053900	His2B:CG33900	HGNC:13954	OMIM:615045	HIST1H2BK	3		
FBgn0053900	His2B:CG33900	HGNC:4758	OMIM:602808	HIST1H2BO	4		
FBgn0053900	His2B:CG33900	HGNC:4749	OMIM:602801	HIST1H2BN	3		
FBgn0053900	His2B:CG33900	HGNC:18730	OMIM:609904	HIST1H2BA	5		
FBgn0053900	His2B:CG33900	HGNC:4761	OMIM:615044	HIST1H2BJ	3		
FBgn0053900	His2B:CG33900	HGNC:20514	OMIM:615046	HIST3H2BB	4		
FBgn0053901	His4:CG33901	HGNC:20510	OMIM:615069	HIST4H4	5		
FBgn0053901	His4:CG33901	HGNC:4787	OMIM:602827	H4C3	4	619758	619758[TESSADORI-VAN HAAFTEN NEURODEVELOPMENTAL SYNDROME 1; TEVANED1]
FBgn0053901	His4:CG33901	HGNC:29607		HIST2H4B	4		
FBgn0053901	His4:CG33901	HGNC:4789	OMIM:602829	HIST1H4B	4		
FBgn0053901	His4:CG33901	HGNC:4788	OMIM:602828	HIST1H4H	4		
FBgn0053901	His4:CG33901	HGNC:4782	OMIM:602823	HIST1H4D	5		
FBgn0053901	His4:CG33901	HGNC:4790	OMIM:602830	HIST1H4E	4	619950	619950[TESSADORI-VAN HAAFTEN NEURODEVELOPMENTAL SYNDROME 3; TEVANED3]
FBgn0053901	His4:CG33901	HGNC:4783	OMIM:602824	HIST1H4F	5		
FBgn0053901	His4:CG33901	HGNC:4794	OMIM:142750	HIST2H4A	5		
FBgn0053901	His4:CG33901	HGNC:4785	OMIM:602826	H4C11	4	619759	619759[TESSADORI-VAN HAAFTEN NEURODEVELOPMENTAL SYNDROME 2; TEVANED2]
FBgn0053901	His4:CG33901	HGNC:4791	OMIM:602831	HIST1H4L	4		
FBgn0053901	His4:CG33901	HGNC:4784	OMIM:602825	HIST1H4K	4		
FBgn0053901	His4:CG33901	HGNC:4793	OMIM:602833	H4C9	4	619951	619951[TESSADORI-VAN HAAFTEN NEURODEVELOPMENTAL SYNDROME 4; TEVANED4]
FBgn0053901	His4:CG33901	HGNC:4781	OMIM:602822	HIST1H4A	4		
FBgn0053901	His4:CG33901	HGNC:4792	OMIM:602832	HIST1H4G	4		
FBgn0053902	His2B:CG33902	HGNC:4747	OMIM:602799	HIST1H2BD	3		
FBgn0053902	His2B:CG33902	HGNC:4746	OMIM:602798	HIST1H2BG	3		
FBgn0053902	His2B:CG33902	HGNC:4760	OMIM:601831	H2BC21	3		
FBgn0053902	His2B:CG33902	HGNC:4755	OMIM:602806	HIST1H2BH	3		
FBgn0053902	His2B:CG33902	HGNC:4751	OMIM:602803	HIST1H2BB	3		
FBgn0053902	His2B:CG33902	HGNC:4757	OMIM:602847	HIST1H2BC	3		
FBgn0053902	His2B:CG33902	HGNC:4750	OMIM:602802	HIST1H2BM	3		
FBgn0053902	His2B:CG33902	HGNC:4748	OMIM:602800	HIST1H2BL	3		
FBgn0053902	His2B:CG33902	HGNC:4753	OMIM:602805	HIST1H2BE	3		
FBgn0053902	His2B:CG33902	HGNC:4756	OMIM:602807	HIST1H2BI	3		
FBgn0053902	His2B:CG33902	HGNC:24700		HIST2H2BF	3		
FBgn0053902	His2B:CG33902	HGNC:13954	OMIM:615045	HIST1H2BK	3		
FBgn0053902	His2B:CG33902	HGNC:4758	OMIM:602808	HIST1H2BO	4		
FBgn0053902	His2B:CG33902	HGNC:4749	OMIM:602801	HIST1H2BN	3		
FBgn0053902	His2B:CG33902	HGNC:18730	OMIM:609904	HIST1H2BA	5		
FBgn0053902	His2B:CG33902	HGNC:4761	OMIM:615044	HIST1H2BJ	3		
FBgn0053902	His2B:CG33902	HGNC:20514	OMIM:615046	HIST3H2BB	4		
FBgn0053903	His4:CG33903	HGNC:20510	OMIM:615069	HIST4H4	6		
FBgn0053903	His4:CG33903	HGNC:4787	OMIM:602827	H4C3	4	619758	619758[TESSADORI-VAN HAAFTEN NEURODEVELOPMENTAL SYNDROME 1; TEVANED1]
FBgn0053903	His4:CG33903	HGNC:29607		HIST2H4B	4		
FBgn0053903	His4:CG33903	HGNC:4789	OMIM:602829	HIST1H4B	4		
FBgn0053903	His4:CG33903	HGNC:4788	OMIM:602828	HIST1H4H	4		
FBgn0053903	His4:CG33903	HGNC:4782	OMIM:602823	HIST1H4D	5		
FBgn0053903	His4:CG33903	HGNC:4790	OMIM:602830	HIST1H4E	4	619950	619950[TESSADORI-VAN HAAFTEN NEURODEVELOPMENTAL SYNDROME 3; TEVANED3]
FBgn0053903	His4:CG33903	HGNC:4783	OMIM:602824	HIST1H4F	5		
FBgn0053903	His4:CG33903	HGNC:4794	OMIM:142750	HIST2H4A	5		
FBgn0053903	His4:CG33903	HGNC:4785	OMIM:602826	H4C11	4	619759	619759[TESSADORI-VAN HAAFTEN NEURODEVELOPMENTAL SYNDROME 2; TEVANED2]
FBgn0053903	His4:CG33903	HGNC:4791	OMIM:602831	HIST1H4L	4		
FBgn0053903	His4:CG33903	HGNC:4784	OMIM:602825	HIST1H4K	4		
FBgn0053903	His4:CG33903	HGNC:4793	OMIM:602833	H4C9	4	619951	619951[TESSADORI-VAN HAAFTEN NEURODEVELOPMENTAL SYNDROME 4; TEVANED4]
FBgn0053903	His4:CG33903	HGNC:4781	OMIM:602822	HIST1H4A	4		
FBgn0053903	His4:CG33903	HGNC:4792	OMIM:602832	HIST1H4G	4		
FBgn0053904	His2B:CG33904	HGNC:4747	OMIM:602799	HIST1H2BD	3		
FBgn0053904	His2B:CG33904	HGNC:4746	OMIM:602798	HIST1H2BG	3		
FBgn0053904	His2B:CG33904	HGNC:4760	OMIM:601831	H2BC21	3		
FBgn0053904	His2B:CG33904	HGNC:4755	OMIM:602806	HIST1H2BH	3		
FBgn0053904	His2B:CG33904	HGNC:4751	OMIM:602803	HIST1H2BB	3		
FBgn0053904	His2B:CG33904	HGNC:4757	OMIM:602847	HIST1H2BC	3		
FBgn0053904	His2B:CG33904	HGNC:4750	OMIM:602802	HIST1H2BM	3		
FBgn0053904	His2B:CG33904	HGNC:4748	OMIM:602800	HIST1H2BL	3		
FBgn0053904	His2B:CG33904	HGNC:4753	OMIM:602805	HIST1H2BE	3		
FBgn0053904	His2B:CG33904	HGNC:4756	OMIM:602807	HIST1H2BI	3		
FBgn0053904	His2B:CG33904	HGNC:24700		HIST2H2BF	3		
FBgn0053904	His2B:CG33904	HGNC:13954	OMIM:615045	HIST1H2BK	3		
FBgn0053904	His2B:CG33904	HGNC:4758	OMIM:602808	HIST1H2BO	4		
FBgn0053904	His2B:CG33904	HGNC:4749	OMIM:602801	HIST1H2BN	3		
FBgn0053904	His2B:CG33904	HGNC:18730	OMIM:609904	HIST1H2BA	5		
FBgn0053904	His2B:CG33904	HGNC:4761	OMIM:615044	HIST1H2BJ	3		
FBgn0053904	His2B:CG33904	HGNC:20514	OMIM:615046	HIST3H2BB	4		
FBgn0053905	His4:CG33905	HGNC:20510	OMIM:615069	HIST4H4	5		
FBgn0053905	His4:CG33905	HGNC:4787	OMIM:602827	H4C3	4	619758	619758[TESSADORI-VAN HAAFTEN NEURODEVELOPMENTAL SYNDROME 1; TEVANED1]
FBgn0053905	His4:CG33905	HGNC:29607		HIST2H4B	4		
FBgn0053905	His4:CG33905	HGNC:4789	OMIM:602829	HIST1H4B	4		
FBgn0053905	His4:CG33905	HGNC:4788	OMIM:602828	HIST1H4H	4		
FBgn0053905	His4:CG33905	HGNC:4782	OMIM:602823	HIST1H4D	5		
FBgn0053905	His4:CG33905	HGNC:4790	OMIM:602830	HIST1H4E	4	619950	619950[TESSADORI-VAN HAAFTEN NEURODEVELOPMENTAL SYNDROME 3; TEVANED3]
FBgn0053905	His4:CG33905	HGNC:4783	OMIM:602824	HIST1H4F	5		
FBgn0053905	His4:CG33905	HGNC:4794	OMIM:142750	HIST2H4A	6		
FBgn0053905	His4:CG33905	HGNC:4785	OMIM:602826	H4C11	4	619759	619759[TESSADORI-VAN HAAFTEN NEURODEVELOPMENTAL SYNDROME 2; TEVANED2]
FBgn0053905	His4:CG33905	HGNC:4791	OMIM:602831	HIST1H4L	4		
FBgn0053905	His4:CG33905	HGNC:4784	OMIM:602825	HIST1H4K	4		
FBgn0053905	His4:CG33905	HGNC:4793	OMIM:602833	H4C9	4	619951	619951[TESSADORI-VAN HAAFTEN NEURODEVELOPMENTAL SYNDROME 4; TEVANED4]
FBgn0053905	His4:CG33905	HGNC:4781	OMIM:602822	HIST1H4A	4		
FBgn0053905	His4:CG33905	HGNC:4792	OMIM:602832	HIST1H4G	4		
FBgn0053906	His2B:CG33906	HGNC:4747	OMIM:602799	HIST1H2BD	3		
FBgn0053906	His2B:CG33906	HGNC:4746	OMIM:602798	HIST1H2BG	3		
FBgn0053906	His2B:CG33906	HGNC:4760	OMIM:601831	H2BC21	3		
FBgn0053906	His2B:CG33906	HGNC:4755	OMIM:602806	HIST1H2BH	3		
FBgn0053906	His2B:CG33906	HGNC:4751	OMIM:602803	HIST1H2BB	3		
FBgn0053906	His2B:CG33906	HGNC:4757	OMIM:602847	HIST1H2BC	3		
FBgn0053906	His2B:CG33906	HGNC:4750	OMIM:602802	HIST1H2BM	3		
FBgn0053906	His2B:CG33906	HGNC:4748	OMIM:602800	HIST1H2BL	3		
FBgn0053906	His2B:CG33906	HGNC:4753	OMIM:602805	HIST1H2BE	3		
FBgn0053906	His2B:CG33906	HGNC:4756	OMIM:602807	HIST1H2BI	3		
FBgn0053906	His2B:CG33906	HGNC:24700		HIST2H2BF	3		
FBgn0053906	His2B:CG33906	HGNC:13954	OMIM:615045	HIST1H2BK	3		
FBgn0053906	His2B:CG33906	HGNC:4758	OMIM:602808	HIST1H2BO	4		
FBgn0053906	His2B:CG33906	HGNC:4749	OMIM:602801	HIST1H2BN	3		
FBgn0053906	His2B:CG33906	HGNC:18730	OMIM:609904	HIST1H2BA	5		
FBgn0053906	His2B:CG33906	HGNC:4761	OMIM:615044	HIST1H2BJ	3		
FBgn0053906	His2B:CG33906	HGNC:20514	OMIM:615046	HIST3H2BB	4		
FBgn0053907	His4:CG33907	HGNC:20510	OMIM:615069	HIST4H4	5		
FBgn0053907	His4:CG33907	HGNC:4787	OMIM:602827	H4C3	4	619758	619758[TESSADORI-VAN HAAFTEN NEURODEVELOPMENTAL SYNDROME 1; TEVANED1]
FBgn0053907	His4:CG33907	HGNC:29607		HIST2H4B	4		
FBgn0053907	His4:CG33907	HGNC:4789	OMIM:602829	HIST1H4B	4		
FBgn0053907	His4:CG33907	HGNC:4788	OMIM:602828	HIST1H4H	4		
FBgn0053907	His4:CG33907	HGNC:4782	OMIM:602823	HIST1H4D	5		
FBgn0053907	His4:CG33907	HGNC:4790	OMIM:602830	HIST1H4E	5	619950	619950[TESSADORI-VAN HAAFTEN NEURODEVELOPMENTAL SYNDROME 3; TEVANED3]
FBgn0053907	His4:CG33907	HGNC:4783	OMIM:602824	HIST1H4F	5		
FBgn0053907	His4:CG33907	HGNC:4794	OMIM:142750	HIST2H4A	5		
FBgn0053907	His4:CG33907	HGNC:4785	OMIM:602826	H4C11	4	619759	619759[TESSADORI-VAN HAAFTEN NEURODEVELOPMENTAL SYNDROME 2; TEVANED2]
FBgn0053907	His4:CG33907	HGNC:4791	OMIM:602831	HIST1H4L	4		
FBgn0053907	His4:CG33907	HGNC:4784	OMIM:602825	HIST1H4K	4		
FBgn0053907	His4:CG33907	HGNC:4793	OMIM:602833	H4C9	4	619951	619951[TESSADORI-VAN HAAFTEN NEURODEVELOPMENTAL SYNDROME 4; TEVANED4]
FBgn0053907	His4:CG33907	HGNC:4781	OMIM:602822	HIST1H4A	4		
FBgn0053907	His4:CG33907	HGNC:4792	OMIM:602832	HIST1H4G	4		
FBgn0053908	His2B:CG33908	HGNC:4747	OMIM:602799	HIST1H2BD	3		
FBgn0053908	His2B:CG33908	HGNC:4746	OMIM:602798	HIST1H2BG	3		
FBgn0053908	His2B:CG33908	HGNC:4760	OMIM:601831	H2BC21	3		
FBgn0053908	His2B:CG33908	HGNC:4755	OMIM:602806	HIST1H2BH	3		
FBgn0053908	His2B:CG33908	HGNC:4751	OMIM:602803	HIST1H2BB	3		
FBgn0053908	His2B:CG33908	HGNC:4757	OMIM:602847	HIST1H2BC	3		
FBgn0053908	His2B:CG33908	HGNC:4750	OMIM:602802	HIST1H2BM	3		
FBgn0053908	His2B:CG33908	HGNC:4748	OMIM:602800	HIST1H2BL	3		
FBgn0053908	His2B:CG33908	HGNC:4753	OMIM:602805	HIST1H2BE	3		
FBgn0053908	His2B:CG33908	HGNC:4756	OMIM:602807	HIST1H2BI	3		
FBgn0053908	His2B:CG33908	HGNC:24700		HIST2H2BF	3		
FBgn0053908	His2B:CG33908	HGNC:13954	OMIM:615045	HIST1H2BK	3		
FBgn0053908	His2B:CG33908	HGNC:4758	OMIM:602808	HIST1H2BO	4		
FBgn0053908	His2B:CG33908	HGNC:4749	OMIM:602801	HIST1H2BN	3		
FBgn0053908	His2B:CG33908	HGNC:18730	OMIM:609904	HIST1H2BA	5		
FBgn0053908	His2B:CG33908	HGNC:4761	OMIM:615044	HIST1H2BJ	3		
FBgn0053908	His2B:CG33908	HGNC:20514	OMIM:615046	HIST3H2BB	4		
FBgn0051611	His4:CG31611	HGNC:20510	OMIM:615069	HIST4H4	6		
FBgn0051611	His4:CG31611	HGNC:4787	OMIM:602827	H4C3	4	619758	619758[TESSADORI-VAN HAAFTEN NEURODEVELOPMENTAL SYNDROME 1; TEVANED1]
FBgn0051611	His4:CG31611	HGNC:29607		HIST2H4B	4		
FBgn0051611	His4:CG31611	HGNC:4789	OMIM:602829	HIST1H4B	4		
FBgn0051611	His4:CG31611	HGNC:4788	OMIM:602828	HIST1H4H	4		
FBgn0051611	His4:CG31611	HGNC:4782	OMIM:602823	HIST1H4D	5		
FBgn0051611	His4:CG31611	HGNC:4790	OMIM:602830	HIST1H4E	4	619950	619950[TESSADORI-VAN HAAFTEN NEURODEVELOPMENTAL SYNDROME 3; TEVANED3]
FBgn0051611	His4:CG31611	HGNC:4783	OMIM:602824	HIST1H4F	6		
FBgn0051611	His4:CG31611	HGNC:4794	OMIM:142750	HIST2H4A	5		
FBgn0051611	His4:CG31611	HGNC:4785	OMIM:602826	H4C11	4	619759	619759[TESSADORI-VAN HAAFTEN NEURODEVELOPMENTAL SYNDROME 2; TEVANED2]
FBgn0051611	His4:CG31611	HGNC:4791	OMIM:602831	HIST1H4L	4		
FBgn0051611	His4:CG31611	HGNC:4784	OMIM:602825	HIST1H4K	5		
FBgn0051611	His4:CG31611	HGNC:4793	OMIM:602833	H4C9	4	619951	619951[TESSADORI-VAN HAAFTEN NEURODEVELOPMENTAL SYNDROME 4; TEVANED4]
FBgn0051611	His4:CG31611	HGNC:4781	OMIM:602822	HIST1H4A	4		
FBgn0051611	His4:CG31611	HGNC:4792	OMIM:602832	HIST1H4G	5		
FBgn0061209	His2B:CG17949	HGNC:4747	OMIM:602799	HIST1H2BD	3		
FBgn0061209	His2B:CG17949	HGNC:4746	OMIM:602798	HIST1H2BG	3		
FBgn0061209	His2B:CG17949	HGNC:4760	OMIM:601831	H2BC21	3		
FBgn0061209	His2B:CG17949	HGNC:4755	OMIM:602806	HIST1H2BH	3		
FBgn0061209	His2B:CG17949	HGNC:4751	OMIM:602803	HIST1H2BB	3		
FBgn0061209	His2B:CG17949	HGNC:4757	OMIM:602847	HIST1H2BC	3		
FBgn0061209	His2B:CG17949	HGNC:4750	OMIM:602802	HIST1H2BM	3		
FBgn0061209	His2B:CG17949	HGNC:4748	OMIM:602800	HIST1H2BL	3		
FBgn0061209	His2B:CG17949	HGNC:4753	OMIM:602805	HIST1H2BE	3		
FBgn0061209	His2B:CG17949	HGNC:4756	OMIM:602807	HIST1H2BI	3		
FBgn0061209	His2B:CG17949	HGNC:24700		HIST2H2BF	3		
FBgn0061209	His2B:CG17949	HGNC:13954	OMIM:615045	HIST1H2BK	3		
FBgn0061209	His2B:CG17949	HGNC:4758	OMIM:602808	HIST1H2BO	4		
FBgn0061209	His2B:CG17949	HGNC:4749	OMIM:602801	HIST1H2BN	3		
FBgn0061209	His2B:CG17949	HGNC:18730	OMIM:609904	HIST1H2BA	5		
FBgn0061209	His2B:CG17949	HGNC:4761	OMIM:615044	HIST1H2BJ	3		
FBgn0061209	His2B:CG17949	HGNC:20514	OMIM:615046	HIST3H2BB	4		
FBgn0053909	His4:CG33909	HGNC:20510	OMIM:615069	HIST4H4	5		
FBgn0053909	His4:CG33909	HGNC:4787	OMIM:602827	H4C3	4	619758	619758[TESSADORI-VAN HAAFTEN NEURODEVELOPMENTAL SYNDROME 1; TEVANED1]
FBgn0053909	His4:CG33909	HGNC:29607		HIST2H4B	4		
FBgn0053909	His4:CG33909	HGNC:4789	OMIM:602829	HIST1H4B	4		
FBgn0053909	His4:CG33909	HGNC:4788	OMIM:602828	HIST1H4H	5		
FBgn0053909	His4:CG33909	HGNC:4782	OMIM:602823	HIST1H4D	5		
FBgn0053909	His4:CG33909	HGNC:4790	OMIM:602830	HIST1H4E	4	619950	619950[TESSADORI-VAN HAAFTEN NEURODEVELOPMENTAL SYNDROME 3; TEVANED3]
FBgn0053909	His4:CG33909	HGNC:4783	OMIM:602824	HIST1H4F	5		
FBgn0053909	His4:CG33909	HGNC:4794	OMIM:142750	HIST2H4A	5		
FBgn0053909	His4:CG33909	HGNC:4785	OMIM:602826	H4C11	4	619759	619759[TESSADORI-VAN HAAFTEN NEURODEVELOPMENTAL SYNDROME 2; TEVANED2]
FBgn0053909	His4:CG33909	HGNC:4791	OMIM:602831	HIST1H4L	4		
FBgn0053909	His4:CG33909	HGNC:4784	OMIM:602825	HIST1H4K	4		
FBgn0053909	His4:CG33909	HGNC:4793	OMIM:602833	H4C9	4	619951	619951[TESSADORI-VAN HAAFTEN NEURODEVELOPMENTAL SYNDROME 4; TEVANED4]
FBgn0053909	His4:CG33909	HGNC:4781	OMIM:602822	HIST1H4A	4		
FBgn0053909	His4:CG33909	HGNC:4792	OMIM:602832	HIST1H4G	4		
FBgn0053910	His2B:CG33910	HGNC:4747	OMIM:602799	HIST1H2BD	3		
FBgn0053910	His2B:CG33910	HGNC:4746	OMIM:602798	HIST1H2BG	3		
FBgn0053910	His2B:CG33910	HGNC:4760	OMIM:601831	H2BC21	3		
FBgn0053910	His2B:CG33910	HGNC:4755	OMIM:602806	HIST1H2BH	3		
FBgn0053910	His2B:CG33910	HGNC:4751	OMIM:602803	HIST1H2BB	3		
FBgn0053910	His2B:CG33910	HGNC:4757	OMIM:602847	HIST1H2BC	3		
FBgn0053910	His2B:CG33910	HGNC:4750	OMIM:602802	HIST1H2BM	3		
FBgn0053910	His2B:CG33910	HGNC:4748	OMIM:602800	HIST1H2BL	3		
FBgn0053910	His2B:CG33910	HGNC:4753	OMIM:602805	HIST1H2BE	3		
FBgn0053910	His2B:CG33910	HGNC:4756	OMIM:602807	HIST1H2BI	3		
FBgn0053910	His2B:CG33910	HGNC:24700		HIST2H2BF	3		
FBgn0053910	His2B:CG33910	HGNC:13954	OMIM:615045	HIST1H2BK	3		
FBgn0053910	His2B:CG33910	HGNC:4758	OMIM:602808	HIST1H2BO	4		
FBgn0053910	His2B:CG33910	HGNC:4749	OMIM:602801	HIST1H2BN	3		
FBgn0053910	His2B:CG33910	HGNC:18730	OMIM:609904	HIST1H2BA	5		
FBgn0053910	His2B:CG33910	HGNC:4761	OMIM:615044	HIST1H2BJ	3		
FBgn0053910	His2B:CG33910	HGNC:20514	OMIM:615046	HIST3H2BB	4		
FBgn0025455	CycT	HGNC:1599	OMIM:143055	CCNT1	13		
FBgn0025455	CycT	HGNC:1600	OMIM:603862	CCNT2	12		
FBgn0038683	CG11779	HGNC:17316	OMIM:605058	TIMM44	14		
FBgn0033739	Dyb	HGNC:3058	OMIM:602415	DTNB	13		
FBgn0033739	Dyb	HGNC:3057	OMIM:601239	DTNA	12	604169	604169[LEFT VENTRICULAR NONCOMPACTION 1; LVNC1]
FBgn0034081	CG10731	HGNC:18799	OMIM:618579	DMAC2L	13		
FBgn0029175	sotv	HGNC:3513	OMIM:608210	EXT2	14	133701,616682	133701[EXOSTOSES, MULTIPLE, TYPE II; EXT2],616682[SEIZURES, SCOLIOSIS, AND MACROCEPHALY/MICROCEPHALY SYNDROME; SSMS]
FBgn0027358	Tim9b	HGNC:4022	OMIM:607388	TIMM10B	11		
FBgn0031041	Pstk	HGNC:28578	OMIM:611310	PSTK	9		
FBgn0003435	sm	HGNC:5045	OMIM:603083	HNRNPL	12		
FBgn0003435	sm	HGNC:25127	OMIM:611208	HNRNPLL	10		
FBgn0024251	bbx	HGNC:14422		BBX	7		
FBgn0024182	waw	HGNC:25799	OMIM:617064	GUF1	13	617065	617065[DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 40; DEE40]
FBgn0031455	Snapin	HGNC:17145	OMIM:607007	SNAPIN	11		
FBgn0031454	HemK2	HGNC:16021	OMIM:614553	N6AMT1	12		
FBgn0038032	CG10096	HGNC:26222	OMIM:616107	FAR1	5	616154,619338	616154[PEROXISOMAL FATTY ACYL-CoA REDUCTASE 1 DISORDER; PFCRD],619338[CATARACTS, SPASTIC PARAPARESIS, AND SPEECH DELAY; CSPSD]
FBgn0038032	CG10096	HGNC:25531	OMIM:616156	FAR2	4		
FBgn0038033	CG10097	HGNC:26222	OMIM:616107	FAR1	4	616154,619338	616154[PEROXISOMAL FATTY ACYL-CoA REDUCTASE 1 DISORDER; PFCRD],619338[CATARACTS, SPASTIC PARAPARESIS, AND SPEECH DELAY; CSPSD]
FBgn0038033	CG10097	HGNC:25531	OMIM:616156	FAR2	4		
FBgn0011640	lark	HGNC:9901	OMIM:602571	RBM4	10		
FBgn0011640	lark	HGNC:14219	OMIM:612409	RBM14	4		
FBgn0011640	lark	HGNC:28842		RBM4B	9		
FBgn0011640	lark	HGNC:38840		RBM14-RBM4	3		
FBgn0024293	Spn43Ab	HGNC:8955	OMIM:601799	SERPINB9	3		
FBgn0024293	Spn43Ab	HGNC:8945	OMIM:605587	SERPINI2	3		
FBgn0024293	Spn43Ab	HGNC:8943	OMIM:602445	SERPINI1	4	604218	604218[ENCEPHALOPATHY, FAMILIAL, WITH NEUROSERPIN INCLUSION BODIES; FENIB]
FBgn0024293	Spn43Ab	HGNC:10569	OMIM:600517	SERPINB3	3		
FBgn0024293	Spn43Ab	HGNC:3311	OMIM:130135	SERPINB1	4		
FBgn0024293	Spn43Ab	HGNC:8583	OMIM:173360	SERPINE1	3	613329	613329[PLASMINOGEN ACTIVATOR INHIBITOR-1 DEFICIENCY]
FBgn0024293	Spn43Ab	HGNC:8951	OMIM:177010	SERPINE2	3		
FBgn0024293	Spn43Ab	HGNC:14220	OMIM:615662	SERPINB12	3		
FBgn0024293	Spn43Ab	HGNC:15995	OMIM:615677	SERPINA9	3		
FBgn0024293	Spn43Ab	HGNC:8950	OMIM:173321	SERPINB6	3	613453	613453[DEAFNESS, AUTOSOMAL RECESSIVE 91; DFNB91]
FBgn0024293	Spn43Ab	HGNC:1540	OMIM:122500	SERPINA6	3	611489	611489[CORTICOSTEROID-BINDING GLOBULIN DEFICIENCY]
FBgn0024293	Spn43Ab	HGNC:8944	OMIM:604445	SERPINB13	3		
FBgn0024293	Spn43Ab	HGNC:23037	OMIM:612086	HMSD	3		
FBgn0033564	Pex6	HGNC:8859	OMIM:601498	PEX6	11	614862,614863,616617	614862[PEROXISOME BIOGENESIS DISORDER 4A (ZELLWEGER); PBD4A],614863[PEROXISOME BIOGENESIS DISORDER 4B; PBD4B],616617[HEIMLER SYNDROME 2; HMLR2]
FBgn0061356	Hao	HGNC:4810	OMIM:605176	HAO2	7		
FBgn0061356	Hao	HGNC:4809	OMIM:605023	HAO1	14		
FBgn0066304	Rpp20	HGNC:19949	OMIM:606113	POP7	12		
FBgn0066303	CG33932	HGNC:28217	OMIM:616499	TMEM203	12		
FBgn0260466	Indy-2	HGNC:14430	OMIM:606411	SLC13A3	8	618384	618384[LEUKOENCEPHALOPATHY, ACUTE REVERSIBLE, WITH INCREASED URINARY ALPHA-KETOGLUTARATE; ARLIAK]
FBgn0260466	Indy-2	HGNC:23089	OMIM:608305	SLC13A5	10	615905	615905[DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 25 WITH AMELOGENESIS IMPERFECTA; DEE25]
FBgn0260466	Indy-2	HGNC:10916	OMIM:606193	SLC13A1	10		
FBgn0260466	Indy-2	HGNC:15827	OMIM:604309	SLC13A4	9		
FBgn0260466	Indy-2	HGNC:10917	OMIM:604148	SLC13A2	10		
FBgn0064119	CG33934	HGNC:14430	OMIM:606411	SLC13A3	8	618384	618384[LEUKOENCEPHALOPATHY, ACUTE REVERSIBLE, WITH INCREASED URINARY ALPHA-KETOGLUTARATE; ARLIAK]
FBgn0064119	CG33934	HGNC:23089	OMIM:608305	SLC13A5	9	615905	615905[DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 25 WITH AMELOGENESIS IMPERFECTA; DEE25]
FBgn0064119	CG33934	HGNC:10916	OMIM:606193	SLC13A1	10		
FBgn0064119	CG33934	HGNC:15827	OMIM:604309	SLC13A4	9		
FBgn0064119	CG33934	HGNC:10917	OMIM:604148	SLC13A2	9		
FBgn0002709	mei-218	HGNC:26368	OMIM:617545	MCMDC2	5		
FBgn0029153	Menl-2	HGNC:6985	OMIM:604626	ME3	6		
FBgn0029153	Menl-2	HGNC:6984	OMIM:154270	ME2	6		
FBgn0029153	Menl-2	HGNC:6983	OMIM:154250	ME1	6		
FBgn0029154	Menl-1	HGNC:6985	OMIM:604626	ME3	6		
FBgn0029154	Menl-1	HGNC:6984	OMIM:154270	ME2	6		
FBgn0029154	Menl-1	HGNC:6983	OMIM:154250	ME1	6		
FBgn0004507	GlyP	HGNC:9725	OMIM:613741	PYGL	13	232700	232700[GLYCOGEN STORAGE DISEASE VI; GSD6]
FBgn0004507	GlyP	HGNC:9723	OMIM:138550	PYGB	12		
FBgn0004507	GlyP	HGNC:9726	OMIM:608455	PYGM	15	232600	232600[GLYCOGEN STORAGE DISEASE V; GSD5]
FBgn0083167	Neb-cGP	HGNC:30889	OMIM:615204	ATP5MD	7	618683	618683[MITOCHONDRIAL COMPLEX V (ATP SYNTHASE) DEFICIENCY, NUCLEAR TYPE 6; MC5DN6]
FBgn0031414	eys	HGNC:26810	OMIM:617683	EGFLAM	3		
FBgn0031414	eys	HGNC:21555	OMIM:612424	EYS	5	602772	602772[RETINITIS PIGMENTOSA 25; RP25]
FBgn0034903	sona	HGNC:221	OMIM:605007	ADAMTS5	3		
FBgn0001297	kay	HGNC:3796	OMIM:164810	FOS	6		
FBgn0001297	kay	HGNC:3798	OMIM:601575	FOSL2	6		
FBgn0001297	kay	HGNC:13718	OMIM:136515	FOSL1	6		
FBgn0001297	kay	HGNC:3797	OMIM:164772	FOSB	4		
FBgn0024963	GluClalpha	HGNC:4328	OMIM:600421	GLRA3	10		
FBgn0024963	GluClalpha	HGNC:4329	OMIM:138492	GLRB	5	614619	614619[HYPEREKPLEXIA 2; HKPX2]
FBgn0024963	GluClalpha	HGNC:4327	OMIM:305990	GLRA2	10	301076	301076[INTELLECTUAL DEVELOPMENTAL DISORDER, X-LINKED, SYNDROMIC, PILORGE TYPE; MRXSP]
FBgn0024963	GluClalpha	HGNC:31715		GLRA4	10		
FBgn0024963	GluClalpha	HGNC:4326	OMIM:138491	GLRA1	12	149400	149400[HYPEREKPLEXIA 1; HKPX1]
FBgn0036210	CG14130	HGNC:21306	OMIM:613305	ALKBH7	14		
FBgn0032536	Ance-3	HGNC:13557	OMIM:300335	ACE2	6		
FBgn0032536	Ance-3	HGNC:2707	OMIM:106180	ACE	7	267430,612624,614519	267430[RENAL TUBULAR DYSGENESIS; RTD],612624[MICROVASCULAR COMPLICATIONS OF DIABETES, SUSCEPTIBILITY TO, 3; MVCD3],614519[HEMORRHAGE, INTRACEREBRAL, SUSCEPTIBILITY TO; ICH]
FBgn0032812	Hakai	HGNC:26371		CBLL2	7		
FBgn0032812	Hakai	HGNC:21225	OMIM:606872	CBLL1	9		
FBgn0001149	GstD1	HGNC:4642	OMIM:600437	GSTT2	3		
FBgn0001149	GstD1	HGNC:33437		GSTT2B	3		
FBgn0001149	GstD1	HGNC:26930		GSTT4	3		
FBgn0035766	eco	HGNC:27230	OMIM:609353	ESCO2	9	216100,268300	216100[JUBERG-HAYWARD SYNDROME; JHS],268300[ROBERTS-SC PHOCOMELIA SYNDROME; RBS]
FBgn0035766	eco	HGNC:24645	OMIM:609674	ESCO1	10		
FBgn0034314	nopo	HGNC:30764	OMIM:605958	TRAIP	10	616777	616777[SECKEL SYNDROME 9; SCKL9]
FBgn0034315	CG5721	HGNC:25049		ARMC6	14		
FBgn0031191	Cp110	HGNC:24342	OMIM:609544	CCP110	10		
FBgn0031930	CG7025	HGNC:2300	OMIM:603101	CPB2	8		
FBgn0031930	CG7025	HGNC:21011	OMIM:609563	CPO	8		
FBgn0031930	CG7025	HGNC:2298	OMIM:114851	CPA3	7		
FBgn0031930	CG7025	HGNC:2297	OMIM:600688	CPA2	9		
FBgn0031930	CG7025	HGNC:15740	OMIM:607635	CPA4	8		
FBgn0031930	CG7025	HGNC:2299	OMIM:114852	CPB1	10		
FBgn0031930	CG7025	HGNC:2296	OMIM:114850	CPA1	9		
FBgn0031930	CG7025	HGNC:17245	OMIM:609562	CPA6	7	614417,614418	614417[EPILEPSY, FAMILIAL TEMPORAL LOBE, 5; ETL5],614418[FEBRILE SEIZURES, FAMILIAL, 11; FEB11]
FBgn0031930	CG7025	HGNC:15722	OMIM:609561	CPA5	8		
FBgn0017579	RpL14	HGNC:10305	OMIM:617414	RPL14	14		
FBgn0031220	CG4822	HGNC:73	OMIM:603076	ABCG1	7		
FBgn0031220	CG4822	HGNC:13884	OMIM:607784	ABCG4	6		
FBgn0031220	CG4822	HGNC:74	OMIM:603756	ABCG2	3	138900,614490	138900[URIC ACID CONCENTRATION, SERUM, QUANTITATIVE TRAIT LOCUS 1; UAQTL1],614490[BLOOD GROUP, JUNIOR SYSTEM; JR]
FBgn0031220	CG4822	HGNC:13887	OMIM:605460	ABCG8	3	210250,611465	210250[SITOSTEROLEMIA 1; STSL1],611465[GALLBLADDER DISEASE 4; GBD4]
FBgn0000152	Axs	HGNC:29329	OMIM:610216	ANO8	5		
FBgn0000152	Axs	HGNC:25519	OMIM:613726	ANO10	12	613728	613728[SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 10; SCAR10]
FBgn0003900	twi	HGNC:4808	OMIM:602407	HAND2	3		
FBgn0003900	twi	HGNC:20670	OMIM:607556	TWIST2	8	200110,209885,227260	200110[ABLEPHARON-MACROSTOMIA SYNDROME; AMS],209885[BARBER-SAY SYNDROME; BBRSAY],227260[FOCAL FACIAL DERMAL DYSPLASIA 3, SETLEIS TYPE; FFDD3]
FBgn0003900	twi	HGNC:12428	OMIM:601622	TWIST1	9	101400,123100,180750,617746	101400[SAETHRE-CHOTZEN SYNDROME; SCS],123100[CRANIOSYNOSTOSIS 1; CRS1],180750[ROBINOW-SORAUF SYNDROME],617746[SWEENEY-COX SYNDROME; SWCOS]
FBgn0036685	CG6664	HGNC:18782	OMIM:601985	CCDC6	12		
FBgn0030778	CG4678	HGNC:2311	OMIM:114860	CPM	14		
FBgn0030778	CG4678	HGNC:2301	OMIM:603102	CPD	3		
FBgn0030778	CG4678	HGNC:2303	OMIM:114855	CPE	4	619326	619326[BDV SYNDROME; BDVS]
FBgn0013799	Deaf1	HGNC:14677	OMIM:602635	DEAF1	12	615828,617171	615828[VULTO-VAN SILFHOUT-DE VRIES SYNDROME; VSVS],617171[NEURODEVELOPMENTAL DISORDER WITH HYPOTONIA AND IMPAIRED EXPRESSIVE LANGUAGE AND WITH OR WITHOUT SEIZURES; NEDHELS]
FBgn0032515	loqs	HGNC:11370	OMIM:601716	STAU1	3		
FBgn0032515	loqs	HGNC:11371	OMIM:605920	STAU2	3		
FBgn0032515	loqs	HGNC:9438	OMIM:603424	PRKRA	13	612067	612067[DYSTONIA 16; DYT16]
FBgn0032515	loqs	HGNC:11569	OMIM:605053	TARBP2	12		
FBgn0052202	CG32202	HGNC:13630	OMIM:609519	TFPT	5		
FBgn0050280	CG30280	HGNC:3624	OMIM:601624	FCN2	6		
FBgn0050280	CG30280	HGNC:3623	OMIM:601252	FCN1	4		
FBgn0050280	CG30280	HGNC:25922	OMIM:613357	FIBCD1	9		
FBgn0050280	CG30280	HGNC:3695	OMIM:605776	FGL1	4		
FBgn0050280	CG30280	HGNC:3625	OMIM:604973	FCN3	4	613860	613860[FICOLIN 3 DEFICIENCY]
FBgn0050280	CG30280	HGNC:7035	OMIM:600596	MFAP4	4		
FBgn0033712	mIF3	HGNC:29788	OMIM:619554	MTIF3	5		
FBgn0027094	AlaRS	HGNC:20	OMIM:601065	AARS	14	613287,616339,619661,619691	613287[CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2N; CMT2N],616339[DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 29; DEE29],619661[LEUKOENCEPHALOPATHY, HEREDITARY DIFFUSE, WITH SPHEROIDS 2; HDLS2],619691[TRICHOTHIODYSTROPHY 8, NONPHOTOSENSITIVE; TTD8]
FBgn0027094	AlaRS	HGNC:21022	OMIM:612035	AARS2	4	614096,615889	614096[COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 8; COXPD8],615889[LEUKOENCEPHALOPATHY, PROGRESSIVE, WITH OVARIAN FAILURE; LKENP]
FBgn0039648	CG14515	HGNC:27622	OMIM:611578	FRRS1	3		
FBgn0039648	CG14515	HGNC:53638		REELD1	4		
FBgn0035426	CG12078	HGNC:19085	OMIM:610684	CTDNEP1	4		
FBgn0031322	CG5001	HGNC:14887	OMIM:611328	DNAJB5	14		
FBgn0031322	CG5001	HGNC:5270	OMIM:604572	DNAJB1	12		
FBgn0031322	CG5001	HGNC:30718	OMIM:610263	DNAJB13	4	617091	617091[CILIARY DYSKINESIA, PRIMARY, 34; CILD34]
FBgn0031322	CG5001	HGNC:14886	OMIM:611327	DNAJB4	11		
FBgn0035945	CG5026	HGNC:14596	OMIM:606260	MTMR9	15		
FBgn0035945	CG5026	HGNC:7453	OMIM:603561	MTMR6	3		
FBgn0035945	CG5026	HGNC:7454	OMIM:603562	MTMR7	3		
FBgn0031575	Cep97	HGNC:26244	OMIM:615864	CEP97	11		
FBgn0002631	E(spl)m5-HLH	HGNC:24149	OMIM:608060	HES4	4		
FBgn0002631	E(spl)m5-HLH	HGNC:5192	OMIM:139605	HES1	4		
FBgn0002631	E(spl)m5-HLH	HGNC:16005	OMIM:609970	HES2	6		
FBgn0002631	E(spl)m5-HLH	HGNC:18254	OMIM:610331	HES6	4		
FBgn0002631	E(spl)m5-HLH	HGNC:19764	OMIM:607348	HES5	4		
FBgn0002631	E(spl)m5-HLH	HGNC:26226	OMIM:609971	HES3	3		
FBgn0002631	E(spl)m5-HLH	HGNC:15977	OMIM:608059	HES7	3	613686	613686[SPONDYLOCOSTAL DYSOSTOSIS 4, AUTOSOMAL RECESSIVE; SCDO4]
FBgn0002631	E(spl)m5-HLH	HGNC:1046	OMIM:604256	BHLHE40	3		
FBgn0002631	E(spl)m5-HLH	HGNC:16617	OMIM:606200	BHLHE41	3	612975	612975[SHORT SLEEP, FAMILIAL NATURAL, 1; FNSS1]
FBgn0034009	CG8155	HGNC:8092	OMIM:311240	TBC1D25	13		
FBgn0031995	CG8475	HGNC:8927	OMIM:172490	PHKB	12	261750	261750[GLYCOGEN STORAGE DISEASE IXb; GSD9B]
FBgn0004047	Yp3	HGNC:18821	OMIM:609252	LIPI	3		
FBgn0034415	Gpxl	HGNC:4556	OMIM:138322	GPX4	5	250220	250220[SPONDYLOMETAPHYSEAL DYSPLASIA, SEDAGHATIAN TYPE; SMDS]
FBgn0034415	Gpxl	HGNC:4559	OMIM:615784	GPX7	4		
FBgn0034415	Gpxl	HGNC:33100	OMIM:617172	GPX8	4		
FBgn0034415	Gpxl	HGNC:4553	OMIM:138320	GPX1	3	614164	614164[GLUTATHIONE PEROXIDASE DEFICIENCY; GPXD]
FBgn0034415	Gpxl	HGNC:4557	OMIM:603435	GPX5	3		
FBgn0067317	Cby	HGNC:1307	OMIM:607757	CBY1	7		
FBgn0025632	CG4313	HGNC:7463	OMIM:600665	MTNR1A	3		
FBgn0025632	CG4313	HGNC:4535	OMIM:606383	GPR84	5		
FBgn0011837	Tis11	HGNC:1108	OMIM:612053	ZFP36L2	6		
FBgn0011837	Tis11	HGNC:12862	OMIM:190700	ZFP36	7		
FBgn0011837	Tis11	HGNC:1107	OMIM:601064	ZFP36L1	7		
FBgn0036916	Mtr3	HGNC:19055	OMIM:606490	EXOSC6	9		
FBgn0011272	RpL13	HGNC:10303	OMIM:113703	RPL13	14	618728	618728[SPONDYLOEPIMETAPHYSEAL DYSPLASIA, ISIDOR-TOUTAIN TYPE; SEMDIST]
FBgn0053964	CG33964	HGNC:26228		METTL25	9		
FBgn0033453	Sting	HGNC:27962	OMIM:612374	STING1	10	615934	615934[STING-ASSOCIATED VASCULOPATHY, INFANTILE-ONSET; SAVI]
FBgn0010406	RNaseX25	HGNC:21686	OMIM:612944	RNASET2	12	612951	612951[LEUKOENCEPHALOPATHY, CYSTIC, WITHOUT MEGALENCEPHALY]
FBgn0036493	CG7255	HGNC:11060	OMIM:601872	SLC7A2	9		
FBgn0036493	CG7255	HGNC:11057	OMIM:104615	SLC7A1	8		
FBgn0036493	CG7255	HGNC:11061	OMIM:300443	SLC7A3	9		
FBgn0036493	CG7255	HGNC:29326	OMIM:615720	SLC7A14	4	615725	615725[RETINITIS PIGMENTOSA 68; RP68]
FBgn0036493	CG7255	HGNC:11062	OMIM:603752	SLC7A4	5		
FBgn0003028	ovo	HGNC:8525	OMIM:602313	OVOL1	8		
FBgn0003028	ovo	HGNC:15804	OMIM:616441	OVOL2	6	122000	122000[CORNEAL DYSTROPHY, POSTERIOR POLYMORPHOUS, 1; PPCD1]
FBgn0053965	CG33965	HGNC:12404	OMIM:600415	TTPA	3	277460	277460[ATAXIA WITH VITAMIN E DEFICIENCY; AVED]
FBgn0053965	CG33965	HGNC:16114		TTPAL	3		
FBgn0053965	CG33965	HGNC:10024	OMIM:180090	RLBP1	3	136880,607475,607476	136880[FUNDUS ALBIPUNCTATUS],607475[BOTHNIA RETINAL DYSTROPHY],607476[NEWFOUNDLAND ROD-CONE DYSTROPHY; NFRCD]
FBgn0053965	CG33965	HGNC:23046	OMIM:616945	CLVS2	3		
FBgn0053965	CG33965	HGNC:23139	OMIM:611292	CLVS1	3		
FBgn0031726	Cyp6a16	HGNC:2638	OMIM:605325	CYP3A5	3	145500	145500[HYPERTENSION, ESSENTIAL]
FBgn0031726	Cyp6a16	HGNC:17450	OMIM:606534	CYP3A43	3		
FBgn0031726	Cyp6a16	HGNC:2637	OMIM:124010	CYP3A4	3	619073	619073[VITAMIN D-DEPENDENT RICKETS, TYPE 3; VDDR3]
FBgn0031726	Cyp6a16	HGNC:51504		CYP3A7-CYP3A51P	3		
FBgn0004828	His3.3B	HGNC:4764	OMIM:601128	H3-3A	6	619720	619720[BRYANT-LI-BHOJ NEURODEVELOPMENTAL SYNDROME 1; BRYLIB1]
FBgn0004828	His3.3B	HGNC:20505		HIST2H3A	3		
FBgn0004828	His3.3B	HGNC:4766	OMIM:602810	HIST1H3A	3		
FBgn0004828	His3.3B	HGNC:25311		HIST2H3D	3		
FBgn0004828	His3.3B	HGNC:4773	OMIM:602816	H3C7	3		
FBgn0004828	His3.3B	HGNC:20503	OMIM:142780	HIST2H3C	3		
FBgn0004828	His3.3B	HGNC:4771	OMIM:602814	HIST1H3I	3		
FBgn0004828	His3.3B	HGNC:4768	OMIM:602812	H3C3	3		
FBgn0004828	His3.3B	HGNC:4765	OMIM:601058	H3-3B	5	619721	619721[BRYANT-LI-BHOJ NEURODEVELOPMENTAL SYNDROME 2; BRYLIB2]
FBgn0004828	His3.3B	HGNC:4774	OMIM:602817	HIST1H3J	3		
FBgn0004828	His3.3B	HGNC:4776	OMIM:602819	H3C2	3		
FBgn0004828	His3.3B	HGNC:4769	OMIM:602813	HIST1H3E	3		
FBgn0004828	His3.3B	HGNC:4767	OMIM:602811	HIST1H3D	3		
FBgn0004828	His3.3B	HGNC:4775	OMIM:602818	H3C10	3		
FBgn0004828	His3.3B	HGNC:33164	OMIM:616134	H3F3C	3		
FBgn0053517	Dop2R	HGNC:3023	OMIM:126450	DRD2	9		
FBgn0053517	Dop2R	HGNC:3024	OMIM:126451	DRD3	7	181500,190300	181500[SCHIZOPHRENIA; SCZD],190300[TREMOR, HEREDITARY ESSENTIAL, 1; ETM1]
FBgn0053517	Dop2R	HGNC:3025	OMIM:126452	DRD4	4	143465	143465[ATTENTION DEFICIT-HYPERACTIVITY DISORDER; ADHD]
FBgn0035021	CG4622	HGNC:25265	OMIM:616381	ZCCHC8	11	618674	618674[PULMONARY FIBROSIS AND/OR BONE MARROW FAILURE, TELOMERE-RELATED, 5; PFBMFT5]
FBgn0035083	Tina-1	HGNC:25100	OMIM:613378	GGACT	14		
FBgn0037137	Nopp140	HGNC:15608	OMIM:602394	NOLC1	3		
FBgn0010241	Mdr50	HGNC:40	OMIM:171050	ABCB1	11	120080,612244	120080[COLCHICINE RESISTANCE],612244[INFLAMMATORY BOWEL DISEASE 13; IBD13]
FBgn0010241	Mdr50	HGNC:45	OMIM:171060	ABCB4	10	600803,602347,614972	600803[GALLBLADDER DISEASE 1; GBD1],602347[CHOLESTASIS, PROGRESSIVE FAMILIAL INTRAHEPATIC, 3; PFIC3],614972[CHOLESTASIS, INTRAHEPATIC, OF PREGNANCY 3; ICP3]
FBgn0010241	Mdr50	HGNC:42	OMIM:603201	ABCB11	10	601847,605479	601847[CHOLESTASIS, PROGRESSIVE FAMILIAL INTRAHEPATIC, 2; PFIC2],605479[CHOLESTASIS, BENIGN RECURRENT INTRAHEPATIC, 2; BRIC2]
FBgn0010241	Mdr50	HGNC:46	OMIM:611785	ABCB5	10		
FBgn0002283	l(3)73Ah	HGNC:17615	OMIM:610231	PCGF1	4		
FBgn0002283	l(3)73Ah	HGNC:21156	OMIM:607816	PCGF6	3		
FBgn0002283	l(3)73Ah	HGNC:28264	OMIM:617407	PCGF5	3		
FBgn0002283	l(3)73Ah	HGNC:10066	OMIM:617543	PCGF3	14		
FBgn0039020	CG17141	HGNC:32159		MTG1	14		
FBgn0030863	CG8188	HGNC:17895	OMIM:610309	UBE2S	15		
FBgn0003687	Tbp	HGNC:19841	OMIM:608964	TBPL2	10		
FBgn0003687	Tbp	HGNC:11588	OMIM:600075	TBP	11	168600,607136	168600[PARKINSON DISEASE, LATE-ONSET; PD],607136[SPINOCEREBELLAR ATAXIA 17; SCA17]
FBgn0051007	CG31007	HGNC:21645	OMIM:616244	CHCHD2	7	616710	616710[PARKINSON DISEASE 22, AUTOSOMAL DOMINANT; PARK22]
FBgn0051007	CG31007	HGNC:15559	OMIM:615903	CHCHD10	8	615048,615911,616209	615048[SPINAL MUSCULAR ATROPHY, JOKELA TYPE; SMAJ],615911[FRONTOTEMPORAL DEMENTIA AND/OR AMYOTROPHIC LATERAL SCLEROSIS 2; FTDALS2],616209[MYOPATHY, ISOLATED MITOCHONDRIAL, AUTOSOMAL DOMINANT; IMMD]
FBgn0032157	Etl1	HGNC:18398	OMIM:612761	SMARCAD1	14	129200,136000,181600	129200[BASAN SYNDROME],136000[ADERMATOGLYPHIA; ADERM],181600[HURIEZ SYNDROME; HRZ]
FBgn0010265	RpS13	HGNC:10386	OMIM:180476	RPS13	14		
FBgn0052857	CG32857	HGNC:16287	OMIM:608100	NFU1	8	605711	605711[MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 1; MMDS1]
FBgn0032391	escl	HGNC:3188	OMIM:605984	EED	13	617561	617561[COHEN-GIBSON SYNDROME; COGIS]
FBgn0045759	bin	HGNC:3809	OMIM:601089	FOXF1	7	265380	265380[ALVEOLAR CAPILLARY DYSPLASIA WITH MISALIGNMENT OF PULMONARY VEINS; ACDMPV]
FBgn0045759	bin	HGNC:3810	OMIM:603250	FOXF2	8		
FBgn0036374	Spt20	HGNC:20596	OMIM:613417	SUPT20H	10		
FBgn0036374	Spt20	HGNC:31797		SUPT20HL2	5		
FBgn0036374	Spt20	HGNC:30773		SUPT20HL1	5		
FBgn0034566	CG9313	HGNC:2954	OMIM:604366	DNAI1	14	244400	244400[CILIARY DYSKINESIA, PRIMARY, 1; CILD1]
FBgn0031285	CG3662	HGNC:6173	OMIM:300222	ITM2A	11		
FBgn0031285	CG3662	HGNC:6174	OMIM:603904	ITM2B	11	117300,176500,616079	117300[CEREBRAL AMYLOID ANGIOPATHY, ITM2B-RELATED, 2],176500[CEREBRAL AMYLOID ANGIOPATHY, ITM2B-RELATED, 1],616079[RETINAL DYSTROPHY WITH INNER RETINAL DYSFUNCTION AND GANGLION CELL ABNORMALITIES; RDGCA]
FBgn0031285	CG3662	HGNC:6175	OMIM:609554	ITM2C	11		
FBgn0004644	hh	HGNC:2865	OMIM:605423	DHH	12	233420,607080	233420[46,XY SEX REVERSAL 7; SRXY7],607080[46,XY GONADAL DYSGENESIS WITH MINIFASCICULAR NEUROPATHY; GDMN]
FBgn0004644	hh	HGNC:10848	OMIM:600725	SHH	12	142945,147250,269160,611638	142945[HOLOPROSENCEPHALY 3; HPE3],147250[SOLITARY MEDIAN MAXILLARY CENTRAL INCISOR; SMMCI],269160[SCHIZENCEPHALY],611638[MICROPHTHALMIA, ISOLATED, WITH COLOBOMA 5; MCOPCB5]
FBgn0004644	hh	HGNC:5956	OMIM:600726	IHH	10	112500,607778	112500[BRACHYDACTYLY, TYPE A1; BDA1],607778[ACROCAPITOFEMORAL DYSPLASIA; ACFD]
FBgn0031765	CG9109	HGNC:20207	OMIM:610308	B3GLCT	13	261540	261540[PETERS-PLUS SYNDROME; PTRPLS]
FBgn0030522	amrt	HGNC:24127	OMIM:610081	TM2D2	14		
FBgn0000459	disco	HGNC:30988	OMIM:608669	BNC2	10	618612	618612[LOWER URINARY TRACT OBSTRUCTION, CONGENITAL; LUTO]
FBgn0000459	disco	HGNC:1081	OMIM:601930	BNC1	9	618723	618723[PREMATURE OVARIAN FAILURE 16; POF16]
FBgn0038980	Octbeta1R	HGNC:5299	OMIM:602164	HTR4	7		
FBgn0038980	Octbeta1R	HGNC:285	OMIM:109630	ADRB1	4	607276,618591	607276[RESTING HEART RATE, VARIATION IN],618591[SHORT SLEEP, FAMILIAL NATURAL, 2; FNSS2]
FBgn0038980	Octbeta1R	HGNC:286	OMIM:109690	ADRB2	3	600807,601665	600807[ASTHMA, SUSCEPTIBILITY TO],601665[OBESITY]
FBgn0038980	Octbeta1R	HGNC:288	OMIM:109691	ADRB3	3	601665	601665[OBESITY]
FBgn0000529	bsh	HGNC:20450	OMIM:611074	BSX	8		
FBgn0003943	Ubi-p63E	HGNC:12468	OMIM:191340	UBC	11		
FBgn0003943	Ubi-p63E	HGNC:12463	OMIM:191339	UBB	6		
FBgn0052072	Elo68alpha	HGNC:26292	OMIM:614451	ELOVL7	4		
FBgn0052072	Elo68alpha	HGNC:14416	OMIM:611814	ELOVL2	7		
FBgn0052072	Elo68alpha	HGNC:14415	OMIM:605512	ELOVL4	10	133190,600110,614457	133190[SPINOCEREBELLAR ATAXIA 34; SCA34],600110[STARGARDT DISEASE 3; STGD3],614457[ICHTHYOSIS, SPASTIC QUADRIPLEGIA, AND MENTAL RETARDATION; ISQMR]
FBgn0052072	Elo68alpha	HGNC:14418	OMIM:611813	ELOVL1	3	618527	618527[ICHTHYOTIC KERATODERMA, SPASTICITY, HYPOMYELINATION, AND DYSMORPHIC FACIAL FEATURES; IKSHD]
FBgn0052072	Elo68alpha	HGNC:21308	OMIM:611805	ELOVL5	5	615957	615957[SPINOCEREBELLAR ATAXIA 38; SCA38]
FBgn0052056	scramb1	HGNC:16495	OMIM:607611	PLSCR3	7		
FBgn0052056	scramb1	HGNC:19952		PLSCR5	8		
FBgn0052056	scramb1	HGNC:9092	OMIM:604170	PLSCR1	15		
FBgn0052056	scramb1	HGNC:16497	OMIM:607612	PLSCR4	7		
FBgn0052056	scramb1	HGNC:16494	OMIM:607610	PLSCR2	10		
FBgn0015773	NetA	HGNC:8030	OMIM:602349	NTN3	11		
FBgn0015773	NetA	HGNC:8029	OMIM:601614	NTN1	12	618264	618264[MIRROR MOVEMENTS 4; MRMV4]
FBgn0015773	NetA	HGNC:25208		NTN5	4		
FBgn0003002	opa	HGNC:20322	OMIM:617896	ZIC5	7		
FBgn0003002	opa	HGNC:20393	OMIM:608948	ZIC4	9		
FBgn0003002	opa	HGNC:12873	OMIM:603073	ZIC2	9	609637	609637[HOLOPROSENCEPHALY 5; HPE5]
FBgn0003002	opa	HGNC:12874	OMIM:300265	ZIC3	7	306955,314390	306955[HETEROTAXY, VISCERAL, 1, X-LINKED; HTX1],314390[VACTERL ASSOCIATION, X-LINKED, WITH OR WITHOUT HYDROCEPHALUS; VACTERLX]
FBgn0003002	opa	HGNC:12872	OMIM:600470	ZIC1	9	616602,618736	616602[CRANIOSYNOSTOSIS 6; CRS6],618736[STRUCTURAL BRAIN ANOMALIES WITH IMPAIRED INTELLECTUAL DEVELOPMENT AND CRANIOSYNOSTOSIS; BAIDCS]
FBgn0039369	CG17195	HGNC:27387		ZDHHC24	8		
FBgn0039369	CG17195	HGNC:20106		ZDHHC22	4		
FBgn0037326	CG14669	HGNC:30295	OMIM:612128	RASL10B	12		
FBgn0037326	CG14669	HGNC:16954	OMIM:602220	RASL10A	10		
FBgn0004087	Dhfr	HGNC:2861	OMIM:126060	DHFR	10	613839	613839[MEGALOBLASTIC ANEMIA DUE TO DIHYDROFOLATE REDUCTASE DEFICIENCY]
FBgn0004087	Dhfr	HGNC:27309	OMIM:616588	DHFR2	11		
FBgn0004087	Dhfr	HGNC:2862		DHFRP1	6		
FBgn0033631	Sod3	HGNC:11179	OMIM:147450	SOD1	4	105400,618598	105400[AMYOTROPHIC LATERAL SCLEROSIS 1; ALS1],618598[SPASTIC TETRAPLEGIA AND AXIAL HYPOTONIA, PROGRESSIVE; STAHP]
FBgn0033631	Sod3	HGNC:11181	OMIM:185490	SOD3	3		
FBgn0000370	crc	HGNC:786	OMIM:604064	ATF4	7		
FBgn0000370	crc	HGNC:790	OMIM:606398	ATF5	5		
FBgn0026433	Grip128	HGNC:18600	OMIM:608147	TUBGCP5	9		
FBgn0053969	CG33969	HGNC:10847	OMIM:608071	FBXW4	11		
FBgn0039366	CG17198	HGNC:27387		ZDHHC24	7		
FBgn0004363	porin	HGNC:12669	OMIM:604492	VDAC1	13		
FBgn0004363	porin	HGNC:12672	OMIM:193245	VDAC2	14		
FBgn0004363	porin	HGNC:12674	OMIM:610029	VDAC3	14		
FBgn0039370	CG4956	HGNC:27387		ZDHHC24	10		
FBgn0039370	CG4956	HGNC:20106		ZDHHC22	3		
FBgn0013263	Trl	HGNC:37214		BTBD18	3		
FBgn0036306	CG10973	HGNC:24989	OMIM:612939	HSPBP1	12		
FBgn0036306	CG10973	HGNC:24624	OMIM:608005	SIL1	3	248800	248800[MARINESCO-SJOGREN SYNDROME; MSS]
FBgn0024941	RSG7	HGNC:10002	OMIM:603894	RGS6	13		
FBgn0024941	RSG7	HGNC:10004	OMIM:604067	RGS9	3	608415	608415[PROLONGED ELECTRORETINAL RESPONSE SUPPRESSION; PERRS]
FBgn0024941	RSG7	HGNC:14600	OMIM:607193	RGS20	3		
FBgn0024941	RSG7	HGNC:9993	OMIM:603895	RGS11	3		
FBgn0024941	RSG7	HGNC:10003	OMIM:602517	RGS7	14		
FBgn0024941	RSG7	HGNC:9991	OMIM:600323	RGS1	3		
FBgn0024941	RSG7	HGNC:9998	OMIM:600861	RGS2	3		
FBgn0024941	RSG7	HGNC:9997	OMIM:602514	RGS16	3		
FBgn0024941	RSG7	HGNC:14261	OMIM:607192	RGS18	3		
FBgn0024941	RSG7	HGNC:16810	OMIM:607189	RGS8	3		
FBgn0024941	RSG7	HGNC:26839	OMIM:612407	RGS21	3		
FBgn0024941	RSG7	HGNC:10001	OMIM:603276	RGS5	3	145500	145500[HYPERTENSION, ESSENTIAL]
FBgn0014396	tim	HGNC:11813	OMIM:603887	TIMELESS	7	620015	620015[ADVANCE SLEEP PHASE SYNDROME, FAMILIAL, 4; FASPS4]
FBgn0013765	cnn	HGNC:18672	OMIM:608201	CDK5RAP2	5	604804	604804[MICROCEPHALY 3, PRIMARY, AUTOSOMAL RECESSIVE; MCPH3]
FBgn0013765	cnn	HGNC:0		LOC653513	3		
FBgn0016977	spen	HGNC:14959	OMIM:606077	RBM15	3	606077	606077[RNA-BINDING MOTIF PROTEIN 15; RBM15]
FBgn0016977	spen	HGNC:17575	OMIM:613484	SPEN	11	619312	619312[RADIO-TARTAGLIA SYNDROME; RATARS]
FBgn0016930	Dyrk2	HGNC:3094	OMIM:603497	DYRK3	6		
FBgn0016930	Dyrk2	HGNC:3091	OMIM:600855	DYRK1A	3	614104	614104[INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL DOMINANT 7; MRD7]
FBgn0016930	Dyrk2	HGNC:3095	OMIM:609181	DYRK4	12		
FBgn0016930	Dyrk2	HGNC:3093	OMIM:603496	DYRK2	6		
FBgn0031971	Sirup	HGNC:20957	OMIM:619198	SDHAF4	12		
FBgn0031619	CG3355	HGNC:16517	OMIM:609862	TMPRSS6	3	206200	206200[IRON-REFRACTORY IRON DEFICIENCY ANEMIA; IRIDA]
FBgn0010488	NAT1	HGNC:3297	OMIM:602325	EIF4G2	11		
FBgn0033781	CG13319	HGNC:21108	OMIM:617550	PSMG4	5		
FBgn0011205	fbl	HGNC:19366	OMIM:606162	PANK4	4	619593	619593[CATARACT 49; CTRCT49]
FBgn0011205	fbl	HGNC:19365	OMIM:606161	PANK3	14		
FBgn0011205	fbl	HGNC:8598	OMIM:606160	PANK1	13		
FBgn0011205	fbl	HGNC:15894	OMIM:606157	PANK2	13	234200,607236	234200[NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 1; NBIA1],607236[HYPOPREBETALIPOPROTEINEMIA, ACANTHOCYTOSIS, RETINITIS PIGMENTOSA, AND PALLIDAL DEGENERATION]
FBgn0020381	Dredd	HGNC:1511	OMIM:602234	CASP9	3		
FBgn0020381	Dredd	HGNC:1876	OMIM:603599	CFLAR	3		
FBgn0020381	Dredd	HGNC:1509	OMIM:601763	CASP8	4	114480,114550,211980,607271	114480[BREAST CANCER],114550[HEPATOCELLULAR CARCINOMA],211980[LUNG CANCER],607271[CASPASE 8 DEFICIENCY]
FBgn0020381	Dredd	HGNC:1500	OMIM:601762	CASP10	5	603909,605027,613659	603909[AUTOIMMUNE LYMPHOPROLIFERATIVE SYNDROME, TYPE IIA; ALPS2A],605027[LYMPHOMA, NON-HODGKIN, FAMILIAL],613659[GASTRIC CANCER]
FBgn0031623	Taf12L	HGNC:11545	OMIM:600773	TAF12	3		
FBgn0000406	Cyt-b5-r	HGNC:3574	OMIM:606148	FADS1	3		
FBgn0000406	Cyt-b5-r	HGNC:3575	OMIM:606149	FADS2	3		
FBgn0000406	Cyt-b5-r	HGNC:3576	OMIM:606150	FADS3	3		
FBgn0039544	CG12877	HGNC:24616	OMIM:609614	REXO1	8		
FBgn0039544	CG12877	HGNC:24660		REXO1L1P	3		
FBgn0014869	Pglym78	HGNC:8889	OMIM:612931	PGAM2	14	261670	261670[GLYCOGEN STORAGE DISEASE X; GSD10]
FBgn0014869	Pglym78	HGNC:8888	OMIM:172250	PGAM1	14		
FBgn0014869	Pglym78	HGNC:21731	OMIM:300567	PGAM4	10		
FBgn0014869	Pglym78	HGNC:1093	OMIM:613896	BPGM	5	222800	222800[ERYTHROCYTOSIS, FAMILIAL, 8; ECYT8]
FBgn0003638	su(w[a])	HGNC:10790	OMIM:601945	SFSWAP	13		
FBgn0010438	mtSSB	HGNC:11317	OMIM:600439	SSBP1	15	165510	165510[OPTIC ATROPHY 13 WITH RETINAL AND FOVEAL ABNORMALITIES; OPA13]
FBgn0021764	sdk	HGNC:19307	OMIM:607216	SDK1	10		
FBgn0021764	sdk	HGNC:19308	OMIM:607217	SDK2	11		
FBgn0040099	lectin-28C	HGNC:2220	OMIM:607620	COLEC10	3	248340	248340[3MC SYNDROME 3; 3MC3]
FBgn0040099	lectin-28C	HGNC:10799	OMIM:178642	SFTPA2	3	178500	178500[INTERSTITIAL LUNG DISEASE 2; ILD2]
FBgn0040099	lectin-28C	HGNC:17213	OMIM:612502	COLEC11	3	265050	265050[3MC SYNDROME 2; 3MC2]
FBgn0040099	lectin-28C	HGNC:10798	OMIM:178630	SFTPA1	3	619611	619611[INTERSTITIAL LUNG DISEASE 1; ILD1]
FBgn0040099	lectin-28C	HGNC:10803	OMIM:178635	SFTPD	4		
FBgn0029854	CG3566	HGNC:2570	OMIM:613218	CYB5A	7	250790	250790[METHEMOGLOBINEMIA AND AMBIGUOUS GENITALIA; METAG]
FBgn0029854	CG3566	HGNC:24374	OMIM:611964	CYB5B	8		
FBgn0051274	CG31274	HGNC:23405	OMIM:614537	LRMDA	3	615179	615179[ALBINISM, OCULOCUTANEOUS, TYPE VII; OCA7]
FBgn0038427	ema	HGNC:29013	OMIM:611303	CLEC16A	13		
FBgn0035976	PGRP-LC	HGNC:8904	OMIM:604963	PGLYRP1	4		
FBgn0035976	PGRP-LC	HGNC:30014	OMIM:608197	PGLYRP3	4		
FBgn0035976	PGRP-LC	HGNC:30015	OMIM:608198	PGLYRP4	4		
FBgn0038063	Octbeta2R	HGNC:5299	OMIM:602164	HTR4	5		
FBgn0038063	Octbeta2R	HGNC:285	OMIM:109630	ADRB1	4	607276,618591	607276[RESTING HEART RATE, VARIATION IN],618591[SHORT SLEEP, FAMILIAL NATURAL, 2; FNSS2]
FBgn0038063	Octbeta2R	HGNC:286	OMIM:109690	ADRB2	5	600807,601665	600807[ASTHMA, SUSCEPTIBILITY TO],601665[OBESITY]
FBgn0038063	Octbeta2R	HGNC:288	OMIM:109691	ADRB3	3	601665	601665[OBESITY]
FBgn0053977	Dpm3	HGNC:3007	OMIM:605951	DPM3	13	612937,618992	612937[MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (LIMB-GIRDLE), TYPE C, 15; MDDGC15],618992[MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH IMPAIRED INTELLECTUAL DEVELOPMENT), TYPE B, 15; MDDGB15]
FBgn0035879	GAPcenA	HGNC:24663	OMIM:609238	RABGAP1L	12		
FBgn0035879	GAPcenA	HGNC:17155	OMIM:615882	RABGAP1	12		
FBgn0038717	CG17751	HGNC:8494	OMIM:604047	SLC22A13	4		
FBgn0038717	CG17751	HGNC:10970	OMIM:607582	SLC22A6	4		
FBgn0038717	CG17751	HGNC:20302	OMIM:608276	SLC22A16	4		
FBgn0038717	CG17751	HGNC:10968	OMIM:604190	SLC22A4	4	180300	180300[RHEUMATOID ARTHRITIS; RA]
FBgn0038717	CG17751	HGNC:10969	OMIM:603377	SLC22A5	4	212140	212140[CARNITINE DEFICIENCY, SYSTEMIC PRIMARY; CDSP]
FBgn0038717	CG17751	HGNC:8495	OMIM:604048	SLC22A14	4		
FBgn0038717	CG17751	HGNC:10971	OMIM:604995	SLC22A7	5		
FBgn0038717	CG17751	HGNC:10972	OMIM:607581	SLC22A8	4		
FBgn0038717	CG17751	HGNC:10966	OMIM:602608	SLC22A2	4		
FBgn0038717	CG17751	HGNC:21106	OMIM:611697	SLC22A23	3		
FBgn0038717	CG17751	HGNC:32935	OMIM:610792	SLC22A25	5		
FBgn0038717	CG17751	HGNC:10963	OMIM:602607	SLC22A1	4		
FBgn0038717	CG17751	HGNC:10967	OMIM:604842	SLC22A3	4		
FBgn0038717	CG17751	HGNC:23095	OMIM:611461	SLC22A17	3		
FBgn0038717	CG17751	HGNC:20301	OMIM:608275	SLC22A15	3		
FBgn0038717	CG17751	HGNC:17989	OMIM:607096	SLC22A12	4	220150	220150[HYPOURICEMIA, RENAL, 1; RHUC1]
FBgn0038717	CG17751	HGNC:27091		SLC22A31	3		
FBgn0038717	CG17751	HGNC:18120	OMIM:607097	SLC22A11	4		
FBgn0038717	CG17751	HGNC:16261	OMIM:607579	SLC22A9	4		
FBgn0038717	CG17751	HGNC:28542	OMIM:611698	SLC22A24	4		
FBgn0038717	CG17751	HGNC:18057	OMIM:607580	SLC22A10	4		
FBgn0001091	Gapdh1	HGNC:24864	OMIM:609169	GAPDHS	5		
FBgn0001091	Gapdh1	HGNC:4141	OMIM:138400	GAPDH	12		
FBgn0001125	Got2	HGNC:4433	OMIM:138150	GOT2	13	618721	618721[DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 82; DEE82]
FBgn0001125	Got2	HGNC:4432	OMIM:138180	GOT1	4	614419	614419[ASPARTATE AMINOTRANSFERASE, SERUM LEVEL OF, QUANTITATIVE TRAIT LOCUS 1]
FBgn0024983	CG4293	HGNC:30208	OMIM:612236	ERGIC2	13		
FBgn0024983	CG4293	HGNC:15927	OMIM:616971	ERGIC3	3		
FBgn0000640	Fbp2	HGNC:5154	OMIM:601688	HPGD	10	119900,259100	119900[DIGITAL CLUBBING, ISOLATED CONGENITAL; DIGC],259100[HYPERTROPHIC OSTEOARTHROPATHY, PRIMARY, AUTOSOMAL RECESSIVE, 1; PHOAR1]
FBgn0037764	CG9459	HGNC:26292	OMIM:614451	ELOVL7	5		
FBgn0037764	CG9459	HGNC:14416	OMIM:611814	ELOVL2	3		
FBgn0037764	CG9459	HGNC:14415	OMIM:605512	ELOVL4	3	133190,600110,614457	133190[SPINOCEREBELLAR ATAXIA 34; SCA34],600110[STARGARDT DISEASE 3; STGD3],614457[ICHTHYOSIS, SPASTIC QUADRIPLEGIA, AND MENTAL RETARDATION; ISQMR]
FBgn0037764	CG9459	HGNC:18047	OMIM:611815	ELOVL3	3		
FBgn0037764	CG9459	HGNC:14418	OMIM:611813	ELOVL1	5	618527	618527[ICHTHYOTIC KERATODERMA, SPASTICITY, HYPOMYELINATION, AND DYSMORPHIC FACIAL FEATURES; IKSHD]
FBgn0037764	CG9459	HGNC:21308	OMIM:611805	ELOVL5	3	615957	615957[SPINOCEREBELLAR ATAXIA 38; SCA38]
FBgn0025741	PlexA	HGNC:9099	OMIM:601055	PLXNA1	11	619955	619955[DWORSCHAK-PUNETHA NEURODEVELOPMENTAL SYNDROME; DWOPNED]
FBgn0025741	PlexA	HGNC:9101	OMIM:300022	PLXNA3	12		
FBgn0025741	PlexA	HGNC:9102	OMIM:604280	PLXNA4	12		
FBgn0025741	PlexA	HGNC:9100	OMIM:601054	PLXNA2	14		
FBgn0025741	PlexA	HGNC:9104	OMIM:604293	PLXNB2	6		
FBgn0025741	PlexA	HGNC:9105	OMIM:300214	PLXNB3	6		
FBgn0025741	PlexA	HGNC:9107	OMIM:604282	PLXND1	4		
FBgn0025741	PlexA	HGNC:9103	OMIM:601053	PLXNB1	5		
FBgn0025741	PlexA	HGNC:9106	OMIM:604259	PLXNC1	3		
FBgn0000044	Act57B	HGNC:17780	OMIM:614835	ACTBL2	5		
FBgn0000044	Act57B	HGNC:168	OMIM:605144	ACTR1B	3		
FBgn0000044	Act57B	HGNC:129	OMIM:102610	ACTA1	3	161800,255310,616852	161800[NEMALINE MYOPATHY 3; NEM3],255310[MYOPATHY, CONGENITAL, WITH FIBER-TYPE DISPROPORTION; CFTD],616852[MYOPATHY, SCAPULOHUMEROPERONEAL; SHPM]
FBgn0000044	Act57B	HGNC:132	OMIM:102630	ACTB	7	243310,607371	243310[BARAITSER-WINTER SYNDROME 1; BRWS1],607371[DYSTONIA, JUVENILE-ONSET; DJO]
FBgn0000044	Act57B	HGNC:130	OMIM:102620	ACTA2	4	611788,613834,614042	611788[AORTIC ANEURYSM, FAMILIAL THORACIC 6; AAT6],613834[MULTISYSTEMIC SMOOTH MUSCLE DYSFUNCTION SYNDROME; MSMDS],614042[MOYAMOYA DISEASE 5; MYMY5]
FBgn0000044	Act57B	HGNC:143	OMIM:102540	ACTC1	4	612098,612794,613424	612098[CARDIOMYOPATHY, FAMILIAL HYPERTROPHIC, 11; CMH11],612794[ATRIAL SEPTAL DEFECT 5; ASD5],613424[CARDIOMYOPATHY, DILATED, 1R; CMD1R]
FBgn0000044	Act57B	HGNC:167	OMIM:605143	ACTR1A	3		
FBgn0000044	Act57B	HGNC:144	OMIM:102560	ACTG1	5	604717,614583	604717[DEAFNESS, AUTOSOMAL DOMINANT 20; DFNA20],614583[BARAITSER-WINTER SYNDROME 2; BRWS2]
FBgn0000044	Act57B	HGNC:145	OMIM:102545	ACTG2	3	155310,619431	155310[VISCERAL MYOPATHY 1; VSCM1],619431[MEGACYSTIS-MICROCOLON-INTESTINAL HYPOPERISTALSIS SYNDROME 5; MMIHS5]
FBgn0000044	Act57B	HGNC:37093		POTEI	5		
FBgn0000044	Act57B	HGNC:37094		POTEJ	5		
FBgn0000044	Act57B	HGNC:33905		POTEF	5		
FBgn0000044	Act57B	HGNC:33895	OMIM:608914	POTEE	4		
FBgn0000044	Act57B	HGNC:24022	OMIM:608534	ACTRT3	4		
FBgn0000044	Act57B	HGNC:24026	OMIM:608535	ACTRT2	3		
FBgn0000044	Act57B	HGNC:28494	OMIM:619251	ACTL9	3	619258	619258[SPERMATOGENIC FAILURE 53; SPGF53]
FBgn0000044	Act57B	HGNC:16127		ACTL10	3		
FBgn0031504	CG15403	HGNC:16102	OMIM:618722	FAM210B	11		
FBgn0034495	CG11788	HGNC:24453	OMIM:613203	DSCC1	14		
FBgn0039925	Kif3C	HGNC:19167	OMIM:605037	KIF17	12		
FBgn0039925	Kif3C	HGNC:6319	OMIM:604683	KIF3A	3		
FBgn0033104	CG15237	HGNC:24531	OMIM:614717	ANAPC15	3		
FBgn0026086	Adar	HGNC:225	OMIM:146920	ADAR	3	127400,615010	127400[DYSCHROMATOSIS SYMMETRICA HEREDITARIA; DSH],615010[AICARDI-GOUTIERES SYNDROME 6; AGS6]
FBgn0026086	Adar	HGNC:227	OMIM:602065	ADARB2	11		
FBgn0026086	Adar	HGNC:226	OMIM:601218	ADARB1	12	618862	618862[NEURODEVELOPMENTAL DISORDER WITH HYPOTONIA, MICROCEPHALY, AND SEIZURES; NEDHYMS]
FBgn0026086	Adar	HGNC:30714	OMIM:619532	ADAD2	3		
FBgn0026086	Adar	HGNC:30713	OMIM:614130	ADAD1	3		
FBgn0028741	fab1	HGNC:23785	OMIM:609414	PIKFYVE	13	121850	121850[CORNEAL DYSTROPHY, FLECK]
FBgn0010339	128up	HGNC:3030	OMIM:602986	DRG2	3		
FBgn0010339	128up	HGNC:3029	OMIM:603952	DRG1	15		
FBgn0003300	run	HGNC:10473	OMIM:600210	RUNX3	6		
FBgn0003300	run	HGNC:10471	OMIM:151385	RUNX1	7	601399,601626	601399[PLATELET DISORDER, FAMILIAL, WITH ASSOCIATED MYELOID MALIGNANCY; FPDMM],601626[LEUKEMIA, ACUTE MYELOID; AML]
FBgn0003300	run	HGNC:10472	OMIM:600211	RUNX2	7	119600,156510	119600[CLEIDOCRANIAL DYSPLASIA; CCD],156510[METAPHYSEAL DYSPLASIA WITH MAXILLARY HYPOPLASIA WITH OR WITHOUT BRACHYDACTYLY; MDMHB]
FBgn0040508	ACXC	HGNC:235	OMIM:600292	ADCY4	6		
FBgn0040508	ACXC	HGNC:238	OMIM:600385	ADCY7	6		
FBgn0040508	ACXC	HGNC:233	OMIM:103071	ADCY2	6		
FBgn0040508	ACXC	HGNC:239	OMIM:103070	ADCY8	3		
FBgn0028979	tio	HGNC:13010	OMIM:614118	TSHZ2	7		
FBgn0028979	tio	HGNC:10669	OMIM:614427	TSHZ1	8	607842	607842[AURAL ATRESIA, CONGENITAL; CAA]
FBgn0028979	tio	HGNC:30700	OMIM:614119	TSHZ3	6		
FBgn0052176	CG32176	HGNC:25834		CAAP1	4		
FBgn0053082	Rpp21	HGNC:21300	OMIM:612524	RPP21	9		
FBgn0053082	Rpp21	HGNC:38845		TRIM39-RPP21	3		
FBgn0036793	CG4174	HGNC:8546	OMIM:176710	P4HA1	3		
FBgn0036793	CG4174	HGNC:30135	OMIM:608987	P4HA3	4		
FBgn0036793	CG4174	HGNC:8547	OMIM:600608	P4HA2	3	617238	617238[MYOPIA 25, AUTOSOMAL DOMINANT; MYP25]
FBgn0025637	SkpA	HGNC:10899	OMIM:601434	SKP1	14		
FBgn0032151	nAChRalpha6	HGNC:15781	OMIM:609756	CHRFAM7A	11		
FBgn0032151	nAChRalpha6	HGNC:1960	OMIM:118511	CHRNA7	8		
FBgn0043791	phu	HGNC:438	OMIM:171760	ALPL	12	146300,241500,241510	146300[HYPOPHOSPHATASIA, ADULT; HPPA],241500[HYPOPHOSPHATASIA, INFANTILE; HPPI],241510[HYPOPHOSPHATASIA, CHILDHOOD; HPPC]
FBgn0043791	phu	HGNC:441	OMIM:171810	ALPG	12		
FBgn0043791	phu	HGNC:439	OMIM:171800	ALPP	11		
FBgn0043791	phu	HGNC:437	OMIM:171740	ALPI	12		
FBgn0000055	Adh	HGNC:5154	OMIM:601688	HPGD	6	119900,259100	119900[DIGITAL CLUBBING, ISOLATED CONGENITAL; DIGC],259100[HYPERTROPHIC OSTEOARTHROPATHY, PRIMARY, AUTOSOMAL RECESSIVE, 1; PHOAR1]
FBgn0039229	Saf-B	HGNC:20709		SLTM	10		
FBgn0039229	Saf-B	HGNC:21605	OMIM:608066	SAFB2	9		
FBgn0039229	Saf-B	HGNC:10520	OMIM:602895	SAFB	11		
FBgn0032259	CG6144	HGNC:28243	OMIM:613304	ALKBH6	14		
FBgn0052625	CG32625	HGNC:16198		GTSF1L	6		
FBgn0052625	CG32625	HGNC:26565	OMIM:617484	GTSF1	7		
FBgn0010240	Lcch3	HGNC:4083	OMIM:137192	GABRB3	13	612269,617113	612269[EPILEPSY, CHILDHOOD ABSENCE, SUSCEPTIBILITY TO, 5; ECA5],617113[DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 43; DEE43]
FBgn0010240	Lcch3	HGNC:4082	OMIM:600232	GABRB2	12	617829	617829[DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 92; DEE92]
FBgn0010240	Lcch3	HGNC:14454	OMIM:300349	GABRQ	5		
FBgn0010240	Lcch3	HGNC:4084	OMIM:137163	GABRD	3	613060	613060[EPILEPSY, IDIOPATHIC GENERALIZED, SUSCEPTIBILITY TO, 10; EIG10]
FBgn0010240	Lcch3	HGNC:4089	OMIM:602729	GABRP	3		
FBgn0010240	Lcch3	HGNC:4081	OMIM:137190	GABRB1	13	617153	617153[DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 45; DEE45]
FBgn0010240	Lcch3	HGNC:17969	OMIM:618668	GABRR3	3		
FBgn0051693	CG31693	HGNC:8101	OMIM:611409	OCA2	7	203200,227220	203200[ALBINISM, OCULOCUTANEOUS, TYPE II; OCA2],227220[SKIN/HAIR/EYE PIGMENTATION, VARIATION IN, 1; SHEP1]
FBgn0003366	sev	HGNC:10261	OMIM:165020	ROS1	14		
FBgn0041789	Pax	HGNC:9718	OMIM:602505	PXN	11		
FBgn0041789	Pax	HGNC:11767	OMIM:602353	TGFB1I1	11		
FBgn0041789	Pax	HGNC:14061	OMIM:605390	LPXN	9		
FBgn0013718	nuf	HGNC:17224	OMIM:608738	RAB11FIP3	10		
FBgn0013718	nuf	HGNC:30267	OMIM:611999	RAB11FIP4	11		
FBgn0030984	tgy	HGNC:24337	OMIM:610555	C1GALT1	6		
FBgn0030984	tgy	HGNC:24338	OMIM:300611	C1GALT1C1	4	300622	300622[TN POLYAGGLUTINATION SYNDROME; TNPS]
FBgn0039736	CG7912	HGNC:14471	OMIM:610117	SLC26A11	14		
FBgn0039736	CG7912	HGNC:14472	OMIM:610068	SLC26A6	4		
FBgn0039736	CG7912	HGNC:9359	OMIM:604943	SLC26A5	4	613865	613865[DEAFNESS, AUTOSOMAL RECESSIVE 61; DFNB61]
FBgn0039736	CG7912	HGNC:8818	OMIM:605646	SLC26A4	3	274600,600791	274600[PENDRED SYNDROME; PDS],600791[DEAFNESS, AUTOSOMAL RECESSIVE 4, WITH ENLARGED VESTIBULAR AQUEDUCT; DFNB4]
FBgn0022359	Sodh2	HGNC:11184	OMIM:182500	SORD	15	618912	618912[SORBITOL DEHYDROGENASE DEFICIENCY WITH PERIPHERAL NEUROPATHY; SORDD]
FBgn0030336	CG1578	HGNC:30543	OMIM:618391	DPH6	11		
FBgn0031762	CG9098	HGNC:16884	OMIM:604722	SH2D3C	14		
FBgn0031762	CG9098	HGNC:973	OMIM:604704	BCAR3	10		
FBgn0031762	CG9098	HGNC:16885	OMIM:604721	SH2D3A	9		
FBgn0032626	CG12620	HGNC:9288	OMIM:601792	PPP1R2	5		
FBgn0032626	CG12620	HGNC:16324	OMIM:301017	PPP1R2C	4		
FBgn0032626	CG12620	HGNC:16318		PPP1R2B	3		
FBgn0030581	CG14408	HGNC:29360		SH3BP5L	9		
FBgn0030581	CG14408	HGNC:10827	OMIM:605612	SH3BP5	4		
FBgn0030874	Spt7	HGNC:30632	OMIM:612762	SUPT7L	5		
FBgn0004643	Zw10	HGNC:13194	OMIM:603954	ZW10	13		
FBgn0034997	CG3376	HGNC:11120	OMIM:607608	SMPD1	15	257200,607616	257200[NIEMANN-PICK DISEASE, TYPE A],607616[NIEMANN-PICK DISEASE, TYPE B]
FBgn0034997	CG3376	HGNC:17389	OMIM:610728	SMPDL3A	4		
FBgn0034997	CG3376	HGNC:21416	OMIM:617737	SMPDL3B	4		
FBgn0000320	eya	HGNC:3519	OMIM:601653	EYA1	8	113650,166780,602588	113650[BRANCHIOOTORENAL SYNDROME 1; BOR1],166780[OTOFACIOCERVICAL SYNDROME 1; OTFCS],602588[BRANCHIOOTIC SYNDROME 1; BOS1]
FBgn0000320	eya	HGNC:3522	OMIM:603550	EYA4	9	601316,605362	601316[DEAFNESS, AUTOSOMAL DOMINANT 10; DFNA10],605362[CARDIOMYOPATHY, DILATED, 1J; CMD1J]
FBgn0000320	eya	HGNC:3521	OMIM:601655	EYA3	8		
FBgn0000320	eya	HGNC:3520	OMIM:601654	EYA2	10		
FBgn0027101	Dyrk3	HGNC:3094	OMIM:603497	DYRK3	10		
FBgn0027101	Dyrk3	HGNC:3095	OMIM:609181	DYRK4	5		
FBgn0027101	Dyrk3	HGNC:3093	OMIM:603496	DYRK2	11		
FBgn0039924	PIP4K	HGNC:8994	OMIM:603275	PIP5K1A	3		
FBgn0039924	PIP4K	HGNC:8996	OMIM:606102	PIP5K1C	3	611369	611369[LETHAL CONGENITAL CONTRACTURE SYNDROME 3; LCCS3]
FBgn0039924	PIP4K	HGNC:8998	OMIM:603261	PIP4K2B	13		
FBgn0039924	PIP4K	HGNC:8997	OMIM:603140	PIP4K2A	13		
FBgn0039924	PIP4K	HGNC:23786	OMIM:617104	PIP4K2C	9		
FBgn0040344	Lztr1	HGNC:6742	OMIM:600574	LZTR1	13	605275,615670,616564	605275[NOONAN SYNDROME 2; NS2],615670[SCHWANNOMATOSIS 2; SWNTS2],616564[NOONAN SYNDROME 10; NS10]
FBgn0034121	CG6262	HGNC:12266	OMIM:275360	TREH	10	612119	612119[TREHALASE DEFICIENCY]
FBgn0004463	Polr3B	HGNC:9188	OMIM:180661	POLR2B	3		
FBgn0004463	Polr3B	HGNC:30348	OMIM:614366	POLR3B	15	614381,619742	614381[LEUKODYSTROPHY, HYPOMYELINATING, 8, WITH OR WITHOUT OLIGODONTIA AND/OR HYPOGONADOTROPIC HYPOGONADISM; HLD8],619742[CHARCOT-MARIE-TOOTH DISEASE, DEMYELINATING, TYPE 1I; CMT1I]
FBgn0031515	CG9664	HGNC:73	OMIM:603076	ABCG1	6		
FBgn0031515	CG9664	HGNC:13884	OMIM:607784	ABCG4	6		
FBgn0031515	CG9664	HGNC:74	OMIM:603756	ABCG2	4	138900,614490	138900[URIC ACID CONCENTRATION, SERUM, QUANTITATIVE TRAIT LOCUS 1; UAQTL1],614490[BLOOD GROUP, JUNIOR SYSTEM; JR]
FBgn0031515	CG9664	HGNC:13887	OMIM:605460	ABCG8	3	210250,611465	210250[SITOSTEROLEMIA 1; STSL1],611465[GALLBLADDER DISEASE 4; GBD4]
FBgn0014903	CG14630	HGNC:18308	OMIM:300777	TMLHE	4	300872	300872[AUTISM, SUSCEPTIBILITY TO, X-LINKED 6; AUTSX6]
FBgn0014903	CG14630	HGNC:964	OMIM:603312	BBOX1	12		
FBgn0037046	CG10581	HGNC:28204		NTPCR	15		
FBgn0032955	CG2201	HGNC:1938	OMIM:612395	CHKB	14	602541	602541[MUSCULAR DYSTROPHY, CONGENITAL, MEGACONIAL TYPE; MDCMC]
FBgn0032955	CG2201	HGNC:1937	OMIM:118491	CHKA	13	620023	620023[NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, MOVEMENT ABNORMALITIES, AND SEIZURES; NEDMIMS]
FBgn0032405	firl	HGNC:18685	OMIM:612127	HSD17B13	4		
FBgn0032405	firl	HGNC:17693	OMIM:612830	DHRS3	4		
FBgn0032405	firl	HGNC:30311	OMIM:608989	SDR16C5	4		
FBgn0032405	firl	HGNC:22960	OMIM:612831	HSD17B11	5		
FBgn0032405	firl	HGNC:19975	OMIM:607599	RDH10	4		
FBgn0029608	CG3091	HGNC:12404	OMIM:600415	TTPA	3	277460	277460[ATAXIA WITH VITAMIN E DEFICIENCY; AVED]
FBgn0029608	CG3091	HGNC:16114		TTPAL	3		
FBgn0029608	CG3091	HGNC:10024	OMIM:180090	RLBP1	3	136880,607475,607476	136880[FUNDUS ALBIPUNCTATUS],607475[BOTHNIA RETINAL DYSTROPHY],607476[NEWFOUNDLAND ROD-CONE DYSTROPHY; NFRCD]
FBgn0029608	CG3091	HGNC:23046	OMIM:616945	CLVS2	3		
FBgn0029608	CG3091	HGNC:23139	OMIM:611292	CLVS1	3		
FBgn0030897	Frq1	HGNC:3953	OMIM:603315	NCS1	14		
FBgn0030897	Frq1	HGNC:18212	OMIM:619211	HPCAL4	3		
FBgn0030897	Frq1	HGNC:12722	OMIM:600817	VSNL1	3		
FBgn0030897	Frq1	HGNC:5144	OMIM:142622	HPCA	3	224500	224500[DYSTONIA 2, TORSION, AUTOSOMAL RECESSIVE; DYT2]
FBgn0030897	Frq1	HGNC:5145	OMIM:600207	HPCAL1	4		
FBgn0015664	Dref	HGNC:447	OMIM:300178	ZBED1	3		
FBgn0039592	CG14062	HGNC:3346	OMIM:600440	ENDOG	3		
FBgn0053544	Vkor	HGNC:21492	OMIM:608838	VKORC1L1	8		
FBgn0053544	Vkor	HGNC:23663	OMIM:608547	VKORC1	15	122700,607473	122700[COUMARIN RESISTANCE],607473[VITAMIN K-DEPENDENT CLOTTING FACTORS, COMBINED DEFICIENCY OF, 2; VKCFD2]
FBgn0054001	CG34001	HGNC:24353	OMIM:613202	CHTF8	6		
FBgn0054002	CG34002	HGNC:8946	OMIM:607076	PI15	3		
FBgn0054002	CG34002	HGNC:16249		R3HDML	3		
FBgn0054002	CG34002	HGNC:21245		PI16	4		
FBgn0054002	CG34002	HGNC:28592	OMIM:610394	GLIPR1L2	3		
FBgn0054002	CG34002	HGNC:17001	OMIM:602692	GLIPR1	4		
FBgn0054002	CG34002	HGNC:28392	OMIM:610395	GLIPR1L1	3		
FBgn0054002	CG34002	HGNC:18206		CRISPLD1	3		
FBgn0054002	CG34002	HGNC:25248	OMIM:612434	CRISPLD2	3		
FBgn0054002	CG34002	HGNC:16904	OMIM:618062	CRISP3	4		
FBgn0054002	CG34002	HGNC:304	OMIM:601193	CRISP1	5		
FBgn0054002	CG34002	HGNC:12024	OMIM:187430	CRISP2	5		
FBgn0054002	CG34002	HGNC:33849	OMIM:616572	CLEC18B	4		
FBgn0054002	CG34002	HGNC:30388	OMIM:616571	CLEC18A	4		
FBgn0040658	CG13516	HGNC:16841	OMIM:603795	LITAF	4	601098	601098[CHARCOT-MARIE-TOOTH DISEASE, DEMYELINATING, TYPE 1C; CMT1C]
FBgn0054010	Glyat	HGNC:21349	OMIM:614763	GLYATL3	5		
FBgn0054010	Glyat	HGNC:30519	OMIM:614761	GLYATL1	4		
FBgn0054010	Glyat	HGNC:24178	OMIM:614762	GLYATL2	4		
FBgn0054010	Glyat	HGNC:13734	OMIM:607424	GLYAT	4		
FBgn0054010	Glyat	HGNC:37865		GLYATL1B	3		
FBgn0054015	CG34015	HGNC:18468	OMIM:609998	HINT3	13		
FBgn0053635	CG33635	HGNC:28767		SFT2D3	12		
FBgn0054039	CG34039	HGNC:26027	OMIM:616701	COMMD4	13		
FBgn0054041	CG34041	HGNC:30135	OMIM:608987	P4HA3	3		
FBgn0054041	CG34041	HGNC:8547	OMIM:600608	P4HA2	3	617238	617238[MYOPIA 25, AUTOSOMAL DOMINANT; MYP25]
FBgn0065110	ppk10	HGNC:101	OMIM:611741	ASIC3	4		
FBgn0065110	ppk10	HGNC:100	OMIM:602866	ASIC1	4		
FBgn0065110	ppk10	HGNC:21263	OMIM:606715	ASIC4	4		
FBgn0065110	ppk10	HGNC:99	OMIM:601784	ASIC2	3		
FBgn0065110	ppk10	HGNC:17537	OMIM:616693	ASIC5	4		
FBgn0054049	CG34049	HGNC:21245		PI16	3		
FBgn0054049	CG34049	HGNC:18007	OMIM:607141	GLIPR2	4		
FBgn0054049	CG34049	HGNC:28592	OMIM:610394	GLIPR1L2	3		
FBgn0054049	CG34049	HGNC:28392	OMIM:610395	GLIPR1L1	3		
FBgn0054049	CG34049	HGNC:304	OMIM:601193	CRISP1	3		
FBgn0054049	CG34049	HGNC:12024	OMIM:187430	CRISP2	3		
FBgn0054049	CG34049	HGNC:33849	OMIM:616572	CLEC18B	3		
FBgn0054049	CG34049	HGNC:30388	OMIM:616571	CLEC18A	3		
FBgn0065108	ppk16	HGNC:101	OMIM:611741	ASIC3	5		
FBgn0065108	ppk16	HGNC:100	OMIM:602866	ASIC1	5		
FBgn0065108	ppk16	HGNC:21263	OMIM:606715	ASIC4	5		
FBgn0065108	ppk16	HGNC:99	OMIM:601784	ASIC2	5		
FBgn0065108	ppk16	HGNC:17537	OMIM:616693	ASIC5	4		
FBgn0065108	ppk16	HGNC:10600	OMIM:600760	SCNN1B	4	177200,211400,264350	177200[LIDDLE SYNDROME 1; LIDLS1],211400[BRONCHIECTASIS WITH OR WITHOUT ELEVATED SWEAT CHLORIDE 1; BESC1],264350[PSEUDOHYPOALDOSTERONISM, TYPE I, AUTOSOMAL RECESSIVE; PHA1B]
FBgn0065108	ppk16	HGNC:10602	OMIM:600761	SCNN1G	3	264350,613071,618114	264350[PSEUDOHYPOALDOSTERONISM, TYPE I, AUTOSOMAL RECESSIVE; PHA1B],613071[BRONCHIECTASIS WITH OR WITHOUT ELEVATED SWEAT CHLORIDE 3; BESC3],618114[LIDDLE SYNDROME 2; LIDLS2]
FBgn0065109	ppk11	HGNC:101	OMIM:611741	ASIC3	5		
FBgn0065109	ppk11	HGNC:100	OMIM:602866	ASIC1	6		
FBgn0065109	ppk11	HGNC:21263	OMIM:606715	ASIC4	6		
FBgn0065109	ppk11	HGNC:99	OMIM:601784	ASIC2	6		
FBgn0065109	ppk11	HGNC:17537	OMIM:616693	ASIC5	5		
FBgn0065109	ppk11	HGNC:10600	OMIM:600760	SCNN1B	4	177200,211400,264350	177200[LIDDLE SYNDROME 1; LIDLS1],211400[BRONCHIECTASIS WITH OR WITHOUT ELEVATED SWEAT CHLORIDE 1; BESC1],264350[PSEUDOHYPOALDOSTERONISM, TYPE I, AUTOSOMAL RECESSIVE; PHA1B]
FBgn0065109	ppk11	HGNC:10602	OMIM:600761	SCNN1G	3	264350,613071,618114	264350[PSEUDOHYPOALDOSTERONISM, TYPE I, AUTOSOMAL RECESSIVE; PHA1B],613071[BRONCHIECTASIS WITH OR WITHOUT ELEVATED SWEAT CHLORIDE 3; BESC3],618114[LIDDLE SYNDROME 2; LIDLS2]
FBgn0054056	CG34056	HGNC:24337	OMIM:610555	C1GALT1	3		
FBgn0054057	CG34057	HGNC:24337	OMIM:610555	C1GALT1	5		
FBgn0054057	CG34057	HGNC:24338	OMIM:300611	C1GALT1C1	4	300622	300622[TN POLYAGGLUTINATION SYNDROME; TNPS]
FBgn0260453	CG17140	HGNC:12669	OMIM:604492	VDAC1	5		
FBgn0260453	CG17140	HGNC:12672	OMIM:193245	VDAC2	5		
FBgn0260453	CG17140	HGNC:12674	OMIM:610029	VDAC3	5		
FBgn0260454	CG17139	HGNC:12669	OMIM:604492	VDAC1	5		
FBgn0260454	CG17139	HGNC:12672	OMIM:193245	VDAC2	5		
FBgn0260454	CG17139	HGNC:12674	OMIM:610029	VDAC3	6		
FBgn0052529	Hers	HGNC:29153	OMIM:613880	BAHD1	6		
FBgn0013680	mt:ND2	HGNC:7456	OMIM:516001	ND2	12		
FBgn0013674	mt:CoI	HGNC:7419	OMIM:516030	COX1	12		
FBgn0013675	mt:CoII	HGNC:7421	OMIM:516040	COX2	6		
FBgn0013675	mt:CoII	HGNC:52028		MTCO2P12	7		
FBgn0013672	mt:ATPase6	HGNC:7414	OMIM:516060	ATP6	9		
FBgn0013676	mt:CoIII	HGNC:7422	OMIM:516050	COX3	12		
FBgn0013681	mt:ND3	HGNC:7458	OMIM:516002	ND3	11		
FBgn0013684	mt:ND5	HGNC:7461	OMIM:516005	ND5	10		
FBgn0013683	mt:ND4L	HGNC:7460	OMIM:516004	ND4L	11		
FBgn0013678	mt:Cyt-b	HGNC:7427	OMIM:516020	CYTB	10		
FBgn0013679	mt:ND1	HGNC:7455	OMIM:516000	ND1	10		
FBgn0041004	CG17715	HGNC:25203	OMIM:616609	TMEM65	11		
FBgn0058191	CG40191	HGNC:25220		CNPPD1	10		
FBgn0040011	Slmap	HGNC:16643	OMIM:602701	SLMAP	8		
FBgn0040038	klhl10	HGNC:18829	OMIM:608778	KLHL10	13	615081	615081[SPERMATOGENIC FAILURE 11; SPGF11]
FBgn0058006	CG40006	HGNC:1663	OMIM:173510	CD36	4	608404,610938,611162	608404[PLATELET GLYCOPROTEIN IV DEFICIENCY],610938[CORONARY HEART DISEASE, SUSCEPTIBILITY TO, 7; CHDS7],611162[MALARIA, SUSCEPTIBILITY TO]
FBgn0058006	CG40006	HGNC:1664	OMIM:601040	SCARB1	6	610762	610762[HIGH DENSITY LIPOPROTEIN CHOLESTEROL LEVEL QUANTITATIVE TRAIT LOCUS 6; HDLCQ6]
FBgn0058006	CG40006	HGNC:1665	OMIM:602257	SCARB2	4	254900	254900[EPILEPSY, PROGRESSIVE MYOCLONIC, 4, WITH OR WITHOUT RENAL FAILURE; EPM4]
FBgn0000384	cta	HGNC:4387	OMIM:139370	GNAI3	3	602483	602483[AURICULOCONDYLAR SYNDROME 1; ARCND1]
FBgn0000384	cta	HGNC:4379	OMIM:139313	GNA11	3	145981,615361	145981[HYPOCALCIURIC HYPERCALCEMIA, FAMILIAL, TYPE II; HHC2],615361[HYPOCALCEMIA, AUTOSOMAL DOMINANT 2; HYPOC2]
FBgn0000384	cta	HGNC:4381	OMIM:604406	GNA13	14		
FBgn0000384	cta	HGNC:4390	OMIM:600998	GNAQ	4	163000,185300	163000[CAPILLARY MALFORMATIONS, CONGENITAL; CMC],185300[STURGE-WEBER SYNDROME; SWS]
FBgn0000384	cta	HGNC:4385	OMIM:139360	GNAI2	3	192605	192605[VENTRICULAR TACHYCARDIA, FAMILIAL]
FBgn0000384	cta	HGNC:4394	OMIM:139340	GNAT2	4	613856	613856[ACHROMATOPSIA 4; ACHM4]
FBgn0000384	cta	HGNC:4380	OMIM:604394	GNA12	13		
FBgn0000384	cta	HGNC:4395	OMIM:139160	GNAZ	3		
FBgn0000384	cta	HGNC:4382	OMIM:604397	GNA14	4		
FBgn0000384	cta	HGNC:22800	OMIM:139395	GNAT3	4		
FBgn0000384	cta	HGNC:4393	OMIM:139330	GNAT1	3	610444,616389	610444[NIGHT BLINDNESS, CONGENITAL STATIONARY, AUTOSOMAL DOMINANT 3; CSNBAD3],616389[NIGHT BLINDNESS, CONGENITAL STATIONARY, TYPE 1G; CSNB1G]
FBgn0000384	cta	HGNC:4383	OMIM:139314	GNA15	4		
FBgn0000384	cta	HGNC:4392	OMIM:139320	GNAS	3	103580,166350,174800,219080,603233,612462,612463,617686	103580[PSEUDOHYPOPARATHYROIDISM, TYPE IA; PHP1A],166350[OSSEOUS HETEROPLASIA, PROGRESSIVE; POH],174800[MCCUNE-ALBRIGHT SYNDROME; MAS],219080[ACTH-INDEPENDENT MACRONODULAR ADRENAL HYPERPLASIA; AIMAH1],603233[PSEUDOHYPOPARATHYROIDISM, TYPE IB; PHP1B],612462[PSEUDOHYPOPARATHYROIDISM, TYPE IC; PHP1C],612463[PSEUDOPSEUDOHYPOPARATHYROIDISM; PPHP],617686[PITUITARY ADENOMA 3, MULTIPLE TYPES; PITA3]
FBgn0000384	cta	HGNC:4389	OMIM:139311	GNAO1	3	615473,617493	615473[DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 17; DEE17],617493[NEURODEVELOPMENTAL DISORDER WITH INVOLUNTARY MOVEMENTS; NEDIM]
FBgn0039966	Rab21	HGNC:18263	OMIM:612398	RAB21	13		
FBgn0025837	CG17636	HGNC:4250	OMIM:612346	GGT1	13	231950	231950[GLUTATHIONURIA]
FBgn0025837	CG17636	HGNC:4251	OMIM:137181	GGT2	12	137181	137181[GAMMA-GLUTAMYLTRANSFERASE 2; GGT2]
FBgn0025837	CG17636	HGNC:4260	OMIM:137168	GGT5	8		
FBgn0025837	CG17636	HGNC:16437	OMIM:612338	GGTLC1	6		
FBgn0025837	CG17636	HGNC:18596	OMIM:612339	GGTLC2	6		
FBgn0025837	CG17636	HGNC:4259	OMIM:612342	GGT7	4		
FBgn0025837	CG17636	HGNC:4252		GGT3P	4		
FBgn0025837	CG17636	HGNC:33426	OMIM:612340	GGTLC3	5		
FBgn0025836	RhoGAP1A	HGNC:81	OMIM:600365	ABR	13		
FBgn0025836	RhoGAP1A	HGNC:1014	OMIM:151410	BCR	11	608232,613065	608232[LEUKEMIA, CHRONIC MYELOID; CML],613065[LEUKEMIA, ACUTE LYMPHOBLASTIC; ALL]
FBgn0003559	su(f)	HGNC:2485	OMIM:600367	CSTF3	13		
FBgn0039943	CG17168	HGNC:30587	OMIM:608241	SNIP1	12	614501	614501[NEURODEVELOPMENTAL DISORDER WITH HYPOTONIA, CRANIOFACIAL ABNORMALITIES, AND SEIZURES; NEDHCS]
FBgn0039941	CG17167	HGNC:10977	OMIM:609839	SLC24A3	5		
FBgn0039941	CG17167	HGNC:20611	OMIM:609802	SLC24A5	4	113750	113750[ALBINISM, OCULOCUTANEOUS, TYPE VI; OCA6]
FBgn0039941	CG17167	HGNC:10978	OMIM:609840	SLC24A4	4	210750,615887	210750[SKIN/HAIR/EYE PIGMENTATION, VARIATION IN, 6; SHEP6],615887[AMELOGENESIS IMPERFECTA, HYPOMATURATION TYPE, IIA5; AI2A5]
FBgn0040031	CG12061	HGNC:10977	OMIM:609839	SLC24A3	4		
FBgn0040031	CG12061	HGNC:20611	OMIM:609802	SLC24A5	8	113750	113750[ALBINISM, OCULOCUTANEOUS, TYPE VI; OCA6]
FBgn0040031	CG12061	HGNC:10978	OMIM:609840	SLC24A4	4	210750,615887	210750[SKIN/HAIR/EYE PIGMENTATION, VARIATION IN, 6; SHEP6],615887[AMELOGENESIS IMPERFECTA, HYPOMATURATION TYPE, IIA5; AI2A5]
FBgn0039965	Coa7	HGNC:25716	OMIM:615623	COA7	14	618387	618387[SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE, WITH AXONAL NEUROPATHY 3; SCAN3]
FBgn0063670	CG40228	HGNC:28691	OMIM:619818	ELOF1	14		
FBgn0028697	RpL15	HGNC:10306	OMIM:604174	RPL15	12	615550	615550[DIAMOND-BLACKFAN ANEMIA 12; DBA12]
FBgn0058002	ND-AGGG	HGNC:7697	OMIM:603838	NDUFB2	6		
FBgn0037549	CG7878	HGNC:20083	OMIM:301079	DDX53	11		
FBgn0037549	CG7878	HGNC:18677	OMIM:606286	DDX43	14		
FBgn0040022	Set1	HGNC:29010	OMIM:611052	SETD1A	11	618832,619056	618832[EPILEPSY, EARLY-ONSET, WITH OR WITHOUT DEVELOPMENTAL DELAY; EPEDD],619056[NEURODEVELOPMENTAL DISORDER WITH SPEECH IMPAIRMENT AND DYSMORPHIC FACIES; NEDSID]
FBgn0040022	Set1	HGNC:29187	OMIM:611055	SETD1B	10	619000	619000[INTELLECTUAL DEVELOPMENTAL DISORDER WITH SEIZURES AND LANGUAGE DELAY; IDDSELD]
FBgn0058160	CG40160	HGNC:12019	OMIM:191080	TPSAB1	3		
FBgn0040056	CG17698	HGNC:1469	OMIM:611411	CAMKK1	11		
FBgn0040056	CG17698	HGNC:1470	OMIM:615002	CAMKK2	8		
FBgn0039955	CG41099	HGNC:20763	OMIM:607927	ANKFY1	13		
FBgn0083992	Mkp	HGNC:18894	OMIM:611437	DUSP19	10		
FBgn0083992	Mkp	HGNC:11447	OMIM:615814	STYX	3		
FBgn0034389	Mctp	HGNC:26183	OMIM:616296	MCTP1	13		
FBgn0034389	Mctp	HGNC:25636	OMIM:616297	MCTP2	11		
FBgn0083940	RhoU	HGNC:17794	OMIM:606366	RHOU	4		
FBgn0083940	RhoU	HGNC:18313		RHOV	4		
FBgn0083943	CG34107	HGNC:28435	OMIM:614502	C9orf116	11		
FBgn0083943	CG34107	HGNC:44654	OMIM:619669	C15orf65	3		
FBgn0083946	lobo	HGNC:25289	OMIM:618769	DRC7	12		
FBgn0083953	CG34117	HGNC:26946		FMC1	6		
FBgn0083953	CG34117	HGNC:44671		FMC1-LUC7L2	6		
FBgn0083956	CG34120	HGNC:37	OMIM:605414	ABCA7	4	608907	608907[ALZHEIMER DISEASE 9, SUSCEPTIBILITY TO; AD9]
FBgn0083956	CG34120	HGNC:29	OMIM:600046	ABCA1	4	205400,604091	205400[TANGIER DISEASE; TGD],604091[HYPOALPHALIPOPROTEINEMIA, PRIMARY, 1]
FBgn0083956	CG34120	HGNC:32	OMIM:600047	ABCA2	4	618808	618808[INTELLECTUAL DEVELOPMENTAL DISORDER WITH POOR GROWTH AND WITH OR WITHOUT SEIZURES OR ATAXIA; IDPOGSA]
FBgn0083956	CG34120	HGNC:34	OMIM:601691	ABCA4	4	153800,248200,601718,604116	153800[MACULAR DEGENERATION, AGE-RELATED, 2; ARMD2],248200[STARGARDT DISEASE 1; STGD1],601718[RETINITIS PIGMENTOSA 19; RP19],604116[CONE-ROD DYSTROPHY 3; CORD3]
FBgn0083956	CG34120	HGNC:33	OMIM:601615	ABCA3	5	610921	610921[SURFACTANT METABOLISM DYSFUNCTION, PULMONARY, 3; SMDP3]
FBgn0083956	CG34120	HGNC:14637	OMIM:607800	ABCA12	9	242500,601277	242500[ICHTHYOSIS, CONGENITAL, AUTOSOMAL RECESSIVE 4B; ARCI4B],601277[ICHTHYOSIS, CONGENITAL, AUTOSOMAL RECESSIVE 4A; ARCI4A]
FBgn0083956	CG34120	HGNC:30	OMIM:612508	ABCA10	4		
FBgn0083956	CG34120	HGNC:39	OMIM:612507	ABCA9	4		
FBgn0083956	CG34120	HGNC:38	OMIM:612505	ABCA8	4		
FBgn0083956	CG34120	HGNC:36	OMIM:612504	ABCA6	4		
FBgn0083956	CG34120	HGNC:35	OMIM:612503	ABCA5	4	135400	135400[HYPERTRICHOSIS, CONGENITAL GENERALIZED, WITH OR WITHOUT GINGIVAL HYPERPLASIA; HTC3]
FBgn0083956	CG34120	HGNC:14638	OMIM:607807	ABCA13	7		
FBgn0083960	CG34124	HGNC:25631	OMIM:617559	CFAP44	13	617593	617593[SPERMATOGENIC FAILURE 20; SPGF20]
FBgn0083961	CG34125	HGNC:2684	OMIM:607431	DAZAP2	3		
FBgn0083962	CG34126	HGNC:29102	OMIM:619811	UHRF1BP1L	13		
FBgn0083962	CG34126	HGNC:21216	OMIM:619570	UHRF1BP1	12		
FBgn0083963	Nlg3	HGNC:26459	OMIM:618678	CES5A	3		
FBgn0083963	Nlg3	HGNC:1863	OMIM:114835	CES1	3	618057	618057[DRUG METABOLISM, ALTERED, CES1-RELATED]
FBgn0083963	Nlg3	HGNC:1848	OMIM:114840	CEL	4	609812	609812[MATURITY-ONSET DIABETES OF THE YOUNG, TYPE 8, WITH EXOCRINE DYSFUNCTION; MODY8]
FBgn0083963	Nlg3	HGNC:1864	OMIM:605278	CES2	3		
FBgn0083963	Nlg3	HGNC:1865	OMIM:605279	CES3	3		
FBgn0083963	Nlg3	HGNC:15529	OMIM:400028	NLGN4Y	10		
FBgn0083963	Nlg3	HGNC:14291	OMIM:600568	NLGN1	11	618830	618830[AUTISM, SUSCEPTIBILITY TO, 20; AUTS20]
FBgn0083963	Nlg3	HGNC:14289	OMIM:300336	NLGN3	12	300425,300494	300425[AUTISM, SUSCEPTIBILITY TO, X-LINKED 1; AUTSX1],300494[ASPERGER SYNDROME, X-LINKED, SUSCEPTIBILITY TO, 1; ASPGX1]
FBgn0083963	Nlg3	HGNC:14287	OMIM:300427	NLGN4X	11	300495,300497	300495[AUTISM, SUSCEPTIBILITY TO, X-LINKED 2; AUTSX2],300497[ASPERGER SYNDROME, X-LINKED, SUSCEPTIBILITY TO, 2; ASPGX2]
FBgn0083963	Nlg3	HGNC:14290	OMIM:606479	NLGN2	10		
FBgn0083967	Muted	HGNC:18561	OMIM:607289	BLOC1S5	4	619172	619172[HERMANSKY-PUDLAK SYNDROME 11; HPS11]
FBgn0083968	CG34132	HGNC:11816	OMIM:607383	TIMM13	13		
FBgn0083969	CG34133	HGNC:30512	OMIM:301070	WDR44	11		
FBgn0083975	Nlg4	HGNC:1848	OMIM:114840	CEL	3	609812	609812[MATURITY-ONSET DIABETES OF THE YOUNG, TYPE 8, WITH EXOCRINE DYSFUNCTION; MODY8]
FBgn0083975	Nlg4	HGNC:15529	OMIM:400028	NLGN4Y	7		
FBgn0083975	Nlg4	HGNC:14291	OMIM:600568	NLGN1	8	618830	618830[AUTISM, SUSCEPTIBILITY TO, 20; AUTS20]
FBgn0083975	Nlg4	HGNC:14289	OMIM:300336	NLGN3	9	300425,300494	300425[AUTISM, SUSCEPTIBILITY TO, X-LINKED 1; AUTSX1],300494[ASPERGER SYNDROME, X-LINKED, SUSCEPTIBILITY TO, 1; ASPGX1]
FBgn0083975	Nlg4	HGNC:14287	OMIM:300427	NLGN4X	8	300495,300497	300495[AUTISM, SUSCEPTIBILITY TO, X-LINKED 2; AUTSX2],300497[ASPERGER SYNDROME, X-LINKED, SUSCEPTIBILITY TO, 2; ASPGX2]
FBgn0083975	Nlg4	HGNC:14290	OMIM:606479	NLGN2	7		
FBgn0083976	CG34140	HGNC:26914		PUSL1	13		
FBgn0083981	RunxA	HGNC:10473	OMIM:600210	RUNX3	7		
FBgn0083981	RunxA	HGNC:10471	OMIM:151385	RUNX1	6	601399,601626	601399[PLATELET DISORDER, FAMILIAL, WITH ASSOCIATED MYELOID MALIGNANCY; FPDMM],601626[LEUKEMIA, ACUTE MYELOID; AML]
FBgn0083981	RunxA	HGNC:10472	OMIM:600211	RUNX2	6	119600,156510	119600[CLEIDOCRANIAL DYSPLASIA; CCD],156510[METAPHYSEAL DYSPLASIA WITH MAXILLARY HYPOPLASIA WITH OR WITHOUT BRACHYDACTYLY; MDMHB]
FBgn0083983	mRpL34	HGNC:14488	OMIM:611840	MRPL34	9		
FBgn0083984	CG34148	HGNC:34453		C15orf61	13		
FBgn0083986	CG34150	HGNC:28072	OMIM:615831	LYRM7	9	615838	615838[MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 8; MC3DN8]
FBgn0026401	Nipped-B	HGNC:28862	OMIM:608667	NIPBL	12	122470	122470[CORNELIA DE LANGE SYNDROME 1; CDLS1]
FBgn0002566	lt	HGNC:12713	OMIM:605485	VPS41	14	619389	619389[SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 29; SCAR29]
FBgn0016975	stnB	HGNC:17003	OMIM:605357	STON1	3		
FBgn0016975	stnB	HGNC:30652	OMIM:608467	STON2	8		
FBgn0016975	stnB	HGNC:30651		STON1-GTF2A1L	4		
FBgn0003256	rl	HGNC:6871	OMIM:176948	MAPK1	14	619087	619087[NOONAN SYNDROME 13; NS13]
FBgn0003256	rl	HGNC:6877	OMIM:601795	MAPK3	10		
FBgn0003256	rl	HGNC:6880	OMIM:602521	MAPK7	3		
FBgn0032997	CG17486	HGNC:24910	OMIM:619739	ASNSD1	15		
FBgn0033000	CG14464	HGNC:26798	OMIM:612295	ARL14EP	8		
FBgn0033000	CG14464	HGNC:44201		ARL14EPL	7		
FBgn0064225	RpL5	HGNC:10360	OMIM:603634	RPL5	13	612561	612561[DIAMOND-BLACKFAN ANEMIA 6; DBA6]
FBgn0040007	RpL38	HGNC:10349	OMIM:604182	RPL38	14		
FBgn0010247	Parp	HGNC:270	OMIM:173870	PARP1	13		
FBgn0011288	Snap25	HGNC:11132	OMIM:600322	SNAP25	12	616330	616330[MYASTHENIC SYNDROME, CONGENITAL, 18; CMS18]
FBgn0011288	Snap25	HGNC:11131	OMIM:602534	SNAP23	9		
FBgn0046692	Stlk	HGNC:13205	OMIM:607333	STRADB	10		
FBgn0046692	Stlk	HGNC:30172	OMIM:608626	STRADA	13	611087	611087[POLYHYDRAMNIOS, MEGALENCEPHALY, AND SYMPTOMATIC EPILEPSY; PMSE]
FBgn0039994	conu	HGNC:25509	OMIM:610592	ARHGAP28	9		
FBgn0039994	conu	HGNC:21035	OMIM:613351	ARHGAP18	11		
FBgn0039994	conu	HGNC:16226		ARHGAP40	10		
FBgn0044872	FucTC	HGNC:4016	OMIM:136835	FUT5	10		
FBgn0044872	FucTC	HGNC:4017	OMIM:136836	FUT6	7	613852	613852[FUCOSYLTRANSFERASE 6 DEFICIENCY]
FBgn0044872	FucTC	HGNC:4014	OMIM:111100	FUT3	9	618983	618983[BLOOD GROUP, LEWIS SYSTEM; LE]
FBgn0044872	FucTC	HGNC:4015	OMIM:104230	FUT4	9		
FBgn0044872	FucTC	HGNC:4018	OMIM:602030	FUT7	8		
FBgn0044872	FucTC	HGNC:4020	OMIM:606865	FUT9	9		
FBgn0040005	CG17883	HGNC:16133	OMIM:611663	TBC1D20	14	615663	615663[WARBURG MICRO SYNDROME 4; WARBM4]
FBgn0069973	CG40485	HGNC:28639	OMIM:616159	DHRS11	15		
FBgn0069938	Cnep1r1	HGNC:26759	OMIM:616869	CNEP1R1	6		
FBgn0058470	CG40470	HGNC:500	OMIM:151530	ANPEP	3		
FBgn0058470	CG40470	HGNC:30748	OMIM:606950	TRHDE	3		
FBgn0058470	CG40470	HGNC:26904	OMIM:610046	LVRN	3		
FBgn0040010	CG17493	HGNC:1867	OMIM:300006	CETN2	11		
FBgn0040010	CG17493	HGNC:1868	OMIM:602907	CETN3	5		
FBgn0040010	CG17493	HGNC:1866	OMIM:603187	CETN1	11		
FBgn0058045	CG40045	HGNC:12483	OMIM:603124	UBE2G2	3		
FBgn0058045	CG40045	HGNC:12482	OMIM:601569	UBE2G1	15		
FBgn0046706	Haspin	HGNC:19682	OMIM:609240	HASPIN	10		
FBgn0001313	kl-2	HGNC:2940	OMIM:603332	DNAH1	3	617576,617577	617576[SPERMATOGENIC FAILURE 18; SPGF18],617577[CILIARY DYSKINESIA, PRIMARY, 37; CILD37]
FBgn0001313	kl-2	HGNC:2953	OMIM:603330	DNAH9	3	618300	618300[CILIARY DYSKINESIA, PRIMARY, 40; CILD40]
FBgn0001313	kl-2	HGNC:2942	OMIM:603339	DNAH11	3	611884	611884[CILIARY DYSKINESIA, PRIMARY, 7; CILD7]
FBgn0001313	kl-2	HGNC:2948	OMIM:603333	DNAH2	11	619094	619094[SPERMATOGENIC FAILURE 45; SPGF45]
FBgn0001313	kl-2	HGNC:2941	OMIM:605884	DNAH10	3	619515	619515[SPERMATOGENIC FAILURE 56; SPGF56]
FBgn0001313	kl-2	HGNC:2946	OMIM:610063	DNAH17	3	618643	618643[SPERMATOGENIC FAILURE 39; SPGF39]
FBgn0039977	Spf30	HGNC:16900	OMIM:603519	SMNDC1	14		
FBgn0046323	ORY	HGNC:26676	OMIM:619129	CFAP58	7	619144	619144[SPERMATOGENIC FAILURE 49; SPGF49]
FBgn0024804	Dbp80	HGNC:25628		DDX19A	10		
FBgn0024804	Dbp80	HGNC:18698	OMIM:607663	DDX25	8		
FBgn0024804	Dbp80	HGNC:2742	OMIM:605812	DDX19B	10		
FBgn0063368	Gpb5	HGNC:12372	OMIM:188540	TSHB	4	275100	275100[HYPOTHYROIDISM, CONGENITAL, NONGOITROUS, 4; CHNG4]
FBgn0063368	Gpb5	HGNC:6584	OMIM:152780	LHB	5	228300	228300[HYPOGONADOTROPIC HYPOGONADISM 23 WITH OR WITHOUT ANOSMIA; HH23]
FBgn0063368	Gpb5	HGNC:3964	OMIM:136530	FSHB	4	229070	229070[HYPOGONADOTROPIC HYPOGONADISM 24 WITH OR WITHOUT ANOSMIA; HH24]
FBgn0063368	Gpb5	HGNC:16452	OMIM:608825	CGB5	3		
FBgn0063368	Gpb5	HGNC:16451	OMIM:608826	CGB7	4		
FBgn0063368	Gpb5	HGNC:16453	OMIM:608827	CGB8	3		
FBgn0063368	Gpb5	HGNC:16722	OMIM:608824	CGB2	5		
FBgn0063368	Gpb5	HGNC:16721	OMIM:608823	CGB1	4		
FBgn0063368	Gpb5	HGNC:18055	OMIM:609652	GPHB5	10		
FBgn0069923	CG41128	HGNC:32068	OMIM:616574	MICOS10	7		
FBgn0058064	ARY	HGNC:386	OMIM:603966	AKR1C3	4		
FBgn0058064	ARY	HGNC:384	OMIM:600449	AKR1C1	4		
FBgn0058064	ARY	HGNC:387	OMIM:600451	AKR1C4	4	614279	614279[46,XY SEX REVERSAL 8; SRXY8]
FBgn0058064	ARY	HGNC:380	OMIM:103830	AKR1A1	4		
FBgn0058064	ARY	HGNC:381	OMIM:103880	AKR1B1	4		
FBgn0058064	ARY	HGNC:382	OMIM:604707	AKR1B10	5		
FBgn0058064	ARY	HGNC:388	OMIM:604741	AKR1D1	4	235555	235555[BILE ACID SYNTHESIS DEFECT, CONGENITAL, 2; CBAS2]
FBgn0058064	ARY	HGNC:385	OMIM:600450	AKR1C2	4	614279	614279[46,XY SEX REVERSAL 8; SRXY8]
FBgn0058064	ARY	HGNC:23437	OMIM:617451	AKR1E2	4		
FBgn0058064	ARY	HGNC:37281	OMIM:616336	AKR1B15	4		
FBgn0040020	MED21	HGNC:11473	OMIM:603800	MED21	13		
FBgn0058263	MFS17	HGNC:20151	OMIM:607557	SLC17A8	3	605583	605583[DEAFNESS, AUTOSOMAL DOMINANT 25; DFNA25]
FBgn0058263	MFS17	HGNC:10933	OMIM:604322	SLC17A5	3	269920,604369	269920[INFANTILE SIALIC ACID STORAGE DISEASE; ISSD],604369[SALLA DISEASE; SD]
FBgn0058263	MFS17	HGNC:16703	OMIM:607563	SLC17A6	3		
FBgn0058263	MFS17	HGNC:16704	OMIM:605208	SLC17A7	3		
FBgn0058263	MFS17	HGNC:10929	OMIM:182308	SLC17A1	4		
FBgn0058263	MFS17	HGNC:10932	OMIM:604216	SLC17A4	4		
FBgn0058263	MFS17	HGNC:10930	OMIM:611049	SLC17A2	4		
FBgn0058263	MFS17	HGNC:10931	OMIM:611034	SLC17A3	5	612671	612671[URIC ACID CONCENTRATION, SERUM, QUANTITATIVE TRAIT LOCUS 4; UAQTL4]
FBgn0046698	Pp1-Y2	HGNC:9281	OMIM:176875	PPP1CA	5		
FBgn0046698	Pp1-Y2	HGNC:9283	OMIM:176914	PPP1CC	5		
FBgn0046698	Pp1-Y2	HGNC:9282	OMIM:600590	PPP1CB	4	617506	617506[NOONAN SYNDROME-LIKE DISORDER WITH LOOSE ANAGEN HAIR 2; NSLH2]
FBgn0040973	CG16824	HGNC:26932	OMIM:615808	TMA7	9		
FBgn0039993	CG17691	HGNC:987	OMIM:248611	BCKDHB	14	248600	248600[MAPLE SYRUP URINE DISEASE; MSUD]
FBgn0046697	Ppr-Y	HGNC:25384	OMIM:618758	DRC3	14		
FBgn0020660	eIF4B	HGNC:3285	OMIM:603928	EIF4B	12		
FBgn0020660	eIF4B	HGNC:12741	OMIM:603431	EIF4H	4		
FBgn0085188	CG34159	HGNC:14142		MCRIP2	4		
FBgn0085188	CG34159	HGNC:28007	OMIM:616514	MCRIP1	3		
FBgn0085190	CG34161	HGNC:179	OMIM:600875	ACYP1	9		
FBgn0085190	CG34161	HGNC:180	OMIM:102595	ACYP2	8		
FBgn0085191	CG34162	HGNC:26175	OMIM:609841	SLC8B1	3		
FBgn0085201	COX7AL2	HGNC:2287	OMIM:123995	COX7A1	6		
FBgn0085201	COX7AL2	HGNC:2288	OMIM:123996	COX7A2	5		
FBgn0085201	COX7AL2	HGNC:2289	OMIM:605771	COX7A2L	5		
FBgn0085203	CG34174	HGNC:23789	OMIM:613362	CINP	6		
FBgn0085211	RpS28-like	HGNC:10418	OMIM:603685	RPS28	3	606164	606164[DIAMOND-BLACKFAN ANEMIA 15 WITH MANDIBULOFACIAL DYSOSTOSIS; DBA15]
FBgn0085212	CG34183	HGNC:25791	OMIM:611476	RPAP2	9		
FBgn0085220	Ufm1	HGNC:20597	OMIM:610553	UFM1	14	617899	617899[LEUKODYSTROPHY, HYPOMYELINATING, 14; HLD14]
FBgn0085223	CG34194	HGNC:20361	OMIM:613540	SPTSSA	5		
FBgn0085223	CG34194	HGNC:24045	OMIM:610412	SPTSSB	6		
FBgn0085224	CG34195	HGNC:25856	OMIM:609525	METTL8	3		
FBgn0085224	CG34195	HGNC:28343	OMIM:618903	METTL6	14		
FBgn0085224	CG34195	HGNC:25755	OMIM:618902	METTL2A	3		
FBgn0085224	CG34195	HGNC:18272	OMIM:607846	METTL2B	3		
FBgn0085242	CG34213	HGNC:30763	OMIM:608719	NR2C2AP	14		
FBgn0085257	CG34228	HGNC:25154		SMIM12	10		
FBgn0085260	CG34231	HGNC:21785		RBM48	10		
FBgn0085271	CG34242	HGNC:37260	OMIM:617465	SMIM20	4		
FBgn0085284	Blos3	HGNC:20914	OMIM:609762	BLOC1S3	3	614077	614077[HERMANSKY-PUDLAK SYNDROME 8; HPS8]
FBgn0085290	CG34261	HGNC:21257	OMIM:614393	OARD1	8		
FBgn0085303	CG34274	HGNC:23700	OMIM:610732	TTC12	5	618801	618801[CILIARY DYSKINESIA, PRIMARY, 45; CILD45]
FBgn0085312	CG34283	HGNC:16198		GTSF1L	6		
FBgn0085312	CG34283	HGNC:26565	OMIM:617484	GTSF1	7		
FBgn0085322	CG34293	HGNC:20361	OMIM:613540	SPTSSA	8		
FBgn0085322	CG34293	HGNC:24045	OMIM:610412	SPTSSB	6		
FBgn0085326	CG34297	HGNC:23700	OMIM:610732	TTC12	6	618801	618801[CILIARY DYSKINESIA, PRIMARY, 45; CILD45]
FBgn0085342	CG34313	HGNC:14161		SNRNP25	3		
FBgn0085346	Rpp14a	HGNC:30327	OMIM:606112	RPP14	8		
FBgn0085354	CG34325	HGNC:9718	OMIM:602505	PXN	5		
FBgn0085354	CG34325	HGNC:11767	OMIM:602353	TGFB1I1	5		
FBgn0085354	CG34325	HGNC:17371	OMIM:605126	FHL5	3		
FBgn0085354	CG34325	HGNC:14061	OMIM:605390	LPXN	5		
FBgn0085369	Drgx	HGNC:691	OMIM:602753	PHOX2A	3	602078	602078[FIBROSIS OF EXTRAOCULAR MUSCLES, CONGENITAL, 2; CFEOM2]
FBgn0085369	Drgx	HGNC:21536	OMIM:606701	DRGX	7		
FBgn0085369	Drgx	HGNC:9143	OMIM:603851	PHOX2B	3	209880,613013	209880[CENTRAL HYPOVENTILATION SYNDROME, CONGENITAL, 1; CCHS1],613013[NEUROBLASTOMA, SUSCEPTIBILITY TO, 2; NBLST2]
FBgn0085369	Drgx	HGNC:449	OMIM:606014	ALX3	3	136760	136760[FRONTONASAL DYSPLASIA 1; FND1]
FBgn0085370	Pde11	HGNC:8783	OMIM:600129	PDE4D	3	614613	614613[ACRODYSOSTOSIS 2 WITH OR WITHOUT HORMONE RESISTANCE; ACRDYS2]
FBgn0085370	Pde11	HGNC:8773	OMIM:604961	PDE11A	6	610475	610475[PIGMENTED NODULAR ADRENOCORTICAL DISEASE, PRIMARY, 2; PPNAD2]
FBgn0085370	Pde11	HGNC:8780	OMIM:600126	PDE4A	3		
FBgn0085370	Pde11	HGNC:8784	OMIM:603310	PDE5A	11		
FBgn0085370	Pde11	HGNC:8785	OMIM:180071	PDE6A	4	613810	613810[RETINITIS PIGMENTOSA 43; RP43]
FBgn0085370	Pde11	HGNC:8787	OMIM:600827	PDE6C	4	613093	613093[CONE DYSTROPHY 4; COD4]
FBgn0085370	Pde11	HGNC:8786	OMIM:180072	PDE6B	4	163500,613801	163500[NIGHT BLINDNESS, CONGENITAL STATIONARY, AUTOSOMAL DOMINANT 2; CSNBAD2],613801[RETINITIS PIGMENTOSA 40; RP40]
FBgn0085370	Pde11	HGNC:8777	OMIM:602658	PDE2A	3	619150	619150[INTELLECTUAL DEVELOPMENTAL DISORDER WITH PAROXYSMAL DYSKINESIA OR SEIZURES; IDDPADS]
FBgn0085370	Pde11	HGNC:8772	OMIM:610652	PDE10A	4	616921,616922	616921[DYSKINESIA, LIMB AND OROFACIAL, INFANTILE-ONSET; IOLOD],616922[STRIATAL DEGENERATION, AUTOSOMAL DOMINANT 2; ADSD2]
FBgn0085370	Pde11	HGNC:8791	OMIM:171885	PDE7A	3		
FBgn0085370	Pde11	HGNC:8792	OMIM:604645	PDE7B	3		
FBgn0085371	CG34342	HGNC:26222	OMIM:616107	FAR1	6	616154,619338	616154[PEROXISOMAL FATTY ACYL-CoA REDUCTASE 1 DISORDER; PFCRD],619338[CATARACTS, SPASTIC PARAPARESIS, AND SPEECH DELAY; CSPSD]
FBgn0085371	CG34342	HGNC:25531	OMIM:616156	FAR2	5		
FBgn0085374	CG34345	HGNC:8546	OMIM:176710	P4HA1	4		
FBgn0085374	CG34345	HGNC:30135	OMIM:608987	P4HA3	5		
FBgn0085374	CG34345	HGNC:8547	OMIM:600608	P4HA2	4	617238	617238[MYOPIA 25, AUTOSOMAL DOMINANT; MYP25]
FBgn0085374	CG34345	HGNC:28858	OMIM:614584	P4HTM	3	618493	618493[HYPOTONIA, HYPOVENTILATION, IMPAIRED INTELLECTUAL DEVELOPMENT, DYSAUTONOMIA, EPILEPSY, AND EYE ABNORMALITIES; HIDEA]
FBgn0085376	CG34347	HGNC:13278	OMIM:612141	EPB41L4A	9		
FBgn0085377	CG34348	HGNC:26510		TMEM68	15		
FBgn0085380	dcma	HGNC:23271	OMIM:610890	RGS7BP	5		
FBgn0085382	CG34353	HGNC:6705	OMIM:603241	LSAMP	3		
FBgn0085383	CG34354	HGNC:11804	OMIM:603413	TIAL1	7		
FBgn0085383	CG34354	HGNC:11802	OMIM:603518	TIA1	7	604454,619133	604454[WELANDER DISTAL MYOPATHY; WDM],619133[AMYOTROPHIC LATERAL SCLEROSIS 26 WITH OR WITHOUT FRONTOTEMPORAL DEMENTIA; ALS26]
FBgn0085385	bma	HGNC:19286	OMIM:616365	SCYL2	6	618766	618766[ARTHROGRYPOSIS MULTIPLEX CONGENITA 4, NEUROGENIC, WITH AGENESIS OF THE CORPUS CALLOSUM; AMC4]
FBgn0085386	CG34357	HGNC:7943	OMIM:108960	NPR1	3		
FBgn0085386	CG34357	HGNC:7944	OMIM:108961	NPR2	3	602875,615923,616255	602875[ACROMESOMELIC DYSPLASIA 1; AMD1],615923[EPIPHYSEAL CHONDRODYSPLASIA, MIURA TYPE; ECDM],616255[SHORT STATURE WITH NONSPECIFIC SKELETAL ABNORMALITIES; SNSK]
FBgn0085386	CG34357	HGNC:4691	OMIM:300041	GUCY2F	9		
FBgn0085386	CG34357	HGNC:4689	OMIM:600179	GUCY2D	8	204000,215500,601777,618555	204000[LEBER CONGENITAL AMAUROSIS 1; LCA1],215500[CHOROIDAL DYSTROPHY, CENTRAL AREOLAR, 1; CACD1],601777[CONE-ROD DYSTROPHY 6; CORD6],618555[NIGHT BLINDNESS, CONGENITAL STATIONARY, TYPE1I; CSNB1I]
FBgn0085386	CG34357	HGNC:4688	OMIM:601330	GUCY2C	3	614616,614665	614616[DIARRHEA 6; DIAR6],614665[MECONIUM ILEUS]
FBgn0085390	Dgk	HGNC:2849	OMIM:125855	DGKA	9		
FBgn0085390	Dgk	HGNC:2853	OMIM:601854	DGKG	10		
FBgn0085390	Dgk	HGNC:2850	OMIM:604070	DGKB	13		
FBgn0085391	trv	HGNC:11804	OMIM:603413	TIAL1	6		
FBgn0085391	trv	HGNC:11802	OMIM:603518	TIA1	6	604454,619133	604454[WELANDER DISTAL MYOPATHY; WDM],619133[AMYOTROPHIC LATERAL SCLEROSIS 26 WITH OR WITHOUT FRONTOTEMPORAL DEMENTIA; ALS26]
FBgn0085395	Shawl	HGNC:6236	OMIM:176265	KCNC4	7		
FBgn0085395	Shawl	HGNC:6233	OMIM:176258	KCNC1	7	616187	616187[EPILEPSY, PROGRESSIVE MYOCLONIC 7; EPM7]
FBgn0085395	Shawl	HGNC:6235	OMIM:176264	KCNC3	7	605259	605259[SPINOCEREBELLAR ATAXIA 13; SCA13]
FBgn0085395	Shawl	HGNC:6234	OMIM:176256	KCNC2	7	619913	619913[DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 103; DEE103]
FBgn0085396	CG34367	HGNC:10854	OMIM:602504	SHOX2	8		
FBgn0085396	CG34367	HGNC:10853	OMIM:312865	SHOX	8		
FBgn0085397	Fili	HGNC:16914	OMIM:605492	LRRN2	3		
FBgn0085397	Fili	HGNC:20980	OMIM:619623	LRRN1	3		
FBgn0085398	ppk9	HGNC:101	OMIM:611741	ASIC3	5		
FBgn0085398	ppk9	HGNC:100	OMIM:602866	ASIC1	5		
FBgn0085398	ppk9	HGNC:21263	OMIM:606715	ASIC4	5		
FBgn0085398	ppk9	HGNC:99	OMIM:601784	ASIC2	4		
FBgn0085398	ppk9	HGNC:17537	OMIM:616693	ASIC5	4		
FBgn0085398	ppk9	HGNC:10599	OMIM:600228	SCNN1A	3	264350,613021,618126	264350[PSEUDOHYPOALDOSTERONISM, TYPE I, AUTOSOMAL RECESSIVE; PHA1B],613021[BRONCHIECTASIS WITH OR WITHOUT ELEVATED SWEAT CHLORIDE 2; BESC2],618126[LIDDLE SYNDROME 3; LIDLS3]
FBgn0085398	ppk9	HGNC:10600	OMIM:600760	SCNN1B	3	177200,211400,264350	177200[LIDDLE SYNDROME 1; LIDLS1],211400[BRONCHIECTASIS WITH OR WITHOUT ELEVATED SWEAT CHLORIDE 1; BESC1],264350[PSEUDOHYPOALDOSTERONISM, TYPE I, AUTOSOMAL RECESSIVE; PHA1B]
FBgn0085398	ppk9	HGNC:10601	OMIM:601328	SCNN1D	3		
FBgn0085398	ppk9	HGNC:10602	OMIM:600761	SCNN1G	3	264350,613071,618114	264350[PSEUDOHYPOALDOSTERONISM, TYPE I, AUTOSOMAL RECESSIVE; PHA1B],613071[BRONCHIECTASIS WITH OR WITHOUT ELEVATED SWEAT CHLORIDE 3; BESC3],618114[LIDDLE SYNDROME 2; LIDLS2]
FBgn0085408	Shrm	HGNC:630	OMIM:300103	SHROOM2	8		
FBgn0085408	Shrm	HGNC:29215	OMIM:300579	SHROOM4	4	300434	300434[INTELLECTUAL DEVELOPMENTAL DISORDER, X-LINKED, SYNDROMIC, STOCCO DOS SANTOS TYPE; SDSX]
FBgn0085408	Shrm	HGNC:30422	OMIM:604570	SHROOM3	8		
FBgn0085409	smal	HGNC:2730	OMIM:600408	DDR1	9		
FBgn0085409	smal	HGNC:2731	OMIM:191311	DDR2	10	271665,618175	271665[SPONDYLOMETAEPIPHYSEAL DYSPLASIA, SHORT LIMB-HAND TYPE],618175[WARBURG-CINOTTI SYNDROME; WRCN]
FBgn0085412	kmr	HGNC:27049	OMIM:612686	PLEKHA7	4		
FBgn0085412	kmr	HGNC:17053	OMIM:607771	PLEKHA6	5		
FBgn0085412	kmr	HGNC:30036	OMIM:607770	PLEKHA5	5		
FBgn0085412	kmr	HGNC:14339	OMIM:607769	PLEKHA4	3		
FBgn0085413	CG34384	HGNC:2851	OMIM:601826	DGKD	13		
FBgn0085413	CG34384	HGNC:2854	OMIM:604071	DGKH	14		
FBgn0085413	CG34384	HGNC:32395	OMIM:300837	DGKK	5		
FBgn0085419	Rgk2	HGNC:4234	OMIM:600164	GEM	4		
FBgn0085419	Rgk2	HGNC:10446	OMIM:179503	RRAD	6		
FBgn0085419	Rgk2	HGNC:15922	OMIM:610388	REM1	7		
FBgn0085419	Rgk2	HGNC:20248	OMIM:616955	REM2	4		
FBgn0085420	DIP-delta	HGNC:17302	OMIM:613173	NEGR1	6		
FBgn0085420	DIP-delta	HGNC:34550	OMIM:618861	IGLON5	7		
FBgn0085420	DIP-delta	HGNC:6705	OMIM:603241	LSAMP	6		
FBgn0085420	DIP-delta	HGNC:8143	OMIM:600632	OPCML	6	167000	167000[OVARIAN CANCER]
FBgn0085420	DIP-delta	HGNC:17941	OMIM:607938	NTM	7		
FBgn0085421	Epac	HGNC:16862	OMIM:609527	RAPGEF5	7		
FBgn0085421	Epac	HGNC:17428		RAPGEFL1	4		
FBgn0085421	Epac	HGNC:16629	OMIM:606057	RAPGEF3	9		
FBgn0085421	Epac	HGNC:16626	OMIM:606058	RAPGEF4	14		
FBgn0085422	CG34393	HGNC:24246	OMIM:614531	RASGEF1A	5		
FBgn0085422	CG34393	HGNC:24881	OMIM:614532	RASGEF1B	6		
FBgn0085422	CG34393	HGNC:27400		RASGEF1C	5		
FBgn0085423	GramD1B	HGNC:25252		GRAMD1C	10		
FBgn0085423	GramD1B	HGNC:29305		GRAMD1A	11		
FBgn0085423	GramD1B	HGNC:29214		GRAMD1B	12		
FBgn0085423	GramD1B	HGNC:24911		GRAMD2B	4		
FBgn0085423	GramD1B	HGNC:27287		GRAMD2A	3		
FBgn0085424	nub	HGNC:9217	OMIM:300039	POU3F4	3	304400	304400[DEAFNESS, X-LINKED 2; DFNX2]
FBgn0085424	nub	HGNC:9214	OMIM:602479	POU3F1	3		
FBgn0085424	nub	HGNC:9212	OMIM:164175	POU2F1	7		
FBgn0085424	nub	HGNC:9221	OMIM:164177	POU5F1	3		
FBgn0085424	nub	HGNC:9216	OMIM:602480	POU3F3	3	618604	618604[SNIJDERS BLOK-FISHER SYNDROME; SNIBFIS]
FBgn0085424	nub	HGNC:19864	OMIM:607394	POU2F3	6		
FBgn0085424	nub	HGNC:9223	OMIM:615739	POU5F1B	3		
FBgn0085424	nub	HGNC:9213	OMIM:164176	POU2F2	7		
FBgn0085424	nub	HGNC:26367		POU5F2	3		
FBgn0085425	CG34396	HGNC:19439	OMIM:613655	KCNK18	8	613656	613656[MIGRAINE WITH OR WITHOUT AURA, SUSCEPTIBILITY TO, 13; MGR13]
FBgn0085425	CG34396	HGNC:14465	OMIM:607370	KCNK17	3		
FBgn0085426	Rgk3	HGNC:4234	OMIM:600164	GEM	3		
FBgn0085426	Rgk3	HGNC:10446	OMIM:179503	RRAD	5		
FBgn0085426	Rgk3	HGNC:15922	OMIM:610388	REM1	3		
FBgn0085426	Rgk3	HGNC:20248	OMIM:616955	REM2	3		
FBgn0085428	Nox	HGNC:14874	OMIM:606572	NOX5	13		
FBgn0085428	Nox	HGNC:7889	OMIM:300225	NOX1	3		
FBgn0085430	Dora	HGNC:23528	OMIM:619213	ZSWIM8	13		
FBgn0085432	pan	HGNC:11639	OMIM:189908	TCF7	5		
FBgn0085432	pan	HGNC:11641	OMIM:602228	TCF7L2	8	125853	125853[TYPE 2 DIABETES MELLITUS; T2D]
FBgn0085432	pan	HGNC:6551	OMIM:153245	LEF1	6		
FBgn0085432	pan	HGNC:11640	OMIM:604652	TCF7L1	6		
FBgn0085433	CG34404	HGNC:6935	OMIM:159350	MCC	11	114500	114500[COLORECTAL CANCER; CRC]
FBgn0085433	CG34404	HGNC:24058	OMIM:611810	USHBP1	3		
FBgn0085434	NaCP60E	HGNC:10594	OMIM:182392	SCN7A	3		
FBgn0085434	NaCP60E	HGNC:10590	OMIM:182391	SCN3A	3	617935,617938	617935[EPILEPSY, FAMILIAL FOCAL, WITH VARIABLE FOCI 4; FFEVF4],617938[DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 62; DEE62]
FBgn0085434	NaCP60E	HGNC:10597	OMIM:603415	SCN9A	3	133020,167400,243000	133020[ERYTHERMALGIA, PRIMARY],167400[PAROXYSMAL EXTREME PAIN DISORDER],243000[INDIFFERENCE TO PAIN, CONGENITAL, AUTOSOMAL RECESSIVE; CIP]
FBgn0085434	NaCP60E	HGNC:10582	OMIM:604427	SCN10A	3	615551	615551[EPISODIC PAIN SYNDROME, FAMILIAL, 2; FEPS2]
FBgn0085434	NaCP60E	HGNC:10593	OMIM:600163	SCN5A	3	113900,272120,601144,601154,603829,603830,608567,614022	113900[PROGRESSIVE FAMILIAL HEART BLOCK, TYPE IA; PFHB1A],272120[SUDDEN INFANT DEATH SYNDROME],601144[BRUGADA SYNDROME 1; BRGDA1],601154[CARDIOMYOPATHY, DILATED, 1E; CMD1E],603829[VENTRICULAR FIBRILLATION, PAROXYSMAL FAMILIAL, 1; VF1],603830[LONG QT SYNDROME 3; LQT3],608567[SICK SINUS SYNDROME 1; SSS1],614022[ATRIAL FIBRILLATION, FAMILIAL, 10; ATFB10]
FBgn0085434	NaCP60E	HGNC:10588	OMIM:182390	SCN2A	3	607745,613721,618924	607745[SEIZURES, BENIGN FAMILIAL INFANTILE, 3; BFIS3],613721[DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 11; DEE11],618924[EPISODIC ATAXIA, TYPE 9; EA9]
FBgn0085434	NaCP60E	HGNC:10591	OMIM:603967	SCN4A	3	168300,170500,608390,613345,614198	168300[PARAMYOTONIA CONGENITA OF VON EULENBURG; PMC],170500[HYPERKALEMIC PERIODIC PARALYSIS; HYPP],608390[MYOTONIA, POTASSIUM-AGGRAVATED],613345[HYPOKALEMIC PERIODIC PARALYSIS, TYPE 2; HOKPP2],614198[MYASTHENIC SYNDROME, CONGENITAL, 16; CMS16]
FBgn0085434	NaCP60E	HGNC:10585	OMIM:182389	SCN1A	3	604403,607208,609634,619317	604403[GENERALIZED EPILEPSY WITH FEBRILE SEIZURES PLUS, TYPE 2; GEFSP2],607208[DRAVET SYNDROME; DRVT],609634[MIGRAINE, FAMILIAL HEMIPLEGIC, 3; FHM3],619317[DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 6B; DEE6B]
FBgn0085434	NaCP60E	HGNC:10583	OMIM:604385	SCN11A	4	615548,615552	615548[NEUROPATHY, HEREDITARY SENSORY AND AUTONOMIC, TYPE VII; HSAN7],615552[EPISODIC PAIN SYNDROME, FAMILIAL, 3; FEPS3]
FBgn0085434	NaCP60E	HGNC:10596	OMIM:600702	SCN8A	4	614306,614558,617080,618364	614306[COGNITIVE IMPAIRMENT WITH OR WITHOUT CEREBELLAR ATAXIA; CIAT],614558[DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 13; DEE13],617080[SEIZURES, BENIGN FAMILIAL INFANTILE, 5; BFIS5],618364[MYOCLONUS, FAMILIAL, 2; MYOCL2]
FBgn0085436	Not1	HGNC:7877	OMIM:604917	CNOT1	13	618500,619033	618500[HOLOPROSENCEPHALY 12 WITH OR WITHOUT PANCREATIC AGENESIS; HPE12],619033[VISSERS-BODMER SYNDROME; VIBOS]
FBgn0085437	CG34408	HGNC:29221	OMIM:618833	RALGAPB	14		
FBgn0085440	Lgr4	HGNC:17318	OMIM:606655	RXFP2	5		
FBgn0085440	Lgr4	HGNC:19718	OMIM:606654	RXFP1	6		
FBgn0085442	NKAIN	HGNC:16443	OMIM:609758	NKAIN2	9		
FBgn0085442	NKAIN	HGNC:25743	OMIM:612871	NKAIN1	8		
FBgn0085442	NKAIN	HGNC:16191	OMIM:612873	NKAIN4	9		
FBgn0085442	NKAIN	HGNC:26829	OMIM:612872	NKAIN3	8		
FBgn0085443	spri	HGNC:18749	OMIM:605965	RIN1	6		
FBgn0085443	spri	HGNC:18750	OMIM:610222	RIN2	10	613075	613075[MACS SYNDROME]
FBgn0085443	spri	HGNC:18751	OMIM:610223	RIN3	7		
FBgn0085443	spri	HGNC:24795		RINL	3		
FBgn0085444	mute	HGNC:30935	OMIM:607860	YY1AP1	6	602531	602531[GRANGE SYNDROME; GRNG]
FBgn0085444	mute	HGNC:25973	OMIM:610393	GON4L	10		
FBgn0085446	CG34417	HGNC:24764		SMTNL2	3		
FBgn0085446	CG34417	HGNC:32394	OMIM:613664	SMTNL1	5		
FBgn0085446	CG34417	HGNC:11126	OMIM:602127	SMTN	4		
FBgn0085447	sif	HGNC:23222	OMIM:613324	SPATA13	3		
FBgn0085447	sif	HGNC:14561	OMIM:300429	ARHGEF9	3	300607	300607[DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 8; DEE8]
FBgn0085447	sif	HGNC:11806	OMIM:604709	TIAM2	8		
FBgn0085447	sif	HGNC:684	OMIM:605216	ARHGEF4	3		
FBgn0085447	sif	HGNC:11805	OMIM:600687	TIAM1	11	619908	619908[NEURODEVELOPMENTAL DISORDER WITH LANGUAGE DELAY AND SEIZURES; NEDLDS]
FBgn0085450	Snoo	HGNC:10896	OMIM:164780	SKI	7	182212	182212[SHPRINTZEN-GOLDBERG CRANIOSYNOSTOSIS SYNDROME; SGS]
FBgn0085450	Snoo	HGNC:10897	OMIM:165340	SKIL	5		
FBgn0085451	htk	HGNC:15550	OMIM:609696	ARID4B	10		
FBgn0085451	htk	HGNC:9885	OMIM:180201	ARID4A	11		
FBgn0085451	htk	HGNC:17361	OMIM:611583	ARID5A	3		
FBgn0085451	htk	HGNC:17362	OMIM:608538	ARID5B	3		
FBgn0085452	CG34423	HGNC:871	OMIM:614981	ATP5IF1	6		
FBgn0085453	Mthfs	HGNC:7437	OMIM:604197	MTHFS	8	618367	618367[NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, EPILEPSY, AND HYPOMYELINATION; NEDMEHM]
FBgn0085453	Mthfs	HGNC:44655		ST20-MTHFS	12		
FBgn0085464	CG34435	HGNC:29823	OMIM:609930	MYL6B	3		
FBgn0085464	CG34435	HGNC:7587	OMIM:609931	MYL6	3		
FBgn0085468	ND-MWFE	HGNC:7683	OMIM:300078	NDUFA1	5	301020	301020[MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 12; MC1DN12]
FBgn0085470	lmgB	HGNC:16708	OMIM:616128	FAM89B	5		
FBgn0085477	CG34448	HGNC:9155	OMIM:246600	PNLIP	3	614338	614338[PANCREATIC LIPASE DEFICIENCY; PNLIPD]
FBgn0085477	CG34448	HGNC:9156	OMIM:604422	PNLIPRP1	3		
FBgn0085477	CG34448	HGNC:23492		PNLIPRP3	3		
FBgn0085477	CG34448	HGNC:18821	OMIM:609252	LIPI	3		
FBgn0085478	Zdhhc8	HGNC:20712		ZDHHC18	3		
FBgn0085478	Zdhhc8	HGNC:18472	OMIM:614586	ZDHHC5	10		
FBgn0085478	Zdhhc8	HGNC:18474	OMIM:608784	ZDHHC8	9		
FBgn0085478	Zdhhc8	HGNC:20341	OMIM:619295	ZDHHC14	3		
FBgn0085478	Zdhhc8	HGNC:18475	OMIM:300646	ZDHHC9	3	300799	300799[INTELLECTUAL DEVELOPMENTAL DISORDER, X-LINKED, SYNDROMIC, RAYMOND TYPE; MRXSR]
FBgn0085480	CG34451	HGNC:24337	OMIM:610555	C1GALT1	5		
FBgn0085480	CG34451	HGNC:24338	OMIM:300611	C1GALT1C1	4	300622	300622[TN POLYAGGLUTINATION SYNDROME; TNPS]
FBgn0085481	CG34452	HGNC:24337	OMIM:610555	C1GALT1	4		
FBgn0085481	CG34452	HGNC:24338	OMIM:300611	C1GALT1C1	3	300622	300622[TN POLYAGGLUTINATION SYNDROME; TNPS]
FBgn0085484	Pdxk	HGNC:8819	OMIM:179020	PDXK	13	618511	618511[NEUROPATHY, HEREDITARY MOTOR AND SENSORY, TYPE VIC, WITH OPTIC ATROPHY; HMSN6C]
FBgn0085484	Pdxk	HGNC:0		LOC105372824	3		
FBgn0085486	CG34457	HGNC:26782		CFAP161	12		
FBgn0085521	CG40813	HGNC:17369	OMIM:618750	ABT1	11		
FBgn0085638	CG41378	HGNC:5398	OMIM:604664	IFI30	12		
FBgn0085736	CG40472	HGNC:7697	OMIM:603838	NDUFB2	8		
FBgn0085693	CG41562	HGNC:17369	OMIM:618750	ABT1	11		
FBgn0086129	snama	HGNC:9889	OMIM:600938	RBBP6	11		
FBgn0086130	Dbp21E2	HGNC:17330	OMIM:607618	DDX28	15		
FBgn0086134	Prosalpha2	HGNC:9531	OMIM:176842	PSMA2	15		
FBgn0086253	rumi	HGNC:22954	OMIM:615618	POGLUT1	15	615696,617232	615696[DOWLING-DEGOS DISEASE 4; DDD4],617232[MUSCULAR DYSTROPHY, LIMB-GIRDLE, AUTOSOMAL RECESSIVE 21; LGMDR21]
FBgn0086254	Akr1B	HGNC:386	OMIM:603966	AKR1C3	5		
FBgn0086254	Akr1B	HGNC:384	OMIM:600449	AKR1C1	5		
FBgn0086254	Akr1B	HGNC:387	OMIM:600451	AKR1C4	5	614279	614279[46,XY SEX REVERSAL 8; SRXY8]
FBgn0086254	Akr1B	HGNC:380	OMIM:103830	AKR1A1	5		
FBgn0086254	Akr1B	HGNC:381	OMIM:103880	AKR1B1	13		
FBgn0086254	Akr1B	HGNC:382	OMIM:604707	AKR1B10	13		
FBgn0086254	Akr1B	HGNC:388	OMIM:604741	AKR1D1	8	235555	235555[BILE ACID SYNTHESIS DEFECT, CONGENITAL, 2; CBAS2]
FBgn0086254	Akr1B	HGNC:385	OMIM:600450	AKR1C2	5	614279	614279[46,XY SEX REVERSAL 8; SRXY8]
FBgn0086254	Akr1B	HGNC:23437	OMIM:617451	AKR1E2	8		
FBgn0086254	Akr1B	HGNC:37281	OMIM:616336	AKR1B15	10		
FBgn0086346	ALiX	HGNC:8766	OMIM:608074	PDCD6IP	14		
FBgn0086346	ALiX	HGNC:14406	OMIM:606584	PTPN23	4	618890	618890[NEURODEVELOPMENTAL DISORDER AND STRUCTURAL BRAIN ANOMALIES WITH OR WITHOUT SEIZURES AND SPASTICITY; NEDBASS]
FBgn0086347	Myo31DF	HGNC:13880	OMIM:600642	MYO1G	12		
FBgn0086347	Myo31DF	HGNC:7595	OMIM:601478	MYO1A	4		
FBgn0086347	Myo31DF	HGNC:13879	OMIM:614636	MYO1H	3	619482	619482[CENTRAL HYPOVENTILATION SYNDROME, CONGENITAL, 2, AND AUTONOMIC DYSFUNCTION; CCHS2]
FBgn0086347	Myo31DF	HGNC:7597	OMIM:606538	MYO1C	4		
FBgn0086347	Myo31DF	HGNC:7598	OMIM:606539	MYO1D	14		
FBgn0086347	Myo31DF	HGNC:7596	OMIM:606537	MYO1B	4		
FBgn0086347	Myo31DF	HGNC:7600	OMIM:601480	MYO1F	4		
FBgn0086347	Myo31DF	HGNC:7599	OMIM:601479	MYO1E	4	614131	614131[FOCAL SEGMENTAL GLOMERULOSCLEROSIS 6; FSGS6]
FBgn0086348	se	HGNC:13312	OMIM:605482	GSTO1	14		
FBgn0086348	se	HGNC:23064	OMIM:612314	GSTO2	12		
FBgn0086355	Tpi	HGNC:12009	OMIM:190450	TPI1	13	615512	615512[TRIOSEPHOSPHATE ISOMERASE DEFICIENCY; TPID]
FBgn0086356	tum	HGNC:9804	OMIM:604980	RACGAP1	14	619789	619789[ANEMIA, CONGENITAL DYSERYTHROPOIETIC, TYPE IIIb, AUTOSOMAL RECESSIVE; CDAN3B]
FBgn0086357	Sec61alpha	HGNC:18276	OMIM:609213	SEC61A1	13	617056	617056[TUBULOINTERSTITIAL KIDNEY DISEASE, AUTOSOMAL DOMINANT, 5; ADTKD5]
FBgn0086357	Sec61alpha	HGNC:17702	OMIM:618271	SEC61A2	15		
FBgn0086358	Tab2	HGNC:17075	OMIM:605101	TAB2	4	614980	614980[CONGENITAL HEART DEFECTS, MULTIPLE TYPES, 2; CHTD2]
FBgn0086358	Tab2	HGNC:30681	OMIM:300480	TAB3	4		
FBgn0086359	Invadolysin	HGNC:15991	OMIM:609380	LMLN	15		
FBgn0086361	alph	HGNC:19388	OMIM:619309	PPM1F	3		
FBgn0086361	alph	HGNC:9278	OMIM:605119	PPM1G	3		
FBgn0086361	alph	HGNC:9275	OMIM:606108	PPM1A	13		
FBgn0086361	alph	HGNC:9276	OMIM:603770	PPM1B	12		
FBgn0086361	alph	HGNC:26845		PPM1N	7		
FBgn0086365	Orct2	HGNC:25417	OMIM:611699	SVOP	3		
FBgn0086365	Orct2	HGNC:8494	OMIM:604047	SLC22A13	7		
FBgn0086365	Orct2	HGNC:10970	OMIM:607582	SLC22A6	6		
FBgn0086365	Orct2	HGNC:20302	OMIM:608276	SLC22A16	7		
FBgn0086365	Orct2	HGNC:10968	OMIM:604190	SLC22A4	7	180300	180300[RHEUMATOID ARTHRITIS; RA]
FBgn0086365	Orct2	HGNC:10969	OMIM:603377	SLC22A5	7	212140	212140[CARNITINE DEFICIENCY, SYSTEMIC PRIMARY; CDSP]
FBgn0086365	Orct2	HGNC:8495	OMIM:604048	SLC22A14	4		
FBgn0086365	Orct2	HGNC:10971	OMIM:604995	SLC22A7	4		
FBgn0086365	Orct2	HGNC:10972	OMIM:607581	SLC22A8	5		
FBgn0086365	Orct2	HGNC:10966	OMIM:602608	SLC22A2	5		
FBgn0086365	Orct2	HGNC:21106	OMIM:611697	SLC22A23	3		
FBgn0086365	Orct2	HGNC:32935	OMIM:610792	SLC22A25	4		
FBgn0086365	Orct2	HGNC:10963	OMIM:602607	SLC22A1	5		
FBgn0086365	Orct2	HGNC:10967	OMIM:604842	SLC22A3	5		
FBgn0086365	Orct2	HGNC:23095	OMIM:611461	SLC22A17	3		
FBgn0086365	Orct2	HGNC:20301	OMIM:608275	SLC22A15	4		
FBgn0086365	Orct2	HGNC:17989	OMIM:607096	SLC22A12	6	220150	220150[HYPOURICEMIA, RENAL, 1; RHUC1]
FBgn0086365	Orct2	HGNC:27091		SLC22A31	3		
FBgn0086365	Orct2	HGNC:18120	OMIM:607097	SLC22A11	6		
FBgn0086365	Orct2	HGNC:16261	OMIM:607579	SLC22A9	4		
FBgn0086365	Orct2	HGNC:28542	OMIM:611698	SLC22A24	3		
FBgn0086365	Orct2	HGNC:18057	OMIM:607580	SLC22A10	4		
FBgn0086368	tw	HGNC:9202	OMIM:607423	POMT1	3	236670,609308,613155	236670[MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 1; MDDGA1],609308[MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (LIMB-GIRDLE), TYPE C, 1; MDDGC1],613155[MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH IMPAIRED INTELLECTUAL IMPAIRMENT), TYPE B, 1; MDDGB1]
FBgn0086368	tw	HGNC:19743	OMIM:607439	POMT2	14	613150,613156,613158	613150[MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 2; MDDGA2],613156[MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH IMPAIRED INTELLECTUAL DEVELOPMENT), TYPE B, 2; MDDGB2],613158[MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (LIMB-GIRDLE), TYPE C, 2; MDDGC2]
FBgn0086370	sra	HGNC:3042	OMIM:605860	RCAN3	11		
FBgn0086370	sra	HGNC:3041	OMIM:604876	RCAN2	14		
FBgn0086370	sra	HGNC:3040	OMIM:602917	RCAN1	12		
FBgn0086371	poly	HGNC:25976	OMIM:615020	ELP6	5		
FBgn0086372	lap	HGNC:15514	OMIM:603025	PICALM	14	601626	601626[LEUKEMIA, ACUTE MYELOID; AML]
FBgn0086372	lap	HGNC:14986	OMIM:607923	SNAP91	12		
FBgn0086378	Alg-2	HGNC:8765	OMIM:601057	PDCD6	12		
FBgn0086378	Alg-2	HGNC:30009	OMIM:610033	PEF1	3		
FBgn0086378	Alg-2	HGNC:11292	OMIM:182520	SRI	3		
FBgn0086378	Alg-2	HGNC:15990	OMIM:607030	GCA	3		
FBgn0086384	Mer	HGNC:7773	OMIM:607379	NF2	14	101000,162091,607174	101000[NEUROFIBROMATOSIS, TYPE II; NF2],162091[SCHWANNOMATOSIS 1; SWNTS1],607174[MENINGIOMA, FAMILIAL, SUSCEPTIBILITY TO]
FBgn0086442	mib2	HGNC:21086	OMIM:608677	MIB1	5	615092	615092[LEFT VENTRICULAR NONCOMPACTION 7; LVNC7]
FBgn0086442	mib2	HGNC:30577	OMIM:611141	MIB2	14		
FBgn0086443	AsnRS	HGNC:7643	OMIM:108410	NARS	15	619091,619092	619091[NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, IMPAIRED LANGUAGE, AND GAIT ABNORMALITIES; NEDMILG],619092[NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, IMPAIRED LANGUAGE, EPILEPSY, AND GAIT ABNORMALITIES; NEDMILEG]
FBgn0086443	AsnRS	HGNC:26274	OMIM:612803	NARS2	3	616239,618434	616239[COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 24; COXPD24],618434[DEAFNESS, AUTOSOMAL RECESSIVE 94; DFNB94]
FBgn0086444	l(2)37Cb	HGNC:17211	OMIM:605584	DHX38	4	618220	618220[RETINITIS PIGMENTOSA 84; RP84]
FBgn0086444	l(2)37Cb	HGNC:2738	OMIM:603403	DHX15	4		
FBgn0086444	l(2)37Cb	HGNC:2739	OMIM:603405	DHX16	14	618733	618733[NEUROMUSCULAR OCULOAUDITORY SYNDROME; NMOAS]
FBgn0086444	l(2)37Cb	HGNC:15861		DHX35	3		
FBgn0086444	l(2)37Cb	HGNC:16718	OMIM:614405	DHX33	3		
FBgn0086444	l(2)37Cb	HGNC:2749	OMIM:600396	DHX8	4		
FBgn0086444	l(2)37Cb	HGNC:18018	OMIM:607570	DHX40	3		
FBgn0086444	l(2)37Cb	HGNC:16717	OMIM:607960	DHX32	3		
FBgn0086444	l(2)37Cb	HGNC:20410		DQX1	3		
FBgn0086445	l(2)37Cd	HGNC:4668	OMIM:604890	GTF3C5	13		
FBgn0086446	DCTN6-p27	HGNC:16964	OMIM:612963	DCTN6	14		
FBgn0086447	Polr1D	HGNC:20422	OMIM:613715	POLR1D	15	613717	613717[TREACHER COLLINS SYNDROME 2; TCS2]
FBgn0086448	PIG-Q	HGNC:14135	OMIM:605754	PIGQ	8	618548	618548[MULTIPLE CONGENITAL ANOMALIES-HYPOTONIA-SEIZURES SYNDROME 4; MCAHS4]
FBgn0086450	su(r)	HGNC:3012	OMIM:612779	DPYD	15	274270	274270[DIHYDROPYRIMIDINE DEHYDROGENASE DEFICIENCY]
FBgn0086451	l(2)k09022	HGNC:25517		HEATR1	14		
FBgn0086472	RpS25	HGNC:10413	OMIM:180465	RPS25	14		
FBgn0086532	Spt-I	HGNC:11277	OMIM:605712	SPTLC1	15	162400	162400[NEUROPATHY, HEREDITARY SENSORY AND AUTONOMIC, TYPE IA; HSAN1A]
FBgn0086558	Ubi-p5E	HGNC:12468	OMIM:191340	UBC	5		
FBgn0086558	Ubi-p5E	HGNC:12463	OMIM:191339	UBB	4		
FBgn0086605	CG9853	HGNC:21690	OMIM:612056	GET4	13		
FBgn0086613	Ino80	HGNC:26956	OMIM:610169	INO80	14		
FBgn0086655	jing	HGNC:24051	OMIM:617934	AEBP2	6		
FBgn0086656	shrb	HGNC:30599	OMIM:610899	CHMP4C	8		
FBgn0086656	shrb	HGNC:20274	OMIM:610051	CHMP4A	11		
FBgn0086656	shrb	HGNC:16171	OMIM:610897	CHMP4B	14	605387	605387[CATARACT 31, MULTIPLE TYPES; CTRCT31]
FBgn0086657	IKKepsilon	HGNC:11584	OMIM:604834	TBK1	13	616439,617900	616439[FRONTOTEMPORAL DEMENTIA AND/OR AMYOTROPHIC LATERAL SCLEROSIS 4; FTDALS4],617900[ENCEPHALOPATHY, ACUTE, INFECTION-INDUCED (HERPES-SPECIFIC), SUSCEPTIBILITY TO, 8; IIAE8]
FBgn0086657	IKKepsilon	HGNC:14552	OMIM:605048	IKBKE	10		
FBgn0086674	Tpst	HGNC:12020	OMIM:603125	TPST1	12		
FBgn0086674	Tpst	HGNC:12021	OMIM:603126	TPST2	12		
FBgn0086675	fne	HGNC:3313	OMIM:601673	ELAVL2	14		
FBgn0086675	fne	HGNC:3312	OMIM:603466	ELAVL1	10		
FBgn0086675	fne	HGNC:3314	OMIM:603458	ELAVL3	10		
FBgn0086675	fne	HGNC:3315	OMIM:168360	ELAVL4	13		
FBgn0086676	spin	HGNC:28433	OMIM:611701	SPNS3	9		
FBgn0086676	spin	HGNC:26992	OMIM:612584	SPNS2	9	618457	618457[DEAFNESS, AUTOSOMAL RECESSIVE 115; DFNB115]
FBgn0086676	spin	HGNC:30621	OMIM:612583	SPNS1	13		
FBgn0086679	p	HGNC:17022	OMIM:607521	HPS5	9	614074	614074[HERMANSKY-PUDLAK SYNDROME 5; HPS5]
FBgn0086680	vvl	HGNC:9217	OMIM:300039	POU3F4	11	304400	304400[DEAFNESS, X-LINKED 2; DFNX2]
FBgn0086680	vvl	HGNC:9219	OMIM:113725	POU4F2	3		
FBgn0086680	vvl	HGNC:9214	OMIM:602479	POU3F1	8		
FBgn0086680	vvl	HGNC:9221	OMIM:164177	POU5F1	3		
FBgn0086680	vvl	HGNC:9216	OMIM:602480	POU3F3	11	618604	618604[SNIJDERS BLOK-FISHER SYNDROME; SNIBFIS]
FBgn0086680	vvl	HGNC:9210	OMIM:173110	POU1F1	3	613038	613038[PITUITARY HORMONE DEFICIENCY, COMBINED OR ISOLATED, 1; CPHD1]
FBgn0086680	vvl	HGNC:9223	OMIM:615739	POU5F1B	3		
FBgn0086680	vvl	HGNC:9215	OMIM:600494	POU3F2	11		
FBgn0086680	vvl	HGNC:9220	OMIM:602460	POU4F3	3	602459	602459[DEAFNESS, AUTOSOMAL DOMINANT 15; DFNA15]
FBgn0086680	vvl	HGNC:9218	OMIM:601632	POU4F1	3	619352	619352[ATAXIA, INTENTION TREMOR, AND HYPOTONIA SYNDROME, CHILDHOOD-ONSET; ATITHS]
FBgn0086680	vvl	HGNC:26367		POU5F2	3		
FBgn0086683	Spf45	HGNC:16944	OMIM:606935	RBM17	14		
FBgn0086686	l(3)L1231	HGNC:25997	OMIM:619207	INO80D	6		
FBgn0086687	Desat1	HGNC:21088	OMIM:608370	SCD5	14	619086	619086[DEAFNESS, AUTOSOMAL DOMINANT 79; DFNA79]
FBgn0086687	Desat1	HGNC:10571	OMIM:604031	SCD	12		
FBgn0086690	Plp	HGNC:379	OMIM:604001	AKAP9	5	611820	611820[LONG QT SYNDROME 11; LQT11]
FBgn0086690	Plp	HGNC:16068	OMIM:605925	PCNT	6	210720	210720[MICROCEPHALIC OSTEODYSPLASTIC PRIMORDIAL DWARFISM, TYPE II; MOPD2]
FBgn0086691	UK114	HGNC:16897	OMIM:602487	RIDA	15		
FBgn0086693	iav	HGNC:14006	OMIM:606680	TRPV6	9	618188	618188[HYPERPARATHYROIDISM, TRANSIENT NEONATAL; HRPTTN]
FBgn0086693	iav	HGNC:12716	OMIM:602076	TRPV1	5		
FBgn0086693	iav	HGNC:18082	OMIM:606676	TRPV2	4		
FBgn0086693	iav	HGNC:3145	OMIM:606679	TRPV5	8		
FBgn0086693	iav	HGNC:18083	OMIM:605427	TRPV4	5	113500,156530,168400,181405,184095,184252,600175,606071,606835,613508,617383	113500[BRACHYOLMIA TYPE 3; BCYM3],156530[METATROPIC DYSPLASIA; MTD],168400[PARASTREMMATIC DWARFISM],181405[SCAPULOPERONEAL SPINAL MUSCULAR ATROPHY; SPSMA],184095[SPONDYLOEPIPHYSEAL DYSPLASIA, MAROTEAUX TYPE],184252[SPONDYLOMETAPHYSEAL DYSPLASIA, KOZLOWSKI TYPE; SMDK],600175[NEURONOPATHY, DISTAL HEREDITARY MOTOR, TYPE VIII; HMN8],606071[HEREDITARY MOTOR AND SENSORY NEUROPATHY, TYPE IIC; HMSN2C],606835[DIGITAL ARTHROPATHY-BRACHYDACTYLY, FAMILIAL; FDAB],613508[SODIUM SERUM LEVEL QUANTITATIVE TRAIT LOCUS 1; SSQTL1],617383[AVASCULAR NECROSIS OF FEMORAL HEAD, PRIMARY, 2; ANFH2]
FBgn0086693	iav	HGNC:18084	OMIM:607066	TRPV3	5	614594,616400	614594[OLMSTED SYNDROME 1; OLMS1],616400[PALMOPLANTAR KERATODERMA, NONEPIDERMOLYTIC, FOCAL 2; FNEPPK2]
FBgn0086694	Bre1	HGNC:16867	OMIM:607700	RNF40	15		
FBgn0086694	Bre1	HGNC:10062	OMIM:607699	RNF20	12		
FBgn0086695	hd	HGNC:2993	OMIM:611428	DONSON	11	251230,617604	251230[MICROCEPHALY-MICROMELIA SYNDROME; MIMIS],617604[MICROCEPHALY, SHORT STATURE, AND LIMB ABNORMALITIES; MISSLA]
FBgn0086698	frtz	HGNC:28027	OMIM:613580	WDPCP	13	217085,615992	217085[CONGENITAL HEART DEFECTS, HAMARTOMAS OF TONGUE, AND POLYSYNDACTYLY; CHDTHP],615992[BARDET-BIEDL SYNDROME 15; BBS15]
FBgn0086704	stops	HGNC:19769	OMIM:619936	ASB17	4		
FBgn0086706	pix	HGNC:69	OMIM:601213	ABCE1	15		
FBgn0086707	ncm	HGNC:29322	OMIM:615186	CWC22	11		
FBgn0086708	stv	HGNC:941	OMIM:603885	BAG5	3	619747	619747[CARDIOMYOPATHY, DILATED, 2F; CMD2F]
FBgn0086708	stv	HGNC:940	OMIM:603884	BAG4	6		
FBgn0086708	stv	HGNC:939	OMIM:603883	BAG3	9	612954,613881	612954[MYOPATHY, MYOFIBRILLAR, 6; MFM6],613881[CARDIOMYOPATHY, DILATED, 1HH; CMD1HH]
FBgn0086710	RpL30	HGNC:10333	OMIM:180467	RPL30	11		
FBgn0086711	mol	HGNC:26507	OMIM:612771	DUOXA1	13		
FBgn0086711	mol	HGNC:32698	OMIM:612772	DUOXA2	12	274900	274900[THYROID DYSHORMONOGENESIS 5; TDH5]
FBgn0086712	Egm	HGNC:21497	OMIM:611103	ACAD9	3	611126	611126[MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 20; MC1DN20]
FBgn0086757	cbs	HGNC:4424	OMIM:602502	GOLGA1	12		
FBgn0086768	Pcmt	HGNC:8728	OMIM:176851	PCMT1	15		
FBgn0086778	nAChRalpha7	HGNC:15781	OMIM:609756	CHRFAM7A	12		
FBgn0086778	nAChRalpha7	HGNC:1960	OMIM:118511	CHRNA7	8		
FBgn0086779	step	HGNC:9501	OMIM:182115	CYTH1	11		
FBgn0086779	step	HGNC:9502	OMIM:602488	CYTH2	8		
FBgn0086779	step	HGNC:9504	OMIM:605081	CYTH3	10		
FBgn0086779	step	HGNC:9505	OMIM:606514	CYTH4	7		
FBgn0086784	stmA	HGNC:28970	OMIM:611798	EFR3A	12		
FBgn0086784	stmA	HGNC:29155	OMIM:616797	EFR3B	13		
FBgn0086785	Vps36	HGNC:20312	OMIM:610903	VPS36	14		
FBgn0086895	pea	HGNC:17211	OMIM:605584	DHX38	4	618220	618220[RETINITIS PIGMENTOSA 84; RP84]
FBgn0086895	pea	HGNC:2738	OMIM:603403	DHX15	4		
FBgn0086895	pea	HGNC:2739	OMIM:603405	DHX16	4	618733	618733[NEUROMUSCULAR OCULOAUDITORY SYNDROME; NMOAS]
FBgn0086895	pea	HGNC:15861		DHX35	3		
FBgn0086895	pea	HGNC:16718	OMIM:614405	DHX33	3		
FBgn0086895	pea	HGNC:2749	OMIM:600396	DHX8	14		
FBgn0086895	pea	HGNC:18018	OMIM:607570	DHX40	3		
FBgn0086895	pea	HGNC:16717	OMIM:607960	DHX32	3		
FBgn0086895	pea	HGNC:20410		DQX1	3		
FBgn0086898	dgo	HGNC:17280	OMIM:610583	ANKRD6	6		
FBgn0086904	Nacalpha	HGNC:23290	OMIM:609274	NACA2	9		
FBgn0086904	Nacalpha	HGNC:22196	OMIM:619419	NACAD	7		
FBgn0086904	Nacalpha	HGNC:7629	OMIM:601234	NACA	11		
FBgn0086904	Nacalpha	HGNC:24688		NACA4P	4		
FBgn0086906	sls	HGNC:15719	OMIM:608616	OBSCN	3		
FBgn0086906	sls	HGNC:19194	OMIM:608548	HMCN1	3	603075	603075[MACULAR DEGENERATION, AGE-RELATED, 1; ARMD1]
FBgn0086907	Cyt-c-d	HGNC:19986	OMIM:123970	CYCS	8	612004	612004[THROMBOCYTOPENIA 4; THC4]
FBgn0086908	egg	HGNC:10761	OMIM:604396	SETDB1	12		
FBgn0086908	egg	HGNC:20263	OMIM:607865	SETDB2	7		
FBgn0086909	CG31751	HGNC:34403	OMIM:614681	HYKK	13		
FBgn0086913	Rab26	HGNC:30268	OMIM:609956	RAB37	10		
FBgn0086913	Rab26	HGNC:14259	OMIM:605455	RAB26	10		
FBgn0086916	snky	HGNC:26539	OMIM:619860	DCST1	13		
FBgn0086916	snky	HGNC:26562	OMIM:619861	DCST2	3		
FBgn0087002	apolpp	HGNC:603	OMIM:107730	APOB	4	144010,615558	144010[HYPERCHOLESTEROLEMIA, FAMILIAL, 2; FHCL2],615558[HYPOBETALIPOPROTEINEMIA, FAMILIAL, 1; FHBL1]
FBgn0087002	apolpp	HGNC:0		LOC400499	4		
FBgn0087005	rtp	HGNC:24001	OMIM:617736	MORN4	13		
FBgn0087007	bbg	HGNC:5980	OMIM:603035	IL16	3		
FBgn0087008	e(y)3	HGNC:18250	OMIM:613069	PHF10	9		
FBgn0087011	CG41520	HGNC:3696	OMIM:605351	FGL2	3		
FBgn0087011	CG41520	HGNC:485	OMIM:601922	ANGPT2	5	619369	619369[LYMPHATIC MALFORMATION 10; LMPHM10]
FBgn0087011	CG41520	HGNC:3624	OMIM:601624	FCN2	3		
FBgn0087011	CG41520	HGNC:484	OMIM:601667	ANGPT1	6	619361	619361[ANGIOEDEMA, HEREDITARY, 5; HAE5]
FBgn0087011	CG41520	HGNC:24078	OMIM:618517	ANGPTL7	3		
FBgn0087011	CG41520	HGNC:487	OMIM:603705	ANGPT4	5		
FBgn0087011	CG41520	HGNC:3623	OMIM:601252	FCN1	3		
FBgn0087011	CG41520	HGNC:3695	OMIM:605776	FGL1	4		
FBgn0087011	CG41520	HGNC:3625	OMIM:604973	FCN3	4	613860	613860[FICOLIN 3 DEFICIENCY]
FBgn0087011	CG41520	HGNC:23140	OMIM:609336	ANGPTL6	3		
FBgn0087011	CG41520	HGNC:7035	OMIM:600596	MFAP4	3		
FBgn0087011	CG41520	HGNC:16039	OMIM:605910	ANGPTL4	3	615881	615881[PLASMA TRIGLYCERIDE LEVEL QUANTITATIVE TRAIT LOCUS; TGQTL]
FBgn0087011	CG41520	HGNC:491	OMIM:604774	ANGPTL3	3	605019	605019[HYPOBETALIPOPROTEINEMIA, FAMILIAL, 2; FHBL2]
FBgn0087012	5-HT2A	HGNC:5294	OMIM:601122	HTR2B	7		
FBgn0087012	5-HT2A	HGNC:5295	OMIM:312861	HTR2C	10		
FBgn0087012	5-HT2A	HGNC:5293	OMIM:182135	HTR2A	7	103780,164230,181500,606788,608516	103780[ALCOHOL DEPENDENCE],164230[OBSESSIVE-COMPULSIVE DISORDER; OCD],181500[SCHIZOPHRENIA; SCZD],606788[ANOREXIA NERVOSA, SUSCEPTIBILITY TO; ANON],608516[MAJOR DEPRESSIVE DISORDER; MDD]
FBgn0087013	Karybeta3	HGNC:9851		RANBP6	12		
FBgn0087013	Karybeta3	HGNC:6402	OMIM:602008	IPO5	14		
FBgn0087039	Sbp2	HGNC:30972	OMIM:607693	SECISBP2	8	609698	609698[THYROID HORMONE METABOLISM, ABNORMAL, 1; THMA1]
FBgn0087039	Sbp2	HGNC:28997	OMIM:615756	SECISBP2L	7		
FBgn0087040	alphaTub67C	HGNC:12408	OMIM:602528	TUBA3C	4		
FBgn0087040	alphaTub67C	HGNC:24071	OMIM:617878	TUBA3D	4	617928	617928[KERATOCONUS 9; KTCN9]
FBgn0087040	alphaTub67C	HGNC:20768		TUBA1C	4		
FBgn0087040	alphaTub67C	HGNC:20765	OMIM:619918	TUBA3E	3		
FBgn0087040	alphaTub67C	HGNC:12407	OMIM:191110	TUBA4A	5	616208	616208[AMYOTROPHIC LATERAL SCLEROSIS 22 WITH OR WITHOUT FRONTOTEMPORAL DEMENTIA; ALS22]
FBgn0087040	alphaTub67C	HGNC:18809	OMIM:602530	TUBA1B	4		
FBgn0087040	alphaTub67C	HGNC:20766	OMIM:602529	TUBA1A	4	611603	611603[LISSENCEPHALY 3; LIS3]
FBgn0087040	alphaTub67C	HGNC:12410	OMIM:605742	TUBA8	4	619840	619840[MACROTHROMBOCYTOPENIA, ISOLATED, 2, AUTOSOMAL DOMINANT; MACTHC2]
FBgn0087040	alphaTub67C	HGNC:23534		TUBAL3	6		
FBgn0243511	psidin	HGNC:25783	OMIM:612755	NAA25	15		
FBgn0243512	puc	HGNC:30580	OMIM:606779	SSH2	3		
FBgn0243512	puc	HGNC:30581	OMIM:606780	SSH3	3		
FBgn0243512	puc	HGNC:17007	OMIM:606618	DUSP14	3		
FBgn0243512	puc	HGNC:3065	OMIM:608867	DUSP10	8		
FBgn0243512	puc	HGNC:3064	OMIM:600714	DUSP1	3		
FBgn0243512	puc	HGNC:3070	OMIM:602747	DUSP4	3		
FBgn0243512	puc	HGNC:3074	OMIM:602038	DUSP8	4		
FBgn0243512	puc	HGNC:17909	OMIM:607175	DUSP16	4		
FBgn0243512	puc	HGNC:18484	OMIM:611446	DUSP18	3		
FBgn0243512	puc	HGNC:33237		DUSP28	3		
FBgn0243513	cnir	HGNC:25013	OMIM:617483	CNIH4	14		
FBgn0243513	cnir	HGNC:19431	OMIM:611287	CNIH1	5		
FBgn0243513	cnir	HGNC:26802		CNIH3	3		
FBgn0243513	cnir	HGNC:28744	OMIM:611288	CNIH2	3		
FBgn0243516	Vrp1	HGNC:12736	OMIM:602357	WIPF1	5	614493	614493[WISKOTT-ALDRICH SYNDROME 2; WAS2]
FBgn0243516	Vrp1	HGNC:30923	OMIM:609692	WIPF2	4		
FBgn0250746	Prosbeta7	HGNC:9541	OMIM:602177	PSMB4	15	617591	617591[PROTEASOME-ASSOCIATED AUTOINFLAMMATORY SYNDROME 3; PRAAS3]
FBgn0250753	kra	HGNC:18380	OMIM:619252	BZW1	14		
FBgn0250753	kra	HGNC:18808	OMIM:619275	BZW2	12		
FBgn0250755	CG42233	HGNC:20224	OMIM:603812	DCAF5	10		
FBgn0250757	kumpel	HGNC:11041	OMIM:604024	SLC5A6	4	618973,619903	618973[SODIUM-DEPENDENT MULTIVITAMIN TRANSPORTER DEFICIENCY; SMVTD],619903[PERIPHERAL MOTOR NEUROPATHY, CHILDHOOD-ONSET, BIOTIN-RESPONSIVE; COMNB]
FBgn0250757	kumpel	HGNC:11040	OMIM:601843	SLC5A5	6	274400	274400[THYROID DYSHORMONOGENESIS 1; TDH1]
FBgn0250757	kumpel	HGNC:28750	OMIM:612455	SLC5A12	6		
FBgn0250757	kumpel	HGNC:19119	OMIM:608044	SLC5A8	6		
FBgn0250757	kumpel	HGNC:11036	OMIM:182380	SLC5A1	3	606824	606824[GLUCOSE/GALACTOSE MALABSORPTION; GGM]
FBgn0250757	kumpel	HGNC:11037	OMIM:182381	SLC5A2	3	233100	233100[RENAL GLUCOSURIA; GLYS]
FBgn0250757	kumpel	HGNC:11038	OMIM:600444	SLC5A3	3		
FBgn0250757	kumpel	HGNC:11039	OMIM:618633	SLC5A4	3		
FBgn0250757	kumpel	HGNC:23091	OMIM:610238	SLC5A11	3		
FBgn0250757	kumpel	HGNC:23155	OMIM:618636	SLC5A10	3		
FBgn0250757	kumpel	HGNC:22146		SLC5A9	3		
FBgn0250785	vari	HGNC:7220	OMIM:600723	MPP2	10		
FBgn0250785	vari	HGNC:7219	OMIM:305360	MPP1	3		
FBgn0250785	vari	HGNC:18167	OMIM:606959	MPP6	13		
FBgn0250786	Chd1	HGNC:1915	OMIM:602118	CHD1	12	617682	617682[PILAROWSKI-BJORNSSON SYNDROME; PILBOS]
FBgn0250786	Chd1	HGNC:1917	OMIM:602119	CHD2	13	615369	615369[DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 94; DEE94]
FBgn0250788	beta-Spec	HGNC:11274	OMIM:182870	SPTB	11	616649,617948	616649[SPHEROCYTOSIS, TYPE 2; SPH2],617948[ELLIPTOCYTOSIS 3; EL3]
FBgn0250788	beta-Spec	HGNC:15680	OMIM:605916	SPTBN5	3		
FBgn0250788	beta-Spec	HGNC:14896	OMIM:606214	SPTBN4	8	617519	617519[NEURODEVELOPMENTAL DISORDER WITH HYPOTONIA, NEUROPATHY, AND DEAFNESS; NEDHND]
FBgn0250788	beta-Spec	HGNC:11276	OMIM:604985	SPTBN2	12	600224,615386	600224[SPINOCEREBELLAR ATAXIA 5; SCA5],615386[SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 14; SCAR14]
FBgn0250788	beta-Spec	HGNC:11275	OMIM:182790	SPTBN1	15	619475	619475[DEVELOPMENTAL DELAY, IMPAIRED SPEECH, AND BEHAVIORAL ABNORMALITIES; DDISBA]
FBgn0250789	alpha-Spec	HGNC:11272	OMIM:182860	SPTA1	8	130600,266140,270970	130600[ELLIPTOCYTOSIS 2; EL2],266140[PYROPOIKILOCYTOSIS, HEREDITARY; HPP],270970[SPHEROCYTOSIS, TYPE 3; SPH3]
FBgn0250789	alpha-Spec	HGNC:11273	OMIM:182810	SPTAN1	15	613477	613477[DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 5; DEE5]
FBgn0250791	alphaSnap	HGNC:7641	OMIM:603215	NAPA	14		
FBgn0250791	alphaSnap	HGNC:15751	OMIM:611270	NAPB	13		
FBgn0250814	UQCR-C2	HGNC:12586	OMIM:191329	UQCRC2	14	615160	615160[MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 5; MC3DN5]
FBgn0250816	AGO3	HGNC:17644	OMIM:610312	PIWIL2	10		
FBgn0250816	AGO3	HGNC:9007	OMIM:605571	PIWIL1	9		
FBgn0250816	AGO3	HGNC:18443	OMIM:610314	PIWIL3	6		
FBgn0250816	AGO3	HGNC:18444	OMIM:610315	PIWIL4	5		
FBgn0250819	CG33521	HGNC:24636	OMIM:608364	LIMA1	3	618079	618079[LOW DENSITY LIPOPROTEIN CHOLESTEROL LEVEL QUANTITATIVE TRAIT LOCUS 8; LDLCQ8]
FBgn0250819	CG33521	HGNC:28142		LIMD2	3		
FBgn0250820	meigo	HGNC:16872	OMIM:610788	SLC35B2	3		
FBgn0250820	meigo	HGNC:20798	OMIM:610790	SLC35B1	15		
FBgn0250821	CG14644	HGNC:13394	OMIM:604766	NPHS2	4	600995	600995[NEPHROTIC SYNDROME, TYPE 2; NPHS2]
FBgn0250821	CG14644	HGNC:3383	OMIM:133090	STOM	4		
FBgn0250821	CG14644	HGNC:19420	OMIM:608327	STOML3	4		
FBgn0250823	gish	HGNC:2456	OMIM:604253	CSNK1G3	13		
FBgn0250823	gish	HGNC:2454	OMIM:606274	CSNK1G1	12		
FBgn0250823	gish	HGNC:2455	OMIM:602214	CSNK1G2	14		
FBgn0250830	CG12547	HGNC:24731	OMIM:618277	NHLRC2	14	618278	618278[FIBROSIS, NEURODEGENERATION, AND CEREBRAL ANGIOMATOSIS; FINCA]
FBgn0250836	Acbp3	HGNC:17715		ACBD7	6		
FBgn0250836	Acbp3	HGNC:2690	OMIM:125950	DBI	4		
FBgn0250837	dUTPase	HGNC:3078	OMIM:601266	DUT	13		
FBgn0250842	CG17575	HGNC:8946	OMIM:607076	PI15	4		
FBgn0250842	CG17575	HGNC:16249		R3HDML	4		
FBgn0250842	CG17575	HGNC:21245		PI16	3		
FBgn0250842	CG17575	HGNC:28392	OMIM:610395	GLIPR1L1	5		
FBgn0250842	CG17575	HGNC:25248	OMIM:612434	CRISPLD2	3		
FBgn0250842	CG17575	HGNC:16904	OMIM:618062	CRISP3	3		
FBgn0250842	CG17575	HGNC:304	OMIM:601193	CRISP1	3		
FBgn0250842	CG17575	HGNC:12024	OMIM:187430	CRISP2	3		
FBgn0250842	CG17575	HGNC:33849	OMIM:616572	CLEC18B	4		
FBgn0250842	CG17575	HGNC:30388	OMIM:616571	CLEC18A	3		
FBgn0250843	Prosalpha6	HGNC:9530	OMIM:602854	PSMA1	13		
FBgn0250847	CG14034	HGNC:9155	OMIM:246600	PNLIP	3	614338	614338[PANCREATIC LIPASE DEFICIENCY; PNLIPD]
FBgn0250847	CG14034	HGNC:9156	OMIM:604422	PNLIPRP1	3		
FBgn0250847	CG14034	HGNC:23492		PNLIPRP3	3		
FBgn0250847	CG14034	HGNC:18821	OMIM:609252	LIPI	3		
FBgn0250848	26-29-p	HGNC:2538	OMIM:603308	CTSV	3		
FBgn0250848	26-29-p	HGNC:2537	OMIM:116880	CTSL	3		
FBgn0250848	26-29-p	HGNC:2531	OMIM:603539	CTSF	3	615362	615362[CEROID LIPOFUSCINOSIS, NEURONAL, 13 (KUFS TYPE); CLN13]
FBgn0250850	rig	HGNC:20043	OMIM:607005	GEMIN5	6	619333	619333[NEURODEVELOPMENTAL DISORDER WITH CEREBELLAR ATROPHY AND MOTOR DYSFUNCTION; NEDCAM]
FBgn0250851	CG33981	HGNC:24540	OMIM:614484	ANAPC13	10		
FBgn0250862	CG42237	HGNC:17934	OMIM:611651	PLA2G3	4		
FBgn0250874	ttm50	HGNC:23656	OMIM:607381	TIMM50	14	617698	617698[3-METHYLGLUTACONIC ACIDURIA, TYPE IX; MGCA9]
FBgn0250903	lmgA	HGNC:14452	OMIM:614534	ANAPC11	9		
FBgn0250906	Pgk	HGNC:8898	OMIM:172270	PGK2	12		
FBgn0250906	Pgk	HGNC:8896	OMIM:311800	PGK1	14	300653	300653[PHOSPHOGLYCERATE KINASE 1 DEFICIENCY]
FBgn0250907	Cht10	HGNC:8524	OMIM:603578	OVGP1	6		
FBgn0250907	Cht10	HGNC:1932	OMIM:601525	CHI3L1	7	181500,611960	181500[SCHIZOPHRENIA; SCZD],611960[ASTHMA-RELATED TRAITS, SUSCEPTIBILITY TO, 7; ASRT7]
FBgn0250907	Cht10	HGNC:2496	OMIM:600873	CTBS	3		
FBgn0250907	Cht10	HGNC:1936	OMIM:600031	CHIT1	6	614122	614122[CHITOTRIOSIDASE DEFICIENCY; CHITD]
FBgn0250907	Cht10	HGNC:17432	OMIM:606080	CHIA	7		
FBgn0250907	Cht10	HGNC:1933	OMIM:601526	CHI3L2	6		
FBgn0250910	Octbeta3R	HGNC:5299	OMIM:602164	HTR4	5		
FBgn0250910	Octbeta3R	HGNC:285	OMIM:109630	ADRB1	3	607276,618591	607276[RESTING HEART RATE, VARIATION IN],618591[SHORT SLEEP, FAMILIAL NATURAL, 2; FNSS2]
FBgn0250910	Octbeta3R	HGNC:286	OMIM:109690	ADRB2	3	600807,601665	600807[ASTHMA, SUSCEPTIBILITY TO],601665[OBESITY]
FBgn0250910	Octbeta3R	HGNC:288	OMIM:109691	ADRB3	3	601665	601665[OBESITY]
FBgn0250911	CG42245	HGNC:29198		KIAA1143	11		
FBgn0259099	DCX-EMAP	HGNC:3330	OMIM:602033	EML1	10	600348	600348[BAND HETEROTOPIA; BH]
FBgn0259099	DCX-EMAP	HGNC:26666	OMIM:618118	EML3	9		
FBgn0259099	DCX-EMAP	HGNC:1316	OMIM:607442	EML4	10		
FBgn0259099	DCX-EMAP	HGNC:18035	OMIM:617494	EML2	10		
FBgn0259101	CG42249	HGNC:8021	OMIM:129190	NT5E	8	211800	211800[CALCIFICATION OF JOINTS AND ARTERIES; CALJA]
FBgn0259108	futsch	HGNC:15715	OMIM:607573	MAP1S	6		
FBgn0259108	futsch	HGNC:6836	OMIM:157129	MAP1B	8	618918,619808	618918[PERIVENTRICULAR NODULAR HETEROTOPIA 9; PVNH9],619808[DEAFNESS, AUTOSOMAL DOMINANT 83; DFNA83]
FBgn0259108	futsch	HGNC:6835	OMIM:600178	MAP1A	8		
FBgn0259110	mmd	HGNC:216	OMIM:602713	ADAM9	6	612775	612775[CONE-ROD DYSTROPHY 9; CORD9]
FBgn0259110	mmd	HGNC:190	OMIM:602714	ADAM12	5		
FBgn0259110	mmd	HGNC:15478	OMIM:607114	ADAM33	4		
FBgn0259110	mmd	HGNC:197	OMIM:603640	ADAM19	4		
FBgn0259110	mmd	HGNC:193	OMIM:605548	ADAM15	4		
FBgn0259110	mmd	HGNC:202	OMIM:603710	ADAM23	8		
FBgn0259110	mmd	HGNC:198	OMIM:601533	ADAM2	5		
FBgn0259110	mmd	HGNC:200	OMIM:603713	ADAM21	5		
FBgn0259110	mmd	HGNC:199	OMIM:603712	ADAM20	5		
FBgn0259110	mmd	HGNC:207	OMIM:604778	ADAM29	4		
FBgn0259110	mmd	HGNC:215	OMIM:602267	ADAM8	3		
FBgn0259110	mmd	HGNC:189	OMIM:155120	ADAM11	9		
FBgn0259110	mmd	HGNC:214	OMIM:607310	ADAM7	4		
FBgn0259110	mmd	HGNC:206	OMIM:606188	ADAM28	5		
FBgn0259110	mmd	HGNC:208	OMIM:604779	ADAM30	5		
FBgn0259110	mmd	HGNC:16299	OMIM:606393	ADAMDEC1	4		
FBgn0259110	mmd	HGNC:201	OMIM:603709	ADAM22	7	617933	617933[DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 61; DEE61]
FBgn0259110	mmd	HGNC:196	OMIM:619495	ADAM18	5		
FBgn0259110	mmd	HGNC:15479	OMIM:618602	ADAM32	5		
FBgn0259111	Ndae1	HGNC:11035	OMIM:610207	SLC4A9	6		
FBgn0259111	Ndae1	HGNC:11028	OMIM:109280	SLC4A2	6		
FBgn0259111	Ndae1	HGNC:18168	OMIM:606757	SLC4A5	7		
FBgn0259111	Ndae1	HGNC:11027	OMIM:109270	SLC4A1	6	110500,112010,112050,166900,179800,185020,601550,601551,611162,611590,612653	110500[BLOOD GROUP, DIEGO SYSTEM; DI],112010[BLOOD GROUP--WALDNER TYPE; WD],112050[BLOOD GROUP--WRIGHT ANTIGEN; WR],166900[OVALOCYTOSIS, SOUTHEAST ASIAN; SAO],179800[RENAL TUBULAR ACIDOSIS, DISTAL, 1; DRTA1],185020[CRYOHYDROCYTOSIS; CHC],601550[BLOOD GROUP--SWANN SYSTEM; SW],601551[BLOOD GROUP--FROESE],611162[MALARIA, SUSCEPTIBILITY TO],611590[RENAL TUBULAR ACIDOSIS, DISTAL, 4, WITH HEMOLYTIC ANEMIA; DRTA4],612653[SPHEROCYTOSIS, TYPE 4; SPH4]
FBgn0259111	Ndae1	HGNC:11034	OMIM:605024	SLC4A8	12		
FBgn0259111	Ndae1	HGNC:13811	OMIM:605556	SLC4A10	12		
FBgn0259111	Ndae1	HGNC:11030	OMIM:603345	SLC4A4	8	604278	604278[RENAL TUBULAR ACIDOSIS, PROXIMAL, WITH OCULAR ABNORMALITIES AND MENTAL RETARDATION]
FBgn0259111	Ndae1	HGNC:11029	OMIM:106195	SLC4A3	6		
FBgn0259111	Ndae1	HGNC:11033	OMIM:603353	SLC4A7	12		
FBgn0259111	Ndae1	HGNC:16438	OMIM:610206	SLC4A11	5	217400,217700,613268	217400[CORNEAL DYSTROPHY AND PERCEPTIVE DEAFNESS; CDPD],217700[CORNEAL ENDOTHELIAL DYSTROPHY; CHED],613268[CORNEAL DYSTROPHY, FUCHS ENDOTHELIAL, 4; FECD4]
FBgn0259113	PolA1	HGNC:9173	OMIM:312040	POLA1	15	301030,301220	301030[VAN ESCH-O&apos;DRISCOLL SYNDROME; VEODS],301220[PIGMENTARY DISORDER, RETICULATE, WITH SYSTEMIC MANIFESTATIONS, X-LINKED; PDR]
FBgn0259139	glo	HGNC:4610	OMIM:604851	GRSF1	7		
FBgn0259139	glo	HGNC:5039	OMIM:601037	HNRNPF	9		
FBgn0259139	glo	HGNC:5041	OMIM:601035	HNRNPH1	10		
FBgn0259139	glo	HGNC:5042	OMIM:300610	HNRNPH2	10	300986	300986[INTELLECTUAL DEVELOPMENTAL DISORDER, X-LINKED, SYNDROMIC, BAIN TYPE; MRXSB]
FBgn0259139	glo	HGNC:5043	OMIM:602324	HNRNPH3	7		
FBgn0259140	Cubn2	HGNC:2548	OMIM:602997	CUBN	9	261100,618884	261100[IMERSLUND-GRASBECK SYNDROME 1; IGS1],618884[PROTEINURIA, CHRONIC BENIGN; PROCHOB]
FBgn0259145	CG42260	HGNC:2152	OMIM:609472	CNGA4	3		
FBgn0259145	CG42260	HGNC:2150	OMIM:600053	CNGA3	3	216900	216900[ACHROMATOPSIA 2; ACHM2]
FBgn0259145	CG42260	HGNC:2149	OMIM:300338	CNGA2	4		
FBgn0259145	CG42260	HGNC:2148	OMIM:123825	CNGA1	3	613756	613756[RETINITIS PIGMENTOSA 49; RP49]
FBgn0259146	fid	HGNC:25189	OMIM:613306	ALKBH8	5	618504	618504[INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 71; MRT71]
FBgn0259146	fid	HGNC:26725	OMIM:615666	TRMT9B	7		
FBgn0259149	CG42264	HGNC:2300	OMIM:603101	CPB2	5		
FBgn0259149	CG42264	HGNC:21011	OMIM:609563	CPO	5		
FBgn0259149	CG42264	HGNC:2298	OMIM:114851	CPA3	4		
FBgn0259149	CG42264	HGNC:2297	OMIM:600688	CPA2	5		
FBgn0259149	CG42264	HGNC:15740	OMIM:607635	CPA4	5		
FBgn0259149	CG42264	HGNC:2299	OMIM:114852	CPB1	5		
FBgn0259149	CG42264	HGNC:2296	OMIM:114850	CPA1	5		
FBgn0259149	CG42264	HGNC:17245	OMIM:609562	CPA6	5	614417,614418	614417[EPILEPSY, FAMILIAL TEMPORAL LOBE, 5; ETL5],614418[FEBRILE SEIZURES, FAMILIAL, 11; FEB11]
FBgn0259149	CG42264	HGNC:15722	OMIM:609561	CPA5	5		
FBgn0259150	OtopLc	HGNC:19657	OMIM:607827	OTOP2	9		
FBgn0259150	OtopLc	HGNC:19656	OMIM:607806	OTOP1	7		
FBgn0259150	OtopLc	HGNC:19658	OMIM:607828	OTOP3	6		
FBgn0259152	Clbn	HGNC:10663	OMIM:608378	NEMF	13	619099	619099[INTELLECTUAL DEVELOPMENTAL DISORDER WITH SPEECH DELAY AND AXONAL PERIPHERAL NEUROPATHY; IDDSAPN]
FBgn0259162	RunxB	HGNC:10473	OMIM:600210	RUNX3	5		
FBgn0259162	RunxB	HGNC:10471	OMIM:151385	RUNX1	5	601399,601626	601399[PLATELET DISORDER, FAMILIAL, WITH ASSOCIATED MYELOID MALIGNANCY; FPDMM],601626[LEUKEMIA, ACUTE MYELOID; AML]
FBgn0259162	RunxB	HGNC:10472	OMIM:600211	RUNX2	5	119600,156510	119600[CLEIDOCRANIAL DYSPLASIA; CCD],156510[METAPHYSEAL DYSPLASIA WITH MAXILLARY HYPOPLASIA WITH OR WITHOUT BRACHYDACTYLY; MDMHB]
FBgn0259164	CG42269	HGNC:8494	OMIM:604047	SLC22A13	4		
FBgn0259164	CG42269	HGNC:10970	OMIM:607582	SLC22A6	4		
FBgn0259164	CG42269	HGNC:20302	OMIM:608276	SLC22A16	4		
FBgn0259164	CG42269	HGNC:10968	OMIM:604190	SLC22A4	4	180300	180300[RHEUMATOID ARTHRITIS; RA]
FBgn0259164	CG42269	HGNC:10969	OMIM:603377	SLC22A5	4	212140	212140[CARNITINE DEFICIENCY, SYSTEMIC PRIMARY; CDSP]
FBgn0259164	CG42269	HGNC:8495	OMIM:604048	SLC22A14	4		
FBgn0259164	CG42269	HGNC:10971	OMIM:604995	SLC22A7	5		
FBgn0259164	CG42269	HGNC:10972	OMIM:607581	SLC22A8	4		
FBgn0259164	CG42269	HGNC:10966	OMIM:602608	SLC22A2	4		
FBgn0259164	CG42269	HGNC:21106	OMIM:611697	SLC22A23	3		
FBgn0259164	CG42269	HGNC:32935	OMIM:610792	SLC22A25	4		
FBgn0259164	CG42269	HGNC:10963	OMIM:602607	SLC22A1	4		
FBgn0259164	CG42269	HGNC:10967	OMIM:604842	SLC22A3	4		
FBgn0259164	CG42269	HGNC:23095	OMIM:611461	SLC22A17	3		
FBgn0259164	CG42269	HGNC:20301	OMIM:608275	SLC22A15	3		
FBgn0259164	CG42269	HGNC:17989	OMIM:607096	SLC22A12	4	220150	220150[HYPOURICEMIA, RENAL, 1; RHUC1]
FBgn0259164	CG42269	HGNC:27091		SLC22A31	3		
FBgn0259164	CG42269	HGNC:18120	OMIM:607097	SLC22A11	4		
FBgn0259164	CG42269	HGNC:16261	OMIM:607579	SLC22A9	4		
FBgn0259164	CG42269	HGNC:28542	OMIM:611698	SLC22A24	4		
FBgn0259164	CG42269	HGNC:18057	OMIM:607580	SLC22A10	4		
FBgn0259166	CG42271	HGNC:6074	OMIM:600916	INPP4A	13		
FBgn0259166	CG42271	HGNC:6075	OMIM:607494	INPP4B	13		
FBgn0259168	mnb	HGNC:3094	OMIM:603497	DYRK3	4		
FBgn0259168	mnb	HGNC:3091	OMIM:600855	DYRK1A	10	614104	614104[INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL DOMINANT 7; MRD7]
FBgn0259168	mnb	HGNC:3095	OMIM:609181	DYRK4	3		
FBgn0259168	mnb	HGNC:3092	OMIM:604556	DYRK1B	9	615812	615812[ABDOMINAL OBESITY-METABOLIC SYNDROME 3; AOMS3]
FBgn0259168	mnb	HGNC:14402	OMIM:606868	HIPK2	3		
FBgn0259168	mnb	HGNC:3093	OMIM:603496	DYRK2	3		
FBgn0259168	mnb	HGNC:19006	OMIM:608003	HIPK1	3		
FBgn0259170	alpha-Man-Ia	HGNC:6822	OMIM:604345	MAN1A2	13		
FBgn0259170	alpha-Man-Ia	HGNC:19080	OMIM:616772	MAN1C1	9		
FBgn0259170	alpha-Man-Ia	HGNC:6821	OMIM:604344	MAN1A1	12		
FBgn0259171	Pde9	HGNC:8781	OMIM:600127	PDE4B	3		
FBgn0259171	Pde9	HGNC:8795	OMIM:602973	PDE9A	6		
FBgn0259171	Pde9	HGNC:8783	OMIM:600129	PDE4D	3	614613	614613[ACRODYSOSTOSIS 2 WITH OR WITHOUT HORMONE RESISTANCE; ACRDYS2]
FBgn0259171	Pde9	HGNC:8773	OMIM:604961	PDE11A	3	610475	610475[PIGMENTED NODULAR ADRENOCORTICAL DISEASE, PRIMARY, 2; PPNAD2]
FBgn0259171	Pde9	HGNC:8780	OMIM:600126	PDE4A	3		
FBgn0259171	Pde9	HGNC:8782	OMIM:600128	PDE4C	3		
FBgn0259174	Nedd4	HGNC:7727	OMIM:602278	NEDD4	12		
FBgn0259174	Nedd4	HGNC:16809	OMIM:605532	SMURF2	3		
FBgn0259174	Nedd4	HGNC:7728	OMIM:606384	NEDD4L	13	617201	617201[PERIVENTRICULAR NODULAR HETEROTOPIA 7; PVNH7]
FBgn0259174	Nedd4	HGNC:13890	OMIM:606409	ITCH	5	613385	613385[AUTOIMMUNE DISEASE, MULTISYSTEM, WITH FACIAL DYSMORPHISM; ADMFD]
FBgn0259174	Nedd4	HGNC:16807	OMIM:605568	SMURF1	4		
FBgn0259174	Nedd4	HGNC:17004	OMIM:602307	WWP1	3		
FBgn0259174	Nedd4	HGNC:16804	OMIM:602308	WWP2	5		
FBgn0259175	ome	HGNC:3009	OMIM:102720	DPP4	9		
FBgn0259175	ome	HGNC:3010	OMIM:126141	DPP6	8	612956,616311	612956[VENTRICULAR FIBRILLATION, PAROXYSMAL FAMILIAL, 2; VF2],616311[INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL DOMINANT 33; MRD33]
FBgn0259175	ome	HGNC:3590	OMIM:600403	FAP	10		
FBgn0259175	ome	HGNC:20823	OMIM:608209	DPP10	8		
FBgn0259176	bun	HGNC:3051	OMIM:300506	TSC22D3	5		
FBgn0259176	bun	HGNC:16826	OMIM:607715	TSC22D1	10		
FBgn0259176	bun	HGNC:29095	OMIM:617724	TSC22D2	7		
FBgn0259176	bun	HGNC:21696	OMIM:611914	TSC22D4	5		
FBgn0259178	5PtaseI	HGNC:6076	OMIM:600106	INPP5A	11		
FBgn0259189	Ir7e	HGNC:4580	OMIM:138244	GRIK2	3	611092,619580	611092[INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 6; MRT6],619580[NEURODEVELOPMENTAL DISORDER WITH IMPAIRED LANGUAGE AND ATAXIA AND WITH OR WITHOUT SEIZURES; NEDLAS]
FBgn0259189	Ir7e	HGNC:4581	OMIM:138243	GRIK3	3		
FBgn0259189	Ir7e	HGNC:4587	OMIM:138254	GRIN2C	3		
FBgn0259189	Ir7e	HGNC:4576	OMIM:602368	GRID2	3	616204	616204[SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 18; SCAR18]
FBgn0259189	Ir7e	HGNC:4575	OMIM:610659	GRID1	3		
FBgn0259195	CG42299	HGNC:26513	OMIM:617246	NSMCE2	7	617253	617253[SECKEL SYNDROME 10; SCKL10]
FBgn0259196	CG42300	HGNC:26513	OMIM:617246	NSMCE2	7	617253	617253[SECKEL SYNDROME 10; SCKL10]
FBgn0259198	CG42302	HGNC:11816	OMIM:607383	TIMM13	5		
FBgn0259199	Snup	HGNC:14245	OMIM:607902	SNUPN	8		
FBgn0259200	CG42304	HGNC:16160	OMIM:611388	DNTTIP1	10		
FBgn0259204	CG42308	HGNC:34450	OMIM:618812	C12orf73	8		
FBgn0259209	Mlp60A	HGNC:2469	OMIM:123876	CSRP1	7		
FBgn0259209	Mlp60A	HGNC:2472	OMIM:600824	CSRP3	8	607482,612124	607482[CARDIOMYOPATHY, DILATED, 1M; CMD1M],612124[CARDIOMYOPATHY, FAMILIAL HYPERTROPHIC, 12; CMH12]
FBgn0259209	Mlp60A	HGNC:2360	OMIM:123875	CRIP1	3		
FBgn0259209	Mlp60A	HGNC:2470	OMIM:601871	CSRP2	6		
FBgn0259210	prom	HGNC:20685	OMIM:617160	PROM2	6		
FBgn0259210	prom	HGNC:9454	OMIM:604365	PROM1	5	603786,608051,612095,612657	603786[STARGARDT DISEASE 4; STGD4],608051[MACULAR DYSTROPHY, RETINAL, 2; MCDR2],612095[RETINITIS PIGMENTOSA 41; RP41],612657[CONE-ROD DYSTROPHY 12; CORD12]
FBgn0259211	grh	HGNC:17923	OMIM:609786	GRHL1	8		
FBgn0259211	grh	HGNC:25839	OMIM:608317	GRHL3	6	606713	606713[VAN DER WOUDE SYNDROME 2; VWS2]
FBgn0259211	grh	HGNC:2799	OMIM:608576	GRHL2	7	608641,616029,618031	608641[DEAFNESS, AUTOSOMAL DOMINANT 28; DFNA28],616029[ECTODERMAL DYSPLASIA/SHORT STATURE SYNDROME; ECTDS],618031[CORNEAL DYSTROPHY, POSTERIOR POLYMORPHOUS, 4; PPCD4]
FBgn0259212	cno	HGNC:7137	OMIM:159559	AFDN	11		
FBgn0259214	PMCA	HGNC:814	OMIM:108731	ATP2B1	12	619910	619910[INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL DOMINANT 66; MRD66]
FBgn0259214	PMCA	HGNC:815	OMIM:108733	ATP2B2	12	601386,619804	601386[DEAFNESS, AUTOSOMAL RECESSIVE 12; DFNB12],619804[DEAFNESS, AUTOSOMAL DOMINANT 82; DFNA82]
FBgn0259214	PMCA	HGNC:817	OMIM:108732	ATP2B4	13		
FBgn0259214	PMCA	HGNC:816	OMIM:300014	ATP2B3	13	302500	302500[SPINOCEREBELLAR ATAXIA, X-LINKED 1; SCAX1]
FBgn0259215	Ir93a	HGNC:4572	OMIM:138247	GRIA2	3	618917	618917[NEURODEVELOPMENTAL DISORDER WITH LANGUAGE IMPAIRMENT AND BEHAVIORAL ABNORMALITIES; NEDLIB]
FBgn0259215	Ir93a	HGNC:4573	OMIM:305915	GRIA3	3	300699	300699[INTELLECTUAL DEVELOPMENTAL DISORDER, X-LINKED, SYNDROMIC, WU TYPE; MRXSW]
FBgn0259215	Ir93a	HGNC:4571	OMIM:138248	GRIA1	3	619927,619931	619927[INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL DOMINANT 67; MRD67],619931[INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 76; MRT76]
FBgn0259215	Ir93a	HGNC:4574	OMIM:138246	GRIA4	3	617864	617864[NEURODEVELOPMENTAL DISORDER WITH OR WITHOUT SEIZURES AND GAIT ABNORMALITIES; NEDSGA]
FBgn0259216	RhoGAP102A	HGNC:26388	OMIM:300937	ARHGAP36	4		
FBgn0259216	RhoGAP102A	HGNC:676	OMIM:300118	ARHGAP6	6		
FBgn0259219	CG42319	HGNC:13992	OMIM:609722	PDLIM2	4		
FBgn0259221	ATP8A	HGNC:13534	OMIM:605867	ATP8B2	4		
FBgn0259221	ATP8A	HGNC:3706	OMIM:602397	ATP8B1	4	147480,211600,243300	147480[CHOLESTASIS, INTRAHEPATIC, OF PREGNANCY, 1; ICP1],211600[CHOLESTASIS, PROGRESSIVE FAMILIAL INTRAHEPATIC, 1; PFIC1],243300[CHOLESTASIS, BENIGN RECURRENT INTRAHEPATIC, 1; BRIC1]
FBgn0259221	ATP8A	HGNC:13536	OMIM:609123	ATP8B4	4		
FBgn0259221	ATP8A	HGNC:13554	OMIM:300516	ATP11C	3	301015	301015[HEMOLYTIC ANEMIA, CONGENITAL, X-LINKED; HACXL]
FBgn0259221	ATP8A	HGNC:13552	OMIM:605868	ATP11A	3	619810,619851	619810[DEAFNESS, AUTOSOMAL DOMINANT 84; DFNA84],619851[LEUKODYSTROPHY, HYPOMYELINATING, 24; HLD24]
FBgn0259221	ATP8A	HGNC:13533	OMIM:605870	ATP8A2	12	615268	615268[CEREBELLAR ATAXIA, MENTAL RETARDATION, AND DYSEQUILIBRIUM SYNDROME 4; CAMRQ4]
FBgn0259221	ATP8A	HGNC:13553	OMIM:605869	ATP11B	4		
FBgn0259221	ATP8A	HGNC:13531	OMIM:609542	ATP8A1	14		
FBgn0259221	ATP8A	HGNC:13535	OMIM:605866	ATP8B3	4		
FBgn0259222	CG42322	HGNC:23616		SLC35F3	12		
FBgn0259222	CG42322	HGNC:19845		SLC35F4	11		
FBgn0259224	CG42324	HGNC:17949	OMIM:612658	TJAP1	5		
FBgn0259224	CG42324	HGNC:24163	OMIM:618597	BEGAIN	5		
FBgn0259227	CG42327	HGNC:9659	OMIM:176889	PTPN7	3		
FBgn0259227	CG42327	HGNC:9680	OMIM:602853	PTPRR	3		
FBgn0259227	CG42327	HGNC:9657	OMIM:176879	PTPN5	3		
FBgn0259228	C3G	HGNC:4568	OMIM:600303	RAPGEF1	11		
FBgn0259230	lectin-22C	HGNC:17213	OMIM:612502	COLEC11	3	265050	265050[3MC SYNDROME 2; 3MC2]
FBgn0259231	CCKLR-17D1	HGNC:1571	OMIM:118445	CCKBR	10		
FBgn0259231	CCKLR-17D1	HGNC:1570	OMIM:118444	CCKAR	11		
FBgn0259237	CG42335	HGNC:500	OMIM:151530	ANPEP	3		
FBgn0259237	CG42335	HGNC:30748	OMIM:606950	TRHDE	3		
FBgn0259237	CG42335	HGNC:26904	OMIM:610046	LVRN	3		
FBgn0259241	CG42339	HGNC:30362		SBSPON	10		
FBgn0259242	CG42340	HGNC:19439	OMIM:613655	KCNK18	5	613656	613656[MIGRAINE WITH OR WITHOUT AURA, SUSCEPTIBILITY TO, 13; MGR13]
FBgn0259243	Pka-R1	HGNC:9391	OMIM:176910	PRKAR2A	5		
FBgn0259243	Pka-R1	HGNC:9388	OMIM:188830	PRKAR1A	14	101800,160980,255960,610489	101800[ACRODYSOSTOSIS 1 WITH OR WITHOUT HORMONE RESISTANCE; ACRDYS1],160980[CARNEY COMPLEX, TYPE 1; CNC1],255960[MYXOMA, INTRACARDIAC],610489[PIGMENTED NODULAR ADRENOCORTICAL DISEASE, PRIMARY, 1; PPNAD1]
FBgn0259243	Pka-R1	HGNC:9390	OMIM:176911	PRKAR1B	14	619680	619680[MARBACH-SCHAAF NEURODEVELOPMENTAL SYNDROME; MASNS]
FBgn0259243	Pka-R1	HGNC:9392	OMIM:176912	PRKAR2B	5		
FBgn0259244	CG42342	HGNC:2190	OMIM:120350	COL13A1	3	616720	616720[MYASTHENIC SYNDROME, CONGENITAL, 19; CMS19]
FBgn0259245	DIP-beta	HGNC:17302	OMIM:613173	NEGR1	7		
FBgn0259245	DIP-beta	HGNC:34550	OMIM:618861	IGLON5	8		
FBgn0259245	DIP-beta	HGNC:6705	OMIM:603241	LSAMP	7		
FBgn0259245	DIP-beta	HGNC:8143	OMIM:600632	OPCML	7	167000	167000[OVARIAN CANCER]
FBgn0259245	DIP-beta	HGNC:17941	OMIM:607938	NTM	7		
FBgn0259246	brp	HGNC:17072	OMIM:607127	ERC1	6		
FBgn0259246	brp	HGNC:31922	OMIM:617250	ERC2	7		
FBgn0259481	Mob2	HGNC:24904	OMIM:611969	MOB2	8		
FBgn0259482	Mob3	HGNC:29802		MOB3A	13		
FBgn0259482	Mob3	HGNC:23825	OMIM:617652	MOB3B	13		
FBgn0259482	Mob3	HGNC:29800		MOB3C	12		
FBgn0259482	Mob3	HGNC:16015	OMIM:609281	MOB1A	5		
FBgn0259482	Mob3	HGNC:29801	OMIM:609282	MOB1B	5		
FBgn0259483	Mob4	HGNC:17261	OMIM:609361	MOB4	13		
FBgn0259483	Mob4	HGNC:49184		HSPE1-MOB4	7		
FBgn0259676	Prim2	HGNC:9370	OMIM:176636	PRIM2	14		
FBgn0259678	sqa	HGNC:16243	OMIM:606566	MYLK2	4	192600	192600[CARDIOMYOPATHY, FAMILIAL HYPERTROPHIC, 1; CMH1]
FBgn0259678	sqa	HGNC:29826	OMIM:612147	MYLK3	5		
FBgn0259678	sqa	HGNC:27972		MYLK4	3		
FBgn0259685	crb	HGNC:7882	OMIM:600275	NOTCH2	3	102500,610205	102500[HAJDU-CHENEY SYNDROME; HJCYS],610205[ALAGILLE SYNDROME 2; ALGS2]
FBgn0259685	crb	HGNC:7883	OMIM:600276	NOTCH3	3	125310,130720,615293	125310[CEREBRAL ARTERIOPATHY, AUTOSOMAL DOMINANT, WITH SUBCORTICAL INFARCTS AND LEUKOENCEPHALOPATHY, TYPE 1; CADASIL1],130720[LATERAL MENINGOCELE SYNDROME; LMNS],615293[MYOFIBROMATOSIS, INFANTILE, 2; IMF2]
FBgn0259685	crb	HGNC:7881	OMIM:190198	NOTCH1	3	109730,616028	109730[AORTIC VALVE DISEASE 1; AOVD1],616028[ADAMS-OLIVER SYNDROME 5; AOS5]
FBgn0259685	crb	HGNC:7884	OMIM:164951	NOTCH4	3		
FBgn0259685	crb	HGNC:2343	OMIM:604210	CRB1	9	172870,600105,613835	172870[PIGMENTED PARAVENOUS CHORIORETINAL ATROPHY; PPCRA],600105[RETINITIS PIGMENTOSA 12; RP12],613835[LEBER CONGENITAL AMAUROSIS 8; LCA8]
FBgn0259685	crb	HGNC:18688	OMIM:609720	CRB2	7	219730,616220	219730[VENTRICULOMEGALY WITH CYSTIC KIDNEY DISEASE; VMCKD],616220[FOCAL SEGMENTAL GLOMERULOSCLEROSIS 9; FSGS9]
FBgn0259704	Nsun5	HGNC:16385	OMIM:615732	NSUN5	14		
FBgn0259704	Nsun5	HGNC:25857	OMIM:617185	NSUN7	3		
FBgn0259704	Nsun5	HGNC:16609		NSUN5P2	6		
FBgn0259712	CG42366	HGNC:21219	OMIM:612325	ICK	9	612651,617924	612651[ENDOCRINE-CEREBROOSTEODYSPLASIA; ECO],617924[EPILEPSY, JUVENILE MYOCLONIC, SUSCEPTIBILITY TO, 10; EJM10]
FBgn0259712	CG42366	HGNC:6816	OMIM:154235	MAK	9	614181	614181[RETINITIS PIGMENTOSA 62; RP62]
FBgn0259714	DIP-epsilon	HGNC:17302	OMIM:613173	NEGR1	7		
FBgn0259714	DIP-epsilon	HGNC:34550	OMIM:618861	IGLON5	7		
FBgn0259714	DIP-epsilon	HGNC:6705	OMIM:603241	LSAMP	8		
FBgn0259714	DIP-epsilon	HGNC:8143	OMIM:600632	OPCML	8	167000	167000[OVARIAN CANCER]
FBgn0259714	DIP-epsilon	HGNC:17941	OMIM:607938	NTM	8		
FBgn0259716	Nepl6	HGNC:6308	OMIM:613883	KEL	3	110900	110900[BLOOD GROUP--KELL SYSTEM; KEL]
FBgn0259717	CG42371	HGNC:49288		CEBPZOS	7		
FBgn0259720	CG42374	HGNC:24994	OMIM:613273	INIP	7		
FBgn0259721	CG42375	HGNC:24447		CMC2	11		
FBgn0259722	CG42376	HGNC:18025	OMIM:614772	COA6	11	616501	616501[MITOCHONDRIAL COMPLEX IV DEFICIENCY, NUCLEAR TYPE 13; MC4DN13]
FBgn0259726	CG42380	HGNC:33551	OMIM:618461	NDUFAF8	3	618776	618776[MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 34; MC1DN34]
FBgn0259727	CG42381	HGNC:35428		CMC4	12		
FBgn0259729	CG42383	HGNC:27035	OMIM:610686	UBXN2B	8		
FBgn0259729	CG42383	HGNC:15912	OMIM:606610	NSFL1C	7		
FBgn0259729	CG42383	HGNC:27265		UBXN2A	7		
FBgn0259734	Nost	HGNC:20203	OMIM:607496	NOSTRIN	9		
FBgn0259735	mtgo	HGNC:20296	OMIM:615794	FNDC3A	12		
FBgn0259735	mtgo	HGNC:24670	OMIM:611909	FNDC3B	9		
FBgn0259737	CG42391	HGNC:26812	OMIM:619348	ANKLE1	6		
FBgn0259741	CG42395	HGNC:28618	OMIM:617779	TMEM256	13		
FBgn0259742	CG42360	HGNC:21175	OMIM:611106	ZC3H12D	4		
FBgn0259742	CG42360	HGNC:17407	OMIM:300889	ZC3H12B	4		
FBgn0259742	CG42360	HGNC:29362	OMIM:615001	ZC3H12C	4		
FBgn0259742	CG42360	HGNC:26259	OMIM:610562	ZC3H12A	3		
FBgn0259742	CG42360	HGNC:20165		NYNRIN	3		
FBgn0259742	CG42360	HGNC:20166	OMIM:619579	KHNYN	7		
FBgn0259742	CG42360	HGNC:29850	OMIM:619138	N4BP1	5		
FBgn0259745	wech	HGNC:32669	OMIM:618570	TRIM71	13	618667	618667[HYDROCEPHALUS, CONGENITAL COMMUNICATING, 1; HYDCC1]
FBgn0259745	wech	HGNC:10064	OMIM:605493	TRIM3	3		
FBgn0259749	mmy	HGNC:12457	OMIM:602862	UAP1	14		
FBgn0259749	mmy	HGNC:28082		UAP1L1	11		
FBgn0259791	bora	HGNC:24724	OMIM:610510	BORA	8		
FBgn0259794	sinah	HGNC:10857	OMIM:602212	SIAH1	4	619314	619314[BURATTI-HAREL SYNDROME; BURHAS]
FBgn0259794	sinah	HGNC:10858	OMIM:602213	SIAH2	4		
FBgn0259794	sinah	HGNC:30553	OMIM:615609	SIAH3	4		
FBgn0259795	loopin-1	HGNC:18449	OMIM:170250	LAP3	9		
FBgn0259817	SteXh:CG42398	HGNC:2460	OMIM:115441	CSNK2B	4	618732	618732[POIRIER-BIENVENU NEURODEVELOPMENTAL SYNDROME; POBINDS]
FBgn0259818	CG42399	HGNC:19959	OMIM:617618	TOGARAM1	6	619185	619185[JOUBERT SYNDROME 37; JBTS37]
FBgn0259818	CG42399	HGNC:33715		TOGARAM2	5		
FBgn0259821	CG42402	HGNC:13239		EVA1C	8		
FBgn0259824	Hip14	HGNC:18412	OMIM:607799	ZDHHC17	15		
FBgn0259824	Hip14	HGNC:18413	OMIM:612815	ZDHHC13	11		
FBgn0259832	CG34229	HGNC:25229		LYRM2	12		
FBgn0259834	out	HGNC:17027	OMIM:607550	SLC16A10	3		
FBgn0259834	out	HGNC:10923	OMIM:300095	SLC16A2	3	300523	300523[ALLAN-HERNDON-DUDLEY SYNDROME; AHDS]
FBgn0259834	out	HGNC:10924	OMIM:603877	SLC16A3	5		
FBgn0259834	out	HGNC:16270	OMIM:610409	SLC16A8	5		
FBgn0259834	out	HGNC:26417		SLC16A14	5		
FBgn0259834	out	HGNC:23093	OMIM:615765	SLC16A11	5		
FBgn0259834	out	HGNC:23520	OMIM:614242	SLC16A9	4		
FBgn0259834	out	HGNC:10922	OMIM:600682	SLC16A1	6	245340,610021,616095	245340[ERYTHROCYTE LACTATE TRANSPORTER DEFECT],610021[HYPERINSULINEMIC HYPOGLYCEMIA, FAMILIAL, 7; HHF7],616095[MONOCARBOXYLATE TRANSPORTER 1 DEFICIENCY; MCT1D]
FBgn0259834	out	HGNC:10927	OMIM:603880	SLC16A6	5		
FBgn0259834	out	HGNC:10925	OMIM:603878	SLC16A4	5		
FBgn0259834	out	HGNC:31037		SLC16A13	6		
FBgn0259834	out	HGNC:10926	OMIM:603879	SLC16A5	5		
FBgn0259834	out	HGNC:10928	OMIM:603654	SLC16A7	6		
FBgn0259834	out	HGNC:23094	OMIM:611910	SLC16A12	6	612018	612018[CATARACT 47; CTRCT47]
FBgn0259876	Cap-G	HGNC:24304	OMIM:606280	NCAPG	12		
FBgn0259878	Fs	HGNC:3973	OMIM:605343	FSTL3	7		
FBgn0259878	Fs	HGNC:3971	OMIM:136470	FST	10		
FBgn0259923	Septin4	HGNC:33280	OMIM:612140	SEPTIN14	3		
FBgn0259923	Septin4	HGNC:1717	OMIM:603151	SEPTIN7	4		
FBgn0259923	Septin4	HGNC:9165	OMIM:603696	SEPTIN4	11		
FBgn0259923	Septin4	HGNC:15848	OMIM:300683	SEPTIN6	4		
FBgn0259923	Septin4	HGNC:2879	OMIM:612897	SEPTIN1	6		
FBgn0259923	Septin4	HGNC:25589	OMIM:612887	SEPTIN11	4		
FBgn0259923	Septin4	HGNC:7729	OMIM:601506	SEPTIN2	6		
FBgn0259923	Septin4	HGNC:9164	OMIM:602724	SEPTIN5	11		
FBgn0259923	Septin4	HGNC:16511	OMIM:608418	SEPTIN8	4		
FBgn0259923	Septin4	HGNC:14349	OMIM:611737	SEPTIN10	4		
FBgn0259923	Septin4	HGNC:7323	OMIM:604061	SEPTIN9	4	162100	162100[AMYOTROPHY, HEREDITARY NEURALGIC; HNA]
FBgn0259923	Septin4	HGNC:10750	OMIM:608314	SEPTIN3	4		
FBgn0259923	Septin4	HGNC:26348	OMIM:611562	SEPTIN12	4	614822	614822[SPERMATOGENIC FAILURE 10; SPGF10]
FBgn0259927	CG42450	HGNC:10002	OMIM:603894	RGS6	3		
FBgn0259927	CG42450	HGNC:10004	OMIM:604067	RGS9	7	608415	608415[PROLONGED ELECTRORETINAL RESPONSE SUPPRESSION; PERRS]
FBgn0259927	CG42450	HGNC:9993	OMIM:603895	RGS11	6		
FBgn0259927	CG42450	HGNC:10003	OMIM:602517	RGS7	3		
FBgn0259932	CG42455	HGNC:27356		SMIM13	6		
FBgn0259933	Dpm2	HGNC:3006	OMIM:603564	DPM2	4	615042	615042[CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Iu; CDG1U]
FBgn0259935	CG42458	HGNC:5035	OMIM:164020	HNRNPC	6		
FBgn0259935	CG42458	HGNC:29295		HNRNPCL1	5		
FBgn0259935	CG42458	HGNC:27036	OMIM:614648	RALYL	5		
FBgn0259935	CG42458	HGNC:15921	OMIM:614663	RALY	5		
FBgn0259935	CG42458	HGNC:48813		HNRNPCL2	4		
FBgn0259935	CG42458	HGNC:51235		HNRNPCL3	4		
FBgn0259935	CG42458	HGNC:51333		HNRNPCL4	4		
FBgn0259937	Nop60B	HGNC:2890	OMIM:300126	DKC1	14	305000	305000[DYSKERATOSIS CONGENITA, X-LINKED; DKCX]
FBgn0259938	cwo	HGNC:4881	OMIM:604674	HEY2	3		
FBgn0259938	cwo	HGNC:4880	OMIM:602953	HEY1	3		
FBgn0259938	cwo	HGNC:4882	OMIM:609034	HEYL	3		
FBgn0259938	cwo	HGNC:33783	OMIM:617546	HELT	3		
FBgn0259954	CG42464	HGNC:11248	OMIM:613941	SPINT3	3		
FBgn0259954	CG42464	HGNC:38825		EPPIN-WFDC6	3		
FBgn0259977	Tdc1	HGNC:4855	OMIM:142704	HDC	3	137580	137580[GILLES DE LA TOURETTE SYNDROME; GTS]
FBgn0259977	Tdc1	HGNC:2719	OMIM:107930	DDC	5	608643	608643[AROMATIC L-AMINO ACID DECARBOXYLASE DEFICIENCY; AADCD]
FBgn0259978	vlc	HGNC:24476	OMIM:616191	DLGAP4	7		
FBgn0259978	vlc	HGNC:30368	OMIM:611413	DLGAP3	7		
FBgn0259978	vlc	HGNC:2905	OMIM:605445	DLGAP1	7		
FBgn0259978	vlc	HGNC:2906	OMIM:605438	DLGAP2	6		
FBgn0259978	vlc	HGNC:16864	OMIM:617859	DLGAP5	4		
FBgn0259982	Uxt	HGNC:12641	OMIM:300234	UXT	13		
FBgn0259984	kuz	HGNC:188	OMIM:602192	ADAM10	14	615537,615590	615537[RETICULATE ACROPIGMENTATION OF KITAMURA; RAK],615590[ALZHEIMER DISEASE 18; AD18]
FBgn0259985	Mppe	HGNC:15988	OMIM:611900	MPPE1	4		
FBgn0259986	nab	HGNC:7627	OMIM:602381	NAB2	11		
FBgn0259986	nab	HGNC:7626	OMIM:600800	NAB1	11		
FBgn0259991	CG42488	HGNC:28211		TMEM141	8		
FBgn0259994	OtopLa	HGNC:19657	OMIM:607827	OTOP2	9		
FBgn0259994	OtopLa	HGNC:19656	OMIM:607806	OTOP1	9		
FBgn0259994	OtopLa	HGNC:19658	OMIM:607828	OTOP3	8		
FBgn0259998	CG17571	HGNC:9486	OMIM:613578	PRSS3	4		
FBgn0259998	CG17571	HGNC:9475	OMIM:276000	PRSS1	4	167800	167800[PANCREATITIS, HEREDITARY; PCTT]
FBgn0260003	Dys	HGNC:2928	OMIM:300377	DMD	11	300376,302045,310200	300376[MUSCULAR DYSTROPHY, BECKER TYPE; BMD],302045[CARDIOMYOPATHY, DILATED, 3B; CMD3B],310200[MUSCULAR DYSTROPHY, DUCHENNE TYPE; DMD]
FBgn0260003	Dys	HGNC:12635	OMIM:128240	UTRN	9		
FBgn0260003	Dys	HGNC:3032	OMIM:300052	DRP2	5		
FBgn0260004	Snmp1	HGNC:1663	OMIM:173510	CD36	6	608404,610938,611162	608404[PLATELET GLYCOPROTEIN IV DEFICIENCY],610938[CORONARY HEART DISEASE, SUSCEPTIBILITY TO, 7; CHDS7],611162[MALARIA, SUSCEPTIBILITY TO]
FBgn0260004	Snmp1	HGNC:1664	OMIM:601040	SCARB1	5	610762	610762[HIGH DENSITY LIPOPROTEIN CHOLESTEROL LEVEL QUANTITATIVE TRAIT LOCUS 6; HDLCQ6]
FBgn0260004	Snmp1	HGNC:1665	OMIM:602257	SCARB2	6	254900	254900[EPILEPSY, PROGRESSIVE MYOCLONIC, 4, WITH OR WITHOUT RENAL FAILURE; EPM4]
FBgn0260008	UQCR-11	HGNC:12590	OMIM:613844	UQCRH	10		
FBgn0260008	UQCR-11	HGNC:51714		UQCRHL	7		
FBgn0260012	pds5	HGNC:20418	OMIM:605333	PDS5B	14		
FBgn0260012	pds5	HGNC:29088	OMIM:613200	PDS5A	12		
FBgn0260027	CG42495	HGNC:28444		TMEM42	4		
FBgn0260049	flr	HGNC:12754	OMIM:604734	WDR1	13	150550	150550[PERIODIC FEVER, IMMUNODEFICIENCY, AND THROMBOCYTOPENIA SYNDROME; PFITS]
FBgn0260222	CG42496	HGNC:28074	OMIM:610429	COX19	9		
FBgn0260224	Tcs6	HGNC:26058	OMIM:300060	LAGE3	9	301006	301006[GALLOWAY-MOWAT SYNDROME 2, X-LINKED; GAMOS2]
FBgn0260224	Tcs6	HGNC:24198	OMIM:300657	CTAG1A	4		
FBgn0260388	CG42514	HGNC:16055	OMIM:608956	SLC46A2	7		
FBgn0260388	CG42514	HGNC:30521	OMIM:611672	SLC46A1	7	229050	229050[FOLATE MALABSORPTION, HEREDITARY]
FBgn0260388	CG42514	HGNC:27501	OMIM:616764	SLC46A3	7		
FBgn0260390	CG42516	HGNC:20872	OMIM:611784	GTF3C6	5		
FBgn0260392	CG42518	HGNC:25121		NCBP2AS2	4		
FBgn0260397	Su(var)3-3	HGNC:29079	OMIM:609132	KDM1A	14	616728	616728[CLEFT PALATE, PSYCHOMOTOR RETARDATION, AND DISTINCTIVE FACIAL FEATURES; CPRF]
FBgn0260397	Su(var)3-3	HGNC:21577	OMIM:613081	KDM1B	3		
FBgn0260398	Pbp49	HGNC:11136	OMIM:602348	SNAPC3	9		
FBgn0260399	gwl	HGNC:19042	OMIM:608221	MASTL	13		
FBgn0260400	elav	HGNC:3313	OMIM:601673	ELAVL2	7		
FBgn0260400	elav	HGNC:3312	OMIM:603466	ELAVL1	6		
FBgn0260400	elav	HGNC:3314	OMIM:603458	ELAVL3	6		
FBgn0260400	elav	HGNC:3315	OMIM:168360	ELAVL4	7		
FBgn0260401	MED9	HGNC:25487	OMIM:609878	MED9	9		
FBgn0260407	mRpS23	HGNC:14509	OMIM:611985	MRPS23	14	618952	618952[COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 46; COXPD46]
FBgn0260486	Ziz	HGNC:19190	OMIM:615730	DOCK7	3	615859	615859[DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 23; DEE23]
FBgn0260486	Ziz	HGNC:14132	OMIM:607325	DOCK9	12		
FBgn0260486	Ziz	HGNC:23479	OMIM:611518	DOCK10	11		
FBgn0260486	Ziz	HGNC:23483	OMIM:300681	DOCK11	11		
FBgn0260486	Ziz	HGNC:19191	OMIM:611432	DOCK8	3	243700	243700[HYPER-IgE RECURRENT INFECTION SYNDROME 2, AUTOSOMAL RECESSIVE; HIES2]
FBgn0260632	dl	HGNC:7795	OMIM:164012	NFKB2	3	615577	615577[IMMUNODEFICIENCY, COMMON VARIABLE, 10; CVID10]
FBgn0260632	dl	HGNC:7794	OMIM:164011	NFKB1	4	616576	616576[IMMUNODEFICIENCY, COMMON VARIABLE, 12, WITH AUTOIMMUNITY; CVID12]
FBgn0260632	dl	HGNC:9954	OMIM:164910	REL	9	619652	619652[IMMUNODEFICIENCY 92; IMD92]
FBgn0260632	dl	HGNC:9955	OMIM:164014	RELA	9	618287	618287[MUCOCUTANEOUS ULCERATION, CHRONIC; CMCU]
FBgn0260632	dl	HGNC:9956	OMIM:604758	RELB	7	617585	617585[IMMUNODEFICIENCY 53; IMD53]
FBgn0260634	eIF4G2	HGNC:3298	OMIM:603929	EIF4G3	6		
FBgn0260634	eIF4G2	HGNC:3296	OMIM:600495	EIF4G1	6	614251	614251[PARKINSON DISEASE 18, AUTOSOMAL DOMINANT, SUSCEPTIBILITY TO; PARK18]
FBgn0260635	Diap1	HGNC:13702	OMIM:605737	BIRC7	4		
FBgn0260635	Diap1	HGNC:14878		BIRC8	3		
FBgn0260635	Diap1	HGNC:591	OMIM:601721	BIRC3	6		
FBgn0260635	Diap1	HGNC:590	OMIM:601712	BIRC2	6		
FBgn0260635	Diap1	HGNC:592	OMIM:300079	XIAP	7	300635	300635[LYMPHOPROLIFERATIVE SYNDROME, X-LINKED, 2; XLP2]
FBgn0260639	gammaTub23C	HGNC:12417	OMIM:191135	TUBG1	14	615412	615412[CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 4; CDCBM4]
FBgn0260639	gammaTub23C	HGNC:12419	OMIM:605785	TUBG2	13		
FBgn0260642	Antp	HGNC:5118	OMIM:142962	HOXB7	9		
FBgn0260642	Antp	HGNC:5106	OMIM:142952	HOXA5	3		
FBgn0260642	Antp	HGNC:5127	OMIM:142973	HOXC5	3		
FBgn0260642	Antp	HGNC:5128	OMIM:142972	HOXC6	4		
FBgn0260642	Antp	HGNC:5116	OMIM:142960	HOXB5	3		
FBgn0260642	Antp	HGNC:5107	OMIM:142951	HOXA6	4		
FBgn0260642	Antp	HGNC:5119	OMIM:142963	HOXB8	3		
FBgn0260642	Antp	HGNC:5117	OMIM:142961	HOXB6	4		
FBgn0260642	Antp	HGNC:5129	OMIM:142970	HOXC8	4		
FBgn0260642	Antp	HGNC:5108	OMIM:142950	HOXA7	7		
FBgn0260648	Rrp40	HGNC:17944	OMIM:606489	EXOSC3	15	614678	614678[PONTOCEREBELLAR HYPOPLASIA, TYPE 1B; PCH1B]
FBgn0260655	l(3)76BDm	HGNC:29169	OMIM:614136	TRAPPC8	14		
FBgn0260657	CG42540	HGNC:13394	OMIM:604766	NPHS2	3	600995	600995[NEPHROTIC SYNDROME, TYPE 2; NPHS2]
FBgn0260657	CG42540	HGNC:3383	OMIM:133090	STOM	12		
FBgn0260657	CG42540	HGNC:19420	OMIM:608327	STOML3	9		
FBgn0260658	CG42541	HGNC:10446	OMIM:179503	RRAD	3		
FBgn0260659	CG42542	HGNC:30760	OMIM:614726	TMEM165	11	614727	614727[CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIk; CDG2K]
FBgn0260660	Mp	HGNC:2192	OMIM:120325	COL15A1	8		
FBgn0260660	Mp	HGNC:2195	OMIM:120328	COL18A1	6	267750,618880	267750[KNOBLOCH SYNDROME 1; KNO1],618880[GLAUCOMA, PRIMARY CLOSED-ANGLE; GLCC]
FBgn0260743	GC1	HGNC:10988	OMIM:609303	SLC25A18	11		
FBgn0260743	GC1	HGNC:19954	OMIM:609302	SLC25A22	14	609304	609304[DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 3; DEE3]
FBgn0260744	Tango9	HGNC:26055	OMIM:619667	SLC35F6	13		
FBgn0260745	mfas	HGNC:11771	OMIM:601692	TGFBI	14	121820,121900,122200,602082,607541,608470,608471	121820[CORNEAL DYSTROPHY, EPITHELIAL BASEMENT MEMBRANE; EBMD],121900[CORNEAL DYSTROPHY, GROENOUW TYPE I; CDGG1],122200[CORNEAL DYSTROPHY, LATTICE TYPE I; CDL1],602082[CORNEAL DYSTROPHY, THIEL-BEHNKE TYPE; CDTB],607541[CORNEAL DYSTROPHY, AVELLINO TYPE; CDA],608470[CORNEAL DYSTROPHY, REIS-BUCKLERS TYPE; CDRB],608471[CORNEAL DYSTROPHY, LATTICE TYPE IIIA; CDL3A]
FBgn0260745	mfas	HGNC:16953	OMIM:608777	POSTN	10		
FBgn0260746	Ect3	HGNC:4298	OMIM:611458	GLB1	12	230500,230600,230650,253010	230500[GM1-GANGLIOSIDOSIS, TYPE I; GM1G1],230600[GM1-GANGLIOSIDOSIS, TYPE II; GM1G2],230650[GM1-GANGLIOSIDOSIS, TYPE III; GM1G3],253010[MUCOPOLYSACCHARIDOSIS, TYPE IVB; MPS4B]
FBgn0260746	Ect3	HGNC:28129		GLB1L	15		
FBgn0260746	Ect3	HGNC:25147		GLB1L3	3		
FBgn0260746	Ect3	HGNC:25129		GLB1L2	4		
FBgn0260747	Chchd2	HGNC:21645	OMIM:616244	CHCHD2	13	616710	616710[PARKINSON DISEASE 22, AUTOSOMAL DOMINANT; PARK22]
FBgn0260747	Chchd2	HGNC:15559	OMIM:615903	CHCHD10	11	615048,615911,616209	615048[SPINAL MUSCULAR ATROPHY, JOKELA TYPE; SMAJ],615911[FRONTOTEMPORAL DEMENTIA AND/OR AMYOTROPHIC LATERAL SCLEROSIS 2; FTDALS2],616209[MYOPATHY, ISOLATED MITOCHONDRIAL, AUTOSOMAL DOMINANT; IMMD]
FBgn0260748	CG5004	HGNC:23697	OMIM:612834	PHLDB1	10		
FBgn0260748	CG5004	HGNC:29573	OMIM:610298	PHLDB2	9		
FBgn0260748	CG5004	HGNC:30499		PHLDB3	5		
FBgn0260749	Utx	HGNC:12637	OMIM:300128	KDM6A	14	300867	300867[KABUKI SYNDROME 2; KABUK2]
FBgn0260749	Utx	HGNC:29012	OMIM:611577	KDM6B	9	618505	618505[NEURODEVELOPMENTAL DISORDER WITH COARSE FACIES AND MILD DISTAL SKELETAL ABNORMALITIES; NEDCFSA]
FBgn0260749	Utx	HGNC:12638	OMIM:400009	UTY	12		
FBgn0260750	Mulk	HGNC:21869	OMIM:610345	AGK	14	212350,614691	212350[SENGERS SYNDROME],614691[CATARACT 38; CTRCT38]
FBgn0260753	Pdfr	HGNC:242	OMIM:102981	ADCYAP1R1	3		
FBgn0260753	Pdfr	HGNC:2358	OMIM:602034	CRHR2	3		
FBgn0260753	Pdfr	HGNC:4266	OMIM:139191	GHRHR	3	618157	618157[ISOLATED GROWTH HORMONE DEFICIENCY, TYPE IV; IGHD4]
FBgn0260753	Pdfr	HGNC:10608	OMIM:182098	SCTR	3		
FBgn0260753	Pdfr	HGNC:12694	OMIM:192321	VIPR1	3		
FBgn0260753	Pdfr	HGNC:12695	OMIM:601970	VIPR2	3		
FBgn0260753	Pdfr	HGNC:4271	OMIM:137241	GIPR	3		
FBgn0260753	Pdfr	HGNC:4324	OMIM:138032	GLP1R	3		
FBgn0260753	Pdfr	HGNC:4325	OMIM:603659	GLP2R	3		
FBgn0260753	Pdfr	HGNC:1440	OMIM:114131	CALCR	5	166710	166710[OSTEOPOROSIS]
FBgn0260753	Pdfr	HGNC:16709	OMIM:114190	CALCRL	3	618773	618773[LYMPHATIC MALFORMATION 8; LMPHM8]
FBgn0260753	Pdfr	HGNC:9608	OMIM:168468	PTH1R	3	125350,156400,215045,600002	125350[FAILURE OF TOOTH ERUPTION, PRIMARY; PFE],156400[METAPHYSEAL CHONDRODYSPLASIA, JANSEN TYPE; MCDJ],215045[CHONDRODYSPLASIA, BLOMSTRAND TYPE; BOCD],600002[EIKEN SYNDROME; EKNS]
FBgn0260753	Pdfr	HGNC:9609	OMIM:601469	PTH2R	3		
FBgn0260755	CG42553	HGNC:21703		C7orf25	13		
FBgn0260756	CG42554	HGNC:19692	OMIM:616477	NRBF2	4		
FBgn0260759	CG42557	HGNC:28295	OMIM:618941	CCDC32	3	619123	619123[CARDIOFACIONEURODEVELOPMENTAL SYNDROME; CFNDS]
FBgn0260766	CG42564	HGNC:28392	OMIM:610395	GLIPR1L1	3		
FBgn0260771	Larp7	HGNC:24912	OMIM:612026	LARP7	10	615071	615071[ALAZAMI SYNDROME; ALAZS]
FBgn0260775	DnaJ-60	HGNC:5271	OMIM:604189	DNAJC4	7		
FBgn0260779	GatA	HGNC:21020	OMIM:617209	QRSL1	15	618835	618835[COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 40; COXPD40]
FBgn0260780	wisp	HGNC:26776	OMIM:614121	TENT2	10		
FBgn0260794	ctrip	HGNC:20157	OMIM:618649	HECTD1	3		
FBgn0260794	ctrip	HGNC:12306	OMIM:604506	TRIP12	10	617752	617752[CLARK-BARAITSER SYNDROME; CLABARS]
FBgn0260795	NaPi-III	HGNC:10946	OMIM:137570	SLC20A1	13		
FBgn0260795	NaPi-III	HGNC:10947	OMIM:158378	SLC20A2	12	213600	213600[BASAL GANGLIA CALCIFICATION, IDIOPATHIC, 1; IBGC1]
FBgn0260798	Gprk1	HGNC:4543	OMIM:137026	GRK4	3		
FBgn0260798	Gprk1	HGNC:4545	OMIM:600869	GRK6	3		
FBgn0260798	Gprk1	HGNC:290	OMIM:109636	GRK3	15		
FBgn0260798	Gprk1	HGNC:289	OMIM:109635	GRK2	13		
FBgn0260798	Gprk1	HGNC:4544	OMIM:600870	GRK5	3		
FBgn0260799	p120ctn	HGNC:728	OMIM:602269	ARVCF	7		
FBgn0260799	p120ctn	HGNC:2516	OMIM:604275	CTNND2	10		
FBgn0260799	p120ctn	HGNC:9026	OMIM:604276	PKP4	9		
FBgn0260799	p120ctn	HGNC:2515	OMIM:601045	CTNND1	6	617681	617681[BLEPHAROCHEILODONTIC SYNDROME 2; BCDS2]
FBgn0260799	p120ctn	HGNC:9023	OMIM:601975	PKP1	4	604536	604536[ECTODERMAL DYSPLASIA/SKIN FRAGILITY SYNDROME; EDSFS]
FBgn0260799	p120ctn	HGNC:9024	OMIM:602861	PKP2	4	609040	609040[ARRHYTHMOGENIC RIGHT VENTRICULAR DYSPLASIA, FAMILIAL, 9; ARVD9]
FBgn0260799	p120ctn	HGNC:9025	OMIM:605561	PKP3	5		
FBgn0260812	inaF-D	HGNC:27406		INAFM1	3		
FBgn0260812	inaF-D	HGNC:35165		INAFM2	3		
FBgn0260817	gkt	HGNC:18884	OMIM:607198	TDP1	14	607250	607250[SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE, WITH AXONAL NEUROPATHY 1; SCAN1]
FBgn0260855	Sec22	HGNC:10700	OMIM:604029	SEC22B	12		
FBgn0260856	Membrin	HGNC:4431	OMIM:604027	GOSR2	13	614018	614018[EPILEPSY, PROGRESSIVE MYOCLONIC, 6; EPM6]
FBgn0260857	Bet1	HGNC:14562	OMIM:605456	BET1	13		
FBgn0260858	Ykt6	HGNC:16959	OMIM:606209	YKT6	14		
FBgn0260859	Bet3	HGNC:19942	OMIM:610955	TRAPPC3	14		
FBgn0260859	Bet3	HGNC:21090	OMIM:614137	TRAPPC3L	8		
FBgn0260860	Bet5	HGNC:19894	OMIM:610969	TRAPPC1	14		
FBgn0260861	Trs23	HGNC:19943	OMIM:610971	TRAPPC4	15	618741	618741[NEURODEVELOPMENTAL DISORDER WITH EPILEPSY, SPASTICITY, AND BRAIN ATROPHY; NEDESBA]
FBgn0260862	Vti1a	HGNC:17792	OMIM:614316	VTI1A	14		
FBgn0260862	Vti1a	HGNC:17793	OMIM:603207	VTI1B	3		
FBgn0260866	dnr1	HGNC:21155	OMIM:610082	MYLIP	13		
FBgn0260932	cuff	HGNC:2992	OMIM:605996	DXO	7		
FBgn0260933	rempA	HGNC:29077	OMIM:614620	IFT140	14	266920,617781	266920[SHORT-RIB THORACIC DYSPLASIA 9 WITH OR WITHOUT POLYDACTYLY; SRTD9],617781[RETINITIS PIGMENTOSA 80; RP80]
FBgn0260934	par-1	HGNC:13538	OMIM:606495	MARK4	8		
FBgn0260934	par-1	HGNC:6896	OMIM:606511	MARK1	10		
FBgn0260934	par-1	HGNC:3332	OMIM:600526	MARK2	9		
FBgn0260934	par-1	HGNC:6897	OMIM:602678	MARK3	12	618283	618283[VISUAL IMPAIRMENT AND PROGRESSIVE PHTHISIS BULBI; VIPB]
FBgn0260935	Vps15	HGNC:8982	OMIM:602610	PIK3R4	15		
FBgn0260936	scny	HGNC:37177		USP17L5	4		
FBgn0260936	scny	HGNC:44441		USP17L13	4		
FBgn0260936	scny	HGNC:37182		USP17L1	5		
FBgn0260936	scny	HGNC:37175		USP17L3	5		
FBgn0260936	scny	HGNC:44445		USP17L17	4		
FBgn0260936	scny	HGNC:20062	OMIM:612543	USP36	9		
FBgn0260936	scny	HGNC:34434	OMIM:610186	USP17L2	5		
FBgn0260936	scny	HGNC:37181		USP17L8	5		
FBgn0260936	scny	HGNC:37176		USP17L4	5		
FBgn0260936	scny	HGNC:44438		USP17L10	4		
FBgn0260936	scny	HGNC:44439		USP17L11	4		
FBgn0260936	scny	HGNC:44440		USP17L12	4		
FBgn0260936	scny	HGNC:44443		USP17L15	3		
FBgn0260936	scny	HGNC:20068		USP42	8		
FBgn0260936	scny	HGNC:44452		USP17L25	3		
FBgn0260936	scny	HGNC:37180		USP17L7	5		
FBgn0260936	scny	HGNC:44446		USP17L18	4		
FBgn0260936	scny	HGNC:44447		USP17L19	4		
FBgn0260936	scny	HGNC:44448		USP17L20	4		
FBgn0260936	scny	HGNC:44449		USP17L21	4		
FBgn0260936	scny	HGNC:44450		USP17L22	4		
FBgn0260936	scny	HGNC:37179		USP17L6P	3		
FBgn0260938	tay	HGNC:14262	OMIM:607270	AUTS2	4	615834	615834[INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL DOMINANT 26; MRD26]
FBgn0260938	tay	HGNC:29308		FBRSL1	3		
FBgn0260940	lsn	HGNC:17028	OMIM:610904	SNF8	14		
FBgn0260941	app	HGNC:20712		ZDHHC18	8		
FBgn0260941	app	HGNC:18472	OMIM:614586	ZDHHC5	3		
FBgn0260941	app	HGNC:20341	OMIM:619295	ZDHHC14	10		
FBgn0260941	app	HGNC:18475	OMIM:300646	ZDHHC9	6	300799	300799[INTELLECTUAL DEVELOPMENTAL DISORDER, X-LINKED, SYNDROMIC, RAYMOND TYPE; MRXSR]
FBgn0260942	bond	HGNC:26292	OMIM:614451	ELOVL7	5		
FBgn0260942	bond	HGNC:14416	OMIM:611814	ELOVL2	3		
FBgn0260942	bond	HGNC:14415	OMIM:605512	ELOVL4	3	133190,600110,614457	133190[SPINOCEREBELLAR ATAXIA 34; SCA34],600110[STARGARDT DISEASE 3; STGD3],614457[ICHTHYOSIS, SPASTIC QUADRIPLEGIA, AND MENTAL RETARDATION; ISQMR]
FBgn0260942	bond	HGNC:18047	OMIM:611815	ELOVL3	3		
FBgn0260942	bond	HGNC:14418	OMIM:611813	ELOVL1	5	618527	618527[ICHTHYOTIC KERATODERMA, SPASTICITY, HYPOMYELINATION, AND DYSMORPHIC FACIAL FEATURES; IKSHD]
FBgn0260942	bond	HGNC:21308	OMIM:611805	ELOVL5	3	615957	615957[SPINOCEREBELLAR ATAXIA 38; SCA38]
FBgn0260943	Rbp6	HGNC:7330	OMIM:603328	MSI1	11		
FBgn0260943	Rbp6	HGNC:2683	OMIM:607430	DAZAP1	3		
FBgn0260943	Rbp6	HGNC:18585	OMIM:607897	MSI2	13		
FBgn0260944	Rbp1	HGNC:10789	OMIM:600572	SRSF7	6		
FBgn0260944	Rbp1	HGNC:10785	OMIM:603364	SRSF3	8		
FBgn0260945	Atg1	HGNC:19703	OMIM:613472	ULK3	4		
FBgn0260945	Atg1	HGNC:12558	OMIM:603168	ULK1	13		
FBgn0260945	Atg1	HGNC:13480	OMIM:608650	ULK2	13		
FBgn0260959	MCPH1	HGNC:6954	OMIM:607117	MCPH1	10	251200	251200[MICROCEPHALY 1, PRIMARY, AUTOSOMAL RECESSIVE; MCPH1]
FBgn0260960	Baldspot	HGNC:15829	OMIM:611546	ELOVL6	15		
FBgn0260960	Baldspot	HGNC:18047	OMIM:611815	ELOVL3	9		
FBgn0260962	pic	HGNC:2717	OMIM:600045	DDB1	14	619426	619426[WHITE-KERNOHAN SYNDROME; WHIKERS]
FBgn0260964	Vmat	HGNC:10934	OMIM:193002	SLC18A1	13		
FBgn0260964	Vmat	HGNC:10935	OMIM:193001	SLC18A2	14	618049	618049[PARKINSONISM-DYSTONIA 2, INFANTILE-ONSET; PKDYS2]
FBgn0260964	Vmat	HGNC:10936	OMIM:600336	SLC18A3	3	617239	617239[MYASTHENIC SYNDROME, CONGENITAL, 21, PRESYNAPTIC; CMS21]
FBgn0260965	CG42588	HGNC:4665	OMIM:604883	GTF3C2	3		
FBgn0260970	Ubr3	HGNC:30467	OMIM:613831	UBR3	12		
FBgn0260971	CG42594	HGNC:19439	OMIM:613655	KCNK18	5	613656	613656[MIGRAINE WITH OR WITHOUT AURA, SUSCEPTIBILITY TO, 13; MGR13]
FBgn0260972	alc	HGNC:9379	OMIM:602741	PRKAB2	12		
FBgn0260972	alc	HGNC:9378	OMIM:602740	PRKAB1	13		
FBgn0260985	RfC4	HGNC:9970	OMIM:600404	RFC2	14		
FBgn0260987	vtd	HGNC:16271	OMIM:619533	RAD21L1	10		
FBgn0260987	vtd	HGNC:9811	OMIM:606462	RAD21	11	611376,614701	611376[MUNGAN SYNDROME; MGS],614701[CORNELIA DE LANGE SYNDROME 4 WITH OR WITHOUT MIDLINE BRAIN DEFECTS; CDLS4]
FBgn0260987	vtd	HGNC:16879	OMIM:608193	REC8	3		
FBgn0260990	yata	HGNC:14372	OMIM:607982	SCYL1	15	616719	616719[SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 21; SCAR21]
FBgn0260991	Incenp	HGNC:6058	OMIM:604411	INCENP	5		
FBgn0261016	clos	HGNC:1268	OMIM:612920	TSPEAR	6	614861,618180	614861[DEAFNESS, AUTOSOMAL RECESSIVE 98; DFNB98],618180[ECTODERMAL DYSPLASIA 14, HAIR/TOOTH TYPE WITH OR WITHOUT HYPOHIDROSIS; ECTD14]
FBgn0261020	wol	HGNC:20266	OMIM:604565	ALG5	14		
FBgn0261041	stj	HGNC:1399	OMIM:114204	CACNA2D1	5		
FBgn0261041	stj	HGNC:1400	OMIM:607082	CACNA2D2	4	618501	618501[CEREBELLAR ATROPHY WITH SEIZURES AND VARIABLE DEVELOPMENTAL DELAY; CASVDD]
FBgn0261041	stj	HGNC:15460	OMIM:606399	CACNA2D3	15		
FBgn0261041	stj	HGNC:20202	OMIM:608171	CACNA2D4	13	610478	610478[RETINAL CONE DYSTROPHY 4; RCD4]
FBgn0261046	Dscam3	HGNC:3039	OMIM:602523	DSCAM	9		
FBgn0261046	Dscam3	HGNC:14656	OMIM:611782	DSCAML1	9		
FBgn0261049	Vps45	HGNC:14579	OMIM:610035	VPS45	14	615285	615285[NEUTROPENIA, SEVERE CONGENITAL, 5, AUTOSOMAL RECESSIVE; SCN5]
FBgn0261064	Rbsn-5	HGNC:20759	OMIM:609511	RBSN	12		
FBgn0261065	Cpsf73	HGNC:2326	OMIM:606029	CPSF3	15	619876	619876[NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, HYPOTONIA, NYSTAGMUS, AND SEIZURES; NEDMHS]
FBgn0261067	LSm1	HGNC:20472	OMIM:607281	LSM1	14		
FBgn0261068	LSm7	HGNC:20470	OMIM:607287	LSM7	15		
FBgn0261085	Syt12	HGNC:19265	OMIM:613528	SYT9	3		
FBgn0261085	Syt12	HGNC:11511	OMIM:600327	SYT3	3		
FBgn0261085	Syt12	HGNC:19266		SYT10	3		
FBgn0261085	Syt12	HGNC:18381	OMIM:606436	SYT12	10		
FBgn0261086	Syt14	HGNC:23143	OMIM:610949	SYT14	9	614229	614229[SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 11; SCAR11]
FBgn0261086	Syt14	HGNC:23142	OMIM:610950	SYT16	11		
FBgn0261089	Sytalpha	HGNC:11510	OMIM:600104	SYT2	4	616040,619461	616040[MYASTHENIC SYNDROME, CONGENITAL, 7A, PRESYNAPTIC, AND DISTAL MOTOR NEUROPATHY, AUTOSOMAL DOMINANT; CMS7A],619461[MYASTHENIC SYNDROME, CONGENITAL, 7B, PRESYNAPTIC, AUTOSOMAL RECESSIVE; CMS7B]
FBgn0261089	Sytalpha	HGNC:19265	OMIM:613528	SYT9	4		
FBgn0261089	Sytalpha	HGNC:18638	OMIM:607718	SYT6	3		
FBgn0261089	Sytalpha	HGNC:11512	OMIM:600103	SYT4	3		
FBgn0261089	Sytalpha	HGNC:19239	OMIM:608741	SYT11	3		
FBgn0261089	Sytalpha	HGNC:11509	OMIM:185605	SYT1	4	618218	618218[BAKER-GORDON SYNDROME; BAGOS]
FBgn0261089	Sytalpha	HGNC:11514	OMIM:604146	SYT7	3		
FBgn0261089	Sytalpha	HGNC:11511	OMIM:600327	SYT3	4		
FBgn0261089	Sytalpha	HGNC:19266		SYT10	4		
FBgn0261089	Sytalpha	HGNC:11513	OMIM:600782	SYT5	4		
FBgn0261089	Sytalpha	HGNC:24119		SYT17	3		
FBgn0261089	Sytalpha	HGNC:19264	OMIM:607719	SYT8	4		
FBgn0261089	Sytalpha	HGNC:0		LOC102724488	3		
FBgn0261090	Sytbeta	HGNC:11510	OMIM:600104	SYT2	3	616040,619461	616040[MYASTHENIC SYNDROME, CONGENITAL, 7A, PRESYNAPTIC, AND DISTAL MOTOR NEUROPATHY, AUTOSOMAL DOMINANT; CMS7A],619461[MYASTHENIC SYNDROME, CONGENITAL, 7B, PRESYNAPTIC, AUTOSOMAL RECESSIVE; CMS7B]
FBgn0261090	Sytbeta	HGNC:19265	OMIM:613528	SYT9	5		
FBgn0261090	Sytbeta	HGNC:18638	OMIM:607718	SYT6	4		
FBgn0261090	Sytbeta	HGNC:11512	OMIM:600103	SYT4	3		
FBgn0261090	Sytbeta	HGNC:19239	OMIM:608741	SYT11	3		
FBgn0261090	Sytbeta	HGNC:11509	OMIM:185605	SYT1	3	618218	618218[BAKER-GORDON SYNDROME; BAGOS]
FBgn0261090	Sytbeta	HGNC:11514	OMIM:604146	SYT7	3		
FBgn0261090	Sytbeta	HGNC:11511	OMIM:600327	SYT3	5		
FBgn0261090	Sytbeta	HGNC:19266		SYT10	5		
FBgn0261090	Sytbeta	HGNC:11513	OMIM:600782	SYT5	3		
FBgn0261090	Sytbeta	HGNC:18381	OMIM:606436	SYT12	3		
FBgn0261090	Sytbeta	HGNC:14962	OMIM:607716	SYT13	3		
FBgn0261090	Sytbeta	HGNC:19264	OMIM:607719	SYT8	3		
FBgn0261090	Sytbeta	HGNC:0		LOC102724488	3		
FBgn0261108	Atg13	HGNC:29091	OMIM:615088	ATG13	11		
FBgn0261109	mrn	HGNC:4658	OMIM:601760	GTF2H4	14		
FBgn0261111	BHD	HGNC:27310	OMIM:607273	FLCN	13	114500,135150,144700,173600	114500[COLORECTAL CANCER; CRC],135150[BIRT-HOGG-DUBE SYNDROME; BHD],144700[RENAL CELL CARCINOMA, NONPAPILLARY; RCC],173600[PNEUMOTHORAX, PRIMARY SPONTANEOUS]
FBgn0261112	APP-BP1	HGNC:621	OMIM:603385	NAE1	15		
FBgn0261119	Prp19	HGNC:17896	OMIM:608330	PRPF19	15		
FBgn0261238	Alh	HGNC:1102	OMIM:604589	BRD1	3		
FBgn0261238	Alh	HGNC:16063	OMIM:602409	MLLT10	6	601626	601626[LEUKEMIA, ACUTE MYELOID; AML]
FBgn0261238	Alh	HGNC:7138	OMIM:600328	MLLT6	7		
FBgn0261238	Alh	HGNC:14255	OMIM:602410	BRPF1	3	617333	617333[INTELLECTUAL DEVELOPMENTAL DISORDER WITH DYSMORPHIC FACIES AND PTOSIS; IDDDFP]
FBgn0261238	Alh	HGNC:14256	OMIM:616856	BRPF3	3		
FBgn0261239	Hr39	HGNC:7985	OMIM:602778	NR6A1	3		
FBgn0261243	Psa	HGNC:500	OMIM:151530	ANPEP	3		
FBgn0261243	Psa	HGNC:18173	OMIM:606832	ERAP1	4		
FBgn0261243	Psa	HGNC:26904	OMIM:610046	LVRN	3		
FBgn0261243	Psa	HGNC:7900	OMIM:606793	NPEPPS	15		
FBgn0261243	Psa	HGNC:29499	OMIM:609497	ERAP2	4		
FBgn0261243	Psa	HGNC:6656	OMIM:151300	LNPEP	4		
FBgn0261243	Psa	HGNC:0		LOC440434	3		
FBgn0261244	inaE	HGNC:1165	OMIM:614015	DAGLA	13		
FBgn0261244	inaE	HGNC:28923	OMIM:614016	DAGLB	5		
FBgn0261258	rgn	HGNC:9951	OMIM:167770	REG1A	3		
FBgn0261260	mgl	HGNC:6694	OMIM:600073	LRP2	11	222448	222448[DONNAI-BARROW SYNDROME]
FBgn0261260	mgl	HGNC:6692	OMIM:107770	LRP1	4	604093	604093[KERATOSIS PILARIS ATROPHICANS; KPA]
FBgn0261260	mgl	HGNC:6693	OMIM:608766	LRP1B	5		
FBgn0261261	plx	HGNC:19165	OMIM:612465	TBC1D4	11	616087	616087[TYPE 2 DIABETES 5; T2D5]
FBgn0261261	plx	HGNC:11578	OMIM:609850	TBC1D1	10		
FBgn0261266	zuc	HGNC:30447	OMIM:614960	PLD6	12		
FBgn0261268	Cul3	HGNC:2555	OMIM:300304	CUL4B	3	300354	300354[INTELLECTUAL DEVELOPMENTAL DISORDER, X-LINKED, SYNDROMIC, CABEZAS TYPE; MRXSC]
FBgn0261268	Cul3	HGNC:2553	OMIM:603136	CUL3	13	614496,619239	614496[PSEUDOHYPOALDOSTERONISM, TYPE IIE; PHA2E],619239[NEURODEVELOPMENTAL DISORDER WITH OR WITHOUT AUTISM OR SEIZURES; NEDAUS]
FBgn0261268	Cul3	HGNC:2554	OMIM:603137	CUL4A	3		
FBgn0261269	conv	HGNC:5468	OMIM:601489	IGFALS	3	615961	615961[ACID-LABILE SUBUNIT DEFICIENCY; ACLSD]
FBgn0261270	Sps1	HGNC:19685	OMIM:600902	SEPHS1	15		
FBgn0261270	Sps1	HGNC:19686	OMIM:606218	SEPHS2	13		
FBgn0261274	Ero1L	HGNC:14355	OMIM:615437	ERO1B	13		
FBgn0261274	Ero1L	HGNC:13280	OMIM:615435	ERO1A	12		
FBgn0261276	Opa1	HGNC:8140	OMIM:605290	OPA1	14	125250,165500,210000,606657,616896	125250[OPTIC ATROPHY WITH OR WITHOUT DEAFNESS, OPHTHALMOPLEGIA, MYOPATHY, ATAXIA, AND NEUROPATHY],165500[OPTIC ATROPHY 1; OPA1],210000[BEHR SYNDROME; BEHRS],606657[GLAUCOMA, NORMAL TENSION, SUSCEPTIBILITY TO],616896[MITOCHONDRIAL DNA DEPLETION SYNDROME 14 (CARDIOENCEPHALOMYOPATHIC TYPE); MTDPS14]
FBgn0261278	grp	HGNC:1925	OMIM:603078	CHEK1	15		
FBgn0261279	lqfR	HGNC:23186	OMIM:607265	CLINT1	9		
FBgn0261279	lqfR	HGNC:29099	OMIM:611140	TELO2	5	616954	616954[YOU-HOOVER-FONG SYNDROME; YHFS]
FBgn0261283	SREBP	HGNC:11289	OMIM:184756	SREBF1	12	158310,619016	158310[MUCOEPITHELIAL DYSPLASIA, HEREDITARY; HMD],619016[IFAP SYNDROME 2; IFAP2]
FBgn0261283	SREBP	HGNC:11290	OMIM:600481	SREBF2	13		
FBgn0261285	Ppcs	HGNC:25686	OMIM:609853	PPCS	13	618189	618189[CARDIOMYOPATHY, DILATED, 2C; CMD2C]
FBgn0261286	Mat89Ba	HGNC:19910	OMIM:611532	NOL6	13		
FBgn0261353	Ccdc56	HGNC:24990	OMIM:614775	COA3	8	619058	619058[MITOCHONDRIAL COMPLEX IV DEFICIENCY, NUCLEAR TYPE 14; MC4DN14]
FBgn0261361	CG42638	HGNC:13358	OMIM:607400	MCOLN3	7		
FBgn0261361	CG42638	HGNC:13356	OMIM:605248	MCOLN1	6	252650	252650[MUCOLIPIDOSIS IV; ML4]
FBgn0261361	CG42638	HGNC:13357	OMIM:607399	MCOLN2	6		
FBgn0261380	mRpL37	HGNC:14034	OMIM:611843	MRPL37	12		
FBgn0261381	mtTFB1	HGNC:17037	OMIM:607033	TFB1M	13		
FBgn0261385	scra	HGNC:14082	OMIM:616027	ANLN	10	616032	616032[FOCAL SEGMENTAL GLOMERULOSCLEROSIS 8; FSGS8]
FBgn0261386	Gpa2	HGNC:18054	OMIM:609651	GPHA2	7		
FBgn0261387	CG17528	HGNC:19005	OMIM:613167	DCLK3	3		
FBgn0261387	CG17528	HGNC:19002	OMIM:613166	DCLK2	11		
FBgn0261387	CG17528	HGNC:2700	OMIM:604742	DCLK1	11		
FBgn0261387	CG17528	HGNC:2714	OMIM:300121	DCX	5	300067	300067[LISSENCEPHALY, X-LINKED, 1; LISX1]
FBgn0261387	CG17528	HGNC:1464	OMIM:114080	CAMK4	3		
FBgn0261393	alpha-Est5	HGNC:26741		CES4A	5		
FBgn0261393	alpha-Est5	HGNC:11764	OMIM:188450	TG	3	274700,608175	274700[THYROID DYSHORMONOGENESIS 3; TDH3],608175[AUTOIMMUNE THYROID DISEASE, SUSCEPTIBILITY TO, 3; AITD3]
FBgn0261393	alpha-Est5	HGNC:108	OMIM:100740	ACHE	4	112100	112100[YT BLOOD GROUP ANTIGEN]
FBgn0261393	alpha-Est5	HGNC:983	OMIM:177400	BCHE	3	617936	617936[BUTYRYLCHOLINESTERASE DEFICIENCY; BCHED]
FBgn0261393	alpha-Est5	HGNC:26459	OMIM:618678	CES5A	5		
FBgn0261393	alpha-Est5	HGNC:1863	OMIM:114835	CES1	5	618057	618057[DRUG METABOLISM, ALTERED, CES1-RELATED]
FBgn0261393	alpha-Est5	HGNC:1848	OMIM:114840	CEL	3	609812	609812[MATURITY-ONSET DIABETES OF THE YOUNG, TYPE 8, WITH EXOCRINE DYSFUNCTION; MODY8]
FBgn0261393	alpha-Est5	HGNC:1864	OMIM:605278	CES2	5		
FBgn0261393	alpha-Est5	HGNC:1865	OMIM:605279	CES3	5		
FBgn0261393	alpha-Est5	HGNC:14291	OMIM:600568	NLGN1	3	618830	618830[AUTISM, SUSCEPTIBILITY TO, 20; AUTS20]
FBgn0261393	alpha-Est5	HGNC:14289	OMIM:300336	NLGN3	3	300425,300494	300425[AUTISM, SUSCEPTIBILITY TO, X-LINKED 1; AUTSX1],300494[ASPERGER SYNDROME, X-LINKED, SUSCEPTIBILITY TO, 1; ASPGX1]
FBgn0261393	alpha-Est5	HGNC:14287	OMIM:300427	NLGN4X	3	300495,300497	300495[AUTISM, SUSCEPTIBILITY TO, X-LINKED 2; AUTSX2],300497[ASPERGER SYNDROME, X-LINKED, SUSCEPTIBILITY TO, 2; ASPGX2]
FBgn0261393	alpha-Est5	HGNC:14290	OMIM:606479	NLGN2	3		
FBgn0261394	Prosalpha3	HGNC:9533	OMIM:176846	PSMA4	15		
FBgn0261395	Prosalpha3T	HGNC:9533	OMIM:176846	PSMA4	8		
FBgn0261396	Rpn3	HGNC:9560	OMIM:617676	PSMD3	12		
FBgn0261397	didum	HGNC:7568	OMIM:160776	MYH10	3		
FBgn0261397	didum	HGNC:7603	OMIM:606540	MYO5B	11	251850,619868	251850[DIARRHEA 2, WITH MICROVILLUS ATROPHY, WITH OR WITHOUT CHOLESTASIS; DIAR2],619868[CHOLESTASIS, PROGRESSIVE FAMILIAL INTRAHEPATIC, 10; PFIC10]
FBgn0261397	didum	HGNC:7604	OMIM:610022	MYO5C	10		
FBgn0261397	didum	HGNC:7602	OMIM:160777	MYO5A	12	214450	214450[GRISCELLI SYNDROME, TYPE 1; GS1]
FBgn0261397	didum	HGNC:26234	OMIM:617379	MYO19	3		
FBgn0261399	Pp1-Y1	HGNC:9281	OMIM:176875	PPP1CA	3		
FBgn0261399	Pp1-Y1	HGNC:9283	OMIM:176914	PPP1CC	4		
FBgn0261399	Pp1-Y1	HGNC:9282	OMIM:600590	PPP1CB	4	617506	617506[NOONAN SYNDROME-LIKE DISORDER WITH LOOSE ANAGEN HAIR 2; NSLH2]
FBgn0261401	Ir75c	HGNC:4572	OMIM:138247	GRIA2	3	618917	618917[NEURODEVELOPMENTAL DISORDER WITH LANGUAGE IMPAIRMENT AND BEHAVIORAL ABNORMALITIES; NEDLIB]
FBgn0261401	Ir75c	HGNC:4573	OMIM:305915	GRIA3	3	300699	300699[INTELLECTUAL DEVELOPMENTAL DISORDER, X-LINKED, SYNDROMIC, WU TYPE; MRXSW]
FBgn0261401	Ir75c	HGNC:4571	OMIM:138248	GRIA1	3	619927,619931	619927[INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL DOMINANT 67; MRD67],619931[INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 76; MRT76]
FBgn0261401	Ir75c	HGNC:4574	OMIM:138246	GRIA4	3	617864	617864[NEURODEVELOPMENTAL DISORDER WITH OR WITHOUT SEIZURES AND GAIT ABNORMALITIES; NEDSGA]
FBgn0261402	Ir75b	HGNC:4575	OMIM:610659	GRID1	3		
FBgn0261403	sxc	HGNC:8127	OMIM:300255	OGT	13	300997	300997[INTELLECTUAL DEVELOPMENTAL DISORDER, X-LINKED 106; XLID106]
FBgn0261436	DhpD	HGNC:4212	OMIM:139260	GDA	15		
FBgn0261437	CSN8	HGNC:24335	OMIM:616011	COPS8	12		
FBgn0261439	SdhA	HGNC:10680	OMIM:600857	SDHA	15	252011,613642,614165,619259	252011[MITOCHONDRIAL COMPLEX II DEFICIENCY, NUCLEAR TYPE 1; MC2DN1],613642[CARDIOMYOPATHY, DILATED, 1GG; CMD1GG],614165[PARAGANGLIOMAS 5; PGL5],619259[NEURODEGENERATION WITH ATAXIA AND LATE-ONSET OPTIC ATROPHY; NDAXOA]
FBgn0261444	CG3638	HGNC:13476	OMIM:605784	TTYH1	12		
FBgn0261444	CG3638	HGNC:22222	OMIM:608919	TTYH3	11		
FBgn0261444	CG3638	HGNC:13877	OMIM:608855	TTYH2	10		
FBgn0261445	sgl	HGNC:12525	OMIM:603370	UGDH	15	618792	618792[DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 84; DEE84]
FBgn0261446	CG13377	HGNC:5209	OMIM:614232	HSD11B2	3	218030	218030[APPARENT MINERALOCORTICOID EXCESS; AME]
FBgn0261446	CG13377	HGNC:5211	OMIM:109685	HSD17B2	3		
FBgn0261456	hpo	HGNC:11406	OMIM:605030	STK3	13		
FBgn0261456	hpo	HGNC:11408	OMIM:604965	STK4	11	614868	614868[T-CELL IMMUNODEFICIENCY, RECURRENT INFECTIONS, AND AUTOIMMUNITY WITH OR WITHOUT CARDIAC MALFORMATIONS; TIIAC]
FBgn0261458	capt	HGNC:20039	OMIM:618385	CAP2	12		
FBgn0261458	capt	HGNC:20040	OMIM:617801	CAP1	14		
FBgn0261477	slim	HGNC:22194	OMIM:615152	KLHDC10	11		
FBgn0261479	nero	HGNC:28662	OMIM:611262	DOHH	13		
FBgn0261514	NimA	HGNC:33631	OMIM:610278	PEAR1	4		
FBgn0261524	lic	HGNC:6844	OMIM:601335	MAP2K4	3		
FBgn0261524	lic	HGNC:6846	OMIM:601254	MAP2K6	12		
FBgn0261524	lic	HGNC:6843	OMIM:602315	MAP2K3	11		
FBgn0261530	nbs	HGNC:7652	OMIM:602667	NBN	10	251260,609135,613065	251260[NIJMEGEN BREAKAGE SYNDROME; NBS],609135[APLASTIC ANEMIA],613065[LEUKEMIA, ACUTE LYMPHOBLASTIC; ALL]
FBgn0261532	cdm	HGNC:16853	OMIM:610411	IPO13	14		
FBgn0261534	l(2)34Fc	HGNC:27622	OMIM:611578	FRRS1	6		
FBgn0261535	l(2)34Fd	HGNC:25862	OMIM:616197	NOL10	14		
FBgn0261545	CG42663	HGNC:29321	OMIM:615104	NCKAP5L	3		
FBgn0261545	CG42663	HGNC:29847	OMIM:608789	NCKAP5	4		
FBgn0261547	Exn	HGNC:15590	OMIM:608504	ARHGEF15	4		
FBgn0261547	Exn	HGNC:7807	OMIM:605991	NGEF	5		
FBgn0261547	Exn	HGNC:15515	OMIM:618871	ARHGEF16	5		
FBgn0261547	Exn	HGNC:24490	OMIM:617552	ARHGEF26	3		
FBgn0261547	Exn	HGNC:13209	OMIM:600888	ARHGEF5	3		
FBgn0261547	Exn	HGNC:26604	OMIM:612496	ARHGEF19	3		
FBgn0261549	rdgA	HGNC:2857	OMIM:601441	DGKZ	14		
FBgn0261549	rdgA	HGNC:2855	OMIM:604072	DGKI	12		
FBgn0261550	Orp8	HGNC:16386	OMIM:606737	OSBPL9	3		
FBgn0261550	Orp8	HGNC:16397	OMIM:606739	OSBPL11	3		
FBgn0261550	Orp8	HGNC:16392	OMIM:606733	OSBPL5	12		
FBgn0261550	Orp8	HGNC:16396	OMIM:606736	OSBPL8	12		
FBgn0261552	ps	HGNC:7886	OMIM:602157	NOVA1	12		
FBgn0261552	ps	HGNC:7887	OMIM:601991	NOVA2	11	618859	618859[NEURODEVELOPMENTAL DISORDER WITH OR WITHOUT AUTISTIC FEATURES AND/OR STRUCTURAL BRAIN ABNORMALITIES; NEDASB]
FBgn0261554	CG42672	HGNC:29508	OMIM:615759	KIDINS220	10	617296,619501	617296[SPASTIC PARAPLEGIA, INTELLECTUAL DISABILITY, NYSTAGMUS, AND OBESITY; SINO],619501[VENTRICULOMEGALY AND ARTHROGRYPOSIS; VENARG]
FBgn0261554	CG42672	HGNC:24739		NKPD1	3		
FBgn0261555	CG42673	HGNC:16859	OMIM:605551	NOS1AP	10	619155	619155[NEPHROTIC SYNDROME, TYPE 22; NPHS22]
FBgn0261555	CG42673	HGNC:34351		C1orf226	3		
FBgn0261556	CG42674	HGNC:29105	OMIM:611101	PLEKHG5	6	611067,615376	611067[SPINAL MUSCULAR ATROPHY, DISTAL, AUTOSOMAL RECESSIVE, 4; DSMA4],615376[CHARCOT-MARIE-TOOTH DISEASE, RECESSIVE INTERMEDIATE C; CMTRIC]
FBgn0261556	CG42674	HGNC:25562	OMIM:611743	PLEKHG6	5		
FBgn0261560	Thor	HGNC:3290	OMIM:603483	EIF4EBP3	11		
FBgn0261560	Thor	HGNC:3289	OMIM:602224	EIF4EBP2	13		
FBgn0261560	Thor	HGNC:3288	OMIM:602223	EIF4EBP1	12		
FBgn0261561	CG42675	HGNC:24277		ZC2HC1A	5		
FBgn0261561	CG42675	HGNC:21174		ZC2HC1B	4		
FBgn0261563	wb	HGNC:6483	OMIM:600805	LAMA3	4	245660,619783,619784	245660[EPIDERMOLYSIS BULLOSA, JUNCTIONAL 2C, LARYNGOONYCHOCUTANEOUS; JEB2C],619783[EPIDERMOLYSIS BULLOSA, JUNCTIONAL 2A, INTERMEDIATE; JEB2A],619784[EPIDERMOLYSIS BULLOSA, JUNCTIONAL 2B, SEVERE; JEB2B]
FBgn0261563	wb	HGNC:6481	OMIM:150320	LAMA1	9	615960	615960[PORETTI-BOLTSHAUSER SYNDROME; PTBHS]
FBgn0261563	wb	HGNC:6482	OMIM:156225	LAMA2	8	607855,618138	607855[MUSCULAR DYSTROPHY, CONGENITAL MEROSIN-DEFICIENT, 1A; MDC1A],618138[MUSCULAR DYSTROPHY, LIMB-GIRDLE, AUTOSOMAL RECESSIVE 23; LGMDR23]
FBgn0261563	wb	HGNC:6485	OMIM:601033	LAMA5	3		
FBgn0261564	ReepA	HGNC:26176	OMIM:609349	REEP4	8		
FBgn0261564	ReepA	HGNC:23711	OMIM:609348	REEP3	7		
FBgn0261564	ReepA	HGNC:17975	OMIM:609347	REEP2	9	615625	615625[SPASTIC PARAPLEGIA 72, AUTOSOMAL RECESSIVE; SPG72]
FBgn0261564	ReepA	HGNC:25786	OMIM:609139	REEP1	8	610250,614751,620011	610250[SPASTIC PARAPLEGIA 31, AUTOSOMAL DOMINANT; SPG31],614751[NEURONOPATHY, DISTAL HEREDITARY MOTOR, TYPE VB; HMN5B],620011[SPINAL MUSCULAR ATROPHY, DISTAL, AUTOSOMAL RECESSIVE, 6; DSMA6]
FBgn0261565	Lmpt	HGNC:3703	OMIM:602633	FHL2	3		
FBgn0261570	raskol	HGNC:11497	OMIM:603384	SYNGAP1	9	612621	612621[INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL DOMINANT 5; MRD5]
FBgn0261570	raskol	HGNC:9874	OMIM:606136	RASAL2	10		
FBgn0261570	raskol	HGNC:26129	OMIM:616561	RASAL3	6		
FBgn0261570	raskol	HGNC:17294	OMIM:609205	DAB2IP	10		
FBgn0261573	CoRest	HGNC:17441	OMIM:607675	RCOR1	11		
FBgn0261573	CoRest	HGNC:27455	OMIM:616019	RCOR2	11		
FBgn0261573	CoRest	HGNC:25594		RCOR3	10		
FBgn0261574	kug	HGNC:3595	OMIM:600976	FAT1	12		
FBgn0261574	kug	HGNC:23112	OMIM:612483	FAT3	13		
FBgn0261574	kug	HGNC:3596	OMIM:604269	FAT2	11	617769	617769[SPINOCEREBELLAR ATAXIA 45; SCA45]
FBgn0261575	tobi	HGNC:19918	OMIM:618255	MYORG	14	618317	618317[BASAL GANGLIA CALCIFICATION, IDIOPATHIC, 7, AUTOSOMAL RECESSIVE; IBGC7]
FBgn0261588	pdm3	HGNC:21694	OMIM:609062	POU6F2	5	601583	601583[WILMS TUMOR 5; WT5]
FBgn0261588	pdm3	HGNC:9224	OMIM:618043	POU6F1	6		
FBgn0261592	RpS6	HGNC:10429	OMIM:180460	RPS6	14		
FBgn0261596	RpS24	HGNC:10411	OMIM:602412	RPS24	13	610629	610629[DIAMOND-BLACKFAN ANEMIA 3; DBA3]
FBgn0261597	RpS26	HGNC:10414	OMIM:603701	RPS26	14	613309	613309[DIAMOND-BLACKFAN ANEMIA 10; DBA10]
FBgn0261597	RpS26	HGNC:31817		RPS26P11	5		
FBgn0261597	RpS26	HGNC:0		LOC100996747	3		
FBgn0261599	RpS29	HGNC:10419	OMIM:603633	RPS29	13	615909	615909[DIAMOND-BLACKFAN ANEMIA 13; DBA13]
FBgn0261602	RpL8	HGNC:14056	OMIM:611822	MRPL2	3		
FBgn0261602	RpL8	HGNC:10368	OMIM:604177	RPL8	13		
FBgn0261608	RpL37A	HGNC:10348	OMIM:613314	RPL37A	12		
FBgn0261608	RpL37A	HGNC:35645		RPL37AP8	3		
FBgn0261609	eIF2alpha	HGNC:3265	OMIM:603907	EIF2S1	13		
FBgn0261610	CG42699	HGNC:21107	OMIM:610201	CEP162	5		
FBgn0261612	CngA	HGNC:2152	OMIM:609472	CNGA4	9		
FBgn0261612	CngA	HGNC:2150	OMIM:600053	CNGA3	14	216900	216900[ACHROMATOPSIA 2; ACHM2]
FBgn0261612	CngA	HGNC:2149	OMIM:300338	CNGA2	13		
FBgn0261612	CngA	HGNC:2148	OMIM:123825	CNGA1	12	613756	613756[RETINITIS PIGMENTOSA 49; RP49]
FBgn0261617	nej	HGNC:2348	OMIM:600140	CREBBP	12	180849,618332	180849[RUBINSTEIN-TAYBI SYNDROME 1; RSTS1],618332[MENKE-HENNEKAM SYNDROME 1; MKHK1]
FBgn0261617	nej	HGNC:3373	OMIM:602700	EP300	12	114500,613684,618333	114500[COLORECTAL CANCER; CRC],613684[RUBINSTEIN-TAYBI SYNDROME 2; RSTS2],618333[MENKE-HENNEKAM SYNDROME 2; MKHK2]
FBgn0261618	larp	HGNC:24704		LARP1B	11		
FBgn0261618	larp	HGNC:29531	OMIM:612059	LARP1	10		
FBgn0261624	I-3	HGNC:9285	OMIM:606670	PPP1R11	9		
FBgn0261625	GLS	HGNC:4331	OMIM:138280	GLS	14	618328,618339,618412	618328[DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 71; DEE71],618339[INFANTILE CATARACT, SKIN ABNORMALITIES, GLUTAMATE EXCESS, AND IMPAIRED INTELLECTUAL DEVELOPMENT; CASGID],618412[GLOBAL DEVELOPMENTAL DELAY, PROGRESSIVE ATAXIA, AND ELEVATED GLUTAMINE; GDPAG]
FBgn0261625	GLS	HGNC:29570	OMIM:606365	GLS2	13		
FBgn0261641	CG42724	HGNC:15630	OMIM:605409	TCERG1	12		
FBgn0261641	CG42724	HGNC:23533		TCERG1L	6		
FBgn0261647	Axud1	HGNC:14300	OMIM:606458	CSRNP1	9		
FBgn0261647	Axud1	HGNC:30729		CSRNP3	9		
FBgn0261647	Axud1	HGNC:16006		CSRNP2	9		
FBgn0261648	salm	HGNC:10524	OMIM:602218	SALL1	12	107480	107480[TOWNES-BROCKS SYNDROME 1; TBS1]
FBgn0261648	salm	HGNC:10527	OMIM:605079	SALL3	12		
FBgn0261648	salm	HGNC:10526	OMIM:602219	SALL2	8	216820	216820[COLOBOMA, OCULAR, AUTOSOMAL RECESSIVE]
FBgn0261648	salm	HGNC:15924	OMIM:607343	SALL4	10	147750,607323	147750[IVIC SYNDROME; IVIC],607323[DUANE-RADIAL RAY SYNDROME; DRRS]
FBgn0261671	tweek	HGNC:26953	OMIM:611565	BLTP1	11	617822	617822[ALKURAYA-KUCINSKAS SYNDROME; ALKKUCS]
FBgn0261673	nemy	HGNC:20797	OMIM:605745	CYBRD1	5		
FBgn0261673	nemy	HGNC:2571	OMIM:600019	CYB561	5	618182	618182[ORTHOSTATIC HYPOTENSION 2; ORTHYP2]
FBgn0261673	nemy	HGNC:23014	OMIM:618757	CYB561A3	5		
FBgn0261675	Npc1b	HGNC:7898	OMIM:608010	NPC1L1	6	617966	617966[LOW DENSITY LIPOPROTEIN CHOLESTEROL LEVEL QUANTITATIVE TRAIT LOCUS 7; LDLCQ7]
FBgn0261675	Npc1b	HGNC:7897	OMIM:607623	NPC1	9	257220	257220[NIEMANN-PICK DISEASE, TYPE C1; NPC1]
FBgn0261683	B9d2	HGNC:28636	OMIM:611951	B9D2	9	614175	614175[MECKEL SYNDROME, TYPE 10; MKS10]
FBgn0261697	tctn	HGNC:24519	OMIM:613847	TCTN3	7	258860,614815	258860[OROFACIODIGITAL SYNDROME IV; OFD4],614815[JOUBERT SYNDROME 18; JBTS18]
FBgn0261697	tctn	HGNC:26113	OMIM:609863	TCTN1	5	614173	614173[JOUBERT SYNDROME 13; JBTS13]
FBgn0261698	SLO2	HGNC:18866	OMIM:610044	KCNT2	13	617771	617771[DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 57; DEE57]
FBgn0261698	SLO2	HGNC:18865	OMIM:608167	KCNT1	14	614959,615005	614959[DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 14; DEE14],615005[EPILEPSY, NOCTURNAL FRONTAL LOBE, 5; ENFL5]
FBgn0261703	gce	HGNC:701	OMIM:602550	ARNTL	4		
FBgn0261703	gce	HGNC:18984	OMIM:614517	ARNTL2	4		
FBgn0261705	CG42741	HGNC:6346	OMIM:607531	KLF12	3		
FBgn0261705	CG42741	HGNC:16516	OMIM:609392	KLF3	3		
FBgn0261705	CG42741	HGNC:6351	OMIM:300286	KLF8	5		
FBgn0261710	nocte	HGNC:13918	OMIM:142580	PRRC2A	5		
FBgn0261710	nocte	HGNC:24903	OMIM:617373	PRRC2C	4		
FBgn0261710	nocte	HGNC:28121	OMIM:619544	PRRC2B	4		
FBgn0261722	fwe	HGNC:1365	OMIM:613104	CACFD1	12		
FBgn0261723	Dbx	HGNC:33185	OMIM:619830	DBX1	8		
FBgn0261723	Dbx	HGNC:33186		DBX2	3		
FBgn0261787	brun	HGNC:30832	OMIM:611966	TRAPPC9	14	613192	613192[INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 13; MRT13]
FBgn0261788	Ank2	HGNC:492	OMIM:612641	ANK1	5	182900	182900[SPHEROCYTOSIS, TYPE 1; SPH1]
FBgn0261788	Ank2	HGNC:493	OMIM:106410	ANK2	6	600919	600919[CARDIAC ARRHYTHMIA, ANKYRIN-B-RELATED]
FBgn0261788	Ank2	HGNC:494	OMIM:600465	ANK3	5	615493	615493[INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 37; MRT37]
FBgn0261788	Ank2	HGNC:25259		ANKRD44	3		
FBgn0261789	SmD2	HGNC:11159	OMIM:601061	SNRPD2	14		
FBgn0261790	SmE	HGNC:11161	OMIM:128260	SNRPE	13	615059	615059[HYPOTRICHOSIS 11; HYPT11]
FBgn0261791	SNRPG	HGNC:11163	OMIM:603542	SNRPG	13		
FBgn0261791	SNRPG	HGNC:49371		SNRPGP15	4		
FBgn0261792	snRNP-U1-C	HGNC:11157	OMIM:603522	SNRPC	12		
FBgn0261793	Trf2	HGNC:11589	OMIM:605521	TBPL1	9		
FBgn0261794	kcc	HGNC:10914	OMIM:604878	SLC12A6	13	218000	218000[AGENESIS OF THE CORPUS CALLOSUM WITH PERIPHERAL NEUROPATHY; ACCPN]
FBgn0261794	kcc	HGNC:10913	OMIM:604119	SLC12A4	15		
FBgn0261794	kcc	HGNC:13818	OMIM:606726	SLC12A5	12	616645,616685	616645[DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 34; DEE34],616685[EPILEPSY, IDIOPATHIC GENERALIZED, SUSCEPTIBILITY TO, 14; EIG14]
FBgn0261794	kcc	HGNC:10915	OMIM:604879	SLC12A7	12		
FBgn0261797	Dhc64C	HGNC:2961	OMIM:600112	DYNC1H1	15	158600,614228,614563	158600[SPINAL MUSCULAR ATROPHY, LOWER EXTREMITY-PREDOMINANT, 1, AUTOSOMAL DOMINANT; SMALED1],614228[CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2O; CMT2O],614563[INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL DOMINANT 13; MRD13]
FBgn0261797	Dhc64C	HGNC:2962	OMIM:603297	DYNC2H1	3	613091	613091[SHORT-RIB THORACIC DYSPLASIA 3 WITH OR WITHOUT POLYDACTYLY; SRTD3]
FBgn0261800	LanB1	HGNC:6491	OMIM:616380	LAMB4	7		
FBgn0261800	LanB1	HGNC:6486	OMIM:150240	LAMB1	12	615191	615191[LISSENCEPHALY 5; LIS5]
FBgn0261800	LanB1	HGNC:6487	OMIM:150325	LAMB2	13	609049,614199	609049[PIERSON SYNDROME; PIERS],614199[NEPHROTIC SYNDROME, TYPE 5, WITH OR WITHOUT OCULAR ABNORMALITIES; NPHS5]
FBgn0261800	LanB1	HGNC:13658	OMIM:610401	NTN4	3		
FBgn0261800	LanB1	HGNC:6490	OMIM:150310	LAMB3	3	104530,226650,226700	104530[AMELOGENESIS IMPERFECTA, TYPE IA; AI1A],226650[EPIDERMOLYSIS BULLOSA, JUNCTIONAL 1A, INTERMEDIATE; JEB1A],226700[EPIDERMOLYSIS BULLOSA, JUNCTIONAL 1B, SEVERE; JEB1B]
FBgn0261802	CG42748	HGNC:37284		AJM1	6		
FBgn0261804	CG42750	HGNC:23028	OMIM:609925	DPEP2	8		
FBgn0261804	CG42750	HGNC:3002	OMIM:179780	DPEP1	6		
FBgn0261804	CG42750	HGNC:23029	OMIM:609926	DPEP3	6		
FBgn0261808	cu	HGNC:25386	OMIM:616519	PDE12	3		
FBgn0261808	cu	HGNC:14254	OMIM:608468	NOCT	12		
FBgn0261811	pico	HGNC:14436	OMIM:609035	RAPH1	10		
FBgn0261811	pico	HGNC:17379	OMIM:609036	APBB1IP	7		
FBgn0261811	pico	HGNC:4567	OMIM:601522	GRB7	3		
FBgn0261811	pico	HGNC:4564	OMIM:601523	GRB10	3		
FBgn0261811	pico	HGNC:4565	OMIM:601524	GRB14	3		
FBgn0261822	Bsg	HGNC:1116	OMIM:109480	BSG	7	111380	111380[BLOOD GROUP--OK; OK]
FBgn0261822	Bsg	HGNC:17867	OMIM:612820	NPTN	8		
FBgn0261822	Bsg	HGNC:30465	OMIM:615669	EMB	4		
FBgn0261823	Asx	HGNC:23805	OMIM:612991	ASXL2	7	617190	617190[SHASHI-PENA SYNDROME; SHAPNS]
FBgn0261823	Asx	HGNC:18318	OMIM:612990	ASXL1	6	605039,614286	605039[BOHRING-OPITZ SYNDROME; BOPS],614286[MYELODYSPLASTIC SYNDROME; MDS]
FBgn0261823	Asx	HGNC:29357	OMIM:615115	ASXL3	8	615485	615485[BAINBRIDGE-ROPERS SYNDROME; BRPS]
FBgn0261836	Msp300	HGNC:17089	OMIM:608441	SYNE1	5	610743,612998,618484	610743[SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 8; SCAR8],612998[EMERY-DREIFUSS MUSCULAR DYSTROPHY 4, AUTOSOMAL DOMINANT; EDMD4],618484[ARTHROGRYPOSIS MULTIPLEX CONGENITA 3, MYOGENIC TYPE; AMC3]
FBgn0261836	Msp300	HGNC:17084	OMIM:608442	SYNE2	4	612999	612999[EMERY-DREIFUSS MUSCULAR DYSTROPHY 5, AUTOSOMAL DOMINANT; EDMD5]
FBgn0261836	Msp300	HGNC:19972	OMIM:611121	CLMN	3		
FBgn0261848	CG42780	HGNC:21245		PI16	3		
FBgn0261848	CG42780	HGNC:28392	OMIM:610395	GLIPR1L1	3		
FBgn0261848	CG42780	HGNC:16904	OMIM:618062	CRISP3	3		
FBgn0261848	CG42780	HGNC:304	OMIM:601193	CRISP1	3		
FBgn0261848	CG42780	HGNC:12024	OMIM:187430	CRISP2	3		
FBgn0261848	CG42780	HGNC:33849	OMIM:616572	CLEC18B	3		
FBgn0261848	CG42780	HGNC:30388	OMIM:616571	CLEC18A	3		
FBgn0261850	Xpd	HGNC:3434	OMIM:126340	ERCC2	14	278730,601675,610756	278730[XERODERMA PIGMENTOSUM, COMPLEMENTATION GROUP D; XPD],601675[TRICHOTHIODYSTROPHY 1, PHOTOSENSITIVE; TTD1],610756[CEREBROOCULOFACIOSKELETAL SYNDROME 2; COFS2]
FBgn0261854	aPKC	HGNC:9412	OMIM:176982	PRKCZ	9		
FBgn0261854	aPKC	HGNC:9404	OMIM:600539	PRKCI	12		
FBgn0261859	CG42788	HGNC:29159	OMIM:616919	FRMPD1	5		
FBgn0261859	CG42788	HGNC:29382	OMIM:301005	FRMPD3	5		
FBgn0261859	CG42788	HGNC:29007	OMIM:300838	FRMPD4	9	300983	300983[INTELLECTUAL DEVELOPMENTAL DISORDER, X-LINKED 104; XLID104]
FBgn0261862	whd	HGNC:2328	OMIM:600528	CPT1A	13	255120	255120[CARNITINE PALMITOYLTRANSFERASE I DEFICIENCY]
FBgn0261862	whd	HGNC:18540	OMIM:608846	CPT1C	11	616282	616282[SPASTIC PARAPLEGIA 73, AUTOSOMAL DOMINANT; SPG73]
FBgn0261862	whd	HGNC:2329	OMIM:601987	CPT1B	12		
FBgn0261872	scaf6	HGNC:16930	OMIM:618539	CHERP	12		
FBgn0261873	sdt	HGNC:26542	OMIM:610973	MPP7	3		
FBgn0261873	sdt	HGNC:7221	OMIM:601114	MPP3	3		
FBgn0261873	sdt	HGNC:18669	OMIM:606958	MPP5	12		
FBgn0261881	Ankrd49	HGNC:25970	OMIM:619571	ANKRD49	13		
FBgn0261885	osa	HGNC:18040	OMIM:614556	ARID1B	12	135900	135900[COFFIN-SIRIS SYNDROME 1; CSS1]
FBgn0261885	osa	HGNC:11110	OMIM:603024	ARID1A	12	614607	614607[COFFIN-SIRIS SYNDROME 2; CSS2]
FBgn0261928	CG42795	HGNC:29164	OMIM:615077	TBC1D30	6		
FBgn0261928	CG42795	HGNC:29183	OMIM:619152	TBC1D2B	3	619323	619323[NEURODEVELOPMENTAL DISORDER WITH SEIZURES AND GINGIVAL OVERGROWTH; NEDSGO]
FBgn0261928	CG42795	HGNC:18026	OMIM:609871	TBC1D2	3		
FBgn0261929	5-HT2B	HGNC:5294	OMIM:601122	HTR2B	5		
FBgn0261929	5-HT2B	HGNC:5295	OMIM:312861	HTR2C	5		
FBgn0261929	5-HT2B	HGNC:5293	OMIM:182135	HTR2A	5	103780,164230,181500,606788,608516	103780[ALCOHOL DEPENDENCE],164230[OBSESSIVE-COMPULSIVE DISORDER; OCD],181500[SCHIZOPHRENIA; SCZD],606788[ANOREXIA NERVOSA, SUSCEPTIBILITY TO; ANON],608516[MAJOR DEPRESSIVE DISORDER; MDD]
FBgn0261930	vnd	HGNC:7835	OMIM:604612	NKX2-2	10		
FBgn0261930	vnd	HGNC:16364	OMIM:603245	NKX2-8	5		
FBgn0261931	Hecw	HGNC:29853	OMIM:617245	HECW2	8	617268	617268[NEURODEVELOPMENTAL DISORDER WITH HYPOTONIA, SEIZURES, AND ABSENT LANGUAGE; NDHSAL]
FBgn0261931	Hecw	HGNC:22195	OMIM:610384	HECW1	6		
FBgn0261933	SmD1	HGNC:11158	OMIM:601063	SNRPD1	14		
FBgn0261934	dikar	HGNC:1840	OMIM:607576	CECR2	5		
FBgn0261938	PolrMT	HGNC:9200	OMIM:601778	POLRMT	15	619743	619743[COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 55; COXPD55]
FBgn0261952	srw	HGNC:12429	OMIM:605049	TWSG1	6		
FBgn0261953	TfAP-2	HGNC:30774	OMIM:614428	TFAP2E	10		
FBgn0261953	TfAP-2	HGNC:15581	OMIM:610161	TFAP2D	9		
FBgn0261953	TfAP-2	HGNC:11744	OMIM:601602	TFAP2C	10		
FBgn0261953	TfAP-2	HGNC:11743	OMIM:601601	TFAP2B	9	169100,617035	169100[CHAR SYNDROME; CHAR],617035[PATENT DUCTUS ARTERIOSUS 2; PDA2]
FBgn0261953	TfAP-2	HGNC:11742	OMIM:107580	TFAP2A	12	113620	113620[BRANCHIOOCULOFACIAL SYNDROME; BOFS]
FBgn0261955	kdn	HGNC:2422	OMIM:118950	CS	14		
FBgn0261963	mid	HGNC:11515	OMIM:601397	TBXT	3	182940,615709	182940[NEURAL TUBE DEFECTS, SUSCEPTIBILITY TO; NTD],615709[SACRAL AGENESIS WITH VERTEBRAL ANOMALIES; SAVA]
FBgn0261963	mid	HGNC:11605	OMIM:602427	TBX6	3	122600	122600[SPONDYLOCOSTAL DYSOSTOSIS 5; SCDO5]
FBgn0261963	mid	HGNC:11598	OMIM:606061	TBX20	10	611363	611363[ATRIAL SEPTAL DEFECT 4; ASD4]
FBgn0261963	mid	HGNC:11594	OMIM:604127	TBX15	3	260660	260660[COUSIN SYNDROME]
FBgn0261963	mid	HGNC:11595	OMIM:604613	TBX18	3	143400	143400[CONGENITAL ANOMALIES OF KIDNEY AND URINARY TRACT 2; CAKUT2]
FBgn0261963	mid	HGNC:11600	OMIM:300307	TBX22	3	302905,303400	302905[ABRUZZO-ERICKSON SYNDROME; ABERS],303400[CLEFT PALATE WITH OR WITHOUT ANKYLOGLOSSIA, X-LINKED; CPX]
FBgn0261963	mid	HGNC:11596	OMIM:604614	TBX19	3	201400	201400[ACTH DEFICIENCY, ISOLATED; IAD]
FBgn0261963	mid	HGNC:14010	OMIM:616061	MGA	3		
FBgn0261976	Psf2	HGNC:24575	OMIM:610609	GINS2	14		
FBgn0261983	l(2)gd1	HGNC:30237	OMIM:610055	CC2D1A	14	608443	608443[INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 3; MRT3]
FBgn0261983	l(2)gd1	HGNC:29386		CC2D1B	12		
FBgn0261984	Ire1	HGNC:16942	OMIM:604034	ERN2	13		
FBgn0261984	Ire1	HGNC:3449	OMIM:604033	ERN1	12		
FBgn0261985	Ptpmeg	HGNC:9655	OMIM:176877	PTPN3	10		
FBgn0261985	Ptpmeg	HGNC:9656	OMIM:176878	PTPN4	13		
FBgn0261986	RASSF8	HGNC:13232	OMIM:608231	RASSF8	12		
FBgn0261986	RASSF8	HGNC:1166	OMIM:143023	RASSF7	9		
FBgn0261987	Pxt	HGNC:14966	OMIM:605158	PXDN	3	269400	269400[ANTERIOR SEGMENT DYSGENESIS 7; ASGD7]
FBgn0261987	Pxt	HGNC:26359	OMIM:615904	PXDNL	3		
FBgn0261988	Gprk2	HGNC:4543	OMIM:137026	GRK4	12		
FBgn0261988	Gprk2	HGNC:4545	OMIM:600869	GRK6	12		
FBgn0261988	Gprk2	HGNC:289	OMIM:109635	GRK2	3		
FBgn0261988	Gprk2	HGNC:4544	OMIM:600870	GRK5	15		
FBgn0261988	Gprk2	HGNC:17031	OMIM:606987	GRK7	3		
FBgn0261988	Gprk2	HGNC:10013	OMIM:180381	GRK1	3	613411	613411[OGUCHI DISEASE 2]
FBgn0261995	CG42813	HGNC:20141	OMIM:609219	NUDT14	13		
FBgn0261996	CG42814	HGNC:20141	OMIM:609219	NUDT14	9		
FBgn0261998	CG42816	HGNC:33	OMIM:601615	ABCA3	4	610921	610921[SURFACTANT METABOLISM DYSFUNCTION, PULMONARY, 3; SMDP3]
FBgn0261998	CG42816	HGNC:14637	OMIM:607800	ABCA12	3	242500,601277	242500[ICHTHYOSIS, CONGENITAL, AUTOSOMAL RECESSIVE 4B; ARCI4B],601277[ICHTHYOSIS, CONGENITAL, AUTOSOMAL RECESSIVE 4A; ARCI4A]
FBgn0261998	CG42816	HGNC:30	OMIM:612508	ABCA10	3		
FBgn0261998	CG42816	HGNC:36	OMIM:612504	ABCA6	3		
FBgn0261999	Ca-Ma2d	HGNC:1399	OMIM:114204	CACNA2D1	4		
FBgn0261999	Ca-Ma2d	HGNC:1400	OMIM:607082	CACNA2D2	4	618501	618501[CEREBELLAR ATROPHY WITH SEIZURES AND VARIABLE DEVELOPMENTAL DELAY; CASVDD]
FBgn0261999	Ca-Ma2d	HGNC:15460	OMIM:606399	CACNA2D3	9		
FBgn0261999	Ca-Ma2d	HGNC:20202	OMIM:608171	CACNA2D4	9	610478	610478[RETINAL CONE DYSTROPHY 4; RCD4]
FBgn0262009	CG42827	HGNC:11248	OMIM:613941	SPINT3	3		
FBgn0262009	CG42827	HGNC:11761	OMIM:600033	TFPI2	4		
FBgn0262009	CG42827	HGNC:11760	OMIM:152310	TFPI	4		
FBgn0262010	CG42828	HGNC:11248	OMIM:613941	SPINT3	3		
FBgn0262017	CG42830	HGNC:25744	OMIM:615164	AKIRIN1	4		
FBgn0262017	CG42830	HGNC:21407	OMIM:615165	AKIRIN2	4		
FBgn0262081	Csk	HGNC:2444	OMIM:124095	CSK	8		
FBgn0262081	Csk	HGNC:6906	OMIM:600038	MATK	4		
FBgn0262103	Sik3	HGNC:21680	OMIM:608973	SIK2	3		
FBgn0262103	Sik3	HGNC:29165	OMIM:614776	SIK3	3	618162	618162[SPONDYLOEPIMETAPHYSEAL DYSPLASIA, KRAKOW TYPE; SEMDK]
FBgn0262103	Sik3	HGNC:11142	OMIM:605705	SIK1	3	616341	616341[DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 30; DEE30]
FBgn0262103	Sik3	HGNC:0		SIK1B	3		
FBgn0262111	f	HGNC:13281	OMIM:606351	ESPN	6	609006,618632	609006[DEAFNESS, AUTOSOMAL RECESSIVE 36, WITH OR WITHOUT VESTIBULAR INVOLVEMENT; DFNB36],618632[USHER SYNDROME, TYPE 1M; USH1M]
FBgn0262111	f	HGNC:27937	OMIM:619974	ESPNL	3		
FBgn0262112	sro	HGNC:1027	OMIM:603063	BDH1	5		
FBgn0262112	sro	HGNC:5209	OMIM:614232	HSD11B2	5	218030	218030[APPARENT MINERALOCORTICOID EXCESS; AME]
FBgn0262112	sro	HGNC:16888	OMIM:612131	DHRS9	3		
FBgn0262112	sro	HGNC:23316	OMIM:606623	HSD17B6	3		
FBgn0262112	sro	HGNC:29674		RDH16	3		
FBgn0262112	sro	HGNC:29958	OMIM:609769	SDR9C7	4	617574	617574[ICHTHYOSIS, CONGENITAL, AUTOSOMAL RECESSIVE 13; ARCI13]
FBgn0262112	sro	HGNC:5211	OMIM:109685	HSD17B2	4		
FBgn0262112	sro	HGNC:9940	OMIM:601617	RDH5	3	136880	136880[FUNDUS ALBIPUNCTATUS]
FBgn0262114	RanBPM	HGNC:29285	OMIM:614031	RANBP10	12		
FBgn0262114	RanBPM	HGNC:13727	OMIM:603854	RANBP9	13		
FBgn0262115	CG17683	HGNC:14179	OMIM:611118	CIAO3	15		
FBgn0262115	CG17683	HGNC:29916	OMIM:605349	NARF	9		
FBgn0262116	RNASEK	HGNC:33911	OMIM:617098	RNASEK	11		
FBgn0262117	IntS3	HGNC:26153	OMIM:611347	INTS3	14		
FBgn0262123	l(2)41Ab	HGNC:26090	OMIM:613799	CCDC40	14	613808	613808[CILIARY DYSKINESIA, PRIMARY, 15; CILD15]
FBgn0262124	uex	HGNC:103	OMIM:607803	CNNM2	12	613882,616418	613882[HYPOMAGNESEMIA 6, RENAL; HOMG6],616418[HYPOMAGNESEMIA, SEIZURES, AND MENTAL RETARDATION 1; HOMGSMR1]
FBgn0262124	uex	HGNC:102	OMIM:607802	CNNM1	10		
FBgn0262124	uex	HGNC:105	OMIM:607805	CNNM4	12	217080	217080[JALILI SYNDROME]
FBgn0262124	uex	HGNC:104	OMIM:607804	CNNM3	8		
FBgn0262125	Sec23	HGNC:10702	OMIM:610512	SEC23B	13	224100,616858	224100[ANEMIA, CONGENITAL DYSERYTHROPOIETIC, TYPE II; CDAN2],616858[COWDEN SYNDROME 7; CWS7]
FBgn0262125	Sec23	HGNC:10701	OMIM:610511	SEC23A	14	607812	607812[CRANIOLENTICULOSUTURAL DYSPLASIA; CLSD]
FBgn0262126	Sec24CD	HGNC:10705	OMIM:607185	SEC24C	13		
FBgn0262126	Sec24CD	HGNC:10706	OMIM:607186	SEC24D	12	616294	616294[COLE-CARPENTER SYNDROME 2; CLCRP2]
FBgn0262127	kibra	HGNC:29435	OMIM:610533	WWC1	13	615602	615602[MEMORY QUANTITATIVE TRAIT LOCUS; MEMRYQTL]
FBgn0262127	kibra	HGNC:29237		WWC3	11		
FBgn0262127	kibra	HGNC:24148		WWC2	13		
FBgn0262139	trh	HGNC:10882	OMIM:603128	SIM1	3		
FBgn0262139	trh	HGNC:7894	OMIM:603346	NPAS1	9		
FBgn0262139	trh	HGNC:19311	OMIM:609430	NPAS3	9		
FBgn0262139	trh	HGNC:10883	OMIM:600892	SIM2	3		
FBgn0262160	CG9932	HGNC:21684	OMIM:617371	ZNF462	3	618619	618619[WEISS-KRUSZKA SYNDROME; WSKA]
FBgn0262166	caly	HGNC:950	OMIM:603089	BAP1	13	606661,614327,619762	606661[MELANOMA, UVEAL, SUSCEPTIBILITY TO, 2; UVM2],614327[TUMOR PREDISPOSITION SYNDROME 1; TPDS1],619762[KURY-ISIDOR SYNDROME; KURIS]
FBgn0262169	magu	HGNC:20318	OMIM:608488	SMOC1	13	206920	206920[MICROPHTHALMIA WITH LIMB ANOMALIES; MLA]
FBgn0262169	magu	HGNC:20323	OMIM:607223	SMOC2	13	125400	125400[DENTIN DYSPLASIA, TYPE I; DTDP1]
FBgn0262360	CG43058	HGNC:10067	OMIM:602850	RNF4	4		
FBgn0262467	Scox	HGNC:10604	OMIM:604272	SCO2	9	604377,608908	604377[MITOCHONDRIAL COMPLEX IV DEFICIENCY, NUCLEAR TYPE 2; MC4DN2],608908[MYOPIA 6; MYP6]
FBgn0262467	Scox	HGNC:10603	OMIM:603644	SCO1	13	619048	619048[MITOCHONDRIAL COMPLEX IV DEFICIENCY, NUCLEAR TYPE 4; MC4DN4]
FBgn0262473	Tl	HGNC:15631	OMIM:300365	TLR7	3	301051,301080	301051[IMMUNODEFICIENCY 74, COVID19-RELATED, X-LINKED; IMD74],301080[SYSTEMIC LUPUS ERYTHEMATOSUS 17; SLEB17]
FBgn0262473	Tl	HGNC:11849	OMIM:603029	TLR3	3	609423,613002	609423[HUMAN IMMUNODEFICIENCY VIRUS TYPE 1, SUSCEPTIBILITY TO],613002[IMMUNODEFICIENCY 83, SUSCEPTIBILITY TO VIRAL INFECTIONS; IMD83]
FBgn0262473	Tl	HGNC:15633	OMIM:605474	TLR9	3		
FBgn0262473	Tl	HGNC:11851	OMIM:603031	TLR5	3	601744,608556,615557	601744[SYSTEMIC LUPUS ERYTHEMATOSUS, SUSCEPTIBILITY TO, 1; SLEB1],608556[LEGIONNAIRE DISEASE, SUSCEPTIBILITY TO],615557[MELIOIDOSIS, SUSCEPTIBILITY TO]
FBgn0262473	Tl	HGNC:11850	OMIM:603030	TLR4	3		
FBgn0262473	Tl	HGNC:15634	OMIM:606270	TLR10	3		
FBgn0262473	Tl	HGNC:11848	OMIM:603028	TLR2	3	114500,246300,607948	114500[COLORECTAL CANCER; CRC],246300[LEPROSY, SUSCEPTIBILITY TO, 3; LPRS3],607948[MYCOBACTERIUM TUBERCULOSIS, SUSCEPTIBILITY TO]
FBgn0262473	Tl	HGNC:11847	OMIM:601194	TLR1	3	613223	613223[LEPROSY, SUSCEPTIBILITY TO, 5; LPRS5]
FBgn0262473	Tl	HGNC:16711	OMIM:605403	TLR6	3		
FBgn0262475	bru2	HGNC:14058	OMIM:612680	CELF5	3		
FBgn0262475	bru2	HGNC:11967	OMIM:612678	CELF3	4		
FBgn0262475	bru2	HGNC:14059	OMIM:612681	CELF6	3		
FBgn0262475	bru2	HGNC:2550	OMIM:602538	CELF2	10	619561	619561[DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 97; DEE97]
FBgn0262475	bru2	HGNC:2549	OMIM:601074	CELF1	10		
FBgn0262475	bru2	HGNC:14015	OMIM:612679	CELF4	4		
FBgn0262476	CG43066	HGNC:31399	OMIM:610299	SLC6A17	9	616269	616269[INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 48; MRT48]
FBgn0262476	CG43066	HGNC:13621	OMIM:607971	SLC6A15	10		
FBgn0262476	CG43066	HGNC:27960	OMIM:608893	SLC6A19	8	138500,234500,242600	138500[HYPERGLYCINURIA],234500[HARTNUP DISORDER; HND],242600[IMINOGLYCINURIA]
FBgn0262476	CG43066	HGNC:26441	OMIM:610300	SLC6A18	8		
FBgn0262476	CG43066	HGNC:30927	OMIM:605616	SLC6A20	8	138500,242600	138500[HYPERGLYCINURIA],242600[IMINOGLYCINURIA]
FBgn0262476	CG43066	HGNC:13622	OMIM:607972	SLC6A16	4		
FBgn0262477	FoxP	HGNC:20842	OMIM:608924	FOXP4	8		
FBgn0262477	FoxP	HGNC:6106	OMIM:300292	FOXP3	4	304790	304790[IMMUNODYSREGULATION, POLYENDOCRINOPATHY, AND ENTEROPATHY, X-LINKED; IPEX]
FBgn0262477	FoxP	HGNC:3823	OMIM:605515	FOXP1	8	613670	613670[INTELLECTUAL DEVELOPMENTAL DISORDER WITH LANGUAGE IMPAIRMENT AND WITH OR WITHOUT AUTISTIC FEATURES]
FBgn0262477	FoxP	HGNC:13875	OMIM:605317	FOXP2	8	602081	602081[SPEECH-LANGUAGE DISORDER 1; SPCH1]
FBgn0262483	Rbp	HGNC:33892	OMIM:612701	RIMBP3C	6		
FBgn0262483	Rbp	HGNC:33891	OMIM:612700	RIMBP3B	6		
FBgn0262483	Rbp	HGNC:16831	OMIM:610764	TSPOAP1	11		
FBgn0262483	Rbp	HGNC:29344	OMIM:612699	RIMBP3	6		
FBgn0262483	Rbp	HGNC:30339	OMIM:611602	RIMBP2	11		
FBgn0262512	Vha14-1	HGNC:16832	OMIM:607160	ATP6V1F	14		
FBgn0262513	Vha16-4	HGNC:855	OMIM:108745	ATP6V0C	9		
FBgn0262514	VhaPPA1-2	HGNC:861	OMIM:603717	ATP6V0B	9		
FBgn0262515	VhaAC45	HGNC:868	OMIM:300197	ATP6AP1	9	300972	300972[IMMUNODEFICIENCY 47; IMD47]
FBgn0262515	VhaAC45	HGNC:28091		ATP6AP1L	6		
FBgn0262516	Trpml	HGNC:13358	OMIM:607400	MCOLN3	14		
FBgn0262516	Trpml	HGNC:13356	OMIM:605248	MCOLN1	12	252650	252650[MUCOLIPIDOSIS IV; ML4]
FBgn0262516	Trpml	HGNC:13357	OMIM:607399	MCOLN2	11		
FBgn0262517	Ltn1	HGNC:13082	OMIM:613083	LTN1	14		
FBgn0262518	Rab8	HGNC:9762	OMIM:602672	RAB13	5		
FBgn0262518	Rab8	HGNC:7007	OMIM:165040	RAB8A	13		
FBgn0262518	Rab8	HGNC:30273	OMIM:613532	RAB8B	12		
FBgn0262518	Rab8	HGNC:9759	OMIM:612672	RAB10	5		
FBgn0262519	Mi-2	HGNC:1919	OMIM:603277	CHD4	11	617159	617159[SIFRIM-HITZ-WEISS SYNDROME; SIHIWES]
FBgn0262519	Mi-2	HGNC:1918	OMIM:602120	CHD3	12	618205	618205[SNIJDERS BLOK-CAMPEAU SYNDROME; SNIBCPS]
FBgn0262519	Mi-2	HGNC:16816	OMIM:610771	CHD5	12	619873	619873[PARENTI-MIGNOT NEURODEVELOPMENTAL SYNDROME; PMNDS]
FBgn0262527	nsl1	HGNC:24565	OMIM:612452	KANSL1	9	610443	610443[KOOLEN-DE VRIES SYNDROME; KDVS]
FBgn0262527	nsl1	HGNC:26310	OMIM:613833	KANSL1L	7		
FBgn0262534	CG43088	HGNC:26522	OMIM:615086	HARBI1	5		
FBgn0262559	Mdh2	HGNC:6971	OMIM:154100	MDH2	14	617339	617339[DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 51; DEE51]
FBgn0262560	wcd	HGNC:24274	OMIM:612816	UTP18	13		
FBgn0262562	CG43102	HGNC:21726	OMIM:617043	ARHGEF17	9		
FBgn0262562	CG43102	HGNC:14103	OMIM:608136	ARHGEF10	3	608236	608236[SLOWED NERVE CONDUCTION VELOCITY, AUTOSOMAL DOMINANT; SNCV]
FBgn0262562	CG43102	HGNC:25540	OMIM:612494	ARHGEF10L	3		
FBgn0262579	Sarm	HGNC:17074	OMIM:607732	SARM1	10		
FBgn0262582	cic	HGNC:14214	OMIM:612082	CIC	12	617600	617600[INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL DOMINANT 45; MRD45]
FBgn0262593	Shab	HGNC:6231	OMIM:600397	KCNB1	8	616056	616056[DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 26; DEE26]
FBgn0262593	Shab	HGNC:6232	OMIM:607738	KCNB2	8		
FBgn0262593	Shab	HGNC:18861	OMIM:608164	KCNV1	3		
FBgn0262593	Shab	HGNC:6301	OMIM:602906	KCNS2	3		
FBgn0262593	Shab	HGNC:6246	OMIM:603787	KCNF1	3		
FBgn0262593	Shab	HGNC:6302	OMIM:603888	KCNS3	3		
FBgn0262593	Shab	HGNC:6300	OMIM:602905	KCNS1	3		
FBgn0262593	Shab	HGNC:19698	OMIM:607604	KCNV2	3	610356	610356[RETINAL CONE DYSTROPHY 3B; RCD3B]
FBgn0262593	Shab	HGNC:18306	OMIM:606767	KCNG3	3		
FBgn0262593	Shab	HGNC:6249	OMIM:605696	KCNG2	3		
FBgn0262599	SmydA-3	HGNC:15513	OMIM:608783	SMYD3	3		
FBgn0262599	SmydA-3	HGNC:20982	OMIM:610663	SMYD2	3		
FBgn0262599	SmydA-3	HGNC:20986	OMIM:606846	SMYD1	3		
FBgn0262601	SmB	HGNC:11164	OMIM:182279	SNRPN	7		
FBgn0262601	SmB	HGNC:11153	OMIM:182282	SNRPB	11	117650	117650[CEREBROCOSTOMANDIBULAR SYNDROME; CCMS]
FBgn0262601	SmB	HGNC:11171		SNURF	5		
FBgn0262614	pyd	HGNC:11827	OMIM:601009	TJP1	11		
FBgn0262614	pyd	HGNC:11829	OMIM:612689	TJP3	11		
FBgn0262614	pyd	HGNC:11828	OMIM:607709	TJP2	13	607748,615878	607748[HYPERCHOLANEMIA, FAMILIAL 1; FHCA1],615878[CHOLESTASIS, PROGRESSIVE FAMILIAL INTRAHEPATIC, 4; PFIC4]
FBgn0262617	Nuak	HGNC:29558	OMIM:608131	NUAK2	5	619452	619452[ANENCEPHALY 2; ANPH2]
FBgn0262617	Nuak	HGNC:14311	OMIM:608130	NUAK1	6		
FBgn0262619	DNAlig1	HGNC:6598	OMIM:126391	LIG1	15	619774	619774[IMMUNODEFICIENCY 96; IMD96]
FBgn0262624	Tmhs	HGNC:21253	OMIM:609427	LHFPL5	11	610265	610265[DEAFNESS, AUTOSOMAL RECESSIVE 67; DFNB67]
FBgn0262624	Tmhs	HGNC:29568	OMIM:610240	LHFPL4	13		
FBgn0262624	Tmhs	HGNC:6589	OMIM:609719	LHFPL3	12		
FBgn0262647	Nup160	HGNC:18017	OMIM:607614	NUP160	14	618178	618178[NEPHROTIC SYNDROME, TYPE 19; NPHS19]
FBgn0262656	Myc	HGNC:7553	OMIM:190080	MYC	6	113970	113970[BURKITT LYMPHOMA; BL]
FBgn0262685	CG43155	HGNC:6272	OMIM:601745	KCNK1	3		
FBgn0262685	CG43155	HGNC:19439	OMIM:613655	KCNK18	3	613656	613656[MIGRAINE WITH OR WITHOUT AURA, SUSCEPTIBILITY TO, 13; MGR13]
FBgn0262685	CG43155	HGNC:14464	OMIM:607369	KCNK16	3		
FBgn0262685	CG43155	HGNC:14465	OMIM:607370	KCNK17	3		
FBgn0262685	CG43155	HGNC:6281	OMIM:603939	KCNK6	3		
FBgn0262699	fzr	HGNC:24824	OMIM:603619	FZR1	15		
FBgn0262699	fzr	HGNC:1723	OMIM:603618	CDC20	4		
FBgn0262699	fzr	HGNC:24222		CDC20B	3		
FBgn0262714	Sap130	HGNC:29813	OMIM:609697	SAP130	10		
FBgn0262716	Arp3	HGNC:17256		ACTR3B	12		
FBgn0262716	Arp3	HGNC:170	OMIM:604222	ACTR3	14		
FBgn0262716	Arp3	HGNC:37282		ACTR3C	4		
FBgn0262719	CG43163	HGNC:29179	OMIM:615098	TTC28	14		
FBgn0262721	CG43165	HGNC:38825		EPPIN-WFDC6	4		
FBgn0262721	CG43165	HGNC:16164		WFDC6	3		
FBgn0262728	Pal2	HGNC:8596	OMIM:170270	PAM	10		
FBgn0262730	dtn	HGNC:31092	OMIM:617363	TMEM132A	10		
FBgn0262730	dtn	HGNC:25436		TMEM132C	13		
FBgn0262730	dtn	HGNC:29397		TMEM132B	13		
FBgn0262730	dtn	HGNC:29411	OMIM:611257	TMEM132D	13		
FBgn0262730	dtn	HGNC:26991	OMIM:616178	TMEM132E	14	618481	618481[DEAFNESS, AUTOSOMAL RECESSIVE 99; DFNB99]
FBgn0262732	mbf1	HGNC:3164	OMIM:605107	EDF1	15		
FBgn0262733	Src64B	HGNC:4840	OMIM:142370	HCK	6		
FBgn0262733	Src64B	HGNC:1057	OMIM:191305	BLK	6	613375	613375[MATURITY-ONSET DIABETES OF THE YOUNG, TYPE 11; MODY11]
FBgn0262733	Src64B	HGNC:3955	OMIM:606573	FRK	7		
FBgn0262733	Src64B	HGNC:4037	OMIM:137025	FYN	9		
FBgn0262733	Src64B	HGNC:6524	OMIM:153390	LCK	6	615758	615758[IMMUNODEFICIENCY 22; IMD22]
FBgn0262733	Src64B	HGNC:12841	OMIM:164880	YES1	8		
FBgn0262733	Src64B	HGNC:3697	OMIM:164940	FGR	7		
FBgn0262733	Src64B	HGNC:11283	OMIM:190090	SRC	9	114500,616937	114500[COLORECTAL CANCER; CRC],616937[THROMBOCYTOPENIA 6; THC6]
FBgn0262733	Src64B	HGNC:11298	OMIM:617797	SRMS	3		
FBgn0262733	Src64B	HGNC:6735	OMIM:165120	LYN	6		
FBgn0262733	Src64B	HGNC:9617	OMIM:602004	PTK6	3		
FBgn0262734	eIF4H1	HGNC:3285	OMIM:603928	EIF4B	3		
FBgn0262734	eIF4H1	HGNC:12741	OMIM:603431	EIF4H	13		
FBgn0262736	Vha16-1	HGNC:855	OMIM:108745	ATP6V0C	13		
FBgn0262737	mub	HGNC:8648	OMIM:601210	PCBP2	12		
FBgn0262737	mub	HGNC:8651	OMIM:608502	PCBP3	13		
FBgn0262737	mub	HGNC:8647	OMIM:601209	PCBP1	12		
FBgn0262737	mub	HGNC:8652	OMIM:608503	PCBP4	10		
FBgn0262738	norpA	HGNC:9055	OMIM:604114	PLCB2	3		
FBgn0262738	norpA	HGNC:15917	OMIM:607120	PLCB1	4	613722	613722[DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 12; DEE12]
FBgn0262738	norpA	HGNC:9059	OMIM:600810	PLCB4	14	614669	614669[AURICULOCONDYLAR SYNDROME 2; ARCND2]
FBgn0262738	norpA	HGNC:9056	OMIM:600230	PLCB3	4	618961	618961[SPONDYLOMETAPHYSEAL DYSPLASIA WITH CORNEAL DYSTROPHY; SMDCD]
FBgn0262739	AGO1	HGNC:18424	OMIM:607356	AGO4	11		
FBgn0262739	AGO1	HGNC:18421	OMIM:607355	AGO3	12		
FBgn0262739	AGO1	HGNC:3262	OMIM:606228	AGO1	12		
FBgn0262739	AGO1	HGNC:3263	OMIM:606229	AGO2	14	619149	619149[LESSEL-KREIENKAMP SYNDROME; LESKRES]
FBgn0262740	Evi5	HGNC:30464		EVI5L	8		
FBgn0262740	Evi5	HGNC:3501	OMIM:602942	EVI5	11		
FBgn0262743	Fs(2)Ket	HGNC:6400	OMIM:602738	KPNB1	15		
FBgn0262782	Mdh1	HGNC:6970	OMIM:154200	MDH1	14	618959	618959[DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 88; DEE88]
FBgn0262801	twr	HGNC:23400		SEC11C	13		
FBgn0262801	twr	HGNC:17718	OMIM:618258	SEC11A	10		
FBgn0262842	UQCR-6.4L	HGNC:30862	OMIM:609711	UQCR11	4		
FBgn0262866	S6kII	HGNC:10431	OMIM:601685	RPS6KA2	12		
FBgn0262866	S6kII	HGNC:10430	OMIM:601684	RPS6KA1	11		
FBgn0262866	S6kII	HGNC:10433	OMIM:603606	RPS6KA4	3		
FBgn0262866	S6kII	HGNC:10435	OMIM:300303	RPS6KA6	10		
FBgn0262866	S6kII	HGNC:10434	OMIM:603607	RPS6KA5	3		
FBgn0262866	S6kII	HGNC:10432	OMIM:300075	RPS6KA3	12	300844,303600	300844[INTELLECTUAL DEVELOPMENTAL DISORDER, X-LINKED 19; XLID19],303600[COFFIN-LOWRY SYNDROME; CLS]
FBgn0262866	S6kII	HGNC:10436	OMIM:608938	RPS6KB1	3		
FBgn0262866	S6kII	HGNC:10437	OMIM:608939	RPS6KB2	3		
FBgn0262867	Ptr	HGNC:24776	OMIM:611791	PTCHD3	11		
FBgn0262867	Ptr	HGNC:26392	OMIM:300828	PTCHD1	7	300830	300830[AUTISM, SUSCEPTIBILITY TO, X-LINKED 4; AUTSX4]
FBgn0262867	Ptr	HGNC:21345	OMIM:616908	PTCHD4	7		
FBgn0262869	Gfrl	HGNC:13821	OMIM:618679	GFRA4	3		
FBgn0262869	Gfrl	HGNC:4245	OMIM:605710	GFRA3	3		
FBgn0262869	Gfrl	HGNC:4243	OMIM:601496	GFRA1	3	619887	619887[RENAL HYPODYSPLASIA/APLASIA 4; RHDA4]
FBgn0262869	Gfrl	HGNC:4244	OMIM:601956	GFRA2	3		
FBgn0262869	Gfrl	HGNC:32789	OMIM:617837	GFRAL	6		
FBgn0262870	axo	HGNC:8011	OMIM:602346	CNTNAP1	4	616286,618186	616286[LETHAL CONGENITAL CONTRACTURE SYNDROME 7; LCCS7],618186[NEUROPATHY, CONGENITAL HYPOMYELINATING, 3; CHN3]
FBgn0262870	axo	HGNC:13830	OMIM:604569	CNTNAP2	5	610042,612100	610042[PITT-HOPKINS-LIKE SYNDROME 1; PTHSL1],612100[AUTISM, SUSCEPTIBILITY TO, 15; AUTS15]
FBgn0262870	axo	HGNC:18747	OMIM:610518	CNTNAP4	4		
FBgn0262870	axo	HGNC:13834	OMIM:610517	CNTNAP3	4		
FBgn0262870	axo	HGNC:18748	OMIM:610519	CNTNAP5	4		
FBgn0262870	axo	HGNC:32035		CNTNAP3B	4		
FBgn0262871	lute	HGNC:15504	OMIM:608531	BTBD2	4		
FBgn0262871	lute	HGNC:1120	OMIM:608530	BTBD1	3		
FBgn0262871	lute	HGNC:15854	OMIM:615566	BTBD3	14		
FBgn0262871	lute	HGNC:19897		BTBD6	13		
FBgn0262872	milt	HGNC:13206	OMIM:607334	TRAK2	11		
FBgn0262872	milt	HGNC:29947	OMIM:608112	TRAK1	13	618201	618201[DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 68; DEE68]
FBgn0262872	milt	HGNC:4812	OMIM:600947	HAP1	4		
FBgn0262937	Rabex-5	HGNC:17676	OMIM:609700	RABGEF1	13		
FBgn0262952	mt:ND4	HGNC:7459	OMIM:516003	ND4	10		
FBgn0262954	Polr2K	HGNC:9198	OMIM:606033	POLR2K	13		
FBgn0262955	Polr2B	HGNC:9188	OMIM:180661	POLR2B	15		
FBgn0262955	Polr2B	HGNC:30348	OMIM:614366	POLR3B	3	614381,619742	614381[LEUKODYSTROPHY, HYPOMYELINATING, 8, WITH OR WITHOUT OLIGODONTIA AND/OR HYPOGONADOTROPIC HYPOGONADISM; HLD8],619742[CHARCOT-MARIE-TOOTH DISEASE, DEMYELINATING, TYPE 1I; CMT1I]
FBgn0262975	cnc	HGNC:7780	OMIM:601490	NFE2	7		
FBgn0262975	cnc	HGNC:7783	OMIM:604135	NFE2L3	5		
FBgn0262975	cnc	HGNC:7781	OMIM:163260	NFE2L1	8		
FBgn0262975	cnc	HGNC:7782	OMIM:600492	NFE2L2	8	617744	617744[IMMUNODEFICIENCY, DEVELOPMENTAL DELAY, AND HYPOHOMOCYSTEINEMIA; IMDDHH]
FBgn0262987	CG43295	HGNC:30817	OMIM:617154	MRNIP	5		
FBgn0263005	Chpf	HGNC:29270	OMIM:608037	CHPF2	12		
FBgn0263005	Chpf	HGNC:24291	OMIM:610405	CHPF	14		
FBgn0263006	SERCA	HGNC:813	OMIM:601929	ATP2A3	11		
FBgn0263006	SERCA	HGNC:29103	OMIM:613082	ATP2C2	3		
FBgn0263006	SERCA	HGNC:812	OMIM:108740	ATP2A2	11	101900,124200	101900[ACROKERATOSIS VERRUCIFORMIS; AKV],124200[DARIER-WHITE DISEASE; DAR]
FBgn0263006	SERCA	HGNC:13211	OMIM:604384	ATP2C1	3	169600	169600[BENIGN CHRONIC PEMPHIGUS; BCPM]
FBgn0263006	SERCA	HGNC:811	OMIM:108730	ATP2A1	14	601003	601003[BRODY DISEASE; BROD]
FBgn0263025	HSPBAP1	HGNC:16389	OMIM:608263	HSPBAP1	11		
FBgn0263027	CG43322	HGNC:1297		DNAJC28	12		
FBgn0263029	CG43324	HGNC:4403	OMIM:604390	GNG11	4		
FBgn0263029	CG43324	HGNC:4408	OMIM:600874	GNG5	6		
FBgn0263029	CG43324	HGNC:4405	OMIM:608941	GNG3	5		
FBgn0263029	CG43324	HGNC:4412	OMIM:139391	GNGT2	4		
FBgn0263029	CG43324	HGNC:4402	OMIM:604389	GNG10	6		
FBgn0263029	CG43324	HGNC:4410	OMIM:604430	GNG7	5		
FBgn0263029	CG43324	HGNC:4404	OMIM:606981	GNG2	6		
FBgn0263029	CG43324	HGNC:19664		GNG8	6		
FBgn0263029	CG43324	HGNC:4407	OMIM:604388	GNG4	6		
FBgn0263029	CG43324	HGNC:19663	OMIM:615405	GNG12	6		
FBgn0263029	CG43324	HGNC:4411	OMIM:189970	GNGT1	4		
FBgn0263029	CG43324	HGNC:53439		GNG14	4		
FBgn0263038	CG43333	HGNC:11771	OMIM:601692	TGFBI	6	121820,121900,122200,602082,607541,608470,608471	121820[CORNEAL DYSTROPHY, EPITHELIAL BASEMENT MEMBRANE; EBMD],121900[CORNEAL DYSTROPHY, GROENOUW TYPE I; CDGG1],122200[CORNEAL DYSTROPHY, LATTICE TYPE I; CDL1],602082[CORNEAL DYSTROPHY, THIEL-BEHNKE TYPE; CDTB],607541[CORNEAL DYSTROPHY, AVELLINO TYPE; CDA],608470[CORNEAL DYSTROPHY, REIS-BUCKLERS TYPE; CDRB],608471[CORNEAL DYSTROPHY, LATTICE TYPE IIIA; CDL3A]
FBgn0263038	CG43333	HGNC:16953	OMIM:608777	POSTN	5		
FBgn0263048	Gpdh3	HGNC:4455	OMIM:138420	GPD1	6	614480	614480[HYPERTRIGLYCERIDEMIA, TRANSIENT INFANTILE; HTGTI]
FBgn0263048	Gpdh3	HGNC:28956	OMIM:611778	GPD1L	6	611777	611777[BRUGADA SYNDROME 2; BRGDA2]
FBgn0263050	CG43345	HGNC:23792	OMIM:618488	PLD4	8		
FBgn0263050	CG43345	HGNC:17158	OMIM:615698	PLD3	7	617770	617770[SPINOCEREBELLAR ATAXIA 46; SCA46]
FBgn0263050	CG43345	HGNC:26879		PLD5	5		
FBgn0263051	CG43346	HGNC:28086	OMIM:609653	NDUFAF2	6	618233	618233[MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 10; MC1DN10]
FBgn0263076	Klp54D	HGNC:21495	OMIM:611278	KIF12	14	619662	619662[CHOLESTASIS, PROGRESSIVE FAMILIAL INTRAHEPATIC, 8; PFIC8]
FBgn0263079	CG43338	HGNC:21177		CCDC170	14		
FBgn0263106	DnaJ-1	HGNC:14887	OMIM:611328	DNAJB5	13		
FBgn0263106	DnaJ-1	HGNC:5270	OMIM:604572	DNAJB1	12		
FBgn0263106	DnaJ-1	HGNC:30718	OMIM:610263	DNAJB13	4	617091	617091[CILIARY DYSKINESIA, PRIMARY, 34; CILD34]
FBgn0263106	DnaJ-1	HGNC:14886	OMIM:611327	DNAJB4	12		
FBgn0263110	CG43367	HGNC:20681	OMIM:609816	NBEAL1	8		
FBgn0263110	CG43367	HGNC:31928	OMIM:614169	NBEAL2	7	139090	139090[GRAY PLATELET SYNDROME; GPS]
FBgn0263111	cac	HGNC:19082	OMIM:611549	NALCN	3	615419,616266	615419[HYPOTONIA, INFANTILE, WITH PSYCHOMOTOR RETARDATION AND CHARACTERISTIC FACIES 1; IHPRF1],616266[CONGENITAL CONTRACTURES OF THE LIMBS AND FACE, HYPOTONIA, AND DEVELOPMENTAL DELAY; CLIFAHDD]
FBgn0263111	cac	HGNC:1397	OMIM:114208	CACNA1S	5	170400,188580,601887	170400[HYPOKALEMIC PERIODIC PARALYSIS, TYPE 1; HOKPP1],188580[THYROTOXIC PERIODIC PARALYSIS, SUSCEPTIBILITY TO, 1; TTPP1],601887[MALIGNANT HYPERTHERMIA, SUSCEPTIBILITY TO, 5; MHS5]
FBgn0263111	cac	HGNC:1388	OMIM:601011	CACNA1A	9	108500,141500,183086,617106	108500[EPISODIC ATAXIA, TYPE 2; EA2],141500[MIGRAINE, FAMILIAL HEMIPLEGIC, 1; FHM1],183086[SPINOCEREBELLAR ATAXIA 6; SCA6],617106[DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 42; DEE42]
FBgn0263111	cac	HGNC:1389	OMIM:601012	CACNA1B	10	618497	618497[NEURODEVELOPMENTAL DISORDER WITH SEIZURES AND NONEPILEPTIC HYPERKINETIC MOVEMENTS; NEDNEH]
FBgn0263111	cac	HGNC:1392	OMIM:601013	CACNA1E	9	618285	618285[DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 69; DEE69]
FBgn0263111	cac	HGNC:1390	OMIM:114205	CACNA1C	5	601005,611875,618447	601005[TIMOTHY SYNDROME; TS],611875[BRUGADA SYNDROME 3; BRGDA3],618447[LONG QT SYNDROME 8; LQT8]
FBgn0263111	cac	HGNC:1393	OMIM:300110	CACNA1F	4	300071,300476,300600	300071[NIGHT BLINDNESS, CONGENITAL STATIONARY, TYPE 2A; CSNB2A],300476[CONE-ROD DYSTROPHY, X-LINKED, 3; CORDX3],300600[ALAND ISLAND EYE DISEASE; AIED]
FBgn0263111	cac	HGNC:1391	OMIM:114206	CACNA1D	5	614896,615474	614896[SINOATRIAL NODE DYSFUNCTION AND DEAFNESS; SANDD],615474[PRIMARY ALDOSTERONISM, SEIZURES, AND NEUROLOGIC ABNORMALITIES; PASNA]
FBgn0263111	cac	HGNC:10596	OMIM:600702	SCN8A	3	614306,614558,617080,618364	614306[COGNITIVE IMPAIRMENT WITH OR WITHOUT CEREBELLAR ATAXIA; CIAT],614558[DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 13; DEE13],617080[SEIZURES, BENIGN FAMILIAL INFANTILE, 5; BFIS5],618364[MYOCLONUS, FAMILIAL, 2; MYOCL2]
FBgn0263112	Mitf	HGNC:7105	OMIM:156845	MITF	11	103470,103500,193510,614456,617306	103470[MOVED TO 193510 AND 606952],103500[TIETZ ALBINISM-DEAFNESS SYNDROME; TADS],193510[WAARDENBURG SYNDROME, TYPE 2A; WS2A],614456[MELANOMA, CUTANEOUS MALIGNANT, SUSCEPTIBILITY TO, 8; CMM8],617306[COLOBOMA, OSTEOPETROSIS, MICROPHTHALMIA, MACROCEPHALY, ALBINISM, AND DEAFNESS; COMMAD]
FBgn0263112	Mitf	HGNC:11754	OMIM:604732	TFEC	9		
FBgn0263112	Mitf	HGNC:11753	OMIM:600744	TFEB	10		
FBgn0263112	Mitf	HGNC:11752	OMIM:314310	TFE3	9	300854,301066	300854[RENAL CELL CARCINOMA, Xp11-ASSOCIATED; RCCX1],301066[INTELLECTUAL DEVELOPMENTAL DISORDER, X-LINKED, SYNDROMIC, WITH PIGMENTARY MOSAICISM AND COARSE FACIES; MRXSPF]
FBgn0263113	Cc2d2a	HGNC:29253	OMIM:612013	CC2D2A	10	612284,612285,619111,619845	612284[MECKEL SYNDROME, TYPE 6; MKS6],612285[JOUBERT SYNDROME 9; JBTS9],619111[COACH SYNDROME 2; COACH2],619845[RETINITIS PIGMENTOSA 93; RP93]
FBgn0263113	Cc2d2a	HGNC:31666		CC2D2B	6		
FBgn0263116	5-HT1B	HGNC:5289	OMIM:182133	HTR1D	3		
FBgn0263116	5-HT1B	HGNC:5292	OMIM:182134	HTR1F	5		
FBgn0263116	5-HT1B	HGNC:5287	OMIM:182131	HTR1B	5		
FBgn0263116	5-HT1B	HGNC:5291	OMIM:182132	HTR1E	4		
FBgn0263116	5-HT1B	HGNC:5286	OMIM:109760	HTR1A	7	614674	614674[PERIODIC FEVER, MENSTRUAL CYCLE-DEPENDENT]
FBgn0263117	CG34377	HGNC:21180		SAMD5	6		
FBgn0263117	CG34377	HGNC:19182	OMIM:607955	SASH1	3	127500,618373	127500[DYSCHROMATOSIS UNIVERSALIS HEREDITARIA 1; DUH1],618373[CANCER, ALOPECIA, PIGMENT DYSCRASIA, ONYCHODYSTROPHY, AND KERATODERMA; CAPOK]
FBgn0263117	CG34377	HGNC:15975	OMIM:300441	SASH3	3	301082	301082[IMMUNODEFICIENCY 102; IMD102]
FBgn0263117	CG34377	HGNC:10528	OMIM:607978	SAMSN1	3		
FBgn0263120	Acsl	HGNC:3570	OMIM:602371	ACSL3	14		
FBgn0263120	Acsl	HGNC:16496	OMIM:604443	ACSL6	3		
FBgn0263120	Acsl	HGNC:3571	OMIM:300157	ACSL4	13	300387	300387[INTELLECTUAL DEVELOPMENTAL DISORDER, X-LINKED 63; XLID63]
FBgn0263121	Prosalpha1	HGNC:9535	OMIM:602855	PSMA6	11	608446	608446[MYOCARDIAL INFARCTION, SUSCEPTIBILITY TO]
FBgn0263131	CG43373	HGNC:236	OMIM:600293	ADCY5	11	606703,619647,619651	606703[DYSKINESIA WITH OROFACIAL INVOLVEMENT, AUTOSOMAL DOMINANT; DSKOD],619647[DYSKINESIA WITH OROFACIAL INVOLVEMENT, AUTOSOMAL RECESSIVE; DSKOR],619651[NEURODEVELOPMENTAL DISORDER WITH HYPERKINETIC MOVEMENTS AND DYSKINESIA; NEDHYD]
FBgn0263131	CG43373	HGNC:237	OMIM:600294	ADCY6	9	616287	616287[LETHAL CONGENITAL CONTRACTURE SYNDROME 8; LCCS8]
FBgn0263132	Cht6	HGNC:8524	OMIM:603578	OVGP1	5		
FBgn0263132	Cht6	HGNC:1932	OMIM:601525	CHI3L1	4	181500,611960	181500[SCHIZOPHRENIA; SCZD],611960[ASTHMA-RELATED TRAITS, SUSCEPTIBILITY TO, 7; ASRT7]
FBgn0263132	Cht6	HGNC:1936	OMIM:600031	CHIT1	5	614122	614122[CHITOTRIOSIDASE DEFICIENCY; CHITD]
FBgn0263132	Cht6	HGNC:17432	OMIM:606080	CHIA	4		
FBgn0263132	Cht6	HGNC:1933	OMIM:601526	CHI3L2	3		
FBgn0263133	mEFG1	HGNC:13780	OMIM:606639	GFM1	15	609060	609060[COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 1; COXPD1]
FBgn0263144	bin3	HGNC:20247	OMIM:611478	MEPCE	10		
FBgn0263197	Patronin	HGNC:29188	OMIM:613775	CAMSAP2	13		
FBgn0263197	Patronin	HGNC:29307	OMIM:612685	CAMSAP3	11		
FBgn0263197	Patronin	HGNC:19946	OMIM:613774	CAMSAP1	12		
FBgn0263198	Acn	HGNC:17066	OMIM:604562	ACIN1	10		
FBgn0263199	Galk	HGNC:4119	OMIM:137028	GALK2	15		
FBgn0263200	Galt	HGNC:4135	OMIM:606999	GALT	14	230400	230400[GALACTOSEMIA I; GALAC1]
FBgn0263219	Dscam4	HGNC:3039	OMIM:602523	DSCAM	13		
FBgn0263219	Dscam4	HGNC:14656	OMIM:611782	DSCAML1	11		
FBgn0263220	Hk	HGNC:6230	OMIM:604111	KCNAB3	10		
FBgn0263220	Hk	HGNC:6228	OMIM:601141	KCNAB1	11		
FBgn0263220	Hk	HGNC:6229	OMIM:601142	KCNAB2	11		
FBgn0263231	bel	HGNC:2699	OMIM:400010	DDX3Y	12		
FBgn0263231	bel	HGNC:2745	OMIM:300160	DDX3X	13	300958	300958[INTELLECTUAL DEVELOPMENTAL DISORDER, X-LINKED, SYNDROMIC, SNIJDERS BLOK TYPE; MRXSSB]
FBgn0263231	bel	HGNC:18700	OMIM:605281	DDX4	4		
FBgn0263232	Nxf3	HGNC:8073	OMIM:300316	NXF3	6		
FBgn0263232	Nxf3	HGNC:23984		NXF2B	6		
FBgn0263232	Nxf3	HGNC:8071	OMIM:602647	NXF1	6		
FBgn0263232	Nxf3	HGNC:8072	OMIM:300315	NXF2	4		
FBgn0263232	Nxf3	HGNC:8075	OMIM:300319	NXF5	6		
FBgn0263233	robls54B	HGNC:15467	OMIM:607168	DYNLRB2	4		
FBgn0263233	robls54B	HGNC:15468	OMIM:607167	DYNLRB1	4		
FBgn0263236	SP1029	HGNC:500	OMIM:151530	ANPEP	8		
FBgn0263236	SP1029	HGNC:30748	OMIM:606950	TRHDE	3		
FBgn0263236	SP1029	HGNC:3355	OMIM:138297	ENPEP	4		
FBgn0263236	SP1029	HGNC:18173	OMIM:606832	ERAP1	5		
FBgn0263236	SP1029	HGNC:26904	OMIM:610046	LVRN	5		
FBgn0263236	SP1029	HGNC:7900	OMIM:606793	NPEPPS	4		
FBgn0263236	SP1029	HGNC:29499	OMIM:609497	ERAP2	5		
FBgn0263236	SP1029	HGNC:6656	OMIM:151300	LNPEP	5		
FBgn0263237	Cdk7	HGNC:21420	OMIM:610076	CDK20	3		
FBgn0263237	Cdk7	HGNC:1778	OMIM:601955	CDK7	14		
FBgn0263239	dar1	HGNC:6349	OMIM:602903	KLF5	4		
FBgn0263241	Mocs1	HGNC:7190	OMIM:603707	MOCS1	12	252150	252150[MOLYBDENUM COFACTOR DEFICIENCY, COMPLEMENTATION GROUP A; MOCODA]
FBgn0263251	vnc	HGNC:18704	OMIM:300013	NAA10	13	300855,309800	300855[OGDEN SYNDROME; OGDNS],309800[MICROPHTHALMIA, SYNDROMIC 1; MCOPS1]
FBgn0263251	vnc	HGNC:28125	OMIM:619432	NAA11	10		
FBgn0263257	Cngl	HGNC:2152	OMIM:609472	CNGA4	3		
FBgn0263257	Cngl	HGNC:2150	OMIM:600053	CNGA3	3	216900	216900[ACHROMATOPSIA 2; ACHM2]
FBgn0263257	Cngl	HGNC:2148	OMIM:123825	CNGA1	3	613756	613756[RETINITIS PIGMENTOSA 49; RP49]
FBgn0263260	sel	HGNC:27786	OMIM:612493	CNPY1	8		
FBgn0263260	sel	HGNC:13529	OMIM:605861	CNPY2	12		
FBgn0263278	Fic	HGNC:18416		FICD	15		
FBgn0263289	scrib	HGNC:30377	OMIM:607733	SCRIB	7		
FBgn0263289	scrib	HGNC:18531	OMIM:614453	LRRC7	3		
FBgn0263289	scrib	HGNC:14307	OMIM:608195	LRRC1	6		
FBgn0263316	Mrp4	HGNC:55	OMIM:605250	ABCC4	10		
FBgn0263316	Mrp4	HGNC:52	OMIM:612509	ABCC10	4		
FBgn0263316	Mrp4	HGNC:53	OMIM:601107	ABCC2	4	237500	237500[DUBIN-JOHNSON SYNDROME; DJS]
FBgn0263316	Mrp4	HGNC:51	OMIM:158343	ABCC1	4	618915	618915[DEAFNESS, AUTOSOMAL DOMINANT 77; DFNA77]
FBgn0263316	Mrp4	HGNC:59	OMIM:600509	ABCC8	4	125853,240800,256450,610374,618857	125853[TYPE 2 DIABETES MELLITUS; T2D],240800[HYPOGLYCEMIA, LEUCINE-INDUCED; LIH],256450[HYPERINSULINEMIC HYPOGLYCEMIA, FAMILIAL, 1; HHF1],610374[DIABETES MELLITUS, TRANSIENT NEONATAL, 2; TNDM2],618857[DIABETES MELLITUS, PERMANENT NEONATAL, 3; PNDM3]
FBgn0263316	Mrp4	HGNC:14640	OMIM:607041	ABCC12	4		
FBgn0263316	Mrp4	HGNC:60	OMIM:601439	ABCC9	4	239850,608569,614050,619719	239850[CANTU SYNDROME],608569[CARDIOMYOPATHY, DILATED, 1O; CMD1O],614050[ATRIAL FIBRILLATION, FAMILIAL, 12; ATFB12],619719[INTELLECTUAL DISABILITY AND MYOPATHY SYNDROME; IDMYS]
FBgn0263316	Mrp4	HGNC:57	OMIM:603234	ABCC6	4	177850,264800,614473	177850[PSEUDOXANTHOMA ELASTICUM, FORME FRUSTE],264800[PSEUDOXANTHOMA ELASTICUM; PXE],614473[ARTERIAL CALCIFICATION, GENERALIZED, OF INFANCY, 2; GACI2]
FBgn0263316	Mrp4	HGNC:56	OMIM:605251	ABCC5	4		
FBgn0263316	Mrp4	HGNC:14639	OMIM:607040	ABCC11	4	117800	117800[APOCRINE GLAND SECRETION, VARIATION IN]
FBgn0263316	Mrp4	HGNC:54	OMIM:604323	ABCC3	5		
FBgn0263316	Mrp4	HGNC:1884	OMIM:602421	CFTR	5	167800,211400,219700,277180	167800[PANCREATITIS, HEREDITARY; PCTT],211400[BRONCHIECTASIS WITH OR WITHOUT ELEVATED SWEAT CHLORIDE 1; BESC1],219700[CYSTIC FIBROSIS; CF],277180[VAS DEFERENS, CONGENITAL BILATERAL APLASIA OF; CBAVD]
FBgn0263346	smash	HGNC:29191	OMIM:617750	LIMCH1	3		
FBgn0263351	AP-2mu	HGNC:564	OMIM:601024	AP2M1	13	618587	618587[INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL DOMINANT 60, WITH SEIZURES; MRD60]
FBgn0263352	Unr	HGNC:29905	OMIM:191510	CSDE1	15		
FBgn0263390	Nha2	HGNC:24244	OMIM:611527	SLC9B1	9		
FBgn0263390	Nha2	HGNC:25143	OMIM:611789	SLC9B2	9		
FBgn0263391	hts	HGNC:244	OMIM:102681	ADD2	11		
FBgn0263391	hts	HGNC:243	OMIM:102680	ADD1	14	145500	145500[HYPERTENSION, ESSENTIAL]
FBgn0263391	hts	HGNC:245	OMIM:601568	ADD3	11	617008	617008[CEREBRAL PALSY, SPASTIC QUADRIPLEGIC, 3; CPSQ3]
FBgn0263392	Tet	HGNC:29484	OMIM:607790	TET1	8		
FBgn0263392	Tet	HGNC:28313	OMIM:613555	TET3	8	618798	618798[BECK-FAHRNER SYNDROME; BEFAHRS]
FBgn0263392	Tet	HGNC:25941	OMIM:612839	TET2	4	614286,619126	614286[MYELODYSPLASTIC SYNDROME; MDS],619126[IMMUNODEFICIENCY 75; IMD75]
FBgn0263395	hppy	HGNC:6867	OMIM:604923	MAP4K5	13		
FBgn0263395	hppy	HGNC:6863	OMIM:601983	MAP4K1	6		
FBgn0263395	hppy	HGNC:6864	OMIM:603166	MAP4K2	9		
FBgn0263395	hppy	HGNC:6865	OMIM:604921	MAP4K3	13		
FBgn0263396	sqd	HGNC:5036	OMIM:601324	HNRNPD	9		
FBgn0263396	sqd	HGNC:7330	OMIM:603328	MSI1	3		
FBgn0263396	sqd	HGNC:5034	OMIM:602688	HNRNPAB	11		
FBgn0263396	sqd	HGNC:18585	OMIM:607897	MSI2	3		
FBgn0263396	sqd	HGNC:5037	OMIM:607137	HNRNPDL	9	609115	609115[MUSCULAR DYSTROPHY, LIMB-GIRDLE, AUTOSOMAL DOMINANT 3; LGMDD3]
FBgn0263397	Ih	HGNC:4846	OMIM:602781	HCN2	8	602477	602477[EPILEPSY, IDIOPATHIC GENERALIZED, SUSCEPTIBILITY TO, 17; EIG17]
FBgn0263397	Ih	HGNC:19183	OMIM:609973	HCN3	9		
FBgn0263397	Ih	HGNC:4845	OMIM:602780	HCN1	5	615871,618482	615871[DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 24; DEE24],618482[GENERALIZED EPILEPSY WITH FEBRILE SEIZURES PLUS, TYPE 10; GEFSP10]
FBgn0263397	Ih	HGNC:16882	OMIM:605206	HCN4	7	163800,613123,619521	163800[SICK SINUS SYNDROME 2; SSS2],613123[BRUGADA SYNDROME 8; BRGDA8],619521[EPILEPSY, IDIOPATHIC GENERALIZED, SUSCEPTIBILITY TO, 18; EIG18]
FBgn0263398	Uck	HGNC:12562	OMIM:609329	UCK2	14		
FBgn0263398	Uck	HGNC:28334	OMIM:300656	UPRT	3		
FBgn0263398	Uck	HGNC:14859	OMIM:609328	UCK1	13		
FBgn0263398	Uck	HGNC:15938	OMIM:610866	UCKL1	4		
FBgn0263456	nwk	HGNC:29114	OMIM:617556	FCHSD2	14		
FBgn0263456	nwk	HGNC:25463	OMIM:617555	FCHSD1	9		
FBgn0263510	nclb	HGNC:17015		PWP1	14		
FBgn0263511	Vsx1	HGNC:12723	OMIM:605020	VSX1	4	148300,614195	148300[KERATOCONUS 1; KTCN1],614195[CRANIOFACIAL ANOMALIES AND ANTERIOR SEGMENT DYSGENESIS SYNDROME; CAASDS]
FBgn0263511	Vsx1	HGNC:1975	OMIM:142993	VSX2	5	610092,610093	610092[MICROPHTHALMIA, ISOLATED, WITH COLOBOMA 3; MCOPCB3],610093[MICROPHTHALMIA, ISOLATED 2; MCOP2]
FBgn0263512	Vsx2	HGNC:12723	OMIM:605020	VSX1	6	148300,614195	148300[KERATOCONUS 1; KTCN1],614195[CRANIOFACIAL ANOMALIES AND ANTERIOR SEGMENT DYSGENESIS SYNDROME; CAASDS]
FBgn0263512	Vsx2	HGNC:1975	OMIM:142993	VSX2	7	610092,610093	610092[MICROPHTHALMIA, ISOLATED, WITH COLOBOMA 3; MCOPCB3],610093[MICROPHTHALMIA, ISOLATED 2; MCOP2]
FBgn0263593	Lpin	HGNC:14450	OMIM:605519	LPIN2	12	609628	609628[MAJEED SYNDROME; MJDS]
FBgn0263593	Lpin	HGNC:13345	OMIM:605518	LPIN1	12	268200	268200[MYOGLOBINURIA, ACUTE RECURRENT, AUTOSOMAL RECESSIVE]
FBgn0263593	Lpin	HGNC:14451	OMIM:605520	LPIN3	13		
FBgn0263594	lost	HGNC:25778	OMIM:616820	MTHFSD	15		
FBgn0263598	Vha68-2	HGNC:851	OMIM:607027	ATP6V1A	13	617403,618012	617403[CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IID; ARCL2D],618012[DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 93; DEE93]
FBgn0263599	Brr2	HGNC:18697	OMIM:614217	ASCC3	4		
FBgn0263599	Brr2	HGNC:30859	OMIM:601664	SNRNP200	15	610359	610359[RETINITIS PIGMENTOSA 33; RP33]
FBgn0263600	PolD1	HGNC:9175	OMIM:174761	POLD1	15	612591,615381	612591[COLORECTAL CANCER, SUSCEPTIBILITY TO, 10; CRCS10],615381[MANDIBULAR HYPOPLASIA, DEAFNESS, PROGEROID FEATURES, AND LIPODYSTROPHY SYNDROME; MDPL]
FBgn0263601	mib1	HGNC:21086	OMIM:608677	MIB1	15	615092	615092[LEFT VENTRICULAR NONCOMPACTION 7; LVNC7]
FBgn0263601	mib1	HGNC:30577	OMIM:611141	MIB2	4		
FBgn0263602	Tasp1	HGNC:15859	OMIM:608270	TASP1	14	618950	618950[SULEIMAN-EL-HATTAB SYNDROME; SULEHS]
FBgn0263603	Zn72D	HGNC:16462	OMIM:611138	STRBP	5		
FBgn0263603	Zn72D	HGNC:29189	OMIM:619284	ZFR2	11		
FBgn0263603	Zn72D	HGNC:17277	OMIM:615635	ZFR	15		
FBgn0263603	Zn72D	HGNC:6038	OMIM:603182	ILF3	5		
FBgn0263605	l(3)72Dn	HGNC:1983	OMIM:607456	UTP4	14		
FBgn0263606	Hsc20	HGNC:28913	OMIM:608142	HSCB	14	619523	619523[ANEMIA, SIDEROBLASTIC, 5; SIDBA5]
FBgn0263607	l(3)72Dp	HGNC:4248	OMIM:601509	GGH	15		
FBgn0263608	l(3)72Dr	HGNC:4248	OMIM:601509	GGH	10		
FBgn0263667	Lpt	HGNC:7133	OMIM:602113	KMT2D	7	147920	147920[KABUKI SYNDROME 1; KABUK1]
FBgn0263667	Lpt	HGNC:13726	OMIM:606833	KMT2C	7	617768	617768[KLEEFSTRA SYNDROME 2; KLEFS2]
FBgn0263697	Uba3	HGNC:12470	OMIM:603172	UBA3	14		
FBgn0263705	Myo10A	HGNC:7594	OMIM:602666	MYO15A	13	600316	600316[DEAFNESS, AUTOSOMAL RECESSIVE 3; DFNB3]
FBgn0263705	Myo10A	HGNC:14083		MYO15B	3		
FBgn0263706	CG43658	HGNC:21726	OMIM:617043	ARHGEF17	3		
FBgn0263706	CG43658	HGNC:14103	OMIM:608136	ARHGEF10	10	608236	608236[SLOWED NERVE CONDUCTION VELOCITY, AUTOSOMAL DOMINANT; SNCV]
FBgn0263706	CG43658	HGNC:25540	OMIM:612494	ARHGEF10L	10		
FBgn0263738	Ada2a	HGNC:30781	OMIM:608790	TADA2B	5		
FBgn0263738	Ada2a	HGNC:9191	OMIM:606017	POLR2D	4		
FBgn0263738	Ada2a	HGNC:11531	OMIM:602276	TADA2A	12		
FBgn0263740	eIF2gamma	HGNC:3267	OMIM:300161	EIF2S3	11	300148	300148[MEHMO SYNDROME; MEHMO]
FBgn0263740	eIF2gamma	HGNC:11479	OMIM:300254	SUV39H1	6		
FBgn0263740	eIF2gamma	HGNC:17287	OMIM:606503	SUV39H2	6		
FBgn0263740	eIF2gamma	HGNC:43863		EIF2S3B	7		
FBgn0263747	CG43672	HGNC:33	OMIM:601615	ABCA3	4	610921	610921[SURFACTANT METABOLISM DYSFUNCTION, PULMONARY, 3; SMDP3]
FBgn0263747	CG43672	HGNC:14637	OMIM:607800	ABCA12	3	242500,601277	242500[ICHTHYOSIS, CONGENITAL, AUTOSOMAL RECESSIVE 4B; ARCI4B],601277[ICHTHYOSIS, CONGENITAL, AUTOSOMAL RECESSIVE 4A; ARCI4A]
FBgn0263747	CG43672	HGNC:30	OMIM:612508	ABCA10	3		
FBgn0263747	CG43672	HGNC:39	OMIM:612507	ABCA9	3		
FBgn0263747	CG43672	HGNC:38	OMIM:612505	ABCA8	3		
FBgn0263747	CG43672	HGNC:36	OMIM:612504	ABCA6	3		
FBgn0263747	CG43672	HGNC:35	OMIM:612503	ABCA5	3	135400	135400[HYPERTRICHOSIS, CONGENITAL GENERALIZED, WITH OR WITHOUT GINGIVAL HYPERPLASIA; HTC3]
FBgn0263747	CG43672	HGNC:14638	OMIM:607807	ABCA13	3		
FBgn0263755	Su(var)3-9	HGNC:11479	OMIM:300254	SUV39H1	5		
FBgn0263755	Su(var)3-9	HGNC:17287	OMIM:606503	SUV39H2	4		
FBgn0263757	Polr2D	HGNC:9191	OMIM:606017	POLR2D	8		
FBgn0263772	CG43689	HGNC:7623	OMIM:613084	MYT1L	7	616521	616521[INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL DOMINANT 39; MRD39]
FBgn0263772	CG43689	HGNC:7622	OMIM:600379	MYT1	7		
FBgn0263772	CG43689	HGNC:18695	OMIM:617155	ST18	7		
FBgn0263776	CG43693	HGNC:19659	OMIM:608332	SLC36A3	8		
FBgn0263776	CG43693	HGNC:18762	OMIM:608331	SLC36A2	9	138500,242600	138500[HYPERGLYCINURIA],242600[IMINOGLYCINURIA]
FBgn0263776	CG43693	HGNC:19660	OMIM:613760	SLC36A4	10		
FBgn0263776	CG43693	HGNC:18761	OMIM:606561	SLC36A1	10		
FBgn0263780	CG17684	HGNC:3009	OMIM:102720	DPP4	6		
FBgn0263780	CG17684	HGNC:3010	OMIM:126141	DPP6	9	612956,616311	612956[VENTRICULAR FIBRILLATION, PAROXYSMAL FAMILIAL, 2; VF2],616311[INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL DOMINANT 33; MRD33]
FBgn0263780	CG17684	HGNC:3590	OMIM:600403	FAP	7		
FBgn0263780	CG17684	HGNC:20823	OMIM:608209	DPP10	9		
FBgn0263782	Hmgcr	HGNC:5006	OMIM:142910	HMGCR	13		
FBgn0263829	CG34334	HGNC:10080	OMIM:606447	RNPS1	6		
FBgn0263830	CG40486	HGNC:28639	OMIM:616159	DHRS11	12		
FBgn0263831	Gen	HGNC:26881	OMIM:612449	GEN1	12		
FBgn0263832	Rcd5	HGNC:6960	OMIM:609504	MCRS1	14		
FBgn0263852	Dad1	HGNC:2664	OMIM:600243	DAD1	14		
FBgn0263855	BubR1	HGNC:1148	OMIM:602452	BUB1	10	114500	114500[COLORECTAL CANCER; CRC]
FBgn0263855	BubR1	HGNC:1149	OMIM:602860	BUB1B	6	114500,176430,257300	114500[COLORECTAL CANCER; CRC],176430[PREMATURE CHROMATID SEPARATION TRAIT; PCS],257300[MOSAIC VARIEGATED ANEUPLOIDY SYNDROME 1; MVA1]
FBgn0263863	mRpL45	HGNC:16651	OMIM:611850	MRPL45	13		
FBgn0263864	Dark	HGNC:576	OMIM:602233	APAF1	7		
FBgn0263873	sick	HGNC:15989	OMIM:611628	NAV1	3		
FBgn0263873	sick	HGNC:15997	OMIM:607026	NAV2	9		
FBgn0263873	sick	HGNC:15998	OMIM:611629	NAV3	7		
FBgn0263911	COX8	HGNC:2294	OMIM:123870	COX8A	3	619059	619059[MITOCHONDRIAL COMPLEX IV DEFICIENCY, NUCLEAR TYPE 15; MC4DN15]
FBgn0263916	Ent2	HGNC:11003	OMIM:602193	SLC29A1	8		
FBgn0263916	Ent2	HGNC:11004	OMIM:602110	SLC29A2	8		
FBgn0263916	Ent2	HGNC:23096	OMIM:612373	SLC29A3	8	602782	602782[HISTIOCYTOSIS-LYMPHADENOPATHY PLUS SYNDROME]
FBgn0263930	dally	HGNC:4453	OMIM:602446	GPC5	14		
FBgn0263930	dally	HGNC:4451	OMIM:300037	GPC3	9	194070,312870	194070[WILMS TUMOR 1; WT1],312870[SIMPSON-GOLABI-BEHMEL SYNDROME, TYPE 1; SGBS1]
FBgn0263933	ebi	HGNC:18502	OMIM:400033	TBL1Y	11	400047	400047[DEAFNESS, Y-LINKED 2; DFNY2]
FBgn0263933	ebi	HGNC:11585	OMIM:300196	TBL1X	15	301033	301033[HYPOTHYROIDISM, CONGENITAL, NONGOITROUS, 8; CHNG8]
FBgn0263933	ebi	HGNC:29529	OMIM:608628	TBL1XR1	14	602342,616944	602342[PIERPONT SYNDROME; PRPTS],616944[INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL DOMINANT 41; MRD41]
FBgn0263934	esn	HGNC:17019	OMIM:608500	PRICKLE1	11	612437	612437[EPILEPSY, PROGRESSIVE MYOCLONIC, 1B; EPM1B]
FBgn0263934	esn	HGNC:6645	OMIM:300111	PRICKLE3	10	308905	308905[LEBER HEREDITARY OPTIC NEUROPATHY, MODIFIER OF; LOAM]
FBgn0263934	esn	HGNC:20340	OMIM:608501	PRICKLE2	12		
FBgn0263968	nonC	HGNC:30045	OMIM:607032	SMG1	13		
FBgn0263974	qin	HGNC:21339	OMIM:611200	TDRD6	3		
FBgn0263974	qin	HGNC:45037		TDRD15	3		
FBgn0263974	qin	HGNC:11712	OMIM:605796	TDRD1	6		
FBgn0263974	qin	HGNC:10060	OMIM:605793	RNF17	4		
FBgn0263977	Tim17b	HGNC:17315	OMIM:605057	TIMM17A	13		
FBgn0263977	Tim17b	HGNC:17310	OMIM:300249	TIMM17B	15		
FBgn0263979	Caf1-55	HGNC:9887	OMIM:602923	RBBP4	13		
FBgn0263979	Caf1-55	HGNC:9890	OMIM:300825	RBBP7	10		
FBgn0263980	Stacl	HGNC:23990		STAC2	3		
FBgn0263980	Stacl	HGNC:11353	OMIM:602317	STAC	4		
FBgn0263980	Stacl	HGNC:28423	OMIM:615521	STAC3	5	255995	255995[MYOPATHY, CONGENITAL, BAILEY-BLOCH; MYPBB]
FBgn0263986	cd	HGNC:12015	OMIM:606765	TPO	3	274500	274500[THYROID DYSHORMONOGENESIS 2A; TDH2A]
FBgn0263986	cd	HGNC:3423	OMIM:131399	EPX	3	261500	261500[EOSINOPHIL PEROXIDASE DEFICIENCY; EPXD]
FBgn0263987	spoon	HGNC:367	OMIM:602449	AKAP1	11		
FBgn0263988	Dic61B	HGNC:2954	OMIM:604366	DNAI1	3	244400	244400[CILIARY DYSKINESIA, PRIMARY, 1; CILD1]
FBgn0263988	Dic61B	HGNC:26252	OMIM:619156	WDR78	7		
FBgn0263995	cpo	HGNC:19098	OMIM:619034	RBPMS2	8		
FBgn0263995	cpo	HGNC:19097	OMIM:601558	RBPMS	9		
FBgn0264000	GluRIB	HGNC:4572	OMIM:138247	GRIA2	10	618917	618917[NEURODEVELOPMENTAL DISORDER WITH LANGUAGE IMPAIRMENT AND BEHAVIORAL ABNORMALITIES; NEDLIB]
FBgn0264000	GluRIB	HGNC:4573	OMIM:305915	GRIA3	12	300699	300699[INTELLECTUAL DEVELOPMENTAL DISORDER, X-LINKED, SYNDROMIC, WU TYPE; MRXSW]
FBgn0264000	GluRIB	HGNC:4571	OMIM:138248	GRIA1	11	619927,619931	619927[INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL DOMINANT 67; MRD67],619931[INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 76; MRT76]
FBgn0264000	GluRIB	HGNC:4574	OMIM:138246	GRIA4	12	617864	617864[NEURODEVELOPMENTAL DISORDER WITH OR WITHOUT SEIZURES AND GAIT ABNORMALITIES; NEDSGA]
FBgn0264001	bru3	HGNC:14058	OMIM:612680	CELF5	11		
FBgn0264001	bru3	HGNC:11967	OMIM:612678	CELF3	10		
FBgn0264001	bru3	HGNC:14059	OMIM:612681	CELF6	10		
FBgn0264001	bru3	HGNC:2550	OMIM:602538	CELF2	3	619561	619561[DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 97; DEE97]
FBgn0264001	bru3	HGNC:2549	OMIM:601074	CELF1	3		
FBgn0264001	bru3	HGNC:14015	OMIM:612679	CELF4	10		
FBgn0264005	Hmx	HGNC:5019	OMIM:613380	HMX3	6		
FBgn0264005	Hmx	HGNC:5018	OMIM:600647	HMX2	5		
FBgn0264005	Hmx	HGNC:5017	OMIM:142992	HMX1	5	612109	612109[OCULOAURICULAR SYNDROME; OCACS]
FBgn0264006	dysc	HGNC:16361	OMIM:607928	WHRN	11	607084,611383	607084[DEAFNESS, AUTOSOMAL RECESSIVE 31; DFNB31],611383[USHER SYNDROME, TYPE IID; USH2D]
FBgn0264006	dysc	HGNC:26257	OMIM:612971	PDZD7	3	276901,605472,618003	276901[USHER SYNDROME, TYPE IIA; USH2A],605472[USHER SYNDROME, TYPE IIC; USH2C],618003[DEAFNESS, AUTOSOMAL RECESSIVE 57; DFNB57]
FBgn0264075	tgo	HGNC:700	OMIM:126110	ARNT	12		
FBgn0264075	tgo	HGNC:701	OMIM:602550	ARNTL	3		
FBgn0264075	tgo	HGNC:16876	OMIM:606036	ARNT2	11	615926	615926[WEBB-DATTANI SYNDROME; WEDAS]
FBgn0264075	tgo	HGNC:18984	OMIM:614517	ARNTL2	3		
FBgn0264077	Cnx14D	HGNC:2060	OMIM:601858	CLGN	11		
FBgn0264077	Cnx14D	HGNC:1473	OMIM:114217	CANX	14		
FBgn0264078	Flo2	HGNC:3757	OMIM:606998	FLOT1	3		
FBgn0264078	Flo2	HGNC:3758	OMIM:131560	FLOT2	14		
FBgn0264087	Slob	HGNC:23326	OMIM:611450	PXK	4		
FBgn0264089	sli	HGNC:11087	OMIM:603745	SLIT3	13		
FBgn0264089	sli	HGNC:11086	OMIM:603746	SLIT2	12		
FBgn0264089	sli	HGNC:11085	OMIM:603742	SLIT1	10		
FBgn0264272	mwh	HGNC:1212	OMIM:604656	FMNL1	5		
FBgn0264272	mwh	HGNC:23698	OMIM:616288	FMNL3	4		
FBgn0264272	mwh	HGNC:18267	OMIM:616285	FMNL2	4		
FBgn0264273	Sema2b	HGNC:10728	OMIM:601124	SEMA3F	6		
FBgn0264273	Sema2b	HGNC:10741	OMIM:607961	SEMA7A	3	614745,619874	614745[BLOOD GROUP, JOHN MILTON HAGEN SYSTEM; JMH],619874[CHOLESTASIS, PROGRESSIVE FAMILIAL INTRAHEPATIC, 11; PFIC11]
FBgn0264273	Sema2b	HGNC:10727	OMIM:608166	SEMA3E	5	214800	214800[CHARGE SYNDROME]
FBgn0264273	Sema2b	HGNC:10723	OMIM:603961	SEMA3A	7	614897	614897[HYPOGONADOTROPIC HYPOGONADISM 16 WITH OR WITHOUT ANOSMIA; HH16]
FBgn0264273	Sema2b	HGNC:10734	OMIM:603706	SEMA4F	4		
FBgn0264273	Sema2b	HGNC:10732	OMIM:601866	SEMA4D	7		
FBgn0264273	Sema2b	HGNC:10730	OMIM:617029	SEMA4B	4		
FBgn0264273	Sema2b	HGNC:10725	OMIM:602645	SEMA3C	6		
FBgn0264273	Sema2b	HGNC:10731	OMIM:604462	SEMA4C	5		
FBgn0264273	Sema2b	HGNC:30400		SEMA3G	5		
FBgn0264273	Sema2b	HGNC:10735	OMIM:618991	SEMA4G	5		
FBgn0264273	Sema2b	HGNC:10729	OMIM:607292	SEMA4A	5	610282,610283	610282[RETINITIS PIGMENTOSA 35; RP35],610283[CONE-ROD DYSTROPHY 10; CORD10]
FBgn0264273	Sema2b	HGNC:10726	OMIM:609907	SEMA3D	7		
FBgn0264273	Sema2b	HGNC:10740	OMIM:609294	SEMA6C	3		
FBgn0264273	Sema2b	HGNC:10739	OMIM:608873	SEMA6B	3	618876	618876[EPILEPSY, PROGRESSIVE MYOCLONIC, 11; EPM11]
FBgn0264273	Sema2b	HGNC:10738	OMIM:605885	SEMA6A	3		
FBgn0264273	Sema2b	HGNC:16770	OMIM:609295	SEMA6D	3		
FBgn0264273	Sema2b	HGNC:10724	OMIM:601281	SEMA3B	6		
FBgn0264291	Det	HGNC:593	OMIM:603352	BIRC5	11		
FBgn0264294	Cyt-b5	HGNC:2570	OMIM:613218	CYB5A	12	250790	250790[METHEMOGLOBINEMIA AND AMBIGUOUS GENITALIA; METAG]
FBgn0264294	Cyt-b5	HGNC:24374	OMIM:611964	CYB5B	13		
FBgn0264297	CG43775	HGNC:8946	OMIM:607076	PI15	3		
FBgn0264297	CG43775	HGNC:16249		R3HDML	3		
FBgn0264297	CG43775	HGNC:21245		PI16	4		
FBgn0264297	CG43775	HGNC:28392	OMIM:610395	GLIPR1L1	3		
FBgn0264297	CG43775	HGNC:25248	OMIM:612434	CRISPLD2	3		
FBgn0264297	CG43775	HGNC:16904	OMIM:618062	CRISP3	3		
FBgn0264297	CG43775	HGNC:304	OMIM:601193	CRISP1	3		
FBgn0264297	CG43775	HGNC:12024	OMIM:187430	CRISP2	3		
FBgn0264297	CG43775	HGNC:33849	OMIM:616572	CLEC18B	4		
FBgn0264297	CG43775	HGNC:30388	OMIM:616571	CLEC18A	4		
FBgn0264298	CG43776	HGNC:21245		PI16	4		
FBgn0264298	CG43776	HGNC:28392	OMIM:610395	GLIPR1L1	3		
FBgn0264298	CG43776	HGNC:16904	OMIM:618062	CRISP3	3		
FBgn0264298	CG43776	HGNC:304	OMIM:601193	CRISP1	3		
FBgn0264298	CG43776	HGNC:12024	OMIM:187430	CRISP2	3		
FBgn0264298	CG43776	HGNC:33849	OMIM:616572	CLEC18B	3		
FBgn0264298	CG43776	HGNC:30388	OMIM:616571	CLEC18A	3		
FBgn0264299	CG43777	HGNC:21245		PI16	4		
FBgn0264299	CG43777	HGNC:28392	OMIM:610395	GLIPR1L1	3		
FBgn0264299	CG43777	HGNC:16904	OMIM:618062	CRISP3	3		
FBgn0264299	CG43777	HGNC:304	OMIM:601193	CRISP1	3		
FBgn0264299	CG43777	HGNC:12024	OMIM:187430	CRISP2	3		
FBgn0264299	CG43777	HGNC:33849	OMIM:616572	CLEC18B	3		
FBgn0264299	CG43777	HGNC:30388	OMIM:616571	CLEC18A	3		
FBgn0264305	CG43783	HGNC:30884	OMIM:619929	TEX2	7		
FBgn0264307	orb2	HGNC:21747	OMIM:610607	CPEB4	9		
FBgn0264307	orb2	HGNC:21745	OMIM:610605	CPEB2	9		
FBgn0264307	orb2	HGNC:21746	OMIM:610606	CPEB3	7		
FBgn0264324	spg	HGNC:19192	OMIM:607679	DOCK4	10		
FBgn0264324	spg	HGNC:2988	OMIM:603122	DOCK2	4	616433	616433[IMMUNODEFICIENCY 40; IMD40]
FBgn0264324	spg	HGNC:2987	OMIM:601403	DOCK1	6		
FBgn0264324	spg	HGNC:23476	OMIM:616904	DOCK5	5		
FBgn0264324	spg	HGNC:2989	OMIM:603123	DOCK3	13	618292	618292[NEURODEVELOPMENTAL DISORDER WITH IMPAIRED INTELLECTUAL DEVELOPMENT, HYPOTONIA, AND ATAXIA; NEDIDHA]
FBgn0264325	Atg6	HGNC:1034	OMIM:604378	BECN1	15		
FBgn0264325	Atg6	HGNC:38606	OMIM:615687	BECN2	8		
FBgn0264326	PolE1	HGNC:9177	OMIM:174762	POLE	15	615083,615139,618336	615083[COLORECTAL CANCER, SUSCEPTIBILITY TO, 12; CRCS12],615139[FACIAL DYSMORPHISM, IMMUNODEFICIENCY, LIVEDO, AND SHORT STATURE; FILS],618336[INTRAUTERINE GROWTH RETARDATION, METAPHYSEAL DYSPLASIA, ADRENAL HYPOPLASIA CONGENITA, GENITAL ANOMALIES, AND IMMUNODEFICIENCY; IMAGEI]
FBgn0264339	CG43795	HGNC:31371	OMIM:614515	GPR179	6	614565	614565[NIGHT BLINDNESS, CONGENITAL STATIONARY, TYPE 1E; CSNB1E]
FBgn0264339	CG43795	HGNC:23689	OMIM:614573	GPR158	7		
FBgn0264357	SNF4Agamma	HGNC:9386	OMIM:602743	PRKAG2	8	194200,261740,600858	194200[WOLFF-PARKINSON-WHITE SYNDROME],261740[GLYCOGEN STORAGE DISEASE OF HEART, LETHAL CONGENITAL],600858[CARDIOMYOPATHY, FAMILIAL HYPERTROPHIC, 6; CMH6]
FBgn0264357	SNF4Agamma	HGNC:9387	OMIM:604976	PRKAG3	6	619030	619030[SKELETAL MUSCLE GLYCOGEN CONTENT AND METABOLISM QUANTITATIVE TRAIT LOCUS; SMGMQTL]
FBgn0264357	SNF4Agamma	HGNC:9385	OMIM:602742	PRKAG1	9		
FBgn0264386	Ca-alpha1T	HGNC:1395	OMIM:607904	CACNA1H	9	611942,617027	611942[EPILEPSY, CHILDHOOD ABSENCE, SUSCEPTIBILITY TO, 6; ECA6],617027[HYPERALDOSTERONISM, FAMILIAL, TYPE IV; HALD4]
FBgn0264386	Ca-alpha1T	HGNC:1394	OMIM:604065	CACNA1G	9	616795,618087	616795[SPINOCEREBELLAR ATAXIA 42; SCA42],618087[SPINOCEREBELLAR ATAXIA 42, EARLY-ONSET, SEVERE, WITH NEURODEVELOPMENTAL DEFICITS; SCA42ND]
FBgn0264386	Ca-alpha1T	HGNC:1396	OMIM:608230	CACNA1I	11		
FBgn0264389	opm	HGNC:28889		TMED3	3		
FBgn0264389	opm	HGNC:17291	OMIM:605395	TMED1	10		
FBgn0264389	opm	HGNC:24251	OMIM:616876	TMED5	12		
FBgn0264449	CG43867	HGNC:17733		PLEKHH1	13		
FBgn0264449	CG43867	HGNC:30506	OMIM:612723	PLEKHH2	11		
FBgn0264490	Eip93F	HGNC:29503	OMIM:607698	LCOR	6		
FBgn0264490	Eip93F	HGNC:30776	OMIM:611799	LCORL	6		
FBgn0264491	how	HGNC:21100	OMIM:609590	QKI	12		
FBgn0264492	CkIIalpha	HGNC:2457	OMIM:115440	CSNK2A1	15	617062	617062[OKUR-CHUNG NEURODEVELOPMENTAL SYNDROME; OCNDS]
FBgn0264492	CkIIalpha	HGNC:2459	OMIM:115442	CSNK2A2	7		
FBgn0264492	CkIIalpha	HGNC:2458		CSNK2A3	5		
FBgn0264493	rdx	HGNC:27934		SPOPL	9		
FBgn0264493	rdx	HGNC:11254	OMIM:602650	SPOP	10	618828,618829	618828[NABAIS SA-DE VRIES SYNDROME, TYPE 1; NSDVS1],618829[NABAIS SA-DE VRIES SYNDROME, TYPE 2; NSDVS2]
FBgn0264494	CG17646	HGNC:73	OMIM:603076	ABCG1	7		
FBgn0264494	CG17646	HGNC:13884	OMIM:607784	ABCG4	6		
FBgn0264494	CG17646	HGNC:74	OMIM:603756	ABCG2	3	138900,614490	138900[URIC ACID CONCENTRATION, SERUM, QUANTITATIVE TRAIT LOCUS 1; UAQTL1],614490[BLOOD GROUP, JUNIOR SYSTEM; JR]
FBgn0264495	gpp	HGNC:24948	OMIM:607375	DOT1L	12		
FBgn0264542	hwt	HGNC:27004	OMIM:610482	SHE	5		
FBgn0264542	hwt	HGNC:10838	OMIM:600314	SHB	5		
FBgn0264542	hwt	HGNC:30633	OMIM:610481	SHD	5		
FBgn0264542	hwt	HGNC:25116	OMIM:617313	SHF	6		
FBgn0264560	garz	HGNC:15853	OMIM:605371	ARFGEF2	3	608097	608097[PERIVENTRICULAR HETEROTOPIA WITH MICROCEPHALY, AUTOSOMAL RECESSIVE; ARPHM]
FBgn0264560	garz	HGNC:4181	OMIM:603698	GBF1	15	606483	606483[CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2GG; CMT2GG]
FBgn0264560	garz	HGNC:15772	OMIM:604141	ARFGEF1	3	619964	619964[DEVELOPMENTAL DELAY, IMPAIRED SPEECH, AND BEHAVIORAL ABNORMALITIES, WITH OR WITHOUT SEIZURES; DEDISB]
FBgn0264561	Glg1	HGNC:4316	OMIM:600753	GLG1	13		
FBgn0264562	Hr4	HGNC:7985	OMIM:602778	NR6A1	8		
FBgn0264574	Glut1	HGNC:18301	OMIM:611039	SLC2A14	8		
FBgn0264574	Glut1	HGNC:11010	OMIM:138230	SLC2A5	4		
FBgn0264574	Glut1	HGNC:11005	OMIM:138140	SLC2A1	10	601042,606777,608885,612126,614847	601042[DYSTONIA 9; DYT9],606777[GLUT1 DEFICIENCY SYNDROME 1; GLUT1DS1],608885[STOMATIN-DEFICIENT CRYOHYDROCYTOSIS WITH NEUROLOGIC DEFECTS; SDCHCN],612126[GLUT1 DEFICIENCY SYNDROME 2; GLUT1DS2],614847[EPILEPSY, IDIOPATHIC GENERALIZED, SUSCEPTIBILITY TO, 12; EIG12]
FBgn0264574	Glut1	HGNC:13445	OMIM:610371	SLC2A7	3		
FBgn0264574	Glut1	HGNC:11009	OMIM:138190	SLC2A4	9		
FBgn0264574	Glut1	HGNC:13446	OMIM:606142	SLC2A9	3	612076	612076[HYPOURICEMIA, RENAL, 2; RHUC2]
FBgn0264574	Glut1	HGNC:11006	OMIM:138160	SLC2A2	7	125853,227810	125853[TYPE 2 DIABETES MELLITUS; T2D],227810[FANCONI-BICKEL SYNDROME; FBS]
FBgn0264574	Glut1	HGNC:11007	OMIM:138170	SLC2A3	10		
FBgn0264574	Glut1	HGNC:14239	OMIM:610367	SLC2A11	3		
FBgn0264606	Fife	HGNC:17282	OMIM:606629	RIMS1	3	603649	603649[CONE-ROD DYSTROPHY 7; CORD7]
FBgn0264607	CaMKII	HGNC:1462	OMIM:607708	CAMK2D	13		
FBgn0264607	CaMKII	HGNC:1460	OMIM:114078	CAMK2A	9	617798,618095	617798[INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL DOMINANT 53; MRD53],618095[INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 63; MRT63]
FBgn0264607	CaMKII	HGNC:1461	OMIM:607707	CAMK2B	10	617799	617799[INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL DOMINANT 54; MRD54]
FBgn0264607	CaMKII	HGNC:1463	OMIM:602123	CAMK2G	9	618522	618522[INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL DOMINANT 59; MRD59]
FBgn0264672	Eogt	HGNC:28526	OMIM:614789	EOGT	14	615297	615297[ADAMS-OLIVER SYNDROME 4; AOS4]
FBgn0264691	Lst8	HGNC:24825	OMIM:612190	MLST8	15		
FBgn0264693	ens	HGNC:25514		MAP7D1	4		
FBgn0264693	ens	HGNC:25742	OMIM:300930	MAP7D3	3		
FBgn0264693	ens	HGNC:6869	OMIM:604108	MAP7	4		
FBgn0264693	ens	HGNC:25899		MAP7D2	4		
FBgn0264694	mgr	HGNC:12662	OMIM:300133	VBP1	14		
FBgn0264695	Mhc	HGNC:7568	OMIM:160776	MYH10	3		
FBgn0264695	Mhc	HGNC:15906	OMIM:609928	MYH7B	10		
FBgn0264695	Mhc	HGNC:23212	OMIM:608568	MYH14	3	600652,614369	600652[DEAFNESS, AUTOSOMAL DOMINANT 4A; DFNA4A],614369[PERIPHERAL NEUROPATHY, MYOPATHY, HOARSENESS, AND HEARING LOSS; PNMHH]
FBgn0264695	Mhc	HGNC:7569	OMIM:160745	MYH11	3	132900,619350,619351	132900[AORTIC ANEURYSM, FAMILIAL THORACIC 4; AAT4],619350[VISCERAL MYOPATHY 2; VSCM2],619351[MEGACYSTIS-MICROCOLON-INTESTINAL HYPOPERISTALSIS SYNDROME 2; MMIHS2]
FBgn0264695	Mhc	HGNC:7573	OMIM:160720	MYH3	9	178110,193700,618436,618469	178110[CONTRACTURES, PTERYGIA, AND SPONDYLOCARPOTARSAL FUSION SYNDROME 1A; CPSFS1A],193700[ARTHROGRYPOSIS, DISTAL, TYPE 2A; DA2A],618436[ARTHROGRYPOSIS, DISTAL, TYPE 2B3; DA2B3],618469[CONTRACTURES, PTERYGIA, AND SPONDYLOCARPOTARSAL FUSION SYNDROME 1B; CPSFS1B]
FBgn0264695	Mhc	HGNC:7576	OMIM:160710	MYH6	11	613251,613252,614089,614090	613251[CARDIOMYOPATHY, FAMILIAL HYPERTROPHIC, 14; CMH14],613252[CARDIOMYOPATHY, DILATED, 1EE; CMD1EE],614089[ATRIAL SEPTAL DEFECT 3; ASD3],614090[SICK SINUS SYNDROME 3, SUSCEPTIBILITY TO; SSS3]
FBgn0264695	Mhc	HGNC:7577	OMIM:160760	MYH7	12	160500,181430,192600,255160,608358,613426	160500[MYOPATHY, DISTAL, 1; MPD1],181430[SCAPULOPERONEAL MYOPATHY, MYH7-RELATED; SPMM],192600[CARDIOMYOPATHY, FAMILIAL HYPERTROPHIC, 1; CMH1],255160[MYOPATHY, MYOSIN STORAGE, AUTOSOMAL RECESSIVE; MSMB],608358[MYOPATHY, MYOSIN STORAGE, AUTOSOMAL DOMINANT; MSMA],613426[CARDIOMYOPATHY, DILATED, 1S; CMD1S]
FBgn0264695	Mhc	HGNC:7578	OMIM:160741	MYH8	9	158300,608837	158300[ARTHROGRYPOSIS, DISTAL, TYPE 7; DA7],608837[CARNEY COMPLEX VARIANT]
FBgn0264695	Mhc	HGNC:31073	OMIM:609929	MYH15	10		
FBgn0264695	Mhc	HGNC:7567	OMIM:160730	MYH1	10		
FBgn0264695	Mhc	HGNC:7571	OMIM:603487	MYH13	9		
FBgn0264695	Mhc	HGNC:7579	OMIM:160775	MYH9	3	155100,603622	155100[MACROTHROMBOCYTOPENIA AND GRANULOCYTE INCLUSIONS WITH OR WITHOUT NEPHRITIS OR SENSORINEURAL HEARING LOSS; MATINS],603622[DEAFNESS, AUTOSOMAL DOMINANT 17; DFNA17]
FBgn0264695	Mhc	HGNC:7572	OMIM:160740	MYH2	9	605637	605637[MYOPATHY, PROXIMAL, WITH OPHTHALMOPLEGIA; MYPOP]
FBgn0264695	Mhc	HGNC:7574	OMIM:160742	MYH4	10		
FBgn0264707	RhoGEF3	HGNC:23222	OMIM:613324	SPATA13	5		
FBgn0264707	RhoGEF3	HGNC:14561	OMIM:300429	ARHGEF9	5	300607	300607[DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 8; DEE8]
FBgn0264707	RhoGEF3	HGNC:684	OMIM:605216	ARHGEF4	4		
FBgn0264707	RhoGEF3	HGNC:32594	OMIM:606905	PREX1	3		
FBgn0264711	CG43980	HGNC:23842		ABTB2	13		
FBgn0264711	CG43980	HGNC:23844		BTBD11	12		
FBgn0264712	CG1172	HGNC:25683	OMIM:616388	UBTD1	13		
FBgn0264712	CG1172	HGNC:24463	OMIM:610174	UBTD2	13		
FBgn0264740	CG43998	HGNC:8142	OMIM:606580	OPA3	6	165300,258501	165300[OPTIC ATROPHY 3, AUTOSOMAL DOMINANT; OPA3],258501[3-METHYLGLUTACONIC ACIDURIA, TYPE III; MGCA3]
FBgn0264741	CG43999	HGNC:8142	OMIM:606580	OPA3	7	165300,258501	165300[OPTIC ATROPHY 3, AUTOSOMAL DOMINANT; OPA3],258501[3-METHYLGLUTACONIC ACIDURIA, TYPE III; MGCA3]
FBgn0264743	CG44001	HGNC:28640		ANKRD39	12		
FBgn0264750	CG44008	HGNC:24643	OMIM:617288	SPINK7	3		
FBgn0264751	Vti1b	HGNC:28434	OMIM:300708	CCNQ	7	300707	300707[TOE SYNDACTYLY, TELECANTHUS, AND ANOGENITAL AND RENAL MALFORMATIONS; STAR]
FBgn0264751	Vti1b	HGNC:17793	OMIM:603207	VTI1B	5		
FBgn0264751	Vti1b	HGNC:27373		CCNQP1	3		
FBgn0264753	Rgk1	HGNC:4234	OMIM:600164	GEM	4		
FBgn0264753	Rgk1	HGNC:10446	OMIM:179503	RRAD	7		
FBgn0264753	Rgk1	HGNC:15922	OMIM:610388	REM1	5		
FBgn0264753	Rgk1	HGNC:20248	OMIM:616955	REM2	4		
FBgn0264785	Hph	HGNC:14661	OMIM:606426	EGLN3	12		
FBgn0264785	Hph	HGNC:44465	OMIM:606424	EGLN2	9		
FBgn0264785	Hph	HGNC:1232	OMIM:606425	EGLN1	11	609070,609820	609070[HEMOGLOBIN, HIGH ALTITUDE ADAPTATION; HALAH],609820[ERYTHROCYTOSIS, FAMILIAL, 3; ECYT3]
FBgn0264815	Pde1c	HGNC:8775	OMIM:171891	PDE1B	9		
FBgn0264815	Pde1c	HGNC:8774	OMIM:171890	PDE1A	10		
FBgn0264815	Pde1c	HGNC:8776	OMIM:602987	PDE1C	8	618140	618140[DEAFNESS, AUTOSOMAL DOMINANT 74; DFNA74]
FBgn0264816	koko	HGNC:28434	OMIM:300708	CCNQ	5	300707	300707[TOE SYNDACTYLY, TELECANTHUS, AND ANOGENITAL AND RENAL MALFORMATIONS; STAR]
FBgn0264845	Tep5Psi	HGNC:21685	OMIM:608859	CD109	7		
FBgn0264845	Tep5Psi	HGNC:1318	OMIM:120700	C3	4	611378,612925,613779	611378[MACULAR DEGENERATION, AGE-RELATED, 9; ARMD9],612925[HEMOLYTIC UREMIC SYNDROME, ATYPICAL, SUSCEPTIBILITY TO, 5; AHUS5],613779[COMPLEMENT COMPONENT 3 DEFICIENCY, AUTOSOMAL RECESSIVE; C3D]
FBgn0264845	Tep5Psi	HGNC:1323	OMIM:120810	C4A	4	614374,614380	614374[BLOOD GROUP, CHIDO/RODGERS SYSTEM],614380[COMPLEMENT COMPONENT 4A DEFICIENCY; C4AD]
FBgn0264845	Tep5Psi	HGNC:1324	OMIM:120820	C4B	4	614379	614379[COMPLEMENT COMPONENT 4B DEFICIENCY; C4BD]
FBgn0264845	Tep5Psi	HGNC:1331	OMIM:120900	C5	5	609536,615749	609536[COMPLEMENT COMPONENT 5 DEFICIENCY; C5D],615749[ECULIZUMAB, POOR RESPONSE TO]
FBgn0264845	Tep5Psi	HGNC:9750	OMIM:176420	PZP	5		
FBgn0264845	Tep5Psi	HGNC:7	OMIM:103950	A2M	5		
FBgn0264845	Tep5Psi	HGNC:23336	OMIM:610627	A2ML1	5	166760	166760[OTITIS MEDIA, SUSCEPTIBILITY TO; OMS]
FBgn0264845	Tep5Psi	HGNC:23228	OMIM:608841	CPAMD8	3	617319	617319[ANTERIOR SEGMENT DYSGENESIS 8; ASGD8]
FBgn0264848	vih	HGNC:15937	OMIM:605574	UBE2C	15		
FBgn0264855	AP-2alpha	HGNC:561	OMIM:601026	AP2A1	12		
FBgn0264855	AP-2alpha	HGNC:562	OMIM:607242	AP2A2	13		
FBgn0264895	RapGAP1	HGNC:29176	OMIM:618714	RAP1GAP2	11		
FBgn0264895	RapGAP1	HGNC:9858	OMIM:600278	RAP1GAP	12		
FBgn0264895	RapGAP1	HGNC:25425		GARNL3	3		
FBgn0264895	RapGAP1	HGNC:23801	OMIM:616655	SIPA1L3	3	616851	616851[CATARACT 45; CTRCT45]
FBgn0264907	CG44098	HGNC:8494	OMIM:604047	SLC22A13	6		
FBgn0264907	CG44098	HGNC:10970	OMIM:607582	SLC22A6	4		
FBgn0264907	CG44098	HGNC:20302	OMIM:608276	SLC22A16	4		
FBgn0264907	CG44098	HGNC:10968	OMIM:604190	SLC22A4	4	180300	180300[RHEUMATOID ARTHRITIS; RA]
FBgn0264907	CG44098	HGNC:10969	OMIM:603377	SLC22A5	4	212140	212140[CARNITINE DEFICIENCY, SYSTEMIC PRIMARY; CDSP]
FBgn0264907	CG44098	HGNC:8495	OMIM:604048	SLC22A14	6		
FBgn0264907	CG44098	HGNC:10971	OMIM:604995	SLC22A7	4		
FBgn0264907	CG44098	HGNC:10972	OMIM:607581	SLC22A8	4		
FBgn0264907	CG44098	HGNC:10966	OMIM:602608	SLC22A2	4		
FBgn0264907	CG44098	HGNC:21106	OMIM:611697	SLC22A23	3		
FBgn0264907	CG44098	HGNC:32935	OMIM:610792	SLC22A25	4		
FBgn0264907	CG44098	HGNC:10963	OMIM:602607	SLC22A1	5		
FBgn0264907	CG44098	HGNC:10967	OMIM:604842	SLC22A3	4		
FBgn0264907	CG44098	HGNC:23095	OMIM:611461	SLC22A17	3		
FBgn0264907	CG44098	HGNC:20301	OMIM:608275	SLC22A15	3		
FBgn0264907	CG44098	HGNC:17989	OMIM:607096	SLC22A12	4	220150	220150[HYPOURICEMIA, RENAL, 1; RHUC1]
FBgn0264907	CG44098	HGNC:27091		SLC22A31	3		
FBgn0264907	CG44098	HGNC:18120	OMIM:607097	SLC22A11	4		
FBgn0264907	CG44098	HGNC:16261	OMIM:607579	SLC22A9	4		
FBgn0264907	CG44098	HGNC:28542	OMIM:611698	SLC22A24	4		
FBgn0264907	CG44098	HGNC:18057	OMIM:607580	SLC22A10	4		
FBgn0264908	pHCl-1	HGNC:4328	OMIM:600421	GLRA3	3		
FBgn0264908	pHCl-1	HGNC:4327	OMIM:305990	GLRA2	3	301076	301076[INTELLECTUAL DEVELOPMENTAL DISORDER, X-LINKED, SYNDROMIC, PILORGE TYPE; MRXSP]
FBgn0264908	pHCl-1	HGNC:31715		GLRA4	4		
FBgn0264922	Sumo	HGNC:21181	OMIM:608829	SUMO4	11	600320	600320[TYPE 1 DIABETES MELLITUS 5; T1D5]
FBgn0264922	Sumo	HGNC:12502	OMIM:601912	SUMO1	6	613705	613705[OROFACIAL CLEFT 10; OFC10]
FBgn0264922	Sumo	HGNC:11125	OMIM:603042	SUMO2	12		
FBgn0264922	Sumo	HGNC:11124	OMIM:602231	SUMO3	13		
FBgn0264953	Piezo	HGNC:28993	OMIM:611184	PIEZO1	10	194380,616843	194380[DEHYDRATED HEREDITARY STOMATOCYTOSIS 1 WITH OR WITHOUT PSEUDOHYPERKALEMIA AND/OR PERINATAL EDEMA; DHS1],616843[LYMPHATIC MALFORMATION 6; LMPHM6]
FBgn0264953	Piezo	HGNC:26270	OMIM:613629	PIEZO2	13	108145,114300,248700,617146	108145[ARTHROGRYPOSIS, DISTAL, TYPE 5; DA5],114300[ARTHROGRYPOSIS, DISTAL, TYPE 3; DA3],248700[MARDEN-WALKER SYNDROME; MWKS],617146[ARTHROGRYPOSIS, DISTAL, WITH IMPAIRED PROPRIOCEPTION AND TOUCH; DAIPT]
FBgn0264959	Src42A	HGNC:4840	OMIM:142370	HCK	4		
FBgn0264959	Src42A	HGNC:1057	OMIM:191305	BLK	4	613375	613375[MATURITY-ONSET DIABETES OF THE YOUNG, TYPE 11; MODY11]
FBgn0264959	Src42A	HGNC:3955	OMIM:606573	FRK	14		
FBgn0264959	Src42A	HGNC:4037	OMIM:137025	FYN	7		
FBgn0264959	Src42A	HGNC:6524	OMIM:153390	LCK	4	615758	615758[IMMUNODEFICIENCY 22; IMD22]
FBgn0264959	Src42A	HGNC:12841	OMIM:164880	YES1	6		
FBgn0264959	Src42A	HGNC:3697	OMIM:164940	FGR	4		
FBgn0264959	Src42A	HGNC:11283	OMIM:190090	SRC	5	114500,616937	114500[COLORECTAL CANCER; CRC],616937[THROMBOCYTOPENIA 6; THC6]
FBgn0264959	Src42A	HGNC:11298	OMIM:617797	SRMS	3		
FBgn0264959	Src42A	HGNC:6735	OMIM:165120	LYN	4		
FBgn0264959	Src42A	HGNC:9617	OMIM:602004	PTK6	3		
FBgn0264962	Pcf11	HGNC:30097	OMIM:608876	PCF11	11		
FBgn0264975	Nrg	HGNC:1939	OMIM:607416	CHL1	9		
FBgn0264975	Nrg	HGNC:6470	OMIM:308840	L1CAM	10	303350,304100,307000	303350[MASA SYNDROME],304100[CORPUS CALLOSUM, PARTIAL AGENESIS OF, X-LINKED],307000[HYDROCEPHALUS DUE TO CONGENITAL STENOSIS OF AQUEDUCT OF SYLVIUS; HSAS]
FBgn0264975	Nrg	HGNC:7994	OMIM:601581	NRCAM	12	619833	619833[NEURODEVELOPMENTAL DISORDER WITH NEUROMUSCULAR AND SKELETAL ABNORMALITIES; NEDNMS]
FBgn0264975	Nrg	HGNC:29866	OMIM:609145	NFASC	10	618356	618356[NEURODEVELOPMENTAL DISORDER WITH CENTRAL AND PERIPHERAL MOTOR DYSFUNCTION; NEDCPMD]
FBgn0264978	Slh	HGNC:20726	OMIM:618207	SCFD1	15		
FBgn0264979	CG4267	HGNC:9155	OMIM:246600	PNLIP	3	614338	614338[PANCREATIC LIPASE DEFICIENCY; PNLIPD]
FBgn0264979	CG4267	HGNC:17661	OMIM:607460	PLA1A	4		
FBgn0264979	CG4267	HGNC:9156	OMIM:604422	PNLIPRP1	3		
FBgn0264979	CG4267	HGNC:23492		PNLIPRP3	3		
FBgn0264979	CG4267	HGNC:6619	OMIM:151670	LIPC	3	125853,612797,614025	125853[TYPE 2 DIABETES MELLITUS; T2D],612797[HIGH DENSITY LIPOPROTEIN CHOLESTEROL LEVEL QUANTITATIVE TRAIT LOCUS 12; HDLCQ12],614025[HEPATIC LIPASE DEFICIENCY]
FBgn0264979	CG4267	HGNC:18821	OMIM:609252	LIPI	3		
FBgn0264979	CG4267	HGNC:18483	OMIM:607365	LIPH	3	604379	604379[HYPOTRICHOSIS 7; HYPT7]
FBgn0265001	ppk18	HGNC:101	OMIM:611741	ASIC3	6		
FBgn0265001	ppk18	HGNC:100	OMIM:602866	ASIC1	6		
FBgn0265001	ppk18	HGNC:21263	OMIM:606715	ASIC4	6		
FBgn0265001	ppk18	HGNC:99	OMIM:601784	ASIC2	5		
FBgn0265001	ppk18	HGNC:17537	OMIM:616693	ASIC5	5		
FBgn0265001	ppk18	HGNC:10599	OMIM:600228	SCNN1A	3	264350,613021,618126	264350[PSEUDOHYPOALDOSTERONISM, TYPE I, AUTOSOMAL RECESSIVE; PHA1B],613021[BRONCHIECTASIS WITH OR WITHOUT ELEVATED SWEAT CHLORIDE 2; BESC2],618126[LIDDLE SYNDROME 3; LIDLS3]
FBgn0265001	ppk18	HGNC:10600	OMIM:600760	SCNN1B	3	177200,211400,264350	177200[LIDDLE SYNDROME 1; LIDLS1],211400[BRONCHIECTASIS WITH OR WITHOUT ELEVATED SWEAT CHLORIDE 1; BESC1],264350[PSEUDOHYPOALDOSTERONISM, TYPE I, AUTOSOMAL RECESSIVE; PHA1B]
FBgn0265001	ppk18	HGNC:10601	OMIM:601328	SCNN1D	3		
FBgn0265001	ppk18	HGNC:10602	OMIM:600761	SCNN1G	3	264350,613071,618114	264350[PSEUDOHYPOALDOSTERONISM, TYPE I, AUTOSOMAL RECESSIVE; PHA1B],613071[BRONCHIECTASIS WITH OR WITHOUT ELEVATED SWEAT CHLORIDE 3; BESC3],618114[LIDDLE SYNDROME 2; LIDLS2]
FBgn0265003	koi	HGNC:11214	OMIM:603038	SPAG4	3		
FBgn0265003	koi	HGNC:18587	OMIM:607723	SUN1	7		
FBgn0265003	koi	HGNC:22429	OMIM:618984	SUN3	4		
FBgn0265003	koi	HGNC:14210	OMIM:613569	SUN2	6		
FBgn0265003	koi	HGNC:16252	OMIM:613942	SUN5	3	617187	617187[SPERMATOGENIC FAILURE 16; SPGF16]
FBgn0265042	Irk1	HGNC:6270	OMIM:600932	KCNJ9	6		
FBgn0265042	Irk1	HGNC:6262	OMIM:605722	KCNJ16	4	619406	619406[HYPOKALEMIC TUBULOPATHY AND DEAFNESS; HKTD]
FBgn0265042	Irk1	HGNC:6263	OMIM:600681	KCNJ2	9	170390,609622,613980	170390[ANDERSEN CARDIODYSRHYTHMIC PERIODIC PARALYSIS],609622[SHORT QT SYNDROME 3; SQT3],613980[ATRIAL FIBRILLATION, FAMILIAL, 9; ATFB9]
FBgn0265042	Irk1	HGNC:6255	OMIM:600359	KCNJ1	4	241200	241200[BARTTER SYNDROME, TYPE 2, ANTENATAL; BARTS2]
FBgn0265042	Irk1	HGNC:6258	OMIM:602323	KCNJ12	8		
FBgn0265042	Irk1	HGNC:6267	OMIM:600877	KCNJ6	5	614098	614098[KEPPEN-LUBINSKY SYNDROME; KPLBS]
FBgn0265042	Irk1	HGNC:6265	OMIM:600504	KCNJ4	8		
FBgn0265042	Irk1	HGNC:6264	OMIM:601534	KCNJ3	4		
FBgn0265042	Irk1	HGNC:39080	OMIM:613236	KCNJ18	8	613239	613239[THYROTOXIC PERIODIC PARALYSIS, SUSCEPTIBILITY TO, 2; TTPP2]
FBgn0265042	Irk1	HGNC:6260	OMIM:603953	KCNJ14	5		
FBgn0265042	Irk1	HGNC:6269	OMIM:600935	KCNJ8	3		
FBgn0265042	Irk1	HGNC:6257	OMIM:600937	KCNJ11	3	125853,601820,610582,616329,618856	125853[TYPE 2 DIABETES MELLITUS; T2D],601820[HYPERINSULINEMIC HYPOGLYCEMIA, FAMILIAL, 2; HHF2],610582[DIABETES MELLITUS, TRANSIENT NEONATAL, 3],616329[MATURITY-ONSET DIABETES OF THE YOUNG, TYPE 13; MODY13],618856[DIABETES MELLITUS, PERMANENT NEONATAL, 2; PNDM2]
FBgn0265042	Irk1	HGNC:6266	OMIM:600734	KCNJ5	7	613485,613677	613485[LONG QT SYNDROME 13; LQT13],613677[HYPERALDOSTERONISM, FAMILIAL, TYPE III; HALD3]
FBgn0265042	Irk1	HGNC:6256	OMIM:602208	KCNJ10	4	600791,612780	600791[DEAFNESS, AUTOSOMAL RECESSIVE 4, WITH ENLARGED VESTIBULAR AQUEDUCT; DFNB4],612780[SEIZURES, SENSORINEURAL DEAFNESS, ATAXIA, MENTAL RETARDATION, AND ELECTROLYTE IMBALANCE; SESAMES]
FBgn0265042	Irk1	HGNC:6261	OMIM:602106	KCNJ15	4		
FBgn0265042	Irk1	HGNC:6259	OMIM:603208	KCNJ13	4	193230,614186	193230[VITREORETINAL DEGENERATION, SNOWFLAKE TYPE; SVD],614186[LEBER CONGENITAL AMAUROSIS 16; LCA16]
FBgn0265045	Strn-Mlck	HGNC:7590	OMIM:600922	MYLK	4	249210,613780	249210[MEGACYSTIS-MICROCOLON-INTESTINAL HYPOPERISTALSIS SYNDROME 1; MMIHS1],613780[AORTIC ANEURYSM, FAMILIAL THORACIC 7; AAT7]
FBgn0265047	FDY	HGNC:17062	OMIM:617369	HABP4	7		
FBgn0265047	FDY	HGNC:17860	OMIM:607378	SERBP1	8		
FBgn0265052	St3	HGNC:11456	OMIM:602385	SULT1C2	6		
FBgn0265052	St3	HGNC:14903	OMIM:608359	SULT4A1	6		
FBgn0265052	St3	HGNC:30004	OMIM:615819	SULT1A4	7		
FBgn0265052	St3	HGNC:33543	OMIM:617151	SULT1C3	6		
FBgn0265052	St3	HGNC:11459	OMIM:604125	SULT2B1	6	617571	617571[ICHTHYOSIS, CONGENITAL, AUTOSOMAL RECESSIVE 14; ARCI14]
FBgn0265052	St3	HGNC:11457	OMIM:608357	SULT1C4	6		
FBgn0265052	St3	HGNC:17845	OMIM:608436	SULT1B1	7		
FBgn0265052	St3	HGNC:11458	OMIM:125263	SULT2A1	6		
FBgn0265052	St3	HGNC:11377	OMIM:600043	SULT1E1	6		
FBgn0265052	St3	HGNC:11455	OMIM:600641	SULT1A3	4		
FBgn0265052	St3	HGNC:11453	OMIM:171150	SULT1A1	6		
FBgn0265052	St3	HGNC:33433	OMIM:617152	SULT6B1	5		
FBgn0265052	St3	HGNC:11454	OMIM:601292	SULT1A2	7		
FBgn0265082	Cdep	HGNC:3591	OMIM:602654	FARP1	7		
FBgn0265082	Cdep	HGNC:16460	OMIM:617586	FARP2	9		
FBgn0265082	Cdep	HGNC:8079	OMIM:300628	FRMD7	4	310700	310700[NYSTAGMUS 1, CONGENITAL, X-LINKED; NYS1]
FBgn0265083	CG44194	HGNC:24604	OMIM:608016	COA4	4		
FBgn0265089	eIF4E3	HGNC:3293	OMIM:605895	EIF4E2	3		
FBgn0265089	eIF4E3	HGNC:3287	OMIM:133440	EIF4E	13	615091	615091[AUTISM, SUSCEPTIBILITY TO, 19; AUTS19]
FBgn0265089	eIF4E3	HGNC:33179		EIF4E1B	12		
FBgn0265089	eIF4E3	HGNC:31837	OMIM:609896	EIF4E3	3		
FBgn0265101	Sgt1	HGNC:16987	OMIM:604098	SUGT1	12		
FBgn0265102	Oseg1	HGNC:13556	OMIM:606045	IFT122	14	218330	218330[CRANIOECTODERMAL DYSPLASIA 1; CED1]
FBgn0265137	Spn42Da	HGNC:8955	OMIM:601799	SERPINB9	4		
FBgn0265137	Spn42Da	HGNC:8945	OMIM:605587	SERPINI2	7		
FBgn0265137	Spn42Da	HGNC:8943	OMIM:602445	SERPINI1	10	604218	604218[ENCEPHALOPATHY, FAMILIAL, WITH NEUROSERPIN INCLUSION BODIES; FENIB]
FBgn0265137	Spn42Da	HGNC:10569	OMIM:600517	SERPINB3	5		
FBgn0265137	Spn42Da	HGNC:3311	OMIM:130135	SERPINB1	6		
FBgn0265137	Spn42Da	HGNC:775	OMIM:107300	SERPINC1	3	613118	613118[ANTITHROMBIN III DEFICIENCY; AT3D]
FBgn0265137	Spn42Da	HGNC:8583	OMIM:173360	SERPINE1	3	613329	613329[PLASMINOGEN ACTIVATOR INHIBITOR-1 DEFICIENCY]
FBgn0265137	Spn42Da	HGNC:8948	OMIM:147935	SERPINA4	3		
FBgn0265137	Spn42Da	HGNC:10570	OMIM:600518	SERPINB4	4		
FBgn0265137	Spn42Da	HGNC:8952	OMIM:601697	SERPINB8	3	617115	617115[PEELING SKIN SYNDROME 5; PSS5]
FBgn0265137	Spn42Da	HGNC:8951	OMIM:177010	SERPINE2	4		
FBgn0265137	Spn42Da	HGNC:14220	OMIM:615662	SERPINB12	3		
FBgn0265137	Spn42Da	HGNC:8942	OMIM:602058	SERPINB10	4		
FBgn0265137	Spn42Da	HGNC:24774		SERPINE3	3		
FBgn0265137	Spn42Da	HGNC:8950	OMIM:173321	SERPINB6	5	613453	613453[DEAFNESS, AUTOSOMAL RECESSIVE 91; DFNB91]
FBgn0265137	Spn42Da	HGNC:8944	OMIM:604445	SERPINB13	4		
FBgn0265140	Meltrin	HGNC:216	OMIM:602713	ADAM9	7	612775	612775[CONE-ROD DYSTROPHY 9; CORD9]
FBgn0265140	Meltrin	HGNC:190	OMIM:602714	ADAM12	10		
FBgn0265140	Meltrin	HGNC:15478	OMIM:607114	ADAM33	8		
FBgn0265140	Meltrin	HGNC:197	OMIM:603640	ADAM19	10		
FBgn0265140	Meltrin	HGNC:193	OMIM:605548	ADAM15	9		
FBgn0265140	Meltrin	HGNC:202	OMIM:603710	ADAM23	3		
FBgn0265140	Meltrin	HGNC:198	OMIM:601533	ADAM2	3		
FBgn0265140	Meltrin	HGNC:200	OMIM:603713	ADAM21	3		
FBgn0265140	Meltrin	HGNC:199	OMIM:603712	ADAM20	3		
FBgn0265140	Meltrin	HGNC:207	OMIM:604778	ADAM29	3		
FBgn0265140	Meltrin	HGNC:215	OMIM:602267	ADAM8	8		
FBgn0265140	Meltrin	HGNC:189	OMIM:155120	ADAM11	4		
FBgn0265140	Meltrin	HGNC:214	OMIM:607310	ADAM7	6		
FBgn0265140	Meltrin	HGNC:206	OMIM:606188	ADAM28	8		
FBgn0265140	Meltrin	HGNC:208	OMIM:604779	ADAM30	3		
FBgn0265140	Meltrin	HGNC:16299	OMIM:606393	ADAMDEC1	4		
FBgn0265140	Meltrin	HGNC:201	OMIM:603709	ADAM22	4	617933	617933[DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 61; DEE61]
FBgn0265140	Meltrin	HGNC:196	OMIM:619495	ADAM18	3		
FBgn0265140	Meltrin	HGNC:15479	OMIM:618602	ADAM32	3		
FBgn0265174	PIG-V	HGNC:26031	OMIM:610274	PIGV	10	239300	239300[HYPERPHOSPHATASIA WITH MENTAL RETARDATION SYNDROME 1; HPMRS1]
FBgn0265178	CG44243	HGNC:29569	OMIM:610284	LIPT1	13	616299	616299[LIPOYLTRANSFERASE 1 DEFICIENCY; LIPT1D]
FBgn0265184	CG44249	HGNC:18666	OMIM:618016	RNPC3	3	618160	618160[PITUITARY HORMONE DEFICIENCY, COMBINED OR ISOLATED, 7; CPHD7]
FBgn0265187	Fatp2	HGNC:10999	OMIM:603314	SLC27A5	5		
FBgn0265187	Fatp2	HGNC:10997	OMIM:604193	SLC27A3	5		
FBgn0265187	Fatp2	HGNC:10995	OMIM:600691	SLC27A1	13		
FBgn0265187	Fatp2	HGNC:11000	OMIM:604196	SLC27A6	6		
FBgn0265187	Fatp2	HGNC:10996	OMIM:603247	SLC27A2	6		
FBgn0265187	Fatp2	HGNC:10998	OMIM:604194	SLC27A4	14	608649	608649[ICHTHYOSIS PREMATURITY SYNDROME; IPS]
FBgn0265189	sud1	HGNC:25585	OMIM:615857	OGFOD1	3		
FBgn0265190	PIG-S	HGNC:14937	OMIM:610271	PIGS	12	618143	618143[DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 95; DEE95]
FBgn0265190	PIG-S	HGNC:25585	OMIM:615857	OGFOD1	7		
FBgn0265191	Gyg	HGNC:4700	OMIM:300198	GYG2	7		
FBgn0265191	Gyg	HGNC:4699	OMIM:603942	GYG1	11	613507,616199	613507[GLYCOGEN STORAGE DISEASE XV; GSD15],616199[POLYGLUCOSAN BODY MYOPATHY 2; PGBM2]
FBgn0265192	Snp	HGNC:18666	OMIM:618016	RNPC3	4	618160	618160[PITUITARY HORMONE DEFICIENCY, COMBINED OR ISOLATED, 7; CPHD7]
FBgn0265192	Snp	HGNC:30541		ERI2	8		
FBgn0265193	Atf-2	HGNC:784	OMIM:123811	ATF2	6		
FBgn0265193	Atf-2	HGNC:16844	OMIM:618262	CREB5	6		
FBgn0265193	Atf-2	HGNC:7899	OMIM:605798	NPDC1	7		
FBgn0265193	Atf-2	HGNC:792	OMIM:606371	ATF7	6		
FBgn0265194	Trpm	HGNC:17994	OMIM:605692	TRPM7	12	105500	105500[AMYOTROPHIC LATERAL SCLEROSIS-PARKINSONISM/DEMENTIA COMPLEX 1]
FBgn0265194	Trpm	HGNC:7146	OMIM:603576	TRPM1	12	613216	613216[NIGHT BLINDNESS, CONGENITAL STATIONARY, TYPE 1C; CSNB1C]
FBgn0265194	Trpm	HGNC:17995	OMIM:607009	TRPM6	11	602014	602014[HYPOMAGNESEMIA 1, INTESTINAL; HOMG1]
FBgn0265194	Trpm	HGNC:17992	OMIM:608961	TRPM3	15		
FBgn0265194	Trpm	HGNC:12339	OMIM:603749	TRPM2	3		
FBgn0265194	Trpm	HGNC:14323	OMIM:604600	TRPM5	4		
FBgn0265194	Trpm	HGNC:17993	OMIM:606936	TRPM4	4	604559,618531	604559[PROGRESSIVE FAMILIAL HEART BLOCK, TYPE IB; PFHB1B],618531[ERYTHROKERATODERMIA VARIABILIS ET PROGRESSIVA 6; EKVP6]
FBgn0265194	Trpm	HGNC:17961	OMIM:606678	TRPM8	4		
FBgn0265262	Vha68-1	HGNC:851	OMIM:607027	ATP6V1A	13	617403,618012	617403[CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IID; ARCL2D],618012[DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 93; DEE93]
FBgn0265264	CG17097	HGNC:6617	OMIM:613497	LIPA	6	278000	278000[LYSOSOMAL ACID LIPASE DEFICIENCY]
FBgn0265264	CG17097	HGNC:23444	OMIM:613922	LIPK	6		
FBgn0265264	CG17097	HGNC:23455	OMIM:613923	LIPM	6		
FBgn0265264	CG17097	HGNC:6622	OMIM:601980	LIPF	6		
FBgn0265264	CG17097	HGNC:21773	OMIM:613921	LIPJ	5		
FBgn0265264	CG17097	HGNC:23452	OMIM:613924	LIPN	6	613943	613943[ICHTHYOSIS, CONGENITAL, AUTOSOMAL RECESSIVE 8; ARCI8]
FBgn0265265	CG32727	HGNC:20325	OMIM:615339	DNAJC15	5		
FBgn0265265	CG32727	HGNC:30528	OMIM:608977	DNAJC19	5	610198	610198[3-METHYLGLUTACONIC ACIDURIA, TYPE V; MGCA5]
FBgn0265267	CG18258	HGNC:6619	OMIM:151670	LIPC	3	125853,612797,614025	125853[TYPE 2 DIABETES MELLITUS; T2D],612797[HIGH DENSITY LIPOPROTEIN CHOLESTEROL LEVEL QUANTITATIVE TRAIT LOCUS 12; HDLCQ12],614025[HEPATIC LIPASE DEFICIENCY]
FBgn0265268	CG18234	HGNC:8546	OMIM:176710	P4HA1	4		
FBgn0265268	CG18234	HGNC:30135	OMIM:608987	P4HA3	5		
FBgn0265268	CG18234	HGNC:8547	OMIM:600608	P4HA2	4	617238	617238[MYOPIA 25, AUTOSOMAL DOMINANT; MYP25]
FBgn0265271	CG14717	HGNC:16407		ABHD11	6		
FBgn0265272	CG30060	HGNC:8630	OMIM:604591	PEBP1	6		
FBgn0265272	CG30060	HGNC:28319	OMIM:612473	PEBP4	3		
FBgn0265296	Dscam2	HGNC:3039	OMIM:602523	DSCAM	10		
FBgn0265296	Dscam2	HGNC:14656	OMIM:611782	DSCAML1	10		
FBgn0265297	pAbp	HGNC:31852		PABPC1L2B	3		
FBgn0265297	pAbp	HGNC:15797		PABPC1L	11		
FBgn0265297	pAbp	HGNC:8554	OMIM:604679	PABPC1	12		
FBgn0265297	pAbp	HGNC:8557	OMIM:603407	PABPC4	13		
FBgn0265297	pAbp	HGNC:8556	OMIM:604680	PABPC3	11		
FBgn0265297	pAbp	HGNC:13629	OMIM:300407	PABPC5	6		
FBgn0265297	pAbp	HGNC:31955		PABPC4L	7		
FBgn0265298	SC35	HGNC:10783	OMIM:600813	SRSF2	11		
FBgn0265298	SC35	HGNC:16988	OMIM:603269	SRSF8	9		
FBgn0265342	COX7CL	HGNC:2292	OMIM:603774	COX7C	3		
FBgn0265351	nac	HGNC:20197	OMIM:605881	SLC35C1	15	266265	266265[CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIc; CDG2C]
FBgn0265356	tn	HGNC:32669	OMIM:618570	TRIM71	4	618667	618667[HYDROCEPHALUS, CONGENITAL COMMUNICATING, 1; HYDCC1]
FBgn0265356	tn	HGNC:10064	OMIM:605493	TRIM3	4		
FBgn0265356	tn	HGNC:15974	OMIM:614141	TRIM2	5	615490	615490[CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2R; CMT2R]
FBgn0265416	Neto	HGNC:14644	OMIM:607974	NETO2	6		
FBgn0265416	Neto	HGNC:13823	OMIM:607973	NETO1	4		
FBgn0265464	Traf6	HGNC:12036	OMIM:602355	TRAF6	14		
FBgn0265487	mbl	HGNC:16746	OMIM:607327	MBNL2	10		
FBgn0265487	mbl	HGNC:20564	OMIM:300413	MBNL3	9		
FBgn0265487	mbl	HGNC:6923	OMIM:606516	MBNL1	10		
FBgn0265512	mlt	HGNC:28115	OMIM:610451	TBCEL	14		
FBgn0265523	Smr	HGNC:7673	OMIM:600848	NCOR2	9		
FBgn0265523	Smr	HGNC:7672	OMIM:600849	NCOR1	10		
FBgn0265574	Cdc5	HGNC:1743	OMIM:602868	CDC5L	13		
FBgn0265575	yin	HGNC:10920	OMIM:600544	SLC15A1	11		
FBgn0265575	yin	HGNC:10921	OMIM:602339	SLC15A2	10		
FBgn0265575	yin	HGNC:23090	OMIM:615806	SLC15A4	4		
FBgn0265595	CG44422	HGNC:15522	OMIM:604661	KCNIP2	5		
FBgn0265595	CG44422	HGNC:30083	OMIM:608182	KCNIP4	7		
FBgn0265595	CG44422	HGNC:15523	OMIM:604662	KCNIP3	7		
FBgn0265595	CG44422	HGNC:15521	OMIM:604660	KCNIP1	6		
FBgn0265597	rad	HGNC:9858	OMIM:600278	RAP1GAP	3		
FBgn0265597	rad	HGNC:25425		GARNL3	3		
FBgn0265598	Bx	HGNC:6643	OMIM:180386	LMO3	7		
FBgn0265598	Bx	HGNC:6641	OMIM:186921	LMO1	8	186921	186921[LIM DOMAIN ONLY 1; LMO1]
FBgn0265605	Ric	HGNC:10017	OMIM:609592	RIT2	14		
FBgn0265605	Ric	HGNC:10023	OMIM:609591	RIT1	11	615355	615355[NOONAN SYNDROME 8; NS8]
FBgn0265606	Prosalpha4T1	HGNC:22985	OMIM:617841	PSMA8	10		
FBgn0265606	Prosalpha4T1	HGNC:9536	OMIM:606607	PSMA7	10		
FBgn0265623	Su(z)2	HGNC:17615	OMIM:610231	PCGF1	5		
FBgn0265623	Su(z)2	HGNC:12929	OMIM:600346	PCGF2	4	618371	618371[TURNPENNY-FRY SYNDROME; TPFS]
FBgn0265623	Su(z)2	HGNC:21156	OMIM:607816	PCGF6	3		
FBgn0265623	Su(z)2	HGNC:28264	OMIM:617407	PCGF5	4		
FBgn0265623	Su(z)2	HGNC:48326		COMMD3-BMI1	3		
FBgn0265623	Su(z)2	HGNC:1066	OMIM:164831	BMI1	4		
FBgn0265623	Su(z)2	HGNC:10066	OMIM:617543	PCGF3	4		
FBgn0265630	sno	HGNC:29158	OMIM:615729	SBNO2	7		
FBgn0265630	sno	HGNC:22973	OMIM:614274	SBNO1	13		
FBgn0265726	Nna1	HGNC:26296	OMIM:617345	AGBL2	12		
FBgn0265726	Nna1	HGNC:27981	OMIM:617346	AGBL3	10		
FBgn0265726	Nna1	HGNC:17258	OMIM:606830	AGTPBP1	3	618276	618276[NEURODEGENERATION, CHILDHOOD-ONSET, WITH CEREBELLAR ATROPHY; CONDCA]
FBgn0265726	Nna1	HGNC:26504	OMIM:615496	AGBL1	4	615523	615523[CORNEAL DYSTROPHY, FUCHS ENDOTHELIAL, 8; FECD8]
FBgn0265767	zyd	HGNC:10976	OMIM:609838	SLC24A2	3		
FBgn0265767	zyd	HGNC:10977	OMIM:609839	SLC24A3	9		
FBgn0265767	zyd	HGNC:20611	OMIM:609802	SLC24A5	4	113750	113750[ALBINISM, OCULOCUTANEOUS, TYPE VI; OCA6]
FBgn0265767	zyd	HGNC:10978	OMIM:609840	SLC24A4	7	210750,615887	210750[SKIN/HAIR/EYE PIGMENTATION, VARIATION IN, 6; SHEP6],615887[AMELOGENESIS IMPERFECTA, HYPOMATURATION TYPE, IIA5; AI2A5]
FBgn0265778	PDZ-GEF	HGNC:20655	OMIM:610499	RAPGEF6	12		
FBgn0265778	PDZ-GEF	HGNC:16854	OMIM:609530	RAPGEF2	12	618075	618075[EPILEPSY, FAMILIAL ADULT MYOCLONIC, 7; FAME7]
FBgn0265784	CrebB	HGNC:783	OMIM:123803	ATF1	10		
FBgn0265784	CrebB	HGNC:2345	OMIM:123810	CREB1	13	612160	612160[HISTIOCYTOMA, ANGIOMATOID FIBROUS]
FBgn0265784	CrebB	HGNC:2352	OMIM:123812	CREM	11		
FBgn0265935	coro	HGNC:2256	OMIM:605002	CORO2B	6		
FBgn0265935	coro	HGNC:21356		CORO6	14		
FBgn0265935	coro	HGNC:2255	OMIM:602159	CORO2A	5		
FBgn0265935	coro	HGNC:2254	OMIM:605269	CORO1C	15		
FBgn0265935	coro	HGNC:2253	OMIM:609849	CORO1B	13		
FBgn0265935	coro	HGNC:2252	OMIM:605000	CORO1A	13	615401	615401[IMMUNODEFICIENCY 8; IMD8]
FBgn0265959	rdgC	HGNC:9243	OMIM:300109	PPEF1	12		
FBgn0265959	rdgC	HGNC:9244	OMIM:602256	PPEF2	12		
FBgn0265968	Tfb5	HGNC:21157	OMIM:608780	GTF2H5	12	616395	616395[TRICHOTHIODYSTROPHY 3, PHOTOSENSITIVE; TTD3]
FBgn0265974	ttv	HGNC:3512	OMIM:608177	EXT1	13	133700,215300	133700[EXOSTOSES, MULTIPLE, TYPE I; EXT1],215300[CHONDROSARCOMA]
FBgn0265974	ttv	HGNC:3515	OMIM:601738	EXTL1	6		
FBgn0265991	Zasp52	HGNC:2067	OMIM:605900	PDLIM1	4		
FBgn0265991	Zasp52	HGNC:22958	OMIM:605903	PDLIM7	8		
FBgn0265991	Zasp52	HGNC:14061	OMIM:605390	LPXN	3		
FBgn0265991	Zasp52	HGNC:15710	OMIM:605906	LDB3	8	601493,609452	601493[CARDIOMYOPATHY, DILATED, 1C, WITH OR WITHOUT LEFT VENTRICULAR NONCOMPACTION; CMD1C],609452[MYOPATHY, MYOFIBRILLAR, 4; MFM4]
FBgn0265991	Zasp52	HGNC:20767	OMIM:605889	PDLIM3	3		
FBgn0265991	Zasp52	HGNC:16501	OMIM:603422	PDLIM4	3	166710	166710[OSTEOPOROSIS]
FBgn0265991	Zasp52	HGNC:17468	OMIM:605904	PDLIM5	6		
FBgn0265998	Doa	HGNC:2068	OMIM:601951	CLK1	7		
FBgn0265998	Doa	HGNC:2071	OMIM:602990	CLK3	8		
FBgn0265998	Doa	HGNC:13659	OMIM:607969	CLK4	8		
FBgn0265998	Doa	HGNC:2069	OMIM:602989	CLK2	12		
FBgn0266000	CG44774	HGNC:30702	OMIM:615027	SINHCAF	9		
FBgn0266019	rudhira	HGNC:14347	OMIM:607470	BCAS3	11	619641	619641[HENGEL-MAROOFIAN-SCHOLS SYNDROME; HEMARS]
FBgn0266053	Patr-1	HGNC:33630	OMIM:614661	PATL2	10	617743	617743[OOCYTE MATURATION DEFECT 4; OOMD4]
FBgn0266053	Patr-1	HGNC:26721	OMIM:614660	PATL1	11		
FBgn0266064	GlyS	HGNC:4707	OMIM:138571	GYS2	13	240600	240600[GLYCOGEN STORAGE DISEASE 0, LIVER; GSD0A]
FBgn0266064	GlyS	HGNC:4706	OMIM:138570	GYS1	15	611556	611556[GLYCOGEN STORAGE DISEASE 0, MUSCLE; GSD0B]
FBgn0266083	ocm	HGNC:11605	OMIM:602427	TBX6	3	122600	122600[SPONDYLOCOSTAL DYSOSTOSIS 5; SCDO5]
FBgn0266083	ocm	HGNC:11598	OMIM:606061	TBX20	3	611363	611363[ATRIAL SEPTAL DEFECT 4; ASD4]
FBgn0266083	ocm	HGNC:11594	OMIM:604127	TBX15	3	260660	260660[COUSIN SYNDROME]
FBgn0266083	ocm	HGNC:11600	OMIM:300307	TBX22	3	302905,303400	302905[ABRUZZO-ERICKSON SYNDROME; ABERS],303400[CLEFT PALATE WITH OR WITHOUT ANKYLOGLOSSIA, X-LINKED; CPX]
FBgn0266084	Fhos	HGNC:17905	OMIM:606881	FHOD1	8		
FBgn0266084	Fhos	HGNC:26178	OMIM:609691	FHOD3	8	619402	619402[CARDIOMYOPATHY, FAMILIAL HYPERTROPHIC, 28; CMH28]
FBgn0266098	rg	HGNC:1742	OMIM:606453	LRBA	11	614700	614700[IMMUNODEFICIENCY, COMMON VARIABLE, 8, WITH AUTOIMMUNITY; CVID8]
FBgn0266098	rg	HGNC:7648	OMIM:604889	NBEA	12	619157	619157[NEURODEVELOPMENTAL DISORDER WITH OR WITHOUT EARLY-ONSET GENERALIZED EPILEPSY; NEDEGE]
FBgn0266099	CG44836	HGNC:25857	OMIM:617185	NSUN7	8		
FBgn0266100	CG44837	HGNC:23028	OMIM:609925	DPEP2	8		
FBgn0266100	CG44837	HGNC:3002	OMIM:179780	DPEP1	8		
FBgn0266100	CG44837	HGNC:23029	OMIM:609926	DPEP3	9		
FBgn0266111	ana3	HGNC:18654	OMIM:610436	RTTN	5	614833	614833[MICROCEPHALY, SHORT STATURE, AND POLYMICROGYRIA WITH OR WITHOUT SEIZURES; MSSP]
FBgn0266136	Gyc76C	HGNC:7943	OMIM:108960	NPR1	3		
FBgn0266136	Gyc76C	HGNC:7944	OMIM:108961	NPR2	4	602875,615923,616255	602875[ACROMESOMELIC DYSPLASIA 1; AMD1],615923[EPIPHYSEAL CHONDRODYSPLASIA, MIURA TYPE; ECDM],616255[SHORT STATURE WITH NONSPECIFIC SKELETAL ABNORMALITIES; SNSK]
FBgn0266136	Gyc76C	HGNC:4691	OMIM:300041	GUCY2F	4		
FBgn0266136	Gyc76C	HGNC:4689	OMIM:600179	GUCY2D	3	204000,215500,601777,618555	204000[LEBER CONGENITAL AMAUROSIS 1; LCA1],215500[CHOROIDAL DYSTROPHY, CENTRAL AREOLAR, 1; CACD1],601777[CONE-ROD DYSTROPHY 6; CORD6],618555[NIGHT BLINDNESS, CONGENITAL STATIONARY, TYPE1I; CSNB1I]
FBgn0266136	Gyc76C	HGNC:4688	OMIM:601330	GUCY2C	4	614616,614665	614616[DIARRHEA 6; DIAR6],614665[MECONIUM ILEUS]
FBgn0266137	Dop1R2	HGNC:285	OMIM:109630	ADRB1	3	607276,618591	607276[RESTING HEART RATE, VARIATION IN],618591[SHORT SLEEP, FAMILIAL NATURAL, 2; FNSS2]
FBgn0266186	Vamp7	HGNC:11486	OMIM:300053	VAMP7	13		
FBgn0266195	Tgs1	HGNC:17843	OMIM:606461	TGS1	9		
FBgn0266268	FeCH	HGNC:3647	OMIM:612386	FECH	14	177000	177000[PROTOPORPHYRIA, ERYTHROPOIETIC, 1; EPP1]
FBgn0266282	jnj	HGNC:20466	OMIM:609387	SMC6	14		
FBgn0266284	Ns3	HGNC:25652	OMIM:610780	LSG1	14		
FBgn0266346	CngB	HGNC:2151	OMIM:600724	CNGB1	13	613767	613767[RETINITIS PIGMENTOSA 45; RP45]
FBgn0266346	CngB	HGNC:2153	OMIM:605080	CNGB3	12	262300	262300[ACHROMATOPSIA 3; ACHM3]
FBgn0266347	nAChRalpha4	HGNC:1962	OMIM:118507	CHRNB2	3	605375	605375[EPILEPSY, NOCTURNAL FRONTAL LOBE, 3; ENFL3]
FBgn0266347	nAChRalpha4	HGNC:1959	OMIM:118505	CHRNA5	3	612052	612052[SMOKING AS A QUANTITATIVE TRAIT LOCUS 3; SQTL3]
FBgn0266347	nAChRalpha4	HGNC:1955	OMIM:100690	CHRNA1	3	253290,601462,608930	253290[MULTIPLE PTERYGIUM SYNDROME, LETHAL TYPE; LMPS],601462[MYASTHENIC SYNDROME, CONGENITAL, 1A, SLOW-CHANNEL; CMS1A],608930[MYASTHENIC SYNDROME, CONGENITAL, 1B, FAST-CHANNEL; CMS1B]
FBgn0266347	nAChRalpha4	HGNC:1957	OMIM:118503	CHRNA3	10	191800,612052	191800[BLADDER DYSFUNCTION, AUTONOMIC, WITH IMPAIRED PUPILLARY REFLEX AND SECONDARY CAKUT; BAIPRCK],612052[SMOKING AS A QUANTITATIVE TRAIT LOCUS 3; SQTL3]
FBgn0266347	nAChRalpha4	HGNC:1964	OMIM:118509	CHRNB4	3		
FBgn0266347	nAChRalpha4	HGNC:1958	OMIM:118504	CHRNA4	7	188890,600513	188890[TOBACCO ADDICTION, SUSCEPTIBILITY TO],600513[EPILEPSY, NOCTURNAL FRONTAL LOBE, 1; ENFL1]
FBgn0266347	nAChRalpha4	HGNC:15963	OMIM:606888	CHRNA6	9		
FBgn0266347	nAChRalpha4	HGNC:1956	OMIM:118502	CHRNA2	9	610353	610353[EPILEPSY, NOCTURNAL FRONTAL LOBE, 4; ENFL4]
FBgn0266347	nAChRalpha4	HGNC:1963	OMIM:118508	CHRNB3	3		
FBgn0266354	CG45002	HGNC:3009	OMIM:102720	DPP4	4		
FBgn0266354	CG45002	HGNC:3010	OMIM:126141	DPP6	6	612956,616311	612956[VENTRICULAR FIBRILLATION, PAROXYSMAL FAMILIAL, 2; VF2],616311[INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL DOMINANT 33; MRD33]
FBgn0266354	CG45002	HGNC:3590	OMIM:600403	FAP	4		
FBgn0266354	CG45002	HGNC:20823	OMIM:608209	DPP10	6		
FBgn0266363	CG45011	HGNC:32951	OMIM:613511	SPINK9	3		
FBgn0266363	CG45011	HGNC:24643	OMIM:617288	SPINK7	3		
FBgn0266364	CG45012	HGNC:32951	OMIM:613511	SPINK9	3		
FBgn0266364	CG45012	HGNC:24643	OMIM:617288	SPINK7	3		
FBgn0266369	Mtp	HGNC:7467	OMIM:157147	MTTP	14	200100,605552	200100[ABETALIPOPROTEINEMIA; ABL],605552[ABDOMINAL OBESITY-METABOLIC SYNDROME 1; AOMS1]
FBgn0266377	Pde8	HGNC:8794	OMIM:603390	PDE8B	12	609161,614190	609161[STRIATAL DEGENERATION, AUTOSOMAL DOMINANT 1; ADSD1],614190[PIGMENTED NODULAR ADRENOCORTICAL DISEASE, PRIMARY, 3; PPNAD3]
FBgn0266377	Pde8	HGNC:8793	OMIM:602972	PDE8A	10		
FBgn0266409	CG45049	HGNC:17637	OMIM:609301	PERP	10	619208,619209	619208[OLMSTED SYNDROME 2; OLMS2],619209[ERYTHROKERATODERMIA VARIABILIS ET PROGRESSIVA 7; EKVP7]
FBgn0266409	CG45049	HGNC:18515	OMIM:300698	TMEM47	13		
FBgn0266410	CG45050	HGNC:13008	OMIM:604761	ZFAND5	11		
FBgn0266410	CG45050	HGNC:30164	OMIM:610183	ZFAND6	12		
FBgn0266411	sima	HGNC:7894	OMIM:603346	NPAS1	3		
FBgn0266411	sima	HGNC:19311	OMIM:609430	NPAS3	3		
FBgn0266411	sima	HGNC:10883	OMIM:600892	SIM2	3		
FBgn0266411	sima	HGNC:4910	OMIM:603348	HIF1A	9		
FBgn0266411	sima	HGNC:15825	OMIM:609976	HIF3A	7		
FBgn0266411	sima	HGNC:3374	OMIM:603349	EPAS1	8	611783	611783[ERYTHROCYTOSIS, FAMILIAL, 4; ECYT4]
FBgn0266417	ringer	HGNC:24162	OMIM:616957	TPPP3	12		
FBgn0266417	ringer	HGNC:19293	OMIM:616956	TPPP2	12		
FBgn0266417	ringer	HGNC:24164	OMIM:608773	TPPP	12		
FBgn0266418	wake	HGNC:26766		ANKFN1	10		
FBgn0266429	AstA-R1	HGNC:4132	OMIM:600377	GALR1	4		
FBgn0266429	AstA-R1	HGNC:4133	OMIM:603691	GALR2	11		
FBgn0266429	AstA-R1	HGNC:4134	OMIM:603692	GALR3	6		
FBgn0266435	CG45065	HGNC:24288		CHDH	3		
FBgn0266437	CG45067	HGNC:20685	OMIM:617160	PROM2	6		
FBgn0266437	CG45067	HGNC:9454	OMIM:604365	PROM1	7	603786,608051,612095,612657	603786[STARGARDT DISEASE 4; STGD4],608051[MACULAR DYSTROPHY, RETINAL, 2; MCDR2],612095[RETINITIS PIGMENTOSA 41; RP41],612657[CONE-ROD DYSTROPHY 12; CORD12]
FBgn0266438	PIG-Z	HGNC:30596	OMIM:611671	PIGZ	8		
FBgn0266449	Kr-h2	HGNC:25541	OMIM:618515	TMEM33	12		
FBgn0266452	CTPsyn	HGNC:2520	OMIM:300380	CTPS2	13		
FBgn0266452	CTPsyn	HGNC:2519	OMIM:123860	CTPS1	14	615897	615897[IMMUNODEFICIENCY 24; IMD24]
FBgn0266464	Nsf2	HGNC:8016	OMIM:601633	NSF	14	619340	619340[DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 96; DEE96]
FBgn0266465	GckIII	HGNC:18174	OMIM:300547	STK26	10		
FBgn0266465	GckIII	HGNC:11404	OMIM:602255	STK25	10		
FBgn0266465	GckIII	HGNC:11403	OMIM:604984	STK24	11		
FBgn0266518	Dpit47	HGNC:12394	OMIM:606753	TTC4	14		
FBgn0266521	stai	HGNC:6510	OMIM:151442	STMN1	6		
FBgn0266521	stai	HGNC:10577	OMIM:600621	STMN2	7		
FBgn0266521	stai	HGNC:15926	OMIM:608362	STMN3	8		
FBgn0266521	stai	HGNC:16078		STMN4	8		
FBgn0266557	kis	HGNC:20153	OMIM:610528	CHD8	9	615032	615032[INTELLECTUAL DEVELOPMENTAL DISORDER WITH AUTISM AND MACROCEPHALY; IDDAM]
FBgn0266557	kis	HGNC:20626	OMIM:608892	CHD7	10	214800,612370	214800[CHARGE SYNDROME],612370[HYPOGONADOTROPIC HYPOGONADISM 5 WITH OR WITHOUT ANOSMIA; HH5]
FBgn0266557	kis	HGNC:25701	OMIM:616936	CHD9	9		
FBgn0266557	kis	HGNC:19057	OMIM:616114	CHD6	9		
FBgn0266566	CG45105	HGNC:10671	OMIM:613524	SDCCAG8	9	613615,615993	613615[SENIOR-LOKEN SYNDROME 7; SLSN7],615993[BARDET-BIEDL SYNDROME 16; BBS16]
FBgn0266570	NO66	HGNC:19441	OMIM:612049	RIOX2	6		
FBgn0266570	NO66	HGNC:20968	OMIM:611919	RIOX1	12		
FBgn0266572	ebo	HGNC:19733	OMIM:608411	XPO6	12		
FBgn0266579	tau	HGNC:6839	OMIM:157130	MAP2	5		
FBgn0266579	tau	HGNC:6862	OMIM:157132	MAP4	6		
FBgn0266579	tau	HGNC:6893	OMIM:157140	MAPT	7	168600,172700,260540,600274,601104	168600[PARKINSON DISEASE, LATE-ONSET; PD],172700[PICK DISEASE OF BRAIN],260540[PARKINSON-DEMENTIA SYNDROME],600274[FRONTOTEMPORAL DEMENTIA; FTD],601104[SUPRANUCLEAR PALSY, PROGRESSIVE, 1; PSNP1]
FBgn0266580	Gp210	HGNC:30052	OMIM:607703	NUP210	15		
FBgn0266580	Gp210	HGNC:29915		NUP210L	12		
FBgn0266581	pit	HGNC:2741	OMIM:606355	DDX18	15		
FBgn0266582	ND-30	HGNC:7710	OMIM:603846	NDUFS3	14	618230	618230[MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 8; MC1DN8]
FBgn0266599	Hsc70-4	HGNC:5232	OMIM:140550	HSPA1A	6		
FBgn0266599	Hsc70-4	HGNC:5233	OMIM:603012	HSPA1B	9		
FBgn0266599	Hsc70-4	HGNC:5234	OMIM:140559	HSPA1L	7		
FBgn0266599	Hsc70-4	HGNC:5238	OMIM:138120	HSPA5	4		
FBgn0266599	Hsc70-4	HGNC:5244	OMIM:600548	HSPA9	3	182170,616854	182170[ANEMIA, SIDEROBLASTIC, 4; SIDBA4],616854[EVEN-PLUS SYNDROME; EVPLS]
FBgn0266599	Hsc70-4	HGNC:5239	OMIM:140555	HSPA6	7		
FBgn0266599	Hsc70-4	HGNC:5235	OMIM:140560	HSPA2	8		
FBgn0266599	Hsc70-4	HGNC:5241	OMIM:600816	HSPA8	12		
FBgn0266615	CG45122	HGNC:43561		SMKR1	4		
FBgn0266666	Sem1	HGNC:10845	OMIM:601285	SEM1	5		
FBgn0266667	Exo70	HGNC:23214	OMIM:608163	EXOC7	15	619072	619072[NEURODEVELOPMENTAL DISORDER WITH SEIZURES AND BRAIN ATROPHY; NEDSEBA]
FBgn0266668	Exo84	HGNC:24659	OMIM:615283	EXOC8	14	619076	619076[NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, SEIZURES, AND BRAIN ATROPHY; NEDMISB]
FBgn0266669	Sec3	HGNC:30380	OMIM:607879	EXOC1	14		
FBgn0266669	Sec3	HGNC:19666	OMIM:607958	STXBP6	3		
FBgn0266669	Sec3	HGNC:53433		EXOC1L	3		
FBgn0266670	Sec5	HGNC:24968	OMIM:615329	EXOC2	14	619306	619306[NEURODEVELOPMENTAL DISORDER WITH DYSMORPHIC FACIES AND CEREBELLAR HYPOPLASIA; NEDFACH]
FBgn0266671	Sec6	HGNC:30378	OMIM:608186	EXOC3	14		
FBgn0266671	Sec6	HGNC:11895	OMIM:603300	TNFAIP2	4		
FBgn0266671	Sec6	HGNC:30162	OMIM:616927	EXOC3L2	4		
FBgn0266671	Sec6	HGNC:20120		EXOC3L4	4		
FBgn0266671	Sec6	HGNC:27540	OMIM:614117	EXOC3L1	6		
FBgn0266672	Sec8	HGNC:30389	OMIM:608185	EXOC4	14		
FBgn0266673	Sec10	HGNC:10696	OMIM:604469	EXOC5	14		
FBgn0266674	Sec15	HGNC:17085	OMIM:607880	EXOC6B	13	618395	618395[SPONDYLOEPIMETAPHYSEAL DYSPLASIA WITH JOINT LAXITY, TYPE 3; SEMDJL3]
FBgn0266674	Sec15	HGNC:23196	OMIM:609672	EXOC6	13		
FBgn0266696	Svil	HGNC:11480	OMIM:604126	SVIL	6	619040	619040[MYOFIBRILLAR MYOPATHY 10; MFM10]
FBgn0266708	Cep89	HGNC:25907	OMIM:615470	CEP89	7		
FBgn0266709	Zmynd10	HGNC:19412	OMIM:607070	ZMYND10	14	615444	615444[CILIARY DYSKINESIA, PRIMARY, 22; CILD22]
FBgn0266711	EloC	HGNC:11617	OMIM:600788	ELOC	15		
FBgn0266717	Bruce	HGNC:13516	OMIM:605638	BIRC6	15		
FBgn0266719	stac	HGNC:948	OMIM:604009	BAIAP3	5		
FBgn0266719	stac	HGNC:23147	OMIM:608897	UNC13D	4	608898	608898[HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS, FAMILIAL, 3; FHL3]
FBgn0266720	Snap24	HGNC:11132	OMIM:600322	SNAP25	15	616330	616330[MYASTHENIC SYNDROME, CONGENITAL, 18; CMS18]
FBgn0266720	Snap24	HGNC:11131	OMIM:602534	SNAP23	10		
FBgn0266721	gammaSnap2	HGNC:7642	OMIM:603216	NAPG	13		
FBgn0266722	Trs33	HGNC:23066	OMIM:610397	TRAPPC6B	15	617862	617862[NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, EPILEPSY, AND BRAIN ATROPHY; NEDMEBA]
FBgn0266722	Trs33	HGNC:23069	OMIM:610396	TRAPPC6A	11		
FBgn0266723	Trs31	HGNC:23067		TRAPPC5	15		
FBgn0266724	Trs20	HGNC:23068	OMIM:300202	TRAPPC2	14	313400	313400[SPONDYLOEPIPHYSEAL DYSPLASIA TARDA, X-LINKED; SEDT]
FBgn0266724	Trs20	HGNC:10710		TRAPPC2B	4		
FBgn0266756	btsz	HGNC:15587		SYTL3	3		
FBgn0266756	btsz	HGNC:15585	OMIM:612880	SYTL2	3		
FBgn0266756	btsz	HGNC:15584	OMIM:608042	SYTL1	3		
FBgn0266756	btsz	HGNC:15588	OMIM:300723	SYTL4	10		
FBgn0266756	btsz	HGNC:15589		SYTL5	8		
FBgn0266757	mfr	HGNC:19044		FER1L5	5		
FBgn0266757	mfr	HGNC:3097	OMIM:603009	DYSF	8	253601,254130,606768	253601[MUSCULAR DYSTROPHY, LIMB-GIRDLE, AUTOSOMAL RECESSIVE 2; LGMDR2],254130[MIYOSHI MUSCULAR DYSTROPHY 1; MMD1],606768[MYOPATHY, DISTAL, WITH ANTERIOR TIBIAL ONSET; DMAT]
FBgn0266757	mfr	HGNC:8515	OMIM:603681	OTOF	11	601071	601071[DEAFNESS, AUTOSOMAL RECESSIVE 9; DFNB9]
FBgn0266757	mfr	HGNC:3656	OMIM:604603	MYOF	8	619366	619366[ANGIOEDEMA, HEREDITARY, 7; HAE7]
FBgn0266757	mfr	HGNC:28065		FER1L6	13		
FBgn0266757	mfr	HGNC:15801		FER1L4	4		
FBgn0266758	Esyt2	HGNC:24295	OMIM:616692	ESYT3	12		
FBgn0266758	Esyt2	HGNC:22211	OMIM:616691	ESYT2	14		
FBgn0266758	Esyt2	HGNC:29534	OMIM:616670	ESYT1	12		
FBgn0266848	wap	HGNC:30915	OMIM:605973	DCAF7	13		
FBgn0266917	Sf3a1	HGNC:10765	OMIM:605595	SF3A1	14		
FBgn0266918	CG32486	HGNC:17806	OMIM:616635	CYHR1	15		
FBgn0267001	Ten-a	HGNC:29943	OMIM:610119	TENM2	11		
FBgn0267001	Ten-a	HGNC:8117	OMIM:300588	TENM1	11		
FBgn0267001	Ten-a	HGNC:29945	OMIM:610084	TENM4	11	616736	616736[TREMOR, HEREDITARY ESSENTIAL, 5; ETM5]
FBgn0267001	Ten-a	HGNC:29944	OMIM:610083	TENM3	12	615145	615145[MICROPHTHALMIA, ISOLATED, WITH COLOBOMA 9; MCOPCB9]
FBgn0267002	unc-104	HGNC:16636	OMIM:605995	KIF1B	9	118210,171300,256700	118210[CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2A1; CMT2A1],171300[PHEOCHROMOCYTOMA],256700[NEUROBLASTOMA, SUSCEPTIBILITY TO, 1; NBLST1]
FBgn0267002	unc-104	HGNC:888	OMIM:601255	KIF1A	11	610357,614213,614255	610357[SPASTIC PARAPLEGIA 30, AUTOSOMAL DOMINANT; SPG30],614213[NEUROPATHY, HEREDITARY SENSORY, TYPE IIC; HSN2C],614255[NESCAV SYNDROME; NESCAVS]
FBgn0267002	unc-104	HGNC:6317	OMIM:603060	KIF1C	6	611302	611302[SPASTIC ATAXIA 2, AUTOSOMAL RECESSIVE; SPAX2]
FBgn0267252	Ggamma30A	HGNC:19664		GNG8	3		
FBgn0267252	Ggamma30A	HGNC:14131	OMIM:607298	GNG13	13		
FBgn0267326	Ntl	HGNC:11054	OMIM:606205	SLC6A7	5		
FBgn0267326	Ntl	HGNC:11056	OMIM:601019	SLC6A9	4	617301	617301[GLYCINE ENCEPHALOPATHY WITH NORMAL SERUM GLYCINE]
FBgn0267326	Ntl	HGNC:11051	OMIM:604159	SLC6A5	3	614618	614618[HYPEREKPLEXIA 3; HKPX3]
FBgn0267326	Ntl	HGNC:11047	OMIM:300444	SLC6A14	3		
FBgn0267326	Ntl	HGNC:11042	OMIM:137165	SLC6A1	3	616421	616421[MYOCLONIC-ATONIC EPILEPSY; MAE]
FBgn0267330	KdelR	HGNC:6304	OMIM:131235	KDELR1	13		
FBgn0267330	KdelR	HGNC:6305	OMIM:609024	KDELR2	14	619131	619131[OSTEOGENESIS IMPERFECTA, TYPE XXI; OI21]
FBgn0267330	KdelR	HGNC:6306	OMIM:619900	KDELR3	7		
FBgn0267336	Glut4EF	HGNC:15930	OMIM:609493	SLC2A4RG	6		
FBgn0267336	Glut4EF	HGNC:32291		ZNF704	10		
FBgn0267336	Glut4EF	HGNC:18737	OMIM:609494	ZNF395	9		
FBgn0267337	rn	HGNC:18079		ZNF362	4		
FBgn0267339	p38c	HGNC:6876	OMIM:600289	MAPK14	5		
FBgn0267339	p38c	HGNC:6875	OMIM:602899	MAPK13	5		
FBgn0267339	p38c	HGNC:6874	OMIM:602399	MAPK12	5		
FBgn0267339	p38c	HGNC:6873	OMIM:602898	MAPK11	5		
FBgn0267339	p38c	HGNC:6877	OMIM:601795	MAPK3	3		
FBgn0267348	LanB2	HGNC:6492	OMIM:150290	LAMC1	11		
FBgn0267348	LanB2	HGNC:6494	OMIM:604349	LAMC3	8	614115	614115[CORTICAL MALFORMATIONS, OCCIPITAL; OCCM]
FBgn0267348	LanB2	HGNC:6493	OMIM:150292	LAMC2	6	619785,619786	619785[EPIDERMOLYSIS BULLOSA, JUNCTIONAL 3A, INTERMEDIATE; JEB3A],619786[EPIDERMOLYSIS BULLOSA, JUNCTIONAL 3B, SEVERE; JEB3B]
FBgn0267350	Pi4KIIIalpha	HGNC:8983	OMIM:600286	PI4KA	13	616531,619621,619708	616531[NEURODEVELOPMENTAL DISORDER WITH SPASTICITY, HYPOMYELINATING LEUKODYSTROPHY, AND BRAIN ABNORMALITIES; NEDSPLB],619621[SPASTIC PARAPLEGIA 84, AUTOSOMAL RECESSIVE; SPG84],619708[GASTROINTESTINAL DEFECTS AND IMMUNODEFICIENCY SYNDROME 2; GIDID2]
FBgn0267351	Topors	HGNC:21653	OMIM:609507	TOPORS	10	609923	609923[RETINITIS PIGMENTOSA 31; RP31]
FBgn0267363	JYalpha	HGNC:13816	OMIM:182360	ATP12A	5		
FBgn0267363	JYalpha	HGNC:801	OMIM:182350	ATP1A3	3	128235,601338,614820,619606	128235[DYSTONIA 12; DYT12],601338[CEREBELLAR ATAXIA, AREFLEXIA, PES CAVUS, OPTIC ATROPHY, AND SENSORINEURAL HEARING LOSS; CAPOS],614820[ALTERNATING HEMIPLEGIA OF CHILDHOOD 2; AHC2],619606[DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 99; DEE99]
FBgn0267363	JYalpha	HGNC:799	OMIM:182310	ATP1A1	6	618036,618314	618036[CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2DD; CMT2DD],618314[HYPOMAGNESEMIA, SEIZURES, AND MENTAL RETARDATION 2; HOMGSMR2]
FBgn0267363	JYalpha	HGNC:800	OMIM:182340	ATP1A2	4	104290,602481,619602,619605	104290[ALTERNATING HEMIPLEGIA OF CHILDHOOD 1; AHC1],602481[MIGRAINE, FAMILIAL HEMIPLEGIC, 2; FHM2],619602[FETAL AKINESIA, RESPIRATORY INSUFFICIENCY, MICROCEPHALY, POLYMICROGYRIA, AND DYSMORPHIC FACIES; FARIMPD],619605[DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 98; DEE98]
FBgn0267363	JYalpha	HGNC:819	OMIM:137216	ATP4A	4		
FBgn0267363	JYalpha	HGNC:14073	OMIM:607321	ATP1A4	3		
FBgn0267366	mil	HGNC:7637	OMIM:164060	NAP1L1	7		
FBgn0267366	mil	HGNC:7638	OMIM:300026	NAP1L2	6		
FBgn0267366	mil	HGNC:7639	OMIM:300117	NAP1L3	5		
FBgn0267366	mil	HGNC:7640	OMIM:601651	NAP1L4	7		
FBgn0267376	SelR	HGNC:17061	OMIM:613782	MSRB2	7		
FBgn0267376	SelR	HGNC:27375	OMIM:613719	MSRB3	14	613718	613718[DEAFNESS, AUTOSOMAL RECESSIVE 74; DFNB74]
FBgn0267376	SelR	HGNC:14133	OMIM:606216	MSRB1	3		
FBgn0267378	sau	HGNC:24882	OMIM:612208	GOLPH3L	9		
FBgn0267378	sau	HGNC:15452	OMIM:612207	GOLPH3	13		
FBgn0267383	Ubc87F	HGNC:12483	OMIM:603124	UBE2G2	3		
FBgn0267383	Ubc87F	HGNC:12482	OMIM:601569	UBE2G1	11		
FBgn0267384	Ubc7	HGNC:12483	OMIM:603124	UBE2G2	13		
FBgn0267384	Ubc7	HGNC:12482	OMIM:601569	UBE2G1	3		
FBgn0267385	PyK	HGNC:9021	OMIM:179050	PKM	13		
FBgn0267385	PyK	HGNC:9020	OMIM:609712	PKLR	11	102900,266200	102900[ADENOSINE TRIPHOSPHATE, ELEVATED, OF ERYTHROCYTES],266200[PYRUVATE KINASE DEFICIENCY OF RED CELLS]
FBgn0267390	dop	HGNC:19036	OMIM:612258	MAST3	12		
FBgn0267390	dop	HGNC:19037	OMIM:618002	MAST4	12		
FBgn0267390	dop	HGNC:19035	OMIM:612257	MAST2	11		
FBgn0267390	dop	HGNC:19034	OMIM:612256	MAST1	12	618273	618273[MEGA-CORPUS-CALLOSUM SYNDROME WITH CEREBELLAR HYPOPLASIA AND CORTICAL MALFORMATIONS; MCCCHCM]
FBgn0267398	Yeti	HGNC:1873	OMIM:608108	CFDP1	9		
FBgn0267428	DIP-lambda	HGNC:34550	OMIM:618861	IGLON5	3		
FBgn0267428	DIP-lambda	HGNC:6705	OMIM:603241	LSAMP	3		
FBgn0267428	DIP-lambda	HGNC:8143	OMIM:600632	OPCML	4	167000	167000[OVARIAN CANCER]
FBgn0267428	DIP-lambda	HGNC:17941	OMIM:607938	NTM	4		
FBgn0267429	lovit	HGNC:17939	OMIM:605763	SLC45A1	4	617532	617532[INTELLECTUAL DEVELOPMENTAL DISORDER WITH NEUROPSYCHIATRIC FEATURES; IDDNPF]
FBgn0267429	lovit	HGNC:29196	OMIM:619581	SLC45A4	4		
FBgn0267429	lovit	HGNC:16472	OMIM:606202	SLC45A2	5	227240,606574	227240[SKIN/HAIR/EYE PIGMENTATION, VARIATION IN, 5; SHEP5],606574[ALBINISM, OCULOCUTANEOUS, TYPE IV; OCA4]
FBgn0267430	Pzl	HGNC:28993	OMIM:611184	PIEZO1	5	194380,616843	194380[DEHYDRATED HEREDITARY STOMATOCYTOSIS 1 WITH OR WITHOUT PSEUDOHYPERKALEMIA AND/OR PERINATAL EDEMA; DHS1],616843[LYMPHATIC MALFORMATION 6; LMPHM6]
FBgn0267430	Pzl	HGNC:26270	OMIM:613629	PIEZO2	7	108145,114300,248700,617146	108145[ARTHROGRYPOSIS, DISTAL, TYPE 5; DA5],114300[ARTHROGRYPOSIS, DISTAL, TYPE 3; DA3],248700[MARDEN-WALKER SYNDROME; MWKS],617146[ARTHROGRYPOSIS, DISTAL, WITH IMPAIRED PROPRIOCEPTION AND TOUCH; DAIPT]
FBgn0267432	kl-3	HGNC:2952	OMIM:603337	DNAH8	5	619095	619095[SPERMATOGENIC FAILURE 46; SPGF46]
FBgn0267432	kl-3	HGNC:2950	OMIM:603335	DNAH5	6	608644	608644[CILIARY DYSKINESIA, PRIMARY, 3; CILD3]
FBgn0267433	kl-5	HGNC:2953	OMIM:603330	DNAH9	3	618300	618300[CILIARY DYSKINESIA, PRIMARY, 40; CILD40]
FBgn0267449	WDY	HGNC:26587		WDR49	3		
FBgn0267449	WDY	HGNC:34532		EFCAB8	3		
FBgn0267486	Ptp36E	HGNC:9674	OMIM:602545	PTPRK	5		
FBgn0267486	Ptp36E	HGNC:9683	OMIM:602454	PTPRU	3		
FBgn0267487	Ptp61F	HGNC:9650	OMIM:176887	PTPN2	11		
FBgn0267487	Ptp61F	HGNC:9642	OMIM:176885	PTPN1	11	125853	125853[TYPE 2 DIABETES MELLITUS; T2D]
FBgn0267488	Mcr	HGNC:21685	OMIM:608859	CD109	4		
FBgn0267488	Mcr	HGNC:1318	OMIM:120700	C3	3	611378,612925,613779	611378[MACULAR DEGENERATION, AGE-RELATED, 9; ARMD9],612925[HEMOLYTIC UREMIC SYNDROME, ATYPICAL, SUSCEPTIBILITY TO, 5; AHUS5],613779[COMPLEMENT COMPONENT 3 DEFICIENCY, AUTOSOMAL RECESSIVE; C3D]
FBgn0267488	Mcr	HGNC:1323	OMIM:120810	C4A	3	614374,614380	614374[BLOOD GROUP, CHIDO/RODGERS SYSTEM],614380[COMPLEMENT COMPONENT 4A DEFICIENCY; C4AD]
FBgn0267488	Mcr	HGNC:1324	OMIM:120820	C4B	4	614379	614379[COMPLEMENT COMPONENT 4B DEFICIENCY; C4BD]
FBgn0267488	Mcr	HGNC:1331	OMIM:120900	C5	4	609536,615749	609536[COMPLEMENT COMPONENT 5 DEFICIENCY; C5D],615749[ECULIZUMAB, POOR RESPONSE TO]
FBgn0267488	Mcr	HGNC:9750	OMIM:176420	PZP	4		
FBgn0267488	Mcr	HGNC:7	OMIM:103950	A2M	4		
FBgn0267488	Mcr	HGNC:23336	OMIM:610627	A2ML1	4	166760	166760[OTITIS MEDIA, SUSCEPTIBILITY TO; OMS]
FBgn0267488	Mcr	HGNC:23228	OMIM:608841	CPAMD8	3	617319	617319[ANTERIOR SEGMENT DYSGENESIS 8; ASGD8]
FBgn0267698	Pak	HGNC:8592	OMIM:300142	PAK3	12	300558	300558[INTELLECTUAL DEVELOPMENTAL DISORDER, X-LINKED 30; XLID30]
FBgn0267698	Pak	HGNC:16059	OMIM:605451	PAK4	3		
FBgn0267698	Pak	HGNC:8591	OMIM:605022	PAK2	12	618458	618458[KNOBLOCH SYNDROME 2; KNO2]
FBgn0267698	Pak	HGNC:15916	OMIM:608038	PAK5	3		
FBgn0267698	Pak	HGNC:8590	OMIM:602590	PAK1	14	618158	618158[INTELLECTUAL DEVELOPMENTAL DISORDER WITH MACROCEPHALY, SEIZURES, AND SPEECH DELAY; IDDMSSD]
FBgn0267698	Pak	HGNC:16061	OMIM:608110	PAK6	3		
FBgn0267728	otk2	HGNC:9618	OMIM:601890	PTK7	5		
FBgn0267790	rump	HGNC:5046	OMIM:160994	HNRNPM	10		
FBgn0267790	rump	HGNC:17940	OMIM:619395	MYEF2	13		
FBgn0267791	HnRNP-K	HGNC:5044	OMIM:600712	HNRNPK	11	616580	616580[AU-KLINE SYNDROME; AUKS]
FBgn0267795	Frl	HGNC:1212	OMIM:604656	FMNL1	13		
FBgn0267795	Frl	HGNC:23698	OMIM:616288	FMNL3	13		
FBgn0267795	Frl	HGNC:18267	OMIM:616285	FMNL2	11		
FBgn0267796	Tmc	HGNC:16527	OMIM:606707	TMC2	7		
FBgn0267796	Tmc	HGNC:16513	OMIM:606706	TMC1	7	600974,606705	600974[DEAFNESS, AUTOSOMAL RECESSIVE 7; DFNB7],606705[DEAFNESS, AUTOSOMAL DOMINANT 36; DFNA36]
FBgn0267796	Tmc	HGNC:22995	OMIM:617196	TMC3	6		
FBgn0267821	da	HGNC:11634	OMIM:602272	TCF4	12	610954,613267	610954[PITT-HOPKINS SYNDROME; PTHS],613267[CORNEAL DYSTROPHY, FUCHS ENDOTHELIAL, 3; FECD3]
FBgn0267821	da	HGNC:11633	OMIM:147141	TCF3	12	616941,619824	616941[AGAMMAGLOBULINEMIA 8A, AUTOSOMAL DOMINANT; AGM8A],619824[AGAMMAGLOBULINEMIA 8B, AUTOSOMAL RECESSIVE; AGM8B]
FBgn0267821	da	HGNC:11623	OMIM:600480	TCF12	12	615314,619718	615314[CRANIOSYNOSTOSIS 3; CRS3],619718[HYPOGONADOTROPIC HYPOGONADISM 26 WITH OR WITHOUT ANOSMIA; HH26]
FBgn0267823	Gmer	HGNC:12390	OMIM:137020	TSTA3	13		
FBgn0267824	PRAS40	HGNC:28426	OMIM:610221	AKT1S1	3		
FBgn0267828	Fatp1	HGNC:10999	OMIM:603314	SLC27A5	4		
FBgn0267828	Fatp1	HGNC:10997	OMIM:604193	SLC27A3	4		
FBgn0267828	Fatp1	HGNC:10995	OMIM:600691	SLC27A1	10		
FBgn0267828	Fatp1	HGNC:11000	OMIM:604196	SLC27A6	4		
FBgn0267828	Fatp1	HGNC:10996	OMIM:603247	SLC27A2	4		
FBgn0267828	Fatp1	HGNC:10998	OMIM:604194	SLC27A4	10	608649	608649[ICHTHYOSIS PREMATURITY SYNDROME; IPS]
FBgn0267849	Syx7	HGNC:11430	OMIM:606892	STX12	12		
FBgn0267849	Syx7	HGNC:11442	OMIM:603217	STX7	14		
FBgn0267861	Maf1	HGNC:24966	OMIM:610210	MAF1	14		
FBgn0267912	CanA-14F	HGNC:9315	OMIM:114106	PPP3CB	12		
FBgn0267912	CanA-14F	HGNC:9316	OMIM:114107	PPP3CC	12		
FBgn0267912	CanA-14F	HGNC:9314	OMIM:114105	PPP3CA	13	617711,618265	617711[DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 91; DEE91],618265[ARTHROGRYPOSIS, CLEFT PALATE, CRANIOSYNOSTOSIS, AND IMPAIRED INTELLECTUAL DEVELOPMENT; ACCIID]
FBgn0267972	Der-1	HGNC:14236	OMIM:610305	DERL3	4		
FBgn0267972	Der-1	HGNC:17943	OMIM:610304	DERL2	4		
FBgn0267972	Der-1	HGNC:28454	OMIM:608813	DERL1	15		
FBgn0267975	vib	HGNC:9001	OMIM:600174	PITPNA	12		
FBgn0267975	vib	HGNC:9002	OMIM:606876	PITPNB	14		
FBgn0267976	Tim23	HGNC:17312	OMIM:605034	TIMM23	14		
FBgn0267976	Tim23	HGNC:23581		TIMM23B	9		
FBgn0267977	mh	HGNC:25356	OMIM:616086	SPRTN	11	616200	616200[RUIJS-AALFS SYNDROME; RJALS]
FBgn0267978	ap	HGNC:14222	OMIM:606066	LHX9	9		
FBgn0267978	ap	HGNC:6594	OMIM:603759	LHX2	13		
FBgn0270925	CG4836	HGNC:11184	OMIM:182500	SORD	5	618912	618912[SORBITOL DEHYDROGENASE DEFICIENCY WITH PERIPHERAL NEUROPATHY; SORDD]
FBgn0270926	AsnS	HGNC:753	OMIM:108370	ASNS	11	615574	615574[ASPARAGINE SYNTHETASE DEFICIENCY; ASNSD]
FBgn0270927	betaGlu	HGNC:4696	OMIM:611499	GUSB	12	253220	253220[MUCOPOLYSACCHARIDOSIS, TYPE VII; MPS7]
FBgn0270928	VAChT	HGNC:10934	OMIM:193002	SLC18A1	4		
FBgn0270928	VAChT	HGNC:10935	OMIM:193001	SLC18A2	4	618049	618049[PARKINSONISM-DYSTONIA 2, INFANTILE-ONSET; PKDYS2]
FBgn0270928	VAChT	HGNC:10936	OMIM:600336	SLC18A3	14	617239	617239[MYASTHENIC SYNDROME, CONGENITAL, 21, PRESYNAPTIC; CMS21]
FBgn0275436	PheRS-m	HGNC:21062	OMIM:611592	FARS2	15	614946,617046	614946[COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 14; COXPD14],617046[SPASTIC PARAPLEGIA 77, AUTOSOMAL RECESSIVE; SPG77]
FBgn0278608	Dsp1	HGNC:24954	OMIM:617285	HMGB4	4		
FBgn0278608	Dsp1	HGNC:4983	OMIM:163905	HMGB1	8		
FBgn0278608	Dsp1	HGNC:5000	OMIM:163906	HMGB2	10		
FBgn0278608	Dsp1	HGNC:5004	OMIM:300193	HMGB3	11	300915	300915[MICROPHTHALMIA, SYNDROMIC 13; MCOPS13]
FBgn0283427	FASN1	HGNC:3594	OMIM:600212	FASN	14		
FBgn0283433	SdicB	HGNC:2964	OMIM:603331	DYNC1I2	7	618492	618492[NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY AND STRUCTURAL BRAIN ANOMALIES; NEDMIBA]
FBgn0283433	SdicB	HGNC:2963	OMIM:603772	DYNC1I1	7		
FBgn0283434	SdicC	HGNC:2964	OMIM:603331	DYNC1I2	5	618492	618492[NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY AND STRUCTURAL BRAIN ANOMALIES; NEDMIBA]
FBgn0283434	SdicC	HGNC:2963	OMIM:603772	DYNC1I1	5		
FBgn0283438	CG46280	HGNC:28805		TRABD	12		
FBgn0283442	vas	HGNC:18700	OMIM:605281	DDX4	8		
FBgn0283450	Glo1	HGNC:4323	OMIM:138750	GLO1	14		
FBgn0283468	slmb	HGNC:13607	OMIM:605651	FBXW11	11	618914	618914[NEURODEVELOPMENTAL, JAW, EYE, AND DIGITAL SYNDROME; NEDJED]
FBgn0283468	slmb	HGNC:1144	OMIM:603482	BTRC	13		
FBgn0283469	Vps4	HGNC:10895	OMIM:609983	VPS4B	13		
FBgn0283469	Vps4	HGNC:13488	OMIM:609982	VPS4A	13	619273	619273[CIMDAG SYNDROME; CIMDAG]
FBgn0283471	wupA	HGNC:11945	OMIM:191042	TNNI1	12		
FBgn0283471	wupA	HGNC:11946	OMIM:191043	TNNI2	12	601680	601680[ARTHROGRYPOSIS, DISTAL, TYPE 2B1; DA2B1]
FBgn0283471	wupA	HGNC:11947	OMIM:191044	TNNI3	12	115210,611880,613286,613690	115210[CARDIOMYOPATHY, FAMILIAL RESTRICTIVE, 1; RCM1],611880[CARDIOMYOPATHY, DILATED, 2A; CMD2A],613286[CARDIOMYOPATHY, DILATED, 1FF; CMD1FF],613690[CARDIOMYOPATHY, FAMILIAL HYPERTROPHIC, 7; CMH7]
FBgn0283472	S6k	HGNC:10431	OMIM:601685	RPS6KA2	4		
FBgn0283472	S6k	HGNC:10430	OMIM:601684	RPS6KA1	4		
FBgn0283472	S6k	HGNC:13900	OMIM:607589	SGK2	3		
FBgn0283472	S6k	HGNC:10433	OMIM:603606	RPS6KA4	3		
FBgn0283472	S6k	HGNC:10435	OMIM:300303	RPS6KA6	3		
FBgn0283472	S6k	HGNC:10810	OMIM:602958	SGK1	3		
FBgn0283472	S6k	HGNC:10434	OMIM:603607	RPS6KA5	3		
FBgn0283472	S6k	HGNC:10432	OMIM:300075	RPS6KA3	4	300844,303600	300844[INTELLECTUAL DEVELOPMENTAL DISORDER, X-LINKED 19; XLID19],303600[COFFIN-LOWRY SYNDROME; CLS]
FBgn0283472	S6k	HGNC:10436	OMIM:608938	RPS6KB1	13		
FBgn0283472	S6k	HGNC:10437	OMIM:608939	RPS6KB2	13		
FBgn0283473	S6KL	HGNC:26314		RSKR	3		
FBgn0283476	Dhc16F	HGNC:2951	OMIM:603336	DNAH6	12		
FBgn0283476	Dhc16F	HGNC:2949	OMIM:603334	DNAH3	3		
FBgn0283476	Dhc16F	HGNC:2952	OMIM:603337	DNAH8	3	619095	619095[SPERMATOGENIC FAILURE 46; SPGF46]
FBgn0283476	Dhc16F	HGNC:2940	OMIM:603332	DNAH1	5	617576,617577	617576[SPERMATOGENIC FAILURE 18; SPGF18],617577[CILIARY DYSKINESIA, PRIMARY, 37; CILD37]
FBgn0283476	Dhc16F	HGNC:18661	OMIM:610061	DNAH7	3		
FBgn0283476	Dhc16F	HGNC:2953	OMIM:603330	DNAH9	4	618300	618300[CILIARY DYSKINESIA, PRIMARY, 40; CILD40]
FBgn0283476	Dhc16F	HGNC:2942	OMIM:603339	DNAH11	4	611884	611884[CILIARY DYSKINESIA, PRIMARY, 7; CILD7]
FBgn0283476	Dhc16F	HGNC:2950	OMIM:603335	DNAH5	3	608644	608644[CILIARY DYSKINESIA, PRIMARY, 3; CILD3]
FBgn0283476	Dhc16F	HGNC:2948	OMIM:603333	DNAH2	4	619094	619094[SPERMATOGENIC FAILURE 45; SPGF45]
FBgn0283476	Dhc16F	HGNC:2941	OMIM:605884	DNAH10	4	619515	619515[SPERMATOGENIC FAILURE 56; SPGF56]
FBgn0283476	Dhc16F	HGNC:2946	OMIM:610063	DNAH17	4	618643	618643[SPERMATOGENIC FAILURE 39; SPGF39]
FBgn0283476	Dhc16F	HGNC:2945	OMIM:603341	DNAH14	3		
FBgn0283476	Dhc16F	HGNC:2943	OMIM:603340	DNAH12	3		
FBgn0283477	SF2	HGNC:10791	OMIM:601943	SRSF9	8		
FBgn0283477	SF2	HGNC:10788	OMIM:601944	SRSF6	3		
FBgn0283477	SF2	HGNC:10780	OMIM:600812	SRSF1	13		
FBgn0283478	und	HGNC:16672	OMIM:601870	METAP2	13		
FBgn0283479	Alp1	HGNC:438	OMIM:171760	ALPL	12	146300,241500,241510	146300[HYPOPHOSPHATASIA, ADULT; HPPA],241500[HYPOPHOSPHATASIA, INFANTILE; HPPI],241510[HYPOPHOSPHATASIA, CHILDHOOD; HPPC]
FBgn0283479	Alp1	HGNC:441	OMIM:171810	ALPG	11		
FBgn0283479	Alp1	HGNC:439	OMIM:171800	ALPP	12		
FBgn0283479	Alp1	HGNC:437	OMIM:171740	ALPI	11		
FBgn0283480	Alp2	HGNC:438	OMIM:171760	ALPL	7	146300,241500,241510	146300[HYPOPHOSPHATASIA, ADULT; HPPA],241500[HYPOPHOSPHATASIA, INFANTILE; HPPI],241510[HYPOPHOSPHATASIA, CHILDHOOD; HPPC]
FBgn0283480	Alp2	HGNC:441	OMIM:171810	ALPG	8		
FBgn0283480	Alp2	HGNC:439	OMIM:171800	ALPP	7		
FBgn0283480	Alp2	HGNC:437	OMIM:171740	ALPI	7		
FBgn0283494	Ak2	HGNC:362	OMIM:103020	AK2	15	267500	267500[RETICULAR DYSGENESIS]
FBgn0283499	InR	HGNC:5465	OMIM:147370	IGF1R	12	270450	270450[INSULIN-LIKE GROWTH FACTOR I, RESISTANCE TO; IGF1RES]
FBgn0283499	InR	HGNC:6091	OMIM:147670	INSR	10	246200,262190,609968,610549	246200[DONOHUE SYNDROME],262190[PINEAL HYPERPLASIA, INSULIN-RESISTANT DIABETES MELLITUS, AND SOMATIC ABNORMALITIES],609968[HYPERINSULINEMIC HYPOGLYCEMIA, FAMILIAL, 5; HHF5],610549[DIABETES MELLITUS, INSULIN-RESISTANT, WITH ACANTHOSIS NIGRICANS]
FBgn0283499	InR	HGNC:6093	OMIM:147671	INSRR	9		
FBgn0283500	Sac1	HGNC:17054	OMIM:609389	INPP5F	3		
FBgn0283500	Sac1	HGNC:17059	OMIM:606569	SACM1L	14		
FBgn0283503	Neurl4	HGNC:34410	OMIM:615865	NEURL4	12		
FBgn0283509	Phm	HGNC:8596	OMIM:170270	PAM	6		
FBgn0283510	Pal1	HGNC:8596	OMIM:170270	PAM	10		
FBgn0283525	l(2)10685	HGNC:31802	OMIM:615394	NSUN4	13		
FBgn0283525	l(2)10685	HGNC:26208	OMIM:617491	NSUN3	3	619012	619012[COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 48; COXPD48]
FBgn0283531	Duox	HGNC:2578	OMIM:300481	CYBB	3	300645,306400	300645[IMMUNODEFICIENCY 34; IMD34],306400[GRANULOMATOUS DISEASE, CHRONIC, X-LINKED; CGDX]
FBgn0283531	Duox	HGNC:7889	OMIM:300225	NOX1	3		
FBgn0283531	Duox	HGNC:13273	OMIM:606759	DUOX2	12	607200	607200[THYROID DYSHORMONOGENESIS 6; TDH6]
FBgn0283531	Duox	HGNC:7890	OMIM:607105	NOX3	3		
FBgn0283531	Duox	HGNC:3062	OMIM:606758	DUOX1	14		
FBgn0283535	Vha26	HGNC:18125	OMIM:617385	ATP6V1E2	13		
FBgn0283535	Vha26	HGNC:857	OMIM:108746	ATP6V1E1	15	617402	617402[CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IIC; ARCL2C]
FBgn0283536	Vha13	HGNC:18265	OMIM:618071	ATP6V1G3	10		
FBgn0283536	Vha13	HGNC:864	OMIM:607296	ATP6V1G1	13		
FBgn0283536	Vha13	HGNC:862	OMIM:606853	ATP6V1G2	13		
FBgn0283545	vilya	HGNC:20438		RNF212B	3		
FBgn0283649	elgi	HGNC:18401		RNF41	15		
FBgn0283649	elgi	HGNC:23235		RNF151	4		
FBgn0283651	CG46301	HGNC:16106	OMIM:618893	NOL4L	7		
FBgn0283651	CG46301	HGNC:7870	OMIM:603577	NOL4	8		
FBgn0283652	Rpp30	HGNC:17688	OMIM:606115	RPP30	13		
FBgn0283657	Tlk	HGNC:11842	OMIM:608439	TLK2	11	618050	618050[INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL DOMINANT 57; MRD57]
FBgn0283657	Tlk	HGNC:11841	OMIM:608438	TLK1	8		
FBgn0283658	muc	HGNC:2896	OMIM:608770	DLAT	14	245348	245348[PYRUVATE DEHYDROGENASE E2 DEFICIENCY; PDHDD]
FBgn0283658	muc	HGNC:21350	OMIM:608769	PDHX	3	245349	245349[PYRUVATE DEHYDROGENASE E3-BINDING PROTEIN DEFICIENCY; PDHXD]
FBgn0283659	THG	HGNC:26053	OMIM:618802	THG1L	15	618800	618800[SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 28; SCAR28]
FBgn0283666	Rap2l	HGNC:9855	OMIM:179520	RAP1A	3		
FBgn0283666	Rap2l	HGNC:9862	OMIM:179541	RAP2B	12		
FBgn0283666	Rap2l	HGNC:21165	OMIM:301016	RAP2C	12		
FBgn0283666	Rap2l	HGNC:9861	OMIM:179540	RAP2A	12		
FBgn0283666	Rap2l	HGNC:9857	OMIM:179530	RAP1B	3		
FBgn0283680	IP3K2	HGNC:6179	OMIM:147522	ITPKB	11		
FBgn0283680	IP3K2	HGNC:14897	OMIM:606476	ITPKC	8		
FBgn0283680	IP3K2	HGNC:6178	OMIM:147521	ITPKA	12		
FBgn0283681	Tcs3	HGNC:18028	OMIM:610107	OSGEP	15	617729	617729[GALLOWAY-MOWAT SYNDROME 3; GAMOS3]
FBgn0283682	Ge-1	HGNC:17157	OMIM:606030	EDC4	13		
FBgn0283712	LIMK1	HGNC:6613	OMIM:601329	LIMK1	11		
FBgn0283712	LIMK1	HGNC:6614	OMIM:601988	LIMK2	10		
FBgn0283724	Girdin	HGNC:26757	OMIM:611205	CCDC88B	5		
FBgn0283724	Girdin	HGNC:19967	OMIM:611204	CCDC88C	12	236600,616053	236600[HYDROCEPHALUS, CONGENITAL, 1; HYC1],616053[SPINOCEREBELLAR ATAXIA 40; SCA40]
FBgn0283724	Girdin	HGNC:25523	OMIM:609736	CCDC88A	13	617507	617507[PEHO-LIKE SYNDROME; PEHOL]
FBgn0283741	prage	HGNC:24616	OMIM:609614	REXO1	4		
FBgn0283741	prage	HGNC:24660		REXO1L1P	4		
FBgn0284084	wg	HGNC:12774	OMIM:164820	WNT1	14	615220,615221	615220[OSTEOGENESIS IMPERFECTA, TYPE XV; OI15],615221[BONE MINERAL DENSITY QUANTITATIVE TRAIT LOCUS 16; BMND16]
FBgn0284084	wg	HGNC:12783	OMIM:603490	WNT4	3	158330,611812	158330[MULLERIAN APLASIA AND HYPERANDROGENISM],611812[46,XX SEX REVERSAL WITH DYSGENESIS OF KIDNEYS, ADRENALS, AND LUNGS; SERKAL]
FBgn0284220	Top2	HGNC:11990	OMIM:126431	TOP2B	12	609296	609296[B-CELL IMMUNODEFICIENCY, DISTAL LIMB ANOMALIES, AND UROGENITAL MALFORMATIONS; BILU]
FBgn0284220	Top2	HGNC:11989	OMIM:126430	TOP2A	13		
FBgn0284221	Sema5c	HGNC:10736	OMIM:609297	SEMA5A	13		
FBgn0284221	Sema5c	HGNC:10737	OMIM:609298	SEMA5B	13		
FBgn0284243	betaTub56D	HGNC:20774	OMIM:602662	TUBB4A	8	128101,612438	128101[DYSTONIA 4, TORSION, AUTOSOMAL DOMINANT; DYT4],612438[LEUKODYSTROPHY, HYPOMYELINATING, 6; HLD6]
FBgn0284243	betaTub56D	HGNC:12412	OMIM:615101	TUBB2A	6	615763	615763[CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 5; CDCBM5]
FBgn0284243	betaTub56D	HGNC:20778	OMIM:191130	TUBB	8	156610,615771	156610[SKIN CREASES, CONGENITAL SYMMETRIC CIRCUMFERENTIAL, 1; CSCSC1],615771[CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 6; CDCBM6]
FBgn0284243	betaTub56D	HGNC:30829	OMIM:612850	TUBB2B	8	610031	610031[CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 7; CDCBM7]
FBgn0284243	betaTub56D	HGNC:20771	OMIM:602660	TUBB4B	12	617879	617879[LEBER CONGENITAL AMAUROSIS WITH EARLY-ONSET DEAFNESS; LCAEOD]
FBgn0284243	betaTub56D	HGNC:20772	OMIM:602661	TUBB3	4	600638,614039	600638[FIBROSIS OF EXTRAOCULAR MUSCLES, CONGENITAL, 3A, WITH OR WITHOUT EXTRAOCULAR INVOLVEMENT; CFEOM3A],614039[CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 1; CDCBM1]
FBgn0284243	betaTub56D	HGNC:16257	OMIM:612901	TUBB1	4	613112	613112[MACROTHROMBOCYTOPENIA, ISOLATED, 1, AUTOSOMAL DOMINANT; MACTHC1]
FBgn0284243	betaTub56D	HGNC:20776	OMIM:615103	TUBB6	5	617732	617732[FACIAL PALSY, CONGENITAL, WITH PTOSIS AND VELOPHARYNGEAL DYSFUNCTION; FPVEPD]
FBgn0284243	betaTub56D	HGNC:20773	OMIM:616768	TUBB8	4	616780	616780[OOCYTE MATURATION DEFECT 2; OOMD2]
FBgn0284245	eEF1alpha1	HGNC:3189	OMIM:130590	EEF1A1	9		
FBgn0284245	eEF1alpha1	HGNC:3192	OMIM:602959	EEF1A2	11	616393,616409	616393[INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL DOMINANT 38; MRD38],616409[DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 33; DEE33]
FBgn0284245	eEF1alpha1	HGNC:3200		EEF1A1P5	4		
FBgn0284246	l(2)k09848	HGNC:25529	OMIM:617947	WDR74	12		
FBgn0284247	ds	HGNC:23109	OMIM:612411	FAT4	5	615546,616006	615546[VAN MALDERGEM SYNDROME 2; VMLDS2],616006[HENNEKAM LYMPHANGIECTASIA-LYMPHEDEMA SYNDROME 2; HKLLS2]
FBgn0284247	ds	HGNC:13681	OMIM:603057	DCHS1	11	601390,607829	601390[VAN MALDERGEM SYNDROME 1; VMLDS1],607829[MITRAL VALVE PROLAPSE 2; MVP2]
FBgn0284247	ds	HGNC:23111	OMIM:612486	DCHS2	6		
FBgn0284247	ds	HGNC:13733	OMIM:605516	CDH23	3	601067,601386,617540	601067[USHER SYNDROME, TYPE ID; USH1D],601386[DEAFNESS, AUTOSOMAL RECESSIVE 12; DFNB12],617540[PITUITARY ADENOMA 5, MULTIPLE TYPES; PITA5]
FBgn0284248	Cyt-c-p	HGNC:19986	OMIM:123970	CYCS	13	612004	612004[THROMBOCYTOPENIA 4; THC4]
FBgn0284251	l(2)05287	HGNC:25725		WDR75	12		
FBgn0284252	Letm1	HGNC:6556	OMIM:604407	LETM1	12		
FBgn0284252	Letm1	HGNC:14648		LETM2	8		
FBgn0284253	LeuRS	HGNC:6512	OMIM:151350	LARS	14	615438	615438[INFANTILE LIVER FAILURE SYNDROME 1; ILFS1]
FBgn0284254	Impbeta11	HGNC:20628	OMIM:610889	IPO11	13		
FBgn0284255	Arpc4	HGNC:707	OMIM:604226	ARPC4	9		
FBgn0284255	Arpc4	HGNC:38830		ARPC4-TTLL3	7		
FBgn0284256	bsf	HGNC:15714	OMIM:607544	LRPPRC	13	220111	220111[MITOCHONDRIAL COMPLEX IV DEFICIENCY, NUCLEAR TYPE 5; MC4DN5]
FBgn0284408	trol	HGNC:329	OMIM:103320	AGRN	3	615120	615120[MYASTHENIC SYNDROME, CONGENITAL, 8; CMS8]
FBgn0284408	trol	HGNC:5273	OMIM:142461	HSPG2	11	224410,255800	224410[DYSSEGMENTAL DYSPLASIA, SILVERMAN-HANDMAKER TYPE; DDSH],255800[SCHWARTZ-JAMPEL SYNDROME, TYPE 1; SJS1]
FBgn0284421	Psn	HGNC:9508	OMIM:104311	PSEN1	13	172700,600274,607822,613694,613737	172700[PICK DISEASE OF BRAIN],600274[FRONTOTEMPORAL DEMENTIA; FTD],607822[ALZHEIMER DISEASE 3; AD3],613694[CARDIOMYOPATHY, DILATED, 1U; CMD1U],613737[ACNE INVERSA, FAMILIAL, 3; ACNINV3]
FBgn0284421	Psn	HGNC:9509	OMIM:600759	PSEN2	14	606889,613697	606889[ALZHEIMER DISEASE 4],613697[CARDIOMYOPATHY, DILATED, 1V; CMD1V]
FBgn0284436	CCT8	HGNC:1623	OMIM:617786	CCT8	14		
FBgn0284436	CCT8	HGNC:15553		CCT8L2	4		
FBgn0284442	Mcm3	HGNC:6945	OMIM:602693	MCM3	14		
FBgn0285879	disco-r	HGNC:30988	OMIM:608669	BNC2	11	618612	618612[LOWER URINARY TRACT OBSTRUCTION, CONGENITAL; LUTO]
FBgn0285879	disco-r	HGNC:1081	OMIM:601930	BNC1	9	618723	618723[PREMATURE OVARIAN FAILURE 16; POF16]
FBgn0285896	btl	HGNC:3691	OMIM:134935	FGFR4	10		
FBgn0285896	btl	HGNC:3688	OMIM:136350	FGFR1	12	101600,123150,147950,166250,190440,613001,615465	101600[PFEIFFER SYNDROME],123150[JACKSON-WEISS SYNDROME; JWS],147950[HYPOGONADOTROPIC HYPOGONADISM 2 WITH OR WITHOUT ANOSMIA; HH2],166250[OSTEOGLOPHONIC DYSPLASIA; OGD],190440[TRIGONOCEPHALY 1; TRIGNO1],613001[ENCEPHALOCRANIOCUTANEOUS LIPOMATOSIS; ECCL],615465[HARTSFIELD SYNDROME; HRTFDS]
FBgn0285896	btl	HGNC:3690	OMIM:134934	FGFR3	11	100800,109800,114500,146000,149730,162900,187600,187601,273300,602849,603956,610474,612247,616482	100800[ACHONDROPLASIA; ACH],109800[BLADDER CANCER],114500[COLORECTAL CANCER; CRC],146000[HYPOCHONDROPLASIA; HCH],149730[LACRIMOAURICULODENTODIGITAL SYNDROME; LADD],162900[NEVUS, EPIDERMAL],187600[THANATOPHORIC DYSPLASIA, TYPE I; TD1],187601[THANATOPHORIC DYSPLASIA, TYPE II; TD2],273300[TESTICULAR GERM CELL TUMOR; TGCT],602849[MUENKE SYNDROME; MNKES],603956[CERVICAL CANCER],610474[CAMPTODACTYLY, TALL STATURE, AND HEARING LOSS SYNDROME; CATSHLS],612247[CROUZON SYNDROME WITH ACANTHOSIS NIGRICANS; CAN],616482[ACHONDROPLASIA, SEVERE, WITH DEVELOPMENTAL DELAY AND ACANTHOSIS NIGRICANS; SADDAN]
FBgn0285896	btl	HGNC:3689	OMIM:176943	FGFR2	11	101200,101400,101600,123150,123500,123790,149730,207410,609579,613659,614592	101200[APERT SYNDROME],101400[SAETHRE-CHOTZEN SYNDROME; SCS],101600[PFEIFFER SYNDROME],123150[JACKSON-WEISS SYNDROME; JWS],123500[CROUZON SYNDROME],123790[BEARE-STEVENSON CUTIS GYRATA SYNDROME; BSTVS],149730[LACRIMOAURICULODENTODIGITAL SYNDROME; LADD],207410[ANTLEY-BIXLER SYNDROME WITHOUT GENITAL ANOMALIES OR DISORDERED STEROIDOGENESIS; ABS2],609579[SCAPHOCEPHALY, MAXILLARY RETRUSION, AND MENTAL RETARDATION],613659[GASTRIC CANCER],614592[BENT BONE DYSPLASIA SYNDROME; BBDS]
FBgn0285910	VhaAC39-1	HGNC:13724	OMIM:607028	ATP6V0D1	14		
FBgn0285910	VhaAC39-1	HGNC:18266	OMIM:618072	ATP6V0D2	8		
FBgn0285911	Vps16A	HGNC:14584	OMIM:608550	VPS16	14	619291	619291[DYSTONIA 30; DYT30]
FBgn0285912	mah	HGNC:11018	OMIM:616440	SLC32A1	3		
FBgn0285912	mah	HGNC:13447	OMIM:608490	SLC38A1	3		
FBgn0285912	mah	HGNC:13448	OMIM:605180	SLC38A2	3		
FBgn0285913	red	HGNC:28571		LYSMD2	8		
FBgn0285913	red	HGNC:32070		LYSMD1	6		
FBgn0285917	sbb	HGNC:29003	OMIM:617474	ZNF609	9		
FBgn0285917	sbb	HGNC:29238		ZNF608	8		
FBgn0285925	Fas1	HGNC:11771	OMIM:601692	TGFBI	6	121820,121900,122200,602082,607541,608470,608471	121820[CORNEAL DYSTROPHY, EPITHELIAL BASEMENT MEMBRANE; EBMD],121900[CORNEAL DYSTROPHY, GROENOUW TYPE I; CDGG1],122200[CORNEAL DYSTROPHY, LATTICE TYPE I; CDL1],602082[CORNEAL DYSTROPHY, THIEL-BEHNKE TYPE; CDTB],607541[CORNEAL DYSTROPHY, AVELLINO TYPE; CDA],608470[CORNEAL DYSTROPHY, REIS-BUCKLERS TYPE; CDRB],608471[CORNEAL DYSTROPHY, LATTICE TYPE IIIA; CDL3A]
FBgn0285925	Fas1	HGNC:16953	OMIM:608777	POSTN	7		
FBgn0285926	Imp	HGNC:28866	OMIM:608288	IGF2BP1	13		
FBgn0285926	Imp	HGNC:28868	OMIM:608259	IGF2BP3	13		
FBgn0285926	Imp	HGNC:28867	OMIM:608289	IGF2BP2	13	125853	125853[TYPE 2 DIABETES MELLITUS; T2D]
FBgn0285937	Rab1	HGNC:9758	OMIM:179508	RAB1A	13		
FBgn0285937	Rab1	HGNC:18370	OMIM:612565	RAB1B	11		
FBgn0285937	Rab1	HGNC:23683		RAB1C	4		
FBgn0285943	knon	HGNC:845	OMIM:618121	ATP5PD	7		
FBgn0285944	para	HGNC:10594	OMIM:182392	SCN7A	7		
FBgn0285944	para	HGNC:10590	OMIM:182391	SCN3A	9	617935,617938	617935[EPILEPSY, FAMILIAL FOCAL, WITH VARIABLE FOCI 4; FFEVF4],617938[DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 62; DEE62]
FBgn0285944	para	HGNC:10597	OMIM:603415	SCN9A	10	133020,167400,243000	133020[ERYTHERMALGIA, PRIMARY],167400[PAROXYSMAL EXTREME PAIN DISORDER],243000[INDIFFERENCE TO PAIN, CONGENITAL, AUTOSOMAL RECESSIVE; CIP]
FBgn0285944	para	HGNC:10582	OMIM:604427	SCN10A	10	615551	615551[EPISODIC PAIN SYNDROME, FAMILIAL, 2; FEPS2]
FBgn0285944	para	HGNC:10593	OMIM:600163	SCN5A	11	113900,272120,601144,601154,603829,603830,608567,614022	113900[PROGRESSIVE FAMILIAL HEART BLOCK, TYPE IA; PFHB1A],272120[SUDDEN INFANT DEATH SYNDROME],601144[BRUGADA SYNDROME 1; BRGDA1],601154[CARDIOMYOPATHY, DILATED, 1E; CMD1E],603829[VENTRICULAR FIBRILLATION, PAROXYSMAL FAMILIAL, 1; VF1],603830[LONG QT SYNDROME 3; LQT3],608567[SICK SINUS SYNDROME 1; SSS1],614022[ATRIAL FIBRILLATION, FAMILIAL, 10; ATFB10]
FBgn0285944	para	HGNC:10588	OMIM:182390	SCN2A	11	607745,613721,618924	607745[SEIZURES, BENIGN FAMILIAL INFANTILE, 3; BFIS3],613721[DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 11; DEE11],618924[EPISODIC ATAXIA, TYPE 9; EA9]
FBgn0285944	para	HGNC:10591	OMIM:603967	SCN4A	9	168300,170500,608390,613345,614198	168300[PARAMYOTONIA CONGENITA OF VON EULENBURG; PMC],170500[HYPERKALEMIC PERIODIC PARALYSIS; HYPP],608390[MYOTONIA, POTASSIUM-AGGRAVATED],613345[HYPOKALEMIC PERIODIC PARALYSIS, TYPE 2; HOKPP2],614198[MYASTHENIC SYNDROME, CONGENITAL, 16; CMS16]
FBgn0285944	para	HGNC:10585	OMIM:182389	SCN1A	10	604403,607208,609634,619317	604403[GENERALIZED EPILEPSY WITH FEBRILE SEIZURES PLUS, TYPE 2; GEFSP2],607208[DRAVET SYNDROME; DRVT],609634[MIGRAINE, FAMILIAL HEMIPLEGIC, 3; FHM3],619317[DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 6B; DEE6B]
FBgn0285944	para	HGNC:10583	OMIM:604385	SCN11A	8	615548,615552	615548[NEUROPATHY, HEREDITARY SENSORY AND AUTONOMIC, TYPE VII; HSAN7],615552[EPISODIC PAIN SYNDROME, FAMILIAL, 3; FEPS3]
FBgn0285944	para	HGNC:10596	OMIM:600702	SCN8A	12	614306,614558,617080,618364	614306[COGNITIVE IMPAIRMENT WITH OR WITHOUT CEREBELLAR ATAXIA; CIAT],614558[DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 13; DEE13],617080[SEIZURES, BENIGN FAMILIAL INFANTILE, 5; BFIS5],618364[MYOCLONUS, FAMILIAL, 2; MYOCL2]
FBgn0285947	RpS10b	HGNC:10383	OMIM:603632	RPS10	12	613308	613308[DIAMOND-BLACKFAN ANEMIA 9; DBA9]
FBgn0285947	RpS10b	HGNC:49181		RPS10-NUDT3	5		
FBgn0285947	RpS10b	HGNC:15795		RPS10P5	5		
FBgn0285948	RpL27A	HGNC:10329	OMIM:603637	RPL27A	14		
FBgn0285949	RpL31	HGNC:10334	OMIM:617415	RPL31	13		
FBgn0285950	RpL19	HGNC:10312	OMIM:180466	RPL19	14		
FBgn0285951	mRpS34	HGNC:16618	OMIM:611994	MRPS34	9	617664	617664[COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 32; COXPD32]
FBgn0285952	eEF5	HGNC:17419		EIF5AL1	11		
FBgn0285952	eEF5	HGNC:3300	OMIM:600187	EIF5A	14	619376	619376[FAUNDES-BANKA SYNDROME; FABAS]
FBgn0285952	eEF5	HGNC:3301	OMIM:605782	EIF5A2	13		
FBgn0285954	caz	HGNC:3508	OMIM:133450	EWSR1	10	612219	612219[EWING SARCOMA; ES]
FBgn0285954	caz	HGNC:4010	OMIM:137070	FUS	9	608030,614782	608030[AMYOTROPHIC LATERAL SCLEROSIS 6 WITH OR WITHOUT FRONTOTEMPORAL DEMENTIA; ALS6],614782[TREMOR, HEREDITARY ESSENTIAL, 4; ETM4]
FBgn0285954	caz	HGNC:11547	OMIM:601574	TAF15	7	612237	612237[CHONDROSARCOMA, EXTRASKELETAL MYXOID]
FBgn0285955	cv-c	HGNC:2897	OMIM:604258	DLC1	9	114500	114500[COLORECTAL CANCER; CRC]
FBgn0285955	cv-c	HGNC:19164	OMIM:609866	STARD13	8		
FBgn0285955	cv-c	HGNC:19161	OMIM:300689	STARD8	7		
FBgn0285958	Fuca	HGNC:4006	OMIM:612280	FUCA1	8	230000	230000[FUCOSIDOSIS]
FBgn0285958	Fuca	HGNC:4008	OMIM:136820	FUCA2	12		
FBgn0285963	CG46339	HGNC:500	OMIM:151530	ANPEP	3		
FBgn0285963	CG46339	HGNC:30748	OMIM:606950	TRHDE	3		
FBgn0285963	CG46339	HGNC:18173	OMIM:606832	ERAP1	4		
FBgn0285963	CG46339	HGNC:26904	OMIM:610046	LVRN	3		
FBgn0285963	CG46339	HGNC:7900	OMIM:606793	NPEPPS	3		
FBgn0285963	CG46339	HGNC:29499	OMIM:609497	ERAP2	4		
FBgn0285963	CG46339	HGNC:6656	OMIM:151300	LNPEP	4		
FBgn0285970	CG32500	HGNC:16287	OMIM:608100	NFU1	13	605711	605711[MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 1; MMDS1]
FBgn0286027	Rnmt	HGNC:10075	OMIM:603514	RNMT	15		
FBgn0286051	Rexo5	HGNC:24661		REXO5	7		
FBgn0286070	cnk	HGNC:19700	OMIM:603272	CNKSR1	6		
FBgn0286070	cnk	HGNC:19701	OMIM:300724	CNKSR2	13	301008	301008[INTELLECTUAL DEVELOPMENTAL DISORDER, X-LINKED, SYNDROMIC, HOUGE TYPE; MRXSHG]
FBgn0286070	cnk	HGNC:21204	OMIM:619948	IPCEF1	6		
FBgn0286070	cnk	HGNC:23034	OMIM:617476	CNKSR3	10		
FBgn0286071	AdamTS-A	HGNC:13202	OMIM:605421	ADAMTS9	11		
FBgn0286071	AdamTS-A	HGNC:17178	OMIM:611681	ADAMTS20	11		
FBgn0286071	AdamTS-A	HGNC:221	OMIM:605007	ADAMTS5	6		
FBgn0286071	AdamTS-A	HGNC:220	OMIM:603876	ADAMTS4	5		
FBgn0286071	AdamTS-A	HGNC:217	OMIM:605174	ADAMTS1	7		
FBgn0286071	AdamTS-A	HGNC:16305	OMIM:607509	ADAMTS15	5		
FBgn0286071	AdamTS-A	HGNC:224	OMIM:605175	ADAMTS8	6		
FBgn0286071	AdamTS-A	HGNC:17108	OMIM:607510	ADAMTS16	4		
FBgn0286071	AdamTS-A	HGNC:17110	OMIM:607512	ADAMTS18	5	615458	615458[MICROCORNEA, MYOPIC CHORIORETINAL ATROPHY, AND TELECANTHUS; MMCAT]
FBgn0286071	AdamTS-A	HGNC:1366	OMIM:604134	ADAMTS13	4	274150	274150[THROMBOTIC THROMBOCYTOPENIC PURPURA, HEREDITARY; TTP]
FBgn0286071	AdamTS-A	HGNC:223	OMIM:605009	ADAMTS7	3		
FBgn0286071	AdamTS-A	HGNC:222	OMIM:605008	ADAMTS6	4		
FBgn0286071	AdamTS-A	HGNC:14605	OMIM:606184	ADAMTS12	4		
FBgn0286071	AdamTS-A	HGNC:13201	OMIM:608990	ADAMTS10	3	277600	277600[WEILL-MARCHESANI SYNDROME 1; WMS1]
FBgn0286071	AdamTS-A	HGNC:17109	OMIM:607511	ADAMTS17	3	613195	613195[WEILL-MARCHESANI SYNDROME 4; WMS4]
FBgn0286071	AdamTS-A	HGNC:218	OMIM:604539	ADAMTS2	3	225410	225410[EHLERS-DANLOS SYNDROME, DERMATOSPARAXIS TYPE; EDSDERMS]
FBgn0286075	DNAlig3	HGNC:6600	OMIM:600940	LIG3	13	619780	619780[MITOCHONDRIAL DNA DEPLETION SYNDROME 20 (MNGIE TYPE); MTDPS20]
FBgn0286198	LKRSDH	HGNC:17366	OMIM:605113	AASS	15	238700	238700[HYPERLYSINEMIA, TYPE I]
FBgn0286199	shps	HGNC:6833	OMIM:309850	MAOA	4	300615	300615[BRUNNER SYNDROME; BRNRS]
FBgn0286199	shps	HGNC:6834	OMIM:309860	MAOB	3		
FBgn0286203	stw	HGNC:2295	OMIM:117700	CP	4	604290	604290[ACERULOPLASMINEMIA]
FBgn0286203	stw	HGNC:30477	OMIM:618455	HEPHL1	4	261990	261990[ABNORMAL HAIR, JOINT LAXITY, AND DEVELOPMENTAL DELAY; HJDD]
FBgn0286203	stw	HGNC:4866	OMIM:300167	HEPH	4		
FBgn0286213	RpS12	HGNC:10385	OMIM:603660	RPS12	13		
FBgn0286222	Fum1	HGNC:3700	OMIM:136850	FH	15	150800,606812	150800[HEREDITARY LEIOMYOMATOSIS AND RENAL CELL CANCER; HLRCC],606812[FUMARASE DEFICIENCY; FMRD]
FBgn0286506	Mpi	HGNC:7216	OMIM:154550	MPI	14	602579	602579[CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Ib; CDG1B]
FBgn0286508	Had1	HGNC:18246	OMIM:609877	CRYL1	15		
FBgn0286511	Pld	HGNC:9067	OMIM:602382	PLD1	12	212093	212093[CARDIAC VALVULAR DEFECT, DEVELOPMENTAL; CVDD]
FBgn0286511	Pld	HGNC:9068	OMIM:602384	PLD2	13		
FBgn0286567	gry	HGNC:25751	OMIM:614138	TRAPPC11	13	615356	615356[MUSCULAR DYSTROPHY, LIMB-GIRDLE, AUTOSOMAL RECESSIVE 18; LGMDR18]
FBgn0286723	hll	HGNC:24174	OMIM:614363	ACSBG2	11		
FBgn0286723	hll	HGNC:29567	OMIM:614362	ACSBG1	10		
FBgn0286778	CG46385	HGNC:24712	OMIM:613952	TENT5C	11		
FBgn0286778	CG46385	HGNC:28399	OMIM:300976	TENT5D	7		
FBgn0286778	CG46385	HGNC:28273	OMIM:619069	TENT5B	7		
FBgn0286778	CG46385	HGNC:18345	OMIM:611357	TENT5A	8	617952	617952[OSTEOGENESIS IMPERFECTA, TYPE XVIII; OI18]
FBgn0286781	cass	HGNC:594	OMIM:609774	API5	14		
FBgn0286783	Etf-QO	HGNC:3483	OMIM:231675	ETFDH	15	231680	231680[MULTIPLE ACYL-CoA DEHYDROGENASE DEFICIENCY; MADD]
FBgn0286784	TER94	HGNC:8070	OMIM:602426	NVL	3		
FBgn0286784	TER94	HGNC:12666	OMIM:601023	VCP	15	167320,613954,616687	167320[INCLUSION BODY MYOPATHY WITH EARLY-ONSET PAGET DISEASE WITH OR WITHOUT FRONTOTEMPORAL DEMENTIA 1; IBMPFD1],613954[FRONTOTEMPORAL DEMENTIA AND/OR AMYOTROPHIC LATERAL SCLEROSIS 6; FTDALS6],616687[CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2Y; CMT2Y]
FBgn0286784	TER94	HGNC:18119	OMIM:613940	SPATA5	3	616577	616577[NEURODEVELOPMENTAL DISORDER WITH HEARING LOSS, SEIZURES, AND BRAIN ABNORMALITIES; NEDHSB]
FBgn0286784	TER94	HGNC:28762	OMIM:619578	SPATA5L1	3	619615,619616	619615[DEAFNESS, AUTOSOMAL RECESSIVE 119; DFNB119],619616[NEURODEVELOPMENTAL DISORDER WITH HEARING LOSS AND SPASTICITY; NEDHLS]
FBgn0286785	scb	HGNC:6140	OMIM:192975	ITGA4	5		
FBgn0286785	scb	HGNC:6145	OMIM:603963	ITGA9	5		
FBgn0286785	scb	HGNC:6152	OMIM:151510	ITGAX	3		
FBgn0286785	scb	HGNC:6148	OMIM:153370	ITGAL	3		
FBgn0286785	scb	HGNC:6134	OMIM:192968	ITGA1	3		
FBgn0286785	scb	HGNC:6137	OMIM:192974	ITGA2	3		
FBgn0286785	scb	HGNC:6135	OMIM:604042	ITGA10	3		
FBgn0286785	scb	HGNC:6136	OMIM:604789	ITGA11	3		
FBgn0286785	scb	HGNC:6149	OMIM:120980	ITGAM	3		
FBgn0286785	scb	HGNC:6143	OMIM:600536	ITGA7	3	613204	613204[MUSCULAR DYSTROPHY, CONGENITAL, DUE TO INTEGRIN ALPHA-7 DEFICIENCY]
FBgn0286785	scb	HGNC:6142	OMIM:147556	ITGA6	3	619817	619817[EPIDERMOLYSIS BULLOSA, JUNCTIONAL 6, WITH PYLORIC ATRESIA; JEB6]
FBgn0286785	scb	HGNC:6139	OMIM:605025	ITGA3	3	614748	614748[EPIDERMOLYSIS BULLOSA, JUNCTIONAL 7, WITH INTERSTITIAL LUNG DISEASE AND NEPHROTIC SYNDROME; JEB7]
FBgn0286785	scb	HGNC:6146	OMIM:602453	ITGAD	3		
FBgn0286785	scb	HGNC:6147	OMIM:604682	ITGAE	3		
FBgn0286786	hoip	HGNC:7819	OMIM:601304	SNU13	13		
FBgn0286788	Orc1	HGNC:1744	OMIM:602627	CDC6	4	613805	613805[MEIER-GORLIN SYNDROME 5; MGORS5]
FBgn0286788	Orc1	HGNC:8487	OMIM:601902	ORC1	12	224690	224690[MEIER-GORLIN SYNDROME 1; MGORS1]
FBgn0286809	xmas	HGNC:6946	OMIM:603294	MCM3AP	10	618124	618124[PERIPHERAL NEUROPATHY, AUTOSOMAL RECESSIVE, WITH OR WITHOUT IMPAIRED INTELLECTUAL DEVELOPMENT; PNRIID]
FBgn0286809	xmas	HGNC:30179	OMIM:618796	SAC3D1	3		
FBgn0286813	SRPK	HGNC:11305	OMIM:601939	SRPK1	12		
FBgn0286813	SRPK	HGNC:11306	OMIM:602980	SRPK2	11		
FBgn0286813	SRPK	HGNC:11402	OMIM:301002	SRPK3	12		
FBgn0286818	Pdi	HGNC:8548	OMIM:176790	P4HB	15	112240	112240[COLE-CARPENTER SYNDROME 1; CLCRP1]
FBgn0286818	Pdi	HGNC:14180	OMIM:608012	PDIA2	7		
FBgn0286818	Pdi	HGNC:4606	OMIM:602046	PDIA3	6		
FBgn0286818	Pdi	HGNC:27338	OMIM:618588	PDILT	7		
FBgn0286818	Pdi	HGNC:30167	OMIM:620018	PDIA4	5		
FBgn0286818	Pdi	HGNC:26495	OMIM:610642	ERP27	4		
FBgn0286852	naz	HGNC:19979	OMIM:616796	RDH14	3		
FBgn0286852	naz	HGNC:17964	OMIM:607849	RDH11	3	616108	616108[RETINAL DYSTROPHY, JUVENILE CATARACTS, AND SHORT STATURE SYNDROME; RDJCSS]
FBgn0286852	naz	HGNC:19977	OMIM:608830	RDH12	3	612712	612712[LEBER CONGENITAL AMAUROSIS 13; LCA13]
FBgn0286852	naz	HGNC:28326	OMIM:616157	DHRS13	4		
FBgn0286852	naz	HGNC:19978		RDH13	3		
FBgn0286898	Tango1	HGNC:37275		CTAGE9	6		
FBgn0286898	Tango1	HGNC:37294		CTAGE8	7		
FBgn0286898	Tango1	HGNC:24772	OMIM:608910	CTAGE4	5		
FBgn0286898	Tango1	HGNC:24346	OMIM:608856	CTAGE1	6		
FBgn0286898	Tango1	HGNC:18432	OMIM:602132	MIA2	8		
FBgn0286898	Tango1	HGNC:28644		CTAGE6	3		
FBgn0286898	Tango1	HGNC:24008	OMIM:613455	MIA3	7	619269	619269[ODONTOCHONDRODYSPLASIA 2 WITH HEARING LOSS AND DIABETES; ODCD2]
FBgn0286898	Tango1	HGNC:37295		CTAGE15	3		
FBgn0286980	Iyd	HGNC:21071	OMIM:612025	IYD	11	274800	274800[THYROID DYSHORMONOGENESIS 4; TDH4]
FBgn0287182	l(3)80Fj	HGNC:4199	OMIM:605614	GCN1	15		
FBgn0287183	l(3)80Fg	HGNC:29157	OMIM:619973	DNAJC16	14		
FBgn0287184	FASN3	HGNC:3594	OMIM:600212	FASN	8		
FBgn0287186	scro	HGNC:7837	OMIM:607808	NKX2-4	11		
FBgn0287186	scro	HGNC:7836	OMIM:606727	NKX2-3	3		
FBgn0287186	scro	HGNC:2488	OMIM:600584	NKX2-5	3	108900,187500,217095,225250,614432,614435	108900[ATRIAL SEPTAL DEFECT 7 WITH OR WITHOUT ATRIOVENTRICULAR CONDUCTION DEFECTS; ASD7],187500[TETRALOGY OF FALLOT; TOF],217095[CONOTRUNCAL HEART MALFORMATIONS; CTHM],225250[HYPOTHYROIDISM, CONGENITAL, NONGOITROUS, 5; CHNG5],614432[VENTRICULAR SEPTAL DEFECT 3; VSD3],614435[HYPOPLASTIC LEFT HEART SYNDROME 2; HLHS2]
FBgn0287186	scro	HGNC:11825	OMIM:600635	NKX2-1	10	118700,188550,610978	118700[CHOREA, BENIGN HEREDITARY; BHC],188550[THYROID CANCER, NONMEDULLARY, 1; NMTC1],610978[CHOREOATHETOSIS AND CONGENITAL HYPOTHYROIDISM WITH OR WITHOUT PULMONARY DYSFUNCTION; CAHTP]
FBgn0287186	scro	HGNC:7835	OMIM:604612	NKX2-2	3		
FBgn0287186	scro	HGNC:32940	OMIM:611770	NKX2-6	3	217095	217095[CONOTRUNCAL HEART MALFORMATIONS; CTHM]
FBgn0287187	mRpS5	HGNC:14498	OMIM:611972	MRPS5	14		
FBgn0287204	Cog8	HGNC:18623	OMIM:606979	COG8	12	611182	611182[CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIh; CDG2H]
FBgn0287209	Gfat1	HGNC:4241	OMIM:138292	GFPT1	12	610542	610542[MYASTHENIC SYNDROME, CONGENITAL, 12; CMS12]
FBgn0287209	Gfat1	HGNC:4242	OMIM:603865	GFPT2	15		
FBgn0287225	bor	HGNC:32151	OMIM:617227	ATAD3C	6		
FBgn0287225	bor	HGNC:25567	OMIM:612316	ATAD3A	14	617183,618810	617183[HAREL-YOON SYNDROME; HAYOS],618810[PONTOCEREBELLAR HYPOPLASIA, HYPOTONIA, AND RESPIRATORY INSUFFICIENCY SYNDROME, NEONATAL LETHAL; PHRINL]
FBgn0287225	bor	HGNC:24007	OMIM:612317	ATAD3B	12		
FBgn0287454	Pa1	HGNC:28707	OMIM:612033	PAGR1	7		
FBgn0287478	Camta	HGNC:18806	OMIM:611501	CAMTA1	12	614756	614756[CEREBELLAR DYSFUNCTION WITH VARIABLE COGNITIVE AND BEHAVIORAL ABNORMALITIES; CECBA]
FBgn0287478	Camta	HGNC:18807	OMIM:611508	CAMTA2	11		
FBgn0287585	Pss	HGNC:9587	OMIM:612792	PTDSS1	15	151050	151050[LENZ-MAJEWSKI HYPEROSTOTIC DWARFISM; LMHD]
FBgn0287585	Pss	HGNC:15463	OMIM:612793	PTDSS2	3		
FBgn0287630	dbf	HGNC:16403	OMIM:605308	ZNF346	7		
FBgn0287630	dbf	HGNC:29983	OMIM:606452	ZMAT3	5		
FBgn0287630	dbf	HGNC:25844		ZMAT4	5		
FBgn0287630	dbf	HGNC:29377	OMIM:301007	ZMAT1	4		
FBgn0287631	CG46491	HGNC:12303	OMIM:601893	TRIO	3	617061,618825	617061[INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL DOMINANT 44, WITH MICROCEPHALY; MRD44],618825[INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL DOMINANT 63, WITH MACROCEPHALY; MRD63]
FBgn0287631	CG46491	HGNC:4814	OMIM:604605	KALRN	3		
FBgn0287631	CG46491	HGNC:30275	OMIM:610215	ARHGEF25	3		
FBgn0287695	KFase	HGNC:20910		AFMID	15		
FBgn0287696	mus302	HGNC:25539	OMIM:614151	RFWD3	15	617784	617784[FANCONI ANEMIA, COMPLEMENTATION GROUP W; FANCW]
FBgn0287720	Pen	HGNC:6395	OMIM:600685	KPNA2	12		
FBgn0287720	Pen	HGNC:6396	OMIM:601892	KPNA3	3		
FBgn0287720	Pen	HGNC:6397	OMIM:602970	KPNA4	3		
FBgn0287720	Pen	HGNC:6399	OMIM:610563	KPNA6	3		
FBgn0287720	Pen	HGNC:21839	OMIM:614107	KPNA7	8		
FBgn0287720	Pen	HGNC:6394	OMIM:600686	KPNA1	3		
FBgn0287720	Pen	HGNC:6398	OMIM:604545	KPNA5	3		
FBgn0287724	Ca-beta	HGNC:1404	OMIM:601949	CACNB4	12	607682,613855	607682[EPILEPSY, IDIOPATHIC GENERALIZED, SUSCEPTIBILITY TO, 9; EIG9],613855[EPISODIC ATAXIA, TYPE 5; EA5]
FBgn0287724	Ca-beta	HGNC:1402	OMIM:600003	CACNB2	11	611876	611876[BRUGADA SYNDROME 4; BRGDA4]
FBgn0287724	Ca-beta	HGNC:1401	OMIM:114207	CACNB1	12		
FBgn0287724	Ca-beta	HGNC:1403	OMIM:601958	CACNB3	8		
FBgn0287767	Cndp2	HGNC:20675	OMIM:609064	CNDP1	7		
FBgn0287767	Cndp2	HGNC:24437	OMIM:169800	CNDP2	15		
FBgn0287768	esg	HGNC:11128	OMIM:604238	SNAI1	4		
FBgn0287768	esg	HGNC:11094	OMIM:602150	SNAI2	8	172800,608890	172800[PIEBALD TRAIT; PBT],608890[WAARDENBURG SYNDROME, TYPE 2D; WS2D]
FBgn0287768	esg	HGNC:18411	OMIM:612741	SNAI3	4		
FBgn0287774	CG9143	HGNC:13266	OMIM:606181	DDX24	15		
FBgn0287775	18w	HGNC:15631	OMIM:300365	TLR7	3	301051,301080	301051[IMMUNODEFICIENCY 74, COVID19-RELATED, X-LINKED; IMD74],301080[SYSTEMIC LUPUS ERYTHEMATOSUS 17; SLEB17]
FBgn0287775	18w	HGNC:11849	OMIM:603029	TLR3	3	609423,613002	609423[HUMAN IMMUNODEFICIENCY VIRUS TYPE 1, SUSCEPTIBILITY TO],613002[IMMUNODEFICIENCY 83, SUSCEPTIBILITY TO VIRAL INFECTIONS; IMD83]
FBgn0287775	18w	HGNC:15633	OMIM:605474	TLR9	3		
FBgn0287788	Datp	HGNC:8049	OMIM:602852	NUDT2	12	619844	619844[INTELLECTUAL DEVELOPMENTAL DISORDER WITH OR WITHOUT PERIPHERAL NEUROPATHY; IDDPN]
FBgn0287825	Vha44	HGNC:856	OMIM:603097	ATP6V1C1	15		
FBgn0287825	Vha44	HGNC:18264	OMIM:618070	ATP6V1C2	10		
FBgn0287828	Pkcdelta	HGNC:9405	OMIM:601032	PKN1	3		
FBgn0287828	Pkcdelta	HGNC:9403	OMIM:605437	PRKCH	5	601367	601367[STROKE, ISCHEMIC]
FBgn0287828	Pkcdelta	HGNC:9410	OMIM:600448	PRKCQ	10		
FBgn0287828	Pkcdelta	HGNC:9401	OMIM:176975	PRKCE	5		
FBgn0287828	Pkcdelta	HGNC:9395	OMIM:176970	PRKCB	4		
FBgn0287828	Pkcdelta	HGNC:9399	OMIM:176977	PRKCD	12	615559	615559[AUTOIMMUNE LYMPHOPROLIFERATIVE SYNDROME, TYPE III; ALPS3]
FBgn0287828	Pkcdelta	HGNC:9402	OMIM:176980	PRKCG	3	605361	605361[SPINOCEREBELLAR ATAXIA 14; SCA14]
FBgn0287828	Pkcdelta	HGNC:9406	OMIM:602549	PKN2	3		
FBgn0287828	Pkcdelta	HGNC:9393	OMIM:176960	PRKCA	4		
FBgn0287828	Pkcdelta	HGNC:17999	OMIM:610714	PKN3	3		
FBgn0287844	Dhc1	HGNC:2951	OMIM:603336	DNAH6	3		
FBgn0287844	Dhc1	HGNC:2949	OMIM:603334	DNAH3	3		
FBgn0287844	Dhc1	HGNC:2952	OMIM:603337	DNAH8	10	619095	619095[SPERMATOGENIC FAILURE 46; SPGF46]
FBgn0287844	Dhc1	HGNC:2940	OMIM:603332	DNAH1	3	617576,617577	617576[SPERMATOGENIC FAILURE 18; SPGF18],617577[CILIARY DYSKINESIA, PRIMARY, 37; CILD37]
FBgn0287844	Dhc1	HGNC:18661	OMIM:610061	DNAH7	3		
FBgn0287844	Dhc1	HGNC:2953	OMIM:603330	DNAH9	3	618300	618300[CILIARY DYSKINESIA, PRIMARY, 40; CILD40]
FBgn0287844	Dhc1	HGNC:2942	OMIM:603339	DNAH11	3	611884	611884[CILIARY DYSKINESIA, PRIMARY, 7; CILD7]
FBgn0287844	Dhc1	HGNC:2950	OMIM:603335	DNAH5	11	608644	608644[CILIARY DYSKINESIA, PRIMARY, 3; CILD3]
FBgn0287844	Dhc1	HGNC:2948	OMIM:603333	DNAH2	3	619094	619094[SPERMATOGENIC FAILURE 45; SPGF45]
FBgn0287844	Dhc1	HGNC:2941	OMIM:605884	DNAH10	4	619515	619515[SPERMATOGENIC FAILURE 56; SPGF56]
FBgn0287844	Dhc1	HGNC:2946	OMIM:610063	DNAH17	3	618643	618643[SPERMATOGENIC FAILURE 39; SPGF39]
FBgn0287844	Dhc1	HGNC:2943	OMIM:603340	DNAH12	3		
FBgn0287864	hbs	HGNC:7908	OMIM:602716	NPHS1	11	256300	256300[NEPHROTIC SYNDROME, TYPE 1; NPHS1]
FBgn0287873	zip	HGNC:7568	OMIM:160776	MYH10	13		
FBgn0287873	zip	HGNC:15906	OMIM:609928	MYH7B	3		
FBgn0287873	zip	HGNC:23212	OMIM:608568	MYH14	9	600652,614369	600652[DEAFNESS, AUTOSOMAL DOMINANT 4A; DFNA4A],614369[PERIPHERAL NEUROPATHY, MYOPATHY, HOARSENESS, AND HEARING LOSS; PNMHH]
FBgn0287873	zip	HGNC:7569	OMIM:160745	MYH11	10	132900,619350,619351	132900[AORTIC ANEURYSM, FAMILIAL THORACIC 4; AAT4],619350[VISCERAL MYOPATHY 2; VSCM2],619351[MEGACYSTIS-MICROCOLON-INTESTINAL HYPOPERISTALSIS SYNDROME 2; MMIHS2]
FBgn0287873	zip	HGNC:7573	OMIM:160720	MYH3	3	178110,193700,618436,618469	178110[CONTRACTURES, PTERYGIA, AND SPONDYLOCARPOTARSAL FUSION SYNDROME 1A; CPSFS1A],193700[ARTHROGRYPOSIS, DISTAL, TYPE 2A; DA2A],618436[ARTHROGRYPOSIS, DISTAL, TYPE 2B3; DA2B3],618469[CONTRACTURES, PTERYGIA, AND SPONDYLOCARPOTARSAL FUSION SYNDROME 1B; CPSFS1B]
FBgn0287873	zip	HGNC:7576	OMIM:160710	MYH6	3	613251,613252,614089,614090	613251[CARDIOMYOPATHY, FAMILIAL HYPERTROPHIC, 14; CMH14],613252[CARDIOMYOPATHY, DILATED, 1EE; CMD1EE],614089[ATRIAL SEPTAL DEFECT 3; ASD3],614090[SICK SINUS SYNDROME 3, SUSCEPTIBILITY TO; SSS3]
FBgn0287873	zip	HGNC:7577	OMIM:160760	MYH7	3	160500,181430,192600,255160,608358,613426	160500[MYOPATHY, DISTAL, 1; MPD1],181430[SCAPULOPERONEAL MYOPATHY, MYH7-RELATED; SPMM],192600[CARDIOMYOPATHY, FAMILIAL HYPERTROPHIC, 1; CMH1],255160[MYOPATHY, MYOSIN STORAGE, AUTOSOMAL RECESSIVE; MSMB],608358[MYOPATHY, MYOSIN STORAGE, AUTOSOMAL DOMINANT; MSMA],613426[CARDIOMYOPATHY, DILATED, 1S; CMD1S]
FBgn0287873	zip	HGNC:7578	OMIM:160741	MYH8	3	158300,608837	158300[ARTHROGRYPOSIS, DISTAL, TYPE 7; DA7],608837[CARNEY COMPLEX VARIANT]
FBgn0287873	zip	HGNC:31073	OMIM:609929	MYH15	3		
FBgn0287873	zip	HGNC:7567	OMIM:160730	MYH1	3		
FBgn0287873	zip	HGNC:7579	OMIM:160775	MYH9	11	155100,603622	155100[MACROTHROMBOCYTOPENIA AND GRANULOCYTE INCLUSIONS WITH OR WITHOUT NEPHRITIS OR SENSORINEURAL HEARING LOSS; MATINS],603622[DEAFNESS, AUTOSOMAL DOMINANT 17; DFNA17]
FBgn0287873	zip	HGNC:7572	OMIM:160740	MYH2	3	605637	605637[MYOPATHY, PROXIMAL, WITH OPHTHALMOPLEGIA; MYPOP]
FBgn0287873	zip	HGNC:7574	OMIM:160742	MYH4	3		
FBgn0288229	CG3164	HGNC:73	OMIM:603076	ABCG1	7		
FBgn0288229	CG3164	HGNC:13884	OMIM:607784	ABCG4	7		
FBgn0288229	CG3164	HGNC:74	OMIM:603756	ABCG2	4	138900,614490	138900[URIC ACID CONCENTRATION, SERUM, QUANTITATIVE TRAIT LOCUS 1; UAQTL1],614490[BLOOD GROUP, JUNIOR SYSTEM; JR]
FBgn0288229	CG3164	HGNC:13887	OMIM:605460	ABCG8	3	210250,611465	210250[SITOSTEROLEMIA 1; STSL1],611465[GALLBLADDER DISEASE 4; GBD4]
FBgn0288232	Cyp6a21	HGNC:2638	OMIM:605325	CYP3A5	5	145500	145500[HYPERTENSION, ESSENTIAL]
FBgn0288232	Cyp6a21	HGNC:17450	OMIM:606534	CYP3A43	5		
FBgn0288232	Cyp6a21	HGNC:11609	OMIM:274180	TBXAS1	4	231095	231095[GHOSAL HEMATODIAPHYSEAL DYSPLASIA; GHDD]
FBgn0288232	Cyp6a21	HGNC:2637	OMIM:124010	CYP3A4	5	619073	619073[VITAMIN D-DEPENDENT RICKETS, TYPE 3; VDDR3]
FBgn0288232	Cyp6a21	HGNC:51504		CYP3A7-CYP3A51P	4		
FBgn0288310	mv	HGNC:1968	OMIM:606897	LYST	9	214500	214500[CHEDIAK-HIGASHI SYNDROME; CHS]
FBgn0288433	L	HGNC:24605	OMIM:610974	ZNF521	9		
FBgn0288433	L	HGNC:16762	OMIM:604557	ZNF423	12	614844	614844[NEPHRONOPHTHISIS 14; NPHP14]
FBgn0288469	Pex23	HGNC:22214	OMIM:614781	TECPR1	14		
FBgn0288470	Cpsf5	HGNC:13870	OMIM:604978	NUDT21	13		
FBgn0288631	Yif1	HGNC:30511	OMIM:619109	YIF1B	13	619125	619125[KAYA-BARAKAT-MASSON SYNDROME; KABAMAS]
FBgn0288631	Yif1	HGNC:16688	OMIM:611484	YIF1A	12		
FBgn0288686	betaTub60D	HGNC:20774	OMIM:602662	TUBB4A	6	128101,612438	128101[DYSTONIA 4, TORSION, AUTOSOMAL DOMINANT; DYT4],612438[LEUKODYSTROPHY, HYPOMYELINATING, 6; HLD6]
FBgn0288686	betaTub60D	HGNC:12412	OMIM:615101	TUBB2A	5	615763	615763[CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 5; CDCBM5]
FBgn0288686	betaTub60D	HGNC:20778	OMIM:191130	TUBB	5	156610,615771	156610[SKIN CREASES, CONGENITAL SYMMETRIC CIRCUMFERENTIAL, 1; CSCSC1],615771[CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 6; CDCBM6]
FBgn0288686	betaTub60D	HGNC:30829	OMIM:612850	TUBB2B	5	610031	610031[CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 7; CDCBM7]
FBgn0288686	betaTub60D	HGNC:20771	OMIM:602660	TUBB4B	5	617879	617879[LEBER CONGENITAL AMAUROSIS WITH EARLY-ONSET DEAFNESS; LCAEOD]
FBgn0288686	betaTub60D	HGNC:20772	OMIM:602661	TUBB3	5	600638,614039	600638[FIBROSIS OF EXTRAOCULAR MUSCLES, CONGENITAL, 3A, WITH OR WITHOUT EXTRAOCULAR INVOLVEMENT; CFEOM3A],614039[CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 1; CDCBM1]
FBgn0288686	betaTub60D	HGNC:16257	OMIM:612901	TUBB1	5	613112	613112[MACROTHROMBOCYTOPENIA, ISOLATED, 1, AUTOSOMAL DOMINANT; MACTHC1]
FBgn0288686	betaTub60D	HGNC:20776	OMIM:615103	TUBB6	7	617732	617732[FACIAL PALSY, CONGENITAL, WITH PTOSIS AND VELOPHARYNGEAL DYSFUNCTION; FPVEPD]
FBgn0288686	betaTub60D	HGNC:20773	OMIM:616768	TUBB8	4	616780	616780[OOCYTE MATURATION DEFECT 2; OOMD2]
FBgn0288690	Dna2	HGNC:2939	OMIM:601810	DNA2	13	615156,615807	615156[PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL DOMINANT 6; PEOA6],615807[SECKEL SYNDROME 8; SCKL8]
FBgn0288700	stg1	HGNC:1406	OMIM:602911	CACNG2	3	614256	614256[INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL DOMINANT 10; MRD10]
FBgn0288700	stg1	HGNC:1407	OMIM:606403	CACNG3	3		
FBgn0288700	stg1	HGNC:1408	OMIM:606404	CACNG4	3		
FBgn0288700	stg1	HGNC:13628	OMIM:606900	CACNG8	3		
FBgn0288700	stg1	HGNC:13628	OMIM:606900	CACNG8	4		
FBgn0288700	stg1	HGNC:1409	OMIM:606405	CACNG5	3		
FBgn0288700	stg1	HGNC:13626	OMIM:606899	CACNG7	4		
FBgn0288700	stg1	HGNC:13626	OMIM:606899	CACNG7	6		
FBgn0288833	RPA3	HGNC:10291	OMIM:179837	RPA3	7		
FBgn0288834	RPA2	HGNC:30305	OMIM:300767	RPA4	11		
FBgn0288834	RPA2	HGNC:10290	OMIM:179836	RPA2	13		
FBgn0288846	unc-45	HGNC:14304	OMIM:611220	UNC45B	14	616279,619178	616279[CATARACT 43; CTRCT43],619178[MYOFIBRILLAR MYOPATHY 11; MFM11]
FBgn0288846	unc-45	HGNC:30594	OMIM:611219	UNC45A	12	619377	619377[OSTEOOTOHEPATOENTERIC SYNDROME; OOHE]
FBgn0288856	peo	HGNC:16710	OMIM:608483	AKTIP	13		
FBgn0288857	Ype	HGNC:18329	OMIM:609726	YPEL5	14		
FBgn0288857	Ype	HGNC:12845	OMIM:608082	YPEL1	5		
FBgn0288857	Ype	HGNC:18326	OMIM:609723	YPEL2	5		
FBgn0288857	Ype	HGNC:18327	OMIM:609724	YPEL3	5		
FBgn0288857	Ype	HGNC:18328	OMIM:609725	YPEL4	5		
FBgn0288875	Cul5	HGNC:2555	OMIM:300304	CUL4B	3	300354	300354[INTELLECTUAL DEVELOPMENTAL DISORDER, X-LINKED, SYNDROMIC, CABEZAS TYPE; MRXSC]
FBgn0288875	Cul5	HGNC:2556	OMIM:601741	CUL5	14		
FBgn0288966	Med	HGNC:6770	OMIM:600993	SMAD4	12	139210,174900,175050,260350	139210[MYHRE SYNDROME; MYHRS],174900[JUVENILE POLYPOSIS SYNDROME; JPS],175050[JUVENILE POLYPOSIS/HEREDITARY HEMORRHAGIC TELANGIECTASIA SYNDROME; JPHT],260350[PANCREATIC CANCER]
FBgn0288967	CG10793	HGNC:25387	OMIM:614697	KATNAL2	10		
## Finished report_human_orthologs: Tue Sep 13 10:17:48 2022							
